PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jansz, TT; Ozyilmaz, A; van Reekum, FE; Boereboom, FTJ; de Jong, PA; Verhaar, MC; van Jaarsveld, BC				Jansz, Thijs T.; Ozyilmaz, Akin; van Reekum, Franka E.; Boereboom, Franciscus T. J.; de Jong, Pim A.; Verhaar, Marianne C.; van Jaarsveld, Brigit C.			Progression of coronary artery calcification in conventional hemodialysis, nocturnal hemodialysis, and kidney transplantation	PLOS ONE			English	Article							STAGE RENAL-DISEASE; VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; MINERAL METABOLISM; NATURAL-HISTORY; CALCIUM; CINACALCET; MORTALITY; COHORT	Introduction Cardiovascular disease is the leading cause of death in end-stage renal disease (ESRD) and is strongly associated with vascular calcification. An important driver of vascular calcification is high phosphate levels, but these become lower when patients initiate nocturnal hemodialysis or receive a kidney transplant. However, it is unknown whether nocturnal hemodialysis or kidney transplantation mitigate vascular calcification. Therefore, we compared progression of coronary artery calcification (CAC) between patients treated with conventional hemodialysis, nocturnal hemodialysis, and kidney transplant recipients. Methods We measured CAC annually up to 3 years in 114 patients with ESRD that were transplantation candidates: 32 that continued conventional hemodialysis, 34 that initiated nocturnal hemodialysis (>= 4x 8 hours/week), and 48 that received a kidney transplant. We compared CAC progression between groups as the difference in square root transformed volume scores per year (Delta CAC SQRV) using linear mixed models. Reference category was conventional hemodialysis. Results The mean age of the study population was 53 +/- 13 years, 75 (66%) were male, and median dialysis duration was 28 (IQR 12-56) months. Median CAC score at enrollment was 171 (IQR 10-647), which did not differ significantly between treatment groups (P = 0.83). Compared to conventional hemodialysis, CAC progression was non-significantly different in nocturnal hemodialysis -0.10 (95% CI -0.77 to 0.57) and kidney transplantation -0.33 (95% CI -0.96 to 0.29) in adjusted models. Conclusions Nocturnal hemodialysis and kidney transplantation are not associated with significantly less CAC progression compared to conventional hemodialysis during up to 3 years follow-up. Further studies are needed to confirm these findings, to determine which type of calcification is measured with CAC in end-stage renal disease, and whether that reflects cardiovascular risk.	[Jansz, Thijs T.; van Reekum, Franka E.; Verhaar, Marianne C.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands; [Jansz, Thijs T.; Boereboom, Franciscus T. J.] Dianet Dialysis Ctr, Utrecht, Netherlands; [Ozyilmaz, Akin] Dialysis Ctr Groningen, Groningen, Netherlands; [Ozyilmaz, Akin] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [de Jong, Pim A.] Univ Med Ctr Groningen, Dept Radiol, Utrecht, Netherlands; [van Jaarsveld, Brigit C.] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Nephrol, Amsterdam, Netherlands; [van Jaarsveld, Brigit C.] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Amsterdam Cardiovasc Sci ACS, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	van Jaarsveld, BC (corresponding author), Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Nephrol, Amsterdam, Netherlands.; van Jaarsveld, BC (corresponding author), Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Amsterdam Cardiovasc Sci ACS, Amsterdam, Netherlands.	b.jaarsveld@amsterdamumc.nl		van Jaarsveld, Brigit/0000-0001-5871-4952	Amgen; Baxter; Fresenius Medical Care; Novartis; Roche; Shire Pharmaceuticals; Wellerdieck de Goede Foundation; Friends of UMC Utrecht	Amgen(Amgen); Baxter; Fresenius Medical Care; Novartis(Novartis); Roche(Roche Holding); Shire Pharmaceuticals; Wellerdieck de Goede Foundation; Friends of UMC Utrecht	The NOCTx study was supported by unrestricted grants from Amgen, Baxter, Fresenius Medical Care, Novartis, Roche and Shire Pharmaceuticals. T.T. Jansz was supported financially by a grant from the Wellerdieck de Goede Foundation with mediation from Friends of UMC Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, AM J KIDNEY DIS, V67, pA4; Bellasi A, 2009, J NEPHROL, V22, P255; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Daugirdas JT, 2012, J AM SOC NEPHROL, V23, P727, DOI 10.1681/ASN.2011070688; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Hokanson JE, 2004, AM J ROENTGENOL, V182, P1327, DOI 10.2214/ajr.182.5.1821327; Jamal SA, 2013, LANCET, V382, P1268, DOI 10.1016/S0140-6736(13)60897-1; Jansz TT, 2018, AM J NEPHROL, V48, P369, DOI 10.1159/000494665; Jansz TT, 2018, CLIN KIDNEY J, V11, P353, DOI 10.1093/ckj/sfx124; Khan AM, 2012, CLIN J AM SOC NEPHRO, V7, P2017, DOI 10.2215/CJN.02160212; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Leenders NHJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28629-x; Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694; Lomashvili KA, 2014, KIDNEY INT, V85, P1351, DOI 10.1038/ki.2013.521; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Malluche HH, 2015, J AM SOC NEPHROL, V26, P2534, DOI 10.1681/ASN.2014070686; Mazzaferro S, 2009, CLIN J AM SOC NEPHRO, V4, P685, DOI 10.2215/CJN.03930808; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1662, DOI 10.1111/j.1600-6143.2004.00573.x; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; Nakamura S, 2009, CLIN J AM SOC NEPHRO, V4, P1892, DOI 10.2215/CJN.04320709; Pierratos A, 1998, J AM SOC NEPHROL, V9, P859; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; RICHARDSON PD, 1989, LANCET, V2, P941; Sabour S, 2008, J CLIN EPIDEMIOL, V61, P572, DOI 10.1016/j.jclinepi.2007.07.004; Seyahi N, 2012, NEPHROL DIAL TRANSPL, V27, P2101, DOI 10.1093/ndt/gfr558; Sigrist MK, 2007, CLIN J AM SOC NEPHRO, V2, P1241, DOI 10.2215/CJN.02190507; ter Braake AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20241-3; Vervloet M, 2017, KIDNEY INT, V91, P808, DOI 10.1016/j.kint.2016.09.024; Vervloet MC, 2017, NAT REV NEPHROL, V13, P27, DOI 10.1038/nrneph.2016.164; Walsh M, 2005, KIDNEY INT, V67, P1500, DOI 10.1111/j.1523-1755.2005.00228.x; Wolf M, 2016, TRANSPLANTATION, V100, P184, DOI 10.1097/TP.0000000000000823; Yuen D, 2006, NEPHROL DIAL TRANSPL, V21, P1407, DOI 10.1093/ndt/gfl021; Zoccali C, 2015, NEPHROL DIAL TRANSPL, V30, P352, DOI 10.1093/ndt/gfv021	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244639	10.1371/journal.pone.0244639	http://dx.doi.org/10.1371/journal.pone.0244639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378347	Green Published, gold			2022-12-27	WOS:000605651300042
J	Mascioli, G; Lucca, E; Michelotti, F; Tarantino, L; Giofre, F; Finamora, I				Mascioli, Giosue; Lucca, Elena; Michelotti, Federica; Tarantino, Luca; Giofre, Fabrizio; Finamora, Ilaria			Need for MRI scans in a real-world CIED population over long-term follow-up: Data from a large single-centre experience	PLOS ONE			English	Article							EXPERT CONSENSUS STATEMENT; PACEMAKER		[Mascioli, Giosue; Lucca, Elena; Michelotti, Federica; Tarantino, Luca; Giofre, Fabrizio; Finamora, Ilaria] Humanitas Gavazzeni Hosp, Div Electrophysiol, Bergamo, Italy	Istituto Clinico Humanitas Gavazzeni	Mascioli, G (corresponding author), Humanitas Gavazzeni Hosp, Div Electrophysiol, Bergamo, Italy.	giosue.mascioli@gavazzeni.it		Mascioli, Giosue/0000-0002-4340-8415				Bongiorni MG, 2018, EUROPACE, V20, P1217, DOI 10.1093/europace/euy050; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Celentano E, 2018, EUROPACE, V20, P1001, DOI 10.1093/europace/eux118; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Hindricks, 2017, EHRA WHITE BOOK 2017; Kalin R, 2005, PACE, V28, P326, DOI 10.1111/j.1540-8159.2005.50024.x; Kusumoto FM, 2017, HEART RHYTHM, V14, pE503, DOI 10.1016/j.hrthm.2017.09.001; Munawar DA, 2020, EUROPACE, V22, P288, DOI 10.1093/europace/euz343; Nazarian S, 2017, NEW ENGL J MED, V377, P2555, DOI 10.1056/NEJMoa1604267; Padmanabhan D, 2019, HEART RHYTHM, V16, P1645, DOI 10.1016/j.hrthm.2019.05.031; Russo RJ, 2017, NEW ENGL J MED, V376, P755, DOI 10.1056/NEJMoa1603265; Sakakibara Y, 1999, JPN HEART J, V40, P737, DOI 10.1536/jhj.40.737; Seewoster T, 2019, EUROPACE, V21, P1220, DOI 10.1093/europace/euz112; Taruya A, 2015, INT J CARDIOL, V184, P497, DOI 10.1016/j.ijcard.2015.02.080; Vuorinen AM, 2019, ACTA RADIOL, V60, P1414, DOI 10.1177/0284185119830288	15	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244672	10.1371/journal.pone.0244672	http://dx.doi.org/10.1371/journal.pone.0244672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378333	Green Published, gold			2022-12-27	WOS:000605651300019
J	Sreenivasan, H; Cao, W; Hu, YF; Xiao, QF; Shakouri, M; Huttula, M; Provis, JL; Illikainen, M; Kinnunen, P				Sreenivasan, Harisankar; Cao, Wei; Hu, Yongfeng; Xiao, Qunfeng; Shakouri, Mohsen; Huttula, Marko; Provis, John L.; Illikainen, Mirja; Kinnunen, Paivo			Towards designing reactive glasses for alkali activation: Understanding the origins of alkaline reactivity of Na-Mg aluminosilicate glasses	PLOS ONE			English	Article							X-RAY-ABSORPTION; STRUCTURAL-CHANGES; CEMENT PRODUCTION; SILICATE-GLASSES; SODIUM-SILICATE; EDGE STRUCTURE; FLY-ASH; MAS NMR; RAMAN; CALCIUM	Alkali-activated materials (AAMs), sometimes called geopolymers, are eco-friendly cementitious materials with reduced carbon emissions when compared to ordinary Portland cement. However, the availability of most precursors used for AAM production may decline in the future because of changes in industrial sectors. Thus, new precursors must be developed. Recently there has been increased interest in synthetic glass precursors. One major concern with using synthetic glasses is ensuring that they react sufficiently under alkaline conditions. Reactivity is a necessary, although not sufficient, requirement for a suitable precursor for AAMs. This work involves the synthesis, characterization, and estimation of alkaline reactivity of Na-Mg aluminosilicate glasses. Structural characterization showed that replacing Na with Mg led to more depolymerization. Alkaline reactivity studies indicated that, as Mg replaced Na, reactivity of glasses increased at first, reached an optimal value, and then declined. This trend in reactivity could not be explained by the conventional parameters used for estimating glass reactivity: the non-bridging oxygen fraction (which predicts similar reactivity for all glasses) and optical basicity (which predicts a decrease in reactivity with an increase in Mg replacement). The reactivity of the studied glasses was found to depend on two main factors: depolymerization (as indicated by structural characterization) and optical basicity. Depolymerization dominated initially, which led to an increase in reactivity, while the effect of optical basicity dominated later, leading to a decrease in reactivity. Hence, while designing reactive synthetic glasses for alkali activation, structural study of glasses should be given due consideration in addition to the conventional factors.	[Sreenivasan, Harisankar; Illikainen, Mirja; Kinnunen, Paivo] Univ Oulu, Fac Technol, Fibre & Particle Engn Res Unit, Oulu, Finland; [Cao, Wei; Huttula, Marko] Univ Oulu, Nano & Mol Syst Res Unit, Fac Sci, Oulu, Finland; [Hu, Yongfeng; Xiao, Qunfeng; Shakouri, Mohsen] Canadian Light Source Inc, Saskatoon, SK, Canada; [Provis, John L.] Univ Sheffield, Dept Mat Sci & Engn, Sheffield, S Yorkshire, England	University of Oulu; University of Oulu; University of Saskatchewan; University of Sheffield	Kinnunen, P (corresponding author), Univ Oulu, Fac Technol, Fibre & Particle Engn Res Unit, Oulu, Finland.	paivo.kinnunen@oulu.fi	Provis, John/AAR-3260-2020	Provis, John/0000-0003-3372-8922; Illikainen, Mirja/0000-0001-7545-4574; Kinnunen, Paivo/0000-0001-8490-1890; Shakouri, Mohsen/0000-0002-8449-9763	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie COFUND Grant [713606]; Academy of Finland [322085, 329477, 326291]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie COFUND Grant; Academy of Finland(Academy of Finland)	The authors gratefully acknowledge the financial support received from European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie COFUND Grant Agreement no. 713606 (I4FUTURE) https://ec.europa.eu/research/mariecurieactions/.P.K.acknowledges financial support from Academy of Finland (grants 322085, 329477 and 326291) https://www.aka.fi/en.	[Anonymous], 2014, CLIM CHANG 2014 MIT; Assi LN, 2020, J CLEAN PROD, V263, DOI 10.1016/j.jclepro.2020.121477; Bechgaard TK, 2017, J NON-CRYST SOLIDS, V470, P145, DOI 10.1016/j.jnoncrysol.2017.05.014; Bechgaard TK, 2016, J NON-CRYST SOLIDS, V441, P49, DOI 10.1016/j.jnoncrysol.2016.03.011; Bender S, 2002, J NON-CRYST SOLIDS, V298, P99, DOI 10.1016/S0022-3093(02)00943-2; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; BUNKER BC, 1983, J NON-CRYST SOLIDS, V58, P295, DOI 10.1016/0022-3093(83)90031-5; Chen YX, 2016, CONSTR BUILD MATER, V125, P766, DOI 10.1016/j.conbuildmat.2016.08.086; Damtoft JS, 2008, CEMENT CONCRETE RES, V38, P115, DOI 10.1016/j.cemconres.2007.09.008; DAVOLI I, 1992, PHYS CHEM MINER, V19, P171, DOI 10.1007/BF00202105; DAY DE, 1976, J NON-CRYST SOLIDS, V21, P343, DOI 10.1016/0022-3093(76)90026-0; DENTGLASSER LS, 1987, J CHEM SOC DALTON, P2323, DOI 10.1039/dt9870002323; DUFFY JA, 1976, J NON-CRYST SOLIDS, V21, P373, DOI 10.1016/0022-3093(76)90027-2; Dufresne WJB, 2018, J RAMAN SPECTROSC, V49, P1999, DOI 10.1002/jrs.5481; Durdzinski PT, 2015, CEMENT CONCRETE RES, V78, P263, DOI 10.1016/j.cemconres.2015.08.005; Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z; Farfan J, 2019, J CLEAN PROD, V217, P821, DOI 10.1016/j.jclepro.2019.01.226; Gambuzzi E, 2014, GEOCHIM COSMOCHIM AC, V125, P170, DOI 10.1016/j.gca.2013.10.025; Garcia-Lodeiro I, 2016, CERAM INT, V42, P7697, DOI 10.1016/j.ceramint.2016.01.184; Gartner EM, 2011, CEMENT CONCRETE RES, V41, P736, DOI 10.1016/j.cemconres.2011.03.006; GILLET P, 1993, PHYS CHEM MINER, V20, P1; Hajimohammadi A, 2017, MATER DESIGN, V130, P381, DOI 10.1016/j.matdes.2017.05.084; Henderson GS, 2004, CHEM GEOL, V213, P31, DOI 10.1016/j.chemgeo.2004.08.030; HENDERSON GS, 1995, J NON-CRYST SOLIDS, V183, P43, DOI 10.1016/0022-3093(94)00651-2; Hertel T, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120610; International Energy Agency (IEA), 2009, WORLD BUS COUNC SUST, P36, DOI [10.1787/9789264088061-en, DOI 10.1787/9789264088061-EN]; Jones AR, 2001, J NON-CRYST SOLIDS, V293, P87, DOI 10.1016/S0022-3093(01)00656-1; Kanehashi K, 2017, SOLID STATE NUCL MAG, V84, P158, DOI 10.1016/j.ssnmr.2017.03.001; Kinnunen P, 2019, J CLEAN PROD, V213, P126, DOI 10.1016/j.jclepro.2018.12.123; LAGARDE P, 1992, J PHYS I, V2, P1043, DOI 10.1051/jp1:1992113; Le Losq C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16741-3; Le Losq C, 2014, GEOCHIM COSMOCHIM AC, V126, P495, DOI 10.1016/j.gca.2013.11.010; Le Losq C, 2013, CHEM GEOL, V346, P57, DOI 10.1016/j.chemgeo.2012.09.009; Lee SK, 1999, AM MINERAL, V84, P937, DOI 10.2138/am-1999-5-630; Levelut C, 2001, J NON-CRYST SOLIDS, V293, P100, DOI 10.1016/S0022-3093(01)00658-5; LI D, 1994, AM MINERAL, V79, P622; LOCKYER MWG, 1995, J NON-CRYST SOLIDS, V188, P207, DOI 10.1016/0022-3093(95)00188-3; MCMILLAN PF, 1994, GEOCHIM COSMOCHIM AC, V58, P3653, DOI 10.1016/0016-7037(94)90156-2; Mills KC, 1999, IRONMAK STEELMAK, V26, P262, DOI 10.1179/030192399677121; Moesgaard M, 2012, J AM CERAM SOC, V95, P403, DOI 10.1111/j.1551-2916.2011.04902.x; Moesgaard M, 2010, GLASS TECHNOL-PART A, V51, P183; Moulton BJA, 2016, GEOCHIM COSMOCHIM AC, V178, P41, DOI 10.1016/j.gca.2016.01.020; Moulton BJA, 2016, CHEM GEOL, V420, P213, DOI 10.1016/j.chemgeo.2015.11.016; MYSEN BO, 1985, AM MINERAL, V70, P88; Mysen BO, 2003, AM MINERAL, V88, P1668, DOI 10.2138/am-2003-11-1206; MYSEN BO, 1982, REV GEOPHYS, V20, P353, DOI 10.1029/RG020i003p00353; Neuville DR, 2006, CHEM GEOL, V229, P28, DOI 10.1016/j.chemgeo.2006.01.008; Neuville DR, 2005, PHYS CHEM GLASSES, V46, P112; Neuville DR, 2004, GEOCHIM COSMOCHIM AC, V68, P5071, DOI 10.1016/j.gca.2004.05.048; Newlands KC, 2017, ADV APPL CERAM, V116, P216, DOI 10.1080/17436753.2017.1299986; Pontikes Y, 2013, APPL CLAY SCI, V73, P93, DOI 10.1016/j.clay.2012.09.020; Provis J.L., 2014, TC224AAM RILEM, DOI 10.1007/978-94-007-7672-2; Quintas A, 2009, ARXIV09121576CONDMAT; Rahmani A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.184202; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rodrigues A, 2019, J AM CERAM SOC, V102, P7278, DOI 10.1111/jace.16665; Ruiz-Santaquiteria C, 2016, CERAM INT, V42, P9333, DOI 10.1016/j.ceramint.2016.03.111; Schneider M, 2011, CEMENT CONCRETE RES, V41, P642, DOI 10.1016/j.cemconres.2011.03.019; Scrivener KL, 2018, CEMENT CONCRETE RES, V114, P2, DOI 10.1016/j.cemconres.2018.03.015; SEN PN, 1977, PHYS REV B, V15, P4030, DOI 10.1103/PhysRevB.15.4030; Shi CJ, 2019, CEMENT CONCRETE RES, V122, P227, DOI 10.1016/j.cemconres.2019.05.009; SMETS BMJ, 1985, J MATER SCI, V20, P1027, DOI 10.1007/BF00585747; SOSINSKY DJ, 1986, METALL TRANS B, V17, P331; Sreenivasan H, 2020, FRONT MATER, V7, DOI 10.3389/fmats.2020.00267; Tashima MM, 2016, MATER DESIGN, V96, P424, DOI 10.1016/j.matdes.2016.02.036; Tennakoon C, 2017, MATER DESIGN, V116, P287, DOI 10.1016/j.matdes.2016.12.030; Tiwary JN, 2013, EMERG MATER RES, V2, P152, DOI 10.1680/emr.12.00033; Trcera N, 2011, J RAMAN SPECTROSC, V42, P765, DOI 10.1002/jrs.2763; Umari P, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027401; WU ZF, 1986, J NON-CRYST SOLIDS, V84, P468, DOI 10.1016/0022-3093(86)90811-2; Xia M, 2016, MATER DESIGN, V110, P382, DOI 10.1016/j.matdes.2016.07.136; Zhang CY, 2018, J CLEAN PROD, V184, P451, DOI 10.1016/j.jclepro.2018.02.284	72	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244621	10.1371/journal.pone.0244621	http://dx.doi.org/10.1371/journal.pone.0244621			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378374	Green Accepted, Green Published, gold			2022-12-27	WOS:000605651300064
J	Thomas, C; Nothaft, H; Yadav, R; Fodor, C; Alemka, A; Oni, O; Bell, M; Rada, B; Szymanski, CM				Thomas, Cody; Nothaft, Harald; Yadav, Ruchi; Fodor, Christopher; Alemka, Abofu; Oni, Oluwadamilola; Bell, Michael; Rada, Balazs; Szymanski, Christine M.			Characterization of ecotin homologs from Campylobacter rectus and Campylobacter showae	PLOS ONE			English	Article							SERINE-PROTEASE INHIBITOR; NEUTROPHIL ELASTASE INHIBITORS; ESCHERICHIA-COLI; POTENT INHIBITOR; CRYSTAL-STRUCTURE; N-GLYCOSYLATION; REACTIVE-SITE; NADPH OXIDASE; NET FORMATION; JEJUNI	Ecotin, first described in Escherichia coli, is a potent inhibitor of a broad range of serine proteases including those typically released by the innate immune system such as neutrophil elastase (NE). Here we describe the identification of ecotin orthologs in various Campylobacter species, including Campylobacter rectus and Campylobacter showae residing in the oral cavity and implicated in the development and progression of periodontal disease in humans. To investigate the function of these ecotins in vitro, the orthologs from C. rectus and C. showae were recombinantly expressed and purified from E. coli. Using CmeA degradation/protection assays, fluorescence resonance energy transfer and NE activity assays, we found that ecotins from C. rectus and C. showae inhibit NE, factor Xa and trypsin, but not the Campylobacter jejuni serine protease HtrA or its ortholog in E. coli, DegP. To further evaluate ecotin function in vivo, an E. coli ecotin-deficient mutant was complemented with the C. rectus and C. showae homologs. Using a neutrophil killing assay, we demonstrate that the low survival rate of the E. coli ecotin-deficient mutant can be rescued upon expression of ecotins from C. rectus and C. showae. In addition, the C. rectus and C. showae ecotins partially compensate for loss of N-glycosylation and increased protease susceptibility in the related pathogen, Campylobacter jejuni, thus implicating a similar role for these proteins in the native host to cope with the protease-rich environment of the oral cavity.	[Thomas, Cody; Szymanski, Christine M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Thomas, Cody; Szymanski, Christine M.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Nothaft, Harald; Fodor, Christopher; Alemka, Abofu; Szymanski, Christine M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Yadav, Ruchi; Oni, Oluwadamilola; Bell, Michael; Rada, Balazs] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA; [Thomas, Cody] Boehringer Ingelheim Pharmaceut Inc, Drug Metab & Pharmacokinet, 90 E Ridge POB 368, Ridgefield, CT 06877 USA; [Alemka, Abofu] Mallinckrodt Pharmaceut Ireland Ltd, Dublin, Ireland	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Alberta; University System of Georgia; University of Georgia; Boehringer Ingelheim	Szymanski, CM (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.; Szymanski, CM (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.; Szymanski, CM (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	cszymans@uga.edu	; Szymanski, Christine/A-3763-2014	Thomas, Cody/0000-0001-8891-9131; Szymanski, Christine/0000-0002-8464-1352	National Institutes of Health [5R01HL136707]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (5R01HL136707 to BR). CMS was an Alberta Innovates Strategic Chair in Bacterial Glycomics.	Abreu AG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00452; Alemka A, 2013, INFECT IMMUN, V81, P1674, DOI 10.1128/IAI.01370-12; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2019, FASEB J, DOI DOI 10.1096/FJ.201901363RRR; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Boehm M, 2015, EUR J MICROBIOL IMMU, V5, P68, DOI [10.1556/EUJMI-D-15-00003, 10.1556/EuJMI-D-15-00003]; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cain JA, 2019, MOL CELL PROTEOMICS, V18, P715, DOI 10.1074/mcp.RA118.001199; Callahan S, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13210; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Clark EA, 2011, J BIOL CHEM, V286, P24015, DOI 10.1074/jbc.M111.225730; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DZINK JL, 1988, J CLIN PERIODONTOL, V15, P316, DOI 10.1111/j.1600-051X.1988.tb01590.x; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; ETOH Y, 1993, INT J SYST BACTERIOL, V43, P631, DOI 10.1099/00207713-43-4-631; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Floyd M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005987; Garcia FB, 2020, INT J BIOL MACROMOL, V151, P459, DOI 10.1016/j.ijbiomac.2020.02.186; Gray RD, 2018, THORAX, V73, P134, DOI 10.1136/thoraxjnl-2017-210134; Henne K, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.25874; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Hsu T, 2019, EMERG MICROBES INFEC, V8, P827, DOI 10.1080/22221751.2019.1622455; Ireland PM, 2014, MICROB PATHOGENESIS, V67-68, P55, DOI [10.1016/j.micpath.2014.01.001, 10]; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; LABIGNEROUSSEL A, 1987, J BACTERIOL, V169, P5320, DOI 10.1128/jb.169.11.5320-5323.1987; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Lucas SD, 2013, MED RES REV, V33, pE73, DOI 10.1002/med.20247; Macuch PJ, 2000, J DENT RES, V79, P785, DOI 10.1177/00220345000790021301; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; McCrudden MTC, 2009, J ENZYM INHIB MED CH, V24, P1207, DOI 10.3109/14756360902779458; MCGRATH ME, 1991, J BIOL CHEM, V266, P6620; MCGRATH ME, 1994, EMBO J, V13, P1502, DOI 10.1002/j.1460-2075.1994.tb06411.x; Moore W E, 1994, Periodontol 2000, V5, P66, DOI 10.1111/j.1600-0757.1994.tb00019.x; Moraes TJ, 2003, CRIT CARE MED, V31, pS189, DOI 10.1097/01.CCM.0000057842.90746.1E; Murphy H, 2011, MICROBES INFECT, V13, P42, DOI 10.1016/j.micinf.2010.09.007; Nagy ZA, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008232; Nothaft H, 2012, MOL CELL PROTEOMICS, V11, P1203, DOI 10.1074/mcp.M112.021519; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Nothaft H, 2010, METHODS MOL BIOL, V600, P227, DOI 10.1007/978-1-60761-454-8_16; Owen Caroline A, 2008, Int J Chron Obstruct Pulmon Dis, V3, P253; PAL G, 1994, FEBS LETT, V342, P57, DOI 10.1016/0014-5793(94)80584-9; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Podolska MJ, 2019, J LEUKOCYTE BIOL, V106, P1359, DOI 10.1002/JLB.3AB0918-370R; Polverino E, 2017, CHEST, V152, P249, DOI 10.1016/j.chest.2017.03.056; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Ribeiro JKC, 2010, EUR J PHARMACOL, V644, P238, DOI 10.1016/j.ejphar.2010.06.067; Rodems SM, 2002, ASSAY DRUG DEV TECHN, V1, P9, DOI 10.1089/154065802761001266; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3944; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schlueter N, 2010, ARCH ORAL BIOL, V55, P294, DOI 10.1016/j.archoralbio.2010.02.003; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; SEONG IS, 1994, J BIOL CHEM, V269, P21915; SEYMOUR JL, 1994, BIOCHEMISTRY-US, V33, P3949, DOI 10.1021/bi00179a022; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shin DH, 1996, PROTEIN SCI, V5, P2236, DOI 10.1002/pro.5560051110; Siedle B, 2007, PLANTA MED, V73, P401, DOI 10.1055/s-2007-967183; Sil P, 2016, JOVE-J VIS EXP, DOI 10.3791/52779; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Stapels DAC, 2015, CURR OPIN MICROBIOL, V23, P42, DOI 10.1016/j.mib.2014.11.002; Sun XL, 2013, J IMMUNOL, V190, P357, DOI 10.4049/jimmunol.1201825; Szymanski CM, 1999, MOL MICROBIOL, V32, P1022, DOI 10.1046/j.1365-2958.1999.01415.x; TANNER ACR, 1984, J PERIODONTAL RES, V19, P279, DOI 10.1111/j.1600-0765.1984.tb00819.x; TANNER ACR, 1979, J CLIN PERIODONTOL, V6, P278, DOI 10.1111/j.1600-051X.1979.tb01931.x; Teng TS, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/9671604; Tseng BS, 2018, MBIO, V9, DOI 10.1128/mBio.00543-18; ULMER JS, 1995, FEBS LETT, V365, P159, DOI 10.1016/0014-5793(95)00466-M; von Nussbaum F, 2015, BIOORG MED CHEM LETT, V25, P4370, DOI 10.1016/j.bmcl.2015.08.049; von Nussbaum F, 2015, CHEMMEDCHEM, V10, P1163, DOI 10.1002/cmdc.201500131; Wang GQ, 2013, CURR MICROBIOL, V67, P688, DOI 10.1007/s00284-013-0422-6; Wang SX, 2001, BIOCHEMISTRY-US, V40, P10038, DOI 10.1021/bi010712h; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Yang SQ, 1998, J MOL BIOL, V279, P945, DOI 10.1006/jmbi.1998.1748; Yoo DG, 2014, IMMUNOL LETT, V160, P186, DOI 10.1016/j.imlet.2014.03.003; Yoo DG, 2014, J IMMUNOL, V192, P4728, DOI 10.4049/jimmunol.1301589	85	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244031	10.1371/journal.pone.0244031	http://dx.doi.org/10.1371/journal.pone.0244031			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378351	Green Published, gold			2022-12-27	WOS:000605651300016
J	Kim, H; Byun, E; Jeong, MJ; Hong, HS; Han, Y; Kwon, TW; Cho, YP				Kim, Hyangkyoung; Byun, Eunae; Jeong, Min-Jae; Hong, Hee Sun; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil			Duplex ultrasound findings and clinical outcomes of carotid restenosis after carotid endarterectomy	PLOS ONE			English	Article							IPSILATERAL STROKE; STENOSIS; MANAGEMENT; GUIDELINES; SOCIETY; RISK	This study aimed to describe the duplex ultrasound (DUS) findings associated with carotid restenosis after carotid endarterectomy (CEA) and to determine whether carotid restenosis is associated with the clinical outcomes of CEA. Between January 2007 and December 2016, a total of 660 consecutive patients who underwent 717 CEAs were followed up at our hospital with DUS surveillance for at least 3 years after CEA. These patients were analyzed retrospectively for this study. Following CEA, restenosis was defined as the development of >= 50% stenosis, diagnosed on the basis of DUS findings of the luminal narrowing and velocity criteria. The study outcomes were defined as restenosis of the ipsilateral carotid artery after CEA and late (>30days) fatal or nonfatal stroke ipsilateral to the carotid restenosis. During the median follow-up period of 74 months, the restenosis incidence was 2.8% (20/717), and there were 2 strokes (2/20, 10%) ipsilateral to the restenosis after CEA; reintervention was performed for 11 patients with carotid restenosis (55%). Within 2 years after CEA, restenosis was identified in 9 cases (45%, 9/20), and 8 reinterventions (72.7%, 8/11) were performed. According to DUS findings, the morphologic characteristics of carotid restenosis were different from the preoperative plaque morphology. Among the 20 carotid restenosis cases, we observed the following DUS patterns: homogenous isoechoic restenosis (n = 14, 70%), homogenous hypoechoic (n = 2, 10%), isoechoic with hypoechoic surface (n = 3, 15%), and hypoechoic with isoechoic surface (n = 1, 5%). Although 9 carotid restenosis patients received prophylactic reintervention to mitigate the progression of restenosis, the 2 symptomatic restenosis patients had isoechoic lesions with hypoechoic surfaces on DUS. On Kaplan-Meier survival analyses, in terms of stroke-free survival rates, there was a higher risk of stroke among patients with carotid restenosis compared with patients without restenosis, with a non-significant trend (P = 0.051). In conclusion, most carotid restenoses were identified within 2 years after CEA, and there was a non-significant trend toward a higher risk of stroke among patients with carotid restenosis.	[Kim, Hyangkyoung; Byun, Eunae; Hong, Hee Sun; Han, Youngjin; Kwon, Tae-Won; Cho, Yong-Pil] Univ Ulsan, Dept Surg, Asan Med Ctr, Coll Med, Seoul, South Korea; [Jeong, Min-Jae] Univ Ulsan, GangNeung Asan Hosp, Dept Surg, Coll Med, Kangnung, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan	Cho, YP (corresponding author), Univ Ulsan, Dept Surg, Asan Med Ctr, Coll Med, Seoul, South Korea.	ypcho@amc.seoul.kr		BYUN, EUNAE/0000-0002-0130-5549				Abbott AL, 2015, STROKE, V46, P3288, DOI 10.1161/STROKEAHA.115.003390; AbuRahma AF, 2010, J VASC SURG, V52, P1180, DOI 10.1016/j.jvs.2010.06.074; Al Shakarchi J, 2016, J VASC SURG, V63, P1647, DOI 10.1016/j.jvs.2016.01.054; BANDYK DF, 1988, J VASC SURG, V8, P696, DOI 10.1067/mva.1988.avs0080696; Bekelis K, 2013, BRIT J SURG, V100, P440, DOI 10.1002/bjs.9027; Bonati LH, 2018, LANCET NEUROL, V17, P587, DOI 10.1016/S1474-4422(18)30195-9; Brott TG, 2011, J AM COLL CARDIOL, V57, P1002, DOI 10.1016/j.jacc.2010.11.005; De Borst GJ, 2012, J CARDIOVASC SURG, V53, P27; Dorigo W, 2011, EUR J VASC ENDOVASC, V41, P351, DOI 10.1016/j.ejvs.2010.11.026; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Fokkema M, 2015, ANN SURG, V261, P598, DOI 10.1097/SLA.0000000000000799; Frericks H, 1998, STROKE, V29, P244, DOI 10.1161/01.STR.29.1.244; Garzon-Muvdi T, 2016, WORLD NEUROSURG, V89, P159, DOI 10.1016/j.wneu.2016.01.028; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Hunter GC, 1997, AM J SURG, V174, P583, DOI 10.1016/S0002-9610(97)80927-0; Kobayashi E, 2000, INTERV NEURORADIOL, V6, P165, DOI 10.1177/15910199000060S125; Kumar R, 2017, EUR J VASC ENDOVASC, V53, P766, DOI 10.1016/j.ejvs.2017.02.016; Kwon H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23125-8; Kwon H, 2017, J NEUROSURG, V126, P1560, DOI 10.3171/2016.3.JNS16287; Lal BK, 2012, LANCET NEUROL, V11, P755, DOI 10.1016/S1474-4422(12)70159-X; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Naim C, 2014, CAN ASSOC RADIOL J, V65, P275, DOI 10.1016/j.carj.2013.05.003; Orrapin S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001081.pub3; Ricotta JJ, 2011, J VASC SURG, V54, P832, DOI 10.1016/j.jvs.2011.07.004; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vos JA, 2009, J VASC SURG, V50, P755, DOI 10.1016/j.jvs.2009.04.060	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244544	10.1371/journal.pone.0244544	http://dx.doi.org/10.1371/journal.pone.0244544			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373383	Green Published, gold			2022-12-27	WOS:000603612300054
J	Kraus, R; Zwingmann, J; Jablonski, M; Bakir, MS				Kraus, Ralf; Zwingmann, Joern; Jablonski, Manfred; Bakir, M. Sinan			Dislocations of the acromioclavicular and sternoclavicular joint in children and adolescents: A retrospective clinical study and big data analysis of routine data	PLOS ONE			English	Article							RETROSTERNAL DISLOCATION; POSTERIOR DISLOCATION; CLAVICLE; INJURIES; RECONSTRUCTION; INSTABILITY; MANAGEMENT; FRACTURES; DIAGNOSIS	Background Dislocations of the sternoclavicular joint (anterior/posterior) and acromioclavicular joint (SCJ and ACJ, respectively) are rare injuries in childhood/adolescence, each having its own special characteristics. In posterior SCJ dislocation, the concomitant injuries in the upper mediastinum are most important complication, while in anterior SCJ dislocation there is a risk of permanent or recurrent instability. Methods In a retrospective analysis from seven pediatric trauma centers under the leadership of the Section of Pediatric Traumatology of the German Trauma Society, children (<18 years) were analyzed with focus on age, gender, trauma mechanism, diagnostics, treatment strategy and follow-up results. Additional epidemiological big data analysis from routine data was done. Results In total 24 cases with an average age of 14.4 years (23 boys, 1 girl) could be evaluated (7x ACJ dislocation type >= Rockwood III; 17x SCJ dislocation type Allman III, including 12 posterior). All ACJ dislocations were treated surgically. Postoperative immobilization lasted 3-6 weeks, after which a movement limit of 90 degrees was recommended until implant removal. Patients with SCJ dislocation were posterior dislocations in 75%, and 15 of 17 were treated surgically. One patient had a tendency toward sub-dislocation and another had a relapse. Conservatively treated injuries healed without complications. Compared to adults, SCJ injuries were equally rarely found in children (< 1% of clavicle-associated injuries), while pediatric ACJ dislocations were significantly less frequent (p<0.001). Conclusions In cases of SCJ dislocations, our cohort analysis confirmed both the heterogeneous spectrum of the treatment strategies in addition to the problems/complications based on previous literature. The indication for the operative or conservative approach and for the specific method is not standardized. In order to be able to create evidence-based standards, a prospective, multicenter-study with a sufficiently long follow-up time would be necessary due to the rarity of these injuries in children. The rarity was emphasized by our routine data analysis.	[Kraus, Ralf] Klinikum Bad Hersfeld GmbH, Dept Trauma Surg & Orthoped, Bad Hersfeld, Germany; [Kraus, Ralf; Zwingmann, Joern; Jablonski, Manfred; Bakir, M. Sinan] Deutsch Gesell Unfallchirurg, German Trauma Soc, Sekt Kindertraumatol, Sect Pediat Traumatol,SKT,DGU, Berlin, Germany; [Zwingmann, Joern] St Elisabethen Klinikum, Dept Trauma Surg & Orthoped, Ravensburg, Germany; [Jablonski, Manfred] Kinderkrankenhaus Bult, Dept Pediat Surg & Urol, Hannover, Germany; [Bakir, M. Sinan] Med Univ Greifswald, Dept Trauma & Reconstruct Surg & Rehabil Med, Greifswald, Germany; [Bakir, M. Sinan] BG Hosp Unfallkrankenhaus Berlin gGmbH, Dept Trauma Surg & Orthoped, Berlin, Germany	Greifswald Medical School	Kraus, R (corresponding author), Klinikum Bad Hersfeld GmbH, Dept Trauma Surg & Orthoped, Bad Hersfeld, Germany.; Kraus, R; Bakir, MS (corresponding author), Deutsch Gesell Unfallchirurg, German Trauma Soc, Sekt Kindertraumatol, Sect Pediat Traumatol,SKT,DGU, Berlin, Germany.; Bakir, MS (corresponding author), Med Univ Greifswald, Dept Trauma & Reconstruct Surg & Rehabil Med, Greifswald, Germany.; Bakir, MS (corresponding author), BG Hosp Unfallkrankenhaus Berlin gGmbH, Dept Trauma Surg & Orthoped, Berlin, Germany.	ralf.kraus@klinikum-hef.de; sinan.bakir@uni-greifswald.de		Bakir, Sinan/0000-0002-2448-2150				ALLMAN FL, 1967, J BONE JOINT SURG AM, VA 49, P774, DOI 10.2106/00004623-196749040-00024; [Anonymous], 2018, LANCET GLOB HEALTH, V6, pE593, DOI 10.1016/S2214-109X(18)30239-0; [Anonymous], 2013, GES INT; Asadollahi S, 2019, J ORTHOP TRAUMATOL, V20, DOI 10.1186/s10195-019-0533-3; Bae DS, 2006, J PEDIATR ORTHOPED, V26, P71, DOI 10.1097/01.bpo.0000187998.91837.b2; Bakir MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224370; Bakir MS, 2020, EUROPEAN J TRAUMA EM; Bakir MS, 2017, CHIRURGIA-BUCHAREST, V112, P586, DOI 10.21614/chirurgia.112.5.586; Balke M, 2015, UNFALLCHIRURG, V118, P851, DOI 10.1007/s00113-013-2547-2; Beitzel K, 2013, ARTHROSCOPY, V29, P387, DOI 10.1016/j.arthro.2012.11.023; BLACK GB, 1991, AM J SPORT MED, V19, P644, DOI 10.1177/036354659101900616; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; BUCKERFIELD CT, 1984, J BONE JOINT SURG AM, V66A, P379, DOI 10.2106/00004623-198466030-00010; Chaudhry S, 2015, J AM ACAD ORTHOP SUR, V23, P468, DOI 10.5435/JAAOS-D-14-00235; Cheng J, 2014, INT J PEDIATR OTORHI, V78, P152, DOI 10.1016/j.ijporl.2013.09.027; COMBALIA A, 1995, J TRAUMA, V38, P812, DOI 10.1097/00005373-199505000-00024; EIDMAN DK, 1981, AM J SPORT MED, V9, P150, DOI 10.1177/036354658100900304; Galanis N, 2014, CLIN J SPORT MED, V24, P271, DOI 10.1097/JSM.0000000000000020; Gobet R, 2004, Emerg Radiol, V10, P252, DOI 10.1007/s10140-003-0285-4; Helfen T, 2021, EUR J TRAUMA EMERG S, V47, P1399, DOI 10.1007/s00068-019-01178-2; Herteleer M, 2018, J SHOULDER ELB SURG, V27, P1512, DOI 10.1016/j.jse.2018.01.016; Jaggard MKJ, 2009, J TRAUMA, V66, P576, DOI 10.1097/TA.0b013e31817fd96b; Jettoo P, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-77; Keating M, 2010, ANAESTH INTENS CARE, V38, P759, DOI 10.1177/0310057X1003800422; Klein P, 1991, Unfallchirurgie, V17, P14, DOI 10.1007/BF02588171; Maier D, 2011, UNFALLCHIRURG, V114, P611, DOI 10.1007/s00113-011-2049-z; MEIXNER J, 1983, ZBL CHIR, V108, P793; Nenopoulos SP, 2011, INJURY, V42, P376, DOI 10.1016/j.injury.2010.09.036; NETTLES JL, 1968, J TRAUM, V8, P158, DOI 10.1097/00005373-196803000-00004; Ngom G, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.386.5684; Pollock RC, 1996, INJURY, V27, P670, DOI 10.1016/S0020-1383(96)00099-X; Robinson CM, 2008, J BONE JOINT SURG BR, V90B, P685, DOI 10.1302/0301-620X.90B6.20391; Stein T, 2018, AM J SPORT MED, V46, P2725, DOI 10.1177/0363546518788355; Sykes JA, 2011, PEDIATR EMERG CARE, V27, P327, DOI 10.1097/PEC.0b013e318217b58f; Tepolt F, 2014, ORTHOPEDICS, V37, pE174, DOI 10.3928/01477447-20140124-22; Thut D, 2011, BULL HOSP JT DIS, V69, P128; Uri O, 2014, J BONE JOINT SURG AM, V96A, P417, DOI 10.2106/JBJS.M.00681; Van Tongel A, 2012, ACTA ORTHOP BELG, V78, P164; Waters PM, 2003, J PEDIATR ORTHOPED, V23, P464, DOI 10.1097/00004694-200307000-00010; Widodo Wahyu, 2018, Trauma Case Rep, V18, P8, DOI 10.1016/j.tcr.2018.11.006; Wirth, 1996, J Am Acad Orthop Surg, V4, P268; Yeh GL, 2000, ORTHOP CLIN N AM, V31, P189, DOI 10.1016/S0030-5898(05)70140-1	42	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244209	10.1371/journal.pone.0244209	http://dx.doi.org/10.1371/journal.pone.0244209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370356	gold, Green Published			2022-12-27	WOS:000603611900087
J	Luck, S				Luck, Stanley			Nonoverlap proportion and the representation of point-biserial variation	PLOS ONE			English	Article							EFFECT SIZE; RATIOS; INTERVAL	We consider the problem of constructing a complete set of parameters that account for all of the degrees of freedom for point-biserial variation. We devise an algorithm where sort as an intrinsic property of both numbers and labels, is used to generate the parameters. Algebraically, point-biserial variation is represented by a Cartesian product of statistical parameters for two sets of R 1 data, and the difference between mean values (delta) corresponds to the representation of variation in the center of mass coordinates, (delta, mu). The existence of alternative effect size measures is explained by the fact that mathematical considerations alone do not specify a preferred coordinate system for the representation of point-biserial variation. We develop a novel algorithm for estimating the nonoverlap proportion (rho(pb)) of two sets of R 1 data. rho(pb) is obtained by sorting the labeled R 1 data and analyzing the induced order in the categorical data using a diagonally symmetric 2 x 2 contingency table. We examine the correspondence between rho(pb) and point-biserial correlation (r(pb)) for uniform and normal distributions. We identify the R-2, P-1, and S-+(1) representations for Pearson product-moment correlation, Cohen's d, and r(pb). We compare the performance of r(pb) versus rho(pb) and the sample size proportion corrected correlation (r(pbd)), confirm that invariance with respect to the sample size proportion is important in the formulation of the effect size, and give an example where three parameters (r(pbd), mu, rho(pb)) are needed to distinguish different forms of point-biserial variation in CART regression tree analysis. We discuss the importance of providing an assessment of cost-benefit trade-offs between relevant system parameters because 'substantive significance' is specified by mapping functional or engineering requirements into the effect size coordinates. Distributions and confidence intervals for the statistical parameters are obtained using Monte Carlo methods.	[Luck, Stanley] Vector Analyt LLC, Wilmington, DE 19810 USA		Luck, S (corresponding author), Vector Analyt LLC, Wilmington, DE 19810 USA.	stan.luck@vectoranalytics.ai		Luck, Stanley/0000-0001-7081-9407				Agresti A, 2003, STAT METHODS MED RES, V12, P3, DOI 10.1191/0962280203sm311ra; [Anonymous], 2020, NURSING HOME COMP DA; Belo A., 2010, The handbook of plant mutation screening: mining of natural and induced alleles, P231; Bevington P.R., 2003, DATA REDUCTION ERROR, V3th; Bishara AJ, 2015, EDUC PSYCHOL MEAS, V75, P785, DOI 10.1177/0013164414557639; Boyd S., 2004, CONVEX OPTIMIZATION, DOI [DOI 10.1017/CBO9780511804441, 10.1017/CBO9780511804441]; Buonaccorsi JP, 2010, INTERD STAT, P1, DOI 10.1201/9781420066586; Casella G., 2002, STAT INFERENCE, V2nd; CHAMBERS RG, 1982, BRIT J MATH STAT PSY, V35, P216, DOI 10.1111/j.2044-8317.1982.tb00654.x; Cheng Y, 2016, BRIT J MATH STAT PSY, V69, P344, DOI 10.1111/bmsp.12075; Cumming G., 2012, UNDERSTANDING NEW ST; de Ville B, 2013, WIRES COMPUT STAT, V5, P448, DOI 10.1002/wics.1278; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P30, DOI 10.1037/a0026092; Ghali S, 2008, INTRO GEOMETRIC COMP; GRADSTEIN M, 1986, J EDUC STAT, V11, P259, DOI 10.3102/10769986011004259; Grissom RJ, 2011, EFFECT SIZES RES; Hastie T., 2009, SPRINGER SERIES STAT, DOI 10.1007/978-0-387-84858-7; Hofler M, 2005, INT J METH PSYCH RES, V14, P92, DOI 10.1002/mpr.20; Huberty CJ, 2002, EDUC PSYCHOL MEAS, V62, P227, DOI 10.1177/0013164402062002002; Johnson JM, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0225-0; Kelley K, 2012, PSYCHOL METHODS, V17, P137, DOI 10.1037/a0028086; Kroese DP, 2014, WIRES COMPUT STAT, V6, P386, DOI 10.1002/wics.1314; Krzywinksi M, 2017, NAT METHODS, V14, P757, DOI 10.1038/nmeth.4370; Logan JD, 1997, APPL MATH; Luck S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224460; Marsaglia G, 2006, J STAT SOFTW, V16, P1; McGrath RE, 2006, PSYCHOL METHODS, V11, P386, DOI 10.1037/1082-989X.11.4.386; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; NHC, 2020, NHC QUALITY MEASURES; Pastore M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01089; Richardson JTE, 1996, BEHAV RES METH INSTR, V28, P12, DOI 10.3758/BF03203631; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Schafer T, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00813; von Luxburg U, 2009, STAT SINICA, V19, P1095	35	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244517	10.1371/journal.pone.0244517	http://dx.doi.org/10.1371/journal.pone.0244517			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370394	gold, Green Published			2022-12-27	WOS:000603611900005
J	Vidgen, B; Derczynski, L				Vidgen, Bertie; Derczynski, Leon			Directions in abusive language training data, a systematic review: Garbage in, garbage out	PLOS ONE			English	Review							CONTEXT; SCIENCE; SPEECH; SCOPUS; ARXIV; BIAS; TEXT	Data-driven and machine learning based approaches for detecting, categorising and measuring abusive content such as hate speech and harassment have gained traction due to their scalability, robustness and increasingly high performance. Making effective detection systems for abusive content relies on having the right training datasets, reflecting a widely accepted mantra in computer science: Garbage In, Garbage Out. However, creating training datasets which are large, varied, theoretically-informed and that minimize biases is difficult, laborious and requires deep expertise. This paper systematically reviews 63 publicly available training datasets which have been created to train abusive language classifiers. It also reports on creation of a dedicated website for cataloguing abusive language data . We discuss the challenges and opportunities of open science in this field, and argue that although more dataset sharing would bring many benefits it also poses social and ethical risks which need careful consideration. Finally, we provide evidence-based recommendations for practitioners creating new abusive content training datasets.	[Vidgen, Bertie] Alan Turing Inst, London, England; [Derczynski, Leon] IT Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark	IT University Copenhagen	Vidgen, B (corresponding author), Alan Turing Inst, London, England.	bvidgen@turing.ac.uk		Derczynski, Leon/0000-0002-8656-3431	Wave 1 of The UKRI Strategic Priorities Fund under the EPSRC [EP/T001569/1, TPS2019 100065]; IT University of Copenhagen on Abusive Language Detection	Wave 1 of The UKRI Strategic Priorities Fund under the EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); IT University of Copenhagen on Abusive Language Detection	This study was supported by Wave 1 of The UKRI Strategic Priorities Fund under the EPSRC Grant EP/T001569/1 and Grant TPS2019 100065 awarded to BV, as well as an internal grant from the IT University of Copenhagen on Abusive Language Detection awarded to LD.	Alfina I, 2017, INT C ADV COMP SCI I, P233; [Anonymous], 2020, P CORR; [Anonymous], 2009, KIDNEY INT, V6, pS1; Arenas JR, 2019, MOMENTO, P1, DOI 10.15446/mo.n59E.81662; Awan I., 2015, WE FEAR OUR LIVES OF; Aziz N, 2019, DUKE LAW J, V69, P669; Barrett T, 2020, FOCAAL, P1, DOI 10.3167/fcl.2020.012801; Bender EM., 2018, T ASSOC COMPUT LING, V6, P587, DOI [10.1162/tacl_a_00041, 10.1162/tacla00041, DOI 10.1162/TACLA00041]; Benoit K, 2016, AM POLIT SCI REV, V110, P278, DOI 10.1017/S0003055416000058; BINNS R, 2017, INT C SOC INF, P405, DOI DOI 10.1007/978-3-319-67256-4_32; Bird S, 2008, SIXTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, LREC 2008, P1755; Blank G, 2017, SOC SCI COMPUT REV, V35, P679, DOI 10.1177/0894439316671698; Bohannon J, 2011, SCIENCE, V334, P307, DOI 10.1126/science.334.6054.307; Bolukbasi Tolga, 2016, NIPS, DOI DOI 10.5555/3157382; Bontcheva K., 2014, P DEM 14 C EUR CHAPT, P97; Bretschneider U, 2016, ECIS 2016 RES PAPERS; Bretschneider U, 2017, PROCEEDINGS OF THE 50TH ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, P2213; Brooke S, 2019, 1 MONDAY, V24; Burnap P, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0072-6; Chetty N, 2018, AGGRESS VIOLENT BEH, V40, P108, DOI 10.1016/j.avb.2018.05.003; Cheung CMK, 2011, COMPUT HUM BEHAV, V27, P1337, DOI 10.1016/j.chb.2010.07.028; Chung YL, 2019, ARXIV191003270; Cihon P, 2016, FRONT PHYS-LAUSANNE, V4, DOI 10.3389/fphy.2016.00034; D'Orazio V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156527; Daries JP, 2014, COMMUN ACM, V57, P56, DOI 10.1145/2643132; Davidson T., 2017, ICWSM; Davidson Thomas, 2019, ARXIV190512516; Davis PM, 2007, SCIENTOMETRICS, V71, P203, DOI 10.1007/s11192-007-1661 -8; De Gibert O., 2018, P 2 WORKSH AB LANG O; de Pelle R. P., 2017, AN 6 BRAZ WORKSH SOC; Delacroix S, 2018, BOTTOM UP DATA TRUST; Derczynski L., 2019, KVINDER NEDGORES OFT; Derczynski L, 2015, INFORM PROCESS MANAG, V51, P32, DOI 10.1016/j.ipm.2014.10.006; Derczynski Leon, 2016, P COLING 2016 26 INT, P1169; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ElSherief M, 2018, P INT AAAI C WEB SOC, V12; Feng F, LANGUAGE AGNOSTIC BE; Fersini E., 2018, P 3 WORKSHOP EVALUAT, V2150, P214; Fiesler C, 2018, SOC MEDIA SOC, V4, DOI 10.1177/2056305118763366; Fioretti J, 2018, SOCIAL MEDIA CO ACCE; Fort K, 2011, COMPUT LINGUIST, V37, P413, DOI 10.1162/COLI_a_00057; Fortuna P, 2019, THIRD WORKSHOP ON ABUSIVE LANGUAGE ONLINE, P94; Fortuna P, 2018, ACM COMPUT SURV, V51, DOI 10.1145/3232676; Founta AM, 2018, 12 INT C WEB SOC MED; Franceschini F, 2016, SCIENTOMETRICS, V107, P321, DOI 10.1007/s11192-016-1867-8; Gardner Matt, 2020, EVALUATING NLP MODEL; Garg S, 2019, AIES '19: PROCEEDINGS OF THE 2019 AAAI/ACM CONFERENCE ON AI, ETHICS, AND SOCIETY, P219, DOI 10.1145/3306618.3317950; Gillespie T., 2018, CUSTODIANS INTERNET; Gillespie T, 2020, BIG DATA SOC, V7, DOI 10.1177/2053951720943234; Golbeck J, 2017, PROCEEDINGS OF THE 2017 ACM WEB SCIENCE CONFERENCE (WEBSCI '17), P229, DOI 10.1145/3091478.3091509; Gomez Raul, 2020, P WINT C APPL COMP V; Gorwa R, 2020, BIG DATA SOC, V7, DOI 10.1177/2053951719897945; Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028; Guestrin C., 2018, P AAAI C ART INT, V32, P1; Guzman-Falcon E, 2018, NOT PAP 3 SEPLN WORK, V6; Vu-Ngoc H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195955; Hall W., 2017, GROWING ARTIFICIAL I; Hardwicke TE, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180448; Harzing AW, 2016, SCIENTOMETRICS, V106, P787, DOI 10.1007/s11192-015-1798-9; Hine GE, 2017, 11 INT AAAI C WEB SO; Hirsch JD, 2010, PATIENT-RELAT OUTCOM, V1, P1, DOI 10.2147/PROM.S8310; HM Government, 2019, ONL HARMS WHIT PAP; Ian Shapiro, 2004, POLIT THEORY, V30, P596; Ibrohim MO, 2019, THIRD WORKSHOP ON ABUSIVE LANGUAGE ONLINE, P46; IPSOS, 2016, ATT POT OFF LANG GES; Alvarez-Figueroa MJ, 2019, PHARM DEV TECHNOL, V24, P630, DOI 10.1080/10837450.2018.1550789; Jha Akshita, 2017, P 2 WORKSH NLP COMP, P7, DOI DOI 10.18653/V1/W17-2902.; Jiang S, 2020, AAAI CONF ARTIF INTE, V34, P13669; Jurgens D, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P3658; Kaggle, 2020, JIGS MULT TOX COMM C; Kenny A, 2011, FREEWILL RESPONSIBIL; Khatri C, 2018, ARXIV180708000, P1; Kiela D, HATEFUL MEMES CHALLE; Kirsch Andreas, 2019, ADV NEURAL INFORM PR, P7026; Lachenicht Lance G., 1980, INT J HUMAN COMMUNIC, V13, P607; Lin LF, 2018, BIOMETRICS, V74, P785, DOI 10.1111/biom.12817; Ljubesic N, 2018, P 2 WORKSH AB LANG O, P124, DOI [10.18653/v1/W18-5116, DOI 10.18653/V1/W18-5116]; Luo Q, 2017, 2017 INTERNATIONAL WORKSHOP ON ANTENNA TECHNOLOGY: SMALL ANTENNAS, INNOVATIVE STRUCTURES, AND APPLICATIONS (IWAT), P260, DOI 10.1109/IWAT.2017.7915374; Lutzky U, 2016, INT J CORPUS LINGUIS, V21, P165, DOI 10.1075/ijcl.21.2.02lut; Margetts H, 2016, POLITICAL TURBULENCE: HOW SOCIAL MEDIA SHAPE COLLECTIVE ACTION; Marwick A, 2014, ONLINE HARASSMENT DE; Mathew B, 2019, PROCEEDINGS OF THE 11TH ACM CONFERENCE ON WEB SCIENCE (WEBSCI'19), P173, DOI 10.1145/3292522.3326034; Maynard D, 2014, LREC 2014 - NINTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P4238; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; Munafo MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0021; Newton C, 2018, TRAUMA FLOOR SECRET; Nobata C, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P145, DOI 10.1145/2872427.2883062; Ousidhoum N, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P4675; Pavlopoulos John, 2017, P 2017 C EMPIRICAL M, P1125; Pustejovsky J., 2012, NATURAL LANGUAGE ANN; Rezvan M, 2018, WEBSCI'18: PROCEEDINGS OF THE 10TH ACM CONFERENCE ON WEB SCIENCE, P33, DOI 10.1145/3201064.3201103; Ritesh K., 2018, LREC, P1; Ritson S, 2016, SOC STUD SCI, V46, P607, DOI 10.1177/0306312716647508; Rizoiu M.-A., 2019, ARXIV190603829; Ross Bjorn, 2016, P NLP4CMC 3 3 WORKSH, P6; Sabou M, 2014, LREC 2014 - NINTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P859; Salminen J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228723; Salminen J, 2020, HUM-CENTRIC COMPUT I, V10, DOI 10.1186/s13673-019-0205-6; Salminen J, 2018, 2018 FIFTH INTERNATIONAL CONFERENCE ON SOCIAL NETWORKS ANALYSIS, MANAGEMENT AND SECURITY (SNAMS), P88, DOI 10.1109/SNAMS.2018.8554954; Sanguinetti M, 2018, PROCEEDINGS OF THE ELEVENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION (LREC 2018), P1768; Sap M, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P1668; Schafer U, 2011, P 49 ANN M ASS COMP, P7; Sharifirad S., 2018, P 2 WORKSH AB LANG O; Sharma N, 2018, 2018 INTERNATIONAL CONFERENCE ON COMPUTATIONAL AND CHARACTERIZATION TECHNIQUES IN ENGINEERING & SCIENCES (CCTES), P106, DOI 10.1109/CCTES.2018.8674146; Shneiderman B., 2016, NEW ABCS RES ACHIEVI; Sigurbergsson GI, 2020, P 12 LANG RES EV C; Skatova A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224240; Sprugnoli R., 2018, P 2 WORKSH AB LANG O, P51, DOI DOI 10.18653/V1/W18-5107; Strossen N., 2018, HATE WHY WE SHOULD R; Suiter J., 2016, POLITICAL INSIGHT, V7, P25; Taddeo M, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2016.0113; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; Tsvetkova M, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3039868; van Deursen AJAM, 2014, NEW MEDIA SOC, V16, P507, DOI 10.1177/1461444813487959; Vidgen B, 2019, MUCH ONLINE ABUSE IS; Vidgen Bertie, 2019, P 3 WORKSH AB LANG O; Wang W.Y., 2019, ARXIV190904251; Waqas A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222194; Waseem Z., 2016, P HUMAN LANGUAGE TEC, P88, DOI DOI 10.18653/V1/N16-2013; Waseem Zeerak, 2016, P 1 WORKSH NLP COMP, P138, DOI DOI 10.18653/V1/W16-5618; West SM, 2018, NEW MEDIA SOC, V20, P4366, DOI 10.1177/1461444818773059; Wiegand Michael, 2019, P 2019 C N AM CHAPTE, P602; Williams M, 2019, HATRED SCENES REPORT; Williams ML, 2017, SOCIOLOGY, V51, P1149, DOI 10.1177/0038038517708140; Williams ML, 2016, BRIT J CRIMINOL, V56, P211, DOI 10.1093/bjc/azv059; Yang F, 2019, THIRD WORKSHOP ON ABUSIVE LANGUAGE ONLINE, P11; Zampieri M., 2019, P NAACL, V1, P1415, DOI [DOI 10.18653/V1/N19-1144, 10.18653/v1/N19-1144]; Zampieri Marcos, 2019, P SEMEVAL, P75, DOI DOI 10.18653/V1/S19-2010; Zampieri Marcos, 2020, P SEMEVAL, P1425; Zannettou S, 2018, IMC'18: PROCEEDINGS OF THE INTERNET MEASUREMENT CONFERENCE, P188, DOI 10.1145/3278532.3278550	141	40	40	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243300	10.1371/journal.pone.0243300	http://dx.doi.org/10.1371/journal.pone.0243300			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370298	Green Published, Green Submitted, gold			2022-12-27	WOS:000603611900002
J	Josiassen, J; Helgestad, OKL; Moller, JE; Kjaergaard, J; Hoejgaard, HF; Schmidt, H; Jensen, LO; Holmvang, L; Ravn, HB; Hassager, C				Josiassen, Jakob; Lerche Helgestad, Ole Kristian; Moller, Jacob Eifer; Kjaergaard, Jesper; Hoejgaard, Henrik Frederiksen; Schmidt, Henrik; Jensen, Lisette Okkels; Holmvang, Lene; Ravn, Hanne Berg; Hassager, Christian			Hemodynamic and metabolic recovery in acute myocardial infarction-related cardiogenic shock is more rapid among patients presenting with out-of-hospital cardiac arrest	PLOS ONE			English	Article							TARGETED TEMPERATURE MANAGEMENT; VENOUS OXYGEN-SATURATION; VASOPRESSOR SUPPORT; LACTATE CLEARANCE; MORTALITY; 36-DEGREES-C; 33-DEGREES-C; TRENDS; RESUSCITATION; SURVIVAL	Background Most studies in acute myocardial infarction complicated by cardiogenic shock (AMICS) include patients presenting with and without out-of-hospital cardiac arrest (OHCA). The aim was to compare OHCA and non-OHCA AMICS patients in terms of hemodynamics, management in the intensive care unit (ICU) and outcome. Methods From a cohort corresponding to two thirds of the Danish population, all patients with AMICS admitted from 2010-2017 were individually identified through patient records. Results A total of 1716 AMICS patients were identified of which 723 (42%) presented with OHCA. A total of 1532 patients survived to ICU admission. At the time of ICU arrival, there were no differences between OHCA and non-OHCA AMICS patients in variables commonly used in the AMICS definition (mean arterial pressure (MAP) (72mmHg vs 70mmHg, p = 0.12), lactate (4.3mmol/L vs 4.0mmol/L, p = 0.09) and cardiac output (CO) (4.6L/min vs 4.4L/min, p = 0.30)) were observed. However, during the initial days of ICU treatment OHCA patients had a higher MAP despite a lower need for vasoactive drugs, higher CO, SVO2 and lactate clearance compared to non-OHCA patients (p<0.05 for all). In multivariable analysis outcome was similar but cause of death differed significantly with hypoxic brain injury being leading cause in OHCA and cardiac failure in non-OHCA AMICS patients. Conclusion OHCA and non-OHCA AMICS patients initially have comparable metabolic and hemodynamic profiles, but marked differences develop between the groups during the first days of ICU treatment. Thus, pooling of OHCA and non-OHCA patients as one clinical entity in studies should be done with caution.	[Josiassen, Jakob; Moller, Jacob Eifer; Kjaergaard, Jesper; Holmvang, Lene; Hassager, Christian] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark; [Lerche Helgestad, Ole Kristian; Moller, Jacob Eifer; Jensen, Lisette Okkels] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Lerche Helgestad, Ole Kristian; Moller, Jacob Eifer] Univ Southern Denmark, Odense Patient Data Explorat Network, Odense, Denmark; [Hoejgaard, Henrik Frederiksen; Schmidt, Henrik] Odense Univ Hosp, Dept Cardiothorac Anesthesia, Odense, Denmark; [Holmvang, Lene; Ravn, Hanne Berg; Hassager, Christian] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Ravn, Hanne Berg] Copenhagen Univ Hosp, Dept Cardiothorac Anesthesia, Rigshosp, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen	Josiassen, J (corresponding author), Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark.	Jakob.josiassen@regionh.dk	Josiassen, Jakob/AAF-9151-2021; Ravn, Hanne Berg/K-3118-2016	Kjaergaard, Jesper/0000-0001-5244-0399; Helgestad, Ole Kristian Lerche/0000-0003-3847-8758; Jensen, Lisette Okkels/0000-0002-4838-2429; Ravn, Hanne Berg/0000-0003-4702-5195; Hassager, Christian/0000-0002-1199-0981	Danish Heart Foundation; Jorgen Moller foundation; Abiomed	Danish Heart Foundation; Jorgen Moller foundation; Abiomed	The study was funded by The Danish Heart Foundation, The Jorgen Moller foundation and a research grant from Abiomed. The funding parts were not involved in any aspects of the creation or publishing of current study.	[Anonymous], 2017, J COLD WAR STUDIES, V19, P192; Attana P, 2012, EUR HEART J-ACUTE CA, V1, P115, DOI 10.1177/2048872612451168; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bro-Jeppesen J, 2015, CRIT CARE MED, V43, P318, DOI 10.1097/CCM.0000000000000691; Bro-Jeppesen J, 2014, CIRC-CARDIOVASC INTE, V7, P663, DOI 10.1161/CIRCINTERVENTIONS.114.001556; Bro-Jeppesen J, 2009, RESUSCITATION, V80, P171, DOI 10.1016/j.resuscitation.2008.09.009; Fuernau G, 2019, CIRCULATION, V139, P448, DOI 10.1161/CIRCULATIONAHA.117.032722; Goldberg RJ, 2016, CIRC-CARDIOVASC QUAL, V9, P117, DOI 10.1161/CIRCOUTCOMES.115.002359; Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947; Hassager C, 2018, LANCET, V391, P989, DOI 10.1016/S0140-6736(18)30315-5; Helgestad OKL, 2019, EUR J HEART FAIL, V21, P1370, DOI 10.1002/ejhf.1566; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Husain I, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1887; Jentzer JC, 2020, CIRC-CARDIOVASC QUAL, V13, P607, DOI 10.1161/CIRCOUTCOMES.120.006692; Jentzer JC, 2019, J AM COLL CARDIOL, V74, P2117, DOI 10.1016/j.jacc.2019.07.077; Kern KB, 1996, J AM COLL CARDIOL, V28, P232, DOI 10.1016/0735-1097(96)00130-1; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Mentzelopoulos SD, 2017, RESUSCITATION, V121, pA12, DOI 10.1016/j.resuscitation.2017.10.013; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; NIMMO GR, 1994, ANAESTHESIA, V49, P485, DOI 10.1111/j.1365-2044.1994.tb03517.x; NIMMO GR, 1992, AM HEART J, V123, P1720, DOI 10.1016/0002-8703(92)90838-M; Obling L, 2018, EUR HEART J-ACUTE CA, V7, P7, DOI 10.1177/2048872617706503; Ostenfeld S, 2015, RESUSCITATION, V87, P57, DOI 10.1016/j.resuscitation.2014.11.010; Patterson T, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.005346; Samanta R, 2019, IJC HEART VASC, V22, P50, DOI 10.1016/j.ijcha.2018.12.001; Soholm H, 2015, ANN EMERG MED, V65, P523, DOI 10.1016/j.annemergmed.2014.12.009; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; SUMIMOTO T, 1991, AM HEART J, V122, P27, DOI 10.1016/0002-8703(91)90754-6; Thiele H, 2017, NEW ENGL J MED, V377, P2419, DOI 10.1056/NEJMoa1710261; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Ueki Y, 2016, CIRC J, V80, P852, DOI 10.1253/circj.CJ-16-0125; Vallabhajosyula S, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0459-6; Zhang ZH, 2014, CRIT CARE MED, V42, P2118, DOI 10.1097/CCM.0000000000000405	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244294	10.1371/journal.pone.0244294	http://dx.doi.org/10.1371/journal.pone.0244294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362228	Green Published, gold			2022-12-27	WOS:000603071600042
J	Ruba, AL; Pollak, SD				Ruba, Ashley L.; Pollak, Seth D.			Children's emotion inferences from masked faces: Implications for social interactions during COVID-19	PLOS ONE			English	Article							FACIAL EXPRESSIONS; RECOGNIZE EMOTIONS; EYES; HAPPY; MOUTH; CUES; DISCRIMINATION; COMPETENCE; EXPERIENCE; ABILITY	To slow the progression of COVID-19, the Centers for Disease Control (CDC) and the World Health Organization (WHO) have recommended wearing face coverings. However, very little is known about how occluding parts of the face might impact the emotion inferences that children make during social interactions. The current study recruited a racially diverse sample of school-aged (7- to 13-years) children from publicly funded after-school programs. Children made inferences from facial configurations that were not covered, wearing sunglasses to occlude the eyes, or wearing surgical masks to occlude the mouth. Children were still able to make accurate inferences about emotions, even when parts of the faces were covered. These data suggest that while there may be some challenges for children incurred by others wearing masks, in combination with other contextual cues, masks are unlikely to dramatically impair children's social interactions in their everyday lives.	[Ruba, Ashley L.; Pollak, Seth D.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Pollak, Seth D.] Univ Wisconsin, Waisman Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ruba, AL (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	ruba@wisc.edu	Ruba, Ashley L./S-9116-2019	Ruba, Ashley L./0000-0001-6213-6868	National Institute of Mental Health [R01 MH61285, T32 MH018931]; National Institute of Child Health and Human Development [U54 HD090256]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	SDP was supported by the National Institute of Mental Health (R01 MH61285) and a core grant to the Waisman Center from the National Institute of Child Health and Human Development (U54 HD090256). ALR was supported by an Emotion Research Training Grant (T32 MH018931) from the National Institute of Mental Health. Funders did not play any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, J CONSUM PSYCHOL, V10, P83, DOI DOI 10.1361/105996301770349547; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Barrett LF, 2019, PSYCHOL SCI PUBL INT, V20, P1, DOI 10.1177/1529100619832930; Blais C, 2017, EMOTION, V17, P1107, DOI 10.1037/emo0000283; Bombari D, 2013, Q J EXP PSYCHOL, V66, P2426, DOI 10.1080/17470218.2013.789065; Calvo MG, 2013, MOTIV EMOTION, V37, P202, DOI 10.1007/s11031-012-9298-1; Denham SA, 2014, INFANT CHILD DEV, V23, P426, DOI 10.1002/icd.1840; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; Fischer AH, 2012, SOC PSYCHOL PERS SCI, V3, P266, DOI 10.1177/1948550611418534; Fortin Jacey, 2020, NY TIMES; Franco F, 2014, RES DEV DISABIL, V35, P1015, DOI 10.1016/j.ridd.2014.01.037; Gagnon M, 2014, J GENET PSYCHOL, V175, P416, DOI 10.1080/00221325.2014.941322; Green C, 2018, COGNITION EMOTION, V32, P37, DOI 10.1080/02699931.2016.1273200; Grossmann T, 2017, PERSPECT PSYCHOL SCI, V12, P107, DOI 10.1177/1745691616654457; Guarnera M, 2015, EUR J PSYCHOL, V11, P183, DOI 10.5964/ejop.v11i2.890; Izard C, 2001, PSYCHOL SCI, V12, P18, DOI 10.1111/1467-9280.00304; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jack Rachael E, 2009, Curr Biol, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Jessen S, 2016, COGNITION, V150, P163, DOI 10.1016/j.cognition.2016.02.010; Jessen S, 2014, P NATL ACAD SCI USA, V111, P16208, DOI 10.1073/pnas.1411333111; Kanat M, 2015, NEUROPSYCHOPHARMACOL, V40, P287, DOI 10.1038/npp.2014.183; Katz R, 2020, ARE YOU HAPPY SAD WE; KESTENBAUM R, 1992, DEV PSYCHOL, V28, P1132, DOI 10.1037/0012-1649.28.6.1132; Klass P, 2020, NY TIMES; Kret ME, 2018, COGNITION EMOTION, V32, P623, DOI 10.1080/02699931.2017.1330253; Kret ME, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00110; Krol KM, 2015, P NATL ACAD SCI USA, V112, pE5434, DOI 10.1073/pnas.1506352112; Leitzke BT, 2016, DEV PSYCHOL, V52, P572, DOI 10.1037/a0040067; Leppanen JM, 2007, VIS COGN, V15, P468, DOI 10.1080/13506280600765333; Morin-Lessard E, 2019, DEV PSYCHOL, V55, P1640, DOI 10.1037/dev0000750; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Ong S, 2020, BRIT BROADCASTING CO; Plate RC, 2019, J EXP PSYCHOL GEN, V148, P1814, DOI 10.1037/xge0000529; Pollak SD, 2002, DEV PSYCHOL, V38, P784, DOI 10.1037/0012-1649.38.5.784; R Core Team, 2015, R LANGUAGE ENV STAT; Rigoulot S, 2014, SPEECH COMMUN, V65, P36, DOI 10.1016/j.specom.2014.05.006; Roberson D, 2012, COGNITION, V125, P195, DOI 10.1016/j.cognition.2012.06.018; Ruba A.L., 2020, ANN REV DEVELOPMENTA, V2, P503, DOI [10.1146/annurev-devpsych-060320-102556, DOI 10.1146/ANNUREV-DEVPSYCH-060320-102556]; Ruba Ashley L, 2020, Affect Sci, V1, P4, DOI 10.1007/s42761-020-00005-x; Ruba AL, 2020, EMOT REV, V12, P255, DOI 10.1177/1754073920931574; Ruba AL, 2020, EMOT REV, V12, P235, DOI 10.1177/1754073919871098; Ruba AL, 2019, DEV PSYCHOL, V55, P1138, DOI 10.1037/dev0000711; Scheller E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041792; Schwarzer G, 2007, DEVELOPMENTAL SCI, V10, P452, DOI 10.1111/j.1467-7687.2007.00599.x; Schyns PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005625; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Thorstenson CA, 2019, EMOTION, V19, P799, DOI 10.1037/emo0000485; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Wegrzyn M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177239; WICKHAM H, 2009, GGPLOT2 ELEGENT GRAP	50	45	45	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243708	10.1371/journal.pone.0243708	http://dx.doi.org/10.1371/journal.pone.0243708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362251	Green Published, gold			2022-12-27	WOS:000603071600032
J	Yavas, A; Weij, R; van Putten, M; Kourkouta, E; Beekman, C; Puolivali, J; Bragge, T; Ahtoniemi, T; Knijnenburg, J; Hoogenboom, ME; Ariyurek, Y; Aartsma-Rus, A; van Deutekom, J; Datson, N				Yavas, Alper; Weij, Rudie; van Putten, Maaike; Kourkouta, Eleni; Beekman, Chantal; Puolivali, Jukka; Bragge, Timo; Ahtoniemi, Toni; Knijnenburg, Jeroen; Hoogenboom, Marlies Elisabeth; Ariyurek, Yavuz; Aartsma-Rus, Annemieke; van Deutekom, Judith; Datson, Nicole			Detailed genetic and functional analysis of the hDMDdel52/mdx mouse model	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; EFFICACY; DATABASE	Duchenne muscular dystrophy (DMD) is a severe, progressive neuromuscular disorder caused by reading frame disrupting mutations in the DMD gene leading to absence of functional dystrophin. Antisense oligonucleotide (AON)-mediated exon skipping is a therapeutic approach aimed at restoring the reading frame at the pre-mRNA level, allowing the production of internally truncated partly functional dystrophin proteins. AONs work in a sequence specific manner, which warrants generating humanized mouse models for preclinical tests. To address this, we previously generated the hDMDdel52/mdx mouse model using transcription activator like effector nuclease (TALEN) technology. This model contains mutated murine and human DMD genes, and therefore lacks mouse and human dystrophin resulting in a dystrophic phenotype. It allows preclinical evaluation of AONs inducing the skipping of human DMD exons 51 and 53 and resulting in restoration of dystrophin synthesis. Here, we have further characterized this model genetically and functionally. We discovered that the hDMD and hDMDdel52 transgene is present twice per locus, in a tail-to-tail-orientation. Long-read sequencing revealed a partial deletion of exon 52 (first 25 bp), and a 2.3 kb inversion in intron 51 in both copies. These new findings on the genomic make-up of the hDMD and hDMDdel52 transgene do not affect exon 51 and/or 53 skipping, but do underline the need for extensive genetic analysis of mice generated with genome editing techniques to elucidate additional genetic changes that might have occurred. The hDMDdel52/mdx mice were also evaluated functionally using kinematic gait analysis. This revealed a clear and highly significant difference in overall gait between hDMDdel52/mdx mice and C57BL6/J controls. The motor deficit detected in the model confirms its suitability for preclinical testing of exon skipping AONs for human DMD at both the functional and molecular level.	[Yavas, Alper; van Putten, Maaike; Ariyurek, Yavuz; Aartsma-Rus, Annemieke] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Weij, Rudie; Kourkouta, Eleni; Beekman, Chantal; van Deutekom, Judith; Datson, Nicole] BioMarin Nederland BV, Leiden, Netherlands; [Puolivali, Jukka; Bragge, Timo; Ahtoniemi, Toni] Charles River Discovery Serv, Kuopio, Finland; [Knijnenburg, Jeroen; Hoogenboom, Marlies Elisabeth] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aartsma-Rus, A (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	a.m.rus@lumc.nl	Knijnenburg, Jeroen/AAC-1663-2022	Knijnenburg, Jeroen/0000-0001-5662-7054; Bragge, Timo/0000-0002-8634-0297; Kourkouta, Eleni/0000-0002-6178-0712; van Putten, Maaike/0000-0002-0683-8897				Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2020, NUCLEIC ACID THER, V30, P67, DOI 10.1089/nat.2020.0845; Aartsma-Rus A, 2019, NUCLEIC ACID THER, V29, P13, DOI 10.1089/nat.2018.0756; Aartsma-Rus A, 2018, NAT REV NEUROL, V14, P454, DOI 10.1038/s41582-018-0033-8; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Akpulat U, 2018, MOL THER-NUCL ACIDS, V13, P534, DOI 10.1016/j.omtn.2018.10.002; Andrews JG, 2018, ADOLESC HEALTH MED T, V9, P53, DOI 10.2147/AHMT.S125739; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; [Anonymous], 2019, J INORG ORGANOMET PO, V29, P1; Beekman C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195850; Bello L, 2016, NEUROLOGY, V87, P401, DOI 10.1212/WNL.0000000000002891; Bladen CL, 2015, HUM MUTAT, V36, P395, DOI 10.1002/humu.22758; Cold Snow Front, 2016, AUTOMATION TECHNOLOG, V35, P122; Datson NA, 2020, NUCLEIC ACID THER, V30, P50, DOI 10.1089/nat.2019.0824; Dhillon S, 2020, DRUGS, V80, P1027, DOI 10.1007/s40265-020-01339-3; Gao QQ, 2015, COMPR PHYSIOL, V5, P1223, DOI 10.1002/cphy.c140048; Gazzoli I, 2016, RNA BIOL, V13, P290, DOI 10.1080/15476286.2015.1125074; Hendriksen RGF, 2015, NEUROSCI BIOBEHAV R, V51, P255, DOI 10.1016/j.neubiorev.2015.01.023; Lim KRQ, 2017, DRUG DES DEV THER, V11, P533, DOI 10.2147/DDDT.S97635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maruyama R, 2018, METHODS MOL BIOL, V1828, P165, DOI 10.1007/978-1-4939-8651-4_10; McGreevy JW, 2015, DIS MODEL MECH, V8, P195, DOI 10.1242/dmm.018424; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Muntoni F, 2011, NAT REV DRUG DISCOV, V10, P621, DOI 10.1038/nrd3459; Nakamura A, 2016, J HUM GENET, V61, P663, DOI 10.1038/jhg.2016.28; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P451, DOI 10.1016/j.nmd.2013.02.012; Rader EP, 2016, P NATL ACAD SCI USA, V113, P10992, DOI 10.1073/pnas.1605265113; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; 't Hoen PAC, 2008, J BIOL CHEM, V283, P5899, DOI 10.1074/jbc.M709410200; Veltrop M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193289; Verheul RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162467; Young Courtney S, 2017, J Neuromuscul Dis, V4, P139, DOI 10.3233/JND-170218	34	9	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244215	10.1371/journal.pone.0244215	http://dx.doi.org/10.1371/journal.pone.0244215			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362201	gold, Green Published			2022-12-27	WOS:000603071600035
J	Zhou, X; Sobczak, G; McKay, CM; Litovsky, RY				Zhou, Xin; Sobczak, Gabriel; McKay, Colette M.; Litovsky, Ruth Y.			Comparing fNIRS signal qualities between approaches with and without short channels	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; HEMODYNAMIC-RESPONSE; GLOBAL INTERFERENCE; SPEECH; OXYGENATION; DISTANCE; REDUCE; TISSUE; IMPROVEMENT; ACTIVATION	Functional near-infrared spectroscopy (fNIRS) is a non-invasive technique used to measure changes in oxygenated (HbO) and deoxygenated (HbR) hemoglobin, related to neuronal activity. fNIRS signals are contaminated by the systemic responses in the extracerebral tissue (superficial layer) of the head, as fNIRS uses a back-reflection measurement. Using shorter channels that are only sensitive to responses in the extracerebral tissue but not in the deeper layers where target neuronal activity occurs has been a 'gold standard' to reduce the systemic responses in the fNIRS data from adults. When shorter channels are not available or feasible for implementation, an alternative, i.e., anti-correlation (Anti-Corr) method has been adopted. To date, there has not been a study that directly assesses the outcomes from the two approaches. In this study, we compared the Anti-Corr method with the 'gold standard' in reducing systemic responses to improve fNIRS neural signal qualities. We used eight short channels (8-mm) in a group of adults, and conducted a principal component analysis (PCA) to extract two components that contributed the most to responses in the 8 short channels, which were assumed to contain the global components in the extracerebral tissue. We then used a general linear model (GLM), with and without including event-related regressors, to regress out the 2 principal components from regular fNIRS channels (30 mm), i.e., two GLM-PCA methods. Our results found that, the two GLM-PCA methods showed similar performance, both GLM-PCA methods and the Anti-Corr method improved fNIRS signal qualities, and the two GLM-PCA methods had better performance than the Anti-Corr method.	[Zhou, Xin; Litovsky, Ruth Y.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Sobczak, Gabriel] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [McKay, Colette M.] Bion Inst Australia, Melbourne, Vic, Australia; [McKay, Colette M.] Univ Melbourne, Dept Med Bion, Melbourne, Vic, Australia; [Litovsky, Ruth Y.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA; [Litovsky, Ruth Y.] Univ Wisconsin, Dept Surg, Div Otolaryngol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Bionics Institute; University of Melbourne; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhou, X (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	xzhou353@wisc.edu	Zhou, Xin/AAU-7702-2020	Zhou, Xin/0000-0002-5285-947X; McKay, Colette/0000-0002-1659-9789	NIH-NIDCD [R01DC003083]; UW-Madison's Office of the Vice Chancellor for Research; NIH-NICHD [U54HD090256]	NIH-NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); UW-Madison's Office of the Vice Chancellor for Research; NIH-NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by NIH-NIDCD (https://www.nidcd.nih.gov/, R01DC003083 to RL), UW-Madison's Office of the Vice Chancellor for Research, and a Core grant from NIH-NICHD U54HD090256 to Waisman Center). The sponsors and funders were not involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Acharya JN, 2016, J CLIN NEUROPHYSIOL, V33, P308, DOI 10.1097/WNP.0000000000000316; Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Bauernfeind G, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056010; Bliese P. D., 2000, GROUP AGREEMENT NONI; Brigadoi S, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.025005; Cooper RJ, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00147; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Erdogan SB, 2014, NEUROIMAGE, V87, P490, DOI 10.1016/j.neuroimage.2013.10.024; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463, DOI 10.1139/h04-031; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Funane T, 2014, NEUROIMAGE, V85, P150, DOI 10.1016/j.neuroimage.2013.02.026; Gagnon L, 2014, NEUROIMAGE, V85, P127, DOI 10.1016/j.neuroimage.2013.01.073; Gagnon L, 2012, NEUROIMAGE, V59, P2518, DOI 10.1016/j.neuroimage.2011.08.095; Gagnon L, 2011, NEUROIMAGE, V56, P1362, DOI 10.1016/j.neuroimage.2011.03.001; Goodwin JR, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.015002; Gregg Nicholas M, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00014; Habermehl C, 2012, BIOMEDICAL OPTICS; Hirasawa A, 2015, CLIN PHYSIOL FUNCT I, V35, P237, DOI 10.1111/cpf.12156; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Kamran MA, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00151; Kirilina E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00864; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Lawrence RJ, 2018, HEARING RES, V370, P53, DOI 10.1016/j.heares.2018.09.005; Molavi B, 2010, IEEE ENG MED BIO, P5, DOI 10.1109/IEMBS.2010.5626589; Pollonini L, 2014, HEARING RES, V309, P84, DOI 10.1016/j.heares.2013.11.007; Saager RB, 2005, J OPT SOC AM A, V22, P1874, DOI 10.1364/JOSAA.22.001874; Santosa H, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4812785; Sato T, 2016, NEUROIMAGE, V141, P120, DOI 10.1016/j.neuroimage.2016.06.054; Scarpa F, 2010, OPT EXPRESS, V18, P26550, DOI 10.1364/OE.18.026550; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Scholkmann F, 2014, PHYSIOL MEAS, V35, P717, DOI 10.1088/0967-3334/35/4/717; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Scholkmann F, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.105004; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Strangman GE, 2014, NEUROIMAGE, V85, P136, DOI 10.1016/j.neuroimage.2013.04.090; Tachtsidis I, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.039801; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vigneau M, 2011, NEUROIMAGE, V54, P577, DOI 10.1016/j.neuroimage.2010.07.036; Virtanen J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253323; Weder S, 2018, JARO-J ASSOC RES OTO, V19, P273, DOI 10.1007/s10162-018-0661-0; Wijayasiri P, 2017, HEARING RES, V351, P55, DOI 10.1016/j.heares.2017.05.010; Yamada T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050271; Yamada T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275469; Yucel MA, 2016, BIOMED OPT EXPRESS, V7, P3078, DOI 10.1364/BOE.7.003078; Zhang Q, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2754714; Zhang Q, 2009, NEUROIMAGE, V45, P788, DOI 10.1016/j.neuroimage.2008.12.048; Zhang X, 2017, NEUROPHOTONICS, V4, DOI 10.1117/1.NPh.4.4.041409; Zhang X, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.015004; Zhang YH, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852552; Zhou X, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518786850	55	16	16	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244186	10.1371/journal.pone.0244186	http://dx.doi.org/10.1371/journal.pone.0244186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362260	Green Published, gold			2022-12-27	WOS:000603071600066
J	Schmidt, T; Cloete, A; Davids, A; Makola, L; Zondi, N; Jantjies, M				Schmidt, Tenielle; Cloete, Allanise; Davids, Adlai; Makola, Lehlogonolo; Zondi, Nokubonga; Jantjies, Monalisa			Myths, misconceptions, othering and stigmatizing responses to Covid-19 in South Africa: A rapid qualitative assessment	PLOS ONE			English	Article							DISCRIMINATION; EXPERIENCES; TRANSMISSION; MEN; SEX	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new strain of virus in the Coronavirus family that has not been previously identified. Since SARS-CoV-2 is a new virus, everyone is at risk of catching the Coronavirus disease 2019 (Covid-19). No one has immunity to the virus. Despite this, misconceptions about specific groups of people who are immune to Covid-19 emerged with the onset of the pandemic. This paper explores South African communities' misconceptions about who is most vulnerable to Covid-19. A rapid qualitative assessment was conducted remotely in Gauteng, KwaZulu-Natal and the Western Cape provinces of South Africa. Recruitment of study participants took place through established relationships with civil society organizations and contacts made by researchers. In total, 60 key informant interviews and one focus group discussion was conducted. Atlas.ti.8 Windows was used to facilitate qualitative data analysis. The qualitative data was coded, and thematic analysis used to identify themes. The results show a high level of awareness and knowledge of the transmission and prevention of SARS-CoV-2. Qualitative data revealed that there is awareness of elderly people and those with immunocompromised conditions being more vulnerable to catching Covid-19. However, misconceptions of being protected against the virus or having low or no risk were also evident in the data. We found that false information circulated on social media not only instigated confusion, fear and panic, but also contributed to the construction of misconceptions, othering and stigmatizing responses to Covid-19. The study findings bring attention to the importance of developing communication materials adapted to specific communities to help reduce misconceptions, othering and stigmatization around Covid-19.	[Schmidt, Tenielle; Cloete, Allanise; Davids, Adlai; Zondi, Nokubonga; Jantjies, Monalisa] Human Sci Res Council HSRC, Human & Social Capabil Div, Pretoria, South Africa; [Davids, Adlai] Nelson Mandela Univ, Fac Hlth Sci, Port Elizabeth, South Africa; [Makola, Lehlogonolo] Univ Cape Town UCT, Childrens Inst, Cape Town, South Africa	Human Sciences Research Council-South Africa; Nelson Mandela University	Cloete, A (corresponding author), Human Sci Res Council HSRC, Human & Social Capabil Div, Pretoria, South Africa.	acloete@hsrc.ac.za		Cloete, Allanise/0000-0001-6763-9675; Reddy, Priscilla/0000-0002-0432-9060; Zondi, Nokubonga/0000-0003-0027-1962	Human Sciences Research Council (HSRC)	Human Sciences Research Council (HSRC)	We received discretionary funding from the Office of the Chief Executive Officer (CEO), of the Human Sciences Research Council (HSRC), to implement this qualitative study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari M, 2006, J S AFR STUD, V32, P467, DOI 10.1080/03057070600829542; Adja KYC, 2020, PUBLIC HEALTH, V185, P39, DOI 10.1016/j.puhe.2020.05.054; [Anonymous], 2020, COMMUN BIOL, V3, P1; [Anonymous], PEDIAT RHEUMATOLOGY; [Anonymous], 2020, S AFRICAS ACTION COV; Arafat SMY, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113061; Arshad MS, 2020, FOOD SCI NUTR, V8, P3971, DOI 10.1002/fsn3.1719; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Bruns DP, 2020, J TRANSCULT NURS, V31, P326, DOI 10.1177/1043659620917724; Campbell C, 2005, AM J PUBLIC HEALTH, V95, P808, DOI 10.2105/AJPH.2003.037499; Chapter Beyers C., 2009, BURDENED RACE COLOUR, P79; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Chopra K K, 2020, Indian J Tuberc, V67, P284, DOI 10.1016/j.ijtb.2020.07.012; Cloete A, 2008, AIDS CARE, V20, P1105, DOI 10.1080/09540120701842720; Cloete A., 2018, INVENTION MOFFIE LIF; Cloete A, 2013, STIGMA DISCRIMINATIO, DOI [10.1007/978-94-007-6324-1_15, DOI 10.1007/978-94-007-6324-1_15]; Cloete A, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/420270; Cloete Kalichman S., 2013, STIGMA DISCRIMINATIO, P259; Craffert P. F., 2010, NEOT, V44, P292; Daniel Yaw Fiaveh, 2012, J MED RES; Devakumar D, 2020, LANCET, V395, P1194, DOI 10.1016/S0140-6736(20)30792-3; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Grobler R., 2020, NEWS24; Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; Hargreaves J, 2020, LANCET HIV, V7, pE309, DOI 10.1016/S2352-3018(20)30110-7; Harries AD, 2020, INT J TUBERC LUNG D, V24, P550, DOI 10.5588/ijtld.20.0176; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ibrahim OM, 2020, IJMS, DOI 10.20944/PREPRINTS202004.0492.V1; Johns Hopkins University & Medicine: Coronavirus Resource Center, 2020, REG WORLD COUNTR; Karim SSA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2014960; Khumalo TP, 2011, DEV S AFR, DOI [10.1080/0376835X.2011.605559, DOI 10.1080/0376835X.2011.605559]; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lingeswaran M, 2020, INDIAN J CLIN BIOCHE, V35, P260, DOI 10.1007/s12291-020-00897-3; Lithander FE, 2020, AGE AGEING, V49, P501, DOI 10.1093/ageing/afaa093; Logie CH, 2020, AIDS BEHAV, V24, P2003, DOI 10.1007/s10461-020-02856-8; Mwamwenda T.S., 2015, LIFE SCI J, V12, P1576; National Department of Health, 2020, COR VIR COVID 19 OUT; National Department of Health, 2020, FLATT CURV AR LOCKD; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Ngubane S, 2020, COVID 19 IN DEPTH AN; Patton MQ., 2015, BLACKWELL ENCY SOCIO, DOI [10.1002/9781405165518.wbeoss012.pub2, DOI 10.1002/9781405165518.WBEOSS012.PUB2]; Petros G, 2006, CULT HEALTH SEX, V8, P67, DOI 10.1080/13691050500391489; Presidency of South Africa, 2020, COVID 19 PLAN; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; RAS GJ, 1983, S AFR MED J, V64, P140; Rispel LC, 2015, SAHARA J-J SOC ASP H, V12, P10, DOI 10.1080/17290376.2015.1014403; Sahoo Swapnajeet, 2020, NARRATIVE REAL LIFE, DOI [10.1016/j.ajp.2020.102187, DOI 10.1016/J.AJP.2020.102187]; Sano Y, 2016, BMC INT HEALTH HUM R, V16, DOI 10.1186/s12914-016-0089-8; Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005; Simbayi L. C., 2019, S AFRICAN NATL HIV P, DOI [10.1186/s12939-019-1055-6, DOI 10.1186/S12939-019-1055-6]; Singh Lisa, 2020, ArXiv; Singh R, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102222; Skinner D, 2004, SAHARA J, V1, P157; Stiegler N, 2020, ANN MED-PSYCHOL, V178, P695, DOI 10.1016/j.amp.2020.05.006; Tenkorang EY, 2013, CULT HEALTH SEX, V15, P296, DOI 10.1080/13691058.2012.752107; UNAIDS, 2017, CONFR DISCR OV HIV R; WHO U, 2020, SOC STIGM ASS COVID; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; World Health Organisation, 2020, WHO NEWSLETTER; World Health Organization, 2021, RADIOPAEDIA; World Health Organization (WHO), 2020, Q A CORONAVIRUSES CO; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	62	31	31	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244420	10.1371/journal.pone.0244420	http://dx.doi.org/10.1371/journal.pone.0244420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351852	Green Published, gold			2022-12-27	WOS:000603071400051
J	Yan, DQ; Ren, J; Liu, JM; Ding, Y; Niu, JM				Yan, Dongqing; Ren, Jing; Liu, Jiamei; Ding, Yu; Niu, Jianming			De novo assembly, annotation, marker discovery, and genetic diversity of the Stipa breviflora Griseb. (Poaceae) response to grazing	PLOS ONE			English	Article							SOIL PROPERTIES; INNER-MONGOLIA; RNA-SEQ; GRASSLAND; RESISTANCE; EXPRESSION; CHINA; IDENTIFICATION; CHECKLIST; GRASSES	Grassland is one of the most widely-distributed ecosystems on Earth and provides a variety of ecosystem services. Grasslands, however, currently suffer from severe degradation induced by human activities, overgrazing pressure and climate change. In the present study, we explored the transcriptome response of Stipa breviflora, a dominant species in the desert steppe, to grazing through transcriptome sequencing, the development of simple sequence repeat (SSR) markers, and analysis of genetic diversity. De novo assembly produced 111,018 unigenes, of which 88,164 (79.41%) unigenes were annotated. A total of 686 unigenes showed significantly different expression under grazing, including 304 and 382 that were upregulated and downregulated, respectively. These differentially expressed genes (DEGs) were significantly enriched in the "alpha-linolenic acid metabolism" and "plant-pathogen interaction" pathways. Based on transcriptome sequencing data, we developed eight SSR molecular markers and investigated the genetic diversity of S. breviflora in grazed and ungrazed sites. We found that a relatively high level of S. breviflora genetic diversity occurred under grazing. The findings of genes that improve resistance to grazing are helpful for the restoration, conservation, and management of desert steppe.	[Yan, Dongqing; Ren, Jing; Liu, Jiamei; Ding, Yu; Niu, Jianming] Inner Mongolia Univ, Sch Ecol & Environm, Hohhot, Peoples R China; [Niu, Jianming] Minist Sci & Technol, Inner Mongolia Key Lab Grassland Ecol, Hohhot, Peoples R China; [Niu, Jianming] Minist Sci & Technol, Candidate State Key Lab, Hohhot, Peoples R China; [Niu, Jianming] Minist Educ, Key Lab Ecol & Resource Use Mongolian Plateau, Hohhot, Peoples R China	Inner Mongolia University	Niu, JM (corresponding author), Inner Mongolia Univ, Sch Ecol & Environm, Hohhot, Peoples R China.; Niu, JM (corresponding author), Minist Sci & Technol, Inner Mongolia Key Lab Grassland Ecol, Hohhot, Peoples R China.; Niu, JM (corresponding author), Minist Sci & Technol, Candidate State Key Lab, Hohhot, Peoples R China.; Niu, JM (corresponding author), Minist Educ, Key Lab Ecol & Resource Use Mongolian Plateau, Hohhot, Peoples R China.	jmniu2005@163.com			Natural Science Foundation of China (NSFC) [31460154, 31860106]; Major Science and Technology Projects of Inner Mongolia Autonomous Region [2019ZD008]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major Science and Technology Projects of Inner Mongolia Autonomous Region	This study was supported by Natural Science Foundation of China (NSFC) (31460154, 31860106), and Major Science and Technology Projects of Inner Mongolia Autonomous Region (2019ZD008). JN received the above three awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2012, BMC DERMATOLOGY, V12, P13; [Anonymous], 2020, DTSCH ARZTEBL, V117, pA312; [Anonymous], 2014, SELVEDGE MAGAZIN JAN, V56, P16; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Bai YF, 2012, J APPL ECOL, V49, P1204, DOI 10.1111/j.1365-2664.2012.02205.x; Baiakhmetov E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70582-1; Bi GZ, 2018, PLANT CELL, V30, P1543, DOI 10.1105/tpc.17.00981; Bruelheide H, 2019, J VEG SCI, V30, P161, DOI 10.1111/jvs.12710; Chen SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089495; Chen SY, 2009, CURR ISSUES MOL BIOL, V11, P81; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Evju M, 2009, OECOLOGIA, V161, P77, DOI 10.1007/s00442-009-1358-1; Fang JY, 2010, SCI CHINA LIFE SCI, V53, P757, DOI 10.1007/s11427-010-4029-x; FREITAG H, 1985, Notes from the Royal Botanic Garden Edinburgh, V42, P355; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Z, 2010, NZ J AGR RES, V46, P123, DOI [10.1080/00288233.2003.9513538, DOI 10.1080/00288233.2003.9513538]; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jamnadass R, 2006, EUPHYTICA, V151, P431, DOI 10.1007/s10681-006-9175-7; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Klichowska E, 2020, ECOL INDIC, V111, DOI 10.1016/j.ecolind.2019.105998; Klichowska E, 2019, APPL SOIL ECOL, V144, P22, DOI 10.1016/j.apsoil.2019.07.001; Klichowska E, 2018, MOL BIOL REP, V45, P639, DOI 10.1007/s11033-018-4192-x; Krawczyk K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20399-w; Lancet Global Health, 2019, LANCET GLOB HEALTH, V7, pe1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu WT, 2020, GRASSL SCI, V66, P174, DOI 10.1111/grs.12263; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Lu ShengLian, 1996, Acta Phytotaxonomica Sinica, V34, P242; Lv XM, 2019, ECOL EVOL, V9, P9061, DOI 10.1002/ece3.5452; Lv XM, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10103767; Marcotrigiano M, 2000, AM J BOT, V87, P355, DOI 10.2307/2656631; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Matlaga D, 2004, J RANGE MANAGE, V57, P275, DOI 10.2307/4003796; Meng J, 2018, PLANT SCI, V272, P235, DOI 10.1016/j.plantsci.2018.05.003; Nobis M, 2020, ANN MO BOT GARD, V105, P1, DOI 10.3417/2019378; Nobis M, 2019, PERSPECT PLANT ECOL, V39, DOI 10.1016/j.ppees.2019.05.001; Nobis M, 2016, PHYTOTAXA, V267, P29, DOI 10.11646/phytotaxa.267.1.3; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peng JT, 2015, LANDSCAPE ECOL, V30, P1783, DOI 10.1007/s10980-015-0227-z; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Reymond P, 2000, PLANT CELL, V12, P707, DOI 10.1105/tpc.12.5.707; Rico Y, 2014, MOL ECOL, V23, P832, DOI 10.1111/mec.12639; [珊丹 SHAN Dan], 2006, [生态学报, Acta Ecologica Sinica], V26, P3175, DOI 10.1016/S1872-2032(06)60048-6; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0044931, 10.1371/journal.pone.0039812]; Singh HR, 2018, PLANT MOL BIOL REP, V36, P107, DOI 10.1007/s11105-017-1063-x; Smith SE, 2009, RANGELAND ECOL MANAG, V62, P356, DOI 10.2111/08-159.1; Sorensen LI, 2009, ECOSYSTEMS, V12, P830, DOI 10.1007/s10021-009-9260-6; Souto CP, 2019, ENVIRON CONSERV, V46, P59, DOI 10.1017/S0376892918000280; Suza WP, 2010, PLANTA, V231, P717, DOI 10.1007/s00425-009-1080-6; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tsuda K, 2010, CURR OPIN PLANT BIOL, V13, P459, DOI 10.1016/j.pbi.2010.04.006; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Upadhyay RK, 2018, J PLANT PHYSIOL, V231, P318, DOI 10.1016/j.jplph.2018.10.001; Wang JS, 2017, BIOCHEM GENET, V55, P347, DOI 10.1007/s10528-017-9803-z; [王静 Wang Jing], 2004, [生态学报, Acta Ecologica Sinica], V24, P2465; Wang JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19438; WU ZY RP, 2006, FLORA CHINA; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Yang HJ, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2308-2; Yang YH, 2010, GLOBAL CHANGE BIOL, V16, P3036, DOI 10.1111/j.1365-2486.2009.02123.x; Zhai XY, 2015, BIOCHEM SYST ECOL, V62, P51, DOI 10.1016/j.bse.2015.07.036; Zhang B, 2018, GEODERMA, V318, P9, DOI 10.1016/j.geoderma.2017.12.019; Zhang Q, 2012, GENET MOL RES, V11, P2081, DOI 10.4238/2012.August.6.12; Zhang TH, 2004, NEW ZEAL J AGR RES, V47, P307, DOI 10.1080/00288233.2004.9513599; Zhao W, 2009, ECOL RES, V24, P99, DOI 10.1007/s11284-008-0486-0; Zhu XG, 2017, PLANT PHYSIOL, V175, P1853, DOI 10.1104/pp.17.01223; Zuo XA, 2018, ECOL INDIC, V93, P555, DOI 10.1016/j.ecolind.2018.05.032	73	3	3	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244222	10.1371/journal.pone.0244222	http://dx.doi.org/10.1371/journal.pone.0244222			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351838	gold, Green Published			2022-12-27	WOS:000603071400050
J	Yin, M; Zhang, JX; Shu, DM; Liu, DZ				Yin, Ming; Zhang, Jianxin; Shu, Deming; Liu, Dianzhi			The relevant resting-state brain activity of ecological microexpression recognition test (EMERT)	PLOS ONE			English	Article								Zhang, et al. (2017) established the ecological microexpression recognition test (EMERT), but it only used white models' expressions as microexpressions and backgrounds, and there was no research detecting its relevant brain activity. The current study used white, black and yellow models' expressions as microexpressions and backgrounds to improve the materials ecological validity of EMERT, and it used eyes-closed and eyes-open resting-state fMRI to detect relevant brain activity of EMERT for the first time. The results showed: (1) Two new recapitulative indexes of EMERT were adopted, such as microexpression M and microexpression SD. The participants could effectively identify almost all the microexpressions, and each microexpression type had a significantly background effect. The EMERT had good retest reliability and calibration validity. (2) ALFFs (Amplitude of Low-Frequency Fluctuations) in both eyes-closed and eyes-open resting-states and ALFFs-difference could predict microexpression M. The relevant brain areas of microexpression M were some frontal lobes, insula, cingulate cortex, hippocampus, parietal lobe, caudate nucleus, thalamus, amygdala, occipital lobe, fusiform, temporal lobe, cerebellum and vermis. (3) ALFFs in both eyes-closed and eyes-open resting-states and ALFFs-difference could predict microexpression SD, and the ALFFs-difference was more predictive. The relevant brain areas of microexpression SD were some frontal lobes, insula, cingulate cortex, cuneus, amygdala, fusiform, occipital lobe, parietal lobe, precuneus, caudate lobe, putamen lobe, thalamus, temporal lobe, cerebellum and vermis. (4) There were many similarities and some differences in the relevant brain areas between microexpression M and SD. All these brain areas can be trained to enhance ecological microexpression recognition ability.	[Yin, Ming] Jiangsu Police Inst, Nanjing, Peoples R China; [Zhang, Jianxin] Jiangnan Univ, Sch Humanities, Wuxi, Jiangsu, Peoples R China; [Shu, Deming; Liu, Dianzhi] Soochow Univ, Sch Educ, Suzhou, Peoples R China	Jiangsu Police Institute; Jiangnan University; Soochow University - China	Zhang, JX (corresponding author), Jiangnan Univ, Sch Humanities, Wuxi, Jiangsu, Peoples R China.; Liu, DZ (corresponding author), Soochow Univ, Sch Educ, Suzhou, Peoples R China.	8201807147@jiangnan.edu.cn; psydzliu@163.com		Zhang, Jianxin/0000-0002-1280-1708	"Fundamental Research Funds for the Central Universities" of China [JUSRP11983]; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015A003]; Mentoring Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province [2016SJD190004]; National Natural Science Foundation of China [31271084]	"Fundamental Research Funds for the Central Universities" of China(Fundamental Research Funds for the Central Universities); Top-notch Academic Programs Project of Jiangsu Higher Education Institutions; Mentoring Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by "the Fundamental Research Funds for the Central Universities" of China (JUSRP11983, JZ, http://kjc.jiangnan.edu.cn/), the Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015A003, MY, http://jyt.jiangsu.gov.cn/art/2015/6/1/art_38765_3245491.html), the Mentoring Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province (2016): 2016SJD190004 (MY, http://jyt.jiangsu.gov.cn/art/2016/6/28/art_58391_7507970.html) and the National Natural Science Foundation of China (31271084, DL, http://www.nsfc.gov.cn/).JZ provided main research ideas and financial support, and was responsible for research design, data collection and analysis, and article writing. MY provided part of research ideas and financial support, and was responsible for research design, data analysis, and article writing. DS was responsible for experiment rogramming with E-Prime and supporting experiment implementation. DL was responsible for guiding the design, implementation, data analysis and article writing of the whole research, and provided financial support.	Dehaene S, 2011, RES PER NEUROSCI, P55, DOI 10.1007/978-3-642-18015-6_4; Ekman P., 1975, UNMASKING FACEA GUID; [胡晓晴 HU XiaoQing], 2009, [心理科学进展, Advances in Psychological Science], V17, P118; Huang P., 2017, SCI REP, V7, P1, DOI 10.1038/s41598-016-0028-x; [江琦 Jiang Qi], 2018, [心理学报, Acta Psychologica Sinica], V50, P655; [李文福 Li Wenfu], 2016, [心理学报, Acta Psychologica Sinica], V48, P331; Liu J, 2018, HUM BRAIN MAPP, V39, P902, DOI 10.1002/hbm.23890; Matsumoto D, 2000, J NONVERBAL BEHAV, V24, P179, DOI 10.1023/A:1006668120583; Nakano T, 2015, NEUROSCI RES, V96, P54, DOI 10.1016/j.neures.2015.02.010; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; Penhune VB, 2012, BEHAV BRAIN RES, V226, P579, DOI 10.1016/j.bbr.2011.09.044; Porter S, 2012, J NONVERBAL BEHAV, V36, P23, DOI 10.1007/s10919-011-0120-7; Shen X. B., 2012, TEMPORAL CHARACTERIS; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; Yin M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00275; [殷明 Yin Ming], 2016, [心理科学进展, Advances in Psychological Science], V24, P1723; [张剑心 Zhang Jianxin], 2017, [心理学报, Acta Psychologica Sinica], V49, P886; Zhang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095018; Zhang Q, 2014, MECH OCCURRENCE EMOT; Zhu CL, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00199	24	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0241681	10.1371/journal.pone.0241681	http://dx.doi.org/10.1371/journal.pone.0241681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351809	gold, Green Published			2022-12-27	WOS:000603071400003
J	Mosharaf, MP; Rahman, H; Ahsan, MA; Akond, Z; Ahmed, FF; Islam, MM; Moni, MA; Mollah, MNH				Mosharaf, Md. Parvez; Rahman, Hafizur; Ahsan, Md. Asif; Akond, Zobaer; Ahmed, Fee Faysal; Islam, Md. Mazharul; Moni, Mohammad Ali; Mollah, Md. Nurul Haque			In silico identification and characterization of AGO, DCL and RDR gene families and their associated regulatory elements in sweet orange (Citrus sinensis L.)	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASES; TRANSCRIPTION FACTOR FAMILY; DOUBLE-STRANDED-RNA; SALICYLIC-ACID; DICER-LIKE; MOLECULAR-MECHANISMS; ARGONAUTE PROTEINS; DNA-BINDING; G-BOX; ARABIDOPSIS	RNA interference (RNAi) plays key roles in post-transcriptional and chromatin modification levels as well as regulates various eukaryotic gene expressions which are involved in stress responses, development and maintenance of genome integrity during developmental stages. The whole mechanism of RNAi pathway is directly involved with the gene-silencing process by the interaction of Dicer-Like (DCL), Argonaute (AGO) and RNA-dependent RNA polymerase (RDR) gene families and their regulatory elements. However, these RNAi gene families and their sub-cellular locations, functional pathways and regulatory components were not extensively investigated in the case of economically and nutritionally important fruit plant sweet orange (Citrus sinensis L.). Therefore, in silico characterization, gene diversity and regulatory factor analysis of RNA silencing genes in C. sinensis were conducted by using the integrated bioinformatics approaches. Genome-wide comparison analysis based on phylogenetic tree approach detected 4 CsDCL, 8 CsAGO and 4 CsRDR as RNAi candidate genes in C. sinensis corresponding to the RNAi genes of model plant Arabidopsis thaliana. The domain and motif composition and gene structure analyses for all three gene families exhibited almost homogeneity within the same group members. The Gene Ontology enrichment analysis clearly indicated that the predicted genes have direct involvement into the gene-silencing and other important pathways. The key regulatory transcription factors (TFs) MYB, Dof, ERF, NAC, MIKC_MADS, WRKY and bZIP were identified by their interaction network analysis with the predicted genes. The cis-acting regulatory elements associated with the predicted genes were detected as responsive to light, stress and hormone functions. Furthermore, the expressed sequence tag (EST) analysis showed that these RNAi candidate genes were highly expressed in fruit and leaves indicating their organ specific functions. Our genome-wide comparison and integrated bioinformatics analyses provided some necessary information about sweet orange RNA silencing components that would pave a ground for further investigation of functional mechanism of the predicted genes and their regulatory factors.	[Mosharaf, Md. Parvez; Ahsan, Md. Asif; Akond, Zobaer; Ahmed, Fee Faysal; Islam, Md. Mazharul; Mollah, Md. Nurul Haque] Univ Rajshahi, Dept Stat, Bioinformat Lab, Rajshahi, Bangladesh; [Rahman, Hafizur] Univ Rajshahi, Rajshahi Inst Biosci, Dept Microbiol, Rajshahi, Bangladesh; [Akond, Zobaer] Univ Rajshahi, Inst Environm Sci, Rajshahi, Bangladesh; [Akond, Zobaer] Bangladesh Agr Res Inst BARI, Agr Stat & ICT Div, Gazipur, Bangladesh; [Ahmed, Fee Faysal] Jashore Univ Sci & Technol, Dept Math, Jashore, Bangladesh; [Moni, Mohammad Ali] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Biomed Sci, Sydney, NSW, Australia	University of Rajshahi; University of Rajshahi; University of Rajshahi; Bangladesh Agricultural Research Institute (BARI); University of Sydney	Mollah, MNH (corresponding author), Univ Rajshahi, Dept Stat, Bioinformat Lab, Rajshahi, Bangladesh.	mollah.stat.bio@ru.ac.bd	Moni, Mohammad Ali/ABG-3606-2020	Mollah, Md. Nurul Haque/0000-0002-3883-3396; Moni, Mohammad Ali/0000-0003-0756-1006; Akond, Dr. zobaer/0000-0002-8557-7145				Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; [Anonymous], 2006, PLOS CLIN TRIALS, V1, pe33, DOI 10.1371/journal.pctr.0010033; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2014, LANCET ONCOL, V15, pe475; [Anonymous], 2020, CANC DISCOV, V10, pOF8; [Anonymous], 2016, CANC DISCOV; [Anonymous], 2011, J NATL COMPR CANC NE, V9; ARIAS JA, 1993, PLANT CELL, V5, P485, DOI 10.1105/tpc.5.4.485; Arnaud MB, 2009, TRENDS MICROBIOL, V17, P295, DOI 10.1016/j.tim.2009.04.007; Bai M, 2012, GENE, V501, P52, DOI 10.1016/j.gene.2012.02.009; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Borges F, 2015, NAT REV MOL CELL BIO, V16, P727, DOI 10.1038/nrm4085; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Cheng W, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02464-7; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Crowell PL, 1999, J NUTR, V129, p775S, DOI 10.1093/jn/129.3.775S; Csorba T, 2015, VIROLOGY, V479, P85, DOI 10.1016/j.virol.2015.02.028; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Devert A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120100; Di Majo D, 2005, FOOD RES INT, V38, P1161, DOI 10.1016/j.foodres.2005.05.001; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Dong QF, 2005, PLANT PHYSIOL, V139, P610, DOI 10.1104/pp.104.059212; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; du Plessis L, 2011, BRIEF BIOINFORM, V12, P723, DOI 10.1093/bib/bbr002; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Ezcurra I, 2000, PLANT J, V24, P57, DOI 10.1046/j.1365-313x.2000.00857.x; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finnegan EJ, 2003, J CELL SCI, V116, P4689, DOI 10.1242/jcs.00838; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Perotti MF, 2017, IUBMB LIFE, V69, P280, DOI 10.1002/iub.1619; Gan DF, 2017, J GENET, V96, P235, DOI 10.1007/s12041-017-0758-y; Garg V, 2017, FRONT PLANT SCI, P8, DOI [10.3389/fpls.2017.00008, DOI 10.3389/FPLS.2017.00008]; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Gro<ss>hans H, 2008, NATURE, DOI 10.1038/451414a; Guo HY, 2017, PLANT BIOTECHNOL J, V15, P107, DOI 10.1111/pbi.12595; Hamar E, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060929; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Hunter C, 2003, CURR BIOL, V13, P1734, DOI 10.1016/j.cub.2003.09.004; Hunter LJR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23082; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jovel J, 2007, J VIROL, V81, P12285, DOI 10.1128/JVI.01192-07; Kapoor M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-451; Katsarou K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005936; Kaur A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184523; Khan SA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061634; KIM SR, 1993, PLANT PHYSIOL, V103, P97, DOI 10.1104/pp.103.1.97; Lai EC, 2003, CURR BIOL, V13, pR925, DOI 10.1016/j.cub.2003.11.017; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Le Gourrierec J, 1999, PLANT J, V18, P663, DOI 10.1046/j.1365-313x.1999.00482.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lingel A, 2004, RNA, V10, P1675, DOI 10.1261/rna.7175704; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Liu JL, 2015, INT J MOL SCI, V16, P12131, DOI 10.3390/ijms160612131; Liu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075826; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Lutova LA, 2015, RUSS J GENET+, V51, P449, DOI 10.1134/S1022795415030084; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Mao XG, 2012, J EXP BOT, V63, P2933, DOI 10.1093/jxb/err462; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Marker S, 2010, NUCLEIC ACIDS RES, V38, P4092, DOI 10.1093/nar/gkq131; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Millar Anthony A., 2005, Functional & Integrative Genomics, V5, P129, DOI 10.1007/s10142-005-0145-2; Mirzaei K, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/967461; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; Mzid R, 2007, PHYSIOL PLANTARUM, V131, P434, DOI 10.1111/j.1399-3054.2007.00975.x; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Nei M, 1987, MOL BIOL EVOL; Nicholson Allen W., 2003, P149; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; NISHIDA J, 1991, INT IMMUNOL, V3, P245, DOI 10.1093/intimm/3.3.245; Noguero M, 2013, PLANT SCI, V209, P32, DOI 10.1016/j.plantsci.2013.03.016; Oh SK, 2008, NEW PHYTOL, V177, P977, DOI 10.1111/j.1469-8137.2007.02310.x; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Prakash V, 2019, PHYSIOL MOL BIOL PLA, V25, P1055, DOI 10.1007/s12298-019-00660-w; Prakash Ved, 2017, Indian Journal of Plant Physiology, V22, P493, DOI 10.1007/s40502-017-0339-3; Qian YX, 2011, PLANT CELL REP, V30, P1347, DOI 10.1007/s00299-011-1046-6; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sabbione A, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1998-1; Sasaki K, 2018, BREEDING SCI, V68, P88, DOI 10.1270/jsbbs.17114; Schmitz RJ, 2007, GENETICS, V176, P1359, DOI 10.1534/genetics.107.070649; Seo PJ, 2010, NEW PHYTOL, V186, P471, DOI 10.1111/j.1469-8137.2010.03183.x; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shim JS, 2013, PLANT J, V73, P483, DOI 10.1111/tpj.12051; Skirycz A, 2007, NEW PHYTOL, V175, P425, DOI 10.1111/j.1469-8137.2007.02129.x; Skirycz A, 2006, PLANT J, V47, P10, DOI 10.1111/j.1365-313X.2006.02767.x; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Venkataraman S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020076; Venkatesh J, 2015, PLANT PHYSIOL BIOCH, V94, P73, DOI 10.1016/j.plaphy.2015.05.010; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang HC, 2016, PLANT PHYSIOL, V170, P2365, DOI 10.1104/pp.15.01283; Wang J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087451, 10.1371/journal.pone.0107012]; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xia R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08543-0; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yadav CB, 2015, PLANT MOL BIOL REP, V33, P43, DOI 10.1007/s11105-014-0736-y; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang H, 2015, CURR OPIN PLANT BIOL, V27, P84, DOI 10.1016/j.pbi.2015.06.011; Zhang WQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00286-0; Zhao HL, 2015, J PLANT GROWTH REGUL, V34, P108, DOI 10.1007/s00344-014-9448-7; Zhou Y, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/7243973; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	144	2	2	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0228233	10.1371/journal.pone.0228233	http://dx.doi.org/10.1371/journal.pone.0228233			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347517	Green Published, gold			2022-12-27	WOS:000603071100059
J	Matangila, JR; Nyembu, RK; Telo, GM; Ngoy, CD; Sakobo, TM; Massolo, JM; Muyembe, BM; Mvwala, RK; Ilunga, CK; Limbole, EB; Ntalaja, JM; Kongo, RM				Matangila, Junior Rika; Nyembu, Ritha Kibambe; Telo, Gloire Mosala; Ngoy, Christian Djuba; Sakobo, Taty Msueun; Massolo, Joel Mbembo; Muyembe, Blandine Mbo; Mvwala, Richard Kapela; Ilunga, Cedric Kabemba; Limbole, Emmanuel Bakilo; Ntalaja, Jeff Mukengeshay; Kongo, Roger Minga			Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study	PLOS ONE			English	Article								Objectives To describe the clinical characteristics of patients infected with SARS-CoV-2 at Clinique Ngaliema, a public hospital, in Kinshasa, in the Democratic Republic of Congo (DRC). Methods This retrospective study analyzed medical records including socio-demographics, past medical history, clinical manifestation, comorbidities, laboratory data, treatment and disease outcome of 160 hospitalized COVID-19 patients, with confirmed result of SARS-CoV-2 viral infection. Results The median age of patients was 54 years (IQR: 38-64), and there was no significant gender difference (51% of male). The most common comorbidities were hypertension (55 [34%]), diabetes (31 [19%]) and obesity (13 [8%]). Fever (93 [58%]), cough (92 [57%]), fatigue (87 [54%]), shortness of breath (72 [45%]) and myalgia (33 [21%]) were the most common symptoms, upon admission. Patients were categorized into mild (92 [57%]), moderate (19 [12%]) and severe (49 [31%]). Severe patients were older and were more likely to have comorbidities, compared to mild ones. The majority of patients (92% [147 of 160]) patients received hydroxychloroquine or chloroquine phosphate. Regression model revealed that older age, lower SpO2, higher heart rate and elevated AST at admission were all risk factors associated with in-hospital death. The prevalence of COVID-19 and malaria co-infection was 0.63% and 70 (44%) of all patients received antimalarial treatment before hospitalization. Conclusion Our findings indicated that the epidemiological and clinical feature of COVID-19 patients in Kinshasa are broadly similar to previous reports from other settings. Older age, lower SpO2, tachycardia, and elevated AST could help to identify patients at higher risk of death at an early stage of the illness. Plasmodium spp co-infection was not common in hospitalized COVID-19 patients.	[Matangila, Junior Rika; Nyembu, Ritha Kibambe; Telo, Gloire Mosala; Ngoy, Christian Djuba; Sakobo, Taty Msueun; Massolo, Joel Mbembo; Muyembe, Blandine Mbo; Mvwala, Richard Kapela; Ilunga, Cedric Kabemba; Limbole, Emmanuel Bakilo; Ntalaja, Jeff Mukengeshay; Kongo, Roger Minga] Clin Ngaliema, Kinshasa, DEM REP CONGO; [Matangila, Junior Rika] Univ Kinshasa, Dept Med Trop, Kinshasa, DEM REP CONGO; [Nyembu, Ritha Kibambe] Clin Univ Kinshasa, Dept Biol Med, Kinshasa, DEM REP CONGO; [Ilunga, Cedric Kabemba] Clin Univ Kinshasa, Dept Med Interne, Kinshasa, DEM REP CONGO	Universite de Kinshasa; Universite de Kinshasa; Universite de Kinshasa	Matangila, JR (corresponding author), Clin Ngaliema, Kinshasa, DEM REP CONGO.; Matangila, JR (corresponding author), Univ Kinshasa, Dept Med Trop, Kinshasa, DEM REP CONGO.	matangilaj@yahoo.fr						Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bezzio C, 2020, GUT, V69, P1213, DOI 10.1136/gutjnl-2020-321411; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Doumas M, 2020, J HUM HYPERTENS, V34, P764, DOI 10.1038/s41371-020-0380-y; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Giudicessi JR, 2020, HEART RHYTHM, V17, P1487, DOI 10.1016/j.hrthm.2020.04.045; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Han H, 2020, CLIN CHEM LAB MED, V58, P1116, DOI 10.1515/cclm-2020-0188; Iaccarino G, 2020, HYPERTENSION, V76, P366, DOI 10.1161/HYPERTENSIONAHA.120.15324; Ielapi N, 2020, BIOMARK MED, V14, P713, DOI 10.2217/bmm-2020-0201; Katherine Simbana-Rivera LG-BJGFS-GRFVOPL-CSrALVOPO-P, 2020, INT AN PAND COR DIS; Kazadi W, 2004, AM J TROP MED HYG, V71, P97, DOI 10.4269/ajtmh.2004.71.97; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Lei F, 2020, HEPATOLOGY, V72, P389, DOI 10.1002/hep.31301; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775; Mandina MN, 2020, ANN AFR MED; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Parohan M, 2020, HEPATOL RES, V50, P924, DOI 10.1111/hepr.13510; Republique democratique du Congo MdlSSG, 2020, PROT PRIS CHARG EP C; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; Wan SX, 2020, J MED VIROL, V92, P797, DOI 10.1002/jmv.25783; Wee Liang En, 2020, J Clin Virol, V128, P104436, DOI 10.1016/j.jcv.2020.104436; WHO, 2020, COR DIS COVID 19 OUT; World Health Organization, 2020, LAB TEST COR DIS 201; Xie J, 2020, MAYO CLIN PROC, V95, P1138, DOI 10.1016/j.mayocp.2020.04.006; Zhao KC, 2020, EUR J CLIN MICROBIOL, V39, P2279, DOI 10.1007/s10096-020-03976-8; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu Y, 2020, J INFECTION, V81, P154, DOI [10.1016/j.jinf.2020.03.033, 10.1016/j.jinf.2020.02.022]	29	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244272	10.1371/journal.pone.0244272	http://dx.doi.org/10.1371/journal.pone.0244272			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338063	gold, Green Published			2022-12-27	WOS:000601313500030
J	Gungor, O; Gungor, T; Uskudarli, S				Gungor, Onur; Gungor, Tunga; Uskudarli, Suzan			EXSEQREG: Explaining sequence-based NLP tasks with regions with a case study using morphological features for named entity recognition	PLOS ONE			English	Article								The state-of-the-art systems for most natural language engineering tasks employ machine learning methods. Despite the improved performances of these systems, there is a lack of established methods for assessing the quality of their predictions. This work introduces a method for explaining the predictions of any sequence-based natural language processing (NLP) task implemented with any model, neural or non-neural. Our method named EXSEQREG introduces the concept of region that links the prediction and features that are potentially important for the model. A region is a list of positions in the input sentence associated with a single prediction. Many NLP tasks are compatible with the proposed explanation method as regions can be formed according to the nature of the task. The method models the prediction probability differences that are induced by careful removal of features used by the model. The output of the method is a list of importance values. Each value signifies the impact of the corresponding feature on the prediction. The proposed method is demonstrated with a neural network based named entity recognition (NER) tagger using Turkish and Finnish datasets. A qualitative analysis of the explanations is presented. The results are validated with a procedure based on the mutual information score of each feature. We show that this method produces reasonable explanations and may be used for i) assessing the degree of the contribution of features regarding a specific prediction of the model, ii) exploring the features that played a significant role for a trained model when analyzed across the corpus.	[Gungor, Onur; Gungor, Tunga; Uskudarli, Suzan] Bogazici Univ, Dept Comp Engn, Istanbul, Turkey	Bogazici University	Gungor, O (corresponding author), Bogazici Univ, Dept Comp Engn, Istanbul, Turkey.	onurgu@boun.edu.tr	Uskudarli, S/A-8015-2017	Uskudarli, S/0000-0002-0106-0182	Bogazici University Research Fund (BAP) [13083]	Bogazici University Research Fund (BAP)(Bogazici University)	This research was partially supported by Bogazici University Research Fund (BAP) to TG and SU (Grant 13083). Sahibinden.com provided financial support in the form of a contract-based salary for OG. The specific roles of this author are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adi Yossi, 2016, ARXIV160804207; Alishahi Afra, 2017, P 21 C COMP NAT LANG, P368, DOI DOI 10.18653/V1/K17-1037; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Conneau A, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P2126; Datta A, 2016, P IEEE S SECUR PRIV, P598, DOI 10.1109/SP.2016.42; Griffiths, 2018, P EMNLP WORKSH BLACK, P378; Guidotti R., 2018, ABS180510820 CORR, V1805, P10820; Guidotti R, 2019, ACM COMPUT SURV, V51, DOI 10.1145/3236009; Gungor O, 2018, BRANCH UDPIPE TRAINA; Gungor O, 2019, CODE CONDUCTING EXPT; Gungor O, 2019, NAT LANG ENG, V25, P147, DOI 10.1017/S1351324918000281; Gungor T, 2018, P 27 INT C COMP LING, P2082; Hupkes D, 2018, J ARTIF INTELL RES, V61, P907, DOI 10.1613/jair.1.11196; Jacovi Alon, 2018, P 2018 EMNLP WORKSH, P56, DOI DOI 10.18653/V1/W18-5408; Karttunen L, 2010, PATTERN MATCHING FST; Li Jiwei, 2016, ARXIV161208220; Linzen, 2019, ANAL INTERPRETING NE; Lipovetsky S, 2001, APPL STOCH MODEL BUS, V17, P319, DOI 10.1002/asmb.446; Lundberg SM, 2017, ADV NEUR IN, V30; Nivre Joakim, 2018, UNIVERSAL DEPENDENCI; Oflazer Kemal., 1993, P 6 C EUROPEAN CHAPT, P472, DOI [10.3115/976744.976810, DOI 10.3115/976744.976810]; Poerner N, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P340; Pyysalo Sampo, 2015, P 20 NORD C COMP LIN, P163; Ramshaw Lance A., 1995, 3 WORKSH VER LARG CO; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Ruokolainen T, 2020, LANG RESOUR EVAL, V54, P247, DOI 10.1007/s10579-019-09471-7; Schutze, 2018, P 2018 EMNLP WORKSH, P325; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Shrikumar A, 2017, PMLR, V70, P3145, DOI DOI 10.1145/3292500.3330701; Shrikumar Avanti, 2016, ARXIV160501713; Sommerauer Pia, 2018, P 2018 EMNLP WORKSH, P276, DOI DOI 10.18653/V1/W18-5430; Stahlberg LC, 2018, NEW DIRECT RELIG LIT, P175; Straka M, 2016, LREC 2016 - TENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P4290; Strumbelj E, 2014, KNOWL INF SYST, V41, P647, DOI 10.1007/s10115-013-0679-x; University of Helsinki, 2019, FINN TAG TOOLS; University of Helsinki, 2019, FINN NEWS CORP NAM E; Villarroya, 2018, INTERPRETABILITY SEQ; Yin PC, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P754	38	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244179	10.1371/journal.pone.0244179	http://dx.doi.org/10.1371/journal.pone.0244179			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378340	gold, Green Published			2022-12-27	WOS:000605651300055
J	Gyldenkerne, A; Aagaard, N; Jakobsen, M; Toftelund, C; Hjortdal, J				Gyldenkerne, Anders; Aagaard, Nicolaj; Jakobsen, Malene; Toftelund, Carina; Hjortdal, Jesper			Changes in accommodative function following small-incision lenticule extraction for high myopia	PLOS ONE			English	Article							CONTRAST SENSITIVITY; AMPLITUDE; REPEATABILITY; ABERRATIONS; FACILITY; SAFETY	Purpose To examine whether the amplitude of accommodation, the accommodative response, and the accommodative facility is affected and correlated with changes in higher-order aberrations for patients with high myopia surgically treated with small-incision lenticule extraction (SMILE). Methods 35 highly myopic eyes (myopic spherical equivalent of at least 6 diopters) of 35 patients treated with SMILE were included. Assessments were made before and 3 months after surgery. Donders push-up-method was used to measure the amplitude of accommodation. The accommodative response was assessed using an open-field autorefractor"Grand Seiko WAM-5500" (Grand Seiko Co. Ltd., Hiroshima, Japan) in combination with a Badal optometer and stimuli of accommodation at 0.0, 0.5, 1.25, 2.0, 3.0, and 4.0 D, respectively. Accommodative facility was measured at 40 cm with +/- 2,00D flipper lenses. All measurements of accommodation were performed monocularly with the refractive error corrected with soft contact lenses. Results The amplitude of accommodation did not change statistically significantly (mean difference -0.24 D (SD 0.98), 95% CI of mean difference -0.58 D to 0.11 D, paired-sample t(34) = -1.39; P = 0.17). The accommodative responses at 0.0, 0.5, 1.25, 2.0, 3.0, and 4.0 D did not statistically significantly change either (F(6,29) = 1.15; P = .36). Finally, the accommodative facility was also unchanged with a mean difference of 1.11 cycles per minute (SD 5.11, 95% CI of mean difference -0.64 to 2.87, paired-sample t(34) = 1.29; P = 0.21). No clinically significant associations between changes in accommodation and higher-order aberrations were found. Conclusions SMILE does not alter the amplitude of accommodation, the accommodative response, nor the accommodative facility for highly myopic patients, and the surgically induced corneal higher-order aberrations do not affect the accommodative function.	[Gyldenkerne, Anders; Aagaard, Nicolaj; Jakobsen, Malene; Toftelund, Carina; Hjortdal, Jesper] Aarhus Univ Hosp, Dept Ophthalmol, Aarhus, Denmark	Aarhus University	Gyldenkerne, A (corresponding author), Aarhus Univ Hosp, Dept Ophthalmol, Aarhus, Denmark.	agy@dadlnet.dk						Adler P, 2018, CLIN EXP OPTOM, V101, P764, DOI 10.1111/cxo.12691; Aldaba M, 2015, OPTOMETRY VISION SCI, V92, P1003, DOI 10.1097/OPX.0000000000000685; Allen PM, 2006, VISION RES, V46, P491, DOI 10.1016/j.visres.2005.05.007; Antona B, 2009, OPHTHAL PHYSL OPT, V29, P606, DOI 10.1111/j.1475-1313.2009.00679.x; Antona B, 2009, GRAEF ARCH CLIN EXP, V247, P121, DOI 10.1007/s00417-008-0938-9; Applegate RA, 2003, J CATARACT REFR SURG, V29, P1487, DOI 10.1016/S0886-3350(03)00334-1; ATCHISON DA, 1995, OPTOMETRY VISION SCI, V72, P279, DOI 10.1097/00006324-199504000-00010; Blum M, 2019, J REFRACT SURG, V35, P618, DOI 10.3928/1081597X-20190826-02; Buhren J, 2009, J REFRACT SURG, V25, P559, DOI 10.3928/1081597X-20090610-01; Cheng H, 2004, J VIS, V4, P3, DOI 10.1167/4.4.3; Ciuffreda KJ, 2006, BORISHS CLIN REFRACT, V2nd, P101; De Las Bayonas AG, 2019, CURR BIOL, V29, P3370, DOI 10.1016/j.cub.2019.08.017; Gambra E, 2009, J VISION, V9, DOI 10.1167/9.6.4; Ivarsen A, 2014, OPHTHALMOLOGY, V121, P822, DOI 10.1016/j.ophtha.2013.11.006; Karimian F, 2010, OPTOMETRY VISION SCI, V87, P833, DOI 10.1097/OPX.0b013e3181f6fccc; Liu L, 2008, J HUAZHONG U SCI-MED, V28, P596, DOI 10.1007/s11596-008-0524-8; Momeni-Moghaddam H, 2014, GRAEF ARCH CLIN EXP, V252, P509, DOI 10.1007/s00417-013-2480-7; Moshirfar M, 2015, J CATARACT REFR SURG, V41, P652, DOI 10.1016/j.jcrs.2015.02.006; Otero C, 2018, CURR EYE RES, V43, P788, DOI 10.1080/02713683.2018.1444181; Radner W, 2017, GRAEF ARCH CLIN EXP, V255, P1465, DOI 10.1007/s00417-017-3659-0; Rosenfield M, 1996, OPHTHAL PHYSL OPT, V16, P247, DOI 10.1016/0275-5408(95)00093-3; Scheiman M., 2014, CLIN MANAGEMENT BINO; Schwartz SH, 2019, GEOMETRICAL VISUAL O, V3rd, P115; Vestergaard AH, 2014, J CATARACT REFR SURG, V40, P403, DOI 10.1016/j.jcrs.2013.07.053; WICK B, 1987, AM J OPTOM PHYS OPT, V64, P593; Win-Hall DM, 2010, OPTOMETRY VISION SCI, V87, P873, DOI 10.1097/OPX.0b013e3181f6f98f; Xu YS, 2015, OPTOMETRY VISION SCI, V92, P123, DOI 10.1097/OPX.0000000000000451; Zheng K, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0352-8	28	0	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244602	10.1371/journal.pone.0244602	http://dx.doi.org/10.1371/journal.pone.0244602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378342	Green Published, gold			2022-12-27	WOS:000605651300030
J	Nelson, EL; Khan, SA; Thorve, S; Greenough, PG				Nelson, Erica L.; Khan, Saira A.; Thorve, Swapna; Greenough, P. Gregg			Modeling pastoralist movement in response to environmental variables and conflict in Somaliland: Combining agent-based modeling and geospatial data	PLOS ONE			English	Article								Pastoralism is widely practiced in arid lands and is the primary means of livelihood for approximately 268 million people across Africa. Environmental, interpersonal, and transactional variables such as vegetation and water availability, conflict, ethnic tensions, and private/public land delineation influence the movements of these populations. The challenges of climate change and conflict are widely felt by nomadic pastoralists in Somalia, where resources are scarce, natural disasters are increasingly common, and protracted conflict has plagued communities for decades. Bereft of real-time data, researchers and programmatic personnel often turn to post hoc analysis to understand the interaction between climate, conflict, and migration, and design programs to address the needs of nomadic pastoralists. By designing an Agent-Based Model to simulate the movement of nomadic pastoralists based on typologically-diverse, historical data of environmental, interpersonal, and transactional variables in Somaliland and Puntland between 2008 and 2018, this study explores how pastoralists respond to changing environments. Through subsequent application of spatial analysis such as choropleth maps, kernel density mapping, and standard deviational ellipses, we characterize the resultant pastoralist population distribution in response to these variables. Outcomes demonstrate a large scale spatio-temporal trend of pastoralists migrating to the southeast of the study area with high density areas in the south of Nugaal, the northwest of Sool, and along the Ethiopian border. While minimal inter-seasonal variability is seen, multiple analyses support the consolidation of pastoralists to specifically favorable regions. Exploration of the large-scale population, climate, and conflict trends allows for cogent narratives and associative hypotheses regarding the pastoralist migration during the study period. While this model produces compelling associations between pastoralist movements and terrestrial and conflict variables, it relies heavily on assumptions and incomplete data that are not necessarily representative of realities on the ground. Given the paucity of data regarding pastoralist decision-making and migration, validation remains challenging.	[Nelson, Erica L.; Khan, Saira A.; Greenough, P. Gregg] Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Nelson, Erica L.; Greenough, P. Gregg] Harvard Med Sch, Brigham & Womens Hosp, Dept Emergency Med, Div Global Emergency Med & Humanitarian Programs, Boston, MA 02115 USA; [Khan, Saira A.; Greenough, P. Gregg] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Thorve, Swapna] Univ Virginia, Dept Comp Sci, Charlottesville, VA 22903 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Virginia	Nelson, EL (corresponding author), Harvard Univ, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.; Nelson, EL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Emergency Med, Div Global Emergency Med & Humanitarian Programs, Boston, MA 02115 USA.	elnelson@partners.org			National Center for Civic Innovation Inc; Governance Lab ("GovLab"); World Bank	National Center for Civic Innovation Inc; Governance Lab ("GovLab"); World Bank(The World Bank India)	This project was funded by the National Center for Civic Innovation Inc (https://www.fcny.org/fcny/about/ncci/) acting through and on behalf of The Governance Lab ("GovLab"; https://www.thegovlab.org/).The project grant (no available grant #) funded PGG, ELN, and SAK to conduct this research. This project was originally sponsored by the World Bank (https://www.worldbank.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CLJ, V8, P287; Avis W, 2016, RAPID FRAGILITY MIGR; Boone RB, 2016, BUILDING RESILIENCE OF HUMAN-NATURAL SYSTEMS OF PASTORALISM IN THE DEVELOPING WORLD: INTERDISCIPLINARY PERSPECTIVES, P251, DOI 10.1007/978-3-319-30732-9_7; Carr-Hill RA, 2012, ASSESSMENT ED LIVELI; Chainey S, 2008, SECUR J, V21, P4, DOI 10.1057/palgrave.sj.8350066; FAO, 2018, PAST AFR DRYL; FEWS NET, 2017, SEV DROUGHT RIS PRIC; Ginnetti J., 2014, ASSESSING DROUGHT DI; Hailegiorgis AB, 2010, P INT C ENV MOD SOFT; Kennedy WG, 2010, P 3 WORLD C SOC SIM; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Nugraha, 2012, MALARIA J S1, V11, pP130, DOI [10.1186/1475-2875-11-S1-P130, DOI 10.1186/1475-2875-11-S1-P130]; Oba G, 1987, OVERVIEW DROUGHT STR; Onyango P, 2016, PASTORALISM CLIMATE, P123; Pas A, 2018, LAND-BASEL, V7, DOI 10.3390/land7020041; Sakamoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151157; Security in Mobility Inter-Agency Partnership, 2010, ADV SAF MOV CLIM CHA; Shaughnessy S, 2018, DO E AFRICAS PASTORA; Slim H, 2012, IASC REAL TIME EVALU; Smith C, 2011, ADV GLOB CHANGE RES, V43, P179, DOI 10.1007/978-90-481-3842-5_8; United Nations High Commission for Refugees, 2019, SOM INT DISPL; United Nations Population Fund, 2014, POP EST SURV 2014 18; Wang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118537; Wong DWS, 1998, URBAN GEOGR, V19, P77, DOI 10.2747/0272-3638.19.1.77; Xiao NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131697	26	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244185	10.1371/journal.pone.0244185	http://dx.doi.org/10.1371/journal.pone.0244185			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378352	gold, Green Published			2022-12-27	WOS:000605651300072
J	Margolis, EB; Wallace, TL; Van Orden, LJ; Martin, WJ				Margolis, Elyssa B.; Wallace, Tanya L.; Van Orden, Lori Jean; Martin, William J.			Differential effects of novel kappa opioid receptor antagonists on dopamine neurons using acute brain slice electrophysiology	PLOS ONE			English	Article							NOR-BINALTORPHIMINE; STRESS; DYNORPHIN; ACTIVATION; LY2456302; SINGLE; 2-METHYL-N-((2'-(PYRROLIDIN-1-YLSULFONYL)BIPHENYL-4-YL)METHYL)PROPAN-1-AMINE; DEPENDENCE	Activation of the kappa opioid receptor (KOR) contributes to the aversive properties of stress, and modulates key neuronal circuits underlying many neurobehavioral disorders. KOR agonists directly inhibit ventral tegmental area (VTA) dopaminergic neurons, contributing to aversive responses (Margolis et al. 2003, 2006); therefore, selective KOR antagonists represent a novel therapeutic approach to restore circuit function. We used whole cell electrophysiology in acute rat midbrain slices to evaluate pharmacological properties of four novel KOR antagonists: BTRX-335140, BTRX-395750, PF-04455242, and JNJ-67953964. Each compound concentration-dependently reduced the outward current induced by the KOR selective agonist U-69,593. BTRX-335140 and BTRX-395750 fully blocked U-69,593 currents (IC50 = 1.2 +/- 0.9 and 1.2 +/- 1.3 nM, respectively). JNJ-67953964 showed an IC50 of 3.0 +/- 4.6 nM. PF-04455242 exhibited partial antagonist activity asymptoting at 55% blockade (IC50 = 6.7 +/- 15.1 nM). In 3/8 of neurons, 1 mu M PF-04455242 generated an outward current independent of KOR activation. BTRX-335140 (10 nM) did not affect responses to saturating concentrations of the mu opioid receptor (MOR) agonist DAMGO or the delta opioid receptor (DOR) agonist DPDPE, while JNJ-67953964 (10 nM) partially blocked DAMGO and DPDPE responses. Importantly, BTRX-335140 (10 nM) rapidly washed out with complete recovery of U-69,593 responses within 10 min. Collectively, we show electrophysiological evidence of key differences amongst KOR antagonists that could impact their therapeutic potential and have not been observed using recombinant systems. The results of this study demonstrate the value of characterizing compounds in native neuronal tissue and within circuits implicated in the neurobehavioral disorders of interest.	[Margolis, Elyssa B.] Univ Calif San Francisco, UCSF Weill Inst Neurosci, Dept Neurol, San Francisco, CA 94143 USA; [Wallace, Tanya L.; Van Orden, Lori Jean; Martin, William J.] BlackThorn Therapeut, San Francisco, CA USA	University of California System; University of California San Francisco	Margolis, EB (corresponding author), Univ Calif San Francisco, UCSF Weill Inst Neurosci, Dept Neurol, San Francisco, CA 94143 USA.	elyssa.margolis@ucsf.edu			BlackThorn Therapeutics	BlackThorn Therapeutics	EBM's effort on this project was supported by a grant from BlackThorn Therapeutics to UCSF. TLW, LJVO, and WJM are employees of BlackThorn Therapeutics, the funder of this research, and played active roles in the study design and preparation of the manuscript.	Bajo M, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00045; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2007, J BIOL CHEM, V282, P29803, DOI 10.1074/jbc.M705540200; Carroll FI, 2013, J MED CHEM, V56, P2178, DOI 10.1021/jm301783x; Chartoff E, 2012, NEUROPHARMACOLOGY, V62, P167, DOI 10.1016/j.neuropharm.2011.06.014; Chavkin C, 2016, NEUROPSYCHOPHARMACOL, V41, P373, DOI 10.1038/npp.2015.258; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Custodio-Patsey L, 2020, NEUROPHARMACOLOGY, V163, DOI 10.1016/j.neuropharm.2019.107726; Driscoll JR, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0376-19.2020; Ehrich JM, 2015, J NEUROSCI, V35, P12917, DOI 10.1523/JNEUROSCI.2444-15.2015; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; FALLON JH, 1985, NEUROPEPTIDES, V5, P457, DOI 10.1016/0143-4179(85)90053-8; Grimwood S, 2011, J PHARMACOL EXP THER, V339, P555, DOI 10.1124/jpet.111.185108; Guerrero M, 2019, J MED CHEM, V62, P1761, DOI 10.1021/acs.jmedchem.8b01679; Kallupi M, 2013, BIOL PSYCHIAT, V74, P520, DOI 10.1016/j.biopsych.2013.04.028; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Koob GF, 2015, EUR J PHARMACOL, V753, P73, DOI 10.1016/j.ejphar.2014.11.044; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Lowe SL, 2014, J CLIN PHARMACOL, V54, P968, DOI 10.1002/jcph.286; Margolis EB, 2005, J NEUROPHYSIOL, V93, P3086, DOI 10.1152/jn.00855.2004; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2003, J NEUROSCI, V23, P9981; Margolis EB, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104504; Margolis EB, 2017, NEUROPHARMACOLOGY, V123, P420, DOI 10.1016/j.neuropharm.2017.06.019; Margolis EB, 2014, J NEUROSCI, V34, P14707, DOI 10.1523/JNEUROSCI.2144-14.2014; Margolis EB, 2011, J PHYSIOL-LONDON, V589, P4229, DOI 10.1113/jphysiol.2011.209023; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; McPherson KB, 2018, J NEUROSCI, V38, P8737, DOI 10.1523/JNEUROSCI.0516-18.2018; Melief EJ, 2011, MOL PHARMACOL, V80, P920, DOI 10.1124/mol.111.074195; Munro Thomas A., 2012, BMC Pharmacology, V12, P5, DOI 10.1186/1471-2210-12-5; Naganawa M, 2016, J PHARMACOL EXP THER, V356, P260, DOI 10.1124/jpet.115.229278; Navratilova E, 2019, PAIN, V160, P824, DOI 10.1097/j.pain.0000000000001458; Patkar KA, 2013, J PHARMACOL EXP THER, V346, P545, DOI 10.1124/jpet.113.206086; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; Reed B, 2018, NEUROPSYCHOPHARMACOL, V43, P928, DOI 10.1038/npp.2017.245; Rorick-Kehn LM, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu036; Rorick-Kehn LM, 2014, NEUROPHARMACOLOGY, V77, P131, DOI 10.1016/j.neuropharm.2013.09.021; Schattauer SS, 2019, J BIOL CHEM, V294, P16884, DOI 10.1074/jbc.RA119.009592; Tejeda HA, 2019, BRAIN RES, V1713, P91, DOI 10.1016/j.brainres.2018.09.023; Urbano M, 2014, BIOORG MED CHEM LETT, V24, P2021, DOI 10.1016/j.bmcl.2014.03.040; Verhoest PR, 2011, J MED CHEM, V54, P5868, DOI 10.1021/jm2006035; Walker BM, 2011, ADDICT BIOL, V16, P116, DOI 10.1111/j.1369-1600.2010.00226.x; Walsh SL, 2001, PSYCHOPHARMACOLOGY, V157, P151, DOI 10.1007/s002130100788; Wells AM, 2017, J NEUROSCI, V37, P7656, DOI 10.1523/JNEUROSCI.0885-17.2017; Williams CL, 2014, J NEUROSCI, V34, P10402, DOI 10.1523/JNEUROSCI.0911-13.2014	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0232864	10.1371/journal.pone.0232864	http://dx.doi.org/10.1371/journal.pone.0232864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373369	Green Submitted, Green Published, gold			2022-12-27	WOS:000603612300026
J	Piscitello, A; Saoud, L; Fendrick, AM; Borah, BJ; Lich, KH; Matney, M; Ozbay, AB; Parton, M; Limburg, PJ				Piscitello, Andrew; Saoud, Leila; Fendrick, A. Mark; Borah, Bijan J.; Lich, Kristen Hassmiller; Matney, Michael; Ozbay, A. Burak; Parton, Marcus; Limburg, Paul J.			Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model	PLOS ONE			English	Article							SESSILE SERRATED ADENOMAS; SOCIETY TASK-FORCE; COST-EFFECTIVENESS; CT-COLONOGRAPHY; LONGITUDINAL ADHERENCE; PATIENT NAVIGATION; ADVANCED NEOPLASIA; TRIAL; RECOMMENDATIONS; COLONOSCOPY	Background Real-world adherence to colorectal cancer (CRC) screening strategies is imperfect. The CRC-AIM microsimulation model was used to estimate the impact of imperfect adherence on the relative benefits and burdens of guideline-endorsed, stool-based screening strategies. Methods Predicted outcomes of multi-target stool DNA (mt-sDNA), fecal immunochemical tests (FIT), and high-sensitivity guaiac-based fecal occult blood tests (HSgFOBT) were simulated for 40-year-olds free of diagnosed CRC. For robustness, imperfect adherence was incorporated in multiple ways and with extensive sensitivity analysis. Analysis 1 assumed adherence from 0%-100%, in 10% increments. Analysis 2 longitudinally applied real-world first-round differential adherence rates (base-case imperfect rates = 40% annual FIT vs 34% annual HSgFOBT vs 70% triennial mt-sDNA). Analysis 3 randomly assigned individuals to receive 1, 5, or 9 lifetime (9 = 100% adherence) mt-sDNA tests and 1, 5, or 9 to 26 (26 = 100% adherence) FIT tests. Outcomes are reported per 1000 individuals compared with no screening. Results Each screening strategy decreased CRC incidence and mortality versus no screening. In individuals screened between ages 50-75 and adherence ranging from 10%a-100%, the life-years gained (LYG) for triennial mt-sDNA ranged from 133.1-300.0, for annual FIT from 96.3-318.1, and for annual HSgFOBT from 99.8-320.6. At base-case imperfect adherence rates, mt-sDNA resulted in 19.1% more LYG versus FIT, 25.4% more LYG versus HSgFOBT, and generally had preferable efficiency ratios while offering the most LYG. Completion of at least 21 FIT tests is needed to reach approximately the same LYG achieved with 9 mt-sDNA tests. Conclusions Adherence assumptions affect the conclusions of CRC screening microsimulations that are used to inform CRC screening guidelines. LYG from FIT and HSgFOBT are more sensitive to changes in adherence assumptions than mt-sDNA because they require more tests be completed for equivalent benefit. At imperfect adherence rates, mt-sDNA provides more LYG than FIT or HSgFOBT at an acceptable tradeoff in screening burden.	[Piscitello, Andrew] EmpiriQA LLC, Long Grove, IL 60047 USA; [Saoud, Leila; Matney, Michael; Ozbay, A. Burak; Parton, Marcus] Exact Sci Corp, Madison, WI USA; [Fendrick, A. Mark] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Borah, Bijan J.] Mayo Clin, Dept Hlth Serv Res, Rochester, MN USA; [Lich, Kristen Hassmiller] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC 27515 USA; [Limburg, Paul J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA	University of Michigan System; University of Michigan; Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic	Piscitello, A (corresponding author), EmpiriQA LLC, Long Grove, IL 60047 USA.	ajpiscitello@gmail.com	Manager, Exact Sciences Content/AAU-6068-2021		Exact Sciences Corporation	Exact Sciences Corporation	Financial support for this study was provided by a contract with Exact Sciences Corporation. https://www.exactsciences.com/AP received compensation from Exact Sciences through a consulting agreement with Exact Sciences and EmpiriQA, LLC. LS, MM, ABO, and MP are employees of the study sponsor and received a salary. PJL is Chief Medical Officer for Screening at Exact Sciences but is not an employee of Exact Sciences. The specific roles of these authors are articulated in the `author contributions' section. The funder had no other role in in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2017, CLIN GASTROENTEROL H, V15, P1265, DOI 10.1016/j.cgh.2017.01.025; Allison JE, 2010, GASTROINTEST ENDOSC, V71, P342, DOI 10.1016/j.gie.2009.10.032; [Anonymous], 2020, DESCRIPTION VALIDATI; [Anonymous], 2015, HI0010311201570373 C; [Anonymous], 2018, HI001113020189737 CR; [Anonymous], MOD REG; [Anonymous], HEM SENSA PROD INSTR; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Bordacahar B, 2015, DIGEST LIVER DIS, V47, P95, DOI 10.1016/j.dld.2014.09.006; Chang LC, 2017, CLIN GASTROENTEROL H, V15, P872, DOI 10.1016/j.cgh.2016.07.029; Chen SC, 2007, AM J GASTROENTEROL, V102, P856, DOI 10.1111/j.1572-0241.2006.01054.x; Cyhaniuk A, 2016, AM J MANAG CARE, V22, P105; D'Andrea E, 2020, CANCER MED-US, V9, P824, DOI 10.1002/cam4.2735; de Moor JS, 2018, PREV MED, V112, P199, DOI 10.1016/j.ypmed.2018.05.001; Denters MJ, 2012, GASTROENTEROLOGY, V142, P497, DOI 10.1053/j.gastro.2011.11.024; Dougherty MK, 2018, JAMA INTERN MED, V178, P1645, DOI 10.1001/jamainternmed.2018.4637; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Gellad ZF, 2011, AM J GASTROENTEROL, V106, P1125, DOI 10.1038/ajg.2011.11; Greuter MJE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3667-8; Hassan C, 2012, ALIMENT PHARM THER, V36, P929, DOI 10.1111/apt.12071; Hassan C, 2009, RADIOLOGY, V253, P745, DOI 10.1148/radiol.2533090234; Heigh RI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085659; Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089; Honeycutt S, 2013, CANCER-AM CANCER SOC, V119, P3059, DOI 10.1002/cncr.28033; Horne HN, 2015, CANCER CAUSE CONTROL, V26, P239, DOI 10.1007/s10552-014-0505-0; Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194; Inadomi JM, 2012, ARCH INTERN MED, V172, P575, DOI 10.1001/archinternmed.2012.332; Jensen CD, 2016, ANN INTERN MED, V164, P456, DOI 10.7326/M15-0983; Kapidzic A, 2014, AM J GASTROENTEROL, V109, P1257, DOI 10.1038/ajg.2014.168; Knudsen AB, 2016, JAMA-J AM MED ASSOC, V315, P2595, DOI 10.1001/jama.2016.6828; Knudsen AB, 2010, JNCI-J NATL CANCER I, V102, P1238, DOI 10.1093/jnci/djq242; Kuntz KM, 2015, AHRQ TECHNOLOGY ASSE; Ladabaum U, 2016, GASTROENTEROLOGY, V151, P427, DOI 10.1053/j.gastro.2016.06.003; Lansdorp-Vogelaar I, 2011, EPIDEMIOL REV, V33, P88, DOI 10.1093/epirev/mxr004; Liang PS, 2016, AM J GASTROENTEROL, V111, P105, DOI 10.1038/ajg.2015.367; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Ma MX, 2017, GUT LIVER, V11, P747, DOI 10.5009/gnl16523; Naber SK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220234; Peterse EFP, 2018, CANCER-AM CANCER SOC, V124, P2964, DOI 10.1002/cncr.31543; Piscitello A, 2019, VALIDATING NOVEL COL; Rastogi N, 2019, CANCER MED-US, V8, P2572, DOI 10.1002/cam4.2084; Rex DK, 2017, GASTROENTEROLOGY, V153, P307, DOI 10.1053/j.gastro.2017.05.013; Rex DK, 2018, GASTROINTEST ENDOSC, V87, P254, DOI 10.1016/j.gie.2017.04.035; Ritvo PG, 2015, CANCER EPIDEM BIOMAR, V24, P506, DOI 10.1158/1055-9965.EPI-14-0744; Robertson DJ, 2017, GASTROINTEST ENDOSC, V85, P2, DOI 10.1016/j.gie.2016.09.025; Rutter CM, 2016, MED DECIS MAKING, V36, P604, DOI 10.1177/0272989X15622642; Rutter CM, 2010, CANCER EPIDEM BIOMAR, V19, P1992, DOI 10.1158/1055-9965.EPI-09-0954; Rutter CM, 2009, J AM STAT ASSOC, V104, P1338, DOI 10.1198/jasa.2009.ap07466; Senore C, 2019, GUT, V68, P1232, DOI 10.1136/gutjnl-2018-317293; Shapiro JA, 2012, CANCER EPIDEM BIOMAR, V21, P895, DOI 10.1158/1055-9965.EPI-12-0192; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; van der Steen A, 2015, HEALTH SERV RES, V50, P768, DOI 10.1111/1475-6773.12246; van Gils P, 2009, EUR J CANCER, V45, P1554, DOI 10.1016/j.ejca.2009.01.032; van Roon AHC, 2013, GUT, V62, P409, DOI 10.1136/gutjnl-2011-301583; Vanness DJ, 2011, RADIOLOGY, V261, P487, DOI 10.1148/radiol.11102411; Vart G, 2012, PREV MED, V55, P87, DOI 10.1016/j.ypmed.2012.05.006; Weiser E, 2021, J MED SCREEN, V28, P18, DOI 10.1177/0969141320903756; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457; Zauber AG, 2008, ANN INTERN MED, V149, P659, DOI 10.7326/0003-4819-149-9-200811040-00244	59	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244431	10.1371/journal.pone.0244431	http://dx.doi.org/10.1371/journal.pone.0244431			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PS4IU	33373409	Green Submitted, gold, Green Published			2022-12-27	WOS:000607887800002
J	Abd El-Raheem, T; Mahmoud, RH; Hefzy, EM; Masoud, M; Ismail, R; Aboraia, NMM				Abd El-Raheem, Talal; Mahmoud, Rania H.; Hefzy, Enas M.; Masoud, Mohamed; Ismail, Reham; Aboraia, Nesreen M. M.			Tumor necrosis factor (TNF)-alpha-308 G/A gene polymorphism (rs1800629) in Egyptian patients with alopecia areata and vitiligo, a laboratory and in silico analysis	PLOS ONE			English	Article							FACTOR-ALPHA; PROMOTER POLYMORPHISM; ASSOCIATION; EXPRESSION; SUSCEPTIBILITY; AUTOIMMUNITY; STIMULUS; IMPACT; RISK	Purpose & methods Several single-nucleotide polymorphisms (SNPs) in the promoter region of the TNF-alpha gene can cause variations in the gene regulatory sites and act as risk factors for some autoimmune disorders as alopecia areata (AA) and vitiligo. This study aimed to detect the serum TNF-alpha (sTNF) level (by ELISA) and the rs1800629 (by real-time PCR) among AA and vitiligo Egyptian patients and to determine their relation with disease duration and severity. In silico analysis of this SNP to study the molecular regulation of the mutant genotypes was also done. Results In AA patients, no risk was associated with the mutant genotypes vs. the normal genotype, or with A allele vs. G allele. The risk of vitiligo was significantly higher with the G/A and A/A genotypes compared with HCs (p = 0.011). Similarly, a significantly increased risk was noted in patients with A allele vs. G allele (p<0.0001). In AA and vitiligo patients, a significant increase in sTNF-alpha levels was noted in the mutant G/A genotypes vs. the normal G/G genotype (p<0.0001) and in the A allele vs the G allele (p<0.0001). According to the in silico analysis, this SNP could mainly affect the SP1 transcription factor binding site with subsequent effect on TNF-alpha expression. Conclusion According to results of the laboratory and the in silico study, the mutant TNF-alpha (308) genotypes were risk factors that conferred susceptibility to vitiligo among Egyptian patients but had no effect on the susceptibility to AA.	[Abd El-Raheem, Talal; Aboraia, Nesreen M. M.] Fayoum Univ, Fac Med, Dept Dermatol STDs & Androl, Al Fayyum, Egypt; [Mahmoud, Rania H.] Fayoum Univ, Dept Med Biochem & Mol Biol, Fac Med, Al Fayyum, Egypt; [Hefzy, Enas M.] Fayoum Univ, Dept Med Microbiol & Immunol, Fac Med, Al Fayyum, Egypt; [Masoud, Mohamed] Fayoum Univ, Dept Publ Hlth, Fac Med, Al Fayyum, Egypt; [Ismail, Reham] Manshiat Albakry Gen Hosp, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); Fayoum University	Mahmoud, RH (corresponding author), Fayoum Univ, Dept Med Biochem & Mol Biol, Fac Med, Al Fayyum, Egypt.	rhs00@fayoum.edu.eg	Masoud, Mohamed/AAZ-4763-2021; Mahmoud, Rania/AAN-4320-2021	Masoud, Mohamed/0000-0002-5189-0862; 				Abraham LJ, 1999, J LEUKOCYTE BIOL, V66, P562, DOI 10.1002/jlb.66.4.562; Al-Harthi F, 2013, GENET MOL RES, V12, P2196, DOI 10.4238/2013.July.8.1; Alghamdi KM, 2012, J EUR ACAD DERMATOL, V26, P1463, DOI 10.1111/j.1468-3083.2012.04505.x; AlGhamdi KM, 2012, J DRUGS DERMATOL, V11, P534; Amin S, 2013, J SAUDI SOC DERMATOL, V17, P37, DOI 10.1016/j.jssdds.2013.05.004; Associated Press, 2014, BLOOMINGTON HER 0602, V6, pB5; Atwa MA, 2016, INT J DERMATOL, V55, P666, DOI 10.1111/ijd.12808; Aydingoz IE, 2015, CLIN EXP DERMATOL, V40, P71, DOI 10.1111/ced.12446; Barahmani N, 2009, J AM ACAD DERMATOL, V61, P581, DOI 10.1016/j.jaad.2009.04.031; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chagani T, 1999, AM J RESP CRIT CARE, V160, P278, DOI 10.1164/ajrccm.160.1.9808032; Cristina CS, 2012, INT J DERMATOL, V51, P571, DOI 10.1111/j.1365-4632.2011.05291.x; El Sayed MH, 2014, EGYPT J DERMATOL VEN, V34, P36; El-Tahlawi SR, 2013, J EGYPTIAN WOMENS DE, V10, P81, DOI DOI 10.1097/01.EWX.0000427503.58962.9; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; GALBRAITH GMP, 1995, HUM GENET, V96, P433; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; Grabe Niels, 2002, In Silico Biology, V2, pS1; Gregoriou S, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/928030; Harris JE, 2016, IMMUNOL REV, V269, P11, DOI 10.1111/imr.12369; Jadhav Kavita, 2017, Liver Res, V1, P96, DOI 10.1016/j.livres.2017.08.001; Kasumagic-Halilovic Emina, 2011, Indian J Dermatol, V56, P494, DOI 10.4103/0019-5154.87124; Kawakami T, 2011, DERMAT RES PRACT, V2011, DOI 10.1155/2011/750342; Kim HB, 2006, DIABETES, V55, P1342, DOI 10.2337/db05-1507; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kroeger KM, 2000, CYTOKINE, V12, P110, DOI 10.1006/cyto.1999.0529; Laddha NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052298; Lee AY, 2012, ANN DERMATOL, V24, P115, DOI 10.5021/ad.2012.24.2.115; Lee YH, 2015, GENET MOL RES, V14, P5548, DOI 10.4238/2015.May.25.6; Mane Mandar, 2011, Indian J Dermatol, V56, P407, DOI 10.4103/0019-5154.84768; Namian AM, 2009, ARCH DERMATOL RES, V301, P21, DOI 10.1007/s00403-008-0904-8; Olsen EA, 2004, J AM ACAD DERMATOL, V51, P440, DOI 10.1016/j.jaad.2003.09.032; Rork JF, 2016, CURR OPIN PEDIATR, V28, P463, DOI 10.1097/MOP.0000000000000375; Shaker OG, 2013, HUM IMMUNOL, V74, P796, DOI 10.1016/j.humimm.2013.01.004; Simon JA, 2008, DERMATOLOGY, V216, P234, DOI 10.1159/000112932; Singh Suman, 2012, Indian J Dermatol, V57, P12, DOI 10.4103/0019-5154.92668; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; The I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6906; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Whitmore MM, 2007, J IMMUNOL, V179, P3622, DOI 10.4049/jimmunol.179.6.3622; Wu DZ, 2015, INT J DERMATOL, V54, P1045, DOI 10.1111/ijd.12866; Yazici AC, 2006, ARCH DERMATOL RES, V298, P46, DOI 10.1007/s00403-006-0664-2; Younan DNA, 2015, J CLIN LAB ANAL, V29, P74, DOI 10.1002/jcla.21731; Yu Guo-Hua, 2014, Zhongguo Zhen Jiu, V34, P337; Zhu GH, 2002, ONCOGENE, V21, P8477, DOI 10.1038/sj.onc.1206030	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0240221	10.1371/journal.pone.0240221	http://dx.doi.org/10.1371/journal.pone.0240221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370782	Green Published, gold			2022-12-27	WOS:000603611900126
J	Brunner, M; von Felten, J; Hinz, M; Hafner, A				Brunner, Mirco; von Felten, Jonas; Hinz, Martin; Hafner, Albert			Central European Early Bronze Age chronology revisited: A Bayesian examination of large-scale radiocarbon dating	PLOS ONE			English	Article							BERN	In archaeological research, changes in material culture and the evolution of styles are taken as major indicators for socio-cultural transformation. They form the basis for typo-chronological classification and the establishment of phases and periods. Central European Bronze Age material culture from burials reveals changes during the Bronze Age and represents a perfect case study for analyzing phenomena of cultural change and the adoption of innovation in the societies of prehistoric Europe. Our study focuses on the large-scale change in material culture which took place in the second millennium BC and the emergence at the same period of new burial rites: the shift from inhumation burials in flat graves to complex mounds and simple cremation burials. Paul Reinecke was the first to divide the European Bronze Age (EBA) into two phases, Bz A1 and A2. The shift from the first to the second phase has so far been ascribed to technical advances. Our study adopted an innovative approach to quantifying this phenomenon. Through regressive reciprocal averaging and Bayesian analysis of radiocarbon-dated grave contexts located in Switzerland and southern Germany, we modelled chronological changes in the material culture and changes in burial rites in these regions in a probabilistic way. We used kernel density models to summarize radiocarbon dates, with the aim of visualizing cultural changes in the third and second millennium BC. In 2015, Stockhammer et al. cast doubt on the chronological sequence of the Reinecke phases of the EBA on the basis of newly collected radiocarbon dates from southern Germany. Our intervention is a direct response to the results of that study. We fully agree with Stockhammer's et al. dating of the start of EBA, but propose a markedly different dating of the EBA/MBA transition. Our modelling of radiocarbon data demonstrates a statistically significant typological sequence of phases Bz A1, Bz A2 and Bz B and disproves their postulated chronological overlap. The linking of the archaeological relative-chronological system with absolute dates is of major importance to understanding the temporal dimension of the EBA phases.	[Brunner, Mirco; von Felten, Jonas; Hinz, Martin; Hafner, Albert] Univ Bern, Inst Archaeol Sci, Prehist Archaeol, Bern, Switzerland; [Brunner, Mirco; Hinz, Martin; Hafner, Albert] Univ Bern, Oeschger Ctr Climate Change Res OCCR, Bern, Switzerland; [Brunner, Mirco] Univ Kiel, Grad Sch Human Dev Landscapes, Kiel, Germany	University of Bern; University of Bern; University of Kiel	Brunner, M (corresponding author), Univ Bern, Inst Archaeol Sci, Prehist Archaeol, Bern, Switzerland.; Brunner, M (corresponding author), Univ Bern, Oeschger Ctr Climate Change Res OCCR, Bern, Switzerland.; Brunner, M (corresponding author), Univ Kiel, Grad Sch Human Dev Landscapes, Kiel, Germany.	mirco.brunner@iaw.unibe.ch	; Hinz, Martin/N-5549-2015	Brunner, Mirco/0000-0003-0655-7603; von Felten, Jonas/0000-0002-4572-4219; Hinz, Martin/0000-0002-9904-6548	Swiss National Science Foundation (SNSF) [165306]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The research (including all scientific analyses) was mostly funded by the Swiss National Science Foundation (SNSF) within the framework of the CMCT - Project "Chronology, mobility and cultural transfer based on the example of an innerAlpine settlement landscape. A landscape archaeological study of the central Alpine region" (SNSF-Grant number: 165306).	Abels B-U, 1972, RANDLEISTENBEILE BAD; [Anonymous], **DATA OBJECT**; Bayes M., 1763, PHILOS T, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Bayliss A., 2007, VERNAC ARCHIT, V38, P75, DOI DOI 10.1179/174962907X248074; Bayliss A, 2015, WORLD ARCHAEOL, V47, P677, DOI 10.1080/00438243.2015.1067640; Bayliss A, 2009, RADIOCARBON, V51, P123, DOI 10.1017/S0033822200033750; Becker B, 1989, GERMANIA, V67, P421; Bolohan N, 2015, BRONZ AG CHRON CARP; Buck C.E., 1996, BAYESIAN APPROACH IN; BUCK CE, 1994, ANTIQUITY, V68, P252, DOI 10.1017/S0003598X00046561; BUCK CE, 1991, ANTIQUITY, V65, P808, DOI 10.1017/S0003598X00080534; BUCK CE, 1992, J ARCHAEOL SCI, V19, P497, DOI 10.1016/0305-4403(92)90025-X; Burkart W, 1948, UR SCHWEIZ MITTEILUN, V12, P5; Burkart W, 1949, UR SCHWEIZ MITTEILUN, V13, P35; Capuzzo G, 2015, WORLD ARCHAEOL, V47, P622, DOI 10.1080/00438243.2015.1053571; CHRISTEN JA, 1994, J R STAT SOC C-APPL, V43, P489; CHRISTEN JA, 1995, J ARCHAEOL SCI, V22, P719, DOI 10.1016/0305-4403(95)90002-0; Christen JA, 1995, RADIOCARBON, V37, P431, DOI 10.1017/S0033822200030915; David-Elbiali M, 2000, SUISSE OCCIDENTALE I; David-Elbiali M, 2010, GRIFF NACH STERNEN E, P217; Duvanel L, 2018, NECROPOLE AGE BRONZE; Fischer C, 1997, GRABER SIEDLUNGEN NE; Gubler R, 2010, ANNUAIRE SERVICE ARC, V2010, P147; Gubler R, 2014, ARCHAOLOGIE BERN ARC, V2014, P165; Hafner A, 1998, TRADITION INNOVATION, P385; Hafner A, 1995, FRUHE BRONZEZEIT WES; HILL MO, 1973, J ECOL, V61, P237, DOI 10.2307/2258931; Kimmig W, 1954, WALDSHUT GERMANIA AN, V32, P147, DOI [10.11588/ger.1954.45176, DOI 10.11588/GER.1954.45176]; Kneisel J, 2019, HOLOCENE, V29, P1607, DOI 10.1177/0959683619857237; Knoll F, 2016, ARM REICH ZUR RESSOU, P283; Krause R, 1988, ENDNEOLITHISCHEN FRU; Lulewicz J, 2018, ADV ARCHAEOL PRACT, V6, P58, DOI 10.1017/aap.2017.29; Mader A, 2008, MITTELBRONZEZEITLICH; Massy K, 2019, STUDIA HERCYNIA, VXXIII, P22; Massy K, 2018, UNTERSUCHUNGEN BESTA; Massy K, 2018, VORTRAGE 36 NIEDERBA, P123; McLaughlin TR, 2019, J ARCHAEOL METHOD TH, V26, P479, DOI 10.1007/s10816-018-9381-3; Montelius O, 1903, METHODE; Muller J., 2004, ARCHAOLOGIE SACHSEN, V2, P21; Muller J., 2009, GERMANIA, V87, P25; Primas M, 1972, Z SCHWEIZERISCHE ARC, V29, P5, DOI [10.5169/seals-165805, DOI 10.5169/SEALS-165805]; Ramsey CB, 1998, RADIOCARBON, V40, P461; Ramsey CB, 2017, RADIOCARBON, V59, P1809, DOI 10.1017/RDC.2017.108; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Ramseyer D, 1990, JB SCHWEIZERISCHEN G, V73, P136, DOI [10.5169/seals-117267, DOI 10.5169/SEALS-117267]; Reimer PJ, 2020, RADIOCARBON, V62, P725, DOI 10.1017/RDC.2020.41; Reinecke P., 1924, GERMANIA ANZEIGER RO, V8, P43; RUBIN DB, 1981, ANN STAT, V9, P130, DOI 10.1214/aos/1176345338; Ruckdeschel W, 1978, BEITRAG KENNTNIS STR; Schmid C, 2020, ADAPT BEHAV, V28, P359, DOI 10.1177/1059712319860842; Spindler K, 1973, JB SCHWEIZERISCHEN G, V57, P17, DOI [10.5169/seals-115527, DOI 10.5169/SEALS-115527]; Stockhammer PW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139705; Stockli WE, 2016, URGESCHICHTE SCHWEIZ; Suter PJ, 2003, ARCHAOLOGISCHES KORR, V33, P325; Szidat S, 2014, RADIOCARBON, V56, P561, DOI 10.2458/56.17457; Szidat S, 2017, RADIOCARBON, V59, P831, DOI 10.1017/RDC.2016.90; TERBRAAK CJF, 1988, ADV ECOL RES, V18, P271; Whittle A., 2011, GATHERING TIME DATIN	59	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243719	10.1371/journal.pone.0243719	http://dx.doi.org/10.1371/journal.pone.0243719			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370331	gold, Green Submitted, Green Published			2022-12-27	WOS:000603611900108
J	Ziaeetabar, F; Pomp, J; Pfeiffer, S; El-Sourani, N; Schubotz, RI; Tamosiunaite, M; Worgotter, F				Ziaeetabar, Fatemeh; Pomp, Jennifer; Pfeiffer, Stefan; El-Sourani, Nadiya; Schubotz, Ricarda I.; Tamosiunaite, Minija; Woergoetter, Florentin			Using enriched semantic event chains to model human action prediction based on (minimal) spatial information	PLOS ONE			English	Article							ACTION RECOGNITION; CONTEXT; PERCEPTION; SEGMENTATION; MECHANISMS; OBJECTS	Predicting other people's upcoming action is key to successful social interactions. Previous studies have started to disentangle the various sources of information that action observers exploit, including objects, movements, contextual cues and features regarding the acting person's identity. We here focus on the role of static and dynamic inter-object spatial relations that change during an action. We designed a virtual reality setup and tested recognition speed for ten different manipulation actions. Importantly, all objects had been abstracted by emulating them with cubes such that participants could not infer an action using object information. Instead, participants had to rely only on the limited information that comes from the changes in the spatial relations between the cubes. In spite of these constraints, participants were able to predict actions in, on average, less than 64% of the action's duration. Furthermore, we employed a computational model, the so-called enriched Semantic Event Chain (eSEC), which incorporates the information of different types of spatial relations: (a) objects' touching/untouching, (b) static spatial relations between objects and (c) dynamic spatial relations between objects during an action. Assuming the eSEC as an underlying model, we show, using information theoretical analysis, that humans mostly rely on a mixed-cue strategy when predicting actions. Machine-based action prediction is able to produce faster decisions based on individual cues. We argue that human strategy, though slower, may be particularly beneficial for prediction of natural and more complex actions with more variable or partial sources of information. Our findings contribute to the understanding of how individuals afford inferring observed actions' goals even before full goal accomplishment, and may open new avenues for building robots for conflict-free human-robot cooperation.	[Ziaeetabar, Fatemeh; Pfeiffer, Stefan; Tamosiunaite, Minija; Woergoetter, Florentin] Univ Gottingen, Inst Phys 3, Biophys & Bernstein Ctr Computat Neurosci BCCN, Gottingen, Germany; [Pomp, Jennifer; El-Sourani, Nadiya; Schubotz, Ricarda I.] Univ Munster, Dept Psychol, Munster, Germany; [Tamosiunaite, Minija] Vytautas Magnus Univ, Dept Informat, Kaunas, Lithuania	University of Gottingen; University of Munster; Vytautas Magnus University	Ziaeetabar, F (corresponding author), Univ Gottingen, Inst Phys 3, Biophys & Bernstein Ctr Computat Neurosci BCCN, Gottingen, Germany.	fziaeetabar@gwdg.de		Schubotz, Ricarda/0000-0001-5802-6869; Pomp, Jennifer/0000-0002-8577-7948	German Research Foundation (DFG) [WO388/13-1, SCHU1439/8-1]; European Community [732266]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Community(European Commission)	The research leading to these results has received funding from the German Research Foundation (DFG) grant WO388/13-1 and SCHU1439/8-1 as well as the European Community's H2020 Programme (Future and Emerging Technologies, FET) under grant agreement no. 732266, Plan4Act.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Aein MJ, 2019, INT J ROBOT RES, V38, P910, DOI 10.1177/0278364919850295; Aksoy EE, 2017, INT J COMPUT VISION, V122, P84, DOI 10.1007/s11263-016-0956-8; Aksoy EE, 2011, INT J ROBOT RES, V30, P1229, DOI 10.1177/0278364911410459; Bach P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00254; Barros P, 2017, COMPUT VIS IMAGE UND, V155, P139, DOI 10.1016/j.cviu.2016.10.006; Bolei Zhou, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3441, DOI 10.1109/CVPR.2011.5995459; Bulling A, 2014, ACM COMPUT SURV, V46, DOI 10.1145/2499621; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cheng KY, 2020, IEEE ACCESS, V8, P133527, DOI 10.1109/ACCESS.2020.3008848; Ejdeholm D, 2020, MANIPULATION ACTION; El-Sourani N, 2020, J COGNITIVE NEUROSCI, V32, P326, DOI 10.1162/jocn_a_01480; El-Sourani N, 2018, NEUROIMAGE, V167, P429, DOI 10.1016/j.neuroimage.2017.11.047; Elmezain M., 2009, WORLD ACAD SCI ENG T, V60, P395; Elmezain M, 2009, IEEE IMAGE PROC, P3577, DOI 10.1109/ICIP.2009.5414322; Fathi A, 2012, LECT NOTES COMPUT SC, V7572, P314, DOI 10.1007/978-3-642-33718-5_23; Fermuller C, 2018, INT J COMPUT VISION, V126, P358, DOI 10.1007/s11263-017-0992-z; Giese MA, 2015, NEURON, V88, P167, DOI 10.1016/j.neuron.2015.09.040; Gupta A., 2007, IEEE C COMP VIS PATT, DOI 10.1109/CVPR.2007.383331; Hardwick RM, 2018, NEUROSCI BIOBEHAV R, V94, P31, DOI 10.1016/j.neubiorev.2018.08.003; Heumer G, 2008, PRESENCE-VIRTUAL AUG, V17, P121, DOI 10.1162/pres.17.2.121; Ingram JN, 2010, CURR BIOL, V20, P618, DOI 10.1016/j.cub.2010.01.054; Isik L, 2018, J NEUROPHYSIOL, V119, P631, DOI 10.1152/jn.00642.2017; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jimenez P, 2001, COMPUT GRAPH-UK, V25, P269, DOI 10.1016/S0097-8493(00)00130-8; Kurby CA, 2008, TRENDS COGN SCI, V12, P72, DOI 10.1016/j.tics.2007.11.004; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Li YX, 2011, INT GEOSCI REMOTE SE, P487, DOI 10.1109/IGARSS.2011.6049171; Morris BT, 2011, IEEE T PATTERN ANAL, V33, P2287, DOI 10.1109/TPAMI.2011.64; NEWTSON D, 1976, J EXP SOC PSYCHOL, V12, P436, DOI 10.1016/0022-1031(76)90076-7; NEWTSON D, 1973, J PERS SOC PSYCHOL, V28, P28, DOI 10.1037/h0035584; Nicholson T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169700; Pastra K, 2012, PHILOS T R SOC B, V367, P103, DOI 10.1098/rstb.2011.0123; Pei MT, 2011, IEEE I CONF COMP VIS, P487, DOI 10.1109/ICCV.2011.6126279; Ruddle R. A., 2002, ACM Transactions on Computer-Human Interaction, V9, P285, DOI 10.1145/586081.586084; Ryoo MS, 2011, IEEE I CONF COMP VIS, P1036, DOI 10.1109/ICCV.2011.6126349; Schubotz RI, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00636; Schubotz RI, 2012, NEUROIMAGE, V61, P1195, DOI 10.1016/j.neuroimage.2012.04.008; Schubotz RI, 2009, J COGNITIVE NEUROSCI, V21, P642, DOI 10.1162/jocn.2009.21049; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seker MY, 2019, ROBOT AUTON SYST, V119, P173, DOI 10.1016/j.robot.2019.07.003; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shapovalova N, 2011, LECT NOTES COMPUT SC, V6669, P58; Stadler W, 2012, PSYCHOL RES-PSYCH FO, V76, P395, DOI 10.1007/s00426-012-0431-2; Summers-Stay D, 2012, IEEE INT C INT ROBOT, P4104, DOI 10.1109/IROS.2012.6385483; Sun HY, 2019, IEEE ACCESS, V7, P81227, DOI 10.1109/ACCESS.2019.2923574; Tanke J, 2019, ARXIV191206079; Worgotter F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60923-5; Wurm MF, 2017, DEV PSYCHOL, V53, P662, DOI 10.1037/dev0000273; Wurm MF, 2014, BEHAV BRAIN RES, V274, P108, DOI 10.1016/j.bbr.2014.07.053; Wurm MF, 2012, J COGNITIVE NEUROSCI, V24, P1548, DOI 10.1162/jocn_a_00232; Wurm MF, 2012, NEUROIMAGE, V59, P1551, DOI 10.1016/j.neuroimage.2011.08.038; Yang Y., 2014, ADV COGN SYST, V3, P67; Yang YZ, 2013, PROC CVPR IEEE, P2563, DOI 10.1109/CVPR.2013.331; Yin Zheng, 2012, 2012 19th IEEE International Conference on Image Processing (ICIP 2012), P785, DOI 10.1109/ICIP.2012.6466977; Ziaeetabar Fatemeh, 2017, 2017 IEEE International Conference on Robotics and Automation (ICRA), P4612, DOI 10.1109/ICRA.2017.7989536; Ziaeetabar F, 2018, ROBOT AUTON SYST, V110, P173, DOI 10.1016/j.robot.2018.10.005	58	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243829	10.1371/journal.pone.0243829	http://dx.doi.org/10.1371/journal.pone.0243829			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370343	gold, Green Published			2022-12-27	WOS:000603611900038
J	Shibata, K; Fujiwara, A; Hamasaki, I; Shimizu, T; Kono, R; Kanenaga, K; Nakazawa, M; Morizane, Y				Shibata, Kiyo; Fujiwara, Atsushi; Hamasaki, Ichiro; Shimizu, Takehiro; Kono, Reika; Kanenaga, Keisuke; Nakazawa, Masanori; Morizane, Yuki			Shape analysis of rectus extraocular muscles with age and axial length using anterior segment optical coherence tomography	PLOS ONE			English	Article							SAGGING EYE SYNDROME; INSERTION DISTANCE; STRABISMUS	Purpose This study aimed to evaluate the shape of the extraocular muscles (EOMs) in normal subjects using the en-face images of anterior segment optical coherence tomography (AS-OCT). The EOM insertion and the direction of the muscle fibers were investigated. Subjects and methods A total of 97 healthy normal subjects (194 eyes) at Okayama University Hospital (age, 47.1 +/- 21.5 years; range, 8-79 years) participated in the study. A series of 256 tomographic images of the rectus EOMs were captured using the C-scan function of the AS-OCT (CASIA2, TOMEY Co., Japan), and the images were converted to en-face images in multi-TIFF format. The anterior chamber angle to EOM insertion distance (AID) and the angle of the muscle fibers from the insertion site (angle of muscles) were measured from the images. The correlations of AID and angle of muscles with age and axial length were investigated and evaluated. Results AID and angle of muscles were significantly correlated with age or axial length in some EOMs. The AIDs of medial rectus (MR) (P = 0.000) and superior rectus (SR) (P = 0.005) shortened with age. The AIDs of MR (P = 0.001) and inferior rectus (IR) (P = 0.035) elongated with axial length, whereas lateral rectus (LR) (P = 0.013) shortened. The angles of MR (P = 0.001) and LR (P = 0.000) were found to have a more downward direction toward the posterior in older subjects. Conclusion En-face images can be created by AS-OCT, and the shape of the EOMs in normal subjects using these image measurements was available. With the ability to assess the EOMs, AID and angle of muscles are expected give useful information for treating and diagnosing strabismus-related diseases.	[Shibata, Kiyo; Hamasaki, Ichiro; Shimizu, Takehiro; Kono, Reika; Kanenaga, Keisuke; Morizane, Yuki] Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Okayama, Japan; [Fujiwara, Atsushi] Kawasaki Univ Med Welf, Fac Rehabil, Dept Orthopt, Kurashiki, Okayama, Japan; [Nakazawa, Masanori] Kagoshima Univ, Dept Ophthalmol, Grad Sch Med & Dent Sci, Kagoshima, Japan	Okayama University; Kagoshima University	Hamasaki, I (corresponding author), Okayama Univ, Dept Ophthalmol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Okayama, Japan.	hamasaki_16@okayama-u.ac.jp						Athavale S, 2015, ANAT CELL BIOL, V48, P201, DOI 10.5115/acb.2015.48.3.201; Chaudhuri Z, 2013, JAMA OPHTHALMOL, V131, P619, DOI 10.1001/jamaophthalmol.2013.783; Clark RA, 2002, AM J OPHTHALMOL, V134, P872, DOI 10.1016/S0002-9394(02)01695-1; Dhakal R, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.4.6; Villarreal-Silva EE, 2013, INT J MORPHOL, V31, P312, DOI 10.4067/S0717-95022013000100049; Goseki T, 2020, AM J OPHTHALMOL, V209, P55, DOI 10.1016/j.ajo.2019.09.006; Han Jung Yeob, 2018, Korean J Ophthalmol, V32, P83, DOI 10.3341/kjo.2017.0034; John J, 2017, KERALA J OPHTHALMOL, V29, P112, DOI [10.4103/kjo.kjo_32_17, DOI 10.4103/KJO.KJO_32_17]; Kono R, 2019, GRAEF ARCH CLIN EXP, V257, P657, DOI 10.1007/s00417-019-04250-0; Lai YH, 2012, BRIT J OPHTHALMOL, V96, P679, DOI 10.1136/bjophthalmol-2011-300632; Lee JY, 2017, EYE, V31, P1556, DOI 10.1038/eye.2017.89; Liu XQ, 2011, INVEST OPHTH VIS SCI, V52, P8370, DOI 10.1167/iovs.11-7752; Ngo CS, 2015, J AAPOS, V19, P233, DOI 10.1016/j.jaapos.2015.03.012; Ocak OB, 2019, INT OPHTHALMOL, V39, P1037, DOI 10.1007/s10792-018-0903-5; Park KA, 2014, J AAPOS, V18, P15, DOI 10.1016/j.jaapos.2013.11.005; Pihlblad MS, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101732; Pihlblad MS, 2016, J PEDIAT OPHTH STRAB, V53, P141, DOI 10.3928/01913913-20160405-05; Surawatsatien N, 2017, FOLIA MORPHOL, V76, P635, DOI 10.5603/FM.a2017.0024; Suzuki H, 2018, JPN J OPHTHALMOL, V62, P554, DOI 10.1007/s10384-018-0609-2; Tamburrelli C, 2003, INVEST OPHTH VIS SCI, V44, P618, DOI 10.1167/iovs.02-0112; Tan RJD, 2015, J AAPOS, V19, P500, DOI 10.1016/j.jaapos.2015.08.012; Tanaka Akiko, 2010, Journal of Medical and Dental Sciences, V57, P75; von Noorden GK, 2002, THEORY MANAGEMENT ST, P330	23	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243382	10.1371/journal.pone.0243382	http://dx.doi.org/10.1371/journal.pone.0243382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362229	Green Published, gold			2022-12-27	WOS:000603071600010
J	Srivastava, A; Chhibber, G; Bhatnagar, N; Nash-Mercado, A; Samal, J; Trivedi, B; Srivastava, V; Rawlins, B; Yadav, V; Sood, B; Biesma, R; Kim, YM; Stekelenburg, J				Srivastava, Ashish; Chhibber, Geeta; Bhatnagar, Neeta; Nash-Mercado, Angela; Samal, Jyoti; Trivedi, Bhagyashree; Srivastava, Vinod; Rawlins, Barbara; Yadav, Vivek; Sood, Bulbul; Biesma, Regien; Kim, Young-Mi; Stekelenburg, Jelle			Effectiveness of a quality improvement intervention to increase adherence to key practices during female sterilization services in Chhattisgarh and Odisha states of India	PLOS ONE			English	Article							HEALTH-CARE; OF-CARE; GAP	Background In response to longstanding concerns around the quality of female sterilization services provided at public health facilities in India, the Government of India issued standards and quality assurance guidelines for female sterilization services in 2014. However, implementation remains a challenge. The Maternal and Child Survival Program rolled out a package of competency-based trainings, periodic mentoring, and easy-to-use job aids in parts of five states to increase service providers' adherence to key practices identified in the guidelines. Methods The study employed a before-and-after quasi-experimental design with a matched comparison arm to examine the effect of the intervention on provider practices in two states: Odisha and Chhattisgarh. Direct observations of female sterilization services were conducted in selected public health facilities, using a checklist of 30 key practices, at two points in time. Changes in adherence to key practices from baseline to endline were compared at 12 intervention and 12 comparison facilities using a difference in difference analysis. Results Several key practices were well-established prior to the intervention, with adherence levels over 90% at baseline, including hemoglobin and urine testing, use of sterile surgical gloves and instruments, and recommended surgical technique. However, adherence to many other practices was extremely low at baseline. The program significantly increased adherence to nine practices, including those related to ascertaining client's medical eligibility, client-provider interaction, the consent process, and post-operative care. The greatest improvement was observed in the provision of written instructions for clients prior to discharge. At endline, however, adherence remained below 50% for 14 practices. Conclusion Low adherence to key practices at baseline confirmed the need for quality improvement interventions in female sterilization services. While the intervention improved adherence to certain practices around admission and post-operative care, inadequate human resources and infrastructure, among other factors, may have blunted the impact of the intervention.	[Srivastava, Ashish; Chhibber, Geeta; Samal, Jyoti; Trivedi, Bhagyashree; Srivastava, Vinod; Yadav, Vivek; Sood, Bulbul] Jhpiego India, New Delhi, India; [Srivastava, Ashish; Biesma, Regien; Stekelenburg, Jelle] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Global Hlth, Groningen, Netherlands; [Bhatnagar, Neeta; Nash-Mercado, Angela; Rawlins, Barbara; Kim, Young-Mi] Jhpiego, Baltimore, MD USA; [Stekelenburg, Jelle] Leeuwarden Med Ctr, Dept Obstet & Gynecol, Leeuwarden, Netherlands	Jhpiego; University of Groningen; Jhpiego; Medical Center Leeuwarden	Chhibber, G (corresponding author), Jhpiego India, New Delhi, India.	Geeta.Chhibber@Jhpiego.org	Srivastava, Ashish/AAK-1284-2020; Stekelenburg, Jelle/B-3129-2017	Srivastava, Ashish/0000-0003-3100-3581; Stekelenburg, Jelle/0000-0002-2732-6620; Yadav, Vivek/0000-0002-9816-6804	United States Agency for International Development (USAID) [AID-OAA-A-14-00028]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The funding for this study was provided by the United States Agency for International Development (USAID) under the terms of the Cooperative Agreement AID-OAA-A-14-00028. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank India's Ministry of Health and Family Welfare and USAID for their invaluable support and guidance and to acknowledge Academy of Management Studies, Lucknow, India, which was responsible for data collection. The authors are grateful to the government health officials of the states of Chhattisgarh and Odisha for their support during the study. The authors also extend their sincere thanks to all the people who participated in the study. The authors would also like to thank Adrienne Kols for critically reviewing the manuscript and providing valuable inputs.	Achyut P., 2014, QUALITY CARE PROVISI; [Anonymous], 2017, NCCN PRACT GUIDEL, V2017, P1, DOI DOI 10.1155/2017/2683789; [Anonymous], RIGHTS BAS FAM PLANN; Aronson J., 2015, BMJ, V351, DOI [10.1136/bmj.h3521, DOI 10.1136/BMJ.H4672, DOI 10.1136/BMJ.H3521]; Brault MA, 2016, QUAL HEALTH RES, V26, P1550, DOI 10.1177/1049732315589744; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Chowdhury J, 2009, REACHING UNREACHED R, P33; Das A., 2004, ECON POLIT WEEKLY, V39, P3876; Edwards R, 2012, LANCET INFECT DIS, V12, P318, DOI 10.1016/S1473-3099(11)70283-3; EngenderHealth, 2002, CONTR STER GLOB ISS; Family Planning Division Ministry of Health and Family Welfare (MoHFW) India, 2014, REF MAN FEM STER; Family Planning Division Ministry of Health and Family Welfare (MoHFW) India, 2014, STAND QUAL ASS STER; Gage AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208898; Gammon J, 2008, J CLIN NURS, V17, P157, DOI 10.1111/j.1365-2702.2006.01852.x; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Jain AK, 2018, STUD FAMILY PLANN, V49, P171, DOI 10.1111/sifp.12052; Koenig MA, 2000, STUD FAMILY PLANN, V31, P1, DOI 10.1111/j.1728-4465.2000.00001.x; Mathur M, 2017, J CLIN DIAGN RES, V11, DOI 10.7860/JCDR/2017/24630.9793; Ministry of Health and Family Welfare (MoHFW) India, 2011, ANN REP 2012 2011, P15; Ministry of Health and Family Welfare (MoHFW) India, PERF KEY HMIS IND DI; Ministry of Health and Family Welfare (MoHFW) India, 1999, STAND MAL FEM STER; Mohanan M, 2015, JAMA PEDIATR, V169, P349, DOI 10.1001/jamapediatrics.2014.3445; Mule VD, 2017, INT J REPROD CONTRAC, V6, P4309; Pradhan MR, 2019, SEX REPROD HEALTHC, V19, P56, DOI 10.1016/j.srhc.2018.12.006; Pulla P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7509; RamPrakash R., 2007, 4 POP COUNC; Santhya KG., 2003, REGIONAL WORKING PAP, V17; Saxena R., 2002, WEEK; Singh B, 2012, CONTINUING ASSESSMEN; Statistics Division Ministry of Health and Family Welfare (MoHFW) India, 2018, RUR HLTH STAT; Weiser TG, 2018, BRIT J SURG, V105, P927, DOI 10.1002/bjs.10907; World Health Organization, 2009, WHO SURG SAF CHECKL, P13; World Health Organization, 2014, ENS HUM RIGHTS PROV; World Health Organization (WHO), 2016, STANDARDS IMPROVING; Yanikkerem E, 2009, MIDWIFERY, V25, P500, DOI 10.1016/j.midw.2007.08.006	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244088	10.1371/journal.pone.0244088	http://dx.doi.org/10.1371/journal.pone.0244088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362284	Green Published, gold			2022-12-27	WOS:000603071600027
J	Li, LP; Li, RY; Wu, XC				Li, Liping; Li, Ruiying; Wu, Xinchun			The reciprocal relation between morphological awareness and spelling in Chinese: A longitudinal study of primary school students	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; CHARACTER; RECOGNITION	Spelling is a literacy skill that must be mastered during children's academic development. It involves a variety of cognitive factors, including morphological awareness. Studies in the alphabet and Chinese systems have shown that there is a close relationship between morphological awareness and spelling. Although there is clearly a significant unidirectional effect of morphological awareness on spelling significantly, few studies have explored the bidirectional relationship between morphological awareness and spelling. This three-time point longitudinal study was designed to investigate the reciprocal effects of morphological awareness and character spelling in Chinese. Participants included 124 children from two primary schools in Mainland China. The students were tracked from first grade to third grade and were administered a battery of tests to measure morphological awareness (e.g., homophone awareness, homograph awareness, and compounding awareness) and spelling to dictation, controlling for IQ, phonological awareness, and orthographic awareness. A structural equation model was utilized to examine the reciprocal relation between the students' morphological awareness and character spelling. Results showed that earlier morphological awareness predicted subsequent spelling abilities from first grade to third grade and spelling in first grade predicted morphological awareness in second grade; however, spelling in second grade did not predict the subsequent morphological awareness in third grade. This study suggests that there is a bidirectional association between morphological awareness and spelling from first grade to second grade in Chinese, and a unidirectional association between morphological awareness and spelling from second grade to third grade. Future studies could examine the causal relationship between morphological awareness and character spelling by using an instructional intervention.	[Li, Liping; Li, Ruiying] Shanxi Normal Univ, Expt Teaching Ctr Psychol & Cognit Behav, Collaborat Innovat Ctr Fundamental Educ Qual Enha, Sch Educ Sci, Linfen, Shanxi, Peoples R China; [Wu, Xinchun] Beijing Normal Univ, Fac Psychol, Beijing Key Lab Appl Expt Psychol, Res Ctr Childrens Reading & Learning, Beijing, Peoples R China	Shanxi Normal University; Beijing Normal University	Li, LP (corresponding author), Shanxi Normal Univ, Expt Teaching Ctr Psychol & Cognit Behav, Collaborat Innovat Ctr Fundamental Educ Qual Enha, Sch Educ Sci, Linfen, Shanxi, Peoples R China.	liliping2092@163.com		Li, liping/0000-0001-8156-9802	Philosophy and Social Science Planing Foundation of Shanxi Province (CN) [2019B204]; Major Project of the National Social Science Fundation of China [13ZD188]; Graduate Education Innovation Program of Shanxi in 2020 [2020SY311]	Philosophy and Social Science Planing Foundation of Shanxi Province (CN); Major Project of the National Social Science Fundation of China; Graduate Education Innovation Program of Shanxi in 2020	Philosophy and Social Science Planing Foundation of Shanxi Province (CN), 2019B204; Major Project of the National Social Science Fundation of China, 13 & ZD188; Graduate Education Innovation Program of Shanxi in 2020, 2020SY311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2006, Strategic Direction, V22, P35, DOI 10.1108/02580540610635942; Brown AS, 1990, EDUC PSYCHOL REV, V2, P365, DOI 10.1007/BF01323630; Brown G.D., 1994, HDB SPELLING THEORY, P319; Carlisle J.F., 1995, MORPHOLOGICAL ASPECT, P189, DOI DOI 10.4236/PSYCH.2014.58103; Cheng YH, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00440; Desrochers A, 2018, READ WRIT, V31, P1695, DOI 10.1007/s11145-017-9772-y; Diamanti V, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02039; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Koh PW, 2017, DYSLEXIA, V23, P406, DOI 10.1002/dys.1565; Kuo LJ, 2006, EDUC PSYCHOL-US, V41, P161, DOI 10.1207/s15326985ep4103_3; Li LP, 2020, ACTA PSYCHOL SIN, V52, P623, DOI 10.3724/SP.J.1041.2020.00623; Li LP, 2019, J RES READ, V42, P18, DOI 10.1111/1467-9817.12131; Liu PD, 2010, J EDUC PSYCHOL, V102, P62, DOI 10.1037/a0016933; McBride-Chang C, 2003, J EDUC PSYCHOL, V95, P743, DOI 10.1037/0022-0663.95.4.743; Nunes T, 2006, READ WRIT, V19, P767, DOI 10.1007/s11145-006-9025-y; Perfetti C, 2007, SCI STUD READ, V11, P357, DOI 10.1080/10888430701530730; Pittas E, 2014, READ WRIT, V27, P1507, DOI 10.1007/s11145-014-9503-6; Rispens JE, 2008, READ WRIT, V21, P587, DOI 10.1007/s11145-007-9077-7; Saiegh-Haddad E, 2017, DYSLEXIA, V23, P345, DOI 10.1002/dys.1572; Shahar-Yames D, 2008, J RES READ, V31, P22, DOI 10.1111/j.1467-9817.2007.00359.x; Shen HH, 2000, READ WRIT, V13, P197, DOI 10.1023/A:1026484207650; Shu H, 1997, READ RES QUART, V32, P78, DOI 10.1598/RRQ.32.1.5; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Tong XH, 2017, DYSLEXIA, V23, P372, DOI 10.1002/dys.1564; Tong XL, 2011, J RES READ, V34, P315, DOI 10.1111/j.1467-9817.2009.01426.x; Tong XL, 2009, SCI STUD READ, V13, P426, DOI 10.1080/10888430903162910; Verhoeven L., 2017, LEARNING READ LANGUA; Weekes BS, 2002, PICTURE WORD INTERFE; Zhang H. C., 1985, CHINESE VERSION RAVE	30	2	2	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243050	10.1371/journal.pone.0243050	http://dx.doi.org/10.1371/journal.pone.0243050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347514	gold, Green Published			2022-12-27	WOS:000603071100048
J	Vu, MQ; Tran, TTP; Hoang, TA; Khuong, LQ; Hoang, MV				Mai Quynh Vu; Thao Thi Phuong Tran; Thao Anh Hoang; Long Quynh Khuong; Minh Van Hoang			Health-related quality of life of the Vietnamese during the COVID-19 pandemic	PLOS ONE			English	Article							EUROQOL	Background Vietnam applied strict quarantine measures to mitigate the rapid transmission of the SARS-COV-2 virus. Central questions were how the COVID-19 pandemic affected health-related quality of life (HRQOL) of the Vietnamese general population, and whether there is any difference in HRQOL among people under different quarantine conditions. Methods This cross-sectional study was conducted during 1 April- 30 May 2020 when the COVID-19 pandemic was at its peak in Vietnam. Data was collected via an online survey using Google survey tool. A convenient sampling approach was employed, with participants being sorted into three groups: people who were in government quarantine facilities; people who were under self-isolation at their own place; and the general population who did not need enforced quarantine. The Vietnamese EQ-5D-5L instrument was used to measure HRQOL. Differences in HRQOL among people of isolation groups and their socio-demographic characteristics were statistically tested. Results A final sample was made of 406 people, including 10 persons from government quarantine facilities, 57 persons under self-isolation at private places, and the rest were the general population. The mean EQ-VAS was reported the highest at 90.5 (SD: 7.98) among people in government quarantine facilities, followed by 88.54 (SD: 12.24) among general population and 86.54 (SD 13.69) among people in self-isolation group. The EQ-5D-5L value was reported the highest among general population at 0.95 (SD: 0.07), followed by 0.94 (SD: 0.12) among people in government quarantine facilities, and 0.93 (SD: 0.13) among people who did self-isolation. Overall, most people, at any level, reported having problems with anxiety and/or depression in all groups. Conclusion While there have been some worries and debates on implementing strict quarantine measures can hinder people's quality of life, Vietnam showed an opposite tendency in people's HRQOL even under the highest level of enforcement in the prevention and control of COVID-19.	[Mai Quynh Vu; Thao Thi Phuong Tran; Thao Anh Hoang; Long Quynh Khuong] Hanoi Univ Publ Hlth, Ctr Populat Hlth Sci, Hanoi, Vietnam; [Minh Van Hoang] Hanoi Univ Publ Hlth, Hanoi, Vietnam	Hanoi University of Public Health; Hanoi University of Public Health	Vu, MQ (corresponding author), Hanoi Univ Publ Hlth, Ctr Populat Hlth Sci, Hanoi, Vietnam.	vqm@huph.edu.vn	Van Hoang, Minh/AET-0962-2022	Khuong, Quynh Long/0000-0002-1232-6230; Tran, Thi Phuong Thao/0000-0003-4708-6027; Hoang, Thao Anh/0000-0002-1235-1962; Vu, Mai/0000-0001-6962-0564				[Anonymous], 2020, UN LAUNCH COVID 19 P; [Anonymous], 2020, VAL HUM LIF LOCKD EC; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Drummond MF, 2015, METHODS EC EVALUATIO; FAO, 2020, COR DIS 2019 COVID 1; Garcia-Gordillo MA, 2016, QUAL LIFE RES, V25, P1313, DOI 10.1007/s11136-015-1164-7; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Nguyen LH, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0771-0; Mai VQ, 2020, EQ 5D 5L NORMATIVE D; Mai VQ, 2020, QUAL LIFE RES, V29, P1923, DOI 10.1007/s11136-020-02469-7; Marasca C, 2020, CLIN EXP DERMATOL, V45, P749, DOI 10.1111/ced.14245; Nguyen HC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040965; Ping WW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234850; Prime Minister, 2020, OFFICIAL DISPATCH 15; Pulvirenti F, 2020, J ALLER CL IMM-PRACT, V8, P1894, DOI 10.1016/j.jaip.2020.04.003; Rabin R, 2014, VALUE HEALTH, V17, P70, DOI 10.1016/j.jval.2013.10.006; Southeast Asia Covid-19 Tracker, 2020, SE AS COV 19 TRACK; The National Steering Committee for prevention and control the novel coronavirus disease, OFF DISP 1440 CV BCD; Vinh Phuc Provincial People Committe, 2020, IMPL EM RESP DEC 173; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wong ELY, 2019, VALUE HEALTH, V22, P916, DOI 10.1016/j.jval.2019.02.014; Yang ZH, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-1036-2	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244170	10.1371/journal.pone.0244170	http://dx.doi.org/10.1371/journal.pone.0244170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338067	Green Published, gold			2022-12-27	WOS:000601313500015
J	Cullum, RL; Lucas, LM; Senfeld, JI; Piazza, JT; Neel, LT; Whig, K; Zhai, L; Harris, MH; Rael, CC; Taylor, DC; Cook, LJ; Kaufmann, DP; Mill, CP; Jacobi, MA; Smith, FT; Suto, M; Bostwick, R; Gupta, RB; David, AE; Riese, DJ				Cullum, Richard L.; Lucas, Lauren M.; Senfeld, Jared I.; Piazza, John T.; Neel, Logan T.; Whig, Kanupriya; Zhai, Ling; Harris, Mackenzie H.; Rael, Cristina C.; Taylor, Darby C.; Cook, Laura J.; Kaufmann, David P.; Mill, Christopher P.; Jacobi, Megan A.; Smith, Forrest T.; Suto, Mark; Bostwick, Robert; Gupta, Ram B.; David, Allan E.; Riese, David J., II			Development and application of high-throughput screens for the discovery of compounds that disrupt ErbB4 signaling: Candidate cancer therapeutics	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CELLULAR-RESPONSE; PARTIAL AGONISTS; FACTOR RECEPTOR; SURVIVAL; PEMBROLIZUMAB; NEUREGULIN2; DABRAFENIB; IPILIMUMAB; PATTERNS	Whereas recent clinical studies report metastatic melanoma survival rates high as 30-50%, many tumors remain nonresponsive or become resistant to current therapeutic strategies. Analyses of The Cancer Genome Atlas (TCGA) skin cutaneous melanoma (SKCM) data set suggests that a significant fraction of melanomas potentially harbor gain-of-function mutations in the gene that encodes for the ErbB4 receptor tyrosine kinase. In this work, a drug discovery strategy was developed that is based on the observation that the Q43L mutant of the naturally occurring ErbB4 agonist Neuregulin-2beta (NRG2 beta) functions as a partial agonist at ErbB4. NRG2 beta/Q43L stimulates tyrosine phosphorylation, fails to stimulate ErbB4-dependent cell proliferation, and inhibits agonist-induced ErbB4-dependent cell proliferation. Compounds that exhibit these characteristics likely function as ErbB4 partial agonists, and as such hold promise as therapies for ErbB4-dependent melanomas. Consequently, three highly sensitive and reproducible (Z' > 0.5) screening assays were developed and deployed for the identification of small-molecule ErbB4 partial agonists. Six compounds were identified that stimulate ErbB4 phosphorylation, fail to stimulate ErbB4-dependent cell proliferation, and appear to selectively inhibit ErbB4-dependent cell proliferation. Whereas further characterization is needed to evaluate the full therapeutic potential of these molecules, this drug discovery platform establishes reliable and scalable approaches for the discovery of ErbB4 inhibitors.	[Cullum, Richard L.; Lucas, Lauren M.; Senfeld, Jared I.; Piazza, John T.; Neel, Logan T.; Harris, Mackenzie H.; Rael, Cristina C.; Taylor, Darby C.; Cook, Laura J.; Kaufmann, David P.; Mill, Christopher P.; Jacobi, Megan A.; Smith, Forrest T.; Riese, David J., II] Auburn Univ, Dept Drug Discovery & Dev, Auburn, AL 36849 USA; [Cullum, Richard L.; Harris, Mackenzie H.; Gupta, Ram B.; David, Allan E.] Auburn Univ, Dept Chem Engn, Auburn, AL 36849 USA; [Piazza, John T.; Rael, Cristina C.; Taylor, Darby C.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Whig, Kanupriya; Zhai, Ling; Suto, Mark; Bostwick, Robert] Southern Res, Drug Discovery Div, Birmingham, AL USA; [Cook, Laura J.] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA; [Gupta, Ram B.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA USA; [Mill, Christopher P.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Div Canc Med, Houston, TX 77030 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Virginia Commonwealth University; University of Texas System; UTMD Anderson Cancer Center	Riese, DJ (corresponding author), Auburn Univ, Dept Drug Discovery & Dev, Auburn, AL 36849 USA.	djr0009@auburn.edu		Lucas, Lauren/0000-0003-0559-1930; Riese, David/0000-0002-8823-5802	Auburn University Research Initiative in Cancer (AURIC) fellowship; AURIC grant; US Department of Education GAANN Graduate Fellowship Program in Biological & Pharmaceutical Engineering Award [P200A120244]; Auburn University Presidential Graduate Research Fellowship; Auburn University Harrison School of Pharmacy	Auburn University Research Initiative in Cancer (AURIC) fellowship; AURIC grant; US Department of Education GAANN Graduate Fellowship Program in Biological & Pharmaceutical Engineering Award; Auburn University Presidential Graduate Research Fellowship; Auburn University Harrison School of Pharmacy	This research has been funded by an Auburn University Research Initiative in Cancer (AURIC) fellowship to R.L.C., an AURIC grant to D. J.R.,II, a US Department of Education GAANN Graduate Fellowship Program in Biological & Pharmaceutical Engineering Award No. P200A120244 to Auburn University, an Auburn University Presidential Graduate Research Fellowship to L.M.L., and other support from the Auburn University Department of Drug Discovery and Development, and the Auburn University Harrison School of Pharmacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Hamid O, 2019, ANN ONCOL, V30, P582, DOI 10.1093/annonc/mdz011; Hennequin LFA, 2006, BIOORG MED CHEM LETT, V16, P2672, DOI 10.1016/j.bmcl.2006.02.025; Hobbs SS, 2002, ONCOGENE, V21, P8442, DOI 10.1038/sj.onc.1205960; Hobbs SS, 2004, ONCOGENE, V23, P883, DOI 10.1038/sj.onc.1207250; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Kuske M, 2018, PHARMACOL RES, V136, P151, DOI 10.1016/j.phrs.2018.08.019; Long GV, 2018, J CLIN ONCOL, V36, P667, DOI 10.1200/JCO.2017.74.1025; Long GV, 2016, LANCET ONCOL, V17, P1743, DOI 10.1016/S1470-2045(16)30578-2; Mill Christopher P, 2011, Genes Cancer, V2, P792, DOI 10.1177/1947601911431080; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Riese DJ, 2011, EXPERT OPIN DRUG DIS, V6, P185, DOI 10.1517/17460441.2011.547468; Riese DJ, 1998, J BIOL CHEM, V273, P11288, DOI 10.1074/jbc.273.18.11288; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Riese DJ, 1996, ONCOGENE, V12, P345; Riese DJ, 1996, J BIOL CHEM, V271, P20047, DOI 10.1074/jbc.271.33.20047; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Rowinsky E., 2003, HOLLAND FREI CANC ME; Sweeney C, 2000, J BIOL CHEM, V275, P19803, DOI 10.1074/jbc.C901015199; Wakeling AE, 2002, CANCER RES, V62, P5749; Wilson KJ, 2007, BIOCHEM BIOPH RES CO, V364, P351, DOI 10.1016/j.bbrc.2007.10.004; Wilson KJ, 2012, BIOCHEM J, V443, P133, DOI 10.1042/BJ20110921; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	27	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0243901	10.1371/journal.pone.0243901	http://dx.doi.org/10.1371/journal.pone.0243901			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378376	Green Published, gold			2022-12-27	WOS:000605651300013
J	Jing, HY; Wang, YB; Desai, PR; Ramamurthi, KS; Das, S				Jing, Haoyuan; Wang, Yanbin; Desai, Parth Rakesh; Ramamurthi, Kumaran S.; Das, Siddhartha			Lipid flip-flop and desorption from supported lipid bilayers is independent of curvature	PLOS ONE			English	Article							PHOSPHOLIPID ASYMMETRY; TRANSBILAYER MOVEMENT; MEMBRANE CURVATURE; PORE FORMATION; FREE-ENERGY; MECHANISM; EXCHANGE; DYNAMICS; MODEL; PHOSPHATIDYLCHOLINE	Flip-flop of lipids of the lipid bilayer (LBL) constituting the plasma membrane (PM) plays a crucial role in a myriad of events ranging from cellular signaling and regulation of cell shapes to cell homeostasis, membrane asymmetry, phagocytosis, and cell apoptosis. While extensive research has been conducted to probe the lipid flip flop of planar lipid bilayers (LBLs), less is known regarding lipid flip-flop for highly curved, nanoscopic LBL systems despite the vast importance of membrane curvature in defining the morphology of cells and organelles and in maintaining a variety of cellular functions, enabling trafficking, and recruiting and localizing shape-responsive proteins. In this paper, we conduct molecular dynamics (MD) simulations to study the energetics, structure, and configuration of a lipid molecule undergoing flip-flop and desorption in a highly curved LBL, represented as a nanoparticle-supported lipid bilayer (NPSLBL) system. We compare our findings against those of a planar substrate supported lipid bilayer (PSSLBL). Our MD simulation results reveal that despite the vast differences in the curvature and other curvature-dictated properties (e.g., lipid packing fraction, difference in the number of lipids between inner and outer leaflets, etc.) between the NPSLBL and the PSSLBL, the energetics of lipid flip-flop and lipid desorption as well as the configuration of the lipid molecule undergoing lipid flip-flop are very similar for the NPSLBL and the PSSLBL. In other words, our results establish that the curvature of the LBL plays an insignificant role in lipid flip-flop and desorption.	[Jing, Haoyuan; Wang, Yanbin; Desai, Parth Rakesh; Das, Siddhartha] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Jing, Haoyuan; Ramamurthi, Kumaran S.] NCI, Lab Mol Biol, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Das, S (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	sidd@umd.edu	Das, Siddhartha/G-9291-2017		University-of-Maryland-National-Cancer-Institute Partnership for Integrative Cancer Research; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research	University-of-Maryland-National-Cancer-Institute Partnership for Integrative Cancer Research; Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the University-of-Maryland-National-Cancer-Institute Partnership for Integrative Cancer Research (H.J., K.S.R., and S.D.) and the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (K.S.R.).	Allhusen JS, 2017, ACCOUNTS CHEM RES, V50, P58, DOI 10.1021/acs.accounts.6b00435; Anglin TC, 2010, J PHYS CHEM B, V114, P1903, DOI 10.1021/jp909134g; Anglin TC, 2009, BIOCHEMISTRY-US, V48, P10220, DOI 10.1021/bi901096j; Ashley CE, 2011, NAT MATER, V10, P389, DOI [10.1038/NMAT2992, 10.1038/nmat2992]; Bennett WFD, 2011, J CHEM THEORY COMPUT, V7, P2981, DOI 10.1021/ct200291v; Bennett WFD, 2009, J AM CHEM SOC, V131, P1972, DOI 10.1021/ja808541r; Brannigan G, 2006, BIOPHYS J, V90, P1501, DOI 10.1529/biophysj.105.075838; Bratton DL, 1999, J BIOL CHEM, V274, P28113, DOI 10.1074/jbc.274.40.28113; Chao MH, 2017, SMALL, V13, DOI 10.1002/smll.201603408; Contreras FX, 2010, FEBS LETT, V584, P1779, DOI 10.1016/j.febslet.2009.12.049; Devaux PF, 2002, CHEM PHYS LIPIDS, V116, P115, DOI 10.1016/S0009-3084(02)00023-3; Devaux PF, 2008, BBA-BIOMEMBRANES, V1778, P1591, DOI 10.1016/j.bbamem.2008.03.007; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Ferguson MAJ, 1991, CURR OPIN STRUC BIOL, V1, P522, DOI 10.1016/S0959-440X(05)80072-7; Fu RQ, 2015, J AM CHEM SOC, V137, P14031, DOI 10.1021/jacs.5b08303; Garcia-Parajo MF, 2014, J CELL SCI, V127, P4995, DOI 10.1242/jcs.146340; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Gill RL, 2015, P NATL ACAD SCI USA, V112, pE1908, DOI 10.1073/pnas.1423868112; Grossfield A., WHAM WEIGHTED HISTOG; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P13554, DOI 10.1021/jp077094k; HIGGINS CF, 1994, CELL, V79, P393, DOI 10.1016/0092-8674(94)90248-8; HOMAN R, 1988, BIOCHIM BIOPHYS ACTA, V938, P155, DOI 10.1016/0005-2736(88)90155-1; Jing HY, 2020, LANGMUIR, V36, P5524, DOI 10.1021/acs.langmuir.0c00593; Johannes L, 2018, TRENDS CELL BIOL, V28, P405, DOI 10.1016/j.tcb.2018.01.009; John K, 2002, BIOPHYS J, V83, P3315, DOI 10.1016/S0006-3495(02)75332-0; Kabbani AM, 2017, MEMBRANES-BASEL, V7, DOI 10.3390/membranes7040060; Khalifat N, 2014, BIOPHYS J, V107, P879, DOI 10.1016/j.bpj.2014.07.015; Kim EY, 2017, CELL SYST, V5, P518, DOI 10.1016/j.cels.2017.10.004; KORNBERG RD, 1971, BIOCHEMISTRY-US, V10, P1111; Lin YS, 2010, J AM CHEM SOC, V132, P4834, DOI 10.1021/ja910846q; Liu J, 2004, J AM CHEM SOC, V126, P8376, DOI 10.1021/ja048245p; Liu J, 2005, BIOPHYS J, V89, P2522, DOI 10.1529/biophysj.105.065672; Liu JW, 2009, J AM CHEM SOC, V131, P7567, DOI 10.1021/ja902039y; Liu JW, 2009, J AM CHEM SOC, V131, P1354, DOI 10.1021/ja808018y; Maekawa M, 2014, J CELL SCI, V127, P4801, DOI 10.1242/jcs.150524; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marti J, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061918; Marti J, 2003, EUROPHYS LETT, V61, P409, DOI 10.1209/epl/i2003-00192-1; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; MORROT G, 1989, BIOCHEMISTRY-US, V28, P3456, DOI 10.1021/bi00434a046; Nakano M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238101; Nakano M, 2009, J PHYS CHEM B, V113, P6745, DOI 10.1021/jp900913w; Papadopulos A, 2007, J BIOL CHEM, V282, P15559, DOI 10.1074/jbc.M604740200; Ramamurthi KS, 2010, CURR OPIN MICROBIOL, V13, P753, DOI 10.1016/j.mib.2010.09.014; Risselada HJ, 2009, PHYS CHEM CHEM PHYS, V11, P2056, DOI 10.1039/b818782g; ROSEMAN M, 1975, BIOCHEMISTRY-US, V14, P4826, DOI 10.1021/bi00693a008; ROSEMAN MA, 1980, BIOCHEMISTRY-US, V19, P439, DOI 10.1021/bi00544a006; Salamone M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154709; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; Tarn D, 2013, ACCOUNTS CHEM RES, V46, P792, DOI 10.1021/ar3000986; Tieleman DP, 2006, J AM CHEM SOC, V128, P12462, DOI 10.1021/ja0624321; Tieleman DP, 2003, J AM CHEM SOC, V125, P6382, DOI 10.1021/ja029504i; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Volinsky R, 2013, FEBS J, V280, P2806, DOI 10.1111/febs.12247; Wah B, 2017, LANGMUIR, V33, P3384, DOI 10.1021/acs.langmuir.6b04013; WIMLEY WC, 1991, BIOCHEMISTRY-US, V30, P1702, DOI 10.1021/bi00220a036; Zhu FQ, 2012, J COMPUT CHEM, V33, P453, DOI 10.1002/jcc.21989; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121	60	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244460	10.1371/journal.pone.0244460	http://dx.doi.org/10.1371/journal.pone.0244460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378379	Green Published, gold			2022-12-27	WOS:000605651300071
J	Vignery, K; Laurier, W				Vignery, Kristel; Laurier, Wim			A methodology and theoretical taxonomy for centrality measures: What are the best centrality indicators for student networks?	PLOS ONE			English	Article							SOCIAL NETWORKS; BIOLOGICAL NETWORKS; COMPLEX NETWORKS; MISSING DATA; POWER; IDENTIFICATION; DISTRIBUTIONS; PERFORMANCE; FRAMEWORK; TOPOLOGY	In order to understand and represent the importance of nodes within networks better, most of the studies that investigate graphs compute the nodes' centrality within their network(s) of interest. In the literature, the most frequent measures used are degree, closeness and/or betweenness centrality, even if other measures might be valid candidates for representing the importance of nodes within networks. The main contribution of this paper is the development of a methodology that allows one to understand, compare and validate centrality indices when studying a particular network of interest. The proposed methodology integrates the following steps: choosing the centrality measures for the network of interest; developing a theoretical taxonomy of these measures; identifying, by means of Principal Component Analysis (PCA), latent dimensions of centrality within the network of interest; verifying the proposed taxonomy of centrality measures; and identifying the centrality measures that best represent the network of interest. Also, we applied the proposed methodology to an existing graph of interest, in our case a real friendship student network. We chose eighteen centrality measures that were developed in SNA and are available and computed in a specific library (CINNA), defined them thoroughly, and proposed a theoretical taxonomy of these eighteen measures. PCA showed the emergence of six latent dimensions of centrality within the student network and saturation of most of the centrality indices on the same categories as those proposed by the theoretical taxonomy. Additionally, the results suggest that indices other than the ones most frequently applied might be more relevant for research on friendship student networks. Finally, the integrated methodology that we propose can be applied to other centrality indices and/or other network types than student graphs.	[Vignery, Kristel; Laurier, Wim] Univ St Louis Bruxelles, Dept Econ & Management, Brussels, Belgium	University Saint-Louis - Bruxelles	Vignery, K (corresponding author), Univ St Louis Bruxelles, Dept Econ & Management, Brussels, Belgium.	kristel.vignery@gmail.com	; Laurier, Wim/C-9457-2013	Vignery, Kristel/0000-0003-0674-787X; Laurier, Wim/0000-0002-9448-248X				Abbas S. G., 2016, SARHAD J MANAGEMENT, V2, P195; [Anonymous], 2020, LANCET PSYCHIAT, V7, P1, DOI 10.1016/S2215-0366(19)30483-3; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; Asgari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079397; Ashtiani, 2018, NETWORK ANAL R CENTR; Ashtiani M, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0598-2; Baerveldt C., 2004, CONNECTIONS, V26, P11, DOI DOI 10.1016/J.SOCNET.2004.01.003; Baldwin TT, 1997, ACAD MANAGE J, V40, P1369, DOI 10.2307/257037; Bangert-Drowns, 1987, DESIGN CONTEXT CONCE; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Batool K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090283; Bayer J., 2012, PREDICTING DROP OUT; Benaglia T, 2009, J STAT SOFTW, V32, P1; Benoit DF, 2012, EXPERT SYST APPL, V39, P11435, DOI 10.1016/j.eswa.2012.04.016; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Borst W.N., 1997, CONSTRUCTION ENG ONT; Bouguerra A., 2007, ETUDES MARKETING AVE; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Bruun J, 2013, PHYS REV SPEC TOP-PH, V9, DOI 10.1103/PhysRevSTPER.9.020109; Burgess J, 2012, JOURNAL PRACT, V6, P384, DOI 10.1080/17512786.2012.663610; Calvo-Armengol A, 2004, AM ECON REV, V94, P426, DOI 10.1257/0002828041464542; Chen F, 2008, COMMUN NONLINEAR SCI, V13, P1405, DOI 10.1016/j.cnsns.2006.12.003; Chen HC, 2004, COMPUTER, V37, P50, DOI 10.1109/MC.2004.1297301; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Cho HC, 2007, COMPUT EDUC, V49, P309, DOI 10.1016/j.compedu.2005.07.003; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Cruz JE, 2012, DEV PSYCHOL, V48, P1390, DOI 10.1037/a0027515; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Dawson S, 2008, EDUC TECHNOL SOC, V11, P224; de Laat M, 2007, INT J COMP-SUPP COLL, V2, P87, DOI 10.1007/s11412-007-9006-4; de-Marcos L, 2016, COMPUT HUM BEHAV, V60, P312, DOI 10.1016/j.chb.2016.02.052; Dhand A, 2014, ANN NEUROL, V75, P342, DOI 10.1002/ana.24089; Diaz, 2017, INT C INF SYST CRIS; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Ductor L, 2014, REV ECON STAT, V96, P936, DOI 10.1162/REST_a_00430; Duran-Pinedo AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028438; Ennett ST, 2006, J RES ADOLESCENCE, V16, P159, DOI 10.1111/j.1532-7795.2006.00127.x; Faghani MR, 2013, IEEE T INF FOREN SEC, V8, P1815, DOI 10.1109/TIFS.2013.2280884; Florez AF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-484; Fouss F., 2016, ALGORITHMS MODELS NE; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Goodreau SM, 2009, DEMOGRAPHY, V46, P103, DOI 10.1353/dem.0.0045; GRALER J, 2012, BIOINFORMATICS, V28, P1178, DOI DOI 10.1093/bioinformatics/bts106; GUARINO N., 2009, HDB ONTOLOGIES, DOI [DOI 10.1007/978-3-540-92673-3_0, 10.1007/978-3-540-92673-3]; Guizzardi G., 2005, ONTOLOGICAL FDN STRU; Guizzardi G, 2007, FR ART INT, V155, P18; Hair J.F., 2010, MULTIVARIATE DATA AN; Handcock Mark S, 2008, J Stat Softw, V24, P1548; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Hommes J, 2012, ADV HEALTH SCI EDUC, V17, P743, DOI 10.1007/s10459-012-9349-0; Huang, 2008, P 2008 INT C INF SYS; Huisman M., 2009, J SOC STRUCT, V10, P1, DOI DOI 10.21307/joss-2019-051; Iacobucci D, 1996, INT J RES MARKETING, V13, P415, DOI DOI 10.1016/S0167-8116(96)00022-5; Idowu OC, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P623; Jafari, 2017, CINNA DECIPHERING CE; Jalili M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143111; Janzen, 2013, AM BEHAV SCI; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Katona Z, 2011, J MARKETING RES, V48, P425, DOI 10.1509/jmkr.48.3.425; Kim HK, 2012, EXPERT SYST APPL, V39, P7403, DOI 10.1016/j.eswa.2012.01.066; Kiss C, 2008, DECIS SUPPORT SYST, V46, P233, DOI 10.1016/j.dss.2008.06.007; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; KRACKHARDT D, 1990, ADMIN SCI QUART, V35, P342, DOI 10.2307/2393394; Krebs V. E., 2002, First Monday, V7, DOI 10.5210/fm.v7i4.941; Landherr A, 2010, BUS INFORM SYST ENG+, V2, P371, DOI 10.1007/s12599-010-0127-3; Lee C. Y, 2006, PHYSICS0605220 ARXIV; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Liu S, 2018, SUSTAINABILITY, V10, P1, DOI DOI 10.3390/su10051588; Loehrlein AJ, 2014, J ASSOC INF SCI TECH, V65, P263, DOI 10.1002/asi.22969; Lu LY, 2016, PHYS REP, V650, P1, DOI 10.1016/j.physrep.2016.06.007; Mastrobuoni G, 2012, REV NETW ECON, V11, DOI 10.1515/1446-9022.1324; Mehra A, 2001, ADMIN SCI QUART, V46, P121, DOI 10.2307/2667127; Mersch DP, 2016, BEHAV ECOL SOCIOBIOL, V70, P1087, DOI 10.1007/s00265-016-2104-4; MONTGOMERY JD, 1991, AM ECON REV, V81, P1408; Neal ZP, 2008, GLOBAL NETW, V8, P94; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ni L, 2015, OPEN J BUSINESS MANA, V3, P125; Obadi G, 2010, CEUR WORKSHOP PROCEE, V567, P118; PAGE L., 1998, 199966 STANF INFOLAB, P161; Peng XQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130743; Perry-Smith JE, 2006, ACAD MANAGE J, V49, P85, DOI 10.2307/20159747; Pfeffer J., 2012, PROC 21 INT C WORLD, P1043, DOI DOI 10.1145/2187980.2188239; Poldin O, 2016, RES HIGH EDUC, V57, P448, DOI 10.1007/s11162-015-9391-x; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Robins G, 2004, SOC NETWORKS, V26, P257, DOI 10.1016/j.socnet.2004.05.001; Romano CPR, 2011, J INT DISPUT SETTL, V2, P241, DOI 10.1093/jnlids/idq024; ROTHENBERG RB, 1995, SOC NETWORKS, V17, P273, DOI 10.1016/0378-8733(95)00267-R; Russo TC, 2005, COMMUN EDUC, V54, P254, DOI 10.1080/03634520500356394; Saqr M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203590; Saqr M, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1126-1; Snasel, 2012, COMPUTATIONAL SOCIAL, P3, DOI DOI 10.1007/978-1-4471-4054-2_1; Sparrowe RT, 2001, ACAD MANAGE J, V44, P316, DOI 10.2307/3069458; Thomas SL, 2000, J HIGH EDUC, V71, P591, DOI 10.2307/2649261; Traxler A, 2018, PHYS REV PHYS EDUC R, V14, DOI 10.1103/PhysRevPhysEducRes.14.020107; Tsai WP, 2001, ACAD MANAGE J, V44, P996, DOI 10.2307/3069443; Tuffery, 2012, DATA MINING STAT DEC; Valente Thomas W, 2008, Connect (Tor), V28, P16; Vargas DL, 2018, PHYS REV PHYS EDUC R, V14, DOI 10.1103/PhysRevPhysEducRes.14.020112; Vaughan S, 2015, MED EDUC, V49, P114, DOI 10.1111/medu.12597; Vignery K, 2020, INT J EDUC RES, V99, DOI 10.1016/j.ijer.2019.101499; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Wasserman, 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Woolf K, 2012, MED TEACH, V34, P577, DOI 10.3109/0142159X.2012.669082; Xiao Z., 2018, FRONTIERS PHARM, V9; Xu WW, 2014, AM BEHAV SCI, V58, P1278, DOI 10.1177/0002764214527091; Yang D., 2013, NIPS DATA DRIVEN ED, V11, P14, DOI DOI 10.1109/APPEEC.2013.6837188; Yang H.L., 2012, J ASUYNCHRONOUS LEAR, V7, P93; Yilmaz, 2014, GRASAS ACEITES, V65, pe040; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang K, 2011, IEEE INT CONF NETWOR, P231, DOI 10.1109/ICON.2011.6168480; Znidarsic A, 2012, SOC NETWORKS, V34, P438, DOI 10.1016/j.socnet.2012.02.002; Zwolak JP, 2017, PHYS REV PHYS EDUC R, V13, DOI 10.1103/PhysRevPhysEducRes.13.010113	115	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244377	10.1371/journal.pone.0244377	http://dx.doi.org/10.1371/journal.pone.0244377			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378341	Green Published, gold			2022-12-27	WOS:000605651300056
J	Ali, S; Khan, FD; Ullah, R; Shah, RU; Alamri, S; AlHarthi, M; Siddiqui, MH				Ali, Safdar; Khan, Fakhar Din; Ullah, Rehmat; Shah, Rahmat Ullah; Alamri, Saud; AlHarthi, Maeesh; Siddiqui, Manzer H.			Seed germination ecology of Conyza stricta Willd. and implications for management	PLOS ONE			English	Article							CONSERVATION TILLAGE; AMBROSIA-ARTEMISIIFOLIA; ENVIRONMENTAL-FACTORS; SPECIES-DIVERSITY; EMERGENCE MODEL; RANGE EXPANSION; BONARIENSIS; WEED; BIOLOGY; IMPACT	Numerous cropping systems of the world are experiencing the emergence of new weed species in response to conservation agriculture. Conyza stricta Willd. is being a newly emerging weed of barley-based cropping systems in response to conservational tillage practices. Seed germination ecology of four populations (irrigated, rainfed, abandoned and ruderal habitats) was studied in laboratory and greenhouse experiments. The presence/absence of seed dormancy was inferred first, which indicated seeds were non-dormant. Seed germination was then recorded under various photoperiods, constant and alternating day/night temperatures, and pH, salinity and osmotic potential levels. Seedling emergence was observed from various seed burial depths. Seeds of all populations proved photoblastic and required 12-hour light/dark period for germination. Seeds of all populations germinated under 5-30 degrees C constant temperature; however, peak germination was recorded under 17.22-18.11 degrees C. Nonetheless, the highest germination was noted under 20/15 degrees C alternating day/night temperature. Ruderal and irrigated populations better tolerated salinity and germinated under 0-500 mM salinity. Similarly, rainfed population proved more tolerant to osmotic potential than other populations. Seeds of all populations required neutral pH for the highest germination, whereas decline was noted in germination under basic and alkaline pH. Seedling emergence was retarded for seeds buried >2 cm depth and no emergence was recorded from >4 cm depth. These results add valuable information towards our understanding of seed germination ecology of C. stricta. Seed germination ability of different populations under diverse environmental conditions suspects that the species can present severe challenges in future if not managed. Deep seed burial along with effective management of the emerging seedlings seems a pragmatic option to manage the species in cultivated fields. However, immediate management strategies are needed for rest of the habitats.	[Ali, Safdar; Khan, Fakhar Din] Govt Punjab, Directorate Land Reclamat, Lahore, Pakistan; [Ullah, Rehmat] Soil & Water Testing Lab Res, Dera Ghazi Khan, Pakistan; [Shah, Rahmat Ullah] Bahauddin Zakariya Univ, Fac Agr Sci & Technol, Dept Soil Sci, Multan, Pakistan; [Alamri, Saud; AlHarthi, Maeesh; Siddiqui, Manzer H.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia	Bahauddin Zakariya University; King Saud University	Ali, S (corresponding author), Govt Punjab, Directorate Land Reclamat, Lahore, Pakistan.	sakheradlr@gmail.com	Siddiqui, Manzer H./M-5028-2019; Alamri, Saud/Q-2264-2018; Siddiqui, Manzer H/Q-1519-2017	Siddiqui, Manzer H./0000-0003-2840-4608; Alamri, Saud/0000-0003-2565-1101; Siddiqui, Manzer H/0000-0003-2840-4608	Directorate of Land Reclamation, Lahore, Pakistan; King Saud University, Riyadh, Saudi Arabia [RSP-2020/173, RSP-2020/194]	Directorate of Land Reclamation, Lahore, Pakistan; King Saud University, Riyadh, Saudi Arabia(King Saud University)	The current study was partially supported by Directorate of Land Reclamation, Lahore, Pakistan. The study also was also supported by the Researchers Supporting Project (RSP-2020/173), King Saud University, Riyadh, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors would like to extend their sincere appreciation to the Researchers Supporting Project number (RSP-2020/194), King Saud University, Riyadh, Saudi Arabia. The authors are indebted to Dr. Ali Bakhsh for help in seed collection.	Agostinetto D, 2018, CIENC RURAL, V48, DOI 10.1590/0103-8478cr20170687; AHMED M, 1990, PHYTOCHEMISTRY, V29, P2715, DOI 10.1016/0031-9422(90)85226-6; Al-Wahaibi LH, 2019, BIOCHEM SYST ECOL, V87, DOI 10.1016/j.bse.2019.103959; Awan TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090305; Barberi P., 2001, Conservation agriculture, a worldwide challenge. First World Congress on conservation agriculture, Madrid, Spain, 1-5 October, 2001. Volume 2: offered contributions, P451; Barreto LC, 2016, FLORA, V225, P37, DOI 10.1016/j.flora.2016.09.009; Bewley J., 2013, SEEDS, P299, DOI [DOI 10.1007/978-1-4614-4693-4, 10.1007/978-1-4614-4693-4_7, DOI 10.1007/978-1-4614-4693-4_7]; Boscutti F, 2015, ENVIRON MANAGE, V55, P443, DOI 10.1007/s00267-014-0402-z; Burger J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240538; Buhler DD, 1997, WEED SCI, V45, P98, DOI 10.1017/S0043174500092535; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Chauhan BS, 2008, WEED SCI, V56, P820, DOI 10.1614/WS-08-070.1; Chauhan BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep26006; Chauhan BS, 2006, WEED SCI, V54, P471, DOI 10.1614/WS-05-176R1.1; Eslami SV, 2011, WEED SCI, V59, P90, DOI 10.1614/WS-D-10-00059.1; Farooq M, 2014, SOIL TILL RES, V141, P1, DOI 10.1016/j.still.2014.03.012; Farooq S, 2019, S AFR J BOT, V123, P361, DOI 10.1016/j.sajb.2019.03.031; Farooq S, 2017, ACTA OECOL, V84, P23, DOI 10.1016/j.actao.2017.08.004; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; Fowler R, 2001, SOIL TILL RES, V61, P93, DOI 10.1016/S0167-1987(01)00181-7; Garcia AL, 2013, WEED SCI, V61, P146, DOI 10.1614/WS-D-12-00023.1; GORSKI T, 1975, PHYSIOL PLANTARUM, V34, P342, DOI 10.1111/j.1399-3054.1975.tb03850.x; Heap I., 2020, INT HERBICIDE RESIST; IBM C., 2012, SPSS STAT WIND, P1; Karlsson LM, 2007, WEED RES, V47, P433, DOI 10.1111/j.1365-3180.2007.00576.x; Kassam A., 2019, International Journal of Environmental Studies, V76, P29, DOI 10.1080/00207233.2018.1494927; Lazaroto CA, 2008, CIENC RURAL, V38, P852, DOI 10.1590/S0103-84782008000300045; Li TSC, 2016, CHINESE RELATED N AM, DOI [10.1201/9781420094169, DOI 10.1201/9781420094169]; Lommen STE, 2018, BIOL INVASIONS, V20, P1475, DOI 10.1007/s10530-017-1640-9; Loura D, 2020, WEED SCI, V68, P411, DOI 10.1017/wsc.2020.28; Mahmood AH, 2016, WEED SCI, V64, P486, DOI 10.1614/WS-D-15-00184.1; Michael, 1977, P 6 AS PAC WEED SCI, P87; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Murphy SD, 2006, WEED SCI, V54, P69, DOI 10.1614/WS-04-125R1.1; Nandula VK, 2006, WEED SCI, V54, P898, DOI 10.1614/WS-06-006R2.1; Nichols V, 2015, FIELD CROP RES, V183, P56, DOI 10.1016/j.fcr.2015.07.012; Onen H, 2018, WEED SCI, V66, P494, DOI 10.1017/wsc.2018.20; Onen H, 2017, WEED SCI, V65, P115, DOI 10.1614/WS-D-16-00011.1; Ottavini D, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9090533; Ozaslan C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17169-5; Ozaslan C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164369; Pamplona JD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233228; Pittelkow CM, 2015, NATURE, V517, P365, DOI 10.1038/nature13809; Royo-Esnal A, 2015, WEED RES, V55, P387, DOI 10.1111/wre.12154; Saeed A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241601; Shahzad M, 2016, CROP PROT, V89, P161, DOI 10.1016/j.cropro.2016.07.019; Shahzad M, 2016, SOIL TILL RES, V163, P71, DOI 10.1016/j.still.2016.05.012; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; Sosnoskie LM, 2004, HORTSCIENCE, V39, P845; Steel RGD, 1980, PRINCIPLES PROCEDURE; TREMMEL DC, 1983, AM J BOT, V70, P1125, DOI 10.2307/2443282; Trezzi MM, 2015, WEED RES, V55, P34, DOI 10.1111/wre.12125; Valencia-Gredilla F, 2020, ANN APPL BIOL, V176, P36, DOI 10.1111/aab.12556; Vargas L, 2007, PLANTA DANINHA, V25, P573, DOI 10.1590/S0100-83582007000300017; Vidal RA, 2007, PLANTA DANINHA, V25, P309, DOI 10.1590/S0100-83582007000200010; Weaver SE, 2001, CAN J PLANT SCI, V81, P867, DOI 10.4141/P00-196; Weller SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22345; Wu H, 2007, WEED BIOL MANAG, V7, P192, DOI 10.1111/j.1445-6664.2007.00256.x; Yamashita O. M., 2016, Ambiencia, V12, P655; Zambrano-Navea C, 2013, WEED RES, V53, P213, DOI 10.1111/wre.12020; Zambrano-Navea C, 2016, CROP PROT, V80, P15, DOI 10.1016/j.cropro.2015.10.023; ZINZOLKER A, 1985, PHYTOPARASITICA, V13, P229	63	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244059	10.1371/journal.pone.0244059	http://dx.doi.org/10.1371/journal.pone.0244059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373381	Green Published, gold			2022-12-27	WOS:000603612300029
J	Bates, M; Spillane, CD; Gallagher, MF; McCann, A; Martin, C; Blackshields, G; Keegan, H; Gubbins, L; Brooks, R; Brooks, D; Selemidis, S; O'Toole, S; O'Leary, JJ				Bates, Mark; Spillane, Cathy D.; Gallagher, Michael F.; McCann, Amanda; Martin, Cara; Blackshields, Gordon; Keegan, Helen; Gubbins, Luke; Brooks, Robert; Brooks, Doug; Selemidis, Stavros; O'Toole, Sharon; O'Leary, John J.			The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SECRETORY PHENOTYPE; MAD2 EXPRESSION; TUMOR-GROWTH; TLR4; SENESCENCE; CELLS; CARCINOMA; MYD88; CHEMORESISTANCE	Despite the use of front-line anticancer drugs such as paclitaxel for ovarian cancer treatment, mortality rates have remained almost unchanged for the past three decades and the majority of patients will develop recurrent chemoresistant disease which remains largely untreatable. Overcoming chemoresistance or preventing its onset in the first instance remains one of the major challenges for ovarian cancer research. In this study, we demonstrate a key link between senescence and inflammation and how this complex network involving the biomarkers MAD2, TLR4 and MyD88 drives paclitaxel resistance in ovarian cancer. This was investigated using siRNA knockdown of MAD2, TLR4 and MyD88 in two ovarian cancer cell lines, A2780 and SKOV-3 cells and overexpression of MyD88 in A2780 cells. Interestingly, siRNA knockdown of MAD2 led to a significant increase in TLR4 gene expression, this was coupled with the development of a highly paclitaxel-resistant cell phenotype. Additionally, siRNA knockdown of MAD2 or TLR4 in the serous ovarian cell model OVCAR-3 resulted in a significant increase in TLR4 or MAD2 expression respectively. Microarray analysis of SKOV-3 cells following knockdown of TLR4 or MAD2 highlighted a number of significantly altered biological processes including EMT, complement, coagulation, proliferation and survival, ECM remodelling, olfactory receptor signalling, ErbB signalling, DNA packaging, Insulin-like growth factor signalling, ion transport and alteration of components of the cytoskeleton. Cross comparison of the microarray data sets identified 7 overlapping genes including MMP13, ACTBL2, AMTN, PLXDC2, LYZL1, CCBE1 and CKS2. These results demonstrate an important link between these biomarkers, which to our knowledge has never before been shown in ovarian cancer. In the future, we hope that triaging patients into alterative treatment groups based on the expression of these three biomarkers or therapeutic targeting of the mechanisms they are involved in will lead to improvements in patient outcome and prevent the development of chemoresistance.	[Bates, Mark; Spillane, Cathy D.; Gallagher, Michael F.; Martin, Cara; Keegan, Helen; O'Toole, Sharon; O'Leary, John J.] Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland; [Bates, Mark; Spillane, Cathy D.; Gallagher, Michael F.; Martin, Cara; Blackshields, Gordon; Keegan, Helen; O'Toole, Sharon; O'Leary, John J.] Coombe Women & Infants Univ Hosp, Emer Casey Mol Pathol Res Lab, Dublin, Ireland; [Bates, Mark; Spillane, Cathy D.; Gallagher, Michael F.; Martin, Cara; Blackshields, Gordon; Keegan, Helen; O'Toole, Sharon; O'Leary, John J.] Trinity St Jamess Canc Inst, Dublin, Ireland; [Bates, Mark; O'Toole, Sharon] Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland; [McCann, Amanda; Gubbins, Luke] Univ Coll Dublin, Coll Hlth Sci, Dublin, Ireland; [Martin, Cara; Blackshields, Gordon; Keegan, Helen; O'Leary, John J.] Coombe Women & Infants Univ Hosp, Dept Pathol, Dublin, Ireland; [Brooks, Robert; Brooks, Doug] Univ South Australia, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Selemidis, Stavros] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University College Dublin; Trinity College Dublin; University of South Australia; Royal Melbourne Institute of Technology (RMIT)	Bates, M (corresponding author), Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland.; Bates, M (corresponding author), Coombe Women & Infants Univ Hosp, Emer Casey Mol Pathol Res Lab, Dublin, Ireland.; Bates, M (corresponding author), Trinity St Jamess Canc Inst, Dublin, Ireland.; Bates, M (corresponding author), Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland.	batesm1@tcd.ie		Brooks, Doug/0000-0001-9098-3626; Bates, Mark/0000-0002-5916-5403; Selemidis, Stavros/0000-0002-3989-7615; O'Leary, John/0000-0001-7311-9326; Brooks, Robert/0000-0003-1535-8999; o toole, sharon/0000-0002-9260-3225	Royal City of Dublin Hospital Trust; Emer Casey Foundation, SOCK; Irish Ladies Golf Union	Royal City of Dublin Hospital Trust; Emer Casey Foundation, SOCK; Irish Ladies Golf Union	NO - This research was supported by a research grant from the Royal City of Dublin Hospital Trust, the Emer Casey Foundation, SOCK and the Irish Ladies Golf Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533; [Anonymous], 2019, AESTHET SURG J, V39, P1, DOI 10.1093/asj/sjz164; [Anonymous], 2015, BMJ, V2015, ph1887; Arnason T, 2015, CANCERS, V7, P2063, DOI 10.3390/cancers7040877; Asakura H, 2001, BLOOD COAGUL FIBRIN, V12, P1, DOI 10.1097/00001721-200101000-00001; Bareke H, 2018, SCAND J IMMUNOL, V88, DOI 10.1111/sji.12672; Barton CA, 2010, BRIT J CANCER, V102, P87, DOI 10.1038/sj.bjc.6605429; Bates M, 2020, CANCER LETT, V469, P11, DOI 10.1016/j.canlet.2019.10.005; Block MS, 2018, MAYO CLIN PROC, V93, P307, DOI 10.1016/j.mayocp.2017.10.023; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Byrne T, 2018, INT J GYNECOL CANCER, V28, P472, DOI 10.1097/IGC.0000000000001214; Byrne T, 2017, ONCOTARGET, V8, P102223, DOI 10.18632/oncotarget.18414; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140918; Cheng G, 2014, ELIFE, V3, DOI 10.7554/eLife.05401; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; d'Adhemar CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100816; D'Amico L, 2013, BRIT J CANCER, V108, P2525, DOI 10.1038/bjc.2013.271; Davalos AR, 2013, J CELL BIOL, V201, P613, DOI 10.1083/jcb.201206006; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Davies GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084611; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dias-Melicio LA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/236839; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Farfariello V., 2014, BIOCH BIOPHYS ACTA M, P1974; Furlong F, 2012, J PATHOL, V226, P746, DOI 10.1002/path.3035; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971; Guo JY, 2017, ONCOGENE, V36, P2457, DOI 10.1038/onc.2016.404; Hao Bo, 2018, Oncotarget, V9, P13088, DOI 10.18632/oncotarget.24178; Hao X, 2010, J HUAZHONG U SCI-MED, V30, P620, DOI 10.1007/s11596-010-0553-y; Hishida T, 2007, FEBS LETT, V581, P4272, DOI 10.1016/j.febslet.2007.07.074; Hodebeck M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00467; Huang B, 2008, ONCOGENE, V27, P218, DOI 10.1038/sj.onc.1210904; Huang JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep03840; Huhta H, 2016, ONCOTARGET, V7, P23658, DOI 10.18632/oncotarget.8151; Iversen N, 1998, BRIT J HAEMATOL, V102, P889, DOI 10.1046/j.1365-2141.1998.00875.x; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kim KH, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-193; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Kitazono AA, 2002, J BIOL CHEM, V277, P48627, DOI 10.1074/jbc.M207247200; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; KRYSTOSEK A, 1976, CELL, V9, P675, DOI 10.1016/0092-8674(76)90131-8; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Kwon MJ, 2013, INT J MOL SCI, V14, P18148, DOI 10.3390/ijms140918148; Lacruz RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035200; Li Z, 2016, TUMOR BIOL, V37, P13279, DOI 10.1007/s13277-016-5163-2; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; Lorenzini A, 2001, EXP GERONTOL, V36, P65, DOI 10.1016/S0531-5565(00)00192-3; Luo XZ, 2015, INT J CLIN EXP MED, V8, P14323; Maher SG, 2011, ANN SURG, V254, P809, DOI 10.1097/SLA.0b013e31823699f2; Marcus AI, 2006, CANCER RES, V66, P8838, DOI 10.1158/0008-5472.CAN-06-0699; McGrogan B, 2014, HUM PATHOL, V45, P1509, DOI 10.1016/j.humpath.2014.03.004; Meier W, 2012, GYNECOL ONCOL, V126, P236, DOI 10.1016/j.ygyno.2012.04.050; Miake J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183225; Nakano Y, 2012, ONCOL REP, V28, P1200, DOI 10.3892/or.2012.1907; Nakayasu C, 2000, PHYSIOL BEHAV, V70, P135, DOI 10.1016/S0031-9384(00)00234-1; Park PF, 2013, KOREAN J PATHOL, V47, P418, DOI 10.4132/KoreanJPathol.2013.47.5.418; Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773; Pivetta E, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3047; Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014; Prencipe M, 2009, BRIT J CANCER, V101, P1900, DOI 10.1038/sj.bjc.6605419; Rajput S, 2013, MOL CANCER THER, V12, P1676, DOI 10.1158/1535-7163.MCT-12-1019; Ran S, 2015, CANCER RES, V75, P2405, DOI 10.1158/0008-5472.CAN-14-3525; Salminen A, 2012, CELL SIGNAL, V24, P835, DOI 10.1016/j.cellsig.2011.12.006; Sato Y, 2009, CANCER MICROENVIRON, V2, pS205, DOI 10.1007/s12307-009-0022-y; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharpless NE, 2015, NAT REV CANCER, V15, P397, DOI 10.1038/nrc3960; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Short S, 2019, EBIOMEDICINE, V41, P683, DOI 10.1016/j.ebiom.2019.01.056; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Silasi Dan-Arin, 2006, Yale J Biol Med, V79, P153; Sukhanova A, 2013, CANCER DISCOV, V3, P96, DOI 10.1158/2159-8290.CD-12-0031; Sulaiman G, 2017, CELL DEATH DIFFER, V24, P1975, DOI 10.1038/cdd.2017.124; Sun NK, 2018, J CELL PHYSIOL, V233, P2489, DOI 10.1002/jcp.26125; Szajnik M, 2009, ONCOGENE, V28, P4353, DOI 10.1038/onc.2009.289; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamandl D, 2003, SHOCK, V20, P224, DOI 10.1097/00024382-200309000-00005; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Vathipadiekal V, 2015, CLIN CANCER RES, V21, P4960, DOI 10.1158/1078-0432.CCR-14-3173; Wang AC, 2009, EUR J CLIN INVEST, V39, P157, DOI 10.1111/j.1365-2362.2008.02070.x; Wang AC, 2014, ONCOL LETT, V7, P871, DOI 10.3892/ol.2013.1759; Yang WS, 2018, CELL PHYSIOL BIOCHEM, V51, P1632, DOI 10.1159/000495651; Yoneda M, 2019, ONCOL LETT, V17, P913, DOI 10.3892/ol.2018.9715; Zeng LC, 2020, J INT MED RES, V48, DOI 10.1177/0300060519825983; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982	93	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243715	10.1371/journal.pone.0243715	http://dx.doi.org/10.1371/journal.pone.0243715			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370338	gold, Green Published			2022-12-27	WOS:000603611900107
J	Kushitor, SB; Owusu, L; Kushitor, MK				Kushitor, Sandra Boatemaa; Owusu, Lily; Kushitor, Mawuli Kobla			The prevalence and correlates of the double burden of malnutrition among women in Ghana	PLOS ONE			English	Article							IRON-DEFICIENCY; OBESITY; ANEMIA; PREGNANCY; FOOD	Anaemia and underweight or overweight/obesity are major public health problems driving maternal and child mortality in low- and middle-income countries. While the burden of these conditions is recognised, the evidence for the co-occurrence of these conditions is fragmented and mixed, especially at the individual level. Further, many studies have focused on families and communities. The different pathways for the occurrence of anaemia and BMI challenges indicate that an individual can potentially live with both conditions and suffer the complications. This study examined the prevalence and factors associated with the co-occurrence of anaemia and BMI challenges among a cohort of women in Ghana. Data from the 2014 Ghana Demographic and Health Survey were used. The sample size was 4 337 women aged 15-49 years who were not pregnant during the survey. Women who suffered simultaneously from underweight or overweight/obesity and anaemia were considered as having the double burden of malnutrition. The data were analysed using descriptive statistics, Chi-square test and logistic regression in STATA. One-fifth of the participants were overweight (21%), 4% were underweight and about one-tenth were obese (12%). The prevalence of anaemia was 41%. Only one in three women had normal weight and was not anaemic (34%). About 14% of the women experienced the double burden of malnutrition. Being overweight and anaemic (57%) was the most common form of this double burden. Age, marital status, parity, and wealth were t key risk factors associated with the double burden of malnutrition. The findings from this study show that women experience multiple nutritional challenges concurrently and that only a few women had healthy nutritional status. This information is particularly important and can be introduced into health education programmes to help address misconceptions about body weight and health.	[Kushitor, Sandra Boatemaa] Stellenbosch Univ, Food Secur Initiat, Stellenbosch, South Africa; [Kushitor, Sandra Boatemaa] Stellenbosch Univ, Ctr Complex Syst Transit, Stellenbosch, South Africa; [Owusu, Lily] Univ Ghana, Reg Inst Populat Studies, Accra, Ghana; [Kushitor, Mawuli Kobla] Univ Hlth & Allied Sci, Dept Hlth Policy Planning & Management, Hohoe, Ghana	Stellenbosch University; Stellenbosch University; University of Ghana	Kushitor, SB (corresponding author), Stellenbosch Univ, Food Secur Initiat, Stellenbosch, South Africa.; Kushitor, SB (corresponding author), Stellenbosch Univ, Ctr Complex Syst Transit, Stellenbosch, South Africa.	boatemaa@sun.ac.za	Kushitor, Sandra Boatemaa/CAG-8145-2022	Kushitor, Sandra Boatemaa/0000-0002-0638-6261	Dean's Division, Faculty of AgriSciences, Stellenbosch University, Stellenbosch, South Africa	Dean's Division, Faculty of AgriSciences, Stellenbosch University, Stellenbosch, South Africa	Sandra Boatemaa Kushitor was supported by the Dean's Division, Faculty of AgriSciences, Stellenbosch University, Stellenbosch, South Africa.	Agyemang C, 2015, METABOLIC SYNDROME C, P41, DOI 10.1007/978-3-319-12125-3; Aigner E, 2014, NUTRIENTS, V6, P3587, DOI 10.3390/nu6093587; Aikins AD, 2014, HEALTH CARE WOMEN IN, V35, P954, DOI 10.1080/07399332.2014.926902; Amugsi DA, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0053-1; Amugsi DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136748; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2017, DRUG SAF UPDATE, DOI DOI 10.1186/s13104-016-2345-3; Appiah C. A., 2016, PANAFRICAN MED J, V23, P1; Arshad M, 2017, ROM J INTERN MED, V55, P3, DOI 10.1515/rjim-2016-0046; Ayensu J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226026; Biritwum Rb, 2005, Ghana Med J, V39, P82; Cepeda-Lopez AC, 2011, AM J CLIN NUTR, V93, P975, DOI 10.3945/ajcn.110.005439; de-Graft Aikins A., 2011, FATNESS MATERNAL BOD; Ezzati M, 2015, COMP QUANTIFICATION; Mujica-Coopman MF, 2015, J TRACE ELEM MED BIO, V30, P215, DOI 10.1016/j.jtemb.2014.03.008; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; Ghana Statistical Service, 2013, 2010 POP HOUS CENS N; Global Nutrition Report, 2020, 2020 GLOB NUTR REP A; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; IFPRI, 2019, GLOB NUTR REP 2018; Kandala NB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101103; Kimani-Murage EW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129943; Kodaman N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162753; Lartey ST, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215045; Little M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08679-5; Milman N, 2006, ANN HEMATOL, V85, P559, DOI 10.1007/s00277-006-0108-2; Minicuci N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.21292; Mocking M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5704-2; Mugisha JO, 2014, J AGING HEALTH, V26, P316, DOI 10.1177/0898264313516165; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Obai G, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0865-4; Olutayo AO, 2009, AFRICA, V79, P207, DOI 10.3366/E0001972009000692; Onyango AW, 2019, ANN NUTR METAB, V75, P127, DOI 10.1159/000503671; onzalez-Socoloske D., 2012, OPEN REMOTE SENS J, V5, P1, DOI DOI 10.2174/1875413901205010001; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Otoo GE, 2009, J HUM LACT, V25, P34, DOI 10.1177/0890334408325072; Pereko KKA, 2013, PUBLIC HEALTH NUTR, V16, P591, DOI 10.1017/S1368980012002698; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Wegmuller R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228258	39	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244362	10.1371/journal.pone.0244362	http://dx.doi.org/10.1371/journal.pone.0244362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370352	Green Published, gold			2022-12-27	WOS:000603611900029
J	Nevers, MB; Przybyla-Kelly, K; Shively, D; Morris, CC; Dickey, J; Byappanahalli, MN				Nevers, Meredith B.; Przybyla-Kelly, Kasia; Shively, Dawn; Morris, Charles C.; Dickey, Joshua; Byappanahalli, Murulee N.			Influence of sediment and stream transport on detecting a source of environmental DNA	PLOS ONE			English	Article							DECAY-RATES; LAKES; SURVEILLANCE; QUANTIFICATION; DEGRADATION; SUBSTRATE; BIGHEAD	Environmental DNA (eDNA) can be used for early detection, population estimations, and assessment of potential spread of invasive species, but questions remain about factors that influence eDNA detection results. Efforts are being made to understand how physical, chemical, and biological factors-settling, resuspension, dispersion, eDNA stability/decay-influence eDNA estimations and potentially population abundance. In a series of field and controlled mesocosm experiments, we examined the detection and accumulation of eDNA in sediment and water and the transport of eDNA in a small stream in the Lake Michigan watershed, using the invasive round goby fish (Neogobius melanostomus) as a DNA source. Experiment 1: caged fish (average n = 44) were placed in a stream devoid of round goby; water was collected over 24 hours along 120-m of stream, including a simultaneous sampling event at 7 distances from DNA source; stream monitoring continued for 24 hours after fish were removed. Experiment 2: round goby were placed in laboratory tanks; water and sediment were collected over 14 days and for another 150 days post-fish removal to calculate eDNA shedding and decay rates for water and sediment. For samples from both experiments, DNA was extracted, and qPCR targeted a cytochrome oxidase I gene (COI) fragment specific to round goby. Results indicated that eDNA accumulated and decayed more slowly in sediment than water. In the stream, DNA shedding was markedly lower than calculated in the laboratory, but models indicate eDNA could potentially travel long distances (up to 50 km) under certain circumstances. Collectively, these findings show that the interactive effects of ambient conditions (e.g., eDNA stability and decay, hydrology, settling-resuspension) are important to consider when developing comprehensive models. Results of this study can help resource managers target representative sites downstream of potential invasion sites, thereby maximizing resource use.	[Nevers, Meredith B.; Przybyla-Kelly, Kasia; Byappanahalli, Murulee N.] US Geol Survey, Great Lakes Sci Ctr, Chesterton, IN USA; [Shively, Dawn] Michigan State Univ, Dept Civil & Environm Engn, E Lansing, MI 48824 USA; [Morris, Charles C.; Dickey, Joshua] Natl Pk Serv, Indiana Dunes Natl Pk, Porter, IN USA	United States Department of the Interior; United States Geological Survey; Michigan State University; United States Department of the Interior	Nevers, MB (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Chesterton, IN USA.	mnevers@usgs.gov		Byappanahalli, Muruleedhara/0000-0001-5376-597X; Nevers, Meredith/0000-0001-6963-6734				AARDEMA BW, 1983, APPL ENVIRON MICROB, V46, P417, DOI 10.1128/AEM.46.2.417-420.1983; [Anonymous], 2009, SYSTAT SYST 13 0; Atkinson J.F., 2015, LESSONS CONSERVATION, P17; Aubeneau AF, 2014, GEOPHYS RES LETT, V41, P8335, DOI 10.1002/2014GL061838; Baldigo BP, 2017, T AM FISH SOC, V146, P99, DOI 10.1080/00028487.2016.1243578; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beng KC, 2020, BIODIVERS CONSERV, V29, P2089, DOI 10.1007/s10531-020-01980-0; Bunnell DB, 2014, BIOSCIENCE, V64, P26, DOI 10.1093/biosci/bit001; Buxton AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183371; Corinaldesi C, 2008, MOL ECOL, V17, P3939, DOI 10.1111/j.1365-294X.2008.03880.x; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Eichmiller JJ, 2016, ENVIRON SCI TECHNOL, V50, P1859, DOI 10.1021/acs.est.5b05672; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Fremier AK, 2019, ENVIRON SCI TECHNOL, V53, P6640, DOI 10.1021/acs.est.8b06829; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Harrison JB, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1409; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Honjo MN, 2012, VET MICROBIOL, V155, P183, DOI 10.1016/j.vetmic.2011.09.005; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2016, ENVIRON SCI TECHNOL, V50, P8770, DOI 10.1021/acs.est.6b01761; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Klymus K.E., 2020, ENV DNA, V2, P271, DOI [10.1002/edn3.29, DOI 10.1002/EDN3.29]; Klymus KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177643; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Lance RF, 2017, MANAG BIOL INVASION, V8, P343, DOI 10.3391/mbi.2017.8.3.08; Limburg KE, 2010, J GREAT LAKES RES, V36, P86, DOI 10.1016/j.jglr.2009.11.007; LORENZ MG, 1981, MAR BIOL, V64, P225, DOI 10.1007/BF00397113; Martinez B., 2017, ADV FEDERAL CAPACITI; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Nathan LR, 2015, CONSERV BIOL, V29, P430, DOI 10.1111/cobi.12381; Nevers Meredith B, 2020, USGS, DOI 10.5066/P9HI425V; Nevers MB, 2020, WATER RES, V178, DOI 10.1016/j.watres.2020.115671; Nevers MB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191720; Nevers MB, 2011, FECAL BACTERIA, P165; Nukazawa K, 2018, ENVIRON SCI TECHNOL, V52, P10562, DOI 10.1021/acs.est.8b02293; Pochardt M, 2020, MOL ECOL RESOUR, V20, P457, DOI 10.1111/1755-0998.13123; R Core Team, 2020, R LANG ENV STAT COMP; Sansom BJ, 2017, ENVIRON SCI TECHNOL, V51, P14244, DOI 10.1021/acs.est.7b05199; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Shelton AO, 2019, BIOL CONSERV, V237, P383, DOI 10.1016/j.biocon.2019.07.003; Shogren AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05223-1; Simon TP, 2016, ENVIRON MANAGE, V58, P1059, DOI 10.1007/s00267-016-0750-y; SPSS, 2019, SPSS VERV 26; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Stoeckle MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175186; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2019, ECOL EVOL, V9, P1665, DOI 10.1002/ece3.4809; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Torti A, 2018, ENVIRON MICROBIOL, V20, P4526, DOI 10.1111/1462-2920.14401; Trebitz AS, 2017, J ENVIRON MANAGE, V202, P299, DOI 10.1016/j.jenvman.2017.07.045; Tucker AJ, 2016, BIOL INVASIONS, V18, P3205, DOI 10.1007/s10530-016-1209-z; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Turschak BA, 2014, ECOLOGY, V95, P1243, DOI 10.1890/13-0329.1; Wei N, 2018, ENVIRON SCI TECHNOL, V52, P12428, DOI 10.1021/acs.est.8b04956; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [DOI 10.21105/JOSS.01686, 10.21105/joss.01686]	59	7	7	8	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244086	10.1371/journal.pone.0244086	http://dx.doi.org/10.1371/journal.pone.0244086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370371	Green Published, gold			2022-12-27	WOS:000603611900025
J	Ye, XH; Yang, ZH; Jiang, YQ; Yu, L; Guo, RK; Meng, YJ; Shao, CG				Ye, Xinghuo; Yang, Zhihong; Jiang, Yeqin; Yu, Lan; Guo, Rongkai; Meng, Yijun; Shao, Chaogang			sRNATargetDigger: A bioinformatics software for bidirectional identification of sRNA-target pairs with co-regulatory sRNAs information	PLOS ONE			English	Article							MICRORNA; PREDICTION; EXPRESSION; FRAMEWORK; SIRNA	Identification of the target genes of microRNAs (miRNAs), trans-acting small interfering RNAs (ta-siRNAs), and small interfering RNAs (siRNAs) is an important step for understanding their regulatory roles in plants. In recent years, many bioinformatics software packages based on small RNA (sRNA) high-throughput sequencing (HTS) and degradome sequencing data analysis have provided strong technical support for large-scale mining of sRNA-target pairs. However, sRNA-target regulation is achieved using a complex network of interactions since one transcript might be co-regulated by multiple sRNAs and one sRNA may also affect multiple targets. Currently used mining software can realize the mining of multiple unknown targets using known sRNA, but it cannot rule out the possibility of co-regulation of the same target by other unknown sRNAs. Hence, the obtained regulatory network may be incomplete. We have developed a new mining software, sRNATargetDigger, that includes two function modules, "Forward Digger" and "Reverse Digger", which can identify regulatory sRNA-target pairs bidirectionally. Moreover, it has the ability to identify unknown sRNAs co-regulating the same target, in order to obtain a more authentic and reliable sRNA-target regulatory network. Upon re-examination of the published sRNA-target pairs in Arabidopsis thaliana, sRNATargetDigger found 170 novel co-regulatory sRNA-target pairs. This software can be downloaded from .	[Ye, Xinghuo; Yang, Zhihong; Jiang, Yeqin; Yu, Lan; Shao, Chaogang] Huzhou Univ, Coll Life Sci, Huzhou, Zhejiang, Peoples R China; [Guo, Rongkai] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Meng, Yijun] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	Huzhou University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Hangzhou Normal University	Shao, CG (corresponding author), Huzhou Univ, Coll Life Sci, Huzhou, Zhejiang, Peoples R China.	shaocg@zjhu.edu.cn			National Natural Science Foundation of China [31771457, 31801102, 31970637]; Zhejiang Provincial Natural Science Foundation of China [LY17C190001]; Public Welfare Technology Application Research Project of Zhejiang Province [2016C33193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Public Welfare Technology Application Research Project of Zhejiang Province	This work was supported by National Natural Science Foundation of China [31771457, 31801102, 31970637]; Zhejiang Provincial Natural Science Foundation of China [LY17C190001] and Public Welfare Technology Application Research Project of Zhejiang Province [2016C33193].The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barturen G., 2014, METHODS NEXT GENERAT, V1, P21, DOI [DOI 10.2478/MNGS-2014-0001, 10.2478/mngs-2014-0001]; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dai XB, 2018, NUCLEIC ACIDS RES, V46, pW49, DOI 10.1093/nar/gky316; Fahlgren N, 2010, METHODS MOL BIOL, V592, P51, DOI 10.1007/978-1-60327-005-2_4; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Huen A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5258-9; Kakrana A, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku693; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Lee H, 2010, NUCLEIC ACIDS RES, V38, P3081, DOI 10.1093/nar/gkp1240; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu DM, 2009, PHYSIOL PLANTARUM, V136, P223, DOI 10.1111/j.1399-3054.2009.01229.x; Luria N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170429; Mutum RD, 2016, SCI REP-UK, V6, DOI 10.1038/srep30786; Naya L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084416; Nicolas FE, 2011, METHODS MOL BIOL, V732, P139, DOI 10.1007/978-1-61779-083-6_11; Shao CG, 2013, BRIEF BIOINFORM, V14, P293, DOI 10.1093/bib/bbs040; Thody J, 2018, NUCLEIC ACIDS RES, V46, P8730, DOI 10.1093/nar/gky609; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xu MY, 2014, J EXP BOT, V65, P89, DOI 10.1093/jxb/ert353; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Ye XH, 2019, PLANT BIOSYST, V153, P506, DOI 10.1080/11263504.2018.1524800; Yu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18901; Zheng Y, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1155/2012/360358, 10.1093/nar/gkr1092]; Zhu H, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5395-1	34	0	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244480	10.1371/journal.pone.0244480	http://dx.doi.org/10.1371/journal.pone.0244480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370386	Green Published, gold			2022-12-27	WOS:000603611900021
J	Ajibola, G; Bennett, K; Powis, KM; Hughes, MD; Leidner, J; Kgole, S; Batlang, O; Mmalane, M; Makhema, J; Lockman, S; Shapiro, R				Ajibola, Gbolahan; Bennett, Kara; Powis, Kathleen M.; Hughes, Michael D.; Leidner, Jean; Kgole, Samuel; Batlang, Oganne; Mmalane, Mompati; Makhema, Joseph; Lockman, Shahin; Shapiro, Roger			Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines	PLOS ONE			English	Article							PNEUMONIA; IMPACT; MORTALITY; HOSPITALIZATION; SURVEILLANCE; PREVENTION; MALAWI	Background Rotavirus vaccine (RV) and pneumococcal vaccine (PCV) decrease diarrheal and respiratory disease incidence and severity, but there are few data about the effects of these vaccines among HIV-exposed uninfected (HEU) children. Methods We recorded RV and PCV vaccination history in a placebo-controlled trial that studied the need for cotrimoxazole among HEU infants in Botswana (the Mpepu Study). We categorized infants by enrollment before or after the simultaneous April 2012 introduction of RV and PCV, and compared diagnoses of diarrhea and pneumonia (grade 3/4), hospitalizations, and deaths from both disease conditions through the 12-month study visit by vaccine era/status across two sites (a city and a village) by Kaplan-Meier estimates. Results Two thousand six hundred and thirty-five HEU infants were included in this secondary analysis, of these 1689 (64%) were enrolled in Gaborone (344 pre-vaccine, 1345 vaccine) and 946 (36%) in Molepolole (209 pre-vaccine, 737 vaccine). We observed substantial reduction in hazard of hospitalization or death for reason of diarrhea and pneumonia in the vaccine era versus the pre-vaccine era in Molepolole (hazard ratio, HR = 0.44, 95% confidence interval, CI = 0.28, 0.71) with smaller reduction in Gaborone (HR = 0.91, 95% CI = 0.57, 1.45). Similar downward trends were observed for diagnoses of diarrhea and pneumonia separately during the vaccine versus pre-vaccine era. Conclusions Although temporal confounding cannot be excluded, significant declines in the burden of diarrheal and respiratory illness were observed among HEU children in Botswana following the introduction of RV and PCV. RV and PCV may maximally benefit HEU children in rural areas with higher disease burden.	[Ajibola, Gbolahan; Powis, Kathleen M.; Kgole, Samuel; Batlang, Oganne; Mmalane, Mompati; Makhema, Joseph] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Bennett, Kara] Bennett Stat Consulting Inc, Ballston Lake, NY USA; [Powis, Kathleen M.] Massachusetts Gen Hosp, Dept Internal Med, Boston, MA 02114 USA; [Powis, Kathleen M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Powis, Kathleen M.; Shapiro, Roger] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Hughes, Michael D.] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Leidner, Jean] Goodtables Data Consulting LLC, Norman, OK USA; [Lockman, Shahin] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA	Botswana-Harvard AIDS Institute Partnership; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Ajibola, G (corresponding author), Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana.	gajibola@bhp.org.bw	Powis, Kathleen/AAU-5123-2021	Kgole, Samuel Wilson/0000-0001-7078-9041; Ajibola, Gbolahan/0000-0002-5408-4823	US National Institutes of Health [R01HD061265]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Effect of Co-Trimoxazole on Mortality in HIV-exposed but Uninfected Children in Botswana (The Mpepu Study): A Double-Blind, Randomized, Placebo-Controlled Trial was funded by the US National Institutes of Health, grant R01HD061265 (to SL, RS). The funder provided support in the form of salaries for authors [G.A, K.M.P, M.D.H, S. K, O.B, M.M, J.M, S.L and R.S], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abuka T., 2017, CURR PEDIAT, V21, P19; Ajibola G, 2018, J PEDIATR-US, V203, P68, DOI 10.1016/j.jpeds.2018.08.009; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; [Anonymous], 2018, EFSA J, V3, P4; Bar-Zeev N, 2018, LANCET GLOB HEALTH, V6, pE1036, DOI 10.1016/S2214-109X(18)30314-0; Bar-Zen N, 2015, LANCET INFECT DIS, V15, P422, DOI 10.1016/S1473-3099(14)71060-6; Benet T, 2017, AM J TROP MED HYG, V97, P68, DOI 10.4269/ajtmh.16-0733; Enane LA, 2016, CLIN INFECT DIS, V62, pS168, DOI 10.1093/cid/civ1210; Enweronu-Laryea CC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-431; Fishel Joy D., 2014, DHS COMP REPORTS; Francis Magitta Ng'weina, 2018, EC PULMONOLOGY RESP, V5, P334; Leung DT, 2016, PEDIATR CLIN N AM, V63, P67, DOI 10.1016/j.pcl.2015.08.003; Lockman S, 2017, LANCET GLOB HEALTH, V5, pE491, DOI 10.1016/s2214-109x(17)30143-2; Lugangira Kristina, 2017, BMC Res Notes, V10, P502, DOI 10.1186/s13104-017-2818-z; Mackenzie GA, 2017, LANCET INFECT DIS, V17, P965, DOI 10.1016/S1473-3099(17)30321-3; Madhi SA, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005881; Madhi SA, 2015, THORAX, V70, P1149, DOI 10.1136/thoraxjnl-2014-206593; Melese B, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7579-2; Mokomane M, 2018, THER ADV INFECT DIS, V5, P29, DOI 10.1177/2049936117744429; Msimang VMY, 2013, PEDIATR INFECT DIS J, V32, P1359, DOI 10.1097/INF.0b013e3182a72fc0; Ngabo F, 2016, LANCET GLOB HEALTH, V4, pE129, DOI 10.1016/S2214-109X(15)00270-3; Operario DJ, 2017, J INFECT DIS, V216, P220, DOI 10.1093/infdis/jix294; Otieno GP, 2020, CLIN INFECT DIS, V70, P2306, DOI 10.1093/cid/ciz912; United Nations Inter-agency Group for Child Mortality Estimation (UN IGME), 2021, LEVELS TRENDS CHILD; Van Malderen C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7111-8; Vesikari T, 2012, PEDIATR INFECT DIS J, V31, P509, DOI 10.1097/INF.0b013e3182489cac; Zash R, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0635-5	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244100	10.1371/journal.pone.0244100	http://dx.doi.org/10.1371/journal.pone.0244100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347474	Green Published, gold			2022-12-27	WOS:000603071100054
J	Dong, RY; Liu, CJ; Tian, SY; Bai, JB; Yu, KL; Liu, L; Tian, DH				Dong, Ruiyi; Liu, Chunjie; Tian, Siyu; Bai, Jiangbo; Yu, Kunlun; Liu, Lei; Tian, Dehu			Electrospun polycaprolactone (PCL)-amnion nanofibrous membrane prevents adhesions and promotes nerve repair in a rat model of sciatic nerve compression	PLOS ONE			English	Article							AMNIOTIC MEMBRANE; GROWTH-FACTOR; INJURY; CELLS; REGENERATION; DELIVERY	Adhesion and scarring after neural surgery are detrimental to nerve regeneration and functional recovery. Amniotic membranes have been used in tissue repair due to their immunogenicity and richness in cytokines. In this study, an electrospun polycaprolactone (PCL)-amnion nanofibrous membrane was prepared for the treatment of sciatic nerve compression in a rat model. The effects of the PCL-amnion nanofibrous membrane on the prevention of adhesion formation and nerve regeneration were evaluated using electrophysiology and histological analyses. Compared with the medical chitosan hydrogel dressing, the PCL-amnion nanofibrous membrane significantly reduced peripheral nerve adhesion and promoted the rapid recovery of nerve conduction. Moreover, the immunohistochemical analysis identified more Schwann cells and less pro-inflammatory M1 macrophages in the PCL-amnion group. Western blot and RT-PCR results showed that the expression levels of type-? and ? collagen in the PCL-treated rats were half of those in the control group after 12 weeks, while the expression level of nerve growth factor was approximately 3.5 times that found in the rats treated with medical chitosan hydrogel. In summary, electrospun PCL-amnion nanofibrous membranes can effectively reduce adhesion after neural surgery and promote nerve repair and regeneration. The long-term retention in vivo and sustained release of cytokines make PCL-amnion a promising biomaterial for clinical application.	[Dong, Ruiyi; Tian, Dehu] Cangzhou Integrated Tradit Chinese & Western Med, Dept Orthoped, Cangzhou, Hebei, Peoples R China; [Liu, Chunjie] Tangshan Workers Hosp, Dept Orthoped, Tangshan, Hebei, Peoples R China; [Tian, Siyu; Bai, Jiangbo; Yu, Kunlun; Tian, Dehu] Hebei Med Univ, Affiliated Hosp 3, Dept Hand Surg, Shijiazhuang, Hebei, Peoples R China; [Liu, Lei] Changping Dist Hosp, Dept Orthoped, Beijing, Peoples R China	Hebei Medical University	Tian, DH (corresponding author), Hebei Med Univ, Affiliated Hosp 3, Dept Hand Surg, Shijiazhuang, Hebei, Peoples R China.	tiandehu899@outlook.com		tian, de hu/0000-0002-6065-0828				Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Braga-Silva J, 1999, J HAND SURG-BRIT EUR, V24B, P703, DOI 10.1054/jhsb.1999.0276; Braun DA, 2016, KIDNEY INT, V89, P468, DOI 10.1038/ki.2015.317; Brugmans MMCP, 2015, J TISSUE ENG REGEN M, V9, pE289, DOI 10.1002/term.1753; Brull R, 2015, REGION ANESTH PAIN M, V40, P479, DOI 10.1097/AAP.0000000000000125; Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2; Carr MJ, 2017, CURR OPIN NEUROBIOL, V47, P52, DOI 10.1016/j.conb.2017.09.003; Chang DS, 2016, J PAIN RES, V9, P373, DOI 10.2147/JPR.S89061; Choi J, 2020, J PLAST RECONSTR AES, V73, P214, DOI 10.1016/j.bjps.2019.09.031; Dam-Hieu Phong, 2005, Neurosurgery, V56, P425, DOI 10.1227/01.NEU.0000156845.41626.E9; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; Dy CJ, 2018, J HAND SURG-AM, V43, P360, DOI 10.1016/j.jhsa.2018.01.013; Gaspar MP, 2016, J SHOULDER ELB SURG, V25, P2057, DOI 10.1016/j.jse.2016.09.013; Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015; Gobinathan S, 2018, J BIOMAT SCI-POLYM E, V29, P2051, DOI 10.1080/09205063.2018.1485814; Gonzalez-Andrades M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142099; Irifune H, 2018, J HAND SURG-ASIAN-PA, V23, P116, DOI 10.1142/S2424835518720025; Jirsova K, 2017, CELL TISSUE BANK, V18, P193, DOI 10.1007/s10561-017-9618-5; Kemp SWP, 2011, EXP NEUROL, V229, P460, DOI 10.1016/j.expneurol.2011.03.017; Kesting MR, 2008, J BURN CARE RES, V29, P907, DOI 10.1097/BCR.0b013e31818b9e40; Kim PD, 2010, MICROSURG, V30, P392, DOI 10.1002/micr.20760; Koob TJ, 2015, J BIOMED MATER RES B, V103, P1133, DOI 10.1002/jbm.b.33265; Kshersagar J, 2018, CELL TISSUE BANK, V19, P423, DOI 10.1007/s10561-018-9688-z; Lemke A, 2018, ACTA BIOMATER, V66, P335, DOI 10.1016/j.actbio.2017.11.042; Lin YL, 2008, SURG NEUROL, V70, P9, DOI 10.1016/j.surneu.2008.01.057; Liu CJ, 2020, INT J NANOMED, V15, P927, DOI 10.2147/IJN.S231538; Lorenz J, 2016, J ORAL IMPLANTOL, V42, P273, DOI 10.1563/aaid-joi-D-15-00133; MACKINNON SE, 1984, ANN PLAS SURG, V13, P112, DOI 10.1097/00000637-198408000-00004; Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6; Mardanpour Keykhosro, 2019, Asian J Neurosurg, V14, P693, DOI 10.4103/ajns.AJNS_31_17; Nishimura T, 2008, HISTOL HISTOPATHOL, V23, P157, DOI 10.14670/HH-23.157; Pan HC, 2007, J CLIN NEUROSCI, V14, P1089, DOI 10.1016/j.jocn.2006.08.008; Parolini O, 2014, ARTHRITIS RHEUMATOL, V66, P327, DOI 10.1002/art.38206; Petersen J, 1996, NEUROSURGERY, V38, P976, DOI 10.1097/00006123-199605000-00025; Rasulic L, 2018, ACTA NEUROCHIR, V160, P1587, DOI 10.1007/s00701-018-3569-x; Riccio M, 2019, J CELL PHYSIOL, V234, P3362, DOI 10.1002/jcp.27299; ROBSON MC, 1973, ANN SURG, V177, P144, DOI 10.1097/00000658-197302000-00003; Sanli E, 2021, J INVEST SURG, V34, P454, DOI 10.1080/08941939.2019.1644403; Sarker MD, 2018, PROG NEUROBIOL, V171, P125, DOI 10.1016/j.pneurobio.2018.07.002; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shintani K, 2018, J NEUROSURG, V129, P815, DOI 10.3171/2017.4.JNS162522; Urano H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164572; Usami S, 2019, MICROSURG, V39, P647, DOI 10.1002/micr.30496; Vijayavenkataraman S, 2020, ACTA BIOMATER, V106, P54, DOI 10.1016/j.actbio.2020.02.003; von Bergen TN, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118807131; Wang ML, 2019, CONNECT TISSUE RES, V60, P3, DOI 10.1080/03008207.2018.1489381; Wu QQ, 2017, INT J MOL MED, V39, P918, DOI 10.3892/ijmm.2017.2897; Yu HL, 2014, NEUROSCI LETT, V566, P177, DOI 10.1016/j.neulet.2014.02.065; Zatroch KK, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0982-y; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zuo EJ, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181122	51	5	5	8	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244301	10.1371/journal.pone.0244301	http://dx.doi.org/10.1371/journal.pone.0244301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338083	gold, Green Published			2022-12-27	WOS:000601313500044
J	Reilly, J; Gallagher, L; Leader, G; Shen, SB				Reilly, Jamie; Gallagher, Louise; Leader, Geraldine; Shen, Sanbing			Coupling of autism genes to tissue-wide expression and dysfunction of synapse, calcium signalling and transcriptional regulation	PLOS ONE			English	Article							DE-NOVO MUTATIONS; COPY-NUMBER VARIATION; CONGENITAL HEART-DISEASE; SPECTRUM DISORDER; INTELLECTUAL DISABILITY; SLEEP PROBLEMS; CHILDREN; CACNA1D; RISK; DYSREGULATION	Autism Spectrum Disorder (ASD) is a heterogeneous disorder that is often accompanied with many co-morbidities. Recent genetic studies have identified various pathways from hundreds of candidate risk genes with varying levels of association to ASD. However, it is unknown which pathways are specific to the core symptoms or which are shared by the co-morbidities. We hypothesised that critical ASD candidates should appear widely across different scoring systems, and that comorbidity pathways should be constituted by genes expressed in the relevant tissues. We analysed the Simons Foundation for Autism Research Initiative (SFARI) database and four independently published scoring systems and identified 292 overlapping genes. We examined their mRNA expression using the Genotype-Tissue Expression (GTEx) database and validated protein expression levels using the human protein atlas (HPA) dataset. This led to clustering of the overlapping ASD genes into 2 groups; one with 91 genes primarily expressed in the central nervous system (CNS geneset) and another with 201 genes expressed in both CNS and peripheral tissues (CNS+PT geneset). Bioinformatic analyses showed a high enrichment of CNS development and synaptic transmission in the CNS geneset, and an enrichment of synapse, chromatin remodelling, gene regulation and endocrine signalling in the CNS+PT geneset. Calcium signalling and the glutamatergic synapse were found to be highly interconnected among pathways in the combined geneset. Our analyses demonstrate that 2/3 of ASD genes are expressed beyond the brain, which may impact peripheral function and involve in ASD co-morbidities, and relevant pathways may be explored for the treatment of ASD co-morbidities.	[Reilly, Jamie; Shen, Sanbing] Natl Univ Ireland NUI Galway, Sch Med, Regenerat Med Inst, Biomed Sci Bldg, Galway, Ireland; [Gallagher, Louise] Trinity Coll Dublin, Sch Med, Discipline Psychiat, Dublin, Ireland; [Gallagher, Louise] Trinity Coll Dublin, St Jamess Hosp, Trinity Ctr Hlth Sci, Trinity Translat Med Inst, Dublin, Ireland; [Leader, Geraldine] Natl Univ Ireland NUI Galway, Dept Psychol, Irish Ctr Autism & Neurodev Res ICAN, Galway, Ireland; [Shen, Sanbing] Royal Coll Surg Ireland RCSI, FutureNeuro Res Ctr, Dublin, Ireland	Ollscoil na Gaillimhe-University of Galway; Trinity College Dublin; Trinity College Dublin; Ollscoil na Gaillimhe-University of Galway; Royal College of Surgeons - Ireland	Reilly, J; Shen, SB (corresponding author), Natl Univ Ireland NUI Galway, Sch Med, Regenerat Med Inst, Biomed Sci Bldg, Galway, Ireland.; Shen, SB (corresponding author), Royal Coll Surg Ireland RCSI, FutureNeuro Res Ctr, Dublin, Ireland.	J.Reilly12@nuigalway.ie; Sanbing.shen@nuigalway.ie		Leader, Geraldine/0000-0001-8719-0617; Shen, Sanbing/0000-0002-8217-9811; Reilly, Jamie/0000-0002-7474-127X; Gallagher, Louise/0000-0001-9462-2836	Science Foundation Ireland [13/IA/1787, 16/RC/3948]; National University of Ireland Galway [RSU002]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National University of Ireland Galway	Funding was provided by Science Foundation Ireland (Grant 13/IA/1787 to S.S. and L.G., 16/RC/3948 to FutureNeuro), and National University of Ireland Galway (Grant RSU002 to S. S.) for funding the research.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Al-jawahiri R, 2017, PEERJ, V5, DOI 10.7717/peerj.2880; Aldridge K, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-15; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Tran AN, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3059-z; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; [Anonymous], 2012, INSIGHT WORLD J INFR, V3, P18; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Avazzadeh S, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-019-0303-3; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; Breen MS, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-020-00355-0; Breitenkamp AFS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095579; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Cervantes PE, 2015, J AUTISM DEV DISORD, V45, P3961, DOI 10.1007/s10803-015-2553-z; Chien WH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-23; Cohen S, 2015, J CLIN CHILD ADOLESC, V44, P250, DOI 10.1080/15374416.2013.843462; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; Daraio T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08082-y; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; DeRosa BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26495-1; Djeddi DD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083464; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Duda M, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0098-6; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ellenbroek B., 2017, HEAR MIND, V1, P78, DOI [10.4103/hm.hm_5_17, DOI 10.4103/HM.HM_5_17]; Flanagan SE, 2017, PEDIATR DIABETES, V18, P320, DOI 10.1111/pedi.12512; Frohlich H, 2019, P NATL ACAD SCI USA, V116, P22237, DOI 10.1073/pnas.1911429116; Fujiwara T, 2011, J NEUROENDOCRINOL, V23, P1222, DOI 10.1111/j.1365-2826.2011.02214.x; Gao R, 2015, CURR MOL MED, V15, P146, DOI 10.2174/1566524015666150303003028; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Garza-Lopez E, 2018, J BIOL CHEM, V293, P14444, DOI 10.1074/jbc.RA118.003681; Ginsberg MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044736; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Griesi-Oliveira K, 2021, MOL PSYCHIATR, V26, P1589, DOI 10.1038/s41380-020-0669-9; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Gupta S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6748; Gutierrez-Sacristan A, 2015, BIOINFORMATICS, V31, P3075, DOI 10.1093/bioinformatics/btv301; Herrero MJ, 2020, MOL AUTISM, V11, DOI 10.1186/s13229-020-00346-1; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; James DM, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-018-0250-4; Jaworski JLB, 2017, CONGENIT HEART DIS, V12, P421, DOI 10.1111/chd.12461; Jin SC, 2017, NAT GENET, V49, P1593, DOI 10.1038/ng.3970; Kohler S, 2019, NUCLEIC ACIDS RES, V47, pD1018, DOI 10.1093/nar/gky1105; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Kose S, 2017, SLEEP MED, V40, P69, DOI 10.1016/j.sleep.2017.09.021; Krishnan A, 2016, NAT NEUROSCI, V19, P1454, DOI 10.1038/nn.4353; Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005; Krumm N, 2013, AM J HUM GENET, V93, P595, DOI 10.1016/j.ajhg.2013.07.024; Leblond CS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004580; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Lim ET, 2017, NAT NEUROSCI, V20, P1217, DOI 10.1038/nn.4598; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Lutz AK, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz3267; Mannion A, 2014, REV J AUTISM DEV DIS, V1, P101, DOI 10.1007/s40489-013-0009-y; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Masi A, 2017, NEUROSCI BULL, V33, P183, DOI 10.1007/s12264-017-0100-y; Milovanovic B, 2015, WORLD J GASTROENTERO, V21, P6982, DOI 10.3748/wjg.v21.i22.6982; Moshkovskii SA, 2020, BIOCHEMISTRY-MOSCOW+, V85, P140, DOI 10.1134/S0006297920020029; Myers CT, 2016, AM J HUM GENET, V99, P287, DOI 10.1016/j.ajhg.2016.06.003; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nguyen RL, 2018, BBA-MOL CELL RES, V1865, P1718, DOI 10.1016/j.bbamcr.2018.08.003; Niesler B, 2021, MOL PSYCHIATR, V26, P1442, DOI 10.1038/s41380-020-0778-5; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Panju S, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0057-5; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pinggera A, 2017, HUM MOL GENET, V26, P2923, DOI 10.1093/hmg/ddx175; Pinggera A, 2015, BIOL PSYCHIAT, V77, P816, DOI 10.1016/j.biopsych.2014.11.020; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pramparo T, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156108; Quesnel-Vallieres M, 2019, NAT REV GENET, V20, P51, DOI 10.1038/s41576-018-0066-2; Rao M, 2016, NAT REV GASTRO HEPAT, V13, DOI 10.1038/nrgastro.2016.107; Regev A, 2019, HUMAN CELL ATLAS WHI, DOI [10.17863/cam.40032, DOI 10.17863/CAM.40032]; Rojas DC, 2014, J NEURAL TRANSM, V121, P891, DOI 10.1007/s00702-014-1216-0; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sauer AK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092134; Schmunk G, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.123; Schmunk G, 2017, SCI REP-UK, V7, DOI 10.1038/srep40740; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shedlock K, 2016, J PEDIATR-US, V178, P183, DOI 10.1016/j.jpeds.2016.07.055; Sheinkopf SJ, 2019, BIOL PSYCHOL, V142, P13, DOI 10.1016/j.biopsycho.2019.01.003; Shi L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21181; Shteyer E, 2015, GASTROENTEROLOGY, V148, P533, DOI 10.1053/j.gastro.2014.11.044; Sirmaci A, 2011, AM J HUM GENET, V89, P289, DOI 10.1016/j.ajhg.2011.06.007; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Soldatov NM, 2015, CURR MOL PHARMACOL, V8, P32, DOI 10.2174/1874467208666150507093258; Spaeth JM, 2015, DIABETOLOGIA, V58, P1836, DOI 10.1007/s00125-015-3635-3; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Stessman HAF, 2017, NAT GENET, V49, P515, DOI 10.1038/ng.3792; Stessman HAF, 2016, AM J HUM GENET, V98, P541, DOI 10.1016/j.ajhg.2016.02.004; Tan DW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09939-y; Taylor DM, 2019, DEV CELL, V49, P10, DOI 10.1016/j.devcel.2019.03.001; Thapa R, 2019, AUTISM RES, V12, P922, DOI 10.1002/aur.2104; Tong XJ, 2017, NEURON, V95, P326, DOI 10.1016/j.neuron.2017.06.018; Trabzuni D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3771; Tripi G, 2019, J CLIN MED, V8, DOI 10.3390/jcm8050641; Uzunova G, 2014, CURR NEUROPHARMACOL, V12, P71, DOI 10.2174/1570159X113116660046; van Bon BWM, 2016, MOL PSYCHIATR, V21, P126, DOI 10.1038/mp.2015.5; Velmeshev D, 2019, SCIENCE, V364, P685, DOI 10.1126/science.aav8130; Vergult S, 2015, EUR J HUM GENET, V23, P628, DOI 10.1038/ejhg.2014.141; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Walker SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35820; Walker SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058058; Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1; Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Wasilewska J, 2015, PEDIATR HEALTH MED T, V6, P153, DOI 10.2147/PHMT.S85717; Wen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153329; Werling DM, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0112-8; Werling DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10717; Werling DM, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0004-5; Wickham H., 2016, GGPLOT2; Xing JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27491; Xu XX, 2014, J NEUROSCI, V34, P1420, DOI 10.1523/JNEUROSCI.4488-13.2014; Yang SN, 2006, ENDOCR REV, V27, P621, DOI 10.1210/er.2005-0888; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zhang AH, 2007, BIOCHEM BIOPH RES CO, V358, P1034, DOI 10.1016/j.bbrc.2007.05.017; Zhang CL, 2017, HUM MUTAT, V38, P204, DOI 10.1002/humu.23147	136	8	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0242773	10.1371/journal.pone.0242773	http://dx.doi.org/10.1371/journal.pone.0242773			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338084	gold, Green Published			2022-12-27	WOS:000601313500031
J	de Glanville, WA; Davis, A; Allan, KJ; Buza, J; Claxton, JR; Crump, JA; Halliday, JEB; Johnson, PCD; Kibona, TJ; Mmbaga, BT; Swai, ES; Uzzell, CB; Yoder, J; Sharp, J; Cleaveland, S				de Glanville, William A.; Davis, Alicia; Allan, Kathryn J.; Buza, Joram; Claxton, John R.; Crump, John A.; Halliday, Jo E. B.; Johnson, Paul C. D.; Kibona, Tito J.; Mmbaga, Blandina T.; Swai, Emmanuel S.; Uzzell, Christopher B.; Yoder, Jonathan; Sharp, Jo; Cleaveland, Sarah			Classification and characterisation of livestock production systems in northern Tanzania	PLOS ONE			English	Article							CROP DIVERSIFICATION; FOOD SECURITY; RESPONSE DIVERSITY; DIETARY DIVERSITY; AFRICA; EAST; LAND; PASTORALISTS; POVERTY; MAASAI	Livestock keepers in sub-Saharan Africa face a range of pressures, including climate change, land loss, restrictive policies, and population increase. Widespread adaptation in response can lead to the emergence of new, non-traditional typologies of livestock production. We sought to characterise livestock production systems in two administrative regions in northern Tanzania, an area undergoing rapid social, economic, and environmental change. Questionnaire and spatial data were collected from 404 livestock-keeping households in 21 villages in Arusha and Manyara Regions in 2016. Multiple factor analysis and hierarchical cluster analysis were used to classify households into livestock production systems based on household-level characteristics. Adversity-based indicators of vulnerability, including reports of hunger, illness, and livestock, land and crop losses were compared between production systems. Three distinct clusters emerged through this process. The ethnic, environmental and livestock management characteristics of households in each cluster broadly mapped onto traditional definitions of 'pastoral', 'agro-pastoral' and 'smallholder' livestock production in the study area, suggesting that this quantitative classification system is complementary to more qualitative classification methods. Our approach allowed us to demonstrate a diversity in typologies of livestock production at small spatial scales, with almost half of study villages comprising more than one production system. We also found indicators of change within livestock production systems, most notably the adoption of crop agriculture in the majority of pastoral households. System-level heterogeneities in vulnerability were evident, with agro-pastoral households most likely to report hunger and pastoral households most likely to report illness in people and livestock, and livestock losses. We demonstrate that livestock production systems can provide context for assessing household vulnerability in northern Tanzania. Policy initiatives to improve household and community well-being should recognise the continuing diversity of traditional livestock production systems in northern Tanzania, including the diversity that can exist at small spatial scales.	[de Glanville, William A.; Allan, Kathryn J.; Claxton, John R.; Halliday, Jo E. B.; Johnson, Paul C. D.; Cleaveland, Sarah] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Davis, Alicia] Univ Glasgow, Sch Social & Polit Sci, Glasgow, Lanark, Scotland; [Buza, Joram; Kibona, Tito J.] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Crump, John A.] Univ Otago, Ctr Int Hlth, Dunedin, New Zealand; [Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Durham, NC USA; [Crump, John A.; Mmbaga, Blandina T.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Crump, John A.; Mmbaga, Blandina T.] Tumaini Univ, Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Mmbaga, Blandina T.] Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Swai, Emmanuel S.] Minist Livestock & Fisheries, Dept Vet Serv, Dhaka, Tanzania; [Uzzell, Christopher B.] Univ Glasgow, Sch Geog & Earth Sci, Glasgow, Lanark, Scotland; [Yoder, Jonathan] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA; [Sharp, Jo] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Uzzell, Christopher B.] Imperial Coll, Dept Infect Dis Epidemiol, London, England	University of Glasgow; University of Glasgow; Nelson Mandela African Institution of Science & Technology; University of Otago; Duke University; Duke University; University of Glasgow; Washington State University; University of St Andrews; Imperial College London	de Glanville, WA (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	will.deglanville@glasgow.ac.uk	Mmbaga, Blandina Theophil/AAR-8707-2021; Crump, John A./AAZ-6412-2020; Johnson, Paul/O-9695-2014	Mmbaga, Blandina Theophil/0000-0002-5550-1916; Crump, John A./0000-0002-4529-102X; Halliday, Jo/0000-0002-1329-9035; davis, alicia/0000-0003-1347-7708; Johnson, Paul/0000-0001-6663-7520; Claxton, John/0000-0002-0948-3155; Uzzell, Christopher/0000-0002-4204-3485; Sharp, Joanne/0000-0001-5805-4296	Biotechnology and Biological Sciences Research Council; Department for International Development; Economic & Social Research Council; Medical Research Council; Natural Environment Research Council; Defence Science & Technology Laboratory, under the "Zoonoses and Emerging Livestock Systems" (ZELS) programme [BB/L018926/1, BB/L018845/1]; Wellcome Trust [096400/Z/11/Z]; Lord Kelvin/Adam Smith (LKAS) PhD scholarship; BBSRC [BB/L018926/1, BB/L018845/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for International Development; Economic & Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Defence Science & Technology Laboratory, under the "Zoonoses and Emerging Livestock Systems" (ZELS) programme; Wellcome Trust(Wellcome Trust); Lord Kelvin/Adam Smith (LKAS) PhD scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Sciences Research Council, Department for International Development, the Economic & Social Research Council, the Medical Research Council, the Natural Environment Research Council and the Defence Science & Technology Laboratory, under the "Zoonoses and Emerging Livestock Systems" (ZELS) programme (BB/L018926/1 and BB/L018845/1). KJA received support from the Wellcome Trust (096400/Z/11/Z). CBU received support from a Lord Kelvin/Adam Smith (LKAS) PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2013, WIRES COMPUT STAT, V5, P149, DOI 10.1002/wics.1246; Adger W.N., 2004, NEW INDICATORS VULNE; [Anonymous], 2005, CONDITIONS AGR GROWT; [Anonymous], 1982, LIVESTOCK PRODUCTION; Archambault CS, 2016, INT J COMMONS, V10, P728, DOI 10.18352/ijc.685; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Aryal S, 2018, SUSTAIN AGR REV, V31, P25, DOI 10.1007/978-3-319-94232-2_2; Bill and Melinda Gates Foundation, AGR DEV STRAT OV; Birthal PS, 2015, WORLD DEV, V72, P70, DOI 10.1016/j.worlddev.2015.02.015; Borjeson L, 2008, INT J AFR HIST STUD, V41, P523; Bourn D, 1994, LIVESTOCK LAND USE A; Cecchi G, 2010, AGR ECOSYST ENVIRON, V135, P98, DOI 10.1016/j.agee.2009.08.011; Conroy AB, 2001, THESIS; Costard S, 2009, PREV VET MED, V92, P199, DOI 10.1016/j.prevetmed.2009.08.010; Covarrubias K., 2012, LIVESTOCK LIVELIHOOD; CRUZDEVA.E, 1974, J DEV AREAS, V8, P199; de Glanville WA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39375-z; Dearden KA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4033-1; Debsu DN, 2016, NOMAD PEOPLES, V20, P35, DOI 10.3197/np.2016.200104; Ecker O, 2018, FOOD POLICY, V79, P271, DOI 10.1016/j.foodpol.2018.08.002; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.1890/1540-9295(2003)001[0488:RDECAR]2.0.CO;2; FAO, 2018, WORLD LIV TRANSF LIV; Feliciano D, 2019, SUSTAIN DEV, V27, P795, DOI 10.1002/sd.1923; Fernandes E. C. M., 1984, Agroforestry Systems, V2, P73; Fraval S, 2018, AGR SYST, V160, P87, DOI 10.1016/j.agsy.2017.10.013; Galvin Kathleen A., 2004, African Journal of Range & Forage Science, V21, P183, DOI 10.2989/10220110409485850; Galvin KA, 2009, ANNU REV ANTHROPOL, V38, P185, DOI 10.1146/annurev-anthro-091908-164442; Goldman MJ, 2016, J PEASANT STUD, V43, P777, DOI 10.1080/03066150.2015.1130701; Goldman MJ, 2013, GLOBAL ENVIRON CHANG, V23, P588, DOI 10.1016/j.gloenvcha.2013.02.010; Hauck S, 2017, PASTORALISM, V7, DOI 10.1186/s13570-017-0090-4; Herrero M, 2013, ANIMAL, V7, P3, DOI 10.1017/S1751731112001954; Herzog CM, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s0950268819001262, 10.1017/S0950268819001262]; Homewood K, 2009, STUD HUM ECOL ADAPT, V5, P369, DOI 10.1007/978-0-387-87492-0_10; HOWARD M, 1994, SOC SCI MED, V38, P239, DOI 10.1016/0277-9536(94)90394-8; Husson F, 2013, J STAT SOFTW, V25, P1; International Livestock Research Institute, 2019, MEAT FUT SER; Kadohira M, 1997, EPIDEMIOL INFECT, V118, P35, DOI 10.1017/S0950268896007005; Kagunyu AW, 2014, PASTORALISM, V4, DOI 10.1186/s13570-014-0013-6; Karanja DR, VARIETY CHARACTERIST; Kihupi N. I., 2015, Journal of Agricultural Science (Toronto), V7, P45; Kimiti KS, 2018, ECOL PROCESS, V7, DOI 10.1186/s13717-018-0115-y; Kincaid T.M., 2012, SPSURVEY SPATIAL SUR; Lane C., 1994, NOMADIC PEOPLES, V34/ 35, P81; Lawson DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110447; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leslie P, 2013, CURR ANTHROPOL, V54, P114, DOI 10.1086/669563; Lesorogol CK, 2008, DEV CHANGE, V39, P309, DOI 10.1111/j.1467-7660.2007.00481.x; Little PD, 2008, DEV CHANGE, V39, P587, DOI 10.1111/j.1467-7660.2008.00497.x; Maro P., 1975, THESIS; McCabe JT, 2010, HUM ECOL, V38, P322, DOI 10.1007/s10745-010-9312-8; McCabe JT, 2003, HUM ORGAN, V62, P100, DOI 10.17730/humo.62.2.4rwrt1n3xptg29b8; McCord PF, 2015, LAND USE POLICY, V42, P738, DOI 10.1016/j.landusepol.2014.10.012; MLFD, 2015, LIV MOD IN; Morineau A, 1984, B TECHN CTR STAT INF, P9; Morton J, POLICY SERIES; Murphy SP, 2003, J NUTR, V133, p3950S, DOI 10.1093/jn/133.11.3950S; NBS. United Republic of Tanzania, 2007, NAT SAMPL CENS AGR 2; Neumann CG, 2007, J NUTR, V137, P1119, DOI 10.1093/jn/137.4.1119; Nkedianye DK, 2019, WORLD DEV PERSPECT, V14, DOI 10.1016/j.wdp.2019.02.017; Nyariki D. M., 2009, Journal of Human Ecology, V26, P163; Ogola J, 2018, PREV VET MED, V158, P43, DOI 10.1016/j.prevetmed.2018.06.010; Okello Moses Makonjio, 2005, Human Dimensions of Wildlife, V10, P19, DOI 10.1080/10871200590904851; Ole Kuney R O, 1994, Nomad People, P95; Omoyo NN., 2015, AGR FOOD SECUR, V4, P1, DOI [10.1186/s40066-015-0028-2, DOI 10.1186/S40066-015-0028-2]; Ongoma V, 2018, INT J CLIMATOL, V38, P1375, DOI 10.1002/joc.5252; Otte J, 2003, OUTLOOK AGR, V32, P183, DOI 10.5367/000000003101294451; Otte M.J., 2002, CATTLE SMALL RUMINAN; Pica-Ciamarra U., 2014, INVESTING LIVESTOCK; Pradere J-P, 2014, REV SCI TECH, V33, P735; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Robinson T.P., 2011, GLOBAL LIVESTOCK PRO; Rufino MC, 2013, AGR ECOSYST ENVIRON, V179, P215, DOI 10.1016/j.agee.2013.08.019; Schelling E., 2008, HDB TRANSDISCIPLINAR, P277, DOI [10.1007/978-1-4020-6699-3_17, DOI 10.1007/978-1-4020-6699-3_17]; Schwei RJ, 2017, PUBLIC HEALTH NUTR, V20, P1540, DOI 10.1017/S1368980017000350; Semango G, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00327; Sere C, 1996, 127 FAO; Shiferaw B, 2014, WEATHER CLIM EXTREME, V3, P67, DOI 10.1016/j.wace.2014.04.004; Shongwe ME, 2011, J CLIMATE, V24, P3718, DOI 10.1175/2010JCLI2883.1; Spear T., 1993, BEING MAASAI ETHNICI, P120; Spear T, 1997, MOUNTAIN FARMERS MOR, P1; Spear Thomas, 1993, BEING MAASAI ETHNICI; Sperling L., 1987, Nomadic Peoples, P1; Steinfeld H, 2006, REV SCI TECH OIE, V25, P505, DOI 10.20506/rst.25.2.1677; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Thornton PK, 2007, HUM ECOL, V35, P461, DOI 10.1007/s10745-007-9118-5; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; Thornton PhilipK., 2006, MAPPING CLIMATE VULN; Tierney JE, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500682; Tilahun Minyahel, 2016, ECOL PROCESS, V5, DOI DOI 10.1186/s13717-016-0062-4; Turner MD, 2019, PASTORALISM, V9, DOI 10.1186/s13570-019-0150-z; Wynants M, 2019, REG ENVIRON CHANGE, V19, P1909, DOI 10.1007/s10113-019-01520-9	91	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0229478	10.1371/journal.pone.0229478	http://dx.doi.org/10.1371/journal.pone.0229478			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378382	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000605651300017
J	Gonen, OM; Moffat, BA; Kwan, P; O'Brien, TJ; Desmond, PM; Lui, E				Gonen, Ofer M.; Moffat, Bradford A.; Kwan, Patrick; O'Brien, Terence J.; Desmond, Patricia M.; Lui, Elaine			Resting-state functional connectivity and quantitation of glutamate and GABA of the PCC/precuneus by magnetic resonance spectroscopy at 7T in healthy individuals	PLOS ONE			English	Article							METABOLITE CONCENTRATIONS; HUMAN BRAIN; EPI; AGE; DEACTIVATION; SENSITIVITY; NETWORKS; CORTEX; MEMORY; ECHO	The default mode network (DMN) is the main large-scale network of the resting brain and the PCC/precuneus is a major hub of this network. Glutamate and GABA (gamma-amino butyric acid) are the main excitatory and inhibitory neurotransmitters in the CNS, respectively. We studied glutamate and GABA concentrations in the PCC/precuneus via magnetic resonance spectroscopy (MRS) at 7T in relation to age and correlated them with functional connectivity between this region and other DMN nodes in ten healthy right-handed volunteers ranging in age between 23-68 years. Mean functional connectivity of the PCC/precuneus to the other DMN nodes and the glutamate/GABA ratio significantly correlated with age (r = 0.802, p = 0.005 and r = 0.793, p = 0.006, respectively) but not with each other. Glutamate and GABA alone did not significantly correlate with age nor with functional connectivity within the DMN. The glutamate/GABA ratio and functional connectivity of the PCC/precuneus are, therefore, independent age-related biomarkers of the DMN and may be combined in a multimodal pipeline to study DMN alterations in various disease states.	[Gonen, Ofer M.; Kwan, Patrick; O'Brien, Terence J.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia; [Gonen, Ofer M.; Moffat, Bradford A.; Kwan, Patrick; O'Brien, Terence J.; Desmond, Patricia M.; Lui, Elaine] Univ Melbourne, Dept Med & Radiol, Melbourne, Vic, Australia; [Gonen, Ofer M.; Kwan, Patrick; O'Brien, Terence J.] Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia; [Kwan, Patrick; O'Brien, Terence J.] Monash Univ, Cent Clin Sch, Dept Neurosci, Clayton, Vic, Australia; [Desmond, Patricia M.; Lui, Elaine] Royal Melbourne Hosp, Dept Radiol, Parkville, Vic, Australia	Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; Royal Melbourne Hospital	Gonen, OM (corresponding author), Royal Melbourne Hosp, Dept Neurol, Parkville, Vic, Australia.; Gonen, OM (corresponding author), Univ Melbourne, Dept Med & Radiol, Melbourne, Vic, Australia.; Gonen, OM (corresponding author), Alfred Hosp, Dept Neurol, Melbourne, Vic, Australia.	Ofer.Gonen@mh.org.au	O'Brien, Terence/L-8102-2013; O'Brien, Terence/AAU-5525-2021; Desmond, Patricia/D-1966-2014	O'Brien, Terence/0000-0002-7198-8621; Gonen, Ofer/0000-0002-3833-9128; Desmond, Patricia/0000-0002-4803-6323	Melbourne Research Scholarship (MRS); University of Melbourne; Neuroscience Foundation, The Royal Melbourne Hospital	Melbourne Research Scholarship (MRS); University of Melbourne(University of Melbourne); Neuroscience Foundation, The Royal Melbourne Hospital	The authors acknowledge the facilities, scientific and technical assistance, and salary support of BAM from the National Imaging Facility, a National Collaborative Research Infrastructure Strategy (NCRIS) capability, at the Melbourne Brain Center Imaging Unit, The University of Melbourne. OGM was supported by the Melbourne Research Scholarship (MRS), The University of Melbourne and The Neuroscience Foundation, The Royal Melbourne Hospital.	Alves PN, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0611-3; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Arrubla J, 2017, J NEUROSCI RES, V95, P1796, DOI 10.1002/jnr.24010; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Benarroch EE, 2010, NEUROLOGY, V74, P259, DOI 10.1212/WNL.0b013e3181cc89e3; Boyacioglu R, 2015, NEUROIMAGE, V119, P352, DOI 10.1016/j.neuroimage.2015.06.089; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Campbell KL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00073; de Barros NP, 2017, ANAL BIOCHEM, V529, P98, DOI 10.1016/j.ab.2017.01.017; Dennis EL, 2014, NEUROPSYCHOL REV, V24, P49, DOI 10.1007/s11065-014-9249-6; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gu H, 2019, NEUROIMAGE, V185, P388, DOI 10.1016/j.neuroimage.2018.10.055; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hu YZ, 2013, J NEUROSCI, V33, P18566, DOI 10.1523/JNEUROSCI.1973-13.2013; Huang CC, 2015, CNS NEUROSCI THER, V21, P817, DOI 10.1111/cns.12396; Huang DD, 2017, EUR RADIOL, V27, P2698, DOI 10.1007/s00330-016-4669-8; Ip IB, 2017, NEUROIMAGE, V155, P113, DOI 10.1016/j.neuroimage.2017.04.030; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kantarci K, 2007, NEUROBIOL AGING, V28, P1330, DOI 10.1016/j.neurobiolaging.2006.06.018; Kapogiannis D, 2013, NEUROIMAGE, V64, P112, DOI 10.1016/j.neuroimage.2012.09.029; Khalsa S, 2014, NEUROIMAGE, V102, P118, DOI 10.1016/j.neuroimage.2013.12.022; Kocsis JD, 1996, NEUROSCIENTIST, V2, P326, DOI 10.1177/107385849600200610; Lee H, 2013, MAGN RESON IMAGING, V31, P1197, DOI 10.1016/j.mri.2013.04.001; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lehmann K, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/892784; Liguz-Lecznar M, 2015, BRAIN STRUCT FUNCT, V220, P1681, DOI 10.1007/s00429-014-0752-6; Mandal PK, 2012, J ALZHEIMERS DIS, V31, pS169, DOI 10.3233/JAD-2012-120412; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Shah NJ, 2017, SCI REP, V7, P1, DOI 10.1038/s41598-016-0028-x; Shannon BJ, 2013, J NEUROPHYSIOL, V109, P1444, DOI 10.1152/jn.00651.2012; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Staffaroni AM, 2018, J NEUROSCI, V38, P2809, DOI 10.1523/JNEUROSCI.3067-17.2018; Suri S, 2017, NEUROIMAGE, V152, P509, DOI 10.1016/j.neuroimage.2017.03.031; Terpstra M, 2016, MAGN RESON MED, V76, P1083, DOI 10.1002/mrm.26022; Tkac I, 2001, MAGNET RESON MED, V46, P451, DOI 10.1002/mrm.1213; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yoo PE, 2018, NEUROIMAGE, V164, P214, DOI 10.1016/j.neuroimage.2017.03.002; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244491	10.1371/journal.pone.0244491	http://dx.doi.org/10.1371/journal.pone.0244491			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373387	gold, Green Published			2022-12-27	WOS:000603612300039
J	Inghammar, M; Sunden-Cullberg, J				Inghammar, Malin; Sunden-Cullberg, Jonas			Prognostic significance of body temperature in the emergency department vs the ICU in Patients with severe sepsis or septic shock: A nationwide cohort study	PLOS ONE			English	Article							FEVER; MORTALITY; CARE; EPIDEMIOLOGY; BACTEREMIA; INFECTION; MODEL; OLDER	Background Increased body temperature in the Emergency Department (BT-ED) and the ICU (BT-ICU) is associated with lower mortality in patients with sepsis. Here, we compared how well BT-ED and BT-ICU predict mortality; investigated mortality in various combinations of BT-ED and BT-ICU, and; compared degree of fever in the ED and ICU and associated quality of care. Methods 2385 adults who were admitted to an ICU within 24 hours of ED arrival with severe sepsis or septic shock were included. Results Thirty-day mortality was 23.6%. Median BT-ED and BT-ICU was 38.1 and 37.6 degrees C. Crude mortality decreased more than 5% points per degrees C increase for both BT-ED and BT-ICU. Adjusted OR for mortality was 0.82/degrees C increase for BT-ED (0.76-0.88, p < 0.001), and 0.89 for BT-ICU (0.83-0.95, p<0.001). Patients who were at/below median temperature in both the ED and in the ICU had the highest mortality, 32%, and those with over median in the ED and at/below in the ICU had the lowest, 16%, (p<0.001). Women had 0.2 degrees C lower median BT-ED (p = 0.03) and 0.3 degrees C lower BT-ICU (p<0.0001) than men. Older patients had lower BT in the ICU, but not in the ED. Fever was associated with a higher rate of sepsis bundle achievement in the ED, but lower nurse workload in the ICU. Conclusions BT-ED was more useful to prognosticate mortality than BT-ICU. Despite better prognosis in patients with elevated BT, fever was associated with higher quality of care in the ED. Future studies should assess how BT-ED can be used to improve triage of infected patients, assigning higher priority to patients with low-grade/no fever and vice versa. Patients with at/below median BT in both ED and ICU have the highest mortality and should receive special attention. Different BT according to sex and age also needs further study.	[Inghammar, Malin] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Sect Infect Med, Lund, Sweden; [Sunden-Cullberg, Jonas] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Infect Dis, Stockholm, Sweden; [Sunden-Cullberg, Jonas] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med, Stockholm, Sweden	Lund University; Skane University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Sunden-Cullberg, J (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Infect Dis, Stockholm, Sweden.; Sunden-Cullberg, J (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Ctr Infect Med, Stockholm, Sweden.	jonas.sunden-cullberg@ki.se	Sundén-Cullberg, Jonas/AAW-5210-2020	Sundén-Cullberg, Jonas/0000-0002-8189-4960; Inghammar, Malin/0000-0003-2995-1312	Swedish Government [20180058]; Center for Innovative Medicine, Karolinska Institute [CIMED 20180856]	Swedish Government; Center for Innovative Medicine, Karolinska Institute	JSC and MI: Swedish Government Research Grant (ALF) 20180058 (JSC) JSC: Center for Innovative Medicine, Karolinska Institute (CIMED 20180856) MI: Royal Physiographic Society The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angstwurm MWA, 2005, CRIT CARE MED, V33, P2786, DOI 10.1097/01.CCM.0000190242.24410.17; [Anonymous], 1871, MED THERMOMETRY HUMA; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BRYANT RE, 1971, ARCH INTERN MED, V127, P120, DOI 10.1001/archinte.127.1.120; CASTLE SC, 1991, J AM GERIATR SOC, V39, P853, DOI 10.1111/j.1532-5415.1991.tb04450.x; Crabtree TD, 1999, JAMA-J AM MED ASSOC, V282, P2143, DOI 10.1001/jama.282.22.2143; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Diekema DJ, 2003, J CLIN MICROBIOL, V41, P3655, DOI 10.1128/JCM.41.8.3655-3660.2003; Engerstrom L, 2017, CRIT CARE MED, V45, P2006, DOI 10.1097/CCM.0000000000002706; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; GLECKMAN R, 1982, JAMA-J AM MED ASSOC, V248, P1478, DOI 10.1001/jama.248.12.1478; Henning DJ, 2017, CRIT CARE MED, V45, pE575, DOI 10.1097/CCM.0000000000002311; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kushimoto S, 2019, CRIT CARE MED, V47, P691, DOI 10.1097/CCM.0000000000003688; LEIBOVICI L, 1993, AGE AGEING, V22, P431, DOI 10.1093/ageing/22.6.431; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MACKOWIAK PA, 1982, J INFECT DIS, V145, P550, DOI 10.1093/infdis/145.4.550; Miranda DR, 1997, INTENS CARE MED, V23, P760, DOI 10.1007/s001340050406; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; SepNet Critical Care Trials Grp, 2016, INTENS CARE MED, V42, P1980, DOI 10.1007/s00134-016-4504-3; Sjoberg F, 2012, ACTA ANAESTH SCAND, V56, P1073, DOI 10.1111/j.1399-6576.2012.02757.x; Sunden-Cullberg J, 2017, CRIT CARE MED, V45, P591, DOI 10.1097/CCM.0000000000002249; Surviving Sepsis Campaign, UPD BUNDL RESP NEW E, DOI [10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-012-2769-8]; Svefors J, 2017, RSRAPPORT SVAR SEPSI; Walther SM, 2004, ACTA ANAESTH SCAND, V48, P690, DOI 10.1111/j.0001-5172.2004.00397.x; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Yamamoto S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003628; Young PJ, 2012, INTENS CARE MED, V38, P437, DOI 10.1007/s00134-012-2478-3	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0243990	10.1371/journal.pone.0243990	http://dx.doi.org/10.1371/journal.pone.0243990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373376	Green Published, gold			2022-12-27	WOS:000603612300020
J	Namaganda, LH; Almeida, R; Kajungu, D; Wabwire-Mangen, F; Peterson, S; Andrews, C; Eliasson, AC; Kakooza-Mwesige, A; Forssberg, H				Namaganda, Lukia H.; Almeida, Rita; Kajungu, Dan; Wabwire-Mangen, Fred; Peterson, Stefan; Andrews, Carin; Eliasson, Ann Christin; Kakooza-Mwesige, Angelina; Forssberg, Hans			Excessive premature mortality among children with cerebral palsy in rural Uganda: A longitudinal, population-based study	PLOS ONE			English	Article							SURVIVAL; PREVALENCE; CAREGIVERS; CARERS	Background Studies from high-income countries reported reduced life expectancy in children with cerebral palsy (CP), while no population-based study has evaluated mortality of children with CP in sub-Saharan Africa. This study aimed to estimate the mortality rate (MR) of children with CP in a rural region of Uganda and identify risk factors and causes of death (CODs). Methods and findings This population-based, longitudinal cohort study was based on data from Iganga-Mayuge Health and Demographic Surveillance System in eastern Uganda. We identified 97 children (aged 2-17 years) with CP in 2015, whom we followed to 2019. They were compared with an age-matched cohort from the general population (n = 41 319). MRs, MR ratios (MRRs), hazard ratios (HRs), and immediate CODs were determined. MR was 3952 per 100 000 person years (95% CI 2212-6519) in children with CP and 137 per 100 000 person years (95% CI 117-159) in the general population. Standardized MRR was 25 center dot 3 in the CP cohort, compared with the general population. In children with CP, risk of death was higher in those with severe gross motor impairments than in those with milder impairments (HR 6 center dot 8; p = 0 center dot 007) and in those with severe malnutrition than in those less malnourished (HR = 3 center dot 7; p = 0 center dot 052). MR was higher in females in the CP cohort, with a higher MRR in females (53 center dot 0; 95% CI 26 center dot 4-106 center dot 3) than in males (16 center dot 3; 95% CI 7 center dot 2-37 center dot 2). Age had no significant effect on MR in the CP cohort, but MRR was higher at 10-18 years (39 center dot 6; 95% CI 14 center dot 2-110 center dot 0) than at 2-6 years (21 center dot 0; 95% CI 10 center dot 2-43 center dot 2). Anaemia, malaria, and other infections were the most common CODs in the CP cohort. Conclusions Risk of premature death was excessively high in children with CP in rural sub-Saharan Africa, especially in those with severe motor impairments or malnutrition. While global childhood mortality has significantly decreased during recent decades, this observed excessive mortality is a hidden humanitarian crisis that needs to be addressed.	[Namaganda, Lukia H.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Almeida, Rita] Stockholm Univ, Stockholm Univ Brain Imaging Ctr SUBIC, Stockholm, Sweden; [Kajungu, Dan] Makerere Univ, Iganga Mayuge Hlth & Demog Surveillance Site IMHD, Makerere Univ Ctr Hlth & Populat Res MUCHAP, Kampala, Uganda; [Wabwire-Mangen, Fred] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Peterson, Stefan] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Peterson, Stefan] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Andrews, Carin; Eliasson, Ann Christin; Forssberg, Hans] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Kakooza-Mwesige, Angelina] Makerere Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Kampala, Uganda	Makerere University; Stockholm University; Makerere University; Makerere University; Uppsala University; Karolinska Institutet; Karolinska Institutet; Makerere University	Forssberg, H (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	hans.forssberg@ki.se	Almeida, Rita/H-6676-2015	Almeida, Rita/0000-0002-9559-9903; Kajungu PhD, Dan/0000-0002-3363-7062; Forssberg, Hans/0000-0003-2069-6618; Andrews, Carin/0000-0002-9928-4423	Swedish Research Council [2017-05474]; Foundation Frimurare Barnhuset	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundation Frimurare Barnhuset	HF received a grant from Swedish Research Council (2017-05474), HF received a grant from the Foundation Frimurare Barnhuset. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuga JA, 2019, LANCET GLOB HEALTH, V7, pE1728, DOI 10.1016/S2214-109X(19)30425-5; Adams MS, 2012, CHILD CARE HLTH DEV, V38, P878, DOI 10.1111/j.1365-2214.2011.01327.x; Alam N, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25510; Amer A, 2018, CHILD CARE HLTH DEV, V44, P562, DOI 10.1111/cch.12562; Andrews C, 2020, DEV MED CHILD NEUROL, V62, P454, DOI 10.1111/dmcn.14401; Aragon TJ., EPITOOLS EPIDEMIOLOG; Brooks JC, 2014, DEV MED CHILD NEUROL, V56, P1065, DOI 10.1111/dmcn.12519; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Day SM, 2015, DEV MED CHILD NEUROL, V57, P1105, DOI 10.1111/dmcn.12849; Gona JK, 2011, CHILD CARE HLTH DEV, V37, P175, DOI 10.1111/j.1365-2214.2010.01124.x; Hartley S, 2005, CHILD CARE HLTH DEV, V31, P167, DOI 10.1111/j.1365-2214.2004.00464.x; Himmelmann K, 2015, DEV MED CHILD NEUROL, V57, P762, DOI 10.1111/dmcn.12718; INDEPTH Network, 2020, VERB SOC AUT TOOL 20; Jahan I, 2019, DEV MED CHILD NEUROL, V61, P1336, DOI 10.1111/dmcn.14256; Jin Y, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1546095; Kajungu D, 2020, INT J EPIDEMIOL; Kakooza-Mwesige A, 2018, CHILD CARE HLTH DEV, V44, P552, DOI 10.1111/cch.12563; Kakooza-Mwesige A, 2017, LANCET GLOB HEALTH, V5, pE1275, DOI 10.1016/S2214-109X(17)30374-1; Kananura RM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234573; Kassambara A., 2021, RSTATIX PIPE FRIENDL; Khandaker G, 2019, DEV MED CHILD NEUROL, V61, P601, DOI 10.1111/dmcn.14013; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Mlinda SJ, 2018, CHILD CARE HLTH DEV, V44, P452, DOI 10.1111/cch.12553; Namazzi G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236488; Nambuusi BB, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7636-x; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Patel P, 2017, CHILD CARE HLTH DEV, V43, P861, DOI 10.1111/cch.12490; R Development Core Team, 2009, R LANG ENV STAT COMP; Sellier E, 2016, DEV MED CHILD NEUROL, V58, P85, DOI 10.1111/dmcn.12865; Smithers-Sheedy H, 2016, DEV MED CHILD NEUROL, V58, P5, DOI 10.1111/dmcn.13026; Uganda Bureau of Statistics (UBOS), 2017, UG DEM HLTH SURV 201; United Nations (UN) General Assembly, 2007, CONV RIGHTS PERS DIS; Westbom L, 2011, DEV MED CHILD NEUROL, V53, P808, DOI 10.1111/j.1469-8749.2011.04027.x; WHO, 2006, ACTA PAEDIATR, P76, DOI DOI 10.1111/J.1651-2227.2006.TB02378.X; Winters N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184541; World Health Organization, STANDARD VERBAL AUTO; World Health Organization, 2011, WHO ANTHR PERS COMP	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0243948	10.1371/journal.pone.0243948	http://dx.doi.org/10.1371/journal.pone.0243948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373366	Green Published, gold			2022-12-27	WOS:000603612300027
J	Cai, GY; Zhang, JX; Du, MY; Li, CP; Peng, S				Cai, Guoyin; Zhang, Jinxi; Du, Mingyi; Li, Chaopeng; Peng, Shu			Identification of urban land use efficiency by indicator-SDG 11.3.1	PLOS ONE			English	Article							ENVIRONMENTAL DEGRADATION; AREA; URBANIZATION; ACCURACY; DENSITY; POLICY; GROWTH; CITIES	Inefficiency in urban land use is one of the problems caused by rapid urbanization. The UN Sustainable Development Goals (SDGs) indicator 11.3.1 is designed to test urban land use efficiency. This study employed geospatial and statistical data to compute land use efficiencies from 1990 to 2015 with five 5-year and ten 15-year intervals in Wukang, center of Deqing County, China. A flowchart was designed to extract the built-up lands from multiple data sources. The produced built-up lands were demonstrated to provide good accuracy by constructing an error matrix between the extracted and manually interpreted built-up lands as classified and reference images, respectively. By using the model provided by UN metadata to calculate SDG 11.3.1, the land use efficiencies from 1990 to 2015 were identified in Wukang. Our results indicate that the land use efficiency in Deqing County center is lower than the average of cities around the world, primarily because our in-situ study focused on a county center with larger rural regions than urban areas. Over the long term, urban land use becomes denser as the population grows, which will have a positive impact on the sustainability of urban development. This work is helpful for the local government to balance urban land consumption and population growth.	[Cai, Guoyin; Zhang, Jinxi; Du, Mingyi; Li, Chaopeng] Beijing Univ Civil Engn & Architecture, Sch Geomat & Urban Spatial Informat, Beijing, Peoples R China; [Cai, Guoyin; Du, Mingyi] Beijing Univ Civil Engn & Architecture, Beijing Adv Innovat Ctr Future Urban Design, Beijing, Peoples R China; [Peng, Shu] Natl Geomat Ctr China, Beijing, Peoples R China	Beijing University of Civil Engineering & Architecture; Beijing University of Civil Engineering & Architecture	Cai, GY (corresponding author), Beijing Univ Civil Engn & Architecture, Sch Geomat & Urban Spatial Informat, Beijing, Peoples R China.; Cai, GY (corresponding author), Beijing Univ Civil Engn & Architecture, Beijing Adv Innovat Ctr Future Urban Design, Beijing, Peoples R China.	cgyin@bucea.edu.cn			National Natural Science Foundation (NSFC) [41390650]; Land Use Change Detection from Satellite GF-7 by Ministry of Housing and Urban-Rural Development of the People's Republic of China [06-Y20A17-9001-17/18]; Fundamental Research Funds for Beijing University of Civil Engineering and Architecture [2018N060301]	National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); Land Use Change Detection from Satellite GF-7 by Ministry of Housing and Urban-Rural Development of the People's Republic of China; Fundamental Research Funds for Beijing University of Civil Engineering and Architecture	This work is financially supported by National Natural Science Foundation (NSFC) (Key Project #41390650), the Land Use Change Detection from Satellite GF-7 by Ministry of Housing and Urban-Rural Development of the People's Republic of China (No. 06-Y20A17-9001-17/18), and by The Fundamental Research Funds for Beijing University of Civil Engineering and Architecture (No. 2018N060301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JAA., 2018, EGYPT J REMOTE SENS, V21, P391, DOI [10.1016/j.ejrs.2018.01.004, DOI 10.1016/J.EJRS.2018.01.004]; [Anonymous], 2018, ENV MANAG; Brovelli MA, 2015, REMOTE SENS-BASEL, V7, P4191, DOI 10.3390/rs70404191; Cao XS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36368-2; Caprotti F, 2017, URBAN RES PRACT, V10, P367, DOI 10.1080/17535069.2016.1275618; Chen J, 2018, GLOBAL LAND COVER MA; Chen J, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9090522; Chen J, 2015, ISPRS J PHOTOGRAMM, V103, P7, DOI 10.1016/j.isprsjprs.2014.09.002; Choy LHT, 2013, HABITAT INT, V40, P184, DOI 10.1016/j.habitatint.2013.04.003; Constantin C, 2017, LAND USE POLICY, V62, P143, DOI 10.1016/j.landusepol.2017.01.001; Dadhich AP, 2018, EGYPT J REMOTE SENS, V21, P173, DOI 10.1016/j.ejrs.2017.04.002; Ehrlich D, 2018, ENVIRON SCI POLICY, V90, P73, DOI 10.1016/j.envsci.2018.10.001; Glaeser E.L., 2004, HDB REGIONAL URBAN E, P2481, DOI [10.1016/S1574-0080(04)80013-0, DOI 10.1016/S1574-0080(04)80013-0]; Haldorson M, 2018, SEM NAIR 7 DEC; Han G, 2015, ISPRS J PHOTOGRAMM, V103, P66, DOI 10.1016/j.isprsjprs.2014.07.012; He SW, 2020, LAND USE POLICY, V95, DOI 10.1016/j.landusepol.2020.104576; Horn P, 2018, WORLD DEV, V109, P73, DOI 10.1016/j.worlddev.2018.04.005; Jun C, 2014, NATURE, V514, P434, DOI 10.1038/514434c; Kit O, 2013, ISPRS J PHOTOGRAMM, V83, P130, DOI 10.1016/j.isprsjprs.2013.06.009; Klopp JM, 2017, CITIES, V63, P92, DOI 10.1016/j.cities.2016.12.019; Liu J, 2020, SCI TOTAL ENVIRON, V710, DOI 10.1016/j.scitotenv.2019.135670; Liu XP, 2018, REMOTE SENS ENVIRON, V209, P227, DOI 10.1016/j.rse.2018.02.055; Nor ANM, 2017, ECOL INDIC, V81, P274, DOI 10.1016/j.ecolind.2017.05.031; Olofsson P, 2014, REMOTE SENS ENVIRON, V148, P42, DOI 10.1016/j.rse.2014.02.015; Ozcan B, 2020, ECON MODEL, V84, P203, DOI 10.1016/j.econmod.2019.04.010; Parnell S, 2016, WORLD DEV, V78, P529, DOI 10.1016/j.worlddev.2015.10.028; PEISER RB, 1989, LAND ECON, V65, P193, DOI 10.2307/3146665; Pesaresi M., 2015, GHS POPULATION GRID; Pribadi DO, 2015, LAND USE POLICY, V48, P13, DOI 10.1016/j.landusepol.2015.05.009; Rehman MU, 2017, RENEW ENERG, V111, P284, DOI 10.1016/j.renene.2017.03.100; Roy DP, 2014, REMOTE SENS ENVIRON, V145, P154, DOI 10.1016/j.rse.2014.02.001; Rozhenkova V, 2019, CITIES, V95, DOI 10.1016/j.cities.2019.05.026; Saha D, 2019, REMOTE SENS APPL, V15, DOI 10.1016/j.rsase.2019.05.003; Schneider A, 2008, URBAN STUD, V45, P659, DOI 10.1177/0042098007087340; Stokes EC, 2019, REMOTE SENS ENVIRON, V234, DOI 10.1016/j.rse.2019.111430; Timko J, 2018, CURR OPIN ENV SUST, V34, P7, DOI 10.1016/j.cosust.2018.06.004; UN habitat Programme, 2018, 11 SDG UN HAB PROGR; United Nations, 2015, CRIT MIL COH EFF INC; Wang JY, 2019, SCI TOTAL ENVIRON, V656, P165, DOI 10.1016/j.scitotenv.2018.11.354; Wang L, 2020, REMOTE SENS ENVIRON, V251, DOI 10.1016/j.rse.2020.112067; Wurm M, 2019, ISPRS J PHOTOGRAMM, V150, P59, DOI 10.1016/j.isprsjprs.2019.02.006; Yang XD, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9030410; Zhu XH, 2019, SUSTAIN CITIES SOC, V50, DOI 10.1016/j.scs.2019.101646; Zoomers A, 2017, WORLD DEV, V92, P242, DOI 10.1016/j.worlddev.2016.11.016	44	14	15	8	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244318	10.1371/journal.pone.0244318	http://dx.doi.org/10.1371/journal.pone.0244318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370312	Green Published, gold			2022-12-27	WOS:000603611900071
J	Forte, CC; Pedrollo, EF; Nicoletto, BB; Lopes, JB; Manfro, RC; Souza, GC; Leitao, CB				Forte, Cristina Carra; Pedrollo, Elis Forcellini; Nicoletto, Bruna Bellincanta; Lopes, Jessica Blatt; Manfro, Roberto Ceratti; Souza, Gabriela Correa; Leitao, Cristiane Bauermann			Risk factors associated with weight gain after kidney transplantation: A cohort study	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; OBESITY; PREVALENCE; PREDICTORS; RECIPIENTS; DIALYSIS	Background Renal transplantation is the best modality of renal replacement therapy for patients with end-stage renal disease. However, it is associated with weight gain and metabolic abnormalities, which adversely impact transplant outcomes. Objective The objective of this study was to identify the risk factors of one-year weight gain after renal transplantation. Methods A retrospective cohort study was conducted with 374 patients that underwent kidney transplantation between January 2006 and July 2013. Clinical and laboratory variables were collected from electronic records, and the outcome of interest was weight gain during the first year after renal transplantation. The data were reported as mean +/- standard deviation, median (interquartile range) or number of subjects (%). The association between variables were assessed via chi-square test and ANOVA. For analysis of risk factors related to the outcomes of interest, multivariable logistic regression models were used. Results There were 181 (48.4%) female patients, 334 (89.3%) with white ethnicity and the mean age was 44.4 +/- 12.8 years. The mean BMI pre-transplant was 24.7 +/- 4.1 kg/m(2), and 35 (9.9%) patients were classified as obese; 119 (33.6%) as overweight; 187 (52.8%) as normal weight; and 13 (3.7%) as malnourished. After one year of follow-up, the mean BMI was 26.2 +/- 5.0 kg/m(2), and 61 (17.3%) patients were classified as obese; 133 (37.8%) as overweight; 148 (42.0%) as normal weight; and 10 (2.8%) as malnourished. Weight gain was observed in 72.7% patients, and the average increase was 7.12 +/- 5.9 kg. The female gender, lower pre-transplant body weight, lower number of hospitalizations, and a kidney received from a living donor were associated with weight gain by more than 5% in the first year post-transplant. Conclusion Female gender and lower pre-transplant body weight were independently associated with weight gain by more than 5% in the first year after kidney transplantation; lower rates of hospitalization and donation from living donors were also risk factors for this outcome.	[Forte, Cristina Carra; Pedrollo, Elis Forcellini; Leitao, Cristiane Bauermann] Univ Fed Rio Grande do Sul, Sch Med, Postgrad Program Med Sci Endocrinol, Fac Med, Porto Alegre, RS, Brazil; [Forte, Cristina Carra; Pedrollo, Elis Forcellini; Nicoletto, Bruna Bellincanta; Lopes, Jessica Blatt; Manfro, Roberto Ceratti; Souza, Gabriela Correa; Leitao, Cristiane Bauermann] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Nicoletto, Bruna Bellincanta] Univ Caxias Do Sul, Life Sci Knowledge Area, Caxias Do Sul, RS, Brazil; [Lopes, Jessica Blatt] Univ Fed Rio Grande do Sul, Sch Med, Nutr Grad Course, Porto Alegre, RS, Brazil; [Manfro, Roberto Ceratti] Univ Fed Rio Grande do Sul, Postgrad Med Med Sci, Porto Alegre, RS, Brazil; [Manfro, Roberto Ceratti] Hosp Clin Porto Alegre, Div Nephrol, Porto Alegre, RS, Brazil; [Souza, Gabriela Correa] Hosp Clin Porto Alegre, Div Nutr, Porto Alegre, RS, Brazil; [Leitao, Cristiane Bauermann] Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade de Caxias do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Forte, CC (corresponding author), Univ Fed Rio Grande do Sul, Sch Med, Postgrad Program Med Sci Endocrinol, Fac Med, Porto Alegre, RS, Brazil.; Forte, CC (corresponding author), Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.	cristinacarraforte@gmail.com		Leitao, Cristiane/0000-0002-2106-309X	Research Incentive Fund (FIPE) of Hospital de Clinicas de Porto Alegre (HCPA); National Council for Scientific and Technological Development (CNPq); Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS); Coordination of Improvement of Superior Education Personnel (CAPES)	Research Incentive Fund (FIPE) of Hospital de Clinicas de Porto Alegre (HCPA); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Coordination of Improvement of Superior Education Personnel (CAPES)	This work was supported by from the Research Incentive Fund (FIPE) of Hospital de Clinicas de Porto Alegre (HCPA), National Council for Scientific and Technological Development (CNPq), Foundation for Research Support of the State of Rio Grande do Sul (FAPERGS) as well as the Coordination of Improvement of Superior Education Personnel (CAPES).	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 2017, GODT 2015 REP; [Anonymous], 2017, SURV RISK PROT FACT; Armstrong KA, 2005, NEPHROLOGY, V10, P405, DOI 10.1111/j.1440-1797.2005.00406.x; Baum CL, 2002, NUTRITION, V18, P139, DOI 10.1016/S0899-9007(01)00723-7; Baum CL, 2001, JPEN-PARENTER ENTER, V25, P114, DOI 10.1177/0148607101025003114; Beckmann S, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12896; Bloodworth RF, 2014, RES NURS HEALTH, V37, P253, DOI 10.1002/nur.21599; Brito TNS, 2016, REV BRASILEIRA ANALI; Cashion AK, 2014, CLIN TRANSPLANT, V28, P1271, DOI 10.1111/ctr.12456; Chan W, 2014, J RENAL NUTR, V24, P1, DOI 10.1053/j.jrn.2013.09.002; Chang A, 2015, NEPHROL DIAL TRANSPL, V30, P1870, DOI 10.1093/ndt/gfv219; Costa B, 2014, TRANSPL P, V46, P1750, DOI 10.1016/j.transproceed.2014.05.021; de Oliveira CMC, 2014, TRANSPL P, V46, P1735, DOI 10.1016/j.transproceed.2014.05.027; DeclaracAo de Helsinque da AssociacAo Medica Mundial (WMA), 2013, PRINC ET PESQ MED EN; Diaz JM, 2005, TRANSPL P, V37, P3839, DOI 10.1016/j.transproceed.2005.09.200; Dimeny EM, 2002, KIDNEY INT, V61, pS78, DOI 10.1046/j.1523-1755.61.s80.14.x; Hap K, 2019, ANN TRANSPL, V24, P57, DOI 10.12659/AOT.912096; Heng AE, 2015, CLIN NUTR, V34, P457, DOI 10.1016/j.clnu.2014.05.003; Henggeler CK, 2018, J RENAL NUTR, V28, P340, DOI 10.1053/j.jrn.2018.03.001; Hricik DE, 2001, AM J KIDNEY DIS, V38, P409, DOI 10.1053/ajkd.2001.27006; JOHNSON CP, 1993, TRANSPLANTATION, V56, P822, DOI 10.1097/00007890-199310000-00008; Kim IK, 2016, TRANSPL P, V48, P893, DOI 10.1016/j.transproceed.2015.10.064; Mehrabi A, 2006, CLIN TRANSPLANT, V20, P97, DOI 10.1111/j.1399-0012.2006.00608.x; Moreso F, 2013, NEFROLOGIA, V33, P14, DOI 10.3265/Nefrologia.pre2012.Oct.11739; Mucha K, 2015, ANN TRANSPL, V20, P16, DOI 10.12659/AOT.892754; Nicoletto BB, 2012, J RENAL NUTR, V22, P440, DOI 10.1053/j.jrn.2011.09.003; Palepu S, 2015, WORLD J DIABETES, V6, P445, DOI 10.4239/wjd.v6.i3.445; Pantik C, 2017, PROG TRANSPLANT, V27, P10, DOI 10.1177/1526924816681007; Pedrollo EF, 2016, TRANSPL INT, V29, P1059, DOI 10.1111/tri.12805; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Pirsch JD, 2008, TRANSPLANTATION, V85, P1387, DOI 10.1097/TP.0b013e31816f1d58; Pischon T, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.1.14; Souza GC, 2008, J RENAL NUTR, V18, P479, DOI 10.1053/j.jrn.2008.05.008; Thoma B, 2006, CLIN NEPHROL, V65, P408; Tonelli M, 2011, AM J TRANSPLANT, V11, P2093, DOI 10.1111/j.1600-6143.2011.03686.x; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wissing KM, 2014, TRANSPLANT REV-ORLAN, V28, P37, DOI 10.1016/j.trre.2013.12.004; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Workeneh B, 2019, J RENAL NUTR, V29, P548, DOI 10.1053/j.jrn.2019.01.009	40	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243394	10.1371/journal.pone.0243394	http://dx.doi.org/10.1371/journal.pone.0243394			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370293	Green Published, gold			2022-12-27	WOS:000603611900028
J	Kapitza, C; Ludtke, K; Tampin, B; Ballenberger, N				Kapitza, Camilla; Luedtke, Kerstin; Tampin, Brigitte; Ballenberger, Nikolaus			Application and utility of a clinical framework for spinally referred neck-arm pain: A cross-sectional and longitudinal study protocol	PLOS ONE			English	Article							LOW-BACK-PAIN; NEUROPATHIC PAIN; CERVICAL-RADICULOPATHY; DIAGNOSTIC-ACCURACY; PRACTICE GUIDELINES; RISK-FACTORS; TAMPA SCALE; CLASSIFICATION; WHIPLASH; RELIABILITY	Background The clinical presentation of neck-arm pain is heterogeneous with varying underlying pain types (nociceptive/neuropathic/mixed) and pain mechanisms (peripheral/central sensitization). A mechanism-based clinical framework for spinally referred pain has been proposed, which classifies into (1) somatic pain, (2) neural mechanosensitivity, (3) radicular pain, (4) radiculopathy and mixed pain presentations. This study aims to (i) investigate the application of the clinical framework in patients with neck-arm pain, (ii) determine their somatosensory, clinical and psychosocial profile and (iii) observe their clinical course over time. Method We describe a study protocol. Patients with unilateral neck-arm pain (n = 180) will undergo a clinical examination, after which they will be classified into subgroups according to the proposed clinical framework. Standardized quantitative sensory testing (QST) measurements will be taken in their main pain area and contralateral side. Participants will have to complete questionnaires to assess function (Neck Disability Index), psychosocial factors (Tampa Scale of Kinesiophobia, Pain Catastrophizing Scale, Depression, anxiety and stress scale), neuropathic pain (Douleur Neuropathique 4 Questions, PainDETECT Questionnaire) and central sensitization features (Central Sensitization Inventory). Follow-ups at three, six and 12 months include the baseline questionnaires. The differences of QST data and questionnaire outcomes between and within groups will be analyzed using (M)AN(C)OVA and/or regression models. Repeated measurement analysis of variance or a linear mixed model will be used to calculate the differences between three, six, and 12 months outcomes. Multiple regression models will be used to analyze potential predictors for the clinical course. Conclusion The rationale for this study is to assess the usability and utility of the proposed clinical framework as well as to identify possible differing somatosensory and psychosocial phenotypes between the subgroups. This could increase our knowledge of the underlying pain mechanisms. The longitudinal analysis may help to assess possible predictors for pain persistency.	[Kapitza, Camilla; Tampin, Brigitte; Ballenberger, Nikolaus] Univ Appl Sci, Hsch Osnabrueck, Dept Movement & Rehabil Sci, Fac Business Management & Social Sci, Osnabruck, Germany; [Luedtke, Kerstin] Acad Physiotherapy Pain & Exercise Res Luebeck PE, Dept Hlth Sci, Lubeck, Germany; [Tampin, Brigitte] Sir Charles Gairdner Hosp, Dept Physiotherapy, Perth, Australia; [Tampin, Brigitte] Curtin Univ, Sch Physiotherapy & Exercises Sci, Perth, WA, Australia	Curtin University	Kapitza, C (corresponding author), Univ Appl Sci, Hsch Osnabrueck, Dept Movement & Rehabil Sci, Fac Business Management & Social Sci, Osnabruck, Germany.	c.kapitza@hs-osnabrueck.de	Tampin, Brigitte/N-2858-2014	Tampin, Brigitte/0000-0002-8404-7847	Hochschule Osnabrueck, University of Applied Sciences; Physio Deutschland, Deutscher Verband fur Physiotherapie (ZVK) e.V.	Hochschule Osnabrueck, University of Applied Sciences; Physio Deutschland, Deutscher Verband fur Physiotherapie (ZVK) e.V.	Camilla Kapitza is supported by the Hochschule Osnabrueck, University of Applied Sciences and she received a grant from Physio Deutschland, Deutscher Verband fur Physiotherapie (ZVK) e.V.	Albright J, 2001, PHYS THER, V81, P1701; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Baron R, 2017, PAIN, V158, P261, DOI 10.1097/j.pain.0000000000000753; Beltran-Alacreuu H, 2018, PATIENT PREFER ADHER, V12, P657, DOI 10.2147/PPA.S162702; Blanpied Peter R, 2017, J Orthop Sports Phys Ther, V47, pA1, DOI 10.2519/jospt.2017.0302; Bogduk N, 2009, PAIN, V147, P17, DOI 10.1016/j.pain.2009.08.020; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Carroll LJ, 2008, EUR SPINE J, V17, pS83, DOI 10.1007/s00586-008-0628-7; Childs JD, 2008, J ORTHOP SPORT PHYS, V38, pA1, DOI 10.2519/jospt.2008.0303; Cramer H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-91; Dewitte V, 2016, MANUAL THER, V26, P87, DOI 10.1016/j.math.2016.07.005; Dimitriadis Z, 2015, J BACK MUSCULOSKELET, V28, P797, DOI 10.3233/BMR-150587; Elvey R L, 1997, J Hand Ther, V10, P122; Fernandez de las Penas C., 2016, MANUAL THERAPY MUSCU, V1, P848; Fersum KV, 2013, EUR J PAIN, V17, P916, DOI 10.1002/j.1532-2149.2012.00252.x; Finnerup NB, 2016, PAIN, V157, P1599, DOI 10.1097/j.pain.0000000000000492; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Fritz JM, 2007, PHYS THER, V87, P513, DOI 10.2522/ptj.20060192; Geber C, 2009, SCHMERZ, V23, P65, DOI 10.1007/s00482-008-0771-4; Hall T, 2010, MANUAL THER, V15, P542, DOI 10.1016/j.math.2010.06.002; Hoy DG, 2010, BEST PRACT RES CL RH, V24, P783, DOI 10.1016/j.berh.2011.01.019; Huisstede BMA, 2007, OCCUP ENVIRON MED, V64, P313, DOI 10.1136/oem.2005.023861; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Jepsen JR, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-8; Jull G., 2019, MANAGEMENT NECK PAIN, V1; Kent P, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-22; Laekeman Marjan K.K., 2017, Z PHYSIOTHERAPEU MAI; Liu R, 2017, REGION ANESTH PAIN M, V42, P52, DOI 10.1097/AAP.0000000000000505; Lundberg Mari, 2009, Physiotherapy Theory and Practice, V25, P495, DOI [10.1080/09593980802662160, 10.3109/09593980802662160]; MacDermid Joy C, 2016, Open Orthop J, V10, P746, DOI 10.2174/1874325001610010746; Maier C, 2010, PAIN, V150, P439, DOI 10.1016/j.pain.2010.05.002; Maissan F, 2020, MUSCULOSKEL SCI PRAC, V47, DOI 10.1016/j.msksp.2020.102133; Maxwell S, 2013, MANUAL THER, V18, P172, DOI 10.1016/j.math.2012.07.004; Mayer TG, 2012, PAIN PRACT, V12, P276, DOI 10.1111/j.1533-2500.2011.00493.x; Costa LDM, 2013, SPINE, V38, P148, DOI 10.1097/BRS.0b013e318267a92f; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Mitchell Tim B.D., 2017, MUSCULOSKELETAL CLIN; Moloney N, 2018, MUSCULOSKELET CARE, V16, P415, DOI 10.1002/msc.1247; Moloney N, 2015, ARCH PHYS MED REHAB, V96, P269, DOI 10.1016/j.apmr.2014.09.015; Moloney N, 2013, CLIN J PAIN, V29, P948, DOI 10.1097/AJP.0b013e31827c7ae8; Moloney NA, 2015, MANUAL THER, V20, P157, DOI 10.1016/j.math.2014.08.010; Neblett R, 2013, J PAIN, V14, P438, DOI 10.1016/j.jpain.2012.11.012; Nee RJ, 2012, J ORTHOP SPORT PHYS, V42, P413, DOI 10.2519/jospt.2012.3988; Nilges P, 2015, SCHMERZ, V29, P649, DOI 10.1007/s00482-015-0019-z; O'Sullivan P, 2005, MANUAL THER, V10, P242, DOI 10.1016/j.math.2005.07.001; Ottiger-Boettger K, 2020, MUSCULOSKEL SCI PRAC, V50, DOI 10.1016/j.msksp.2020.102261; Park SJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004698; Pedler A, 2013, PAIN, V154, P1640, DOI 10.1016/j.pain.2013.05.005; Rampakakis E, 2015, RMD OPEN, V1, DOI 10.1136/rmdopen-2015-000146; Rasmussen H, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0609-z; Ridehalgh C, 2018, J ORTHOP SPORT PHYS, V48, P767, DOI 10.2519/jospt.2018.8230; Rodriguez-Sanz J, 2019, J BACK MUSCULOSKELET, V32, P619, DOI 10.3233/BMR-181260; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rusu AC, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-280; Schafer A, 2013, ORTHOPADE, V42, P90, DOI 10.1007/s00132-012-2041-5; Schafer A, 2011, EUR SPINE J, V20, P482, DOI 10.1007/s00586-010-1632-2; Scherer M, 2007, Z ALLGEMEINMEDIZIN, V83, P507; Schmid AB, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-11; Schmidt A., 2018, ONLINE BOOK INT SOC; Shahidi B, 2015, J PAIN, V16, P1288, DOI 10.1016/j.jpain.2015.09.002; Sterling M, 2011, SPINE, V36, pS330, DOI 10.1097/BRS.0b013e3182388523; Tampin B, 2020, MANUELLE THER, V24, P21, DOI 10.1055/a-1080-7999; Tampin B, 2013, CLIN J PAIN, V29, P846, DOI 10.1097/AJP.0b013e318278d434; Tampin B, 2012, PAIN, V153, P2403, DOI 10.1016/j.pain.2012.08.007; Tousignant-Laflamme Y, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-69; Treede RD, 2019, PAIN, V160, pS66, DOI 10.1097/j.pain.0000000000001544; Treede RD, 2018, PAIN REP, V3, DOI 10.1097/PR9.0000000000000643; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wainner RS, 2003, SPINE, V28, P52, DOI 10.1097/00007632-200301010-00014; Walton DM, 2017, CLIN J PAIN, V33, P422, DOI 10.1097/AJP.0000000000000421; Walton David M, 2013, Open Orthop J, V7, P494, DOI 10.2174/1874325001307010494; Walton DM, 2013, J ORTHOP SPORT PHYS, V43, P31, DOI 10.2519/jospt.2013.4507; Werneke M, 1999, SPINE, V24, P676, DOI 10.1097/00007632-199904010-00012; Woby SR, 2005, PAIN, V117, P137, DOI 10.1016/j.pain.2005.05.029; Yarznbowicz R, 2020, J MAN MANIP THER, V28, P160, DOI 10.1080/10669817.2019.1587135; [. . . .], 2017, [Российский кардиологический журнал, Russian Journal of Cardiology, Rossiiskii kardiologicheskii zhurnal], P7	76	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244137	10.1371/journal.pone.0244137	http://dx.doi.org/10.1371/journal.pone.0244137			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370389	Green Published, gold			2022-12-27	WOS:000603611900095
J	Lanini, S; Montaldo, C; Nicastri, E; Vairo, F; Agrati, C; Petrosillo, N; Scognamiglio, P; Antinori, A; Puro, V; Di Caro, A; De Carli, G; Navarra, A; Agresta, A; Cimaglia, C; Palmieri, F; D'Offizi, G; Marchioni, L; Kobinger, GP; Maeurer, M; Girardi, E; Capobianchi, MR; Zumla, A; Locatelli, F; Ippolito, G				Lanini, Simone; Montaldo, Chiara; Nicastri, Emanuele; Vairo, Francesco; Agrati, Chiara; Petrosillo, Nicola; Scognamiglio, Paola; Antinori, Andrea; Puro, Vincenzo; Di Caro, Antonino; De Carli, Gabriella; Navarra, Assunta; Agresta, Alessandro; Cimaglia, Claudia; Palmieri, Fabrizio; D'Offizi, Gianpiero; Marchioni, Luisa; Kobinger, Gary Pignac; Maeurer, Markus; Girardi, Enrico; Capobianchi, Maria Rosaria; Zumla, Alimuddin; Locatelli, Franco; Ippolito, Giuseppe			COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study	PLOS ONE			English	Article							EBOLA-VIRUS	Background Detailed temporal analyses of complete (full) blood count (CBC) parameters, their evolution and relationship to patient age, gender, co-morbidities and management outcomes in survivors and non-survivors with COVID-19 disease, could identify prognostic clinical biomarkers. Methods From 29 January 2020 until 28 March 2020, we performed a longitudinal cohort study of COVID-19 inpatients at the Italian National Institute for Infectious Diseases, Rome, Italy. 9 CBC parameters were studied as continuous variables [neutrophils, lymphocytes, monocytes, platelets, mean platelet volume, red blood cell count, haemoglobin concentration, mean red blood cell volume and red blood cell distribution width (RDW %)]. Model-based punctual estimates, as average of all patients' values, and differences between survivors and non-survivors, overall, and by co-morbidities, at specific times after symptoms, with relative 95% CI and P-values, were obtained by marginal prediction and ANOVA- style joint tests. All analyses were carried out by STATA 15 statistical package. Main findings 379 COVID-19 patients [273 (72% were male; mean age was 61.67 (SD 15.60)] were enrolled and 1,805 measures per parameter were analysed. Neutrophils' counts were on average significantly higher in non-survivors than in survivors (P<0.001) and lymphocytes were on average higher in survivors (P<0.001). These differences were time dependent. Average platelets' counts (P<0.001) and median platelets' volume (P<0.001) were significantly different in survivors and non-survivors. The differences were time dependent and consistent with acute inflammation followed either by recovery or by death. Anaemia with anisocytosis was observed in the later phase of COVID-19 disease in non-survivors only. Mortality was significantly higher in patients with diabetes (OR = 3.28; 95%CI 1.51-7.13; p = 0.005), obesity (OR = 3.89; 95%CI 1.51-10.04; p = 0.010), chronic renal failure (OR = 9.23; 95%CI 3.49-24.36; p = 0.001), COPD (OR = 2.47; 95% IC 1.13-5.43; p = 0.033), cardiovascular diseases (OR = 4.46; 95%CI 2.25-8.86; p = 0.001), and those >60 years (OR = 4.21; 95%CI 1.82-9.77; p = 0.001). Age (OR = 2.59; 95%CI 1.04-6.45; p = 0.042), obesity (OR = 5.13; 95%CI 1.81-14.50; p = 0.002), renal chronic failure (OR = 5.20; 95%CI 1.80-14.97; p = 0.002) and cardiovascular diseases (OR 2.79; 95%CI 1.29-6.03; p = 0.009) were independently associated with poor clinical outcome at 30 days after symptoms' onset. Interpretation Increased neutrophil counts, reduced lymphocyte counts, increased median platelet volume and anaemia with anisocytosis, are poor prognostic indicators for COVID19, after adjusting for the confounding effect of obesity, chronic renal failure, COPD, cardiovascular diseases and age >60 years.	[Lanini, Simone; Montaldo, Chiara; Nicastri, Emanuele; Vairo, Francesco; Agrati, Chiara; Petrosillo, Nicola; Scognamiglio, Paola; Antinori, Andrea; Puro, Vincenzo; Di Caro, Antonino; De Carli, Gabriella; Navarra, Assunta; Agresta, Alessandro; Cimaglia, Claudia; Palmieri, Fabrizio; D'Offizi, Gianpiero; Marchioni, Luisa; Girardi, Enrico; Capobianchi, Maria Rosaria; Ippolito, Giuseppe] IRCCS, Lazzaro Spallanzani, Natl Inst Infect Dis, Rome, Italy; [Kobinger, Gary Pignac] Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Maeurer, Markus] Champalimaud Ctr Unknown, Lisbon, Portugal; [Maeurer, Markus] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Zumla, Alimuddin] UCL, Div Infect & Immun, Dept Infect, London, England; [Zumla, Alimuddin] NHS Fdn Trust, London, England; [Locatelli, Franco] IRCCS Osped Pediat Bambino Gesu, Dept Pediat Hematol & Oncol, Rome, Italy	Laval University; Fundacao Champalimaud; Johannes Gutenberg University of Mainz; University of London; University College London; Oxford University Hospitals NHS Foundation Trust; IRCCS Bambino Gesu	Lanini, S (corresponding author), IRCCS, Lazzaro Spallanzani, Natl Inst Infect Dis, Rome, Italy.	simone.lanini@inmi.it	Petrosillo, Nicola/AAZ-2095-2021; Di Caro, Antonino/K-6854-2016; Marchioni, Luisa/AGK-4889-2022; Scognamiglio, Paola/B-4754-2017; Lanini, Simone/C-7523-2012	Di Caro, Antonino/0000-0001-6027-3009; Marchioni, Luisa/0000-0003-3273-7309; Scognamiglio, Paola/0000-0002-7938-6457; puro, vincenzo/0000-0003-0291-4490; Antinori, Andrea/0000-0003-2121-4684; Lanini, Simone/0000-0002-6743-4001; Montaldo, Chiara/0000-0001-7346-7507; Zumla, Professor Sir Alimuddin/0000-0002-5111-5735; Maeurer, Markus/0000-0002-8436-8077	Line one-Ricerca Corrente 'Infezioni Emergenti e Riemergenti' - Italian Ministry of Health; Progetto COVID 2020 - Italian Ministry of Health [12371675]; AIRC [IG2018-21880]; Regione Lazio (Gruppi di ricerca) [E56C18000460002]	Line one-Ricerca Corrente 'Infezioni Emergenti e Riemergenti' - Italian Ministry of Health; Progetto COVID 2020 - Italian Ministry of Health; AIRC(Fondazione AIRC per la ricerca sul cancro); Regione Lazio (Gruppi di ricerca)	This work was supported by Line one-Ricerca Corrente 'Infezioni Emergenti e Riemergenti' and by Progetto COVID 2020 12371675 both funded by Italian Ministry of Health; AIRC (IG2018-21880); Regione Lazio (Gruppi di ricerca, E56C18000460002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajaimy M, 2020, CLIN J AM SOC NEPHRO, V15, P1087, DOI 10.2215/CJN.09730620; Albarello F, 2020, INT J INFECT DIS, V93, P192, DOI 10.1016/j.ijid.2020.02.043; Ambrosino I, 2020, MONALDI ARCH CHEST D, V90, P318, DOI 10.4081/monaldi.2020.1389; [Anonymous], 2020, LANCET, V395, P1054; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Bordoni V, 2020, CLIN INFECT DIS, V71, P2272, DOI 10.1093/cid/ciaa577; Braun E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-129; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Cohen-Wolkowiez M, 2014, ANTIMICROB AGENTS CH, V58, P2856, DOI 10.1128/AAC.02139-13; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Ge YL, 2019, CLIN LAB, V65, P379, DOI 10.7754/Clin.Lab.2018.180828; Hoekstra Trynke, LIFE COURSE PERSPECT; Horta-Baas G, 2019, INT J RHEUM DIS, V22, P47, DOI 10.1111/1756-185X.13332; Horton S, 2019, AM J CLIN PATHOL, V151, P446, DOI 10.1093/ajcp/aqy165; Lanini S, 2018, CLIN INFECT DIS, V66, P36, DOI 10.1093/cid/cix704; Lanini S, 2015, J CLIN INVEST, V125, P4692, DOI 10.1172/JCI83111; Lazzerini M, 2020, LANCET GLOB HEALTH, V8, pE641, DOI 10.1016/S2214-109X(20)30110-8; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Liu J, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102763; Memish ZA, 2020, LANCET, V395, P1063, DOI 10.1016/S0140-6736(19)33221-0; Pironti A, 2017, JAIDS-J ACQ IMM DEF, V74, pE129, DOI 10.1097/QAI.0000000000001198; Reisler RB, 2018, CLIN INFECT DIS, V66, P1479, DOI 10.1093/cid/cix1025; Shaul ME, 2019, NAT REV CLIN ONCOL, V16, P601, DOI 10.1038/s41571-019-0222-4; Sun YXH, 2020, CLIN INFECT DIS, V71, P786, DOI 10.1093/cid/ciaa322; Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; World Health Organization, 2020, 64 WHO; World Health Organization (WHO), NAM COR DIS COVID 19; Xiao CH, 2019, BURNS, V45, P1158, DOI 10.1016/j.burns.2019.01.006; Xu PY, 2020, ANN HEMATOL, V99, P1205, DOI 10.1007/s00277-020-04019-0; Yang XB, 2020, J THROMB HAEMOST, V18, P1469, DOI 10.1111/jth.14848; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895	34	23	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244129	10.1371/journal.pone.0244129	http://dx.doi.org/10.1371/journal.pone.0244129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370366	Green Published, gold			2022-12-27	WOS:000603611900020
J	Mollashahi, H; Szymura, M; Szymura, TH				Mollashahi, Hassanali; Szymura, Magdalena; Szymura, Tomasz H.			Connectivity assessment and prioritization of urban grasslands as a helpful tool for effective management of urban ecosystem services	PLOS ONE			English	Article							PLANT-SPECIES RICHNESS; GREEN SPACE; LANDSCAPE CONNECTIVITY; SEED DISPERSAL; ECOLOGICAL CONNECTIVITY; RESTORATION SUCCESS; DIVERSITY; CONSERVATION; BIODIVERSITY; IMPACT	Urban grasslands are usually managed as short-cut lawns and have limited biodiversity. Urban grasslands with low-intensity management are species rich and can perform numerous ecosystem services, but they are not accepted by citizens everywhere. Further, increasing and/or maintaining a relatively high level of plant species richness in an urban environment is limited by restricted plant dispersal. In this study, we examined the connectivity of urban grasslands and prioritized the grassland patches with regard to their role in connectivity in an urban landscape. We used high-resolution data from a land use system to map grassland patches in Wroclaw city, Silesia, southwest Poland, Central Europe, and applied a graph theory approach to assess their connectivity and prioritization. We next constructed a model for several dispersal distance thresholds (2, 20, 44, 100, and 1000 m), reflecting plants with differing dispersal potential. Our results revealed low connectivity of urban grassland patches, especially for plants with low dispersal ability (2-20 m). The priority of patches was correlated with their area for all dispersal distance thresholds. Most of the large patches important to overall connectivity were located in urban peripheries, while in the city center, connectivity was more restricted and grassland area per capita was the lowest. The presence of a river created a corridor, allowing plants to migrate along watercourse, but it also created a barrier dividing the system. The results suggest that increasing the plant species richness in urban grasslands in the city center requires seed addition.	[Mollashahi, Hassanali; Szymura, Magdalena] Wroclaw Univ Environm & Life Sci, Inst Agroecol & Plant Prod, Wroclaw, Poland; [Szymura, Tomasz H.] Univ Wroclaw, Dept Ecol Biogeochem & Environm Protect, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; University of Wroclaw	Mollashahi, H (corresponding author), Wroclaw Univ Environm & Life Sci, Inst Agroecol & Plant Prod, Wroclaw, Poland.	hassanali.mollashahi@upwr.edu.pl		Mollashahi, Hassanali/0000-0002-6100-9186; Szymura, Magdalena/0000-0002-5726-7393	project "UPWR 2.0: international and interdisciplinary programme of development of Wroclaw University of Environmental and Life Sciences"; European Social Fund under the Operational Program Knowledge Education Development [POWR.03.05.00-00-Z062 / 18]	project "UPWR 2.0: international and interdisciplinary programme of development of Wroclaw University of Environmental and Life Sciences"; European Social Fund under the Operational Program Knowledge Education Development	Publication financed by the project "UPWR 2.0: international and interdisciplinary programme of development of Wroclaw University of Environmental and Life Sciences", co-financed by the European Social Fund under the Operational Program Knowledge Education Development, under contract No. POWR.03.05.00-00-Z062 / 18 of June 4, 2019.	Aavik T, 2014, HEREDITY, V112, P471, DOI 10.1038/hdy.2013.120; [Anonymous], 1994, ILM, V33, P173; [Anonymous], 2020, PUBLIC INFORM B MUNI; [Anonymous], 2020, WROC DISTR BOUND; [Anonymous], 2020, POL DAT TOP OBJ; [Anonymous], 1991, ECOL STUD ANAL SYNTH, DOI DOI 10.1007/978-1-4757-4244-2_10; [Anonymous], 2017, JLSRF, V3, pA104; Aronson MFJ, 2017, FRONT ECOL ENVIRON, V15, P189, DOI 10.1002/fee.1480; Auffret AG, 2017, J ECOL, V105, P1648, DOI 10.1111/1365-2745.12742; Baasch A, 2016, ECOL ENG, V94, P583, DOI 10.1016/j.ecoleng.2016.06.062; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Beninde J, 2015, ECOL LETT, V18, P581, DOI 10.1111/ele.12427; Bennett AB, 2012, LANDSCAPE URBAN PLAN, V104, P26, DOI 10.1016/j.landurbplan.2011.09.007; Bischoff A, 2002, BIOL CONSERV, V104, P25, DOI 10.1016/S0006-3207(01)00151-3; Bissels S, 2004, BIOL CONSERV, V118, P641, DOI 10.1016/j.biocon.2003.10.013; Buchholz S, 2018, URBAN ECOSYST, V21, P1139, DOI 10.1007/s11252-018-0786-2; Buglife, 2019, B LIN; Bylok F, 2013, MARKETING ZARZDZANIE, P25; Capotorti G, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9010010; Carlier J, 2019, SCI TOTAL ENVIRON, V651, P3241, DOI 10.1016/j.scitotenv.2018.10.077; Casalegno S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45571; Chollet S, 2018, LANDSCAPE URBAN PLAN, V180, P121, DOI 10.1016/j.landurbplan.2018.08.009; Clark NE, 2014, TRENDS ECOL EVOL, V29, P198, DOI 10.1016/j.tree.2014.01.009; Coppel G, 2017, LANDSCAPE URBAN PLAN, V167, P410, DOI 10.1016/j.landurbplan.2017.06.015; Cousins SAO, 2006, BIOL CONSERV, V127, P500, DOI 10.1016/j.biocon.2005.09.009; Crooks K. R., 2006, CONNECTIVITY CONSERV; Daniels B, 2018, SCI TOTAL ENVIRON, V615, P1364, DOI [10.1016/j.scitotenv.2017.09.167, 10.1016/j.scitotenv.2017.]; Donath TW, 2003, APPL VEG SCI, V6, P13, DOI 10.1111/j.1654-109X.2003.tb00560.x; Dylewski L, 2019, ECOL ENTOMOL, V44, P678, DOI 10.1111/een.12744; Ellstrand NC, 2003, PHILOS T R SOC B, V358, P1163, DOI 10.1098/rstb.2003.1299; EU-DEM, 2020, EU DEM; Evju M, 2016, LANDSCAPE ECOL, V31, P1891, DOI 10.1007/s10980-016-0405-7; Evju M, 2015, BIODIVERS CONSERV, V24, P547, DOI 10.1007/s10531-014-0835-y; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Feltynowski M, 2018, URBAN FOR URBAN GREE, V31, P56, DOI 10.1016/j.ufug.2017.12.003; Fierer N, 2017, NAT REV MICROBIOL, V15, P579, DOI 10.1038/nrmicro.2017.87; Filibeck G, 2016, URBAN FOR URBAN GREE, V15, P32, DOI 10.1016/j.ufug.2015.11.005; Fischer LK, 2013, BIOL CONSERV, V159, P119, DOI 10.1016/j.biocon.2012.11.028; Fischer LK, 2013, APPL VEG SCI, V16, P272, DOI 10.1111/j.1654-109X.2012.01216.x; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Fuller RA, 2009, BIOL LETTERS, V5, P352, DOI 10.1098/rsbl.2009.0010; Gardiner MM, 2018, FRONT ECOL ENVIRON, V16, P149, DOI 10.1002/fee.1778; Geng QF, 2015, ECOL EVOL, V5, P4617, DOI 10.1002/ece3.1734; Gerard M, 2008, PLANT ECOL, V194, P85, DOI 10.1007/s11258-007-9276-y; Gurnell A, 2008, J ECOL, V96, P553, DOI 10.1111/j.1365-2745.2008.01358.x; Hampe A, 2004, J ECOL, V92, P797, DOI 10.1111/j.0022-0477.2004.00918.x; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hedberg P, 2010, J NAT CONSERV, V18, P304, DOI 10.1016/j.jnc.2010.01.003; Hedblom M, 2017, URBAN ECOSYST, V20, P1109, DOI 10.1007/s11252-017-0658-1; Hejkal J, 2017, URBAN ECOSYST, V20, P511, DOI 10.1007/s11252-016-0611-8; Hewitt CN, 2020, AMBIO, V49, P62, DOI 10.1007/s13280-019-01164-3; Hulnick AS, 2006, INTELL NATL SECUR, V21, P959, DOI 10.1080/02684520601046291; Ignatieva M, 2020, LAND-BASEL, V9, DOI 10.3390/land9030073; Ignatieva M, 2017, URBAN FOR URBAN GREE, V21, P213, DOI 10.1016/j.ufug.2016.12.006; Ignatieva M, 2015, URBAN FOR URBAN GREE, V14, P383, DOI 10.1016/j.ufug.2015.04.003; Jakobsson S, 2016, J VEG SCI, V27, P19, DOI 10.1111/jvs.12344; Jalkanen J, 2020, LANDSCAPE ECOL, V35, P353, DOI 10.1007/s10980-019-00950-4; Janhall S, 2015, ATMOS ENVIRON, V105, P130, DOI 10.1016/j.atmosenv.2015.01.052; Jarosinska E, 2020, URBAN CLIM, V34, DOI 10.1016/j.uclim.2020.100695; Keitt TH, 1997, CONSERV ECOL; Kiehl K, 2010, BASIC APPL ECOL, V11, P285, DOI 10.1016/j.baae.2009.12.004; Klaus VH, 2013, RESTOR ECOL, V21, P665, DOI 10.1111/rec.12051; KNAAPEN JP, 1992, LANDSCAPE URBAN PLAN, V23, P1, DOI 10.1016/0169-2046(92)90060-D; Kolasiska A., 2020, BOOK ART NAT SCI C K, P32; Kong FH, 2010, LANDSCAPE URBAN PLAN, V95, P16, DOI 10.1016/j.landurbplan.2009.11.001; Kovendi-Jako A, 2019, APPL VEG SCI, V22, P138, DOI 10.1111/avsc.12410; La Sorte FA, 2014, GLOBAL ECOL BIOGEOGR, V23, P769, DOI 10.1111/geb.12159; Lachowycz K, 2013, LANDSCAPE URBAN PLAN, V118, P62, DOI 10.1016/j.landurbplan.2012.10.012; Langemeyer J, 2020, SCI TOTAL ENVIRON, V707, DOI 10.1016/j.scitotenv.2019.135487; Lindborg R, 2014, BIOL CONSERV, V169, P206, DOI 10.1016/j.biocon.2013.11.015; Lososova Z, 2012, GLOBAL ECOL BIOGEOGR, V21, P545, DOI 10.1111/j.1466-8238.2011.00704.x; Lowenstein DM, 2014, BIODIVERS CONSERV, V23, P2857, DOI 10.1007/s10531-014-0752-0; Matos C, 2019, BIOL CONSERV, V237, P238, DOI 10.1016/j.biocon.2019.06.035; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; McLaughlin ME, 2014, J FIELD ORNITHOL, V85, P258, DOI 10.1111/jofo.12066; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meerow S, 2017, LANDSCAPE URBAN PLAN, V159, P62, DOI 10.1016/j.landurbplan.2016.10.005; Micholap P, 2017, URBAN ECOSYST, V20, P1339, DOI 10.1007/s11252-017-0686-x; Monika MM, 2017, OVIDIUS U ANN EC SCI, V17, P38; Muller-Landau HC, 2008, J ECOL, V96, P653, DOI 10.1111/j.1365-2745.2008.01399.x; Neel MC, 2008, BIOL CONSERV, V141, P938, DOI 10.1016/j.biocon.2007.12.031; Norton BA, 2019, ECOL APPL, V29, DOI 10.1002/eap.1946; Ntakirutimana F, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8120561; Oster M, 2009, AGR ECOSYST ENVIRON, V130, P93, DOI 10.1016/j.agee.2008.12.005; Onandia G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225438; Pauleit S, 2019, URBAN FOR URBAN GREE, V40, P1, DOI 10.1016/j.ufug.2019.04.007; Pelorosso R, 2017, ECOSYST SERV, V26, P476, DOI 10.1016/j.ecoser.2017.05.016; Peng J., 2017, SHENGTAI XUEBAO, V37, P23, DOI [10.1016/j.chnaes.2016.12.002, DOI 10.1016/J.CHNAES.2016.12.002]; Penone C, 2012, BIOL CONSERV, V148, P126, DOI 10.1016/j.biocon.2012.01.041; Phillips BB, 2020, J APPL ECOL, V57, P488, DOI 10.1111/1365-2664.13556; Piana MR, 2019, FRONT ECOL ENVIRON, V17, P455, DOI 10.1002/fee.2098; Ranta P, 2015, URBAN ECOSYST, V18, P341, DOI 10.1007/s11252-014-0402-z; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Riechers M, 2016, ECOSYST SERV, V17, P33, DOI 10.1016/j.ecoser.2015.11.007; Rudolph M, 2017, APPL VEG SCI, V20, P18, DOI 10.1111/avsc.12267; Saura S, 2009, ENVIRON MODELL SOFTW, V24, P135, DOI 10.1016/j.envsoft.2008.05.005; Saura S, 2014, J APPL ECOL, V51, P171, DOI 10.1111/1365-2664.12179; Saura S, 2010, ECOGRAPHY, V33, P523, DOI 10.1111/j.1600-0587.2009.05760.x; Sehrt M, 2020, BASIC APPL ECOL, V42, P47, DOI 10.1016/j.baae.2019.10.008; Shwartz A, 2014, GLOBAL ENVIRON CHANG, V28, P39, DOI 10.1016/j.gloenvcha.2014.06.002; Sikorski P, 2018, URBAN FOR URBAN GREE, V35, P148, DOI 10.1016/j.ufug.2018.08.017; Smith LS, 2015, BIODIVERS CONSERV, V24, P47, DOI 10.1007/s10531-014-0788-1; Southon GE, 2018, LANDSCAPE URBAN PLAN, V172, P1, DOI [10.1016/j.andurbplan.2017.12.002, 10.1016/j.landurbplan.2017.12.002]; Sun RH, 2018, LANDSCAPE URBAN PLAN, V178, P43, DOI 10.1016/j.landurbplan.2018.05.015; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Terracini B, 2013, EPIDEMIOL PREV, V37, P1; Thompson GL, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00315; Thompson GL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155986; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Tost H, 2019, NAT NEUROSCI, V22, P1389, DOI 10.1038/s41593-019-0451-y; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Watson CJ, 2020, J APPL ECOL, V57, P436, DOI 10.1111/1365-2664.13542; Yang J, 2018, SCI TOTAL ENVIRON, V639, P1453, DOI 10.1016/j.scitotenv.2018.05.253; Yang J, 2017, URBAN FOR URBAN GREE, V22, P1, DOI 10.1016/j.ufug.2017.01.002; Zhang ZZ, 2019, URBAN FOR URBAN GREE, V38, P305, DOI 10.1016/j.ufug.2018.10.014; Zhang ZY, 2007, BIOCHEM SYST ECOL, V35, P506, DOI 10.1016/j.bse.2007.01.014; Zlender V, 2020, CITIES, V98, DOI 10.1016/j.cities.2019.102579	118	4	4	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244452	10.1371/journal.pone.0244452	http://dx.doi.org/10.1371/journal.pone.0244452			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370396	gold, Green Published			2022-12-27	WOS:000603611900048
J	Ramirez, JL; Rosas-Puchuri, U; Canedo, RM; Alfaro-Shigueto, J; Ayon, P; Zelada-Mazmela, E; Siccha-Ramirez, R; Velez-Zuazo, X				Ramirez, Jorge L.; Rosas-Puchuri, Ulises; Canedo, Rosa Maria; Alfaro-Shigueto, Joanna; Ayon, Patricia; Zelada-Mazmela, Eliana; Siccha-Ramirez, Raquel; Velez-Zuazo, Ximena			DNA barcoding in the Southeast Pacific marine realm: Low coverage and geographic representation despite high diversity	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; CONSERVATION	The Southeast Pacific comprises two Large Marine Ecosystems, the Pacific Central-American Coastal and the Humboldt Current System; and is one of the less well known in the tropical subregions in terms of biodiversity. To address this, we compared DNA barcoding repositories with the marine biodiversity species for the Southeast Pacific. We obtained a checklist of marine species in the Southeast Pacific (i.e. Colombia, Ecuador, Chile, and Peru) from the Ocean Biodiversity Information System (OBIS) database and compared it with species available at the Barcoding of Life Data System (BOLD) repository. Of the 5504 species records retrieved from OBIS, 42% of them had at least one registered specimen in BOLD (including specimens around the world); however, only 4.5% of records corresponded to publicly available DNA barcodes including specimens collected from a Southeast Pacific country. The low representation of barcoded species does not vary much across the different taxonomic groups or within countries, but we observed an asymmetric distribution of DNA barcoding records for taxonomic groups along the coast, being more abundant for the Humboldt Current System than the Pacific Central-American Coastal. We observed high-level of barcode records with Barcode Index Number (BIN) incongruences, particularly for fishes (Actinopterygii = 30.27% and Elasmobranchii = 24.71%), reflecting taxonomic uncertainties for fishes, whereas for Invertebrates and Mammalia more than 85% of records were classified as data deficient or inadequate procedure for DNA barcoding. DNA barcoding is a powerful tool to study biodiversity, with a great potential to increase the knowledge of the Southeast Pacific marine biodiversity. Our results highlight the critical need for increasing taxonomic sampling effort, the number of trained taxonomic specialists, laboratory facilities, scientific collections, and genetic reference libraries.	[Ramirez, Jorge L.; Canedo, Rosa Maria] Univ Nacl Mayor San Marcos, Fac Ciencias Biol, Lima, Peru; [Rosas-Puchuri, Ulises; Velez-Zuazo, Ximena] Smithsonian Conservat Biol Inst, Ctr Conservat & Sustainabil, Natl Zool Pk, Washington, DC USA; [Rosas-Puchuri, Ulises] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Alfaro-Shigueto, Joanna] Univ Cient Lima, Fac Biol Marina, Lima, Peru; [Alfaro-Shigueto, Joanna] ProDelphinus, Lima, Peru; [Ayon, Patricia] Inst Mar Peru, Callao, Peru; [Zelada-Mazmela, Eliana] Univ Nacl Santa, Fac Ciencias, Lab Genet Fisiol & Reprod, Chimbote, Peru; [Siccha-Ramirez, Raquel] Inst Mar Peru, Lab Costero Tumbes, Zorritos, Peru; [Velez-Zuazo, Ximena] Asociac Peruana Conservac Nat, Lima, Peru	Universidad Nacional Mayor de San Marcos; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; George Washington University; Universidad Cientifica del Sur (CIENTIFICA); Instituto del Mar del Peru; Instituto del Mar del Peru	Ramirez, JL (corresponding author), Univ Nacl Mayor San Marcos, Fac Ciencias Biol, Lima, Peru.	jramirezma@unmsm.edu.pe	; Ramirez, Jorge L/F-4984-2011	Rosas, Ulises/0000-0003-0529-2623; Canedo Apolaya, Rosa Maria Lorena/0000-0002-6207-9530; Ramirez, Jorge L/0000-0001-8138-9203; Zelada, Eliana/0000-0002-5813-0954; Siccha-Ramirez, Raquel/0000-0002-5597-3948	Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) - Peru (Circulos de Investigacion) [023-2016-FONDECYT]	Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) - Peru (Circulos de Investigacion)	This research was supported by the Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica (CONCYTEC) - Peru (Circulos de Investigacion 023-2016-FONDECYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Alfaro Shigueto Joanna, 2008, Endangered Species Research, V5, P129, DOI 10.3354/esr00142; [Anonymous], 2015, J CASE REP STUD, V3, P2; [Anonymous], 2020, OBIS OC BIOD INF SYS; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Asis AMJM, 2016, MITOCHONDRIAL DNA A, V27, P659, DOI 10.3109/19401736.2014.913138; Barahona SP, 2019, MAR ECOL-EVOL PERSP, V40, DOI 10.1111/maec.12556; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Cheng J, 2015, BIOCHEM SYST ECOL, V61, P376, DOI 10.1016/j.bse.2015.07.005; Ciocca DR, 2017, CELL STRESS CHAPERON, V22, P847, DOI 10.1007/s12192-017-0815-8; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Diaz S, 2019, IPBES 2019 SUMMARY P, DOI [10.1111/padr.12283, DOI 10.1111/PADR.12283]; Evans Nathaniel, 2012, Methods Mol Biol, V858, P47, DOI 10.1007/978-1-61779-591-6_4; FAO, 2016, CONTR SEG AL NUTR TO; FAO, 2018, STAT WORLD FISH AQ 2, DOI [10.1093/japr/3.1.101, DOI 10.1093/JAPR/3.1.101]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoover AL, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2644; KUSANAGI K, 1992, J VET MED SCI, V54, P313, DOI 10.1292/jvms.54.313; Lukhtanov VA, 2019, ENTOMOL REV, V99, P463, DOI [10.1134/S0013873819040055, DOI 10.1134/S0013873819040055]; Mangel JC, 2011, MAR ECOL PROG SER, V433, P261, DOI 10.3354/meps09152; Miloslavich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014631; Oliveira LM, 2016, J FISH BIOL, V89, P2741, DOI 10.1111/jfb.13169; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Raupach MJ, 2015, ZOOKEYS, P53, DOI 10.3897/zookeys.539.6530; Reis RE, 2016, J FISH BIOL, V89, P12, DOI 10.1111/jfb.13016; Rosas U, 2018, MITOCHONDRIAL DNA A, V29, P1174, DOI 10.1080/24701394.2018.1431225; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sherman K, 2019, ENCYCLOPEDIA OF OCEAN SCIENCES, VOL 1: MARINE BIOGEOCHEMISTRY, 3RD EDITION, P709, DOI 10.1016/B978-0-12-409548-9.11117-0; Stat M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12501-5; Tarazona J, 2001, PERUVIAN COASTAL UPW, P229, DOI DOI 10.1007/978-3-662-04482-7_17; Tarazona Juan, 2003, Gayana (Concepc.), V67, P206; Thomas VG, 2016, GENOME, V59, P1023, DOI 10.1139/gen-2016-0022; Trivedi S, 2016, SAUDI J BIOL SCI, V23, P161, DOI 10.1016/j.sjbs.2015.01.001; Velez-Zuazo X, 2015, FISH RES, V161, P34, DOI 10.1016/j.fishres.2014.06.005; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Webb KE, 2006, DEEP-SEA RES PT II, V53, P1053, DOI 10.1016/j.dsr2.2006.02.013; Weigand H, 2019, SCI TOTAL ENVIRON, V678, P499, DOI 10.1016/j.scitotenv.2019.04.247	41	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244323	10.1371/journal.pone.0244323	http://dx.doi.org/10.1371/journal.pone.0244323			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370342	Green Published, gold			2022-12-27	WOS:000603611900079
J	Efstathiou, NE; Moustafa, GA; Maidana, DE; Konstantinou, EK; Notomi, S; Barbisan, PRT; Georgakopoulos, CD; Miller, JW; Vavvas, DG				Efstathiou, Nikolaos E.; Moustafa, Giannis A.; Maidana, Daniel E.; Konstantinou, Eleni K.; Notomi, Shoji; Barbisan, Paulo R. T.; Georgakopoulos, Constantine D.; Miller, Joan W.; Vavvas, Demetrios G.			Acadesine suppresses TNF-alpha induced complement component 3 (C3), in retinal pigment epithelial (RPE) cells	PLOS ONE			English	Article							FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; HIGH-RISK; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE; CHOROIDAL NEOVASCULARIZATION; GENE-EXPRESSION; RARE VARIANTS; FACTOR-B; ACTIVATION; AMPK	Rationale Age-related macular degeneration (AMD) is the most prevalent form of irreversible blindness in the developed world. Aging, inflammation and complement dysregulation affecting the retinal pigment epithelium (RPE), are considered significant contributors in its pathogenesis and several evidences have linked tumor necrosis factor alpha (TNF-alpha) and complement component 3 (C3) with AMD. Acadesine, an analog of AMP and an AMP-activated protein kinase (AMPK) activator, has been shown to have cytoprotective effects in human clinical trials as well as having anti-inflammatory and anti-vascular exudative effects in animals. The purpose of this study was to evaluate if acadesine is able to suppress TNF-alpha induced C3 in RPE cells. Methods ARPE-19 and human primary RPE cells were cultured and allowed to grow to confluence. TNF-alpha was used for C3 induction in the presence or absence of acadesine. Small molecule inhibitors and siRNA were used to determine if acadesine exerts its effect via the extracellular or intracellular pathway and to evaluate the importance of AMPK for these effects. The expression level of C3 was determined by immunoblot analysis. Results Acadesine suppresses TNF-alpha induced C3 in a dose dependent manner. When we utilized the adenosine receptor inhibitor dipyridamole (DPY) along with acadesine, acadesine's effects were abolished, indicating the necessity of acadesine to enter the cell in order to exert it's action. However, pretreatment with 5-iodotubericidin (5-Iodo), an adenosine kinase (AK) inhibitor, didn't prevent acadesine from decreasing TNF-alpha induced C3 expression suggesting that acadesine does not exert its effect through AMP conversion and subsequent activation of AMPK. Consistent with this, knockdown of AMPK alpha catalytic subunit did not affect the inhibitory effect of acadesine on TNF-alpha upregulation of C3. Conclusions Our results suggest that acadesine suppresses TNF-alpha induced C3, likely through an AMPK-independent pathway, and could have potential use in complement over activation diseases.	[Efstathiou, Nikolaos E.; Moustafa, Giannis A.; Maidana, Daniel E.; Konstantinou, Eleni K.; Notomi, Shoji; Barbisan, Paulo R. T.; Miller, Joan W.; Vavvas, Demetrios G.] Harvard Med Sch, Massachusetts Eye & Ear, Retina Serv, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA; [Georgakopoulos, Constantine D.] Univ Patras, Med Sch, Dept Ophthalmol, Patras, Greece	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Patras	Vavvas, DG (corresponding author), Harvard Med Sch, Massachusetts Eye & Ear, Retina Serv, Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02115 USA.	Demetrios_Vavvas@MEEI.HARVARD.EDU		Efstathiou, Nikolaos/0000-0002-6635-0391	STAMATIOU Foundation; New England Hellenic Medical and Dental Society; National Eye Institute [R01EY025362-01, R21EY023079-01/A1]	STAMATIOU Foundation; New England Hellenic Medical and Dental Society; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by STAMATIOU Foundation Scholarship (N.E.E), New England Hellenic Medical and Dental Society Scholarship (N.E.E), National Eye Institute, R01EY025362-01 (D.G.V), National Eye Institute, R21EY023079-01/A1 (D.G.V).	Al-Moujahed A, 2019, STEM CELL RES, V35, DOI 10.1016/j.scr.2019.101387; Al-Moujahed A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07632-8; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BAUDOUIN C, 1992, JPN J OPHTHALMOL, V36, P443; Boss M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32111; Cao SJ, 2013, AM J OPHTHALMOL, V156, P1176, DOI 10.1016/j.ajo.2013.08.003; Chung EJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17744-w; Curcio CA, 2011, BRIT J OPHTHALMOL, V95, P1638, DOI 10.1136/bjophthalmol-2011-300344; Cuthbertson DJ, 2007, DIABETES, V56, P2078, DOI 10.2337/db06-1716; Despriet DDG, 2009, OPHTHALMOLOGY, V116, P474, DOI 10.1016/j.ophtha.2008.09.055; Duvvari MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094165; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Geerlings MJ, 2017, MOL IMMUNOL, V84, P65, DOI 10.1016/j.molimm.2016.11.016; Geerlings MJ, 2017, JAMA OPHTHALMOL, V135, P39, DOI 10.1001/jamaophthalmol.2016.4604; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hamdulay SS, 2014, J IMMUNOL, V192, P4316, DOI 10.4049/jimmunol.1301702; Handa JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11262-1; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Holz FG, 2018, JAMA OPHTHALMOL, V136, P666, DOI 10.1001/jamaophthalmol.2018.1544; Jakobsdottir J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002199; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; Kawakami Y, 1997, CANCER LETT, V116, P21, DOI 10.1016/S0304-3835(97)04737-X; Kim JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.115; Kirchner J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26102-3; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kosmidou C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17634-1; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kumase F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147279; Kuo CL, 2008, J CELL BIOCHEM, V103, P931, DOI 10.1002/jcb.21466; Law SKA, 1997, PROTEIN SCI, V6, P263; Lechner J, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0060-5; LEUNG JM, 1994, ANESTH ANALG, V78, P420; Liao DS, 2020, OPHTHALMOLOGY, V127, P186, DOI 10.1016/j.ophtha.2019.07.011; Lores-Motta L, 2018, OPHTHALMOLOGY, V125, P1064, DOI 10.1016/j.ophtha.2017.12.023; Luo C, 2011, MOL VIS, V17, P1588; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; MENASCHE P, 1995, J THORAC CARDIOV SUR, V110, P1096, DOI 10.1016/S0022-5223(05)80179-5; Miller Joan W, 2017, US Ophthalmic Rev, V10, P119, DOI 10.17925/USOR.2017.10.02.119; Miller JW, 2013, AM J OPHTHALMOL, V155, P1, DOI 10.1016/j.ajo.2012.10.018; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Natoli R, 2017, INVEST OPHTH VIS SCI, V58, P2977, DOI 10.1167/iovs.17-21672; Newman MF, 2012, JAMA-J AM MED ASSOC, V308, P157, DOI 10.1001/jama.2012.7633; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Notomi S, 2019, P NATL ACAD SCI USA, V116, P23724, DOI 10.1073/pnas.1906643116; Nymo S, 2014, IMMUNOBIOLOGY, V219, P786, DOI 10.1016/j.imbio.2014.06.006; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Park KH, 2009, INVEST OPHTH VIS SCI, V50, P3386, DOI 10.1167/iovs.08-3231; Poor SH, 2014, INVEST OPHTH VIS SCI, V55, P6525, DOI 10.1167/iovs.14-15067; Ratnapriya R, 2019, NAT GENET, V51, P606, DOI 10.1038/s41588-019-0351-9; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ristau T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093459; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Samuel MA, 2014, NAT NEUROSCI, V17, P1190, DOI 10.1038/nn.3772; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Sivaprasad S, 2007, ARCH OPHTHALMOL-CHIC, V125, P515, DOI 10.1001/archopht.125.4.515; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Stanton CM, 2011, INVEST OPHTH VIS SCI, V52, P8828, DOI 10.1167/iovs.11-7933; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Takeuchi K, 2013, J BIOL CHEM, V288, P20581, DOI 10.1074/jbc.M113.460832; Touhami S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1106-8; Ueta T, 2019, P NATL ACAD SCI USA, V116, P23705, DOI 10.1073/pnas.1908355116; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657; Vavvas DG, 2018, P NATL ACAD SCI USA, V115, pE696, DOI 10.1073/pnas.1718059115; Vavvas DG, 2016, EBIOMEDICINE, V5, P198, DOI 10.1016/j.ebiom.2016.01.033; Wen ZK, 2019, NAT IMMUNOL, V20, P313, DOI 10.1038/s41590-018-0296-7; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yehoshua Z, 2014, OPHTHALMOLOGY, V121, P693, DOI 10.1016/j.ophtha.2013.09.044; Ying Y, 2017, ONCOTARGET, V8, P32794, DOI 10.18632/oncotarget.15825; Yu JR, 2014, CONTEMP CHIN THOUGHT, V45, P18, DOI 10.2753/CSP1097-1467450401; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zhang J, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0945-5; 2008, DRUGS R&D, V9, P169; 2018, CURR OPIN TOXICOL, V10	87	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244307	10.1371/journal.pone.0244307	http://dx.doi.org/10.1371/journal.pone.0244307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362238	Green Published, gold			2022-12-27	WOS:000603071600062
J	Iglesias, K; Lannoy, S; Sporkert, F; Daeppen, JB; Gmel, G; Baggio, S				Iglesias, Katia; Lannoy, Severine; Sporkert, Frank; Daeppen, Jean-Bernard; Gmel, Gerhard; Baggio, Stephanie			Performance of self-reported measures of alcohol use and of harmful drinking patterns against ethyl glucuronide hair testing among young Swiss men	PLOS ONE			English	Article							IDENTIFICATION TEST AUDIT; CONSUMPTION; INSTRUMENTS; VALIDITY; MARKERS; STATE	Background There is a need for empirical studies assessing the psychometric properties of self-reported alcohol use as measures of excessive chronic drinking (ECD) compared to those of objective measures, such as ethyl glucuronide (EtG). Objectives To test the quality of self-reported measures of alcohol use and of risky single-occasion drinking (RSOD) to detect ECD assessed by EtG. Methods A total of 227 samples of hair from young Swiss men were used for the determination of EtG. Self-reported measures of alcohol use (previous twelve-month and previous-week alcohol use) and RSOD were assessed. Using EtG (<30 pg/mg) as the gold standard of ECD assessment, the sensitivity and specificity were computed, and the AUROC were compared for alcohol use measures and RSOD. Logistic regressions were used to test the contribution of RSOD to the understanding of ECD after controlling for alcohol use. Results A total of 23.3% of participants presented with ECD. Previous twelve-month alcohol use with a cut-off of >15 drinks per week (sensitivity = 75.5%, specificity = 78.7%) and weekly RSOD (sensitivity = 75.5%, specificity = 70.1%) yielded acceptable psychometric properties. No cut-off for previous-week alcohol use gave acceptable results. In the multivariate logistic regression, after controlling for the previous twelve months of alcohol use, RSOD was still significantly associated with EtG (p = .016). Conclusion Self-reported measures of the previous twelve months of alcohol use and RSOD were acceptable measures of ECD for population-based screening. Self-reported RSOD appeared to be an interesting screening measure, in addition to the previous twelve months of alcohol use, to understand ECD among young people.	[Iglesias, Katia] HES SO Univ Appl Sci & Arts Western Switzerland, Sch Hlth Sci HEdS FR, Fribourg, Switzerland; [Lannoy, Severine] Stanford Univ, Dept Psychiat & Behav Sci, Sch Med, Stanford, CA 94305 USA; [Lannoy, Severine] Catholic Univ Louvain, Lab Expt Psychopathol, Psychol Sci Res Inst, Louvain La Neuve, Brabant Wallon, Belgium; [Sporkert, Frank] Lausanne Univ, Ctr Legal Med, Forens Toxicol & Chem Unit, Lausanne, Vaud, Switzerland; [Sporkert, Frank] Univ Geneva, Ctr Legal Med, Forens Toxicol & Chem Unit, Lausanne, Vaud, Switzerland; [Daeppen, Jean-Bernard; Gmel, Gerhard] Lausanne Univ Hosp, Dept Psychiat, Addict Med, Lausanne, Vaud, Switzerland; [Gmel, Gerhard] Addict Switzerland, Lausanne, Vaud, Switzerland; [Gmel, Gerhard] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Gmel, Gerhard] Univ West England, Bristol, Avon, England; [Baggio, Stephanie] Geneva Univ Hosp, Div Prison Hlth, Geneva, Switzerland; [Baggio, Stephanie] Univ Geneva, Geneva, Switzerland; [Baggio, Stephanie] Dept Justice & Home Affairs Canton Zurich, Off Correct, Zurich, Switzerland	University of Applied Sciences & Arts Western Switzerland; Stanford University; Universite Catholique Louvain; University of Lausanne; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of West England; University of Geneva; University of Geneva	Iglesias, K (corresponding author), HES SO Univ Appl Sci & Arts Western Switzerland, Sch Hlth Sci HEdS FR, Fribourg, Switzerland.	Katia.Iglesias@hefr.ch	Lannoy, Séverine/AAN-8312-2021; Gachoud, Céline/K-1104-2018; Baggio, Stephanie/J-6009-2017	Iglesias, Katia/0000-0003-1308-1631; Baggio, Stephanie/0000-0002-5347-5937	Swiss National Science Foundation [10001C_173418/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Grant awarded to SB and KI: Swiss National Science Foundation, no. 10001C_173418/1 URL: www.snf.ch/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Andreasson S, 2016, ADDICTION, V111, P1727, DOI 10.1111/add.13278; Baggio S, ADDICTION; Biondi A, 2019, FORENSIC SCI INT, V300, P106, DOI 10.1016/j.forsciint.2019.05.004; Bonomo YA, 2004, ADDICTION, V99, P1520, DOI 10.1111/j.1360-0443.2004.00846.x; Boscolo-Berto R, 2013, INT J LEGAL MED, V127, P611, DOI 10.1007/s00414-012-0809-0; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cabarcos P, 2015, ANAL BIOANAL CHEM, V407, P4907, DOI 10.1007/s00216-015-8701-7; Crunelle CL, 2014, DRUG ALCOHOL DEPEN, V134, P1, DOI 10.1016/j.drugalcdep.2013.10.008; Del Boca FK, 2003, ADDICTION, V98, P1, DOI 10.1046/j.1359-6357.2003.00586.x; Delker E, 2016, ALCOHOL RES-CURR REV, V38, P7; Dupuis M, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14017; Enoch MA, 2006, ANN NY ACAD SCI, V1094, P193, DOI 10.1196/annals.1376.019; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Gmel G., 2015, SUCHT, V61, P251, DOI [10.1024/0939-5911.a000380, DOI 10.1024/0939-5911.A000380]; Gmel G, 2014, J STUD ALCOHOL DRUGS, V75, P880, DOI 10.15288/jsad.2014.75.880; Iglesias K, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023632; Kharbouche H, 2009, J CHROMATOGR B, V877, P2337, DOI 10.1016/j.jchromb.2008.11.046; Kuntsche E, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13826; Leigh BC, 2000, J SUBST ABUSE, V12, P51, DOI 10.1016/S0899-3289(00)00040-7; Liskola J, 2018, DRUG ALCOHOL DEPEN, V188, P266, DOI 10.1016/j.drugalcdep.2018.04.015; Moss HB, 2013, SOC WORK PUBLIC HLTH, V28, P175, DOI 10.1080/19371918.2013.758987; Oppolzer D, 2019, FORENSIC SCI INT, V294, P39, DOI 10.1016/j.forsciint.2018.10.028; Pearson MR, 2016, ADDICTION, V111, P1720, DOI 10.1111/add.13210; Pirro V, 2011, FORENSIC SCI INT, V210, P271, DOI 10.1016/j.forsciint.2011.03.026; Pragst F, 1998, Forensic Sci Rev, V10, P81; Pragst F, 2017, FORENSIC SCI INT, V278, P326, DOI 10.1016/j.forsciint.2017.07.023; Regie federale des alcools (RFA), 2017, ALC CHIFFR 2017; Sacks Jeffrey J, 2015, Am J Prev Med, V49, pe73, DOI 10.1016/j.amepre.2015.05.031; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Society of Hair Testing, 2016, GLOB STRAT RED HARMF; Studer J, 2013, DRUG ALCOHOL DEPEN, V132, P316, DOI 10.1016/j.drugalcdep.2013.02.029; Tuunanen M, 2007, DRUG ALCOHOL REV, V26, P295, DOI 10.1080/09595230701247756; World Health Organization, 2018, AIR POLL CHILD HLTH; 2019, WHO TECH REP SER, V1022, P1	35	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244336	10.1371/journal.pone.0244336	http://dx.doi.org/10.1371/journal.pone.0244336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362226	Green Published, gold			2022-12-27	WOS:000603071600036
J	de Oliveira, AP; Cunha, CS; Pereira, ES; Biffani, S; de Medeiros, AN; Silva, AMD; Marcondes, MI				Oliveira, Alessandra Pinto de; Cunha, Camila Soares; Pereira, Elzania Sales; Biffani, Stefano; Medeiros, Ariosvaldo Nunes de; Silva, Aderbal Marcos de Azevedo; Marcondes, Marcos Inacio			'Meta-analysis of dry matter intake and neutral detergent fiber intake of hair sheep raised in tropical areas'	PLOS ONE			English	Article							AFFECTING SILAGE INTAKE; DAIRY-COWS; MATHEMATICAL-MODELS; VOLUNTARY INTAKE; FEED-INTAKE; DIGESTIBILITY; PERFORMANCE; FORAGE; CATTLE; REQUIREMENTS	Inadequate estimates of fiber and dry matter intake of sheep raised in tropical conditions may explain part of the inefficiency of those production systems. Therefore, we aimed to estimate dry matter intake (DMI) and neutral detergent fiber intake (NDFI) of hair sheep raised under tropical conditions. A meta-analysis of 61 independent performance experiments, comprising a total of 413 experimental units (treatment means or animals), was performed. Trials were conducted in tropical conditions, using hair sheep in growing and finishing phases and endowed with the following information: neutral detergent fiber (NDF) in diet, initial and final body weight (BW), average daily gain (ADG), DMI and NDFI of treatment means (51 studies) or individual data (10 studies). Data on organic matter and NDF digestibilities were collected to estimate D-value (Dv) and B-value (Bv) (20 and 33 studies, respectively). The equations obtained were: MI(g/day) = 50.5773(+/- 71.0504) + 1.4423(+/- 0.1704) x ADG+28.4406(+/- 2.9697) x BW; DMI(g/kgBW) = 42.1088(+/- 4.7298) + 0.05516(+/- 0.009427) x ADG -0.4402(+/- 0.1865) x BW; NDFI(g/day) =-52.2187(+/- 47.7718) +1.3773(+/- 0.2292) x NDF(g/kgDM) -0.0007(+/- 0.0002) x NDF(g/kgDM)2. DMI (g/kg BW) as a function of Dv (g/kg DM) revealed a quadratic relationship, whose point of maximum DMI (38.69 g/kg BW) was obtained at 634.1 g/kg DM Dv. On the other hand, DMI decreased linearly as Bv (g/kg DM) increased. In conclusion, equations to predict DMI from BW and ADG as well to predict NDFI from dietary NDF were fitted with great accuracy and are recommended for hair sheep raised in tropical regions. DMI values were, in general, greater than those reported by the NRC, AFRC and INRA systems, which may be a reflection of the sheep breeds used in this study. Using Dv and Bv concepts was satisfactory to describe an integrated mechanism between metabolic and bulking regulation of DMI in sheep.	[Oliveira, Alessandra Pinto de; Pereira, Elzania Sales] Univ Fed Ceara, Dept Anim Sci, Fortaleza, Ceara, Brazil; [Cunha, Camila Soares; Marcondes, Marcos Inacio] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Biffani, Stefano] CNR, Ist Biol & Biotecnol Agr, Lodi, Italy; [Medeiros, Ariosvaldo Nunes de] Univ Fed Paraiba, Dept Anim Sci, Areia, Paraiba, Brazil; [Silva, Aderbal Marcos de Azevedo] Univ Fed Campina Grande, Rural Hlth & Technol Ctr, Patos de Minas, Paraiba, Brazil; [Cunha, Camila Soares] Univ Fed Mato Grosso do Sul, Fac Vet Med & Anim Sci, Campo Grande, MS, Brazil	Universidade Federal do Ceara; Universidade Federal de Vicosa; Consiglio Nazionale delle Ricerche (CNR); Universidade Federal da Paraiba; Universidade Federal de Campina Grande; Universidade Federal de Mato Grosso do Sul	Marcondes, MI (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.	marcos.marcondes@ufv.br	Biffani, Stefano/X-8264-2019; Medeiros, Ariosvaldo Nunes de/AAX-8291-2021	Biffani, Stefano/0000-0001-5559-3630; Medeiros, Ariosvaldo Nunes de/0000-0002-1997-2649; Marcondes, Marcos/0000-0003-4843-2809				AFRC (Agricultural and Food Research Council), 1993, EN PROT REQ RUM ADV, P100; Allen MS, 1996, J ANIM SCI, V74, P3063; Aregheore EM, 2004, J ANIM FEED SCI, V13, P575; Bibby J., 1977, PREDICTION IMPROVED; Cannas A, 2004, J ANIM SCI, V82, P149; CONRAD HR, 1964, J DAIRY SCI, V47, P54, DOI 10.3168/jds.S0022-0302(64)88581-7; Cook RD, 1982, RESIDUALS INFLUENCE; de Almeida AK, 2019, LIVEST SCI, V219, P1, DOI 10.1016/j.livsci.2018.11.002; Rodrigues RTDS, 2014, J ANIM FEED SCI, V23, P117, DOI 10.22358/jafs/65699/2014; Detmann E, 2014, J ANIM SCI, V92, P4632, DOI 10.2527/jas.2014-7717; Detmann E, 2003, REV BRAS ZOOTECN, V32, P1763, DOI 10.1590/S1516-35982003000700027; Efron B, 1998, INTRO BOOTSTRAP; Fisher DS, 2002, CROP SCI, V42, P1651, DOI 10.2135/cropsci2002.1651; Forbes J. Michael, 2007, P1, DOI [10.1079/9781845932794.0341, 10.1079/9781845932794.0041, 10.1079/9781845932794.0310, 10.1079/9781845932794.0365, 10.1079/9781845932794.0243, 10.1079/9781845932794.0000]; Huhtanen P, 2008, ANIMAL, V2, P942, DOI 10.1017/S1751731108001924; Huhtanen P, 2007, ANIMAL, V1, P758, DOI 10.1017/S175173110773673X; Institut National de la Recherche Agronomique, 2018, INRA FEEDING SYSTEM; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Mazon Madeline Rezende, 2017, Acta Sci., Anim. Sci., V39, P103, DOI 10.4025/actascianimsci.v39i1.32749; Vieira RAM, 2012, ANIM FEED SCI TECH, V171, P154, DOI 10.1016/j.anifeedsci.2011.11.001; MERTENS DR, 1987, J ANIM SCI, V64, P1548, DOI 10.2527/jas1987.6451548x; Mertens DR., 1994, REGULATION FORAGE IN, P450; National Research Council, 2000, NUTR REQ BEEF CATTL; National Research Council, 2007, NUTR REQ SMALL RUM; Nie HT, 2015, TROP ANIM HEALTH PRO, V47, P841, DOI 10.1007/s11250-015-0797-4; Valente TNP, 2011, REV BRAS ZOOTECN, V40, P1596, DOI 10.1590/S1516-35982011000700027; Pittroff W., 1999, P366; Paulino PVR, 2008, REV BRAS ZOOTECN, V37, P1079, DOI 10.1590/S1516-35982008000600019; Vieira PAS, 2013, SMALL RUMINANT RES, V112, P78, DOI 10.1016/j.smallrumres.2012.10.007; Sauvant D, 2008, ANIMAL, V2, P1203, DOI 10.1017/S1751731108002280; Silva JFC, 2006, RUMINANT NUTR, P57; SOLIS G, 1991, SMALL RUMINANT RES, V4, P115, DOI 10.1016/0921-4488(91)90058-X; Souza MA, 2010, TROP ANIM HEALTH PRO, V42, P1299, DOI 10.1007/s11250-010-9566-6; St-Pierre NR, 2001, J DAIRY SCI, V84, P741, DOI 10.3168/jds.S0022-0302(01)74530-4; Tedeschi LO, 2006, AGR SYST, V89, P225, DOI 10.1016/j.agsy.2005.11.004; van Milgen J, 1999, J ANIM SCI, V77, P2154; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Weston RH, 1996, AUST J AGR RES, V47, P175, DOI 10.1071/AR9960175	38	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244201	10.1371/journal.pone.0244201	http://dx.doi.org/10.1371/journal.pone.0244201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351827	gold, Green Published			2022-12-27	WOS:000603071400027
J	Wang, J; Zhang, YX; Yan, XR; Guo, JP				Wang, Juan; Zhang, Yunxiang; Yan, Xingrong; Guo, Jinping			Physiological and transcriptomic analyses of yellow horn (Xanthoceras sorbifolia) provide important insights into salt and saline-alkali stress tolerance	PLOS ONE			English	Article							ANTIOXIDANT ENZYMES; ABIOTIC STRESSES; DROUGHT STRESS; PHOTOSYSTEM-II; H+-ATPASE; PROTEIN; RESPONSES; TRAITS; GROWTH; GENES	Yellow horn (Xanthoceras sorbifolia) is an oil-rich woody plant cultivated for bio-energy production in China. Soil saline-alkalization is a prominent agricultural-related environmental problem limiting plant growth and productivity. In this study, we performed comparative physiological and transcriptomic analyses to examine the mechanisms of X. sorbifolia seedling responding to salt and alkaline-salt stress. With the exception of chlorophyll content, physiological experiments revealed significant increases in all assessed indices in response to salt and saline-alkali treatments. Notably, compared with salt stress, we observed more pronounced changes in electrolyte leakage (EL) and malondialdehyde (MDA) levels in response to saline-alkali stress, which may contribute to the greater toxicity of saline-alkali soils. In total, 3,087 and 2,715 genes were differentially expressed in response to salt and saline-alkali treatments, respectively, among which carbon metabolism, biosynthesis of amino acids, starch and sucrose metabolism, and reactive oxygen species signaling networks were extensively enriched, and transcription factor families of bHLH, C2H2, bZIP, NAC, and ERF were transcriptionally activated. Moreover, relative to salt stress, saline-alkali stress activated more significant upregulation of genes related to H+ transport, indicating that regulation of intracellular pH may play an important role in coping with saline-alkali stress. These findings provide new insights for investigating the physiological changes and molecular mechanisms underlying the responses of X. sorbifolia to salt and saline-alkali stress.	[Wang, Juan; Zhang, Yunxiang; Yan, Xingrong; Guo, Jinping] Shanxi Agr Univ, Coll Forestry, Taigu, Shanxi, Peoples R China; [Wang, Juan; Zhang, Yunxiang; Yan, Xingrong; Guo, Jinping] Shanxi Key Lab Funct Oil Tree Cultivat & Res, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University	Guo, JP (corresponding author), Shanxi Agr Univ, Coll Forestry, Taigu, Shanxi, Peoples R China.; Guo, JP (corresponding author), Shanxi Key Lab Funct Oil Tree Cultivat & Res, Taigu, Shanxi, Peoples R China.	jinpguo@126.com		guo, jin ping/0000-0002-5075-5917	Shanxi Key Laboratory of Northern Functional Oil Tree Cultivation and Research [201805D111010]; Science and Technology Research Project of Shanxi Province [20120311015-3]	Shanxi Key Laboratory of Northern Functional Oil Tree Cultivation and Research; Science and Technology Research Project of Shanxi Province	This study was supported by Shanxi Key Laboratory of Northern Functional Oil Tree Cultivation and Research (201805D111010) and Science and Technology Research Project of Shanxi Province (20120311015-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneim AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144509; Ahmad P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31917-1; Ali MA, 2018, J PLANT PHYSIOL, V226, P12, DOI 10.1016/j.jplph.2018.04.007; Allakhverdiev SI, 2002, PLANT PHYSIOL, V130, P1443, DOI 10.1104/pp.011114; An YM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00931; Anita Mann, 2019, Indian Journal of Experimental Biology, V57, P672; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Aprile A, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1473-4; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chauhan A, 2019, SAUDI J BIOL SCI, V26, P1298, DOI 10.1016/j.sjbs.2019.04.014; COLE S, 2006, LAW POLICY, V28, P109, DOI DOI 10.1111/J.1467-9930.2005.00219.X; Davey MW, 2005, ANAL BIOCHEM, V347, P201, DOI 10.1016/j.ab.2005.09.041; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Demir Y, 2008, FRESEN ENVIRON BULL, V17, P536; Doganlar ZB, 2010, AFR J AGR RES, V5, P2056; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fariduddin Qazi, 2012, Braz. J. Plant Physiol., V24, P281, DOI 10.1590/S1677-04202012000400007; Geng G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20235910; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo R, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0994-6; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hasegawa PM, 2013, ENVIRON EXP BOT, V92, P19, DOI 10.1016/j.envexpbot.2013.03.001; Hershkovitz V, 2012, MOL PLANT PATHOL, V13, P338, DOI 10.1111/j.1364-3703.2011.00750.x; Huang BR, 2014, CRIT REV PLANT SCI, V33, P141, DOI 10.1080/07352689.2014.870411; Jamro GM, 2015, ECOL EVOL, V5, P4655, DOI 10.1002/ece3.1742; Kawa D, 2017, CELL MOL LIFE SCI, V74, P1165, DOI 10.1007/s00018-016-2376-x; Kirsch M, 1996, PLANT MOL BIOL, V32, P543, DOI 10.1007/BF00019107; Kong WL, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8030064; Kumar A, 2018, INDIAN J EXP BIOL, V56, P573; Lang YH, 2020, RSC ADV, V10, P6512, DOI 10.1039/c9ra09535g; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020; Lehner B, 2006, CLIMATIC CHANGE, V75, P273, DOI 10.1007/s10584-006-6338-4; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27940-x; Lima JV, 2017, PHYSIOL MOL BIOL PLA, V23, P59, DOI 10.1007/s12298-016-0410-y; Lin JX, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01458; Liu CY, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10010044; Magnan F, 2008, PLANT J, V56, P575, DOI 10.1111/j.1365-313X.2008.03622.x; Mann Anita, 2019, Plant Physiology Reports, V24, P104, DOI 10.1007/s40502-019-0434-8; Arias-Moreno DM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08744-x; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Meng C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3421-8; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mohammadkhani N, 2008, TURK J BIOL, V32, P23; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nouri MZ, 2015, INT J MOL SCI, V16, P20392, DOI 10.3390/ijms160920392; Ohyama Yoshiaki, 2013, J Cardiol Cases, V8, pe13, DOI 10.1016/j.jccase.2013.02.015; Olfatmiri H, 2014, MOL BIOL RES COMMUN, V3, P67; Panchy NL, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1398-z; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Qiu NW, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091953; Rahaie M, 2010, PLANT CELL REP, V29, P835, DOI 10.1007/s00299-010-0868-y; Rouphael Y, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00249; Ruan CJ, 2017, ECOL ENG, V99, P504, DOI 10.1016/j.ecoleng.2016.11.073; Sakamoto H, 2008, PLANT J, V56, P411, DOI 10.1111/j.1365-313X.2008.03614.x; Shen Z, 2019, J FORESTRY RES, V30, P869, DOI 10.1007/s11676-018-0683-9; Shinde H, 2019, PLANT PHYSIOL BIOCH, V135, P546, DOI 10.1016/j.plaphy.2018.11.004; Sicilia A, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1964-y; Sivankalyani V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01579; Subramanian S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160660; Sun SX, 2020, HEREDITAS, V157, DOI 10.1186/s41065-020-00122-4; Upadhyay A, 2018, PLANT PHYSIOL BIOCH, V129, P168, DOI 10.1016/j.plaphy.2018.05.032; Wang HY, 2015, J MATER SCI TECHNOL, V31, P164, DOI 10.1016/j.jmst.2014.07.004; Wang J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236588; Wang L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103071; Wang R, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9040458; Wang SN, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072921; Wang YP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01004; Wang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126050; Yang CW, 2008, PHOTOSYNTHETICA, V46, P107, DOI [10.1007/s11099-008-0018-8, 10.1007/s11099-008-0047-3]; Yang CY, 2016, MOLECULES, V21, DOI 10.3390/molecules21121694; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Yang EZ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010004; Yao ZY, 2013, RENEW SUST ENERG REV, V24, P57, DOI 10.1016/j.rser.2013.03.047; Yin ZP, 2019, PLANT SOIL, V437, P137, DOI 10.1007/s11104-019-03955-9; Yu Y, 2017, PLANT MOL BIOL, V94, P509, DOI 10.1007/s11103-017-0623-7; Yu Y, 2014, GENE, V549, P113, DOI [10.1016/j.gene.2014.07.053, 10.1016/j.gene.2013.12.057]; Zhang X, 2013, J INTEGR PLANT BIOL, V55, P262, DOI 10.1111/jipb.12013; Zhang Y, 2015, PHYTOCHEMISTRY, V110, P13, DOI 10.1016/j.phytochem.2014.12.021; Zhao DQ, 2019, FORESTS, V10, DOI 10.3390/f10020135; Zhou QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140507	86	17	17	10	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244365	10.1371/journal.pone.0244365	http://dx.doi.org/10.1371/journal.pone.0244365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351842	gold, Green Published			2022-12-27	WOS:000603071400026
J	Kim, T; Bahk, J; Lim, HK; Khang, YH				Kim, Taejae; Bahk, Jinwook; Lim, Hwa Kyung; Khang, Young-Ho			Stagnation of life expectancy in Korea in 2018: A cause-specific decomposition analysis	PLOS ONE			English	Article							PNEUMONIA	According to the most recent annual report released by Korea Statistics, the life expectancy at birth (for both sexes) in 2018 was 82.7 years, an increase of 0.0 years over 2017, reflecting the first stagnation in life expectancy since 1960. In this study, a time-series analysis was conducted of trends in life expectancy from 2003 to 2018, and causes of death were analyzed using the Kannisto-Thatcher method and the Arriaga decomposition method. The time trend analysis of yearly life expectancy changes indicated that, in Korea, there was a tendency for the yearly increase in life expectancy between 2003 and 2018 to decrease by 0.0211 years per calendar year. The contribution of cardiovascular diseases, the most important contributor to the life expectancy increase in Korea, gradually decreased over this period. The contribution of cardiovascular diseases to the life expectancy increase was 0.506 years in 2003-2006, but this contribution decreased to 0.218 years in 2015-2018. The positive contributions of ill-defined causes and external causes to life expectancy increase detected in previous periods were not evident in 2015-2018. Diseases of the respiratory system made the largest negative contribution both between 2015 and 2018 and between 2017-2018. The life expectancy stagnation in 2018 could be understood as the combined effect of (a) decreasing momentum in the increase of life expectancy and (b) a chance event in 2018 involving life expectancy. Currently, it is difficult to judge whether the stagnation of life expectancy in 2018 is temporary, and further analyses of life expectancy and contributing causes of death in the future are needed.	[Kim, Taejae; Khang, Young-Ho] Seoul Natl Univ, Dept Hlth Policy & Management, Coll Med, Seoul, South Korea; [Bahk, Jinwook] Keimyung Univ, Dept Publ Hlth, Daegu, South Korea; [Lim, Hwa Kyung; Khang, Young-Ho] Seoul Natl Univ, Inst Hlth Policy & Management, Med Res Ctr, Seoul, South Korea	Seoul National University (SNU); Keimyung University; Seoul National University (SNU)	Khang, YH (corresponding author), Seoul Natl Univ, Dept Hlth Policy & Management, Coll Med, Seoul, South Korea.; Khang, YH (corresponding author), Seoul Natl Univ, Inst Hlth Policy & Management, Med Res Ctr, Seoul, South Korea.	yhkhang@snu.ac.kr		KIM, TAEJAE/0000-0001-9409-9352	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI18C0446]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0446). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Bergeron-Boucher MP, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173093; Byeon KH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e121; Cho YJ, 2011, TUBERC RESPIR DIS, V70, P224, DOI 10.4046/trd.2011.70.3.224; Khang YH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030683; Khang YH, 2019, YONSEI MED J, V60, P687, DOI 10.3349/ymj.2019.60.7.687; Kim CH, 2015, ANN GERIATR MED RES, V19, P80, DOI 10.4235/jkgs.2015.19.2.80; Korea CDC, 2019, 2018 INF DIS SURV YB; Lee HB, 2011, TUBERC RESPIR DIS, V70, P105, DOI 10.4046/trd.2011.70.2.105; OECD, 2019, NEG OUR WAY UP; Park Kyung Ae, 2001, [Korea Journal of Population Studies, 한국인구학], V24, P67; Statistics Korea, 2019, 2018 ANN REP CAUS DE; Statistics Korea, 2019, 2018 LIF TABL BRIEF; Statistics Korea, 2017, 2017 ANN REP CAUS DA; Thatcher A. R., 1998, FORCE MORTALITY AGES; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; Yang S, 2010, AM J PUBLIC HEALTH, V100, P896, DOI 10.2105/AJPH.2009.160341	17	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244380	10.1371/journal.pone.0244380	http://dx.doi.org/10.1371/journal.pone.0244380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347505	Green Published, gold			2022-12-27	WOS:000603071100064
J	Millard, AR; Annis, RG; Caffell, AC; Dodd, LL; Fischer, R; Gerrard, CM; Graves, CP; Hendy, J; Mackenzie, L; Montgomery, J; Nowell, GM; Radini, A; Beaumont, J; Koon, HEC; Speller, CF				Millard, Andrew R.; Annis, Richard G.; Caffell, Anwen C.; Dodd, Laura L.; Fischer, Roman; Gerrard, Christopher M.; Graves, C. Pamela; Hendy, Jessica; Mackenzie, Lisa; Montgomery, Janet; Nowell, Geoff M.; Radini, Anita; Beaumont, Julia; Koon, Hannah E. C.; Speller, Camilla F.			Scottish soldiers from the Battle of Dunbar 1650: A prosopographical approach to a skeletal assemblage	PLOS ONE			English	Article							HUMAN TOOTH ENAMEL; OSTEOLOGICAL PARADOX; PROTEOMIC ANALYSIS; COLLAGEN; PATHOGENS; MODEL	After the Battle Dunbar between English and Scottish forces in 1650, captured Scottish soldiers were imprisoned in Durham and many hundreds died there within a few weeks. The partial skeletal remains of 28 of these men were discovered in 2013. Building on previous osteological work, here we report wide-ranging scientific studies of the remains to address the following questions: Did they have comparable diet, health and disease throughout their lives? Did they have common histories of movement (or lack of movement) during their childhoods? Can we create a collective biography of these men? Strontium and oxygen isotope analysis of tooth enamel investigated childhood movement. Carbon and nitrogen isotope analysis of incrementally sampled dentine addressed childhood diet and nutrition. Metaproteomic analysis of dental calculus investigated oral microbiomes and food residues; this was complemented by microscopic analysis of debris in calculus from ingested materials. Selected individuals were examined for dental microwear. The extent of hydroxylation of proline in collagen was examined as a potential biomarker for scurvy. An osteobiography for each man was created using the full range of data generated about him, and these were synthesised using an approach based on the historical method for a collective biography or prosopography. The childhood residences of the men were primarily within the Midland Valley of Scotland, though some spent parts of their childhood outside the British Isles. This is concordant with the known recruitment areas of the Scottish army in 1650. Their diets included oats, brassicas and milk but little seafood, as expected for lowland rather than highland diets of the period. Childhood periods of starvation or illness were almost ubiquitous, but not simultaneous, suggesting regionally variable food shortages in the 1620s and 1630s. It is likely there was widespread low-level scurvy, ameliorating in later years of life, which suggests historically unrecorded shortages of fruit and vegetables in the early 1640s. Almost all men were exposed to burnt plant matter, probably as inhaled soot, and this may relate to the high proportion of them with of sinusitis. Interpersonal violence causing skeletal trauma was rare. Based on commonalities in their osteobiographies, we argue that these men were drawn from the same stratum of society. This study is perhaps the most extensive to date of individuals from 17(th) century Scotland. Combined with a precise historical context it allows the lives of these men to be investigated and compared to the historical record with unprecedented precision. It illustrates the power of archaeological science methods to confirm, challenge and complement historical evidence.	[Millard, Andrew R.; Caffell, Anwen C.; Dodd, Laura L.; Gerrard, Christopher M.; Graves, C. Pamela; Montgomery, Janet] Univ Durham, Dept Archaeol, Durham, England; [Annis, Richard G.] Univ Durham, Archaeol Serv, Durham, England; [Dodd, Laura L.] KDK Archaeol Ltd, Leighton Buzzard, England; [Fischer, Roman] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Oxford, England; [Hendy, Jessica; Mackenzie, Lisa; Radini, Anita] Univ York, Dept Archaeol, York, N Yorkshire, England; [Nowell, Geoff M.] Univ Durham, Dept Earth Sci, Durham, England; [Beaumont, Julia; Koon, Hannah E. C.] Univ Bradford, Sch Archaeol & Forens Sci, Bradford, W Yorkshire, England; [Speller, Camilla F.] Univ British Columbia, Dept Anthropol, Vancouver, BC, Canada	Durham University; Durham University; University of Oxford; University of York - UK; Durham University; University of Bradford; University of British Columbia	Millard, AR (corresponding author), Univ Durham, Dept Archaeol, Durham, England.	a.r.millard@durham.ac.uk	Speller, Camilla/GLV-4769-2022; Fischer, Roman/N-4408-2017; Millard, Andrew/AAE-5302-2022	Fischer, Roman/0000-0002-9715-5951; Millard, Andrew/0000-0002-8290-7428; MacKenzie, Lisa/0000-0001-9780-5435; Gerrard, Christopher/0000-0002-7001-1800; koon, hannah/0000-0002-6849-2676	Durham University; Wellcome Trust [108375/Z/15/Z]	Durham University; Wellcome Trust(Wellcome Trust)	The excavation and post-excavation programme was primarily funded by Durham University, with the palaeoproteomic analysis funded through the Wellcome Trust www.wellcome.ac.uk (108375/Z/15/Z to CFS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WC, 1937, WRITINGS SPEECHES OL; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; [Anonymous], 2000, CAD USER AEC MAGAZIN, V13, P3; [Anonymous], 2019, AESTHET SURG J S1, V38, pS1; [Anonymous], 1762, COLLECTED JOURNALS B, P1762; [Anonymous], 2000, HIST COMPUTING; Baliban RC, 2012, J CLIN PERIODONTOL, V39, P203, DOI 10.1111/j.1600-051X.2011.01805.x; Beaumont J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160065; BERG RA, 1973, BIOCHEM BIOPH RES CO, V52, P115, DOI 10.1016/0006-291X(73)90961-3; Bostanci N, 2010, J PROTEOME RES, V9, P2191, DOI 10.1021/pr900941z; Bothelo E, 2006, J CLIN MICROBIOL, V44, P657, DOI 10.1128/JCM.44.2.657-658.2006; Boutin AT, 2016, INT J PALEOPATHOL, V12, P17, DOI 10.1016/j.ijpp.2015.10.005; Brereton W., 1844, JOURNEY DURHAM NORTH; Brickley M, 2008, BIOARCHAEOLOGY OF METABOLIC BONE DISEASE, P1, DOI 10.1016/B978-0-12-370486-3.00001-9; British Library, BRIT LIB; Brown KM, 2007, RECORDS PARLIAMENTS; Caffell A, 2014, PALACE GREEN LIB EXC; Curtis-Summers S, 2014, MEDIEV ARCHAEOL, V58, P21, DOI 10.1179/0076609714Z.00000000030; Darling WG, 2003, HYDROL EARTH SYST SC, V7, P183, DOI 10.5194/hess-7-183-2003; DeWitte SN, 2015, J ARCHAEOL RES, V23, P397, DOI 10.1007/s10814-015-9084-1; Dingwall H.M., 2010, HIST EVERYDAY LIFE S, P108; Evans JA, 2012, J ANAL ATOM SPECTROM, V27, P754, DOI 10.1039/c2ja10362a; Evans JA, 2010, J GEOL SOC LONDON, V167, P1, DOI 10.1144/0016-76492009-090; Faccia KJ, 2008, INT J OSTEOARCHAEOL, V18, P28, DOI 10.1002/oa.924; Farrell M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184354; Firth C. H., 1911, ACTS ORDINANCES INTE; Firth CH, 1900, T ROYAL HIST SOC, V14, P19; Furgol EM, 1990, REGIMENTAL HIST COVE; Gerrard C, 2018, LOST LIVES NEW VOICE; Gibson A, 2005, SCOTTISH SOC 1500 18, P59; Gibson A, 1989, SCOTTISH SOC 1500 18, P59; Glendor U., 2007, TXB COLOR ATLAS TRAU, P217; Grant MM, 2010, J PROTEOME RES, V9, P4732, DOI 10.1021/pr100446f; Grosjean A, 2005, SCOTTISH COMMUNITIES; Hendy J, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0977; Hosek Lauren, 2019, Bioarchaeol Int, V3, P1, DOI 10.5744/bi.2019.1005; Howard Deborah., 1995, SCOTTISH ARCHITECTUR; Johnston A, 2019, ESSENTIAL AGONY BATT; Keats-Rohan KSB, 2007, PROSOPOGRAPHY APPROA, P1; Koon HEC, 2012, AM J PHYS ANTHROPOL, V147, P184; Koon HEC, 2013, EXPLORING ATLANTIC T, P57; Lewis ME, 2004, INT J OSTEOARCHAEOL, V14, P82, DOI 10.1002/oa.713; Longstaffe WHD, 1867, MEMOIRS LIFE AMBROSE; Macdonald HM, 2011, OSTEOPOROSIS INT, V22, P2461, DOI 10.1007/s00198-010-1467-z; Mays S, 2018, J ARCHAEOL SCI-REP, V20, P692, DOI 10.1016/j.jasrep.2018.06.008; McIlvaine BK, 2015, INT J OSTEOARCHAEOL, V25, P997, DOI 10.1002/oa.2383; McKean C, 2011, HIST EVERYDAY LIFE S, P51; Millard AR, 2015, PALACE GREEN LIB EXC; Montgomery H, 2012, J PROTEOME RES, V11, P5890, DOI 10.1021/pr300656r; PETERKOFSKY B, 1991, American Journal of Clinical Nutrition, V54, p1135S, DOI 10.1093/ajcn/54.6.1135s; Raine J, 1845, DESCRIPTION BREIFE D; RAMACHAN.GN, 1973, BIOCHIM BIOPHYS ACTA, V322, P166, DOI 10.1016/0005-2795(73)90187-6; Reese P, 2006, CROMWELLS MASTERSTRO; Reid S, 2004, DUNBAR 1650 CROMWELL; Robba John, 2019, Bioarchaeol Int, V3, P58, DOI 10.5744/bi.2019.1008; Scott WK, 1806, ORIGINAL MEMOIRS WRI; Slinn S., 2017, ED ANGLICAN CLERGY 1; Smout TC, 1977, COMP ASPECTS SCOTTIS, P21; Snoeck C, 2020, SCI TOTAL ENVIRON, V712, DOI 10.1016/j.scitotenv.2019.136248; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; STONE L, 1971, DAEDALUS-US, V100, P46; Symes R, 1939, ROMAN REVOLUTION; Symonds DA, 2010, HIST EVERYDAY LIFE S, P83; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tarlow S., 2002, THINKING BODY ARCHAE, P153; Valtuena J, 2013, J NUTR SCI VITAMINOL, V59, P161; Verboven Koenraad., 2007, PROSOPOGRAPHY APPROA; Colombo APV, 2016, MICROB PATHOGENESIS, V94, P27, DOI 10.1016/j.micpath.2015.09.009; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; Whatley CA, 2010, HIST EVERYDAY LIFE S, P273; Whyte I., 1979, AGR SOC 17 CENTURY S; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1	74	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243369	10.1371/journal.pone.0243369	http://dx.doi.org/10.1371/journal.pone.0243369			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347451	Green Published, Green Accepted, gold			2022-12-27	WOS:000603071100029
J	White, CJM; Norenzayan, A; Schaller, M				White, Cindel J. M.; Norenzayan, Ara; Schaller, Mark			How strongly do moral character inferences predict forecasts of the future? Testing the moderating roles of transgressor age, implicit personality theories, and belief in karma	PLOS ONE			English	Article							ATTRIBUTION; EVOLUTION; WORLD; SELF	Three studies (total N = 1486) investigated how inferences about a person's current moral character guide forecasts about that person's future moral character and future misfortunes, and tested several plausible moderating variables. Inferences about current moral character related (very strongly) to forecasts about future moral character and also (less strongly) to forecasts about future misfortunes. These relationships were moderated by two variables: Relations between inferences and forecasts were somewhat weaker when perceivers made judgments about children, compared to judgments about adults, and relations between character inferences and forecasts about misfortunes were somewhat stronger among perceivers who more strongly believed in karma. In contrast, results provided no evidence of any moderating effects due to perceivers' beliefs about the stability of moral dispositions (i.e., implicit personality theories). These results show how dispositional inferences, moral judgments, and beliefs about karmic justice interact to shape forecasts about the future.	[White, Cindel J. M.; Norenzayan, Ara; Schaller, Mark] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	White, CJM (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	cwhite@psych.ubc.ca			Social Sciences and Humanities Research Council of Canada [435-2012-0519]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was funded by an Insight grant from the Social Sciences and Humanities Research Council of Canada to M.S. (435-2012-0519). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DL, 2013, PSYCHOL SCI, V24, P1755, DOI 10.1177/0956797613480507; Andrews PW, 2001, EVOL HUM BEHAV, V22, P11, DOI 10.1016/S1090-5138(00)00059-3; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Callan MJ, 2014, ADV EXP SOC PSYCHOL, V49, P105, DOI 10.1016/B978-0-12-800052-6.00002-0; Campbell AN, 2013, ORG PROCESS RES DEV, V17, P273, DOI 10.1021/op300344m; Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P923, DOI 10.1037/0022-3514.73.5.923; Choi I, 1999, PSYCHOL BULL, V125, P47, DOI 10.1037/0033-2909.125.1.47; Costabile KA, 2019, PERS SOC PSYCHOL B, V45, P557, DOI 10.1177/0146167218789624; DWECK CS, 1995, PSYCHOL INQ, V6, P267, DOI 10.1207/s15327965pli0604_1; ERDLEY CA, 1993, CHILD DEV, V64, P863, DOI 10.2307/1131223; Goodwin GP, 2014, J PERS SOC PSYCHOL, V106, P148, DOI 10.1037/a0034726; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Hafer CL, 2015, ADV EXP SOC PSYCHOL, V51, P41, DOI 10.1016/bs.aesp.2014.09.001; Haselton M. G., 2006, EVOLUTION SOCIAL PSY, P15, DOI [DOI 10.4324/9780203782965, 10.4324/9780203782965]; Heiphetz L, 2017, COGNITIVE SCI, V41, P744, DOI 10.1111/cogs.12354; Hughes JS, 2015, PERS INDIV DIFFER, V86, P195, DOI 10.1016/j.paid.2015.05.042; Humphrey N, 1976, GROWING POINTS ETHOL; JONES EE, 1979, AM PSYCHOL, V34, P107, DOI 10.1037/0003-066X.34.2.107; Khamitov M, 2016, COGNITION, V146, P33, DOI 10.1016/j.cognition.2015.09.009; Klein N, 2017, J PERS SOC PSYCHOL, V113, P210, DOI 10.1037/pspa0000088; Klein N, 2015, BASIC APPL SOC PSYCH, V37, P348, DOI 10.1080/01973533.2015.1111213; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P875, DOI 10.1177/1948550617693058; Lerner M., 1980, BELIEF JUST WORLD FU, DOI DOI 10.1007/978-1-4899-0448-5; Lindzey G., 1998, HDB SOCIAL PSYCHOL, V4th ed., P89; Lipkus IM, 1996, PERS SOC PSYCHOL B, V22, P666, DOI 10.1177/0146167296227002; Miller CH, 2007, SOC COGNITION, V25, P819, DOI 10.1521/soco.2007.25.6.819; Mumtaz F, 2016, IEEE T SUSTAIN ENERG, V7, P493, DOI 10.1109/TSTE.2015.2502482; Norenzayan A, 2002, PERS SOC PSYCHOL B, V28, P109, DOI 10.1177/0146167202281010; Rutledge EL, 2018, PERS INDIV DIFFER, V128, P113, DOI 10.1016/j.paid.2018.02.021; Schaller M., 2008, 1 IMPRESSIONS, P15; Siegel JZ, 2018, NAT HUM BEHAV, V2, P750, DOI 10.1038/s41562-018-0425-1; Stellar JE, 2018, J PERS SOC PSYCHOL, V114, P195, DOI 10.1037/pspa0000097; Strohminger N, 2017, PERSPECT PSYCHOL SCI, V12, P551, DOI 10.1177/1745691616689495; The Research Group, 2006, SOCIAL SCI FRONT, V3, P81; Trope Y., 2007, SAGE HDB SOCIAL PSYC, P176; Uhlmann EL, 2015, PERSPECT PSYCHOL SCI, V10, P72, DOI 10.1177/1745691614556679; White CJM, 2019, PERS SOC PSYCHOL B, V45, P1184, DOI 10.1177/0146167218808502; White CJM, 2018, PERS SOC PSYCHOL B, V44, P1147, DOI 10.1177/0146167218760800; White CJM, 2019, ADV EXPT SOCIAL PSYC	39	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244144	10.1371/journal.pone.0244144	http://dx.doi.org/10.1371/journal.pone.0244144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347513	Green Submitted, Green Published, gold			2022-12-27	WOS:000603071100052
J	Ykema, BLM; Hoefnagel, SJM; Rigter, LS; Kodach, LL; Meijer, GA; van Leeuwen, FE; Khan, HN; Snaebjornsson, P; Aleman, BMP; Broeks, A; Meijer, SL; Wang, KK; Carvalho, B; Krishnadath, KK; van Leerdam, ME				Ykema, Berbel L. M.; Hoefnagel, Sanne J. M.; Rigter, Lisanne S.; Kodach, Liudmila L.; Meijer, Gerrit A.; van Leeuwen, Flora E.; Khan, Hina N.; Snaebjornsson, Petur; Aleman, Berthe M. P.; Broeks, Annegien; Meijer, Sybren L.; Wang, Kenneth K.; Carvalho, Beatriz; Krishnadath, Kausilia K.; van Leerdam, Monique E.		GIOCA-OES	Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases	PLOS ONE			English	Article							FIELD CANCERIZATION; MISMATCH REPAIR; RADIATION; RISK; TUMORS	Hodgkin lymphoma (HL) survivors are at increased risk of developing second primary esophageal squamous cell cancer (ESCC). We aimed to gain insight in the driving events of ESCC in HL survivors (hESCC) by using RNA sequencing and NanoString profiling. Objectives were to investigate differences in RNA signaling between hESCC and sporadic ESCC (sESCC), and to look for early malignant changes in non-neoplastic esophageal tissue of HL survivors (hNN-tissue). We analyzed material of 26 hESCC cases, identified via the Dutch pathology registry (PALGA) and 17 sESCC cases from one academic institute and RNA sequencing data of 44 sESCC cases from TCGA. Gene expression profiles for the NanoString panel PanCancer IO 360 were obtained from 16/26 hESCC and four hNN-tissue, while non-neoplastic squamous tissue of four sporadic cases (sNN-tissue) served as reference profile. Hierarchical clustering, differential expression and pathway analyses were performed. Overall, the molecular profiles of hESCC and sESCC were similar. There was increased immune, HMGB1 and ILK signaling compared to sNN-tissue. The profiles of hNN-tissue were distinct from sNN-tissue, indicating early field effects in the esophagus of HL survivors. The BRCA1 pathway was upregulated in hESCC tissue, compared to hNN tissue. Analysis of expression profiles reveals overlap between hESCC and sESCC, and differences between hESCC and its surrounding hNN-tissue. Further research is required to validate our results and to investigate whether the changes observed in hNN-tissue are already detectable before development of hESCC. In the future, our findings could be used to improve hESCC patient management.	[Ykema, Berbel L. M.; Rigter, Lisanne S.; van Leerdam, Monique E.] Netherlands Canc Inst, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Hoefnagel, Sanne J. M.; Krishnadath, Kausilia K.] Amsterdam UMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Hoefnagel, Sanne J. M.; Khan, Hina N.; Krishnadath, Kausilia K.] Amsterdam UMC, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Kodach, Liudmila L.; Meijer, Gerrit A.; Snaebjornsson, Petur; Carvalho, Beatriz] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Aleman, Berthe M. P.] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands; [Broeks, Annegien] Netherlands Canc Inst, Div Mol Pathol, Core Facil Mol Pathol & Biobanking, Amsterdam, Netherlands; [Meijer, Sybren L.] Amsterdam UMC, Dept Pathol, Amsterdam, Netherlands; [Wang, Kenneth K.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [van Leerdam, Monique E.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands	Netherlands Cancer Institute; University of Amsterdam; University of Amsterdam; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Mayo Clinic; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Leerdam, ME (corresponding author), Netherlands Canc Inst, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands.; van Leerdam, ME (corresponding author), Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands.	m.v.leerdam@nki.nl	Carvalho, Beatriz/GXA-0720-2022; Ykema, Berbel/AAG-4828-2021; van Leerdam, Monique/AAV-9185-2020	Ykema, Berbel/0000-0002-0314-7986; van Leerdam, Monique/0000-0002-5719-3208; van Laarhoven, H.W.M./0000-0003-1274-5643; van Berge Henegouwen, Mark/0000-0001-8689-3134; Meijer, Gerrit/0000-0003-0330-3130; Gisbertz, Suzanne/0000-0001-9655-7601				Abnet CC, 2018, GASTROENTEROLOGY, V154, P360, DOI 10.1053/j.gastro.2017.08.023; Aebi S, 1996, CANCER RES, V56, P3087; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; [Anonymous], **DATA OBJECT**; Antoniali G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00842-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boldrin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117070; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Broeks A, 2010, INT J RADIAT ONCOL, V76, P540, DOI 10.1016/j.ijrobp.2009.09.004; Brown University, 2017, NATURE, V541, P169, DOI [DOI 10.1038/NATURE20805, 10.1038/nature20805]; Casparie M, 2007, CELL ONCOL, V29, P19; Cheng CX, 2016, AM J HUM GENET, V98, P256, DOI 10.1016/j.ajhg.2015.12.013; Danaher P, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0367-1; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gonin-Laurent N, 2006, CARCINOGENESIS, V27, P1266, DOI 10.1093/carcin/bgi356; Hadj-Hamou NS, 2011, CARCINOGENESIS, V32, P929, DOI 10.1093/carcin/bgr064; Hodgson DC, 2007, J CLIN ONCOL, V25, P1489, DOI 10.1200/JCO.2006.09.0936; Journy N, 2019, RADIOTHER ONCOL, V131, P150, DOI 10.1016/j.radonc.2018.09.017; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Little JB, 2000, CARCINOGENESIS, V21, P397, DOI 10.1093/carcin/21.3.397; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Morton LM, 2014, HAEMATOLOGICA, V99, pE193, DOI 10.3324/haematol.2014.108258; Pich O, 2019, NAT GENET, V51, P1732, DOI 10.1038/s41588-019-0525-5; Rigter LS, 2019, CANCER MED-US, V8, P190, DOI 10.1002/cam4.1922; Rigter LS, 2018, GUT, V67, P447, DOI 10.1136/gutjnl-2016-312608; Sawada G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139808; Schaapveld M, 2015, NEW ENGL J MED, V373, P2499, DOI 10.1056/NEJMoa1505949; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Speranza E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15145-7; Swerdlow AJ, 2011, J CLIN ONCOL, V29, P4096, DOI 10.1200/JCO.2011.34.8268; Tokairin Y, 2006, INT J EXP PATHOL, V87, P89, DOI 10.1111/j.0959-9673.2006.00464.x; Tsang HF, 2017, EXPERT REV MOL DIAGN, V17, P95, DOI 10.1080/14737159.2017.1268533; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Wang H, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw677; Weiss MM, 2003, J PATHOL, V199, P157, DOI 10.1002/path.1260; West CM, 2011, GENOME MED, V3, DOI 10.1186/gm268; Zeki SS, 2011, DISCOV MED, V12, P371	37	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243178	10.1371/journal.pone.0243178	http://dx.doi.org/10.1371/journal.pone.0243178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347497	Green Published, gold			2022-12-27	WOS:000603071100062
J	Jamshidi, S; Yadollahi, A; Arab, MM; Soltani, M; Eftekhari, M; Shiri, J				Jamshidi, Saeid; Yadollahi, Abbas; Arab, Mohammad Mehdi; Soltani, Mohammad; Eftekhari, Maliheh; Shiri, Jalal			High throughput mathematical modeling and multi-objective evolutionary algorithms for plant tissue culture media formulation: Case study of pear rootstocks	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; ARTIFICIAL NEURAL-NETWORK; SURFACE METHODOLOGY RSM; REFERENCE EVAPOTRANSPIRATION; INORGANIC NITROGEN; GEP MODEL; TREE; MICROPROPAGATION; PROLIFERATION; GROWTH	Simplified prediction of the interactions of plant tissue culture media components is of critical importance to efficient development and optimization of new media. We applied two algorithms, gene expression programming (GEP) and M5' model tree, to predict the effects of media components on in vitro proliferation rate (PR), shoot length (SL), shoot tip necrosis (STN), vitrification (Vitri) and quality index (QI) in pear rootstocks (Pyrodwarf and OHF 69). In order to optimize the selected prediction models, as well as achieving a precise multi-optimization method, multi-objective evolutionary optimization algorithms using genetic algorithm (GA) and particle swarm optimization (PSO) techniques were compared to the mono-objective GA optimization technique. A Gamma test (GT) was used to find the most important determinant input for optimizing each output factor. GEP had a higher prediction accuracy than M5' model tree. GT results showed that BA (Gamma = 4.0178), Mesos (Gamma = 0.5482), Mesos (Gamma = 184.0100), Micros (Gamma = 136.6100) and Mesos (Gamma = 1.1146), for PR, SL, STN, Vitri and QI respectively, were the most important factors in culturing OHF 69, while for Pyrodwarf culture, BA (Gamma = 10.2920), Micros (Gamma = 0.7874), NH4NO3 (Gamma = 166.410), KNO3 (Gamma = 168.4400), and Mesos (Gamma = 1.4860) were the most important influences on PR, SL, STN, Vitri and QI respectively. The PSO optimized GEP models produced the best outputs for both rootstocks.	[Jamshidi, Saeid; Yadollahi, Abbas; Arab, Mohammad Mehdi; Eftekhari, Maliheh] Tarbiat Modares Univ TMU, Dept Hort Sci, Fac Agr, Tehran, Iran; [Arab, Mohammad Mehdi] Univ Tehran UT, Dept Hort Sci, Coll Aburaihan, Tehran, Iran; [Soltani, Mohammad] Univ Tehran, Dept Irrigat & Drainage Engn, Coll Aburaihan, Tehran, Iran; [Shiri, Jalal] Univ Tabriz, Dept Water Engn, Fac Agr, Tabriz, Iran	Tarbiat Modares University; University of Tehran; University of Tabriz	Yadollahi, A (corresponding author), Tarbiat Modares Univ TMU, Dept Hort Sci, Fac Agr, Tehran, Iran.	yadollah@modares.ac.ir	Soltani, Mohammad/CAF-8113-2022		Tarbiat Modares University Technological Research Core [IG-461 39806]	Tarbiat Modares University Technological Research Core	This work was supported by the Tarbiat Modares University Technological Research Core [grant number IG-461 39806].	Ali I, 2018, J MOL LIQ, V250, P1, DOI 10.1016/j.molliq.2017.11.163; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2006, GENE EXPRESSION PROG; Arab MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01853; Arab MM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01526; Arab MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27858-4; Aygun A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00225; Bajaj YPS., 1986, BIOTECHNOLOGY AGR FO; Banzhaf W, 1998, GEN PROGR 1 EUR WORK, V1; Baviera JA, 1988, 5 INT S PEAR GROW, V256, P63; Behnood A, 2015, CONSTR BUILD MATER, V94, P137, DOI 10.1016/j.conbuildmat.2015.06.055; Benali L, 2019, RENEW ENERG, V132, P871, DOI 10.1016/j.renene.2018.08.044; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Bhowmik S, 2019, FUEL, V235, P317, DOI 10.1016/j.fuel.2018.07.116; Bilgili M, 2010, METEOROL ATMOS PHYS, V110, P59, DOI 10.1007/s00703-010-0104-x; Burgac A, 2019, ENERGY, V170, P1202, DOI 10.1016/j.energy.2018.12.090; Cassells AC., 2011, PLANT TISSUE CULT DE, V378, P223; Damiano C., 2009, Italus Hortus, V16, P113; Dey P, 2016, ENERGY, V95, P447, DOI 10.1016/j.energy.2015.12.021; Dikmen E, 2015, NEURAL COMPUT APPL, V26, P409, DOI 10.1007/s00521-014-1723-9; Durillo JJ, 2010, IEEE T EVOLUT COMPUT, V14, P618, DOI 10.1109/TEVC.2009.2034647; Eftekhari M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00837; Emamipour N, 2019, APPL MICROBIOL BIOT, P1; Esha R, 2020, ECOHYDROLOGY, V13, DOI 10.1002/eco.2242; Etemad-Shahidi A, 2012, J HYDRAUL ENG, V138, P542, DOI 10.1061/(ASCE)HY.1943-7900.0000550; Evans D, 2002, P ROY SOC A-MATH PHY, V458, P2759, DOI 10.1098/rspa.2002.1010; Ferreira C., 2001, Complex Systems, V13, P87; Ferreira C., 2001, CS0102027 ARXIV; Gago J, 2010, J PLANT PHYSIOL, V167, P23, DOI 10.1016/j.jplph.2009.07.007; Gago J, 2010, VITIS VINIFERA, P241; Gago J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085989; Gago J, 2011, J PLANT PHYSIOL, V168, P1858, DOI 10.1016/j.jplph.2011.04.008; Gallego PP, 2011, ARTIFICIAL NEURAL NETWORKS - METHODOLOGICAL ADVANCES AND BIOMEDICAL APPLICATIONS, P197; Gandomi AH, 2012, NEURAL COMPUT APPL, V21, P171, DOI 10.1007/s00521-011-0734-z; Gandomi AH, 2010, J MECH MATER STRUCT, V5, P735, DOI 10.2140/jomms.2010.5.735; Garcia-Nieto PJ, 2019, ECOL ENG, V130, P198, DOI 10.1016/j.ecoleng.2019.02.020; Ghaedrahmat Z, 2019, ENVIRON SCI POLLUT R, P1; Goldberg D. E., 1989, COMPLEX SYST, V3, P493, DOI DOI 10.1007/978-1-4757-3643-4; Grigoriadou K, 1998, 25 INT HORT C 10, V520, P103; Hashemi SH, 2019, ANALYST, V144, P3525, DOI [10.1039/c9an00165d, 10.1039/C9AN00165D]; Hong T, 2018, APPL ENERG, V228, P808, DOI 10.1016/j.apenergy.2018.06.106; Huang SM, 2017, ULTRASON SONOCHEM, V36, P112, DOI 10.1016/j.ultsonch.2016.11.016; Ikinci A, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-71; Ivanova M, 2009, PLANT CELL TISS ORG, V99, P167, DOI 10.1007/s11240-009-9589-8; Jacob H. B., 1997, ISHS ACTA HORT, V475, P169; Jamshidi S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00274; Jamshidi S, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0520-y; Janani P, 2020, CURR J APPL SCI TECH, P1; Kadota M, 2003, PLANT CELL TISS ORG, V72, P261, DOI 10.1023/A:1022378511659; Karimaldini F, 2012, J IRRIG DRAIN ENG, V138, P21, DOI 10.1061/(ASCE)IR.1943-4774.0000343; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Kumar A, 2019, WATER RESOUR MANAG, V33, P1217, DOI 10.1007/s11269-018-2178-z; Leon LP, 2019, CONSTR BUILD MATER, V211, P470, DOI 10.1016/j.conbuildmat.2019.03.225; Li LJ, 2019, APPL SOFT COMPUT, V81, DOI 10.1016/j.asoc.2019.105490; Lotfi M, 2019, PLANT GROWTH REGUL, V88, P173, DOI 10.1007/s10725-019-00498-y; Lv L, 2019, FUTURE GENER COMP SY, V91, P37, DOI 10.1016/j.future.2018.07.047; Malik A, 2018, J IRRIG DRAIN ENG, V144, DOI [10.1061/(ASCE)IR.1943-4774.0001336, 10.1061/(asce)ir.1943-4774.0001336]; Mansseri-Lamrioui A, 2009, EFFECT MEDIUM CULTUR; Maran JP, 2013, CARBOHYD POLYM, V92, P604, DOI 10.1016/j.carbpol.2012.09.020; Mazhar S, 2019, CHEMOSPHERE, V227, P256, DOI 10.1016/j.chemosphere.2019.04.022; Micieli D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38903-1; Antonio LM, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P2758; Mirjalili S, 2019, STUD COMPUT INTELL, V780, P43, DOI 10.1007/978-3-319-93025-1_4; Moghaddamnia A, 2009, J ATMOS SOL-TERR PHY, V71, P975, DOI 10.1016/j.jastp.2009.04.009; MURASHIGE T, 1974, ANNU REV PLANT PHYS, V25, P135, DOI 10.1146/annurev.pp.25.060174.001031; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nas MN, 2004, SCI HORTIC-AMSTERDAM, V101, P189, DOI 10.1016/j.scienta.2003.10.004; Nazari A, 2019, NEURAL COMPUT APPL, V31, P767, DOI 10.1007/s00521-012-1137-5; Nazari A, 2013, NEURAL COMPUT APPL, V23, P1677, DOI 10.1007/s00521-012-1127-7; Niedz RP, 2007, IN VITRO CELL DEV-PL, V43, P370, DOI 10.1007/s11627-007-9062-5; Niu WJ, 2018, APPL SOFT COMPUT, V70, P562, DOI 10.1016/j.asoc.2018.06.011; Nowak B, 2007, ACTA PHYSIOL PLANT, V29, P479, DOI 10.1007/s11738-007-0058-x; Oliveira V, 2019, J CLEAN PROD, V210, P401, DOI 10.1016/j.jclepro.2018.11.063; Pal M, 2009, HYDROL PROCESS, V23, P1437, DOI 10.1002/hyp.7266; Petri C, 2010, ANN APPL BIOL, V156, P79, DOI 10.1111/j.1744-7348.2009.00364.x; Pilkington JL, 2014, IND CROP PROD, V58, P15, DOI 10.1016/j.indcrop.2014.03.016; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; Rahimikhoob A, 2013, WATER RESOUR MANAG, V27, P4815, DOI 10.1007/s11269-013-0440-y; Ramage CM, 2002, IN VITRO CELL DEV-PL, V38, P116, DOI [10.1079/IVP2002269, 10.1079/IVP2001269]; Reed BM, 2013, IN VITRO CELL DEV-PL, V49, P343, DOI [10.1007/s11627-013-9556-2, 10.1007/s11627-013-9504-1]; Remesan R, 2008, HYDROL PROCESS, V22, P4301, DOI 10.1002/hyp.7044; Roy S, 2015, APPL ENERG, V140, P52, DOI 10.1016/j.apenergy.2014.11.065; Rui D, 2011, ROM BIOTECH LETT, V16, P6631; Sedghi M, 2012, BRAZ J POULTRY SCI, V14, P57, DOI 10.1590/S1516-635X2012000100010; Shirdel M, 2011, J MED PLANTS RES, V5, P4605; Shiri J, 2014, COMPUT ELECTRON AGR, V108, P230, DOI 10.1016/j.compag.2014.08.007; Shiri J, 2012, J HYDROL, V414, P302, DOI 10.1016/j.jhydrol.2011.11.004; Stefansson A, 1997, NEURAL COMPUT APPL, V5, P131, DOI 10.1007/BF01413858; Thakur A, 2008, NOT BOT HORTI AGROBO, V36, P104; Wada S, 2015, IN VITRO CELL DEV-PL, V51, P19, DOI 10.1007/s11627-015-9662-4; Wada S, 2013, IN VITRO CELL DEV-PL, V49, P356, DOI 10.1007/s11627-013-9508-x; Wang Y, 1997, P EUR C MACH LEARN; Zhong JH, 2017, IEEE COMPUT INTELL M, V12, P54, DOI 10.1109/MCI.2017.2708618; Zou DX, 2019, APPL ENERG, V237, P646, DOI 10.1016/j.apenergy.2019.01.056	95	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243940	10.1371/journal.pone.0243940	http://dx.doi.org/10.1371/journal.pone.0243940			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338074	gold, Green Published			2022-12-27	WOS:000601313500001
J	Kathree, BA; Khan, SB; Ahmed, R; Maart, R; Layloo, N; Asia-Michaels, W				Kathree, Bashier Ahmed; Khan, Saadika B.; Ahmed, Rukshana; Maart, Ronel; Layloo, Nazreen; Asia-Michaels, Winifred			COVID-19 and its impact in the dental setting: A scoping review	PLOS ONE			English	Review							RECOMMENDATIONS; CARE	Introduction The scoping review examined the evidence related to infection control and transmission measures of the SARS-CoV-2 virus in a dental setting during this pandemic. Dental practitioners are normally guided in practice by set ethical principles, thus the researchers wanted to determine how these rules are managed during this pandemic. Methods A protocol specific for the objectives of this study was developed according to the criteria for a scoping review. Relevant databases (Pubmed, Scopus, Elsevier, Science Direct, Wiley), including online access to health/ dental organizations (World Health Organization/ American Dental Association), were searched to identify evidence which was restricted to the English language for the period 2015-2020. Predetermined eligibility criteria were applied, evidence was assessed and data extracted for each included article. Relevant outcomes assessed were: infection control measures, transmission of the SARS-CoV-2 virus, such as modes and sources of transmission and the ethical principles related to the dental setting with a focus on the COVID-19 pandemic. Results Searches yielded a total of 402 articles: 387 from electronic databases and 15 from other sources. Of these, 231 were unrelated to the objectives of the current scoping review. The full text of 69 studies was assessed for eligibility, of which 26 were finalized for inclusion following the objectives and inclusion criteria set for the scoping review. Most of the included articles were reviews, recommendations and guidelines for dentists. A narrative explanation of the pre-specified outcomes is reported for the 3 areas covered for this review. There is no clinical evidence available that can support the recommendations by individuals, dental organizations or health authorities related to the objectives of this review, but these may be considered as the much needed guidelines during the unprecedented COVID-19 pandemic. A different ethical framework is required during a pandemic and these must be informed by evidence.	[Kathree, Bashier Ahmed; Khan, Saadika B.; Ahmed, Rukshana; Maart, Ronel; Layloo, Nazreen; Asia-Michaels, Winifred] Univ Western Cape, Dept Restorat Dent, Fac Dent, Cape Town, South Africa	University of Limpopo; University of the Western Cape	Khan, SB (corresponding author), Univ Western Cape, Dept Restorat Dent, Fac Dent, Cape Town, South Africa.	skhan@uwc.ac.za						Alagl AS, 2019, MATERIALS, V12, DOI 10.3390/ma12132073; [Anonymous], 2020, GUID CONT PRACT ETH; [Anonymous], 2020, J CLIN ENDOCRINOL ME, V105, pe32; Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008; Bizzoca ME, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01301-5; Campisi G, 2020, MINERVA STOMATOL, V69, P251, DOI 10.23736/S0026-4970.20.04396-4; CDC, 1994, GUID PREV TRANSM MYC; Chisini LA, 2021, INT J PAEDIATR DENT, V31, P31, DOI 10.1111/ipd.12741; Chu DK, 2020, PHYS DISTANCING FACE; Dacic SD, 2020, J INFECT DEV COUNTR, V14, P1111, DOI 10.3855/jidc.13147; Ethics Subcommittee of the Council on Ethics Bylaws and Judicial Affairs, 2020, J Am Dent Assoc, V151, P377, DOI 10.1016/j.adaj.2020.03.038; Fini MB, 2020, ORAL ONCOL, V108, DOI 10.1016/j.oraloncology.2020.104821; Ge ZY, 2020, J ZHEJIANG UNIV-SC B, V21, P361, DOI 10.1631/jzus.B2010010; Giudice A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103399; Guo H, 2020, J DENT SCI, DOI [10.1016/j.jds.2020.02.002, DOI 10.1016/J.JDS.2020.02.00232296495]; Harkin DW, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1606; Huxtable R, 2020, BMC MED ETHICS, V21, DOI 10.1186/s12910-020-00478-2; Izzetti R, 2020, J DENT RES, V99, P1030, DOI 10.1177/0022034520920580; Jamal M, 2021, ORAL DIS, V27, P655, DOI 10.1111/odi.13431; Kamate SK, 2020, DENT MED PROBL, V57, P11, DOI 10.17219/dmp/119743; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Khalil H, 2016, WORLDV EVID-BASED NU, V13, P118, DOI 10.1111/wvn.12144; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Li RWK, 2004, BRIT DENT J, V197, P130, DOI 10.1038/sj.bdj.4811522; Lucaciu O, 2020, J DENT SCI, DOI [10.1016/j.jds.2020.04.012, DOI 10.1016/J.JDS.2020.04.01232837682]; Lundberg A, 2021, GERODONTOLOGY, V38, P174, DOI 10.1111/ger.12509; Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Murray M, 2010, INFECT CONT HOSP EP, V31, P1011, DOI 10.1086/656564; Panesar K, 2020, J ORAL MAXILLOFAC SU, P1, DOI [10.1016/j.joms.2019.11.003, DOI 10.1016/J.J0MS.2019.11.00331888859]; Papi P, 2021, ORAL DIS, V27, P723, DOI 10.1111/odi.13442; Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9; Poggio C, 2020, MATERIALS, V13, DOI 10.3390/ma13153244; Sabino-Silva R, 2020, CLIN ORAL INVEST, V24, P1619, DOI 10.1007/s00784-020-03248-x; Sfondrini MF, 2012, J APPL ORAL SCI, V20, P357, DOI 10.1590/S1678-77572012000300011; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Spagnuolo G, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062094; Stencel R, 2018, MATERIALS, V11, DOI 10.3390/ma11061031; Talla PK, 2020, QUINTESSENCE INT, V51, P672, DOI 10.3290/j.qi.a44920; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; Turkistani KA, 2020, AM J ORTHOD DENTOFAC, V158, P175, DOI 10.1016/j.ajodo.2020.04.016; WHO, 2020, RAT US PERS PROT EQ; WHO, 2020, RESP COMM SPREAD COV, DOI DOI 10.1017/DMP.2020.166; Wood Neil H, 2020, S. Afr. dent. j., V75, P172; World Health Organization, WHO2019NCOVHCWADVICE; World Health Organization, 2019, MIN REQ INF PREV CON; Zimmermann M, 2020, J CRANIO MAXILL SURG, V48, P521, DOI 10.1016/j.jcms.2020.03.011	47	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244352	10.1371/journal.pone.0244352	http://dx.doi.org/10.1371/journal.pone.0244352			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338073	gold, Green Published			2022-12-27	WOS:000601313500003
J	Alhubail, A; Sewify, M; Messenger, G; Masoetsa, R; Hussain, I; Nair, S; Tiss, A				Alhubail, Asma; Sewify, May; Messenger, Grace; Masoetsa, Richard; Hussain, Imtiaz; Nair, Shinu; Tiss, Ali			Microbiological profile of diabetic foot ulcers in Kuwait	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; LINEZOLID RESISTANCE; INFECTIONS; PREVALENCE; ISCHEMIA; DISEASE; RISK	Introduction Diabetic foot ulcers (DFU) and infection (DFI) are a major diabetes-related problem around the world due to the high prevalence of diabetes in the population. The aim of our study was to determine the microbiological profile of infected ulcers in patients attending Dasman Diabetes Institute (DDI) clinics in Kuwait and to analyze the distribution of microbial isolates according to wound grade, sex, age and diabetes control. Methods We collected and analyzed clinical data and samples from 513 diabetic patients with foot ulcers referred to our podiatry clinic at DDI from Jan 2011 till Dec 2017. Results We show a higher prevalence of DFU in men than in women, and a greater percentage of DFU occurred in men at an earlier age (p<0.05). Only about half of the DFU were clinically infected (49.3%) but 92% of DFU showed bacterial growth in the microbiological lab analysis. In addition, we isolated more monomicrobial (57.3%) than polymicrobial (34.8%) DFI and representing an average of 1.30 pathogens per patient. The presence of Gram-positive and Gram-negative strains was comparable between men and women regardless their age or glucose levels. Interestingly, more Gram-positive strains are present in ulcers without ischemia while more Gram-negative strains are present in ulcers with ischemia (p<0.05). While Staphylococcus aureus was common in infected ulcers without ischemia, Pseudomonas aeruginosa was predominant in ulcers with infection and ischemia, regardless of ulcer depth. Finally, a higher percentage of women has controlled HbA1c levels (19.41% versus 11.95% in men) and more women in this group displayed non-infected wounds (60.6% and 43.90% for women and men, respectively). Conclusion Our results provide an updated picture of the DFI patterns and antibiotics resistance in patients attending Dasman Diabetes Institute (DDI) clinics in Kuwait which might help in adopting the appropriate treatment of infected foot and improving clinical outcomes.	[Alhubail, Asma; Sewify, May; Messenger, Grace; Masoetsa, Richard; Hussain, Imtiaz; Nair, Shinu] Dasman Diabet Inst, Med Div, Kuwait, Kuwait; [Tiss, Ali] Dasman Diabet Inst, Biochem & Mol Biol Dept, Res Div, Kuwait, Kuwait		Tiss, A (corresponding author), Dasman Diabet Inst, Biochem & Mol Biol Dept, Res Div, Kuwait, Kuwait.	ali.tiss@dasmaninstitute.org	Tiss, Ali/L-6656-2019; Hussain, Imtiaz/GZA-6905-2022	Tiss, Ali/0000-0002-3024-5370; 				Abdulrazak A, 2005, J DIABETES COMPLICAT, V19, P138, DOI 10.1016/j.jdiacomp.2004.06.001; Al Benwan Khalifa, 2012, J Infect Public Health, V5, P1, DOI 10.1016/j.jiph.2011.07.004; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2017, EPICAST REP DIAB FOO, P1; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Armstrong DG, 1998, DIABETES CARE, V21, P855, DOI 10.2337/diacare.21.5.855; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Citron DM, 2007, J CLIN MICROBIOL, V45, P2819, DOI 10.1128/JCM.00551-07; Crouzet J, 2011, INT J INFECT DIS, V15, pE601, DOI 10.1016/j.ijid.2011.05.003; Dunyach-Remy C, 2016, TOXINS, V8, DOI 10.3390/toxins8070209; Ertugrul BM, 2017, J AM PODIAT MED ASSN, V107, P483, DOI 10.7547/15-167; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Gardiner M, 2017, PEERJ, V5, DOI 10.7717/peerj.3543; Hicks CW, 2016, ANN VASC SURG, V33, P149, DOI 10.1016/j.avsg.2015.11.025; *IDF, 2019, IDF DIABETES ATLAS, P1; Jia LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177916; Kinross P, 2017, EUROSURVEILLANCE, V22, P32, DOI 10.2807/1560-7917.ES.2017.22.44.16-00696; Lavery LA, 2003, DIABETES CARE, V26, P1435, DOI 10.2337/diacare.26.5.1435; LEVINE NS, 1976, J TRAUMA, V16, P89, DOI 10.1097/00005373-197602000-00002; Lipsky BA, 2004, CLIN INFECT DIS, V38, P17, DOI 10.1086/380449; Lipsky BA, 2012, CLIN INFECT DIS, V54, P132, DOI [10.1093/cid/cis346, DOI 10.1093/cid/cis346]; Lipsky BA, 2016, DIABETES-METAB RES, V32, P246, DOI 10.1002/dmrr.2739; Mendes JJ, 2012, DIABETES RES CLIN PR, V95, P153, DOI 10.1016/j.diabres.2011.10.001; Messenger G, 2018, DIABET FOOT ANKLE, V9, DOI 10.1080/2000625X.2018.1471927; Neves JM, 2019, INT J LOW EXTR WOUND, V18, P122, DOI 10.1177/1534734619839815; Patil SV, 2017, INT J RES MED SC, V5, P496, DOI [10.18203/2320-6012.ijrms20170139, DOI 10.18203/2320-6012.IJRMS20170139]; Pereira SG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01791; Prompers L, 2008, DIABETIC MED, V25, P700, DOI 10.1111/j.1464-5491.2008.02445.x; Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1; Rahim Fawad, 2016, J Ayub Med Coll Abbottabad, V28, P528; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Reiber GE, 2001, J REHABIL RES DEV, V38, P309; Saseedharan S, 2018, BRAZ J MICROBIOL, V49, P401, DOI 10.1016/j.bjm.2017.09.003; Shakil S, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-2; Shankar E M, 2005, Eur J Intern Med, V16, P567, DOI 10.1016/j.ejim.2005.06.016; Shanthi M, 2014, INDIAN J MED RES, V140, P546; Sotto A, 2010, DIABETOLOGIA, V53, P2249, DOI 10.1007/s00125-010-1828-3; Sugandhi P, 2014, INT J INNOV RES SCI, V3, P14688; Tascini C, 2011, DIABETES RES CLIN PR, V94, P133, DOI 10.1016/j.diabres.2011.07.017; Tiwari S, 2012, J INFECT DEV COUNTR, V6, P329, DOI 10.3855/jidc.1827; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Viswanathan V, 2019, INT J LOW EXTR WOUND, V18, P236, DOI 10.1177/1534734619853668; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104	44	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244306	10.1371/journal.pone.0244306	http://dx.doi.org/10.1371/journal.pone.0244306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378365	gold, Green Published			2022-12-27	WOS:000605651300068
J	King, WP; Amos, J; Azer, M; Baker, D; Bashir, R; Best, C; Bethke, E; Boppart, SA; Bralts, E; Corey, RM; Dietkus, R; Durack, G; Elbel, S; Elliott, G; Fava, J; Goldenfeld, N; Goldstein, MH; Hayes, C; Herndon, N; Jamison, S; Johnson, B; Johnson, H; Johnson, M; Kolaczynski, J; Lee, T; Maslov, S; McGregor, DJ; Milner, D; Moller, R; Mosley, J; Musser, A; Newberger, M; Null, D; O'Bryan, L; Oelze, M; O'Leary, J; Pagano, A; Philpott, M; Pianfetti, B; Pille, A; Pizzuto, L; Ricconi, B; Rubessa, M; Rylowicz, S; Shipley, C; Singer, AC; Stewart, B; Switzky, R; Tawfick, S; Wheeler, M; White, K; Widloski, EM; Wood, E; Wood, C; Wooldridge, AR				King, William P.; Amos, Jennifer; Azer, Magdi; Baker, Daniel; Bashir, Rashid; Best, Catherine; Bethke, Eliot; Boppart, Stephen A.; Bralts, Elisabeth; Corey, Ryan M.; Dietkus, Rachael; Durack, Gary; Elbel, Stefan; Elliott, Greg; Fava, Jake; Goldenfeld, Nigel; Goldstein, Molly H.; Hayes, Courtney; Herndon, Nicole; Jamison, Shandra; Johnson, Blake; Johnson, Harley; Johnson, Mark; Kolaczynski, John; Lee, Tonghun; Maslov, Sergei; McGregor, Davis J.; Milner, Derek; Moller, Ralf; Mosley, Jonathan; Musser, Andy; Newberger, Max; Null, David; O'Bryan, Lucas; Oelze, Michael; O'Leary, Jerry; Pagano, Alex; Philpott, Michael; Pianfetti, Brian; Pille, Alex; Pizzuto, Luca; Ricconi, Brian; Rubessa, Marcello; Rylowicz, Sam; Shipley, Clifford; Singer, Andrew C.; Stewart, Brian; Switzky, Rachel; Tawfick, Sameh; Wheeler, Matthew; White, Karen; Widloski, Evan M.; Wood, Eric; Wood, Charles; Wooldridge, Abigail R.			Emergency ventilator for COVID-19	PLOS ONE			English	Article							SMALL-WORLD; TRANSMISSION; PERFORMANCE; MODEL	The COVID-19 pandemic disrupted the world in 2020 by spreading at unprecedented rates and causing tens of thousands of fatalities within a few months. The number of deaths dramatically increased in regions where the number of patients in need of hospital care exceeded the availability of care. Many COVID-19 patients experience Acute Respiratory Distress Syndrome (ARDS), a condition that can be treated with mechanical ventilation. In response to the need for mechanical ventilators, designed and tested an emergency ventilator (EV) that can control a patient's peak inspiratory pressure (PIP) and breathing rate, while keeping a positive end expiratory pressure (PEEP). This article describes the rapid design, prototyping, and testing of the EV. The development process was enabled by rapid design iterations using additive manufacturing (AM). In the initial design phase, iterations between design, AM, and testing enabled a working prototype within one week. The designs of the 16 different components of the ventilator were locked by additively manufacturing and testing a total of 283 parts having parametrically varied dimensions. In the second stage, AM was used to produce 75 functional prototypes to support engineering evaluation and animal testing. The devices were tested over more than two million cycles. We also developed an electronic monitoring system and with automatic alarm to provide for safe operation, along with training materials and user guides. The final designs are available online under a free license. The designs have been transferred to more than 70 organizations in 15 countries. This project demonstrates the potential for ultra-fast product design, engineering, and testing of medical devices needed for COVID-19 emergency response.	[King, William P.; Amos, Jennifer; Bashir, Rashid; Best, Catherine; Bethke, Eliot; Boppart, Stephen A.; Corey, Ryan M.; Elbel, Stefan; Elliott, Greg; Goldenfeld, Nigel; Goldstein, Molly H.; Jamison, Shandra; Johnson, Blake; Johnson, Harley; Lee, Tonghun; Maslov, Sergei; McGregor, Davis J.; Milner, Derek; Moller, Ralf; Null, David; Oelze, Michael; Pagano, Alex; Philpott, Michael; Pianfetti, Brian; Singer, Andrew C.; Switzky, Rachel; Tawfick, Sameh; Widloski, Evan M.; Wood, Eric; Wooldridge, Abigail R.] Univ Illinois, Grainger Coll Engn, Urbana, IL 61801 USA; [King, William P.; Amos, Jennifer; Bashir, Rashid; Bethke, Eliot; Boppart, Stephen A.; Johnson, Mark; White, Karen] Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61801 USA; [Azer, Magdi] Univ Illinois, Appl Res Inst, Urbana, IL USA; [Baker, Daniel; Kolaczynski, John; Newberger, Max; O'Leary, Jerry; Pille, Alex; Pizzuto, Luca; Rylowicz, Sam; Wood, Charles] Fast Radius, Chicago, IL USA; [Bralts, Elisabeth; Dietkus, Rachael; Fava, Jake; O'Bryan, Lucas; Pagano, Alex] Univ Illinois, Siebel Ctr Design, Urbana, IL USA; [Durack, Gary] Tekmill, Champaign, IL USA; [Elbel, Stefan; Musser, Andy; Ricconi, Brian] Creat Thermal Solut, Urbana, IL USA; [Hayes, Courtney; Herndon, Nicole; Shipley, Clifford] Univ Illinois, Coll Vet Med, Urbana, IL USA; [Johnson, Mark; Stewart, Brian; White, Karen] Carle Fdn Hosp, Urbana, IL USA; [Mosley, Jonathan; Rubessa, Marcello; Wheeler, Matthew] Univ Illinois, Coll Agr Consumer & Anim Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	King, WP (corresponding author), Univ Illinois, Grainger Coll Engn, Urbana, IL 61801 USA.; King, WP (corresponding author), Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61801 USA.	wpk@illinois.edu	Maslov, Sergei/C-2397-2009; Lee, Tonghun/A-5263-2014; McGregor, Davis/AAN-8966-2021; Tawfick, Sameh/A-6249-2014	Maslov, Sergei/0000-0002-3701-492X; McGregor, Davis/0000-0001-6857-8528; Wooldridge, Abigail/0000-0001-8914-1130; Amos, Jennifer/0000-0002-9437-8201; Tawfick, Sameh/0000-0003-3645-527X; Best-Popescu, Catherine/0000-0003-3857-5953; Corey, Ryan/0000-0002-3122-124X	University of Illinois Urbana-Champaign; Carle Foundation Hospital	University of Illinois Urbana-Champaign; Carle Foundation Hospital	The study was funded by University of Illinois Urbana-Champaign and by Carle Foundation Hospital. Employees of University of Illinois Urbana-Champaign received salary compensation from University of Illinois Urbana-Champaign. Employees of Carle Foundation Hospital received salary compensation from Carle Foundation Hospital. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the `author contributions' section.	Aequs, 2020, AQOVENT; Aksamentov I, 2020, COVID 19 SCENARIOS; Albergotti R., 2020, WASH POST; American Association for Respiratory Care, 2020, SARS COV 2 GUID DOC; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], [No title captured]; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Babic MD, 2007, RESP CARE, V52, P1718; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Branson RD, 2008, RESP CARE, V53, P78; Cooke RH, 2008, Ventilator for rapid response to respiratory disease conditions, Patent No. [US8714156B2, 8714156]; Corey RM, 2020, IEEE T BIOMED CIRC S, V14, P1088, DOI 10.1109/TBCAS.2020.3020702; Cutchis PN, 2002, P SOC PHOTO-OPT INS, V4615, P45, DOI 10.1117/12.466646; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Dickson RP, 2011, CRIT CARE MED, V39, P527, DOI 10.1097/CCM.0b013e318206b99b; Ferguson NM, 2020, IMPACT NONPHARMACEUT; Graham J., 2020, US TODAY; Grimm CA, 2020, OEI062000300; JOHANNIGMAN JA, 1995, ACAD EMERG MED, V2, P719, DOI 10.1111/j.1553-2712.1995.tb03624.x; Kwon AH, 2020, INTENS CARE MED, V46, P1642, DOI 10.1007/s00134-020-06113-3; L'Her E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0506-0; L'Her E, 2011, RESP CARE, V56, P751, DOI 10.4187/respcare.00841; Levy S., 2020, WIRED; Maslov S, 2020, FLATTENING CURVE FAI; Matthay MA, 2020, LANCET RESP MED, V8, P433, DOI 10.1016/S2213-2600(20)30127-2; McGregor DJ, 2019, ADDIT MANUF, V28, P535, DOI 10.1016/j.addma.2019.05.026; Parra-Rojas C, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.062408; Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925; Piper SD, 2008, RESP CARE, V53, P1089; Radermacher P, 2017, AM J RESP CRIT CARE, V196, P964, DOI 10.1164/rccm.201610-2156SO; Sanger DE, 2020, NEW YORK TIMES; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Small M, 2005, INT J BIFURCAT CHAOS, V15, P1745, DOI 10.1142/S0218127405012776; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V41, P145, DOI DOI 10.1056/NEJMcp2009249; Tumbleston JR, 2015, SCIENCE, V347, P1349, DOI 10.1126/science.aaa2397; University of Illinois Urbana-Champaign, 2020, ILL RAPIDALARM EM VE; University of Illinois Urbana-Champaign, 2020, ILL RAPIDVENT; Vasan Aditya, 2020, Med Devices Sens, V3, pe10106, DOI 10.1002/mds3.10106; Vicenzi RL, 1990, Portable light weight completely self-contained emergency single patient ventilator/resuscitator., Patent No. [US4905688A, 4905688]; Walter JM, 2018, SOUTH MED J, V111, P746, DOI 10.14423/SMJ.0000000000000905; Xu ZW, 2009, GEOGR ANAL, V41, P263, DOI 10.1111/j.1538-4632.2009.00754.x; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zuckerberg J, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118113	43	10	11	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244963	10.1371/journal.pone.0244963	http://dx.doi.org/10.1371/journal.pone.0244963			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378363	Green Published, gold			2022-12-27	WOS:000605651300028
J	Litwin, P; Zybura, B; Motyka, P				Litwin, Piotr; Zybura, Beata; Motyka, Pawel			Tactile information counteracts the attenuation of rubber hand illusion attributable to increased visuo-proprioceptive divergence	PLOS ONE			English	Article							QUANTILE REGRESSION; BODY; OWNERSHIP; POSITION; DISTANCE; THATS; SENSE; SELF	Sense of body ownership is an immediate and distinct experience of one's body as belonging to oneself. While it is well-recognized that ownership feelings emerge from the integration of visual and somatosensory signals, the principles upon which they are integrated are still intensely debated. Here, we used the rubber hand illusion (RHI) to examine how the interplay of visual, tactile, and proprioceptive signals is governed depending on their spatiotemporal properties. For this purpose, the RHI was elicited in different conditions varying with respect to the extent of visuo-proprioceptive divergence (i.e., the distance between the real and fake hands) and differing in terms of the availability and spatiotemporal complexity of tactile stimulation (none, simple, or complex). We expected that the attenuating effect of distance on illusion strength will be more pronounced in the absence of touch (when proprioception gains relatively higher importance) and absent in the presence of complex tactile signals. Additionally, we hypothesized that participants with greater proprioceptive acuity-assessed using an elbow joint position discrimination task-will be less susceptible to the illusion, but only under the conditions of limited tactile stimulation. In line with our prediction, RHI was attenuated at the farthest distance only when tactile information was absent or simplified, but the attenuation was effectively prevented by the use of complex tactile stimulation-in this case, RHI was comparably vivid at both distances. However, passive proprioceptive acuity was not related to RHI strength in either of the conditions. The results indicate that complex-structured tactile signals can override the influence of proprioceptive signals in body attribution processes. These findings extend our understanding of body ownership by showing that it is primarily determined by informative cues from the most relevant sensory domains, rather than mere accumulation of multisensory evidence.	[Litwin, Piotr; Zybura, Beata; Motyka, Pawel] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Litwin, Piotr] Polish Acad Sci, Inst Philosophy & Sociol, Warsaw, Poland	University of Warsaw; Polish Academy of Sciences; Institute of Philosophy & Sociology of the Polish Academy of Sciences	Litwin, P (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.; Litwin, P (corresponding author), Polish Acad Sci, Inst Philosophy & Sociol, Warsaw, Poland.	piotr.litwin@psych.uw.edu.pl		Litwin, Piotr/0000-0003-4296-5313	National Science Centre (Poland) [2014/14/E/HS1/00803, 2020/36/T/HS6/00071, 2016/23/N/HS6/02920]	National Science Centre (Poland)(National Science Centre, Poland)	The work in this paper was funded by National Science Centre (Poland) (https://www.ncn.gov.pl/) research grants under the decisions 2014/14/E/HS1/00803, 2020/36/T/HS6/00071 (P. L.) and 2016/23/N/HS6/02920 (P. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkarim Z, 2016, ATTEN PERCEPT PSYCHO, V78, P707, DOI 10.3758/s13414-015-1016-0; Bottai M, 2014, OBESITY, V22, pE149, DOI 10.1002/oby.20618; Bottai M, 2010, STAT MED, V29, P309, DOI 10.1002/sim.3781; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Chancel M, 2020, ATTEN PERCEPT PSYCHO, V82, P4058, DOI 10.3758/s13414-020-02107-x; Chander G, 2015, JAIDS-J ACQ IMM DEF, V70, P137, DOI 10.1097/QAI.0000000000000679; Crucianelli Laura, 2013, Front Psychol, V4, P703, DOI 10.3389/fpsyg.2013.00703; D'Alonzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050756; Dempsey-Jones H, 2019, EXP BRAIN RES, V237, P351, DOI 10.1007/s00221-018-5391-3; Dienes Z., 2020, NATURE COMMS; Ehrsson HH, 2020, MULTISENSORY PERCEPTION: FROM LABORATORY TO CLINIC, P179, DOI 10.1016/B978-0-12-812492-5.00008-5; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Elangovan N, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01053; Elangovan N, 2014, PHYS THER, V94, P553, DOI 10.2522/ptj.20130103; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Erro R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20551-6; Fang W, 2019, P NATL ACAD SCI USA, V116, P20151, DOI 10.1073/pnas.1902334116; Fang W, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00261; Filippetti ML, 2019, SCI REP, V9, P1; Fiorio M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62745-x; Fuchs X, 2016, SCI REP-UK, V6, DOI 10.1038/srep24362; Geraci M, 2014, J STAT SOFTW, V57, P1; Geraci M, 2014, STAT COMPUT, V24, P461, DOI 10.1007/s11222-013-9381-9; Han J, 2016, J SPORT HEALTH SCI, V5, P93, DOI 10.1016/j.jshs.2015.11.002; Holle H, 2011, COGN NEUROSCI-UK, V2, P171, DOI 10.1080/17588928.2011.603828; Holst-Wolf J, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00818; Kalckert A, 2019, EXP BRAIN RES, V237, P1821, DOI 10.1007/s00221-019-05539-6; Kalckert A, 2014, CONSCIOUS COGN, V30, P118, DOI 10.1016/j.concog.2014.08.022; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kerby D.S., 2014, INNOVATIVE TEACHING, V3, DOI [10.2466/11.IT.3.1, DOI 10.2466/11.IT.3.1]; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Lenggenhager B, 2013, NEUROREHAB NEURAL RE, V27, P704, DOI 10.1177/1545968313491009; Litwin P, 2020, MULTISENS RES, V33, P127, DOI 10.1163/22134808-20191440; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Lubiatowski Przemyslaw, 2013, Eur J Orthop Surg Traumatol, V23, P177, DOI 10.1007/s00590-012-0950-y; Lush P, 2020, COLLABRA-PSYCHOL, V6, DOI 10.1525/collabra.325; Marotta A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168489; Motyka P, 2019, PERCEPTION, V48, P882, DOI 10.1177/0301006619865189; Niehof N, 2016, PSI ADAPTIVE STAIRCA; Noel JP, 2017, SCHIZOPHR RES, V179, P8, DOI 10.1016/j.schres.2016.09.021; Perepelkina O, 2018, CONSCIOUS COGN, V65, P216, DOI 10.1016/j.concog.2018.09.005; Pickett K, 2009, DEV MED CHILD NEUROL, V51, P711, DOI 10.1111/j.1469-8749.2008.03229.x; Preston C, 2013, ACTA PSYCHOL, V142, P177, DOI 10.1016/j.actpsy.2012.12.005; Prins N, 2013, J VISION, V13, DOI 10.1167/13.7.3; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Riemer M, 2019, NEUROSCI BIOBEHAV R, V104, P268, DOI 10.1016/j.neubiorev.2019.07.008; Riemer M, 2015, BIOL PSYCHOL, V109, P86, DOI 10.1016/j.biopsycho.2015.04.011; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Samad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117178; Shibuya S, 2017, EXP BRAIN RES, V235, P121, DOI 10.1007/s00221-016-4777-3; Tame L, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00291; Tame L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206367; Tidoni E, 2014, RESTOR NEUROL NEUROS, V32, P611, DOI 10.3233/RNN-130385; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; van Doorn J, 2021, PSYCHON B REV, V28, P813, DOI 10.3758/s13423-020-01798-5; Walsh E, 2015, PERCEPTION, V44, P709, DOI 10.1177/0301006615594266	57	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244594	10.1371/journal.pone.0244594	http://dx.doi.org/10.1371/journal.pone.0244594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378385	gold, Green Published			2022-12-27	WOS:000605651300018
J	Mudhune, S; Phiri, SC; Prescott, MR; McCarthy, EA; Banda, A; Haimbe, P; Mwansa, FD; Mwiche, A; Silumesii, A; Micheck, K; Shakwelele, H; Prust, ML				Mudhune, Sandra; Phiri, Sydney Chauwa; Prescott, Marta R.; McCarthy, Elizabeth A.; Banda, Aaron; Haimbe, Prudence; Mwansa, Francis Dien; Mwiche, Angel; Silumesii, Andrew; Micheck, Kabamba; Shakwelele, Hilda; Prust, Margaret L.			Improving the quality of childbirth services in Zambia through introduction of the Safe Childbirth Checklist and systems-focused mentorship	PLOS ONE			English	Article							PROGRAM	Although strong evidence exists about the effectiveness of basic childbirth services in reducing maternal and newborn mortality, these services are not provided in every childbirth, even those at health facilities. The WHO Safe Childbirth Checklist (SCC) was developed as a job aide to remind health workers of evidenced-based practices to be provided at specific points in the childbirth process. The Zambian government requested context-specific evidence on the feasibility and outcomes associated with introducing the checklist and related mentorship. A study was conducted on use of the SCC in four facilities in Nchelenge District of Zambia. Observations of childbirth services were conducted just before and six months after the introduction of the intervention. Observers used a structured tool to record adherence to essential services indicated on the checklist. The primary outcome of interest was the change in the average proportion of essential childbirth practices completed. Feedback questionnaires were administered to health workers before and six months after the intervention. At baseline and endline, 108 and 148 pause points were observed, respectively. There was an increase from 57% to 76% of tasks performed (p = 0.04). Considering only these cases where necessary supplies were available, health workers completed 60% of associated tasks at baseline compared to 84% at endline (p<0.01). Some tasks, such as taking an infant's temperature and hand washing, were never or rarely performed at baseline. Feedback from the health workers indicated that nearly all health workers agreed or strongly agreed with positive statements about the intervention. The performance of health workers in Zambia in completing essential practices in childbirth was low at baseline but improvements were observed with the introduction of the SCC and mentorship. Our results suggest that such interventions could improve quality of care for facility-based childbirth. However, national-level commitment to ensuring availability of trained staff and supplies is essential for success.	[Mudhune, Sandra; Phiri, Sydney Chauwa; Banda, Aaron; Haimbe, Prudence; Shakwelele, Hilda] Clinton Hlth Access Initiat, Lusaka, Zambia; [Prescott, Marta R.; McCarthy, Elizabeth A.; Prust, Margaret L.] Clinton Hlth Access Initiat, Boston, MA USA; [Mwansa, Francis Dien; Mwiche, Angel; Silumesii, Andrew; Micheck, Kabamba] Minist Hlth, Lusaka, Zambia		Mudhune, S (corresponding author), Clinton Hlth Access Initiat, Lusaka, Zambia.	mudhune@outlook.com		Mudhune, Sandra/0000-0001-9899-4821	UK Department for International Development (DFID) through the Demand-Driven Evaluations for Decisions (3DE) program at CHAI; Swedish Agency for International Development (SIDA) through CHAI's Human Resources for Health program	UK Department for International Development (DFID) through the Demand-Driven Evaluations for Decisions (3DE) program at CHAI; Swedish Agency for International Development (SIDA) through CHAI's Human Resources for Health program	This evaluation funded by the UK Department for International Development (DFID) through the Demand-Driven Evaluations for Decisions (3DE) program at CHAI. The SCC introduction and coaching activities were supported by the Swedish Agency for International Development (SIDA) through CHAI's Human Resources for Health program. DFID had no role in the design of the study and collection, analysis and interpretation of data and in writing the manuscript.	Albolino S, 2015, PROCEDIA MANUF, V3, P242, DOI 10.1016/j.promfg.2015.07.135; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Davoodi R, 2013, PATIENT SAF QUAL IMP, V2, P97; Hirschhorn LR, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0309-y; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; Kumar S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1139-x; Kusum, 2016, INT J MULTIDISCIPLIN, V2, P212; Lunze K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0784-9; Mudhune S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5813-y; Otieno P, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2696-2; Patabendige M, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0436-0; Population Council, 2018, STAT EM OBST NEWB CA; Semrau KEA, 2017, NEW ENGL J MED, V377, P2313, DOI 10.1056/NEJMoa1701075; Spector JM, 2013, INT J GYNECOL OBSTET, V122, P164, DOI 10.1016/j.ijgo.2013.03.022; Spector JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035151; Tuyishime Eugene, 2018, Matern Health Neonatol Perinatol, V4, P7, DOI 10.1186/s40748-018-0075-3; Zambia Statistics Agency Ministry of Health Zambia ICF., 2019, ZAMB DEM HLTH SURV 2	17	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244310	10.1371/journal.pone.0244310	http://dx.doi.org/10.1371/journal.pone.0244310			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378372	gold, Green Published			2022-12-27	WOS:000605651300021
J	Daversin-Catty, C; Vinje, V; Mardal, KA; Rognes, ME				Daversin-Catty, Cecile; Vinje, Vegard; Mardal, Kent-Andre; Rognes, Marie E.			The mechanisms behind perivascular fluid flow	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; INTERSTITIAL FLUID; INTRACRANIAL-PRESSURE; DRAINAGE PATHWAYS; SOLUTE TRANSPORT; BRAIN; ARTERIAL; EXCHANGE; CSF; RESISTANCE	Flow of cerebrospinal fluid (CSF) in perivascular spaces (PVS) is one of the key concepts involved in theories concerning clearance from the brain. Experimental studies have demonstrated both net and oscillatory movement of microspheres in PVS (Mestre et al. (2018), Bedussi et al. (2018)). The oscillatory particle movement has a clear cardiac component, while the mechanisms involved in net movement remain disputed. Using computational fluid dynamics, we computed the CSF velocity and pressure in a PVS surrounding a cerebral artery subject to different forces, representing arterial wall expansion, systemic CSF pressure changes and rigid motions of the artery. The arterial wall expansion generated velocity amplitudes of 60-260 mu m/s, which is in the upper range of previously observed values. In the absence of a static pressure gradient, predicted net flow velocities were small (mu m/s), though reaching up to 7 mu m/s for non-physiological PVS lengths. In realistic geometries, a static systemic pressure increase of physiologically plausible magnitude was sufficient to induce net flow velocities of 20-30 mu m/s. Moreover, rigid motions of the artery added to the complexity of flow patterns in the PVS. Our study demonstrates that the combination of arterial wall expansion, rigid motions and a static CSF pressure gradient generates net and oscillatory PVS flow, quantitatively comparable with experimental findings. The static CSF pressure gradient required for net flow is small, suggesting that its origin is yet to be determined.	[Daversin-Catty, Cecile; Vinje, Vegard; Mardal, Kent-Andre; Rognes, Marie E.] Simula Res Lab, Dept Numer Anal & Sci Comp, Lysaker, Norway; [Mardal, Kent-Andre] Univ Oslo, Dept Math, Oslo, Norway	University of Oslo	Rognes, ME (corresponding author), Simula Res Lab, Dept Numer Anal & Sci Comp, Lysaker, Norway.	meg@simula.no	Mardal, Kent-Andre/G-8296-2018; Rognes, Marie E./J-7901-2015	Mardal, Kent-Andre/0000-0002-4946-1110; Vinje, Vegard/0000-0003-2928-3385; Rognes, Marie E./0000-0002-6872-3710; Catty, Cecile/0000-0001-6247-9940	European Research Council (ERC) under the European Union [714892]; NOTUR [NN9316K]; Research Council of Norway [301013]	European Research Council (ERC) under the European Union(European Research Council (ERC)); NOTUR; Research Council of Norway(Research Council of Norway)	CDC and MER are supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme under grant agreement 714892, and by the NOTUR grant NN9316K. KAM is supported by the Research Council of Norway under grant agreement 301013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2018, ACTA NEUROPATHOL, V135, P387, DOI 10.1007/s00401-018-1812-4; Albargothy NJ, 2018, ACTA NEUROPATHOL, V136, P139, DOI 10.1007/s00401-018-1862-7; Alns Martin, 2015, ARCH NUMER SOFTW, V3; [Anonymous], 2017, GNU IMAGE MANIPULATI; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Asgari M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38635; Bedussi B, 2018, J CEREBR BLOOD F MET, V38, P719, DOI 10.1177/0271678X17737984; Bilston LE, 2010, J NEUROSURG, V112, P808, DOI 10.3171/2009.5.JNS08945; Carare RO, 2020, NEURON, V105, P400, DOI 10.1016/j.neuron.2020.01.011; Cushing H, 1925, LANCET, V2, P851; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Diem AK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00475; Eide PK, 2011, CLIN NEUROL NEUROSUR, V113, P123, DOI 10.1016/j.clineuro.2010.10.008; Eide PK, 2010, ACTA NEUROCHIR, V152, P989, DOI 10.1007/s00701-010-0605-x; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Hannocks MJ, 2018, J CEREBR BLOOD F MET, V38, P669, DOI 10.1177/0271678X17749689; Holmlund P, 2018, AM J PHYSIOL-REG I, V314, pE377, DOI 10.1152/ajpregu.00291.2017; Holter KE, 2017, P NATL ACAD SCI USA, V114, P9894, DOI 10.1073/pnas.1706942114; Iliff J, 2019, J PHYSIOL-LONDON, V597, P4417, DOI 10.1113/JP277635; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kaese S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00345; Kedarasetti RT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66887-w; Ladron-de Guevara A, 2020, BIORXIV; Ma QL, 2019, ACTA NEUROPATHOL, V137, P151, DOI 10.1007/s00401-018-1916-x; Malm J, 2011, NEUROLOGY, V76, P903, DOI 10.1212/WNL.0b013e31820f2dd0; Martinac AD, 2020, BIOMECH MODEL MECHAN, V19, P781, DOI 10.1007/s10237-019-01253-y; Mestre H, 2020, TRENDS NEUROSCI, V43, P458, DOI 10.1016/j.tins.2020.04.003; Mestre H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07318-3; Morris AWJ, 2016, ACTA NEUROPATHOL, V131, P725, DOI 10.1007/s00401-016-1555-z; Pardridge WM, 2016, EXPERT OPIN DRUG DEL, V13, P963, DOI 10.1517/17425247.2016.1171315; Ray L, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0126-9; Rey J, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0105-6; Ringstad G, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121537; Ringstad G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188896; Rohatgi A, 2017, WEBPLOTDIGITIZER; San Martin J, 2009, J COMPUT APPL MATH, V230, P521, DOI 10.1016/j.cam.2008.12.021; Sharp MK, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0132-y; Smith AJ, 2019, J PHYSIOL-LONDON, V597, P4421, DOI 10.1113/JP277636; Smith AJ, 2017, ELIFE, V6, DOI [10.7554/elife.27679, 10.7554/eLife.27679]; Smith JH, 2007, MICROVASC RES, V73, P58, DOI 10.1016/j.mvr.2006.07.001; Thomas JH, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0572; Tithof J, 2019, FLUIDS BARRIERS CNS, V16, DOI 10.1186/s12987-019-0140-y; TOY SM, 1985, IEEE T BIO-MED ENG, V32, P174, DOI 10.1109/TBME.1985.325439; Uldall M, 2014, J NEUROSCI METH, V227, P1, DOI 10.1016/j.jneumeth.2014.01.036; Valnes LM, 2020, SCI REPORTS, V10, P1; Vinje V, 2020, FLUIDS BARRIERS CNS, V17, DOI 10.1186/s12987-020-00189-1; Vinje V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46055-5; Wagshul ME, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-5; Wang P, 2011, J THEOR BIOL, V274, P52, DOI 10.1016/j.jtbi.2011.01.014; Weller R. O., 2005, Morphologie, V89, P22, DOI 10.1016/S1286-0115(05)83235-7; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	53	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244442	10.1371/journal.pone.0244442	http://dx.doi.org/10.1371/journal.pone.0244442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373419	Green Published, Green Submitted, gold			2022-12-27	WOS:000603612300022
J	Park, JM; Choi, CH; Wu, HG; Kim, JI				Park, Jong Min; Choi, Chang Heon; Wu, Hong-Gyun; Kim, Jung-in			Correlation of the gamma passing rates with the differences in the dose-volumetric parameters between the original VMAT plans and actual deliveries of the VMAT plans	PLOS ONE			English	Article							IMRT; IMPLEMENTATION; INDEX; DOSIMETRY	Purpose The aim of this study was to investigate the correlations of the gamma passing rates (GPR) with the dose-volumetric parameter changes between the original volumetric modulated arc therapy (VMAT) plans and the actual deliveries of the VMAT plans (DV errors). We compared the correlations of the TrueBeam STx system to those of a C-series linac. Methods A total of 20 patients with head and neck (H&N) cancer were retrospectively selected for this study. For each patient, two VMAT plans with the TrueBeam STx and Trilogy (C-series linac) systems were generated under similar modulation degrees. Both the global and local GPRs with various gamma criteria (3%/3 mm, 2%/2 mm, 2%/1 mm, 1%/2 mm, and 1%/1 mm) were acquired with the 2D dose distributions measured using the MapCHECK2 detector array. During VMAT deliveries, the linac log files of the multi-leaf collimator positions, gantry angles, and delivered monitor units were acquired. The DV errors were calculated with the 3D dose distributions reconstructed using the log files. Subsequently, Spearman's rank correlation coefficients (r(s)) and the corresponding p values were calculated between the GPRs and the DV errors. Results For the Trilogy system, the r(s) values with p < 0.05 showed weak correlations between the GPRs and the DV errors (r(s)<0.4) whereas for the TrueBeam STx system, moderate or strong correlations were observed (r(s)>= 0.4). The DV errors in the V-20Gy of the left parotid gland and those in the mean dose of the right parotid gland showed strong correlations (always with r(s) > 0.6) with the GPRs with gamma criteria except 3%/3 mm. As the GPRs increased, the DV errors decreased. Conclusion The GPRs showed strong correlations with some of the DV errors for the VMAT plans for H&N cancer with the TrueBeam STx system.	[Park, Jong Min; Choi, Chang Heon; Wu, Hong-Gyun; Kim, Jung-in] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Park, Jong Min; Choi, Chang Heon; Wu, Hong-Gyun; Kim, Jung-in] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Jong Min; Choi, Chang Heon; Wu, Hong-Gyun; Kim, Jung-in] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Park, Jong Min; Wu, Hong-Gyun] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, JI (corresponding author), Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Kim, JI (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.	madangin@gmail.com		Kim, Jung-in/0000-0002-0305-5969	National Research Foundation of Korea - Ministry of Science and ICT [2019M2A2B4095126, 2019M2A2B4096540, 0411-20190090]	National Research Foundation of Korea - Ministry of Science and ICT	This work was supported by the National Research Foundation of Korea funded by the Ministry of Science and ICT (No. 2019M2A2B4095126, 2019M2A2B4096540, and 0411-20190090).	Agnew CE, 2012, PHYS MED BIOL, V57, P6761, DOI 10.1088/0031-9155/57/21/6761; Almond PR, 1999, MED PHYS, V26, P1847, DOI 10.1118/1.598691; Bentzen SM, 2010, INT J RADIAT ONCOL, V76, pS3, DOI 10.1016/j.ijrobp.2009.09.040; Du WL, 2014, MED PHYS, V41, DOI 10.1118/1.4861821; Evans JD, 1996, STRAIGHTFORWARD STAT, pxxii; Ezzell GA, 2003, MED PHYS, V30, P2089, DOI 10.1118/1.1591194; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Fredh A, 2013, MED PHYS, V40, DOI 10.1118/1.4788645; Heilemann G, 2013, MED PHYS, V40, DOI 10.1118/1.4789580; Kim JI, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-167; LoSasso T, 1998, MED PHYS, V25, P1919, DOI 10.1118/1.598381; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Masi L, 2013, MED PHYS, V40, DOI 10.1118/1.4810969; Miften M, 2018, MED PHYS, V45, pE53, DOI 10.1002/mp.12810; Nelms BE, 2011, MED PHYS, V38, P1037, DOI 10.1118/1.3544657; Nicolini G, 2011, MED PHYS, V38, P264, DOI 10.1118/1.3528214; Park JM, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20140698; Park JI, 2015, PHYS MEDICA, V31, P1118, DOI 10.1016/j.ejmp.2015.08.005; Park JM, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1123-x; Park JM, 2015, PHYS MED BIOL, V60, P7101, DOI 10.1088/0031-9155/60/18/7101; Park JM, 2014, PHYS MED BIOL, V59, P7315, DOI 10.1088/0031-9155/59/23/7315; Park SY, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0382-z; Stasi M, 2012, MED PHYS, V39, P7626, DOI 10.1118/1.4767763; Sun BZ, 2013, PRACT RADIAT ONCOL, V3, pE199, DOI 10.1016/j.prro.2012.11.013; Teke T, 2010, MED PHYS, V37, P116, DOI 10.1118/1.3266821	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244690	10.1371/journal.pone.0244690	http://dx.doi.org/10.1371/journal.pone.0244690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373394	Green Published, gold			2022-12-27	WOS:000603612300041
J	von Maydell, D; Lehnert, H; Berner, T; Klocke, E; Junghanns, W; Keilwagen, J; Marthe, F				von Maydell, Daniel; Lehnert, Heike; Berner, Thomas; Klocke, Evelyn; Junghanns, Wolfram; Keilwagen, Jens; Marthe, Frank			On genetic diversity in caraway: Genotyping of a large germplasm collection	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; GENOME SIZE; POPULATION-STRUCTURE; CARUM-CARVI; FLOW-CYTOMETRY; INFERENCE; MARKERS; APIACEAE; WINTER	Caraway (Carum carvi) is a widespread and frequently used spice and medicinal plant with a long history of cultivation. However, due to ongoing climatic changes, the cultivation is becoming increasingly risky. To secure caraway cultivation in future, timely breeding efforts to develop adapted material are necessary. Analysis of genetic diversity can accompany this process, for instance, by revealing untapped gene pools. Here, we analyzed 137 accessions using genotyping by sequencing (GBS). Hence, we can report a broad overview of population structure and genetic diversity of caraway. Population structure was determined using a principal coordinate analysis, a Bayesian clustering analysis, phylogenetic trees and a neighbor network based on 13,155 SNPs. Genotypic data indicate a clear separation of accessions into two subpopulations, which correlates with the flowering type (annual vs. biennial). Four winter-annual accessions were closer related to biennial accessions. In an analysis of molecular variance, genetic variation between the two subpopulations was 7.84%. In addition, we estimated the genome size for 35 accessions by flow cytometry. An average genome size of 4.282 pg/2C (+/- 0.0096 S.E.) was estimated. Therefore, we suggest a significantly smaller genome size than stated in literature.	[von Maydell, Daniel; Klocke, Evelyn; Marthe, Frank] Julius Kuehn Inst, Inst Breeding Res Hort Crops, Inst Fed Res Ctr Cultivated Plants, Quedlinburg, Germany; [Lehnert, Heike; Berner, Thomas; Keilwagen, Jens] Julius Kuehn Inst, Inst Biosafety Plant Biotechnol, Inst Fed Res Ctr Cultivated Plants, Quedlinburg, Germany; [Junghanns, Wolfram] Dr Junghanns GmbH, Aschersleben, Gross Schierste, Germany	Julius Kuhn-Institut; Julius Kuhn-Institut	von Maydell, D (corresponding author), Julius Kuehn Inst, Inst Breeding Res Hort Crops, Inst Fed Res Ctr Cultivated Plants, Quedlinburg, Germany.	daniel.maydell@julius-kuehn.de		von Maydell, Daniel/0000-0001-7674-1559	"Fachagentur Nachwachsende Rohstoffe" (FNR) on behalf of the Federal Ministry of Food and Agriculture (BMEL) [22023215]; Dr. Junghanns GmbH; Aschersleben OT Grobeta Schierstedt; BBG Kilian-Horsch GbR, Aschersleben OT Mehringen; Horrmann GbR, Bo<spacing diaeresis> rdeland OT Welsleben; Landwirtschaftsbetrieb Hans-Eckhard Kittler, Aschersleben; Institute of Federal Research Centre for Cultivated Plants, Julius Kuehn-Institute (JKI), Quedlinburg, Germany	"Fachagentur Nachwachsende Rohstoffe" (FNR) on behalf of the Federal Ministry of Food and Agriculture (BMEL); Dr. Junghanns GmbH; Aschersleben OT Grobeta Schierstedt; BBG Kilian-Horsch GbR, Aschersleben OT Mehringen; Horrmann GbR, Bo<spacing diaeresis> rdeland OT Welsleben; Landwirtschaftsbetrieb Hans-Eckhard Kittler, Aschersleben; Institute of Federal Research Centre for Cultivated Plants, Julius Kuehn-Institute (JKI), Quedlinburg, Germany	This project was funded by the "Fachagentur Nachwachsende Rohstoffe" (FNR) on behalf of the Federal Ministry of Food and Agriculture (BMEL) (Funding ID: 22023215). https://www.fnr.de/The funding was supported by Dr. Junghanns GmbH, Aschersleben OT Gro beta Schierstedt; BBG Kilian-Horsch GbR, Aschersleben OT Mehringen; Horrmann GbR, Bo<spacing diaeresis> rdeland OT Welsleben; Landwirtschaftsbetrieb Hans-Eckhard Kittler, Aschersleben. A fund for open access publication was granted by the Institute of Federal Research Centre for Cultivated Plants, Julius Kuehn-Institute (JKI), Quedlinburg, Germany. The co-funder Dr. Junghanns contributed as author to this publication as well. The specific role of this author is articulated in the 'author contributions' section.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Garrido-Cardenas JA, 2018, PLANTA, V247, P543, DOI 10.1007/s00425-017-2829-y; Bocianowski J, 2012, IND CROP PROD, V36, P135, DOI 10.1016/j.indcrop.2011.08.019; Clark JW, 2018, TRENDS PLANT SCI, V23, P933, DOI 10.1016/j.tplants.2018.07.006; DAS A B, 1991, Cytologia (Tokyo), V56, P627, DOI 10.1508/cytologia.56.627; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Dolezel J, 2010, CYTOM PART A, V77A, P635, DOI 10.1002/cyto.a.20915; Dufresne F, 2014, MOL ECOL, V23, P40, DOI 10.1111/mec.12581; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferrie AMR, 2011, PLANT CELL TISS ORG, V104, P399, DOI 10.1007/s11240-010-9770-0; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Greilhuber J, 2005, ANN BOT-LONDON, V95, P91, DOI 10.1093/aob/mci004; Grover A, 2016, CRIT REV BIOTECHNOL, V36, P290, DOI 10.3109/07388551.2014.959891; Hack H, 1992, NACHRICHTENBLATT DTS, V44, P265; Hardie DC, 2002, J HISTOCHEM CYTOCHEM, V50, P735, DOI 10.1177/002215540205000601; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iorizzo M, 2016, NAT GENET, V48, P657, DOI 10.1038/ng.3565; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kim C, 2016, PLANT SCI, V242, P14, DOI 10.1016/j.plantsci.2015.04.016; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Langenberger MW, 2002, CAN J PLANT SCI, V82, P203, DOI 10.4141/P01-019; Langenberger MW, 2002, AM J BOT, V89, P1588, DOI 10.3732/ajb.89.10.1588; Laribi B, 2011, EURASIA J BIOSCI, V5, P37, DOI DOI 10.5053/EJOBIOS.2011.5.0.5; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MY, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-019-0235-2; Luo X, 2020, J INTEGR PLANT BIOL, V62, P104, DOI 10.1111/jipb.12896; McKinney GJ, 2017, MOL ECOL RESOUR, V17, P656, DOI 10.1111/1755-0998.12613; Melo ATO, 2019, BIOINFORMATICS, V35, P1783, DOI 10.1093/bioinformatics/bty873; Mihalik E, 1998, CARAWAY GENUS CARUM, V7, P9; Nemeckova H, 2019, ANN BOT FENN, V56, P57, DOI 10.5735/085.056.0111; Nemeth E, 1999, ACTA HORTIC, P77, DOI 10.17660/ActaHortic.1999.502.9; Nemeth E, 1998, CARAWAY GENUS CARUM, V7, P1; Nowicka A, 2016, SCI HORTIC-AMSTERDAM, V209, P132, DOI 10.1016/j.scienta.2016.06.023; Otto LG, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3991-0; Pank F, 2008, Z ARZNEI- GEWURZPFLA, V13, P24; Pank F., 2012, HDB ARZNEI GEWURZPFL, V4, P728; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Praca-Fontes MM, 2011, PLANT CELL REP, V30, P1183, DOI 10.1007/s00299-011-1026-x; Pritchard JK, 2000, GENETICS, V155, P945; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schulz H, 2009, GENETISCHE VARIABILI; Seidler-Lozykowska K, 2014, ACTA SCI-AGRON, V36, P183, DOI 10.4025/actasciagron.v36i2.18197; Shi AN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188745; Sliwinska E, 2018, FOLIA HORTIC, V30, P103, DOI 10.2478/fhort-2018-0011; Song XM, 2020, PLANT BIOTECHNOL J, V18, P1444, DOI 10.1111/pbi.13310; Stansell Z, 2018, HORTIC RES-ENGLAND, V5, P10, DOI [10.1038/s41438-018-0020-7, DOI 10.1038/S41438-018-0020-7]; Suda J, 2010, CYTOM PART A, V77A, P717, DOI 10.1002/cyto.a.20907; Tavares AC, 2013, PLANT SYST EVOL, V299, P611, DOI 10.1007/s00606-012-0747-9; Team RC., 2013, R LANG ENV STAT COMP; Tiley GP, 2016, GENOME BIOL EVOL, V8, P1023, DOI 10.1093/gbe/evw058; Toxopeus H., 1998, CARAWAY GENUS CARUM, P105; Weglarz Z., 1998, CARAWAY GENUS CARUM, P129; Wickam, 2016, ELEGANT GRAPHICS DAT; Xu SJ, 2018, NAT PLANTS, V4, P997, DOI 10.1038/s41477-018-0301-z; Yousef EAA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192062	66	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244666	10.1371/journal.pone.0244666	http://dx.doi.org/10.1371/journal.pone.0244666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373410	Green Published, gold			2022-12-27	WOS:000603612300057
J	Hajek, A; Kretzler, B; Konig, HH				Hajek, Andre; Kretzler, Benedikt; Koenig, Hans-Helmut			Personality and the use of cancer screenings. A systematic review	PLOS ONE			English	Review							HEALTH-RELATED BEHAVIORS; SELF-EFFICACY; ALTERNATIVE MEDICINE; BREAST; ADULTS; MODEL; CONSCIENTIOUSNESS; PARTICIPATION; COMPLEMENTARY; METAANALYSIS	Background No systematic review exists synthesizing studies examining the association between personality factors and use of cancer screenings. Hence, the aim of this systematic review is to provide an overview of empirical findings from observational studies investigating the link between personality factors (in terms of agreeableness, conscientiousness, extraversion, neuroticism and openness to experience) and use of cancer screenings. Methods Medline, PsycInfo and CINAHL were searched using predefined search terms. Observational studies examining the link between personality factors and use of cancer screenings using validated tools were included. Study selection, data extraction, and quality assessment were performed by two reviewers. Results In total, n = 11 studies were included in our systematic review. There is mostly inconclusive evidence regarding the link between agreeableness, neuroticism, openness to experience and the use of cancer screenings. Clearer evidence was identified for an association between increased extraversion and an increased use of cancer screenings. Moreover, the majority of studies identified a link between increased conscientiousness and an increased use of cancer screenings. Discussion Studies indicate that personality factors, particularly an increased extraversion and increased conscientiousness, are associated with an increased use of cancer screenings. This knowledge may be beneficial to address individuals at risk for underuse. PROSPERO registration number	[Hajek, Andre; Kretzler, Benedikt; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Hajek, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany.	a.hajek@uke.de		Hajek, Andre/0000-0002-6886-2745				Arai S, 2009, J EPIDEMIOL, V19, P34, DOI 10.2188/jea.JE20080024; Arampatzi E, 2020, J HAPPINESS STUD, V21, P965, DOI 10.1007/s10902-019-00115-9; Armon G, 2013, J PERS, V81, P452, DOI 10.1111/jopy.12021; Aschwanden D, 2019, PREV MED, V126, DOI 10.1016/j.ypmed.2019.105763; Ashton MC, 2004, J PERS SOC PSYCHOL, V86, P356, DOI 10.1037/0022-3514.86.2.356; Austin LT, 2002, WOMEN HEALTH ISS, V12, P122, DOI 10.1016/S1049-3867(02)00132-9; Bertz J, 2010, VERBREITUNG KREBSERK; Bogg T, 2004, PSYCHOL BULL, V130, P887, DOI 10.1037/0033-2909.130.6.887; BROWN ML, 1990, PREV MED, V19, P562, DOI 10.1016/0091-7435(90)90054-N; Champion V, 2005, RES NURS HEALTH, V28, P329, DOI 10.1002/nur.20088; Costa P.T., 1989, NEO 5 FACTOR INVENTO, V3; Costa PT., 2008, SAGE HDB PERSONALITY, VLondon, P179, DOI [DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.n9]; Costa S, 2018, PSYCHOL HEALTH MED, V23, P880, DOI 10.1080/13548506.2018.1437278; Deandrea S, 2016, PREV MED, V91, P250, DOI 10.1016/j.ypmed.2016.08.021; Ebell MH, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0080-0; Egger M., 2008, SYSTEMATIC REV HLTH, V2nd, DOI DOI 10.1002/9780470693926.CH12; Flynn KE, 2007, J GERONTOL B-PSYCHOL, V62, pP261, DOI 10.1093/geronb/62.5.P261; Friedman B, 2013, MILBANK Q, V91, P491, DOI 10.1111/1468-0009.12024; Gale CR, 2015, J EPIDEMIOL COMMUN H, V69, P530, DOI 10.1136/jech-2014-204888; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; Gorin SS, 2005, PREV MED, V40, P515, DOI 10.1016/j.ypmed.2004.09.031; Hajek A, 2020, PERSONALITY HEALTHCA; Hajek A, 2017, CANCER MED-US, V6, P3025, DOI 10.1002/cam4.1226; Hajek A, 2017, PREV MED, V105, P47, DOI 10.1016/j.ypmed.2017.08.030; Hajek A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181716; Hakulinen C, 2015, ADDICTION, V110, P1844, DOI 10.1111/add.13079; Hill EM, 2013, J HEALTH PSYCHOL, V18, P648, DOI 10.1177/1359105312454910; Hill EM, 2011, PERS INDIV DIFFER, V50, P662, DOI 10.1016/j.paid.2010.12.013; Hohls JK, 2018, J AFFECT DISORDERS, V232, P163, DOI 10.1016/j.jad.2018.02.011; Honda K, 2005, PREV MED, V40, P46, DOI 10.1016/j.ypmed.2004.05.001; Hsia J, 2000, PREV MED, V31, P261, DOI 10.1006/pmed.2000.0697; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jordan S, 2012, GBE KOMPAKT, V3, P1, DOI DOI 10.25646/3034; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; Lachman ME, 1997, MIDLIFE DEV INVENTOR, P1; Lang KM, 2018, PREV SCI, V19, P284, DOI 10.1007/s11121-016-0644-5; Lench HC, 2011, J HAPPINESS STUD, V12, P493, DOI 10.1007/s10902-010-9212-z; Marusic A, 2001, NORD J PSYCHIAT, V55, P157; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Mueller MK, 2018, BMC PUBLIC HEALTH, V18, DOI [10.1186/s12889-018-5188-0, 10.1186/s12889-018-5585-4]; Niedzwiedz CL, 2020, PSYCHO-ONCOLOGY, V29, P381, DOI 10.1002/pon.5272; Nolan A, 2019, PREV MED, V120, P107, DOI 10.1016/j.ypmed.2018.12.029; Pandhi N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009738; Paunonen SV, 2003, EUR J PERSONALITY, V17, P413, DOI 10.1002/per.496; Pearlman DN, 1999, WOMEN HEALTH, V28, P93, DOI 10.1300/J013v28n04_06; Robert-Koch-Institut, 2012, KREBS DEUTSCHLAND 20; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Sa<ss> A-C, 2009, BEITRAGE GESUNDHEITS, P134; Schwartz MD, 1999, HEALTH PSYCHOL, V18, P327, DOI 10.1037/0278-6133.18.4.327; Sen CKN, 2016, J HEALTH PSYCHOL, V21, P2838, DOI 10.1177/1359105315587138; Sirois FM, 2008, J ALTERN COMPLEM MED, V14, P1151, DOI 10.1089/acm.2007.0801; Spuling SM, 2016, ALTERN WANDEL ZWEI J, P141; Starker A, 2013, BUNDESGESUNDHEITSBLA, V56, P858, DOI 10.1007/s00103-012-1655-4; Stuhldreher N, 2012, INT J EAT DISORDER, V45, P476, DOI 10.1002/eat.20977; Takahashi Y, 2013, J PERS, V81, P417, DOI 10.1111/jopy.12007; Taylor S. E., 2001, ADV MIND BODY MED, V17, P48, DOI DOI 10.1054/AMBM.2000.0292; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; von Hippel PT, 2016, STRUCT EQU MODELING, V23, P422, DOI 10.1080/10705511.2015.1047931; Wilson JMG, 1968, PRINCIPLES PRACTICES; World Health Organization, CANC PREV UNKN; Yoshitake N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211728	62	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244655	10.1371/journal.pone.0244655	http://dx.doi.org/10.1371/journal.pone.0244655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370379	gold, Green Published			2022-12-27	WOS:000603611900098
J	Hatmaker, EA; Wadl, PA; Rinehart, TA; Carroll, J; Lane, TS; Trigiano, RN; Staton, ME; Schilling, EE				Hatmaker, E. Anne; Wadl, Phillip A.; Rinehart, Timothy A.; Carroll, Jennifer; Lane, Thomas S.; Trigiano, Robert N.; Staton, Margaret E.; Schilling, Edward E.			Complete chloroplast genome comparisons for Pityopsis (Asteraceae)	PLOS ONE			English	Article							MICROSATELLITE LOCI; SEQUENCE; ALIGNMENT; ORGANIZATION; CONSERVATION; PHYLOGENY	Pityopsis includes several regionally and one federally endangered species of herbaceous perennials. Four species are highly localized, including the federally endangered P. ruthii. The genus includes several ploidy levels and interesting ecological traits such as drought tolerance and fire-dependent flowering. Results from previous cladistic analyses of morphology and from initial DNA sequence studies did not agree with one another or with the infrageneric taxonomic classification, with the result that infrageneric relationships remain unresolved. We sequenced, assembled, and compared the chloroplast (cp) genomes of 12 species or varieties of Pityopsis to better understand generic evolution. A reference cp genome 152,569 bp in length was assembled de novo from P. falcata. Reads from other sampled species were then aligned to the P. falcata reference and individual chloroplast genomes were assembled for each, with manual gapfilling and polishing. After removing the duplicated second inverted region, a multiple sequence alignment of the cp genomes was used to construct a maximum likelihood (ML) phylogeny for the twelve cp genomes. Additionally, we constructed a ML phylogeny from the nuclear ribosomal repeat region after mapping reads to the Helianthus annuus region. The chloroplast phylogeny supported two clades. Previously proposed clades and taxonomic sections within the genus were largely unsupported by both nuclear and chloroplast phylogenies. Our results provide tools for exploring hybridity and examining the physiological and genetic basis for drought tolerance and fire-dependent flowering. This study will inform breeding and conservation practices, and general knowledge of evolutionary history, hybridization, and speciation within Pityopsis.	[Hatmaker, E. Anne; Carroll, Jennifer; Lane, Thomas S.; Trigiano, Robert N.; Staton, Margaret E.] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Wadl, Phillip A.] ARS, USDA, US Vegetable Lab, Charleston, SC USA; [Rinehart, Timothy A.] ARS, USDA, Crop Prod & Protect, Beltsville, MD USA; [Carroll, Jennifer] ARS, USDA, Thad Cochran Southern Hort Lab, Poplarville, MS USA; [Schilling, Edward E.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville	Trigiano, RN; Staton, ME (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.; Schilling, EE (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	rtrigian@utk.edu; mstaton1@utk.edu; eschilling@utk.edu	Hatmaker, Anne/AFS-4874-2022	Hatmaker, Elizabeth/0000-0002-7821-8160; Staton, Margaret/0000-0003-2971-9353	U.S. Department of Agriculture [58-6404-1-637]	U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by the U.S. Department of Agriculture (USDA/MOA number 58-6404-1-637 received by RT, https://www.usda.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], J AM GERIATR SOC; [Anonymous], 2008, MOL ECOL, DOI [DOI 10.1111/j.1365-294X.2008.03887.x, DOI 10.1186/S40665-014-0009-X]; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Boggess SL, 2014, CONSERV GENET RESOUR, V6, P1043, DOI 10.1007/s12686-014-0282-9; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Byrne M, 2007, AUST J BOT, V55, P316, DOI 10.1071/BT06072; Choi KS, 2015, GENE, V572, P214, DOI 10.1016/j.gene.2015.07.020; Clewell A., 1985, GUIDE VASCULAR PLANT; Committee FNAE, 2006, FLORA N AM, V20; Costa CM, 2014, MOL PHYLOGENY GOLDEN; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gornish ES, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt041; Gowe AK, 2005, J TORREY BOT SOC, V132, P384, DOI 10.3159/1095-5674(2005)132[384:TEOFFI]2.0.CO;2; Greiner S, 2019, NUCLEIC ACIDS RES, V47, pW59, DOI 10.1093/nar/gkz238; Hatmaker EA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00943; Huang H, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-151; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Moore PA, 2016, J TORREY BOT SOC; Nesom G.L., 2019, PHYTONEURON, V2019-1, P1; Njuguna W, 2013, MOL PHYLOGENET EVOL, V66, P17, DOI 10.1016/j.ympev.2012.08.026; Ohyama Yoshiaki, 2013, J Cardiol Cases, V8, pe13, DOI 10.1016/j.jccase.2013.02.015; Parks M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-84; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; SEMPLE JC, 1987, RHODORA, V89, P381; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Teoh V-H, 2008, PHYLOGENY HYBRIDIZAT; Timme RE, 2007, AM J BOT, V94, P302, DOI 10.3732/ajb.94.3.302; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Wadl PA, 2011, AM J BOT, V98, pE342, DOI 10.3732/ajb.1100100; Wakasugi T, 2001, PHOTOSYNTH RES, V70, P107, DOI 10.1023/A:1013892009589; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Wang MX, 2015, PLANT MOL BIOL REP, V33, P1526, DOI 10.1007/s11105-015-0853-2; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037128	41	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0241391	10.1371/journal.pone.0241391	http://dx.doi.org/10.1371/journal.pone.0241391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370297	gold, Green Published			2022-12-27	WOS:000603611900120
J	Jayawardana, S; Arambepola, C; Chang, TS; Gnanathasan, A				Jayawardana, Subashini; Arambepola, Carukshi; Chang, Thashi; Gnanathasan, Ariaranee			Prevalence, vulnerability and epidemiological characteristics of snakebite in agricultural settings in rural Sri Lanka: A population-based study from South Asia	PLOS ONE			English	Article							BITES	Background The burden of snakebite remains poorly characterised because of the paucity of population-based data. Further, factors determining the vulnerability of individuals within rural communities to snakebite have been rarely investigated. We undertook a population-based study to determine the prevalence, vulnerability and epidemiological characteristics of snakebite in rural Sri Lanka. Methods and findings A population-based cross-sectional study was conducted among 8707 current residents in the district of Ampara, representing typical rural Sri Lanka. The sample was recruited using multi-stage cluster sampling with probability proportionate-to-size. Snakebite victims were identified using the WHO criteria. Data were collected using a pre-tested interviewer-administered questionnaire. Each household had on average 3.8 persons; mean age 28.3 years (SD = 18.2); 51.3% males. The one-year point prevalence of snakebites was 17.6 per 1000 residents (95% CI: 15-20.6) and 6.12 per 100 households (95% CI: 5.25-7.13), while the lifetime prevalence was 9.4 per 100 residents (95% CI: 8.8-10.0) and 30.5 per 100 households (95% CI: 28.6-32.2) with a case fatality ratio of 0.033. Venomous snakebites accounted for 28.1%; snakes were unidentified among 30.1%. Compared to the non-snakebite victims, being single, males, of Sinhala ethnicity, aged >19 years, low education and socioeconomic status, engaging in farming or unskilled outdoor occupations denoted vulnerability to snakebites. Outdoor bites (77.8%) were more common among males; during daytime; mostly while walking; within the rural terrains and home gardens; on lower limbs; mostly by hump-nosed and Russell viper. Indoor bites were more common among females; during night-time; while sleeping and barefooted; on lower limbs; mostly by hump-nosed vipers, kraits and non-venomous snakes. Conclusions The burden of snakebite is considerably high among rural populations. The concept of vulnerability can be useful in healthcare decision-making and resource allocation.	[Jayawardana, Subashini] Univ Colombo, Dept Allied Hlth Sci, Fac Med, Colombo, Sri Lanka; [Arambepola, Carukshi] Univ Colombo, Dept Community Med, Fac Med, Colombo, Sri Lanka; [Chang, Thashi; Gnanathasan, Ariaranee] Univ Colombo, Dept Clin Med, Fac Med, Colombo, Sri Lanka	University of Colombo; University of Colombo; University of Colombo	Arambepola, C (corresponding author), Univ Colombo, Dept Community Med, Fac Med, Colombo, Sri Lanka.	gnanathasanca@clinmed.cmb.ac.lk			World Bank through Higher Education for Twenty first Century, Quality and Innovative grant (HETC QIG W3)	World Bank through Higher Education for Twenty first Century, Quality and Innovative grant (HETC QIG W3)	The study was supported by World Bank funds through Higher Education for Twenty first Century, Quality and Innovative grant (HETC QIG W3) (http://www.worldbank.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000603; Anjum Arshad, 2012, J FORENSIC RES, V3, P4; Ariaratnam CA, 2008, T ROY SOC TROP MED H, V102, P1120, DOI 10.1016/j.trstmh.2008.03.023; Ariaratnam CA, 2008, AM J TROP MED HYG, V79, P458, DOI 10.4269/ajtmh.2008.79.458; Ariaratnam CA, 2009, AM J TROP MED HYG, V81, P725, DOI 10.4269/ajtmh.2009.09-0225; Arnott I, 2016, J CROHNS COLITIS, V10, pS21; Bertolozzi MR, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005839; Chew KS, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-41; de Silva A., 1981, Snake, V13, P117; De Silva A, 1990, VENOMOUS SNAKES THEI, P479; de Silva HJ, 2013, CEYLON MED J, V58, P93, DOI 10.4038/cmj.v58i3.6101; Fernando M, 2019, MED IMPORTANT SNAKES; Jamaiah I., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P200; Jarwani Bhavesh, 2013, J Emerg Trauma Shock, V6, P199, DOI 10.4103/0974-2700.115343; Jayawardana S, 2018, J MULTIDISCIP HEALTH, V11, P279, DOI 10.2147/JMDH.S126648; Jayawardena SK, 2017, THESIS; Kasturiratne A., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P733; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Keyler DE, 2013, TOXICON, V69, P90, DOI 10.1016/j.toxicon.2013.01.022; Kularatne S A M, 2003, Southeast Asian J Trop Med Public Health, V34, P855; Leesberg, 2012, THE NEW HOLLSTEIN, V1, plvi; Longbottom J, 2018, LANCET, V392, P673, DOI 10.1016/S0140-6736(18)31224-8; Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020; Miah M. T., 2009, J BANGLADESH COLL PH, V27, P70; Pandey DP, 2007, J MED TOXICOL, V3, P164, DOI 10.1007/BF03160933; Parekh U, 2019, J FORENSIC LEG MED, V65, P124, DOI 10.1016/j.jflm.2019.05.013; Rahman R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000860; RATNAPALA R, 1983, Ceylon Medical Journal, V28, P112; Sharma N, 2005, EMERG MED J, V22, P118, DOI 10.1136/emj.2003.008458; Sharma SK, 2004, AM J TROP MED HYG, V71, P234, DOI 10.4269/ajtmh.2004.71.234; Sharma SK, 2003, TOXICON, V41, P285, DOI 10.1016/S0041-0101(02)00289-1; Vaiyapuri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080090; Warrell D., 2016, GUID MAN SNAK, V2; Welton RE, 2017, TOXICON, V131, P11, DOI 10.1016/j.toxicon.2017.03.008; World Health Organization, 2010, GUIDELINES MANAGEMEN	35	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243991	10.1371/journal.pone.0243991	http://dx.doi.org/10.1371/journal.pone.0243991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370325	gold, Green Published			2022-12-27	WOS:000603611900090
J	Joshi, S; Borkotoky, K; Gautam, A; Datta, N; Achyut, P; Nanda, P; Verma, R				Joshi, Shareen; Borkotoky, Kakoli; Gautam, Abhishek; Datta, Nitin; Achyut, Pranita; Nanda, Priya; Verma, Ravi			Poised for a dividend? Changes in the life trajectories of India's young women over the past two decades	PLOS ONE			English	Article							LABOR-FORCE PARTICIPATION; FERTILITY; AGE; MARRIAGE; HEALTH; OPPORTUNITIES; CONSEQUENCES	This paper examines recent changes in the life trajectories of Indian women. We use data from four major national population surveys that span the years 1998-2016. We look at several cohorts of women across the states and regions. We compare decisions related to education, marriage, childbearing and participation in the labor force. Though there is considerable diversity across states and regions, as well as religious groups, we find some consistent patterns that emerge everywhere. First, educational attainment and the age at marriage have been steadily increasing. Women who do not complete secondary school are more likely to marry early. Second, caste and religion (rather than education) play a significant role in decisions after marriage, such as the timing of births, the use of contraception and labor force participation. Third, women from disadvantaged communities continue to have very different life trajectories than other social groups. They are more likely to use contraception and participate in the labor force. Lower levels of schooling also appear to exacerbate the disadvantages of social identity. The pace of these changes varies sharply across states as well as regions of the country.	[Joshi, Shareen] Georgetown Univ, Edmund Walsh Sch Foreign Serv, Int Dev, Washington, DC USA; [Borkotoky, Kakoli; Verma, Ravi] Asia Reg Off, Int Ctr Res Women, New Delhi, India; [Gautam, Abhishek; Achyut, Pranita] Asia Reg Off, Int Ctr Res Women, Res & Programs, New Delhi, India; [Datta, Nitin] Asia Reg Off, Int Ctr Res Women, Monitoring & Evaluat, New Delhi, India; [Nanda, Priya] Bill Melinda Gates Fdn, New Delhi, India	Georgetown University	Joshi, S (corresponding author), Georgetown Univ, Edmund Walsh Sch Foreign Serv, Int Dev, Washington, DC USA.	shareen.joshi@georgetown.edu		Verma, Ravi/0000-0002-9499-5648; Joshi, Shareen/0000-0001-5693-7140	Bill and Melinda Gates Foundation [OPP1142874]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by the Bill and Melinda Gates Foundation Grant No. OPP1142874.	Afridi F, 2018, J POPUL ECON, V31, P783, DOI 10.1007/s00148-017-0671-y; Aills L, 2008, SURG OBES RELAT DI S, V4, pS73; Andres LA, 2017, PRECARIOUS DROP REA; [Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; [Anonymous], 2019, WORLD DEV IND; Arokiasamy P., 2009, Economic and Political Weekly, V44, P55; Arokiasamy Perianayagam, 2012, Genus, V68, P65; Bloom D., 2003, DEMOGRAPHIC DIVIDEND; Borkotoky K., 2013, INT RES J SOCIAL SCI, V2, P6; Borkotoky K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090113; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Chakrabarty TK, 2018, ISSUES HLTH HEALTHCA, P255; Chari AV, 2017, J DEV ECON, V127, P42, DOI 10.1016/j.jdeveco.2017.02.002; Dandona R, 2016, B WORLD HEALTH ORGAN, V94, P286, DOI 10.2471/BLT.15.158493; DAS NP, 1998, DEMOGRAPHY INDIA, V27, P91; Desai S, 2019, POP ASS AM ANN M; Desai Sonalde, 2010, Econ Polit Wkly, V45, P12; Desai S, 2010, DEMOGRAPHY, V47, P667; Deshpande A, 2015, ELGAR COMPANION SOCI; Dharmalingam A, 2014, DEMOGRAPHY, V51, P1451, DOI 10.1007/s13524-014-0314-9; DOMMARAJU P., 2012, ASIA PACIFIC POPULAT, V26, P21; Dreze J., 2013, UNCERTAIN GLORY INDI, DOI 10.2307/j.ctt32bcbm; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Elder G.H., 2009, CRAFT LIFE COURSE RE, P1; Ghimire DJ, 2013, DEMOGRAPHY, V50, P1663, DOI 10.1007/s13524-013-0221-5; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Guilmoto CZ, 2016, DEMOG TRANSFORM SOC, V5, P113, DOI 10.1007/978-3-319-24783-0_7; Guilmoto CZ, 2013, ECON POLIT WEEKLY, V48, P59; Haub C., 2015, Population Bulletin, V70; Huinink J, 2009, INT SOCIOL, V24, P299, DOI 10.1177/0268580909102910; Hutchison E.D., 2011, ENCY ADOLESCENCE; James KS, 2011, SCIENCE, V333, P576, DOI 10.1126/science.1207969; Joshi S, 2018, GENDER EQUITY DEV; Klasen S, 2015, WORLD BANK ECON REV, V29, P449, DOI 10.1093/wber/lhv003; Lahoti R, 2016, FEM ECON, V22, P168, DOI 10.1080/13545701.2015.1066022; Marphatia AA, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00269; McKinsey Global Institute, 2018, POW PAR ADV WOM EQ A; Moore AM., 2009, ADOLESCENT MARRIAGE; Munshi V, 2016, HEALTH AFFAIR, V35, P1759, DOI 10.1377/hlthaff.2016.0552; Navaneetham K, 2012, J POPUL AGEING, V5, P281, DOI 10.1007/s12062-012-9071-y; Neal SE, 2015, INT PERSPECT SEX R H, V41, P210, DOI 10.1363/4121015; Patricia Uberoi, 1994, FAMILY KINSHIP MARRI; Nguyen PH, 2019, LANCET CHILD ADOLESC, V3, P463, DOI 10.1016/S2352-4642(19)30110-5; Rai RK, 2017, SEX REPROD HEALTHC, V14, P13, DOI 10.1016/j.srhc.2017.08.006; Ross, 2007, GLOBAL FAMILY PLANNI, DOI 10.1038/sj.onc.1209990; ROSS JA, 1992, STUD FAMILY PLANN, V23, P187, DOI 10.2307/1966727; Sekhri S, 2014, J DEV STUD, V50, P1670, DOI 10.1080/00220388.2014.936397; Solotaroff JL., 2014, VIOLENCE WOMEN GIRLS; Srinivasan K, 2020, EC POLITICAL WEEKLY, V55; UN, 2019, WORLD POP PROSP; Verick S., 2018, IZA WORLD LABOR, V87	51	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242876	10.1371/journal.pone.0242876	http://dx.doi.org/10.1371/journal.pone.0242876			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370321	Green Published, gold			2022-12-27	WOS:000603611900101
J	Kamali, S; Mehraban, A				Kamali, Shirzad; Mehraban, Ahmad			Effects of Nitroxin and arbuscular mycorrhizal fungi on the agro-physiological traits and grain yield of sorghum (Sorghum bicolor L.) under drought stress conditions	PLOS ONE			English	Article							WATER-USE EFFICIENCY; OXIDATIVE DAMAGE; GROWTH; MAIZE; WHEAT; BACTERIA; LEAVES; PHOTOSYNTHESIS; ACCUMULATION; TOLERANCE	The use of bio-fertilizers in agro-ecosystems is considered to have the potential to improve plant growth in extreme environments featuring water shortages. However, while arbuscular mycorrhizal fungi (AMF) and bacteria bio-fertilizers have been used in other plants to enhance stress tolerance, little is known about their symbiotic effect on sorghum (Sorghum bicolor L.) growth under drought stress conditions. Therefore the aim of this study was to investigate the inoculation of sorghum with Nitroxin and Glomus mosseae and their interaction effects on the agro-physiological characteristics and grain yield of sorghum under drought stress conditions. Nitroxin is a bio-fertilizer that consists of a mixture of Azospirillum and Azotobacter bacteria. The results showed that co-inoculation of sorghum seeds with Nitroxin and AMF improved the chlorophyll (a, b and total) content, soluble proteins, water use efficiency) WUE(, relative water content (RWC), nitrogen (N) content in the plant, AMF spore density, proline content, grain yield, panicle length, the number of panicles per plant, grain number per panicle, 1000-grain weight and decreased the electrolyte leakage and water saturation deficit (WSD) in drought stress and non-stress conditions. Under drought stress conditions, there was a 27% increase in grain yield under the synergistic effects of bacteria and fungi compared to the non-application of these microorganisms. The results of this experiment show that Nitroxin and AMF bio-fertilizers can mitigate the negative effects of stress on plants in drought stress conditions by increasing the amount of photosynthetic pigments, soluble proteins and osmotic regulation and decreasing electrolyte leakage. We found that the combination of bacteria and AMF for sorghum growth and yield increment is a promising method to cope with the stress caused by drought.	[Kamali, Shirzad; Mehraban, Ahmad] Islamic Azad Univ, Zahedan Branch, Dept Agr, Zahedan, Iran	Islamic Azad University	Mehraban, A (corresponding author), Islamic Azad Univ, Zahedan Branch, Dept Agr, Zahedan, Iran.	Ahmadmehraban127@gmail.com						Abdelraouf R. E., 2013, Journal of Applied Sciences Research, V9, P2135; [Anonymous], 2017, Aesthet Surg J, V37, P1, DOI 10.1093/asj/sjx076; [Anonymous], 2017, INT J TECHNOL ASSESS, V33, P1, DOI 10.1017/S0266078417000050; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; [Anonymous], 2016, BMJ-BRIT MED J, V354, pi5130; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; [Anonymous], 2017, MORBIDITY MORTALITY, V66, P1; Antonelli M, 2014, BLOOD PURIFICAT, V37, P22, DOI 10.1159/000356835; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Azarpour E, 2012, J AGR RES, V7, P1534, DOI [10.5897/AJAR11.1767, DOI 10.5897/AJAR11.1767]; Bagheri V, 2019, J PLANT PROD, V41, P83; Barati V, 2020, J AGR SCI TECH-IRAN, V22, P1295; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Behl RK, 2007, J APPL BOT FOOD QUAL, V81, P95; Behrooz A, 2019, HORTSCIENCE, V54, P1087, DOI [10.21273/HORTSCI13961-19, 10.21273/HORTSCI13961-1]; Bouchemal K, 2017, ARCH AGRON SOIL SCI, V63, P710, DOI 10.1080/03650340.2016.1235267; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buranova S, 2015, INT J PLANT PROD, V9, P257; Cakir R, 2004, FIELD CROP RES, V89, P1, DOI 10.1016/j.fcr.2004.01.005; Carina V. T., 2016, Journal of Applied Pharmaceutical Science, V6, P131; Cely MVT, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00720; Cheng NH, 2004, J BIOL CHEM, V279, P2922, DOI 10.1074/jbc.M309084200; Chu XT, 2016, S AFR J BOT, V104, P21, DOI 10.1016/j.sajb.2015.10.001; Chutipaijit S, 2016, CHIL J AGR RES, V76, DOI 10.4067/S0718-583920160004-00009; Copetta A, 2006, MYCORRHIZA, V16, P485, DOI 10.1007/s00572-006-0065-6; Daniels BA, 1982, METHODS PRINCIPLES M; Darbani M., 2017, Journal of Chemical Health Risks, V7, P313; DEHKHODA A, 2013, INT J FARMING ALLIED, V2, P1319; Dordas CA, 2008, IND CROP PROD, V27, P75, DOI 10.1016/j.indcrop.2007.07.020; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Evelin H, 2009, ANN BOT-LONDON, V104, P1263, DOI 10.1093/aob/mcp251; Farnia A, 2015, INT J BIOL PHARM ALL, V4, P661; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Gholiloo MJ, 2019, J PLANT NUTR, V42, P1417, DOI 10.1080/01904167.2019.1628972; Harishkumar JM, 2019, INT J CURR MICROBIOL, V8, P1316, DOI [10.20546/ijcmas.2019.806.159, DOI 10.20546/IJCMAS.2019.806.159]; Hashem A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01089; Hopkins W. G, 2008, INTRO PLANT PHYSL; Jabereldar A. A., 2017, International Journal of Agriculture and Forestry, V7, P1; JAIN DK, 1985, CAN J MICROBIOL, V31, P206, DOI 10.1139/m85-039; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Kahil A., 2017, ANN RES REV BIOL, V17, P1, DOI DOI 10.9734/ARRB/2017/36099; Kazemi J. S., 2018, Journal of Agronomy, V17, P18; Khaitov B, 2015, ECOL EVOL, V5, P3756, DOI 10.1002/ece3.1654; Kishor K, 2017, J PHARMACOGN PHYTOCH, V6; Lamochi S, 2018, J CROP NUTR SCI, V4, P2423; LEVY D, 1983, POTATO RES, V26, P315, DOI 10.1007/BF02356153; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mafakheri A, 2010, AUST J CROP SCI, V4, P580; Miller MH, 2000, CAN J PLANT SCI, V80, P47, DOI 10.4141/P98-130; Morgan JM, 1999, AUST J AGR RES, V50, P953, DOI 10.1071/AR98143; NAIK VV, 2015, INT J PLANT BIOL RES, V3, P1031; Nanjundappa Anuroopa, 2019, Fungal Biol Biotechnol, V6, P23, DOI 10.1186/s40694-019-0086-5; Niu XG, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02580; Nosheen A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00104; Nxele X, 2017, S AFR J BOT, V108, P261, DOI 10.1016/j.sajb.2016.11.003; Oliveira L. A. R. de, 2018, Journal of Agricultural Science (Toronto), V10, P135, DOI 10.5539/jas.v10n5p135; Oliveira Neto CF-D, 2014, J FOOD AGRIC ENVIRON, V12, P223; Omae H, 2007, PLANT PROD SCI, V10, P28, DOI 10.1626/pps.10.28; Promita Datta, 2014, Notulae Scientia Biologicae, V6, P381; Rahimi A, 2019, AGRICULTURE-BASEL, V9, DOI 10.3390/agriculture9060122; Rane J., 2001, Indian Journal of Plant Physiology, V6, P53; Rani B., 2017, INT J CURR MICROBIOL, V6, P916, DOI [10.20546/ijcmas.2017.610.110, DOI 10.20546/IJCMAS.2017.610.110]; Ribaut JM, 2012, HDB MAIZE ITS BIOL, P11; Rouphael Y, 2008, HORTSCIENCE, V43, P730, DOI 10.21273/HORTSCI.43.3.730; Russo A, 2005, BIOL FERT SOILS, V41, P301, DOI 10.1007/s00374-005-0854-7; SAADALLA MM, 1990, CROP SCI, V30, P1243, DOI 10.2135/cropsci1990.0011183X003000060017x; Saud S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00983; Shi ZY, 2020, J FUNGI, V6, DOI 10.3390/jof6020044; Szopinski M., 2019, FRONT PLANT SCI, P1; Tambussi EA, 2000, PHYSIOL PLANTARUM, V108, P398, DOI 10.1034/j.1399-3054.2000.108004398.x; Vamerali T, 2003, PLANT SOIL, V255, P157, DOI 10.1023/A:1026123129575; Van Oosten MJ, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1411-5; Wang FY, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090289; Xiong X, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8050066; Xu HW, 2018, EMIR J FOOD AGR, V30, P199, DOI 10.9755/ejfa.2018.v30.i3.1642; Yadav R. S., 2001, Indian Journal of Agricultural Research, V35, P104; Yan WM, 2016, ACTA AGR SCAND B-S P, V66, P133, DOI 10.1080/09064710.2015.1083610; Yang X, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37161-x; Zahir ZA, 2004, ADV AGRON, V81, P97, DOI 10.1016/S0065-2113(03)81003-9; Zarei M, 2014, ARCH AGRON SOIL SCI, V60, P993, DOI 10.1080/03650340.2013.853289; Zhang JT, 2007, ECOL ENG, V31, P115, DOI 10.1016/j.ecoleng.2007.06.003; Zhang ZJ, 2006, BIOL PLANTARUM, V50, P453, DOI 10.1007/s10535-006-0069-2; Zhao Z., 2012, J COMPUTER SCI COMPU, V2, P35; Zhong C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01079; 2015, J BRIT ACAD, V3, P24; 2005, BIOL SCI SER, P1	86	9	9	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243824	10.1371/journal.pone.0243824	http://dx.doi.org/10.1371/journal.pone.0243824			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370318	Green Published, gold			2022-12-27	WOS:000603611900006
J	Rodriguez, PE; Frutos, MC; Adamo, MP; Cuffini, C; Camara, JA; Paglini, MG; Moreno, L; Camara, A				Rodriguez, Pamela Elizabeth; Frutos, Maria Celia; Adamo, Maria Pilar; Cuffini, Cecilia; Camara, Jorge Augusto; Paglini, Maria Gabriela; Moreno, Laura; Camara, Alicia			Human Metapneumovirus: Epidemiology and genotype diversity in children and adult patients with respiratory infection in Cordoba, Argentina	PLOS ONE			English	Article							GENETIC-VARIABILITY; PREVALENCE	Human Metapneumovirus (hMPV) is responsible for acute respiratory infections in humans, with clinical and epidemiological relevance in pediatric, elderly, and immunocompromised populations. These features are largely unknown in Cordoba, Argentina and in adults in general. Hence, our goal was to broadly characterize hMPV infection in patients of all ages hospitalized with acute respiratory infections in Cordoba, Argentina, including epidemiology, clinical features and genetic diversity. Nasopharyngeal secretions were obtained from 795 patients during 2011-2013, 621 patients were 0-25 years old and 174 were 26-85 years old. HMPV was assayed by RT-PCR and other respiratory viruses by indirect immunofluorescence. Local strains were identified by sequence analysis. Human Metapneumovirus was detected in 20.3% (161/795) patients, 13.1% as single infections and 7.2% in co-infections, more frequently with Respiratory Syncytial Virus. HMPV circulated during late winter and spring in all age patients, but mainly in children under 4 years old in 71.4% (115/161) and adults between 26 and 59 years old in 12.4% (20/161). The most prevalent diagnosis was mild acute respiratory infection in 59.6% (96/161) and bronchiolitis in 9.3% (15/161). Local strains were clustered within A(2) subtype; they presented 73-100% identities among them, showing a high degree of homology compared to isolations from neighboring countries. We demonstrate that hMPV circulated among all age patients with respiratory infection during 2011-2013 in Cordoba, contributing to the understanding of this virus, its diagnosis and patient handling in local health-care centers.	[Rodriguez, Pamela Elizabeth; Frutos, Maria Celia; Adamo, Maria Pilar; Cuffini, Cecilia; Camara, Jorge Augusto; Paglini, Maria Gabriela; Camara, Alicia] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Cordoba, Argentina; [Paglini, Maria Gabriela] Univ Nacl Cordoba, CONICET, INIMEC, Inst Invest Med Mercedes & Martin Ferreyra, Cordoba, Argentina; [Moreno, Laura] Univ Nacl Cordoba, Hosp Ninos Santisima Trinidad Cordoba, Catedra Clin Pediat, Fac Ciencias Med, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba	Rodriguez, PE (corresponding author), Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Cordoba, Argentina.	rpamelaelizabeth@gmail.com	Rodriguez, Pamela Elizabeth/GLQ-6088-2022	Rodriguez, Pamela Elizabeth/0000-0003-3827-3760	SECyT-UNC; Fundacion A. J. Roemmers	SECyT-UNC(Secretaria de Ciencia y Tecnologia (SECYT)); Fundacion A. J. Roemmers	A. C. [2014-2015, 2016-2017] SECyT-UNC. https://www.unc.edu.ar/ciencia-y-tecnolog% C3%ADa/subsidios-secyt A. C. [Consolidar 2018-2021] SECyT-UNC. https://www.unc.edu.ar/ciencia-y-tecnolog%C3%ADa/subsidios-secyt A. C. [2014-2016, 2018-2020] Fundacion A. J. Roemmers. https://www.roemmers.com.ar/es/compromiso/fundacion/investigacion The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego LE, 2018, J MED VIROL, V90, P604, DOI 10.1002/jmv.24969; Afonso CL, 2016, ARCH VIROL, V161, P2351, DOI 10.1007/s00705-016-2880-1; Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; [Anonymous], 2014, SCI BACKGR NOBEL PRI, V2014, P1, DOI DOI 10.1186/1687-1847-2014-1; Talavera GA, 2007, AM J TROP MED HYG, V76, P182, DOI 10.4269/ajtmh.2007.76.182; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Bedolla-Barajas M, 2017, GAC MED MEX, V153, P329; Boivin G, 2004, EMERG INFECT DIS, V10, P1154, DOI 10.3201/eid1006.031097; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Bouscambert-Duchamp M, 2005, J CLIN MICROBIOL, V43, P1411, DOI 10.1128/JCM.43.3.1411-1414.2005; Broor S, 2008, J BIOSCIENCES, V33, P483, DOI 10.1007/s12038-008-0067-y; Caballero MT, 2019, J INFECT DIS, V219, P358, DOI 10.1093/infdis/jiy517; Camps M, 2008, J MED VIROL, V80, P1452, DOI 10.1002/jmv.21209; Carneiro BM, 2009, J MED VIROL, V81, P1814, DOI 10.1002/jmv.21555; Debur MDC., 2010, METAPNEUMOVIRUS HUMA; Divarathna MVM, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2090; Easton AJ, 2004, CLIN MICROBIOL REV, V17, P390, DOI 10.1128/CMR.17.2.390-412.2004; Feuillet F, 2012, J CLIN VIROL, V53, P97, DOI 10.1016/j.jcv.2011.10.002; Galiano M, 2006, J MED VIROL, V78, P631, DOI 10.1002/jmv.20586; Galiano M, 2004, J MED VIROL, V72, P299, DOI 10.1002/jmv.10536; Gregianini TS, 2018, REV SOC BRAS MED TRO, V51, P30, DOI 10.1590/0037-8682-0435-2017; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas LEM, 2013, VIRUSES-BASEL, V5, P87, DOI 10.3390/v5010087; Jallow MM, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4096-y; Kim CK, 2010, J KOREAN MED SCI, V25, P342, DOI 10.3346/jkms.2010.25.3.342; Garcia-Garcia ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173504; Marcone DN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1213-4; Marcone DN, 2013, PEDIATR INFECT DIS J, V32, pE105, DOI 10.1097/INF.0b013e31827cd06f; Panda S, 2014, INT J INFECT DIS, V25, P45, DOI 10.1016/j.ijid.2014.03.1394; Papenburg J, 2013, J CLIN VIROL, V58, P541, DOI 10.1016/j.jcv.2013.08.029; Pizzorno A, 2010, J MED VIROL, V82, P861, DOI 10.1002/jmv.21752; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prado MA, 2007, REV CHIL INFECTOL, V24, P19; Rodriguez Pamela Elizabeth, 2016, Rev Fac Cien Med Univ Nac Cordoba, V73, P170; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Shafagati Nazly, 2018, F1000Res, V7, P135, DOI 10.12688/f1000research.12625.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van den Hoogen BG, 2004, EMERG INFECT DIS, V10, P658, DOI 10.3201/eid1004.030393; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; Van den Hoogen BG, 2004, PEDIATR INFECT DIS J, V23, pS25, DOI 10.1097/01.inf.0000108190.09824.e8; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Wentworth D., 2014, HUMAN METAPNEUMOVIRU; Wolf JM, 2015, REV SOC BRAS MED TRO, V48, P762, DOI 10.1590/0037-8682-0107-2015; Zhang L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019308	44	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244093	10.1371/journal.pone.0244093	http://dx.doi.org/10.1371/journal.pone.0244093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370354	Green Published, gold			2022-12-27	WOS:000603611900106
J	Shirasuna, K; Ito, M; Matsuda, T; Enomoto, T; Ohara, Y; Yamamoto, M; Nishijima, S; Ohkohchi, N; Kuromitsu, S				Shirasuna, Kenna; Ito, Masayuki; Matsuda, Takashi; Enomoto, Tsuyoshi; Ohara, Yusuke; Yamamoto, Masayoshi; Nishijima, Satomi; Ohkohchi, Nobuhiro; Kuromitsu, Sadao			Correlation analysis of the proportion of monocytic myeloid-derived suppressor cells in colorectal cancer patients	PLOS ONE			English	Article							T-CELLS; STAGE; PROGRESSION; CHEMOTHERAPY; SURVIVAL	Monocytic myeloid-derived suppressor cells (mMDSCs) are a class of immunosuppressive immune cells with prognostic value in many solid tumors. It is reported that the proportion of mMDSCs in the peripheral blood can be a predictive marker for response to cancer immunotherapy. In this study, we performed a correlation analysis of the proportion of mMDSCs in freshly-drawn peripheral blood, levels of plasma proteins, and demographic factors in colorectal cancer (CRC) patients, to find factors that could be used to predict mMDSC proportions. Freshly-drawn mMDSCs were measured using flow cytometry on peripheral blood mononuclear cells (PBMCs) from healthy donors (n = 24) and CRC patients (n = 78). The plasma concentrations of 29 different cytokines, chemokines, growth factors, and enzymes were measured using a multiplex assay or enzyme-linked immunosorbent assay. Correlation analysis to find mMDSC-associated factors was conducted using univariate and multivariate models. In univariate correlation analysis, there were no plasma proteins that were associated with mMDSC proportions in CRC patients. In multivariate analysis, considering all variables including age, sex, and plasma proteins, levels of inducible nitric acid synthase (iNOS) (p = 0.013) and platelet-derived growth factor (PDGF)-BB (p = 0.035) were associated with mMDSC proportion in PBMCs (mMDSC proportion [%] = 0.2929 - 0.2389 * PDGF-BB + 0.3582 * iNOS) (p < 0.005, r = 0.32). Measuring the plasma concentrations of iNOS and PDGF-BB may be useful in predicting the proportion of mMDSCs in CRC patients' peripheral blood. Further research is required to establish and validate these predictive factors. Data registration Patient data were registered in an anonymization system at Tsukuba Clinical Research & Development Organization (T-CReDO).	[Shirasuna, Kenna; Ito, Masayuki; Matsuda, Takashi; Nishijima, Satomi; Kuromitsu, Sadao] Astellas Pharma Inc, Drug Discovery Res, Ibaraki, Japan; [Enomoto, Tsuyoshi; Ohara, Yusuke; Ohkohchi, Nobuhiro] Univ Tsukuba Hosp, Fac Med, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Ibaraki, Japan; [Yamamoto, Masayoshi] Ibaraki Western Med Ctr, Ibaraki, Japan	Astellas Pharmaceuticals; University of Tsukuba	Shirasuna, K (corresponding author), Astellas Pharma Inc, Drug Discovery Res, Ibaraki, Japan.	kenna.shirasuna@astellas.com			Astellas Pharma, Inc.	Astellas Pharma, Inc.(Astellas Pharmaceuticals)	The authors declare that, other than income received from our primary employers, no financial support or compensation has been received for this research and that there are no personal conflicts of interest to declare. This research did not receive any specific grant from funding agencies in the public, commercial, or not for profit sectors. The funding organization (Astellas Pharma, Inc.) did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of author's salaries and/or research materials.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Bronte V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12150; Bruger AM, 2019, CANCER IMMUNOL IMMUN, V68, P631, DOI 10.1007/s00262-018-2170-8; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Florcken A, 2015, IMMUNOL LETT, V168, P260, DOI 10.1016/j.imlet.2015.10.001; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gebhardt C, 2015, CLIN CANCER RES, V21, P5453, DOI 10.1158/1078-0432.CCR-15-0676; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grutzner E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0755-y; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Kanterman J, 2014, CANCER RES, V74, P6022, DOI 10.1158/0008-5472.CAN-14-0657; Kitano S, 2014, CANCER IMMUNOL RES, V2, P812, DOI 10.1158/2326-6066.CIR-14-0013; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Ma PW, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01401; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2010, EUR J IMMUNOL, V40, P3317, DOI 10.1002/eji.201041170; Markowitz J, 2015, CANCER IMMUNOL IMMUN, V64, P149, DOI 10.1007/s00262-014-1618-8; Martens A, 2016, CLIN CANCER RES, V22, P2908, DOI 10.1158/1078-0432.CCR-15-2412; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Poschke I, 2012, CLIN IMMUNOL, V144, P250, DOI 10.1016/j.clim.2012.06.003; R Core Team, 2019, R LANG ENV STAT COMP; Sade-Feldman M, 2016, CLIN CANCER RES, V22, P5661, DOI 10.1158/1078-0432.CCR-15-3104; Santegoetst SJAM, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0031-3; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Stanojevic I, 2016, INT IMMUNOL, V28, P87, DOI 10.1093/intimm/dxv053; Tada K, 2016, CANCER IMMUNOL RES, V4, P592, DOI 10.1158/2326-6066.CIR-15-0298; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Weber J, 2016, CANCER IMMUNOL RES, V4, P345, DOI 10.1158/2326-6066.CIR-15-0193; Weide B, 2014, CLIN CANCER RES, V20, P1601, DOI 10.1158/1078-0432.CCR-13-2508; Yaddanapudi K, 2016, CANCER IMMUNOL RES, V4, P101, DOI 10.1158/2326-6066.CIR-15-0070-T; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057114	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243643	10.1371/journal.pone.0243643	http://dx.doi.org/10.1371/journal.pone.0243643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370317	Green Published, gold			2022-12-27	WOS:000603611900044
J	Kwon, HC; Yu, YW; Fairclough, RH; Chen, TY				Kwon, Hwoi Chan; Yu, Yawei; Fairclough, Robert H.; Chen, Tsung-Yu			Proton-dependent inhibition, inverted voltage activation, and slow gating of CLC-0 Chloride Channel	PLOS ONE			English	Article							TORPEDO ELECTROPLAX; C-TERMINUS; EXPRESSION; CLONING; STATE; RECONSTITUTION; DISRUPTION; MUTATIONS; DISEASE; RESIDUE	CLC-0, a prototype Cl- channel in the CLC family, employs two gating mechanisms that control its ion-permeation pore: fast gating and slow gating. The negatively-charged sidechain of a pore glutamate residue, E166, is known to be the fast gate, and the swinging of this sidechain opens or closes the pore of CLC-0 on the millisecond time scale. The other gating mechanism, slow gating, operates with much slower kinetics in the range of seconds to tens or even hundreds of seconds, and it is thought to involve still-unknown conformational rearrangements. Here, we find that low intracellular pH (pH(i)) facilitates the closure of the CLC-0's slow gate, thus generating current inhibition. The rate of low pH(i)-induced current inhibition increases with intracellular H+ concentration ([H+](i))-the time constants of current inhibition by low pH(i) = 4.5, 5.5 and 6 are roughly 0.1, 1 and 10 sec, respectively, at room temperature. In comparison, the time constant of the slow gate closure at pH(i) = 7.4 at room temperature is hundreds of seconds. The inhibition by low pH(i) is significantly less prominent in mutants favoring the slow-gate open state (such as C212S and Y512A), further supporting the fact that intracellular H+ enhances the slow-gate closure in CLC-0. A fast inhibition by low pH(i) causes an apparent inverted voltage-dependent activation in the wild-type CLC-0, a behavior similar to those in some channel mutants such as V490W in which only membrane hyperpolarization can open the channel. Interestingly, when V490W mutation is constructed in the background of C212S or Y512A mutation, the inverted voltage-dependent activation disappears. We propose that the slow kinetics of CLC-0's slow-gate closure may be due to low [H+](i) rather than due to the proposed large conformational change of the channel protein. Our results also suggest that the inverted voltage-dependent opening observed in some mutant channels may result from fast closure of the slow gate by the mutations.	[Kwon, Hwoi Chan; Fairclough, Robert H.; Chen, Tsung-Yu] Univ Calif Davis, Biophys Grad Program, Davis, CA 95616 USA; [Yu, Yawei; Fairclough, Robert H.; Chen, Tsung-Yu] Univ Calif Davis, BMCDB Grad Program, Davis, CA 95616 USA; [Fairclough, Robert H.; Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Yu, Yawei] Univ Calif Berkeley, Dept Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Berkeley	Chen, TY (corresponding author), Univ Calif Davis, Biophys Grad Program, Davis, CA 95616 USA.; Chen, TY (corresponding author), Univ Calif Davis, BMCDB Grad Program, Davis, CA 95616 USA.; Chen, TY (corresponding author), Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA.; Chen, TY (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	tycchen@ucdavis.edu			NIH [R01GM065447]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an NIH grant R01GM065447. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts of the American Society of Hematology, 2003, BLOOD, V2003, p1a; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Awards Arbitral, 1999, ILR, V114, P1; Bennetts B, 2007, J BIOL CHEM, V282, P32780, DOI 10.1074/jbc.M703259200; Bennetts B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3507; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Chen MF, 2001, J GEN PHYSIOL, V118, P23, DOI 10.1085/jgp.118.1.23; Chen TY, 2012, J PHYSIOL-LONDON, V590, P3407, DOI 10.1113/jphysiol.2012.238337; Chen TY, 1998, J GEN PHYSIOL, V112, P715, DOI 10.1085/jgp.112.6.715; Chen TY, 2005, ANNU REV PHYSIOL, V67, P809, DOI 10.1146/annurev.physiol.67.032003.153012; Chen TY, 2003, J GEN PHYSIOL, V122, P641, DOI 10.1085/jgp.200308846; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Dutzler R, 2004, FEBS LETT, V564, P229, DOI 10.1016/S0014-5793(04)00210-8; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Engh AM, 2007, J GEN PHYSIOL, V130, P335, DOI 10.1085/jgp.200709759; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fong PY, 1998, AM J PHYSIOL-CELL PH, V274, pC966, DOI 10.1152/ajpcell.1998.274.4.C966; Gradogna A, 2013, BIOPHYS J, V105, P80, DOI 10.1016/j.bpj.2013.05.044; HANKE W, 1983, J GEN PHYSIOL, V82, P25, DOI 10.1085/jgp.82.1.25; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Jentsch TJ, 2018, PHYSIOL REV, V98, P1493, DOI 10.1152/physrev.00047.2017; Jentsch TJ, 2015, J PHYSIOL-LONDON, V593, P4091, DOI 10.1113/JP270043; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lin CW, 2000, J GEN PHYSIOL, V116, P535, DOI 10.1085/jgp.116.4.535; Lisal J, 2008, NAT STRUCT MOL BIOL, V15, P805, DOI 10.1038/nsmb.1466; Lloyd SE, 1997, HUM MOL GENET, V6, P1233, DOI 10.1093/hmg/6.8.1233; Macias MJ, 2007, BIOCHEM J, V403, P79, DOI 10.1042/BJ20061230; Maduke M, 1999, J GEN PHYSIOL, V114, P713, DOI 10.1085/jgp.114.5.713; Matsumoto A, 2018, INTERNAL MED, V57, P3603, DOI 10.2169/internalmedicine.1272-18; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Miller C., 1980, Annals of the New York Academy of Sciences, V341, P534, DOI 10.1111/j.1749-6632.1980.tb47197.x; Miller C, 2006, NATURE, V440, P484, DOI 10.1038/nature04713; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Park E, 2018, ELIFE, V7, DOI 10.7554/eLife.36629; Park E, 2017, NATURE, V541, P500, DOI 10.1038/nature20812; Pedersen TH, 2016, J GEN PHYSIOL, V147, P291, DOI 10.1085/jgp.201611582; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Pusch M, 1997, J GEN PHYSIOL, V109, P105, DOI 10.1085/jgp.109.1.105; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Schrecker M, 2020, ELIFE, V9, DOI 10.7554/eLife.59555; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Tseng PY, 2007, J GEN PHYSIOL, V130, P217, DOI 10.1085/jgp.200709817; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Wang KT, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000218; WHITE MM, 1979, J BIOL CHEM, V254, P161; Yu YW, 2015, J GEN PHYSIOL, V146, P495, DOI 10.1085/jgp.201511413; Zhang SS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb4747; Zifarelli G, 2008, J GEN PHYSIOL, V132, P185, DOI 10.1085/jgp.200809999; Zifarelli G, 2010, EUR BIOPHYS J BIOPHY, V39, P869, DOI 10.1007/s00249-008-0393-x	60	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0240704	10.1371/journal.pone.0240704	http://dx.doi.org/10.1371/journal.pone.0240704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362212	Green Published, Green Submitted, gold			2022-12-27	WOS:000603071600018
J	Finn, PB; Bhimsaria, D; Ali, A; Eguchi, A; Ansari, AZ; Dervan, PB				Finn, Paul B.; Bhimsaria, Devesh; Ali, Asfa; Eguchi, Asuka; Ansari, Aseem Z.; Dervan, Peter B.			Single position substitution of hairpin pyrrole-imidazole polyamides imparts distinct DNA-binding profiles across the human genome	PLOS ONE			English	Article							SEQUENCE-SPECIFIC RECOGNITION; MINOR-GROOVE; TRANSCRIPTION FACTORS; GENE-EXPRESSION; NUCLEAR-LOCALIZATION; STRUCTURAL BASIS; OPEN CHROMATIN; BASE-PAIRS; DESIGN; SPECIFICITY	Pyrrole-imidazole (Py-Im) polyamides are synthetic molecules that can be rationally designed to target specific DNA sequences to both disrupt and recruit transcriptional machinery. While in vitro binding has been extensively studied, in vivo effects are often difficult to predict using current models of DNA binding. Determining the impact of genomic architecture and the local chromatin landscape on polyamide-DNA sequence specificity remains an unresolved question that impedes their effective deployment in vivo. In this report we identified polyamide-DNA interaction sites across the entire genome, by covalently crosslinking and capturing these events in the nuclei of human LNCaP cells. This technique confirms the ability of two eight ring hairpin-polyamides, with similar architectures but differing at a single ring position (Py to Im), to retain in vitro specificities and display distinct genome-wide binding profiles.	[Finn, Paul B.; Dervan, Peter B.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Bhimsaria, Devesh] Bio Informat, Jaipur, Rajasthan, India; [Ali, Asfa] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Eguchi, Asuka] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Ansari, Aseem Z.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA; [Finn, Paul B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	California Institute of Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; St Jude Children's Research Hospital; Stanford University	Finn, PB; Dervan, PB (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.; Finn, PB (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	pbfinn@stanford.edu; dervan@caltech.edu		Bhimsaria, Devesh/0000-0001-8413-3801				Anders L, 2014, NAT BIOTECHNOL, V32, P92, DOI 10.1038/nbt.2776; Ansari AZ, 2001, CHEM BIOL, V8, P583, DOI 10.1016/S1074-5521(01)00037-0; Arora PS, 2002, J AM CHEM SOC, V124, P13067, DOI 10.1021/ja0208355; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Best TP, 2003, P NATL ACAD SCI USA, V100, P12063, DOI 10.1073/pnas.2035074100; Bhimsaria D, 2018, P NATL ACAD SCI USA, V115, pE10586, DOI 10.1073/pnas.1811431115; Black JB, 2018, CURR OPIN GENET DEV, V52, P13, DOI 10.1016/j.gde.2018.05.001; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Carlson CD, 2010, P NATL ACAD SCI USA, V107, P4544, DOI 10.1073/pnas.0914023107; Chandran A, 2016, NUCLEIC ACIDS RES, V44, P4014, DOI 10.1093/nar/gkw283; Charlesworth CT, 2019, NAT MED, V25, P249, DOI 10.1038/s41591-018-0326-x; Chenoweth DM, 2010, J AM CHEM SOC, V132, P14521, DOI 10.1021/ja105068b; Chenoweth DM, 2009, P NATL ACAD SCI USA, V106, P13175, DOI 10.1073/pnas.0906532106; Crudele JM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05843-9; Dervan PB, 2018, DNA TARGETING MOL TH, P298, DOI 10.1039/; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edayathumangalam RS, 2004, P NATL ACAD SCI USA, V101, P6864, DOI 10.1073/pnas.0401743101; Erwin GS, 2017, SCIENCE, V358, P1617, DOI 10.1126/science.aan6414; Erwin GS, 2016, P NATL ACAD SCI USA, V113, pE7418, DOI 10.1073/pnas.1604847113; Erwin GS, 2014, ANGEW CHEM INT EDIT, V53, P10124, DOI 10.1002/anie.201405497; Gottesfeld JM, 1997, NATURE, V387, P202, DOI 10.1038/387202a0; Gottesfeld JM, 2001, J MOL BIOL, V309, P615, DOI 10.1006/jmbi.2001.4694; Heiderscheit EA, 2018, FEBS LETT, V592, P888, DOI 10.1002/1873-3468.12993; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hsu CF, 2007, TETRAHEDRON, V63, P6146, DOI 10.1016/j.tet.2007.03.041; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kabadi AM, 2014, METHODS, V69, P188, DOI 10.1016/j.ymeth.2014.06.014; Kashiwazaki G, 2016, CHEMBIOCHEM, V17, P1752, DOI 10.1002/cbic.201600282; Kawamoto Y, 2018, BIOORGAN MED CHEM, V26, P1393, DOI 10.1016/j.bmc.2018.01.026; Kielkopf CL, 1998, SCIENCE, V282, P111, DOI 10.1126/science.282.5386.111; Kurmis AA, 2019, NUCLEIC ACIDS RES, V47, P3828, DOI 10.1093/nar/gkz153; Kurmis AA, 2017, CANCER RES, V77, P2207, DOI 10.1158/0008-5472.CAN-16-2503; Kwonj Y, 2004, J AM CHEM SOC, V126, P15940, DOI 10.1021/ja0445140; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Lin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165581; Mapp AK, 2000, P NATL ACAD SCI USA, V97, P3930, DOI 10.1073/pnas.97.8.3930; Martinez TF, 2014, NUCLEIC ACIDS RES, V42, P11546, DOI 10.1093/nar/gku866; Meier JL, 2012, J AM CHEM SOC, V134, P17814, DOI 10.1021/ja308888c; Minoshima M, 2008, NUCLEIC ACIDS RES, V36, P2889, DOI 10.1093/nar/gkn116; Moretti R, 2008, ACS CHEM BIOL, V3, P220, DOI 10.1021/cb700258r; MRKSICH M, 1992, P NATL ACAD SCI USA, V89, P7586, DOI 10.1073/pnas.89.16.7586; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Nickols NG, 2007, NUCLEIC ACIDS RES, V35, P363, DOI 10.1093/nar/gkl1042; Nickols NG, 2013, MOL CANCER THER, V12, P675, DOI 10.1158/1535-7163.MCT-12-1040; Olenyuk BZ, 2004, P NATL ACAD SCI USA, V101, P16768, DOI 10.1073/pnas.0407617101; Puckett JW, 2007, J AM CHEM SOC, V129, P12310, DOI 10.1021/ja0744899; Puckett JW, 2012, ORG LETT, V14, P2774, DOI 10.1021/ol3010003; Rodriguez-Martinez JA, 2017, ELIFE, V6, DOI 10.7554/elife.19272.001; Sastry SS, 1997, J BIOL CHEM, V272, P3715, DOI 10.1074/jbc.272.6.3715; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Tietjen JR, 2011, METHOD ENZYMOL, V497, P3, DOI 10.1016/B978-0-12-385075-1.00001-9; Trauger JW, 1996, NATURE, V382, P559, DOI 10.1038/382559a0; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Urbach AR, 2002, J MOL BIOL, V320, P55, DOI 10.1016/S0022-2836(02)00430-8; Urbach AR, 2001, P NATL ACAD SCI USA, V98, P4343, DOI 10.1073/pnas.081070798; WADE WS, 1992, J AM CHEM SOC, V114, P8783, DOI 10.1021/ja00049a006; WADE WS, 1993, BIOCHEMISTRY-US, V32, P11385, DOI 10.1021/bi00093a015; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; White S, 1998, NATURE, V391, P468, DOI 10.1038/35106; White S, 1997, CHEM BIOL, V4, P569, DOI 10.1016/S1074-5521(97)90243-X; Wurtz NR, 2001, ORG LETT, V3, P1201, DOI 10.1021/ol0156796; Xu L, 2016, P NATL ACAD SCI USA, V113, P12426, DOI 10.1073/pnas.1612745113; Yang F, 2013, P NATL ACAD SCI USA, V110, P1863, DOI 10.1073/pnas.1222035110	67	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243905	10.1371/journal.pone.0243905	http://dx.doi.org/10.1371/journal.pone.0243905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351840	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000603071400029
J	Mainardi, F; Prozorovscaia, D; Sweeney, G; Green, H				Mainardi, Fabio; Prozorovscaia, Daniela; Sweeney, Gary; Green, Hilary			Development and validation of a meal quality index with applications to NHANES 2005-2014	PLOS ONE			English	Article							METHODOLOGY; PATTERNS	The Meal Balance Index (MBI) assesses the nutritional quality and balance of meals. It is a score between 0 and 100 that takes into account both shortfall and excess nutrients, adjusted for the energy content of the meal. In the present study the score was applied to 147849 meals reported in the National Health and Nutrition Examination Surveys (NHANES) 2005-2014 in order to evaluate its validity and compare against exemplary meals designed as part of 24h diets that meet US dietary guidelines. Meals from exemplary menu plans developed by nutrition experts scored on average 76 +/- 14 (mean +/- standard deviation) whereas those of NHANES participants scored 45 +/- 14. Scores of breakfast, lunch, dinner, snack, considered jointly as independent variables, were moderately but positively and significantly associated with the Healthy Eating Index (Pearson correlation 0.6). MBI scores were significantly associated with the density of positive micronutrients (e.g. Vit A, Vit C) and favorable food groups (e.g. fruits, whole grains) not directly included in the MBI algorithm. The MBI is a valid tool to assess the nutritional quality of meals reported in the US population and if applied to culinary recipe websites could potentially help users to understand which meals are nutritionally balanced. Choice of more balanced individual meals can guide healthier cooking and eating.	[Mainardi, Fabio; Prozorovscaia, Daniela; Green, Hilary] Nestle Res, Lausanne, Switzerland; [Sweeney, Gary] British Dietet Assoc, Birmingham, W Midlands, England	Nestle SA	Mainardi, F (corresponding author), Nestle Res, Lausanne, Switzerland.	fabio.mainardi@rd.nestle.com		Mainardi, Fabio/0000-0002-4825-4283				Cule E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-372; Drewnowski A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091200; Food and Agriculture Organization of the United Nations (FAO), FOOD BAS DIET GUID; Gorgulho BM, 2016, BRIT J NUTR, V115, P2017, DOI 10.1017/S0007114516000994; Gorgulho B, 2018, REV NUTR, V31, P567, DOI 10.1590/1678-98652018000600006; Gorski MT, 2015, J HEALTHC LEADERSH, V7, P81, DOI 10.2147/JHL.S69188; Guenther PM, 2014, J NUTR, V144, P399, DOI 10.3945/jn.113.183079; Herforth A, 2019, ADV NUTR, V10, P590, DOI 10.1093/advances/nmy130; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hyseni L, 2017, EUR J CLIN NUTR, V71, P694, DOI 10.1038/ejcn.2016.234; Krebs-Smith SM, 2010, J NUTR, V140, P1832, DOI 10.3945/jn.110.124826; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Louie JCY, 2015, EUR J CLIN NUTR, V69, P154, DOI 10.1038/ejcn.2014.256; Mainardi F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020379; McGuire S, 2016, ADV NUTR, V7, P202, DOI 10.3945/an.115.011684; Murakami K, 2019, NUTRITION, V59, P108, DOI 10.1016/j.nut.2018.07.110; Murakami K, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0283-0; Perez-Escamilla R, 2016, J NUTR, V146, P1924, DOI 10.3945/jn.115.218784; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Trattner C, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00016	21	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244391	10.1371/journal.pone.0244391	http://dx.doi.org/10.1371/journal.pone.0244391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351843	Green Published, gold			2022-12-27	WOS:000603071400013
J	Zhou, ZY; Yu, MH; Ding, GD; Gao, GL; He, YY				Zhou, Ziyuan; Yu, Minghan; Ding, Guodong; Gao, Guanglei; He, Yingying			Diversity and structural differences of bacterial microbial communities in rhizocompartments of desert leguminous plants	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; CARAGANA-KORSHINSKII; SUGAR-BEET; RHIZOSPHERE; ROOT; ESTABLISHMENT; AMENDMENT; GROWTH; SYMBIOSIS; SEEDLINGS	By assessing diversity variations of bacterial communities under different rhizocompartment types (i.e., roots, rhizosphere soil, root zone soil, and inter-shrub bulk soil), we explore the structural difference of bacterial communities in different root microenvironments under desert leguminous plant shrubs. Results will enable the influence of niche differentiation of plant roots and root soil on the structural stability of bacterial communities under three desert leguminous plant shrubs to be examined. High-throughput 16S rRNA genome sequencing was used to characterize diversity and structural differences of bacterial microbes in the rhizocompartments of three xeric leguminous plants. Results from this study confirm previous findings relating to niche differentiation in rhizocompartments under related shrubs, and they demonstrate that diversity and structural composition of bacterial communities have significant hierarchical differences across four rhizocompartment types under leguminous plant shrubs. Desert leguminous plants showed significant hierarchical filtration and enrichment of the specific bacterial microbiome across different rhizocompartments (P < 0.05). The dominant bacterial microbiome responsible for the differences in microbial community structure and composition across different niches of desert leguminous plants mainly consisted of Proteobacteria, Actinobacteria, and Bacteroidetes. All soil factors of rhizosphere and root zone soils, except for NO3-N and TP under C. microphylla and the two Hedysarum spp., recorded significant differences (P < 0.05). Moreover, soil physicochemical factors have a significant impact on driving the differentiation of bacterial communities under desert leguminous plant shrubs. By investigating the influence of niches on the structural difference of soil bacterial communities with the differentiation of rhizocompartments under desert leguminous plant shrubs, we provide data support for the identification of dominant bacteria and future preparation of inocula, and provide a foundation for further study of the host plants-microbial interactions.	[Zhou, Ziyuan; Yu, Minghan; Ding, Guodong; Gao, Guanglei; He, Yingying] Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing, Peoples R China; [Zhou, Ziyuan; Yu, Minghan; Ding, Guodong; Gao, Guanglei; He, Yingying] Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Yu, MH; Ding, GD (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Yanchi Res Stn, Beijing, Peoples R China.; Yu, MH; Ding, GD (corresponding author), Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Beijing, Peoples R China.	yuminghan@bjfu.edu.cn; dingguodong@bjfu.edu.cn			National Key Research and Development Program of China [2016YFC0500905, 2018YFC0507102]; National Natural Science Foundation of China [31270749]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Research and Development Program of China (no. 2016YFC0500905 and 2018YFC0507102), and the National Natural Science Foundation of China (no. 31270749).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Acosta-Martinez V, 2010, APPL SOIL ECOL, V45, P13, DOI 10.1016/j.apsoil.2010.01.005; Alguacil MM, 2003, SOIL USE MANAGE, V19, P277, DOI 10.1079/SUM2003206; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Azcon R, 2009, CHEMOSPHERE, V75, P327, DOI 10.1016/j.chemosphere.2008.12.029; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Barrett LG, 2015, J ECOL, V103, P130, DOI 10.1111/1365-2745.12336; Bashan Y, 2004, CAN J MICROBIOL, V50, P521, DOI [10.1139/w04-035, 10.1139/W04-035]; Beckers B, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0241-2; Beckers B, 2016, P NATL ACAD SCI USA, V113, P2312, DOI 10.1073/pnas.1523264113; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2006, FEMS MICROBIOL ECOL, V56, P250, DOI 10.1111/j.1574-6941.2005.00025.x; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bever JD, 2013, ECOL LETT, V16, P167, DOI 10.1111/ele.12024; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Bruneau A, 2013, TAXON, V62, P217, DOI 10.12705/622.8; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caravaca F, 2005, MICROB ECOL, V49, P73, DOI 10.1007/s00248-003-0131-y; Caravaca F, 2003, ENVIRON MANAGE, V31, P412, DOI 10.1007/s00267-002-2879-0; Caravaca F, 2002, SOIL BIOL BIOCHEM, V34, P1139, DOI 10.1016/S0038-0717(02)00047-0; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Costa R, 2006, FEMS MICROBIOL ECOL, V56, P236, DOI 10.1111/j.1574-6941.2005.00026.x; Deng ZS, 2011, FEMS MICROBIOL ECOL, V76, P463, DOI 10.1111/j.1574-6941.2011.01063.x; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; Dinnage R, 2019, J ECOL, V107, P977, DOI 10.1111/1365-2745.13083; Du YX, 2011, ENVIRON EARTH SCI, V64, P299, DOI 10.1007/s12665-010-0847-1; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Egamberdieva D, 2008, ENVIRON MICROBIOL, V10, P1, DOI 10.1111/j.1462-2920.2007.01424.x; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gao GL, 2014, ECOL INDIC, V43, P236, DOI 10.1016/j.ecolind.2014.03.001; Gao LF, 2002, LETT APPL MICROBIOL, V35, P347, DOI 10.1046/j.1472-765X.2002.01192.x; Garbeva P, 2008, PLANT SOIL, V302, P19, DOI 10.1007/s11104-007-9432-0; Garbeva P, 2011, SOIL BIOL BIOCHEM, V43, P469, DOI 10.1016/j.soilbio.2010.11.020; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Girvan MS, 2003, APPL ENVIRON MICROB, V69, P1800, DOI 10.1128/AEM.69.3.1800-1809.2003; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Heath KD, 2010, EVOLUTION, V64, P1446, DOI 10.1111/j.1558-5646.2009.00913.x; Hein JW, 2008, MICROB ECOL, V55, P333, DOI 10.1007/s00248-007-9279-1; Hoque MS, 2011, INT J SYST EVOL MICR, V61, P299, DOI 10.1099/ijs.0.021014-0; JENKINSON DS, 1989, SOIL BIOL BIOCHEM, V21, P535, DOI 10.1016/0038-0717(89)90127-2; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lai FR, 2010, CARBOHYD POLYM, V81, P323, DOI 10.1016/j.carbpol.2010.02.011; Lai ZR, 2016, FOREST ECOL MANAG, V359, P381, DOI 10.1016/j.foreco.2015.04.025; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li XZ, 2014, SOIL BIOL BIOCHEM, V68, P392, DOI 10.1016/j.soilbio.2013.10.017; Liu HW, 2017, SCI REP-UK, V7, DOI 10.1038/srep41766; Lu YL, 2009, INT J SYST EVOL MICR, V59, P3006, DOI 10.1099/ijs.0.007237-0; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Luo GW, 2018, FUNCT ECOL, V32, P1103, DOI 10.1111/1365-2435.13039; Lybrand RA, 2015, SOIL SCI SOC AM J, V79, P104, DOI 10.2136/sssaj2014.06.0242; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Medina A, 2004, CHEMOSPHERE, V56, P449, DOI 10.1016/j.chemosphere.2004.04.003; Mengual C, 2014, J ENVIRON MANAGE, V134, P1, DOI 10.1016/j.jenvman.2014.01.008; Mercado-Blanco J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01006; Merila P, 2010, APPL SOIL ECOL, V46, P259, DOI 10.1016/j.apsoil.2010.08.003; Miao L, 2016, WATER RES, V100, P405, DOI 10.1016/j.watres.2016.05.010; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; Narteh LT, 1997, GEODERMA, V76, P145, DOI 10.1016/S0016-7061(96)00097-3; Nemergut DR, 2010, SOIL BIOL BIOCHEM, V42, P2153, DOI 10.1016/j.soilbio.2010.08.011; Ojo VOA, 2019, TROP ANIM HEALTH PRO, V51, P867, DOI 10.1007/s11250-018-1767-4; Perez-Bejarano A, 2010, EUR J FOREST RES, V129, P15, DOI 10.1007/s10342-008-0246-2; R Development Core Team, 2011, R FDN STAT COMP; RECOUS S, 1990, SOIL BIOL BIOCHEM, V22, P913, DOI 10.1016/0038-0717(90)90129-N; Reinhold-Hurek B, 2006, MOL PLANT MICROBE IN, V19, P181, DOI 10.1094/MPMI-19-0181; Rilling JI, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02710; Rotenberg E, 2010, SCIENCE, V327, P451, DOI 10.1126/science.1179998; Sablok G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01348; Sanchez-Lopez AS, 2018, PLANT SOIL, V422, P51, DOI 10.1007/s11104-017-3176-2; Saul-Tcherkas V, 2011, MICROB ECOL, V61, P64, DOI 10.1007/s00248-010-9763-x; Sun YF, 2017, PLANT SOIL, V414, P281, DOI 10.1007/s11104-016-3111-y; Tang GY, 2008, MOLECULES, V13, P1189, DOI 10.3390/molecules13051189; Turner TR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-209; Van Horn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066103; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang D, 2012, CELL MICROBIOL, V14, P334, DOI 10.1111/j.1462-5822.2011.01736.x; Wang GH, 2015, ECOL RES, V30, P639, DOI 10.1007/s11284-015-1267-1; Wang JM, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02126; Wang YB, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00588; WICKRAMASINGHE KN, 1985, SOIL BIOL BIOCHEM, V17, P249, DOI 10.1016/0038-0717(85)90123-3; Xiao X, 2017, APPL MICROBIOL BIOT, V101, P8485, DOI 10.1007/s00253-017-8550-8; Xiao X, 2017, MOL ECOL, V26, P1641, DOI 10.1111/mec.14027; Yates R, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0020-2; Young JPW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r34; Zgadzaj R, 2016, P NATL ACAD SCI USA, V113, pE7996, DOI 10.1073/pnas.1616564113; Zhang ZS, 2009, J PLANT RES, V122, P109, DOI 10.1007/s10265-008-0196-2; Zhu FX, 2018, SCI TOTAL ENVIRON, V637, P460, DOI 10.1016/j.scitotenv.2018.05.055	97	6	6	9	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0241057	10.1371/journal.pone.0241057	http://dx.doi.org/10.1371/journal.pone.0241057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351824	gold, Green Published			2022-12-27	WOS:000603071400025
J	Gildner, TE; Laugier, EJ; Thayer, ZM				Gildner, Theresa E.; Laugier, Elise J.; Thayer, Zaneta M.			Exercise routine change is associated with prenatal depression scores during the COVID-19 pandemic among pregnant women across the United States	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; POSTPARTUM DEPRESSION; AEROBIC EXERCISE; BENEFITS; RISK; ANXIETY; SAFETY	Background The COVID-19 pandemic has negatively affected physical and mental health worldwide. Pregnant women already exhibit an elevated risk for depression compared to the general public, a pattern expected to be exacerbated by the pandemic. Certain lifestyle factors, including moderate exercise, may help support mental health during pregnancy, but it is unclear how the pandemic may impact these associations across different locations. Here, we test whether: (i) reported exercise routine alterations during the pandemic are associated with depression scores; and, (ii) the likelihood of reporting pandemic-related exercise changes varies between women living in metro areas and those in non-metro areas. Methods This cross-sectional study used data from the COVID-19 And Reproductive Effects (CARE) study, an online survey of pregnant women in the United States. Participants were recruited April-June 2020 (n = 1,856). Linear regression analyses assessed whether reported COVID-19-related exercise change was associated with depression score as measured by the Edinburgh Postnatal Depression Survey. Logistic regression analyses tested whether a participant's Rural-Urban Continuum Code classification of "metro" was linked with higher odds of reporting exercise changes compared to a "non-metro" classification. Results Women who reported exercise changes during the pandemic exhibited significantly higher depression scores compared to those reporting no changes. Moreover, individuals living in metro areas of all sizes were significantly more likely to report exercise changes compared to women living in non-metro areas. Conclusions These results suggest that the ability to maintain an exercise routine during the pandemic may help support maternal mental health. It may therefore be prudent for providers to explicitly ask patients how the pandemic has impacted their exercise routines and consider altered exercise routines a potential risk factor for depression. An effort should also be made to recommend exercises that are tailored to individual space restrictions and physical health.	[Gildner, Theresa E.; Laugier, Elise J.; Thayer, Zaneta M.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [Gildner, Theresa E.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Laugier, Elise J.; Thayer, Zaneta M.] Dartmouth Coll, Ecol Evolut Environm & Soc Program, Hanover, NH 03755 USA	Dartmouth College; Washington University (WUSTL); Dartmouth College	Gildner, TE (corresponding author), Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA.; Gildner, TE (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	Theresa.E.Gildner@dartmouth.edu		Laugier, Elise/0000-0002-4313-4821				Abbas AM, 2020, SCAND J IMMUNOL, V92, DOI 10.1111/sji.12918; American College of Obstetricians and Gynecologists (ACOG), 2019, EX PREGN; [Anonymous], 2019, NATL VITAL STAT REP; Boscaglia N, 2003, AUST NZ J OBSTET GYN, V43, P41, DOI 10.1046/j.0004-8666.2003.00016.x; Brun CR, 2011, APPL PHYSIOL NUTR ME, V36, P577, DOI [10.1139/h11-036, 10.1139/H11-036]; Campolong K, 2018, ARCH WOMEN MENT HLTH, V21, P215, DOI 10.1007/s00737-017-0783-0; Center for Systems Science and Engineering (CSSE), 2020, COVID 19 DASHB; Centers for Disease Control and Prevention, 2020, COR DIS 2019 PEOPL C; Centers for Disease Control and Prevention (CDC), 2020, REPR HLTH DEPR PREGN; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cramp AG, 2009, ANN BEHAV MED, V37, P325, DOI 10.1007/s12160-009-9102-y; Dashraath P, 2020, AM J OBSTET GYNECOL, V222, P521, DOI 10.1016/j.ajog.2020.03.021; Davenport Margie H, 2020, Front Glob Womens Health, V1, P1, DOI 10.3389/fgwh.2020.00001; DiPietro L, 2019, MED SCI SPORT EXER, V51, P1292, DOI 10.1249/MSS.0000000000001941; El-Rafie MM, 2016, INT J WOMENS HEALTH, V8, P53, DOI 10.2147/IJWH.S94112; Fell DB, 2009, MATERN CHILD HLTH J, V13, P597, DOI 10.1007/s10995-008-0404-7; Robledo-Colonia AF, 2012, J PHYSIOTHER, V58, P9, DOI 10.1016/S1836-9553(12)70067-X; Haakstad LAH, 2020, ACTA OBSTET GYN SCAN, V99, P240, DOI 10.1111/aogs.13738; Hadi AS, 2006, REGRESSION ANAL EXAM, P281, DOI [10.1002/0470055464.ch11, DOI 10.1002/0470055464.CH11]; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hinton P S, 2001, Matern Child Health J, V5, P7, DOI 10.1023/A:1011315616694; Horwitz SM, 2007, J WOMENS HEALTH, V16, P678, DOI 10.1089/jwh.2006.0185; Mandolesi L, 2018, FRONT PSYCHOL, P9, DOI [10.3389/fpsyg.2018.00009, DOI 10.3389/FPSYG.2018.00009]; Mappa I, 2020, J PERINAT MED, V48, P545, DOI 10.1515/jpm-2020-0182; Marshall ES, 2013, PUBLIC HEALTH NURS, V30, P361, DOI 10.1111/phn.12006; Melton B, 2013, NURS HEALTH SCI, V15, P468, DOI 10.1111/nhs.12057; Mikkelsen K, 2017, MATURITAS, V106, P48, DOI 10.1016/j.maturitas.2017.09.003; Moreland A, 2020, MMWR-MORBID MORTAL W, V69, P1198, DOI 10.15585/mmwr.mm6935a2; Mudd LM, 2009, PREV MED, V49, P194, DOI 10.1016/j.ypmed.2009.06.004; Nakamura A, 2019, J AFFECT DISORDERS, V246, P29, DOI 10.1016/j.jad.2018.12.009; Narang K, 2020, MAYO CLIN PROC, V95, P1750, DOI 10.1016/j.mayocp.2020.05.011; Nascimento SL, 2012, CURR OPIN OBSTET GYN, V24, P387, DOI 10.1097/GCO.0b013e328359f131; Office of Management and Budget Standards, 1997, REV STAND CLASS FED; OpenStreetMap, 2017, TIGER LIN SHAP 2017; Poyatos-Leon R, 2017, BIRTH-ISS PERINAT C, V44, P200, DOI 10.1111/birt.12294; Prather H, 2012, PM&R, V4, P845, DOI 10.1016/j.pmrj.2012.07.012; Rallis S, 2014, WOMEN BIRTH, V27, pE36, DOI 10.1016/j.wombi.2014.08.002; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Santos-Rocha R., 2019, EXERCISE SPORTING AC, P95, DOI [10.1007/978-3-319-91032-1_5, DOI 10.1007/978-3-319-91032-1_5]; Shanes ED, 2020, AM J CLIN PATHOL, V154, P23, DOI 10.1093/ajcp/aqaa089; Sherin M, OBSTET GYNECOLOGY; Songoygard KM, 2012, ACTA OBSTET GYN SCAN, V91, P62, DOI 10.1111/j.1600-0412.2011.01262.x; Taylor Wendell C, 2006, J Phys Act Health, V3, pS30, DOI 10.1123/jpah.3.s1.s30; Thayer ZM, 2021, AM J HUM BIOL, V33, DOI 10.1002/ajhb.23508; Tinloy J, 2014, WOMEN HEALTH ISS, V24, pE99, DOI 10.1016/j.whi.2013.11.003; Tsakiridis I, 2019, ARCH GYNECOL OBSTET, V300, P849, DOI 10.1007/s00404-019-05270-1; United States Department of Agriculture, 2013, RUR URB CONT COD; Vargas-Terrones M, 2019, BRIT J SPORT MED, V53, P348, DOI 10.1136/bjsports-2017-098926; Weinberg R. S., 2014, HUMAN KINETICS	51	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243188	10.1371/journal.pone.0243188	http://dx.doi.org/10.1371/journal.pone.0243188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347484	Green Published, gold			2022-12-27	WOS:000603071100012
J	Murakami, M; Toyama, Y; Yonekura, M; Ohba, T; Matsuzaki, Y; Sawamura, D; Murakami, AM; Nishi, M; Itagaki, S; Tomita, H; Takeshima, H				Murakami, Manabu; Toyama, Yuichi; Yonekura, Manabu; Ohba, Takayoshi; Matsuzaki, Yasushi; Sawamura, Daisuke; Murakami, Agnieszka M.; Nishi, Miyuki; Itagaki, Shirou; Tomita, Hirofumi; Takeshima, Hiroshi			Decreased cardiac pacemaking and attenuated beta-adrenergic response in TRIC-A knockout mice	PLOS ONE			English	Article							BLOOD-PRESSURE; RYANODINE RECEPTOR; HEART-RATE; CHANNELS; MECHANISM; BASAL	Changes in intracellular calcium levels in the sinus node modulate cardiac pacemaking (the calcium clock). Trimeric intracellular cation (TRIC) channels are counterion channels on the surface of the sarcoplasmic reticulum and compensate for calcium release from ryanodine receptors, which play a major role in calcium-induced calcium release (CICR) and the calcium clock. TRIC channels are expected to affect the calcium clock in the sinus node. However, their physiological importance in cardiac rhythm formation remains unclear. We evaluated the importance of TRIC channels on cardiac pacemaking using TRIC-A-null (TRIC-A(-/-)) as well as TRIC-B(+/-)mice. Although systolic blood pressure (SBP) was not significantly different between wild-type (WT), TRIC-B+/-, and TRIC-A(-/-)mice, heart rate (HR) was significantly lower in TRIC-A(-/-)mice than other lines. Interestingly, HR and SBP showed a positive correlation in WT and TRIC-B(+/-)mice, while no such correlation was observed in TRIC-A(-/-)mice, suggesting modification of the blood pressure regulatory system in these mice. Isoproterenol (0.3 mg/kg) increased the HR in WT mice (98.8 +/- 15.1 bpm), whereas a decreased response in HR was observed in TRIC-A(-/-)mice (23.8 +/- 5.8 bpm), suggesting decreased sympathetic responses in TRIC-A(-/-)mice. Electrocardiography revealed unstable R-R intervals in TRIC-A(-/-)mice. Furthermore, TRIC-A(-/-)mice sometimes showed sinus pauses, suggesting a significant role of TRIC-A channels in cardiac pacemaking. In isolated atrium contraction or action potential recording, TRIC-A(-/-)mice showed decreased response to a beta-adrenergic sympathetic nerve agonist (isoproterenol, 100 nM), indicating decreased sympathetic responses. In summary, TRIC-A(-/-)mice showed decreased cardiac pacemaking in the sinus node and attenuated responses to beta-adrenergic stimulation, indicating the involvement of TRIC-A channels in cardiac rhythm formation and decreased sympathetic responses.	[Murakami, Manabu; Murakami, Agnieszka M.] Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori, Japan; [Toyama, Yuichi; Yonekura, Manabu; Tomita, Hirofumi] Hirosaki Univ, Grad Sch Med, Dept Cardiol & Nephrol, Hirosaki, Aomori, Japan; [Ohba, Takayoshi] Akita Univ, Grad Sch Med, Dept Cellular Physiol, Akita, Japan; [Matsuzaki, Yasushi; Sawamura, Daisuke] Hirosaki Univ, Grad Sch Med, Dept Dermatol, Hirosaki, Aomori, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch, Dept Biol Chem, Kyoto, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Fac Pharmaceut Sci, Kyoto, Japan; [Itagaki, Shirou] Sapporo Med Univ, Collaborat Ctr Community & Ind, Sapporo, Hokkaido, Japan	Hirosaki University; Hirosaki University; Akita University; Hirosaki University; Kyoto University; Sapporo Medical University	Murakami, M (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Pharmacol, Hirosaki, Aomori, Japan.	mmura0123@hotmail.co.jp	Tomita, Hirofumi/E-8627-2013	murakami, manabu/0000-0001-6704-1796	JSPS, KAKENHI [17K08527, 17H04319, 16K09489, 20K07255]	JSPS, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was sponsored in part by Grants-in-Aid for Scientific Research from JSPS, KAKENHI (17K08527(MM), 17H04319(MM), 16K09489(HT), and 20K07255(MM)).	[Anonymous], 2014, AM J PHYSIOL-RENAL, V307, pF891; Bitar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130487; Christofaro DGD, 2017, ARQ BRAS CARDIOL, V108, P405, DOI 10.5935/abc.20170050; EBASHI S, 1991, ANNU REV PHYSIOL, V53, P1, DOI 10.1146/annurev.ph.53.030191.000245; El-Ajouz S, 2017, J PHYSIOL-LONDON, V595, P4769, DOI 10.1113/JP273550; Han C, 2016, BIOCHEM BIOPH RES CO, V469, P897, DOI 10.1016/j.bbrc.2015.12.057; Huang CLH, 2017, PHYSIOL REV, V97, P283, DOI 10.1152/physrev.00007.2016; Imlach WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008698; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Larsson HP, 2010, J GEN PHYSIOL, V136, P237, DOI 10.1085/jgp.201010506; Murakami Manabu, 2008, J Biol Chem, V283, P24554, DOI 10.1074/jbc.M802319200; Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899; Shrestha N, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000700; TOCHIKUBO O, 1993, JPN CIRC J, V57, P1128, DOI 10.1253/jcj.57.1128; Vinogradova TM, 2009, J MOL CELL CARDIOL, V47, P456, DOI 10.1016/j.yjmcc.2009.06.014; Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1; Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yonekura M, 2018, J PHARMACOL SCI, V137, P55, DOI 10.1016/j.jphs.2018.04.003; Zhou XY, 2020, CIRC RES, V126, P417, DOI 10.1161/CIRCRESAHA.119.316241; ZHOU ZF, 1993, J PHYSIOL-LONDON, V466, P263	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244254	10.1371/journal.pone.0244254	http://dx.doi.org/10.1371/journal.pone.0244254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347504	gold, Green Published			2022-12-27	WOS:000603071100034
J	Boima, V; Agyabeng, K; Ganu, V; Dey, D; Yorke, E; Amissah-Arthur, MB; Wilson, AA; Yawson, AE; Mate-Kole, CC; Nonvignon, J				Boima, V.; Agyabeng, K.; Ganu, V.; Dey, D.; Yorke, E.; Amissah-Arthur, M. B.; Wilson, A. A.; Yawson, A. E.; Mate-Kole, C. C.; Nonvignon, J.			Willingness to pay for kidney transplantation among chronic kidney disease patients in Ghana	PLOS ONE			English	Article							GLOBAL BURDEN; PREFERENCES; VALUATION; DELIVERY	Background Kidney transplantation is the preferred treatment for patients with end stage renal disease. However, it is largely unavailable in many sub-Sahara African countries including Ghana. In Ghana, treatment for end stage renal disease including transplantation, is usually financed out-of-pocket. As efforts continue to be made to expand the kidney transplantation programme in Ghana, it remains unclear whether patients with Chronic Kidney Disease (CKD) would be willing to pay for a kidney transplant. Aim The aim of the study was to assess CKD patients' willingness to pay for kidney transplantation as a treatment option for end stage renal disease in Ghana. Methods A facility based cross-sectional study conducted at the Renal Outpatient clinic and Dialysis Unit of Korle-Bu Teaching Hospital among 342 CKD patients 18 years and above including those receiving haemodialysis. A consecutive sampling approach was used to recruit patients. Structured questionnaires were administered to obtain information on demographic, socio-economic, knowledge about transplant, perception of transplantation and willingness to pay for transplant. In addition, the INSPIRIT questionnaire was used to assess patients' level of religiosity and spirituality. Contingent valuation method (CVM) method was used to assess willingness to pay (WTP) for kidney transplantation. Logistic regression model was used to determine the significant predictors of WTP. Results The average age of respondents was 50.2 +/- 17.1 years with most (56.7% (194/342) being male. Overall, 90 out of the 342 study participants (26.3%, 95%CI: 21.7-31.3%) were willing to pay for a kidney transplant at the current going price (>= $ 17,550) or more. The median amount participants were willing to pay below the current price was $986 (IQR: $197 -$1972). Among those willing to accept (67.3%, 230/342), 29.1% (67/230) were willing to pay for kidney transplant at the prevailing price. Wealth quintile, social support in terms of number of family friends one could talk to about personal issues and number of family members one can call on for help were the only factors identified to be significantly predictive of willingness to pay (p-value < 0.05). Conclusion The overall willingness to pay for kidney transplant is low among chronic kidney disease patients attending Korle-Bu Teaching Hospital. Patients with higher socio-economic status and those with more family members one can call on for help were more likely to pay for kidney transplantation. The study's findings give policy makers an understanding of CKD patients circumstances regarding affordability of the medical management of CKD including kidney transplantation. This can help develop pricing models to attain an ideal poise between a cost effective but sustainable kidney transplant programme and improve patient access to this ultimate treatment option.	[Boima, V.; Dey, D.; Yorke, E.; Amissah-Arthur, M. B.; Mate-Kole, C. C.] Univ Ghana, Dept Med & Therapeut, Sch Med, Coll Hlth Sci, Accra, Ghana; [Agyabeng, K.; Yawson, A. E.] Univ Ghana, Dept Biostat, Sch Publ Hlth, Coll Hlth Sci, Accra, Ghana; [Ganu, V.] Korle Bu Teaching Hosp, Dept Med & Therapeut, Accra, Ghana; [Wilson, A. A.] Ghana Hlth Serv, Dept Publ Hlth, Greater Accra Reg Hosp, Accra, Ghana; [Mate-Kole, C. C.] Univ Ghana, Dept Psychol, Ctr Ageing Studies, Coll Humanities, Legon, Ghana; [Nonvignon, J.] Univ Ghana, Dept Hlth Policy Planning & Management, Sch Publ Hlth, Coll Hlth Sci, Accra, Ghana	University of Ghana; University of Ghana; Ghana Health Service; University of Ghana; University of Ghana	Boima, V (corresponding author), Univ Ghana, Dept Med & Therapeut, Sch Med, Coll Hlth Sci, Accra, Ghana.	vboima@ug.edu.gh		Boima, Vincent/0000-0002-0562-6307; Agyabeng, Kofi/0000-0001-8417-8161				Akazili J, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-26; Akoh JA, 2011, SAUDI J KIDNEY DIS T, V22, P637; Audureau E, 2019, J COMP EFFECT RES, V8, P357, DOI 10.2217/cer-2018-0106; Tran BX, 2018, PATIENT PREFER ADHER, V12, P2253, DOI 10.2147/PPA.S176262; Blanchet N J, 2012, Ghana Med J, V46, P76; Boima V, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13061; Cisse B, 2007, HEALTH POLICY, V80, P51, DOI 10.1016/j.healthpol.2006.02.011; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dolgin E, 2019, CANCER DISCOV, V9, P8, DOI 10.1158/2159-8290.CD-NB2018-163; Ene-Iordache B, 2016, LANCET GLOB HEALTH, V4, pE307, DOI 10.1016/S2214-109X(16)00071-1; Fryer D, 1986, EMPLOYMENT DEPRIVATI; Guimaraes C, 2009, DIABETES TECHNOL THE, V11, P567, DOI 10.1089/dia.2009.0034; HANEMANN M, 1991, AM J AGR ECON, V73, P1255, DOI 10.2307/1242453; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; HOEHN JP, 1987, J ENVIRON ECON MANAG, V14, P226, DOI 10.1016/0095-0696(87)90018-0; Ilori TO, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0186-2; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Klose T, 1999, HEALTH POLICY, V47, P97, DOI 10.1016/S0168-8510(99)00010-X; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Macro I., 2009, GHAN DEM HLTH SURV 2; Marra CA, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-43; MATEKOLE M, 1993, J HUM HYPERTENS, V7, P443; Mills KT, 2015, KIDNEY INT, V88, P950, DOI 10.1038/ki.2015.230; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Naicker Saraladevi, 2009, Ethn Dis, V19, pS1; OBRIEN B, 1994, MED DECIS MAKING, V14, P289, DOI 10.1177/0272989X9401400311; Osafo C, 2018, TRANSPLANTATION, V102, P539, DOI 10.1097/TP.0000000000002119; Pinto SL, 2009, RES SOC ADMIN PHARM, V5, P253, DOI 10.1016/j.sapharm.2008.10.001; Puteh Sharifa Ezat Wan, 2017, Asia Pac Fam Med, V16, P5, DOI 10.1186/s12930-017-0035-5; RANDALL A, 1974, J ENVIRON ECON MANAG, V1, P132, DOI 10.1016/0095-0696(74)90010-2; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Tannor EK, 2019, J CLIN HYPERTENS, V21, P1542, DOI 10.1111/jch.13672; Unutzer J, 2003, PSYCHIAT SERV, V54, P340, DOI 10.1176/appi.ps.54.3.340; Uzochukwu BSC, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-1; Yasunaga H, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-12; Zhou Q, 2018, WORLD J GASTROENTERO, V24, P4708, DOI 10.3748/wjg.v24.i41.4708	36	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244437	10.1371/journal.pone.0244437	http://dx.doi.org/10.1371/journal.pone.0244437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378327	Green Published, gold			2022-12-27	WOS:000605651300009
J	Holz, FG; Minnella, AM; Tuli, R; Yoganathan, P; Parikh, S; Hamilton, R				Holz, Frank G.; Minnella, Angelo M.; Tuli, Raman; Yoganathan, Pradeepa; Parikh, Soumil; Hamilton, Robin		LUMINOUS Study Grp	Ranibizumab treatment patterns in prior ranibizumab-treated neovascular age-related macular degeneration patients: Real-world outcomes from the LUMINOUS study	PLOS ONE			English	Article							VISUAL IMPAIRMENT; LEGAL BLINDNESS; POOLED ANALYSIS; AMD; PREVALENCE; SAFETY	Purpose To evaluate the effectiveness, safety, and treatment patterns of ranibizumab 0.5 mg in prior ranibizumab-treated patients with neovascular age-related macular degeneration (nAMD) enrolled in the LUMINOUS (TM) study. Patients and methods LUMINOUS, a 5-year, prospective, multicenter, observational study, recruited 30,138 adult patients (treatment-naive or prior ranibizumab-treated or other ocular treatments) across all approved indications for ranibizumab. Patients were treated as per local ranibizumab label of participating countries. Here we report the mean change in visual acuity (VA) at Year 1, treatment exposure, overall incidence of ocular, non-ocular adverse events (AEs) and serious AEs (SAEs) in prior ranibizumab-treated nAMD patients (n = 16,167). Results At baseline, the mean (standard deviation [SD]) age of patients was 78.4 (9.0) years, 59.0% were female, and 80.0% were Caucasian. At Year 1 (n = 10,168), the mean (SD) VA change was -1.6 (12.6) letters (baseline VA: 58.3 [19.0] letters) with a mean (SD) of 4.7 (3.1) ranibizumab injections. Stratified by duration of prior ranibizumab treatment of <1 (n = 4,112), 1 to <2 (n = 2,095), 2 to <3 (n = 1,506), 3 to <4 (n = 1,123), 4 to <5 (n = 689), and >= 5 (n = 256) years, the mean (SD) VA change at Year 1 were -1.2 (13.5), -2.0 (12.3), -2.0 (11.3), -1.9 (11.8), -2.5 (10.9), and 0.0 (11.2) letters, respectively. Mean (SD) VA change in patients who received <= 6 and >6 injections over 1 year was -1.8 (13.8) and +0.5 (12.5) letters, respectively. The rate of ocular/non-ocular AEs and SAEs across all prior ranibizumab-treated patients over 5 years were 13.29%/23.02% and 0.84%/13.66%, respectively. Conclusions Overall, regardless of the prior ranibizumab-treatment duration, VA was maintained in these patients at Year 1, and those receiving >= 6 injections showed a trend towards gaining letters. There were no new safety signals. These results may help inform routine clinical practice to appropriately treat nAMD patients with ranibizumab to achieve optimal visual outcomes.	[Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Minnella, Angelo M.] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli IRCCS, Dept Ophthalmol, Rome, Italy; [Tuli, Raman] Retina Ctr Ottawa, Ottawa, ON, Canada; [Tuli, Raman] Univ Ottawa, Dept Ophthalmol, Ottawa, ON, Canada; [Yoganathan, Pradeepa] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Yoganathan, Pradeepa] Windsor Eye Associates, Windsor, ON, Canada; [Yoganathan, Pradeepa] Wayne State Univ, Kresge Eye Inst, Detroit, MI USA; [Parikh, Soumil] Novartis Pharma AG, Basel, Switzerland; [Hamilton, Robin] Moorfields Eye Hosp, Moorfields Eye Hosp NHS Fdn Trust, Dept Med Retina, London, England; [Hamilton, Robin] Moorfields Eye Hosp, Biomed Res Ctr BRC, Natl Inst Hlth Res NIHR, London, England	University of Bonn; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Ottawa; University of Toronto; Wayne State University; Novartis; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Hamilton, R (corresponding author), Moorfields Eye Hosp, Moorfields Eye Hosp NHS Fdn Trust, Dept Med Retina, London, England.; Hamilton, R (corresponding author), Moorfields Eye Hosp, Biomed Res Ctr BRC, Natl Inst Hlth Res NIHR, London, England.	Robin.Hamilton@moorfields.nhs.uk		Hamilton, Robin/0000-0003-2861-8761	Bayer; Centervue; Genentech/Roche; Heidelberg Engineering; Novartis; Zeiss; Allergan; Bayer Healthcare; Novartis Pharmaceutical; Thea Laboratoire; Roche; Apelis; Novartis Pharmaceuticals; Novartis Pharma AG, Basel, Switzerland	Bayer(Bayer AG); Centervue; Genentech/Roche(Roche HoldingGenentech); Heidelberg Engineering; Novartis(Novartis); Zeiss; Allergan(AbbVieAllergan); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Novartis Pharmaceutical; Thea Laboratoire; Roche(Roche Holding); Apelis; Novartis Pharmaceuticals(Novartis); Novartis Pharma AG, Basel, Switzerland	FGH receives grants from Bayer, Centervue, Genentech/Roche, Heidelberg Engineering, Novartis, and Zeiss, and is a consultant for Acucela, Alcon, Bayer, BoehringerIngelheim, Galimedix, Genentech, Heidelberg Engineering, Lin-Bioscience, Khanghong, Oxurion, Novartis, Roche, and Zeiss. AMM is a consultant for Thea Laboratoire and receives travel and meeting grant from Allergan, Bayer Healthcare, Novartis Pharmaceutical, Thea Laboratoire. RT receives grants from Novartis, Roche and Apelis and is a member of Advisory boards in Novartis, Bayer. PY receives honoraria and non-financial support from Bayer and Novartis, honoraria from Alcon, Alimera Sciences, Allergan, Bausch and Lomb, Genentech, and Knight Therapeutics. SP is an employee of Novartis Pharma AG, Basel, Switzerland. RH Consultant for Allergan, Bayer Healthcare, Novartis Pharmaceuticals, and Roche; receives grants from Bayer Healthcare, Novartis Pharmaceuticals and Roche; receives lecture fees from Allergan, Roche, Bayer Healthcare, and Novartis Pharmaceuticals. Funding was provided by Novartis Pharma AG, Basel, Switzerland for the overall study design and medical writing and editorial assistance for this article. In conjunction with the LUMINOUS study group, Novartis Pharma AG, Basel, Switzerland, participated in the design of the study; analysis and interpretation of the data; preparation, review, and approval of the manuscript; and decision to submit the manuscript for publication. Additionally, Novartis Pharma AG was responsible for the conduct of the study and oversight of the collection and management of data. The study is registered with www.clinicaltrials.gov (NCT01318941).	Bloch SB, 2012, AM J OPHTHALMOL, V153, P209, DOI 10.1016/j.ajo.2011.10.016; Borooah S, 2015, EYE, V29, P1156, DOI 10.1038/eye.2015.83; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Bressler NM, 2011, ARCH OPHTHALMOL-CHIC, V129, P709, DOI 10.1001/archophthalmol.2011.140; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; DSUR, 2018, NOV DAT FIL; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gillies MC, 2015, OPHTHALMOLOGY, V122, P1837, DOI 10.1016/j.ophtha.2015.05.010; Holz FG, 2019, RETINA; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P1161, DOI 10.1136/bjophthalmol-2013-303232; Johnston RL, 2017, ADV THER, V34, P703, DOI 10.1007/s12325-017-0483-1; Johnston RL, 2016, OPHTHALMOLOGY, V123, P2386, DOI 10.1016/j.ophtha.2016.07.037; Kertes PJ, 2019, OPHTHALMOLOGY, V126, P841, DOI 10.1016/j.ophtha.2019.01.013; Kim HS, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e213; Lee AY, 2015, BRIT J OPHTHALMOL, V99, P1045, DOI 10.1136/bjophthalmol-2014-306229; Maguire MG, 2016, OPHTHALMOLOGY, V123, P1751, DOI 10.1016/j.ophtha.2016.03.045; Mitchell P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101072; Pagliarini S, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/857148; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rousseau C, 2015, VALUE HLTH, V18, P2670; Singer MA, 2012, OPHTHALMOLOGY, V119, P1175, DOI 10.1016/j.ophtha.2011.12.016; Tufail A, 2014, OPHTHALMOLOGY, V121, P1092, DOI 10.1016/j.ophtha.2013.11.031; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Zarbin MA, 2017, JAMA OPHTHALMOL, V135, P424, DOI 10.1001/jamaophthalmol.2017.0455	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244183	10.1371/journal.pone.0244183	http://dx.doi.org/10.1371/journal.pone.0244183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378369	Green Published, gold			2022-12-27	WOS:000605651300070
J	Yang, JCS; Lobenhoffer, P; Chang, CM; Chen, CF; Lin, HC; Ma, HH; Lee, PY; Lee, OKS				Yang, Jesse Chieh-Szu; Lobenhoffer, Philipp; Chang, Chia-Ming; Chen, Cheng-Fong; Lin, Hsiu-Chen; Ma, Hsuan-Hsiao; Lee, Pei-Yuan; Lee, Oscar Kuang-Sheng			A supplemental screw enhances the biomechanical stability in medial open-wedge high tibial osteotomy	PLOS ONE			English	Article							OSTEOARTHRITIS; KNEE; COMPLICATIONS; FRACTURES; SURVIVAL; CORTEX; UNION	Background The supplemental screw technique was introduced for salvage of lateral hinge fracture in medial open-wedge high tibial osteotomy (owHTO). The efficacy of its use in protection of lateral hinge fracture and corresponding biomechanical behaviors remained unclear. The current study was aimed to clarify if a supplemental screw can provide better protection to lateral hinge in biomechanical perspective. Materials An in vitro biomechanical test was conducted. Tibial sawbones, commercial owHTO plates and a cannulated screw were utilized for preparing the intact, owHTO, and owHTO with cannulated screw insertion specimens. A "staircase" dynamic load protocol was adopted for axial compressive test with increasing load levels to determine structural strength and durability by using a material testing system, while a motion capture system was applied for determining the dynamic changes in varus angle and posterior slope of the tibia plateau with various specimen preparation conditions. Results Type II lateral hinge fracture were the major failure pattern in all specimens prepared with owHTO. The insertion of a supplemental cannulated screw in medial owHTO specimens reinforced structural stability and durability in dynamic cyclic loading tests: the compressive stiffness increased to 58.9-62.2% of an intact specimen, whereas the owHTO specimens provided only 23.7-29.2% of stiffness of an intact specimen. In view of tibial plateau alignment, the insertion of a supplemental screw improved the structural deficiency caused by owHTO, and reduced the posterior slope increase and excessive varus deformity by 81.8% and 83.2%, respectively. Conclusion The current study revealed that supplemental screw insertion is a simple and effective technique to improve the structural stability and durability in medial owHTO.	[Yang, Jesse Chieh-Szu; Chen, Cheng-Fong; Ma, Hsuan-Hsiao] Taipei Vet Gen Hosp, Dept Orthoped & Traumatol, Taipei, Taiwan; [Yang, Jesse Chieh-Szu; Lee, Oscar Kuang-Sheng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Lobenhoffer, Philipp] Sportsclin Germany, Hannover, Germany; [Chang, Chia-Ming; Lin, Hsiu-Chen] China Med Univ, Dept Phys Therapy, Taichung, Taiwan; [Chang, Chia-Ming; Lin, Hsiu-Chen] China Med Univ, Grad Inst Rehabil Sci, Taichung, Taiwan; [Chang, Chia-Ming] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei, Taiwan; [Chen, Cheng-Fong] Natl Yang Ming Univ, Sch Med, Dept Orthoped, Taipei, Taiwan; [Lee, Pei-Yuan] Show Chwan Mem Hosp, Orthoped Dept, Changhua, Taiwan; [Lee, Pei-Yuan] Dayeh Univ, Coll Nursing & Hlth Sci, Changhua, Taiwan; [Lee, Oscar Kuang-Sheng] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Show Chwan Memorial Hospital; Da Yeh University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lee, OKS (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.; Lee, OKS (corresponding author), China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan.	kslee.nymu@gmail.com		Chang, Chia-Ming/0000-0002-6073-8272				Abbey EJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239398; Agneskirchner JD, 2006, KNEE SURG SPORT TR A, V14, P291, DOI 10.1007/s00167-005-0690-1; Bonasia DE, 2014, AM J SPORT MED, V42, P690, DOI 10.1177/0363546513516577; Chae DJ, 2011, KNEE, V18, P278, DOI 10.1016/j.knee.2010.05.009; de Freitas RL, 2010, ACTA ORTOP BRAS, V18, P224, DOI 10.1590/S1413-78522010000400010; DEBEYRE J, 1962, Rev Rhum Mal Osteoartic, V29, P722; DEJOUR H, 1994, CLIN ORTHOP RELAT R, P220; Dexel J, 2017, KNEE SURG SPORT TR A, V25, P832, DOI 10.1007/s00167-015-3730-5; Diffo Kaze Arnaud, 2017, J Exp Orthop, V4, P23, DOI 10.1186/s40634-017-0098-0; Dorsey William O P, 2006, J Knee Surg, V19, P95; Floerkemeier S, 2013, KNEE SURG SPORT TR A, V21, P170, DOI 10.1007/s00167-012-2087-2; FUJISAWA Y, 1979, ORTHOP CLIN N AM, V10, P585; Harris JD, 2013, KNEE, V20, P154, DOI 10.1016/j.knee.2012.12.012; HERNIGOU P, 1987, J BONE JOINT SURG AM, V69A, P332; Hui C, 2011, AM J SPORT MED, V39, P64, DOI 10.1177/0363546510377445; JACKSON JP, 1961, J BONE JOINT SURG BR, V43, P746, DOI 10.1302/0301-620X.43B4.746; Jacobi M, 2015, KNEE SURG SPORT TR A, V23, P2762, DOI 10.1007/s00167-014-3100-8; Lobenhoffer P, 2003, KNEE SURG SPORT TR A, V11, P132, DOI 10.1007/s00167-002-0334-7; Marti CB, 2004, ARTHROSCOPY, V20, P366, DOI 10.1016/j.arthro.2004.01.024; Miller BS, 2009, ARTHROSCOPY, V25, P639, DOI 10.1016/j.arthro.2008.12.020; Nawas HT, 2016, OCHSNER J, V16, P464; Noyes FR, 2005, AM J SPORT MED, V33, P378, DOI 10.1177/0363546504269034; Paccola CAJ, 2005, KNEE SURG SPORT TR A, V13, P19, DOI 10.1007/s00167-003-0480-6; Patond K R, 1993, Natl Med J India, V6, P104; Schroter S, 2017, KNEE SURG SPORT TR A, V25, P325, DOI 10.1007/s00167-015-3592-x; Schroter S, 2018, CLIN BIOMECH, V60, P108, DOI 10.1016/j.clinbiomech.2018.10.010; Seo Seung-Suk, 2016, Knee Surg Relat Res, V28, P289, DOI 10.5792/ksrr.16.028; Smith JO, 2013, KNEE SURG SPORT TR A, V21, P3, DOI 10.1007/s00167-012-2206-0; Takeuchi R, 2012, ARTHROSCOPY, V28, P85, DOI 10.1016/j.arthro.2011.06.034; Yacobucci GN, 2008, AM J SPORT MED, V36, P713, DOI 10.1177/0363546507312646; Yang JCS, 2020, J ORTHOP TRANSL, V20, P31, DOI 10.1016/j.jot.2019.06.004; Zdero R, 2008, P I MECH ENG H, V222, P1175, DOI 10.1243/09544119JEIM409	32	4	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244557	10.1371/journal.pone.0244557	http://dx.doi.org/10.1371/journal.pone.0244557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378331	Green Published, gold			2022-12-27	WOS:000605651300004
J	Rajbanshi, S; Norhayati, MN; Hazlina, NHN				Rajbanshi, Sushma; Norhayati, Mohd Noor; Nik Hazlina, Nik Hussain			High-risk pregnancies and their association with severe maternal morbidity in Nepal: A prospective cohort study	PLOS ONE			English	Article							SCORING SYSTEM; CARE; PREDICTION; MORTALITY; IDENTIFICATION; VALIDATION	Background The early identification of pregnant women at risk of developing complications at birth is fundamental to antenatal care and an important strategy in preventing maternal death. This study aimed to determine the prevalence of high-risk pregnancies and explore the association between risk stratification and severe maternal morbidity. Methods This hospital-based prospective cohort study included 346 pregnant women between 28-32 gestational weeks who were followed up after childbirth at Koshi Hospital in Nepal. The Malaysian antenatal risk stratification approach, which applies four color codes, was used: red and yellow denote high-risk women, while green and white indicate low-risk women based on maternal past and present medical and obstetric risk factors. The World Health Organization criteria were used to identify women with severe maternal morbidity. Multivariate confirmatory logistic regression analysis was performed to adjust for possible confounders (age and mode of birth) and explore the association between risk stratification and severe maternal morbidity. Results The prevalence of high-risk pregnancies was 14.4%. Based on the color-coded risk stratification, 7.5% of the women were categorized red, 6.9% yellow, 72.0% green, and 13.6% white. The women with high-risk pregnancies were 4.2 times more likely to develop severe maternal morbidity conditions during childbirth. Conclusions Although smaller in percentage, the chances of severe maternal morbidity among high-risk pregnancies were higher than those of low-risk pregnancies. This risk scoring approach shows the potential to predict severe maternal morbidity if routine screening is implemented at antenatal care services. Notwithstanding, unpredictable severe maternal morbidity events also occur among low-risk pregnant women, thus all pregnant women require vigilance and quality obstetrics care but high-risk pregnant women require specialized care and referral.	[Rajbanshi, Sushma; Nik Hazlina, Nik Hussain] Univ Sains Malaysia, Sch Med Sci, Womens Hlth Dev Unit, Kubang Kerian, Kelantan, Malaysia; [Norhayati, Mohd Noor] Univ Sains Malaysia, Sch Med Sci, Dept Family Med, Kubang Kerian, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Norhayati, MN (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Family Med, Kubang Kerian, Kelantan, Malaysia.	hayatikk@usm.my	Norhayati, Mohd Noor/ABH-3248-2021; Norhayati, Mohd Noor/E-3868-2012	Norhayati, Mohd Noor/0000-0002-6372-1476; Norhayati, Mohd Noor/0000-0002-6372-1476	Universiti Sains Malaysia Graduate Development Incentive Grant [311/PPSP/4404848]	Universiti Sains Malaysia Graduate Development Incentive Grant	This research was funded by the Universiti Sains Malaysia Graduate Development Incentive Grant (311/PPSP/4404848). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeoye IA, 2015, HEALTH CARE WOMEN IN, V36, P70, DOI 10.1080/07399332.2014.943839; [Anonymous], 2013, OBSTET GYNECOL, V122, P957, DOI 10.1097/AOG.0b013e3182a603bb; [Anonymous], 2017, J CURR MED RES PRAC, DOI [10.4103/2357-0121.210300, DOI 10.4103/2357-0121.210300]; [Anonymous], 2017, RESEARCH2GUIDANCE, V7, P10, DOI DOI 10.1038/s41598-017-00036-8; Aryal KK, 2019, DHS FURTHER ANAL REP, V118; BAAQEEL HS, 1989, ANN SAUDI MED, V9, P140, DOI 10.5144/0256-4947.1989.140; de Lima THB, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2381-9; Dias MAB, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00154213; Berglund A, 1999, ACTA OBSTET GYN SCAN, V78, P871, DOI 10.1034/j.1600-0412.1999.781007.x; Bharti M, 2013, INT J BASIC APPL MED, V3, P212; Bliddal M, 2020, ACTA OBSTET GYN SCAN, V99, P399, DOI 10.1111/aogs.13749; Burstyn I, 2010, J OBSTET GYNAECOL CA, V32, P16, DOI 10.1016/S1701-2163(16)34398-5; Chen XK, 2007, AUST NZ J OBSTET GYN, V47, P122, DOI 10.1111/j.1479-828X.2007.00697.x; Clapp MA, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.015; Pacheco AJC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-91; Davey MA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004902.pub5; De A., 2015, AM J PUBLIC HEALTH, V3, P35; DEGROOT ANJA, 1993, INT J GYNECOL OBSTET, V40, P33, DOI 10.1016/0020-7292(93)90769-S; DUJARDIN B, 1995, SOC SCI MED, V40, P529, DOI 10.1016/0277-9536(94)E0095-A; Easter SR, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.06.025; Gao HY, 2007, INTENS CARE MED, V33, P667, DOI 10.1007/s00134-007-0532-3; Geller SE, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0527-2; GOODWIN JW, 1969, CAN MED ASSOC J, V101, P57; Government of Nepal Ministry of Health and Population Department of Health Services., 2017, ANN REP DEP HLTH SER; Government of Nepal Ministry of Health and Population Department of Health Services Eastern Health Development Region District Public Health Office., 2017, 20742075 GOV NEP MIN; Gray KE, 2012, PAEDIATR PERINAT EP, V26, P506, DOI 10.1111/ppe.12011; Hacettepe University Institute of Population Studies, 2004, TURK DEM HLTH SURV 2; Hafez S. K., 2014, World Journal of Medical Sciences, V11, P90; HALL MH, 1990, BAILLIERE CLIN OB GY, V4, P65, DOI 10.1016/S0950-3552(05)80212-3; HALL PF, 1994, CAN FAM PHYSICIAN, V40, P1239; HEINS HC, 1983, OBSTET GYNECOL, V62, P294, DOI 10.1097/00006250-198309000-00005; HOBEL CJ, 1973, AM J OBSTET GYNECOL, V117, P1; Holness N, 2018, NURS CLIN N AM, V53, P241, DOI 10.1016/j.cnur.2018.01.010; Jahn A, 2000, TROP MED INT HEALTH, V5, P657, DOI 10.1046/j.1365-3156.2000.00611.x; Jahn A, 2001, STUD HLTH SERV ORGAN, V17, P229; Jaideep KC, 2017, INT J COMMUNITY MED, V4, P1257; Jordan RG, 2009, J MIDWIFERY WOM HEAL, V54, P191, DOI 10.1016/j.jmwh.2009.02.001; Joshi C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-94; Kashani E., 2012, ADV ENVIRON BIOL, V6, P1319; Kementerian Kesihatan Malaysia, 2013, GAR PAND SEN SEM BAG; KNOX AJ, 1993, OBSTET GYNECOL, V81, P195; Kolluru V., 2016, IJOGR, V3, P407; Kuru A, 2013, CLIN EXP OBSTET GYN, V40, P381; LENNOX CE, 1984, TROP DOCT, V14, P125, DOI 10.1177/004947558401400309; Leonard SA, 2020, OBSTET GYNECOL, V136, P440, DOI 10.1097/AOG.0000000000004022; LESINSKI J, 1975, OBSTET GYNECOL, V46, P599; Lisonkova S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002307; Madeiro AP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0648-3; Majoko F, 2002, J Obstet Gynaecol, V22, P604, DOI 10.1080/0144361021000020358; Metcalfe A, 2015, BJOG-INT J OBSTET GY, V122, P1748, DOI 10.1111/1471-0528.13254; Mhyre JM, 2011, ANESTHESIOLOGY, V115, P963, DOI 10.1097/ALN.0b013e318233042d; Ministry of Health Nepal; New ERA; ICF, 2017, NEP DEM HLTH SURV 20; Mohamed H, 2002, J Obstet Gynaecol, V22, P389; MORRISON I, 1980, AM J OBSTET GYNECOL, V138, P175, DOI 10.1016/0002-9378(80)90031-9; MURPHY PA, 1994, J NURSE-MIDWIFERY, V39, P67, DOI 10.1016/0091-2182(94)90013-2; NESBITT REL, 1969, AM J OBSTET GYNECOL, V103, P972, DOI 10.1016/S0002-9378(16)34448-9; Norhayati MN, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0980-2; Norhayati MN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2895-2; Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159; PATTISON NS, 1990, NEW ZEAL MED J, V103, P257; Province Government Province No 1 Ministry of Social Development Morang Health Office., 2019, 2074075 MIN SOC DEV; Prual A, 2000, HEALTH POLICY PLANN, V15, P11, DOI 10.1093/heapol/15.1.11; Ravindran J, 2003, Med J Malaysia, V58, P37; Ryan HM, 2017, J OBSTET GYNAECOL CA, V39, P728, DOI 10.1016/j.jogc.2017.01.028; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Shields LE, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.01.154; Singh S, 2012, ANAESTHESIA, V67, P12, DOI 10.1111/j.1365-2044.2011.06896.x; SOKOL RJ, 1977, AM J OBSTET GYNECOL, V128, P652, DOI 10.1016/0002-9378(77)90212-5; Somerville NJ, 2019, MATERN CHILD HLTH J, V23, P1152, DOI 10.1007/s10995-019-02796-3; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Vanderlaan J, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2500-7; WEBSTER MA, 1988, AUST NZ J OBSTET GYN, V28, P6, DOI 10.1111/j.1479-828X.1988.tb01602.x; Wen SW, 2005, CAN MED ASSOC J, V173, P759, DOI 10.1503/cmaj.045156; WHO, 1996, WHOFHEMSM9411; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; Worke MD, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4628-y; World Health Organization, 2010, EFF PER CAR EPC MIDW; Yassin Shadia A T, 2005, J Egypt Public Health Assoc, V80, P687; Yeoh PL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152167; Yeoh PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135301; Zuckerwise LC, 2017, SEMIN PERINATOL, V41, P161, DOI 10.1053/j.semperi.2017.03.005	82	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244072	10.1371/journal.pone.0244072	http://dx.doi.org/10.1371/journal.pone.0244072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370361	Green Published, gold			2022-12-27	WOS:000603611900010
J	Vanzyl, EJ; Sayed, H; Blackmore, AB; Rick, KRC; Fernando, P; McKay, BC				Vanzyl, Erin J.; Sayed, Hadil; Blackmore, Alex B.; Rick, Kayleigh R. C.; Fernando, Pasan; McKay, Bruce C.			The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death	PLOS ONE			English	Article							PROTEIN; TARGET; SF3B	The spliceosome assembles on pre-mRNA in a stepwise manner through five successive pre-spliceosome complexes. The spliceosome functions to remove introns from pre-mRNAs to generate mature mRNAs that encode functional proteins. Many small molecule inhibitors of the spliceosome have been identified and they are cytotoxic. However, little is known about genetic determinants of cell sensitivity. Activating transcription factor 3 (ATF3) is a transcription factor that can stimulate apoptotic cell death in response to a variety of cellular stresses. Here, we used a genetic approach to determine if ATF3 was important in determining the sensitivity of mouse embryonic fibroblasts (MEFs) to two splicing inhibitors: pladienolide B (PB) and isoginkgetin (IGG), that target different pre-spliceosome complexes. Both compounds led to increased ATF3 expression and apoptosis in control MEFs while ATF3 null cells were significantly protected from the cytotoxic effects of these drugs. Similarly, ATF3 was induced in response to IGG and PB in the two human tumour cell lines tested while knockdown of ATF3 protected cells from both drugs. Taken together, ATF3 appears to contribute to the cytotoxicity elicited by these spliceosome inhibitors in both murine and human cells.	[Vanzyl, Erin J.; Sayed, Hadil; Blackmore, Alex B.; Rick, Kayleigh R. C.; Fernando, Pasan; McKay, Bruce C.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [McKay, Bruce C.] Carleton Univ, Inst Biochem, Ottawa, ON, Canada	Carleton University; Carleton University	McKay, BC (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.; McKay, BC (corresponding author), Carleton Univ, Inst Biochem, Ottawa, ON, Canada.	bruce_mckay@carleton.ca	McKay, Bruce Campbell/I-4081-2013	McKay, Bruce Campbell/0000-0002-7921-1331	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-03645, RGPIN-2019-06146]; J.P. Bickell Foundation; Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); J.P. Bickell Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded through the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp)[RGPIN-2014-03645 and RGPIN-2019-06146] to B.C.M. and a J.P. Bickell Foundation grant (https://www.scotiawealthmanagement.com/ca/en/home/resource-centre/jp-bickell-foundation.html) to P.F. E.J.V. is supported with a Vanier Canada Graduate Scholarship through the Natural Sciences and Engineering Research Council of Canada.	Albert BJ, 2009, MOL CANCER THER, V8, P2308, DOI 10.1158/1535-7163.MCT-09-0051; [Anonymous], 2007, GYNECOL ONCOL, V107, pS56; [Anonymous], 2014, INSIGHTS IMAGING, V5, P1, DOI [10.1007/s13244-013-0307-z, DOI 10.1007/S13244-013-0307-Z.]; Bai B, 2018, ACS OMEGA, V3, P2798, DOI 10.1021/acsomega.7b02073; Boswell SA, 2017, NAT CHEM BIOL, V13, P501, DOI [10.1038/NCHEMBIO.2317, 10.1038/nchembio.2317]; Effenberger KA, 2014, J BIOL CHEM, V289, P1938, DOI 10.1074/jbc.M113.515536; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; Gurzov EN, 2012, ONCOGENE, V31, P1723, DOI 10.1038/onc.2011.353; Hoskins AA, 2016, ELIFE, V5, DOI 10.7554/eLife.14166; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lee KM, 2013, RNA BIOL, V10, P386, DOI 10.4161/rna.23697; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nowak E, 2018, CLIN HEMORHEOL MICRO, V69, P327, DOI 10.3233/CH-189120; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; St Germain C, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-32; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; Tsalikis J, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00489-18; Vanzyl EJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191178; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Yoon SO, 2006, MOL CANCER THER, V5, P2666, DOI 10.1158/1535-7163.MCT-06-0321	24	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0224953	10.1371/journal.pone.0224953	http://dx.doi.org/10.1371/journal.pone.0224953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370278	Green Submitted, gold, Green Published			2022-12-27	WOS:000603611900119
J	Ferrer-Sargues, FJ; Fabregat-Andres, O; Martinez-Hurtado, I; Salvador-Coloma, P; Martinez-Olmos, FJ; Lluesma-Vidal, M; Bivia-Roig, G; Segrera-Rovira, MJ; Arguisuelas, MD; Valtuena-Gimeno, N				Ferrer-Sargues, Francisco Jose; Fabregat-Andres, Oscar; Martinez-Hurtado, Isabel; Salvador-Coloma, Pablo; Martinez-Olmos, Francisco Jose; Lluesma-Vidal, Marta; Bivia-Roig, Gemma; Segrera-Rovira, Maria Jose; Arguisuelas, Maria Dolores; Valtuena-Gimeno, Noemi			Effects of neuromuscular training compared to classic strength-resistance training in patients with acute coronary syndrome: A study protocol for a randomized controlled trial	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; CHESTER STEP TEST; SCIENTIFIC STATEMENT; CARDIAC REHABILITATION; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; EXERCISE CAPACITY; SEXUAL-ACTIVITY; ARTERY-DISEASE; RELIABILITY	The aim of the present clinical trial is to evaluate the effectiveness of neuromuscular versus classical strength-resistance training as part of a cardiac rehabilitation programme in patients following acute coronary syndrome. The study is designed as a double-blinded, randomised, and controlled clinical trial. Thirty participants suffering from acute coronary syndrome who meet our inclusion criteria will be recruited by a private tertiary hospital. The intervention group will follow 20 sessions of a cardiac rehabilitation programme divided into two parts: aerobic training and neuromuscular strength-resistance training. The control group will complete the same aerobic training as well as a classical strength-resistance training workout programme. The primary outcome of the study will be the mean difference in change from baseline in the Incremental Shuttle Walking Test. The secondary outcomes will be the cardiorespiratory fitness of the patients (assessed by means of the Chester Step Test), lower-limb performance (assessed with the 30-Second Chair Stand Test and Single-Leg Squat Test), lower-limb strength (hip flexor handheld dynamometry), sexual dysfunction assessment (Sex Health Inventory for Men) and quality of life (EQ-5D-5L). This work will provide evidence for the effectiveness of a neuromuscular versus a classic strength-training programme in terms of cardiorespiratory fitness, lower-limb performance capacities and quality of life, in cardiac patients. The data obtained could lead to more effective and functional workouts which, in turn, may enhance the speed at which these patients can return to their everyday activities of life and improve the efficiency of their movement patterns and heart responses. Furthermore, patients may find neuromuscular workout routines more motivating and engaging, thus encouraging them to adopt healthier lifestyle patterns.	[Ferrer-Sargues, Francisco Jose; Martinez-Hurtado, Isabel; Salvador-Coloma, Pablo; Martinez-Olmos, Francisco Jose; Bivia-Roig, Gemma; Segrera-Rovira, Maria Jose; Arguisuelas, Maria Dolores; Valtuena-Gimeno, Noemi] CEU Univ, Univ Cardenal Herrera CEU, Dept Physiotherapy, Valencia, Spain; [Fabregat-Andres, Oscar] CEU Univ, Univ Cardenal Herrera CEU, Dept Med, Valencia, Spain; [Fabregat-Andres, Oscar] Hosp IMED, Dept Cardiol, Valencia, Spain; [Lluesma-Vidal, Marta] CEU Univ, Univ Cardenal Herrera CEU, Dept Nursing, Valencia, Spain	Universidad CEU Cardenal Herrera; Universidad CEU Cardenal Herrera; Universidad CEU Cardenal Herrera	Arguisuelas, MD (corresponding author), CEU Univ, Univ Cardenal Herrera CEU, Dept Physiotherapy, Valencia, Spain.	doloresarguisuelas@uchceu.es	DOLORES, ARGUISUELAS MARTINEZ/ADZ-2640-2022; Martinez-Olmos, Francisco José/B-2059-2018; Biviá-roig, Gemma/AAA-4945-2020	Martinez-Olmos, Francisco José/0000-0001-8308-2686; Biviá-roig, Gemma/0000-0001-7611-5347; Ferrer Sargues, Francisco Jose/0000-0001-9016-5543; , Arguisuelas/0000-0002-9437-6513; Martinez-Hurtado, Isabel/0000-0002-9635-8562; Valtuena-Gimeno, Noemi/0000-0002-5305-1245	University CEU Cardenal Herrera [ICLINIC/1907]	University CEU Cardenal Herrera	NVG received a grant from the University CEU Cardenal Herrera (ICLINIC/1907). www. uchceu.es The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageberg E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-232; Alvarenga G, 2019, ACTA ORTOP BRAS, V27, P124, DOI 10.1590/1413-785220192702202596; Bailly L, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0973-3; Barrios-Fernandez S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041450; Buckley JP, 2004, BRIT J SPORT MED, V38, P197, DOI 10.1136/bjsm.2003.005389; Calvo M, 2013, INT J ENV RES PUB HE, V10, P5266, DOI 10.3390/ijerph10115266; de la Cuerda RC, 2012, REV ESP CARDIOL, V65, P72, DOI [10.1016/j.recesp.2011.07.016, 10.1016/j.rec.2011.07.015]; Cappelleri JC, 2001, CLIN THER, V23, P1707, DOI 10.1016/S0149-2918(01)80138-7; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Clark AM, 2005, ANN INTERN MED, V143, P659, DOI 10.7326/0003-4819-143-9-200511010-00010; Conraads VM, 2015, INT J CARDIOL, V179, P203, DOI 10.1016/j.ijcard.2014.10.155; Cornelis J, 2016, INT J CARDIOL, V221, P867, DOI 10.1016/j.ijcard.2016.07.105; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P1225, DOI 10.1001/jama.2011.336; de Camargo AA, 2011, RESP CARE, V56, P995, DOI 10.4187/respcare.01047; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Gianola S, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1660-8; Hollings M, 2017, EUR J PREV CARDIOL, V24, P1242, DOI 10.1177/2047487317713329; Kamiya K, 2014, EUR J PREV CARDIOL, V21, P1285, DOI 10.1177/2047487313492252; Levine GN, 2012, CIRCULATION, V125, P1058, DOI 10.1161/CIR.0b013e3182447787; McGovern RP, 2018, INT J SPORTS PHYS TH, V13, P526, DOI 10.26603/ijspt20180526; Medicine AC of S, 2013, ACSMS GUIDELINES EXE; Mischiati CR, 2015, J SPORT SCI MED, V14, P427; Moalla W, 2012, APPL PHYSIOL NUTR ME, V37, P621, DOI [10.1139/h2012-036, 10.1139/H2012-036]; Montero JMM, 2005, REV ESP CARDIOL, V58, P1181; Munro A, 2012, J SPORT REHABIL, V21, P7, DOI 10.1123/jsr.21.1.7; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Oldridge N, 2020, EUR J PREV CARDIOL, V27, P1045, DOI 10.1177/2047487319881839; Organization WH, 1993, REH CORD DIS SPEC EM; Parreira VF, 2014, CHEST, V145, P1357, DOI 10.1378/chest.13-2071; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Saghaei Mahmood, 2004, BMC Med Res Methodol, V4, P26, DOI 10.1186/1471-2288-4-26; Shah Nishant P, 2018, Curr Treat Options Cardiovasc Med, V20, P12, DOI 10.1007/s11936-018-0611-5; Shields GE, 2018, HEART, V104, P1403, DOI 10.1136/heartjnl-2017-312809; Skou ST, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1439-y; Smith SMS, 2019, J CARDIOPULM REHABIL, V39, P9, DOI 10.1097/HCR.0000000000000359; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Stevens N, 1996, Occup Health (Lond), V48, P436; Travensolo C, 2018, REV PORT CARDIOL, V37, P525, DOI 10.1016/j.repc.2017.07.008; Van Dillen LR, 2009, MANUAL THER, V14, P52, DOI 10.1016/j.math.2007.09.012; Van Dillen LR, 2001, J ORTHOP SPORT PHYS, V31, P402, DOI 10.2519/jospt.2001.31.8.402; Wang J, 2017, J GERIATR CARDIOL, V14, P135, DOI 10.11909/j.issn.1671-5411.2017.02.008; Williams MA, 2007, CIRCULATION, V116, P572, DOI 10.1161/CIRCULATIONAHA.107.185214; Wingham J, 2019, EUR J CARDIOVASC NUR, V18, P611, DOI 10.1177/1474515119850011	43	0	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243917	10.1371/journal.pone.0243917	http://dx.doi.org/10.1371/journal.pone.0243917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362223	Green Published, gold			2022-12-27	WOS:000603071600056
J	Koyama, A; Hirata, T; Kawahara, Y; Iyooka, H; Kubozono, H; Onikura, N; Itaya, S; Minagawa, T				Koyama, Akihiko; Hirata, Taiga; Kawahara, Yuki; Iyooka, Hiroki; Kubozono, Haruka; Onikura, Norio; Itaya, Shinji; Minagawa, Tomoko			Habitat suitability maps for juvenile tri-spine horseshoe crabs in Japanese intertidal zones: A model approach using unmanned aerial vehicles and the Structure from Motion technique	PLOS ONE			English	Article							HONG-KONG SAR; TACHYPLEUS-TRIDENTATUS; SPECIES DISTRIBUTIONS; GLOBAL PATTERNS; BEACH; CONSERVATION; ECOLOGY	The tri-spine horseshoe crab, Tachypleus tridentatus, is a threatened species that inhabits coastal areas from South to East Asia. A Conservation management system is urgently required for managing its nursery habitats, i.e., intertidal flats, especially in Japan. Habitat suitability maps are useful in drafting conservation plans; however, they have rarely been prepared for juvenile T. tridentatus. In this study, we examined the possibility of constructing robust habitat suitability models (HSMs) for juveniles based on topographical data acquired using unmanned aerial vehicles and the Structure from Motion (UAV-SfM) technique. The distribution data of the juveniles in the Tsuyazaki and Imazu intertidal flats from 2017 to 2019 were determined. The data were divided into a training dataset for HSM construction and three test datasets for model evaluation. High accuracy digital surface models were built for each region using the UAV-SfM technique. Normalized elevation was assessed by converting the topographical models that consider the tidal range in each region, and the slope was calculated based on these models. Using the training data, HSMs of the juveniles were constructed with normalized elevation and slope as the predictor variables. The HSMs were evaluated using the test data. The results showed that HSMs exhibited acceptable discrimination performance for each region. Habitat suitability maps were built for the juveniles in each region, and the suitable areas were estimated to be approximately 6.1 ha of the total 19.5 ha in Tuyazaki, and 3.7 ha of the total 7.9 ha area in Imazu. In conclusion, our findings support the usefulness of the UAV-SfM technique in constructing HSMs for juvenile T. tridentatus. The monitoring of suitable habitat areas for the juveniles using the UAV-SfM technique is expected to reduce survey costs, as it can be conducted with fewer investigators over vast intertidal zones within a short period of time.	[Koyama, Akihiko; Minagawa, Tomoko] Kumamoto Univ, Fac Adv Sci & Technol, Chuo Ku, Kumamoto, Japan; [Hirata, Taiga; Kawahara, Yuki] Kumamoto Univ, Dept Civil & Environm Engn, Chuo Ku, Kumamoto, Japan; [Iyooka, Hiroki] Fukuoka Univ, Dept Civil Engn, Jonan Ku, Fukuoka, Japan; [Kubozono, Haruka] Kyushu Univ, 21st Century Program, Nishi Ku, Fukuoka, Japan; [Onikura, Norio] Kyushu Univ, Fishery Res Lab, Tsuyazaki, Fukutsu, Japan; [Itaya, Shinji] Tsuyazaki Seaside Nat Sch, Tsuyazaki, Fukutsu, Japan; [Kawahara, Yuki] Kobe Univ, Fac Civil Engn, Nada Ku, Rokkodai Cho, Kobe, Hyogo, Japan; [Kubozono, Haruka] Arithmer Inc, Off President Publ Relat, Minato Ku, Tokyo, Japan	Kumamoto University; Kumamoto University; Fukuoka University; Kyushu University; Kyushu University; Kobe University	Koyama, A (corresponding author), Kumamoto Univ, Fac Adv Sci & Technol, Chuo Ku, Kumamoto, Japan.	koyamaakihiko15@gmail.com			Japan Society for the Promotion of Science [JP18K14482, JP18J00211, JP15H02456]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research Program (KAKENHI), Grant Numbers JP18K14482 (AK), JP18J00211 (AK), and JP15H02456 (NO, HI, and TM). Arithmer Inc. provided support in the form of salary for author HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2015, MED J ARMED FORCES I, V71, pS221; [Anonymous], 2019, R PACKAGE VERSION, DOI DOI 10.1007/s00114-004-0520-1; Baejowski B, 2015, OLDEST SPECIES GENUS, P3; Ballesteros JA, 2019, SYST BIOL, V68, P896, DOI 10.1093/sysbio/syz011; Botton M. L, 2015, CHANGING GLOBAL PERS, P369, DOI DOI 10.1007/978-3-319-19542-1_21; Chen CP, 2004, BIODIVERS CONSERV, V13, P1889, DOI 10.1023/B:BIOC.0000035868.11083.84; Chiu HMC, 2004, HYDROBIOLOGIA, V523, P29, DOI 10.1023/B:HYDR.0000033085.71861.63; Cote IM, 2002, SCIENCE, V298, P1181; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Gogol-Prokurat M, 2011, ECOL APPL, V21, P33, DOI 10.1890/09-1190.1; Gong L, 2019, MOL ECOL RESOUR, V19, P744, DOI 10.1111/1755-0998.12988; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hanawa S., 2006, GLOB ENV RES, V11, P235; Hara Y, 2007, PROC CIV ENG OCEAN, V23, P447; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hsieh HL, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P417, DOI 10.1007/978-0-387-89959-6_26; Hu MH, 2009, AQUAT BIOL, V7, P107, DOI 10.3354/ab00194; Inoue H., 2014, REPORT NATL RES INST, V81, P61; Itaya S, 2019, JPN J CONSERV ECOL, V24, P1817; Iyooka H, 2019, J JPN SOC WATER ENV, V42, P164; Jaud M, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5040050; Jedrzejewski W, 2008, ANIM CONSERV, V11, P377, DOI 10.1111/j.1469-1795.2008.00193.x; Kalacska M, 2017, REMOTE SENS ENVIRON, V199, P14, DOI 10.1016/j.rse.2017.06.023; Kawahara D., 1982, AQUABIOLOGY KAIYOU S, V4, P380; Koljonen S, 2013, RESTOR ECOL, V21, P344, DOI 10.1111/j.1526-100X.2012.00908.x; Krisfalusi-Gannon J, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00185; KUROYANAGI K., 2015, CHANGING GLOBAL PERS, P129; Kwan BKY, 2016, BIODIVERS CONSERV, V25, P673, DOI 10.1007/s10531-016-1084-z; Kwan BKY., 2015, CHANGING GLOBAL PERS, P149, DOI [10.1007/978-3-319-19542-1_7, DOI 10.1007/978-3-319-19542-1_7]; Kwan KY, 2020, J ENVIRON MANAGE, V271, DOI 10.1016/j.jenvman.2020.110925; Laurie K., 2019, IUCN RED LIST THREAT; Lee CN, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P275, DOI 10.1007/978-0-387-89959-6_17; Lee CNW, 2016, MAR POLLUT BULL, V108, P134, DOI 10.1016/j.marpolbul.2016.04.037; Loveland R.E., 2015, CHANGING GLOBAL PERS, P41; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; McLachlan A, 2005, J COASTAL RES, V21, P674, DOI 10.2112/03-0114.1; Ministry of the Environment, 2014, RED DATA BOOK 2014 T, V7; Mizota Chitoshi, 1999, Benthos Research, V54, P81; Mizrahi DS, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P65, DOI 10.1007/978-0-387-89959-6_4; Mod HK, 2016, J VEG SCI, V27, P1308, DOI 10.1111/jvs.12444; Morton B, 2011, J NAT HIST, V45, P227, DOI 10.1080/00222933.2010.522263; Murray NJ, 2015, AUSTRAL ECOL, V40, P472, DOI 10.1111/aec.12211; Ohtsubo M., 2005, JAPANESE SOC SOIL PH, V99, P55; Ohtsuka Susumu, 2017, Japanese Journal of Benthology, V72, P16; Onikura N, 2015, ICHTHYOL RES, V62, P197, DOI 10.1007/s10228-014-0427-6; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rasband W., 2006, IMAGEJ; Ricciardi A, 1999, MAR ECOL PROG SER, V185, P21, DOI 10.3354/meps185021; Sato Masanori, 2010, Plankton & Benthos Research, V5, P202; Sekiguchi K., 1999, BIOL HORSESHOE CRABS; Shin PKS, 2009, BIOLOGY AND CONSERVATION OF HORSESHOE CRABS, P347, DOI 10.1007/978-0-387-89959-6_22; Smith DR, 2017, REV FISH BIOL FISHER, V27, P135, DOI 10.1007/s11160-016-9461-y; Team RC., 2013, R LANG ENV STAT COMP; Turner D, 2012, REMOTE SENS-BASEL, V4, P1392, DOI 10.3390/rs4051392; Vestbo S, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00164; Wada T, 2008, JPN J CONSERV ECOL, V13, P199; Wada T., 2010, JAPANESE J CONSERVAT, V15, P163; Wada T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147429; Wang CC, 2019, ENDANGER SPECIES RES, V40, P369, DOI 10.3354/esr01003; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Xie XY, 2020, AQUAT CONSERV, V30, P260, DOI 10.1002/aqc.3259; Yang H, 2019, SCIENCE, V366, P813, DOI 10.1126/science.aaz8654	63	2	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244494	10.1371/journal.pone.0244494	http://dx.doi.org/10.1371/journal.pone.0244494			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362230	Green Published, gold			2022-12-27	WOS:000603071600045
J	Ryu, H; Kim, JH; Lee, S; Han, JK				Ryu, Hwaseong; Kim, Jung Hoon; Lee, Seunghyun; Han, Joon Koo			Therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma using contrast-enhanced ultrasound: Focusing on inter-scanner, and inter-operator reproducibility	PLOS ONE			English	Article							QUANTITATIVE-EVALUATION; CEUS; SORAFENIB; PERFUSION; MICROCIRCULATION; QUANTIFICATION; MICE	Purpose To assess therapeutic response monitoring after targeted therapy in an orthotopic rat model of hepatocellular carcinoma (HCC) using CEUS with focusing on inter-scanner and inter-operator reproducibility. Materials and methods For reproducibility, CEUS was performed using two different US scanners by two operators in sixteen rat models of HCC. Using perfusion analysis software (VueBox (R)), eleven parameters were collected, and intra-class correlation coefficient (ICC) was used to analyze reproducibility. Then seventeen rat models of HCC were divided into treatment group (n = 8, 30 mg/kg/day sorafenib for five days) and control group (n = 9). CEUS was performed at baseline and 14 days after first treatment, and changes of perfusion parameters were analyzed. Results In treatment group, CEUS perfusion parameters showed a significant change. The peak enhancement (PE, 2.50 x10(3)+/- 1.68 x10(3) vs 5.55x10(2)+/- 4.65x10(2), p = 0.010) and wash-in and wash out AUC ((WiWo)AUC, 1.07x10(5)+/- 6.48 x10(4) vs 2.65x10(4)+/- 2.25x10(4), p = 0.009) had significantly decreased two weeks after treatment. On the contrary, control group did not show a significant change, including PE (1.15 x10(3)+/- 7.53x10(2) vs 9.43x10(2)+/- 7.81 x10(2), p = 0.632) and (WiWo)AUC (5.09 x10(4)+/- 3.25x10(4) vs 5.92 x10(4)+/- 3.20x10(4), p = 0.646). For reproducibility, the various degrees of inter-scanner reproducibility were from poor to good (ICC: <0.01-0.63). However, inter-operator reproducibility of important perfusion parameters, including (Wi)AUC, (Wo)AUC, and (WiWo)AUC, ranged from fair to excellent (ICC: 0.59-0.93) in a different scanner. Conclusion Our results suggest that CEUS is useful for assessment of the treatment response after targeted therapy and with fair to excellent inter-operator reproducibility.	[Ryu, Hwaseong] Pusan Natl Univ, Yangsan Hosp, Dept Radiol, Yangsan Si, Gyeongsangnam D, South Korea; [Kim, Jung Hoon; Lee, Seunghyun; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Lee, Seunghyun; Han, Joon Koo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea	Pusan National University; Pusan National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.	jhkim2008@gmail.com		Lee, Seunghyun/0000-0003-1858-0640	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017R1A2B4004951]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by a grant from the research supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2017R1A2B4004951). JHK.	Arditi M, 2006, IEEE T ULTRASON FERR, V53, P1118, DOI 10.1109/TUFFC.2006.1642510; Averkiou MA, 2020, INVEST RADIOL, V55, P643, DOI 10.1097/RLI.0000000000000702; Chen MYM, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.4.1791059; Dizeux A, 2016, MOL IMAGING BIOL, V18, P651, DOI 10.1007/s11307-016-0952-y; Ghulam QM, 2018, EUR J VASC ENDOVASC, V56, P673, DOI 10.1016/j.ejvs.2018.07.029; Greis C, 2011, CLIN HEMORHEOL MICRO, V49, P137, DOI 10.3233/CH-2011-1464; Guibal A, 2010, RADIOLOGY, V254, P420, DOI 10.1148/radiol.09090728; Hoff L, 2013, ACOUSTIC CHARACTERIZ; Hornung M, 2011, CLIN HEMORHEOL MICRO, V49, P83, DOI 10.3233/CH-2011-1459; Hudson JM, 2009, ULTRASOUND MED BIOL, V35, P2007, DOI 10.1016/j.ultrasmedbio.2009.06.1102; Jung EM, 2010, CLIN HEMORHEOL MICRO, V46, P89, DOI 10.3233/CH-2010-1336; Kuzuya T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138776; Lamby P, 2011, CLIN HEMORHEOL MICRO, V48, P105, DOI 10.3233/CH-2011-1405; Lamuraglia M, 2010, CRIT REV ONCOL HEMAT, V73, P202, DOI 10.1016/j.critrevonc.2009.06.001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lassau N, 2004, J RADIOL, V85, P704, DOI 10.1016/S0221-0363(04)97651-2; Lavisse S, 2008, INVEST RADIOL, V43, P100, DOI 10.1097/RLI.0b013e3181577cfc; Lee S, 2018, EUR RADIOL, V28, P372, DOI 10.1007/s00330-017-4960-3; Leen E, 2012, EUR RADIOL, V22, P1442, DOI 10.1007/s00330-011-2373-2; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Mueller-Peltzer K, 2019, CLIN HEMORHEOL MICRO, V71, P159, DOI 10.3233/CH-189406; Pysz MA, 2011, INVEST RADIOL, V46, P187, DOI 10.1097/RLI.0b013e3181f9202d; Quaia E, 2016, RADIOLOGY, V281, P606, DOI 10.1148/radiol.2016152461; Rubenthaler J, 2017, CLIN HEMORHEOL MICRO, V66, P283, DOI 10.3233/CH-179102; Sullivan DC, 2015, RADIOLOGY, V277, P813, DOI 10.1148/radiol.2015142202; Tang MX, 2011, INTERFACE FOCUS, V1, P520, DOI 10.1098/rsfs.2011.0026; Wang HJ, 2015, RADIOLOGY, V277, P424, DOI 10.1148/radiol.2015142824; WEIDNER N, 1995, AM J PATHOL, V147, P9; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007; Yamashita Y, 2001, CANCER RES, V61, P1005; Zhou JH, 2010, ACAD RADIOL, V17, P646, DOI 10.1016/j.acra.2010.01.008; Zocco MA, 2013, J HEPATOL, V59, P1014, DOI 10.1016/j.jhep.2013.06.011; Zoppellaro G, 2016, ECHOCARDIOGR-J CARD, V33, P889, DOI 10.1111/echo.13190	33	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244304	10.1371/journal.pone.0244304	http://dx.doi.org/10.1371/journal.pone.0244304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362203	Green Published, gold			2022-12-27	WOS:000603071600059
J	Van Boetzelaer, E; Chowdhury, S; Etsay, B; Faruque, A; Lenglet, A; Kuehne, A; Carrion-Martin, I; Keating, P; Dada, M; Vyncke, J; Kazungu, DS; Verdecchia, M				Van Boetzelaer, Elburg; Chowdhury, Samiur; Etsay, Berhe; Faruque, Abu; Lenglet, Annick; Kuehne, Anna; Carrion-Martin, Isidro; Keating, Patrick; Dada, Martins; Vyncke, Jorieke; Sonne Kazungu, Donald; Verdecchia, Maria			Evaluation of community based surveillance in the Rohingya refugee camps in Cox's Bazar, Bangladesh, 2019	PLOS ONE			English	Article							EVENT-BASED SURVEILLANCE	Background Following an influx of an estimated 742,000 Rohingya refugees in Bangladesh, Medecins sans Frontieres (MSF) established an active indicator-based Community Based Surveillance (CBS) in 13 sub-camps in Cox's Bazar in August 2017. Its objective was to detect epidemic prone diseases early for rapid response. We describe the surveillance, alert and response in place from epidemiological week 20 (12 May 2019) until 44 (2 November 2019). Methods Suspected cases were identified through passive health facility surveillance and active indicator-based CBS. CBS-teams conducted active case finding for suspected cases of acute watery diarrhea (AWD), acute jaundice syndrome (AJS), acute flaccid paralysis (AFP), dengue, diphtheria, measles and meningitis. We evaluate the following surveillance system attributes: usefulness, Positive Predictive Value (PPV), timeliness, simplicity, flexibility, acceptability, representativeness and stability. Results Between epidemiological weeks 20 and 44, an average of 97,340 households were included in the CBS per surveillance cycle. Household coverage reached over 85%. Twenty-one RDT positive cholera cases and two clusters of AWD were identified by the CBS and health facility surveillance that triggered the response mechanism within 12 hours. The PPV of the CBS varied per disease between 41.7%-100%. The CBS required 354 full-time staff in 10 different roles. The CBS was sufficiently flexible to integrate dengue surveillance. The CBS was representative of the population in the catchment area due to its exhaustive character and high household coverage. All households consented to CBS participation, showing acceptability. Discussion The CBS allowed for timely response but was resource intensive. Disease trends identified by the health facility surveillance and suspected diseases trends identified by CBS were similar, which might indicate limited additional value of the CBS in a dense and stable setting such as Cox's Bazar. Instead, a passive community-event-based surveillance mechanism combined with health facility-based surveillance could be more appropriate.	[Van Boetzelaer, Elburg; Chowdhury, Samiur; Etsay, Berhe; Sonne Kazungu, Donald] Med Sans Frontieres, Dhaka, Bangladesh; [Faruque, Abu] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [Lenglet, Annick; Dada, Martins] Med Sans Frontieres, Amsterdam, Netherlands; [Lenglet, Annick] Radboudumc, Dept Med Microbiol, Nijmegen, Netherlands; [Kuehne, Anna; Carrion-Martin, Isidro; Keating, Patrick; Vyncke, Jorieke; Verdecchia, Maria] Med Sans Frontieres, London, England; [Kuehne, Anna] Med Sans Frontieres, Berlin, Germany	International Centre for Diarrhoeal Disease Research (ICDDR); Doctors Without Borders; Radboud University Nijmegen; Doctors Without Borders; Doctors Without Borders	Van Boetzelaer, E (corresponding author), Med Sans Frontieres, Dhaka, Bangladesh.	elburgvb@gmail.com	Kuehne, Anna/AAD-7816-2022; Lenglet, Annick/U-8949-2017	Kuehne, Anna/0000-0002-8578-0362; Carrion Martin, Antonio Isidro/0000-0002-8845-3447; Van Boetzelaer, Elburg/0000-0002-1168-8491; Lenglet, Annick/0000-0003-2013-8405				[Anonymous], 2019, LANCET CHILD ADOLESC, V3, P55, DOI 10.1016/S2352-4642(18)30409-7; [Anonymous], 2012, DRUG SAFETY UPDATE, V6, pA1; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; [Anonymous], 2016, EVIDENCE, V8, pe1000; Cairns KL, 2009, DISASTERS, V33, P503, DOI 10.1111/j.1467-7717.2008.01085.x; Caleo GM, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-18; CDC, 2001, UPD GUID EV PUBL HLT; Clara Alexey, 2018, Emerg Infect Dis, V24, P1649, DOI [10.3201/eid2409, 10.3201/eid2409.171851]; Clara A, 2018, HEALTH SECUR, V16, pS66, DOI 10.1089/hs.2018.0066; Coughlin SS, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-16; Guerra J, 2019, EUROSURVEILLANCE, V24, P21, DOI 10.2807/1560-7917.ES.2019.24.2.1800681; Karo B, 2018, EMERG INFECT DIS, V24, P2074, DOI 10.3201/eid2411.181237; Kuehne A, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001878; MSF-OCA, 2018, FOLL HLTH SURV KUT B; MSF-OCA, 2018, CAS DEF EP THRESH IN; Ratnayake R, 2016, EMERG INFECT DIS, V22, P1431, DOI 10.3201/eid2208.160205; UNHCR, 2019, SIT REF RESP BANGL 2; UNHCR, 2019, BANGL ROH EM	18	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244214	10.1371/journal.pone.0244214	http://dx.doi.org/10.1371/journal.pone.0244214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362236	gold, Green Published			2022-12-27	WOS:000603071600034
J	Zhang, BB; Kreps, S; McMurry, N; McCain, RM				Zhang, Baobao; Kreps, Sarah; McMurry, Nina; McCain, R. Miles			Americans' perceptions of privacy and surveillance in the COVID-19 pandemic	PLOS ONE			English	Article								Objective To study the U.S. public's attitudes toward surveillance measures aimed at curbing the spread of COVID-19, particularly smartphone applications (apps) that supplement traditional contact tracing. Method We deployed a survey of approximately 2,000 American adults to measure support for nine COVID-19 surveillance measures. We assessed attitudes toward contact tracing apps by manipulating six different attributes of a hypothetical app through a conjoint analysis experiment. Results A smaller percentage of respondents support the government encouraging everyone to download and use contact tracing apps (42%) compared with other surveillance measures such as enforcing temperature checks (62%), expanding traditional contact tracing (57%), carrying out centralized quarantine (49%), deploying electronic device monitoring (44%), or implementing immunity passes (44%). Despite partisan differences on a range of surveillance measures, support for the government encouraging digital contact tracing is indistinguishable between Democrats (47%) and Republicans (46%), although more Republicans oppose the policy (39%) compared to Democrats (27%). Of the app features we tested in our conjoint analysis experiment, only one had statistically significant effects on the self-reported likelihood of downloading the app: decentralized data architecture increased the likelihood by 5.4 percentage points. Conclusion Support for public health surveillance policies to curb the spread of COVID-19 is relatively low in the U.S. Contact tracing apps that use decentralized data storage, compared with those that use centralized data storage, are more accepted by the public. While respondents' support for expanding traditional contact tracing is greater than their support for the government encouraging the public to download and use contact tracing apps, there are smaller partisan differences in support for the latter policy.	[Zhang, Baobao; Kreps, Sarah] Cornell Univ, Dept Govt, Ithaca, NY USA; [McMurry, Nina] WZB Berlin Social Sci Ctr, Inst & Polit Inequal Unit, Berlin, Germany; [McCain, R. Miles] Stanford Univ, Palo Alto, CA 94304 USA	Cornell University; Stanford University	McMurry, N (corresponding author), WZB Berlin Social Sci Ctr, Inst & Polit Inequal Unit, Berlin, Germany.	nina.mcmurry@wzb.eu		McCain, R. Miles/0000-0001-5326-9212	Berkman Klein Center for Internet and Society, Harvard University	Berkman Klein Center for Internet and Society, Harvard University	The study was supported by the Berkman Klein Center for Internet and Society, Harvard University received by Dr. Baobao Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann S., 2020, ACCEPTABILITY APP BA, DOI [10.1101/2020.05.05.20091587, DOI 10.1101/2020.05.05.20091587]; Anderson M., 2020, MOST AM DONT THINK C; Begley Sharon, 2020, STAT NEWS; CATTIN P, 1982, J MARKETING, V46, P44, DOI 10.2307/1251701; Cheung H, 2020, BBC NEWS 0123; Coppock A, 2019, RES POLITICS, V6, DOI 10.1177/2053168018822174; Fairbank NA., 2020, THERES APP DIGITAL C; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Forsyth DR, 2020, GROUP DYNAMICS THEOR; Hainmueller J, 2014, POLIT ANAL, V22, P1, DOI 10.1093/pan/mpt024; Hargittai Eszter, 2020, SCI AM; Hinch R, 2020, DIGITAL CONTACT TRAC; Hurst D., 2020, GUARDIAN; Kaptchuk G., 2020, GOOD IS GOOD ENOUGH; Khazan O., 2020, ATLANTIC; Landau S, 2020, IMPORTANCE EQUITY CO; Lesser B, 2020, REUTERS; Lomas N., 2020, TECH CRUNCH; Newzoo, 2019, GLOB MOB MARK REP; ONeill P. H., 2020, MIT TECHNOL REV; Opsahl K., 2020, CHALLENGE PROXIMITY; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Simko L, 2020, COVID 19 CONTACT TRA; Timberg C., 2020, WASHINGTON POST	25	43	43	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242652	10.1371/journal.pone.0242652	http://dx.doi.org/10.1371/journal.pone.0242652			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362218	Green Submitted, gold, Green Published			2022-12-27	WOS:000603071600015
J	Zhen, JH; Liang, G; Chen, RC; Jia, WS				Zhen, Jianhui; Liang, Gang; Chen, Ruichun; Jia, Wenshen			Label-free hairpin-like aptamer and EIS-based practical, biostable sensor for acetamiprid detection	PLOS ONE			English	Article							ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; SENSITIVE DETECTION; LIQUID-CHROMATOGRAPHY; COLORIMETRIC APTASENSOR; IMPEDIMETRIC APTASENSOR; DNA; BIOSENSOR; PESTICIDES; ELECTRODE; RESIDUES	Acetamiprid (ACE) is a kind of broad-spectrum pesticide that has potential health risk to human beings. Aptamers (Ap-DNA (1)) have a great potential as analytical tools for pesticide detection. In this work, a label-free electrochemical sensing assay for ACE determination is presented by electrochemical impedance spectroscopy (EIS). And the specific binding model between ACE and Ap-DNA (1) was further investigated for the first time. Circular dichroism (CD) spectroscopy and EIS demonstrated that the single strand AP-DNA (1) first formed a loosely secondary structure in Tris-HClO4 (20 mM, pH = 7.4), and then transformed into a more stable hairpin-like structure when incubated in binding buffer (B-buffer). The formed stem-loop bulge provides the specific capturing sites for ACE, forming ACE/AP-DNA (1) complex, and induced the R-CT (charge transfer resistance) increase between the solution-based redox probe [Fe(CN)(6)](3-/4-) and the electrode surface. The change of Delta R-CT (charge transfer resistance change, Delta R-CT = R-CT(after)-R-CT(before)) is positively related to the ACE level. As a result, the AP-DNA (1) biosensor showed a high sensitivity with the ACE concentration range spanning from 5 nM to 200 mM and a detection limit of 1 nM. The impedimetric AP-DNA (1) sensor also showed good selectivity to ACE over other selected pesticides and exhbited excellent performance in environmental water and orange juice samples analysis, with spiked recoveries in the range of 85.8% to 93.4% in lake water and 83.7% to 89.4% in orange juice. With good performance characteristics of practicality, sensitivity and selectivity, the AP-DNA (1) sensor holds a promising application for the on-site ACE detection.	[Zhen, Jianhui; Chen, Ruichun] Shijiazhuang Customs Technol Ctr PR China, Shijiazhuang, Hebei, Peoples R China; [Liang, Gang; Jia, Wenshen] Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Agr Stand & Testing, Beijing, Peoples R China; [Liang, Gang; Jia, Wenshen] Minist Agr, Risk Assessment Lab Agroprod Beijing, Beijing, Peoples R China; [Liang, Gang; Jia, Wenshen] Beijing Municipal Key Lab Agr Environm Monitoring, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry; Ministry of Agriculture & Rural Affairs	Liang, G (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res Ctr Agr Stand & Testing, Beijing, Peoples R China.; Liang, G (corresponding author), Minist Agr, Risk Assessment Lab Agroprod Beijing, Beijing, Peoples R China.; Liang, G (corresponding author), Beijing Municipal Key Lab Agr Environm Monitoring, Beijing, Peoples R China.	liangg@brcast.org.cn	liang, gang/ACU-9853-2022	Liang, Gang/0000-0001-6543-1248	Beijing Natural Science Foundation [L182031]; National Natural Science Foundation of China [21806013]; Hebei Province Key Research and Development Program [20325502D]; Project of Beijing Excellent Talents [2017000020060G127]; Special Projects of Construction of Science and Technology Innovation Ability of Beijing Academy of Agriculture and Forestry Sciences [KJCX20170420]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Province Key Research and Development Program; Project of Beijing Excellent Talents; Special Projects of Construction of Science and Technology Innovation Ability of Beijing Academy of Agriculture and Forestry Sciences	We are grateful for financial support from the Beijing Natural Science Foundation (NO. L182031), the National Natural Science Foundation of China (NO. 21806013), Hebei Province Key Research and Development Program (NO. 20325502D), the Project of Beijing Excellent Talents (NO. 2017000020060G127), the Special Projects of Construction of Science and Technology Innovation Ability of Beijing Academy of Agriculture and Forestry Sciences (NO. KJCX20170420).	Akiyama Y, 2002, J AOAC INT, V85, P692; [Anonymous], 2018, CANC DISCOV, V8, pOF6; Bai WH, 2015, ENVIRON TOXICOL CHEM, V34, P2244, DOI 10.1002/etc.3088; Bogomolova A, 2009, ANAL CHEM, V81, P3944, DOI 10.1021/ac9002358; Dharuman V, 2011, ELECTROCHIM ACTA, V56, P8147, DOI 10.1016/j.electacta.2011.05.115; Drummond TG, 2003, NAT BIOTECHNOL, V21, P1192, DOI 10.1038/nbt873; Fan KM, 2019, TALANTA, V197, P645, DOI 10.1016/j.talanta.2019.01.069; Fan LF, 2013, BIOSENS BIOELECTRON, V43, P12, DOI 10.1016/j.bios.2012.11.033; Faraji M, 2018, FOOD CHEM, V240, P634, DOI 10.1016/j.foodchem.2017.08.012; Fei AR, 2015, BIOSENS BIOELECTRON, V70, P122, DOI 10.1016/j.bios.2015.03.028; Feng C, 2020, FOOD CHEM, V320, DOI 10.1016/j.foodchem.2020.126576; Fu JY, 2019, SENSOR ACTUAT B-CHEM, V287, P503, DOI 10.1016/j.snb.2019.02.057; Guzsvany V, 2007, ENVIRON CHEM LETT, V5, P203, DOI 10.1007/s10311-007-0102-5; Han LJ, 2020, FOOD CHEM, V319, DOI 10.1016/j.foodchem.2020.126592; Hassani S, 2018, BIOSENS BIOELECTRON, V120, P122, DOI 10.1016/j.bios.2018.08.041; He JA, 2011, J AGR FOOD CHEM, V59, P1582, DOI 10.1021/jf104189g; Jin DQ, 2016, FOOD CHEM, V194, P959, DOI 10.1016/j.foodchem.2015.08.118; Kerman K, 2004, MEAS SCI TECHNOL, V15, pR1, DOI 10.1088/0957-0233/15/2/R01; Lee HS, 2017, J CHROMATOGR B, V1055, P172, DOI 10.1016/j.jchromb.2017.04.021; Li L, 2018, J AM CHEM SOC, V140, P13335, DOI 10.1021/jacs.8b08047; Li T, 2013, ANALYST, V138, P1898, DOI 10.1039/c3an36673a; Li ZY, 2019, BIOSENS BIOELECTRON, V126, P632, DOI 10.1016/j.bios.2018.10.025; Liang G, 2016, ANAL CHIM ACTA, V936, P222, DOI 10.1016/j.aca.2016.06.056; Liang G, 2015, MICROCHIM ACTA, V182, P2233, DOI 10.1007/s00604-015-1565-x; Liang G, 2013, BIOSENS BIOELECTRON, V48, P238, DOI 10.1016/j.bios.2013.04.008; Liang G, 2013, BIOSENS BIOELECTRON, V45, P46, DOI 10.1016/j.bios.2013.01.046; Liang G, 2013, ANALYST, V138, P1032, DOI 10.1039/c2an36255d; Liu X, 2016, TALANTA, V160, P99, DOI 10.1016/j.talanta.2016.07.010; Ma XY, 2020, FOOD CHEM, V302, DOI 10.1016/j.foodchem.2019.125359; Madianos L, 2018, BIOSENS BIOELECTRON, V101, P268, DOI 10.1016/j.bios.2017.10.034; Mostafalou S, 2017, ARCH TOXICOL, V91, P549, DOI 10.1007/s00204-016-1849-x; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Qi YY, 2020, SENSOR ACTUAT B-CHEM, V304, DOI 10.1016/j.snb.2019.127359; Qi YY, 2016, BIOSENS BIOELECTRON, V83, P243, DOI 10.1016/j.bios.2016.04.074; Rapini R, 2016, TALANTA, V161, P15, DOI 10.1016/j.talanta.2016.08.026; Rhouati A, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122178; Shadboorestan A, 2016, J ENVIRON SCI HEAL C, V34, P187, DOI 10.1080/10590501.2016.1202756; Shi L, 2012, ANAL METHODS-UK, V4, P1036, DOI 10.1039/c2ay05758a; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Sui CJ, 2018, SENSOR ACTUAT B-CHEM, V266, P514, DOI 10.1016/j.snb.2018.03.171; Tang XM, 2018, TALANTA, V189, P599, DOI 10.1016/j.talanta.2018.07.025; Tian Y, 2016, ANAL BIOCHEM, V513, P87, DOI 10.1016/j.ab.2016.09.004; Verdian A, 2018, TALANTA, V176, P456, DOI 10.1016/j.talanta.2017.08.070; Verma N, 2015, APPL BIOCHEM BIOTECH, V175, P3093, DOI 10.1007/s12010-015-1489-2; Wang TT, 2020, FOOD CHEM, V318, DOI 10.1016/j.foodchem.2020.126460; Xu HC, 2015, ANAL METHODS-UK, V7, P6260, DOI 10.1039/c5ay01282a; Yang ZT, 2015, BIOSENS BIOELECTRON, V65, P39, DOI 10.1016/j.bios.2014.10.004; Yao YW, 2019, SEP PURIF TECHNOL, V211, P456, DOI 10.1016/j.seppur.2018.10.021; Yi JL, 2020, BIOSENS BIOELECTRON, V148, DOI 10.1016/j.bios.2019.111827; Zhang BH, 2008, TALANTA, V75, P1055, DOI 10.1016/j.talanta.2008.01.032; Zhang J, 2018, ELECTROANAL, V30, P955, DOI 10.1002/elan.201700818; Zhang W, 2018, MOLECULES, V23, DOI 10.3390/molecules23020344; Zhao MM, 2018, TALANTA, V176, P34, DOI 10.1016/j.talanta.2017.08.006	53	5	6	12	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244297	10.1371/journal.pone.0244297	http://dx.doi.org/10.1371/journal.pone.0244297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362222	Green Published, gold			2022-12-27	WOS:000603071600049
J	Kruik-Kolloffel, WJ; van der Palen, J; Doggen, CJM; van Maaren, MC; Kruik, HJ; Heintjes, EM; Movig, KLL; Linssen, GCM				Kruik-Kolloffel, Willemien J.; van der Palen, Job; Doggen, Carine J. M.; van Maaren, Marissa C.; Kruik, H. Joost; Heintjes, Edith M.; Movig, Kris L. L.; Linssen, Gerard C. M.			Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases	PLOS ONE			English	Article							INITIATE LIFESAVING TREATMENT; ORGANIZED PROGRAM; MORTALITY; CARVEDILOL; ASSOCIATION; METOPROLOL; MORBIDITY; COMET; REHOSPITALIZATION; MANAGEMENT	Background This study assessed the association between heart failure (HF) medication (angiotensin-converting-enzyme inhibitors (ACEI)/angiotensin-receptor blockers (ARB), beta-blockers (BB), mineralocorticoid-receptor antagonists (MRA) and diuretics) and HF readmissions in a real-world unselected group of patients after a first hospital admission for HF. Furthermore we analysed readmission rates for ACEI versus ARB and for carvedilol versus beta 1-selective BB and we investigated the effect of HF medication in relation to time since discharge. Methods and findings Medication at discharge was determined with dispensing data from the Dutch PHARMO Database Network including 22,476 patients with HF between 2001 and 2015. After adjustment for age, gender, number of medications and year of admission no associations were found for users versus non-users of ACEI/ARB (hazard ratio, HR = 1.01; 95%CI 0.96-1.06), BB (HR = 1.00; 95%CI 0.95-1.05) and readmissions. The risk of readmission for patients prescribed MRA (HR = 1.11; 95%CI 1.05-1.16) or diuretics (HR = 1.17; 95%CI 1.09-1.25) was higher than for non-users. The HR for ARB relative to ACEI was 1.04 (95%CI 0.97-1.12) and for carvedilol relative to beta 1-selective BB 1.33 (95%CI 1.20-1.46). Post-hoc analyses showed a protective effect shortly after discharge for most medications. For example one month post discharge the HR for ACEI/ARB was 0.77 (95%CI 0.69-0.86). Although we did try to adjust for confounding by indication, probably residual confounding is still present. Conclusions Patients who were prescribed carvedilol have a higher or at least a similar risk of HF readmission compared to beta 1-selective BB. This study showed that all groups of HF medication -some more pronounced than others- were more effective immediately following discharge.	[Kruik-Kolloffel, Willemien J.] Ziekenhuisgrp Twente Hosp Grp Twente, Dept Clin Pharm, Almelo, Netherlands; [Kruik-Kolloffel, Willemien J.] Ziekenhuisgrp Twente Hosp Grp Twente, Dept Clin Pharm, Hengelo, Netherlands; [van der Palen, Job] Med Spectrum Twente, Med Sch Twente, Enschede, Netherlands; [van der Palen, Job] Univ Twente, Dept Res Methodol Measurement & Data Anal, Enschede, Netherlands; [Doggen, Carine J. M.; van Maaren, Marissa C.] Univ Twente, Dept Hlth Technol & Serv Res, Tech Med Ctr, Enschede, Netherlands; [van Maaren, Marissa C.] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands; [Kruik, H. Joost; Linssen, Gerard C. M.] Ziekenhuisgrp Twente Hosp Grp Twente, Dept Cardiol, Almelo, Netherlands; [Kruik, H. Joost; Linssen, Gerard C. M.] Ziekenhuisgrp Twente Hosp Grp Twente, Dept Cardiol, Hengelo, Netherlands; [Heintjes, Edith M.] PHARMO Inst, Utrecht, Netherlands; [Movig, Kris L. L.] Med Spectrum Twente, Dept Clin Pharm, Enschede, Netherlands	Medical Spectrum Twente; University of Twente; University of Twente; Medical Spectrum Twente	Kruik-Kolloffel, WJ (corresponding author), Ziekenhuisgrp Twente Hosp Grp Twente, Dept Clin Pharm, Almelo, Netherlands.; Kruik-Kolloffel, WJ (corresponding author), Ziekenhuisgrp Twente Hosp Grp Twente, Dept Clin Pharm, Hengelo, Netherlands.	w.kruik@sxb.nl		van der Palen, Job/0000-0003-1071-6769; Heintjes, Edith/0000-0002-2617-3845				[Anonymous], 2019, DIABETES CARE, V40, pS13; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bolling R, 2014, EUR J HEART FAIL, V16, P678, DOI 10.1002/ejhf.81; Bowman L, 2020, EUR HEART J, V41, P2571, DOI 10.1093/eurheartj/ehaa020; Bristow MR, 2003, J CARD FAIL, V9, P444, DOI 10.1016/j.cardfail.2003.10.009; Camm AJ, 2018, OPEN HEART, V5, DOI 10.1136/openhrt-2018-000788; Chatterjee S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f55; Cleland JGF, 2018, EUR HEART J, V39, P26, DOI 10.1093/eurheartj/ehx564; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; Crespo-Leiro MG, 2016, EUR J HEART FAIL, V18, P613, DOI 10.1002/ejhf.566; Dargie HJ, 2003, LANCET, V362, P2, DOI 10.1016/S0140-6736(03)13842-1; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Eschalier R, 2015, CARDIOVASC DRUG THER, V29, P89, DOI 10.1007/s10557-015-6572-y; Freemantle N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6409; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Go AS, 2007, AM J CARDIOL, V100, P690, DOI 10.1016/j.amjcard.2007.03.084; Goldgrab D, 2019, HEART FAIL REV, V24, P177, DOI 10.1007/s10741-018-9754-4; Herings RMC, 2012, PHARMACOEPIDEM DR S; Hernandez AF, 2009, J AM COLL CARDIOL, V53, P184, DOI 10.1016/j.jacc.2008.09.031; Jhund PS, 2020, EUR J HEART FAIL, V22, P249, DOI 10.1002/ejhf.1721; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kapelios CJ, 2018, EUR HEART J-CARD PHA, V4, P54, DOI 10.1093/ehjcvp/pvx020; KOTECHA D, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I1855; Kruik-Kolloffel WJ, 2019, HEART FAIL REV, V24, P499, DOI 10.1007/s10741-019-09777-2; Kruik-Kolloffel WJ, 2019, THESIS; Lazarus DL, 2011, AM J CARDIOL, V107, P1196, DOI 10.1016/j.amjcard.2010.12.017; Lund LH, 2018, EUR J HEART FAIL, V20, P511, DOI 10.1002/ejhf.1107; Mullens W, 2019, EUR J HEART FAIL, V21, P137, DOI 10.1002/ejhf.1369; Network Equator, 2019, REPORTING STUD COND; O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030; Packer M, 2002, CIRCULATION, V106, P2194, DOI 10.1161/01.CIR.0000035653.72855.BF; Packer M, 2003, J CARD FAIL, V9, P429, DOI 10.1016/j.cardfail.2003.08.003; Page RL, 2016, CIRCULATION, V134, pE32, DOI 10.1161/CIR.0000000000000426; Paolillo S, 2017, EUR J HEART FAIL, V19, P904, DOI 10.1002/ejhf.775; Pasternak B, 2014, JAMA INTERN MED, V174, P1597, DOI 10.1001/jamainternmed.2014.3258; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Rush CJ, 2018, EUR HEART J, V39, P3417, DOI 10.1093/eurheartj/ehy407; Sanam K, 2016, AM J MED, V129, P1067, DOI 10.1016/j.amjmed.2016.05.008; Schmidt M, 2016, EUR J HEART FAIL, V18, P490, DOI 10.1002/ejhf.486; Solomon SD, 2007, CIRCULATION, V116, P1482, DOI 10.1161/CIRCULATIONAHA.107.696906; Stolfo D, 2020, EUR J HEART FAIL, V22, P103, DOI 10.1002/ejhf.1615; Sulo G, 2020, EUR J HEART FAIL, V22, P241, DOI 10.1002/ejhf.1609; van Herk-Sukel MPP, 2010, EUR J CANCER, V46, P395, DOI 10.1016/j.ejca.2009.09.010; Wolsk E, 2018, EUR J HEART FAIL, V20, P1267, DOI 10.1002/ejhf.1225; Yamaguchi T, 2018, AM J CARDIOL, V121, P969, DOI 10.1016/j.amjcard.2018.01.006; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	48	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244231	10.1371/journal.pone.0244231	http://dx.doi.org/10.1371/journal.pone.0244231			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351823	Green Published, gold			2022-12-27	WOS:000603071400011
J	Naffa, H; Fain, M				Naffa, Helena; Fain, Mate			Performance measurement of ESG-themed megatrend investments in global equity markets using pure factor portfolios methodology	PLOS ONE			English	Article							CORPORATE SOCIAL-RESPONSIBILITY; MUTUAL FUND PERFORMANCE; STOCK RETURNS; FINANCIAL PERFORMANCE; SIGNALING THEORY; CROSS-SECTION; RISK; ERRORS; EQUILIBRIUM; ILLIQUIDITY	ESG factors are becoming mainstream in portfolio investment strategies, attracting increasing fund inflows from investors who are aligning their investment values to Sustainable Development Goals (SDG) declared by the United Nations Principles for Responsible Investments. Do investors sacrifice return for pursuing ESG-aligned megatrend goals? The study analyses the risk-adjusted financial performance of ESG-themed megatrend investment strategies in global equity markets. The analysis covers nine themes for the period 2015-2019: environmental megatrends covering energy efficiency, food security, and water scarcity; social megatrends covering ageing, millennials, and urbanisation; governance megatrends covered by cybersecurity, disruptive technologies, and robotics. We construct megatrend factor portfolios based on signalling theory and formulate a novel measure for stock megatrend exposure (MTE), based on the relative fund flows into the corresponding thematic ETFs. We apply pure factor portfolios methodology based on constrained WLS cross-sectional regressions to calculate Fama-French factor returns. Time-series regression rests on the generalised method of moments estimator (GMM) that uses robust distance instruments. Our findings show that each environmental megatrend, as well as the disruptive technologies megatrend, yielded positive and significant alphas relative to the passive strategy, although this outperformance becomes statistically insignificant in the Fama-French 5-factor model context. The important result is that most of the megatrend factor portfolios yielded significant non-negative alphas; which supports our assumption that megatrend investing strategy promotes SDGs while not sacrificing returns, even when accounting for transaction costs up to 50bps/annum. Higher transaction costs, as is the case for some of these ETFs with expense ratios reaching 80-100bps, may be an indication of two things: ESG-themed megatrend investors were willing to sacrifice ca. 30-50bps of annual return to remain aligned with sustainability targets, or that expense ratio may well decline in the future.	[Naffa, Helena; Fain, Mate] Corvinus Univ Budapest, Dept Finance, Budapest, Hungary	Corvinus University Budapest	Fain, M (corresponding author), Corvinus Univ Budapest, Dept Finance, Budapest, Hungary.	mate.fain@uni-corvinus.hu	Naffa, Helena/ABE-3227-2021	Naffa, Helena/0000-0003-4284-1601; Fain, Mate/0000-0002-4828-5880	Higher Education Institutional Excellence Program of the Ministry for Human Capacities at Corvinus University of Budapest [NKFIH-1163-10/2019]	Higher Education Institutional Excellence Program of the Ministry for Human Capacities at Corvinus University of Budapest	The work of HN and MF was supported by the Higher Education Institutional Excellence Program of the Ministry for Human Capacities in the framework of the `Financial and Public Services' research project (NKFIH-1163-10/2019) at Corvinus University of Budapest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque RA, 2020, CEPR DISCUSSION PAPE; Alda M, 2020, FINANC RES LETT, V36, DOI 10.1016/j.frl.2019.101313; Alvarez M, 2015, SOC RESPONSIB J, V11, P502, DOI 10.1108/SRJ-08-2013-0104; American Society for Interventional and Therapeutic Neuroradiology, 2001, AJNR Am J Neuroradiol, V22, pS28; Amihud Y, 2002, J FINANC MARK, V5, P31, DOI 10.1016/S1386-4181(01)00024-6; Andersson M, 2016, FINANC ANAL J, V72, P13, DOI 10.2469/faj.v72.n3.4; [Anonymous], 1970, NEW YORK TIMES; Asness C, 2013, J PORTFOLIO MANAGE, V39, P49, DOI 10.3905/jpm.2013.39.4.049; AUPPERLE KE, 1985, ACAD MANAGE J, V28, P446, DOI 10.2307/256210; Back K, 2015, TESTING FACTOR MODEL, DOI [10.2139/ssrn.2621696, DOI 10.2139/SSRN.2621696]; Back K, 2013, 2295993 SOC SCI RES, DOI [10.2139/ssrn.2295993, DOI 10.2139/SSRN.2295993]; Bauer R, 2005, J BANK FINANC, V29, P1751, DOI 10.1016/j.jbankfin.2004.06.035; BELKAOUI A, 1976, FINANC MANAGE, V5, P26, DOI 10.2307/3665454; Bergh DD, 2011, J MANAGE STUD, V48, P544, DOI 10.1111/j.1467-6486.2010.00957.x; Bodie Z, 2018, INVESTMENTS, V11th; Boesl DBO, 2016, 2016 IEEE INT C EM T; Boutin-Dufresne F., 2004, J INVEST, V13, P57; BOWMAN EH, 1975, CALIF MANAGE REV, V18, P49, DOI 10.2307/41164638; Bragdon H.J., 1972, RISK MANAGBUS SOC RE, V19, P9, DOI DOI 10.1017/CBO9781107415324.004; Cajias M, 2014, STUD ECON FINANC, V31, P202, DOI 10.1108/SEF-05-2013-0067; Capelle-Blancard G, 2012, BUS ETHICS, V21, P239, DOI 10.1111/j.1467-8608.2012.01658.x; Chan LKC, 2001, J FINANC, V56, P2431, DOI 10.1111/0022-1082.00411; Chao YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181990; Clarke R, 2017, J PORTFOLIO MANAGE, V43, P16, DOI 10.3905/jpm.2017.43.3.016; Clarke R, 2014, FINANC ANAL J, V70, P13, DOI 10.2469/faj.v70.n5.3; CLARKSON MBE, 1995, ACAD MANAGE REV, V20, P92, DOI 10.2307/258888; Cochrane JH, 2005, ASSET PRICING, P1; Cochrane JH, 2011, J FINANC, V66, P1047, DOI 10.1111/j.1540-6261.2011.01671.x; Connelly BL, 2011, J MANAGE, V37, P39, DOI 10.1177/0149206310388419; Csoka P, 2009, GAME ECON BEHAV, V67, P266, DOI 10.1016/j.geb.2008.11.001; Dam L, 2008, THESIS U GRONINGEN G; Danyliv O, 2014, J TRADING, V9, P57, DOI 10.3905/jot.2014.9.3.057; Darbyshire M, 2020, ESG FUNDS CONTINUE O; Daugaard D, 2020, ACCOUNT FINANC, V60, P1501, DOI 10.1111/acfi.12479; Della Corte P, 2009, REV FINANC STUD, V22, P3491, DOI 10.1093/rfs/hhn058; Demirtas H, 2008, J STAT COMPUT SIM, V78, P69, DOI 10.1080/10629360600903866; Derwall J, 2005, FINANC ANAL J, V61, P51, DOI 10.2469/faj.v61.n2.2716; Diltz J.D., 1995, APPL FINANCIAL EC, V5, P69, DOI DOI 10.1080/758529174; Dopierala L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12020654; Durbin J, 1954, REV INT STAT I, V22, P23, DOI [10.2307/1401917, DOI 10.2307/1401917]; Fama EF, 1996, J FINANC, V51, P55, DOI 10.2307/2329302; FAMA EF, 1973, J POLIT ECON, V81, P607, DOI 10.1086/260061; FAMA EF, 1992, J FINANC, V47, P427, DOI 10.2307/2329112; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Fama EF, 1976, FDN FINANCE PORTFOLI; Fama EF, 2008, J FINANC, V63, P1653, DOI 10.1111/j.1540-6261.2008.01371.x; Fama EF, 2020, REV FINANC STUD, V33, P1891, DOI 10.1093/rfs/hhz089; Fama EF, 2015, J FINANC ECON, V116, P1, DOI 10.1016/j.jfineco.2014.10.010; Ferson W, 2019, EMPIRICAL ASSET PRICING: MODELS AND METHODS, P1; Frazzini A, 2014, J FINANC ECON, V111, P1, DOI 10.1016/j.jfineco.2013.10.005; Freeman R.E, 2015, STRATEG MANAG, DOI [10.1017/CBO9781139192675, DOI 10.1017/CBO9781139192675]; Freeze J, 2018, PROCEEDINGS OF THE 51ST ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES (HICSS), P913; Friede G., 2015, J SUSTAIN FINANC INV, V5, P210, DOI [10.1080/20430795.2015.1118917, DOI 10.1080/20430795.2015.1118917]; FTSE, 2014, FACT EXP IND MON FAC; Galema R, 2008, J BANK FINANC, V32, P2646, DOI 10.1016/j.jbankfin.2008.06.002; Global Sustainable Investment Alliance (GSIA), 2018, GLOB SUST INV REV 20; Griffin JJ., 1997, BUS SOC, V36, P5, DOI [DOI 10.1177/000765039703600102, 10.1177/000765039703600102]; Grossman BR., 1986, FINANC ANAL J, V42, P15, DOI 10.2469/faj.v42.n4.15; GSIA, 2014, GLOBAL SUSTAINABLE I; Hamilton S., 1993, FINANC ANAL J, V49, P62, DOI 10.2469/faj.v49.n6.62; Heinkel R, 2001, J FINANC QUANT ANAL, V36, P431, DOI 10.2307/2676219; HESTON SL, 1994, J FINANC ECON, V36, P3, DOI 10.1016/0304-405X(94)90028-0; Ibikunle G, 2017, J BUS ETHICS, V145, P337, DOI 10.1007/s10551-015-2850-7; Ielasi F, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11123304; Jakab S, 2020, WALL STREET J; Jo HJ, 2012, J BUS ETHICS, V110, P441, DOI 10.1007/s10551-012-1492-2; JOBSON JD, 1981, J FINANC, V36, P889, DOI 10.1111/j.1540-6261.1981.tb04891.x; Kempf A, 2007, EUR FINANC MANAG, V13, P908, DOI 10.1111/j.1468-036X.2007.00402.x; Ledoit O, 2008, J EMPIR FINANC, V15, P850, DOI 10.1016/j.jempfin.2008.03.002; Lee KJ, 2010, AM J EPIDEMIOL, V171, P624, DOI 10.1093/aje/kwp425; LHer J. F., 2004, J INT FINANCIAL MARK, V14, P310, DOI 10.1016/j.intfin.2003.09.001; Lin LW, 2010, BERKELEY J INT LAW, V28, P64; Lopez-Garcia MN, 2021, EUR J OPER RES, V291, P421, DOI 10.1016/j.ejor.2019.07.071; Lynch K, FIND LOW COST ESG FU; Mahieu R, 2019, JIPITEC, V10, P85; Manohar S, 2019, MKTGH0919A938961320; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Margolis JD, 2003, ADMIN SCI QUART, V48, P268, DOI 10.2307/3556659; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Marti-Ballester CP, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12052032; Marti-Ballester CP, 2019, BUS STRATEG ENVIRON, V28, P1107, DOI 10.1002/bse.2305; Marti-Ballester CP, 2019, ENERGY ENV SUSTAIN, P201, DOI 10.1007/978-981-13-3284-5_9; Marti-Ballester CP, 2019, RENEW ENERG, V143, P1299, DOI 10.1016/j.renene.2019.05.095; McWilliams A, 2001, ACAD MANAGE REV, V26, P117, DOI 10.5465/AMR.2001.4011987; McWilliams A, 2006, J MANAGE STUD, V43, P1, DOI 10.1111/j.1467-6486.2006.00580.x; McWilliams A, 2000, STRATEGIC MANAGE J, V21, P603, DOI 10.1002/(SICI)1097-0266(200005)21:5<603::AID-SMJ101>3.3.CO;2-V; Memmel C., 2003, FINANCE LETT, V1, P21; Menchero J., 2015, J INVEST MANAG, V13, P71; Menchero J., 2010, J PERFORMANCE MANAGE, V15, P52; Menchero J, 2017, BLOOMBERG WHITE PAPE, P1; Mer B, SZIGMA, V50, P263; MERTON RC, 1987, J FINANC, V42, P483, DOI 10.2307/2328367; Mitchell RK, 1997, ACAD MANAGE REV, V22, P853, DOI 10.2307/259247; Morgan J.P., 2019, JP MORGAN PERSPECTIV; Moskowitz M., 1972, BUS SOC REV, P71; Muley A, 2019, INT J SCI RES REV, V7, P2277; Muradoglu YG, 2013, STUD ECON FINANC, V30, P94, DOI 10.1108/10867371311325417; Naisbitt J, 1982, MEGATRENDS 10 NEW DI; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Ormos M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115742; PAL M, 1980, J ECONOMETRICS, V14, P349, DOI 10.1016/0304-4076(80)90032-9; Pastor L, 2003, J POLIT ECON, V111, P642, DOI 10.1086/374184; Preston L., 1997, BUS SOC, V36, P419, DOI [10.1177/000765039703600406, DOI 10.1177/000765039703600406]; Racicot F. E., 2012, APPL FINANCIAL EC, V22, P1135, DOI 10.1080/09603107.2011.629983; Racicot FE, 2018, FINANCE, P45; Racicot FE, 2015, APPL ECON, V47, P981, DOI 10.1080/00036846.2014.985373; Racicot FE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221599; Racicot FE, 2019, BORSA ISTANB REV, V19, P117, DOI 10.1016/j.bir.2018.12.001; Racicot FE, 2015, J ASSET MANAG, V16, P329, DOI 10.1057/jam.2015.22; Racicot FE, 2014, APPL ECON, V46, P1134, DOI 10.1080/00036846.2013.868591; Reboredo JC, 2017, RENEW SUST ENERG REV, V73, P512, DOI 10.1016/j.rser.2017.01.158; Reiser D.B., 2019, CARDOZO LAW REV, V41, P1921, DOI 10.2139/ssrn.3440768; Renneboog L, 2008, J BANK FINANC, V32, P1723, DOI 10.1016/j.jbankfin.2007.12.039; Revelli C., 2013, MANAG INT, V17, P105; Revelli C, 2015, BUS ETHICS, V24, P158, DOI 10.1111/beer.12076; Roy R, 2018, BORSA ISTANB REV, V18, P205, DOI 10.1016/j.bir.2018.02.001; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Simlai P, 2009, STUD ECON FINANC, V26, P198, DOI 10.1108/10867370910974026; Skocir M, 2018, J INT FINANC MARK I, V55, P65, DOI 10.1016/j.intfin.2018.02.006; Sparkes R., 2003, SOCIALLY RESPONSIBLE; Spence A. M., 1974, MARKET SIGNALING INF; SPENCE M, 1973, Q J ECON, V87, P355, DOI 10.2307/1882010; StataCorp LP, 2013, LP GAS SAFETY REFERE; Thomas J.K., 2002, REV ACCOUNT STUD, V7, P163; UCLA: Statistical Consulting Group, MULT IMP STAT; UNCTAD, 2020, UNCTADDIAE20201; United Nations, 2015, TRANSF OUR WORLD 203; Vance S., 1975, MANAGE REV, V64, P18; Vermeulen E, 2019, TEX J BUS LAW, V48, P1; von Solms B, 2018, INF COMPUT SECUR, V26, P2, DOI 10.1108/ICS-04-2017-0025; Waddock SA, 1997, STRATEGIC MANAGE J, V18, P303, DOI 10.1002/(SICI)1097-0266(199704)18:4<303::AID-SMJ869>3.0.CO;2-G; Walter G, 1999, BANKSZEMLE, V43, P34	132	5	5	22	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244225	10.1371/journal.pone.0244225	http://dx.doi.org/10.1371/journal.pone.0244225			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351834	Green Published, gold, Green Accepted			2022-12-27	WOS:000603071400043
J	Komsalova, LY; Salinas, MPM; Jimenez, JFG				Komsalova, Liliya Yankova; Martinez Salinas, Ma Pilar; Jimenez, Jose Fermin Gomez			Predictive values of inflammatory back pain, positive HLA B27 antigen and acute and chronic magnetic resonance changes in early diagnosis of Spondyloarthritis. A study of 133 patients	PLOS ONE			English	Article							SOCIETY CLASSIFICATION CRITERIA; AXIAL SPONDYLOARTHRITIS; ANKYLOSING-SPONDYLITIS; SACROILIAC JOINT; SHORT-DURATION; VALIDATION; COHORT; MRI; VALIDITY; HLA-B27	Objectives To analyse the predictive values of inflammatory back pain (IBP), positive HLA B27 antigen, increased C-reactive protein (CRP), Spondyloarthritis (SpA) features, familial history (FH), magnetic resonance sacroiliac joints (MRI-SIJ) imaging and its weight in early SpA diagnosis. Methods 133 patients with back pain, aged <50, duration of the pain <2 years were included. Data such as IBP, HLA B27, increased CRP, SpA features, FH, SIJ ' s radiography and MRI were collected for each patient. STIR sequences were classified as strongly positive bone morrow oedema (SPBME >= 2), clearly present and easily recognisable as positive according to the ASAS criterion, weakly positive (WPBME >= 2), suggestive, but not easily recognisable and, clearly negative none of those features. T1-weighted sequences were assessed as positive/negative for erosion, fat metaplasia, backfill and sclerosis, if >= 1, for each lesion was present. MRI images were read by three blinded readers. Results The average age was 38.9 years. 47 (35.3%) patients received SpA diagnosis according to the clinical opinion. IBP was highly specific, 0.81 and sensitive, 0.83. HLA B27 was positive in a half of the SpA patients. SPBME >= 2 provided a great specificity, 0.94 and an acceptable sensitivity, 0.79. Erosion was significantly more frequent in SpA patients (72% vs 7%), specificity 0.93. The addition of erosion >= 1 to the WPBME >= 2 noticeably improved specificity, 0.98, although slightly decreased sensitivity, 0.64. Fat metaplasia and backfill were highly specific, but poorly sensitive. Factors forecasting positive diagnosis were IBP, followed by SpA features and increased CRP. Conclusions At the onset, IBP might be a good marker for selecting patients with suspicion of SpA. The addition of erosion to the ASAS criterion might be helpful for early diagnosis, especially in patients with doubtful STIR imaging where BME is present but it is hard to determinate whether the ASAS "highly suggestive" criterion is met.	[Komsalova, Liliya Yankova] Hosp Marina Salud, Rheumatol Dept, Alicante, Spain; [Martinez Salinas, Ma Pilar; Jimenez, Jose Fermin Gomez] Hosp Marina Salud, Radiol Dept, Alicante, Spain		Komsalova, LY (corresponding author), Hosp Marina Salud, Rheumatol Dept, Alicante, Spain.	liliya.yankova.kom@gmail.com						AMOR B, 1991, ANN MED INTERNE, V142, P85; Aydin SZ, 2012, ANN RHEUM DIS, V71, P56, DOI 10.1136/ard.2011.153064; Baraliakos X, 2019, J RHEUMATOL, V46, P1445, DOI 10.3899/jrheum.181304; Braun J, 2019, RHEUMATOLOGY, V58, P859, DOI 10.1093/rheumatology/key375; Braun J, 2017, ANN RHEUM DIS, V76, P1070, DOI 10.1136/annrheumdis-2016-209730; Brown MA, 2010, CURR OPIN RHEUMATOL, V22, P126, DOI 10.1097/BOR.0b013e3283364483; Chung HY, 2011, ANN RHEUM DIS, V70, P1930, DOI 10.1136/ard.2011.152975; de Hooge M, 2016, ANN RHEUM DIS, V75, P1308, DOI 10.1136/annrheumdis-2015-207823; de Winter J, 2018, ARTHRITIS RHEUMATOL, V70, P1042, DOI 10.1002/art.40475; Heuft-Dorenbosch L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1859; Heuft-Dorenbosch L, 2007, ANN RHEUM DIS, V66, P92, DOI 10.1136/ard.2006.053918; Hu ZY, 2016, JOINT BONE SPINE, V83, P179, DOI 10.1016/j.jbspin.2015.05.011; Jones A, 2019, RHEUMATOLOGY, V58, P1955, DOI 10.1093/rheumatology/kez172; Jovani V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205751; Joven BE, 2017, ARTHRIT CARE RES, V69, P938, DOI 10.1002/acr.23017; Lambert RGW, 2016, ANN RHEUM DIS, V75, P1958, DOI 10.1136/annrheumdis-2015-208642; Maksymowych WP, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1342-9; Maksymowych WP, 2014, ARTHRITIS RHEUMATOL, V66, P2958, DOI 10.1002/art.38792; Maksymowych WP, 2013, ANN RHEUM DIS, V72, P23, DOI 10.1136/annrheumdis-2011-200859; Maksymowych WP, 2009, J RHEUMATOL, V36, P48, DOI 10.3899/jrheum.090620; Meghnathi B, 2019, CLIN EXP RHEUMATOL, V37, P797; Molnar C, 2018, ANN RHEUM DIS, V77, P63, DOI 10.1136/annrheumdis-2017-211544; Molto A, 2019, RMD OPEN, V5, DOI 10.1136/rmdopen-2019-000918; Navarro-Compan V, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0779-y; Oliveira TL, 2017, J RHEUMATOL, V44, P1833, DOI 10.3899/jrheum.170036; Ostergaard M, 2012, THER ADV MUSCULOSKEL, V4, P301, DOI 10.1177/1759720X11436240; Robinson PC, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4561; Rudwaleit M, 2006, ARTHRITIS RHEUM, V54, P569, DOI 10.1002/art.21619; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247; Rudwaleit M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P1520, DOI 10.1136/ard.2009.110767; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P770, DOI 10.1136/ard.2009.108217; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P777, DOI 10.1136/ard.2009.108233; Rueda JC, 2017, INT J RHEUMATOL, V2017, P1, DOI 10.1155/2017/3143069; Sieper J, 2009, ANN RHEUM DIS, V68, P784, DOI 10.1136/ard.2008.101501; Tournadre A, 2013, ARTHRIT CARE RES, V65, P1482, DOI 10.1002/acr.22001; van der Heijde D, 2018, ANN RHEUM DIS, V77, P699, DOI 10.1136/annrheumdis-2017-212377; van Hoeven L, 2014, ARTHRIT CARE RES, V66, P446, DOI 10.1002/acr.22180; van Lunteren M, 2019, RHEUMATOLOGY, V58, P1649, DOI 10.1093/rheumatology/kez095; van Onna M, 2011, ANN RHEUM DIS, V70, P1981, DOI 10.1136/annrheumdis-2011-200025; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Weber U, 2015, ANN RHEUM DIS, V74, P1976, DOI 10.1136/annrheumdis-2014-205408; Weber U, 2013, ARTHRIT CARE RES, V65, P977, DOI 10.1002/acr.21893; Weber U, 2010, ARTHRITIS RHEUM-US, V62, P3048, DOI 10.1002/art.27571	45	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244184	10.1371/journal.pone.0244184	http://dx.doi.org/10.1371/journal.pone.0244184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347471	Green Published, gold			2022-12-27	WOS:000603071100049
J	Li, ZW; Wang, JH				Li, Zhangwei; Wang, Juhong			Identification and similarity analysis of aroma substances in main types of Fenghuang Dancong tea	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; PU-ERH TEA; CAMELLIA-SINENSIS; OOLONG TEA; VOLATILE PROFILES; ACTIVE COMPOUNDS; ELECTRONIC NOSE; BLACK TEA; HS-SPME; GC-MS	Fenghuang Dancong tea covers the oolong tea category and is widely acknowledged for its unique floral and honey flavor. In order to characterize the volatile components in nine different aroma types of Fenghuang Dancong tea, the Headspace solid-phase microextraction (HS-SPME) coupled with gas chromatography-mass spectrometry (GC- MS) were employed. In addition, the similarity analysis and cluster analysis (CA) were performed to compare the aroma characteristics and establish the correlation between the nine types of teas. The principal component analysis (PCA) and orthogonal partial least squares discrimination analysis (OPLS-DA) method were employed to determine the volatile components with a high contribution to the overall aroma of each type of tea. The results presented a total of 122 volatile aroma components including 24 kinds of alcohol, 23 kinds of esters, 15 kinds of olefins, 12 kinds of aldehydes, 12 kinds of ketones, 13 kinds of alkanes and 23 kinds of other components from the nine types of Fenghuang Dancong tea. Of these volatile aroma components, 22 types were common with linalool, dehydrolinalool, linalool oxide I, linalool oxide II, etc. The similarity of the nine types of Fenghuang Dancong tea was found between 46.79% and 95.94%. The CA indicated that the nine types of Fenghuang Dancong tea could be clustered into four categories when the ordinate distance reached to 10. The PCA demonstrated that decane, octadecane, 2,2,4,6,6-pentamethylheptane, dehydrolinalool, geraniol and nerol were the important aroma components to Fenghuang Dancong Tea. OPLS-DA proved that 2,2,4,6,6-pentamethylheptane, dehydrolinalool, phenylacetaldehyde, nerolidol, linalool oxide I and hexanal were the key differential compounds between the various types of tea samples. This study provides a theoretical basis for characterizing the volatile aroma components in the main types of Fenghuang Dancong tea as well as the similarity and correlation between various types of Fenghuang Dancong tea.	[Li, Zhangwei] Hanshan Normal Univ, Inst Chem & Environm Engn, Chaozhou, Peoples R China; [Wang, Juhong] Hanshan Normal Univ, Inst Food Engn & Biotechnol, Chaozhou, Peoples R China	Hanshan Normal University; Hanshan Normal University	Li, ZW (corresponding author), Hanshan Normal Univ, Inst Chem & Environm Engn, Chaozhou, Peoples R China.	99094001@163.com	LI, Zhangwei/HGV-1926-2022	LI, Zhangwei/0000-0001-8456-7386	Science and Technology Planing Project of Guangdong Province, China [2017A030303086]; National Natural Science Foundation of China [31770584]; Science and Technology Planing Project of Chaozhou City [2017GY04]	Science and Technology Planing Project of Guangdong Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planing Project of Chaozhou City	1.Science and Technology Planing Project of Guangdong Province, China (2017A030303086), 2.National Natural Science Foundation of China(31770584) 3.Science and Technology Planing Project of Chaozhou City (2017GY04).	Baldermann S., 2014, AM J ANAL CHEM, V5, P620, DOI DOI 10.4236/ajac.2014.59070; Chen XH, 2019, FOOD CHEM, V274, P130, DOI 10.1016/j.foodchem.2018.08.124; Dong WJ, 2019, FOOD CHEM, V272, P723, DOI 10.1016/j.foodchem.2018.08.068; Du LP, 2019, MICROCHEM J, V146, P986, DOI 10.1016/j.microc.2019.02.036; Gao XM, 2017, INT J FOOD PROP, V20, pS240, DOI 10.1080/10942912.2017.1295256; Guo XY, 2018, FOOD CHEM, V263, P18, DOI 10.1016/j.foodchem.2018.04.117; Haeck C, 2015, LABOUR ECON, V36, P137, DOI 10.1016/j.labeco.2015.05.002; Jang J, 2010, INT J FOOD PROP, V13, P608, DOI 10.1080/10942910902716976; Jeon DB, 2017, FOOD CHEM, V219, P443, DOI 10.1016/j.foodchem.2016.09.184; Landmann C, 2007, ARCH BIOCHEM BIOPHYS, V465, P417, DOI 10.1016/j.abb.2007.06.011; Lin J, 2012, J ZHEJIANG UNIV-SC B, V13, P972, DOI 10.1631/jzus.B1200086; Lin SY, 2013, J HORTIC SCI BIOTECH, V88, P159, DOI 10.1080/14620316.2013.11512951; Lv SD, 2015, RSC ADV, V5, P87806, DOI 10.1039/c5ra15381f; Ma CY, 2018, FOOD RES INT, V108, P413, DOI 10.1016/j.foodres.2018.03.052; Ma CH, 2014, FOOD CHEM, V152, P285, DOI 10.1016/j.foodchem.2013.11.010; Ma CH, 2013, J AGR FOOD CHEM, V61, P3548, DOI 10.1021/jf400515g; Mondal TK, 2004, PLANT CELL TISS ORG, V76, P195, DOI 10.1023/B:TICU.0000009254.87882.71; Morales-Hidalgo P, 2017, INT J CLIN HLTH PSYC, V17, P269, DOI 10.1016/j.ijchp.2017.05.002; Mukhopadhyay M, 2016, PLANT CELL REP, V35, P255, DOI 10.1007/s00299-015-1884-8; Nie CN, 2019, EUR FOOD RES TECHNOL, V245, P1963, DOI 10.1007/s00217-019-03304-1; Qin ZH, 2013, FOOD RES INT, V53, P864, DOI 10.1016/j.foodres.2013.02.005; Schuh C, 2006, J AGR FOOD CHEM, V54, P916, DOI 10.1021/jf052495n; Sheibani E, 2016, J FOOD SCI, V81, pC348, DOI 10.1111/1750-3841.13203; Shen CJ, 2012, BIOTECHNOL & BIOPROC, V34, P165; [史敬芳 Shi Jingfang], 2016, [食品科学, Food Science], V37, P111; Song SQ, 2013, J CHROMATOGR A, V1278, P145, DOI 10.1016/j.chroma.2012.12.062; Su XG, 2006, J FOOD COMPOS ANAL, V19, P348, DOI 10.1016/j.jfca.2005.02.005; Tan HR, 2019, LWT-FOOD SCI TECHNOL, V108, P221, DOI 10.1016/j.lwt.2019.03.054; Wang C, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2229-y; Wang YF, 2012, FOOD RES INT, V46, P158, DOI 10.1016/j.foodres.2011.11.027; Wu SB, 2013, J CHROMATOGR A, V1314, P154, DOI 10.1016/j.chroma.2013.09.017; Wu SBA, 2012, J AGR FOOD CHEM, V60, P7513, DOI 10.1021/jf301888y; [肖凌 Xiao Ling], 2018, [食品科学, Food Science], V39, P233; Xu YQ, 2016, FOOD ANAL METHOD, V9, P1188, DOI 10.1007/s12161-015-0303-7; Yang ZY, 2013, FOOD RES INT, V53, P585, DOI 10.1016/j.foodres.2013.02.011; Yang ZY, 2009, J PLANT PHYSIOL, V166, P887, DOI 10.1016/j.jplph.2008.11.001; Zhang WJ, 2019, J ZHEJIANG UNIV-SC B, V20, P563, DOI 10.1631/jzus.B1800183; Zhou ChunJuan, 2014, Journal of Tea Science, V34, P609	38	9	9	17	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244224	10.1371/journal.pone.0244224	http://dx.doi.org/10.1371/journal.pone.0244224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347483	gold, Green Published			2022-12-27	WOS:000603071100043
J	Migita, K; Nakamura, M; Aiba, Y; Kozuru, H; Abiru, S; Komori, A; Fujita, Y; Temmoku, J; Asano, T; Sato, S; Furuya, M; Naganuma, A; Yoshizawa, K; Shimada, M; Ario, K; Mannami, T; Kohno, H; Kaneyoshi, T; Komura, T; Ohira, H; Yatsuhashi, H				Migita, Kiyoshi; Nakamura, Minoru; Aiba, Yoshihiro; Kozuru, Hideko; Abiru, Seigo; Komori, Atsumasa; Fujita, Yuya; Temmoku, Junpei; Asano, Tomoyuki; Sato, Shuzo; Furuya, Makiko; Naganuma, Atsushi; Yoshizawa, Kaname; Shimada, Masaaki; Ario, Keisuke; Mannami, Tomohiko; Kohno, Hiroshi; Kaneyoshi, Toshihiko; Komura, Takuya; Ohira, Hiromasa; Yatsuhashi, Hiroshi			Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TIM-3; DIAGNOSIS	Background Autoimmune hepatitis (AIH) is a disorder of unknown etiology in which immune-mediated liver injury progress to cirrhosis or hepatocellular carcinoma (HCC). The aim of the present study was to determine whether circulating soluble TIM3 (sTIM3) is elevated in patients with AIH patients and whether sTIM-3 levels are associated with clinical parameters of AIH. Methods We enrolled 123 Japanese patients with AIH who were identified from the National Hospital Organization-AIH-liver-network database, as well as 32 patients with chronic hepatitis C (CHC), 30 patients with primary biliary cholangitis (PBC) and healthy control subjects. Serum sTIM-3 concentrations were quantified by ELISA. Results Serum levels of sTIM-3 were significantly higher in AIH patients (median 4865 pg/ml; [interquartile range (IQR); 3122-7471]) compared to those in CHC (1026 pg/ml [IQR: 806-1283] p<0.001), PBC (2395 pg/ml [IQR: 2012-3422] p<0.001) or healthy controls (1285 pg/ml [IQR: 1098-1812] p<0.001). In AIH group, serum sTIM-3 were correlated with alanine aminotransferase (ALT), or total bilirubin (TB) and negatively correlated with serum levels of albumin (Alb). Serum levels of sTIM-3 were also strongly correlated with Mac-2 binding protein glycosylation isomer (M2BPGi) levels, but did not correlate with the histological grade of liver fibrosis. Steroid treatment of AIH patients significantly reduced serum sTIM-3 levels (2147 +/- 623pg/ml versus 1321 +/- 378pg/ml, p<0.001). Conclusions Circulating sTIM-3 levels were elevated in AIH patients and are associated with AIH disease activity and AIH-related liver damage. These findings indicate that serum sTIM-3 correlated with disease status of AIH and could be useful biomarkers to detect autoimmune-mediated liver injury. Our data suggest a possible link between the TIM-3/GAL-9 pathway and AIH severity or phenotype, and further investigations of the TIM-3 pathway and AIH pathophysiology is warranted.	[Migita, Kiyoshi; Nakamura, Minoru; Aiba, Yoshihiro; Kozuru, Hideko; Abiru, Seigo; Komori, Atsumasa; Yatsuhashi, Hiroshi] Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan; [Migita, Kiyoshi; Fujita, Yuya; Temmoku, Junpei; Asano, Tomoyuki; Sato, Shuzo; Furuya, Makiko] Fukushima Med Univ, Dept Rheumatol, Fukushima, Japan; [Naganuma, Atsushi] Natl Hosp Org, Takasaki Med Ctr, Takasaki, Gumma, Japan; [Yoshizawa, Kaname] Natl Hosp Org, Shinsyu Ueda Med Ctr, Ueda, Nagano, Japan; [Shimada, Masaaki] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Ario, Keisuke] Natl Hosp Org, Ureshino Med Ctr, Ureshino, Saga, Japan; [Mannami, Tomohiko] Natl Hosp Org, Okayama Med Ctr, Okayama, Okayama, Japan; [Kohno, Hiroshi] Natl Hosp Org, Kure Med Ctr, Kure, Hiroshima, Japan; [Kaneyoshi, Toshihiko] Natl Hosp Org, Fukuyama Med Ctr, Kanazawa, Ishikawa, Japan; [Komura, Takuya] Natl Hosp Org, Kanazawa Med Ctr, Kanazawa, Ishikawa, Japan; [Ohira, Hiromasa] Fukushima Med Univ, Dept Gastroenterol, Fukushima, Japan	Fukushima Medical University; Nagoya Medical Center; Fukushima Medical University	Migita, K (corresponding author), Nagasaki Med Ctr, Clin Res Ctr, Nagasaki, Japan.; Migita, K (corresponding author), Fukushima Med Univ, Dept Rheumatol, Fukushima, Japan.	migita@fmu.ac.jp			National Hospital Organization [H29-NHOL-01]	National Hospital Organization	The study was supported by a grant from the National Hospital Organization (grant number H29-NHOL-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Bekki Y, 2017, J GASTROEN HEPATOL, V32, P1387, DOI 10.1111/jgh.13708; Cox MA, 2017, CURR OPIN IMMUNOL, V48, P61, DOI 10.1016/j.coi.2017.07.016; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; de Boer YS, 2014, GASTROENTEROLOGY, V147, P443, DOI 10.1053/j.gastro.2014.04.022; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Fleury M, 2018, ARTHRITIS RHEUMATOL, V70, P566, DOI 10.1002/art.40399; Floreani A, 2018, J AUTOIMMUN, V95, P133, DOI 10.1016/j.jaut.2018.10.020; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Golden-Mason L, 2015, CLIN IMMUNOL, V158, P114, DOI 10.1016/j.clim.2015.03.008; Han GC, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00449; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Heneghan MA, 2013, LANCET, V382, P1433, DOI 10.1016/S0140-6736(12)62163-1; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2014, MOL IMMUNOL, V58, P85, DOI 10.1016/j.molimm.2013.11.001; Kocer B, 2018, TURK J NEUROL, V24, P168, DOI 10.4274/tnd.65624; Liberal R, 2017, HEPATOLOGY, V66, P1570, DOI 10.1002/hep.29307; Liberal R, 2012, HEPATOLOGY, V56, P677, DOI 10.1002/hep.25682; Longhi MS, 2010, DIGEST DIS, V28, P63, DOI 10.1159/000282066; Longhi MS, 2010, J AUTOIMMUN, V34, P7, DOI 10.1016/j.jaut.2009.08.010; Matsuoka N, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016924; McGrath MM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00047; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Moller-Hackbarth K, 2013, J BIOL CHEM, V288, P34529, DOI 10.1074/jbc.M113.488478; Oka S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187325; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Song LJ, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0306-0; Tang RH, 2019, SEMIN IMMUNOL, V42, DOI 10.1016/j.smim.2019.101302; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu C, 2011, CURR TOP MICROBIOL, V350, P1, DOI 10.1007/82_2010_84	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0238540	10.1371/journal.pone.0238540	http://dx.doi.org/10.1371/journal.pone.0238540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347507	gold, Green Published			2022-12-27	WOS:000603071100066
J	Hammoudi, N; Fellag, M; Militello, M; Bouam, A; Drancourt, M				Hammoudi, Nassim; Fellag, Mustapha; Militello, Muriel; Bouam, Amar; Drancourt, Michel			Translocating Mycobacterium ulcerans: An experimental model	PLOS ONE			English	Article								Mycobacterium ulcerans is a non-tuberculous environmental mycobacterium responsible for extensive cutaneous and subcutaneous ulcers in mammals, known as Buruli ulcer in humans. M. ulcerans has seldom been detected in the faeces of mammals and has not been detected in human faeces. Nevertheless, the detection and isolation of M. ulcerans in animal faeces does not fit with the current epidemiological schemes for the disease. Here, using an experimental model in which rats were fed with 10(9) colony-forming units of M. ulcerans, we detected M. ulcerans DNA in the faeces of challenged rats for two weeks and along their digestive tract for 10 days. M. ulcerans DNA was further detected in the lymphatic system including in the cervical and axillary lymph nodes and the spleen, but not in any other tissue including healthy and broken skin, 10 days post-challenge. These observations indicate that in some herbivorous mammals, M. ulcerans contamination by the digestive route may precede translocation and limited contamination of the lymphatic tissues without systemic infection. These herbivorous mammals may be sources of M. ulcerans for exposed populations but are unlikely to be reservoirs for the pathogen.	[Hammoudi, Nassim; Fellag, Mustapha; Militello, Muriel; Bouam, Amar; Drancourt, Michel] Aix Marseille Univ, IHU Mediterranee Infect, MEPHI, IRD, Marseille, France; [Hammoudi, Nassim; Fellag, Mustapha; Drancourt, Michel] IHU Mediterranee Infect, Marseille, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Drancourt, M (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, MEPHI, IRD, Marseille, France.; Drancourt, M (corresponding author), IHU Mediterranee Infect, Marseille, France.	michel.drancourt@univ-amu.fr			Fondation Mediterranee Infection, Marseille, France; Agence Nationale de la Recherche [ANR-17-CE35-0006-01 PRIME]; French Government under the "Investissements d'Avenir" (Investments for the Future) program [Mediterranee Infection 10-IAHU-03]; Region Provence Alpes Cote d'Azur; European funding FEDER IHUBIOTK	Fondation Mediterranee Infection, Marseille, France; Agence Nationale de la Recherche(French National Research Agency (ANR)); French Government under the "Investissements d'Avenir" (Investments for the Future) program(French National Research Agency (ANR)); Region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); European funding FEDER IHUBIOTK	NH obtained a PhD grant from the Fondation Me ' diterrane ' e Infection, Marseille, France. This work was supported by Agence Nationale de la Recherche (ANR-17-CE35-0006-01 PRIME, http://www.agencenationale-recherche.fr/) and by the French Government under the "Investissements d'Avenir" (Investments for the Future) program managed by the ANR (reference: Mediterranee Infection 10-IAHU-03), as well as the Agence Nationale de la Recherche (ANR-17-CE35-0006-01 PRIME, http://www.agencenationale-recherche.fr/).This work was supported by Re ' gion Provence Alpes Cote d'Azur and European funding FEDER IHUBIOTK.	[Anonymous], 2010, FRONT SYST NEUROSCI, V4, P8, DOI [10.3389/fnsys.2010.00008, DOI 10.3389/FNSYS.2010.00008]; Behr MA, 2014, LANCET INFECT DIS, V14, P250, DOI 10.1016/S1473-3099(13)70253-6; Bouzid F, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00507-17; Dassi C, 2015, MYCOBACT DIS, V5, P2161; Drancourt M, 2002, APPL ENVIRON MICROB, V68, P6403, DOI 10.1128/AEM.68.12.6403-6404.2002; Fellag M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227005; Fyfe JAM, 2007, APPL ENVIRON MICROB, V73, P4733, DOI 10.1128/AEM.02971-06; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Hammoudi N, 2019, AM J TROP MED HYG, V101, P491, DOI 10.4269/ajtmh.19-0137; MACCALLUM P, 1948, J PATHOL BACTERIOL, V60, P93, DOI 10.1002/path.1700600111; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; Narh CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003437; O'Brien CR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002666; Portaels F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000178; Sarfo FS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001237; Sarfo FS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000577; Stienstra Y, 2006, GENES IMMUN, V7, P185, DOI 10.1038/sj.gene.6364281; Vincent QB, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006429; Zingue D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25278-y; Zingue D, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00045-17	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0230544	10.1371/journal.pone.0230544	http://dx.doi.org/10.1371/journal.pone.0230544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378325	Green Published, Green Submitted, gold			2022-12-27	WOS:000605651300080
J	Mier, P; Andrade-Navarro, MA				Mier, Pablo; Andrade-Navarro, Miguel A.			Assessing the low complexity of protein sequences via the low complexity triangle	PLOS ONE			English	Article							INTRINSIC DISORDER; HOMOREPEATS; REGIONS; EVOLUTION; PATTERNS; DATABASE	Background Proteins with low complexity regions (LCRs) have atypical sequence and structural features. Their amino acid composition varies from the expected, determined proteome-wise, and they do not follow the rules of structural folding that prevail in globular regions. One way to characterize these regions is by assessing the repeatability of a sequence, that is, calculating the local propensity of a region to be part of a repeat. Results We combine two local measures of low complexity, repeatability (using the RES algorithm) and fraction of the most frequent amino acid, to evaluate different proteomes, datasets of protein regions with specific features, and individual cases of proteins with extreme compositions. We apply a representation called 'low complexity triangle' as a proof-of-concept to represent the low complexity measured values. Results show that proteomes have distinct signatures in the low complexity triangle, and that these signatures are associated to complexity features of the sequences. We developed a web tool called LCT (http://cbdm-01.zdv.uni-mainz.de/similar to munoz/lct/) to allow users to calculate the low complexity triangle of a given protein or region of interest. Conclusions The low complexity triangle proves to be a suitable procedure to represent the general low complexity of a sequence or protein dataset. Homorepeats, direpeats, compositionally biased regions and globular regions occupy characteristic positions in the triangle. The described pipeline can be used to characterize LCRs and may help in quantifying the content of degenerated tandem repeats in proteins and proteomes.	[Mier, Pablo; Andrade-Navarro, Miguel A.] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Fac Biol, Mainz, Germany	Johannes Gutenberg University of Mainz	Mier, P (corresponding author), Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Fac Biol, Mainz, Germany.	munoz@uni-mainz.de		Mier, Pablo/0000-0003-3663-2352	Deutsche Forschungsgemeinschaft [AN735/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft [AN735/4-1 to M.A.A.N.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba MM, 2002, BIOINFORMATICS, V18, P672, DOI 10.1093/bioinformatics/18.5.672; Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Darling AL, 2017, MOLECULES, V22, DOI 10.3390/molecules22122027; Di Domenico T, 2014, NUCLEIC ACIDS RES, V42, pD352, DOI 10.1093/nar/gkt1175; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Harbi D, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq031; Harrison PM, 2017, BMC BIOINFORMATICS, V18, DOI [10.1186/S12859-017-1906-3, 10.1186/s12859-017-1906-3]; Hatos A, 2020, NUCLEIC ACIDS RES, V48, pD269, DOI 10.1093/nar/gkz975; Hurst KR, 2013, J VIROL, V87, P9159, DOI 10.1128/JVI.01275-13; Jarnot P, 2020, NUCLEIC ACIDS RES, V48, pW77, DOI 10.1093/nar/gkaa339; Jorda J, 2010, ADV PROTEIN CHEM STR, V79, P59, DOI 10.1016/S1876-1623(10)79002-7; Kajava AV, 2012, J STRUCT BIOL, V179, P279, DOI 10.1016/j.jsb.2011.08.009; Kamel M, 2019, J STRUCT BIOL, V208, P86, DOI 10.1016/j.jsb.2019.08.003; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kirmitzoglou I, 2015, BIOINFORMATICS, V31, P2208, DOI 10.1093/bioinformatics/btv115; Kumari B, 2015, MOL BIOSYST, V11, P585, DOI 10.1039/c4mb00425f; Lobanov MY, 2012, MOL BIOSYST, V8, P327, DOI 10.1039/c1mb05318c; Lobanov MY, 2014, NUCLEIC ACIDS RES, V42, pD273, DOI 10.1093/nar/gkt927; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Mier P, 2020, BRIEF BIOINFORM, V21, P458, DOI 10.1093/bib/bbz007; Mier P, 2017, BIOINFORMATICS, V33, P1221, DOI 10.1093/bioinformatics/btw790; Mier P, 2017, PROTEINS, V85, P709, DOI 10.1002/prot.25250; Ntountoumi C, 2019, NUCLEIC ACIDS RES, V47, P9998, DOI 10.1093/nar/gkz730; Peng ZL, 2015, CELL MOL LIFE SCI, V72, P137, DOI 10.1007/s00018-014-1661-9; Perovic V, 2020, BIOINFORMATICS, V36, P3260, DOI 10.1093/bioinformatics/btaa121; Piovesan D, 2018, NUCLEIC ACIDS RES, V46, pD471, DOI 10.1093/nar/gkx1071; Promponas VJ, 2000, BIOINFORMATICS, V16, P915, DOI 10.1093/bioinformatics/16.10.915; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Simon M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r59; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Urbanek A, 2020, STRUCTURE, V28, P733, DOI 10.1016/j.str.2020.04.008; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X	39	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0239154	10.1371/journal.pone.0239154	http://dx.doi.org/10.1371/journal.pone.0239154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378336	gold, Green Published			2022-12-27	WOS:000605651300065
J	Norton, LA; Abdala, F; Rubidge, BS; Botha, J				Norton, Luke A.; Abdala, Fernando; Rubidge, Bruce S.; Botha, Jennifer			Tooth replacement patterns in the Early Triassic epicynodont Galesaurus planiceps (Therapsida, Cynodontia)	PLOS ONE			English	Article							DOUBLE-TUSKED DICYNODONT; KAROO BASIN; SOUTH-AFRICA; THRINAXODON-LIORHINUS; EARLIEST EVIDENCE; MASS EXTINCTION; ONTOGENY; MORPHOLOGY; EVOLUTION; BOUNDARY	Sixteen specimens of the Early Triassic cynodont Galesaurus planiceps (including eight that were scanned using micro-computed tomography) representing different ontogenetic stages were assembled to study the dental replacement in the species. The growth series shows that the incisors and postcanines continue to develop and replace, even in the largest (presumably oldest) specimen. In contrast, replacement of the canines ceased with the attainment of skeletal maturity, at a basal skull length of similar to 90 mm, suggesting that Galesaurus had a finite number of canine replacement cycles. Additionally, the functional canine root morphology of these larger specimens showed a tendency to be open-rooted, a condition not previously reported in Mesozoic theriodonts. An alternating pattern of tooth replacement was documented in the maxillary and mandibular postcanine series. Both postcanine series increased in tooth number as the skull lengthened, with the mandibular postcanine series containing more teeth than the maxillary series. In the maxilla, the first postcanine is consistently the smallest tooth, showing a proportional reduction in size as skull length increased. The longer retention of a tooth in this first locus is a key difference between Galesaurus and Thrinaxodon, in which the mesial-most postcanines are lost after replacement. This difference has contributed to the lengthening of the postcanine series in Galesaurus, as teeth continued to be added to the distal end of the tooth row through ontogeny. Overall, there are considerable differences between Galesaurus and Thrinaxodon relating to the replacement and development of their teeth.	[Norton, Luke A.; Abdala, Fernando; Rubidge, Bruce S.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa; [Norton, Luke A.; Rubidge, Bruce S.] Univ Witwatersrand, Sch Geosci, Johannesburg, Gauteng, South Africa; [Abdala, Fernando] Consejo Nacl Invest Cient & Tecn, Fdn Miguel Lillo, Unidad Ejecutora Lillo, San Miguel De Tucuman, Argentina; [Botha, Jennifer] Natl Museum, Karoo Palaeontol, Bloemfontein, Free State, South Africa; [Botha, Jennifer] Univ Free State, Dept Zool & Entomol, Bloemfontein, Free State, South Africa	University of Witwatersrand; University of Witwatersrand; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Miguel Lillo Foundation; University of the Free State	Norton, LA (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, Gauteng, South Africa.; Norton, LA (corresponding author), Univ Witwatersrand, Sch Geosci, Johannesburg, Gauteng, South Africa.	luke.norton@students.wits.ac.za	Norton, Luke/R-2446-2017; Botha, Jennifer/N-1893-2013	Norton, Luke/0000-0002-9434-9267; Abdala, Nestor/0000-0001-9838-2497; Botha, Jennifer/0000-0001-8824-9334	National Research Foundation [UID 95980]; Professional Development Programme Doctoral Scholarship; Palaeontological Scientific Trust; DSI/NRF Centre of Excellence in Palaeosciences; Consejo Nacional de Investigaciones Cientificas y Tecnicas	National Research Foundation; Professional Development Programme Doctoral Scholarship; Palaeontological Scientific Trust; DSI/NRF Centre of Excellence in Palaeosciences; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This research was funded by the National Research Foundation (www.nrf.ac.za) Award ID UID 95980 to JB, and a Professional Development Programme Doctoral Scholarship to LAN; the Palaeontological Scientific Trust (www.past.org.za) to JB and BSR; the DSI/NRF Centre of Excellence in Palaeosciences (www.wits.co.za/coepalaeo) to JB and BSR; and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (www.conicet.gov.ar) to FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2003, S AFR J SCI, V99, P95; Abdala F, 2007, PALAEONTOLOGY, V50, P591, DOI 10.1111/j.1475-4983.2007.00646.x; Abdala F, 2006, PALAIOS, V21, P507, DOI 10.2110/palo.2005.P06-001R; Abdala F, 2019, ZOOL J LINN SOC-LOND, V186, P983, DOI 10.1093/zoolinnean/zlz004; Abdala F, 2013, J VERTEBR PALEONTOL, V33, P1408, DOI 10.1080/02724634.2013.775140; Abdala F, 2010, PALAEOGEOGR PALAEOCL, V286, P202, DOI 10.1016/j.palaeo.2010.01.011; Abel RL, 2012, PALAEONTOL ELECTRON, V15; AMERICAN MARKETING ASSOCIATION (AMA), 1985, MARKETING NEWS 0301, V19, P1; Anderson Paul K., 2002, Journal of Mammalian Evolution, V9, P55, DOI 10.1023/A:1021383827946; Avery S, 2006, INTEGRATED FOOD SAFETY AND VETERINARY PUBLIC HEALTH, P3; Benoit J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172047; Blink A. S., 1959, Palaeontologia Africana, V6, P15; Bonaparte JF, 2001, PALAEONTOLOGY, V44, P623, DOI 10.1111/1475-4983.00194; Boonstra L. D., 1962, Annals of the South African Museum, V46, P57; Botha J, 2007, ZOOL J LINN SOC-LOND, V149, P477; Botha J, 2006, J AFR EARTH SCI, V45, P502, DOI 10.1016/j.jafrearsci.2006.04.006; Botha J, 2020, S AFR J GEOL, V123, P207, DOI 10.25131/sajg.123.0015; Botha J, 2005, PALAEONTOLOGY, V48, P385, DOI 10.1111/j.1475-4983.2005.00447.x; Brink A. S., 1961, Palaeontologia Africana, V7, P119; Brink A. S., 1965, Palaeontologia Africana, V9, P107; BRINK A. S., 1954, NAVORS NAS MUS [BLOEMFONTEIN], V1, P115; BRINK A. S., 1955, PALAEONTOL AFRICANA, V3, P73; Broom, 1932, MAMMAL LIKE REPTILES; Broom R., 1938, ANN TRANSVAAL MUS, V19, P279; BROOM R., 1932, ANN NATL MUS, V7, P61; Broom R, 1937, P ZOOL SOC LOND B-SY, V107, P299; Butler, 2009, THESIS; Butler E, 2019, PAP PALAEONTOL, V5, P1, DOI 10.1002/spp2.1220; Butler Percy M., 2016, PALAEONTOLOGIA POLONICA, P35, DOI 10.4202/pp.2016.67_035; Camp C. L., 1956, Memoirs of the University of California, V13, P305; Chinsamy-Turan A, 2011, FORERUNNERS MAMMALS, P31; Cox C. B., 1968, Breviora, VNo. 295, P1; CROMPTON A. W., 1963, ANN S AFRICAN MUS, V46, P479; CROMPTON AW, 1968, BIOL REV, V43, P427, DOI 10.1111/j.1469-185X.1968.tb00966.x; CROMPTON AW, 1973, ANNU REV EARTH PL SC, V1, P131, DOI 10.1146/annurev.ea.01.050173.001023; Damiani R, 2003, P ROY SOC B-BIOL SCI, V270, P1747, DOI 10.1098/rspb.2003.2427; Edmund A.G., 1962, Contributions of the Royal Ontario Museum (Life Sci), V56, P1; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Estes R., 1961, Bulletin of the Museum of Comparative Zoology, V125, P165; FAY F H, 1985, Mammalian Species, P1, DOI 10.2307/3503810; Fernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064978; FOURIE S., 1963, S AFRICAN JOUR SCI, V59, P211; FOURIE S, 1974, Annals of the South African Museum, V65, P337; Fourie S., 1964, THESIS; Frobisch J, 2008, J VERTEBR PALEONTOL, V28, P770, DOI 10.1671/0272-4634(2008)28[770:ANSOES]2.0.CO;2; Frobisch J, 2011, SCIENCE, V331, P1525, DOI 10.1126/science.1204206; Froebisch J, 2005, J VERTEBR PALEONTOL, V25, p61A; Groenewald G.H., 1995, S AFRICAN COMMITTEE, V1, P35; Hancox PJ, 2013, J VERTEBR PALEONTOL, V33, P655, DOI 10.1080/02724634.2013.723551; Haughton S. H., 1924, Annals of the Transvaal Museum, V11, P74; HEYNING JE, 1984, CAN J ZOOL, V62, P1645, DOI 10.1139/z84-239; Hopson J.A., 1986, P83; HOPSON J A, 1972, Palaeontologia Africana, V14, P71; Hopson J. A., 1969, P15; Hopson J.A., 1971, EARLY MAMMALS, P1, DOI DOI 10.1111/J.1096-3642.1971.TB00748.X; Hopson James A., 2001, Bulletin of the Museum of Comparative Zoology, V156, P5; HOPSON JAMES A., 1964, PROC ZOOL SOC LONDON, V142, P625; Huttenlocker AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087553; Jasinoski SC, 2017, PEERJ, V5, DOI 10.7717/peerj.2875; Jasinoski SC, 2017, ANAT REC, V300, P353, DOI 10.1002/ar.23473; Jasinoski SC, 2015, ANAT REC, V298, P1440, DOI 10.1002/ar.23116; Jenkins F.A., 1971, B PEABODY MUS NAT HI, V36, P1, DOI DOI 10.1671/0272-4634(2008)28[445:NMOMBC]2.0CO;2; Jia C, 2012, GEOBIOLOGY, V10, P60, DOI 10.1111/j.1472-4669.2011.00310.x; Jinnah ZA, 2007, S AFR J SCI, V103, P51; Joachimski MM, 2012, GEOLOGY, V40, P195, DOI 10.1130/G32707.1; Kammerer CF, 2016, PAP PALAEONTOL, V2, P387, DOI 10.1002/spp2.1046; KEMP TS, 1979, PHILOS T ROY SOC B, V285, P73, DOI 10.1098/rstb.1979.0001; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KERMACK KA, 1956, PHILOS T ROY SOC B, V240, P95, DOI 10.1098/rstb.1956.0013; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; KIESER JA, 1993, J MORPHOL, V218, P195, DOI 10.1002/jmor.1052180208; Kingdon, 1989, E AFRICAN MAMMALS AT; LAWS R M, 1968, East African Wildlife Journal, V6, P19; LeBlanc ARH, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1792; LeBlanc ARH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074697; Liu J, 2009, AM MUS NOVIT, P1, DOI 10.1206/606.1; Luckett W. Patrick, 1993, Journal of Mammalian Evolution, V1, P269, DOI 10.1007/BF01041667; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo Zhe-Xi, 2004, Bulletin of Carnegie Museum of Natural History, V36, P159, DOI 10.2992/0145-9058(2004)36[159:EODRIM]2.0.CO;2; Luo ZX, 2015, P NATL ACAD SCI USA, V112, pE7101, DOI 10.1073/pnas.1519387112; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; Martinelli A.G., 2011, PALEONTOLOGIA DINOSA, P179; Martinez RN, 1996, J VERTEBR PALEONTOL, V16, P271, DOI 10.1080/02724634.1996.10011314; McKenna MC, 1997, CLASSIFICATION MAMMA; McLoughlin, 1980, SYNAPSIDA NEW LOOK O; Mead J.G., 1989, P349; Norton L, 2009, J VERTEBR PALEONTOL, V29, p156A; Nweeia MT, 2014, ANAT REC, V297, P599, DOI 10.1002/ar.22886; Nweeia MT, 2012, ANAT REC, V295, P1006, DOI 10.1002/ar.22449; Osborn J.W., 1973, Breviora, VNo. 399, P1; OSBORN JW, 1974, EVOLUTION, V28, P141, DOI 10.1111/j.1558-5646.1974.tb00733.x; OSBORN JW, 1973, AM SCI, V61, P548; OSBORN JW, 1971, PROC R SOC SER B-BIO, V179, P261, DOI 10.1098/rspb.1971.0097; Owen R., 1887, Q J GEOL SOC LOND, V43, P1, DOI [10.1144/GSL, DOI 10.1144/GSL.JGS.1887.043.01-04.03, 10.1144/GSL.JGS.1887.043.01-04.03]; Owen R., 1859, Q J GEOL SOC LOND, V16, DOI [10.1144/GSL.JGS.1860.016.01-02.07, DOI 10.1144/GSL.JGS.1860.016.01-02.07]; Owen R., 1861, PALAEONTOLOGY SYSTEM; Parrington FR, 1936, PHILOS T ROY SOC B, V226, P121, DOI 10.1098/rstb.1936.0005; PARRINGTON FR, 1934, ANN MAG NAT HIST, V13, P38, DOI DOI 10.1080/00222933408654791; POOLE D. F. G., 1961, PROC ZOOL SOC LONDON, V136, P131; Pusch LC, 2019, J ANAT, V234, P592, DOI 10.1111/joa.12958; RETALLACK GJ, 1995, SCIENCE, V267, P77, DOI 10.1126/science.267.5194.77; Rigney HW, 1938, J MORPHOL, V63, P491, DOI 10.1002/jmor.1050630305; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Rowe T., 1988, Journal of Vertebrate Paleontology, V8, P241; Rozefelds AC, 2011, J VERTEBR PALEONTOL, V31, P1158, DOI 10.1080/02724634.2011.595858; Ruta M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1865; Seeley H.G., 1894, PHILOS T ROYAL SOC, V185, P987; Seeley HG, 1889, PHILOS T R SOC B, V180, P215, DOI [DOI 10.1098/RSTB.1889.0006, 10.1098/rstb.1889.0006]; Sidor CA, 2004, PALAEONTOLOGY, V47, P535, DOI 10.1111/j.0031-0239.2004.00378.x; SILVERMAN HB, 1980, NATURE, V284, P57, DOI 10.1038/284057a0; Smith Kathleen K., 1993, P150; Smith RMH, 2001, GEOLOGY, V29, P1147, DOI 10.1130/0091-7613(2001)029<1147:POVEAA>2.0.CO;2; SMITH RMH, 1995, PALAEOGEOGR PALAEOCL, V117, P81, DOI 10.1016/0031-0182(94)00119-S; Smith RMH, 2014, PALAEOGEOGR PALAEOCL, V396, P99, DOI 10.1016/j.palaeo.2014.01.002; Soares MB, 2011, AN ACAD BRAS CIENC, V83, P329, DOI 10.1590/S0001-37652011000100021; Tiedemann R, 1997, SCIENCE, V278, P1550; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Van den Brandt Marc J., 2017, Palaeontologia Africana, V52, P201; van Heerden J., 1976, Navorsinge van die Nasionale Museum (Bloemfontein), V3, P141; van Heerden J., 1990, Palaeontologia Africana, V27, P41; van Hoepen, 1916, ANN TRANSVAAL MUSEUM, V5, P1; Watson D. M. S., 1920, Annals & Magazine of Natural History, V6; Whitney Megan R., 2018, Palaeontologia Africana, V53, P75; Wignall PB, 2009, SCIENCE, V324, P1179, DOI 10.1126/science.1171956; Wu P, 2013, P NATL ACAD SCI USA, V110, pE2009, DOI 10.1073/pnas.1213202110; Zhou CF, 2013, NATURE, V500, P163, DOI 10.1038/nature12429; ZIEGLER A C, 1969, Journal of Paleontology, V43, P771	127	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0243985	10.1371/journal.pone.0243985	http://dx.doi.org/10.1371/journal.pone.0243985			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378326	gold, Green Published			2022-12-27	WOS:000605651300005
J	Chafi, YK; Amare, T; Haile, K; Damene, W; Tesfaye, G; Minichil, W				Chafi, Yohannes Kifle; Amare, Tadele; Haile, Kelemua; Damene, Woynabeba; Tesfaye, Getaneh; Minichil, Woredaw			Prevalence and correlates of job loss among schizophrenia outpatients at St. AmanuelMental Specialized Hospital, Addis Ababa, Ethiopia; cross sectional study	PLOS ONE			English	Article							FOLLOW-UP; EMPLOYMENT; HEALTH; PEOPLE; WORK; EXIT	Background Job loss in patient with chronic illness like schizophrenia is the most serious public concern in the clinical and socio-economic terms worldwide. Patients with schizophrenia usually have unsatisfactory job termination like quitting or getting fired which results well-established negative outcomes. The complex interplay between one another has made job and mental illness the focus areas. In the developing nations, there is limited study on these areas in spite of higher rates of job loss. Objectives This study aimed to assess the prevalence and correlates of job loss among schizophrenia outpatient units in Addis Ababa, Ethiopia. Methods Institutional based cross-sectional study was conducted at Saint Amanuel Mental Specialized Hospital among schizophrenia outpatient units in Addis Ababa from May to June 2018. A total of 421 study subjects were interviewed using Positive and Negative Syndrome Scale and Perceived devaluation and discrimination scale. Out of the total study participants, female populations were slightly higher (50.4%) and the majorities (38.6%) were orthodox religion followers. Study characteristics was summarized using descriptive statistics and bi-variable and multivariable analysis was performed using Statistical Package for Social Science version 24. Furthermore, those factors at p value <= 0.05 were considered as statistically significant. Results The prevalence of job loss among patients with schizophrenia was 37.3%. Factors including unmarried [AOR = 2.42:95% CI (1.28, 4.54)], divorced [AOR = 2.34: 95% CI (1.16, 4.71)], severe positive symptoms [AOR = 2.03: 95% CI (1.15, 3.60)], severe general psychopathology [AOR = 1.76: 95% CI (1.01, 3.08)], and poor level of social and occupational functioning [AOR = 5.05: 95% CI (2.81, 9.09)] were significantly associated with job loss among schizophrenia people. Conclusion This study suggested that job loss among schizophrenia outpatients was high. There was significant association among people with unmarried, divorced, severe positive symptoms, poor functionality and higher general psychopathology. Therefore, clinical and psychosocial factors were responsible for job loss which warrant further attention and investigation.	[Chafi, Yohannes Kifle; Tesfaye, Getaneh] Aksum Univ, Dept Psychiat, Coll Hlth Sci, Axum, Ethiopia; [Amare, Tadele; Minichil, Woredaw] Univ Gondar, Dept Psychiat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Haile, Kelemua; Damene, Woynabeba] St Amanuel Mental Specialized Hosp, Res & Training Dept, Addis Ababa, Ethiopia	University of Gondar	Chafi, YK (corresponding author), Aksum Univ, Dept Psychiat, Coll Hlth Sci, Axum, Ethiopia.	johnkifli7@gmail.com	Amare, Tadele/AAE-6814-2021		University of Gondar, Gondar, Ethiopia; St. Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia	University of Gondar, Gondar, Ethiopia; St. Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia	This study was supported by the joint program of University of Gondar (www.uog.edu.et), Gondar, Ethiopia and St. Amanuel Mental Specialized Hospital (www.amsh.gov.et), Addis Ababa, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajorek Z., 2016, IMPACT LONG TERM CON; Bambling M, 2008, COUNS PSYCHOTHER RES, V8, P110, DOI 10.1080/14733140802055011; Batic-Mujanovic Olivera, 2017, Mater Sociomed, V29, P92, DOI 10.5455/msm.2017.29.92-96; Bell MD, 1996, SCHIZOPHRENIA BULL, V22, P51, DOI 10.1093/schbul/22.1.51; Bevan S., 2013, WORKING SCHIZOPHRENI; Boardman J, 2003, WORK EMPLOYMENT PEOP, P467; Chieng JKC, 2016, JOB REFUSAL PEOPLE S; Cook JA, 2000, SCHIZOPHRENIA BULL, V26, P87, DOI 10.1093/oxfordjournals.schbul.a033448; Creegan S, 1997, OCCUPATIONAL THERAPY, V4, P99; Harvey C., 2006, J MENTAL HLTH, V15, P43, DOI [10.1080/09638230500513118, DOI 10.1080/09638230500513118]; Harvey PD, 2019, J EXP PSYCHOPATHOL, V10, DOI 10.1177/2043808719865693; Harvey S, 2009, MENTAL HLTH EMPLOYME; Henderson M, 2011, J ROY SOC MED, V104, P198, DOI 10.1258/jrsm.2011.100231; Kang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113495; Kiejna A, 2015, INT J SOC PSYCHIATR, V61, DOI 10.1177/0020764015577841; Kleim B, 2008, J MENT HEALTH, V17, P482, DOI 10.1080/09638230701506283; Liechti Stacy, 2017, Innov Clin Neurosci, V14, P12; Macias C, 2001, ADM POLICY MENT HLTH, V28, P279, DOI 10.1023/A:1011185513720; Malkowska Agnieszka, 2004, Med Wieku Rozwoj, V8, P551; Marwaha S, 2005, INT J SOC PSYCHIATR, V51, P302, DOI 10.1177/0020764005057386; Marwaha S, 2008, EXPLAINING RATES COR; Marwaha S, 2007, BRIT J PSYCHIAT, V191, P30, DOI 10.1192/bjp.bp.105.020982; Milner A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051333; Moilanen J, 2013, EUR PSYCHIAT, V28, P53, DOI 10.1016/j.eurpsy.2011.06.009; Moilanen JM, 2016, EUR PSYCHIAT, V36, P7, DOI 10.1016/j.eurpsy.2016.03.002; Nathwani T, 2015, EMPLOYMENT OUTCOMES; Opler Mark G A, 2017, Innov Clin Neurosci, V14, P77; PERALTA V, 1994, PSYCHIAT RES, V53, P31, DOI 10.1016/0165-1781(94)90093-0; Poon Ronnie T P, 2007, HPB (Oxford), V9, P166, DOI 10.1080/13651820701216182; Rampton N, 2010, AM J PSYCHIATR REHAB, V13, P22, DOI 10.1080/15487760903248507; Rybarczyk B., 2011, ENCY CLIN NEUROPSYCH, V2313, DOI [DOI 10.1007/978-0-387-79948-3_428, 10.1007/978-0-387-79948-3_428]; Sadock BJ, 2011, KAPLAN SADOCKS SYNOP, DOI [10.1016/j.genhosppsych.2011.02.011, DOI 10.1016/J.GENHOSPPSYCH.2011.02.011]; Schuring M, 2013, SCAND J WORK ENV HEA, V39, P134, DOI 10.5271/sjweh.3321; Secker J, 2003, HEALTH EDUC RES, V18, P207, DOI 10.1093/her/18.2.207; Solomon C, 2007, OCCUP ENVIRON MED, V64, P144, DOI 10.1136/oem.2005.024257; van Meijel B, 2004, INT J MENT HEALTH NU, V13, P107, DOI 10.1111/j.1440-0979.2004.00314.x; van Rijn RM, 2014, OCCUP ENVIRON MED, V71, P295, DOI 10.1136/oemed-2013-101591; Waghorn G, 2004, ACTA PSYCHIAT SCAND, V109, P279, DOI 10.1046/j.1600-0447.2003.00269.x; Waghorn G, 2005, ADV MENT HEALTH, V4, P129, DOI 10.5172/jamh.4.2.129; Yang LH, 2013, BRIT J PSYCHIAT, V203, P272, DOI 10.1192/bjp.bp.112.118927	40	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242352	10.1371/journal.pone.0242352	http://dx.doi.org/10.1371/journal.pone.0242352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370291	Green Published, gold			2022-12-27	WOS:000603611900097
J	Goncalves, D; Rignol, G; Dellugat, P; Hartmann, G; Garcia, SS; Stavenhagen, J; Santarelli, L; Gouze, E; Czech, C				Goncalves, Diogo; Rignol, Guylene; Dellugat, Pierre; Hartmann, Guido; Sarrazy Garcia, Stephanie; Stavenhagen, Jeffrey; Santarelli, Luca; Gouze, Elvire; Czech, Christian			In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia	PLOS ONE			English	Article							FGFR3; DIFFERENTIATION; MUTATIONS; CARTILAGE; DWARFISM; G380R	Achondroplasia is a rare genetic disorder caused by mutations in the Fibroblast Growth Factor receptor 3 (FGFR3). These mutations lead to aberrant increase of inhibitory signaling in proliferating chondrocytes at the growth plate. Recifercept is a potential treatment for this disease using a decoy approach to sequester FGFR3 ligands subsequently normalizing activation of the mutated FGFR3 receptor. Recifercept binds to FGF isoforms in vitro and in cellular model systems and reduces FGFR3 signaling. In addition, in a transgenic mouse model of achondroplasia, Recifercept restores reduced body weight and long bone growth in these mice. These data suggest that Recifercept treatment could lead to clinical benefits in children treated with this molecule.	[Goncalves, Diogo; Rignol, Guylene; Dellugat, Pierre; Hartmann, Guido; Czech, Christian] Pfizer, Rare Dis Unit, Res & Dev, Nice, France; [Hartmann, Guido] TOLREMO Therapeut AG, Muttenz, Switzerland; [Sarrazy Garcia, Stephanie] Bionea, Biot, France; [Stavenhagen, Jeffrey] Therini Bio, San Francisco, CA USA; [Santarelli, Luca] VectivBio, Basel, Switzerland; [Gouze, Elvire] Univ Cote Azur, CNRS, INSERM, iBV, Nice, France	Pfizer; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Czech, C (corresponding author), Pfizer, Rare Dis Unit, Res & Dev, Nice, France.	christian.czech@pfizer.com		Czech, Christian/0000-0001-7746-0134	Therachon AG; Pfizer	Therachon AG; Pfizer(Pfizer)	This study was funded by Therachon AG, a wholly owned subsidiary of Pfizer. The funder provided support in the form of salaries for authors [DG, GR, PD, GH, SG, JS, LS, EG and CC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The support provided by Marcella DeSimone at Caudex, funded by Pfizer, consisted solely of manuscript formatting and no contribution was made to editorial content.	Beenken A, 2012, ADV EXP MED BIOL, V728, P1, DOI 10.1007/978-1-4614-0887-1_1; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Breinholt VM, 2019, J PHARMACOL EXP THER, V370, P459, DOI 10.1124/jpet.119.258251; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Garcia S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006247; Garofalo S, 1999, J BONE MINER RES, V14, P1909, DOI 10.1359/jbmr.1999.14.11.1909; Harada D, 2007, BONE, V41, P273, DOI 10.1016/j.bone.2006.11.030; Harada D, 2017, EUR J PEDIATR, V176, P873, DOI 10.1007/s00431-017-2923-y; Hosny GA, 2020, J ORTHOP TRAUMATOL, V21, DOI 10.1186/s10195-019-0541-3; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Monsonego-Ornan E, 2000, MOL CELL BIOL, V20, P516, DOI 10.1128/MCB.20.2.516-522.2000; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Naski M C, 1998, Front Biosci, V3, pd781; Naski MC, 1998, DEVELOPMENT, V125, P4977; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Ozasa A, 2005, BONE, V36, P1056, DOI 10.1016/j.bone.2005.03.006; Pauli RM, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-018-0972-6; Qing J, 2009, J CLIN INVEST, V119, P1216, DOI 10.1172/JCI38017; Savarirayan R, 2019, NEW ENGL J MED, V381, P25, DOI 10.1056/NEJMoa1813446; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Unger S, 2017, CURR OSTEOPOROS REP, V15, P53, DOI 10.1007/s11914-017-0347-2	27	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244368	10.1371/journal.pone.0244368	http://dx.doi.org/10.1371/journal.pone.0244368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370388	Green Published, gold			2022-12-27	WOS:000603611900016
J	Guyon, A; Rousseau, J; Lamothe, G; Tremblay, JP				Guyon, Antoine; Rousseau, Joel; Lamothe, Gabriel; Tremblay, Jacques P.			The protective mutation A673T in amyloid precursor protein gene decreases A beta peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells	PLOS ONE			English	Article							DEMENTIA; PREVALENCE; SECRETASE; ALLELE; A2T	The deposition of A beta plaques in the brain leads to the onset and development of Alzheimer's disease. The Amyloid precursor protein (APP) is cleaved by alpha-secretase (non-amyloidogenic processing of APP), however increased cleavage by beta-secretase (BACE1) leads to the accumulation of A beta peptides, which forms plaques. APP mutations mapping to exons 16 and 17 favor plaque accumulation and cause Familial Alzheimer Disease (FAD). However, a variant of the APP gene (A673T) originally found in an Icelandic population reduces BACE1 cleavage by 40%. A series of plasmids containing the APP gene, each with one of 29 different FAD mutations mapping to exon 16 and exon 17 was created. These plasmids were then replicated with the addition of the A673T mutation. Combined these formed the library of plasmids that was used in this study. The plasmids were transfected in neuroblastomas to assess the effect of this mutation on A beta peptide production. The production of A beta peptides was decreased for some FAD mutations due to the presence of the co-dominant A673T mutation. The reduction of A beta peptide concentrations for the London mutation (V717I) even reached the same level as for A673T control in SH-SY5Y cells. These preliminary results suggest that the insertion of A673T in APP genes containing FAD mutations might confer a clinical benefit in preventing or delaying the onset of some FADs.	[Guyon, Antoine; Rousseau, Joel; Lamothe, Gabriel; Tremblay, Jacques P.] Quebec Univ Laval, CHU, Ctr Rech, Quebec City, PQ, Canada; [Guyon, Antoine; Rousseau, Joel; Lamothe, Gabriel; Tremblay, Jacques P.] Univ Laval Quebec, Dept Med Mol, Quebec City, PQ, Canada	Laval University; Laval University	Guyon, A (corresponding author), Quebec Univ Laval, CHU, Ctr Rech, Quebec City, PQ, Canada.; Guyon, A (corresponding author), Univ Laval Quebec, Dept Med Mol, Quebec City, PQ, Canada.	antoine.guyon.1@ulaval.ca		Tremblay, Jacques P./0000-0001-9404-9195	Weston Brain Institute (WBI); CIHR	Weston Brain Institute (WBI); CIHR(Canadian Institutes of Health Research (CIHR))	This project was funded by the Weston Brain Institute (WBI). AG holds a Bourse de la Fondation du CHU de Quebec. GL holds a Training award from the CIHR. https://westonbraininstitute.ca/home/https://fondationduchudequebec.org/?gclid=Cj0KCQjw9b_4BRCMARIsADMUIyrETbZQ7IdT9XBUtrTNt8ivE7VxeTfFOz33hLRR1h8MizZH8NoGnwoaAjS1EALw_wcBhttps://cihr-irsc.gc.ca/e/193.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Vilatela MEA, 2012, ARCH MED RES, V43, P622, DOI 10.1016/j.arcmed.2012.10.017; Alzheimer's Disease International, 2015, WORLD ALZHEIMER REPO; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Das B, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0093-5; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fogel DB, 2018, CONT CLIN TRIAL COMM, V11, P156, DOI 10.1016/j.conctc.2018.08.001; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gyorgy B, 2018, MOL THER-NUCL ACIDS, V11, P429, DOI 10.1016/j.omtn.2018.03.007; Hartmann S, 2018, J NEUROSCI, V38, P3480, DOI 10.1523/JNEUROSCI.2643-17.2018; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hu XY, 2016, J NEUROCHEM, V136, P234, DOI 10.1111/jnc.13395; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kero M, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.09.017; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lehmann S, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00138; Lewczuk P, 2004, NEUROBIOL AGING, V25, P273, DOI 10.1016/S0197-4580(03)00086-1; Limegrover CS, 2021, J NEUROCHEM, V157, P1316, DOI 10.1111/jnc.15212; Maloney JA, 2014, J BIOL CHEM, V289, P30990, DOI 10.1074/jbc.M114.589069; Mann DMA, 1996, AM J PATHOL, V148, P1257; Martiskainen H, 2017, ANN NEUROL, V82, P128, DOI 10.1002/ana.24969; MASTERS CL, 1985, EMBO J, V4, P2757, DOI 10.1002/j.1460-2075.1985.tb04000.x; Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8; Mohr NM, 2011, ACAD EMERG MED, V18, P190, DOI 10.1111/j.1553-2712.2010.00985.x; Murray B, 2016, PROTEINS, V84, P488, DOI 10.1002/prot.24995; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; Qiu Chengxuan, 2009, Dialogues Clin Neurosci, V11, P111; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Urbanc B, 2004, BIOPHYS J, V87, P2310, DOI 10.1529/biophysj.104.040980; World health organization, DEM 2020; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0237122	10.1371/journal.pone.0237122	http://dx.doi.org/10.1371/journal.pone.0237122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370284	gold, Green Published			2022-12-27	WOS:000603611900053
J	Hofhuis, J; Jongerling, J; van der Zee, KI; Jansz, J				Hofhuis, Joep; Jongerling, Joran; van der Zee, Karen I.; Jansz, Jeroen			Validation of the Multicultural Personality Questionnaire Short Form (MPQ-SF) for use in the context of international education	PLOS ONE			English	Article							ACCULTURATION STRATEGIES; MEASUREMENT INVARIANCE; ADJUSTMENT; VALIDITY; COMPETENCE; STUDENTS; TRAITS; ABROAD	The Multicultural Personality Questionnaire (MPQ) is one of the most widely used instruments for measuring individuals' intercultural competences. The original version consists of 91 items, divided into five subscales, and has been shown to predict attitudes, behavior, and outcomes in a variety of intercultural contexts. Recently, a 40-item short form of the MPQ was developed (MPQ-SF), which may be particularly useful in settings in which time or survey space are limited, or where respondent drop-out is likely to occur. For example, the MPQ-SF would be a valuable tool for assessing longitudinal development of multicultural personality traits in training or educational settings. A prerequisite for such research is to establish measurement invariance of the MPQ-SF between different respondent groups, as well as across time points. Using a sample of students in an international university program (n = 519), the present study examines how the scales perform among male and female respondents, between students of Western and Non-Western background, and across two time points, five months apart. Based on our findings, we conclude that all five subscales of the MPQ-SF display sufficient measurement invariance to be reliably used in this and similar contexts, in comparative as well as longitudinal study designs.	[Hofhuis, Joep; Jansz, Jeroen] Erasmus Univ, Erasmus Res Ctr Media Commun & Culture ERMeCC, Rotterdam, Netherlands; [Jongerling, Joran] Erasmus Univ, Erasmus Sch Social & Behav Sci ESSB, Rotterdam, Netherlands; [van der Zee, Karen I.] Vrije Univ Amsterdam, Fac Social Sci, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus University Rotterdam; Vrije Universiteit Amsterdam	Hofhuis, J (corresponding author), Erasmus Univ, Erasmus Res Ctr Media Commun & Culture ERMeCC, Rotterdam, Netherlands.	j.hofhuis@eshcc.eur.nl	Jansz, Jeroen/AAH-1000-2021; Hofhuis, Joep/H-4265-2016	Hofhuis, Joep/0000-0001-7531-8644; , Joran/0000-0001-5697-1381	Community for Learning and Innovation (CLI) at Erasmus University Rotterdam	Community for Learning and Innovation (CLI) at Erasmus University Rotterdam	The study was supported by the Community for Learning and Innovation (CLI) at Erasmus University Rotterdam, through a research fellowship awarded to the first author (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NJ, 2018, ANNU REV ORGAN PSYCH, V5, P307, DOI 10.1146/annurev-orgpsych-032117-104528; Albrecht AG, 2014, J PERS ASSESS, V96, P64, DOI 10.1080/00223891.2013.821074; [Anonymous], 2018, J AM COLL CARDIOLO S, V61, pE1039; Clumeck N, 2003, AIDS, V17, pS3, DOI 10.1097/01.aids.0000060397.18106.12; Fantini AE, 2018, INTERCULTURAL COMMUN; Hofhuis J, 2020, INT J PSYCHOL, V55, P812, DOI 10.1002/ijop.12647; Hofhuis J, 2015, QUAL QUANT, V49, P177, DOI 10.1007/s11135-013-9981-7; Horverak JG, 2013, EUR REV APPL PSYCHOL, V63, P267, DOI 10.1016/j.erap.2013.07.003; Horverak JG, 2013, J INT MIGR INTEGR, V14, P493, DOI 10.1007/s12134-012-0247-3; Huang TJ, 2005, INT J HUM RESOUR MAN, V16, P1656, DOI 10.1080/09585190500239325; Kim YY, 2017, OXFORD RES ENCY COMM; Leone L, 2005, PERS INDIV DIFFER, V38, P1449, DOI 10.1016/j.paid.2004.09.010; Leong CH, 2007, INT J INTERCULT REL, V31, P545, DOI 10.1016/j.ijintrel.2007.01.004; Liang Y, 2020, J STUD INT EDUC; Little TD, 2007, MODEL CONTEXT EFF LO, V121; Luijters K, 2006, GROUP PROCESS INTERG, V9, P561, DOI 10.1177/1368430206067554; Matsumoto D, 2013, J CROSS CULT PSYCHOL, V44, P849, DOI 10.1177/0022022113492891; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; PENTZ MA, 1994, J CONSULT CLIN PSYCH, V62, P450, DOI 10.1037/0022-006X.62.3.450; Ponterotto JG, 2010, COUNS PSYCHOL, V38, P714, DOI 10.1177/0011000009359203; Putnick DL, 2016, DEV REV, V41, P71, DOI 10.1016/j.dr.2016.06.004; Ramirez M, 1999, MULTICULTURAL PSYCHO; Schartner A, 2016, J MULTILING MULTICUL, V37, P402, DOI 10.1080/01434632.2015.1073737; Smith GT, 2000, PSYCHOL ASSESSMENT, V12, P102, DOI 10.1037/1040-3590.12.1.102; Tracy-Ventura N., 2016, STUDY ABROAD RES 2 L, V1, P107, DOI DOI 10.1075/SAR.1.1.05TRA; Van de Vijver F., 1997, HDB CROSS CULTURAL P, V2nd ed., P257; van der Geest K, 2018, INT J DISAST RISK SC, V9, P157, DOI 10.1007/s13753-018-0178-5; van der Zee K, 2013, J CROSS CULT PSYCHOL, V44, P928, DOI 10.1177/0022022113493138; van der Zee K, 2013, J PERS ASSESS, V95, P118, DOI 10.1080/00223891.2012.718302; Van der Zee KI, 2000, EUR J PERSONALITY, V14, P291, DOI 10.1002/1099-0984(200007/08)14:4<291::AID-PER377>3.3.CO;2-Y; Van der Zee KI, 2001, J RES PERS, V35, P278, DOI 10.1006/jrpe.2001.2320; van Niejenhuis C, 2018, INT J INTERCULT REL, V63, P68, DOI 10.1016/j.ijintrel.2018.01.001; van Oudenhoven JP, 2003, ASIAN J SOC PSYCHOL, V6, P159, DOI 10.1111/1467-839X.t01-1-00018; Van Oudenhoven JP, 2002, INT J INTERCULT REL, V26, P679, DOI 10.1016/S0147-1767(02)00041-X; Ward C, 2004, J CROSS CULT PSYCHOL, V35, P137, DOI 10.1177/0022022103260719; Ward C., 2008, HDB CULTURAL INTELLI, P159; Ward C, 2009, EDUC PSYCHOL MEAS, V69, P85, DOI 10.1177/0013164408322001; Wilson J, 2013, J CROSS CULT PSYCHOL, V44, P900, DOI 10.1177/0022022113492889; Wohrle J, 2015, EUR J WORK ORGAN PSY, V24, P161, DOI 10.1080/1359432X.2014.891583; Yakunina ES, 2012, INT J INTERCULT REL, V36, P533, DOI 10.1016/j.ijintrel.2011.12.008	41	2	2	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244425	10.1371/journal.pone.0244425	http://dx.doi.org/10.1371/journal.pone.0244425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370395	Green Published, gold			2022-12-27	WOS:000603611900117
J	Lee, WH; Lee, Y; Na, JY; Kim, SH; Lee, HJ; Lim, YH; Cho, SH; Cho, SH; Park, HK				Lee, Won Hyuk; Lee, Yonggu; Na, Jae Yoon; Kim, Seung Hyun; Lee, Hyun Ju; Lim, Young-Hyo; Cho, Seok Hyun; Cho, Sung Ho; Park, Hyun-Kyung			Feasibility of non-contact cardiorespiratory monitoring using impulse-radio ultra-wideband radar in the neonatal intensive care unit	PLOS ONE			English	Article							RESPIRATORY RATE; HEART-RATE; INFANTS; SENSOR; BIRTH	Background Current cardiorespiratory monitoring equipment can cause injuries and infections in neonates with fragile skin. Impulse-radio ultra-wideband (IR-UWB) radar was recently demonstrated to be an effective contactless vital sign monitor in adults. The purpose of this study was to assess heart rates (HRs) and respiratory rates (RRs) in the neonatal intensive care unit (NICU) using IR-UWB radar and to evaluate its accuracy and reliability compared to conventional electrocardiography (ECG)/impedance pneumography (IPG). Methods The HR and RR were recorded in 34 neonates between 3 and 72 days of age during minimal movement (51 measurements in total) using IR-UWB radar (HRRd, RRRd) and ECG/IPG (HRECG, RRIPG) simultaneously. The radar signals were processed in real time using algorithms for neonates. Radar and ECG/IPG measurements were compared using concordance correlation coefficients (CCCs) and Bland-Altman plots. Results From the 34 neonates, 12,530 HR samples and 3,504 RR samples were measured. Both the HR and RR measured using the two methods were highly concordant when the neonates had minimal movements (CCC = 0.95 between the RRRd and RRIPG, CCC = 0.97 between the HRRd and HRECG). In the Bland-Altman plot, the mean biases were 0.17 breaths/min (95% limit of agreement [LOA] -7.0-7.3) between the RRRd and RRIPG and -0.23 bpm (95% LOA -5.3-4.8) between the HRRd and HRECG. Moreover, the agreement for the HR and RR measurements between the two modalities was consistently high regardless of neonate weight. Conclusions A cardiorespiratory monitor using IR-UWB radar may provide accurate non-contact HR and RR estimates without wires and electrodes for neonates in the NICU.	[Lee, Won Hyuk; Cho, Sung Ho] Hanyang Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Lee, Yonggu; Lim, Young-Hyo] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea; [Na, Jae Yoon; Kim, Seung Hyun; Lee, Hyun Ju; Park, Hyun-Kyung] Hanyang Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Cho, Seok Hyun] Hanyang Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea	Hanyang University; Hanyang University; Hanyang University; Hanyang University	Cho, SH (corresponding author), Hanyang Univ, Dept Elect & Comp Engn, Seoul, South Korea.; Park, HK (corresponding author), Hanyang Univ, Coll Med, Dept Pediat, Seoul, South Korea.	dragon@hanyang.ac.kr; neopark@hanyang.ac.kr	Cho, Sung Ho/P-1657-2015; Cho, Seok Hyun/F-6753-2017	Cho, Sung Ho/0000-0002-2393-1428; Park, Hyun-Kyung/0000-0001-5956-9208; Cho, Seok Hyun/0000-0001-8218-5894; Lim, Young-Hyo/0000-0001-7203-7425	Korea Special Therapeutic Education Center of Anyang, Korea; Bio and Medical Technology Development Program (Next Generation Biotechnology) through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017M3A9E2064735]	Korea Special Therapeutic Education Center of Anyang, Korea; Bio and Medical Technology Development Program (Next Generation Biotechnology) through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by the Korea Special Therapeutic Education Center (Chairman Il-Kewon Kim) of Anyang, Korea, and the Bio and Medical Technology Development Program (Next Generation Biotechnology) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017M3A9E2064735).	Aarts LAM, 2013, EARLY HUM DEV, V89, P943, DOI 10.1016/j.earlhumdev.2013.09.016; Als H, 2003, J DEV BEHAV PEDIATR, V24, P399, DOI 10.1097/00004703-200312000-00001; Anand KJS, 2000, BIOL NEONATE, V77, P69, DOI 10.1159/000014197; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Atallah L, 2014, PHYSIOL MEAS, V35, P895, DOI 10.1088/0967-3334/35/5/895; Bonner Oliver, 2017, BMJ Innov, V3, P12, DOI 10.1136/bmjinnov-2016-000145; Chen W, 2010, INTELLIGENT AND BIOSENSORS, P1; Choliz J, 2011, SENSORS-BASEL, V11, P9045, DOI 10.3390/s110909045; Chung HU, 2019, SCIENCE, V363, P947, DOI 10.1126/science.aau0780; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105; Eeles AL, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000136; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Gibson K, 2019, JMIR RES PROTOC, V8, DOI 10.2196/13400; Kevat AC, 2017, ACTA PAEDIATR, V106, P710, DOI 10.1111/apa.13786; Khan F, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17020290; Klaessens JHGM, 2014, PROC SPIE, V8935, DOI 10.1117/12.2038353; Kohn S, 2016, J PERINATOL, V36, P116, DOI 10.1038/jp.2015.173; Lazaro A, 2010, PROG ELECTROMAGN RES, V100, P265, DOI 10.2528/PIER09120302; Lazaro A, 2014, SENSORS-BASEL, V14, P2595, DOI 10.3390/s140202595; Lee Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31411-8; Leem SK, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17061240; Li B, 2010, SENSORS-BASEL, V10, P11038, DOI 10.3390/s101211038; Marchionni P, 2018, PROC SPIE, V10582, DOI 10.1117/12.2316345; Nukaya S, 2014, ARTIF LIFE ROBOT, V19, P414, DOI 10.1007/s10015-014-0179-4; Park JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48386-9; Ramanathan R, 2001, JAMA-J AM MED ASSOC, V285, P2199, DOI 10.1001/jama.285.17.2199; Sato S, 2010, NEONATOLOGY, V98, P179, DOI 10.1159/000283994; Schires E, 2018, IEEE T BIOMED CIRC S, V12, P292, DOI 10.1109/TBCAS.2018.2799322; Schleicher B, 2013, IEEE T MICROW THEORY, V61, P2076, DOI 10.1109/TMTT.2013.2252185; van Gastel M, 2018, PROC SPIE, V10501, DOI 10.1117/12.2293521; Villarroel M, 2014, HEALTHC TECHNOL LETT, V1, P87, DOI 10.1049/htl.2014.0077; von Steinburg SP, 2013, PEERJ, V1, DOI 10.7717/peerj.82; Yim D, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19030688; Zhao F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00236; Zito D, 2011, IEEE T BIOMED CIRC S, V5, P503, DOI 10.1109/TBCAS.2011.2176937	36	9	10	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243939	10.1371/journal.pone.0243939	http://dx.doi.org/10.1371/journal.pone.0243939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370375	gold, Green Published			2022-12-27	WOS:000603611900012
J	Rice, D; Corace, K; Wolfe, D; Esmaeilisaraji, L; Michaud, A; Grima, A; Austin, B; Douma, R; Barbeau, P; Butler, C; Willows, M; Poulin, PA; Sproule, BA; Porath, A; Garber, G; Taha, S; Garner, G; Skidmore, B; Moher, D; Thavorn, K; Hutton, B				Rice, Danielle; Corace, Kimberly; Wolfe, Dianna; Esmaeilisaraji, Leila; Michaud, Alan; Grima, Alicia; Austin, Bradley; Douma, Reuben; Barbeau, Pauline; Butler, Claire; Willows, Melanie; Poulin, Patricia A.; Sproule, Beth A.; Porath, Amy; Garber, Gary; Taha, Sheena; Garner, Gord; Skidmore, Becky; Moher, David; Thavorn, Kednapa; Hutton, Brian			Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses	PLOS ONE			English	Review							METHADONE-MAINTENANCE TREATMENT; CONTINGENCY MANAGEMENT; RANDOMIZED-TRIAL; BUPRENORPHINE MAINTENANCE; ABSTINENCE REINFORCEMENT; PROMOTING ABSTINENCE; BEHAVIORAL TREATMENT; MULTIPLE-TREATMENTS; DEPENDENT PATIENTS; OPIATE ADDICTS	Background Guidelines recommend that individuals with opioid use disorder (OUD) receive pharmacological and psychosocial interventions; however, the most appropriate psychosocial intervention is not known. In collaboration with people with lived experience, clinicians, and policy makers, we sought to assess the relative benefits of psychosocial interventions as an adjunct to opioid agonist therapy (OAT) among persons with OUD. Methods A review protocol was registered a priori (CRD42018090761), and a comprehensive search for randomized controlled trials (RCT) was conducted from database inception to June 2020 in MEDLINE, Embase, PsycINFO and the Cochrane Central Register of Controlled Trials. Established methods for study selection and data extraction were used. Primary outcomes were treatment retention and opioid use (measured by urinalysis for opioid use and opioid abstinence outcomes). Odds ratios were estimated using network meta-analyses (NMA) as appropriate based on available evidence, and in remaining cases alternative approaches to synthesis were used. Results Seventy-two RCTs met the inclusion criteria. Risk of bias evaluations commonly identified study limitations and poor reporting with regard to methods used for allocation concealment and selective outcome reporting. Due to inconsistency in reporting of outcome measures, only 48 RCTs (20 unique interventions, 5,404 participants) were included for NMA of treatment retention, where statistically significant differences were found when psychosocial interventions were used as an adjunct to OAT as compared to OAT-only. The addition of rewards-based interventions such as contingency management (alone or with community reinforcement approach) to OAT was superior to OAT-only. Few statistically significant differences between psychosocial interventions were identified among any other pairwise comparisons. Heterogeneity in reporting formats precluded an NMA for opioid use. A structured synthesis was undertaken for the remaining outcomes which included opioid use (n = 18 studies) and opioid abstinence (n = 35 studies), where the majority of studies found no significant difference between OAT plus psychosocial interventions as compared to OAT-only. Conclusions This systematic review offers a comprehensive synthesis of the available evidence and the limitations of current trials of psychosocial interventions applied as an adjunct to OAT for OUD. Clinicians and health services may wish to consider integrating contingency management in addition to OAT for OUD in their settings to improve treatment retention. Aside from treatment retention, few differences were consistently found between psychosocial interventions adjunctive to OAT and OAT-only. There is a need for high-quality RCTs to establish more definitive conclusions.	[Rice, Danielle; Corace, Kimberly; Wolfe, Dianna; Esmaeilisaraji, Leila; Michaud, Alan; Grima, Alicia; Austin, Bradley; Douma, Reuben; Barbeau, Pauline; Butler, Claire; Poulin, Patricia A.; Garber, Gary; Skidmore, Becky; Moher, David; Thavorn, Kednapa; Hutton, Brian] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Rice, Danielle] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Corace, Kimberly; Willows, Melanie] Royal Ottawa Mental Hlth Ctr, Subst Use & Concurrent Disorders Program, Ottawa, ON, Canada; [Corace, Kimberly; Willows, Melanie] Univ Ottawa, Dept Psychiat, Fac Med, Ottawa, ON, Canada; [Corace, Kimberly; Willows, Melanie] Univ Ottawa, Inst Mental Hlth Res, Ottawa, ON, Canada; [Willows, Melanie] Univ Ottawa, Dept Family Med, Fac Med, Ottawa, ON, Canada; [Poulin, Patricia A.] Univ Ottawa, Dept Anesthesiol & Pain Med, Fac Med, Ottawa, ON, Canada; [Poulin, Patricia A.] Ottawa Hosp, Pain Clin, Ottawa, ON, Canada; [Sproule, Beth A.] Ctr Addict & Mental Hlth, Dept Pharm, Toronto, ON, Canada; [Sproule, Beth A.] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Sproule, Beth A.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Porath, Amy; Taha, Sheena] Canadian Ctr Subst Use & Addict, Ottawa, ON, Canada; [Garber, Gary; Moher, David; Thavorn, Kednapa; Hutton, Brian] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Garber, Gary] Publ Hlth Ontario, Toronto, ON, Canada; [Garner, Gord] Community Addict Peer Support Assoc CAPSA, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; McGill University; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Ottawa	Hutton, B (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Hutton, B (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	bhutton@ohri.ca	; Wolfe, Dianna/ABA-4768-2020	Michaud, Alan/0000-0001-9217-7361; Wolfe, Dianna/0000-0003-1807-6647; Sproule, Beth/0000-0001-7960-3696; Esmaeilisaraji, Leila/0000-0002-6096-267X	Canadian Institutes of Health Research (CIHR) [397976]; Vanier Canada Graduate CIHR Scholarship; Psychology Foundation of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate CIHR Scholarship(Canadian Institutes of Health Research (CIHR)); Psychology Foundation of Canada	Funding for this work was provided by the Canadian Institutes of Health Research (CIHR) grant number 397976. DBR is supported by a Vanier Canada Graduate CIHR Scholarship and received a student grant from the Psychology Foundation of Canada. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL of funder websites: https://cihrirsc.gc.ca/e/193.html https://vanier.gc.ca/en/homeaccueil.html https://psychologyfoundation.org/.	Abbott PJ, 1998, AM J DRUG ALCOHOL AB, V24, P17, DOI 10.3109/00952999809001696; ABRAHMS JL, 1979, INT J ADDICT, V14, P503, DOI 10.3109/10826087909054598; Altarum, 2018, EC TOLL OP CRIS US E; Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004147.pub4; [Anonymous], 2018, LANCET ONCOL, V19, pe581; [Anonymous], 2018, BEST PRACTICES CONTI; [Anonymous], 2017, J PROSTHET DENT, V11, pe1; [Anonymous], 2018, OP OV UND EP; Asl NH, 2014, ARCH PSYCHIAT NURS, V28, P314, DOI 10.1016/j.apnu.2014.05.003; Avants SK, 1999, AM J PSYCHIAT, V156, P27, DOI 10.1176/ajp.156.1.27; Ball SA, 2007, J PERS DISORD, V21, P305, DOI 10.1521/pedi.2007.21.3.305; Ball SA, 2007, J CONSULT CLIN PSYCH, V75, P556, DOI 10.1037/0022-006X.75.4.556; Barry DT, 2019, DRUG ALCOHOL DEPEN, V194, P460, DOI 10.1016/j.drugalcdep.2018.10.015; Bickel WK, 2008, EXP CLIN PSYCHOPHARM, V16, P132, DOI 10.1037/1064-1297.16.2.132; British Columbia Centre on Substance Use, 2017, GUID CLIN MAN OP US; Brooner RK, 2007, DRUG ALCOHOL DEPEN, V88, pS14, DOI 10.1016/j.drugalcdep.2006.12.006; Bruneau J, 2018, CAN MED ASSOC J, V190, pE247, DOI 10.1503/cmaj.170958; Busse JW, 2017, CAN MED ASSOC J, V189, pE659, DOI 10.1503/cmaj.170363; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Canadian Institute for Health Information (CIHI), 2017, PRESCR DRUG SPEND CA; Carroll KM, 2017, AM J PSYCHIAT, V174, P738, DOI 10.1176/appi.ajp.2016.16070792; CARROLL KM, 1995, AM J ADDICTION, V4, P56; Catala-Lopez F, 2014, RHEUMATOL INT, V34, P1489, DOI 10.1007/s00296-014-2994-2; Catalano RF, 1999, ADDICTION, V94, P241, DOI 10.1046/j.1360-0443.1999.9422418.x; Center for Disease Control and Prevention, 2019, OV DAT TRENDS US STA; Centers for Disease Control and Prevention, 2020, SUBST US DRUG OV DEA; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Chawarski MC, 2008, DRUG ALCOHOL DEPEN, V94, P281, DOI 10.1016/j.drugalcdep.2007.11.008; Chawarski MC, 2011, DRUG ALCOHOL DEPEN, V115, P237, DOI 10.1016/j.drugalcdep.2010.09.024; Chen J, 2013, J PSYCHOSOM RES, V75, P72, DOI 10.1016/j.jpsychores.2013.03.006; Chen W, 2013, DRUG ALCOHOL DEPEN, V133, P270, DOI 10.1016/j.drugalcdep.2013.05.028; Chopra MP, 2009, EXP CLIN PSYCHOPHARM, V17, P226, DOI 10.1037/a0016597; Christensen DR, 2014, J CONSULT CLIN PSYCH, V82, P964, DOI 10.1037/a0037496; Chutuape MA, 1999, DRUG ALCOHOL DEPEN, V54, P69, DOI 10.1016/S0376-8716(98)00144-6; Cochrane Effective Practice and Organisation of Care (EPOC), 2017, EPOC RES REV AUTH; Corace K, 2018, CAN J ADDICT, V9, P15, DOI 10.1097/CXA.0000000000000032; Czuchry M, 2009, J PSYCHOACTIVE DRUGS, V41, P181, DOI 10.1080/02791072.2009.10399911; Day E, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1600-7; Dennis BB, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0942-4; Donroe JH, 2018, CURRENT ADDICTION RE, V5, P454, DOI DOI 10.1007/S40429-018-0228-5; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Downey KK, 2000, EXP CLIN PSYCHOPHARM, V8, P176, DOI 10.1037/1064-1297.8.2.176; Dugosh K, 2016, J ADDICT MED, V10, P93, DOI 10.1097/ADM.0000000000000193; Epstein DH, 2009, DRUG ALCOHOL DEPEN, V101, P92, DOI 10.1016/j.drugalcdep.2008.11.006; European Monitering Centre for Drugs and Drug Addiction, 2019, DRUG REL DEATHS MORT; European Monitoring Centre for Drugs and Drug Addiction, 2017, EUR DRUG REP 2017 TR; European Monitoring Centre for Drugs and Drug Addiction, 2018, EUR DRUG REP 2018 TR; Fals-Stewart W, 2001, BEHAV THER, V32, P391, DOI 10.1016/S0005-7894(01)80010-1; Fiellin DA., 2020, EPIDEMICS COLLIDE CO; Fiellin DA, 2006, NEW ENGL J MED, V355, P365, DOI 10.1056/NEJMoa055255; Fiellin DA, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.07.005; Ghitza UE, 2008, ADDICT BEHAV, V33, P593, DOI 10.1016/j.addbeh.2007.11.009; Grande LA, 2016, J AM BOARD FAM MED, V29, P718, DOI 10.3122/jabfm.2016.06.160073; Gross A, 2006, EXP CLIN PSYCHOPHARM, V14, P148, DOI 10.1037/1064-1297.14.2.148; Gu J, 2013, AIDS BEHAV, V17, P2002, DOI 10.1007/s10461-012-0393-9; Haight SC, 2018, MMWR-MORBID MORTAL W, V67, P845, DOI 10.15585/mmwr.mm6731a1; Hedegaard H., 2017, DRUG OVERDOSE DEATHS; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hrobjartsson A, 2014, INT J EPIDEMIOL, V43, P1272, DOI 10.1093/ije/dyu115; Hser YI, 2011, ADDICTION, V106, P1801, DOI 10.1111/j.1360-0443.2011.03490.x; Huhn AS, 2019, AM J ADDICTION, V28, P246, DOI 10.1111/ajad.12921; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Iguchi MY, 1997, J CONSULT CLIN PSYCH, V65, P421, DOI 10.1037/0022-006X.65.3.421; Jaffray Mariesha, 2014, Int J Pharm Pract, V22, P4, DOI 10.1111/ijpp.12049; Jiang Haifeng, 2012, Shanghai Arch Psychiatry, V24, P11, DOI 10.3969/j.issn.1002-0829.2012.01.002; Joe GW, 1997, J NERV MENT DIS, V185, P306, DOI 10.1097/00005053-199705000-00004; Karow A, 2010, DRUG ALCOHOL DEPEN, V112, P209, DOI 10.1016/j.drugalcdep.2010.06.009; Kelly SM, 2012, J ADDICT MED, V6, P145, DOI 10.1097/ADM.0b013e31823ae556; Khangura S, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-10; Kidorf M, 2018, DRUG ALCOHOL DEPEN, V187, P343, DOI 10.1016/j.drugalcdep.2018.03.009; Kolodny A, 2015, ANNU REV PUBL HEALTH, V36, P559, DOI 10.1146/annurev-publhealth-031914-122957; Korownyk C, 2019, CAN FAM PHYSICIAN, V65, pE194; Kosten T, 2003, DRUG ALCOHOL DEPEN, V70, P315, DOI 10.1016/S0376-8716(03)00032-2; Kosten T, 2003, ADDICTION, V98, P665, DOI 10.1046/j.1360-0443.2003.00380.x; Linehan MM, 2002, DRUG ALCOHOL DEPEN, V67, P13, DOI 10.1016/S0376-8716(02)00011-X; Ling W, 2013, ADDICTION, V108, P1788, DOI 10.1111/add.12266; Liu PL, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00113; Marsch LA, 2014, J SUBST ABUSE TREAT, V46, P43, DOI 10.1016/j.jsat.2013.08.012; MCLELLAN AT, 1993, JAMA-J AM MED ASSOC, V269, P1953, DOI 10.1001/jama.269.15.1953; MILBY JB, 1978, ADDICT BEHAV, V3, P215, DOI 10.1016/0306-4603(78)90022-9; Miotto K, 2012, J ADDICT MED, V6, P68, DOI 10.1097/ADM.0b013e318233d621; Moore BA, 2019, J SUBST ABUSE TREAT, V97, P68, DOI 10.1016/j.jsat.2018.11.011; Moore BA, 2013, J SUBST ABUSE TREAT, V45, P63, DOI 10.1016/j.jsat.2012.12.011; Nyamathi AM, 2011, J ADDICT DIS, V30, P6, DOI 10.1080/10550887.2010.531669; O'Brlen, 1993, J ADDICT NURS, V5, P38, DOI 10.3109/10884609309149701; O'Connor PG, 1998, AM J MED, V105, P100, DOI 10.1016/S0002-9343(98)00194-6; Oliveto A, 2005, DRUG ALCOHOL DEPEN, V79, P157, DOI 10.1016/j.drugalcdep.2005.01.007; ONeill K, 1996, ADDICTION, V91, P1115, DOI 10.1046/j.1360-0443.1996.91811154.x; Otto MW, 2014, J PSYCHOACTIVE DRUGS, V46, P402, DOI 10.1080/02791072.2014.960110; Pan SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127598; Pashaei T, 2013, IRAN J PUBLIC HEALTH, V42, P896; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Petty NM, 2002, J CONSULT CLIN PSYCH, V70, P398, DOI 10.1037//0022-006X.70.2.398; Poling J, 2006, ARCH GEN PSYCHIAT, V63, P219, DOI 10.1001/archpsyc.63.2.219; Pollack MH, 2002, J SUBST ABUSE TREAT, V23, P335, DOI 10.1016/S0740-5472(02)00298-2; Preston KL, 2000, ARCH GEN PSYCHIAT, V57, P395, DOI 10.1001/archpsyc.57.4.395; Preston KL, 2002, DRUG ALCOHOL DEPEN, V67, P125, DOI 10.1016/S0376-8716(02)00023-6; Public Health Agency of Canada, 2020, OP REL HARMS CAN; Rice DB, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023902; ROUNSAVILLE BJ, 1983, ARCH GEN PSYCHIAT, V40, P629; ROWANSZAL GA, 1997, J MAINTENANCE ADDICT, V1, P49, DOI DOI 10.1300/J126V01N01_; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Sampson M, 2009, J CLIN EPIDEMIOL, V62, P944, DOI 10.1016/j.jclinepi.2008.10.012; Scherbaum N, 2005, EUR ADDICT RES, V11, P163, DOI 10.1159/000086397; Schottenfeld RS, 2005, AM J PSYCHIAT, V162, P340, DOI 10.1176/appi.ajp.162.2.340; Schwartz RP, 2012, ADDICTION, V107, P943, DOI 10.1111/j.1360-0443.2011.03700.x; Shi JM, 2019, SUBST ABUS, V40, P132, DOI 10.1080/08897077.2019.1569192; Silverman K, 2004, J CONSULT CLIN PSYCH, V72, P839, DOI 10.1037/0022-006X.72.5.839; Special Advisory Committee on the Epidemic of Opioid Overdoses, 2019, NAT REP APP OP REL D; Stein MD, 2015, DRUG ALCOHOL DEPEN, V147, P243, DOI 10.1016/j.drugalcdep.2014.11.007; Sullivan LE, 2006, CLIN INFECT DIS, V43, pS184, DOI 10.1086/508182; Sun YK, 2020, AM J ADDICTION, V29, P174, DOI 10.1111/ajad.13031; Tetrault JM, 2012, J SUBST ABUSE TREAT, V43, P433, DOI 10.1016/j.jsat.2012.07.011; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; Tuten M, 2012, AM J DRUG ALCOHOL AB, V38, P286, DOI 10.3109/00952990.2011.643977; United Nations Office on Drugs and Crime, 2015, WORLD DRUG REP 2015; WOODY GE, 1995, AM J PSYCHIAT, V152, P1302; WOODY GE, 1987, AM J PSYCHIAT, V144, P590; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Yaghubi Mehdi, 2017, Addict Health, V9, P156	121	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244401	10.1371/journal.pone.0244401	http://dx.doi.org/10.1371/journal.pone.0244401			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370393	Green Published, gold			2022-12-27	WOS:000603611900017
J	Riveiro-Barciela, M; Labrador-Horrillo, M; Camps-Relats, L; Gonzalez-Sans, D; Ventura-Cots, M; Terrones-Peinador, M; Nunez-Conde, A; Martinez-Gallo, M; Hernandez, M; Anton, A; Gonzalez, A; Pujol-Borrell, R; Martinez-Valle, F				Riveiro-Barciela, Mar; Labrador-Horrillo, Moises; Camps-Relats, Laura; Gonzalez-Sans, Didac; Ventura-Cots, Meritxell; Terrones-Peinador, Maria; Nunez-Conde, Andrea; Martinez-Gallo, Monica; Hernandez, Manuel; Anton, Andres; Gonzalez, Antonio; Pujol-Borrell, Ricardo; Martinez-Valle, Fernando			Simple predictive models identify patients with COVID-19 pneumonia and poor prognosis	PLOS ONE			English	Article								Background and aims Identification of SARS-CoV-2-infected patients at high-risk of poor prognosis is crucial. We aimed to establish predictive models for COVID-19 pneumonia severity in hospitalized patients. Methods Retrospective study of 430 patients admitted in Vall d'Hebron Hospital (Barcelona) between 03-12-2020 and 04-28-2020 due to COVID-19 pneumonia. Two models to identify the patients who required high-flow-oxygen-support were generated, one using baseline data and another with also follow-up analytical results. Calibration was performed by a 1000-bootstrap replication model. Results 249 were male, mean age 57.9 years. Overall, 135 (31.4%) required high-flow-oxygen-support. The baseline predictive model showed a ROC of 0.800 based on: SpO2/FiO2 (adjusted Hazard Ratio-aHR = 8), chest x-ray (aHR = 4), prior immunosuppressive therapy (aHR = 4), obesity (aHR = 2), IL-6 (aHR = 2), platelets (aHR = 0.5). The cut-off of 11 presented a specificity of 94.8%. The second model included changes on the analytical parameters: ferritin (aHR = 7.5 if >= 200ng/mL) and IL-6 (aHR = 18 if >= 64pg/mL) plus chest x-ray (aHR = 2) showing a ROC of 0.877. The cut-off of 12 exhibited a negative predictive value of 92%. Conclusions SpO2/FiO2 and chest x-ray on admission or changes on inflammatory parameters as IL-6 and ferritin allow us early identification of COVID-19 patients at risk of high-flow-oxygen-support that may benefit from a more intensive disease management.	[Riveiro-Barciela, Mar; Camps-Relats, Laura; Ventura-Cots, Meritxell] Hosp Univ Vall dHebron, Internal Med Dept, Liver Unit, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain; [Riveiro-Barciela, Mar; Ventura-Cots, Meritxell] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Riveiro-Barciela, Mar; Labrador-Horrillo, Moises; Martinez-Gallo, Monica; Hernandez, Manuel; Anton, Andres; Pujol-Borrell, Ricardo; Martinez-Valle, Fernando] Univ Autonoma Barcelona, Barcelona, Spain; [Labrador-Horrillo, Moises] Hosp Univ Vall dHebron, Internal Med Dept, Allergy Sect, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain; [Labrador-Horrillo, Moises] Inst Salud Carlos III, ARADyAL Res Network, Madrid, Spain; [Gonzalez-Sans, Didac; Terrones-Peinador, Maria; Nunez-Conde, Andrea; Gonzalez, Antonio; Martinez-Valle, Fernando] Hosp Univ Vall dHebron, Internal Med Dept, Syst Autoimmune Dis Unit, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain; [Martinez-Gallo, Monica; Hernandez, Manuel; Pujol-Borrell, Ricardo] Vall dHebron Inst Recerca VHIR, Diagnost Immunol Grp, Barcelona, Spain; [Martinez-Gallo, Monica; Hernandez, Manuel; Pujol-Borrell, Ricardo] Hosp Univ Vall dHebron, Dept Cell Biol Physiol & Immunol, Div Immunol, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain; [Anton, Andres] Hosp Univ, Vall dHebron Vall dHebron Inst Recerca VHIR, Microbiol Dept, Resp Viruses Unit, Barcelona Hosp Campus, Barcelona, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; University of Sevilla	Labrador-Horrillo, M (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.; Labrador-Horrillo, M (corresponding author), Hosp Univ Vall dHebron, Internal Med Dept, Allergy Sect, Vall dHebron Barcelona Hosp Campus, Barcelona, Spain.; Labrador-Horrillo, M (corresponding author), Inst Salud Carlos III, ARADyAL Res Network, Madrid, Spain.	mlabrador@vhebron.net	Labrador Horrillo, Moisés/O-6434-2016; Antón, Andrés/B-3308-2011; Pujol Borrell, Ricardo/N-3415-2013; Hernandez-Gonzalez, Manuel/K-5888-2017	Labrador Horrillo, Moisés/0000-0003-3222-2380; Antón, Andrés/0000-0002-1476-0815; Terrones-Peinador, Maria/0000-0003-4035-4930; Pujol Borrell, Ricardo/0000-0001-7833-675X; Hernandez-Gonzalez, Manuel/0000-0002-6932-5853; Martinez Gallo, Monica/0000-0002-7340-2161	Instituto de Salud Carlos III - European Regional Development Fund (ERDF) [PI20/00416]	Instituto de Salud Carlos III - European Regional Development Fund (ERDF)	This work was supported in part by grant PI20/00416 from the Instituto de Salud Carlos III and was co-financed by the European Regional Development Fund (ERDF). Principal investigator: Ricardo Pujol-Borrell The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, CLIN DIABETOLOGY, V9, P1; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Helmy YA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041225; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Nicolas Vabret, 2020, IMMUNITY, P19, DOI [10.1016/j.immuni.2020.06.017, DOI 10.1016/J.IMMUNI.2020.06.017]; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244627	10.1371/journal.pone.0244627	http://dx.doi.org/10.1371/journal.pone.0244627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370397	Green Published, gold			2022-12-27	WOS:000603611900058
J	Rowe, GT; Fernando, H; Elferink, C; Ansari, GAS; Sullivan, J; Heathman, T; Quigg, A; Croisant, SP; Wade, TL; Santschi, PH				Rowe, Gilbert T.; Fernando, Harshica; Elferink, Cornelis; Ansari, G. A. Shakeel; Sullivan, John; Heathman, Thomas; Quigg, Antonietta; Petronella Croisant, Sharon; Wade, Terry L.; Santschi, Peter H.			Polycyclic aromatic hydrocarbons (PAHs) cycling and fates in Galveston Bay, Texas, USA	PLOS ONE			English	Article							HOUSTON SHIP CHANNEL; VERTICAL FLUXES; SURFACE WATERS; ORGANIC-CARBON; TRINITY RIVER; ATMOSPHERIC DEPOSITION; COMMUNITY COMPOSITION; ESTUARINE WATERS; AQUATIC SYSTEMS; CHESAPEAKE BAY	The cycling and fate of polycyclic aromatic hydrocarbons (PAHs) is not well understood in estuarine systems. It is critical now more than ever given the increased ecosystem pressures on these critical coastal habitats. A budget of PAHs and cycling has been created for Galveston Bay (Texas) in the northwestern Gulf of Mexico, an estuary surrounded by 30-50% of the US capacity of oil refineries and chemical industry. We estimate that approximately 3 to 4 mt per year of pyrogenic PAHs are introduced to Galveston Bay via gaseous exchange from the atmosphere (ca. 2 mt/year) in addition to numerous spills of petrogenic PAHs from oil and gas operations (ca. 1.0 to 1.9 mt/year). PAHs are cycled through and stored in the biota, and ca. 20 to 30% of the total (0.8 to 1.5 mt per year) are estimated to be buried in the sediments. Oysters concentrate PAHs to levels above their surroundings (water and sediments) and contain substantially greater concentrations than other fish catch (shrimp, blue crabs and fin fish). Smaller organisms (infaunal invertebrates, phytoplankton and zooplankton) might also retain a significant fraction of the total, but direct evidence for this is lacking. The amount of PAHs delivered to humans in seafood, based on reported landings, is trivially small compared to the total inputs, sediment accumulation and other possible fates (metabolic remineralization, export in tides, etc.), which remain poorly known. The generally higher concentrations in biota from Galveston Bay compared to other coastal habitats can be attributed to both intermittent spills of gas and oil and the bay's close proximity to high production of pyrogenic PAHs within the urban industrial complex of the city of Houston as well as periodic flood events that transport PAHs from land surfaces to the Bay.	[Rowe, Gilbert T.; Heathman, Thomas; Quigg, Antonietta] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Fernando, Harshica] Prairie View A&M Univ, Dept Chem, Prairie View, TX USA; [Elferink, Cornelis; Ansari, G. A. Shakeel; Sullivan, John; Petronella Croisant, Sharon] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Quigg, Antonietta; Wade, Terry L.; Santschi, Peter H.] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA; [Santschi, Peter H.] Texas A&M Univ, Dept Marine & Coastal Environm Sci, Galveston, TX 77554 USA	Texas A&M University System; Texas A&M University System; Prairie View A&M University; University of Texas System; University of Texas Medical Branch Galveston; Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Santschi, PH (corresponding author), Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA.; Santschi, PH (corresponding author), Texas A&M Univ, Dept Marine & Coastal Environm Sci, Galveston, TX 77554 USA.	Santschi@tamug.edu	Santschi, Peter H/D-5712-2012	Santschi, Peter H/0000-0001-8188-7691; Quigg, Antonietta/0000-0001-5640-1426	US National Institute of Environmental Health Sciences (NIEHS) [5U19ES020676]; Gulf of Mexico Research Initiative (GOMRI); NIH [P42 ES027704]; Texas General Land Office [20-057-000-B908]	US National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Gulf of Mexico Research Initiative (GOMRI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas General Land Office	This summary of PAH concentrations and fluxes was initiated with support from the US National Institute of Environmental Health Sciences (NIEHS) grant entitled "Gulf Coast Health Alliance: health risks related to the Macondo Spill (GCHARMS)", Grant Number: 5U19ES020676. It provided funding to co-authors GTR, HF, CE, SA, JS, TH, and SP. TW, PS and AQ are being supported by a grant from the Gulf of Mexico Research Initiative (GOMRI) to support the ADDOMEx and ADDOMEx-2 consortia research (Aggregation and Degradation of Dispersants and Oil by Microbial Exopolymers). Data from ADDOMEx/ADDOMEx-2 is publicly available through the Gulf of Mexico Research Initiative Information and Data Cooperative (GRIIDC; https://gulfresearchinitiative.org/); however, no new data was deposited in relation to the current study. TW's participation on this publication was made possible, in part, by NIH grant P42 ES027704. Its contents are solely the responsibility of the grantee and do not necessarily represent the official views of the NIH. Further, the NIH does not endorse the purchase of any commercial products or services mentioned in the publication. TW's participation on this publication was made possible, in part, by NIH grant P42 ES027704. This research was partially funded by Texas General Land Office grant number 20-057-000-B908 to AQ. None of the authors have received salary for preparing this manuscript from the above sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adhikari PL, 2015, MAR CHEM, V168, P60, DOI 10.1016/j.marchem.2014.11.001; Al Mukaimi ME, 2018, ENVIRON POLLUT, V237, P887, DOI 10.1016/j.envpol.2018.01.027; Anderson JW, 1987, TOXICITY DISPERSED U; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2019, NAT STAT TRENDS BIOE; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Bacosa HP, 2020, ENVIRON SCI POLLUT R, V27, P34987, DOI 10.1007/s11356-020-09754-5; Bacosa HP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01325; BASKARAN M, 1993, MAR CHEM, V43, P95, DOI 10.1016/0304-4203(93)90218-D; BENOIT G, 1994, MAR CHEM, V45, P307, DOI 10.1016/0304-4203(94)90076-0; Berrojalbiz N, 2009, ENVIRON SCI TECHNOL, V43, P2295, DOI 10.1021/es8018226; Broach L, 2001, LONG TERM CHARACTERI; Carls MG, 2005, ACCUMULATION POLYCYC; Choi H, 2010, POLYCYCL AROMAT COMP; Colombo JC, 2006, ENVIRON SCI TECHNOL, V40, P734, DOI 10.1021/es051672y; D'Andrea MA, 2014, J OCCUP ENVIRON MED, V56, P1029, DOI 10.1097/JOM.0000000000000217; Dekshenieks MM, 2000, ESTUARIES, V23, P593, DOI 10.2307/1352887; Del Vento S, 2002, ENVIRON TOXICOL CHEM, V21, P2099, DOI 10.1002/etc.5620211013; Deyme R, 2011, ENVIRON POLLUT, V159, P3681, DOI 10.1016/j.envpol.2011.07.017; Doyle SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00689; Du JB, 2019, SCI TOTAL ENVIRON, V653, P554, DOI 10.1016/j.scitotenv.2018.10.403; Fan CW, 2003, ENVIRON SCI TECHNOL, V37, P3405, DOI 10.1021/es026367g; Fernando H, 2019, MAR POLLUT BULL, V145, P200, DOI 10.1016/j.marpolbul.2019.05.015; FONTAINE CT, 1971, T AM FISH SOC, V100, P584, DOI 10.1577/1548-8659(1971)100<584:LRFTCI>2.0.CO;2; Freeman LA, 2019, ESTUAR COAST, V42, P1821, DOI 10.1007/s12237-019-00597-z; Galveston Bay Estuary Program, 2018, GALVESTON BAY ESTUAR; Galveston Bay National Estuary Program, 1993, 2 NAT COAST COND; Galveston Bay National Estuary Program, 1992, GALVESTON BAY NATL E; GoldBouchot G, 1995, MAR POLLUT BULL, V31, P439, DOI 10.1016/0025-326X(95)00171-I; Gonzalez LA, 2011, STATE BAY CHARACTERI; Guo LD, 1997, MAR CHEM, V59, P1, DOI 10.1016/S0304-4203(97)00072-8; Harris R.P., 1977, FACTORS AFFECTING RE; HARRIS RP, 1977, MAR BIOL, V42, P187, DOI 10.1007/BF00397743; Hayes CT, 2019, TRACE METALS GULF ME; Hieke ASC, 2016, MAR BIOTECHNOL, V18, P630, DOI 10.1007/s10126-016-9723-7; Hofstetter RP, 1983, OYSTER POPULATION TR; Hung CC, 2001, MAR CHEM, V73, P305, DOI 10.1016/S0304-4203(00)00114-6; IVERSON DG, 1979, ABSTR PAP AM CHEM S, P3; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; Jiann KT, 2013, AQUAT GEOCHEM, V19, P173, DOI 10.1007/s10498-013-9187-6; Jonsson G, 2004, ENVIRON TOXICOL CHEM, V23, P1538, DOI 10.1897/03-173; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Ko FC, 2003, MAR CHEM, V81, P163, DOI 10.1016/S0304-4203(03)00027-6; LANDRUM PF, 1992, ENVIRON TOXICOL CHEM, V11, P1709, DOI 10.1897/1552-8618(1992)11[1709:TIASMC]2.0.CO;2; Lei AP, 2002, WATER SCI TECHNOL, V46, P195, DOI 10.2166/wst.2002.0738; LIPIATOU E, 1993, MAR CHEM, V44, P43, DOI 10.1016/0304-4203(93)90005-9; Louchouarn P, 2009, 582572502WO13 TEX CO; Louchouarn P, 2018, ENVIRON POLLUT, V238, P988, DOI 10.1016/j.envpol.2018.02.003; MACKAY D, 1979, ENVIRON SCI TECHNOL, V13, P333, DOI 10.1021/es60151a012; McDonald SJ, 1991, ASSESSING EXPOSURE F; MCVEETY BD, 1988, ATMOS ENVIRON, V22, P511, DOI 10.1016/0004-6981(88)90196-5; MINELLO TJ, 1981, CONTRIB MAR SCI, V24, P81; MORSE JW, 1993, MAR ENVIRON RES, V36, P1, DOI 10.1016/0141-1136(93)90087-G; Ornolfsdottir EB, 2004, J PLANKTON RES, V26, P325, DOI 10.1093/plankt/fbh035; Overton EB, 2016, OCEANOGRAPHY, V29, P50, DOI 10.5670/oceanog.2016.62; Pampanin D, 2013, HYDROCARBON INTECHOP; Park JS, 2001, ATMOS ENVIRON, V35, P3241, DOI 10.1016/S1352-2310(01)00080-2; Powell EN, 2007, N AM J FISH MANAGE, V27, P492, DOI 10.1577/M04-205.1; PULLEN EJ, 1970, T AM FISH SOC, V99, P795, DOI 10.1577/1548-8659(1970)99<795:CWWROB>2.0.CO;2; Qian YR, 2001, ESTUARIES, V24, P817, DOI 10.2307/1353173; Qu F, 2015, J MARINE BIOL; Raoux C, 1999, ESTUAR COAST SHELF S, V48, P605, DOI 10.1006/ecss.1998.0458; Ravens TM, 2009, J COASTAL RES, V25, P265, DOI 10.2112/07-0942.1; Roelke DL, 2013, MAR ECOL PROG SER, V477, P61, DOI 10.3354/meps10182; Salas-Monreal D, 2018, OCEANOLOGIA, V60, P232, DOI 10.1016/j.oceano.2017.10.005; Santschi PH, 2018, MAR CHEM, V207, P124, DOI 10.1016/j.marchem.2018.11.003; Santschi PH, 2001, MAR ENVIRON RES, V52, P51, DOI 10.1016/S0141-1136(00)00260-9; SANTSCHI PH, 1995, GEOCHIM COSMOCHIM AC, V59, P625, DOI 10.1016/0016-7037(94)00378-Y; Santschi PH, 1997, MAR CHEM, V58, P99, DOI 10.1016/S0304-4203(97)00029-7; SANTSCHI PH, 1995, MAR ENVIRON RES, V40, P337, DOI 10.1016/0141-1136(95)92644-J; Santschi PH, 2020, MARINE CHEM; Santschi PH, 2009, FACTORS REGULATING M; Sediment contamination toxicity and macroinvertbrates infaunal community in Galveston Bay., 2003, 122 NOAA NOS NCCOS C, P122; Sinaei M, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-59; Soliman YS, 2008, DEEP-SEA RES PT II, V55, P2577, DOI 10.1016/j.dsr2.2008.07.007; Solis R., 1999, HYDROGRAPHY MIXING C; Steichen JL, 2012, MAR POLLUT BULL, V64, P779, DOI 10.1016/j.marpolbul.2012.01.028; Stordal MC, 1996, LIMNOL OCEANOGR, V41, P52, DOI 10.4319/lo.1996.41.1.0052; Sverdrup LE, 2002, ENVIRON SCI TECHNOL, V36, P2429, DOI 10.1021/es010180s; Tang DG, 2002, MAR CHEM, V78, P29, DOI 10.1016/S0304-4203(02)00007-5; Tang DG, 2001, LIMNOL OCEANOGR, V46, P321, DOI 10.4319/lo.2001.46.2.0321; Tang DG, 2000, LIMNOL OCEANOGR, V45, P1289, DOI 10.4319/lo.2000.45.6.1289; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Tsapakis M, 2006, ENVIRON SCI TECHNOL, V40, P4922, DOI 10.1021/es060487x; Ventikos NP, 2014, MAR POLLUT BULL, V81, P116, DOI 10.1016/j.marpolbul.2014.02.007; Wang XH, 2006, MAR ECOL PROG SER, V312, P101, DOI 10.3354/meps312101; Warnken KW, 2008, ESTUAR COAST SHELF S, V76, P69, DOI 10.1016/j.ecss.2007.06.010; Warnken KW, 2009, ESTUAR COAST, V32, P158, DOI 10.1007/s12237-008-9088-x; Warnken KW, 2004, SCI TOTAL ENVIRON, V329, P131, DOI 10.1016/j.scitotenv.2004.02.017; Warnken KW, 2001, MAR CHEM, V73, P215, DOI 10.1016/S0304-4203(00)00108-0; Warnken KW, 2000, ESTUARIES, V23, P647, DOI 10.2307/1352891; Wen LS, 2008, MAR CHEM, V112, P20, DOI 10.1016/j.marchem.2008.06.003; Wen LS, 1999, MAR CHEM, V63, P185, DOI 10.1016/S0304-4203(98)00062-0; Wen LS, 1997, ENVIRON SCI TECHNOL, V31, P723, DOI 10.1021/es9603057; Williams AK, 2017, MAR POLLUT BULL, V121, P32, DOI 10.1016/j.marpolbul.2017.05.033; Wozniak AS, 2019, ENVIRON SCI TECHNOL, V53, P3441, DOI 10.1021/acs.est.8b06532; Yeager KM, 2007, ENVIRON SCI TECHNOL, V41, P5291, DOI 10.1021/es062917p; Yeager KM, 2010, J COASTAL RES, V26, P743, DOI 10.2112/JCOASTRES-D-09-00009.1; Zaugg SD, 2006, DETERMINATION SEMIVO; Zhang C, 2003, CHARACTERIZATION DES	101	4	4	5	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243734	10.1371/journal.pone.0243734	http://dx.doi.org/10.1371/journal.pone.0243734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370322	Green Published, gold			2022-12-27	WOS:000603611900118
J	Gonzalez-Molina, I; Jimenez-Garcia, B; Maillo-Fernandez, JM; Baquedano, E; Dominguez-Rodrigo, M				Gonzalez-Molina, Irene; Jimenez-Garcia, Blanca; Maillo-Fernandez, Jose-Manuel; Baquedano, Enrique; Dominguez-Rodrigo, Manuel			Distinguishing Discoid and Centripetal Levallois methods through machine learning	PLOS ONE			English	Article							CLASSIFICATION; ASSEMBLAGES; TECHNOLOGY; ALGORITHMS; HOMININ; MODELS	In this paper, we apply Machine Learning (ML) algorithms to study the differences between Discoid and Centripetal Levallois methods. For this purpose, we have used experimentally knapped flint flakes, measuring several parameters that have been analyzed by seven ML algorithms. From these analyses, it has been possible to demonstrate the existence of statistically significant differences between Discoid products and Centripetal Levallois products, thus contributing with new data and a new method to this traditional debate. The new approach enabled differentiating the blanks created by both knapping methods with an accuracy >80% using only ten typometric variables. The most relevant variables were maximum length, width to the 25%, 50% and 75% of the flake length, external and internal platform angles, maximum width and number of dorsal scars. This study also demonstrates the advantages of the application of multivariate ML methods to lithic studies.	[Gonzalez-Molina, Irene; Jimenez-Garcia, Blanca; Maillo-Fernandez, Jose-Manuel; Baquedano, Enrique; Dominguez-Rodrigo, Manuel] Univ Alcala, Inst Evolut Africa, IDEA, Madrid, Spain; [Jimenez-Garcia, Blanca] Univ Nacl Educ Distancia, UNED, Artificial Intelligence Dept, Madrid, Spain; [Maillo-Fernandez, Jose-Manuel] Univ Nacl Educ Distancia, UNED, Dept Prehist & Archaeol, Madrid, Spain; [Baquedano, Enrique] Museo Arqueol Reg, Madrid, Spain	Universidad de Alcala; Universidad Nacional de Educacion a Distancia (UNED); Universidad Nacional de Educacion a Distancia (UNED)	Gonzalez-Molina, I; Jimenez-Garcia, B; Maillo-Fernandez, JM; Baquedano, E; Dominguez-Rodrigo, M (corresponding author), Univ Alcala, Inst Evolut Africa, IDEA, Madrid, Spain.; Jimenez-Garcia, B (corresponding author), Univ Nacl Educ Distancia, UNED, Artificial Intelligence Dept, Madrid, Spain.; Maillo-Fernandez, JM (corresponding author), Univ Nacl Educ Distancia, UNED, Dept Prehist & Archaeol, Madrid, Spain.; Baquedano, E (corresponding author), Museo Arqueol Reg, Madrid, Spain.	4e.irene.gonzalez@gmail.com; blanchejg97@gmail.com; jlmaillo@geo.uned.es; enrique.baquedano@madrid.org; m.dominguez.rodrigo@gmail.com	Maíllo-Fernández, José-Manuel/AAU-3715-2020	Maíllo-Fernández, José-Manuel/0000-0002-7555-4943; Jimenez-Garcia, Blanca/0000-0001-8402-4648; Gonzalez-Molina, Irene/0000-0002-1925-8314	Ministry of Science, Innovation and Universities [HAR2017-82463-C4-1-P, HAR2015-64407-P]; Fundacion Palarq	Ministry of Science, Innovation and Universities; Fundacion Palarq	This research has been funded by the Ministry of Science, Innovation and Universities with projects HAR2017-82463-C4-1-P and HAR2015-64407-P and Fundacion Palarq. Sponsors had not any role in the study desing, data and collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, PALEORIENT, DOI DOI 10.3406/PALE0.1983.4338; Baena J., 2003, BAR INT SERIES, V1120, P117; Bernaldo de Quiros F, 2010, CUEVA CASTILLO PERSP, P291; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI DOI 10.3406/BSPF.1993.9669; Boeda E., 1994, CONCEPT LEVALLOIS VA; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Boeda E, 2013, TECHNO LOGIQUE TECHN, DOI [10.1083/jcb.201206010, DOI 10.1083/JCB.201206010]; Bordes F., 1961, TYPOLOGIE PALEOLITHI; Bordes F., 1980, B SOC PREHISTORIQUE, V77, P45, DOI [10.3406/BSPF.1980.5242, DOI 10.3406/BSPF.1980.5242]; Bordes F, 1950, ANTHROPOLOGIE, V54, P19; Bordes F, 1953, BULL SOC PREHIST FR, V50, P457, DOI 10.3406/bspf.1953.5156; Bourguignon L., 1998, RECHERCHES GROTTES S, V2, P249; Brantingham PJ, 2001, J ARCHAEOL SCI, V28, P747, DOI 10.1006/jasc.2000.0594; Bretzke K, 2012, J ARCHAEOL SCI, V39, P3741, DOI 10.1016/j.jas.2012.06.039; Arriaza MC, 2016, QUATERNARY SCI REV, V139, P43, DOI 10.1016/j.quascirev.2016.03.005; Clarkson C, 2006, J ARCHAEOL SCI, V33, P132, DOI 10.1016/j.jas.2005.07.007; Commont V, 1913, HOMMES CONT RENNE VA; Commont V, 1911, B ARCHEOLOGIQUE, P173; Commont V, 1909, IND MOUSTERIENNE REG, P115; Courtenay LA, 2019, PALAEOGEOGR PALAEOCL, V522, P28, DOI 10.1016/j.palaeo.2019.03.007; Dauvois M, 1976, PERIGUEUX; Delpiano D, 2018, J ANTHROPOL SCI, V96, P89, DOI [10.4436/jass.96006, 10.4436/JASS.96006]; Dibble E., 1995, DEFINITION INTERPRET, P41; Dominguez-Rodrigo M, 2019, ARCHAEOL ANTHROP SCI, V11, P2711, DOI 10.1007/s12520-018-0684-9; Dominguez-Rodrigo M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24071-1; Egeland CP, 2018, P NATL ACAD SCI USA, V115, P4601, DOI 10.1073/pnas.1718678115; Eren MI, 2016, J ARCHAEOL METHOD TH, V23, P379, DOI 10.1007/s10816-015-9245-z; Eren MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029273; Faivre JP, 2017, QUATERN INT, V433, P116, DOI 10.1016/j.quaint.2016.02.060; Gouedo J. M., 1990, MEMOIRE MUSEE PREHIS, V3, P305; Guette C, 2002, BULL SOC PREHIST FR, V99, P237, DOI [10.3406/BSPF.2002.12655, DOI 10.3406/BSPF.2002.12655]; Herisson D, 2016, QUATERN INT, V411, P233, DOI 10.1016/j.quaint.2016.02.049; Inizan ML, 1995, TECHNOLOGIE PIERRE T, V4; Jaubert J., 1993, B SOCI T PR HISTORIQ, V90, P328; Jaubert J, 1995, DEFINITION INTERPRET, P11; Karlin C, 1992, PROCESSUS TECHNIQUES, P101; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Lenoir M, 1995, RECURRENT CENTRIPETA, P249; Li YH, 2019, ANTHROPOLOGIE, V123, P769, DOI 10.1016/j.anthro.2019.102728; Lin SCH, 2010, J ARCHAEOL SCI, V37, P694, DOI 10.1016/j.jas.2009.10.030; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2016, LITHIC TECHNOL, V41, P19, DOI 10.1179/2051618515Y.0000000012; Lycett SJ, 2013, WORLD ARCHAEOL, V45, P519, DOI 10.1080/00438243.2013.821670; Marks AE., 1983, MOUSTERIAN LEGACY HU, P13; Martinez K, 2006, CYPSELA, V16, P111; Martinez K., 2003, BAR INT SERIES, V1120, P241; Matthews GJ, 2018, J APPL STAT, V45, P2773, DOI 10.1080/02664763.2018.1441381; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Ministere de L'education Nationale, 1986, ACT 111 C NAT SOC SA, P103; Moclan A, 2019, ARCHAEOL ANTHROP SCI, V11, P4663, DOI 10.1007/s12520-019-00815-6; Monson Tesla A., 2018, PALEOBIOS, V35, P1; Mourre V., 2003, DISCOID LITHIC TECHN, P1; Pasty J.-F., 2000, BULL SOC PREHIST FR, V97, P165; Peresani M., 2003, DISCOID LITHIC TECHN, P19; Peresani M., 2003, BAR INT SER, V1120; Perles C., 1991, 11 RENCONTRES INTERN, P35; Perpere M, 1983, B SOC PREHISTORIQUE, V83, P115; Picin A, 2016, J ARCHAEOL SCI-REP, V8, P70, DOI 10.1016/j.jasrep.2016.05.062; Picin A, 2014, QUATERN INT, V350, P84, DOI 10.1016/j.quaint.2014.05.004; Pigeot N., 1991, PALEO, P167, DOI [10.3406/PAL.1991.1046, DOI 10.3406/PAL.1991.1046]; Ranhorn KL, 2019, ARCHAEOL ANTHROP SCI, V11, P3225, DOI 10.1007/s12520-018-0746-z; Richter J, 2011, VERTEBR PALEOBIOL PA, P7, DOI 10.1007/978-94-007-0415-2_2; Rios-Garaizar J, 2017, QUATERN INT, V433, P50, DOI 10.1016/j.quaint.2016.02.020; Shott Michael J., 2003, LITHIC TECHNOL, V28, P95, DOI DOI 10.1080/01977261.2003.11721005; Slimak L., 2003, DISCOID LITHIC TECHN, P33; Slimak L., 2008, TREBALLS ARQUEOLOGIA, V14, P9; Thiebaut C, 2013, PALETHNOLOGY, P3; Turq A, 2000, PALEO; Van Peer P., 1992, LEVALLOIS REDUCTION, V13; Vaquero M, 2012, MAINAKE, V33, P233; Wainberg M, 2016, J MACH LEARN RES, V17	71	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244288	10.1371/journal.pone.0244288	http://dx.doi.org/10.1371/journal.pone.0244288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362257	gold, Green Published			2022-12-27	WOS:000603071600029
J	Shtienberg, G; Yasur-Landau, A; Norris, RD; Lazar, M; Rittenour, TM; Tamberino, A; Gadol, O; Cantu, K; Arkin-Shalev, E; Ward, SN; Levy, TE				Shtienberg, Gilad; Yasur-Landau, Assaf; Norris, Richard D.; Lazar, Michael; Rittenour, Tammy M.; Tamberino, Anthony; Gadol, Omri; Cantu, Katrina; Arkin-Shalev, Ehud; Ward, Steven N.; Levy, Thomas E.			A Neolithic mega-tsunami event in the eastern Mediterranean: Prehistoric settlement vulnerability along the Carmel coast, Israel	PLOS ONE			English	Article							SUBMARINE LANDSLIDES; LATE PLEISTOCENE; SEA-LEVEL; WAVES; LUMINESCENCE; MECHANISMS; TRIGGER	Tsunami events in antiquity had a profound influence on coastal societies. Six thousand years of historical records and geological data show that tsunamis are a common phenomenon affecting the eastern Mediterranean coastline. However, the possible impact of older tsunamis on prehistoric societies has not been investigated. Here we report, based on optically stimulated luminescence chronology, the earliest documented Holocene tsunami event, between 9.91 to 9.29 ka (kilo-annum), from the eastern Mediterranean at Dor, Israel. Tsunami debris from the early Neolithic is composed of marine sand embedded within fresh-brackish wetland deposits. Global and local sea-level curves for the period, 9.91-9.29 ka, as well as surface elevation reconstructions, show that the tsunami had a run-up of at least similar to 16 m and traveled between 3.5 to 1.5 km inland from the palaeo-coastline. Submerged slump scars on the continental slope, 16 km west of Dor, point to the nearby "Dor-complex" as a likely cause. The near absence of Pre-Pottery Neolithic A-B archaeological sites (11.70-9.80 cal. ka) suggest these sites were removed by the tsunami, whereas younger, late Pre-Pottery Neolithic B-C (9.25-8.35 cal. ka) and later Pottery-Neolithic sites (8.25-7.80 cal. ka) indicate resettlement following the event. The large run-up of this event highlights the disruptive impact of tsunamis on past societies along the Levantine coast.	[Shtienberg, Gilad; Levy, Thomas E.] Univ Calif San Diego, Dept Anthropol, Scripps Ctr Marine Archaeol, San Diego, CA 92103 USA; [Yasur-Landau, Assaf; Arkin-Shalev, Ehud] Univ Haifa, LH Charney Sch Marine Sci, Dept Maritime Civilizat, Haifa, Israel; [Yasur-Landau, Assaf; Arkin-Shalev, Ehud] Univ Haifa, Recanati Inst Maritime Studies RIMS, Haifa, Israel; [Norris, Richard D.; Cantu, Katrina] Univ Calif San Diego, Scripps Inst Oceanog, Scripps Ctr Marine Archaeol, San Diego, CA 92103 USA; [Lazar, Michael] Univ Haifa, LH Charney Sch Marine Sci, Dr Moses Strauss Dept Marine Geosci, Haifa, Israel; [Rittenour, Tammy M.] Utah State Univ, Dept Geosci, Logan, UT 84322 USA; [Tamberino, Anthony; Levy, Thomas E.] Univ Calif San Diego, Scripps Ctr Marine Archaeol, Levant & Cyber Archaeol Lab, San Diego, CA 92103 USA; [Gadol, Omri] Univ Haifa, Hatter Dept Marine Technol, Haifa, Israel; [Ward, Steven N.] Univ Calif Santa Cruz, Inst Geophys & Planetary Phys, Santa Cruz, CA 95064 USA	University of California System; University of California San Diego; University of Haifa; University of Haifa; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Haifa; Utah System of Higher Education; Utah State University; University of California System; University of California San Diego; University of Haifa; University of California System; University of California Santa Cruz	Shtienberg, G (corresponding author), Univ Calif San Diego, Dept Anthropol, Scripps Ctr Marine Archaeol, San Diego, CA 92103 USA.	Gshtienberg@ucsd.edu	Lazar, Michael/G-5038-2015	Lazar, Michael/0000-0003-0892-5166; Arkin Shalev, Ehud/0000-0003-1592-3679; Rittenour, Tammy/0000-0003-1925-0395; Shtienberg, Gilad/0000-0003-0303-7872	Scripps Center for Marine Archaeology, Scripps Institution of Oceanography, UC San Diego; Koret Foundation [19-0295]; Murray Galinson San Diego - Israel Initiative; Marian Scheuer-Sofaer and Abraham Sofaer Foundation; Norma and Reuben Kershaw Family Foundation; Alan G Lehman and Jane A Lehman Foundation; Israel Science Foundation [495/18]; Israel Institute (Washington, D.C.)	Scripps Center for Marine Archaeology, Scripps Institution of Oceanography, UC San Diego; Koret Foundation; Murray Galinson San Diego - Israel Initiative; Marian Scheuer-Sofaer and Abraham Sofaer Foundation; Norma and Reuben Kershaw Family Foundation; Alan G Lehman and Jane A Lehman Foundation; Israel Science Foundation(Israel Science Foundation); Israel Institute (Washington, D.C.)	The Authors gratefully acknowledge the generous support provided by Scripps Center for Marine Archaeology, Scripps Institution of Oceanography, UC San Diego; The Koret Foundation (Grant ID 19-0295); Murray Galinson San Diego - Israel Initiative; the Israel Institute (Washington, D.C.); Marian Scheuer-Sofaer and Abraham Sofaer Foundation; Norma and Reuben Kershaw Family Foundation; Ellen Lehman and Charles Kennel - Alan G Lehman and Jane A Lehman Foundation; Paul and Margaret Meyer and the Israel Science Foundation (Grant ID 495/18).	Abadie SM, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007646; [Anonymous], 2019, WE T MAGAZINE, V31, P1, DOI DOI 10.1007/s42241-019-0020-6; Beisel S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005262; Bocquet-Appel JP, 2008, NEOLITHIC DEMOGRAPHIC TRANSITION AND ITS CONSEQUENCES, P1, DOI 10.1007/978-1-4020-8539-0_1; Braun Y., 2010, ISR J EARTH SCI, V58, P257, DOI DOI 10.1560/IJES.58.3-4.257; Catuneanu O, 2002, J AFR EARTH SCI, V35, P1, DOI 10.1016/S0899-5362(02)00004-0; Edwards L, 2016, 2016 IEEE SYMPOSIUM ON SECURITY AND PRIVACY WORKSHOPS (SPW 2016), P53, DOI 10.1109/SPW.2016.19; Gadol O, 2020, BASIN RES, V32, P1166, DOI 10.1111/bre.12420; Galbraith RF, 2012, QUAT GEOCHRONOL, V11, P1, DOI 10.1016/j.quageo.2012.04.020; Galili E., 2017, MAT CULTURE DEV SEPA, P105; Galili E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222560; GARFUNKEL Z, 1984, MAR GEOL, V55, P305, DOI 10.1016/0025-3227(84)90074-4; GARFUNKEL Z, 1981, TECTONOPHYSICS, V80, P81, DOI 10.1016/0040-1951(81)90143-8; Garziglia S, 2007, ADV NAT TECH HAZ RES, V27, P347, DOI 10.1007/978-1-4020-6512-5_36; Goodman-Tchernov BN, 2009, GEOLOGY, V37, P943, DOI 10.1130/G25704A.1; Goring-Morris A., 1984, EXCAVATIONS TEL MEVO, V18, P81; Grosman L, 2008, P NATL ACAD SCI USA, V105, P17665, DOI 10.1073/pnas.0806030105; Guerin G., 2011, ANCIENT TL, V29, P5; Gvirtzman Z, 2015, MAR GEOL, V360, P25, DOI 10.1016/j.margeo.2014.12.001; Hofstetter A, 1996, TECTONOPHYSICS, V267, P317, DOI 10.1016/S0040-1951(96)00108-4; Hubscher C, 2016, MAR PETROL GEOL, V77, P526, DOI 10.1016/j.marpetgeo.2016.07.008; Kadosh Dafna, 2004, Palynology, V28, P143, DOI 10.2113/28.1.143; Kaldaron-Asael B, 2008, MODELING RELATION AR; Katz O, 2015, MAR GEOL, V369, P100, DOI 10.1016/j.margeo.2015.08.006; Koji M., 2001, J NAT DISASTER SCI, V23, P83; Lee HJ, 2009, MAR GEOL, V264, P53, DOI 10.1016/j.margeo.2008.09.009; Marder O, 2007, PALEORIENT, V32, P79; Marriner N, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700485; Mauz B, 2013, EARTH-SCI REV, V121, P31, DOI 10.1016/j.earscirev.2013.03.003; Morton RA, 2007, SEDIMENT GEOL, V200, P184, DOI 10.1016/j.sedgeo.2007.01.003; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Nadel D., 2012, JOURNAL OF THE ISRAE, V42, P75; Obrocki L, 2020, SEDIMENTOLOGY, V67, P1274, DOI 10.1111/sed.12555; Papadopoulos GA, 2014, MAR GEOL, V354, P81, DOI 10.1016/j.margeo.2014.04.014; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Reinhardt EG, 2006, GEOLOGY, V34, P1061, DOI 10.1130/G22780A.1; Rohling EJ, 2014, NATURE, V508, P477, DOI 10.1038/nature13230; Salamon A, 2007, B SEISMOL SOC AM, V97, P705, DOI 10.1785/0120060147; Salamon A, 2019, EARTH-SCI REV, V191, P66, DOI 10.1016/j.earscirev.2019.02.001; Schattner U, 2010, MAR GEOL, V278, P165, DOI 10.1016/j.margeo.2010.10.006; Sivan D, 2004, J COASTAL RES, V20, P1035, DOI 10.2112/03503A.1; Sivan D, 2015, QUATERN INT, DOI [10.1016/j.quaint.2014.10.013, DOI 10.1016/J.QUAINT.2014.10.013]; Tyuleneva N, 2017, MAR GEOL, DOI [10.1016/j.margeo.2017.09.007, DOI 10.1016/J.MARGEO.2017.09.007]; Urgeles R, 2013, J GEOPHYS RES-EARTH, V118, P2600, DOI 10.1002/2013JF002720; Vott A, 2019, Z GEOMORPHOL, V62, P7, DOI 10.1127/zfg_suppl/2018/0547; Waddington C, 2017, J ARCHAEOL SCI-REP, V14, P692, DOI 10.1016/j.jasrep.2017.04.015; Wang JJ, 2019, ENG GEOL, V256, P121, DOI 10.1016/j.enggeo.2019.04.020; 2011, FORUM GEOM, V11, P9; 2014, NEUROLOGIA MEDICOCHI, V54, P1	49	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243619	10.1371/journal.pone.0243619	http://dx.doi.org/10.1371/journal.pone.0243619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362214	Green Published, gold			2022-12-27	WOS:000603071600022
J	Anger, M; Scheufele, F; Ramanujam, D; Meyer, K; Nakajima, H; Field, LJ; Engelhardt, S; Sarikas, A				Anger, Melanie; Scheufele, Florian; Ramanujam, Deepak; Meyer, Kathleen; Nakajima, Hidehiro; Field, Loren J.; Engelhardt, Stefan; Sarikas, Antonio			Genetic ablation of Cullin-RING E3 ubiquitin ligase 7 restrains pressure overload-induced myocardial fibrosis	PLOS ONE			English	Article							PRESERVES CARDIAC-FUNCTION; RECEPTOR SUBSTRATE 1; HEART-FAILURE; PROTEASOME SYSTEM; TGF-BETA; AKT; EXPRESSION; PROTEIN; CARDIOMYOCYTES; ACTIVATION	Fibrosis is a pathognomonic feature of structural heart disease and counteracted by distinct cardioprotective mechanisms, e.g. activation of the phosphoinositide 3-kinase (PI3K) / AKT pro-survival pathway. The Cullin-RING E3 ubiquitin ligase 7 (CRL7) was identified as negative regulator of PI3K/AKT signalling in skeletal muscle, but its role in the heart remains to be elucidated. Here, we sought to determine whether CRL7 modulates to cardiac fibrosis following pressure overload and dissect its underlying mechanisms. For inactivation of CRL7, the Cullin 7 (Cul7) gene was deleted in cardiac myocytes (CM) by injection of adeno-associated virus subtype 9 (AAV9) vectors encoding codon improved Cre-recombinase (AAV9-CMV-iCre) in Cul7(flox/flox) mice. In addition, Myosin Heavy Chain 6 (Myh6; alpha-MHC)-MerCreMer transgenic mice with tamoxifen-induced CM-specific expression of iCre were used as alternate model. After transverse aortic constriction (TAC), causing chronic pressure overload and fibrosis, AAV9-CMV-iCre induced Cul7-/- mice displayed a similar to 50% reduction of interstitial cardiac fibrosis when compared to Cul7+/+ animals (6.7% vs. 3.4%, p<0.01). Similar results were obtained with Cul7(flox/flox) Myh6-Mer-Cre-Mer(Tg(1/0)) mice which displayed a similar to 30% reduction of cardiac fibrosis after TAC when compared to Cul7(+/+) Myh6-Mer-Cre-Mer(Tg(1/0)) controls after TAC surgery (12.4% vs. 8.7%, p<0.05). No hemodynamic alterations were observed. AKT(Ser473) phosphorylation was increased 3-fold (p<0.01) in Cul7-/- vs. control mice, together with a similar to 78% (p<0.001) reduction of TUNEL-positive apoptotic cells three weeks after TAC. In addition, CM-specific expression of a dominant-negative CUL7(1152stop) mutant resulted in a 16.3-fold decrease (p<0.001) of in situ end-labelling (ISEL) positive apoptotic cells. Collectively, our data demonstrate that CM-specific ablation of Cul7 restrains myocardial fibrosis and apoptosis upon pressure overload, and introduce CRL7 as a potential target for anti-fibrotic therapeutic strategies of the heart.	[Anger, Melanie; Scheufele, Florian; Ramanujam, Deepak; Meyer, Kathleen; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, Munich, Germany; [Anger, Melanie; Scheufele, Florian; Ramanujam, Deepak; Meyer, Kathleen; Engelhardt, Stefan] Partner Site Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany; [Nakajima, Hidehiro; Field, Loren J.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Nakajima, Hidehiro; Field, Loren J.] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Sarikas, Antonio] Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria	Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Paracelsus Private Medical University	Sarikas, A (corresponding author), Paracelsus Med Univ, Inst Pharmacol & Toxicol, Salzburg, Austria.	antonio.sarikas@pmu.ac.at		Ramanujam, Deepak Prabhu/0000-0003-4854-6355; Meyer, Kathleen/0000-0002-5128-3616	Marie Curie International Reintegration Grant [256584]	Marie Curie International Reintegration Grant(European Commission)	AS: Marie Curie International Reintegration Grant https://ec.europa.eu (#256584) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan R, 2005, MOL CELL BIOCHEM, V268, P103, DOI 10.1007/s11010-005-3699-3; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Bae SC, 2005, J PHARMACOL EXP THER, V315, P1125, DOI 10.1124/jpet.105.090803; Ceci M, 2007, CELL DEATH DIFFER, V14, P1060, DOI 10.1038/sj.cdd.4402095; Chen RH, 1998, ONCOGENE, V17, P1959, DOI 10.1038/sj.onc.1202111; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; DAUD AI, 1993, AM J PHYSIOL, V264, pH1693, DOI 10.1152/ajpheart.1993.264.5.H1693; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Hartmann T, 2014, P NATL ACAD SCI USA, V111, P3371, DOI 10.1073/pnas.1401556111; Hassink RJ, 2009, HEART, V95, P1159, DOI 10.1136/hrt.2008.150128; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hong F, 2000, BIOCHEM BIOPH RES CO, V279, P974, DOI 10.1006/bbrc.2000.4044; Hulot JS, 2011, CIRCULATION, V124, P796, DOI 10.1161/CIRCULATIONAHA.111.031229; Inagaki K, 2006, MOL THER, V14, P45, DOI 10.1016/j.ymthe.2006.03.014; KIM KK, 1994, J BIOL CHEM, V269, P22607; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Matsui T, 2001, CIRCULATION, V104, P330; Matsui T, 1999, CIRCULATION, V100, P2373, DOI 10.1161/01.CIR.100.23.2373; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Meyer K, 2016, J AM COLL CARDIOL, V67, P2018, DOI 10.1016/j.jacc.2016.02.047; Nakajima H, 2004, CIRC RES, V94, P1606, DOI 10.1161/01.RES.0000132279.99249.f4; Paradis V, 2013, GUT, V62, P911, DOI 10.1136/gutjnl-2012-302091; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Pasumarthi KBS, 2001, CIRC RES, V88, P1004, DOI 10.1161/hh1001.090878; Piek A, 2016, HEART FAIL REV, V21, P199, DOI 10.1007/s10741-016-9536-9; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sarikas A, 2008, CELL CYCLE, V7, P3154, DOI 10.4161/cc.7.20.6922; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Scheufele F, 2014, CELL SIGNAL, V26, P233, DOI 10.1016/j.cellsig.2013.11.005; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Suckau L, 2009, CIRCULATION, V119, P1241, DOI 10.1161/CIRCULATIONAHA.108.783852; Sussman MA, 2011, PHYSIOL REV, V91, P1023, DOI 10.1152/physrev.00024.2010; Tanaka S, 1996, CANCER RES, V56, P3391; Taniyama Y, 2002, J MOL CELL CARDIOL, V34, P1241, DOI 10.1006/jmcc.2002.2068; Tsai SC, 2000, J BIOL CHEM, V275, P3239, DOI 10.1074/jbc.275.5.3239; Wu K, 2016, P NATL ACAD SCI USA, V113, pE2011, DOI 10.1073/pnas.1601089113; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Xu XS, 2012, J BIOL CHEM, V287, P40758, DOI 10.1074/jbc.M112.405209; Yang F, 2004, HYPERTENSION, V43, P229, DOI 10.1161/01.HYP.0000107777.91185.89; Zentilin L, 2001, J VIROL, V75, P12279, DOI 10.1128/JVI.75.24.12279-12287.2001; Zolk O, 2006, CARDIOVASC RES, V70, P410, DOI 10.1016/j.cardiores.2005.12.021	45	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244096	10.1371/journal.pone.0244096	http://dx.doi.org/10.1371/journal.pone.0244096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351822	Green Published, gold			2022-12-27	WOS:000603071400036
J	de Wolff, T; Pfluger, D; Rehme, M; Heuer, J; Bittner, MI				de Wolff, Timo; Pfluger, Dirk; Rehme, Michael; Heuer, Janin; Bittner, Martin-Immanuel			Evaluation of pool-based testing approaches to enable population-wide screening for COVID-19	PLOS ONE			English	Article							DEFECTIVE MEMBERS	Objective Rapid testing is paramount during a pandemic to prevent continued viral spread and excess morbidity and mortality. This study investigates whether testing strategies based on sample pooling can increase the speed and throughput of screening for SARS-CoV-2, especially in resource-limited settings. Methods In a mathematical modelling approach conducted in May 2020, six different testing strategies were simulated based on key input parameters such as infection rate, test characteristics, population size, and testing capacity. The situations in five countries were simulated, reflecting a broad variety of population sizes and testing capacities. The primary study outcome measurements were time and number of tests required, number of cases identified, and number of false positives. Findings The performance of all tested methods depends on the input parameters, i.e. the specific circumstances of a screening campaign. To screen one tenth of each country's population at an infection rate of 1%, realistic optimised testing strategies enable such a campaign to be completed in ca. 29 days in the US, 71 in the UK, 25 in Singapore, 17 in Italy, and 10 in Germany. This is ca. eight times faster compared to individual testing. When infection rates are lower, or when employing an optimal, yet more complex pooling method, the gains are more pronounced. Pool-based approaches also reduce the number of false positive diagnoses by a factor of up to 100. Conclusions The results of this study provide a rationale for adoption of pool-based testing strategies to increase speed and throughput of testing for SARS-CoV-2, hence saving time and resources compared with individual testing.	[de Wolff, Timo; Pfluger, Dirk; Bittner, Martin-Immanuel] German Natl Acad Sci, Young Acad, Junge Akad, Berlin, Germany; [de Wolff, Timo; Rehme, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Anal & Algebra, Braunschweig, Germany; [Pfluger, Dirk; Heuer, Janin] Univ Stuttgart, Inst Parallel & Distributed Syst, Stuttgart, Germany; [Bittner, Martin-Immanuel] Arctoris, Oxford, England	Braunschweig University of Technology; University of Stuttgart	Bittner, MI (corresponding author), German Natl Acad Sci, Young Acad, Junge Akad, Berlin, Germany.; Bittner, MI (corresponding author), Arctoris, Oxford, England.	martin-immanuel.bittner@arctoris.com		Pfluger, Dirk/0000-0002-4360-0212; Heuer, Janin/0000-0003-2386-8294	Young Academy of the German National Academy of Sciences; German Research Foundation (DFG) [WO 2206/1-1]; Cluster of Excellence Data Integrated Simulation Science under Germany's Excellence Strategy [EXC 2075, 390740016]	Young Academy of the German National Academy of Sciences; German Research Foundation (DFG)(German Research Foundation (DFG)); Cluster of Excellence Data Integrated Simulation Science under Germany's Excellence Strategy	TdW, DP and MIB are supported by the Young Academy of the German National Academy of Sciences. TdW is funded by the German Research Foundation (DFG) grant WO 2206/1-1 under the Emmy Noether Programme. DP is funded by the Cluster of Excellence Data Integrated Simulation Science under Germany's Excellence Strategy (EXC 2075 -DFG grant 390740016). MIB receives a salary from Arctoris Ltd. The funders provided support in the form of salaries for TdW, DP and MIB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	[Anonymous], 2019, CIRCULATION, V2019; Burki TK, 2020, LANCET RESP MED, V8, pE63, DOI 10.1016/S2213-2600(20)30247-2; Busenberg GJ, 2020, POLICY LESSONS HIST; Cheng Y, NEW STRONGLY COMPETI; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Fargion BI, 2020, 200311975 ARXIV; Hanel R, 2020, 200309944 ARXIV; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; Kelly-Cirino CD, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001179; LabCorp, 2020, ACC EM US AUTH EUA S; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1063, DOI 10.1515/cclm-2020-0240; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Narayanan KR, 2020, POOLING RT PCR NGS S, DOI [10.1101/2020.04.03.20051995, DOI 10.1101/2020.04.03.20051995]; Noriega R., 2020, INCREASING TESTING T, DOI [10.1101/2020.04.03.024216v1.full.pdf, DOI 10.1101/2020.04.03.024216V1.FULL.PDF]; Peto J, 2020, LANCET, V395, P1420, DOI 10.1016/S0140-6736(20)30936-3; Peto J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1163; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Prakash S, 2020, ADVISORY FEASIBILITY; Pulia MS, 2020, ANN MED, V52, P207, DOI 10.1080/07853890.2020.1763449; Rubin Eric J, 2020, N Engl J Med, V382, pe67, DOI 10.1056/NEJMe2014793; Shah P, 2020, TESTING IS OUR WAY O; Shani-Narkiss H., 2020, EFFICIENT PRACTICAL, DOI [10.1101/2020.04.06.20052159., DOI 10.1101/2020.04.06.20052159]; Silvis L, 2020, DUKE MARGOLIS CTR HL; Simpson S, 2020, LANCET INFECT DIS, V20, pE108, DOI 10.1016/S1473-3099(20)30123-7; Sinnott-Armstrong N, 2020, EVALUATION GROUP TES, DOI [DOI 10.1101/2020.03.27.20043968, 10.1101/2020.03.27.20043968]; SOBEL M, 1959, AT&T TECH J, V38, P1179, DOI 10.1002/j.1538-7305.1959.tb03914.x; STERRETT A, 1957, ANN MATH STAT, V28, P1033, DOI 10.1214/aoms/1177706807; Taufer M, 2020, J THEOR BIOL, V506, DOI 10.1016/j.jtbi.2020.110450; Yang Y, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100061; Yelin I, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa53132358960, DOI 10.1093/CID/CIAA53132358960]	31	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243692	10.1371/journal.pone.0243692	http://dx.doi.org/10.1371/journal.pone.0243692			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347458	Green Submitted, gold, Green Published			2022-12-27	WOS:000603071100050
J	Guo, J; Chen, M; Sun, XL; Wang, ZZ; Xue, JL				Guo, Jin; Chen, Meng; Sun, Xialing; Wang, Zhanzhao; Xue, Jinli			Leveraging industrial-technological innovation to achieve sustainable development: A systems thinking perspective	PLOS ONE			English	Article							MODERATING ROLE; EFFICIENCY; CHINA; INTERMEDIARIES; MANAGEMENT; POLICY	Industrial-technological innovation (ITI) has become an important requirement for the sustainable development of China. ITI development requires a comprehensive understanding of the dynamic complexity associated with ITI systems. Previous research into ITI systems is based primarily on static methods that isolate system components, and ignore feedback on adjustments made. Based on systems thinking, this paper develop six archetypes ("Limit to Growth," "Success to the Successful," "Tragedy of the Commons," "Fixes that Fail," "Accidental Adversaries," and "Shifting the Burden") and an ITI system integration model. The model visualizes the ITI system as a whole and identifies bottlenecks that may affect ITI development. This conceptual model provides a more effective method of judgment, which can better explain the operational mechanism of the ITI system and improve the system's operational characteristics. Finally, we evaluate the ITI system and propose that self-organization is a key lever of a systemic intervention framework for ITI.	[Guo, Jin] Henan Polytech Univ, Sch Surveying & Land Informat Engn, Jiaozuo, Henan, Peoples R China; [Chen, Meng] Shandong Geol Environm Monitoring Stn, Jinan, Peoples R China; [Sun, Xialing] China Univ Min & Technol, Sch Management, Beijing, Peoples R China; [Wang, Zhanzhao; Xue, Jinli] Henan Polytech Univ, Res Ctr Energy Econ, Sch Business Adm, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University; China University of Mining & Technology; Henan Polytechnic University	Xue, JL (corresponding author), Henan Polytech Univ, Res Ctr Energy Econ, Sch Business Adm, Jiaozuo, Henan, Peoples R China.	xuejinli@hpu.edu.cn	xialing, sun/GQA-9136-2022	Sun, Xialing/0000-0002-1617-5513	Key Scientific Research Projects of Henan Higher Education Institutions [17A630022]; National Natural Science Foundation of China [41801176]; Ministry of Education Humanities and Social Sciences Research Project [19YJC630178]; General Project of Humanities and Social Sciences of Henan Education Department [2019-ZZJH-043]; Philosophy and Social Science Planning Project of Henan Province [2018BKS011, 2018CJJ080]; German Research Foundation (DFG); Leipzig University	Key Scientific Research Projects of Henan Higher Education Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Humanities and Social Sciences Research Project; General Project of Humanities and Social Sciences of Henan Education Department; Philosophy and Social Science Planning Project of Henan Province; German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	This research was funded by Key Scientific Research Projects of Henan Higher Education Institutions (17A630022); National Natural Science Foundation of China (41801176); Ministry of Education Humanities and Social Sciences Research Project (19YJC630178); General Project of Humanities and Social Sciences of Henan Education Department (2019-ZZJH-043); The Philosophy and Social Science Planning Project of Henan Province (2018BKS011; 2018CJJ080). We acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Hepatol Int, V11, P1, DOI 10.1007/s12072-016-9783-9; [Anonymous], 2002, SCI UNCERTAINTY COMP; [Anonymous], 2016, OCEAN NEWS TECHNOLOG, V27, P52; [Anonymous], 2019, CAP TODAY, V33, P52; [Anonymous], 2020, CLIN DIABETOLOGY, V9, P1; Arranz N, 2020, BUS STRATEG ENVIRON, V29, P1494, DOI 10.1002/bse.2448; Banson KE, 2018, SYSTEMS, V6, DOI 10.3390/systems6040035; BAPTISTS R., 1996, BUSINESS STRATEGY RE, V7, P59, DOI [DOI 10.1111/J.1467-8616.1996.TB00124.X, 10.1111/j.1467-8616.1996.tb00124.x]; Barasa L, 2019, EUR J INNOV MANAG, V22, P59, DOI 10.1108/EJIM-11-2017-0176; Barrie J, 2019, J CLEAN PROD, V214, P209, DOI 10.1016/j.jclepro.2018.12.287; Bergman E. M, 2020, IND REGIONAL CLUSTER; Betz F., 2003, MANAGING TECHNOLOGIC, V2nd ed.; Bloom N, 2019, J ECON PERSPECT, V33, P163, DOI 10.1257/jep.33.3.163; Chalvatzis KJ, 2019, TECHNOL FORECAST SOC, V144, P381, DOI 10.1016/j.techfore.2018.04.031; Cheah SLY, 2020, TECHNOL FORECAST SOC, V151, DOI 10.1016/j.techfore.2019.119845; Chen J, 2020, RESOUR POLICY, V66, DOI 10.1016/j.resourpol.2020.101643; Chen K, 2012, INT J ARTS SCI, V5, P491; Chen YF, 2020, J CLEAN PROD, V261, DOI 10.1016/j.jclepro.2020.121186; Chertow M, 2012, J IND ECOL, V16, P13, DOI 10.1111/j.1530-9290.2011.00450.x; Chu HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152015; Coccia M, 2020, J ENG TECHNOL MANAGE, V55, DOI 10.1016/j.jengtecman.2019.11.003; De Dreu CKW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190122; Du MZ, 2018, ENERG POLICY, V120, P335, DOI 10.1016/j.enpol.2018.05.058; Edquist C JB, 1996, 1 ORG SYST INNOVATIO; Edsand HE, 2019, TECHNOL SOC, V58, DOI 10.1016/j.techsoc.2019.101150; Eugster S., 2013, ANN SOLID STRUCT MEC, V5, P1, DOI DOI 10.1007/S12356-013-0032-9; Farrand L, 2020, USING SYSTEM ARCHETY, P3; Godin B, 2016, TECHNOL CULT, V57, P527, DOI 10.1353/tech.2016.0070; Grillitsch M, 2019, RES POLICY, V48, P1048, DOI 10.1016/j.respol.2018.10.004; GUO J, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/SU11184841; Hallett LM, 2020, RESTOR ECOL, V28, P1017, DOI 10.1111/rec.13220; Haraldsson H.V, 2004, INTRO SYSTEM THINKIN; Heisenberg, 1974, UNCERTAINTY PRINCIPL; Henderson D, 2020, REG STUD, V54, P429, DOI 10.1080/00343404.2019.1634251; Hossain NUI, 2020, SYSTEMS-BASEL, V8, DOI 10.3390/systems8030023; Hullova D, 2019, RES POLICY, V48, P339, DOI 10.1016/j.respol.2018.09.001; Israeli Milana., 2020, ECOSOEN, V3, P155; Jaaron AAM, 2018, SERV IND J, V38, P561, DOI 10.1080/02642069.2017.1411480; Kanda W, 2019, J CLEAN PROD, V227, P1136, DOI 10.1016/j.jclepro.2019.04.230; Kekezi O, 2020, IND INNOV, V27, P538, DOI 10.1080/13662716.2019.1573660; Kumar S, 2019, EC MODELLING; Kurakin A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000953; Ladyman J, 2013, EUR J PHILOS SCI, V3, P33, DOI 10.1007/s13194-012-0056-8; Land KC., 1969, SOCIOL METHODOL, V1, P3, DOI [DOI 10.2307/270879, 10.2307/270879]; Li W, 2019, J CLEAN PROD, V222, P344, DOI 10.1016/j.jclepro.2019.03.027; Liping W., 2019, CHIN J MANAG, V5, P704; Liu HW, 2019, TECHNOL FORECAST SOC, V144, P475, DOI 10.1016/j.techfore.2018.02.005; Liu K, 2019, J CLEAN PROD, V206, P356, DOI 10.1016/j.jclepro.2018.09.194; Lorenz E., 2000, Chaos avant-garde memories of the early days of chaos theory, P91; Lorenz EU, 1972, AM ASS ADVANCEMENT S, V20, P260; Lyu YB, 2017, SCIENTOMETRICS, V111, P889, DOI 10.1007/s11192-017-2320-3; Malamud S, 2019, J FINANC ECON, V132, P519, DOI 10.1016/j.jfineco.2018.11.002; MANSFIELD E, 1995, REV ECON STAT, V77, P55, DOI 10.2307/2109992; Markard J, 2020, TECHNOL FORECAST SOC, V153, DOI 10.1016/j.techfore.2018.07.045; Mella P, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10010021; Oberlack C, 2019, ECOL SOC, V24, DOI 10.5751/ES-10747-240226; Odilova D, 2020, IMPROVEMENT EC MECH; Oliveira BG, 2020, SYST RES BEHAV SCI, V37, P593, DOI 10.1002/sres.2703; Omri A, 2020, ENVIRON RES, V185, DOI 10.1016/j.envres.2020.109469; Petrakis P.E., 2020, EC GROWTH DEV POLICY, P235; Philipson S, 2020, J INNOV KNOWL, V5, P50, DOI 10.1016/j.jik.2019.01.002; Rangarajan G, 2000, PHYS REV E, V61, P4991, DOI 10.1103/PhysRevE.61.4991; Rebs T, 2019, J CLEAN PROD, V208, P1265, DOI 10.1016/j.jclepro.2018.10.100; Rugh W. J, 1981, NONLINEAR SYSTEM THE; Saenz-Royo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126076; Saleem H, 2019, J EC STRUCTURES, V8; Sardjono W., 2020, Journal of Physics: Conference Series, V1465, DOI 10.1088/1742-6596/1465/1/012023; Schubert T, 2020, ACAD MANAGE J, V63, P272, DOI 10.5465/amj.2017.0741; Scott S, 2019, ENTREP REGION DEV, V31, P22, DOI 10.1080/08985626.2018.1537145; Scuotto V, 2020, TECHNOL FORECAST SOC, V152, DOI 10.1016/j.techfore.2019.119906; Senbeto DL, 2020, SERV IND J, V40, P1119, DOI 10.1080/02642069.2020.1734573; Serebryakova NA, 2020, INNOVATIVE ACTIVITY, P580; Shujahat M, 2019, J BUS RES, V94, P442, DOI 10.1016/j.jbusres.2017.11.001; Speldekamp D, 2020, RES POLICY, V49, DOI 10.1016/j.respol.2020.103921; Steiber A, 2020, EUROPEAN J INNOVATIO; Surrs RAA, 2009, TECHNOL FORECAST SOC, V76, P1003, DOI 10.1016/j.techfore.2009.03.002; Mai T, 2019, LAND USE POLICY, V82, P595, DOI 10.1016/j.landusepol.2019.01.004; Thongsri N, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11102793; Turkina E, 2019, REG STUD, V53, P1193, DOI 10.1080/00343404.2019.1566697; Wang PJ, 2019, TECHNOL FORECAST SOC, V146, P304, DOI 10.1016/j.techfore.2019.05.029; WARDIANA E, 2020, JURNAL PENELITIAN TA, V20, P77; Wu WB, 2005, P NATL ACAD SCI USA, V102, P14150, DOI 10.1073/pnas.0506715102; Yan ZX, 2010, SYST RES BEHAV SCI, V27, P140, DOI 10.1002/sres.1021; Yao JG, 2020, J KNOWL MANAG, V24, P607, DOI 10.1108/JKM-08-2019-0445; Yu FF, 2019, B ECON RES, V71, P18, DOI 10.1111/boer.12146; Yuan BL, 2020, J CLEAN PROD, V243, DOI 10.1016/j.jclepro.2019.118543; Zheng SQ, 2020, CITIES, V97, DOI 10.1016/j.cities.2019.102529	87	4	5	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0242981	10.1371/journal.pone.0242981	http://dx.doi.org/10.1371/journal.pone.0242981			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347480	gold, Green Published			2022-12-27	WOS:000603071100018
J	Liang, S; Liu, ZY; Wang, SL; Liu, J; Shi, L; Mao, W; Liu, CX; Wan, JH; Zhu, LL; Huang, M; Liu, Y; Wang, JX; Ness, P; Shan, H; Zeng, PB; He, M				Liang, Shan; Liu, Zhiyang; Wang, Shaoli; Liu, Jing; Shi, Ling; Mao, Wei; Liu, Cunxu; Wan, Jianhua; Zhu, Lili; Huang, Mei; Liu, Yu; Wang, Jingxing; Ness, Paul; Shan, Hua; Zeng, Peibin; He, Miao			The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017	PLOS ONE			English	Article							HIV PREVALENCE; SEX; MEN; RISK; SURVEILLANCE; CHALLENGES; DIVERSITY; GUANGXI	Human immunodeficiency virus-1 (HIV-1) exhibits high diversity and complexity in China, challenging the disease surveillance and antiretroviral therapy. Between July 1, 2014 and January 30, 2017, we investigated the profiles of HIV-1 infection stages, genotype distribution and drug resistance mutations (DRMs) using plasma samples from HIV Western blot (WB) confirmed blood donors from five Chinese blood centers (Chongqing, Guangxi, Luoyang, Mianyang, and Urumqi). HIV pol regions consisted of whole protease and partial reverse transcriptase were genotyped and analyzed for DRMs. Lag-Avidity testing was performed to identify the infection stages. Of the 356 HIV-1 WB positive samples tested by Lag-avidity assay, 19.1% (68/356) were recent infections. Genotyping on 356 amplified sequences presented the subtype distributions as following: CRF07_BC (65.7%), CRF08_BC (7.3%), CRF01_AE (19.1%), B (4.2%), CRF55_01B (3.1%), CRF59_01B (0.3%) and CRF68_01B (0.3%). No significant difference in genotype distribution was observed between recent and long-term infections. 48 DRMs were identified from 43 samples, indicating a drug resistance prevalence of 12.1% (43/356), which include seven protease inhibitors (PIs) accessory DRMs (Q58E, L23I and I84M), two PIs major DRMs (M46I, M46L), seven nucleoside RT inhibitors DRMs (D67N, K70Q, K219R and M184L), and 32 non-nucleoside RT inhibitors DRMs (K103N, V179E, K238N, V179D, E138G, G190E, A98G, Y188D and E138A). In addition, we had also identified CRFs from the 01B subtype including CRF55_01B (3.1%), CRF59_01B (0.3%) and CRF68_01B (0.3%). As an important part of the continuous monitoring of HIV-1 circulating strains among blood donors, our findings were expected to contribute to the comprehensive AIDS control and development of proper diagnostics for HIV-1 in China.	[Liang, Shan; Liu, Zhiyang; Wang, Shaoli; Liu, Yu; Wang, Jingxing; He, Miao] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China; [Liang, Shan; Liu, Zhiyang; Wang, Shaoli; Liu, Yu; Wang, Jingxing; He, Miao] Sichuan Blood Safety & Blood Substitute Int Sci &, Chengdu, Peoples R China; [Liu, Jing; Ness, Paul] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Shi, Ling] Univ Massachusetts, Boston, MA 02125 USA; [Mao, Wei] Chongqing Blood Ctr, Chongqing, Peoples R China; [Liu, Cunxu] Guangxi Blood Ctr, Liuzhou, Guangxi, Peoples R China; [Wan, Jianhua] Urumqi Blood Ctr, Urumqi, Xinjiang, Peoples R China; [Zhu, Lili] Luoyang Blood Ctr, Luoyang, Henan, Peoples R China; [Huang, Mei] Mianyang Blood Ctr, Mianyang, Sichuan, Peoples R China; [Shan, Hua] Stanford Univ, Stanford, CA 94305 USA; [Zeng, Peibin] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Zeng, Peibin] Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; Johns Hopkins University; Johns Hopkins Medicine; University of Massachusetts System; University of Massachusetts Boston; Stanford University; Sichuan University; Sichuan University	He, M (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu, Peoples R China.; He, M (corresponding author), Sichuan Blood Safety & Blood Substitute Int Sci &, Chengdu, Peoples R China.; Zeng, PB (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.; Zeng, PB (corresponding author), Sichuan Univ, West China Hosp 4, Chengdu, Sichuan, Peoples R China.	zengpeibin@live.cn; hemiao@ibt.pumc.edu.cn	He, Miao/AAB-6972-2020; miao, he/GQP-0932-2022		Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) International Component (China) [HHSN268201100008I]; CAMS Innovation Fund for Medical Sciences (CIFMS) [CAMS-2016-I2M-3-025]; Basic research plan of Guizhou science and Technology Department [Qian ke he ji chu [2018]1095]	Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) International Component (China); CAMS Innovation Fund for Medical Sciences (CIFMS); Basic research plan of Guizhou science and Technology Department	The study was supported by the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) International Component (China) (HHSN268201100008I) and the CAMS Innovation Fund for Medical Sciences (CIFMS) (CAMS-2016-I2M-3-025) to all authors, and the Basic research plan of Guizhou science and Technology Department to PZ (Qian ke he ji chu [2018]1095).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2013, J CARDIOLOGY CASES, V8, pe13; [Anonymous], 2013, LANCET GLOB HLTH; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2015, CHINA AIDS RESPONSE; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2014, J DENT RES S, V93, p120S; Bes M, 2017, TRANSFUSION, V57, P2164, DOI 10.1111/trf.14195; Biyun Q, 2012, CHINA TROP MED, V12, P677; Biyun Q, 2012, CHINA TROP MED, V12, P687; Chen XS, 2012, SEX TRANSM DIS, V39, P226, DOI 10.1097/OLQ.0b013e31823d2cd3; Chow EPF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607261; Custer B, 2015, TRANSFUSION, V55, P2826, DOI 10.1111/trf.13247; De Buck E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122523; Duong YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114947; Ferreira ACG, 2017, BRAZ J INFECT DIS, V21, P396, DOI 10.1016/j.bjid.2017.03.013; Freed EO, 2004, TRENDS MICROBIOL, V12, P170, DOI 10.1016/j.tim.2004.02.001; Gao MT, 2017, PSYCHOL HEALTH MED, V22, P596, DOI 10.1080/13548506.2016.1200729; Han M, 2017, BIOMED ENVIRON SCI, V30, P913, DOI 10.3967/bes2017.122; Han XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep18147; Huang MB, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010030; Jia D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1189-6; Jie L, 2010, PRACT PREV MED, V17, P227; Lee CK, 2013, TRANSFUSION, V53, P2441, DOI 10.1111/trf.12365; Li GJ, 2014, INTERVIROLOGY, V57, P270, DOI 10.1159/000362366; Li L, 2017, TRANSFUS MED REV, V31, P89, DOI 10.1016/j.tmrv.2016.11.001; Li XS, 2016, AIDS RES HUM RETROV, V32, P851, DOI [10.1089/aid.2016.0029, 10.1089/AID.2016.0029]; Li YZ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-531; Lin HJ, 2013, AM J EPIDEMIOL, V177, P343, DOI 10.1093/aje/kws256; Ministry of Health, PEOPL REP CHIN 2012; Musto JA, 2008, TRANSFUSION MED, V18, P49, DOI 10.1111/j.1365-3148.2007.00804.x; Reynolds C, 2019, TRANSFUSION MED, V29, P239, DOI [10.1111/tme.12576, 10.1111/tm]; Ross LL, 2018, AIDS RES HUM RETROV, V34, P672, DOI [10.1089/AID.2017.0295, 10.1089/aid.2017.0295]; Tang WM, 2016, SEX TRANSM INFECT, V92, P508, DOI 10.1136/sextrans-2015-052469; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Wang JX, 2013, TRANSFUSION, V53, P2431, DOI 10.1111/trf.12062; Wang N, 2016, AIDS BEHAV, V20, P2976, DOI 10.1007/s10461-016-1356-3; Wang ST, 2011, VIRUS RES, V155, P137, DOI 10.1016/j.virusres.2010.09.012; Wu JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054322; Yang Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009826; Zeng HY, 2012, AIDS RES HUM RETROV, V28, P1352, DOI 10.1089/aid.2011.0364; Zeng PB, 2020, TRANSFUSION, V60, P326, DOI 10.1111/trf.15659; Zeng P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179328; Zeng PB, 2013, VIRUS GENES, V47, P408, DOI 10.1007/s11262-013-0958-3; Zeng PB, 2012, TRANSFUSION, V52, P1041, DOI 10.1111/j.1537-2995.2011.03415.x; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang YC, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7730-0; Zhao S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29202-2; Zhou PP, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3788-7; [朱明泉 Zhu Mingquan], 2004, [中华皮肤科杂志, Chinese Journa of Dermatology], V37, P635; Zuo LL, 2020, ECLINICALMEDICINE, V18, DOI 10.1016/j.eclinm.2019.100238; 2013, MEMBR MEMBR TEKHNOL, V3, P74; 2014, REG ANESTH PAIN MED, V9	55	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243650	10.1371/journal.pone.0243650	http://dx.doi.org/10.1371/journal.pone.0243650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347449	Green Published, gold			2022-12-27	WOS:000603071100060
J	Gollan, N; Barclay, K				Gollan, Natalie; Barclay, Kate			'It's not just about fish': Assessing the social impacts of marine protected areas on the wellbeing of coastal communities in New South Wales	PLOS ONE			English	Article							CONSERVATION; ENFORCEMENT; FRAMEWORK; OUTCOMES	Managing Marine Protected Areas (MPAs) is about managing human behaviours, but decision-making processes have traditionally focussed on ecological aspects, treating social aspects as secondary. It is now becoming more evident that an equal focus on the ecological and social aspects is required. Without the collection of information about social aspect such as impacts and sharing this as well as ecological information with communities, MPAs are at higher risk of opposition and social acceptability problems. This paper explores the development of a wellbeing framework to understand the social aspects, including the impacts of MPAs on the wellbeing of local communities. This research investigates two case study MPAs: Cape Byron and Port Stephens-Great Lakes Marine Parks in New South Wales, Australia. The MPAs are multiple-use and were implemented in 2006 and 2007, respectively. The research began with a review of the literature, followed by fieldwork, including semi-structured qualitative interviews with community members. Through thematic coding of the interview transcripts in light of the literature on assessing the social impacts of MPAs, a community wellbeing framework of domains and associated attributes was developed to investigate social impacts. Our analysis shows; first, local perspectives are crucial to understanding social impacts. Second, understanding social impacts gives insight into the nature of trade-offs that occur in decision-making regarding MPAs. Third, the intangible social impacts experienced by local communities are just as significant as the tangible ones for understanding how MPAs operate. Fourth, governance impacts have been the most influential factor affecting the social acceptability of the case study parks. We argue that failure to address negative social impacts can undermine the legitimacy of MPAs. We propose that the framework will support policymakers to work towards more effective, equitable and socially sustainable MPAs by employing much-needed monitoring of human dimensions of conservation interventions at the community level to shape adaptive management.	[Gollan, Natalie; Barclay, Kate] Univ Technol Sydney, Fac Arts & Social Sci, Broadway, NSW, Australia; [Gollan, Natalie] Port Stephens Fisheries Inst, New South Wales Dept Primary Ind Fisheries, Nelson Bay, NSW, Australia	University of Technology Sydney; NSW Department of Primary Industries	Gollan, N (corresponding author), Univ Technol Sydney, Fac Arts & Social Sci, Broadway, NSW, Australia.; Gollan, N (corresponding author), Port Stephens Fisheries Inst, New South Wales Dept Primary Ind Fisheries, Nelson Bay, NSW, Australia.	natalie.gollan@dpi.nsw.gov.au	Barclay, Kate/GSM-7610-2022	Barclay, Kate/0000-0002-4779-0965				Abraham A, 2010, INT J PUBLIC HEALTH, V55, P59, DOI 10.1007/s00038-009-0069-z; ABS, 2013, MEAS AUSTR PROGR 201; AIMS, 2016, AIMSINDEX MAR IND; Alder J, 1996, ENVIRON MANAGE, V20, P541, DOI 10.1007/BF01474654; Angulo-Valdes JA, 2010, MAR POLICY, V34, P635, DOI 10.1016/j.marpol.2009.12.002; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 1999, DEV FREEDOM; Armitage D, 2012, ECOL SOC, V17, DOI 10.5751/ES-04940-170415; Authority NMP, 2010, CAP BYR MAR PARK OP; Ban NC, 2019, NAT SUSTAIN, V2, P524, DOI 10.1038/s41893-019-0306-2; Bennett NJ, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12640; Bennett NJ, 2016, CONSERV BIOL, V30, P582, DOI 10.1111/cobi.12681; Biedenweg K, 2016, MAR POLICY, V64, P31, DOI 10.1016/j.marpol.2015.11.002; Blaikie N., 2009, DESIGNING SOCIAL RES; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Breslow SJ, 2017, ECOSYST HEALTH SUST, V3, DOI 10.1080/20964129.2017.1411767; Breslow SJ, 2016, ENVIRON SCI POLICY, V66, P250, DOI 10.1016/j.envsci.2016.06.023; Britton E, 2013, MAR POLICY, V37, P28, DOI 10.1016/j.marpol.2012.04.011; Brooks K., 2020, MAR POLICY; CAMFIELD L, 2006, 26 WED U BATH; Camfield L, 2009, SOC INDIC RES, V90, P5, DOI 10.1007/s11205-008-9310-z; Chaigneau T, 2019, ECOSYST SERV, V38, DOI 10.1016/j.ecoser.2019.100957; Costanza R, 2007, ECOL ECON, V61, P267, DOI 10.1016/j.ecolecon.2006.02.023; Davies TE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195760; de Lange E, 2016, CONSERV LETT, V9, P327, DOI 10.1111/conl.12223; Diversity CoB, QUICK GUID AICH BIOD; Doyal L., 1991, THEORY HUMAN NEED, DOI DOI 10.1007/978-1-349-21500-3; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; Feary S, 2015, SEA COUNTRIES NEW S; Fox HE, 2012, CONSERV LETT, V5, P1, DOI 10.1111/j.1755-263X.2011.00207.x; Franks P, 2016, METHODOLOGY MANUAL S; Fry BP, 2017, ORYX, V51, P68, DOI 10.1017/S003060531500112X; Gill DA, 2019, ANNU REV ENV RESOUR, V44, P347, DOI 10.1146/annurev-environ-110718-032344; Gollan N, 2019, OCEAN COAST MANAGE, V168, P12, DOI 10.1016/j.ocecoaman.2018.10.020; Gough I, 2007, WELLBEING IN DEVELOPING COUNTRIES: FROM THEORY TO RESEARCH, P1, DOI 10.1017/CBO9780511488986; Gough I, 2007, WELLBEING IN DEVELOPING COUNTRIES: FROM THEORY TO RESEARCH, P3, DOI 10.1017/CBO9780511488986.002; Government NSW, 2013, GOV RESP REP IND SCI; Hammerton Z, 2019, AQUAT CONSERV, V29, P1623, DOI 10.1002/aqc.3140; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harasti D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105462; Harris PNA, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0055-6; Jones N, 2017, ENVIRON IMPACT ASSES, V64, P1, DOI 10.1016/j.eiar.2016.12.007; Kaplan-Hallam M, 2018, CONSERV BIOL, V32, P304, DOI 10.1111/cobi.12985; Kelaher BP, 2015, GLOB ECOL CONSERV, V3, P503, DOI 10.1016/j.gecco.2015.02.002; King MF, 2014, SOC INDIC RES, V116, P681, DOI 10.1007/s11205-013-0320-0; Kingsley J, 2013, INT J ENV RES PUB HE, V10, P678, DOI 10.3390/ijerph10020678; Leisher C, 2013, SUSTAINABILITY-BASEL, V5, P997, DOI 10.3390/su5030997; Lewis S, 2015, HEALTH PROMOT PRACT, V16, P473, DOI 10.1177/1524839915580941; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Marine Parks Authority, 2010, PORT STEPH GREAT LAK; Mascia MB, 2010, CONSERV BIOL, V24, P1424, DOI 10.1111/j.1523-1739.2010.01523.x; McGregor A, 2015, MEASURING WHAT MATTE; McGregor A, 2008, 108 ESRC RES GROUP W; McLeod K, 2018, OUR PEOPLE MULTIDIME; Miles MB., 2018, QUALITATIVE DATA ANA, DOI DOI 10.1016/0149-7189(96)88232-2; Narayan D., 2000, VOICES POOR CRYING O; Newig J, 2012, ENVIRONMENTAL GOVERNANCE: THE CHALLENGE OF LEGITIMACY AND EFFECTIVENESS, P29; Oldekop JA, 2016, CONSERV BIOL, V30, P133, DOI 10.1111/cobi.12568; Rasheed AR, 2020, ECOSYST SERV, V41, DOI 10.1016/j.ecoser.2019.101048; Reed MS, 2009, J ENVIRON MANAGE, V90, P1933, DOI 10.1016/j.jenvman.2009.01.001; Research Sweeney, 2014, MARINE ESTATE COMMUN; Rogers DS, 2012, CURR OPIN ENV SUST, V4, P61, DOI 10.1016/j.cosust.2012.01.013; Schirmer J, 2015, PEOPLE COMMUNITIES 2; Schreckenberg K, 2010, REV RAPID METHODOLOG; Scrivens K., 2013, OECD STAT WORKING PA, DOI 10.1787/5jzbcx010wmt-en; Sen A, 2013, J HUM DEV CAPABIL, V14, P6, DOI 10.1080/19452829.2012.747492; Sowman M, 2018, OCEAN COAST MANAGE, V157, P168, DOI 10.1016/j.ocecoaman.2018.02.013; Spalding MD, 2016, BIG BOLD BLUE LESSON; Stiglitz J.E., 2009, REPORT COMMISSION ME; UNEP, UNEPCBDCOPDEC102 SEC; UNEP-WCMC and IUCN, 2016, PROTECTED PLANET REP; Vanclay F., 2015, SOCIAL IMPACT ASSESS; Voyer M, 2015, MAR POLICY, V52, P93, DOI 10.1016/j.marpol.2014.10.027; Voyer M, 2014, AQUAT CONSERV, V24, P441, DOI 10.1002/aqc.2363; Young MAL, 2016, MAR POLICY, V66, P114, DOI 10.1016/j.marpol.2016.01.018	75	3	3	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244605	10.1371/journal.pone.0244605	http://dx.doi.org/10.1371/journal.pone.0244605			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378377	gold, Green Published			2022-12-27	WOS:000605651300032
J	Barallat, J; Fernandez-Rivas, G; Quirant-Sanchez, B; Gonzalez, V; Dolade, M; Martinez-Caceres, E; Pina, M; Matllo, J; Estrada, O; Blanco, I				Barallat, Jaume; Fernandez-Rivas, Gema; Quirant-Sanchez, Bibiana; Gonzalez, Victoria; Dolade, Maria; Martinez-Caceres, Eva; Pina, Monica; Matllo, Joan; Estrada, Oriol; Blanco, Ignacio			Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave	PLOS ONE			English	Article								Background The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) around the world has caused a global pandemic, infecting millions of individuals, with an unprecedented impact in health care systems worldwide. Healthcare workers are one of the risk groups that need to be well protected, due to their strategic role in patient management, presently and in prevention of healthcare needs for future outbreaks. Here, we present the results of the first SARS-CoV-2 seroprevalence study in the Northern Metropolitan Area of Barcelona, Spain. Methods IgG SARS-CoV-2 antibodies were analyzed in serum samples from 7563 healthcare workers of the Northern Metropolitan Area of Barcelona. Samples were collected after the first pandemic wave (from May 4th to May 22nd, 2020) and were analyzed by automated chemiluminescence assays. All samples were tested for IgG anti-S1/S2. Participant samples with negative or equivocal results but with analytical signals above the limit of detection and/or previously confirmed COVID-19 diagnosis were also tested for IgG anti-Nucleocapsid. Results A total of 779 of 7563 (10.3%) healthcare workers were positive for anti-SARS-CoV-2 IgG (specific for either S1/S2 or N antigens). No significant differences were observed between those working at primary care or at the reference hospital. Interestingly, among 341 participants with a confirmed COVID-19 diagnosis, 36 (10.55%) tested negative for SARS-CoV-2 IgG (both S1/S2 and recombinant N antigen). Conclusion Seroprevalence of anti-SARS-CoV-2 IgG in the healthcare workers of the North Metropolitan Area of Barcelona was higher than in the general population in the same geographical area. Safety measures have to be stressed in order to protect these essential workers from future pandemic waves.	[Barallat, Jaume; Dolade, Maria] Inst Catala Salut, Gerencia Terr Metropolitana Nord, Lab Clin Metropolitana Nord, Serv Anal Clin & Bioquim, Barcelona, Spain; [Fernandez-Rivas, Gema; Gonzalez, Victoria] Inst Catala Salut, Gerencia Terr Metropolitana Nord, Lab Clin Metropolitana Nord, Serv Microbiol, Barcelona, Spain; [Fernandez-Rivas, Gema] Univ Autonoma Barcelona, Dept Genet & Microbiol, Barcelona, Spain; [Quirant-Sanchez, Bibiana; Martinez-Caceres, Eva] Inst Catala Salut, Gerencia Terr Metropolitana Nord, Lab Clin Metropolitana Nord, Serv Immunol, Barcelona, Spain; [Quirant-Sanchez, Bibiana; Martinez-Caceres, Eva] Univ Autonoma Barcelona, Dept Biol Celular Fisiol & Immunol, Barcelona, Spain; [Gonzalez, Victoria] Generalitat Catalunya, Dept Salut, Ctr Estudis Epidemiol Infecc Transmissio Sexual &, Badalona, Spain; [Gonzalez, Victoria] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Pina, Monica] Inst Catala Salut, Gerencia Terr Metropolitana Nord, Unitat Basica Prevencio, Direccio Atencio Primaria, Barcelona, Spain; [Matllo, Joan] Hosp Badalona Germans Trias & Pujol, Inst Catala Salut, Gerencia Terr Metropolitana Nord, Unitat Basica Prevencio, Barcelona, Spain; [Estrada, Oriol] Inst Catala Salut, Gerencia Terr Metropolitana Nord, Direccio Innovacio & Proc Transversals, Barcelona, Spain; [Blanco, Ignacio] Inst Catala Salut, Gerencia Terr Metropolitana Nord, Lab Clin Metropolitana Nord, Serv Genet Clin, Barcelona, Spain; [Blanco, Ignacio] Univ Autonoma Barcelona, Dept Cirurgia, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Germans Trias i Pujol; Autonomous University of Barcelona	Blanco, I (corresponding author), Inst Catala Salut, Gerencia Terr Metropolitana Nord, Lab Clin Metropolitana Nord, Serv Genet Clin, Barcelona, Spain.; Blanco, I (corresponding author), Univ Autonoma Barcelona, Dept Cirurgia, Barcelona, Spain.	iblanco.germanstrias@gencat.cat	Blanco, Ignacio/AAN-5426-2021; Blanco, Ignacio/D-2565-2013	Blanco, Ignacio/0000-0002-7414-7481; Blanco, Ignacio/0000-0002-7414-7481; Barallat, Jaume/0000-0003-3493-5958; Dolade Botias, Maria/0000-0001-8263-3087; Martinez-Caceres, Eva/0000-0002-6762-8025; Estrada, Oriol/0000-0003-1414-5000				Castoldi M, 2020, IGG SEROLOGY HLTH CA; Chang MS, 2004, BIOCHEM BIOPH RES CO, V314, P931, DOI 10.1016/j.bbrc.2003.12.195; Cutts FT, 2016, TROP MED INT HEALTH, V21, P1086, DOI 10.1111/tmi.12737; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Garcia-Basteiro AL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17318-x; Garcia-Fernandez L, 2022, PSYCHOL MED, V52, P195, DOI 10.1017/S0033291720002019; Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437; MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2066; Martin C, 2020, J HOSP INFECT, V106, P102, DOI 10.1016/j.jhin.2020.06.028; Mesnil M, 2020, ANAESTH CRIT CARE PA, V39, P595, DOI 10.1016/j.accpm.2020.08.003; Narayanan K, 2003, J VIROL, V77, P2922, DOI 10.1128/JVI.77.5.2922-2927.2003; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Petherick A, 2020, LANCET, V395, P1101, DOI 10.1016/S0140-6736(20)30788-1; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Schmidt SB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235417; Siracusano G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01049; Steensels D, 2020, JAMA-J AM MED ASSOC, V324, P195, DOI 10.1001/jama.2020.11160; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]	19	20	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244348	10.1371/journal.pone.0244348	http://dx.doi.org/10.1371/journal.pone.0244348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370363	Green Published, Green Submitted, gold			2022-12-27	WOS:000603611900056
J	Biswas, B; Roy, SK				Biswas, Bikram; Roy, Sajib Kumar			Service quality, satisfaction and intention to use Union Digital Center in Bangladesh: The moderating effect of citizen participation	PLOS ONE			English	Article							INFORMATION-SYSTEMS SUCCESS; RURAL-DEVELOPMENT; MCLEAN MODEL; DELONE	This paper examines the service quality, satisfaction and intention to use Union Digital Center (UDC) in Bangladesh: The moderating effect of citizen participation. The study intends to measure the quality of service on the basis of satisfaction by adopting citizen participation as a moderator. Theoretically this study has used DeLone & McLean Information Systems (D&M IS) Success Model. The existing studies of Bangladesh are mostly qualitative and the correlation between the quality of service, satisfaction, and desire for using UDC has not verified. This research has adopted the D&M IS model while measuring and verifying the service quality based on satisfaction and use intention. A structured questionnaire method was used and data collected from 499 respondents from 10 UDC of 10 upazila under 8 divisions in Bangladesh. Partial Least Square (PLS), a statistical method that emerged on the basis of Structure Equation Modeling (SEM), technique has been used while analyzing the data. The result of this study has showed the quality (p<0.05) of information, system and service of UDC affects citizen satisfaction effectively where the moderator of citizen participation is also significant. This paper has constructed on the basis of a model and empirical data to verify the moderating effects of citizen participation. To ensure the improvement of service quality of UDC all of the dimensions related to the quality of service should be modified, develop the administrative system and citizen should be encouraging to participate in all aspects of services.	[Biswas, Bikram] Noakhali Sci & Technol Univ, Dept Educ Adm, Noakhali, Bangladesh; [Roy, Sajib Kumar] Hajee Mohammad Danesh Sci & Technol Univ, Dept Dev Studies, Dinajpur, Bangladesh	Noakhali Science & Technology University (NSTU)	Biswas, B (corresponding author), Noakhali Sci & Technol Univ, Dept Educ Adm, Noakhali, Bangladesh.	bikramju1020@gmail.com		Biswas, Bikram/0000-0002-5429-3916				Alanazi, 2013, 24 AUSTR C INF SYST, P1; [Anonymous], 2017, UN DIG CTR UDCS DEL; [Anonymous], 2004, CHRONICLE HIGHER ED, V15, pC1; BAGOZZI RP, 1991, J PERS SOC PSYCHOL, V61, P98, DOI 10.1037/0022-3514.61.1.98; Breitenbach MC, 2013, DEV SO AFR, V30, P262, DOI 10.1080/0376835X.2013.797229; DeLone WH, 2003, J MANAGE INFORM SYST, V19, P9, DOI 10.1080/07421222.2003.11045748; DeLone WH, 1992, INFORM SYST RES, V3, P60, DOI 10.1287/isre.3.1.60; Efron B., 1994, INTRO BOOTSTRAP; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hair J. F., 2016, PRIMER PARTIAL LEAST; Henseler J, 2009, ADV INT MARKETING, V20, P277, DOI 10.1108/S1474-7979(2009)0000020014; Inks L.W., 2001, J BUSINESS STRATEGIE, V18, P47; Kai Zou, 2011, SOFT SCI; Kang YS, 2010, COMPUT HUM BEHAV, V26, P353, DOI 10.1016/j.chb.2009.11.006; Kumar V., 2007, ELECT J E GOVT, V5, P63, DOI DOI 10.1128/AAC.03728-14; Lin KM, 2011, BEHAV INFORM TECHNOL, V30, P77, DOI 10.1080/01449291003752948; Locke E., 1976, HDB IND ORG PSYCHOL, P1297, DOI DOI 10.1207/S15427633SCC0304; Mahmood K, 2005, ELECTRON LIBR, V23, P204, DOI 10.1108/02640470510592906; Olever R., 1997, SATISFACTION BEHAV P; OLIVER RL, 1981, J RETAILING, V57, P25; PARASURAMAN A, 1988, J RETAILING, V64, P12; Sarker AK., 2013, DIGITAL BANGLADESH S; Suphattanakul O, 2014, THESIS; Wang YS, 2008, GOV INFORM Q, V25, P717, DOI 10.1016/j.giq.2007.06.002; Wangpipatwong S, 2005, PROCEEDINGS OF THE NINTH IASTED INTERNATIONAL CONFERENCE ON INTERNET AND MULTIMEDIA SYSTEMS AND APPLICATIONS, P65, DOI 10.1142/9781860947322_0007; Wangpipatwong S, 2009, INT J ELECTRON GOV R, V5, P19, DOI 10.4018/jegr.2009092202; Yanjun Peng, 2008, J BEIJING TECHNOLOGY; Zhang L., 2009, THESIS	29	2	2	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244609	10.1371/journal.pone.0244609	http://dx.doi.org/10.1371/journal.pone.0244609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370421	gold, Green Published			2022-12-27	WOS:000603611900052
J	Khayat, AS; de Assumpcao, PP; Khayat, BCM; Araujo, TMT; Batista-Gomes, JA; Imbiriba, LC; Ishak, G; de Assumpcao, PB; Moreira, FC; Burbano, RR; Ribeiro-dos-Santos, A; Ribeiro-dos-Santos, AK; dos Santos, NPC; dos Santos, SEB				Khayat, Andre Salim; de Assumpcao, Paulo Pimentel; Meireles Khayat, Bruna Claudia; Thomaz Araujo, Taissa Maira; Batista-Gomes, Jessica Almeida; Imbiriba, Luciana Carvalho; Ishak, Geraldo; de Assumpcao, Paula Barauna; Moreira, Fabiano Cordeiro; Burbano, Rommel Rodriguez; Ribeiro-dos-Santos, Andre; Ribeiro-dos-Santos, Andrea Kelly; dos Santos, Ney Pereira Carneiro; dos Santos, Sidney Emmanuel Batista			ACE2 polymorphisms as potential players in COVID-19 outcome	PLOS ONE			English	Article							INTERETHNIC ADMIXTURE; ASSOCIATION; POPULATION; ANCESTRY; SYSTEM	The clinical condition COVID-19, caused by SARS-CoV-2, was declared a pandemic by the WHO in March 2020. Currently, there are more than 5 million cases worldwide, and the pandemic has increased exponentially in many countries, with different incidences and death rates among regions/ethnicities and, intriguingly, between sexes. In addition to the many factors that can influence these discrepancies, we suggest a biological aspect, the genetic variation at the viral S protein receptor in human cells, ACE2 (angiotensin I-converting enzyme 2), which may contribute to the worse clinical outcome in males and in some regions worldwide. We performed exomics analysis in native and admixed South American populations, and we also conducted in silico genomics databank investigations in populations from other continents. Interestingly, at least ten polymorphisms in coding, noncoding and regulatory sites were found that can shed light on this issue and offer a plausible biological explanation for these epidemiological differences. In conclusion, there are ACE2 polymorphisms that could influence epidemiological discrepancies observed among ancestry and, moreover, between sexes.	[Khayat, Andre Salim; Meireles Khayat, Bruna Claudia; Batista-Gomes, Jessica Almeida; Ribeiro-dos-Santos, Andre; Ribeiro-dos-Santos, Andrea Kelly; dos Santos, Ney Pereira Carneiro; dos Santos, Sidney Emmanuel Batista] Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil; [Khayat, Andre Salim; de Assumpcao, Paulo Pimentel; Thomaz Araujo, Taissa Maira; Imbiriba, Luciana Carvalho; Ishak, Geraldo; de Assumpcao, Paula Barauna; Moreira, Fabiano Cordeiro; Burbano, Rommel Rodriguez; Ribeiro-dos-Santos, Andrea Kelly; dos Santos, Ney Pereira Carneiro; dos Santos, Sidney Emmanuel Batista] Univ Fed Para, Nucleo Pesquisas Oncol, Belem, Para, Brazil; [Burbano, Rommel Rodriguez] Hosp Ophir Loyola, Lab Biol Mol, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para	Khayat, AS (corresponding author), Univ Fed Para, Inst Ciencias Biol, Belem, Para, Brazil.; Khayat, AS (corresponding author), Univ Fed Para, Nucleo Pesquisas Oncol, Belem, Para, Brazil.	khayatas@gmail.com	Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Burbano, Rommel R/C-4149-2012; Moreira, Fabiano/I-2817-2015	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Burbano, Rommel R/0000-0002-4872-234X; Moreira, Fabiano/0000-0002-2799-3546; Santos, Ney Pereira Carneiro dos/0000-0001-8087-7037; Araujo, Taissa Maira/0000-0002-1716-4445	Brazilian National Council for Scientific and Technological Development (CNPq) [431488/2016-9]; Coordination for the Improvement of Higher Education Personnel (CAPES); CNPq; Federal University of Para (UFPA)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Para (UFPA)	S.E.B.S. received from The Brazilian National Council for Scientific and Technological Development (CNPq, www.cnpq.br) financial support (number 431488/2016-9) to perform exome sequencing assays. J.A.B.G. received a Doctoral fellowship from Coordination for the Improvement of Higher Education Personnel (CAPES, www.gov.br/capes). A.S.K., P.P.A, R.M.R.R., A.K.R.S., S.E.B.S. received Researcher Fellowship (PQ), and L.C.I. received Master fellowship from CNPq. the Federal University of Para (UFPA, www.ufpa.br) financial support part of this work. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Boccia S, 2020, JAMA INTERN MED, V180, P927, DOI 10.1001/jamainternmed.2020.1447; Cao YN, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0147-1; Carvalho DC, 2015, LEUKEMIA RES, V39, P1239, DOI 10.1016/j.leukres.2015.08.008; Chan KK, 2020, SCIENCE, V369, P1261, DOI 10.1126/science.abc0870; Chen JW, 2020, AGING CELL, V19, DOI 10.1111/acel.13168; Chen L, 2020, CARDIOVASC RES, V116, P1097, DOI 10.1093/cvr/cvaa078; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Rodrigues JCG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43610-y; Gouveia MH, 2020, MOL BIOL EVOL, V37, P1647, DOI 10.1093/molbev/msaa033; GTEx Portal, GEN TISS EXPR GTEX; Kemp JR, 2014, J MOL CELL CARDIOL, V75, P25, DOI 10.1016/j.yjmcc.2014.06.008; Leitao LPC, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030262; Li YW, 2020, PHARMACOL RES, V157, DOI 10.1016/j.phrs.2020.104833; Lindenau JD, 2014, TISSUE ANTIGENS, V84, P479, DOI 10.1111/tan.12451; Lindenau JD, 2016, AM J PHYS ANTHROPOL, V159, P722, DOI 10.1002/ajpa.22917; Luo Y, 2019, HYPERTENS RES, V42, P681, DOI 10.1038/s41440-018-0166-6; Merriwether A, 2003, AM J HUM BIOL, V15, P595, DOI 10.1002/ajhb.10174; Mingroni-Netto RC, 2002, AM J MED GENET, V111, P243, DOI 10.1002/ajmg.10572; NCBI, ACE2 ANG I CONV ENZ; Ortega JT, 2020, EXCLI J, V19, P410, DOI 10.17179/excli2020-1167; Othman H, INTERACTION SPIKE PR, DOI [10.1101/2020.03.04.976027, DOI 10.1101/2020.03.04.976027]; Rozenberg S, 2020, MATURITAS, V138, P62, DOI 10.1016/j.maturitas.2020.05.009; Sambrook J., 1989, MOL CLONING LAB MANU; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; WHO, WHO MEMB STAT REG; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhao Q, 2010, AM J HYPERTENS, V23, P606, DOI 10.1038/ajh.2010.36; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	35	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243887	10.1371/journal.pone.0243887	http://dx.doi.org/10.1371/journal.pone.0243887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370311	Green Published, gold, Green Submitted			2022-12-27	WOS:000603611900046
J	Nie, DQ; Yan, GX; Zhou, WY; Wang, ZY; Yu, GM; Liu, D; Yuan, N; Li, HB				Nie, Daqing; Yan, Guixin; Zhou, Wenyu; Wang, Zhengyi; Yu, Guimei; Liu, Di; Yuan, Na; Li, Hongbo			Metabolic syndrome and the incidence of knee osteoarthritis: A meta-analysis of prospective cohort studies	PLOS ONE			English	Article							CARTILAGE VOLUME; HIP; RISK; COMPONENTS; GENDER; HETEROGENEITY; REPLACEMENT; MANAGEMENT; HAND; SEX	Background Cross-sectional studies suggest an association between metabolic syndrome (MetS) and knee osteoarthritis (KOA). We performed a meta-analysis to evaluate whether MetS is an independent risk factor for KOA. Methods Prospective cohort studies evaluating the association between MetS and KOA in general population were retrieved from PubMed and Embase. Only studies with multivariate analyses were included. Data were pooled with a random-effect model, which is considered to incorporate heterogeneity among the included studies. Results Five studies including 94,965 participants were included, with 18,990 people with MetS (20.0%). With a mean follow-up duration of 14.5 years, 2,447 KOA cases occurred. Pooled results showed that MetS was not significant associated with an increased risk of KOA after controlling of factors including body mass index (adjusted risk ratio [RR]: 1.06, 95% CI: 0.92 similar to 1.23, p = 0.40; I-2 = 33%). Subgroup analysis showed that MetS was independently associated with an increased risk of severe KOA that needed total knee arthroplasty (RR = 1.16, 95% CI: 1.03 similar to 1.30, p = 0.02), but not total symptomatic KOA (RR = 0.84, 95% CI: 0.65 similar to 1.08, p = 0.18). Stratified analyses suggested that MetS was independently associated with an increased risk of KOA in women (RR = 1.23, 95% CI: 1.03 similar to 1.47, p = 0.02), but not in men (RR = 0.90, 95% CI: 0.70 similar to 1.14, p = 0.37). Conclusions Current evidence from prospective cohort studies did not support MetS was an independent risk factor of overall KOA in general population. However, MetS may be associated with an increased risk of severe KOA in general population, or overall KOA risk in women.	[Nie, Daqing; Yu, Guimei; Liu, Di; Yuan, Na] Changchun Univ Chinese Med, Affiliated Hosp, Dept Rheumat Dis, Changchun, Peoples R China; [Yan, Guixin] Changchun Univ Chinese Med, Innovat Practice Ctr, Changchun, Peoples R China; [Zhou, Wenyu] Fourth Hosp Wuhan, Dept Immunol & Rheumatol, Wuhan, Peoples R China; [Wang, Zhengyi] Sun Yat Sen Univ, Nanfang Med Coll, Coll Nursing & Hlth Sci, Guangzhou, Peoples R China; [Li, Hongbo] Changchun Univ Chinese Med, Clin Affiliated Hosp 3, Dept Rheumat Dis, Changchun, Peoples R China	Changchun University of Chinese Medicine; Changchun University of Chinese Medicine; Sun Yat Sen University; Changchun University of Chinese Medicine	Li, HB (corresponding author), Changchun Univ Chinese Med, Clin Affiliated Hosp 3, Dept Rheumat Dis, Changchun, Peoples R China.	hongbolicc@163.com						Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; [Anonymous], 2020, Circulation, V141, pe33, DOI 10.1161/CIR.0000000000000746; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2010, INT J ORAL MAXILLOFA, V25, P416; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; [Anonymous], 1880, RPH S 2, VIV, P2; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Cicuttini FM, 1999, OSTEOARTHR CARTILAGE, V7, P265, DOI 10.1053/joca.1998.0200; Courties A, 2019, JOINT BONE SPINE, V86, P725, DOI 10.1016/j.jbspin.2018.12.005; Courties A, 2017, CURR OPIN RHEUMATOL, V29, P214, DOI 10.1097/BOR.0000000000000373; Ding CH, 2007, RHEUMATOLOGY, V46, P273, DOI 10.1093/rheumatology/kel243; Dominguez LJ, 2016, CURR OPIN CLIN NUTR, V19, P5, DOI 10.1097/MCO.0000000000000243; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engstrom G, 2009, OSTEOARTHR CARTILAGE, V17, P168, DOI 10.1016/j.joca.2008.07.003; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Gao YH, 2020, CYTOKINE, V129, DOI 10.1016/j.cyto.2020.155043; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hanna FS, 2009, MENOPAUSE, V16, P666, DOI 10.1097/gme.0b013e318198e30e; Hellevik AI, 2018, CLIN EPIDEMIOL, V10, P83, DOI 10.2147/CLEP.S145823; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hunter DJ, 2019, LANCET, V393, P1745, DOI 10.1016/S0140-6736(19)30417-9; Hussain SM, 2018, CLIMACTERIC, V21, P132, DOI 10.1080/13697137.2017.1421926; Hussain SM, 2014, SEMIN ARTHRITIS RHEU, V43, P429, DOI 10.1016/j.semarthrit.2013.07.013; Khor A, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2019-001030; Kolasinski SL, 2020, ARTHRITIS RHEUMATOL, V72, P220, DOI [10.1002/art.41142, 10.1002/acr.24131]; Konstari S, 2021, CARTILAGE, V13, p1445S, DOI 10.1177/1947603519894731; Li HX, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.48; Li SS, 2019, ARTHRIT CARE RES, V71, P875, DOI 10.1002/acr.23698; Li YS, 2017, MECH AGEING DEV, V162, P80, DOI 10.1016/j.mad.2016.12.012; Lu Y, 2019, ORTHOP SURG, V11, P835, DOI 10.1111/os.12529; Mathieu S, 2019, JOINT BONE SPINE, V86, P679, DOI 10.1016/j.jbspin.2019.06.013; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Niu JB, 2017, ARTHRITIS RHEUMATOL, V69, P1194, DOI 10.1002/art.40087; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Ro DH, 2017, J ORTHOP RES, V35, P1283, DOI 10.1002/jor.23374; Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Shin D, 2014, J CLIN ENDOCR METAB, V99, P3177, DOI 10.1210/jc.2014-1043; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Swain S, 2020, ARTHRIT CARE RES, V72, P991, DOI 10.1002/acr.24008; Xin W, 2014, HEART, V100, P406, DOI 10.1136/heartjnl-2013-304121; Yoshimura N, 2015, MOD RHEUMATOL, V25, P438, DOI 10.3109/14397595.2014.972607; Zhang YM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007584; Zhou ZY, 2014, OBESITY, V22, P2180, DOI 10.1002/oby.20835	45	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243576	10.1371/journal.pone.0243576	http://dx.doi.org/10.1371/journal.pone.0243576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362213	Green Published, gold			2022-12-27	WOS:000603071600057
J	Ibanez-Peinado, D; Ubeda-Manzanaro, M; Martinez, A; Rodrigo, D				Ibanez-Peinado, Diana; Ubeda-Manzanaro, Maria; Martinez, Antonio; Rodrigo, Dolores			Antimicrobial effect of insect chitosan on Salmonella Typhimurium, Escherichia coli O157:H7 and Listeria monocytogenes survival	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; UNITED-STATES; FOOD; RESISTANCE; PREVALENCE; CHITIN	The antimicrobial capability of chitosan from Tenebrio molitor as compared with chitosan from crustacean (Penaeus monodon) on different pathogenic microorganisms of concern in food safety was studied. The antimicrobial effect was tested at pH 5 and pH 6.2 and at two different initial concentrations (10(3) or 10(6) CFU/mL). Results indicated that chitosan from both sources have antimicrobial activity, although the effect depended on the microorganism considered (Salmonella Typhimurium, Listeria monocytogenes and Escherichia coli O157:H7). Our results indicated that Salmonella was the most resistant bacteria, and that chitosan from insect was less active than chitosan from crustacean, especially against Salmonella. Another important factor on antimicrobial activity was the pH of the sample. When chitosan was added to a solution with a pH of 6.2 it was more active against Listeria and Escherichia coli, than at pH 5.00. Besides, the effect of chitosan appears to decrease with the incubation time, since some increases in counts were observed on E. coli and Salmonella after the 24 and 49 hours of incubation.	[Ibanez-Peinado, Diana; Ubeda-Manzanaro, Maria; Martinez, Antonio; Rodrigo, Dolores] Inst Agroquim & Tecnol Alimentos IATA CSIC, Dept Preservat & Food Safety, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC)	Rodrigo, D (corresponding author), Inst Agroquim & Tecnol Alimentos IATA CSIC, Dept Preservat & Food Safety, Valencia, Spain.	lolesra@iata.csic.es	Rodrigo, Dolores/H-6083-2012	Rodrigo, Dolores/0000-0001-9854-111X	Spanish Ministry of Science [AGL2017-86840-C2-2-R]; EU	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EU(European Commission)	The authors are grateful to the Spanish Ministry of Science for funding through project AGL2017-86840-C2-2-R, and to FEDER funds from EU. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Agencia Espanola de Seguridad Alimentaria y Nutricion (AESAN), 2011, 14 AESAN, P43; Allan G. G., 1984, CHITIN CHITOSAN RELA, V1, P119; [Anonymous], 2020, LANCET PLANET HEALTH, V4, pE168, DOI 10.1016/S2542-5196(20)30110-8; [Anonymous], 2017, Med Lett Drugs Ther, V59, pe56; [Anonymous], 2018, 7 SER FPGAS DAT SHEE, V2, P1; Ardila N, 2017, J FOOD SCI, V82, P679, DOI 10.1111/1750-3841.13635; Badwal SPS, 2018, WIRES ENERGY ENVIRON, V7, DOI 10.1002/wene.286; Barroso FG, 2014, AQUACULTURE, V422, P193, DOI 10.1016/j.aquaculture.2013.12.024; Munoz AB, 2013, BIOMEDICA, V33, P283, DOI 10.7705/biomedica.v33i2.716; Buchanan RL, 1997, FOOD TECHNOL-CHICAGO, V51, P69; Chaudhary S, 2020, INT J BIOL MACROMOL, V152, P154, DOI 10.1016/j.ijbiomac.2020.02.276; Cho YI, 1998, J AGR FOOD CHEM, V46, P3839, DOI 10.1021/jf971047f; Du YJ, 2009, INNOV FOOD SCI EMERG, V10, P103, DOI 10.1016/j.ifset.2008.07.004; Ed-dra A, 2017, MICROB PATHOGENESIS, V105, P340, DOI 10.1016/j.micpath.2017.02.042; EFSA European Food Safety Authority, 2007, EFSA J, V599, P1; European Food Safety Authority, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5926; European Food Safety Authority, 2007, EFSA J, V5, P579, DOI [10.2903/j.efsa.2007.579, DOI 10.2903/J.EFSA.2007.579]; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fernandes JC, 2008, FOOD MICROBIOL, V25, P922, DOI 10.1016/j.fm.2008.05.003; Gerasimenko D. V., 2004, Prikladnaya Biokhimiya i Mikrobiologiya, V40, P301; Goy RC, 2014, BRAZ J CHEM ENG, V31, P643, DOI 10.1590/0104-6632.20140313s00003014; Goy RC, 2009, POLIMEROS, V19, P241, DOI 10.1590/S0104-14282009000300013; Gucukoglu A., 2016, Erciyes Universitesi Veteriner Fakultesi Dergisi, V13, P11; Hu ZY, 2019, J APPL MICROBIOL, V126, P1318, DOI 10.1111/jam.14131; Ibitoye EB, 2018, BIOMED MATER, V13, DOI 10.1088/1748-605X/aa9dde; Jia ZS, 2001, CARBOHYD RES, V333, P1, DOI 10.1016/S0008-6215(01)00112-4; Jumaa M, 2002, EUR J PHARM BIOPHARM, V53, P115, DOI 10.1016/S0939-6411(01)00191-6; Kasaal MR, 2008, CARBOHYD POLYM, V71, P497, DOI 10.1016/j.carbpol.2007.07.009; Kulawik P, 2020, ENVIRON CHEM LETT, V18, P61, DOI 10.1007/s10311-019-00935-4; Liu QX, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00617; Luber P, 2011, FOOD CONTROL, V22, P1535, DOI 10.1016/j.foodcont.2011.01.008; Mora A, 2011, INT MICROBIOL, V14, P121, DOI 10.2436/20.1501.01.142; No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Raafat D, 2004, THESIS; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Rajoka MSR, 2020, CRIT REV BIOTECHNOL, V40, P365, DOI 10.1080/07388551.2020.1713719; Rehman A, 2020, TRENDS FOOD SCI TECH, V101, P106, DOI 10.1016/j.tifs.2020.05.001; Sanz-Puig M, 2019, INNOV FOOD SCI EMERG, V51, P51, DOI 10.1016/j.ifset.2018.04.002; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Shin CS, 2019, INT J BIOL MACROMOL, V125, P72, DOI 10.1016/j.ijbiomac.2018.11.242; Tian BR, 2020, POLYM ADVAN TECHNOL, V31, P2408, DOI 10.1002/pat.5010; Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239; Venter T. van de, 2000, Food, Nutrition and Agriculture, P4; WANG GH, 1992, J FOOD PROTECT, V55, P916, DOI 10.4315/0362-028X-55.11.916; WHO (World Health Organization) /Food and Agriculture Organization (FAO), 2004, MICR RISK ASS SER, V4; Xu XB, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000401; Yang XJ, 2016, FOOD CONTROL, V60, P50, DOI 10.1016/j.foodcont.2015.07.019; Yilmaz Atay H., 2020, FUNCTIONAL CHITOSAN, P457, DOI [DOI 10.1007/978-981-15-0263-7_15, 10.1007/978-981-15-0263-7_15]	49	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244153	10.1371/journal.pone.0244153	http://dx.doi.org/10.1371/journal.pone.0244153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351851	Green Published, gold			2022-12-27	WOS:000603071400009
J	Sagbakken, M; Ingebretsen, R; Spilker, RS				Sagbakken, Mette; Ingebretsen, Reidun; Spilker, Ragnhild Storstein			How to adapt caring services to migration-driven diversity? A qualitative study exploring challenges and possible adjustments in the care of people living with dementia	PLOS ONE			English	Article							RESIDENTIAL CARE; FAMILY CARE; CULTURE; COMMUNICATION; IMMIGRANTS; ETHNICITY; SWEDEN; MAINSTREAM; PROVISION; COMMUNITY	Background Research on how services can be adapted to meet the needs of people with dementia with an immigrant or minority ethnic background is scarce. Several approaches have been discussed: offering services adapted to language and culture, adding bilingual staff to mainstream services, and providing cultural awareness and sensitivity training to health personnel in mainstream services. This study seeks to develop more knowledge of challenges and possible adjustments related to receive and provide public care for people living with dementia with an immigrant or minority ethnic background. Methods and materials Through a qualitative design, including 19 single interviews, 3 dyad interviews and 16 focus groups with older immigrants, relatives of immigrants with dementia, and health personnel, we explored experiences and perceptions related to receive and provide care for people with immigrant backgrounds living with dementia in Norway. The analysis were conducted inspired by Kvale and Brinkmann's three contexts of interpretations. Results Challenges related to language and communication were emphasized as the most fundamental barrier to provide adjusted care; exemplified through cases of isolation and agitation among patients not able to communicate. Care services framed by the majority culture creates feelings of alienation and exclusion. Not having access to specific types of food and the possibility to listen to songs, music, literature or TV programs representing a familiar and homely context may prevent use of public dementia care. Findings also point to differences in moral views regarding life-prolonging treatment in advanced stages of dementia. Conclusion This study argues that to be able to address challenges related to migration-driven diversity one needs holistic care services that addresses individual as well as socio-cultural needs. A linguistically and culturally diverse workforce may represent an important resource, potentially reducing some of the problems related to communication. On a structural level, it seems necessary to allocate more time and resources, including the use of interpreters, when assessing and getting to know persons with dementia with another linguistic and cultural background. However, shared language does not guarantee understanding. Rather, one needs to become familiar with each person's way of being ill, on a cultural and individual level, including changes occurring living with progressive dementia. Getting to know a person and his/her family will also facilitate the possibility to ensure a more familiar and homely context. Thus, continuity in relation to language and culture is important, but continuity in relations may be equally important ensuring that people with dementia receive equitable care.	[Sagbakken, Mette] OsloMet Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, Fac Hlth Sci, Oslo, Norway; [Ingebretsen, Reidun] OsloMet Oslo Metropolitan Univ, Norwegian Social Res NOVA, Oslo, Norway; [Spilker, Ragnhild Storstein] Norwegian Inst Publ Hlth, Unit Migrat & Hlth, Oslo, Norway	Oslo Metropolitan University (OsloMet); Oslo Metropolitan University (OsloMet); Norwegian Institute of Public Health (NIPH)	Sagbakken, M (corresponding author), OsloMet Oslo Metropolitan Univ, Dept Nursing & Hlth Promot, Fac Hlth Sci, Oslo, Norway.	metsa@oslomet.no	Giacalone, Laura/AHD-0203-2022		Norwegian Directorate of Health	Norwegian Directorate of Health	The study was supported by the Norwegian Directorate of Health. The financial sponsor played no role in the design, execution, analysis and interpretation of data.	Agotnes G., 2017, I PRACTICE NURSING H; [Anonymous], 2014, 20148 NOU MIN CHILDR; [Anonymous], 2002, 200229 SOU SWED GOV; Antelius E, 2016, ANTHROPOL AGING, V37, P9, DOI 10.5195/aa.2016.107; Antelius Eleonor, 2015, Care Manag J, V16, P79; Barrett AE, 2003, J GERONTOL B-PSYCHOL, V58, pS101, DOI 10.1093/geronb/58.2.S101; BAUM SK, 1983, GERONTOLOGIST, V23, P532, DOI 10.1093/geront/23.5.532; Botsford J, 2011, J RES NURS, V16, P437, DOI 10.1177/1744987111414531; Bowes A, 2003, HEALTH SOC CARE COMM, V11, P387, DOI 10.1046/j.1365-2524.2003.00440.x; Connolly A, 2012, J AM GERIATR SOC, V60, P351, DOI 10.1111/j.1532-5415.2011.03754.x; Cooper C, 2018, INT J GERIATR PSYCH, V33, P504, DOI 10.1002/gps.4786; Cooper C, 2010, AM J GERIAT PSYCHIAT, V18, P193, DOI 10.1097/JGP.0b013e3181bf9caf; Daker-White G, 2002, AGING MENT HEALTH, V6, P101, DOI 10.1080/13607860220126835; Davies AA, 2014, MIGRATION SOCIAL DET; Debesay J, 2014, J ADV NURS, V70, P2107, DOI 10.1111/jan.12369; Diaz E, 2015, DEMENT GERIATR COGN, V39, P321, DOI 10.1159/000375526; Ekman S L, 1994, Int Psychogeriatr, V6, P105, DOI 10.1017/S1041610294001675; EKMAN SL, 1993, INT J AGING HUM DEV, V37, P37, DOI 10.2190/NU87-FGP0-CNEU-DCH5; Erikson E, 1986, VITAL INVOLVEMENT OL; European Parliament and Council of the European Union, 2002, OFF J EUR UNION L, V037, P19; Folkehelseinstituttet [Norwegian Institute of Public Health], 2018, FOLK; Goral M, 2013, ANNU REV APPL LINGUI, V33, P128, DOI 10.1017/S026719051300010X; Harper S, 2005, SOC POLICY SOC, V4, P157, DOI 10.1017/S1474746404002295; Heikkila K, 2007, SCAND J CARING SCI, V21, P354, DOI 10.1111/j.1471-6712.2007.00480.x; Hill Collins P., 1991, BLACK FEMINIST THOUG; Hossain M, 2020, DEMENTIA-LONDON, V19, P1441, DOI 10.1177/1471301218800641; Hossain MZ, 2020, J EVAL CLIN PRACT, V26, P1629, DOI 10.1111/jep.13361; Hossain MZ, 2019, J EVAL CLIN PRACT, V25, P769, DOI 10.1111/jep.13117; Hyden LC, 2013, J INTERACT RES COM D, V4, P211, DOI 10.1558/jircd.v4i2.211; Iliffe S, 2004, AGING MENT HEALTH, V8, P283, DOI 10.1080/13607860410001709656; IMDi, 2020, INNV ARB; JONES DC, 1986, J ADV NURS, V11, P265, DOI 10.1111/j.1365-2648.1986.tb01247.x; Jonson H, 2018, EUR J SOC WORK, V21, P235, DOI 10.1080/13691457.2017.1288087; Jutlla K., 2013, J DEMENTIA CARE, V21, P33; Kiwi M, 2018, J CROSS-CULT GERONTO, V33, P21, DOI 10.1007/s10823-017-9337-1; KOENIG BA, 1995, WESTERN J MED, V163, P244; Kvale S., 2015, INTERVIEW LEARNING C, V3rd; Leininger M, 1991, J Transcult Nurs, V2, P32, DOI 10.1177/104365969100200205; Leininger M, 2007, NURS SCI QUART, V20, P9, DOI 10.1177/0894318406296784; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lucy JA, 1997, ANNU REV ANTHROPOL, V26, P291, DOI 10.1146/annurev.anthro.26.1.291; Mackenzie J., 2006, DEMENTIA, V5, P233, DOI [10.1177/1471301206062252, DOI 10.1177/1471301206062252]; MacLean MJ, 1986, INT SOCIAL WORK, V29, P227; McCleary L., 2013, INDIAN J GERONTOL, V27, P178; McFarland MR, 1997, NURS SCI QUART, V10, P186, DOI 10.1177/089431849701000412; Mold F, 2005, AGE AGEING, V34, P107, DOI 10.1093/ageing/afi009; Moriarty J., 2011, BLACK MINORITY ETHNI; Mukadam N, 2011, INT J GERIATR PSYCH, V26, P12, DOI 10.1002/gps.2484; Nielsen TR, 2011, DEMENT GERIATR COGN, V31, P388, DOI 10.1159/000327362; Norwegian Directorate of Health, 2015, ALZH ANDR DEM; Norwegian Directorate of Health, 2017, NASJ FAGL RETN DEM; Norwegian Institute of Public Health, 2016, DEM NORW PUBL HLTH R; Patton MQ, 2002, QUALITATIVE RES EVAL; Phillimore J, 2016, IRIS WORKING PAPER S, V15; Plejert C, 2014, J CROSS-CULT GERONTO, V29, P1, DOI 10.1007/s10823-013-9217-2; Prince R, 2017, DEMENTIA ETHNIC MINO; Ringard A, 2013, HEALT SYST TRANSIT, V15, P1; Rosendahl SP, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0200-y; Runci S, 1999, Int Psychogeriatr, V11, P301, DOI 10.1017/S1041610299005864; Runci SJ, 2005, INT PSYCHOGERIATR, V17, P699, DOI 10.1017/S1041610205002309; Runci SJ, 2005, AUSTRALAS J AGEING, V24, P157, DOI 10.1111/j.1741-6612.2005.00106.x; Runci SJ, 2012, INT PSYCHOGERIATR, V24, P733, DOI 10.1017/S1041610211002134; Sagbakken M, 2019, AGEING SOC, P1; Sagbakken M, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3720-7; Sagbakken M, 2018, QUAL HEALTH RES, V28, P16, DOI 10.1177/1049732317730818; Seeberg ML, 2012, EUR J WOMENS STUD, V19, P173, DOI 10.1177/1350506811434665; Sjogren K, 2013, J ADV NURS, V69, P2196, DOI 10.1111/jan.12085; Strandroos L, 2017, HEALTH-LONDON, V21, P538, DOI 10.1177/1363459316677626; TOnnessen M, OKONOMISKE ANAL 3 20; Torres S, 2006, J ETHN MIGR STUD, V32, P1341, DOI 10.1080/13691830600928730; Uppal G, 2014, MENT HEALTH RELIG CU, V17, P143, DOI 10.1080/13674676.2013.764515; Viruell-Fuentes EA, 2012, SOC SCI MED, V75, P2099, DOI 10.1016/j.socscimed.2011.12.037; Yee D L, 1992, J Health Care Poor Underserved, V2, P448	73	0	0	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243803	10.1371/journal.pone.0243803	http://dx.doi.org/10.1371/journal.pone.0243803			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351820	Green Published, gold			2022-12-27	WOS:000603071400054
J	Kehali, H; Berhane, Y; Gize, A				Kehali, Habtamu; Berhane, Yemane; Gize, Addisu			A phenomenological study on the lived experiences of families of ICU patients, Addis Ababa, Ethiopia	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; DECISION-MAKING; COMMUNICATION; MEMBERS; NEEDS	Background Family-centered care of ICU patients is increasingly recommended as it is believed to have effect on family members' psychosocial status and patient outcomes. Defining the nature and extent of families' involvement in a given health care environment for different stakeholders is a challenge. Understanding the lived experiences of families of ICU patients would help strategize on how to better engage family members for improved ICU care processes and outcomes. Objectives The aim of this study is to explore the lived experiences of families of patients in the ICUs of hospitals in Addis Ababa, Ethiopia. Methods The study adopted a qualitative approach and a phenomenological research design. In-depth interviews were conducted with twelve (12) family members who were purposively sampled from two government hospitals and four private hospitals. Thematic approach with the application of hermeneutic circle of interpretation was applied to understand the meanings of their experiences. Results The study revealed the following major themes: financial burden, challenge in decision making, shattered family integrity and expectations, information and communication gap between family members and health professionals, lack of confidence in the service delivery of hospitals, social pressure against patient families, and families being immersed in an unfriendly environment. Though they do not explicitly mention it to the health care tram, further interpretation of the main themes elucidated that family's need the intensive care process be cut shorter irrespective of the outcome of the patient condition. Conclusion The study gave an insight on the multiple and interrelated challenges faced by families of ICU patients admitted in the hospitals of Addis Ababa. Further contextualized interpretation of their experiences revealed that families were somehow in a state of despair and they implicitly need the ICU care for their family member be ended irrespective of the potential clinical consequences on the patient. The philosophy of family-centered care be advocated in hospitals. The study result affirms the need to include family members during nursing assessment of patients in ICUs and also offers the basis for guidelines development on informational support to the families of the patients hospitalized in ICUs.	[Kehali, Habtamu; Gize, Addisu] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia	Addis Continental Institute of Public Health	Gize, A (corresponding author), St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia.	addisu.gize@sphmmc.edu.et						[Anonymous], 2012, Manag Care, V21, P43; [Anonymous], 2012, CHALLENGES CRITICAL; Asrat A, 2014, INT J MED MED SCI, V6, P195, DOI [10.5897/IJMMS2013.0883, DOI 10.5897/IJMMS2013.0883]; Auerbach SM, 2005, AM J CRIT CARE, V14, P202, DOI 10.4037/ajcc2005.14.3.202; Azoulay E, 2004, CRIT CARE MED, V32, P1832, DOI 10.1097/01.CCM.0000139693.88931.59; Birhanu Z, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-78; Curtis JR, 2006, CRIT CARE MED, V34, P211, DOI 10.1097/01.CCM.0000190617.76104.AC; Dahlgren Lars, 2007, QUALITATIVE METHODOL; Epstein EG, 2016, APPL NURS RES, V32, P286, DOI 10.1016/j.apnr.2016.08.011; Eriksson Thomas, 2011, Intensive Crit Care Nurs, V27, P60, DOI 10.1016/j.iccn.2011.01.001; Fritsch Jenna, 2013, J Clin Ethics, V24, P125; Hashim F, 2012, PROCD SOC BEHV, V36, P103, DOI 10.1016/j.sbspro.2012.03.012; Heyland DK, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2379-4; Hickman RL, 2010, AACN ADV CRIT CARE, V21, P80, DOI 10.1097/NCI.0b013e3181c930a3; Hinkle Janice L, 2011, Intensive Crit Care Nurs, V27, P218, DOI 10.1016/j.iccn.2011.04.003; Hoye Sevald, 2010, Intensive Crit Care Nurs, V26, P24, DOI 10.1016/j.iccn.2009.10.003; Iverson E, 2014, INTENS CRIT CARE NUR, V30, P77, DOI 10.1016/j.iccn.2013.08.008; Kruisselbrink R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151408; McKiernan Margaret, 2010, Intensive Crit Care Nurs, V26, P254, DOI 10.1016/j.iccn.2010.06.004; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Olding M, 2016, HEALTH EXPECT, V19, P1183, DOI 10.1111/hex.12402; Osborn TR, 2012, CHEST, V142, P1185, DOI 10.1378/chest.11-3277; Fortunatti CP, 2018, AUST CRIT CARE, V31, P318, DOI 10.1016/j.aucc.2017.08.003; Petty NJ, 2012, MANUAL THER, V17, P378, DOI 10.1016/j.math.2012.03.004; Prevett M, 2012, ETHIOP J HEALTH SCI, V22, P1; Roche SD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214918; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Torke AM, 2012, PATIENT EDUC COUNS, V87, P54, DOI 10.1016/j.pec.2011.07.027; Wall JM, 2017, PSYCHOTHER RES, V27, P539, DOI 10.1080/10503307.2015.1136441; Woldemichael A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213896; Zewdneh D, 2011, ETHIOP J HEALTH DEV, V25, P3	31	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244073	10.1371/journal.pone.0244073	http://dx.doi.org/10.1371/journal.pone.0244073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338068	gold, Green Published			2022-12-27	WOS:000601313500002
J	Morin, KA; Eibl, JK; Caswell, JM; Rush, B; Mushquash, C; Lightfoot, NE; Marsh, DC				Morin, Kristen A.; Eibl, Joseph K.; Caswell, Joseph M.; Rush, Brian; Mushquash, Christopher; Lightfoot, Nancy E.; Marsh, David C.			Evaluating the effectiveness of concurrent opioid agonist treatment and physician-based mental health services for patients with mental disorders in Ontario, Canada	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; METHADONE-MAINTENANCE; PSYCHIATRIC COMORBIDITY; SEPTIC ARTHRITIS; FREQUENT USERS; HEROIN USERS; EMERGENCY; OVERDOSE; THERAPIES; DIAGNOSIS	Objective The objective of this study was to evaluate the relationship between concurrent physician-based mental health services, all-cause mortality, and acute health service use for individuals enrolled in Opioid Agonist Treatment in Ontario, Canada. Methods A cohort study of patients enrolled in opioid agonist treatment in Ontario was conducted between January 1, 2011, and December 31, 2015, in Ontario with an inverse probability of treatment weights using the propensity score to estimate the effect of physician-based mental health services. Treatment groups were created based on opioid agonist treatment patients' utilization of physician-based mental health services. Propensity score weighted odds ratios were calculated to assess the relationship between the treatment groups and the outcomes of interest. The outcomes included all-cause mortality using data from the Registered Persons Database, Emergency Department visits from the National Ambulatory Care Database, and hospitalizations using data from the Discharge Abstract Database. Encrypted patient identifiers were used to link across databases. Results A total of 48,679 individuals in OAT with mental disorders. Opioid agonist treatment alone was associated with reduced odds of all-cause mortality (odds ratio (OR) 0.4, 95% confidence interval (CI) 0.3-0.4). Patients who received mental health services from a psychiatrist and primary care physician while engaged in OAT, the estimated rate of ED visits per year was higher (OR = 1.3, 95% CI 1.2-1.4) and the rate of hospitalizations (OR = 0.5, 95% CI 0.4-0.6) than in the control group. Conclusion Our findings support the view that opioid agonist treatment and concurrent mental health services can improve clinical outcomes for complex patients, and is associated with enhanced use of acute care services.	[Morin, Kristen A.; Mushquash, Christopher; Marsh, David C.] Northern Ontario Sch Med, Sudbury, ON, Canada; [Eibl, Joseph K.] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Caswell, Joseph M.] ICES North, Sudbury, ON, Canada; [Rush, Brian; Marsh, David C.] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Mushquash, Christopher] Lakehead Univ, Thunder Bay, ON, Canada; [Lightfoot, Nancy E.; Marsh, David C.] Laurentian Univ, Sudbury, ON, Canada; [Marsh, David C.] Canadian Addict Treatment Ctr, Markam, ON, Canada	Northern Ontario School of Medicine; Health Sciences North; Northern Ontario School of Medicine; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Lakehead University; Laurentian University	Marsh, DC (corresponding author), Northern Ontario Sch Med, Sudbury, ON, Canada.; Marsh, DC (corresponding author), Ctr Addict & Mental Hlth, Toronto, ON, Canada.; Marsh, DC (corresponding author), Laurentian Univ, Sudbury, ON, Canada.; Marsh, DC (corresponding author), Canadian Addict Treatment Ctr, Markam, ON, Canada.	dmarsh@nosm.ca		Marsh, David C./0000-0002-8769-1785	Northern Ontario Academic Medical Association from the Academic Funding Plan Innovation Fund [A-17-05]	Northern Ontario Academic Medical Association from the Academic Funding Plan Innovation Fund	We received funding from the Northern Ontario Academic Medical Association from the Academic Funding Plan Innovation Fund: project No: A-17-05 to conduct this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This funding contributed to K.A. Morin's postdoctoral fellowship salary.	Althaus F, 2011, ANN EMERG MED, V58, P41, DOI 10.1016/j.annemergmed.2011.03.007; Amato L, 2005, J SUBST ABUSE TREAT, V28, P321, DOI 10.1016/j.jsat.2005.02.007; Amato L, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004147.pub4; ANDREN KG, 1987, SOC SCI MED, V25, P825, DOI 10.1016/0277-9536(87)90040-2; [Anonymous], KINGST FRONT ADD PUB; [Anonymous], 2011, HLTH PROTECTION REPO, V5, P28; [Anonymous], 2011, METH MAINT TREATM PR; Astals M, 2008, SUBST USE MISUSE, V43, P612, DOI 10.1080/10826080701204813; Astals M, 2009, INT J ENV RES PUB HE, V6, P2822, DOI 10.3390/ijerph6112822; Austin PC, 2017, STAT METHODS MED RES, V26, P1654, DOI 10.1177/0962280215584401; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Ball C, 1991, EFFECTIVENESS METHAD; Bart G, 2012, J ADDICT DIS, V31, P207, DOI 10.1080/10550887.2012.694598; Bekele T, 2018, AIDS BEHAV, V22, P2214, DOI 10.1007/s10461-018-2040-6; Bogdanowicz KM, 2015, DRUG ALCOHOL DEPEN, V148, P85, DOI 10.1016/j.drugalcdep.2014.12.025; Brooner RK, 2013, ADDICTION, V108, P1942, DOI 10.1111/add.12269; Brugal MT, 2005, ADDICTION, V100, P981, DOI 10.1111/j.1360-0443.2005.01089.x; Canadian Food Inspection Agency, 2019, RURAL NO COMMUNITY I, P1; Canadian Institute for Health Information, 2017, PAN CAN TRENDS PRESC; Canadian Institute of Health Information, 2014, SOURC POT AV EM  DEP; Canadian Mental Health Association Ontario, 2016, ADDR MENT HLTH ADD N; Davis KAS, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0963-x; Dhalla IA, 2011, CAN FAM PHYSICIAN, V57, pE92; Dugosh K, 2016, J ADDICT MED, V10, P93, DOI 10.1097/ADM.0000000000000193; Durbin J., 2010, STUDY HOSP EMERGENCY; Enhancing the Continuum of Care, 2011, ENH CONT CAR REP AV; Forbes A, 2007, STAT MED; Galea S, 2002, PUBLIC HEALTH REP, V117, pS135; Gao L, 2019, DRUG ALCOHOL DEPEN, V197, P262, DOI 10.1016/j.drugalcdep.2019.01.019; Gomes T, 2017, LATEST TRENDS OPIOID; Gomes Tara, 2011, Healthc Q, V14, P22; Government of Canada, 2020, OP REL HARMS CAN; Grogan CM, 2016, HEALTH AFFAIR, V35, P2289, DOI 10.1377/hlthaff.2016.0623; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; Hassan AN, 2017, DRUG ALCOHOL DEPEN, V179, P260, DOI 10.1016/j.drugalcdep.2017.07.012; Hazlett SB, 2004, ACAD EMERG MED, V11, P193, DOI 10.1197/j.aem.2003.09.014; Health Canada, 2002, METH MAINT THER; Health Canada National report, 2018, HLTH CAN NAT REP APP; Health Quality Ontario, 2017, UND EM DEP PERF ONT; Howlett K, 2017, CANADAS EXPENSIVE HA; Juurlink DN, 2009, CIRCULATION, V120, P2310, DOI 10.1161/CIRCULATIONAHA.109.907295; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Kalvik API., 2012, BUPRENORPHINE TREATM; Kraft MK, 1997, AM J PSYCHIAT, V154, P1214; Kurdyak PA, 2014, OPEN MED, V8, P87; Leslie K., 2016, CTV NEWS; Leslie S., 2007, SAS GLOBAL FORUM; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Ma J, 2018, MOL PSYCHIATR, DOI [10.1038/s41380-018-0094-5, DOI 10.1038/S41380-018-0094-529934549]; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Martins DGS., 2016, OPIOID USE RELATED A; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Mattoo SK, 2009, INDIAN J MED RES, V130, P702; Meltzer EC, 2012, J BEHAV HEALTH SER R, V39, P190, DOI 10.1007/s11414-011-9263-x; Moineddin R, 2011, BMC EMERG MED, V11, DOI 10.1186/1471-227X-11-13; Morin K. A, 2018, J CLIN PSYCHIAT; Morin KA, 2020, HARM REDUCT J, V17, DOI 10.1186/s12954-020-00396-x; Morin KA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232191; Nosyk B, 2010, J SUBST ABUSE TREAT, V39, P22, DOI 10.1016/j.jsat.2010.03.008; Nutt DS M., 2009, POSTTRAUMATIC STRESS; Nuttall GA, 2008, ANESTHESIOLOGY, V108, P3, DOI 10.1097/01.anes.0000296718.35703.20; O'Grady CL, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-9; Okin RL, 2000, AM J EMERG MED, V18, P603, DOI 10.1053/ajem.2000.9292; Oquendo MA, 2018, NEW ENGL J MED, V378, P1567, DOI 10.1056/NEJMp1801417; Peterson TC, 2014, J EMERG MED, V47, P723, DOI 10.1016/j.jemermed.2014.06.059; Pope D, 2000, CAN MED ASSOC J, V162, P1017; Rush, 2016, NE LHIN ADD SERV REV; Rutherford AI, 2016, RHEUMATOLOGY, V55, P2176, DOI 10.1093/rheumatology/kew323; SAS, 2020, VERS 9 4; Stein MD, 2017, DRUG ALCOHOL DEPEN, V179, P325, DOI 10.1016/j.drugalcdep.2017.07.007; Sullivan LE, 2005, ADDICTION, V100, P150, DOI 10.1111/j.1360-0443.2004.00963.x; Tsui JI, 2014, JAMA INTERN MED, V174, P1974, DOI 10.1001/jamainternmed.2014.5416; Urbanoski KA, 2008, PSYCHIAT SERV, V59, P283, DOI 10.1176/appi.ps.59.3.283; Vickerman KA, 2007, PROF PSYCHOL-RES PR, V38, P620, DOI 10.1037/0735-7028.38.6.620; Volkow ND, 2014, NEW ENGL J MED, V370, P2063, DOI 10.1056/NEJMp1402780; von Elm E, 2008, REV ESP SALUD PUBLIC, V82, P251; Weinstein D, 2000, CLIN PSYCHOL REV, V20, P359, DOI 10.1016/S0272-7358(98)00107-X; WOODY GE, 1995, AM J PSYCHIAT, V152, P1302; Wurcel AG, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw157	80	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243317	10.1371/journal.pone.0243317	http://dx.doi.org/10.1371/journal.pone.0243317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338065	gold, Green Published			2022-12-27	WOS:000601313500008
J	Adamo, M; Voyron, S; Chialva, M; Marmeisse, R; Girlanda, M				Adamo, Martino; Voyron, Samuele; Chialva, Matteo; Marmeisse, Roland; Girlanda, Mariangela			Metabarcoding on both environmental DNA and RNA highlights differences between fungal communities sampled in different habitats	PLOS ONE			English	Article							RIBOSOMAL-RNA; ECTOMYCORRHIZAL FUNGI; MICROBIAL ACTIVITY; SOIL; DIVERSITY; FOREST; DECOMPOSITION; PLANT; WOOD; IDENTIFICATION	In recent years, metabarcoding has become a key tool to describe microbial communities from natural and artificial environments. Thanks to its high throughput nature, metabarcoding efficiently explores microbial biodiversity under different conditions. It can be performed on environmental (e)DNA to describe so-called total microbial community, or from environmental (e)RNA to describe active microbial community. As opposed to total microbial communities, active ones exclude dead or dormant organisms. For what concerns Fungi, which are mostly filamentous microorganisms, the relationship between DNA-based (total) and RNA-based (active) communities is unclear. In the present study, we evaluated the consequences of performing metabarcoding on both soil and wood-extracted eDNA and eRNA to delineate molecular operational taxonomic units (MOTUs) and differentiate fungal communities according to the environment they originate from. DNA and RNA-based communities differed not only in their taxonomic composition, but also in the relative abundances of several functional guilds. From a taxonomic perspective, we showed that several higher taxa are globally more represented in either "active" or "total" microbial communities. We also observed that delineation of MOTUs based on their co-occurrence among DNA and RNA sequences highlighted differences between the studied habitats that were overlooked when all MOTUs were considered, including those identified exclusively by eDNA sequences. We conclude that metabarcoding on eRNA provides original functional information on the specific roles of several taxonomic or functional groups that would not have been revealed using eDNA alone.	[Adamo, Martino] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, INRAE,VetAgro Sup,UMR Ecol Microbienne, Villeurbanne, France; [Adamo, Martino; Voyron, Samuele; Chialva, Matteo; Marmeisse, Roland; Girlanda, Mariangela] Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Turin, Italy; [Voyron, Samuele; Girlanda, Mariangela] CNR, Ist Protez Piante, Turin, Italy; [Marmeisse, Roland] Univ Antilles, Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat,Evolut,Biodivers ISYEB,CNRS,EPHE, Paris, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; University of Turin; Consiglio Nazionale delle Ricerche (CNR); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Girlanda, M (corresponding author), Univ Torino, Dipartimento Sci Vita & Biol Sistemi, Turin, Italy.; Girlanda, M (corresponding author), CNR, Ist Protez Piante, Turin, Italy.	mariangela.girlanda@unito.it	Chialva, Matteo/I-2751-2019; ADAMO, MARTINO/ABD-3211-2020	Chialva, Matteo/0000-0002-6996-6642; ADAMO, MARTINO/0000-0001-7571-3505; Marmeisse, Roland/0000-0003-1653-3517	Agence nationale de la recherche, (France) [ANR-RF-2015-01]; DFG (Deutsche Forschungsgemeinschaft, Germany); "Region Auvergne-Rhone-Alpes" CMIRA fellowship	Agence nationale de la recherche, (France)(French National Research Agency (ANR)); DFG (Deutsche Forschungsgemeinschaft, Germany)(German Research Foundation (DFG)); "Region Auvergne-Rhone-Alpes" CMIRA fellowship	Experiments were performed in the framework of the PeroxiDiv project co-funded by the Agence nationale de la recherche, (France, project ANR-RF-2015-01) and the DFG (Deutsche Forschungsgemeinschaft, Germany). MA was the recipient of a "Region Auvergne-Rhone-Alpes" CMIRA fellowship grant to support his work at the University of Lyon.	Adamo M, 2017, CAN J MICROBIOL, V63, P841, DOI 10.1139/cjm-2017-0230; Aliyu H, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01676-18; Anderson IC, 2008, SOIL BIOL BIOCHEM, V40, P2358, DOI 10.1016/j.soilbio.2008.05.015; Anderson IC, 2007, J MICROBIOL METH, V68, P248, DOI 10.1016/j.mimet.2006.08.005; Badotti F, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0958-x; Baldrian P, 2016, FUNGAL ECOL, V23, P109, DOI 10.1016/j.funeco.2016.07.001; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Barnard RL, 2013, ISME J, V7, P2229, DOI 10.1038/ismej.2013.104; Bastias BA, 2007, SOIL BIOL BIOCHEM, V39, P3108, DOI 10.1016/j.soilbio.2007.06.022; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Blaser S, 2013, FOREST ECOL MANAG, V304, P42, DOI 10.1016/j.foreco.2013.04.043; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Brabcova V, 2016, NEW PHYTOL, V210, P1369, DOI 10.1111/nph.13849; Brundrett M, 2004, BIOL REV, V79, P473, DOI 10.1017/S1464793103006316; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choma M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38455; Clemmensen KE, 2006, NEW PHYTOL, V171, P391, DOI 10.1111/j.1469-8137.2006.01778.x; Close D, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01238-16; Cox F, 2019, ENVIRON MICROBIOL, V21, P1586, DOI 10.1111/1462-2920.14533; Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574; Cristescu ME, 2019, TRENDS ECOL EVOL, V34, P694, DOI 10.1016/j.tree.2019.05.003; Damon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028967; Denef VJ, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00606, 10.3389/fmicb.2076.00606]; Desiro A, 2017, IMA FUNGUS, V8, P245, DOI 10.5598/imafungus.2017.08.02.03; Dinno A, 2015, STATA J, V15, P292, DOI 10.1177/1536867X1501500117; Dlott G, 2015, J MICROBIOL METH, V115, P112, DOI 10.1016/j.mimet.2015.05.027; Dowle E, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv089; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eyssartier G., 2011, GUIDE CHAMPIGNONS; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gardes M, 1996, NEW PHYTOL, V133, P147, DOI 10.1111/j.1469-8137.1996.tb04350.x; Genevieve L, 2019, FORESTS, V10, DOI 10.3390/f10121096; Griffith Gareth W., 2002, Botanical Journal of Scotland, V54, P7; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guardiola M, 2016, PEERJ, V4, DOI 10.7717/peerj.2807; Hamilton NE, 2018, J STAT SOFTW, V87, P1, DOI 10.18637/jss.v087.c03; Hemkemeyer M, 2019, EUR J SOIL BIOL, V94, DOI 10.1016/j.ejsobi.2019.103103; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hiscox J, 2016, ENVIRON MICROBIOL, V18, P1954, DOI 10.1111/1462-2920.13141; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Krishna MP, 2017, ENERGY ECOL ENVIRON, V2, P236, DOI 10.1007/s40974-017-0064-9; Lalev AI, 2001, J BIOL CHEM, V276, P16655, DOI 10.1074/jbc.M101157200; Laroche O, 2017, PEERJ, V5, DOI 10.7717/peerj.3347; Laroche O, 2016, MAR ENVIRON RES, V120, P225, DOI 10.1016/j.marenvres.2016.08.009; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Li J, 2019, SOIL BIOL BIOCHEM, V136, DOI 10.1016/j.soilbio.2019.107526; Lofgren LA, 2019, MOL ECOL, V28, P721, DOI 10.1111/mec.14995; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Makipaa R, 2017, ISME J, V11, P1964, DOI 10.1038/ismej.2017.57; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mueller RC, 2016, MICROB ECOL, V71, P57, DOI 10.1007/s00248-015-0655-y; Mundra S, 2016, MICROBIOLOGYOPEN, V5, P856, DOI 10.1002/mbo3.375; Navratilova D, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiy208; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Nicolas C, 2019, ISME J, V13, P977, DOI 10.1038/s41396-018-0331-6; Nilsson RH, 2019, NAT REV MICROBIOL, V17, P95, DOI 10.1038/s41579-018-0116-y; Noui A., 2019, Acta Agriculturae Slovenica, V114, P103, DOI 10.14720/aas.2019.114.1.12; Oksanen J., 2017, VEGAN ECOLOGICAL DIV, DOI DOI 10.1029/2006JF000545; Pauvert C, 2019, FUNGAL ECOL, V41, P23, DOI 10.1016/j.funeco.2019.03.005; Pawlowski J, 2014, MOL ECOL RESOUR, V14, P1129, DOI 10.1111/1755-0998.12261; Peter M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12662; Pochon X, 2015, MAR POLLUT BULL, V100, P370, DOI 10.1016/j.marpolbul.2015.08.022; Polme S, 2013, NEW PHYTOL, V198, P1239, DOI 10.1111/nph.12170; Purahong W, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00574; Purahong W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093700; R Development Core Team, 2009, R LANG ENV STAT COMP; Rayner A. D. M., 1979, Advances in Botanical Research, V7, P333, DOI 10.1016/S0065-2296(08)60090-7; Rineau F, 2013, ISME J, V7, P2010, DOI 10.1038/ismej.2013.91; Rinne KT, 2017, FUNCT ECOL, V31, P530, DOI 10.1111/1365-2435.12734; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; RStudio, 2021, RSTUDIO INT DEV ENV; Ruppert KM, 2019, GLOB ECOL CONSERV, V17, DOI 10.1016/j.gecco.2019.e00547; Saitta A, 2018, MYCORRHIZA, V28, P39, DOI 10.1007/s00572-017-0806-8; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt O., 2006, WOOD TREE FUNGI BIOL, P334, DOI [10.1007/3-540-32139-X, DOI 10.1007/3-540-32139-X]; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shi LL, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00080-19; SINDACO R., 2009, RETE NATURA 2000 PIE; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Springer, 1986, ADV PENICILLIUM ASPE, P255; Tallarida R.J., 1987, CHI SQUARE TEST MANU, P140, DOI DOI 10.1007/978-1-4612-4974-0_43; Tedersoo L, 2016, ISME J, V10, P346, DOI 10.1038/ismej.2015.116; Vargas-Gastelum L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv044; Visco JA, 2015, ENVIRON SCI TECHNOL, V49, P7597, DOI 10.1021/es506158m; Voyron S, 2017, NEW PHYTOL, V213, P1428, DOI 10.1111/nph.14286; Wagg C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12798-y; Wardle DA, 2014, SCIENCE, V346, P1052, DOI 10.1126/science.aaa1185; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066829; Wutkowska M, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03243; Yang X, 2017, AGR ECOSYST ENVIRON, V240, P24, DOI 10.1016/j.agee.2017.02.001; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zifcakova L, 2016, ENVIRON MICROBIOL, V18, P288, DOI 10.1111/1462-2920.13026	103	8	8	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244682	10.1371/journal.pone.0244682	http://dx.doi.org/10.1371/journal.pone.0244682			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378355	Green Published, gold			2022-12-27	WOS:000605651300037
J	Wang, XY; Lu, GQ; Zhao, LL; Yang, Q; Gao, TX				Wang, Xiaoyan; Lu, Guoqing; Zhao, Linlin; Yang, Qiao; Gao, Tianxiang			Assessment of fishery resources using environmental DNA: Small yellow croaker (Larimichthys polyactis) in East China Sea	PLOS ONE			English	Article							RIVER ESTUARY; CONSERVATION	Species distribution monitoring and biomass assessment are crucial for fishery management and resource conservation. However, traditional methods such as motor trawling are costly and less effective than the novel environmental DNA (eDNA) approach. This study employs eDNA approach to investigate horizontal and vertical distributions of small yellow croaker (Larimichthys polyactis), an economically important species, in the East China Sea. The analysis of 171 eDNA samples collected from 44 stations using the species-specific primers and Taqman probe suggests a presence of small yellow croaker at 28 sampling layers in 44 stations. Significant differences in croaker eDNA concentrations were revealed among sampling stations and layers, consistent with previous findings through motor-trawl capture offshore and nearshore ichthyoplakton surveys, indicating small yellow croaker exhibits strong regional distribution and layer preference. In addition, we found a high eDNA concentration of small yellow croaker in the surface waters beyond the motor-trawl prohibition line, which confirms spawning grounds have been expanded from nearshore to offshore areas. Such expansion of spawning grounds could be a response by small yellow croaker to stressors such as overfishing, climate change, and nearshore environment contamination. To identify environmental variables potentially associated with small yellow croaker presence and absence, we conducted a correlation analysis between eDNA concentration and environmental variables, and the results provide a guideline for further investigation of fishery resources in the future. In conclusion, this study demonstrates the power of the eDNA approach in monitoring small yellow croaker at extensive geographic scales. The developed protocols and the findings are expected to assist in long-term monitoring and protection programs and benefit sustainable fishery in small yellow croaker.	[Wang, Xiaoyan; Gao, Tianxiang] Zhejiang Ocean Univ, Natl Engn Res Ctr Marine Facil Aquaculture, Zhoushan, Peoples R China; [Lu, Guoqing] Univ Nebraska Omaha, Dept Biol, Omaha, NE USA; [Zhao, Linlin] Minist Nat Resources, Inst Oceanog 1, Qingdao, Peoples R China; [Yang, Qiao] Zhejiang Ocean Univ, ABI Grp, GPM Project, Zhoushan, Peoples R China	Chinese Academy of Sciences; Zhejiang Ocean University; University of Nebraska System; University of Nebraska Omaha; Ministry of Natural Resources of the People's Republic of China; Zhejiang Ocean University	Gao, TX (corresponding author), Zhejiang Ocean Univ, Natl Engn Res Ctr Marine Facil Aquaculture, Zhoushan, Peoples R China.	gaotianxiang0611@163.com	wang, xiaoyan/ABE-3431-2021	wang, xiaoyan/0000-0002-7520-541X	National Key Research and Development Program of China [2019YFD0901301]; National Natural Science Foundation of China [41806180, 41776171]; Shared Voyage Program of the National Natural Science Foundation of China in the East China Sea [NORC2019-02, Xiangyanghong 18]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shared Voyage Program of the National Natural Science Foundation of China in the East China Sea	This research was funded by the National Key Research and Development Program of China (2019YFD0901301), the National Natural Science Foundation of China (41806180, 41776171), the Shared Voyage Program of the National Natural Science Foundation of China in the East China Sea (NORC2019-02, Xiangyanghong 18).	Bylemans J, 2018, ENVIRON SCI TECHNOL, V52, P6408, DOI 10.1021/acs.est.8b01071; [陈佳杰 Chen Jiajie], 2010, [水产学报, Journal of Fisheries of China], V34, P236, DOI 10.3724/SP.J.1231.2010.06371; Cheung WWL, 2008, MAR ECOL PROG SER, V365, P187, DOI 10.3354/meps07414; Doi H, 2015, ENVIRON SCI TECHNOL, V49, P5601, DOI 10.1021/acs.est.5b00253; Evans NT, 2018, FISH RES, V197, P60, DOI 10.1016/j.fishres.2017.09.013; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Itakura H, 2019, AQUAT CONSERV, V29, P361, DOI 10.1002/aqc.3058; Jeunen G.J., 2020, ENV DNA, V2, P99, DOI [DOI 10.1002/EDN3.49, 10.1002/EDN3.49]; Jeunen GJ, 2019, MOL ECOL RESOUR, V19, P426, DOI 10.1111/1755-0998.12982; Kuroki M, 2020, PROG OCEANOGR, V180, DOI 10.1016/j.pocean.2019.102234; Lacoursiere-Roussel A, 2016, J APPL ECOL, V53, P1148, DOI 10.1111/1365-2664.12598; Levi T, 2019, MOL ECOL RESOUR, V19, P597, DOI 10.1111/1755-0998.12987; Lin LS, 2014, ACTA OCEANOL SIN, V33, P63, DOI 10.1007/s13131-014-0490-x; Lin LS, 2011, CHIN J OCEANOL LIMN, V29, P547, DOI 10.1007/s00343-011-0182-8; [林龙山 LIN LongShan], 2008, [生态学报, Acta Ecologica Sinica], V28, P3485; Lin N, 2018, FISHERIES SCI, V84, P357, DOI 10.1007/s12562-018-1177-6; Liu M, 2008, FISH FISH, V9, P219, DOI 10.1111/j.1467-2979.2008.00278.x; Mauvisseau Q, 2017, FISH RES, V191, P41, DOI 10.1016/j.fishres.2017.02.023; Minegishi Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222052; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Murakami H, 2019, FISHERIES SCI, V85, P327, DOI 10.1007/s12562-018-1282-6; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Seymour M, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0330-9; Shan XJ, 2013, MAR COAST FISH, V5, P65, DOI 10.1080/19425120.2013.768571; Stewart KA, 2019, BIODIVERS CONSERV, V28, P983, DOI 10.1007/s10531-019-01709-8; Taberlet P, 2018, ENVIRONMENTAL DNA: FOR BIODIVERSITY RESEARCH AND MONITORING; Takasu H, 2019, PLANKTON BENTHOS RES, V14, P320, DOI 10.3800/pbr.14.320; Takeuchi A, 2019, MAR ECOL PROG SER, V609, P187, DOI 10.3354/meps12828; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Tillotson MD, 2018, BIOL CONSERV, V220, P1, DOI 10.1016/j.biocon.2018.01.030; Wang L, 2015, FISH RES, V161, P86, DOI 10.1016/j.fishres.2014.06.006; Xiong Y, 2017, MAR BIOL RES, V13, P993, DOI 10.1080/17451000.2017.1319067; Xiong Y, 2016, ACTA OCEANOL SIN, V35, P34, DOI 10.1007/s13131-016-0844-7; [徐兆礼 XU Zhao-li], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P931; Yamada U., 2007, FISHES FISHERIES E C; Yatsuyanagi T., 2020, ENV DNA, V2, P130, DOI [10.1002/edn3.50, DOI 10.1002/EDN3.50]; Zhang J, 2015, ESTUAR WOR, P1, DOI 10.1007/978-3-319-16339-0_1; Zhang K, 2018, ACTA OCEANOL SIN, V37, P102, DOI 10.1007/s13131-018-1173-9	38	7	8	9	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244495	10.1371/journal.pone.0244495	http://dx.doi.org/10.1371/journal.pone.0244495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373404	Green Published, gold			2022-12-27	WOS:000603612300044
J	Colon, C; Brannstrom, A; Rovenskaya, E; Dieckmann, U				Colon, Celian; Braennstroem, Ake; Rovenskaya, Elena; Dieckmann, Ulf			Fragmentation of production amplifies systemic risks from extreme events in supply-chain networks	PLOS ONE			English	Article							COORDINATION; DYNAMICS	Climatic and other extreme events threaten the globalized economy, which relies on increasingly complex and specialized supply-chain networks. Disasters generate (i) direct economic losses due to reduced production in the locations where they occur, and (ii) to indirect losses from the supply shortages and demand changes that cascade along the supply chains. Firms can use inventories to reduce their risk of shortages. Since firms are interconnected through the supply chain, the level of inventory hold by one firm influences the risk of shortages of the others. Such interdependencies lead to systemic risks in supply chain networks. We introduce a stylized model of complex supply-chain networks in which firms adjust their inventory to maximize profit. We analyze the resulting risks and inventory patterns using evolutionary game theory. We report the following findings. Inventories significantly reduce disruption cascades and indirect losses at the expense of a moderate increase in direct losses. The more fragmented a supply chain is, the less beneficial it is for individual firms to maintain inventories, resulting in higher systemic risks. One way to mitigate such systemic risks is to prescribe inventory sizes to individual firms-a measure that could, for instance, be fostered by insurers. We found that prescribing firm-specific inventory sizes based on their position in the supply chain mitigates systemic risk more effectively than setting the same inventory requirements for all firms.	[Colon, Celian; Braennstroem, Ake; Dieckmann, Ulf] Int Inst Appl Syst Anal, Evolut & Ecol Program, Laxenburg, Austria; [Braennstroem, Ake] Umea Univ, Dept Math & Math Stat, Umea, Sweden; [Rovenskaya, Elena] Int Inst Appl Syst Anal, Adv Syst Anal Program, Laxenburg, Austria; [Rovenskaya, Elena] Moscow MV Lomonosov State Univ, Fac Computat Math & Cybernet, Optimal Control Dept, Moscow, Russia	International Institute for Applied Systems Analysis (IIASA); Umea University; International Institute for Applied Systems Analysis (IIASA); Lomonosov Moscow State University	Colon, C (corresponding author), Int Inst Appl Syst Anal, Evolut & Ecol Program, Laxenburg, Austria.	celian.colon@polytechnique.edu	Rovenskaya, Elena/CAF-1378-2022	Brannstrom, Ake/0000-0001-9862-816X	International Institute for Applied System Analysis (IIASA) through the Young Scientists Summer Program (YSSP)	International Institute for Applied System Analysis (IIASA) through the Young Scientists Summer Program (YSSP)	CC received a stipend from the International Institute for Applied System Analysis (IIASA, http://www.iiasa.ac.at/), through the Young Scientists Summer Program (YSSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allianz Global Corporate Specialty, 2012, MAN DISR SUPPL CHAIN; Atalay E, 2011, P NATL ACAD SCI USA, V108, P5199, DOI 10.1073/pnas.1015564108; Baldwin R, 2015, WORLD ECON, V38, P1682, DOI 10.1111/twec.12189; Barrot JN, 2016, Q J ECON, pqjw018; Bitran GR, 2007, MIT SLOAN MANAGE REV, V48, P30; Blackhurst J, 2005, INT J PROD RES, V43, P4067, DOI 10.1080/00207540500151549; Cachon GP, 2003, HDBK OPER R, V11, P229, DOI 10.1016/s0927-0507(03)11006-7; Cachon GP, 2005, MANAGE SCI, V51, P30, DOI 10.1287/mnsc.1040.0215; Chongvilaivan A, 2012, ARTNET WORKING PAPER; Christopher M., 2004, INT J LOGIST MANAG, V15, P1, DOI [10.1108/09574090410700275, DOI 10.1108/09574090410700275]; Colon C, 2017, CHAOS, V27, DOI 10.1063/1.5017851; Coluzzi B, 2011, INT J BIFURCAT CHAOS, V21, P3511, DOI 10.1142/S0218127411030702; Corsten D., 2003, INT J RETAIL DISTRIB, V31, P605, DOI DOI 10.1108/09590550310507731; Erdos P., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Fujiwara Y, 2010, EUR PHYS J B, V77, P565, DOI 10.1140/epjb/e2010-00275-2; Ghil M, 2011, NONLINEAR PROC GEOPH, V18, P295, DOI 10.5194/npg-18-295-2011; Gledhill R., 2013, BUSINESS NOT USUAL T; Glendon L, 2013, SUPPLY CHAIN RESILIE; Goldin I, 2010, GLOBALISATION RISKS; Hendricks KB, 2005, PROD OPER MANAG, V14, P35, DOI 10.1111/j.1937-5956.2005.tb00008.x; Hendricks KB, 2003, J OPER MANAG, V21, P501, DOI 10.1016/j.jom.2003.02.003; Hennet JC, 2008, ENG APPL ARTIF INTEL, V21, P399, DOI 10.1016/j.engappai.2007.10.003; Henriet F, 2012, J ECON DYN CONTROL, V36, P150, DOI 10.1016/j.jedc.2011.10.001; Hohn M.I., 2010, RELATIONAL SUPPLY CO, P19; Hummels D, 2001, J INT ECON, V54, P75, DOI 10.1016/S0022-1996(00)00093-3; Johnson, 2011, JAPANS 2011 EARTHQUA; Jones RW., 2005, INT REV ECON FINANC, V14, P305, DOI DOI 10.1016/J.IREF.2004.12.010; Karrer B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046110; Kim G, 2015, ADV ENG INFORM, V29, P139, DOI 10.1016/j.aei.2014.12.002; KPMG, 2013, GLOB MAN OUTL COMP A; Lambert D.M., 1998, INT J LOGIST MANAG, V9, P1, DOI [10.1108/09574099810805807, DOI 10.1108/09574099810805807]; LEVINE S, 1980, J THEOR BIOL, V83, P195, DOI 10.1016/0022-5193(80)90288-X; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; McCarter MW, 2007, J OPER MANAG, V25, P498, DOI 10.1016/j.jom.2006.05.005; Mizuno T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100712; Nagarajan M, 2008, EUR J OPER RES, V187, P719, DOI 10.1016/j.ejor.2006.05.045; National Research Council of the National Academies, 2007, NEW DIR UND SYST RIS; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Norrman A., 2004, International Journal of Physical Distribution & Logistics Management, V34, P434, DOI 10.1108/09600030410545463; OECD, 2020, INP OUTP TABL; Ohnishi T, 2010, J ECON INTERACT COOR, V5, P171, DOI 10.1007/s11403-010-0066-6; Osner R., 1982, NUTR FOOD SCI, V82, P13, DOI [DOI 10.1108/EB058904, 10.1108/eb058904]; PUNTER A, 2013, SUPPLY CHAIN FAILURE; Qin Y, 2011, EUR J OPER RES, V213, P361, DOI 10.1016/j.ejor.2010.11.024; Simatupang T.M., 2002, BUS PROCESS MANAG J, V8, P289, DOI [DOI 10.1108/14637150210428989, 10.1108/14637150210428989]; Snyder LV, 2016, IIE TRANS, V48, P89, DOI 10.1080/0740817X.2015.1067735; Srivastava SK, 2007, INT J MANAG REV, V9, P53, DOI 10.1111/j.1468-2370.2007.00202.x; Suguitan Jr AL, 2011, PLOS ONE, V6; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Todo Y, 2013, EVIDENCE GREAT E JAP; Trautrims A, 2009, J BUS LOGIST, V30, P231, DOI 10.1002/j.2158-1592.2009.tb00122.x; Wang Y.I., 2015, ROSS SCH BUSINESS WO, V1297; World Economic Forum, 2012, NEW MOD ADDR SUPPL C; Xu M, 2011, ADV COMPLEX SYST, V14, P649, DOI 10.1142/S0219525911003335; Zacharia ZG, 2011, J BUS LOGIST, V32, P40, DOI 10.1111/j.2158-1592.2011.01004.x	55	2	2	8	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244196	10.1371/journal.pone.0244196	http://dx.doi.org/10.1371/journal.pone.0244196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370350	Green Published, Green Accepted, gold			2022-12-27	WOS:000603611900008
J	Devereux, G; Wrolstad, D; Bourke, SJ; Daines, CL; Doe, S; Dougherty, R; Franco, R; Innes, A; Kopp, BT; Lascano, J; Layish, D; MacGregor, G; Murray, L; Peckham, D; Lucidi, V; Lovie, E; Robertson, J; Fraser-Pitt, DJ; O'Neil, DA				Devereux, Graham; Wrolstad, Danielle; Bourke, Stephen J.; Daines, Cori L.; Doe, Simon; Dougherty, Ryan; Franco, Rose; Innes, Alastair; Kopp, Benjamin T.; Lascano, Jorge; Layish, Daniel; MacGregor, Gordon; Murray, Lorna; Peckham, Daniel; Lucidi, Vincenzina; Lovie, Emma; Robertson, Jennifer; Fraser-Pitt, Douglas J.; O'Neil, Deborah A.			Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trial	PLOS ONE			English	Article							QUALITY-OF-LIFE; AZITHROMYCIN; AUTOPHAGY; OUTCOMES; DISEASE	Background Emerging data suggests a possible role for cysteamine as an adjunct treatment for pulmonary exacerbations of cystic fibrosis (CF) that continue to be a major clinical challenge. There are no studies investigating the use of cysteamine in pulmonary exacerbations of CF. This exploratory randomized clinical trial was conducted to answer the question: In future pivotal trials of cysteamine as an adjunct treatment in pulmonary exacerbations of CF, which candidate cysteamine dosing regimens should be tested and which are the most appropriate, clinically meaningful outcome measures to employ as endpoints? Methods and findings Multicentre double-blind randomized clinical trial. Adults experiencing a pulmonary exacerbation of CF being treated with standard care that included aminoglycoside therapy were randomized equally to a concomitant 14-day course of placebo, or one of 5 dosing regimens of cysteamine. Outcomes were recorded on days 0, 7, 14 and 21 and included sputum bacterial load and the patient reported outcome measures (PROMs): Chronic Respiratory Infection Symptom Score (CRISS), the Cystic Fibrosis Questionnaire-Revised (CFQ-R); FEV1, blood leukocyte count, and inflammatory markers. Eighty nine participants in fifteen US and EU centres were randomized, 78 completed the 14-day treatment period. Cysteamine had no significant effect on sputum bacterial load, however technical difficulties limited interpretation. The most consistent findings were for cysteamine 450mg twice daily that had effects additional to that observed with placebo, with improved symptoms, CRISS additional 9.85 points (95% CI 0.02, 19.7) p = 0.05, reduced blood leukocyte count by 2.46x10(9) /l (95% CI 0.11, 4.80), p = 0.041 and reduced CRP by geometric mean 2.57 nmol/l (95% CI 0.15, 0.99), p = 0.049. Conclusion In this exploratory study cysteamine appeared to be safe and well-tolerated. Future pivotal trials investigating the utility of cysteamine in pulmonary exacerbations of CF need to include the cysteamine 450mg doses and CRISS and blood leukocyte count as outcome measures.	[Devereux, Graham] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Wrolstad, Danielle] Precis Med Oncol & Rare Dis, Carlsbad, CA USA; [Bourke, Stephen J.; Doe, Simon] Royal Victoria Infirm, Newcastle, England; [Daines, Cori L.] Banner Univ, Arizona Med Ctr, Tucson, AZ USA; [Dougherty, Ryan] Calif Pacific Med Ctr, San Francisco Crit Care Med Grp, San Francisco, CA USA; [Franco, Rose] Med Coll Wisconsin, Froedtert Hosp, Milwaukee, WI 53226 USA; [Innes, Alastair] Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Kopp, Benjamin T.] Nationwide Childrens Hosp, Columbus, OH USA; [Lascano, Jorge] Univ Florida, Gainesville, FL USA; [Layish, Daniel] Cent Florida Pulm Grp, Orlando, FL USA; [MacGregor, Gordon] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland; [Murray, Lorna] Raigmore Hosp, Inverness, Scotland; [Peckham, Daniel] St James Univ Hosp, Leeds, W Yorkshire, England; [Lucidi, Vincenzina] Osped Padiat Bambino Gesu, Ctr Fibrosi Cist, Rome, Italy; [Lovie, Emma; Robertson, Jennifer; Fraser-Pitt, Douglas J.; O'Neil, Deborah A.] NovaBiot Ltd, Aberdeen, Scotland	Liverpool School of Tropical Medicine; California Pacific Medical Center; Medical College of Wisconsin; University of Edinburgh; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; State University System of Florida; University of Florida; Queen Elizabeth University Hospital (QEUH); Saint James's University Hospital	Fraser-Pitt, DJ (corresponding author), NovaBiot Ltd, Aberdeen, Scotland.	Doug@novabiotics.co.uk	ONeil, Deborah/GWN-2741-2022; Lascano, Jorge/AAR-5731-2020	Lascano, Jorge/0000-0002-9546-1867; Peckham, Daniel/0000-0001-7723-1868; Fraser-Pitt, Douglas/0000-0002-2846-6772; Lucidi, Vincenzina/0000-0003-3661-607X	NovaBiotics Ltd	NovaBiotics Ltd	This trial was funded and sponsored by sponsored by NovaBiotics Ltd (www.novabiotics.co.uk) who contributed to trial design, management, data analysis and interpretation, and the preparation, review, and decision to submit the manuscript for publication. The funder provided support in the form of salaries for authors [JR, EL, DFP and DO]. The specific roles of the salaried authors are articulated in the 'author contributions' section. No additional external funding was received for this study.	Al-Aloul M, 2014, J AEROSOL MED PULM D, V27, P299, DOI 10.1089/jamp.2013.1055; Bergamini A, 1996, J INFECT DIS, V174, P214, DOI 10.1093/infdis/174.1.214; Besouw M, 2013, DRUG DISCOV TODAY, V18, P785, DOI 10.1016/j.drudis.2013.02.003; Bocedi A, 2018, FEBS J, V285, P3225, DOI 10.1111/febs.14609; Britto MT, 2002, CHEST, V121, P64, DOI 10.1378/chest.121.1.64; Charrier C, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0189-2; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; Devereux G, 2016, CLIN DRUG INVEST, V36, P605, DOI 10.1007/s40261-016-0405-z; Devereux G, 2015, EBIOMEDICINE, V2, P1507, DOI 10.1016/j.ebiom.2015.08.018; Dohil R, 2014, FUND CLIN PHARM, V28, P123, DOI [10.1111/fcp.12018, DOI 10.1111/FCP.12018]; Domenech M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01992-16; DUPRE S, 1970, EUR J BIOCHEM, V16, P571, DOI 10.1111/j.1432-1033.1970.tb01119.x; Ferrari E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.476; Fraser-Pitt D, 2016, ANTIMICROB AGENTS CH, V60, P6200, DOI 10.1128/AAC.01198-16; Fraser-Pitt DJ, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00947-17; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Goss CH, 2013, PEDIAT PULMONOL, pA251; Goss Christopher H, 2007, Proc Am Thorac Soc, V4, P378, DOI 10.1513/pats.200703-039BR; Hegarty M, 2009, CHILD CARE HLTH DEV, V35, P462, DOI 10.1111/j.1365-2214.2008.00900.x; Jarad NA, 2012, QJM-INT J MED, V105, P137, DOI 10.1093/qjmed/hcr149; Labro MT, 2001, J CHEMOTHERAPY, V13, P3, DOI 10.1179/joc.2001.13.1.3; Moriya S, 2013, INT J ONCOL, V42, P1541, DOI 10.3892/ijo.2013.1870; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; Peckham D, 2017, J PATHOL, V241, P123, DOI 10.1002/path.4812; Quittner AL, 2009, CHEST, V135, P1610, DOI 10.1378/chest.08-1190; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Sanders DB, 2010, AM J RESP CRIT CARE, V182, P627, DOI 10.1164/rccm.200909-1421OC; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Scambler T, 2018, IMMUNOLOGY, V154, P563, DOI 10.1111/imm.12937; Shrestha CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186169; Smith DJ, 2014, J CYST FIBROS, V13, P289, DOI 10.1016/j.jcf.2013.12.001; Stamatiou R, 2009, EUR RESPIR J, V34, P721, DOI 10.1183/09031936.00089407; VanDevanter DR, 2017, J CYST FIBROS, V16, P607, DOI 10.1016/j.jcf.2017.04.004; Villella VR, 2013, AUTOPHAGY, V9, P1431, DOI 10.4161/auto.25517; West NE, 2017, J CYST FIBROS, V16, P600, DOI 10.1016/j.jcf.2017.04.003	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242945	10.1371/journal.pone.0242945	http://dx.doi.org/10.1371/journal.pone.0242945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370348	Green Published, gold, Green Accepted			2022-12-27	WOS:000603611900051
J	Ziebell, L; Collin, C; Mazalu, M; Rainville, S; Weippert, M; Skolov, M				Ziebell, Laura; Collin, Charles; Mazalu, Monica; Rainville, Stephane; Weippert, Madyson; Skolov, Misha			Electromyographic evidence of reduced emotion mimicry in individuals with a history of non-suicidal self-injury	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; FACIAL EXPRESSIONS; PSYCHOMETRIC PROPERTIES; RESPONSES; ADOLESCENTS; DISPLAYS; FEATURES; BEHAVIOR; MODULATION; INVENTORY	Engaging in facial emotion mimicry during social interactions encourages empathy and functions as a catalyst for interpersonal bonding. Decreased reflexive mirroring of facial expressions has been observed in individuals with different non-psychotic disorders, relative to healthy controls. Given reports of interpersonal relationship difficulties experienced by those who engage in non-suicidal self-injury (NSSI), it is of interest to explore facial emotion mimicry in individuals with a history of this behaviour (HNSSI). Among other things, this will enable us to better understand their emotion regulation and social interaction challenges. Surface facial electromyography (fEMG) was used to record the reflexive facial mimicry of 30 HNSSI and 30 controls while they passively observed a series of dynamic facial stimuli showing various facial expressions of emotion. Beginning with a neutral expression, the stimuli quickly morphed to one of 6 prototypic emotional expressions (anger, fear, surprise, disgust, happiness, or sadness). Mimicry was assessed by affixing surface electrodes to facial muscles known to exhibit a high degree of electrical activity in response to positive and negative emotions: the corrugator supercilii and the zygomaticus major. HNSSI participants, relative to controls, exhibited significantly less electrical activity in the corrugator muscle in response to viewing angry stimuli, and significantly less of an expected relaxation in muscle activity in response to viewing happy stimuli. Mirroring these results, greater endorsement of social influence as a motivator for engaging in NSSI was associated with less mimicry, and greater endorsement of emotion regulation as a motivator was associated with greater incongruent muscle response when viewing happy faces. These findings lend support to the theory that social interaction difficulties in HNSSI might be related to implicit violations of expected social rules exhibited through facial mimicry nonconformity.	[Ziebell, Laura; Collin, Charles; Mazalu, Monica; Weippert, Madyson; Skolov, Misha] Univ Ottawa, Dept Psychol, Ottawa, ON, Canada; [Rainville, Stephane] VizirLabs Consulting, Chelsea, PQ, Canada; [Weippert, Madyson] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Skolov, Misha] Carleton Univ, Dept Psychol, Ottawa, ON, Canada	University of Ottawa; University of Toronto; Carleton University	Ziebell, L (corresponding author), Univ Ottawa, Dept Psychol, Ottawa, ON, Canada.	lzieb079@uottawa.ca		Ziebell, Laura/0000-0003-4145-0254	Canadian Institutes of Health Research [201310GAD]; Natural Sciences and Engineering Research Council of Canada [2015-05067]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by funding from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to LZ under Grant 201310GAD; and the Natural Sciences and Engineering Research Council of Canada (https://www.nserc-crsng.gc.ca/index_eng.asp) to CC under Grant 2015-05067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VizirLabs Consulting did not provide any financial contributions to this research. The author, Ste ' phane Rainville, is the founder and sole employee of VizirLabs Consulting. No funding was provided to this research study by VizirLabs Consulting at any time and the co-author had no commercial interest in the outcome of this research. Dr. Rainville collaborated on this project by contributing to methodology, software, visualization, reviewing and editing, as solely directed by the primary author.	Achaibou A, 2008, NEUROPSYCHOLOGIA, V46, P1104, DOI 10.1016/j.neuropsychologia.2007.10.019; Adrian M, 2018, PROF PSYCHOL-RES PR, V49, P274, DOI 10.1037/pro0000200; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2007, EINLEITUNG VORLESUNG, V2, P167; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Butler EA, 2003, EMOTION, V3, P48, DOI 10.1037/1528-3542.3.1.48; Carlson JG, 1997, APPL PSYCHOPHYS BIOF, V22, P247, DOI 10.1007/BF02438979; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Davies H, 2016, NEUROSCI BIOBEHAV R, V64, P252, DOI 10.1016/j.neubiorev.2016.02.015; de Wied M, 2012, J ABNORM CHILD PSYCH, V40, P211, DOI 10.1007/s10802-011-9557-8; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 2000, PSYCHOPHYSIOLOGY, V37, P693, DOI 10.1111/1469-8986.3750693; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Fischer AH, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00475; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Fridlund AJ, 2014, HUMAN FACIAL EXPRESS; GOSSELIN P, 1995, CAN J EXP PSYCHOL, V49, P313, DOI 10.1037/1196-1961.49.3.313; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hall E.T., 1959, SILENT LANGUAGE, V948; Hatfield E., 1994, EMOTIONAL CONTAGION, P7, DOI [DOI 10.1017/CBO9781139174138, 10.1017/CBO9781139174138]; Hermans EJ, 2009, BIOL PSYCHOL, V80, P348, DOI 10.1016/j.biopsycho.2008.12.002; Herpertz SC, 2001, ARCH GEN PSYCHIAT, V58, P737, DOI 10.1001/archpsyc.58.8.737; Hess U, 2001, INT J PSYCHOPHYSIOL, V40, P129, DOI 10.1016/S0167-8760(00)00161-6; Hess U, 2017, PSYCHOPHYSIOLOGY, V54, P12, DOI 10.1111/psyp.12676; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Hess U, 2010, BIOL PSYCHOL, V84, P514, DOI 10.1016/j.biopsycho.2009.11.001; Hilt LM, 2008, J CONSULT CLIN PSYCH, V76, P63, DOI 10.1037/0022-006X.76.1.63; Huhnel I, 2018, COGNITION EMOTION, V32, P92, DOI 10.1080/02699931.2017.1284046; In-Albon T, 2013, CHILD ADOL PSYCH MEN, V7, DOI 10.1186/1753-2000-7-5; Jacobson CM, 2007, ARCH SUICIDE RES, V11, P129, DOI 10.1080/13811110701247602; Klonsky ED, 2011, PSYCHOL MED, V41, P1981, DOI 10.1017/S0033291710002497; Klonsky ED, 2008, J CONSULT CLIN PSYCH, V76, P22, DOI 10.1037/0022-006X.76.1.22; Klonsky ED, 2007, J CLIN PSYCHOL, V63, P1045, DOI 10.1002/jclp.20412; Klonsky ED, 2007, CLIN PSYCHOL REV, V27, P226, DOI 10.1016/j.cpr.2006.08.002; Klonsky ED, 2013, J ABNORM PSYCHOL, V122, P231, DOI 10.1037/a0030278; Klonsky ED, 2009, J PSYCHOPATHOL BEHAV, V31, P215, DOI 10.1007/s10862-008-9107-z; Knox J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/113004; Kopper BA, 1996, J COUNS PSYCHOL, V43, P158, DOI 10.1037/0022-0167.43.2.158; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Litz BT, 2000, J ABNORM PSYCHOL, V109, P26, DOI 10.1037/0021-843X.109.1.26; Lloyd-Richardson EE, 2007, PSYCHOL MED, V37, P1183, DOI 10.1017/S003329170700027X; Lundh LG, 2011, SCAND J PSYCHOL, V52, P476, DOI 10.1111/j.1467-9450.2011.00894.x; Lundh Lars-Gunnar, 2011, Depress Res Treat, V2011, P935871, DOI 10.1155/2011/935871; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; LUNDQVIST LO, 1995, SCAND J PSYCHOL, V36, P130, DOI 10.1111/j.1467-9450.1995.tb00974.x; LUNDQVIST LO, 1995, J PSYCHOPHYSIOL, V9, P203; Lydon DM, 2014, IRISH J PSYCHOL, V35, P106, DOI [10.1080/03033910.2014.982145, DOI 10.1080/03033910.2014.982145]; Maringer M, 2011, EMOTION, V11, P181, DOI 10.1037/a0022596; Martin J, 2013, PSYCHOL ASSESSMENT, V25, P1013, DOI 10.1037/a0032575; Mattes RM, 1995, SCHIZOPHR RES, V17, P249, DOI 10.1016/0920-9964(95)00014-3; Matzke B, 2014, PSYCHOPATHOLOGY, V47, P101, DOI 10.1159/000351122; Miller AB, 2018, J ADOLESCENT HEALTH, V63, P694, DOI 10.1016/j.jadohealth.2018.06.033; Mingzhe Jiang, 2015, 2015 IEEE International Conferences on Computer and Information Technology; Ubiquitous Computing and Communications; Dependable, Autonomic and Secure Computing; and Pervasive Intelligence and Computing (CIT/IUCC/DASC/PICOM). Proceedings, P981, DOI 10.1109/CIT/IUCC/DASC/PICOM.2015.148; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Muehlenkamp J, 2013, SUICIDE LIFE-THREAT, V43, P67, DOI 10.1111/j.1943-278X.2012.00128.x; Muehlenkamp Jennifer J, 2012, Child Adolesc Psychiatry Ment Health, V6, P10, DOI 10.1186/1753-2000-6-10; Neta M, 2009, EMOTION, V9, P640, DOI 10.1037/a0016819; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; Nixon MK, 2005, OTTAWA SELF INJURY I; Nock M.K., 2009, UNDERSTANDING NONSUI, DOI [DOI 10.1037/11875-001, 10.1037/11875-001]; Nock MK, 2008, J CONSULT CLIN PSYCH, V76, P28, DOI 10.1037/0022-006X.76.1.28; Nock MK, 2010, ANNU REV CLIN PSYCHO, V6, P339, DOI 10.1146/annurev.clinpsy.121208.131258; Nock MK, 2009, CURR DIR PSYCHOL SCI, V18, P78, DOI 10.1111/j.1467-8721.2009.01613.x; Nock MK, 2005, J ABNORM PSYCHOL, V114, P140, DOI 10.1037/0021-843X.114.1.140; Nock MK, 2004, J CONSULT CLIN PSYCH, V72, P885, DOI 10.1037/0022-006X.72.5.885; Piran N, 2005, J COUNS PSYCHOL, V52, P549, DOI 10.1037/0022-0167.52.4.549; Renneberg B, 2005, J BEHAV THER EXP PSY, V36, P183, DOI 10.1016/j.jbtep.2005.05.002; Roemer L, 2001, J TRAUMA STRESS, V14, P149, DOI 10.1023/A:1007895817502; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Rottenberg J, 2005, J ABNORM PSYCHOL, V114, P627, DOI 10.1037/0021-843X.114.4.627; Rozga A, 2013, DEVELOPMENTAL SCI, V16, P499, DOI 10.1111/desc.12062; Rymarczyk K, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00701; Rymarczyk K, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01853; Rymarczyk K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158534; Rymarczyk K, 2011, INT J PSYCHOPHYSIOL, V79, P330, DOI 10.1016/j.ijpsycho.2010.11.001; Scarpazza C, 2018, EXP BRAIN RES, V236, P195, DOI 10.1007/s00221-017-5118-x; Sonnby-Borgstrom M., 2009, NEUROPSYCHOANALYSIS, V11, P111, DOI DOI 10.1080/15294145.2009.10773602; Soussignan R, 2010, PSYCHOL MED, V40, P503, DOI 10.1017/S0033291709990377; Staebler K, 2011, PSYCHOL MED, V41, P1929, DOI 10.1017/S0033291711000080; Taffler S, 1999, MYOEL S; Turner BJ, 2012, SUICIDE LIFE-THREAT, V42, P36, DOI 10.1111/j.1943-278X.2011.00069.x; van Boxtel AV, 2009, OXFORD COMPANION EMO, P419; van Boxtel AV, 2009, OXFORD COMPANION EMO, P105; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; Van Kleef GA, 2009, CURR DIR PSYCHOL SCI, V18, P184, DOI 10.1111/j.1467-8721.2009.01633.x; Vonderlin E, 2011, KINDH ENTWICKL, V20, P111, DOI 10.1026/0942-5403/a000047; WALKER EF, 1993, AM J PSYCHIAT, V150, P1654; Waller G, 2003, INT J EAT DISORDER, V34, P118, DOI 10.1002/eat.10163; Wastell CA, 2002, J NERV MENT DIS, V190, P839, DOI 10.1097/00005053-200212000-00006; Weyers P, 2009, PSYCHOPHYSIOLOGY, V46, P328, DOI 10.1111/j.1469-8986.2008.00771.x; Whitlock J, 2013, J ADOLESCENT HEALTH, V52, P486, DOI 10.1016/j.jadohealth.2012.09.010; Wilkinson P, 2011, AM J PSYCHIAT, V168, P495, DOI 10.1176/appi.ajp.2010.10050718; ZAJONC RB, 1989, PSYCHOL REV, V96, P395, DOI 10.1037/0033-295X.96.3.395; Zhu Y, 2016, N AM J PSYCHOL, V18, P45; Ziebell L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227019	96	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243860	10.1371/journal.pone.0243860	http://dx.doi.org/10.1371/journal.pone.0243860			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370320	gold, Green Published			2022-12-27	WOS:000603611900075
J	Darba, J; Marsa, A				Darba, Josep; Marsa, Alicia			Evaluation of productivity losses due to premature mortality from colorectal cancer	PLOS ONE			English	Article							SPAIN; COST; TRENDS; BURDEN	Cancer is responsible annually for around 27% of all deaths in Spain, 15% of which are caused by colorectal cancer. This malignancy has increased its incidence considerably over the past years, which surely impacts global productivity losses. The evaluation of lost productivity due to premature mortality provides valuable information that guides healthcare policies into the establishment of prevention and screening programs. The purpose of this study was to assess the productivity losses from premature deaths due to colorectal cancer over a ten year period (2008-2017). The costs derived from premature mortality due to this highly prevalent cancer were estimated using data on mortality, age- and sex-specific reference salaries and unemployment rates in Spain via the human capital approach. Between 2008 and 2017, 15,103 persons died per year from colorectal cancer, representing almost 15% of all cancer-related deaths. Annually, 25,333 years of potential productive life were estimated to be lost on average, 14,992 in males and 10,341 in females. Productivity losses summed euro510.8 million in in 2017, and the cancers of the colon and rectum accounted for 9.6% of cancer-related productivity losses in 2017 in Spain. Colorectal cancer has an important weight in terms of productivity losses within the Spanish population, consequently, prevention and early detection programmes should be promoted and implemented to achieve significant reductions in mortality and productivity losses.	[Darba, Josep] Univ Barcelona, Dept Econ, Barcelona, Spain; [Marsa, Alicia] BCN Hlth Econ & Outcomes Res SL, Dept Hlth Econ, Barcelona, Spain	University of Barcelona	Darba, J (corresponding author), Univ Barcelona, Dept Econ, Barcelona, Spain.	darba@ub.edu		Darba, Josep/0000-0003-2371-0999				Binefa G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19532; Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P1763, DOI 10.1093/jnci/djn384; Cabanes A, 2010, ANN ONCOL, V21, piii14, DOI 10.1093/annonc/mdq089; Corral J, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1297-6; Darba J, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6243-7; Esteva M, 2014, CANCER EPIDEMIOL, V38, P346, DOI 10.1016/j.canep.2014.05.002; Ferlay J, 2018, EUR J CANCER, V103, P356, DOI 10.1016/j.ejca.2018.07.005; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Galceran J, 2017, CLIN TRANSL ONCOL, V19, P799, DOI 10.1007/s12094-016-1607-9; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hanly P, 2014, EXPERT REV PHARM OUT, V14, P355, DOI 10.1586/14737167.2014.909287; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Lopez-Bastida J, 2010, EUR J HEALTH ECON, V11, P513, DOI 10.1007/s10198-010-0244-4; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Oliva-Moreno J, 2018, BREAST CANCER RES TR, V172, P571, DOI 10.1007/s10549-018-4963-z; Oliva-Moreno J, 2012, EUR J HEALTH ECON, V13, P605, DOI 10.1007/s10198-011-0344-9; Pearce A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2854-4; Longobardo LMP, 2015, REV ESP SALUD PUBLIC, V89, P39, DOI 10.4321/S1135-57272015000100005; Ribes J, 2009, EUR J GASTROEN HEPAT, V21, P92, DOI 10.1097/MEG.0b013e32830b5f39; Schofield D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011151; Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035; Tengo M, 2017, CURR OPIN ENV SUST, V26-27, P17, DOI 10.1016/j.cosust.2016.12.005; World Health Organization (WHO) Mortality Database, HLTH STAT INF SYST; Yabroff K. Robin, 2013, Journal of the National Cancer Institute Monographs, P62, DOI 10.1093/jncimonographs/lgt001; Zhang W, 2011, SOC SCI MED, V72, P185, DOI 10.1016/j.socscimed.2010.10.026	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244375	10.1371/journal.pone.0244375	http://dx.doi.org/10.1371/journal.pone.0244375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362274	Green Published, gold			2022-12-27	WOS:000603071600050
J	Aisyah, DN; Mayadewi, CA; Diva, H; Kozlakidis, Z; Siswanto; Adisasmito, W				Aisyah, Dewi Nur; Mayadewi, Chyntia Aryanti; Diva, Haniena; Kozlakidis, Zisis; Siswanto; Adisasmito, Wiku			A spatial-temporal description of the SARS-CoV-2 infections in Indonesia during the first six months of outbreak	PLOS ONE			English	Article							COVID-19	Background Since the first cases reported in Wuhan, China, in December 2019, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread worldwide. In Indonesia, the first case was reported in early March 2020, and the numbers of confirmed infections have been increasing until now. Efforts to contain the virus globally and in Indonesia are ongoing. This is the very first manuscript using a spatial-temporal model to describe the SARS-CoV-2 transmission in Indonesia, as well as providing a patient profile for all confirmed COVID-19 cases. Method Data was collected from the official website of the Indonesia National Task Force for the Acceleration of COVID-19, from the period of 02 March 2020-02 August 2020. The data from RT-PCR confirmed, SARS-CoV-2 positive patients was categorized according to demographics, symptoms and comorbidities based on case categorization (confirmed, recovered, dead). The data collected provides granular and thorough information on time and geographical location for all 34 Provinces across Indonesia. Results A cumulative total of 111,450 confirmed cases of were reported in Indonesia during the study period. Of those confirmed cases 67.79% (75,551/111,450) were shown as recovered and 4.83% (5,382/111,450) of them as died. Patients were mostly male (50.52%; 56,300/111,450) and adults aged 31 to 45 years old (29.73%; 33,132/111,450). Overall patient presentation symptoms of cough and fever, as well as chronic disease comorbidities were in line with previously published data from elsewhere in South-East Asia. The data reported here, shows that from the detection of the first confirmed case and within a short time period of 40 days, all the provinces of Indonesia were affected by COVID-19. Conclusions This study is the first to provide detailed characteristics of the confirmed SARS-CoV-2 patients in Indonesia, including their demographic profile and COVID-19 presentation history. It used a spatial-temporal analysis to present the epidemic spread from the very beginning of the outbreak throughout all provinces in the country. The increase of new confirmed cases has been consistent during this time period for all provinces, with some demonstrating a sharp increase, in part due to the surge in national diagnostic capacity. This information delivers a ready resource that can be used for prediction modelling, and is utilized continuously by the current Indonesian Task Force in order to advise on potential implementation or removal of public distancing measures, and on potential availability of healthcare capacity in their efforts to ultimately manage the outbreak.	[Aisyah, Dewi Nur; Mayadewi, Chyntia Aryanti; Diva, Haniena; Adisasmito, Wiku] Indonesia One Hlth Univ Network, Depok, West Java, Indonesia; [Aisyah, Dewi Nur] UCL, Inst Epidmiol & Hlth Care, London, England; [Kozlakidis, Zisis] World Hlth Org, Int Agcy Res Canc, Lyon, France; [Siswanto] Natl Inst Hlth Res & Dev, Jakarta, Indonesia; [Adisasmito, Wiku] Univ Indonesia, Fac Publ Hlth, Depok, West Java, Indonesia; [Adisasmito, Wiku] Indonesia Natl Task Force Accelerat COVID 19, Jakarta, Indonesia	University of London; University College London; World Health Organization; International Agency for Research on Cancer (IARC); National Institute of Health Research & Development - Indonesia; University of Indonesia	Aisyah, DN (corresponding author), Indonesia One Hlth Univ Network, Depok, West Java, Indonesia.; Aisyah, DN (corresponding author), UCL, Inst Epidmiol & Hlth Care, London, England.	dewi.aisyah@indohun.org	Kozlakidis, Zisis/AAX-8081-2020	Kozlakidis, Zisis/0000-0002-3836-7209				Adioetomo Sri Moertiningsih, 2014, UNFPA INDONESIA MONO, V1; AL-Rousan N, 2020, J MED VIROL, V92, P1603, DOI 10.1002/jmv.25850; [Anonymous], 2020, LANCET, V395, P1089, DOI 10.1016/S0140-6736(20)30757-1; [Anonymous], 2020, KOMPAS; [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961; [Anonymous], 2020, ACAD EMERG MED, V27, pS7, DOI 10.1111/acem.13961; Cowling BJ, 2020, J INFECT DIS, V221, P1749, DOI 10.1093/infdis/jiaa123; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Government of Indonesia, 2020, LIST COVID 19 REF HO; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Indonesian Government, TASK FORC ACC HANDL; Indonesian Ministry of Health, 2020, GUID PREV CONTR COVI; Indonesian News Agency, JAKARTA GLOBE NEWS; Kelvin AA, 2020, LANCET INFECT DIS, V20, P633, DOI 10.1016/S1473-3099(20)30236-X; Konstantinoudis G, 2020, SPAT SPATIO-TEMPORAL, V32, DOI 10.1016/j.sste.2019.100319; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Lippi G, 2020, ANN CLIN BIOCHEM, V57, P262, DOI 10.1177/0004563220922255; Liu Y, 2020, ECLINICALMEDICINE, V22, DOI 10.1016/j.eclinm.2020.100354; MAHASE E, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1327; Morand A, 2020, ARCH PEDIATRIE, V27, P117, DOI 10.1016/j.arcped.2020.03.001; Nanni M, 2005, LECT NOTES COMPUT SC, V3392, P98, DOI 10.1007/11415763_7; Nguyen THD, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101651; Okada P, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.8.2000097; Riccardo F, 2020, MEDRXIV, DOI [10.1101/2020.04.08.20056861, DOI 10.1101/2020.04.08.20056861V1]; Setiati S, 2020, ACTA MED INDONES, V52, P84; Sperandei S, 2014, BIOCHEM MEDICA, V24, P12, DOI 10.11613/BM.2014.003; The World Bank, POP FEM TOTO POP IND; Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018; Tsang TK, LANCET PUBLIC HELATH, V5, pe289, DOI DOI 10.1016/S2468-2667(20)30089-X32330458; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; WHO, COVID 19 STRAT UPD; World Health Organization, 2019, COVID 19 WEEKL EP UP; World Health Organization, 2020, CRIT PREP READ RESP; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	39	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243703	10.1371/journal.pone.0243703	http://dx.doi.org/10.1371/journal.pone.0243703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351801	Green Published, gold			2022-12-27	WOS:000603071400007
J	Ari, MD; Iskander, J; Araujo, J; Casey, C; Kools, J; Chen, B; Swain, R; Kelly, M; Popovic, T				Ari, Mary D.; Iskander, John; Araujo, John; Casey, Christine; Kools, John; Chen, Bin; Swain, Robert; Kelly, Miriam; Popovic, Tanja			A science impact framework to measure impact beyond journal metrics	PLOS ONE			English	Article							B STREPTOCOCCAL DISEASE; COLD MEDICATIONS; ADVERSE EVENTS; POLICY CHANGE; PREVENTION; INFECTION; INTERVENTIONS; TUBERCULOSIS; PREVALENCE; PROTECTS	Measuring the impact of public health science or research is important especially when it comes to health outcomes. Achieving the desired health outcomes take time and may be influenced by several contributors, making attribution of credit to any one entity or effort problematic. Here we offer a science impact framework (SIF) for tracing and linking public health science to events and/or actions with recognized impact beyond journal metrics. The SIF was modeled on the Institute of Medicine's (IOM) Degrees of Impact Thermometer, but differs in that SIF is not incremental, not chronological, and has expanded scope. The SIF recognizes five domains of influence: disseminating science, creating awareness, catalyzing action, effecting change and shaping the future (scope differs from IOM). For public health, the goal is to achieve one or more specific health outcomes. What is unique about this framework is that the focus is not just on the projected impact or outcome but rather the effects that are occurring in real time with the recognition that the measurement field is complex, and it takes time for the ultimate outcome to occur. The SIF is flexible and can be tailored to measure the impact of any scientific effort: from complex initiatives to individual publications. The SIF may be used to measure impact prospectively of an ongoing or new body of work (e.g., research, guidelines and recommendations, or technology) and retrospectively of completed and disseminated work, through linking of events using indicators that are known and have been used for measuring impact. Additionally, linking events offers an approach to both tell our story and also acknowledge other players in the chain of events. The value added by science can easily be relayed to the scientific community, policy makers and the public.	[Ari, Mary D.; Iskander, John; Araujo, John; Casey, Christine; Kools, John; Chen, Bin; Swain, Robert; Kelly, Miriam; Popovic, Tanja] CDC, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Araujo, John] US Dept Justice, Drug Enforcement Adm, Arlington, VA USA	Centers for Disease Control & Prevention - USA	Ari, MD (corresponding author), CDC, Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	Mkb9@cdc.gov						Alston JM, 2001, AGR ECON-BLACKWELL, V25, P141, DOI 10.1111/j.1574-0862.2001.tb00195.x; [Anonymous], 2013, NATURE, V502, P271; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; [Anonymous], 1999, SUCCESSFUL M, V48, pA4; [Anonymous], 2011, GUID INT TUB CAS FIN; Association of Public Health Laboratories and CDC, 2014, UT CDC REC GOOD LAB; Bauhoff S, 2011, HEALTH POLICY, V102, P286, DOI 10.1016/j.healthpol.2011.06.015; Berg J, 2010, MEASURING SCI OUTPUT; Bergen G., 2010, MORB MORTAL REP, V60, P1351; Broussard Meredith, 2018, COMPUTERS MISUNDERST; Budd JM, 1998, JAMA-J AM MED ASSOC, V280, P296, DOI 10.1001/jama.280.3.296; Buykx P, 2012, AUST J RURAL HEALTH, V20, P51, DOI 10.1111/j.1440-1584.2012.01256.x; Cain KP, 2010, NEW ENGL J MED, V362, P707, DOI 10.1056/NEJMoa0907488; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P931; Centers for Disease Control and Prevention, C SHEP AW; Centers for Disease Control and Prevention, 2014, PUBL HLTH GRAND ROUN; Centers for Medicare and Medicaid Services, 2011, CMS APPL AARP LEAV F; Chae Y.K., 2009, PLOS ONE, V4, pe6523; Chang GJJ, 2007, VACCINE, V25, P2325, DOI 10.1016/j.vaccine.2006.11.056; Consumer Healthcare Products Association, 2007, MAK OTC COUGH COLD M; Dance Amber, 2013, Nature, V502, P397; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Decker SL, 2009, INQUIRY-J HEALTH CAR, V46, P291, DOI 10.5034/inquiryjrnl_46.03.291; Deeming S, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0300-6; Dixon Richard E, 2011, MMWR Suppl, V60, P58; Donovan C, 2011, RES EVALUAT, V20, P175, DOI 10.3152/095820211X13118583635918; Faul M, 2012, LARGE COST SAVINGS R; Fielding JE, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120160; Finberg HV, 2013, I MED WHAT MAKES IT; FLANDERS WD, 1989, AM J PUBLIC HEALTH, V79, P1301, DOI 10.2105/AJPH.79.9.1301; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Gordon LG, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-015-0073-0; Green RF, 2019, GENET MED, V21, P28, DOI 10.1038/s41436-018-0028-2; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Harris JR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110081; HealthyPeople.gov, MED PROD SAF; Iskander J, 2014, J PUBLIC HEALTH MAN, V20, P542, DOI 10.1097/PHH.0b013e3182aa6560; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; King DK, 2010, AM J PUBLIC HEALTH, V100, P2076, DOI 10.2105/AJPH.2009.190959; Ko LK, 2019, PREV MED, V129, DOI 10.1016/j.ypmed.2019.105821; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; McKibben L, 2005, AM J INFECT CONTROL, V33, P217, DOI 10.1016/j.ajic.2005.04.001; Mei ZG, 2008, J PEDIATR-US, V153, P622, DOI 10.1016/j.jpeds.2008.05.048; Mervis J, 2011, SCIENCE, V334, P169, DOI 10.1126/science.334.6053.169; MMWR, 2004, MMWR-MORBID MORTAL W, V53, P108; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Moore A, 2006, EMBO REP, V7, P1193, DOI 10.1038/sj.embor.7400862; National Highway Traffic Safety Administration, 2010, TRAFF SAF FACTS 2009; Oddeleni vyzkumu a vyvoje Migatronic A/S, 2011, SVET SVARU, V15, P12; Owens B, 2013, NATURE, V502, P288, DOI 10.1038/502288a; Penfield T, 2014, RES EVALUAT, V23, P21, DOI 10.1093/reseval/rvt021; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Reed RL, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0179-7; Reefhuis J, 2003, NEW ENGL J MED, V349, P435, DOI 10.1056/NEJMoa031101; Ruegg R., 2007, OVERVIEW EVALUATION; Rukmani R, 2008, CURR SCI INDIA, V95, P1694; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Schaefer MK, 2008, PEDIATRICS, V121, P783, DOI 10.1542/peds.2007-3638; Schneider C., 2007, S M LOTHAR COMBIN, V56, P1; Schrag Stephanie, 2002, MMWR Recomm Rep, V51, P1; Shehab N, 2010, PEDIATRICS, V126, P1100, DOI 10.1542/peds.2010-1839; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Sleet DA, 2011, GLOB HEALTH PROMOT, V18, P23, DOI 10.1177/1757975910393707; Srinivasan A, 2012, CLIN INFECT DIS, V55, P426, DOI 10.1093/cid/cis407; Stephens David S, 2011, Trans Am Clin Climatol Assoc, V122, P115; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Trivers KF, 2015, HEALTHCARE-BASEL, V3, P948, DOI 10.3390/healthcare3040948; US Department of Transportation Federal Highway Administration, 2006, SAF ACC FLEX EFF TRA; Van Noorden R, 2010, NATURE, V465, P864, DOI 10.1038/465864a; Verani JR, 2010, CLIN PERINATOL, V37, P375, DOI 10.1016/j.clp.2010.02.002; Wei BPC, 2006, OTOL NEUROTOL, V27, P844, DOI 10.1097/01.mao.0000231603.25961.f1; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wilson KM, 2011, PREV CHRONIC DIS, V8; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; Yang CH, 2019, ZOOKEYS, P1, DOI 10.3897/zookeys.838.33051; 2005, MMWR, V54, P893	78	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244407	10.1371/journal.pone.0244407	http://dx.doi.org/10.1371/journal.pone.0244407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351845	gold, Green Published			2022-12-27	WOS:000603071400022
J	Goldsztejn, U; Schwartzman, D; Nehorai, A				Goldsztejn, Uri; Schwartzman, David; Nehorai, Arye			Public policy and economic dynamics of COVID-19 spread: A mathematical modeling study	PLOS ONE			English	Article							OUTBREAKS; LIFE	With the COVID-19 pandemic infecting millions of people, large-scale isolation policies have been enacted across the globe. To assess the impact of isolation measures on deaths, hospitalizations, and economic output, we create a mathematical model to simulate the spread of COVID-19, incorporating effects of restrictive measures and segmenting the population based on health risk and economic vulnerability. Policymakers make isolation policy decisions based on current levels of disease spread and economic damage. For 76 weeks in a population of 330 million, we simulate a baseline scenario leaving strong isolation restrictions in place, rapidly reducing isolation restrictions for non-seniors shortly after outbreak containment, and gradually relaxing isolation restrictions for non-seniors. We use 76 weeks as an approximation of the time at which a vaccine will be available. In the baseline scenario, there are 235,724 deaths and the economy shrinks by 34.0%. With a rapid relaxation, a second outbreak takes place, with 525,558 deaths, and the economy shrinks by 32.3%. With a gradual relaxation, there are 262,917 deaths, and the economy shrinks by 29.8%. We also show that hospitalizations, deaths, and economic output are quite sensitive to disease spread by asymptomatic people. Strict restrictions on seniors with very gradual lifting of isolation for non-seniors results in a limited number of deaths and lesser economic damage. Therefore, we recommend this strategy and measures that reduce non-isolated disease spread to control the pandemic while making isolation economically viable.	[Goldsztejn, Uri] Washington Univ, McKelvey Sch Engn, Dept Biomed Engn, St Louis, MO 63110 USA; [Schwartzman, David] Washington Univ, Olin Sch Business, St Louis, MO 63110 USA; [Nehorai, Arye] Washington Univ, McKelvey Sch Engn, Preston M Green Dept Elect & Syst Engn, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Nehorai, A (corresponding author), Washington Univ, McKelvey Sch Engn, Preston M Green Dept Elect & Syst Engn, St Louis, MO 63110 USA.	nehorai@wustl.edu	Goldsztejn, Uri/ABG-8779-2021	Goldsztejn, Uri/0000-0001-7040-7007; Nehorai, Arye/0000-0002-9055-9865				Acemoglu D., 2020, MULTIRISK SIR MODEL, DOI [10.1920/wp.cem.2020.1420, DOI 10.1920/WP.CEM.2020.1420]; Alva-Manchego F, 2020, COMPUT LINGUIST, V46, P135, DOI [10.1162/coli_a_00370, 10.1162/COLI_a_00370]; Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; Baqaee D., 2020, 27244 NBER, DOI [10.3386/w27244, DOI 10.3386/W27244]; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Berger D. W., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w26901; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8, 10.1016/S0140-6736(20)30460-8.]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; Cutler DM., 2016, EC CONDITIONS MORTAL; Deb S, 2020, ARXIV; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Enserink M, 2020, SCIENCE, V367, P1414, DOI 10.1126/science.367.6485.1414-b; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Glover A., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hu Z., 2020, INT J ED EXCELL, DOI DOI 10.18562/IJEE.054; Jamieson-Lane AD, 2020, EFFECTIVENESS TARGET; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lipsitch M, 2020, CTR COMMUNICABLE DIS; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Mongey S, 2020, BECKER FRIEDMAN I EC; Noorbhai H, 2020, ANN MED SURG, V57, P5, DOI 10.1016/j.amsu.2020.06.041; Panovska-Griffiths J, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08671-z; Potter GE, 2011, ANN APPL STAT, V5, P1816, DOI 10.1214/11-AOAS474; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Stehle J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-87; Stock JH., 2020, REOPENING CORONAVIRU; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wilder-Smith A, 2020, LANCET INFECT DIS, V20, pE102, DOI 10.1016/S1473-3099(20)30129-8; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	39	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244174	10.1371/journal.pone.0244174	http://dx.doi.org/10.1371/journal.pone.0244174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351835	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071400037
J	Ramos, MC; Barreto, JOM; Shimizu, HE; de Moraes, APG; da Silva, EN				Ramos, Maira Catharina; Barreto, Jorge Otavio Maia; Shimizu, Helena Eri; de Moraes, Amanda Pereira Gomes; da Silva, Everton Nunes			Regionalization for health improvement: A systematic review	PLOS ONE			English	Review							HOSPITAL VOLUME; UNITED-STATES; OPERATIVE MORTALITY; CARE SERVICES; IMPACT; CANCER; DECENTRALIZATION; SURVIVAL; OUTCOMES; SURGERY	Regionalization is the integrated organization of a healthcare system, wherein regional structures are responsible for providing and administrating health services in a specific region. This method was adopted by several countries to improve the quality of provided care and to properly utilize available resources. Thus, a systematic review was conducted to verify effective interventions to improve health and management indicators within the health services regionalization. The protocol was registered in PROSPERO (CRD42016042314). We performed a systematic search in databases during February and March 2017 which was updated in October 2020. There was no language or date restriction. We included experimental and observational studies with interventions focused on regionalization-related actions, measures or policies aimed at decentralizing and organizing health offerings, rationalizing scarce capital and human resources, coordinating health services. A methodological assessment of the studies was performed using instruments from the Joanna Briggs Institute and GRADE was also used to assess outcomes. Thirty-nine articles fulfilled the eligibility criteria and sixteen interventions were identified that indicated different degrees of recommendations for improving the management of health system regionalization. The results showed that regionalization was effective under administrative decentralization and for rationalization of resources. The most investigated intervention was the strategy of concentrating procedures in high-volume hospitals, which showed positive outcomes, especially with the reduction of hospitalization days and in-hospital mortality rates. When implementing regionalization, it must be noted that it involves changes in current standards of health practice and in the distribution of health resources, especially for specialized services.	[Ramos, Maira Catharina; Shimizu, Helena Eri] Univ Brasilia, Fac Hlth Sci, Brasilia, DF, Brazil; [Ramos, Maira Catharina; Barreto, Jorge Otavio Maia] Fundacao Oswaldo Cruz, Brasilia, DF, Brazil; [de Moraes, Amanda Pereira Gomes] Univ Fed Sergipe, Dept Med, Lagarto, Brazil; [da Silva, Everton Nunes] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil	Universidade de Brasilia; Fundacao Oswaldo Cruz; Universidade Federal de Sergipe; Universidade de Brasilia	Ramos, MC (corresponding author), Univ Brasilia, Fac Hlth Sci, Brasilia, DF, Brazil.; Ramos, MC (corresponding author), Fundacao Oswaldo Cruz, Brasilia, DF, Brazil.	maira.ramos@fiocruz.br	; Ramos, Maira/C-9769-2019	Silva, Everton/0000-0001-8747-4185; Ramos, Maira/0000-0003-3829-975X				[Anonymous], 2003, GARTENKUNST, V15, P290; [Anonymous], 2002, ASP TEOR CONC FIN PO, P23; Atkinson S, 2004, B WORLD HEALTH ORGAN, V82, P822; Bardach NS, 2004, CIRCULATION, V109, P2207, DOI 10.1161/01.CIR.0000126433.12527.E6; Barker P, 2017, INT J HEALTH SERV, V47, P333, DOI 10.1177/0020731416681229; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Bossert T, 2003, HEALTH POLICY PLANN, V18, P357, DOI 10.1093/heapol/czg044; Brookfield KF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004049; Castonguay Claude, 1967, CAST CLAUD; Cavalieri M, 2020, HEALTH POLICY, V124, P164, DOI 10.1016/j.healthpol.2019.12.001; Chen MM, 2019, LARYNGOSCOPE, V129, P1413, DOI 10.1002/lary.27440; Cohen JP, 2008, REG SCI URBAN ECON, V38, P553, DOI 10.1016/j.regsciurbeco.2008.05.011; Concannon TW, 2010, CIRC-CARDIOVASC QUAL, V3, P506, DOI 10.1161/CIRCOUTCOMES.109.908541; Costa-Font J, 2018, REG STUD, V52, P974, DOI 10.1080/00343404.2017.1361527; Cowan JA, 2003, NEUROSURGERY, V52, P48, DOI 10.1097/00006123-200301000-00005; Viana ALD, 2009, CIENC SAUDE COLETIVA, V14, P807, DOI 10.1590/S1413-81232009000300016; De Nicola A, 2014, INT J HEALTH PLAN M, V29, pE48, DOI 10.1002/hpm.2183; Di Novi C, 2019, REG SCI URBAN ECON, V78, DOI 10.1016/j.regsciurbeco.2019.103465; DiBrito Sandra R, 2018, AMA J Ethics, V20, P439, DOI 10.1001/journalofethics.2018.20.5.ecas3-1805; Dimick JB, 2002, ANN SURG, V235, P579, DOI 10.1097/00000658-200204000-00017; Dueck AD, 2004, J VASC SURG, V39, P1253, DOI 10.1016/j.jvs.2004.02.006; DuenasFernandez R., 2016, CORSALUD, V8, P248; EFSA GMO Panel Working Group on Animal Feeding Trials, 2008, FOOD CHEM TOXICOL S1, V46, pS2; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Friedson AI, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0075-1; Glance LG, 2004, J TRAUMA, V56, P682, DOI 10.1097/01.TA.0000053469.92142.40; Glasgow RE, 1999, ARCH SURG-CHICAGO, V134, P30, DOI 10.1001/archsurg.134.1.30; Gordon TA, 1998, ANN SURG, V228, P71, DOI 10.1097/00000658-199807000-00011; Gruen RL, 2002, J EPIDEMIOL COMMUN H, V56, P517, DOI 10.1136/jech.56.7.517; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Hamilton SM, 1997, ARCH SURG-CHICAGO, V132, P605; Herrera CA, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012779, DOI 10.1002/14651858.CD012779]; Imperato P J, 1996, Am J Med Qual, V11, P193, DOI 10.1177/0885713X9601100407; Joanna Briggs Institute, 2017, CHECKLIST ANALYTICAL; Jollis JG, 2018, CIRCULATION, V137, P376, DOI 10.1161/CIRCULATIONAHA.117.032446; Ke KM, 2012, EUR J CANCER CARE, V21, P158, DOI 10.1111/j.1365-2354.2011.01323.x; Khera S, 2017, JAMA CARDIOL, V2, P732, DOI 10.1001/jamacardio.2017.1630; Ko CY, 2002, SURGERY, V132, P268, DOI 10.1067/msy.2002.125721; KONVOLINKA CW, 1995, AM J SURG, V170, P333, DOI 10.1016/S0002-9610(99)80299-2; Lau K, 2014, JAMA SURG, V149, P1153, DOI 10.1001/jamasurg.2014.1711; Lavis JN, 2017, HLTH SYSTEMS EVIDENC; Leow JJ, 2018, EUR UROL FOCUS, V4, P775, DOI 10.1016/j.euf.2017.03.008; Lima MCRde, 2010, FLUXOS UTILIZACAO SE; Lumpkin S, 2018, SURG ONCOL CLIN N AM, V27, P685, DOI 10.1016/j.soc.2018.05.009; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MAERKI SC, 1986, MED CARE, V24, P148, DOI 10.1097/00005650-198602000-00006; Marchildon G, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00084418, 10.1590/0102-311X00084418]; Marchildon GP, 2017, CAN MED ASSOC J, V189, pE1147, DOI 10.1503/cmaj.170164; Marchildon Gregory P, 2016, Healthc Pap, V16, P8; Marcin JP, 2008, HEALTH SERV RES, V43, P174, DOI 10.1111/j.1475-6773.2007.00740.x; Maritaz C, 2019, B CANCER, V106, P734, DOI 10.1016/j.bulcan.2019.03.019; Moberg J, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0320-2; Munn J. G., 2013, J EC FINANC, V39, P412, DOI [10.1007/s12197-013- 9275-x, DOI 10.1007/S12197-013-9275-X]; Muoto I, 2016, HEALTH AFFAIR, V35, P1625, DOI 10.1377/hlthaff.2016.0396; Nallamothu BK, 2001, J AM COLL CARDIOL, V38, P1923, DOI 10.1016/S0735-1097(01)01647-3; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Nimptsch U, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016184; Nuti S, 2016, HEALTH ECON POLICY L, V11, P17, DOI 10.1017/S1744133115000067; Ofstad EH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010098; Okello E, 2018, HEART ASIA, V10, DOI 10.1136/heartasia-2017-010981; Pantoja T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011086.pub2; Pasche DF, 2006, REV PANAM SALUD PUBL, V20, P416, DOI 10.1590/S1020-49892006001100008; Philippon D, 2008, HLTH SYSTEM ORG GOVE; Ramos Maíra Catharina, 2018, Saúde debate, V42, P296, DOI 10.1590/0103-1104201811624; Rashidian A, 2014, PUBLIC HEALTH, V128, P872, DOI 10.1016/j.puhe.2014.08.005; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; Roth-Deubel André N., 2013, Rev. salud pública, V15, P44; Shaxson L, 2019, PUBLIC MONEY MANAGE, V39, P46, DOI 10.1080/09540962.2019.1537705; Shimizu HE, 2016, ACTA PAUL ENFERM, V29, P332, DOI 10.1590/1982-0194201600046; Tanke MAC, 2012, HEALTH POLICY, V105, P282, DOI 10.1016/j.healthpol.2012.02.016; The Reproductive Health Report, 2011, EUR J CONTRACEPT REP, V16, p[sup1, S1], DOI 10.3109/13625187.2011.607690; Turner AW, 2011, CLIN EXP OPHTHALMOL, V39, P344, DOI 10.1111/j.1442-9071.2010.02474.x; Urbach DR, 2003, CAN MED ASSOC J, V168, P1409; Valdes-Stauber J, 2014, NERVENARZT, V85, P596, DOI 10.1007/s00115-013-3836-2; Vali Y, 2017, PUBLIC HEALTH, V146, P92, DOI 10.1016/j.puhe.2016.12.006; Van Aerde J., 2016, CAN J PHYS LEADE, V2, P65; Vernooij F, 2008, JNCI-J NATL CANCER I, V100, P399, DOI 10.1093/jnci/djn033; Wainess RM, 2003, J GASTROINTEST SURG, V7, P879, DOI 10.1016/S1091-255X(03)00150-1; Wiysonge CS, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012779, DOI 10.1002/14651858.CD012779]; Zoetelief J., 2005, 74 ICRU, V74	82	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244078	10.1371/journal.pone.0244078	http://dx.doi.org/10.1371/journal.pone.0244078			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351841	gold, Green Published			2022-12-27	WOS:000603071400012
J	Busse, E; Hickey, C; Vasilakos, N; Stewart, K; O'Brien, F; Rivera, J; Marrero, L; Lacey, M; Schroll, R; Van Meter, K; Sammarco, MC				Busse, Emily; Hickey, Cheryl; Vasilakos, Nicole; Stewart, Kennon; O'Brien, Fred; Rivera, Jessica; Marrero, Luis; Lacey, Michelle; Schroll, Rebecca; Van Meter, Keith; Sammarco, Mimi C.			Plasma flow distal to tourniquet placement provides a physiological mechanism for tissue salvage	PLOS ONE			English	Article							HYPERBARIC-OXYGEN THERAPY; INDOCYANINE GREEN; PULMONARY SEQUESTRATION; REPERFUSION; ANGIOGRAPHY; OBESITY; INJURY; MODEL	Military literature has demonstrated the utility and safety of tourniquets in preventing mortality for some time, paving the way for increased use of tourniquets in civilian settings, including perioperatively to provide a bloodless surgical field. However, tourniquet use is not without risk and the subsequent effects of tissue ischemia can impede downstream rehabilitative efforts to regenerate and salvage nerve, muscle, tissue and bone in the limb. Limb ischemia studies in both the mouse and pig models have indicated not only that there is residual flow past the tourniquet by means of microcirculation, but also that recovery from tissue ischemia is dependent upon this microcirculation. Here we expand upon these previous studies using portable Near-Infrared Imaging to quantify residual plasma flow distal to the tourniquet in mice, pigs, and humans and leverage this flow to show that plasma can be supersaturated with oxygen to reduce intracellular hypoxia and promote tissue salvage following tourniquet placement. Our findings provide a mechanism of delivery for the application of oxygen, tissue preservation solutions, and anti-microbial agents prior to tourniquet release to improve postoperative recovery. In the current environment of increased tourniquet use, techniques which promote distal tissue preservation and limb salvage rates are crucial.	[Busse, Emily; Schroll, Rebecca; Sammarco, Mimi C.] Tulane Sch Med, Dept Surg, New Orleans, LA 70112 USA; [Hickey, Cheryl; Van Meter, Keith] Louisiana State Univ, Hlth Sci Ctr, Dept Emergency Med, New Orleans, LA USA; [Vasilakos, Nicole] Tulane Sch Med, Dept Physiol, New Orleans, LA USA; [Stewart, Kennon; Lacey, Michelle] Tulane Univ, Dept Math, New Orleans, LA 70118 USA; [O'Brien, Fred] Dwight D Eisenhower Army Med Ctr, Orthopaed Surg Serv, Ft Gordon, GA USA; [Rivera, Jessica; Marrero, Luis] Louisiana State Univ, Hlth Sci Ctr, Dept Orthoped, New Orleans, LA USA; [Busse, Emily] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA	Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; Tulane University; United States Department of Defense; United States Army; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Baylor College of Medicine	Sammarco, MC (corresponding author), Tulane Sch Med, Dept Surg, New Orleans, LA 70112 USA.	msammarc@tulane.edu		Busse, Emily/0000-0002-8555-0612	National Institutes of Health, NIGMS [U54GM104940, P20GM103629]	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MCS: National Institutes of Health, NIGMS, P20GM103629 nigms.nih.gov MCS: National Institutes of Health, NIGMS, U54GM104940. nigms.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39; B D, 2013, AORN J, P653; Bratzler DW, 2013, SURG INFECT, V14, P73, DOI 10.1089/sur.2013.9999; Cho SS, 2019, FRONT SURG, V6, DOI 10.3389/fsurg.2019.00011; Choudhury R, 2018, INT J GEN MED, V11, P431, DOI 10.2147/IJGM.S172460; Cleveland Andrew, 2013, J Surg Orthop Adv, V22, P310; Connolly PH, 2015, ANN VASC SURG, V29, DOI 10.1016/j.avsg.2015.04.090; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; Drysch M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210961; DSouza AV, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.8.080901; GABB G, 1987, CHEST, V92, P1074, DOI 10.1378/chest.92.6.1074; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gruneboom A, 2019, NAT METAB, V1, P236, DOI 10.1038/s42255-018-0016-5; Heyboer M, 2017, ADV WOUND CARE, V6, P210, DOI 10.1089/wound.2016.0718; Howard JT, 2019, JAMA SURG, V154, P600, DOI 10.1001/jamasurg.2019.0151; HUTCHINSON DT, 1993, J HAND SURG-AM, V18A, P206, DOI 10.1016/0363-5023(93)90347-6; Joh JH, 2016, ANN SURG TREAT RES, V90, P279, DOI 10.4174/astr.2016.90.5.279; Kamolz LP, 2006, J TRAUMA, V61, P635, DOI 10.1097/01.ta.0000233910.47550.9c; Kumar Kamal, 2016, J Anaesthesiol Clin Pharmacol, V32, P424, DOI 10.4103/0970-9185.168174; Leach RM, 1998, BRIT MED J, V317, P1140; Lee C, 2007, EMERG MED J, V24, P584, DOI 10.1136/emj.2007.046359; Lin JS, 2019, ACTA CARDIOL SIN, V35, P65, DOI 10.6515/ACS.201901_35(1).20180731A; Marenzana M, 2013, BONE RES, V1, P203, DOI 10.4248/BR201303001; McCormack MC, 2008, SURGERY, V143, P126, DOI 10.1016/j.surg.2007.06.005; MESSERLI FH, 1983, ANN INTERN MED, V99, P757, DOI 10.7326/0003-4819-99-6-757; MESSERLI FH, 1982, CIRCULATION, V66, P55, DOI 10.1161/01.CIR.66.1.55; Muller S, 2013, J SURG RES, V181, P170, DOI 10.1016/j.jss.2012.05.088; Ohyama Yoshiaki, 2013, J Cardiol Cases, V8, pe13, DOI 10.1016/j.jccase.2013.02.015; Radowsky JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137430; Saenz-Jalon M, 2018, J PERIANESTH NURS, V33, P699, DOI 10.1016/j.jopan.2016.08.017; Sammarco MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140156; Sammarco MC, 2014, J BONE MINER RES, V29, P2336, DOI 10.1002/jbmr.2261; Schroll R, 2015, J TRAUMA ACUTE CARE, V79, P10, DOI 10.1097/TA.0000000000000689; Shackelford Stacy A, 2015, J Spec Oper Med, V15, P17; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Tjarnstrom J, 1999, EUR SURG RES, V31, P147, DOI 10.1159/000008633; Tomita Masato, 2007, Mod Rheumatol, V17, P409, DOI 10.1007/s10165-007-0609-4; Tran TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043410; Tu HY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00207; Ueno S, 1999, HEPATO-GASTROENTEROL, V46, P1798; Zamboni WA, 1996, ARCH SURG-CHICAGO, V131, P756; Zhang D, 2017, ACTA PHYSIOL, V219, P453, DOI 10.1111/apha.12737	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244236	10.1371/journal.pone.0244236	http://dx.doi.org/10.1371/journal.pone.0244236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347516	Green Published, gold			2022-12-27	WOS:000603071100003
J	Gonzalez, TR; Martin, KP; Barnes, JE; Patel, JS; Ytreberg, FM				Gonzalez, Tawny R.; Martin, Kyle P.; Barnes, Jonathan E.; Patel, Jagdish Suresh; Ytreberg, F. Marty			Assessment of software methods for estimating protein-protein relative binding affinities	PLOS ONE			English	Article							PLACENTAL RIBONUCLEASE INHIBITOR; PANCREATIC TRYPSIN-INHIBITOR; ALANINE-SCANNING MUTAGENESIS; ENHANCED SAMPLING TECHNIQUES; RAY CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; HUMAN ANGIOGENIN; STRUCTURAL BASIS; ALPHA-CHAIN; DIRECTED MUTAGENESIS	A growing number of computational tools have been developed to accurately and rapidly predict the impact of amino acid mutations on protein-protein relative binding affinities. Such tools have many applications, for example, designing new drugs and studying evolutionary mechanisms. In the search for accuracy, many of these methods employ expensive yet rigorous molecular dynamics simulations. By contrast, non-rigorous methods use less exhaustive statistical mechanics, allowing for more efficient calculations. However, it is unclear if such methods retain enough accuracy to replace rigorous methods in binding affinity calculations. This trade-off between accuracy and computational expense makes it difficult to determine the best method for a particular system or study. Here, eight non-rigorous computational methods were assessed using eight antibody-antigen and eight non-antibody-antigen complexes for their ability to accurately predict relative binding affinities (Delta Delta G) for 654 single mutations. In addition to assessing accuracy, we analyzed the CPU cost and performance for each method using a variety of physico-chemical structural features. This allowed us to posit scenarios in which each method may be best utilized. Most methods performed worse when applied to antibody-antigen complexes compared to non-antibody-antigen complexes. Rosetta-based JayZ and EasyE methods classified mutations as destabilizing (Delta Delta G < -0.5 kcal/mol) with high (83-98%) accuracy and a relatively low computational cost for non-antibody-antigen complexes. Some of the most accurate results for antibody-antigen systems came from combining molecular dynamics with FoldX with a correlation coefficient (r) of 0.46, but this was also the most computationally expensive method. Overall, our results suggest these methods can be used to quickly and accurately predict stabilizing versus destabilizing mutations but are less accurate at predicting actual binding affinities. This study highlights the need for continued development of reliable, accessible, and reproducible methods for predicting binding affinities in antibody-antigen proteins and provides a recipe for using current methods.	[Gonzalez, Tawny R.; Martin, Kyle P.; Barnes, Jonathan E.; Patel, Jagdish Suresh; Ytreberg, F. Marty] Univ Idaho, Inst Modeling Collaborat & Innovat, Moscow, ID 83843 USA; [Martin, Kyle P.; Barnes, Jonathan E.; Ytreberg, F. Marty] Univ Idaho, Dept Phys, Moscow, ID 83844 USA; [Patel, Jagdish Suresh] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Patel, JS; Ytreberg, FM (corresponding author), Univ Idaho, Inst Modeling Collaborat & Innovat, Moscow, ID 83843 USA.; Ytreberg, FM (corresponding author), Univ Idaho, Dept Phys, Moscow, ID 83844 USA.; Patel, JS (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA.	thejagdishpatel@gmail.com; ytreberg@uidaho.edu		Barnes, Jonathan/0000-0002-5434-1391; Gonzalez, Tawny/0000-0002-9560-6798	Center for Modeling Complex Interactions - National Institute of General Medical Sciences [P20 GM104420]; National Science Foundation EPSCoR Track-II [OIA1736253]; National Institutes of Health [NIH P30 GM103324]; Office of Nuclear Energy of the U.S. DOE; Nuclear Science User Facilities [DE-AC07-05ID14517]	Center for Modeling Complex Interactions - National Institute of General Medical Sciences; National Science Foundation EPSCoR Track-II; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Nuclear Energy of the U.S. DOE(United States Department of Energy (DOE)); Nuclear Science User Facilities	TRG, KPM, JEB, JSP and FMY were supported by the Center for Modeling Complex Interactions sponsored by the National Institute of General Medical Sciences (https://www.nigms.nih.gov) under award number P20 GM104420 and the National Science Foundation (https://www.nsf.gov) EPSCoR Track-II under award number OIA1736253. Computer resources were provided in part by the Institute for Bioinformatics and Evolutionary Studies Computational Resources Core sponsored by the National Institutes of Health (NIH P30 GM103324). This research also made use of the computational resources provided by the high-performance computing center at Idaho National Laboratory, which is supported by the Office of Nuclear Energy of the U.S. DOE and the Nuclear Science User Facilities under Contract No. DE-AC07-05ID14517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck S, 2000, J MOL BIOL, V298, P503, DOI 10.1006/jmbi.2000.3656; Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; [Anonymous], 2020, CANCER DISCOV, V10, pOF8; Baaden M, 2013, CURR OPIN STRUC BIOL, V23, P878, DOI 10.1016/j.sbi.2013.09.004; Bernardi RC, 2015, BBA-GEN SUBJECTS, V1850, P872, DOI 10.1016/j.bbagen.2014.10.019; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; BRADEN BC, 1994, J MOL BIOL, V243, P767, DOI 10.1016/0022-2836(94)90046-9; Brender JR, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004494; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P8878, DOI 10.1021/bi00196a004; Castro MJM, 1996, BIOCHEMISTRY-US, V35, P11435, DOI 10.1021/bi960515w; Chen CZ, 1997, P NATL ACAD SCI USA, V94, P1761, DOI 10.1073/pnas.94.5.1761; Chen CZ, 1999, BIOCHEMISTRY-US, V38, P9273, DOI 10.1021/bi990762a; Chen Y, 1999, J MOL BIOL, V293, P865, DOI 10.1006/jmbi.1999.3192; Croux C, 2010, STAT METHOD APPL-GER, V19, P497, DOI 10.1007/s10260-010-0142-z; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; DallAcqua W, 1996, BIOCHEMISTRY-US, V35, P9667, DOI 10.1021/bi960819i; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ezkurdia L, 2009, BRIEF BIOINFORM, V10, P233, DOI 10.1093/bib/bbp021; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Geng CL, 2019, PROTEINS, V87, P110, DOI 10.1002/prot.25630; Gromiha MM, 2017, CURR OPIN STRUC BIOL, V44, P31, DOI 10.1016/j.sbi.2016.10.016; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gumbart JC, 2013, J CHEM THEORY COMPUT, V9, P3789, DOI 10.1021/ct400273t; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; Haidar JN, 2014, J MOL BIOL, V426, P1583, DOI 10.1016/j.jmb.2013.12.024; HARTLEY RW, 1993, BIOCHEMISTRY-US, V32, P5978, DOI 10.1021/bi00074a008; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Hurley B, 2016, CONSTRAINTS, V21, P413, DOI 10.1007/s10601-016-9245-y; Jankauskaite J, 2019, BIOINFORMATICS, V35, P462, DOI 10.1093/bioinformatics/bty635; Jemimah S, 2020, BIOINFORMATICS, V36, P1725, DOI 10.1093/bioinformatics/btz829; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAMMORGAN LNW, 1993, P NATL ACAD SCI USA, V90, P3958, DOI 10.1073/pnas.90.9.3958; Kastritis PL, 2010, J PROTEOME RES, V9, P2216, DOI 10.1021/pr9009854; Keeble AH, 2008, J MOL BIOL, V379, P745, DOI 10.1016/j.jmb.2008.03.055; Kiel C, 2004, J MOL BIOL, V340, P1039, DOI 10.1016/j.jmb.2004.05.050; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Kroncke BM, 2016, BIOCHEMISTRY-US, V55, P5002, DOI 10.1021/acs.biochem.6b00537; Krowarsch D, 1999, J MOL BIOL, V289, P175, DOI 10.1006/jmbi.1999.2757; Lang S, 2000, BIOCHEMISTRY-US, V39, P15674, DOI 10.1021/bi000838z; LEE FS, 1989, BIOCHEMISTRY-US, V28, P3556, DOI 10.1021/bi00434a061; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Li W, 1998, BIOCHEMISTRY-US, V37, P11771, DOI 10.1021/bi9808621; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lu SM, 2001, P NATL ACAD SCI USA, V98, P1410, DOI 10.1073/pnas.031581398; Lu WY, 1997, J MOL BIOL, V266, P441, DOI 10.1006/jmbi.1996.0781; Meenan NAG, 2010, P NATL ACAD SCI USA, V107, P10080, DOI 10.1073/pnas.0910756107; Miler CR, 2016, PEERJ, V4, DOI 10.7717/peerj.1674; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; Park H, 2016, J CHEM THEORY COMPUT, V12, P6201, DOI 10.1021/acs.jctc.6b00819; Patel JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211093; Patel JS, 2018, J CHEM THEORY COMPUT, V14, P991, DOI 10.1021/acs.jctc.7b00660; Pokorna P, 2018, J CHEM THEORY COMPUT, V14, P5419, DOI 10.1021/acs.jctc.8b00670; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Prasad L, 1998, J MOL BIOL, V280, P829, DOI 10.1006/jmbi.1998.1888; Rajpal A, 1998, PROTEIN SCI, V7, P1868, DOI 10.1002/pro.5560070903; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Rodrigues CHM, 2019, NUCLEIC ACIDS RES, V47, pW338, DOI 10.1093/nar/gkz383; Scheidig AJ, 1997, PROTEIN SCI, V6, P1806, DOI 10.1002/pro.5560060902; SCHREIBER G, 1993, BIOCHEMISTRY-US, V32, P5145, DOI 10.1021/bi00070a025; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Selzer T, 2000, NAT STRUCT BIOL, V7, P537; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; SHAPIRO R, 1992, BIOCHEMISTRY-US, V31, P12477, DOI 10.1021/bi00164a026; Shapiro R, 2000, J MOL BIOL, V302, P497, DOI 10.1006/jmbi.2000.4075; SHARMA S, 1991, P NATL ACAD SCI USA, V88, P4877, DOI 10.1073/pnas.88.11.4877; SNEATH PHA, 1966, J THEOR BIOL, V12, P157, DOI 10.1016/0022-5193(66)90112-3; Sogabe S, 1997, J MOL BIOL, V273, P882, DOI 10.1006/jmbi.1997.1336; Sokolovski M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00285-1; Spiwok V, 2015, BIOTECHNOL ADV, V33, P1130, DOI 10.1016/j.biotechadv.2014.11.011; Taylor MG, 1998, PROTEIN SCI, V7, P1857, DOI 10.1002/pro.5560070902; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; TSUMOTO K, 1995, J BIOL CHEM, V270, P18551, DOI 10.1074/jbc.270.31.18551; Ultsch M, 2013, J MOL BIOL, V425, P1330, DOI 10.1016/j.jmb.2013.01.024; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Viricel C, 2018, BIOINFORMATICS, V34, P2581, DOI 10.1093/bioinformatics/bty092; Vreven T, 2012, PROTEIN SCI, V21, P396, DOI 10.1002/pro.2027; Wang CH, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00087; Wang EC, 2019, CHEM REV, V119, P9478, DOI 10.1021/acs.chemrev.9b00055; Wang YH, 1997, P NATL ACAD SCI USA, V94, P1657, DOI 10.1073/pnas.94.5.1657; Wassenaar TA, 2012, J GRID COMPUT, V10, P743, DOI 10.1007/s10723-012-9246-z; Xiong P, 2017, J MOL BIOL, V429, P426, DOI 10.1016/j.jmb.2016.11.022; Yang J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233509; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200	96	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0240573	10.1371/journal.pone.0240573	http://dx.doi.org/10.1371/journal.pone.0240573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347442	gold, Green Submitted, Green Published			2022-12-27	WOS:000603071100036
J	Helgoy, KV; Smeby, JC; Bonsaksen, T; Olsen, NR				Helgoy, Kjersti Velde; Smeby, Jens-Christian; Bonsaksen, Tore; Rydland Olsen, Nina			Research-based occupational therapy education: An exploration of students' and faculty members' experiences and perceptions	PLOS ONE			English	Article							UNDERGRADUATE RESEARCH EXPERIENCES; ACADEMICS PERCEPTIONS; ATTITUDES; KNOWLEDGE; ENVIRONMENT; BARRIERS	Introduction One argument for introducing research in bachelor`s degree in health care is to ensure the quality of future health care delivery. The requirements for research-based education have increased, and research on how research-based education is experienced is limited, especially in bachelor health care education programmes. The aim of this study was to explore how occupational therapy students and faculty members experienced and perceived research-based education. Methods This qualitative, interpretative description consisted of three focus group interviews with occupational therapy students in their final year (n = 8, 6 and 4), and three focus group interviews with faculty members affiliated with occupational therapy programmes in Norway (n = 5, 2 and 5). Interviewing both students and faculty members enabled us to explore the differences in their experiences and perceptions. Results Five integrative themes emerged from the analysis: "introducing research early", "setting higher expectations", "ensuring competence in research methods", "having role models" and "providing future best practice". Research was described as an important aspect of the occupational therapy bachelor program as it helps ensure that students achieve the necessary competence for offering future best practice. Students expressed a need to be introduced to research early in the program, and they preferred to have higher expectations regarding use of research. Competence in research methods and the importance of role models were also highlighted. Conclusions Undergraduate health care students are expected to be competent in using research. Findings from our study demonstrated that the participants perceived the use of research during training as important to ensure future best practice. Increasing the focus on research in the programme's curricula and efforts to improve students' formal training in research-specific skills could be a starting point towards increased use of research in the occupational therapy profession.	[Helgoy, Kjersti Velde] VID Specialized Univ, Ctr Diakonia & Profess Practice, Stavanger, Norway; [Smeby, Jens-Christian] OsloMet Oslo Metropolitan Univ, Ctr Study Profess, Oslo, Norway; [Bonsaksen, Tore] Inland Norway Univ Appl Sci, Fac Social & Hlth Sci, Dept Hlth & Nursing Sci, Elverum, Norway; [Bonsaksen, Tore] VID Specialized Univ, Fac Hlth Studies, Sandnes, Norway; [Rydland Olsen, Nina] Western Norway Univ Appl Sci, Fac Hlth & Social Sci, Dept Hlth & Functioning, Bergen, Norway	VID Specialised University; Oslo Metropolitan University (OsloMet); Inland Norway University of Applied Sciences; VID Specialised University; Western Norway University of Applied Sciences	Helgoy, KV (corresponding author), VID Specialized Univ, Ctr Diakonia & Profess Practice, Stavanger, Norway.	kjersti.velde.helgoy@vid.no	Bonsaksen, Tore/U-5148-2018	Bonsaksen, Tore/0000-0001-6315-1111; Olsen, Nina Rydland/0000-0002-5173-1597; Helgoy, Kjersti Velde/0000-0001-9615-9881				[Anonymous], 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14123; [Anonymous], 2015, JMIR MED INFORM, V3, pe22; [Anonymous], 2017, FORSKRIFT TILSYN MED, V2-3; [Anonymous], 2018, 7 SER FPGAS DAT SHEE, V2, P1; [Anonymous], 2016, EVIDENCE, V8, pe1000; Auchincloss LC, 2014, CBE-LIFE SCI EDUC, V13, P29, DOI 10.1187/cbe.14-01-0004; Brew A, 2017, TEACH HIGH EDUC, V22, P551, DOI 10.1080/13562517.2016.1273216; Chang YJ, 2015, ACAD MED, V90, P1162, DOI 10.1097/ACM.0000000000000702; Deicke W., 2014, CUR Q, V35, P27; Griffiths R, 2004, STUD HIGH EDUC, V29, P709, DOI 10.1080/0307507042000287212; Halabi JO., 2016, SAUDI J HLTH SCI, V5, P118, DOI [10. 4103/2278-0521. 195813, DOI 10.4103/2278-0521.195813, 10.4103/2278-0521.195813]; Healey Mick., 2005, RESHAPING U NEW RELA, P67, DOI DOI 10.1371/JOURNAL.PMED.0020124; Healey Mick., 2009, HIGH EDUC; Huet I, 2018, EUR J ENG EDUC, V43, P725, DOI 10.1080/03043797.2017.1415299; Jackson L, 2018, AM J OCCUP THER, V72, DOI 10.5014/ajot.2018.72S1-PO8029; Jenkins A., 2015, COUNC UNDERGRAD RES, V35, P31; Jenkins A., 2007, LINKING RES TEACHING; Jenkins A, 2013, UNIVERSITY TEACHING IN FOCUS: A LEARNING-CENTRED APPROACH, P128; Johansson B, 2010, J NURS MANAGE, V18, P70, DOI 10.1111/j.1365-2834.2009.01060.x; Kamwendo K, 2001, SCAND J CARING SCI, V15, P295, DOI 10.1046/j.1471-6712.2001.00041.x; Kandell GV, 2019, MED STUDENTS UNDERST, P1; Keib CN, 2017, NURS EDUC TODAY, V54, P37, DOI 10.1016/j.nedt.2017.04.007; Krueger R., 2014, PRACTICAL GUIDE APPL; Kunnskapsdepartementet, 2017, KULT KVAL HOYER UTD, P130; Kyvik S., 2014, FORSKNINGSBASERT UTD; Kyvik S, 2015, VOCATIONAL PROFESSIO, P105; Leach MJ, 2016, J CLIN NURS, V25, P194, DOI 10.1111/jocn.13103; Lomborg K., 2010, KLIN SYGEPLEJE, V24, P7; Lopatto D., 2010, SCI SOLUTION IMPACT; Malterud K., 2018, FOKUSGRUPPER SOM FOR; McCluskey A., 2003, AUST OCCUP THER J, V50, P3, DOI [10.1046/j.1440-1630.2003.00303.x, DOI 10.1046/J.1440-1630.2003.00303.X]; Ofsted, 2016, UNKN CHILDR DEST DIS; Olsen NR, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-52; Ordinetz SA., 2009, THESIS; Ozay SB, 2012, TEACH HIGH EDUC, V17, P453, DOI 10.1080/13562517.2011.641009; Paudel S, 2019, MED STUDENTS KNOWLED, P162; Rodenbusch SE, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-03-0117; Ross JG, 2019, NURS EDUC TODAY, V82, P79, DOI 10.1016/j.nedt.2019.08.006; Ryan EJ, 2016, J CLIN NURS, V25, P1548, DOI 10.1111/jocn.13229; Sabzwari S, 2009, BMC MED EDUC, V9, DOI 10.1186/1472-6920-9-68; Samuelsson K, 2015, BRIT J OCCUP THER, V78, P175, DOI 10.1177/0308022615569511; Smyth L, 2016, HIGH EDUC, V72, P191, DOI 10.1007/s10734-015-9945-z; Stronge M, 2012, OCCUP THER INT, V19, P7, DOI 10.1002/oti.328; Stube JE, 2007, AM J OCCUP THER, V61, P53, DOI 10.5014/ajot.61.1.53; Thorne S, 2016, DEV QUAL INQ, V2; Trowler P., 2007, TRIBES TERRITORIES R; Upton D, 2014, BRIT J OCCUP THER, V77, P24, DOI 10.4276/030802214X13887685335544; Utdannings- og forskningsdepartementet, 2005, RAMM ERG, P1; Utdanningsforbundet, 2020, TID FORSK UTV KARTL; Vereijken MWC, 2018, ADV HEALTH SCI EDUC, V23, P371, DOI 10.1007/s10459-017-9803-0; VID Specialized University, 2012, FAGPL BACH ERG 180 S; Visser-Wijnveen G., 2013, INTEGRATIE ONDERZOEK; Walkington H, 2011, J GEOGR HIGHER EDUC, V35, P315, DOI 10.1080/03098265.2011.563377; Wilson A, 2012, STUD HIGH EDUC, V37, P513, DOI 10.1080/03075079.2010.527933	54	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243544	10.1371/journal.pone.0243544	http://dx.doi.org/10.1371/journal.pone.0243544			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347466	Green Published, gold			2022-12-27	WOS:000603071100004
J	Lockwood, J; Townsend, E; Allen, H; Daley, D; Sayal, K				Lockwood, Joanna; Townsend, Ellen; Allen, Heather; Daley, David; Sayal, Kapil			What young people say about impulsivity in the short-term build up to self-harm: A qualitative study using card-sort tasks	PLOS ONE			English	Article							EMOTION REGULATION; MODEL; ADOLESCENTS; SUICIDE; INJURY; VALIDATION; BEHAVIOR; PSYCHOPATHOLOGY; MAINTENANCE; PERSONALITY	Youth who self-harm report high levels of trait impulsivity and identify impulsive behaviour as a proximal factor directly preceding a self-harm act. Yet, impulsivity is a multidimensional construct and distinct impulsivity-related facets relate differentially to self-harm outcomes. Studies have yet to examine if and how a multidimensional account of impulsivity is meaningful to individual experiences and understandings of self-harm in youth. We explored the salience and context of multidimensional impulsivity within narratives of self-harm, and specifically in relation to the short-term build-up to a self-harm episode. Fifteen community-based adolescents (aged 16-22 years) attending Further Education (FE) colleges in the UK took part in individual face-to-face sessions (involving exploratory card-sort tasks and semi-structured interviews) which explored factors relating to self-harm, impulsivity and the broader emotional, developmental and cognitive context. Session data were analysed thematically. Two overarching themes, and associated subthemes, were identified: 'How I respond to strong negative emotions'; and 'Impulse versus deliberation- How much I think through what I'm doing before I do it'. Self-harm was typically a quick, impulsive act in the context of overwhelming emotion, underpinned by cognitive processing deficits. The dynamic tension between emotion-based impulsivity and controlled deliberation was articulated in the immediate moments before self-harm. However, impulsive responses were perceived as modifiable. Where self-harm patterns were established, these related to habitual behaviour and quick go-to responses. Young people identified with a multidimensional conception of impulsivity and described the impulsive context of a self-harm act as dynamic, contextual, and developmentally charged. Findings have implications for youth-focused work. Card-task frameworks are recommended to scaffold and facilitate discussion with young people, particularly where topics are sensitive, complex and multifactorial.	[Lockwood, Joanna; Allen, Heather; Daley, David; Sayal, Kapil] Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England; [Lockwood, Joanna; Townsend, Ellen] Univ Nottingham, Sch Psychol, Self Harm Res Grp, Nottingham, England; [Lockwood, Joanna; Daley, David; Sayal, Kapil] Univ Nottingham, Sch Med, NIHR MindTech MedTech Cooperat, Inst Mental Hlth, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham	Lockwood, J (corresponding author), Univ Nottingham, Div Psychiat & Appl Psychol, Nottingham, England.; Lockwood, J (corresponding author), Univ Nottingham, Sch Psychol, Self Harm Res Grp, Nottingham, England.; Lockwood, J (corresponding author), Univ Nottingham, Sch Med, NIHR MindTech MedTech Cooperat, Inst Mental Hlth, Nottingham, England.	joanna.lockwood@nottingham.ac.uk	Allen, Heather/GWQ-6002-2022	Townsend, Ellen/0000-0002-4677-5958; Daley, David/0000-0002-3597-0408	Economic and Social Research Council [ES/J500100/1]; National Institute of Health Research (NIHR) Nottingham Biomedical Research Centre	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute of Health Research (NIHR) Nottingham Biomedical Research Centre	This work was supported by an Economic and Social Research Council grant awarded to JL (ES/J500100/1). JL also receives financial support from the National Institute of Health Research (NIHR) Nottingham Biomedical Research Centre. The funding source(s) had no involvement in the design of the study, and collection, analysis and interpretation of the data, and in the writing of the manuscript.	Adler PA, 2007, J CONTEMP ETHNOGR, V36, P537, DOI 10.1177/0891241607301968; Allen KJD, 2019, BEHAV THER, V50, P924, DOI 10.1016/j.beth.2019.02.001; Anestis MD, 2014, PERS SOC PSYCHOL REV, V18, P366, DOI 10.1177/1088868314535988; Baetens I, 2011, PERS INDIV DIFFER, V50, P527, DOI 10.1016/j.paid.2010.11.015; BAUMEISTER RF, 1990, PSYCHOL REV, V97, P90, DOI 10.1037/0033-295X.97.1.90; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Berg JM, 2015, PSYCHOL ASSESSMENT, V27, P1129, DOI 10.1037/pas0000111; Billieux J, 2010, BEHAV RES THER, V48, P1085, DOI 10.1016/j.brat.2010.07.008; Braet C, 2014, COGNITIVE THER RES, V38, P493, DOI 10.1007/s10608-014-9616-x; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Carver CS, 2008, PSYCHOL BULL, V134, P912, DOI 10.1037/a0013740; Chandler A, 2018, YOUNG, V26, P313, DOI 10.1177/1103308817717367; Curtis C, 2016, YOUNG, V24, P17, DOI 10.1177/1103308815613680; Cyders MA, 2008, PSYCHOL BULL, V134, P807, DOI 10.1037/a0013341; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; Davidson RJ, 2003, ANN NY ACAD SCI, V1000, P316, DOI 10.1196/annals.1280.014; Garisch JA, 2015, CHILD ADOL PSYCH MEN, V9, DOI 10.1186/s13034-015-0055-6; Geulayov G, 2018, LANCET PSYCHIAT, V5, P167, DOI 10.1016/S2215-0366(17)30478-9; Glenn CR, 2010, PERSONAL DISORD, V1, P67, DOI 10.1037/a0017427; Gratz KL, 2004, J PSYCHOPATHOL BEHAV, V26, P41, DOI 10.1023/B:JOBA.0000007455.08539.94; Gvion Y, 2011, ARCH SUICIDE RES, V15, P93, DOI 10.1080/13811118.2011.565265; Hamza CA, 2015, CLIN PSYCHOL REV, V38, P13, DOI 10.1016/j.cpr.2015.02.010; Hasking P, 2017, COGNITION EMOTION, V31, P1543, DOI 10.1080/02699931.2016.1241219; Hill K, 2012, CLIN CHILD PSYCHOL P, V17, P459, DOI 10.1177/1359104511423364; Hofmann W, 2009, PERSPECT PSYCHOL SCI, V4, P162, DOI 10.1111/j.1745-6924.2009.01116.x; Janis IB, 2009, PSYCHIAT RES, V169, P261, DOI 10.1016/j.psychres.2008.06.041; Johnson SL, 2017, BRIT J CLIN PSYCHOL, V56, P235, DOI 10.1111/bjc.12135; Klonsky ED, 2008, J CONSULT CLIN PSYCH, V76, P22, DOI 10.1037/0022-006X.76.1.22; Liu RT, 2017, NEUROSCI BIOBEHAV R, V83, P440, DOI 10.1016/j.neubiorev.2017.09.019; Lockwood J, 2020, J AFFECT DISORDERS, V274, P583, DOI 10.1016/j.jad.2020.05.021; Lockwood J, 2017, EUR CHILD ADOLES PSY, V26, P387, DOI 10.1007/s00787-016-0915-5; MacKillop J, 2016, PSYCHOPHARMACOLOGY, V233, P3361, DOI 10.1007/s00213-016-4372-0; McManus S, 2019, LANCET PSYCHIAT, V6, P573, DOI 10.1016/S2215-0366(19)30188-9; Miller A., 2007, DIALETICAL BEHAV THE; Moran P, 2012, LANCET, V379, P236, DOI 10.1016/S0140-6736(11)61141-0; Morrison K, 2013, EDUC STUD-UK, V39, P320, DOI 10.1080/03055698.2012.760443; Nock MK, 2009, J ABNORM PSYCHOL, V118, P816, DOI 10.1037/a0016948; O'Connor RC, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P181; Orlando CM, 2015, BEHAV THER, V46, P824, DOI 10.1016/j.beth.2015.01.002; Pearson CM, 2015, PSYCHOL REV, V122, P516, DOI 10.1037/a0039268; Rawlings J, 2015, J AFFECT DISORDERS, V184, P29, DOI 10.1016/j.jad.2015.05.042; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Simons JS, 2005, MOTIV EMOTION, V29, P83, DOI 10.1007/s11031-005-7955-3; Steinberg L, 2007, CURR DIR PSYCHOL SCI, V16, P55, DOI 10.1111/j.1467-8721.2007.00475.x; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Townsend E, 2016, J AFFECT DISORDERS, V206, P161, DOI 10.1016/j.jad.2016.07.004; Wadman R, 2017, J HEALTH PSYCHOL, V22, P1631, DOI 10.1177/1359105316631405; Wenzel A, 2008, APPL PREV PSYCHOL, V12, P189, DOI 10.1016/j.appsy.2008.05.001; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7	50	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244319	10.1371/journal.pone.0244319	http://dx.doi.org/10.1371/journal.pone.0244319			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347492	Green Published, gold			2022-12-27	WOS:000603071100007
J	Sugishita, Y; Kurita, J; Sugawara, T; Ohkusa, Y				Sugishita, Yoshiyuki; Kurita, Junko; Sugawara, Tamie; Ohkusa, Yasushi			Effects of voluntary event cancellation and school closure as countermeasures against COVID-19 outbreak in Japan	PLOS ONE			English	Article							PANDEMIC INFLUENZA; STRATEGIES	Background To control the COVID-19 outbreak in Japan, sports and entertainment events were canceled and schools were closed throughout Japan from February 26 through March 19. That policy has been designated as voluntary event cancellation and school closure (VECSC). Object This study assesses VECSC effectiveness based on predicted outcomes. Methods A simple susceptible-infected-recovered model was applied to data of patients with symptoms in Japan during January 14 through March 26. The respective reproduction numbers for periods before VECSC (R-0), during VECSC (R-e), and after VECSC (R-a) were estimated. Results Results suggest R-0 before VECSC as 2.534 [2.449, 2.598], R-e during VECSC as 1.077 [0.948, 1.228], and R-a after VECSC as 4.455 [3.615, 5.255]. Discussion and conclusion Results demonstrated that VECSC can reduce COVID-19 infectiousness considerably, but after VECSC, the value of the reproduction number rose to exceed 4.0.	[Sugishita, Yoshiyuki; Sugawara, Tamie] Natl Inst Infect Dis, Tokyo, Japan; [Kurita, Junko; Ohkusa, Yasushi] Tokiwa Univ, Collage Nursing, Dept Nursing, Ibaraki, Japan	National Institute of Infectious Diseases (NIID)	Sugishita, Y (corresponding author), Natl Inst Infect Dis, Tokyo, Japan.	yoshiyuk@gmail.com						[Anonymous], 2020, JAPAN TIMES; Britton T, 2009, STOCHASTIC EPIDEMIC; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glockner S, 2020, NOW CASTING COVID 19, DOI [10.1101/2020.03.18.20037473, DOI 10.1101/2020.03.18.20037473]; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Hohle M, 2014, BIOMETRICS, V70, P993, DOI 10.1111/biom.12194; Kelvin AA, 2020, LANCET INFECT DIS, V20, P633, DOI 10.1016/S1473-3099(20)30236-X; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kurita J., 2020, FORECAST COVID 19 OU, DOI [10.1101/2020.04.02.20051490, DOI 10.1101/2020.04.02.20051490]; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee PI, 2020, J MICROBIOL IMMUNOL, V53, P371, DOI 10.1016/j.jmii.2020.02.011; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; NARULA SC, 1982, INT STAT REV, V50, P317, DOI 10.2307/1402501; Nishiura H., 2020, MEDRXIV, DOI 10.1101/2020.02.28.20029272; Ohkusa Y, 2011, J INFECT CHEMOTHER, V17, P468, DOI 10.1007/s10156-010-0200-3; Ohkusa Y, 2009, JPN J INFECT DIS, V62, P98; Oshitani H, 2020, CONCEPT COUNTER MEAS; Phillips RF, 2002, STAT COMPUT, V12, P281, DOI 10.1023/A:1020759012226; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Siemsen E, 2007, SOCIOL METHOD RES, V36, P227, DOI 10.1177/0049124107301946; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	25	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0239455	10.1371/journal.pone.0239455	http://dx.doi.org/10.1371/journal.pone.0239455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347444	gold, Green Published, Green Submitted			2022-12-27	WOS:000603071100027
J	Joshi, P; Skromne, I				Joshi, Piyush; Skromne, Isaac			A theoretical model of neural maturation in the developing chick spinal cord	PLOS ONE			English	Article							HOX GENE-EXPRESSION; NEUROMESODERMAL PROGENITORS; NEURONAL DIFFERENTIATION; RESTRICTED EXPRESSION; TRANSCRIPTION FACTORS; PARAXIAL MESODERM; RETINOID PATHWAYS; OPPOSING FGF; T BRACHYURY; ACTIVATION	Cellular differentiation is a tightly regulated process under the control of intricate signaling and transcription factors interaction network working in coordination. These interactions make the systems dynamic, robust and stable but also difficult to dissect. In the spinal cord, recent work has shown that a network of FGF, WNT and Retinoic Acid (RA) signaling factors regulate neural maturation by directing the activity of a transcription factor network that contains CDX at its core. Here we have used partial and ordinary (Hill) differential equation based models to understand the spatiotemporal dynamics of the FGF/WNT/RA and the CDX/transcription factor networks, alone and in combination. We show that in both networks, the strength of interaction among network partners impacts the dynamics, behavior and output of the system. In the signaling network, interaction strength determine the position and size of discrete regions of cell differentiation and small changes in the strength of the interactions among networking partners can result in a signal overriding, balancing or oscillating with another signal. We also show that the spatiotemporal information generated by the signaling network can be conveyed to the CDX/transcription network to produces a transition zone that separates regions of high cell potency from regions of cell differentiation, in agreement with most in vivo observations. Importantly, one emerging property of the networks is their robustness to extrinsic disturbances, which allows the system to retain or canalize NP cells in developmental trajectories. This analysis provides a model for the interaction conditions underlying spinal cord cell maturation during embryonic axial elongation.	[Joshi, Piyush; Skromne, Isaac] German Canc Res Ctr, Div Pediat Neurooncol, Heidelberg, Germany; [Skromne, Isaac] Univ Richmond, Dept Biol, Richmond, VA 23173 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Richmond	Skromne, I (corresponding author), Univ Richmond, Dept Biol, Richmond, VA 23173 USA.	iskromne@richmond.edu		Skromne, Isaac/0000-0003-2369-7210	Sigma XI GIAR; University of Richmond School of Arts and Sciences; National Science Foundation [IOS-1755386]	Sigma XI GIAR; University of Richmond School of Arts and Sciences; National Science Foundation(National Science Foundation (NSF))	P.J. was supported by Sigma XI GIAR, and I.S. was supported by University of Richmond School of Arts and Sciences and by the National Science Foundation (IOS-1755386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires R, 2019, DEV CELL, V48, P383, DOI 10.1016/j.devcel.2018.12.004; Akai J, 2005, GENE DEV, V19, P2877, DOI 10.1101/gad.357705; Amin S, 2016, CELL REP, V17, P3165, DOI 10.1016/j.celrep.2016.11.069; Atsuta Y, 2015, DEVELOPMENT, V142, P2329, DOI 10.1242/dev.122408; Basson MA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008151; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bel-Vialar S, 2007, DEV BIOL, V305, P659, DOI 10.1016/j.ydbio.2007.02.012; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Castillo HA, 2010, DEVELOPMENT, V137, P507, DOI 10.1242/dev.043257; CATALA M, 1995, MECH DEVELOP, V51, P51, DOI 10.1016/0925-4773(95)00350-A; Cunningham TJ, 2016, BIOL OPEN, V5, P1821, DOI 10.1242/bio.020891; Delfino-Machin M, 2005, DEVELOPMENT, V132, P4273, DOI 10.1242/dev.02009; Denans N, 2015, ELIFE, V4, DOI 10.7554/eLife.04379; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; del Corral RD, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00058; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Eroshkin FM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23049; Gaunt SJ, 2005, INT J DEV BIOL, V49, P901, DOI 10.1387/ijdb.052021sg; Goto H, 2017, DEVELOPMENT, V144, P1412, DOI 10.1242/dev.143578; Gouti M, 2015, TRENDS GENET, V31, P282, DOI 10.1016/j.tig.2015.03.001; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gregory PA, 2006, PHARMACOGENET GENOM, V16, P527, DOI 10.1097/01.fpc.0000215068.06471.35; Hammerle B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001169; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Henrique D, 2015, DEVELOPMENT, V142, P2864, DOI 10.1242/dev.119768; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hou LL, 2017, SEMIN CELL DEV BIOL, V63, P2, DOI 10.1016/j.semcdb.2016.08.005; Housden BE, 2014, TRENDS BIOCHEM SCI, V39, P457, DOI 10.1016/j.tibs.2014.07.008; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Joshi P, 2019, DEV BIOL, V449, P132, DOI 10.1016/j.ydbio.2019.02.014; Jurberg AD, 2013, DEV CELL, V25, P451, DOI 10.1016/j.devcel.2013.05.009; Kawachi T, 2020, DEV BIOL, V461, P160, DOI 10.1016/j.ydbio.2020.02.007; Kiparissides A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014668; Koch F, 2017, DEV CELL, V42, P514, DOI 10.1016/j.devcel.2017.07.021; Kumar S, 2014, DEVELOPMENT, V141, P2972, DOI 10.1242/dev.112367; Li Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep38665; Lunn JS, 2007, DEV BIOL, V302, P536, DOI 10.1016/j.ydbio.2006.10.014; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; Martin BL, 2010, GENE DEV, V24, P2778, DOI 10.1101/gad.1962910; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Oates AC, 2012, DEVELOPMENT, V139, P625, DOI 10.1242/dev.063735; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Olivera-Martinez I, 2014, DEVELOPMENT, V141, P3266, DOI 10.1242/dev.112623; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Perrimon N, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005975; Pituello F, 1999, DEVELOPMENT, V126, P587; Pogenberg V, 2005, J BIOL CHEM, V280, P1625, DOI 10.1074/jbc.M409302200; Pownall ME, 1998, CURR BIOL, V8, P673, DOI 10.1016/S0960-9822(98)70257-X; Santillan M, 2008, MATH MODEL NAT PHENO, V3, P85, DOI 10.1051/mmnp:2008056; Sasai N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001907; SCHOENWOLF GC, 1979, AM J ANAT, V155, P445, DOI 10.1002/aja.1001550404; Sherman MS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002407; Shi WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42648; Singh S, 2000, J BIOL CHEM, V275, P17306, DOI 10.1074/jbc.M000359200; Takada S, 2017, J BIOCHEM, V161, P1, DOI 10.1093/jb/mvw071; Takemoto T, 2006, DEVELOPMENT, V133, P297, DOI 10.1242/dev.02196; Takemoto T, 2011, NATURE, V470, P394, DOI 10.1038/nature09729; Tamashiro DAA, 2012, DIFFERENTIATION, V83, P282, DOI 10.1016/j.diff.2012.02.010; Tiedemann HB, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002586; Tsimring LS, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026601; Vitobello A, 2011, DEV CELL, V20, P469, DOI 10.1016/j.devcel.2011.03.011; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	75	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244219	10.1371/journal.pone.0244219	http://dx.doi.org/10.1371/journal.pone.0244219			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338079	Green Published, gold			2022-12-27	WOS:000601313500011
J	Millioni, R; Mortarino, C				Millioni, Renato; Mortarino, Cinzia			Informed sequential pooling approach to detect SARS-CoV-2 infection	PLOS ONE			English	Article								The alarming spread of the pandemic coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus requires several measures to reduce the risk of contagion. Every successful strategy in controlling the SARS-CoV-2 infection depends on timely diagnosis, which should include testing of asymptomatic carriers. Consequently, increasing the throughput for clinical laboratories for the purposes of conducting large-scale diagnostic testing is urgently needed. Here we support the hypothesis that standard diagnostic protocol for SARS-CoV-2 virus could be conveniently applied to pooled samples obtained from different subjects. We suggest that a two-step sequential pooling procedure could identify positive subjects, ensuring at the same time significant benefits of cost and time. The simulation data presented herein were used to assess the efficiency, in terms of number of required tests, both for random assignment of the subjects to the pools and for situations in which epidemiological and clinical data are used to create "informed" pools. Different scenarios were simulated to measure the effect of different pool sizes and different values for virus frequency. Our results allow for a customization of the pooling strategy according to the specific characteristics of the cohort being tested.	[Millioni, Renato] Fascial Manipulat Inst Stecco, Padua, Italy; [Mortarino, Cinzia] Univ Padua, Dept Stat Sci, Padua, Italy	University of Padua	Mortarino, C (corresponding author), Univ Padua, Dept Stat Sci, Padua, Italy.	cinzia.mortarino@unipd.it	Mortarino, Cinzia/AAM-7109-2020	Mortarino, Cinzia/0000-0003-3849-0378				Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Al-Tawfiq JA, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101608; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; B.Wilder, 2020, medRxiv, DOI 10.1101/2020.06.22.20136309; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Charlton CL, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00042-18; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Falsey AR, 2012, J CLIN MICROBIOL, V50, P2835, DOI 10.1128/JCM.01473-12; Fehr AR, 2017, ANNU REV MED, V68, P387, DOI 10.1146/annurev-med-051215-031152; Gan Yichuan, 2020, SAMPLE POOLING STRAT, DOI [10.1101/2020.05.18.20106138, DOI 10.1101/2020.05.18.20106138]; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1070, DOI 10.1515/cclm-2020-0285; Lu R., 2020, SARS COV 2 DETECTION, V24, DOI DOI 10.1101/2020.03.24.20042689; Mondelli MU, 2021, LANCET INFECT DIS, V21, pE112, DOI 10.1016/S1473-3099(20)30678-2; Ott Isabel M, 2020, medRxiv, DOI 10.1101/2020.08.03.20165233; Panati Kalpana, 2021, Infect Disord Drug Targets, V21, pe160921187709, DOI 10.2174/1871526520666201109115820; Schmidt M, 2020, TRANSFUSION, V60, P2441, DOI 10.1111/trf.15973; Wacharapluesadee S, 2020, J MED VIROL, V92, P2193, DOI 10.1002/jmv.26005; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Watkins Anne E, 2020, medRxiv, DOI 10.1101/2020.09.02.20183830; Yelin I, 2020, CLIN INFECT DIS, V71, P2073, DOI 10.1093/cid/ciaa531	23	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244475	10.1371/journal.pone.0244475	http://dx.doi.org/10.1371/journal.pone.0244475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378344	Green Published, gold			2022-12-27	WOS:000605651300020
J	Weissinger, M; Vogel, J; Kupferschlager, J; Dittmann, H; Vega, SGC; Grosse, U; Artzner, C; Nikolaou, K; la Fougere, C; Grozinger, G				Weissinger, Matthias; Vogel, Jonas; Kupferschlaeger, Jurgen; Dittmann, Helmut; Castaneda Vega, Salvador Guillermo; Grosse, Ulrich; Artzner, Christoph; Nikolaou, Konstantin; la Fougere, Christian; Groezinger, Gerd			Correlation of C-arm CT acquired parenchymal blood volume (PBV) with Tc-99m-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up	PLOS ONE			English	Article							Y-90 RESIN MICROSPHERES; SELECTIVE INTERNAL RADIOTHERAPY; TC-99M MACROAGGREGATED ALBUMIN; HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR RESPONSE; PERFUSION; HETEROGENEITY	Objective SPECT/CT with Tc-99m-macroaggregated albumin (MAA) is generally used for diagnostic work-up prior to transarterial radioembolization (TARE) to exclude shunts and to provide additional information for treatment stratification and dose calculation. C-arm CT is used for determination of lobular vascular supply and assessment of parenchymal blood volume (PBV). Aim of this study was to correlate MAA-uptake and PBV-maps in hepatocellular carcinoma (HCC) and hepatic metastases of the colorectal carcinoma (CRC). Materials and methods 34 patients underwent a PBV C-arm CT immediately followed by Tc-99m-MAA injection and a SPECT/CT acquisition after 1 h uptake. MAA-uptake and PBV-maps were visually assessed and semi-quantitatively analyzed (MAA-tumor/liver-parenchyma = MAA-TBR or PBV in ml/100ml). In case of a poor match, tumors were additionally correlated with post-TARE Y-90-Bremsstrahlung-SPECT/CT as a reference. Results 102 HCC or CRC metastases were analyzed. HCC presented with significantly higher MAA-TBR (7.6 vs. 3.9, p<0.05) compared to CRC. Tumors showed strong intra- and inter-individual dissimilarities between TBR and PBV with a weak correlations for capsular HCCs (r = 0.45, p<0.05) and no correlation for CRC. The demarcation of lesions was slightly better for both HCC and CRC in PBV-maps compared to MAA-SPECT/CT (exact match: 52%/50%; same intensity/homogeneity: 38%/39%; insufficient 10%/11%). MAA-SPECT/CT revealed a better visual correlation with post-therapeutic Y-90-Bremsstrahlung-SPECT/CT. Conclusion The acquisition of PBV can improve the detectability of small intrahepatic tumors and correlates with the MAA-Uptake in HCC. The results indicate that Tc-99m-MAA-SPECT/CT remains to be the superior method for the prediction of post-therapeutic Y-90-particle distribution, especially in CRC. However, intra-procedural PBV acquisition has the potential to become an additional factor for TARE planning, in addition to improving the determination of segment and tumor blood supply, which has been demonstrated previously.	[Weissinger, Matthias; Vogel, Jonas; Kupferschlaeger, Jurgen; Dittmann, Helmut; Castaneda Vega, Salvador Guillermo; la Fougere, Christian] Univ Hosp Tuebingen, Dept Nucl Med & Clin Mol Imaging, Tubingen, Germany; [Vogel, Jonas; Artzner, Christoph; Nikolaou, Konstantin; Groezinger, Gerd] Univ Hosp Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Castaneda Vega, Salvador Guillermo] Univ Hosp Tuebingen, Werner Siemens Imaging Ctr, Dept Preclin Imaging & Radiopharm, Tubingen, Germany; [Grosse, Ulrich] Kantonsspital Frauenfeld, Dept Diagnost & Intervent Radiol, Frauenfeld, Switzerland; [Nikolaou, Konstantin; la Fougere, Christian] Eberhard Karls Univ Tuebingen, iFIT Cluster Excellence, Tubingen, Germany; [Nikolaou, Konstantin; la Fougere, Christian] German Canc Consortium DKTK, Partner Site Tuebingen, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Siemens AG; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ)	la Fougere, C (corresponding author), Univ Hosp Tuebingen, Dept Nucl Med & Clin Mol Imaging, Tubingen, Germany.; la Fougere, C (corresponding author), Eberhard Karls Univ Tuebingen, iFIT Cluster Excellence, Tubingen, Germany.; la Fougere, C (corresponding author), German Canc Consortium DKTK, Partner Site Tuebingen, Tubingen, Germany.	christian.lafougere@med.uni-tuebingen.de	Artzner, Christoph/GLS-9305-2022; la Fougère, Christian/AAN-2811-2021; la Fougere, Christian/G-6514-2012	la Fougère, Christian/0000-0001-7519-0417; Weissinger, Matthias/0000-0003-2044-3047; Grozinger, Gerd/0000-0002-0102-187X; Castaneda Vega, Salvador Guillermo/0000-0002-0484-9904; Vogel, Jonas/0000-0003-3657-7234	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC 2180 - 390900677]; Open Access Publishing Fund of University of Tuebingen	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tuebingen	This study was funded in part by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy to CLF (EXC 2180 - 390900677) and the Open Access Publishing Fund of University of Tuebingen provided support for publishing fees. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AS, 2009, AM J NEURORADIOL, V30, P917, DOI 10.3174/ajnr.A1513; Bailey DL, 2013, J NUCL MED, V54, P83, DOI 10.2967/jnumed.112.111476; Bayer_Pharma_AG, 2020, GEBR ANW ULTR 370 MG; Britten RA, 1996, RADIOTHER ONCOL, V39, P145, DOI 10.1016/0167-8140(96)01719-7; Chiesa C, 2015, EUR J NUCL MED MOL I, V42, P1718, DOI 10.1007/s00259-015-3068-8; Collarino A, 2018, MED PHYS, V45, P2143, DOI 10.1002/mp.12880; Conradt S, 2016, BREMSSTRAHLUNGS SPEC; Demirelli S, 2015, NUCL MED COMMUN, V36, P340, DOI 10.1097/MNM.0000000000000257; Grozinger G, 2016, EUR J RADIOL, V85, P1525, DOI 10.1016/j.ejrad.2016.06.005; Haste P, 2017, J VASC INTERV RADIOL, V28, P722, DOI 10.1016/j.jvir.2016.12.1221; Hendlisz A, 2010, J CLIN ONCOL, V28, P3687, DOI 10.1200/JCO.2010.28.5643; Ho S, 1997, J NUCL MED, V38, P1201; Ilhan H, 2015, J NUCL MED, V56, P1654, DOI 10.2967/jnumed.115.162685; Kaufmann S, 2015, EUR J RADIOL, V84, P1029, DOI 10.1016/j.ejrad.2015.02.020; Kim DH, 2012, EUR J RADIOL, V81, P3542, DOI 10.1016/j.ejrad.2012.02.012; Leebens-Mack Y., 2012, GENOME BIOL, V13, pR3; LEUNG WT, 1994, J NUCL MED, V35, P70; Mallinckrodt_Medical, 2015, FACH TECHN LYOM; Miles KA, 1998, BRIT J RADIOL, V71, P276, DOI 10.1259/bjr.71.843.9616236; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Peynircioglu B, 2015, DIAGN INTERV RADIOL, V21, DOI 10.5152/dir.2014.13290; Reiner CS, 2016, CARDIOVASC INTER RAD, V39, P400, DOI 10.1007/s00270-015-1185-1; Reynolds AR, 2015, RADIOGRAPHICS, V35, P371, DOI 10.1148/rg.352140114; Rhee S, 2016, NUCL MED MOLEC IMAG, V50, P63, DOI 10.1007/s13139-015-0366-9; Salem R, 2006, J VASC INTERV RADIOL, V17, P1251, DOI 10.1097/01.RVI.0000233785.75257.9A; Schlageter M, 2014, WORLD J GASTROENTERO, V20, P15955, DOI 10.3748/wjg.v20.i43.15955; Song YS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000945; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Syha R, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0088-y; Syha R, 2016, INVEST RADIOL, V51, P121, DOI 10.1097/RLI.0000000000000215; Syha R, 2015, CANCER IMAGING, V15, DOI 10.1186/s40644-015-0057-x; Van de Wiele C, 2012, EUR J NUCL MED MOL I, V39, P1646, DOI 10.1007/s00259-012-2189-6; van den Hoven AF, 2016, CARDIOVASC INTER RAD, V39, P64, DOI 10.1007/s00270-015-1146-8; Vilgrain V, 2017, LANCET ONCOL, V18, P1624, DOI 10.1016/S1470-2045(17)30683-6; Vogl TJ, 2016, EUR RADIOL, V26, P755, DOI 10.1007/s00330-015-3869-y; Wang LM, 2013, J CLIN PATHOL, V66, P205, DOI 10.1136/jclinpath-2012-201231; Wondergem M, 2013, J NUCL MED, V54, P1294, DOI 10.2967/jnumed.112.117614; Zhuang ZG, 2014, J VASC INTERV RADIOL, V25, P739, DOI 10.1016/j.jvir.2014.01.021	38	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244235	10.1371/journal.pone.0244235	http://dx.doi.org/10.1371/journal.pone.0244235			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378338	gold, Green Published			2022-12-27	WOS:000605651300001
J	Izuno, A; Maruyama, TE; Ueno, S; Ujino-Ihara, T; Moriguchi, Y				Izuno, Ayako; Maruyama, Tsuyoshi E.; Ueno, Saneyoshi; Ujino-Ihara, Tokuko; Moriguchi, Yoshinari			Genotype and transcriptome effects on somatic embryogenesis in Cryptomeria japonica	PLOS ONE			English	Article							GERMIN-LIKE PROTEIN; ZYGOTIC EMBRYOS; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; PINUS-PINASTER; SEQUENCE; SHOOT; REGENERATION; INDUCTION; IMMATURE	Somatic embryogenesis (SE), which is in vitro regeneration of plant bodies from somatic cells, represents a useful means of clonal propagation and genetic engineering of forest trees. While protocols to obtain calluses and induce regeneration in somatic embryos have been reported for many tree species, the knowledge of molecular mechanisms of SE development is still insufficient to achieve an efficient supply of somatic embryos required for the industrial application. Cryptomeria japonica, a conifer species widely used for plantation forestry in Japan, is one of the tree species waiting for a secure SE protocol; the probability of normal embryo development appears to depend on genotype. To discriminate the embryogenic potential of embryonal masses (EMs) and efficiently obtain normal somatic embryos of C. japonica, we investigated the effects of genotype and transcriptome on the variation in embryogenic potential. Using an induction experiment with 12 EMs each from six genotypes, we showed that embryogenic potential differs between/within genotypes. Comparisons of gene expression profiles among EMs with different embryogenic potentials revealed that 742 differently expressed genes were mainly associated with pattern forming and metabolism. Thus, we suggest that not only genotype but also gene expression profiles can determine success in SE development. Consistent with previous findings for other conifer species, genes encoding leafy cotyledon, wuschel, germin-like proteins, and glutathione-S-transferases are likely to be involved in SE development in C. japonica and indeed highly expressed in EMs with high-embryogenic potential; therefore, these proteins represent candidate markers for distinguishing embryogenic potential.	[Izuno, Ayako; Maruyama, Tsuyoshi E.; Ueno, Saneyoshi; Ujino-Ihara, Tokuko] Forestry & Forest Prod Res Inst, Dept Forest Mol Genet & Biotechnol, Tsukuba, Ibaraki, Japan; [Moriguchi, Yoshinari] Niigata Univ, Grad Sch Sci & Technol, Niigata, Japan	Forestry & Forest Products Research Institute - Japan; Niigata University	Izuno, A (corresponding author), Forestry & Forest Prod Res Inst, Dept Forest Mol Genet & Biotechnol, Tsukuba, Ibaraki, Japan.	izuno@ffpri.affrc.go.jp	Izuno, Ayako/AAJ-8099-2020	Izuno, Ayako/0000-0002-9339-2845	Ministry of Agriculture, Forestry and Fisheries of Japan; NARO Bio-oriented Technology Research Advancement Institution [28013B, 28013BC]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); NARO Bio-oriented Technology Research Advancement Institution	This work was supported in part by grants from the Ministry of Agriculture, Forestry and Fisheries of Japan and NARO Bio-oriented Technology Research Advancement Institution to Y. M. (No. 28013B and No. 28013BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, TOPGO ENRICHMENT ANA; Baba K, 2008, PROG MED, V28, P2001; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bravo S, 2017, PLANT CELL TISS ORG, V130, P521, DOI 10.1007/s11240-017-1242-3; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; DOMON JM, 1995, PLANT PHYSIOL, V108, P141, DOI 10.1104/pp.108.1.141; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Forestry Agency, 2014, STAT HDB FOR FOR, P8; Futamura N, 2006, TREE PHYSIOL, V26, P1517, DOI 10.1093/treephys/26.12.1517; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Galland R, 2007, PLANT SIGNAL BEHAV, V2, P343, DOI 10.4161/psb.2.5.4652; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hasegawa Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206695; Hedman H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-89; Hirakawa Y, 2010, PLANT CELL, V22, P2618, DOI 10.1105/tpc.110.076083; Igasaki T, 2003, PLANT CELL REP, V22, P239, DOI 10.1007/s00299-003-0687-5; Ji JB, 2010, PLANT PHYSIOL, V152, P1346, DOI 10.1104/pp.109.149641; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Klimaszeswka K, 2007, TREE FOR SCI BIOTEC, V1, P11; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lelu-Walter MA, 2013, TREE GENET GENOMES, V9, P883, DOI 10.1007/s11295-013-0620-1; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li QF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-553; Lippert D, 2005, PROTEOMICS, V5, P461, DOI 10.1002/pmic.200400986; Mahdavi-Darvari F, 2015, PLANT CELL TISS ORG, V120, P407, DOI 10.1007/s11240-014-0615-0; Maruyama E., 2000, PLANT BIOTECHNOL-NAR, V17, P281, DOI [10.5511/plantbiotechnology.17.281, DOI 10.5511/PLANTBIOTECHNOLOGY.17.281]; Maruyama E.T., 2017, KANTO SHINRIN KENKYU, V68, P41; Maruyama E, 2007, PROPAG ORNAM PLANTS, V7, P57; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Mishima K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4581-5; Morel A, 2014, PHYSIOL PLANTARUM, V152, P184, DOI 10.1111/ppl.12158; Moriguchi Y, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1149-5; Moriguchi Y, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1011-1; Moriguchi Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-95; Neutelings G, 1998, PLANT MOL BIOL, V38, P1179, DOI 10.1023/A:1006033622928; Noceda C, 2009, TREES-STRUCT FUNCT, V23, P1285, DOI 10.1007/s00468-009-0370-8; Ogita S, 1999, J WOOD SCI, V45, P87, DOI 10.1007/BF01192323; Plomion C, 2016, ANN FOREST SCI, V73, P77, DOI 10.1007/s13595-015-0488-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Singla B, 2007, PLANT MOL BIOL, V65, P677, DOI 10.1007/s11103-007-9234-z; Taniguchi T, 2008, PLANT CELL REP, V27, P1461, DOI 10.1007/s00299-008-0569-y; THOMPSON EW, 1980, J BIOL CHEM, V255, P5965; Uchiyama K, 2012, TREE GENET GENOMES, V8, P1213, DOI 10.1007/s11295-012-0508-5; Uddenberg D, 2011, PLANTA, V234, P527, DOI 10.1007/s00425-011-1418-8; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Wang XC, 2009, CELL RES, V19, P224, DOI 10.1038/cr.2008.276; Wei F-J, 2020, INSPECTING ABUNDANTL; Wojcik AM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041333; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang SG, 2010, BIOCHEM BIOPH RES CO, V398, P355, DOI 10.1016/j.bbrc.2010.06.056	54	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244634	10.1371/journal.pone.0244634	http://dx.doi.org/10.1371/journal.pone.0244634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373415	Green Published, gold			2022-12-27	WOS:000603612300007
J	Kalinda, C; Mindu, T; Chimbari, MJ				Kalinda, Chester; Mindu, Tafadzwa; Chimbari, Moses John			A systematic review and meta-analysis quantifying schistosomiasis infection burden in pre-school aged children (PreSAC) in sub-Saharan Africa for the period 2000-2020	PLOS ONE			English	Review							ANTIGEN URINE ASSAY; MANSONI INFECTION; YOUNG-CHILDREN; ENDEMIC AREA; PREVALENCE; HAEMATOBIUM; INFANTS; STRATEGIES; EXPERIENCE; MORBIDITY	Introduction Following the adoption of the World Health Assembly Resolution WHA 65.21 and Neglected Tropical Diseases road map 2021-2030, schistosomiasis control programmes have shifted from morbidity control to disease elimination. However, several gaps continue to be observed in the implementation of control programmes with certain age groups omitted from these campaigns increasing health inequalities and risks of reinfections to previously treated groups. We used the Inverse Variance Heterogeneity (IVhet) model to estimate the prevalence of schistosomiasis infection among preschool-aged children. Methods We did a systematic review of peer-reviewed literature on schistosomiasis in sub-Saharan Africa for the period January 1, 2000 to November 30, 2020. Quantitative data for cases of schistosomiasis infection were extracted, including country and region where the studies were done, year of publication and specific schistosome species observed. The IVhet model was used to estimate the pooled prevalence estimate (PPE), the heterogeneity and publication bias. Results We screened 2601 articles to obtain 47 eligible studies containing quantitative data on preschool-aged children. Of the selected studies, 44.7% (n = 22) were from East Africa while the least number of studies obtained (2.1%, n = 1) was from Central Africa. 21712 subjects were screened for infection due to Schistosoma spp; 13924 for S. mansoni and 7788 for S. haematobium. The PPE for schistosomiasis among PreSAC was 19% (95% CI: 11-28). Infection due to S. mansoni (IVhet PPE: 22% (95% CI: 9-36) was higher than that due to S. haematobium (15%; 95% CI: 6-25). A Luis Furuya-Kanamori index of 1.83 indicated a lack of publication bias. High level of heterogeneity was observed (I2 > 90%) and this could not be reduced through subgroup analysis. Conclusion Schistosomiasis infection among pre-school aged children 6 years old and below is high. This indicates the importance of including this age group in treatment programmes to reduce infection prevalence and long-term morbidities associated with prolonged schistosome infection.	[Kalinda, Chester] Univ Namibia, Katima Mulilo, Namibia; [Kalinda, Chester; Mindu, Tafadzwa; Chimbari, Moses John] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth, Coll Hlth Sci, Durban, South Africa	University of Namibia; University of Kwazulu Natal	Kalinda, C (corresponding author), Univ Namibia, Katima Mulilo, Namibia.; Kalinda, C (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth, Coll Hlth Sci, Durban, South Africa.	ckalinda@gmail.com	Kalinda, Chester/B-3104-2018	Kalinda, Chester/0000-0002-8144-0248; Mindu, Tafadzwa/0000-0001-8244-8439				Adeniran Adebiyi Abdulhakeem, 2017, BMC Res Notes, V10, P637, DOI 10.1186/s13104-017-2973-2; Albonico M, 1999, ADV PARASIT, V42, P277, DOI 10.1016/S0065-308X(08)60151-7; Alemu A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2864-9; ALEMU M, 2015, INT J PHARM SCI RES, V6, P1392; Anguzu J, 2007, East Afr Med J, V84, P56; [Anonymous], 2019, INT J BIOMEDICAL MAT; [Anonymous], 2012, J NATURAL SCI ENG TE; [Anonymous], 2013, SCHIST PROGR REP 200; Armoo S, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05034-2; BABATUNDE TA, 2013, J PARASITOLOGY VECTO, V5, P96; Barda B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005400; Bergquist R, 2009, TRENDS PARASITOL, V25, P151, DOI 10.1016/j.pt.2009.01.004; Betson M, 2010, AM J TROP MED HYG, V83, P1048, DOI 10.4269/ajtmh.2010.10-0307; Bosompem KM, 2004, TROP MED INT HEALTH, V9, P917, DOI 10.1111/j.1365-3156.2004.01282.x; BRAUNMUNZINGER RA, 1992, TROP MED PARASITOL, V43, P149; Bundy DAP, 1996, PARASITOL TODAY, V12, P1, DOI 10.1016/0169-4758(96)30011-2; Chimponda TN, 2020, TROP MED INT HEALTH, V25, P618, DOI 10.1111/tmi.13376; Chu TB, 2010, TROP BIOMED, V27, P337; Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; Coulibaly JT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002109; Dabo A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-21; de Moira AP, 2013, J INFECT DIS, V207, P362, DOI 10.1093/infdis/jis676; Doi, 2016, METAXL USER GUIDE VE; Doi SAR, 2015, CONTEMP CLIN TRIALS, V45, P130, DOI 10.1016/j.cct.2015.05.009; Ekpo UF, 2012, J HELMINTHOL, V86, P323, DOI 10.1017/S0022149X11000459; Ekpo UF, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-58; Ezeamama A, 2017, PLOS NEGL TROP DIS; Ezeamama AE, 2005, AM J TROP MED HYG, V72, P540, DOI 10.4269/ajtmh.2005.72.540; Faust CL, 2020, TRENDS PARASITOL, V36, P582, DOI 10.1016/j.pt.2020.04.012; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Garba A, 2010, ACTA TROP, V115, P212, DOI 10.1016/j.actatropica.2010.03.005; Ghiwot Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109793; Hodges MH, 2012, ACTA TROP, V124, P120, DOI 10.1016/j.actatropica.2012.07.005; Houmsou RS, 2016, J TROP MED-US, V2016, DOI 10.1155/2016/9831265; Howden-Chapman P., 2017, GUIDE SDG INTERACTIO, P81, DOI DOI 10.24948/2017.01.03; Kemal M, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4246-8; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Kittur N, 2016, AM J TROP MED HYG, V94, P605, DOI 10.4269/ajtmh.15-0725; Knopp S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001036; Lai YS, 2015, LANCET INFECT DIS, V15, P927, DOI 10.1016/S1473-3099(15)00066-3; Lenk EJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004397; Lin DD, 2008, PARASITOL INT, V57, P281, DOI 10.1016/j.parint.2008.04.005; Mackey TK, 2014, CLIN MICROBIOL REV, V27, P949, DOI 10.1128/CMR.00045-14; Macklin G, 2018, T ROY SOC TROP MED H, V112, P361, DOI 10.1093/trstmh/try059; Mafiana CF, 2003, TROP MED INT HEALTH, V8, P78, DOI 10.1046/j.1365-3156.2003.00988.x; Masaku J, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08485-z; Mduluza T, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0300-8; Mduluza-Jokonya TL, 2020, BMC PUBLIC HEALTH, V20, P1; Melchers NVSV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002807; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moyo VB, 2016, MALAWI MED J, V28, P10, DOI 10.4314/mmj.v28i1.3; Mueller A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4451-z; Munn Z, 2014, INT J HEALTH POLICY, V3, P123, DOI 10.15171/ijhpm.2014.71; Mutapi F, 2015, PEDIATRICS, V135, P536, DOI 10.1542/peds.2014-3189; Mutapi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001143; Mutsaka-Makuvaza MJ, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0483-7; Mwai J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3494-y; Nalugwa A, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2040058; Ndokeji S, 2016, TANZANIA J HLTH RES, V18; Niyituma E, 2017, RWANDA J, V4, P29; Odogwu SE, 2006, ANN TROP MED PARASIT, V100, P315, DOI 10.1179/136485906X105552; Olsen A, 2003, ACTA TROP, V86, P255, DOI 10.1016/S0001-706X(03)00046-9; Opara KN, 2007, J HELMINTHOL, V81, P393, DOI 10.1017/S0022149X07853521; Osakunor DNM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006144; Osakunor DNM, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000661; Poole H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-153; Ruganuza DM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0997-9; Rujeni Nadine, 2019, AAS Open Res, V2, P7, DOI 10.12688/aasopenres.12930.1; Sacolo-Gwebu H, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4253-3; Sacolo-Gwebu H, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0561-5; Sakari SSW, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/1013802; Salawu OT, 2014, J PEDIATR UROL, V10, P88, DOI 10.1016/j.jpurol.2013.06.010; Sassa M, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008473; Savioli L, 2009, PARASITOLOGY, V136, P1677, DOI 10.1017/S0031182009991181; Savioli L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0280-8; Simon GG, 2016, INT J INFECT DIS, V42, P54, DOI 10.1016/j.ijid.2015.11.006; Sousa-Figueiredo JC, 2012, INT HEALTH, V4, P95, DOI 10.1016/j.inhe.2012.03.003; Sousa-Figueiredo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033189; Sousa-Figueiredo JC, 2010, INT HEALTH, V2, P103, DOI 10.1016/j.inhe.2010.02.003; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Stothard JR, 2013, TRENDS PARASITOL, V29, P197, DOI 10.1016/j.pt.2013.02.001; Stothard JR, 2011, T ROY SOC TROP MED H, V105, P500, DOI 10.1016/j.trstmh.2011.05.007; Stothard JR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000938; Talaat M, 1999, TROP MED INT HEALTH, V4, P551, DOI 10.1046/j.1365-3156.1999.00439.x; Tchuente LAT, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0256-8; Utzinger J, 2015, CLIN MICROBIOL INFEC, V21, P529, DOI [10.1016/j.cmi.2015.02.016, 10.1016/j.cmi.2015.03.014]; van Lieshout L, 2000, ACTA TROP, V77, P69, DOI 10.1016/S0001-706X(00)00115-7; Verani JR, 2011, AM J TROP MED HYG, V84, P787, DOI 10.4269/ajtmh.2011.10-0685; W. H. Organization, 2016, WORLD HLTH STAT 2016; Wami WM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9162631; Wami WM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003649; WHO, 2002, WHO TECHN REP SER, V912; WHO, 2011, REP M REV RES STUD T	93	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244695	10.1371/journal.pone.0244695	http://dx.doi.org/10.1371/journal.pone.0244695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373405	Green Published, gold			2022-12-27	WOS:000603612300048
J	Mohammed, DY; Koumoulos, LM; Martin, E; Slim, J				Mohammed, Debbie Y.; Koumoulos, Lisa Marie; Martin, Eugene; Slim, Jihad			Annual and durable HIV retention in care and viral suppression among patients of Peter Ho Clinic, 2013-2017	PLOS ONE			English	Article							WHITE HIV/AIDS PROGRAM; ANTIRETROVIRAL THERAPY; TRANSMISSION RISK; INFECTED PATIENTS; UNITED-STATES; CONTINUUM; OUTCOMES; IMPACT; MORTALITY; AGE	Objectives To determine rates of annual and durable retention in medical care and viral suppression among patients enrolled in the Peter Ho Clinic, from 2013-2017. Methods This is a retrospective review of medical record data in an urban clinic, located in Newark, New Jersey, a high prevalence area of persons living with HIV. Viral load data were electronically downloaded, in rolling 1-year intervals, in two-month increments, from January 1, 2013 to December 31, 2019. Three teams were established, and every two months, they were provided with an updated list of patients with virologic failure. Retention and viral suppression rates were first calculated for each calendar-year. After patients were determined to be retained/suppressed annually, the proportion of patients with durable retention and viral suppression were calculated in two, three, four, five and six-year periods. Descriptive statistics were used to summarize sample characteristics by retention in care, virologic failure and viral suppression with Pearson Chi-square; p-value <0.05 was statistically significant. Multiple logistic regression models identified patient characteristics associated with retention in medical care, virologic failure and suppression. Results As of December 31, 2017, 1000 (57%) patients were retained in medical care of whom 870 (87%) were suppressed. Between 2013 and 2016, decreases in annual (85% to 77%) and durable retention in care were noted: two-year (72% to 70%) and three-year (63% to 59%) periods. However, increases were noted for 2017, in annual (89%) and durable retention in the two-year period (79%). In the adjusted model, when compared to current patients, retention in care was less likely among patients reengaging in medical care (adjusted Odds Ratio (aOR): 0.77, 95% CI: 0.61-0.98) but more likely among those newly diagnosed from 2014-2017 (aOR: 1.57, 95% CI: 1.08-2.29), compared to those in care since 2013. A higher proportion of patients re-engaging in medical care had virologic failure than current patients (56% vs. 47%, p < 0.0001). As age decreased, virologic failure was more likely (p<0.0001). Between 2013 and 2017, increases in annual (74% to 87%) and durable viral suppression were noted: two-year (59% to 73%) and three-year (49% to 58%) periods. Viral suppression was more likely among patients retained in medical care up to 2017 versus those who were not (aOR: 5.52, 95% CI: 4.08-7.46). Those less likely to be suppressed were 20-29 vs. 60 years or older (aOR: 0.52, 95% CI: 0.28-0.97), had public vs. private insurance (aOR: 0.29, 95% CI: 0.15-0.55) and public vs. private housing (aOR: 0.59, 95% CI: 0.40-0.87). Conclusions Restructuring clinical services at this urban clinic was associated with improved viral suppression. However, concurrent interventions to ensure retention in medical care were not implemented. Both retention in care and viral suppression interventions should be implemented in tandem to achieve an end to the epidemic. Retention in care and viral suppression should be measured longitudinally, instead of cross-sectional yearly evaluations, to capture dynamic changes in these indicators.	[Mohammed, Debbie Y.; Koumoulos, Lisa Marie] William Paterson Univ, Dept Nursing, Wayne, NJ 07470 USA; [Mohammed, Debbie Y.; Slim, Jihad] St Michaels Hosp, Div Infect Dis, Newark, NJ 07102 USA; [Koumoulos, Lisa Marie] Hackensack Meridian Hlth, Palisades Med Ctr, Dept Qual, North Bergen, NJ USA; [Martin, Eugene] Rutgers Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Somerset, NJ USA; [Slim, Jihad] New York Med Coll, Valhalla, NY 10595 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; New York Medical College	Mohammed, DY (corresponding author), William Paterson Univ, Dept Nursing, Wayne, NJ 07470 USA.; Mohammed, DY (corresponding author), St Michaels Hosp, Div Infect Dis, Newark, NJ 07102 USA.	Mohammedd1@wpunj.edu						Aidala AA, 2016, AM J PUBLIC HEALTH, V106, pE1, DOI 10.2105/AJPH.2015.302905; [Anonymous], 2020, NEW NJ TOP 10 CIT HI; [Anonymous], 2018, NEW NJ COUNT MUN HIV; [Anonymous], 2010, NAT HIV AIDS STRAT U; Beattie CM, 2019, AIDS BEHAV, V23, P784, DOI 10.1007/s10461-019-02399-7; Bello KJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1677-x; Benator DA, 2015, AIDS BEHAV, V19, P594, DOI 10.1007/s10461-014-0917-6; Bradley H, 2016, CLIN INFECT DIS, V62, P90, DOI 10.1093/cid/civ708; Centers for Disease Control and Prevention, 2018, HIV SURV REP, V31; Centers for Disease Control and Prevention, 2016, 4 CDCP; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Cohen S., 2020, AM PUBL HLTH ASS ANN; Colasanti J, 2016, CLIN INFECT DIS, V62, P648, DOI 10.1093/cid/civ941; Crawford Timothy N, 2017, J Int Assoc Provid AIDS Care, V16, P42, DOI 10.1177/2325957416678929; Crepaz N, 2017, AIDS, V31, P2421, DOI [10.1097/QAD.0000000000001660, 10.1097/qad.0000000000001660]; Crepaz N, 2016, CLIN INFECT DIS, V63, P976, DOI 10.1093/cid/ciw418; Dombrowski JC, 2015, AIDS PATIENT CARE ST, V29, P279, DOI 10.1089/apc.2014.0346; Doshi RK, 2015, CLIN INFECT DIS, V60, P117, DOI 10.1093/cid/ciu722; Eaton EF, 2016, CLIN INFECT DIS, V63, P404, DOI 10.1093/cid/ciw280; Enns EA, 2019, AIDS BEHAV, V23, P2532, DOI 10.1007/s10461-019-02450-7; Fauci AS, 2019, JAMA-J AM MED ASSOC, V321, P844, DOI 10.1001/jama.2019.1343; Ghiam MK, 2017, AIDS RES HUM RETROV, V33, P1027, DOI [10.1089/aid.2017.0016, 10.1089/AID.2017.0016]; Health Resources and Services Administration: HIV/AIDS Bureau, 2019, PERF MEAS PORTF COR; Horberg MA, 2015, AIDS PATIENT CARE ST, V29, P582, DOI 10.1089/apc.2015.0139; Kay ES, 2020, AIDS CARE, V32, P89, DOI 10.1080/09540121.2019.1623375; Lee LM, 2003, PUBLIC HEALTH REP, V118, P400, DOI 10.1093/phr/118.5.400; Lesko CR, 2017, AIDS BEHAV, V21, P1016, DOI 10.1007/s10461-016-1585-5; Lesko CR, 2016, INT J EPIDEMIOL, V45, P140, DOI 10.1093/ije/dyv352; Lopez JD, 2018, AIDS BEHAV, V22, P3091, DOI 10.1007/s10461-018-2124-3; Ludema C, 2016, JAIDS-J ACQ IMM DEF, V73, P307, DOI 10.1097/QAI.0000000000001078; Mandsager P, 2018, AM J PUBLIC HEALTH, V108, pS246, DOI [10.2105/AJPH.2018.304689, 10.2105/ajph.2018.304689]; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Marks G, 2016, JAIDS-J ACQ IMM DEF, V73, P205, DOI 10.1097/QAI.0000000000001036; Monroe AK, 2017, JAIDS-J ACQ IMM DEF, V76, P82, DOI 10.1097/QAI.0000000000001469; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; New Jersey Department of Health, 2020, CHAR CAR NEW JERS HO; Ojikutu B, 2014, AIDS CARE, V26, P731, DOI 10.1080/09540121.2013.855299; Powers KA, 2017, JAIDS-J ACQ IMM DEF, V74, pS88, DOI 10.1097/QAI.0000000000001234; Robertson MM, 2019, JAIDS-J ACQ IMM DEF, V80, P46, DOI 10.1097/QAI.0000000000001877; Siddiqi AEA, 2016, JAIDS-J ACQ IMM DEF, V72, P230, DOI 10.1097/QAI.0000000000000960; Terzian AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029679; The White House Office of National AIDS Policy, NAT HIV AIDS STRAT U; United States Department of Health and Human Services, 2019, GUID US ANT THER AD; United States Department of Health and Human Services, 2017, 2017 POV GUID; Watson L, 2019, J RACIAL ETHN HEALTH, V6, P892, DOI 10.1007/s40615-019-00589-6; Yehia BR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129376; Yehia BR, 2015, JAIDS-J ACQ IMM DEF, V68, P413, DOI 10.1097/QAI.0000000000000489; Zhong YY, 2020, AM J PUBLIC HEALTH, V110, P1068, DOI 10.2105/AJPH.2020.305660	48	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244376	10.1371/journal.pone.0244376	http://dx.doi.org/10.1371/journal.pone.0244376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373385	Green Published, gold			2022-12-27	WOS:000603612300047
J	Muwonge, R; Basu, P; Gheit, T; Anantharaman, D; Verma, Y; Bhatla, N; Joshi, S; Esmy, PO; Poli, URR; Shah, A; Zomawia, E; Shastri, SS; Pimple, S; Prabhu, PR; Hingmire, S; Chiwate, A; Sauvaget, C; Lucas, E; Malvi, SG; Siddiqi, M; Sankaran, S; Kannan, TPRA; Varghese, R; Divate, U; Vashist, S; Mishra, G; Jadhav, R; Tommasino, M; Pillai, MR; Sankaranarayanan, R; Jayant, K				Muwonge, Richard; Basu, Partha; Gheit, Tarik; Anantharaman, Devasena; Verma, Yogesh; Bhatla, Neerja; Joshi, Smita; Esmy, Pulikottil O.; Poli, Usha Rani Reddy; Shah, Anand; Zomawia, Eric; Shastri, Surendra S.; Pimple, Sharmila; Prabhu, Priya R.; Hingmire, Sanjay; Chiwate, Aruna; Sauvaget, Catherine; Lucas, Eric; Malvi, Sylla G.; Siddiqi, Maqsood; Sankaran, Subha; Kannan, Thiraviam Pillai Rameshwari Ammal; Varghese, Rintu; Divate, Uma; Vashist, Shachi; Mishra, Gauravi; Jadhav, Radhika; Tommasino, Massimo; Pillai, M. Radhakrishna; Sankaranarayanan, Rengaswamy; Jayant, Kasturi		Indian HPV Vaccine Study Grp	Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: A community-based multicentric cohort study	PLOS ONE			English	Article							ATYPICAL SQUAMOUS-CELLS; RISK-FACTORS; HPV; PERSISTENCE; NEOPLASIA	In context of the ongoing multi-centric HPV vaccine study in India, unvaccinated married women (N = 1484) aged 18-23 years were recruited in 2012-2015 as age-matched controls to the vaccinated women and followed up yearly. We assess type-specific prevalence, natural history and potential determinants of human papillomavirus (HPV) infection in these unvaccinated women. Cervical samples were collected yearly for at least four consecutive years. A Multiplex Type-Specific E7-Based polymerase chain reaction assay was used to detect 21 HPV types. HPV prevalence was 36.4% during 6 years. Most common HPV types were 16 (6.5%) and 31 (6.1%). Highest persistence were observed for HPV 35 (62.5%) and 52 (25%). New HPV acquisition rate was 5.6/1000 person-months of observation (PMO), highest for HPV 16 (1.1/1000 PMO). Type-specific clearance rates ranged between 2.9-5.5/100 PMO. HPV 16 and/or 18 infections were 41% (95% CI 4-63%) lower among women with 2-<3 years between marriage and first cervical sample collection compared to those with <2 years. HPV prevalence and acquisition rates in young Indian women were lower than their Western counterparts. HPV 16 infections being most common shows the importance and potential impact of HPV vaccination in India. Women with 2-3 years exposure had reduced risk possibly due to higher infections clearance.	[Muwonge, Richard; Basu, Partha; Sauvaget, Catherine; Lucas, Eric] Int Agcy Res Canc, Sect Early Detect & Prevent, Screening Grp, Lyon, France; [Gheit, Tarik; Tommasino, Massimo] Int Agcy Res Canc, Sect Infect, Infect & Canc Biol Grp, Lyon, France; [Anantharaman, Devasena; Prabhu, Priya R.; Sankaran, Subha; Kannan, Thiraviam Pillai Rameshwari Ammal; Varghese, Rintu; Pillai, M. Radhakrishna] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram, Kerala, India; [Verma, Yogesh] Sikkim Manipal Univ, Sikkim Manipal Inst Med Sci, Gangtok, Sikkim, India; [Bhatla, Neerja; Vashist, Shachi] All India Inst Med Sci, Dept Obstet & Gynaecol, New Delhi, India; [Joshi, Smita; Divate, Uma; Jadhav, Radhika] Jehangir Hosp Premises, Jehangir Clin Dev Ctr, Pune, Maharashtra, India; [Esmy, Pulikottil O.] Christian Fellowship Community Hlth Ctr, Ambillikai, Tamil Nadu, India; [Poli, Usha Rani Reddy] Publ Hlth Fdn India, Indian Inst Publ Hlth Hyderabad, Hyderabad, India; [Shah, Anand] MP Shah Canc Hosp, Gujarat Canc & Res Inst GCRI, Civil Hosp Campus, Ahmadabad, Gujarat, India; [Zomawia, Eric] Civil Hosp, Aizawl, Mizoram, India; [Shastri, Surendra S.] Univ Texas MD Anderson Canc Ctr, Dept Hlth Dispar Res, Div Canc Prevent & Populat Sci, Houston, TX 77030 USA; [Pimple, Sharmila; Mishra, Gauravi] Tata Mem Hosp & Canc Res Inst, Tata Mem Ctr, Dept Prevent Oncol, Mumbai, Maharashtra, India; [Hingmire, Sanjay; Chiwate, Aruna; Malvi, Sylla G.] Nargis Dutt Mem Canc Hosp, Rural Canc Project, Tata Mem Ctr, Solapur, Maharashtra, India; [Siddiqi, Maqsood] Canc Fdn India, Kolkata, W Bengal, India; [Sankaranarayanan, Rengaswamy; Jayant, Kasturi] Res Triangle Inst RTI Int India, New Delhi, India	World Health Organization; International Agency for Research on Cancer (IARC); World Health Organization; International Agency for Research on Cancer (IARC); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Sikkim Manipal University; All India Institute of Medical Sciences (AIIMS) New Delhi; Public Health Foundation of India; University of Texas System; UTMD Anderson Cancer Center; Tata Memorial Centre (TMC); Tata Memorial Centre (TMC)	Basu, P (corresponding author), Int Agcy Res Canc, Sect Early Detect & Prevent, Screening Grp, Lyon, France.	basup@iarc.fr	Prabhu, Priya Ramesh/GRY-7100-2022; Poli, Usha Rani/GQZ-1778-2022	Prabhu, Priya Ramesh/0000-0002-9168-6233; Poli, Usha Rani/0000-0002-6336-2274; Shah, Anand/0000-0002-9217-9065; Basu, Partha/0000-0003-0124-4050; Tommasino, Massimo/0000-0002-0890-8596	Bill & Melinda Gates Foundation [OPP48979]; European Commission [FP7-HEALTH-2011-282562]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was financially supported by The Bill & Melinda Gates Foundation (grant number OPP48979). Partial support was also obtained from the European Commission Seventh Framework Programme grant HPV-AHEAD (FP7-HEALTH-2011-282562) for the establishment of the Luminex-based assays at Rajiv Gandhi Centre for Biotechnology (RGCB), Trivandrum, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2006, Indian J Cancer, V43, P110; [Anonymous], 2016, 3 YEAR REP POP BAS C; Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; Basu P, 2019, PAPILLOMAVIRUS RES, V7, P75, DOI 10.1016/j.pvr.2019.01.004; Bruni L, 2019, HUMAN PAPILLIMAVIRUS; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Clifford GM, 2016, J CLIN MICROBIOL, V54, P2031, DOI 10.1128/JCM.00618-16; Comar M, 2012, J CLIN MICROBIOL, V50, P4041, DOI 10.1128/JCM.02105-12; Datta P, 2012, ASIAN PAC J CANCER P, V13, P1019, DOI 10.7314/APJCP.2012.13.3.1019; Datta P, 2010, CANCER EPIDEMIOL, V34, P157, DOI 10.1016/j.canep.2009.12.016; Eklund C, 2018, J CLIN VIROL, V101, P74, DOI 10.1016/j.jcv.2018.01.016; Franceschi S, 2005, BRIT J CANCER, V92, P601, DOI 10.1038/sj.bjc.6602348; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Giuliano AR, 2002, J INFECT DIS, V186, P462, DOI 10.1086/341782; International Institute for Population Sciences, 2017, NAT FAM HLTH SURV NF; Kerkar SC, 2011, SEX REPROD HEALTHC, V2, P7, DOI 10.1016/j.srhc.2010.11.001; Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; Maucort-Boulch D, 2008, CANCER EPIDEM BIOMAR, V17, P717, DOI 10.1158/1055-9965.EPI-07-2691; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Ramanakumar AV, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011371; Sankaranarayanan R, 2019, LANCET ONCOL, V20, pE637, DOI 10.1016/S1470-2045(19)30531-5; Sankaranarayanan R, 2016, LANCET ONCOL, V17, P67, DOI 10.1016/S1470-2045(15)00414-3; Schiffman Mark, 2009, Infect Agent Cancer, V4, P8, DOI 10.1186/1750-9378-4-8; Schmitt M, 2010, J CLIN MICROBIOL, V48, P143, DOI 10.1128/JCM.00991-09; Sharma K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125693; Sharma M, 2013, INT J CANCER, V132, P1895, DOI 10.1002/ijc.27835; Srivastava S, 2012, J BIOSCIENCES, V37, P63, DOI 10.1007/s12038-012-9181-y; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Varghese C, 2000, PREVALENCE DETERMINA; Vinodhini K, 2012, INT J GYNECOL OBSTET, V119, P253, DOI 10.1016/j.ijgo.2012.06.019; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244242	10.1371/journal.pone.0244242	http://dx.doi.org/10.1371/journal.pone.0244242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373380	Green Published, gold			2022-12-27	WOS:000603612300018
J	Melo-Nascimento, AOD; Sant'Anna, BMM; Goncalves, CC; Santos, G; Noronha, E; Parachin, N; Roque, MRD; Bruce, T				dos Santos Melo-Nascimento, Amanda Oliveira; Sant'Anna, Brena Mota Moitinho; Goncalves, Carolyne Caetano; Santos, Giovanna; Noronha, Eliane; Parachin, Nadia; de Abreu Roque, Milton Ricardo; Bruce, Thiago			Complete genome reveals genetic repertoire and potential metabolic strategies involved in lignin degradation by environmental ligninolytic Klebsiella variicola P1CD1	PLOS ONE			English	Article							BACILLUS-SUBTILIS; KRAFT-LIGNIN; PULP; LACCASE; STREPTOMYCES; CLEAVAGE; SEQUENCE; ENZYMES; DECOLORIZATION; IDENTIFICATION	Lignin is a recalcitrant macromolecule formed by three alcohols (monolignols) predominantly connected by beta-aryl ether linkages and is one of the most abundant organic macromolecules in the biosphere. However, the role played by environmental bacteria in lignin degradation is still not entirely understood. In this study, we identified an environmental Klebsiella strain isolated from sediment collected from an altitudinal region in a unique Brazilian biome called Caatinga. This organism can also grow in the presence of kraft lignin as a sole source of carbon and aromatic compounds. We performed whole-genome sequencing and conducted an extensive genome-based metabolic reconstruction to reveal the potential mechanisms used by the bacterium Klebsiella variicola P1CD1 for lignin utilization as a carbon source. We identified 262 genes associated with lignin-modifying enzymes (LMEs) and lignin-degrading auxiliary enzymes (LDAs) required for lignin and aromatic compound degradation. The presence of one DyP (Dye-decolorizing Peroxidase) gene suggests the ability of P1CD1 strain to access phenolic and nonphenolic structures of lignin molecules, resulting in the production of catechol and protocatechuate (via vanillin or syringate) along the peripheral pathways of lignin degradation. K. variicola P1CD1 uses aldehyde-alcohol dehydrogenase to perform direct conversion of vanillin to protocatechol. The upper funneling pathways are linked to the central pathways of the protocatechuate/catechol catabolic branches via beta-ketoadipate pathways, connecting the more abundant catabolized aromatic compounds with essential cellular functions, such as energy cellular and biomass production (i.e., via acetyl-CoA formation). The combination of phenotypic and genomic approaches revealed the potential dissimilatory and assimilatory ability of K. variicola P1CD1 to perform base-catalyzed lignin degradation, acting on high- and low-molecular-weight lignin fragments. These findings will be relevant for developing metabolic models to predict the ligninolytic mechanism used by environmental bacteria and shedding light on the flux of carbon in the soil.	[dos Santos Melo-Nascimento, Amanda Oliveira; de Abreu Roque, Milton Ricardo; Bruce, Thiago] Univ Fed Bahia, Dept Microbiol, Inst Biol, Grp Biotecnol Ambiental, Salvador, BA, Brazil; [Sant'Anna, Brena Mota Moitinho; de Abreu Roque, Milton Ricardo] Univ Fed Bahia, Inst Ciencias Saude, Lab Bioprospeccao, Salvador, BA, Brazil; [Goncalves, Carolyne Caetano; Santos, Giovanna; Noronha, Eliane] Univ Brasilia, Dept Biol Celular, Inst Biol, Lab Engn Biocatalizadores, Brasilia, DF, Brazil; [Parachin, Nadia; Bruce, Thiago] Univ Brasilia, Dept Biol Celular, Inst Biol, Brasilia, DF, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade de Brasilia; Universidade de Brasilia	Bruce, T (corresponding author), Univ Fed Bahia, Dept Microbiol, Inst Biol, Grp Biotecnol Ambiental, Salvador, BA, Brazil.; Bruce, T (corresponding author), Univ Brasilia, Dept Biol Celular, Inst Biol, Brasilia, DF, Brazil.	thbruce@gmail.com	Rodrigues, Thiago Bruce B/G-8264-2012; Noronha, Eliane F./D-4812-2016	Mota Moitinho SantAnna, Brena/0000-0002-5678-0750; Noronha, Eliane Ferreira/0000-0002-4081-4979	CAPES/PROEX program; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [408778/2018-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [408778/2018-0]	CAPES/PROEX program; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	TB acknowledge funds from CAPES/PROEX program and grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (408778/2018-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (408778/2018-0).	Abdelaziz OY, 2016, BIOTECHNOL ADV, V34, P1318, DOI 10.1016/j.biotechadv.2016.10.001; Ahmad M, 2011, BIOCHEMISTRY-US, V50, P5096, DOI 10.1021/bi101892z; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Andrade AC, 2017, MICROB ECOL, V74, P89, DOI 10.1007/s00248-016-0911-9; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandounas L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-94; Barapatre A, 2017, BIOCATAL BIOTRANSFOR, V35, P269, DOI 10.1080/10242422.2017.1327953; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bourbonnais R, 1997, APPL ENVIRON MICROB, V63, P4627, DOI 10.1128/AEM.63.12.4627-4632.1997; Brander S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099402; Brown ME, 2014, CURR OPIN CHEM BIOL, V19, P1, DOI 10.1016/j.cbpa.2013.11.015; Brown ME, 2012, ACS CHEM BIOL, V7, P2074, DOI 10.1021/cb300383y; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; Bugg TDH, 1998, NAT PROD REP, V15, P513; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Chandra R, 2011, BIORESOURCE TECHNOL, V102, P6429, DOI 10.1016/j.biortech.2011.03.048; Dailey HA, 2011, MBIO, V2, DOI 10.1128/mBio.00248-11; Davis JR, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00416-13; Davis JR, 2012, J BACTERIOL, V194, P2396, DOI 10.1128/JB.00186-12; de Gonzalo G, 2016, J BIOTECHNOL, V236, P110, DOI 10.1016/j.jbiotec.2016.08.011; DeAngelis KM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00280; Dube E, 2008, APPL MICROBIOL BIOT, V79, P597, DOI 10.1007/s00253-008-1475-5; Galardini M, 2015, METHODS MOL BIOL, V1231, P163, DOI 10.1007/978-1-4939-1720-4_11; Gall DL, 2014, ENVIRON SCI TECHNOL, V48, P12454, DOI 10.1021/es503886d; Gao JF, 2010, NUCLEIC ACIDS RES, V38, pD488, DOI 10.1093/nar/gkp771; Grumaz C, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01562-16; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Kamimura N, 2017, ENV MICROBIOL REP, V9, P679, DOI 10.1111/1758-2229.12597; Kamimura N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44422; Kerepesi C, 2014, GENE, V533, P538, DOI 10.1016/j.gene.2013.10.015; Kontur WS, 2019, J BIOL CHEM, V294, P1877, DOI 10.1074/jbc.RA118.006548; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Li X, 2007, BIOCHEM BIOPH RES CO, V354, P21, DOI 10.1016/j.bbrc.2006.12.116; Louren?o A., 2018, LIGNIN TRENDS APPL; Majumdar S, 2014, BIOCHEMISTRY-US, V53, P4047, DOI 10.1021/bi500285t; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; MASAI E, 1989, FEBS LETT, V249, P348, DOI 10.1016/0014-5793(89)80656-8; Masai E, 1999, J IND MICROBIOL BIOT, V23, P364, DOI 10.1038/sj.jim.2900747; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Melo-Nascimento AOD, 2018, ARCH MICROBIOL, V200, P1267, DOI 10.1007/s00203-018-1532-0; Naseem A, 2016, INT J BIOL MACROMOL, V93, P296, DOI 10.1016/j.ijbiomac.2016.08.030; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Picart P, 2014, CHEMSUSCHEM, V7, P3164, DOI 10.1002/cssc.201402465; Pokhrel D, 2004, SCI TOTAL ENVIRON, V333, P37, DOI 10.1016/j.scitotenv.2004.05.017; POMETTO AL, 1983, APPL ENVIRON MICROB, V45, P1582, DOI 10.1128/AEM.45.5.1582-1585.1983; Prabhakaran M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00019-15; Raj A, 2007, BIODEGRADATION, V18, P783, DOI 10.1007/s10532-007-9107-9; Richter M, 2016, BIOINFORMATICS, V32, P929, DOI 10.1093/bioinformatics/btv681; Roberts JN, 2011, BIOCHEMISTRY-US, V50, P5108, DOI 10.1021/bi200427h; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Shimizu S, 2001, APPL ENVIRON MICROB, V67, P2021, DOI 10.1128/AEM.67.5.2021-2028.2001; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Teylaert B, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-1; Tian JH, 2014, APPL MICROBIOL BIOT, V98, P9527, DOI 10.1007/s00253-014-6142-4; Woo HL, 2014, STAND GENOMIC SCI, V9, DOI 10.1186/1944-3277-9-19; Xu ZX, 2018, ENVIRON SCI POLLUT R, V25, P14171, DOI 10.1007/s11356-018-1633-y; Yadav S, 2015, J ENVIRON SCI-CHINA, V33, P229, DOI 10.1016/j.jes.2015.01.018	64	5	5	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243739	10.1371/journal.pone.0243739	http://dx.doi.org/10.1371/journal.pone.0243739			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351813	Green Published, gold			2022-12-27	WOS:000603071400015
J	Torres-Cristiani, L; Machkour-M'Rabet, S; Calme, S; Weissenberger, H; Escalona-Segura, G				Torres-Cristiani, Leopoldo; Machkour-M'Rabet, Salima; Calme, Sophie; Weissenberger, Holger; Escalona-Segura, Griselda			Assessment of the American Flamingo distribution, trends, and important breeding areas	PLOS ONE			English	Article							PHOENICOPTERUS-RUBER; CITIZEN SCIENCE; YUCATAN; ARUBA	The American Flamingo, Phoenicopterus ruber, is a charismatic bird distributed throughout the Caribbean, North and South America. Its wide distribution, the complexity of international monitoring due to its capacity for long-distance flying, and a focus mostly on local populations, make it difficult to understand the dynamics between sites. Here, we took advantage of the citizen eBird science project to present a global perspective on the distribution of the American Flamingo, and identify the potentially most important countries for breeding. We obtained 16,930 records for the Americas from the 1960s until October 2018, of which 9,283 could be used for our objectives. The eBird database indicated a considerable increase in the total number of records over the last decade (2010s), probably reflecting an increase in tourism facilities, research investment, technological advancement, interest in conservation, and the worldwide availability of eBird. We also observed a range extension in the Gulf of Mexico in the United States and a significant recolonization in the Florida Peninsula. The apparent range extension to the South is more likely to be linked to biases in the data; for example, in any given country the number of records might reflect either reporting efforts or actual numbers. eBird data confirmed that six countries host the main breeding colonies (Bahamas, Bonaire, Cuba, Ecuador, Mexico, and Venezuela). We suggest three additional countries as potential breeding areas for the species (Colombia, Curacao, Turks and Caicos Islands) for which more field observations are necessary to support this possibility. This global appraisal of the distribution of the American Flamingo using citizen science data provides valuable information for national and international management and conservation programs such as the need to verify the species breeding status in areas where it appears to be expanding its distribution.	[Torres-Cristiani, Leopoldo; Machkour-M'Rabet, Salima] El Colegio Frontera Sur, Dept Conservac Biodivers, Chetmal, Quintana Roo, Mexico; [Calme, Sophie; Weissenberger, Holger] El Colegio Frontera, Dept Observac & Estudio Tierra, Atmosfera & Oceano TAQ, Chetmal, Quintana Roo, Mexico; [Calme, Sophie] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada; [Escalona-Segura, Griselda] El Colegio Frontera, Dept Conservac Biodivers, Campeche, Mexico	El Colegio de la Frontera Sur (ECOSUR); University of Sherbrooke	Machkour-M'Rabet, S (corresponding author), El Colegio Frontera Sur, Dept Conservac Biodivers, Chetmal, Quintana Roo, Mexico.; Calme, S (corresponding author), El Colegio Frontera, Dept Observac & Estudio Tierra, Atmosfera & Oceano TAQ, Chetmal, Quintana Roo, Mexico.; Calme, S (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada.	smachkou@ecosur.mx; scalme@ecosur.mx	Calmé, Sophie/ABC-9684-2021	Calmé, Sophie/0000-0003-0818-3932; Torres Cristiani, Leopoldo/0000-0003-3017-029X; Escalona-Segura, Griselda/0000-0002-6735-7878	CONACYT [213403, 21467, 217950]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CONACYT provided financial support in the form of a scholarship for LTC (#213403) and a fellowship for GES (#21467) and SMM (#217950).	Acosta Martin, 2004, Journal of Caribbean Ornithology, V17, P52; Allen R.P, 1956, FLAMINGOS THEIR LIFE; [Anonymous], 2002, PROF ENG, V15, P31; [Anonymous], 2014, APPL GEOMATICS; [Anonymous], 2010, ORF, V18, P62; Arengo F, 2002, CONDOR, V104, P452, DOI 10.1650/0010-5422(2002)104[0452:PCAFBO]2.0.CO;2; Arengo F, 2017, FLAMINGOS BEHAV BIOL, P227; Baldassarre Guy A., 2000, Waterbirds, V23, P70, DOI 10.2307/1522149; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; Baltz ME, 2006, W ANDROS REA REPORT; Bernardon B, 2014, REV BRAS ORNITOL, V22, P285; Bildstein Keith L., 2000, Waterbirds, V23, P206, DOI 10.2307/1522167; BirdLife International, 2018, IUCN RED LIST THREAT; Braun M.J., 2000, FIELD CHECKLIST BIRD; Casler Clark L., 2000, Waterbirds, V23, P95, DOI 10.2307/1522152; Comite Brasileiro de Registros Ornitologicos, 2015, LIST AV BRAS; Coxen CL, 2017, GLOB ECOL CONSERV, V11, P298, DOI 10.1016/j.gecco.2017.08.001; Debrot A, 2008, IMPORTANT BIRD AREAS, P143; ESPINOBARROS R, 1989, CONDOR, V91, P592, DOI 10.2307/1368109; Espinoza Frank, 2000, Waterbirds, V23, P80, DOI 10.2307/1522150; Franke-Ante R, 2013, PROGRAMA CONSERVACIO; Frias-Soler R, 2014, WATERBIRDS, V37, P349, DOI 10.1675/063.037.0402; Galvez X., 2014, REV CUB CIENS BIOL, V3, P52; Galvez X., 2016, REV CUB CIENC BIOL, V4, P93; Plasencia-Vazquez AH, 2017, REV BIOL TROP, V65, P1483, DOI 10.15517/rbt.v65i4.26550; Hilton Geoff M., 2000, Wildfowl, V51, P127; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Izurieta J. C., 2017, GALAPAGOS REPORT 201, P83; Lazell James, 2001, Pitirre, V14, P113; Luksenburg Jolanda A., 2013, Marine Ornithology, V41, P183; Maldonado JH, 2018, WORLD DEV, V106, P78, DOI 10.1016/j.worlddev.2018.01.015; Martínez-Valencia A.B., 2008, Superf. vacío, V21, P18; Mawhinney J., 2008, PHYSIS, V19, P1; Mendoza Luis F., 2013, Huitzil, V14, P84; Morales RA, 2006, MONITOREO AVES MIGRA; Murillo-Pacheco JI, 2013, ORINOQUIA, V18, P105; NORTON R L, 1989, Florida Field Naturalist, V17, P32; PICKERING S, 1992, ZOO BIOL, V11, P229, DOI 10.1002/zoo.1430110402; Porto Tapiquen C.E., 2020, GEOGRAFIA SIG CARTOG; Prins TG, 2009, ARDEA, V97, P137, DOI 10.5253/078.097.0201; Raffaele H., 2021, BIRDS PUERTO RICO VI, V3rd ed.; Sainz-Borgo C., 2018, REV VENEZOLANA ORNIT, V8, P19; Schulz J.P, 1977, Oryx, V14, P133, DOI 10.1017/S0030605300015180; Stephens JL, 1993, VIAJES YUCATAN, VI; Sullivan BL, 2014, BIOL CONSERV, V169, P31, DOI 10.1016/j.biocon.2013.11.003; Tulloch AIT, 2013, BIOL CONSERV, V165, P128, DOI 10.1016/j.biocon.2013.05.025; Vargas FH, 2008, J ZOOL, V276, P252, DOI 10.1111/j.1469-7998.2008.00485.x; Walsh-McGehee Martha, 1998, Bahamas Journal of Science, V5, P28; Wells J, 2008, IMPORTANT BIRD AREAS, P95; Whitfield SM, 2018, PETITION EVALUATE SP; Whitfield SM, 2018, CONDOR, V120, P291, DOI 10.1650/CONDOR-17-187.1; Wilson S., 2014, ECOTOURISM IND CARIB	53	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244117	10.1371/journal.pone.0244117	http://dx.doi.org/10.1371/journal.pone.0244117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351836	gold, Green Published			2022-12-27	WOS:000603071400004
J	Xiao, C; Fu, X; Wang, YT; Liu, H; Jiang, YF; Zhao, ZY; You, FM				Xiao, Chong; Fu, Xi; Wang, Yuting; Liu, Hong; Jiang, Yifang; Zhao, Ziyi; You, Fengming			Transferrin receptor regulates malignancies and the stemness of hepatocellular carcinoma-derived cancer stem-like cells by affecting iron accumulation	PLOS ONE			English	Article							PANCREATIC-CANCER; GROWTH; POPULATION; TUMORS; ROS	Background Iron metabolism is essential because it plays regulatory roles in various physiological and pathological processes. Disorders of iron metabolism balance are related to various cancers, including hepatocellular carcinoma. Cancer stem-like cells (CSCs) exert critical effects on chemotherapy failure, cancer metastasis, and subsequent disease recurrence and relapse. However, little is known about how iron metabolism affects liver CSCs. Here, we investigated the expression of transferrin receptor 1 (TFR1) and ferroportin (FPN), two iron importers, and an upstream regulator, iron regulatory protein 2 (IRP2), in liver hepatocellular carcinoma (LIHC) and related CSCs. Methods The expression levels of TFR1, FPN and IRP2 were analysed using the GEPIA database. CSCs were derived from parental LIHC cells cultured in serum-free medium. After TFR1 knockdown, ROS accumulation and malignant behaviours were measured. The CCK-8 assay was performed to detect cell viability after TFR1 knockdown and erastin treatment. Results TFR1 expression was upregulated in LIHC tissue and CSCs derived from LIHC cell lines, prompting us to investigate the roles of TFR1 in regulating CSCs. Knockdown of TFR1 expression decreased iron accumulation and inhibited malignant behaviour. Knockdown of TFR1 expression decreased reactive oxygen species (ROS) accumulation induced by erastin treatment and maintained mitochondrial function, indicating that TFR1 is critical in regulating erastin-induced cell death in CSCs. Additionally, knockdown of TFR1 expression decreased sphere formation by decreasing iron accumulation in CSCs, indicating a potential role for TFR1 in maintaining stemness. Conclusion These findings, which revealed TFR1 as a critical regulator of LIHC CSCs in malignant behaviour and stemness that functions by regulating iron accumulation, may have implications to improve therapeutic approaches.	[Xiao, Chong] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China; [Fu, Xi; Wang, Yuting; Liu, Hong; Jiang, Yifang; Zhao, Ziyi; You, Fengming] Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China	Chengdu University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine	Zhao, ZY; You, FM (corresponding author), Hosp Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China.	zhaoziyi925@163.com; youfengming@cdutcm.edu.cn			Young Scientists Fund of the National Natural Science Foundation of China [81803994]; General Program of National Natural Science Foundation of China [81774284]; International Cooperation Project of Sichuan Science and Technology Department [2019YFH0152]; Science and Technology Developmental Foundation of Chengdu University of TCM [QNXZ2019022]	Young Scientists Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Project of Sichuan Science and Technology Department; Science and Technology Developmental Foundation of Chengdu University of TCM	This work was supported by Young Scientists Fund of the National Natural Science Foundation of China (Grant No. 81803994), General Program of National Natural Science Foundation of China (Grant No. 81774284), International Cooperation Project of Sichuan Science and Technology Department (Grant No. 2019YFH0152) and Science and Technology Developmental Foundation of Chengdu University of TCM (Grant No. QNXZ2019022) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Ablett MP, 2012, EUR J CANCER, V48, P2104, DOI 10.1016/j.ejca.2012.03.019; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Buas MF, 2015, BREAST CANCER RES TR, V153, P445, DOI 10.1007/s10549-015-3554-5; Camp ER, 2013, CANCER GENE THER, V20, P222, DOI 10.1038/cgt.2013.9; Chanvorachote P, 2016, AM J PHYSIOL-CELL PH, V310, pC728, DOI 10.1152/ajpcell.00322.2015; Chen Y, 2015, CELL SIGNAL, V27, P168, DOI 10.1016/j.cellsig.2014.11.002; Dhar D, 2018, CANCER CELL, V33, P1061, DOI 10.1016/j.ccell.2018.05.003; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Heath JL, 2013, NUTRIENTS, V5, P2836, DOI 10.3390/nu5082836; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Ho JCM, 2001, CANCER RES, V61, P8578; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Jeong SM, 2016, BIOCHEM BIOPH RES CO, V471, P373, DOI 10.1016/j.bbrc.2016.02.023; Kindrat I, 2016, ONCOTARGET, V7, P1276, DOI 10.18632/oncotarget.6004; Kukulj S, 2010, MED ONCOL, V27, P268, DOI 10.1007/s12032-009-9203-2; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Liu P, 2016, J INORG BIOCHEM, V160, P40, DOI 10.1016/j.jinorgbio.2016.04.014; Lobello N, 2016, ONCOTARGET, V7, P62019, DOI 10.18632/oncotarget.11495; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ma S, 2010, CELL STEM CELL, V7, P694, DOI 10.1016/j.stem.2010.11.010; Paul BT, 2017, EXPERT REV HEMATOL, V10, P65, DOI 10.1080/17474086.2016.1268047; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raggi C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17804-1; Respiratory and Meningeal Pathogens Reference Unit National Institute for Communicable Diseases, 2011, COMM DIS SURV B, V9, P50; Sorrentino P, 2009, J HEPATOL, V50, P351, DOI 10.1016/j.jhep.2008.09.011; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tesfay L, 2015, CANCER RES, V75, P2254, DOI 10.1158/0008-5472.CAN-14-2465; Tirnitz-Parker Janina E. E., 2013, Critical Reviews in Oncogenesis, V18, P391; Tominaga K, 2017, ONCOGENE, V36, P1276, DOI 10.1038/onc.2016.293; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Weston C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166593; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yoon SK, 2012, GUT LIVER, V6, P29, DOI 10.5009/gnl.2012.6.1.29; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	39	8	8	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243812	10.1371/journal.pone.0243812	http://dx.doi.org/10.1371/journal.pone.0243812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351833	Green Published, gold			2022-12-27	WOS:000603071400048
J	Heffer, AM; Wang, V; Libby, RT; Feldon, SE; Woeller, CF; Kuriyan, AE				Heffer, Alison M.; Wang, Victor; Libby, Richard T.; Feldon, Steven E.; Woeller, Collynn F.; Kuriyan, Ajay E.			Salinomycin inhibits proliferative vitreoretinopathy formation in a mouse model	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RANDOMIZED CONTROLLED-TRIAL; MOLECULAR-WEIGHT HEPARIN; GROWTH-FACTORS; COMBINED 5-FLUOROURACIL; RISK-FACTORS; FIBRONECTIN; ACTIN; CELLS; EYES	Proliferative vitreoretinopathy (PVR) is a progressive disease that develops in a subset of patients who undergo surgery for retinal detachment repair, and results in significant vision loss. PVR is characterized by the migration of retinal pigment epithelial (RPE) cells into the vitreous cavity, where they undergo epithelial-to-mesenchymal transition and form contractile membranes within the vitreous and along the retina, resulting in recurrent retinal detachments. Currently, surgical intervention is the only treatment for PVR and there are no pharmacological agents that effectively inhibit or prevent PVR formation. Here, we show that a single intravitreal injection of the polyether ionophore salinomycin (SNC) effectively inhibits the formation of PVR in a mouse model with no evidence of retinal toxicity. After 4 weeks, fundus photography and optical coherence tomography (OCT) demonstrated development of mean PVR grade of 3.5 (SD: 1.3) in mouse eyes injected with RPE cells/DMSO (vehicle), compared to mean PVR grade of 1.6 (SD: 1.3) in eyes injected with RPE cells/SNC (p = 0.001). Additionally, immunohistochemistry analysis showed RPE cells/SNC treatment reduced both fibrotic (alpha SMA, FN1, Vim) and inflammatory (GFAP, CD3, CD20) markers compared to control RPE cells/DMSO treatment. Finally, qPCR analysis confirmed that Tgf beta, Tnf alpha, Mcp1 (inflammatory/cytokine markers), and Fn1, Col1a1 and Acta2 (fibrotic markers) were significantly attenuated in the RPE cells/SNC group compared to RPE/DMSO control. These results suggest that SNC is a potential pharmacologic agent for the prevention of PVR in humans and warrants further investigation.	[Heffer, Alison M.; Wang, Victor; Libby, Richard T.; Feldon, Steven E.; Woeller, Collynn F.; Kuriyan, Ajay E.] Univ Rochester, Flaum Eye Inst, Rochester, NY 14642 USA; [Libby, Richard T.; Feldon, Steven E.; Kuriyan, Ajay E.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Kuriyan, Ajay E.] Thomas Jefferson Univ, Wills Eye Hosp, Retina Serv, Philadelphia, PA 19107 USA	University of Rochester; University of Rochester; Jefferson University	Heffer, AM; Kuriyan, AE (corresponding author), Univ Rochester, Flaum Eye Inst, Rochester, NY 14642 USA.; Kuriyan, AE (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.; Kuriyan, AE (corresponding author), Thomas Jefferson Univ, Wills Eye Hosp, Retina Serv, Philadelphia, PA 19107 USA.	alison_heffer@urmc.rochester.edu; ajay_kuriyan@gmail.com		Wang, Victor/0000-0002-9649-2411	Research to Prevent Blindness Unrestricted Grant [NIHP30EY001319]	Research to Prevent Blindness Unrestricted Grant(Research to Prevent Blindness (RPB))	Research to Prevent Blindness Unrestricted Grant (to the Flaum Eye Institute) and NIHP30EY001319 (David Williams, Center for Visual Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GW, 1997, ARCH OPHTHALMOL-CHIC, V115, P335, DOI 10.1001/archopht.1997.01100150337005; Ahmadieh H, 2008, OPHTHALMOLOGY, V115, P1938, DOI 10.1016/j.ophtha.2008.05.016; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Antoszczak M, 2015, ANTI-CANCER AGENT ME, V15, P575, DOI 10.2174/1871520615666150101130209; Asaria RHY, 2001, OPHTHALMOLOGY, V108, P1179, DOI 10.1016/S0161-6420(01)00589-9; Asato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054191; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Bochaton-Piallat ML, 2000, INVEST OPHTH VIS SCI, V41, P2336; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Charteris DG, 2004, OPHTHALMOLOGY, V111, P2240, DOI 10.1016/j.ophtha.2004.05.036; Chen Zhenna, 2015, Mol Vis, V21, P706; Garcia CM, 2006, EXP EYE RES, V83, P999, DOI 10.1016/j.exer.2006.04.009; Grierson I, 1987, SEMINARS OPHTHALMOLO, V2, P99, DOI [10.3109/08820538709062514, DOI 10.3109/08820538709062514]; Hansen TC, 2017, PLAST RECONSTR SURG, V140, P316, DOI 10.1097/PRS.0000000000003542; Hayden JK, 2014, J NURS REGUL, V5, pS3; Heffer A, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.7.9; Heffer AM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222596; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P708, DOI 10.1136/bjo.68.10.708; Idrees Sana, 2019, Int Ophthalmol Clin, V59, P221, DOI 10.1097/IIO.0000000000000258; JHHW, 2017, EJIL, V28, P989; Koeck S, 2016, ONCOL LETT, V11, P2946, DOI 10.3892/ol.2016.4323; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; LIMB G A, 1991, Eye (London), V5, P686; Limb GA, 1996, GRAEF ARCH CLIN EXP, V234, P213, DOI 10.1007/BF00430412; Liu L, 2018, CHEM-BIOL INTERACT, V296, P145, DOI 10.1016/j.cbi.2018.09.018; London NJS, 2019, BRIT J OPHTHALMOL, V103, P1306, DOI 10.1136/bjophthalmol-2018-312839; Mao ZL, 2019, ANTI-CANCER DRUG, V30, P892, DOI 10.1097/CAD.0000000000000786; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Miller CG, 2017, EXP BIOL MED, V242, P1, DOI 10.1177/1535370216675245; Mitamura Y, 2002, JPN J OPHTHALMOL, V46, P218, DOI 10.1016/S0021-5155(01)00497-X; MIYAZAKI Y, 1974, J ANTIBIOT, V27, P814, DOI 10.7164/antibiotics.27.814; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Pennock S, 2014, AM J PATHOL, V184, P3052, DOI 10.1016/j.ajpath.2014.07.026; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Rai G, 2017, BIOMED PHARMACOTHER, V89, P1142, DOI 10.1016/j.biopha.2017.02.110; s NA, 2018, LANCET INFECT DIS, V18, pe228; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SRAMEK SJ, 1989, OPHTHALMOLOGY, V96, P835; Suguitan Jr AL, 2011, PLOS ONE, V6; Sun JH, 2017, TOXICOLOGY, V384, P1, DOI 10.1016/j.tox.2017.04.006; Tseng W, 2004, AM J OPHTHALMOL, V137, P1105, DOI 10.1016/j.ajo.2004.02.008; Wang ZY, 2019, BRIT J PHARMACOL, V176, P3390, DOI 10.1111/bph.14770; Wickham L, 2007, OPHTHALMOLOGY, V114, P698, DOI 10.1016/j.ophtha.2006.08.042; Wiedemann P, 1998, AM J OPHTHALMOL, V126, P550, DOI 10.1016/S0002-9394(98)00115-9; Williams RG, 1996, GRAEF ARCH CLIN EXP, V234, P496, DOI 10.1007/BF00184858; Woeller CF, 2015, J BIOL CHEM, V290, P3563, DOI 10.1074/jbc.M114.601872; Zhang C, 2018, INT J OPHTHALMOL-CHI, V11, P1120, DOI 10.18240/ijo.2018.07.08; Zhang CY, 2016, CHEM-BIOL INTERACT, V248, P74, DOI 10.1016/j.cbi.2016.02.004; Zhou S, 2013, CURR MED CHEM, V20, P4095	51	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243626	10.1371/journal.pone.0243626	http://dx.doi.org/10.1371/journal.pone.0243626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347461	Green Published, gold			2022-12-27	WOS:000603071100008
J	Zhang, J; Zhang, M; Huang, SY; Zha, X				Zhang, Jing; Zhang, Miao; Huang, Shaoyan; Zha, Xuan			Assessing spatial variability of soil organic carbon and total nitrogen in eroded hilly region of subtropical China	PLOS ONE			English	Article							LOESS PLATEAU; LAND-USE; ELEVATION GRADIENT; SLOPE ASPECT; FOREST; STOCKS; RESTORATION; MATTER; TOPOGRAPHY; VEGETATION	The hilly red soil region of southern China suffers from severe soil erosion that has led to soil degradation and loss of soil nutrients. Estimating the content and spatial variability of soil organic carbon (SOC) and soil total nitrogen (STN) and assessing the influence of topography and land-use type on SOC and STN after years of soil erosion control are important for vegetation restoration and ecological reconstruction. A total of 375 topsoil samples were collected from Changting County, and their SOC and STN distributions were studied by using descriptive statistics and geostatistical methods. Elevation, slope, aspect and land-use type were selected to investigate the impacts of natural and human factors on the spatial heterogeneity of SOC and STN. The mean SOC and STN concentrations were 15.85 and 0.98 g kg(-1) with moderate spatial variations, respectively. SOC and STN exhibited relatively uniform distributions that decreased gradually from the outside parts to the center of the study area. The SOC and STN contents in the study area were still at moderate and low levels after years of erosion control, which suggests that soil nutrient improvement is a slow process. The lowest SOC and STN values were at lower elevations in the center of Changting County. The results indicated that the SOC and STN contents increased most significantly with elevation and slope due to the influence of topography on the regional natural environment and soil erosion in the eroded hilly region. No significant variations were observed among different slope directions and land-use types.	[Zhang, Jing; Huang, Shaoyan; Zha, Xuan] Fujian Normal Univ, Coll Geog Sci, Fuzhou, Fujian, Peoples R China; [Zhang, Jing; Huang, Shaoyan; Zha, Xuan] Minist Sci & Technol & Fujian Prov Funded, Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China; [Zhang, Miao] Fujian Prov Invest Design & Res Inst Water Conser, Dept Ecol Environm, Fuzhou, Fujian, Peoples R China	Fujian Normal University	Zha, X (corresponding author), Fujian Normal Univ, Coll Geog Sci, Fuzhou, Fujian, Peoples R China.; Zha, X (corresponding author), Minist Sci & Technol & Fujian Prov Funded, Key Lab Subtrop Mt Ecol, Fuzhou, Fujian, Peoples R China.	xzha@fjnu.edu.cn			National Key Research and Development Program of "Typical fragile ecology restoration and protection": Soil conservation in the hilly red soil region of southern China [2017YFC05054]; National Key Basic Research Development Plan Project 973, China [2007CB407207]	National Key Research and Development Program of "Typical fragile ecology restoration and protection": Soil conservation in the hilly red soil region of southern China; National Key Basic Research Development Plan Project 973, China(National Basic Research Program of China)	The study was funded by the National Key Research and Development Program of "Typical fragile ecology restoration and protection": Soil conservation in the hilly red soil region of southern China (No. 2017YFC05054) and the National Key Basic Research Development Plan Project 973, China (No. 2007CB407207).	Ai ZM, 2017, CATENA, V152, P9, DOI 10.1016/j.catena.2016.12.024; Al-Kaisi MM, 2005, AGR ECOSYST ENVIRON, V105, P635, DOI 10.1016/j.agee.2004.08.002; [Anonymous], 2003, INT J HYDROPOWER DAM, V10, P79; ARMSTRONG M, 1988, MATH GEOL, V20, P447, DOI 10.1007/BF00892988; Asif R, 2012, IEEE INT CONF NETWOR, P109, DOI 10.1109/ICON.2012.6506543; Bai LY, 2014, J MT SCI-ENGL, V11, P1231, DOI 10.1007/s11629-014-3056-7; Bai YH, 2020, J FORESTRY RES, V31, P1295, DOI 10.1007/s11676-019-00879-z; BALE CL, 1994, FOREST ECOL MANAG, V67, P305, DOI 10.1016/0378-1127(94)90025-6; Barnett V., 1994, OUTLIERS STAT DATA; Berhe AA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000751; Bogunovic I, 2014, SOIL TILL RES, V144, P174, DOI 10.1016/j.still.2014.07.020; Brady N.C, 2000, NATURE PROPERTIES SO; Bringmark E, 1998, AMBIO, V27, P45; Ferreira ACC, 2016, LAND DEGRAD DEV, V27, P171, DOI 10.1002/ldr.2282; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Chen CP, 2016, BOT STUD, V57, DOI 10.1186/s40529-016-0147-5; Chen H, 2018, CATENA, V170, P141, DOI 10.1016/j.catena.2018.06.006; Cheng XF, 2004, PEDOSPHERE, V14, P425; China Financial 40 People Forum Project Group, 2013, FINAN RES, V5, P114; Cooke J. A., 2002, Environmental Reviews, V10, P41, DOI 10.1139/a01-014; Cordova C, 2012, AGR ECOSYST ENVIRON, V147, P66, DOI 10.1016/j.agee.2011.06.016; Das B, 2018, MODEL EARTH SYST ENV, V4, P373, DOI 10.1007/s40808-018-0435-z; Dessalegn D, 2014, CATENA, V115, P47, DOI 10.1016/j.catena.2013.11.007; Djukic I, 2010, J PLANT NUTR SOIL SC, V173, P30, DOI 10.1002/jpln.200900027; Du BM, 2014, ECOL RES, V29, P433, DOI 10.1007/s11284-014-1135-4; Egli M, 2012, GEODERMA, V183, P109, DOI 10.1016/j.geoderma.2012.03.017; El Kateb H, 2013, CATENA, V105, P1, DOI 10.1016/j.catena.2012.12.012; Elbasiouny H, 2014, CATENA, V113, P70, DOI 10.1016/j.catena.2013.09.008; Franzluebbers AJ, 2009, AGR ECOSYST ENVIRON, V129, P28, DOI 10.1016/j.agee.2008.06.013; Gao Y, 2011, J APPL ECOL, V48, P1145, DOI 10.1111/j.1365-2664.2011.02011.x; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Gessler PE, 2000, SOIL SCI SOC AM J, V64, P2046, DOI 10.2136/sssaj2000.6462046x; Goovaerts P, 1999, GEODERMA, V89, P1, DOI 10.1016/S0016-7061(98)00078-0; Guo PT, 2011, SOIL RES, V49, P606, DOI 10.1071/SR11134; Guo YY, 2006, SOIL SCI SOC AM J, V70, P601, DOI 10.2136/sssaj2005.0163; Hu KL, 2014, GEODERMA, V226, P54, DOI 10.1016/j.geoderma.2014.03.001; Kravchenko AN, 2003, SOIL SCI SOC AM J, V67, P1564, DOI 10.2136/sssaj2003.1564; Krige D.G, 1951, J S AFR I MIN METALL, V52, P201, DOI DOI 10.2307/3006914; Lacoste M, 2014, GEODERMA, V213, P296, DOI 10.1016/j.geoderma.2013.07.002; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Li QK, 1983, RED EARTHS CHINA, P15; Li SQ, 2013, ENVIRON EARTH SCI, V70, P3323, DOI 10.1007/s12665-013-2397-9; Li ZW, 2015, GEOMORPHOLOGY, V248, P264, DOI 10.1016/j.geomorph.2015.07.036; Liu DW, 2006, AGR ECOSYST ENVIRON, V113, P73, DOI 10.1016/j.agee.2005.09.006; Liu X, 2006, PLANT SOIL ENVIRON, V52, P531, DOI 10.17221/3544-PSE; Liu ZJ, 2014, GEODERMA, V235, P39, DOI 10.1016/j.geoderma.2014.06.027; Lourenco RW, 2010, ENVIRON EARTH SCI, V60, P495, DOI 10.1007/s12665-009-0190-6; Lu R K., 1999, SOIL AGR CHEM ANAL, P106; Matheron G., 1963, ECON GEOL, V58, P1246, DOI [DOI 10.2113/GSECONGEO.58.8.1246, 10.2113/gsecongeo.58.8.1246]; Nielsen D.R., 1985, SOIL SPATIAL VARIABI, P1; Office of the Leading Group of the State Council for the First National Water Resources Census, 2010, GEN SURV SOIL WAT CO, P202; Ou Y, 2017, AGR ECOSYST ENVIRON, V245, P22, DOI 10.1016/j.agee.2017.05.003; Phachomphon K, 2010, GEODERMA, V155, P372, DOI 10.1016/j.geoderma.2009.12.020; Phillips RP, 2011, ECOL LETT, V14, P187, DOI 10.1111/j.1461-0248.2010.01570.x; Prietzel J, 2014, GEODERMA, V221, P28, DOI 10.1016/j.geoderma.2014.01.021; Qin YY, 2016, CATENA, V147, P308, DOI 10.1016/j.catena.2016.07.025; Rabbi SMF, 2014, GEODERMA, V216, P10, DOI 10.1016/j.geoderma.2013.10.023; Ritchie JC, 2007, GEOMORPHOLOGY, V89, P163, DOI 10.1016/j.geomorph.2006.07.021; Rosemary F, 2017, CATENA, V150, P53, DOI 10.1016/j.catena.2016.10.017; Rossi JP, 1995, EUR J SOIL BIOL, V31, P173; Schillaci C, 2018, REND ONLINE SOC GEOL, V46, P161, DOI 10.3301/ROL.2018.68; Schillaci C, 2017, SCI TOTAL ENVIRON, V601, P821, DOI 10.1016/j.scitotenv.2017.05.239; SCHMIDT MG, 1993, J SOIL SCI, V44, P417, DOI 10.1111/j.1365-2389.1993.tb00464.x; Selim HM, 2016, SOIL TILL RES, V155, P401, DOI 10.1016/j.still.2015.09.010; Sheikh M. A., 2009, Carbon Balance and Management, V4; Smith JL, 2002, SOIL BIOL BIOCHEM, V34, P1749, DOI 10.1016/S0038-0717(02)00162-1; Sun WY, 2015, ECOL ENG, V83, P249, DOI 10.1016/j.ecoleng.2015.06.030; Tang K., 2004, SOIL WATER CONSERVAT; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Tu CL, 2018, CATENA, V163, P204, DOI 10.1016/j.catena.2017.12.028; Veronesi F, 2019, ECOL INDIC, V101, P1032, DOI 10.1016/j.ecolind.2019.02.026; Wang CC, 2016, LAND DEGRAD DEV, V27, P387, DOI 10.1002/ldr.2397; Wang HJ, 2009, SOIL TILL RES, V105, P300, DOI 10.1016/j.still.2008.08.010; Wang JM, 2015, ECOL ENG, V82, P159, DOI 10.1016/j.ecoleng.2015.04.103; Wang LY, 2019, J SOIL SEDIMENT, V19, P275, DOI 10.1007/s11368-018-2044-x; Wang S, 2018, CATENA, V166, P134, DOI 10.1016/j.catena.2018.03.023; Wang T, 2017, CATENA, V155, P41, DOI 10.1016/j.catena.2017.03.004; [王维明 Wang Weiming], 2005, [水土保持通报, Bulletin of Soil and Water Conservation], V25, P73; Wang YQ, 2010, GEODERMA, V159, P99, DOI 10.1016/j.geoderma.2010.07.001; Wang ZQ, 1999, GEOSTATISTICS ITS AP, P97; Watson RT, 2000, LAND USE LAND USE CH; Webster R., 1985, Advances in Soil Science, V3, P1; Webster R, 2011, STAT EARTH ENV SCI, P526; Wei ZQ, 2014, PEDOSPHERE, V24, P56, DOI 10.1016/S1002-0160(13)60080-6; Wong VNL, 2008, AUST J SOIL RES, V46, P378, DOI 10.1071/SR07160; Yang L, 2007, J ENVIRON MANAGE, V85, P690, DOI 10.1016/j.jenvman.2006.09.011; Yang RM, 2016, ECOL INDIC, V60, P870, DOI 10.1016/j.ecolind.2015.08.036; Yao X, 2019, J FOR RES, V31, P2385; Yao X, 2019, CATENA, V178, P189, DOI 10.1016/j.catena.2019.03.004; Yimer F, 2006, GEODERMA, V135, P335, DOI 10.1016/j.geoderma.2006.01.005; Yuan XY, 2007, NEW ZEAL J AGR RES, V50, P1157, DOI 10.1080/00288230709510398; Yuan XF, 2019, J GEOGR SCI, V29, P779, DOI 10.1007/s11442-019-1627-9; Zhang SR, 2016, SCI TOTAL ENVIRON, V563, P10, DOI 10.1016/j.scitotenv.2016.04.111; Zhong BL, 2013, LAND USE POLICY, V32, P119, DOI 10.1016/j.landusepol.2012.10.005	94	7	8	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244322	10.1371/journal.pone.0244322	http://dx.doi.org/10.1371/journal.pone.0244322			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347496	gold, Green Published			2022-12-27	WOS:000603071100026
J	Bouffard, J; Weber, Z; Pearsall, L; Emery, K; Cote, JN				Bouffard, Jason; Weber, Zachary; Pearsall, Lyndsey; Emery, Kim; Cote, Julie N.			Similar effects of fatigue induced by a repetitive pointing task on local and remote light touch and pain perception in men and women	PLOS ONE			English	Article							EXERCISE-INDUCED HYPOALGESIA; ISOMETRIC-EXERCISE; MUSCLE FATIGUE; NECK/SHOULDER PAIN; GENDER-DIFFERENCES; SEX-DIFFERENCES; BLOOD-PRESSURE; DOSE-RESPONSE; HEALTHY-MEN; MECHANISMS	Background Women involved in repetitive, fatiguing, jobs develop more neck and/or shoulder musculoskeletal disorders than men. Sex differences in the pain response to exercise could contribute to the higher prevalence of neck/shoulder musculoskeletal disorders in women. The objective of this study was to assess sex differences in pain sensitivity following a fatiguing upper limb task. Relationships between measures of fatigue and of the sensitivity to nociceptive and to non-nociceptive stimulations were also explored. Methods Thirty healthy adults (15 women) performed a fatiguing repetitive pointing task with their dominant arm. Upper limb electromyography was recorded from the dominant upper trapezius, anterior deltoid and bicep brachii and from the contralateral tibialis anterior. Before and immediately after the repetitive pointing task, pressure pain and light touch sensitivity thresholds were measured over the same muscles. Results Electromyographic signs of fatigue were observed only in the anterior deltoid and biceps brachii muscles. Pressure pain thresholds over both muscles increased slightly (effect size <= 0.34), but no changes occurred over the upper trapezius and the tibialis anterior. Light touch thresholds increased moderately to importantly after the repetitive pointing task over all four muscles (effect sizes = 0.58 to 0.87). No sex differences were observed in any sensory variable. Moreover, no or weak correlations (r = -0.27 to 0.39) were observed between electromyographical signs of fatigue, light touch threshold and pressure pain threshold variables. Conclusions We observed sex-independent effects of a repetitive upper limb task on the sensitivity to painful and to nonpainful stimuli. Moreover, the hypoalgesia induced by the repetitive pointing task was weak and localized, and did not directly correlate with the induced muscle fatigue. Results suggest that fatigue-related changes in the sensitivity to noxious and innocuous stimuli could not explain women's greater prevalence of neck/shoulder musculoskeletal disorders.	[Bouffard, Jason; Weber, Zachary; Pearsall, Lyndsey; Emery, Kim; Cote, Julie N.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Bouffard, Jason; Weber, Zachary; Pearsall, Lyndsey; Emery, Kim; Cote, Julie N.] Jewish Rehabil Hosp, Michael Feil & Ted Oberfeld CRIR Res Ctr, Occupat Biomech & Ergon Lab, Laval, PQ, Canada; [Bouffard, Jason] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Bouffard, Jason] Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada	McGill University; McGill University; Laval University; Laval University	Bouffard, J (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.; Bouffard, J (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.; Bouffard, J (corresponding author), Univ Laval, Dept Kinesiol, Quebec City, PQ, Canada.	Jason.bouffard@kin.ulaval.ca	Bouffard, Jason/AFM-1347-2022	Bouffard, Jason/0000-0003-1083-5899	Natural Sciences and Engineering Research Council [RGPIN-2015-0511]; Canadian Institutes for Health Research [MFE-146666]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The project is funded by a Natural Sciences and Engineering Research Council grant (JNC, #RGPIN-2015-0511, https://www.nserccrsng.gc.ca/index_eng.asp). JB was funded by the Canadian Institutes for Health Research (#MFE-146666). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2004, J ELECTROMYOGR KINES, V14, P699, DOI 10.1016/j.jelekin.2004.04.003; [Anonymous], 1999, SENIAM DELIV; ARMSTRONG TJ, 1993, SCAND J WORK ENV HEA, V19, P73, DOI 10.5271/sjweh.1494; BELLKROTOSKI J, 1987, J HAND SURG-AM, V12A, P155, DOI 10.1016/S0363-5023(87)80189-2; Bement MH, 2014, J MOTOR BEHAV, V46, P107, DOI 10.1080/00222895.2013.872078; Bement MKH, 2008, MED SCI SPORT EXER, V40, P1880, DOI 10.1249/MSS.0b013e31817eeecc; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Bouffard J, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0175-9; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cote JN, 2008, MOTOR CONTROL, V12, P79, DOI 10.1123/mcj.12.2.79; Cote JN, 2014, ADV EXP MED BIOL, V826, P205, DOI 10.1007/978-1-4939-1338-1_13; Dannecker EA, 2014, SPORTS MED, V44, P921, DOI 10.1007/s40279-014-0172-z; Dimitrova NA, 2003, J ELECTROMYOGR KINES, V13, P13, DOI 10.1016/S1050-6411(02)00083-4; Emery K, 2010, CLIN BIOMECH, V25, P124, DOI 10.1016/j.clinbiomech.2009.10.003; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Focht BC, 2009, J STRENGTH COND RES, V23, P891, DOI 10.1519/JSC.0b013e3181a05564; Fuller JR, 2009, J ELECTROMYOGR KINES, V19, P1043, DOI 10.1016/j.jelekin.2008.10.009; Gajsar H, 2017, PAIN MED, V18, P917, DOI 10.1093/pm/pnw176; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Han J, 2015, J PHYS THER SCI, V27, P551, DOI 10.1589/jpts.27.551; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Hunter SK, 2004, J APPL PHYSIOL, V96, P2125, DOI 10.1152/japplphysiol.01342.2003; Kami K, 2017, ANAT SCI INT, V92, P79, DOI 10.1007/s12565-016-0360-z; Koltyn KF, 2014, J PAIN, V15, P1294, DOI 10.1016/j.jpain.2014.09.006; Koltyn KF, 1998, BRIT J SPORT MED, V32, P20, DOI 10.1136/bjsm.32.1.20; Koltyn KF, 2001, MED SCI SPORT EXER, V33, P282; Koltyn KF, 2000, SPORTS MED, V29, P85, DOI 10.2165/00007256-200029020-00002; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Lemley KJ, 2016, EUR J APPL PHYSIOL, V116, P1379, DOI 10.1007/s00421-016-3389-8; Lemley KJ, 2014, MED SCI SPORT EXER, V46, P185, DOI 10.1249/MSS.0b013e3182a05de8; Lima LV, 2017, J PHYSIOL-LONDON, V595, P4141, DOI 10.1113/JP273355; Lomond KV, 2011, WORK, V38, P169, DOI 10.3233/WOR-2011-1119; Mayer J, 2012, INT ARCH OCC ENV HEA, V85, P587, DOI 10.1007/s00420-011-0701-0; Naugle KM, 2014, PAIN MED, V15, P692, DOI 10.1111/pme.12312; Naugle KM, 2012, J PAIN, V13, P1139, DOI 10.1016/j.jpain.2012.09.006; Nordander C, 2008, INT ARCH OCC ENV HEA, V81, P939, DOI 10.1007/s00420-007-0286-9; Otto A, 2019, BIOL SEX DIFFER, V10, DOI 10.1186/s13293-019-0253-7; Pereira HM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00517; Peternel L, 2019, ROBOT CIM-INT MANUF, V58, P69, DOI 10.1016/j.rcim.2019.01.013; Racine M, 2012, PAIN, V153, P602, DOI 10.1016/j.pain.2011.11.025; Rice D, 2019, J PAIN, V20, P1249, DOI 10.1016/j.jpain.2019.03.005; Rivest K, 2010, MANUAL THER, V15, P154, DOI 10.1016/j.math.2009.10.001; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Saradjian AH, 2015, NEUROPHYSIOL CLIN, V45, P255, DOI 10.1016/j.neucli.2015.09.004; Sarquis LMM, 2016, PAIN, V157, P1028, DOI 10.1097/j.pain.0000000000000477; Sjogaard G, 1998, CLIN ORTHOP RELAT R, P21; Srinivasan D, 2016, EUR J APPL PHYSIOL, V116, P2357, DOI 10.1007/s00421-016-3487-7; Statistics Canada, 2015, ANTHR MEAS HOUS POP; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Travers M, 2018, SCAND J PAIN, V18, P303, DOI 10.1515/sjpain-2018-0020; Tsai NT, 2003, ARCH PHYS MED REHAB, V84, P1000, DOI 10.1016/S0003-9993(03)00127-8; Tse CTF, 2016, J ELECTROMYOGR KINES, V29, P34, DOI 10.1016/j.jelekin.2015.07.003; Umeda M, 2010, BIOL PSYCHOL, V85, P90, DOI 10.1016/j.biopsycho.2010.05.008; Virta L, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-17; Yung M, 2017, ERGONOMICS, V60, P923, DOI 10.1080/00140139.2016.1243734	58	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244321	10.1371/journal.pone.0244321	http://dx.doi.org/10.1371/journal.pone.0244321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338075	Green Published, gold			2022-12-27	WOS:000601313500037
J	Bocian, K; Baryla, W				Bocian, Konrad; Baryla, Wieslaw			Pain(less) cleansing: Watching other people in pain reduces guilt and sadness but not shame	PLOS ONE			English	Article							EMPATHY; SELF; OTHERS; REPRESENTATIONS; UNDERPINNINGS; STIMULATION; DEVALUATION; ACTIVATION; PRONENESS; EMOTIONS	Past research has shown that pain experience reduces feelings of guilt for earlier wrongdoings. In this paper, we aim to investigate whether watching other people in pain can reduce feelings of guilt. In Study 1 (N = 60), we found that participants' levels of guilt and sadness decreased after they watched a one-minute movie clip showing a painful medical procedure. Study 2 (N = 156), eliminated an alternative explanation in which pain observation but not the misattribution of unrelated excitation reduced guilt. Finally, in Study 3 (N = 60), pain observation lowered participants' feelings of guilt but not their feelings of shame. Overall, these results suggest that the guilt-reducing effect of pain may appear even without the actual experience of physical pain.	[Bocian, Konrad] Univ Kent, Sch Psychol, Canterbury, Kent, England; [Bocian, Konrad; Baryla, Wieslaw] SWPS Univ Social Sci & Humanities, Dept Psychol Sopot, Warsaw, Poland	University of Kent; SWPS University of Social Sciences & Humanities	Bocian, K (corresponding author), Univ Kent, Sch Psychol, Canterbury, Kent, England.; Bocian, K (corresponding author), SWPS Univ Social Sci & Humanities, Dept Psychol Sopot, Warsaw, Poland.	K.Bocian-660@kent.ac.uk	Bocian, Konrad/L-8266-2019	Bocian, Konrad/0000-0002-8652-0167	National Science Center (Poland) [2018/29/B/HS6/00658]; Polish National Agency for Academic Exchange grant [PPN/BEK/2018/1/00056]	National Science Center (Poland)(National Science Centre, Poland); Polish National Agency for Academic Exchange grant(Polish National Agency for Academic Exchange (NAWA))	Preparation of this article was supported by the National Science Center (Poland) grant 2018/29/B/HS6/00658 (OPUS) (https://ncn.gov.pl/?language=en), and by the Polish National Agency for Academic Exchange grant PPN/BEK/2018/1/00056 (Bekker Programme Scholarship) awarded to KB (https://nawa.gov.pl/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Bastian B, 2013, SOC PSYCHOL PERS SCI, V4, P215, DOI 10.1177/1948550612451156; Bastian B, 2011, PSYCHOL SCI, V22, P334, DOI 10.1177/0956797610397058; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Becerra LR, 1999, MAGN RESON MED, V41, P1044, DOI 10.1002/(SICI)1522-2594(199905)41:5<1044::AID-MRM25>3.0.CO;2-M; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Bowlby J., 1969, ATTACHMENT, V1st; Bowlby J, 1999, ATTACHMENT ATTACHMEN; Bufalari I, 2007, CEREB CORTEX, V17, P2553, DOI 10.1093/cercor/bhl161; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; de Hooge IE, 2018, COGNITION EMOTION, V32, P1671, DOI 10.1080/02699931.2017.1422696; de Vignemont F, 2012, PHILOS SCI, V79, P295, DOI 10.1086/664742; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Eisenberger NI, 2004, TRENDS COGN SCI, V8, P294, DOI 10.1016/j.tics.2004.05.010; Fontaine JRJ, 2006, J CROSS CULT PSYCHOL, V37, P273, DOI 10.1177/0022022105284493; Franklin JC, 2013, PSYCHOL SCI, V24, P521, DOI 10.1177/0956797612458805; Freud Sigmund, 1961, STANDARD EDITION COM, P155; Gilbert P, 2003, SOC RES, V70, P1205; Inbar Y, 2013, EMOTION, V13, P14, DOI 10.1037/a0029749; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Krach S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018675; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Leknes S, 2014, PAIN, V155, P652, DOI 10.1016/j.pain.2014.01.001; MARTIN LL, 1992, PERS SOC PSYCHOL B, V18, P412, DOI 10.1177/0146167292184004; Michl P, 2014, SOC COGN AFFECT NEUR, V9, P150, DOI 10.1093/scan/nss114; Navratilova E, 2015, TRENDS NEUROSCI, V38, P741, DOI 10.1016/j.tins.2015.09.003; Nelissen RMA, 2009, EMOTION, V9, P118, DOI 10.1037/a0014540; NIEDENTHAL PM, 1994, J PERS SOC PSYCHOL, V67, P585, DOI 10.1037/0022-3514.67.4.585; Novembre G, 2015, SOC COGN AFFECT NEUR, V10, P153, DOI 10.1093/scan/nsu038; Osborn Jody, 2010, Pain, V148, P268, DOI 10.1016/j.pain.2009.11.007; Poulsen JR, 2012, GROUP PROCESS INTERG, V15, P457, DOI 10.1177/1368430211430517; Robertson TE, 2018, EVOL HUM BEHAV, V39, P566, DOI 10.1016/j.evolhumbehav.2018.05.010; SINCLAIR RC, 1994, PSYCHOL SCI, V5, P15, DOI 10.1111/j.1467-9280.1994.tb00607.x; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Sznycer D, 2016, P NATL ACAD SCI USA, V113, P2625, DOI 10.1073/pnas.1514699113; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Tangney J.P., 2003, SHAME GUILT; TANGNEY JP, 1992, J ABNORM PSYCHOL, V101, P469, DOI 10.1037/0021-843X.101.3.469; TANGNEY JP, 1990, J PERS SOC PSYCHOL, V59, P102, DOI 10.1037/0022-3514.59.1.102; Tangney JP, 2014, PSYCHOL SCI, V25, P799, DOI 10.1177/0956797613508790; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Teroni F, 2008, CONSCIOUS COGN, V17, P725, DOI 10.1016/j.concog.2008.02.002; Tracy JL, 2004, PSYCHOL INQ, V15, P103, DOI 10.1207/s15327965pli1502_01; Wagner U, 2011, CEREB CORTEX, V21, P2461, DOI 10.1093/cercor/bhr016; Wallbott Harald G., 1995, P465; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WEINER B, 1985, PSYCHOL REV, V92, P548, DOI 10.1037/0033-295X.92.4.548; WICKER FW, 1983, MOTIV EMOTION, V7, P25, DOI 10.1007/BF00992963; Zaki J, 2016, TRENDS COGN SCI, V20, P249, DOI 10.1016/j.tics.2016.02.003	57	3	3	0	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244429	10.1371/journal.pone.0244429	http://dx.doi.org/10.1371/journal.pone.0244429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378345	Green Published, gold			2022-12-27	WOS:000605651300069
J	Gao, DS; Barber, PR; Chacko, JV; Sagar, MAK; Rueden, CT; Grislis, AR; Hiner, MC; Eliceiri, KW				Gao, Dasong; Barber, Paul R.; Chacko, Jenu V.; Kader Sagar, Md. Abdul; Rueden, Curtis T.; Grislis, Aivar R.; Hiner, Mark C.; Eliceiri, Kevin W.			FLIMJ: An open-source ImageJ toolkit for fluorescence lifetime image data analysis	PLOS ONE			English	Article							ERROR ANALYSIS; MICROSCOPY; BINDING	In the field of fluorescence microscopy, there is continued demand for dynamic technologies that can exploit the complete information from every pixel of an image. One imaging technique with proven ability for yielding additional information from fluorescence imaging is Fluorescence Lifetime Imaging Microscopy (FLIM). FLIM allows for the measurement of how long a fluorophore stays in an excited energy state, and this measurement is affected by changes in its chemical microenvironment, such as proximity to other fluorophores, pH, and hydrophobic regions. This ability to provide information about the microenvironment has made FLIM a powerful tool for cellular imaging studies ranging from metabolic measurement to measuring distances between proteins. The increased use of FLIM has necessitated the development of computational tools for integrating FLIM analysis with image and data processing. To address this need, we have created FLIMJ, an ImageJ plugin and toolkit that allows for easy use and development of extensible image analysis workflows with FLIM data. Built on the FLIMLib decay curve fitting library and the ImageJ Ops framework, FLIMJ offers FLIM fitting routines with seamless integration with many other ImageJ components, and the ability to be extended to create complex FLIM analysis workflows. Building on ImageJ Ops also enables FLIMJ's routines to be used with Jupyter notebooks and integrate naturally with science-friendly programming in, e.g., Python and Groovy. We show the extensibility of FLIMJ in two analysis scenarios: lifetime-based image segmentation and image colocalization. We also validate the fitting routines by comparing them against industry FLIM analysis standards.	[Gao, Dasong; Chacko, Jenu V.; Kader Sagar, Md. Abdul; Rueden, Curtis T.; Grislis, Aivar R.; Hiner, Mark C.; Eliceiri, Kevin W.] Univ Wisconsin, Ctr Quantitat Cell Imaging, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA; [Barber, Paul R.] UCL, UCL Canc Inst, Paul OGorman Bldg, London, England; [Kader Sagar, Md. Abdul; Eliceiri, Kevin W.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Eliceiri, Kevin W.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Eliceiri, Kevin W.] Univ Wisconsin, Morgridge Inst Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of London; University College London; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Eliceiri, KW (corresponding author), Univ Wisconsin, Ctr Quantitat Cell Imaging, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA.; Eliceiri, KW (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.; Eliceiri, KW (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.; Eliceiri, KW (corresponding author), Univ Wisconsin, Morgridge Inst Res, Madison, WI 53706 USA.	eliceiri@wisc.edu	Chacko, Jenu Varghese/N-1498-2018; Sagar, Md Abdul Kader/ABG-8019-2020; Eliceiri, Kevin/P-8339-2015	Chacko, Jenu Varghese/0000-0002-6676-0358; Barber, Paul/0000-0002-8595-1141; Rueden, Curtis/0000-0001-7055-6707; Sagar, Md Abdul Kader/0000-0002-1564-0727; Eliceiri, Kevin/0000-0001-8678-670X; Hiner, Mark/0000-0001-9404-7579	NIH [R01CA185251, RC2 GM092519, P41GM13501]; U.S. Department of Energy [DE-SC0019013]; Morgridge Institute for Research; Cancer Research UK [C5255/A15935]; CRUK UCL Centre [C416/A25145]; CRUK City of London Centre [C7893/A26233]; CRUK KCL-UCL Comprehensive Cancer Imaging Centre (CRUK EPSRC); MRC [C1519/A16463, C1519/A10331]; DoH [C1519/A16463, C1519/A10331]; UW-Madison Hilldale Undergraduate/Faculty Research Fellowship; UW-Madison Trewartha Senior Thesis Research Grant program; Semiconductor Research Corporation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Morgridge Institute for Research; Cancer Research UK(Cancer Research UK); CRUK UCL Centre; CRUK City of London Centre; CRUK KCL-UCL Comprehensive Cancer Imaging Centre (CRUK EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DoH; UW-Madison Hilldale Undergraduate/Faculty Research Fellowship; UW-Madison Trewartha Senior Thesis Research Grant program; Semiconductor Research Corporation	We acknowledge support from NIH grants R01CA185251 (KWE), RC2 GM092519 (KWE), P41GM13501 (KWE), the Semiconductor Research Corporation (KWE), U.S. Department of Energy grant DE-SC0019013 (KWE), and the Morgridge Institute for Research (KWE). This work was also supported by the Cancer Research UK Programme grant C5255/A15935 (PRB) the CRUK UCL Centre grant C416/A25145 (PRB), CRUK City of London Centre grant C7893/A26233 (PRB), CRUK KCL-UCL Comprehensive Cancer Imaging Centre (CRUK & EPSRC) and MRC and DoH grants C1519/A16463 and C1519/A10331 (PRB). We also thank the UW-Madison Hilldale Undergraduate/Faculty Research Fellowship (DG and KWE) and UW-Madison Trewartha Senior Thesis Research Grant program (DG) for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Garcia A, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.4.046005; [Anonymous], 2019, AESTHET SURG J S1, V38, pS1; Arena ET, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.260; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; BAJZER Z, 1991, EUR BIOPHYS J BIOPHY, V20, P247, DOI 10.1007/BF00450560; BALLEW RM, 1989, ANAL CHEM, V61, P30, DOI 10.1021/ac00176a007; Barber PR, 2009, J R SOC INTERFACE, V6, pS93, DOI 10.1098/rsif.2008.0451.focus; Barber PR, 2020, JNCI-J NATL CANCER I, V112, P944, DOI 10.1093/jnci/djz231; Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Barber PR, 2014, 3 DIMENSIONAL MULTID, p89490D; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Bird DK, 2005, CANCER RES, V65, P8766, DOI 10.1158/0008-5472.CAN-04-3922; BUURMAN EP, 1992, SCANNING, V14, P155, DOI 10.1002/sca.4950140305; Castello M, 2019, NAT METHODS, V16, P175, DOI 10.1038/s41592-018-0291-9; Chacko JV, 2019, METHODS APPL FLUORES, V7, DOI 10.1088/2050-6120/ab47e5; Chacko JV, 2019, CYTOM PART A, V95A, P56, DOI 10.1002/cyto.a.23603; Datta R, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.7.071203; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Emptage Nigel J., 2001, Current Opinion in Pharmacology, V1, P521, DOI 10.1016/S1471-4892(01)00090-X; FLETCHER R, 1963, COMPUT J, V6, P163, DOI 10.1093/comjnl/6.2.163; Healy S, 2018, J NEUROSCI METH, V295, P87, DOI 10.1016/j.jneumeth.2017.12.002; Hiner MC, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1383-0; Hunt J, 2012, J BIOL CHEM, V287, P17459, DOI 10.1074/jbc.M111.331967; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Konig K, 2011, MICROSC RES TECHNIQ, V74, P9, DOI 10.1002/jemt.20866; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, P157; Laurence TA, 2010, NAT METHODS, V7, P338, DOI 10.1038/nmeth0510-338; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI 10.1090/qam/10666; Levine Y., 1997, J FLUORESC, V7, P11, DOI DOI 10.1007/BF02764572; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Pelet S, 2004, BIOPHYS J, V87, P2807, DOI 10.1529/biophysj.104.045492; Perinbam K, 2020, MBIO, V11, DOI 10.1128/mBio.02730-18; Rowley MI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158404; Rueden C, 2004, TRAFFIC, V5, P411, DOI 10.1111/j.1600-0854.2004.00189.x; Rueden C, 2016, IMAGEJ OPS SOFTWARE; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Rueden CT, 2009, IEEE ENG MED BIO, P4077, DOI 10.1109/IEMBS.2009.5334523; Sagar MAK, 2019, LIGHT NATURE, p110990C, DOI 10.1117/12.2529349; Sagar MAK, 2020, NEUROPHOTONICS, V7, DOI 10.1117/1.NPh.7.3.035003; Sagar MAK, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00931; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Sharman KK, 1999, ANAL CHEM, V71, P947, DOI 10.1021/ac981050d; Studier H, 2014, PROC SPIE, V8948, DOI 10.1117/12.2039454; Sun YH, 2013, MICROSC MICROANAL, V19, P791, DOI 10.1017/S1431927613001530; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Verveer PJ, 2000, BIOPHYS J, V78, P2127, DOI 10.1016/S0006-3495(00)76759-2; Wang SL, 2019, BIOMED OPT EXPRESS, V10, P5497, DOI 10.1364/BOE.10.005497; Warren SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070687; Webb SED, 2002, REV SCI INSTRUM, V73, P1898, DOI 10.1063/1.1458061; Weitsman G, 2016, ONCOTARGET, V7, P51012, DOI 10.18632/oncotarget.9963; Wouters FS, 2008, HFSP J, V2, P7, DOI 10.2976/1.2833600; Yan L, 2006, BIOTECHNIQUES, V41, P249, DOI 10.2144/000112251; York EM, 2019, BIOMED OPT EXPRESS, V10, P4381, DOI 10.1364/BOE.10.004381; Zhao QL, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3608997	57	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0238327	10.1371/journal.pone.0238327	http://dx.doi.org/10.1371/journal.pone.0238327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378370	Green Published, Green Submitted, gold			2022-12-27	WOS:000605651300043
J	Gordillo-Delgado, F; Zuluaga-Acosta, J; Restrepo-Guerrero, G				Gordillo-Delgado, Fernando; Zuluaga-Acosta, Jakeline; Restrepo-Guerrero, Gonzalo			Effect of the suspension of Ag-incorporated TiO2 nanoparticles (Ag-TiO2 NPs) on certain growth, physiology and phytotoxicity parameters in spinach seedlings	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; NANOTECHNOLOGY; NANO-TIO2; SILVER; CROP	In this work, the effect of the inoculation of silver-incorporated titanium dioxide nanoparticles (Ag-TiO2 NPs) in spinach seeds was evaluated on certain growth, physiology and phytotoxicity parameters of the plants. This is an important crop for human consumption with high nutritional value due to their low calorie and fat content, providing various vitamins and minerals, especially iron. These NPs were obtained by means of the sol-gel method and heat treatment; the resulting powder material was characterized using X-ray diffraction and scanning electron microscopy and the influence of these NPs on plants was measured by estimating the germination rate, monitoring morphological parameters and evaluating phytotoxicity. The photosynthetic activity of the spinach plants was estimated through the quantification of the Ratio of Oxygen Evolution (ROE) by the photoacoustic technique. Samples of TiO2 powder with particle size between 9 and 43 nm were used to quantify the germination rate, which served to determine a narrower size range between 7 and 26 nm in the experiments with Ag-TiO2 NPs; the presence of Ag in TiO2 powder samples was confirmed by energy-dispersive X-ray spectroscopy. The analysis of variance showed that the dependent variable (plant growth) could be affected by the evaluated factors (concentration and size) with significant differences. The statistical trend indicated that the application of the Ag-TiO2 NPs suspension of lowest concentration and smallest particle size could be a promoting agent of the growth and development of these plants. The inoculation with NPs of 8.3 nm size and lowest concentration was related to the highest average ROE value, 24.6 +/- 0.2%, while the control group was 20.2 +/- 0.2%. The positive effect of the Ag-TiO2 NPs treatment could be associated to the generation of reactive oxygen species, antimicrobial activity, increased biochemical attributes, enzymatic activity or improvements in water absorption.	[Gordillo-Delgado, Fernando; Zuluaga-Acosta, Jakeline; Restrepo-Guerrero, Gonzalo] Univ Quindio, Interdisciplinary Inst Sci, Appl Sci Res Grp Dev Ecoreg GICADE Assigned, Armenia, Quindio, Colombia; [Gordillo-Delgado, Fernando] Univ Quindio, Fac Basic Sci & Technol, Program Elect Instrumentat Technol, Armenia, Colombia	Universidad del Quindio; Universidad del Quindio	Gordillo-Delgado, F (corresponding author), Univ Quindio, Interdisciplinary Inst Sci, Appl Sci Res Grp Dev Ecoreg GICADE Assigned, Armenia, Quindio, Colombia.; Gordillo-Delgado, F (corresponding author), Univ Quindio, Fac Basic Sci & Technol, Program Elect Instrumentat Technol, Armenia, Colombia.	fgordillo@uniquindio.edu.co		GORDILLO-DELGADO, FERNANDO/0000-0002-2940-1129; Restrepo Guerrero, Andres Gonzalo/0000-0001-8189-0030	University of Quindio [869]; COLCIENCIAS [869]; OMICAS program: Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar), within the Colombian Scientific Ecosystem by The WORLD BANK; COLCIENCIAS; ICETEX; Colombian Ministry of Education; Colombian Ministry of Industry and Turism [FP44842217-2018]	University of Quindio; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); OMICAS program: Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar), within the Colombian Scientific Ecosystem by The WORLD BANK; COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); ICETEX; Colombian Ministry of Education; Colombian Ministry of Industry and Turism	Acknowledges to University of Quindio and COLCIENCIAS by financial support through 869 project and young researchers program. This work was partially funded by the OMICAS program: Optimizacion Multiescala In-silico de Cultivos Agricolas Sostenibles (Infraestructura y validacion en Arroz y Cana de Azucar), sponsored within the Colombian Scientific Ecosystem by The WORLD BANK, COLCIENCIAS, ICETEX, the Colombian Ministry of Education and the Colombian Ministry of Industry and Turism under GRANT ID: FP44842217-2018.	Ali T, 2018, MATER CHEM PHYS, V212, P325, DOI 10.1016/j.matchemphys.2018.03.052; Alves FCGBS, 2015, ANAL METHODS-UK, V7, P9702, DOI [10.1039/c5ay02440d, 10.1039/C5AY02440D]; [Anonymous], 2017, J MOL BIOMARKERS DIA, V8, P1, DOI [10.4172/2155-9929.S2-026, DOI 10.4172/2155-9929.S2-026, DOI 10.5334/LABPHON.19]; Avalos A., 2013, Revista Complutense de Ciencias Veterinarias, V7, P1; Bedoya A., 2016, Journal of Physics: Conference Series, V687, DOI 10.1088/1742-6596/687/1/012103; Cargnello M, 2014, CHEM REV, V114, P9319, DOI 10.1021/cr500170p; Cox A, 2017, PLANT PHYSIOL BIOCH, V110, P33, DOI 10.1016/j.plaphy.2016.08.007; Dias RCE, 2018, FOOD CHEM, V255, P132, DOI 10.1016/j.foodchem.2018.02.076; Feizi H, 2013, CHEMOSPHERE, V91, P506, DOI 10.1016/j.chemosphere.2012.12.012; Grzeskowiak M, 2014, MATER SCI-POLAND, V32, P71, DOI 10.2478/s13536-013-0163-z; Haider AJ, 2017, ENRGY PROCED, V119, P332, DOI 10.1016/j.egypro.2017.07.117; Hallstrom E, 2018, ECOL INDIC, V93, P219, DOI 10.1016/j.ecolind.2018.04.071; HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003; Hong F.S., 2001, CHIN J APPL CHEM, V18, P532; Hong FH, 2005, BIOL TRACE ELEM RES, V105, P269, DOI 10.1385/BTER:105:1-3:269; Jagdale S, 2018, BIOSTIMULATION REMED, P259; Jhanzab H.M., 2015, INT J AGRON AGR RES, V7, P15; Jolliffe IT, 2002, PRINCIPAL COMPONENT, P63; Khan I, 2019, ARAB J CHEM, V12, P908, DOI 10.1016/j.arabjc.2017.05.011; Khandelwal A., 2018, J ACTA SCI AGR, V2, P10; Khot LR, 2012, CROP PROT, V35, P64, DOI 10.1016/j.cropro.2012.01.007; Kim S, 2012, WATER AIR SOIL POLL, V223, P2799, DOI 10.1007/s11270-011-1067-3; Larue C, 2014, J HAZARD MATER, V273, P17, DOI 10.1016/j.jhazmat.2014.03.014; Li Y, 2019, J FUNCT FOODS, V60, P1; Masarovicova E, 2013, ECOL CHEM ENG S, V20, P9, DOI 10.2478/eces-2013-0001; Méndez-Argüello B., 2016, Nova scientia, V8, P140; Nations United, 2018, DATABASE FAOSTAT; Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978; Pighin AF, 2010, REV CHIL NUTR, V37, P201, DOI 10.4067/S0717-75182010000200009; Qi J, 2013, WATER SCI TECHNOL, V67, P147, DOI 10.2166/wst.2012.545; Quinteros MA, 2016, TOXICOL IN VITRO, V36, P216, DOI 10.1016/j.tiv.2016.08.007; Rastogi A, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00078; Rawtani D, 2018, J ENVIRON MANAGE, V206, P749, DOI 10.1016/j.jenvman.2017.11.037; Sharma A., 2014, J BASIC APPL ENG RES, V1, P1; Siddiqui MH., 2015, NANOTECHNOLOGY PLANT, P978; Ubonchonlakate K, 2012, PROCEDIA ENGINEER, V32, P656, DOI 10.1016/j.proeng.2012.01.1323; Wang P, 2016, TRENDS PLANT SCI, V21, P699, DOI 10.1016/j.tplants.2016.04.005; Wang Y, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1721-1; Zheng L, 2005, BIOL TRACE ELEM RES, V104, P83, DOI 10.1385/BTER:104:1:083	39	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244511	10.1371/journal.pone.0244511	http://dx.doi.org/10.1371/journal.pone.0244511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373403	Green Published, gold			2022-12-27	WOS:000603612300002
J	Hull, JJA; Qi, MP; Montmayeur, AM; Kumar, D; Velasquez, DE; Moon, SS; Magana, LC; Betrapally, N; Ng, TFF; Jiang, BM; Marthaler, D				Hull, Jennifer J. A.; Qi, Mingpu; Montmayeur, Anna M.; Kumar, Deepak; Velasquez, Daniel E.; Moon, Sung-Sil; Magana, Laura Cristal; Betrapally, Naga; Ng, Terry Fei Fan; Jiang, Baoming; Marthaler, Douglas			Metagenomic sequencing generates the whole genomes of porcine rotavirus A, C, and H from the United States	PLOS ONE			English	Article							GROUP-A; PHYLOGENETIC ANALYSIS; GENETIC-ANALYSIS; RAPID DETECTION; SPECIES C; GROUP-B; DIARRHEA; CLASSIFICATION; STRAINS; GASTROENTERITIS	The genus Rotavirus comprises eight species, designated A to H, and two recently identified tentative species I in dogs and J in bats. Species Rotavirus A, B, C and H (RVA, RVB, RVC and RVH) have been detected in humans and animals. While human and animal RVA are well characterized and defined, complete porcine genome sequences in the GenBank are limited compared to human strains. Here, we used a metagenomic approach to sequence the 11 segments of RVA, RVC and RVH strains from piglets in the United States (US) and explore the evolutionary relations of these RV species. Metagenomics identified Astroviridae, Picornaviridae, Caliciviridae, Coronoviridae in samples MN9.65 and OK5.68 while Picobirnaviridae and Arteriviridae were only identified in sample OK5.68. Whole genome sequencing and phylogenetic analyses identified multiple genotypes with the RVA of strain MN9.65 and OK5.68, with the genome constellation of G5/G9-P[7]/P[13]-I5/I5- R1/R1-C1-M1-A8-N1-T7-E1/E1-H1 and G5/G9-P[6]/P[7]-I5-R1/R1-C1-M1-A8-N1-T1/T7-E1/E1-H1, respectively. The RVA strains had a complex evolutionary relationship with other mammalian strains. The RVC strain OK5.68 had a genome constellation of G9-P[6]-I1-R1-C5-M6-A5-N1-T1-E1-H1, and shared an evolutionary relationship with porcine strains from the US. The RVH strains MN9.65 and OK5.68 had the genome constellation of G5-P1-I1-R1-C1-M1-A5-N1-T1-E4-H1 and G5-P1-I1-R1-C1-M1-A5-N1-T1-E1-H1, indicating multiple RVH genome constellations are circulating in the US. These findings allow us to understand the complexity of the enteric virome, develop improved screening methods for RVC and RVH strains, facilitate expanded rotavirus surveillance in pigs, and increase our understanding of the origin and evolution of rotavirus species.	[Hull, Jennifer J. A.; Montmayeur, Anna M.; Velasquez, Daniel E.; Moon, Sung-Sil; Magana, Laura Cristal; Betrapally, Naga; Ng, Terry Fei Fan; Jiang, Baoming] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Qi, Mingpu] Huazhong Agr Univ, State Key Lab Agr Microbiol, Coll Vet Med, Wuhan, Hubei, Peoples R China; [Qi, Mingpu; Kumar, Deepak; Marthaler, Douglas] Kansas State Univ, Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Magana, Laura Cristal; Betrapally, Naga] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Marthaler, Douglas] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA	Centers for Disease Control & Prevention - USA; Huazhong Agricultural University; Kansas State University; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; University of Minnesota System; University of Minnesota Twin Cities	Jiang, BM (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	bxj4@cdc.gov	kumar, deepak/GQO-8822-2022; Betrapally, Naga/S-9710-2019	kumar, deepak/0000-0002-4535-4174; Betrapally, Naga/0000-0002-7341-4867; Magana, Laura/0000-0001-5917-8629				Alam MM, 2007, ARCH VIROL, V152, P199, DOI 10.1007/s00705-006-0831-y; Banyai K, 2017, INFECT GENET EVOL, V48, P19, DOI 10.1016/j.meegid.2016.12.002; Bhat S, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010023; BOHL EH, 1982, J CLIN MICROBIOL, V15, P312, DOI 10.1128/JCM.15.2.312-319.1982; Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002; Doan YH, 2016, INFECT GENET EVOL, V41, P160, DOI 10.1016/j.meegid.2016.03.027; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Groth D, 2016, AM ASS SWINE VET, P561; Halaihel N, 2010, EPIDEMIOL INFECT, V138, P542, DOI 10.1017/S0950268809990872; HERRING AJ, 1982, J CLIN MICROBIOL, V16, P473, DOI 10.1128/JCM.16.3.473-477.1982; Hull JJ, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01763-15; Jarvis MC, 2016, PREV VET MED, V123, P175, DOI 10.1016/j.prevetmed.2015.10.020; Jeong YJ, 2009, VET MICROBIOL, V138, P217, DOI 10.1016/j.vetmic.2009.03.024; JIANG BM, 1995, J INFECT DIS, V172, P45, DOI 10.1093/infdis/172.1.45; Joshi MS, 2019, J GEN VIROL, V100, P1055, DOI 10.1099/jgv.0.001284; Kattoor JJ, 2017, VET QUART, V37, P252, DOI 10.1080/01652176.2017.1346849; Kim YJ, 1999, J CLIN MICROBIOL, V37, P1484, DOI 10.1128/JCM.37.5.1484-1488.1999; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Martella V, 2007, VET MICROBIOL, V123, P26, DOI 10.1016/j.vetmic.2007.03.003; Marthaler D, 2014, J VIROL METHODS, V209, P30, DOI 10.1016/j.jviromet.2014.08.018; Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.14-0526, 10.3201/eid2008.140526]; Marthaler D, 2014, EMERG INFECT DIS, V20, P1195, DOI 10.3201/eid2007.140034; Marthaler D, 2013, VIROLOGY, V446, P189, DOI 10.1016/j.virol.2013.08.001; Marthaler D, 2012, VIROLOGY, V433, P85, DOI 10.1016/j.virol.2012.07.006; MATSUMOTO K, 1989, J INFECT DIS, V160, P611, DOI 10.1093/infdis/160.4.611; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Mawatari T, 2004, J VET MED SCI, V66, P887, DOI 10.1292/jvms.66.887; Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370; Molinari BLD, 2014, EMERG INFECT DIS, V20, P1019, DOI 10.3201/eid2006.130776; Montmayeur AM, 2017, J CLIN MICROBIOL, V55, P606, DOI 10.1128/JCM.02121-16; Moutelikova R, 2014, ARCH VIROL, V159, P1163, DOI 10.1007/s00705-013-1903-4; Ng TFF, 2015, J VIROL, V89, P5340, DOI 10.1128/JVI.00064-15; Niira K, 2016, INFECT GENET EVOL, V44, P106, DOI 10.1016/j.meegid.2016.06.041; Nyaga MM, 2016, INFECT GENET EVOL, V38, P1, DOI 10.1016/j.meegid.2015.11.032; Otto P, 1999, ARCH VIROL, V144, P2467, DOI 10.1007/s007050050659; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Possatti F, 2016, ARCH VIROL, V161, P1061, DOI 10.1007/s00705-016-2750-x; RODGER SM, 1975, AUST VET J, V51, P536, DOI 10.1111/j.1751-0813.1975.tb06917.x; Rota RP, 2018, J VIROL METHODS, V256, P24, DOI 10.1016/j.jviromet.2018.02.020; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Saif LJ, 1999, ADV EXP MED BIOL, V473, P47; SAIF LJ, 1980, J CLIN MICROBIOL, V12, P105, DOI 10.1128/JCM.12.1.105-111.1980; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shepherd FK, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020044; Sun D, 2017, TRANSBOUND EMERG DIS, V64, P1346, DOI 10.1111/tbed.12669; Sun XM, 2018, J VIROL, V92, DOI 10.1128/JVI.00442-18; Suzuki T, 2018, J GEN VIROL, V99, P1582, DOI 10.1099/jgv.0.001162; Suzuki T, 2017, J GEN VIROL, V98, P2647, DOI 10.1099/jgv.0.000953; Teodoroff TA, 2005, J CLIN MICROBIOL, V43, P1377, DOI 10.1128/JCM.43.3.1377-1384.2005; Theuns S, 2016, VIRUS RES, V213, P172, DOI 10.1016/j.virusres.2015.12.004; Tiku VR, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0767-8; TORRESMEDINA A, 1987, LAB ANIM SCI, V37, P167; Trovao NS, 2019, ZOONOSES PUBLIC HLTH, V66, P546, DOI 10.1111/zph.12575; TSUNEMITSU H, 1991, J CLIN MICROBIOL, V29, P2609, DOI 10.1128/JCM.29.11.2609-2613.1991; Tuanthap S, 2018, PEERJ, V6, DOI 10.7717/peerj.4724; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vlasova AN, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030048; Wakuda M, 2011, EMERG INFECT DIS, V17, P1491, DOI 10.3201/eid1708.101466; Wittum T, 1995, SWINE HLTH PRODUCTIO, P3; Xie XT, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00132; Yamamoto D, 2011, J GEN VIROL, V92, P361, DOI 10.1099/vir.0.027375-0; Yang H, 2004, VIRUS RES, V106, P15, DOI 10.1016/j.virusres.2004.05.011; Yinda CK, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey008; Zhirakovskaia E, 2016, INFECT GENET EVOL, V39, P1, DOI 10.1016/j.meegid.2016.01.001	67	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244498	10.1371/journal.pone.0244498	http://dx.doi.org/10.1371/journal.pone.0244498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373390	gold, Green Published			2022-12-27	WOS:000603612300049
J	Jiang, XL; Wang, LY; Su, XF; Zeng, WP; Xu, AX; Zheng, QJ; Xu, WX				Jiang, Xiaoli; Wang, Lingyu; Su, Xiaofeng; Zeng, Weipeng; Xu, Anxin; Zheng, Qiujin; Xu, Wenxing			Spatial heterogeneity in and distributional characteristics of rural ecological livability in China--The case of Fujian Province	PLOS ONE			English	Article							CITIES	With the outbreak of COVID-19, the importance of rural areas has been gradually highlighted, and the importance of rural ecological livability has been gradually recognized. A growing body of literature recognizes the importance of building a rural ecological livability (REL) system. It is urgent that we clarify the status quo and spatial-temporal differences in and distributional characteristics of rural ecological livability and that we carry out targeted and differentiated construction to promote rural ecological livability in post-epidemic China. This study proposes a conceptual model that incorporates various economic, social and environmental factors and develops a comprehensive multifactor (production-living-ecology) evaluation system. Using Fujian Province as an example, the entropy weight method is used to measure the REL level of 55 counties and cities, which are comprehensively evaluated from 2015 to 2019. Moran's I and Getis-Ord Gi* are used to analyze the spatial and distributional characteristics of the REL level in Fujian. The results show that the level of REL in Fujian Province has been relatively flat over the past five years, with a slight downward trend. The overall value of the rural ecological livability index in 2015 was 0.345, and its overall value in 2019 was 0.334, with an average value of 0.343. The REL of Fujian Province is spatially correlated, with high levels of livability in the southeast and low levels in the northeast. The autocorrelation in the level of ecological livability in Fujian's counties and cities continues to increase.	[Jiang, Xiaoli; Zeng, Weipeng; Xu, Anxin; Zheng, Qiujin; Xu, Wenxing] Fujian Agr & Forestry Univ, Coll Management, Fuzhou, Fujian, Peoples R China; [Wang, Lingyu] Fujian Agr & Forestry Univ, Coll Publ Management, Fuzhou, Fujian, Peoples R China; [Wang, Lingyu] Open Univ Fujian, Coll Publ Management, Fuzhou, Fujian, Peoples R China; [Su, Xiaofeng] Minjiang Univ, Newhuadu Business Sch, Fuzhou, Fujian, Peoples R China; [Zheng, Qiujin] Minjiang Univ, Coll Journalism & Commun, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Minjiang University; Minjiang University	Xu, AX; Zheng, QJ (corresponding author), Fujian Agr & Forestry Univ, Coll Management, Fuzhou, Fujian, Peoples R China.; Zheng, QJ (corresponding author), Minjiang Univ, Coll Journalism & Commun, Fuzhou, Fujian, Peoples R China.	872796767@qq.com; 569343288@qq.com			Fujian Province Social Science Research Base Major project: Fujian Province rural ecological Livability Evaluation research [FJ2019JDZ025]; Project of Yongchun Ecological Civilization Research Institute "Research on the Mobilization Mechanism of Rural Social Organizations in Yongchun County from the Perspective of Localization" [2019001]	Fujian Province Social Science Research Base Major project: Fujian Province rural ecological Livability Evaluation research; Project of Yongchun Ecological Civilization Research Institute "Research on the Mobilization Mechanism of Rural Social Organizations in Yongchun County from the Perspective of Localization"	This research was funded by the Fujian Province Social Science Research Base Major project: Fujian Province rural ecological Livability Evaluation research (No.FJ2019JDZ025), and Project of Yongchun Ecological Civilization Research Institute "Research on the Mobilization Mechanism of Rural Social Organizations in Yongchun County from the Perspective of Localization"(No. 2019001).	Anthopoulou T, 2017, J RURAL STUD, V52, P1, DOI 10.1016/j.jrurstud.2017.03.006; Badland H, 2014, SOC SCI MED, V111, P64, DOI 10.1016/j.socscimed.2014.04.003; Bonaiuto M, 2015, HABITAT INT, V45, P53, DOI 10.1016/j.habitatint.2014.06.015; Casellati A, 1997, MAKING CITIES LIVABL, P21; Ebenezer H, 2000, GARDEN CITIES TOMORR; Evans P. B., 2002, LIVABLE CITIES URBAN; Godavarthy R, 2018, J PUBLIC TRANSPORT, V21, P60, DOI 10.5038/2375-0901.21.2.4; Han R, 2020, SCI TOTAL ENVIRON, V721, DOI 10.1016/j.scitotenv.2020.137818; Hou K, 2016, POL J ENVIRON STUD, V25, P599, DOI 10.15244/pjoes/61312; Hwang C.-L., 1981, MULTIPLE ATTRIBUTE D, P58; Kao J, 2020, THESE 6 INTELLIGENCE; Lennard HL, 1997, MAKING CITIES LIVABL, P5; Liu SA, 2010, ECOL ECON, V69, P1387, DOI 10.1016/j.ecolecon.2010.03.010; Liu Y, 2014, CHINA AGR ECON REV, V6, P558, DOI 10.1108/CAER-05-2013-0076; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Newman PWG, 1999, LANDSCAPE URBAN PLAN, V44, P219, DOI 10.1016/S0169-2046(99)00009-2; Okulicz-Kozaryn A, 2013, SOC INDIC RES, V110, P433, DOI 10.1007/s11205-011-9939-x; Roche S., 2012, P GLOBAL GEOSPATIAL, P215; Sakamoto A., 2004, J GEOGR SYST, V6, P175, DOI [10.1007/s10109-004-0135-2, DOI 10.1007/S10109-004-0135-2]; Shafer CS, 2000, LANDSCAPE URBAN PLAN, V49, P163, DOI 10.1016/S0169-2046(00)00057-8; Timmer V, 2005, LIVABLE CITY VANCOUV; Wang XD, 2010, J ENVIRON MANAGE, V91, P1981, DOI 10.1016/j.jenvman.2010.05.006; Xia F, 2018, CHEMOSPHERE, V207, P218, DOI 10.1016/j.chemosphere.2018.05.090; Zabaniotou Anastasia, 2020, Glob Transit, V2, P116, DOI 10.1016/j.glt.2020.06.002; [张乃明 Zhang Naiming], 2002, [土壤与环境, Soil and environmental sciences], V11, P101; Zhou BY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010286	26	3	3	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244238	10.1371/journal.pone.0244238	http://dx.doi.org/10.1371/journal.pone.0244238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373372	Green Published, gold			2022-12-27	WOS:000603612300006
J	Villatoro, AJ; Alcoholado, C; Martin-Astorga, MD; Rico, G; Fernandez, V; Becerra, J				Villatoro, Antonio J.; Alcoholado, Cristina; Martin-Astorga, Maria del Carmen; Rico, Gustavo; Fernandez, Viviana; Becerra, Jose			Characterization of the secretory profile and exosomes of limbal stem cells in the canine species	PLOS ONE			English	Article							NICHE; EPITHELIUM; CULTURE; MATRIX; TISSUE	Limbal stem cells (LSCs) are a quiescent cell population responsible for the renewal of the corneal epithelium. Their deficiency is responsible for the conjunctivization of the cornea that is seen in different ocular pathologies, both in humans and in the canine species. The canine species represents an interesting preclinical animal model in ocular surface pathologies. However, the role of LSCs in physiological and pathological conditions in canine species is not well understood. Our objective was to characterize for the first time the soluble factors and the proteomic profile of the secretome and exosomes of canine LSCs (cLSCs). In addition, given the important role that fibroblasts play in the repair of the ocular surface, we evaluated the influence of the secretome and exosomes of cLSCs on their proliferation in vitro. Our results demonstrated a secretory profile of cLSCs with high concentrations of MCP-1, IL-8, VEGF-A, and IL-10, as well as significant production of exosomes. Regarding the proteomic profile, 646 total proteins in the secretome and 356 in exosomes were involved in different biological processes. Functionally, the cLSC secretome showed an inhibitory effect on the proliferation of fibroblasts in vitro, which the exosomes did not. These results open the door to new studies on the possible use of the cLSC secretome or some of its components to treat certain pathologies of the ocular surface in canine species.	[Villatoro, Antonio J.; Alcoholado, Cristina; Martin-Astorga, Maria del Carmen; Rico, Gustavo; Becerra, Jose] Univ Malaga, Lab Bioengn & Tissue Regenerat LABRET, Dept Cell Biol Genet & Physiol, Fac Sci,IBIMA, Malaga, Spain; [Villatoro, Antonio J.; Fernandez, Viviana] Inst Immunol Clin & Terapia Celular IMMUNESTEM, Malaga, Spain; [Alcoholado, Cristina] Biomed Res Inst Malaga IBIMA, Campus Univ Teatinos, Malaga, Spain; [Alcoholado, Cristina; Rico, Gustavo; Becerra, Jose] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Malaga, Spain; [Rico, Gustavo; Becerra, Jose] Andalusian Ctr Nanomed & Biotechnol BIONAND, Malaga, Spain	Universidad de Malaga; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Becerra, J (corresponding author), Univ Malaga, Lab Bioengn & Tissue Regenerat LABRET, Dept Cell Biol Genet & Physiol, Fac Sci,IBIMA, Malaga, Spain.; Becerra, J (corresponding author), Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Malaga, Spain.; Becerra, J (corresponding author), Andalusian Ctr Nanomed & Biotechnol BIONAND, Malaga, Spain.	becerra@uma.es	Martín Astorga, María del Carmen/AFO-2575-2022	Martín Astorga, María del Carmen/0000-0003-4784-9944; Villatoro, Antonio Jose/0000-0003-3407-0616	Spanish Network on Cell Therapy (TerCel) [RD16/0011/0022]; Contract Aljama Gestion SL-University of Malaga [8.06/5.02.5013]; Operational programme FEDER Andalucia 2014-2020 [UMA18-FEDERJA-133]; Ministry of Science, Innovation and University [PEJ2018-004785-A]	Spanish Network on Cell Therapy (TerCel); Contract Aljama Gestion SL-University of Malaga; Operational programme FEDER Andalucia 2014-2020; Ministry of Science, Innovation and University	GR was supported by the RD16/0011/0022 grant of the Spanish Network on Cell Therapy (TerCel). AV and VF were supported by the Contract Aljama Gestion SL-University of Malaga (8.06/5.02.5013). MM was supported by the UMA18-FEDERJA-133 grant of the Operational programme FEDER Andalucia 2014-2020. CA was supported by the Promotion of Youth Employment and implementation of the Youth Guarantee in R&D&I, 2018 (PEJ2018-004785-A) grant of the Ministry of Science, Innovation and University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VI National R&D&I Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions, Instituto de Salud Carlos III with assistance from the European Regional Development Fund and Regional Government of Andalusia (Junta de Andalucia, PAIDI (BIO217), provided support in the form of materials, but did not have any additional role in the study design, data Cover Letter collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmad S, 2010, J CELL PHYSIOL, V225, P15, DOI 10.1002/jcp.22251; Cuttone A, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-017-0129-1; Dua H S, 2000, Indian J Ophthalmol, V48, P83; Funderburgh JL, 2016, OCUL SURF, V14, P113, DOI 10.1016/j.jtos.2015.12.006; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Gnecchi M, 2016, METHODS MOL BIOL, V1416, P123, DOI 10.1007/978-1-4939-3584-0_7; Goldberg M F, 1982, Trans Am Ophthalmol Soc, V80, P155; Han KY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40548; Jing Z, 2012, MOL VIS, V18, P161; Joe AW, 2014, STEM CELL TRANSL MED, V3, P318, DOI 10.5966/sctm.2013-0137; Kafarnik C, 2020, STEM CELLS DEV, V29, P425, DOI 10.1089/scd.2019.0163; Keino H, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/1679197; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Leszczynska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33169-5; Li GG, 2012, INVEST OPHTH VIS SCI, V53, P5686, DOI 10.1167/iovs.12-10300; Li J, MOL VIS, V132007, P813; Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; Morita M, 2015, VET OPHTHALMOL, V18, P59, DOI 10.1111/vop.12147; Nam E, 2015, VET OPHTHALMOL, V18, P317, DOI 10.1111/vop.12241; Notara M, 2011, TISSUE ENG PT A, V17, P741, DOI [10.1089/ten.tea.2010.0343, 10.1089/ten.TEA.2010.0343]; Nowell CS, 2017, CORNEAL EPITHELIAL S; Patruno M, 2017, VET RES COMMUN, V41, P169, DOI 10.1007/s11259-017-9676-y; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Reiner AT, 2017, STEM CELL TRANSL MED, V6, P1730, DOI 10.1002/sctm.17-0055; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; Samaeekia R, 2018, INVEST OPHTH VIS SCI, V59, P5194, DOI 10.1167/iovs.18-24803; Sanchez RF, 2016, CURR EYE RES, V41, P425, DOI 10.3109/02713683.2015.1056801; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Shojaati G, 2019, STEM CELL TRANSL MED, V8, P1192, DOI 10.1002/sctm.18-0297; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; THOFT RA, 1983, INVEST OPHTH VIS SCI, V24, P1442; Torricelli AAM, 2016, EXP EYE RES, V142, P110, DOI 10.1016/j.exer.2014.09.012; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Villatoro AJ, 2019, VET IMMUNOL IMMUNOP, V208, P6, DOI 10.1016/j.vetimm.2018.12.003; Villatoro AJ, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1413-4; Villatoro AJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112264; Villatoro AJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/527926; Vlahovi K, IN VITRO CULTIVATION; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Wright B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070860; Zhou Ru, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-3	46	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244327	10.1371/journal.pone.0244327	http://dx.doi.org/10.1371/journal.pone.0244327			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373367	Green Published, gold			2022-12-27	WOS:000603612300017
J	Hernandez, SE; Dorta, R; Suero, J; Barros-Loscertales, A; Gonzalez-Mora, JL; Rubia, K				Hernandez, Sergio Elias; Dorta, Roberto; Suero, Jose; Barros-Loscertales, Alfonso; Gonzalez-Mora, Jose Luis; Rubia, Katya			Larger whole brain grey matter associated with long-term Sahaja Yoga Meditation: A detailed area by area comparison	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER; MENTAL SILENCE; CORTEX; PARCELLATION; VOLUME; CONNECTIVITY; HIPPOCAMPAL; EXTENT	Objectives Our previous study showed that long-term practitioners of Sahaja Yoga Meditation (SYM) had around 7% larger grey matter volume (GMV) in the whole brain compared with healthy controls; however, when testing individual regions, only 5 small brain areas were statistically different between groups. Under the hypothesis that those results were statistically conservative, with the same dataset, we investigated in more detail the regional differences in GMV associated with the practice of SYM, with a different statistical approach. Design Twenty-three experienced practitioners of SYM and 23 healthy non-meditators matched on age, sex and education level, were scanned using structural magnetic resonance imaging (MRI). Their GMV were extracted and compared using Voxel-Based Morphometry (VBM). Using a novel ad-hoc general linear model, statistical comparisons were made to observe if the GMV differences between meditators and controls were statistically significant. Results In the 16 lobe area subdivisions, GMV was statistically significantly different in 4 out of 16 areas: in right hemispheric temporal and frontal lobes, left frontal lobe and brainstem. In the 116 AAL area subdivisions, GMV difference was statistically significant in 11 areas. The GMV differences were statistically more significant in right hemispheric brain areas. Conclusions The study shows that long-term practice of SYM is associated with larger GMV overall, and with significant differences mainly in temporal and frontal areas of the right hemisphere and the brainstem. These neuroplastic changes may reflect emotional and attentional control mechanisms developed with SYM. On the other hand, our statistical ad-hoc method shows that there were more brain areas with statistical significance compared to the traditional methodology which we think is susceptible to conservative Type II errors.	[Hernandez, Sergio Elias] Univ La Laguna, Dept Ingn Ind, Tenerife, Spain; [Dorta, Roberto] Univ La Laguna, Dept Matemat, Estad Invest Operat, Tenerife, Spain; [Suero, Jose] Sermas, Ctr Salud Jazmin, Madrid, Spain; [Barros-Loscertales, Alfonso] Univ Jaume 1, Dept Psicol Bas Clin & Psicobiol, Castellon de La Plana, Spain; [Gonzalez-Mora, Jose Luis] Univ La Laguna, Dept Fisiol, Tenerife, Spain; [Rubia, Katya] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England	Universidad de la Laguna; Universidad de la Laguna; Universitat Jaume I; Universidad de la Laguna; University of London; King's College London	Hernandez, SE (corresponding author), Univ La Laguna, Dept Ingn Ind, Tenerife, Spain.	sehdez@ull.edu.es	Rubia, Katya/H-7497-2012; Dorta-Guerra, Roberto/F-8947-2016	Rubia, Katya/0000-0002-1410-7701; Dorta-Guerra, Roberto/0000-0002-7269-1889; Hernandez Alonso, Sergio Elias/0000-0001-5043-1341				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2010, VBM TUTORIAL; [Anonymous], 1988, J PERCEPT MOTOR SKIL; Ashburner J, 2003, LANCET NEUROL, V2, P79, DOI 10.1016/S1474-4422(03)00304-1; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2018, TRENDS COGN SCI, V22, P170, DOI 10.1016/j.tics.2017.11.005; Beauregard M, 2006, NEUROSCI LETT, V405, P186, DOI 10.1016/j.neulet.2006.06.060; Bellato A, 2020, NEUROSCI BIOBEHAV R, V108, P182, DOI 10.1016/j.neubiorev.2019.11.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boccia M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/419808; Brod G, 2016, J NEUROSCI, V36, P8103, DOI 10.1523/JNEUROSCI.0045-16.2016; Chung SC, 2012, J ALTERN COMPLEM MED, V18, P589, DOI 10.1089/acm.2011.0038; COWARD HG, 1985, J ANAL PSYCHOL, V30, P379, DOI 10.1111/j.1465-5922.1985.t01-1-00379.x; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dixon ML, 2017, PSYCHOL BULL, V143, P1033, DOI 10.1037/bul0000096; Dodich A, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1159; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Hernandez SE, 2018, NEUROSCIENCE, V371, P395, DOI 10.1016/j.neuroscience.2017.12.017; Hernandez SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150757; Fox KCR, 2014, NEUROSCI BIOBEHAV R, V43, P48, DOI 10.1016/j.neubiorev.2014.03.016; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Gonoi W, 2010, NEURORADIOLOGY, V52, P865, DOI 10.1007/s00234-009-0641-5; Harrison L.J., 2004, CLIN, V9, P479, DOI [10.1177/1359104504046155, DOI 10.1177/1359104504046155]; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hernandez SE, 2015, J ALTERN COMPLEM MED, V21, P175, DOI 10.1089/acm.2013.0450; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hung YW, 2018, HUM BRAIN MAPP, V39, P4065, DOI 10.1002/hbm.24232; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Kapogiannis D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007180; Kokodoko A, 2014, LIBR J, V139, P96; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Lorenz R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03657-3; Luders E, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00034; Luders E, 2011, NEUROIMAGE, V57, P1308, DOI 10.1016/j.neuroimage.2011.05.075; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Manocha R, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/960583; Manocha R, 2002, THORAX, V57, P110, DOI 10.1136/thorax.57.2.110; Manocha R, 2007, J CLIN PSYCHOL MED S, V14, P266, DOI 10.1007/s10880-007-9076-5; Manocha R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/350674; Marciniak R, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00017; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Morgan A., 2001, TRANSPERSONAL PSYCHO; Nakata H, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01489; Panjwani U, 1996, INDIAN J MED RES, V103, P165; Panjwani U, 2000, APPL PSYCHOPHYS BIOF, V25, P1, DOI 10.1023/A:1009523904786; Panjwani Usha, 1995, Indian Journal of Physiology and Pharmacology, V39, P111; Pavlov SV, 2015, INT J PSYCHOPHYSIOL, V95, P363, DOI 10.1016/j.ijpsycho.2015.01.002; Peelle JE, 2012, NEUROIMAGE, V60, P1503, DOI 10.1016/j.neuroimage.2011.12.086; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; RAININKO R, 1994, NEURORADIOLOGY, V36, P364, DOI 10.1007/BF00612119; Rolls ET, 2015, NEUROIMAGE, V122, P1, DOI 10.1016/j.neuroimage.2015.07.075; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2007, CHILD NEUROPSYCHOL, V13, P276, DOI 10.1080/09297040600770761; Rubia K, 2009, BIOL PSYCHOL, V82, P1, DOI 10.1016/j.biopsycho.2009.04.003; Ryman SG, 2019, HUM BRAIN MAPP, V40, P955, DOI 10.1002/hbm.24424; Sampaio-Baptista C, 2014, NEUROIMAGE, V96, P158, DOI 10.1016/j.neuroimage.2014.03.056; Sedlmeier P, 2012, PSYCHOL BULL, V138, P1139, DOI 10.1037/a0028168; Shao YH, 2015, MOL PHYS, V113, P184, DOI 10.1080/00268976.2014.952696; Singleton O, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00033; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takeda Y, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00241; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; Tang YY, 2009, P NATL ACAD SCI USA, V106, P8865, DOI 10.1073/pnas.0904031106; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Venkatraman A, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00015; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; Yang CC, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9504642	76	5	5	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0237552	10.1371/journal.pone.0237552	http://dx.doi.org/10.1371/journal.pone.0237552			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370272	Green Published, gold, Green Submitted			2022-12-27	WOS:000603611900039
J	Rath, CL; Jorgensen, NR; Wienecke, T				Rath, Charlotte Lutzhoft; Jorgensen, Niklas Rye; Wienecke, Troels			Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT PLATELET REACTIVITY; CLINICAL-OUTCOMES; CYP2C19 GENOTYPE; CARDIOVASCULAR OUTCOMES; GENETIC POLYMORPHISMS; RESISTANCE; TIME; RESPONSIVENESS	Background Antiplatelet therapy is a cornerstone of secondary stroke prevention, but the responsiveness to antiplatelet medication varies among patients. Clopidogrel is a pro-drug that requires hepatic transformation to reach its active metabolite. Single nucleotide polymorphisms (SNPs) in key enzymes or the target adenosine diphosphate (ADP) receptor on the platelet surface are believed to be involved in clopidogrel-mediated platelet inhibition and decreased antiplatelet effect with high-on-treatment platelet reactivity (HTPR). Objective This study investigated whether specific SNPs in key hepatic enzymes (CYP2C19*2, *3, *17, CYP3A4*1G, and NR1I2) or the ADP receptor (PR2Y12) are associated with HTPR to clopidogrel. Patients & methods This observational study included patients with ischemic stroke (IS) and transient ischemic attacks (TIAs) receiving clopidogrel at a dose of 75 mg/day. Patients were genotyped for eight different SNPs in the genes encoding CYP2C19, CYP3A4, NR1I2, and the P2Y12 receptor. Results Of the 103 patients that were included, 30.7% carried the CYP2C19*2 allele and had higher platelet reaction unit (PRU) values than non-carriers, but no patients showed HTPR. Carriers of the *17 allele had higher platelet inhibition but showed no difference in PRU values compared with non-carriers. The remaining SNPs were neither associated with PRU nor with platelet inhibition. Conclusions Patients with IS and TIAs treated with 75 mg clopidogrel/day do not have HTPR. A genetic analysis of CYP2C19*2, *3, *17, CYP3A4*1G, and NR1I2 revealed no associations with clopidogrel HTPR. CYP2C19*2 carriers and patients with HTPR in the acute phase after ischemic stroke or transient ischemic attacks exhibit higher PRU values, but not long-term treatment HTPR.	[Rath, Charlotte Lutzhoft; Wienecke, Troels] Zealand Univ Hosp, Dept Neurol, Neurovasc Ctr, Roskilde, Denmark; [Jorgensen, Niklas Rye] Univ Copenhagen, Dept Clin Biochem, Rigshosp, Copenhagen, Denmark; [Jorgensen, Niklas Rye] Univ Southern Denmark, Inst Clin Res, Odense Univ Hosp, OPEN,Odense Patient Data Explorat Network, Odense, Denmark; [Wienecke, Troels] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Rath, CL (corresponding author), Zealand Univ Hosp, Dept Neurol, Neurovasc Ctr, Roskilde, Denmark.	clra@regionsjaelland.dk		Wienecke, Troels/0000-0002-5389-1105; Rath, Charlotte Lutzhoft/0000-0002-3011-0070	Novo Nordisk Foundation [NNF14OC0012727]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	T.W. Grant number NNF14OC0012727. Novo Nordisk Foundation. URL: https:// novonordiskfonden.dk/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047; Collet JP, 2011, JACC-CARDIOVASC INTE, V4, P392, DOI 10.1016/j.jcin.2011.03.002; Cui GZ, 2017, ADV CLIN EXP MED, V26, P343, DOI 10.17219/acem/63745; Fiolaki A, 2017, J NEUROL SCI, V376, P112, DOI 10.1016/j.jns.2017.03.010; Ford NF, 2016, J CLIN PHARMACOL, V56, P1474, DOI 10.1002/jcph.769; Frere C, 2009, J THROMB HAEMOST, V7, P1409, DOI 10.1111/j.1538-7836.2009.03500.x; Grau AJ, 1998, THROMB HAEMOSTASIS, V80, P298; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Han Y, 2015, CNS NEUROSCI THER, V21, P692, DOI 10.1111/cns.12426; Hochholzer W, 2014, J AM COLL CARDIOL, V64, P361, DOI 10.1016/j.jacc.2014.03.051; Jia DM, 2013, STROKE, V44, P1717, DOI 10.1161/STROKEAHA.113.000823; Li JB, 2014, HEART, V100, P41, DOI 10.1136/heartjnl-2013-304461; Lim ST, 2015, PLATELETS, V26, P402, DOI 10.3109/09537104.2015.1049139; Liu R, 2016, ACTA PHARMACOL SIN, V37, P882, DOI 10.1038/aps.2016.41; Marginean A, 2017, CLIN APPL THROMB-HEM, V23, P255, DOI 10.1177/1076029616629211; Marquardt L, 2002, STROKE, V33, P2570, DOI 10.1161/01.STR.0000034398.34938.20; Mega JL, 2011, JAMA-J AM MED ASSOC, V306, P2221, DOI 10.1001/jama.2011.1703; Pan YS, 2017, CIRCULATION, V135, P21, DOI 10.1161/CIRCULATIONAHA.116.024913; Pedersen RS, 2010, EUR J CLIN PHARMACOL, V66, P1199, DOI 10.1007/s00228-010-0864-8; Price MJ, 2011, CIRCULATION, V124, P1132, DOI 10.1161/CIRCULATIONAHA.111.029165; Raman S, 2004, J THROMB HAEMOST, V2, P2278, DOI 10.1111/j.1538-7836.2004.01046.x; Rath CL, 2018, J STROKE CEREBROVASC, V27, P2683, DOI 10.1016/j.jstrokecerebrovasdis.2018.05.027; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Scott SA, 2013, CLIN PHARMACOL THER, V94, P317, DOI 10.1038/clpt.2013.105; Siller-Matula JM, 2012, J THROMB HAEMOST, V10, P529, DOI 10.1111/j.1538-7836.2012.04639.x; Stone GW, 2013, LANCET, V382, P614, DOI 10.1016/S0140-6736(13)61170-8; Tobin WO, 2013, EUR J NEUROL, V20, P344, DOI 10.1111/j.1468-1331.2012.03861.x; Yi XY, 2017, EUR J CLIN PHARMACOL, V73, P437, DOI 10.1007/s00228-017-2198-2; Zabalza M, 2012, HEART, V98, P100, DOI 10.1136/hrt.2011.227652	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0236260	10.1371/journal.pone.0236260	http://dx.doi.org/10.1371/journal.pone.0236260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370281	Green Published, gold			2022-12-27	WOS:000603611900086
J	Stevens, JS; King, KL; Robbins-Juarez, SY; Khairallah, P; Toma, K; Verduzco, HA; Daniel, E; Douglas, D; Moses, AA; Peleg, Y; Starakiewicz, P; Li, MT; Kim, DW; Yu, K; Qian, L; Shah, VH; O'Donnell, MR; Cummings, MJ; Zucker, J; Natarajan, K; Perotte, A; Tsapepas, D; Krzysztof, K; Dube, G; Siddall, E; Shirazian, S; Nickolas, TL; Rao, MK; Barasch, JM; Valeri, AM; Radhakrishnan, J; Gharavi, AG; Husain, SA; Mohan, S				Stevens, Jacob S.; King, Kristen L.; Robbins-Juarez, Shelief Y.; Khairallah, Pascale; Toma, Katherine; Alvarado Verduzco, Hector; Daniel, Emily; Douglas, Denzil; Moses, Andrew A.; Peleg, Yonatan; Starakiewicz, Piotr; Li, Miah T.; Kim, Daniel W.; Yu, Kathleen; Qian, Long; Shah, Vaqar H.; O'Donnell, Max R.; Cummings, Matthew J.; Zucker, Jason; Natarajan, Karthik; Perotte, Adler; Tsapepas, Demetra; Krzysztof, Kiryluk; Dube, Geoffrey; Siddall, Eric; Shirazian, Shayan; Nickolas, Thomas L.; Rao, Maya K.; Barasch, Jonathan M.; Valeri, Anthony M.; Radhakrishnan, Jai; Gharavi, Ali G.; Husain, S. Ali; Mohan, Sumit			High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; NEW-YORK-CITY; OUTCOMES	Introduction A large proportion of patients with COVID-19 develop acute kidney injury (AKI). While the most severe of these cases require renal replacement therapy (RRT), little is known about their clinical course. Methods We describe the clinical characteristics of COVID-19 patients in the ICU with AKI requiring RRT at an academic medical center in New York City and followed patients for outcomes of death and renal recovery using time-to-event analyses. Results Our cohort of 115 patients represented 23% of all ICU admissions at our center, with a peak prevalence of 29%. Patients were followed for a median of 29 days (2542 total patient-RRT-days; median 54 days for survivors). Mechanical ventilation and vasopressor use were common (99% and 84%, respectively), and the median Sequential Organ Function Assessment (SOFA) score was 14. By the end of follow-up 51% died, 41% recovered kidney function (84% of survivors), and 8% still needed RRT (survival probability at 60 days: 0.46 [95% CI: 0.36-0.56])). In an adjusted Cox model, coronary artery disease and chronic obstructive pulmonary disease were associated with increased mortality (HRs: 3.99 [95% CI 1.46-10.90] and 3.10 [95% CI 1.25-7.66]) as were angiotensin-converting-enzyme inhibitors (HR 2.33 [95% CI 1.21-4.47]) and a SOFA score >15 (HR 3.46 [95% CI 1.65-7.25). Conclusions and relevance Our analysis demonstrates the high prevalence of AKI requiring RRT among critically ill patients with COVID-19 and is associated with a high mortality, however, the rate of renal recovery is high among survivors and should inform shared-decision making.	[Stevens, Jacob S.; King, Kristen L.; Robbins-Juarez, Shelief Y.; Khairallah, Pascale; Toma, Katherine; Alvarado Verduzco, Hector; Daniel, Emily; Douglas, Denzil; Moses, Andrew A.; Peleg, Yonatan; Starakiewicz, Piotr; Li, Miah T.; Kim, Daniel W.; Shah, Vaqar H.; Krzysztof, Kiryluk; Dube, Geoffrey; Siddall, Eric; Shirazian, Shayan; Nickolas, Thomas L.; Rao, Maya K.; Barasch, Jonathan M.; Valeri, Anthony M.; Radhakrishnan, Jai; Gharavi, Ali G.; Husain, S. Ali; Mohan, Sumit] Columbia Univ, Dept Med, Div Nephrol, Irving Med Ctr, New York, NY 10027 USA; [Stevens, Jacob S.; King, Kristen L.; Li, Miah T.; Kim, Daniel W.; Yu, Kathleen; Qian, Long; Radhakrishnan, Jai; Husain, S. Ali; Mohan, Sumit] Columbia Univ, Renal Epidemiol Grp, New York, NY 10027 USA; [Stevens, Jacob S.; Robbins-Juarez, Shelief Y.; Yu, Kathleen; Qian, Long; Krzysztof, Kiryluk; Dube, Geoffrey; Siddall, Eric; Shirazian, Shayan; Nickolas, Thomas L.; Rao, Maya K.; Barasch, Jonathan M.; Valeri, Anthony M.; Radhakrishnan, Jai; Gharavi, Ali G.; Husain, S. Ali; Mohan, Sumit] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [O'Donnell, Max R.; Cummings, Matthew J.] Columbia Univ, Dept Med, Irving Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY USA; [O'Donnell, Max R.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Zucker, Jason] Columbia Univ, Dept Med, Irving Med Ctr, Div Infect Dis, New York, NY USA; [Natarajan, Karthik; Perotte, Adler] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Tsapepas, Demetra] New York Presbyterian Hosp, Dept Pharm, New York, NY USA; [Tsapepas, Demetra] New York Presbyterian Hosp, Dept Qual, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital	Stevens, JS (corresponding author), Columbia Univ, Dept Med, Div Nephrol, Irving Med Ctr, New York, NY 10027 USA.; Stevens, JS (corresponding author), Columbia Univ, Renal Epidemiol Grp, New York, NY 10027 USA.; Stevens, JS (corresponding author), Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA.	jss2275@cumc.columbia.edu	Zucker, Jason/H-7241-2019; Mohan, Sumit/I-5625-2019	Zucker, Jason/0000-0001-6987-6412; Mohan, Sumit/0000-0002-5305-9685; Yu, Kathleen/0000-0001-5015-4110; Alvarado Verduzco, Hector/0000-0002-9625-8422; Kim, Daniel/0000-0003-0968-4456; Stevens, Jacob/0000-0001-9614-1673; Moses, Andrew/0000-0002-7682-4562; Peleg, Yonatan/0000-0003-3569-1270	Columbia Precision Medicine Pilot Award; Renal Research Institute; National Center for Advancing Translational Sciences [KL2 TR001874]; NIDDK [R01-DK114893, R01-MD014161, U01-DK116066];  [1U54DK104309];  [2R01DK073462];  [UG3 DK114926]	Columbia Precision Medicine Pilot Award; Renal Research Institute; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; ; 	JB is supported by 1U54DK104309, 2R01DK073462, UG3 DK114926, and a Columbia Precision Medicine Pilot Award. AGG is supported by a research grant from the Renal Research Institute. SAH is supported by the National Center for Advancing Translational Sciences (KL2 TR001874). SM is supported by NIDDK grants R01-DK114893, R01-MD014161 and U01-DK116066.	Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Argenziano Michael G, 2020, medRxiv, DOI 10.1101/2020.04.20.20072116; Barbar SD, 2018, NEW ENGL J MED, V379, P1431, DOI 10.1056/NEJMoa1803213; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Cerda J, 2017, KIDNEY INT REP, V2, P530, DOI 10.1016/j.ekir.2017.04.009; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Chung MK, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102907; Cooke CR, 2008, CRIT CARE MED, V36, P1412, DOI 10.1097/CCM.0b013e318170a375; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Darmon M, 2014, CLIN J AM SOC NEPHRO, V9, P1347, DOI 10.2215/CJN.08300813; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Kalra A, 2020, CIRC-CARDIOVASC QUAL, V13, DOI 10.1161/CIRCOUTCOMES.120.007115; Kher V, 2017, KIDNEY INT REP, V2, P544, DOI 10.1016/j.ekir.2017.03.015; Liu KD, 2007, CRIT CARE MED, V35, P2755, DOI 10.1097/01.CCM.0000291649.72238.6D; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Mohan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083447; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Robbins-Juarez SY, 2020, KIDNEY INT REP, V5, P1149, DOI 10.1016/j.ekir.2020.06.013; Vaduganathan M, 2020, NEW ENGL J MED, V382, P1653, DOI 10.1056/NEJMsr2005760; Vasilevskis EE, 2016, CRIT CARE MED, V44, P138, DOI 10.1097/CCM.0000000000001375; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zarbock A, 2016, JAMA-J AM MED ASSOC, V315, P2190, DOI 10.1001/jama.2016.5828	33	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244131	10.1371/journal.pone.0244131	http://dx.doi.org/10.1371/journal.pone.0244131			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370368	gold, Green Published			2022-12-27	WOS:000603611900103
J	Berry, DA; Berry, S; Hale, P; Isakov, L; Lo, AW; Siah, KW; Wong, CH				Berry, Donald A.; Berry, Scott; Hale, Peter; Isakov, Leah; Lo, Andrew W.; Siah, Kien Wei; Wong, Chi Heem			A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates	PLOS ONE			English	Article								We compare and contrast the expected duration and number of infections and deaths averted among several designs for clinical trials of COVID-19 vaccine candidates, including traditional and adaptive randomized clinical trials and human challenge trials. Using epidemiological models calibrated to the current pandemic, we simulate the time course of each clinical trial design for 756 unique combinations of parameters, allowing us to determine which trial design is most effective for a given scenario. A human challenge trial provides maximal net benefits-averting an additional 1.1M infections and 8,000 deaths in the U.S. compared to the next best clinical trial design-if its set-up time is short or the pandemic spreads slowly. In most of the other cases, an adaptive trial provides greater net benefits.	[Berry, Donald A.] Univ Texas Houston, Dept Biostat, Houston, TX USA; [Berry, Donald A.; Berry, Scott] Berry Consultants, Austin, TX USA; [Hale, Peter] Fdn Vaccine Res, Washington, DC USA; [Isakov, Leah] Seqirus, Cambridge, MA USA; [Lo, Andrew W.] MIT Sloan Sch Management, Cambridge, MA 02142 USA; [Lo, Andrew W.; Siah, Kien Wei; Wong, Chi Heem] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	University of Texas System; University of Texas Health Science Center Houston; CSL; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Lo, AW (corresponding author), MIT Sloan Sch Management, Cambridge, MA 02142 USA.; Lo, AW (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	alo-admin@mit.edu	Siah, Kien Wei/AAD-9134-2022	/0000-0002-7837-7030; /0000-0003-2944-7773; /0000-0002-4899-5022	MIT Laboratory for Financial Engineering	MIT Laboratory for Financial Engineering	L.I. is an employee of the biotech company Seqirus, and D.A.B. and S.B are employees of Berry Consultants. These companies did not have any role in study design, data collection and analysis, decision to publish, or preparation of this manuscript. The specific roles of these authors are specified in the 'author contributions' section. Funding support from the MIT Laboratory for Financial Engineering is gratefully acknowledged, but no direct funding was received for this study.	Abutaleb Y., 2020, WASH POST; [Anonymous], 2020, BUSINESS WIRE; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bambery B, 2016, PUBLIC HEALTH ETH-UK, V9, P92, DOI 10.1093/phe/phv026; Bentham Jeremy, 2001, FRAGMENT GOVT; Burton TM, 2020, WALL STREET J; Center for Systems Science and Engineering (CSSE), 2020, COVID 19 DAT RESP CT; Chaudhuri SE, 2018, DRUG DISCOV TODAY, V23, P395, DOI 10.1016/j.drudis.2017.09.016; Cochrane J, 2020, SIR MODEL BEHAV; COVID-19 Provisional Counts, 2020, COVID 19 PROV COUNTS; Deming ME, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2020076; Deutsch J., 2020, POLITICO; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Eyal N, 2020, J INFECT DIS, V221, P1752, DOI 10.1093/infdis/jiaa152; Fernandez-Villaverde J, 2020, ESTIMATING SIMULATIN; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta S, 2020, SAUDI J MED MED SCI, V8, P146, DOI 10.4103/sjmms.sjmms_38_19; Hopkins JS, 2020, CORONAVIRUS RES COMP; Isakov L, 2019, J ECONOMETRICS, V211, P117, DOI 10.1016/j.jeconom.2018.12.009; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jamrozik E, 2020, LANCET INFECT DIS, V20, pE198, DOI 10.1016/S1473-3099(20)30438-2; Jennison C, 1997, J AM STAT ASSOC, V92, P1330; Keown A, 2020, OPERATION WARP SPEED; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; Miller FG, 2001, CLIN INFECT DIS, V33, P1028, DOI 10.1086/322664; Moderna, 2020, COVE STUD PART MAK W; Montazerhodjat V, 2017, JAMA ONCOL, V3, DOI 10.1001/jamaoncol.2017.0123; Nauta J., 2020, STAT CLIN OBSERVATIO, V2nd; Newall AT, 2018, INFLUENZA OTHER RESP, V12, P211, DOI 10.1111/irv.12510; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pfizer, 2020, 2 CIT BRAZ HOST LAT; Plotkin SA, 2020, VACCINE, V38, P3987, DOI 10.1016/j.vaccine.2020.04.039; Ray D., 2020, DATA SCI REV, V2020, P1, DOI [DOI 10.1162/99608F92.60E08ED5, 10.1162/99608f92.60e08ed5, DOI 10.1101/2020.04.15.20067256]; Raymond M, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3844-z; Sarah O, 2020, WHITE HOUSE PRESSURE; Shah SK, 2020, SCIENCE, V368, P832, DOI 10.1126/science.abc1076; Sherman AC, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00107; Shirley Debbie-Ann T, 2011, Vaccine (Auckl), V2011, P3; Stanisic DI, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00479-17; Steenhuysen J, 2020, US MAKE CORONAVIRUS; Taylor NP, 2020, ASTRAZENECAS COVID 1; WHO, 2021, INT RAND TRIAL CAND; Wong C.H., 2020, HARVARD DATA SCI REV; World Health Organization, 2020, KEY CRIT ETH ACC COV, P1; World Health Organization, 2020, FEAS POT VAL LIM EST; Yan W, 2015, CHALLENGE ACCEPTED H	48	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244418	10.1371/journal.pone.0244418	http://dx.doi.org/10.1371/journal.pone.0244418			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362278	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071600040
J	Kobayashi, H; Whitehead, H; Amano, M				Kobayashi, Hayao; Whitehead, Hal; Amano, Masao			Long-term associations among male sperm whales (Physeter macrocephalus)	PLOS ONE			English	Article							SOCIAL-STRUCTURE; BEHAVIOR; AGGREGATIONS; COOPERATION; SELECTION; UNITS	Little is known about the social structure of male sperm whales (Physeter macrocephalus) after they leave their natal units. While previous studies found no evidence for preferred associations among males, the observation of mass-strandings consisting exclusively of males, suggest that they have strong social bonds. To investigate the social associations among male sperm whales, we used half weight index of association, permutation tests and standardized lagged association rate models on a large photo-identification database collected between 2006 and 2017 in Nemuro Strait, Japan. Our results suggest that while male sperm whales are not as social as females, they do form long term associations, have preferred companionship, and forage in social proximity to each other. The best-fitting model to the standardized lagged association rate showed that associations among males last for at least 2.7 years and as most males leave the area after 2 years, associations may last for longer. Twenty dyads were observed associating over more than 2 years, for a maximum 5 years. One dyad was observed associating on 19 different days and clustered on 7 different days. Male associations may function to enhance foraging or to fend off predators. Such relationships seem to be adapted to a pelagic habitat with uncertain resource availability and predation pressure.	[Kobayashi, Hayao; Amano, Masao] Nagasaki Univ, Grad Sch Fisheries & Environm Sci, Nagasaki, Japan; [Whitehead, Hal] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Nagasaki University; Dalhousie University	Kobayashi, H (corresponding author), Nagasaki Univ, Grad Sch Fisheries & Environm Sci, Nagasaki, Japan.	physeter0809@gmail.com		Kobayashi, Hayao/0000-0002-2201-7669; Amano, Masao/0000-0001-9495-5315	JSPS KAKENHI [JP18570010, JP21540020, JP24370012]; Inter College Nemuro Scholarship 2017 (Hokkaido Government Nemuro Sub-prefectural Bureau)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Inter College Nemuro Scholarship 2017 (Hokkaido Government Nemuro Sub-prefectural Bureau)	This study was supported by JSPS KAKENHI Grant Numbers JP18570010, JP21540020, and JP24370012 (MA from Japan Society for the Promotion of Science), and Inter College Nemuro Scholarship 2017 (MA from Hokkaido Government Nemuro Sub-prefectural Bureau). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnbom T., 1987, International Whaling Commission Report of the Commission, P201; Autenrieth M, 2018, MAMM BIOL, V88, P156, DOI 10.1016/j.mambio.2017.09.003; Best P.B., 1979, Behavior of Marine Animals, V3, P227; Best P.B., 1984, Reports of the International Whaling Commission Special Issue, P51; Best P. B., 1983, REPORTS IWC, V5, P41; Bond J, 1999, THESIS; Caldwell KD, 1966, WHALES DOLPHINS PORP, P677; Cantor M, 2015, MAR MAMMAL SCI, V31, P1275, DOI 10.1111/mms.12218; CARO TM, 1987, ETHOLOGY, V74, P52; Chiyo PI, 2011, ANIM BEHAV, V81, P1093, DOI 10.1016/j.anbehav.2011.02.013; Christal J, 1998, CAN J ZOOL, V76, P1431, DOI 10.1139/cjz-76-8-1431; Christal J, 2001, ETHOLOGY, V107, P323, DOI 10.1046/j.1439-0310.2001.00666.x; Christal J, 1997, MAR MAMMAL SCI, V13, P59, DOI 10.1111/j.1748-7692.1997.tb00612.x; CLUTTONBROCK TH, 1989, PROC R SOC SER B-BIO, V236, P339, DOI 10.1098/rspb.1989.0027; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Cure C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01579; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; GASKIN D E, 1970, New Zealand Journal of Marine and Freshwater Research, V4, P456; Gero S, 2015, ANIM BEHAV, V102, P15, DOI 10.1016/j.anbehav.2015.01.008; Gero S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1113; Gillespie Douglas, 1997, Report of the International Whaling Commission, V47, P897; Gordon J.C.D., 1987, International Whaling Commission Report of the Commission, P205; Hammond PS, REP INT WHAL COMM, V12, P440; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Jaquet N, 2000, CAN J ZOOL, V78, P407, DOI 10.1139/cjz-78-3-407; Kasuya Toshio, 1999, Journal of Cetacean Research and Management, V1, P109; Kobayashi H, 2020, MAR MAMMAL SCI, V36, P612, DOI 10.1111/mms.12662; Konrad CM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180914; Leaper Russell, 1998, Report of the International Whaling Commission, V48, P431; Lettevall E, 2002, CAN J ZOOL, V80, P1189, DOI 10.1139/Z02-102; Madsen PT, 2002, J EXP BIOL, V205, P1899; Madsen PT, 2000, J ACOUST SOC AM, V107, P668, DOI 10.1121/1.428568; Madsen PT, 2002, THESIS; Mitani JC, 2000, ANIM BEHAV, V59, P885, DOI 10.1006/anbe.1999.1389; Ohsumi S, 1971, SCI REPORTS WHALE RE, V23, P1; PACKER C, 1982, NATURE, V296, P740, DOI 10.1038/296740a0; Rice D.W., 1989, P177; Schnitzler JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29186-z; SERGEANT D E, 1982, Scientific Reports of the Whales Research Institute Tokyo, P1; VANHOOFF JARAM, 1994, BEHAVIOUR, V130, P309, DOI 10.1163/156853994X00587; Wahlberg M, 2002, J EXP MAR BIOL ECOL, V281, P53, DOI 10.1016/S0022-0981(02)00411-2; Weilgart L, 1996, AM SCI, V84, P278; Wessel Paul, 2013, Eos, Transactions American Geophysical Union, V94, P409, DOI 10.1002/2013EO450001; Whitehead H, 2000, CETACEAN SOCIETIES, P154; WHITEHEAD H, 1991, BEHAVIOUR, V118, P275, DOI 10.1163/156853991X00328; WHITEHEAD H, 1992, CAN J ZOOL, V70, P912, DOI 10.1139/z92-130; Whitehead H, 2001, ECOLOGY, V82, P1417, DOI 10.1890/0012-9658(2001)082[1417:AOAMUO]2.0.CO;2; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H., 2003, SPERM WHALES SOCIAL; Whitehead H., 1986, REPORTS INT WHALING, V8, P149; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2012, INT J PRIMATOL, V33, P1142, DOI 10.1007/s10764-012-9598-z; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y	55	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244204	10.1371/journal.pone.0244204	http://dx.doi.org/10.1371/journal.pone.0244204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362216	gold, Green Published			2022-12-27	WOS:000603071600024
J	Hammond, MM; Shen, CY; Li, SI; Kazi, DS; Sabe, MA; Garan, AR; Markson, LJ; Manning, WJ; Klein, AL; Nagueh, SF; Strom, JB				Hammond, Michael M.; Shen, Changyu; Li, Stephanie; Kazi, Dhruv S.; Sabe, Marwa A.; Garan, A. Reshad; Markson, Lawrence J.; Manning, Warren J.; Klein, Allan L.; Nagueh, Sherif F.; Strom, Jordan B.			Retrospective evaluation of echocardiographic variables for prediction of heart failure hospitalization in heart failure with preserved versus reduced ejection fraction: A single center experience	PLOS ONE			English	Article							END-DIASTOLIC PRESSURE; LEFT ATRIAL FUNCTION; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; MORTALITY; DISEASE; MODELS	Background Limited data exist on the differential ability of variables on transthoracic echocardiogram (TTE) to predict heart failure (HF) readmission across the spectrum of left ventricular (LV) systolic function. Methods We linked 15 years of TTE report data (1/6/2003-5/3/2018) at Beth Israel Deaconess Medical Center to complete Medicare claims. In those with recent HF, we evaluated the relationship between variables on baseline TTE and HF readmission, stratified by LVEF. Results After excluding TTEs with uninterpretable diastology, 5,900 individuals (mean age: 76.9 years; 49.1% female) were included, of which 2545 individuals (41.6%) were admitted for HF. Diastolic variables augmented prediction compared to demographics, comorbidities, and echocardiographic structural variables (p < 0.001), though discrimination was modest (c-statistic = 0.63). LV dimensions and eccentric hypertrophy predicted HF in HF with reduced (HFrEF) but not preserved (HFpEF) systolic function, whereas LV wall thickness, NT-proBNP, pulmonary vein D- and Ar-wave velocities, and atrial dimensions predicted HF in HFpEF but not HFrEF (all interaction p < 0.10). Prediction of HF readmission was not different in HFpEF and HFrEF (p = 0.93). Conclusions In this single-center echocardiographic study linked to Medicare claims, left ventricular dimensions and eccentric hypertrophy predicted HF readmission in HFrEF but not HFpEF and left ventricular wall thickness predicted HF readmission in HFpEF but not HFrEF. Regardless of LVEF, diastolic variables augmented prediction of HF readmission compared to echocardiographic structural variables, demographics, and comorbidities alone. The additional role of medication adherence, readmission history, and functional status in differential prediction of HF readmission by LVEF category should be considered for future study.	[Hammond, Michael M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Shen, Changyu; Kazi, Dhruv S.; Strom, Jordan B.] Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Div Cardiovasc Med, Boston, MA 02215 USA; [Shen, Changyu; Kazi, Dhruv S.; Sabe, Marwa A.; Garan, A. Reshad; Manning, Warren J.; Strom, Jordan B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc Med, Boston, MA 02215 USA; [Shen, Changyu; Li, Stephanie; Kazi, Dhruv S.; Sabe, Marwa A.; Garan, A. Reshad; Markson, Lawrence J.; Manning, Warren J.; Strom, Jordan B.] Harvard Med Sch, Boston, MA 02115 USA; [Li, Stephanie] Beth Israel Deaconess Med Ctr, Ctr Healthcare Delivery Sci, Boston, MA 02215 USA; [Markson, Lawrence J.] Beth Israel Deaconess Med Ctr, Informat Syst, Boston, MA 02215 USA; [Manning, Warren J.] Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA 02215 USA; [Klein, Allan L.] Cleveland Clin, Lerner Coll Med, Robert & Suzanne Tomsich Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Nagueh, Sherif F.] Houston Methodist Hosp, Weill Cornell Med Coll, Dept Cardiol, Houston, TX 77030 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Case Western Reserve University; Cleveland Clinic Foundation; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Strom, JB (corresponding author), Beth Israel Deaconess Med Ctr, Richard A & Susan F Smith Ctr Outcomes Res Cardio, Div Cardiovasc Med, Boston, MA 02215 USA.; Strom, JB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc Med, Boston, MA 02215 USA.; Strom, JB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	jstrom@bidmc.harvard.edu			National, Heart, Lung, and Blood Institute [1K23HL144907]	National, Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was funded by a grant from the National, Heart, Lung, and Blood Institute (1K23HL144907; Dr Strom).	[Anonymous], 2015, CATALAN HIST REV, V8, P96; Benfari G, 2019, JACC-HEART FAIL, V7, P808, DOI 10.1016/j.jchf.2019.04.024; Dokainish H, 2011, EUR J ECHOCARDIOGR, V12, P857, DOI 10.1093/ejechocard/jer157; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fabiani I, 2019, INT J CARDIOVAS IMAG, V35, P1231, DOI 10.1007/s10554-019-01560-6; Gheorghiade M, 2013, J AM COLL CARDIOL, V61, P391, DOI 10.1016/j.jacc.2012.09.038; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Johansen ND, 2017, AM HEART J, V188, P136, DOI 10.1016/j.ahj.2017.03.013; Kundi H, 2019, INT J CARDIOL, V292, P68, DOI 10.1016/j.ijcard.2019.06.061; Kundi H, 2019, JAMA CARDIOL, V4, P16, DOI 10.1001/jamacardio.2018.4051; Kundi H, 2019, AM J CARDIOL, V123, P132, DOI 10.1016/j.amjcard.2018.09.016; Kundi H, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.005048; Kurt M, 2009, CIRC-CARDIOVASC IMAG, V2, P10, DOI 10.1161/CIRCIMAGING.108.813071; Kushwaha S, 2014, NATL TRENDS ADMISSIO; Liang HY, 2006, AM J CARDIOL, V97, P866, DOI 10.1016/j.amjcard.2005.09.136; Machino-Ohtsuka T, 2019, EUR HEART J-CARD IMG, V20, P1129, DOI 10.1093/ehjci/jez082; McMurray JJV, 2020, CIRCULATION, V141, P338, DOI 10.1161/CIRCULATIONAHA.119.044491; Meyer T, 2013, ANN INTERN MED, V158, DOI 10.7326/0003-4819-158-1-201301010-01001; Nagueh SF, 2016, J AM SOC ECHOCARDIOG, V29, P277, DOI 10.1016/j.echo.2016.01.011; Nagueh SF, 2011, CIRC-CARDIOVASC IMAG, V4, P220, DOI 10.1161/CIRCIMAGING.111.963496; Nauta JF, 2020, EUR J HEART FAIL, V22, P1147, DOI 10.1002/ejhf.1632; Omar AMS, 2016, CIRC RES, V119, P357, DOI 10.1161/CIRCRESAHA.116.309128; Ouwerkerk W, 2018, J AM COLL CARDIOL, V71, P386, DOI 10.1016/j.jacc.2017.11.041; Ouwerkerk W, 2014, JACC-HEART FAIL, V2, P429, DOI 10.1016/j.jchf.2014.04.006; Persson H, 2019, INT J CARDIOL, V274, P202, DOI 10.1016/j.ijcard.2018.06.078; Ristow B, 2010, J AM SOC ECHOCARDIOG, V23, P406, DOI 10.1016/j.echo.2010.01.019; Roger VL, 2013, J AM COLL CARDIOL, V61, P1268, DOI 10.1016/j.jacc.2013.01.011; Schwammenthal E, 2000, AM J CARDIOL, V86, P169, DOI 10.1016/S0002-9149(00)00855-9; Shah AM, 2019, J AM COLL CARDIOL, V74, P2858, DOI 10.1016/j.jacc.2019.09.063; Silbiger JJ, 2019, J AM SOC ECHOCARDIOG, V32, P216, DOI 10.1016/j.echo.2018.11.011; Stevens SM, 2009, JACC-CARDIOVASC IMAG, V2, P11, DOI 10.1016/j.jcmg.2008.08.004; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Torii Y, 2019, J AM SOC ECHOCARDIOG, V32, P1286, DOI 10.1016/j.echo.2019.06.006; Upshaw JN, 2016, CIRC-HEART FAIL, V9, DOI 10.1161/CIRCHEARTFAILURE.116.003146; Welles CC, 2012, J AM COLL CARDIOL, V59, P673, DOI 10.1016/j.jacc.2011.11.012	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244379	10.1371/journal.pone.0244379	http://dx.doi.org/10.1371/journal.pone.0244379			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351853	gold, Green Published			2022-12-27	WOS:000603071400030
J	Wang, MM; Zhang, HF; Chen, MGS; Yang, LY; Yang, YC				Wang, Mengmeng; Zhang, Huifen; Chen, Menggaoshan; Yang, Liuyan; Yang, Yichen			Dark accelerates dissolved inorganic phosphorus release of high-density cyanobacteria	PLOS ONE			English	Article							LAKE TAIHU; NUTRIENT RELEASE; EUTROPHIC LAKE; WATER; MICROCYSTIS; DECOMPOSITION; SEDIMENTS; COMMUNITY; BLOOMS; PHYTOPLANKTON	Bloom-forming cyanobacteria dramatically influence nutrient cycling in eutrophic freshwater lakes. The phosphorus (P) assimilation and release of bloom-forming cyanobacteria significantly may also affect the phosphorus source and amounts in water. To understand the phosphorus release process of bloom-forming cyanobacteria below the accumulated surface and sedimentary bloom-forming cyanobacteria, the degradation of bloom-forming cyanobacteria dominated by Microcystis spp. at different cell density in the dark was investigated over a 25-day microcosm experiment. The dissolved inorganic phosphorus (DIP) and dissolved total phosphorus (DTP) contents increased with the increment of cyanobacterial density, and the dark status markedly increased the proportion of DIP in water during the decline period of bloom-forming cyanobacteria. Meanwhile, the process of cyanobacterial apoptosis accompanied by the changes of malondialdehyde (MDA) and phosphatase (AKP) contents, and the increases of superoxide dismutase (SOD) and catalase (CAT) activities of cyanobacteria in the dark, especially in low-density groups (5.23x10(8) cells L-1), which further affect the physicochemical water parameters. Moreover, the DIP release from high-density cyanobacteria (7.86x10(7) cells L-1 similar to 5.23x10(8) cells L-1) resulted from the relative abundance of organophosphorus degrading bacteria in the dark. Therefore, the fast decay of cyanobacteria in the dark could accelerate DIP release, the high DIP release amount from accumulated bloom-cyanobacteria provide adequate P quickly for the sustained growth of cyanobacteria.	[Wang, Mengmeng; Zhang, Huifen; Chen, Menggaoshan; Yang, Liuyan] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Res Reuse, Nanjing, Peoples R China; [Yang, Yichen] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL USA	Nanjing University; State University System of Florida; University of Florida	Yang, LY (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Res Reuse, Nanjing, Peoples R China.	yangly@nju.edu.cn	liu, yang/HHY-8583-2022; yang, liu/GVU-8760-2022		National Natural Science Foundation of China [41871082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41871082). The funders played role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XL, 2009, ENVIRON POLLUT, V157, P2507, DOI 10.1016/j.envpol.2009.03.018; Balasubramanian D, 2012, ECOL ENG, V44, P111, DOI 10.1016/j.ecoleng.2012.03.002; Cao X, 2016, ENVIRON POLLUT, V219, P580, DOI 10.1016/j.envpol.2016.06.017; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chen W.M., 1996, J LAKE SCI, V3, P248; Chuai XM, 2011, ECOL ENG, V37, P842, DOI 10.1016/j.ecoleng.2011.01.001; Collen J., 2010, J PHYCOL, V35, P54; Dai Ji-cui, 2006, Huanjing Kexue, V27, P1953; Eiler A, 2004, ENVIRON MICROBIOL, V6, P1228, DOI 10.1111/j.1462-2920.2004.00657.x; Feng WY, 2016, ENVIRON SCI POLLUT R, V23, P7288, DOI 10.1007/s11356-015-5913-5; Gao G., 2000, J LAKE SCI, V12, P353; Gao L, 2013, ECOL ENG, V60, P19, DOI 10.1016/j.ecoleng.2013.07.055; He XB, 2009, ECOL ENG, V35, P570, DOI 10.1016/j.ecoleng.2008.05.010; JEWELL WJ, 1971, ENVIRON SCI TECHNOL, V5, P1023, DOI 10.1021/es60057a005; Jonna Engstrom-ost<bullet>Riitta, 2013, HYDROBIOLOGIA, V701, P25; Liu H.L., 1987, SPECIFICATION INVEST; [马喆 MA Zhe], 2007, [农业环境科学学报, Journal of Agro-environment Science], V26, P1894; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Niu Y, 2011, WATER RES, V45, P4169, DOI 10.1016/j.watres.2011.05.022; Peng Yu-Ke, 2018, Huan Jing Ke Xue, V39, P4938, DOI 10.13227/j.hjkx.201801195; Perkins RG, 2002, HYDROBIOLOGIA, V481, P75, DOI 10.1023/A:1021281019865; Qian HF, 2012, ENVIRON TOXICOL, V27, P229, DOI 10.1002/tox.20636; Qin BQ, 2007, HYDROBIOLOGIA, V581, P1, DOI 10.1007/s10750-006-0522-4; SEITZINGER SP, 1991, ESTUAR COAST SHELF S, V33, P409, DOI 10.1016/0272-7714(91)90065-J; Shi LM, 2011, ANN LIMNOL-INT J LIM, V47, P355, DOI 10.1051/limn/2011047; Strickland JDH, 1968, PRACTICAL HDB SEAWAT; Sun XiaoJing, 2007, China Environmental Science, V27, P341; Tessarolli LP, 2018, BRAZ J BIOL, V78, P108, DOI 10.1590/1519-6984.07616; Toothman BR, 2009, HYDROBIOLOGIA, V636, P401, DOI 10.1007/s10750-009-9969-4; Voros L, 2003, AQUAT BOT, V77, P99, DOI 10.1016/S0304-3770(03)00090-1; Wang HJ, 2009, PROG NAT SCI, V19, P1445, DOI 10.1016/j.pnsc.2009.03.009; Wang WJ, 2015, BIOCHEM SYST ECOL, V61, P62, DOI 10.1016/j.bse.2015.04.016; WEICH RG, 1989, J EXP MAR BIOL ECOL, V129, P33, DOI 10.1016/0022-0981(89)90061-0; Wu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101837; Wu W., 2015, EXOPOLYSACCHARIDES C; [吴馨婷 Wu Xinting], 2017, [环境科学学报, Acta Scientiae Circumstantiae], V37, P2846; Wu ZX, 2007, ENVIRON POLLUT, V147, P324, DOI 10.1016/j.envpol.2006.05.022; Xie P, 2008, HIST DEV CYANOBACTER; Yamamoto Yoko, 1993, Japanese Journal of Phycology, V41, P215; Yuanyuan W, 2008, J ENVIRON SCI-CHINA, V20, P891, DOI 10.1016/S1001-0742(08)62143-9; Zamyadi A, 2014, ENVIRON SCI-PROC IMP, V16, P313, DOI 10.1039/c3em00603d; Zhang J L, 2016, PHOSPHORUS MINERALIZ; Zhang SH, 2018, ENVIRON SCI POLLUT R, V25, P13579, DOI 10.1007/s11356-018-1517-1; Zhu GW, 2007, HYDROBIOLOGIA, V581, P53, DOI 10.1007/s10750-006-0519-z; Zhu Guangwei, 2020, Hupo Kexue, V32, P21, DOI 10.18307/2020.0103; Zhu MY, 2013, ENVIRON SCI POLLUT R, V20, P1803, DOI 10.1007/s11356-012-1084-9; Zhu YR, 2013, ENVIRON SCI TECHNOL, V47, P7679, DOI 10.1021/es305277g	49	0	1	14	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243582	10.1371/journal.pone.0243582	http://dx.doi.org/10.1371/journal.pone.0243582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351804	Green Published, gold			2022-12-27	WOS:000603071400010
J	Detering, T; Mundry, K; Berger, RG				Detering, Thorben; Mundry, Katharina; Berger, Ralf G.			Generation of 4-vinylguaiacol through a novel high-affinity ferulic acid decarboxylase to obtain smoke flavours without carcinogenic contaminants	PLOS ONE			English	Article							MECHANISM; LACCASE	Traditional smoke flavours bear the risk of containing a multitude of contaminating carcinogenic side-products. Enzymatic decarboxylation of ferulic acid released from agro-industrial side-streams by ferulic acid esterases (FAE) enables the sustainable generation of pure, food grade 4-vinylguaiacol (4-VG), the impact compound of smoke flavour. The first basidiomycetous ferulic acid decarboxylase (FAD) was isolated from Schizophyllum commune (ScoFAD) and heterologously produced by Komagataella phaffii. It showed a molecular mass of 21 kDa, catalytic optima at pH 5.5 and 35 degrees C, and a sequence identity of 63.6% to its next relative, a FAD from the ascomycete Cordyceps farinosa. The ScoFAD exhibited a high affinity to its only known substrate ferulic acid (FA) of 0.16 mmol L-1 and a turnover number of 750 s(-1). The resulting catalytic efficiency k(cat) K-M(-1) of 4,779 L s(-1) mmol(-1) exceeded the next best known enzyme by more than a factor of 50. Immobilised on AminoLink Plus Agarose, ScoFAD maintained its activity for several days. The combination with FAEs and agro-industrial side-streams paves the way for a new generation of sustainable, clean, and safe smoke flavours.	[Detering, Thorben; Mundry, Katharina; Berger, Ralf G.] Leibniz Univ Hannover, Inst Food Chem, Hannover, Lower Saxony, Germany	Leibniz University Hannover	Detering, T (corresponding author), Leibniz Univ Hannover, Inst Food Chem, Hannover, Lower Saxony, Germany.	thorben.detering@lci.uni-hannover.de			BMBF cluster Rauchenzym [031B0586]; Open Access fund of the Gottfried Wilhelm Leibniz Universitat Hannover	BMBF cluster Rauchenzym(Federal Ministry of Education & Research (BMBF)); Open Access fund of the Gottfried Wilhelm Leibniz Universitat Hannover	This research was funded the BMBF cluster Rauchenzym, grant number 031B0586. The APC was funded by the Open Access fund of the Gottfried Wilhelm Leibniz Universitat Hannover. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeboye PT, 2017, SCI REP-UK, V7, DOI 10.1038/srep42635; Behrens CJ, 2017, PROTEIN EXPRES PURIF, V137, P34, DOI 10.1016/j.pep.2017.06.014; Bhuiya MW, 2015, APPL ENVIRON MICROB, V81, P4216, DOI 10.1128/AEM.00762-15; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Ciofalo V, 2006, REGUL TOXICOL PHARM, V45, P1, DOI 10.1016/j.yrtph.2006.02.001; Ferguson KL, 2016, BIOCHEMISTRY-US, V55, P2857, DOI 10.1021/acs.biochem.6b00170; Grosse M, 2020, J AGR FOOD CHEM, V68, P10329, DOI 10.1021/acs.jafc.9b06105; Hokkanen M., 2018, J CHEM, V2018, P1; Huang HK, 2012, J IND MICROBIOL BIOT, V39, P55, DOI 10.1007/s10295-011-0998-4; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1; Kolwek J, 2018, J IND MICROBIOL BIOT, V45, P89, DOI 10.1007/s10295-017-1998-9; Li LL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01798; Lin FM, 2015, ACS CHEM BIOL, V10, P1137, DOI 10.1021/cb5008103; Lin-Cereghino J, 2005, BIOTECHNIQUES, V38, P44, DOI 10.2144/05381BM04; Linke D, 2017, FUNGAL BIOL-UK, V121, P763, DOI 10.1016/j.funbio.2017.05.006; Maeda M, 2018, J BIOSCI BIOENG, V126, P162, DOI 10.1016/j.jbiosc.2018.02.009; Matte A, 2010, ACTA CRYSTALLOGR F, V66, P1407, DOI 10.1107/S174430911003246X; Mittmann E, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10120795; Nagy EZA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36977-x; Nieter A, 2017, NEW BIOTECHNOL, V37, P153, DOI 10.1016/j.nbt.2017.01.002; Nieter A, 2016, BIORESOURCE TECHNOL, V220, P38, DOI 10.1016/j.biortech.2016.08.045; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Payer SE, 2019, ADV SYNTH CATAL, V361, P2402, DOI 10.1002/adsc.201900275; Schwarz KJ, 2012, J I BREWING, V118, P280, DOI 10.1002/jib.41; Siebert M, 2019, LWT-FOOD SCI TECHNOL, V115, DOI 10.1016/j.lwt.2019.108426; Suguitan Jr AL, 2011, PLOS ONE, V6; Thompson CA, 2010, AM J HEALTH-SYST PH, V67, P93, DOI 10.2146/news100005; Woods L., 2003, ENCY FOOD SCI NUTR, P5296, DOI [10.1016/B0-12-227055-X/01093-2, DOI 10.1016/B0-12-227055-X/01093-2]; Zhao ZH, 2008, FOOD CHEM, V109, P691, DOI 10.1016/j.foodchem.2008.02.039	30	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244290	10.1371/journal.pone.0244290	http://dx.doi.org/10.1371/journal.pone.0244290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347481	Green Published, gold			2022-12-27	WOS:000603071100040
J	Noree, C; Sirinonthanawech, N				Noree, Chalongrat; Sirinonthanawech, Naraporn			Nuclear targeted Saccharomyces cerevisiae asparagine synthetases associate with the mitotic spindle regardless of their enzymatic activity	PLOS ONE			English	Article							METABOLIC ENZYMES; CTP SYNTHASE; ASSEMBLIES; PROTEINS	Recently, human asparagine synthetase has been found to be associated with the mitotic spindle. However, this event cannot be seen in yeast because yeast takes a different cell division process via closed mitosis (there is no nuclear envelope breakdown to allow the association between any cytosolic enzyme and mitotic spindle). To find out if yeast asparagine synthetase can also (but hiddenly) have this feature, the coding sequences of green fluorescent protein (GFP) and nuclear localization signal (NLS) were introduced downstream of ASN1 and ASN2, encoding asparagine synthetases Asn1p and Asn2p, respectively, in the yeast genome having mCherrry coding sequence downstream of TUB1 encoding alpha-tubulin, a building block of the mitotic spindle. The genomically engineered yeast strains showed co-localization of Asn1p-GFP-NLS (or Asn2p-GFP-NLS) and Tub1p-mCherry in dividing nuclei. In addition, an activity-disrupted mutation was introduced to ASN1 (or ASN2). The yeast mutants still exhibited co-localization between defective asparagine synthetase and mitotic spindle, indicating that the biochemical activity of asparagine synthetase is not required for its association with the mitotic spindle. Furthermore, nocodazole treatment was used to depolymerize the mitotic spindle, resulting in lack of association between the enzyme and the mitotic spindle. Although yeast cell division undergoes closed mitosis, preventing the association of its asparagine synthetase with the mitotic spindle, however, by using yeast constructs with re-localized Asn1/2p have suggested the moonlighting role of asparagine synthetase in cell division of higher eukaryotes.	[Noree, Chalongrat; Sirinonthanawech, Naraporn] Mahidol Univ, Inst Mol Biosci, Phuttamonthon, Nakhon Pathom, Thailand	Mahidol University	Noree, C (corresponding author), Mahidol Univ, Inst Mol Biosci, Phuttamonthon, Nakhon Pathom, Thailand.	chalongrat.nor@mahidol.edu	Noree, Chalongrat/AAU-3371-2020	Noree, Chalongrat/0000-0002-7774-4281	Coordinating Center for Thai Government Science and Technology Scholarship Students (CSTS) - National Science and Technology Development Agency (NSTDA); National Research Council of Thailand (NRCT) in association with Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (MHESI); Development and Promotion of Science and Technology Talents Project (DPST); Mahidol University (MU)	Coordinating Center for Thai Government Science and Technology Scholarship Students (CSTS) - National Science and Technology Development Agency (NSTDA); National Research Council of Thailand (NRCT) in association with Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (MHESI); Development and Promotion of Science and Technology Talents Project (DPST); Mahidol University (MU)	This project was supported by (1) the Coordinating Center for Thai Government Science and Technology Scholarship Students (CSTS) -the National Science and Technology Development Agency (NSTDA), (2) the National Research Council of Thailand (NRCT) in association with Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation (MHESI), (3) the Development and Promotion of Science and Technology Talents Project (DPST), and (4) Mahidol University (MU).	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; [Anonymous], 2020, CANC DISCOV, V10, pOF8; [Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; ARONOW B, 1987, J BIOL CHEM, V262, P5106; Aughey GN, 2016, CRIT REV BIOCHEM MOL, V51, P282, DOI 10.3109/10409238.2016.1172555; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Boettcher B, 2013, NUCLEUS-PHILA, V4, P160, DOI 10.4161/nucl.24676; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Carcamo WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029690; Espinosa-Cantu A, 2018, GENETICS, V208, P419, DOI 10.1534/genetics.117.300377; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Jeffery CJ, 2017, SCI PROGRESS-UK, V100, P363, DOI 10.3184/003685017X15063357842574; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KLEINSCH.AK, 1969, SCIENCE, V166, P1276, DOI 10.1126/science.166.3910.1276; Liu JL, 2010, J GENET GENOMICS, V37, P281, DOI 10.1016/S1673-8527(09)60046-1; Lynch EM, 2020, CURR OPIN CELL BIOL, V66, P28, DOI 10.1016/j.ceb.2020.04.006; Lynch EM, 2020, NAT STRUCT MOL BIOL, V27, P42, DOI 10.1038/s41594-019-0352-5; Lynch EM, 2017, NAT STRUCT MOL BIOL, V24, P507, DOI 10.1038/nsmb.3407; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2020, BIOL OPEN, V9, DOI 10.1242/bio.051110; Noree C, 2019, MOL BIOL CELL, V30, P2721, DOI 10.1091/mbc.E19-04-0224; Noree C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36719-z; Noree C, 2018, BIOL OPEN, V7, DOI 10.1242/bio.038307; Noree C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24586-7; Noree C, 2014, MOL BIOL CELL, V25, P2282, DOI 10.1091/mbc.E14-04-0912; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; Ostrander DB, 1998, J BIOL CHEM, V273, P18992, DOI 10.1074/jbc.273.30.18992; Park CK, 2020, NAT REV MOL CELL BIO, V21, P1, DOI 10.1038/s41580-019-0188-1; Park Chad K, 2019, Biophys Rev, V11, P927, DOI 10.1007/s12551-019-00602-6; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; Richards NGJ, 1998, ADV ENZYMOL RAMB, V72, P145; Shen QJ, 2016, J GENET GENOMICS, V43, P393, DOI 10.1016/j.jgg.2016.03.008; Sun JG, 2020, J SUPERCOMPUT, V76, P4041, DOI 10.1007/s11227-017-2179-3; Webb BA, 2017, J CELL BIOL, V216, P2305, DOI 10.1083/jcb.201701084; Wilson MZ, 2013, CURR OPIN MICROBIOL, V16, P177, DOI 10.1016/j.mib.2013.03.008; Zhang SS, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007737; Zhu W, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0587-z	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243742	10.1371/journal.pone.0243742	http://dx.doi.org/10.1371/journal.pone.0243742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347445	Green Published, gold			2022-12-27	WOS:000603071100005
J	Gittins, CB; Hunt, C				Gittins, Catherine B.; Hunt, Caroline			Self-criticism and self-esteem in early adolescence: Do they predict depression?	PLOS ONE			English	Article							COMPETENCE-BASED MODEL; PERSONALITY PREDISPOSITIONS; COGNITIVE VULNERABILITY; CHILDRENS DEPRESSION; YOUNG ADULTHOOD; SYMPTOMS; STRESS; DEPENDENCY; GENDER; PREVALENCE	Beck's theory suggests that forming negative self-cognitions is a key early step in the development of depression. However, others have suggested the reverse, arguing that depression leads to development of negative self-beliefs. As such, there is debate about whether these cognitions are precursors to, or alternatively are caused by, depression. Although Beck's theory is supported in older adolescents, it has not been clearly seen in younger adolescents. This study aimed to assess the relation between two major self-cognitions (self-esteem and self-criticism) and depressive symptoms in early adolescence. Two-hundred and forty-three Australian adolescents (mean age = 12.08, 52% female) completed measures of self-esteem, self-criticism and depressive symptoms at baseline, then approximately 12- and 24-months later. Growth-curve modelling was used to assess changes in the variables. Cross-lagged analysis assessed whether either of the self-cognition variables predicted depressive symptoms, or if depressive symptoms predicted self-cognitions. Results indicated that self-criticism and depressive symptoms increased over the time period, while self-esteem decreased, and these changes were all related. Self-esteem predicted depressive symptoms from Time 2 to Time 3, while depressive symptoms predicted self-esteem from Time 1 to Time 2. Self-criticism did not predict depressive symptoms, nor did depressive symptoms predict self-criticism. These links appeared largely independent of gender. Self-esteem and depressive symptoms during the early adolescent period thus appear to have a somewhat reciprocal relation, while self-criticism does not appear to predict the development of depression. As such, while low self-esteem does appear to have an important role of in the development of depression in this age group, it is not strictly predictive, nor is this effect seen across all negative self-cognitions.	[Gittins, Catherine B.; Hunt, Caroline] Univ Sydney, Sch Psychol, Sydney, NSW, Australia; [Gittins, Catherine B.] Charles Darwin Univ, Coll Hlth & Human Sci, Darwin, NT, Australia	University of Sydney; Charles Darwin University	Gittins, CB (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW, Australia.; Gittins, CB (corresponding author), Charles Darwin Univ, Coll Hlth & Human Sci, Darwin, NT, Australia.	cgit5705@uni.sydney.edu.au			Australian Post-Graduate Award; Australian Federal Government	Australian Post-Graduate Award(Australian Government); Australian Federal Government(Australian Government)	This research was supported by an Australian Post-Graduate Award (no grant number) to CG from the Australian Federal Government. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela JRZ, 2003, J CLIN CHILD ADOLESC, V32, P408, DOI 10.1207/S15374424JCCP3203_09; ABRAMSON LY, 1989, PSYCHOL REV, V96, P358, DOI 10.1037/0033-295X.96.2.358; Adams P, 2009, PERS SOC PSYCHOL B, V35, P1440, DOI 10.1177/0146167209343811; Auerbach RP, 2014, J ABNORM CHILD PSYCH, V42, P913, DOI 10.1007/s10802-013-9845-6; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Beck A.T., 1987, J COGN PSYCHOTHER, V1, P5; Beck A.T., 1967, DEPRESSION CLIN EXPT; BENTLER PM, 1992, PSYCHOL BULL, V112, P400, DOI 10.1037/0033-2909.112.3.400; Blatt S.J., 1974, PSYCHOANALYTIC STUDY, V29, P7, DOI DOI 10.1080/00797308.1974.11822616; Burwell RA, 2006, J RES ADOLESCENCE, V16, P479, DOI 10.1111/j.1532-7795.2006.00503.x; Byrne B. M., 2016, STRUCTURAL EQUATION, V3rd, DOI [10.4324/9781315757421, DOI 10.4324/9781315757421]; Campbell JD, 1996, J PERS SOC PSYCHOL, V70, P141, DOI 10.1037/0022-3514.70.1.141; Cheung CSS, 2011, CHILD DEV, V82, P932, DOI 10.1111/j.1467-8624.2011.01582.x; Clark S, 2009, PERS INDIV DIFFER, V47, P321, DOI 10.1016/j.paid.2009.03.020; Cohen JR, 2013, J SOC CLIN PSYCHOL, V32, P596, DOI 10.1521/jscp.2013.32.6.596; COLE DA, 1991, J ABNORM PSYCHOL, V100, P181, DOI 10.1037/0021-843X.100.2.181; Cole DA, 1997, J CHILD PSYCHOL PSYC, V38, P505, DOI 10.1111/j.1469-7610.1997.tb01537.x; Coopersmith S., 1967, ANTECEDENTS SELF-EST; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; COYNE JC, 1995, PSYCHOL BULL, V118, P358, DOI 10.1037/0033-2909.118.3.358; Erikson E.H., 1963, CHILDHOOD SOC; Erikson E.H.., 1998, LIFE CYCLE COMPLETED; ERIKSON EH, 1959, PSYCHOL ISSUES, V1, pUR3; Essau CA, 2004, PREVENTION OF ANXIETY AND DEPRESSION: THEORY, RESEARCH, AND PRACTICE, P185; Ford T, 2003, J AM ACAD CHILD PSY, V42, P1203, DOI 10.1097/00004583-200310000-00011; Garber J, 1997, COGNITION EMOTION, V11, P619, DOI 10.1080/026999397379881b; Gittins CB, 2019, J ADOLESCENCE, V73, P26, DOI 10.1016/j.adolescence.2019.03.004; GrayLittle B, 1997, PERS SOC PSYCHOL B, V23, P443, DOI 10.1177/0146167297235001; Greenberger D., 1995, MIND MOOD CHANGE YOU, V1st; Greenwald, 1986, PSYCHOL PERSPECTIVES, V3; HAGBORG WJ, 1993, PSYCHOL SCHOOLS, V30, P132, DOI 10.1002/1520-6807(199304)30:2<132::AID-PITS2310300205>3.0.CO;2-Z; Hamaker EL, 2015, PSYCHOL METHODS, V20, P102, DOI 10.1037/a0038889; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Huang M, 2019, BRAIN BEHAV IMMUN, V75, P200, DOI 10.1016/j.bbi.2018.10.007; Ingram RE, 2003, COGNITIVE THER RES, V27, P77, DOI 10.1023/A:1022590730752; Jacquez F, 2004, J ABNORM CHILD PSYCH, V32, P355, DOI 10.1023/B:JACP.0000030290.68929.ef; Katz J, 2007, AM J FAM THER, V35, P447, DOI 10.1080/01926180601057630; Kline R. B., 2005, PRINCIPLES PRACTICE; Kopala-Sibley DC, 2015, PERS SOC PSYCHOL B, V41, P1094, DOI 10.1177/0146167215590985; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Kovacs M., 1992, CHILDRENS DEPRESSION; Lee A, 2009, J CLIN CHILD ADOLESC, V38, P219, DOI 10.1080/15374410802698396; LEWINSOHN PM, 1981, J ABNORM PSYCHOL, V90, P213, DOI 10.1037//0021-843X.110.2.203; Little SA, 2000, COGNITIVE THER RES, V24, P651, DOI 10.1023/A:1005535327428; Mund M, 2019, ADV LIFE COURSE RES, V41, DOI 10.1016/j.alcr.2018.10.002; Myers, 1997, FUTURIST, V31, pS1; Orth U, 2008, J PERS SOC PSYCHOL, V95, P695, DOI 10.1037/0022-3514.95.3.695; Raaijmakers QAW, 1999, EDUC PSYCHOL MEAS, V59, P725, DOI 10.1177/00131649921970116; Rieger S, 2016, J PERS SOC PSYCHOL, V110, pE16, DOI 10.1037/pspp0000037; Robins RW, 2002, PSYCHOL AGING, V17, P423, DOI 10.1037//0882-7974.17.3.423; ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350; Rudolph KD, 1999, CHILD DEV, V70, P660, DOI 10.1111/1467-8624.00048; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shahar G, 2004, COGNITIVE THER RES, V28, P85, DOI 10.1023/B:COTR.0000016932.82038.d0; Shahar G, 2003, J CONSULT CLIN PSYCH, V71, P890, DOI 10.1037/0022-006X.71.5.890; Shahar G, 2013, J PSYCHOTHER INTEGR, V23, P236, DOI 10.1037/a0031418; Shahar G, 2010, SELF IDENTITY, V9, P403, DOI 10.1080/15298860903286090; Southall D, 2002, COGNITIVE THER RES, V26, P563, DOI 10.1023/A:1020457508320; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thompson R, 2004, PERS INDIV DIFFER, V36, P419, DOI 10.1016/S0191-8869(03)00106-5; Timbremont B, 2004, J CLIN CHILD ADOLESC, V33, P149, DOI 10.1207/S15374424JCCP3301_14; Van Ouytsel J, 2019, J ADOLESCENCE, V73, P36, DOI 10.1016/j.adolescence.2019.03.008; WAGNER BM, 1990, AM J COMMUN PSYCHOL, V18, P383, DOI 10.1007/BF00938114; WIGFIELD A, 1991, DEV PSYCHOL, V27, P552, DOI 10.1037/0012-1649.27.4.552; WINCH RF, 1965, SOC FORCES, V44, P255; WITZ K, 1990, J EDUC STAT, V15, P84	67	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244182	10.1371/journal.pone.0244182	http://dx.doi.org/10.1371/journal.pone.0244182			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33339021	Green Published, gold			2022-12-27	WOS:000601313500024
J	Rayce, SB; Pontoppidan, M; Nielsen, T				Rayce, Signe Boe; Pontoppidan, Maiken; Nielsen, Tine			Concordance within parent couples' perception of parental stress symptoms among parents to 1-18-year-olds with physical or mental health problems	PLOS ONE			English	Article							CHILD-BEHAVIOR PROBLEMS; PRESCHOOL-CHILDREN; MOTHERS; FATHERS; AUTISM; FAMILIES; ADHD; ADOLESCENTS; EXPERIENCES; TRANSITION	Parents of children with physical or mental health problems are at higher risk for experiencing parental stress. However, mothers and fathers may experience parental stress differently. The aim was to examine whether mothers and fathers of children with physical and/or mental health problems are equally inclined within the couples to experience different aspects of parental stress when considering child and parent couple characteristics. Single aspects of Parental stress were assessed with nine items from the Parental Stress Scale in 197 parent couples of children aged 1-18 years with physical and/or mental health problems. Agreement within parent couples for each item was tested using two tests of marginal homogeneity for dependent data: a nominal G(2)-test and an ordinal gamma -test. Analyses were conditioned on child gender, child age, couple educational level, and overall parental stress. For seven aspects of parental stress, differences in agreement within the couples were found with at least one of the conditioning variables. For five aspects (item 3, 4, 9, 10, 13) addressing specific personal experience of daily stressors related to having children and feeling inadequate as a parent, the differences were systematic. Mothers were more inclined to experience these aspect of parental stress than fathers, specially mothers of boys, a younger child, in couples with an education above high school or with a higher stress level. Agreement was found for two aspects (item 14 and 16) of parental stress. This study suggests that mothers' and fathers' experience of most aspects of parental stress vary within the couples. Knowledge on systematic difference between parents' experience of parental stress may inform future interventions. For aspects where mothers generally experience the highest degree of stress, fathers may be involved as support. Future studies may explore the role of diagnoses, coping strategies and examine concordance in parental stress symptoms in other subgroups.	[Rayce, Signe Boe; Pontoppidan, Maiken] Danish Ctr Social Sci Res, VIVE, Dept Hlth, Copenhagen, Denmark; [Nielsen, Tine] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Nielsen, Tine] UCL Univ Coll, Appl Res Educ & Social Sci, Odense, Denmark	University of Copenhagen	Rayce, SB (corresponding author), Danish Ctr Social Sci Res, VIVE, Dept Hlth, Copenhagen, Denmark.	sbo@vive.dk	Pontoppidan, Maiken/X-2204-2019	Pontoppidan, Maiken/0000-0002-9491-3665; Nielsen, Tine/0000-0002-9087-729X	TrygFonden [121910]	TrygFonden	This study was supported by TrygFonden grant number 121910, https://www.trygfonden.dk/english.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1984, ANAL ORDINAL CATEGOR; Aldwin CM, 2018, HDB HLTH PSYCHOL, P225; Algarvio S, 2018, J CHILD HEALTH CARE, V22, P563, DOI 10.1177/1367493518764337; [Anonymous], 2019, FRONTIERS PLANT SCI; Baker BL, 2003, J INTELL DISABIL RES, V47, P217, DOI 10.1046/j.1365-2788.2003.00484.x; BAKER DB, 1994, J EMOT BEHAV DISORD, V2, P46, DOI 10.1177/106342669400200106; Barroso NE, 2018, J ABNORM CHILD PSYCH, V46, P449, DOI 10.1007/s10802-017-0313-6; Beck A, 2004, J INTELLECT DEV DIS, V29, P339, DOI 10.1080/13668250400014509; Bendixen RM, 2011, AM J OCCUP THER, V65, P679, DOI 10.5014/ajot.2011.001271; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergsma W, 2009, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-09610-0_1; BERRY JO, 1995, J SOC PERS RELAT, V12, P463, DOI 10.1177/0265407595123009; Bodenmann G, 2020, ENCY COUPLE FAM THER, DOI 10.1007/978-3-319-15877-8; Bonis S, 2016, ISSUES MENT HEALTH N, V37, P153, DOI 10.3109/01612840.2015.1116030; Brito D, 2017, DIFERENCAS SEXO ADAP, DOI 10.15689/ap.2017.1601.05; Calzada EJ, 2004, J ABNORM CHILD PSYCH, V32, P203, DOI 10.1023/B:JACP.0000019771.43161.1c; Chacko A, 2018, J ABNORM CHILD PSYCH, V46, P505, DOI 10.1007/s10802-017-0310-9; Cheung SK, 2000, PSYCHOLOGIA, V43, P253; Cousino MK, 2013, J PEDIATR PSYCHOL, V38, P809, DOI 10.1093/jpepsy/jst049; COX DR, 1977, SCAND J STAT, V4, P49; Craig L, 2006, GENDER SOC, V20, P259, DOI 10.1177/0891243205285212; Crnic K., 2017, PARENTAL STRESS EARL, P263, DOI [DOI 10.1007/978-3-319-55376-4_11, 10.1007/978-3-319-55376-4_11]; CRNIC KA, 1991, J MARRIAGE FAM, V53, P1042, DOI 10.2307/353007; Dabrowska A, 2010, J INTELL DISABIL RES, V54, P266, DOI 10.1111/j.1365-2788.2010.01258.x; Danmarks Statistik, 2018, MAEND HAR HOJ ERHV E, P2018; Darra S, 2020, CHILD YOUTH SERV REV, V116, DOI 10.1016/j.childyouth.2020.105146; Davis NO, 2008, J AUTISM DEV DISORD, V38, P1278, DOI 10.1007/s10803-007-0512-z; Deater-Deckard K., 2004, PARENTING STRESS; Deater-Deckard K., 2013, PARENTING STRESS; Deater-Deckard K, 2016, COGNITION EMOTION, V30, P444, DOI 10.1080/02699931.2015.1013087; DeaterDeckard K, 1996, J FAM PSYCHOL, V10, P45, DOI 10.1037/0893-3200.10.1.45; Defazio Giovanni, 2013, Tremor Other Hyperkinet Mov (N Y), V3, DOI 10.7916/D8QN65GQ; Dunnigan K, 2013, PHARM STAT, V12, P213, DOI 10.1002/pst.1573; Falconier MK, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00571; [方荟 Fang Hui], 2012, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V20, P835; Hastings RP, 2005, J AUTISM DEV DISORD, V35, P635, DOI 10.1007/s10803-005-0007-8; Hastings RP, 2003, J INTELL DISABIL RES, V47, P231, DOI 10.1046/j.1365-2788.2003.00485.x; Hayes SA, 2013, J AUTISM DEV DISORD, V43, P629, DOI 10.1007/s10803-012-1604-y; Johnson N, 2011, FAM SYST HEALTH, V29, P232, DOI 10.1037/a0025341; KATZ KS, 2011, MATERN CHILD HLTH J, V15, P75, DOI DOI 10.1007/S10995-011-0858-X; Kayser K, 2005, DECADE BEHAV, DOI 10.1037/11031-000; Khan S, 2014, J PAKISTAN PSYCHIAT, V13, P36; Kotila LE, 2013, FAM RELAT, V62, P795, DOI 10.1111/fare.12037; Kreiner S, 2004, COMMUN STAT-THEOR M, V33, P1239, DOI 10.1081/STA-120030148; Kreiner S., 2003, INTRO DIGRAM; Kreiner S., 2002, STAT METHODS QUALITY, P187, DOI DOI 10.1007/978-1-4757-3625-0_15; Kreiner S, 2007, STAT SOC BEHAV SC, P329, DOI 10.1007/978-0-387-49839-3_21; Leitch S, 2019, INT J QUAL STUD HEAL, V14, DOI 10.1080/17482631.2019.1690091; Lidbeck M, 2018, J REPROD INFANT PSYC, V36, P406, DOI 10.1080/02646838.2018.1468557; Lindo EJ, 2016, FAM RELAT, V65, P207, DOI 10.1111/fare.12185; Lo S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01171; McQuillan M. E., 2017, PARENTAL STRESS EARL, P75, DOI [DOI 10.1007/978-3-319-55376-4_4, 10.1007/978-3-319-55376-4_4]; McStay RL, 2014, AUTISM, V18, P502, DOI 10.1177/1362361313485163; Mueller AK, 2012, ADHD-ATTEND DEFICIT, V4, P101, DOI 10.1007/s12402-012-0085-3; Nadeem M., 2016, PAKISTAN J SOCIAL SC, V36, P1281; Neece C.L., 2017, PARENTAL STRESS EARL, P107, DOI DOI 10.1007/978-3-319-55376-4_5; Neece CL, 2012, AJIDD-AM J INTELLECT, V117, P48, DOI 10.1352/1944-7558-117.1.48; Nielsen T, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01495-w; Oelofsen N, 2006, J INTELLECT DEV DIS, V31, P1, DOI 10.1080/13668250500349367; Oronoz B, 2007, PSICOTHEMA, V19, P687; Ozturk Y, 2014, RES AUTISM SPECT DIS, V8, P1295, DOI 10.1016/j.rasd.2014.07.001; Parkes A, 2015, J FAM PSYCHOL, V29, P907, DOI 10.1037/fam0000129; Pisula E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186536; Pisula E, 2011, COMPREHENSIVE BOOK ON AUTISM SPECTRUM DISORDERS, P87; Pontoppidan M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205662; Porter N, 2019, INT J DISABIL DEV ED, V66, P249, DOI 10.1080/1034912X.2018.1439159; Putnick DL, 2010, PARENT-SCI PRACT, V10, P60, DOI 10.1080/15295190903014638; Shawler PM, 2017, FOCUS AUTISM DEV DIS, V32, P142, DOI 10.1177/1088357615610114; Skreden M, 2012, SCAND J PUBLIC HEALT, V40, P596, DOI 10.1177/1403494812460347; Solmeyer AR, 2011, INFANT BEHAV DEV, V34, P504, DOI 10.1016/j.infbeh.2011.07.006; Song CS, 2015, J PHYS THER SCI, V27, P3825, DOI 10.1589/jpts.27.3825; Steele H, 2016, CAN J BEHAV SCI, V48, P32, DOI 10.1037/cbs0000034; Stone LL, 2016, J PSYCHOPATHOL BEHAV, V38, P76, DOI 10.1007/s10862-015-9500-3; Tehee E, 2009, J APPL RES INTELLECT, V22, P34, DOI 10.1111/j.1468-3148.2008.00437.x; Theule J, 2018, J CHILD FAM STUD, V27, P2744, DOI 10.1007/s10826-018-1137-x; Theule J, 2013, J EMOT BEHAV DISORD, V21, P3, DOI 10.1177/1063426610387433; Widarsson M, 2014, SCAND J CARING SCI, V28, P689, DOI 10.1111/scs.12096; Wiener J, 2016, J ABNORM CHILD PSYCH, V44, P561, DOI 10.1007/s10802-015-0050-7; Williford AP, 2007, J ABNORM CHILD PSYCH, V35, P251, DOI 10.1007/s10802-006-9082-3; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364	80	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244212	10.1371/journal.pone.0244212	http://dx.doi.org/10.1371/journal.pone.0244212			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338059	Green Published, gold			2022-12-27	WOS:000601313500014
J	Mazoni, I; Salim, JA; de Moraes, FR; Borro, L; Neshich, G				Mazoni, Ivan; Salim, Jose Augusto; de Moraes, Fabio Rogerio; Borro, Luiz; Neshich, Goran			A comparison between internal protein nanoenvironments of alpha-helices and beta-sheets	PLOS ONE			English	Article								Secondary structure elements are generally found in almost all protein structures revealed so far. In general, there are more beta-sheets than alpha helices found inside the protein structures. For example, considering the PDB, DSSP and Stride definitions for secondary structure elements and by using the consensus among those, we found 60,727 helices in 4,376 chains identified in all-alpha structures and 129,440 helices in 7,898 chains identified in all-alpha and alpha + beta structures. For beta-sheets, we identified 837,345 strands in 184,925 beta-sheets located within 50,803 chains of all-beta structures and 1,541,961 strands in 355,431 beta-sheets located within 86,939 chains in all-beta and alpha + beta structures (data extracted on February 1, 2019). In this paper we would first like to address a full characterization of the nanoenvironment found at beta sheet locations and then compare those characteristics with the ones we already published for alpha helical secondary structure elements. For such characterization, we use here, as in our previous work about alpha helical nanoenvironments, set of STING protein structure descriptors. As in the previous work, we assume that we will be able to prove that there is a set of protein structure parameters/attributes/descriptors, which could fully describe the nanoenvironment around beta sheets and that appropriate statistically analysis will point out to significant changes in values for those parameters when compared for loci considered inside and outside defined secondary structure element. Clearly, while the univariate analysis is straightforward and intuitively understood, it is severely limited in coverage: it could be successfully applied at best in up to 25% of studied cases. The indication of the main descriptors for the specific secondary structure element (SSE) by means of the multivariate MANOVA test is the strong statistical tool for complete discrimination among the SSEs, and it revealed itself as the one with the highest coverage. The complete description of the nanoenvironment, by analogy, might be understood in terms of describing a key lock system, where all lock mini cylinders need to combine their elevation (controlled by a matching key) to open the lock. The main idea is as follows: a set of descriptors (cylinders in the key-lock example) must precisely combine their values (elevation) to form and maintain a specific secondary structure element nanoenvironment (a required condition for a key being able to open a lock).	[Mazoni, Ivan; Neshich, Goran] Embrapa Agr Informat, Computat Biol Res Grp, Campinas, SP, Brazil; [Salim, Jose Augusto] Univ Sao Paulo, Res Ctr Biodivers & Comp BIOCOMP, Polytech Sch, Sao Paulo, Brazil; [de Moraes, Fabio Rogerio] Sao Paulo State Univ Unesp, Dept Phys, Inst Biosci Languages & Exact Sci IBILCE, Ribeirao Preto, SP, Brazil; [Borro, Luiz] CPqD Fdn, IoT & AI Solut, Campinas, SP, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade Estadual Paulista	Mazoni, I (corresponding author), Embrapa Agr Informat, Computat Biol Res Grp, Campinas, SP, Brazil.	ivan.mazoni@embrapa.br		Mazoni, Ivan/0000-0002-3763-1071	Fapesp [2018/25327-6]	Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Ivan Mazoni and Goran Neshich recurved funding from Fapesp, project 2018/25327-6.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; consortium w, 2018, NUCL ACIDS RES, pgky949; Hand DJ, 1987, MULTIVARIATE ANAL VA, DOI [10.1007/978-94-009-3143-5, DOI 10.1007/978-94-009-3143-5]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Oliveira SRM, 2007, GENET MOL RES, V6, P911; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.1093/biomet/52.3-4.591; SMITH H, 1962, BIOMETRICS, V18, P22, DOI 10.2307/2527708	8	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244315	10.1371/journal.pone.0244315	http://dx.doi.org/10.1371/journal.pone.0244315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378364	gold, Green Published			2022-12-27	WOS:000605651300007
J	Arun, K; Shafeeque, CM; Sudhir, JB; Banerjee, M; Sylaja, PN				Arun, K.; Shafeeque, C. M.; Sudhir, Jayanand B.; Banerjee, Moinak; Sylaja, P. N.			Ethnic variation and the relevance of homozygous RNF 213 p.R4810.K variant in the phenotype of Indian Moya moya disease	PLOS ONE			English	Article							C.14576G-GREATER-THAN-A VARIANT; FAMILIAL OCCURRENCE; R4810K RS112735431; SUSCEPTIBILITY; ASSOCIATION; MECHANISMS; HISTORY	Background and purpose Polymorphisms in Ring Finger Protein 213 (RNF 213) gene have been detected to confer genetic susceptibility to Moya moya disease (MMD) in the East Asian population. We investigated the frequency of RNF 213 gene polymorphism and its association with MMD phenotypes in the Indian population. Materials and methods A case-control study for RNF 213 polymorphism involving 65 MMD patients, 75 parents, and 120 controls were performed. A total of 21 SNPs were screened, of which 17 SNPs were monomorphic. Allelic and genotypic frequency of all polymorphic SNPs were assessed and its association with MMD phenotypes was evaluated. Results The median age of symptom onset was 9 (range 2-17) and 37 years (range 20-58) in paediatric and adult patients respectively. A strong association was observed with RNF 213 rs112735431(p.R4810K) and MMD. Out of 65 patients with MMD, five patients carried the homozygous risk AA genotype. None of the healthy controls carried this homozygous mutation. The mutant allele was detected in MMD patients from Tamil Nadu and North eastern states of India (p = <0.0001). All the patients carrying the mutant allele had an early age of onset (p = <0.0001), higher incidence of bilateral disease (p = <0.002), positive family history (p = 0.03), higher Suzuki angiographic stage (>= 3) (p<0.0006) and recurrent neurological events (ischemic strokes and TIAs) (p = <0.009). Conclusion The homozygous rs112735431(p.R4810K) variant in RNF 213 variant not only predicts the risk for MMD but can also predict the phenotypic variants.	[Arun, K.; Sylaja, P. N.] Sree Chitra Tirunal Inst Med Sci & Technol, Comprehens Stroke Care Program, Dept Neurol, Trivandrum, Kerala, India; [Shafeeque, C. M.; Banerjee, Moinak] Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Trivandrum, Kerala, India; [Sudhir, Jayanand B.] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurosurg, Trivandrum, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Sylaja, PN (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Comprehens Stroke Care Program, Dept Neurol, Trivandrum, Kerala, India.	sylajapn@hotmail.com	Banerjee, Moinak/X-4471-2018	Shafeeque, C M/0000-0003-2795-8086	Wellcome Trust-Department of Biotechnology (DBT)/India Alliance (IA) [IA/R/16/2/502992]	Wellcome Trust-Department of Biotechnology (DBT)/India Alliance (IA)	This study was funded by Wellcome Trust-Department of Biotechnology (DBT)/India Alliance (IA) as part of Research Training Fellowship. (https://www.indiaalliance.org/) with grant number IA/R/16/2/502992 dated 28/11/2017 received by Arun K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2016, INT J STROKE, V11, P999, DOI 10.1177/1747493016662039; Basu A, 2016, P NATL ACAD SCI USA, V113, P1594, DOI 10.1073/pnas.1513197113; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Cecchi AC, 2014, STROKE, V45, P3200, DOI 10.1161/STROKEAHA.114.006244; Gratton JP, 2004, CIRC RES, V94, P1408, DOI 10.1161/01.RES.0000129178.56294.17; Guey S, 2017, EUR J HUM GENET, V25, P995, DOI 10.1038/ejhg.2017.92; Han DH, 1997, CLIN NEUROL NEUROSUR, V99, pS151; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V439, P419, DOI 10.1016/j.bbrc.2013.08.067; Hitomi T, 2013, BIOCHEM BIOPH RES CO, V438, P13, DOI 10.1016/j.bbrc.2013.07.004; Houkin K, 2001, NEUROSURG CLIN N AM, V12, P575, DOI 10.1016/S1042-3680(18)30044-5; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kaneko Y, 1998, NEUROL MED-CHIR, V38, P349, DOI 10.2176/nmc.38.349; Kim EH, 2016, J NEUROSURG, V124, P1221, DOI 10.3171/2015.4.JNS142900; Koizumi A, 2013, ENVIRON HEALTH PREV, V18, P121, DOI 10.1007/s12199-012-0299-1; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Liu JL, 2014, PROG NEUROBIOL, V115, P138, DOI 10.1016/j.pneurobio.2013.11.004; Liu WY, 2012, NEUROL MED-CHIR, V52, P299, DOI 10.2176/nmc.52.299; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Miao W, 2010, CLIN NEUROL NEUROSUR, V112, P199, DOI 10.1016/j.clineuro.2009.11.009; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mineharu Y, 2006, J NEUROL NEUROSUR PS, V77, P1025, DOI 10.1136/jnnp.2006.096040; Mineharu Y, 2013, CEREBROVASC DIS, V36, P155, DOI 10.1159/000352065; Miyatake S, 2012, NEUROLOGY, V78, P803, DOI 10.1212/WNL.0b013e318249f71f; Miyatake S, 2012, J HUM GENET, V57, P804, DOI 10.1038/jhg.2012.105; Nanba R, 2006, CHILD NERV SYST, V22, P258, DOI 10.1007/s00381-005-1230-5; Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523; Sun XS, 2016, MOL GENET GENOMICS, V291, P1193, DOI 10.1007/s00438-016-1172-5; Thomas R, 2006, TISSUE ANTIGENS, V68, P225, DOI 10.1111/j.1399-0039.2006.00652.x; Wang Y, 2020, NEUROLOGY, V94, pE678, DOI 10.1212/WNL.0000000000008901; Wu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048179; Yamauchi T, 1997, CLIN NEUROL NEUROSUR, V99, pS162; Yonekawa Y, 1997, CLIN NEUROL NEUROSUR, V99, pS58, DOI 10.1016/S0303-8467(97)00042-5	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243925	10.1371/journal.pone.0243925	http://dx.doi.org/10.1371/journal.pone.0243925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370357	gold, Green Published			2022-12-27	WOS:000603611900065
J	Boutiette, AL; Toothaker, C; Corless, B; Boukaftane, C; Howell, C				Boutiette, Amber L.; Toothaker, Cristoffer; Corless, Bailey; Boukaftane, Chouaib; Howell, Caitlin			3D printing direct to industrial roll-to-roll casting for fast prototyping of scalable microfluidic systems	PLOS ONE			English	Article							ON-A-CHIP; DEVICES; COMMERCIALIZATION; TECHNOLOGIES; TOOLS	Microfluidic technologies have enormous potential to offer breakthrough solutions across a wide range of applications. However, the rate of scale-up and commercialization of these technologies has lagged significantly behind promising breakthrough developments in the lab, due at least in part to the problems presented by transitioning from benchtop fabrication methods to mass-manufacturing. In this work, we develop and validate a method to create functional microfluidic prototype devices using 3D printed masters in an industrial-scale roll-to-roll continuous casting process. There were no significant difference in mixing performance between the roll-to-roll cast devices and the PDMS controls in fluidic mixing tests. Furthermore, the casting process provided information on the suitability of the prototype microfluidic patterns for scale-up. This work represents an important step in the realization of high-volume prototyping and manufacturing of microfluidic patterns for use across a broad range of applications.	[Boutiette, Amber L.; Toothaker, Cristoffer; Corless, Bailey; Howell, Caitlin] Univ Maine, Dept Chem & Biomed Engn, Orono, ME 04469 USA; [Boukaftane, Chouaib] Sappi North Amer Inc, Westbrook, ME USA; [Howell, Caitlin] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Howell, C (corresponding author), Univ Maine, Dept Chem & Biomed Engn, Orono, ME 04469 USA.; Howell, C (corresponding author), Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA.	Caitlin.howell@maine.edu	Howell, Caitlin/E-4274-2016	Howell, Caitlin/0000-0002-9345-6642	Sappi North America, Inc.	Sappi North America, Inc.	This work was financially supported by and conducted in collaboration with Sappi North America, Inc. The funder provided support in the form of salaries for authors CB and student support (stipend + tuition) for ALB, as well as funds for materials and supplies. The funder provided access to the industrial roll-to-roll casting equipment and employees, including CB, to run the equipment and troubleshoot. The funder did not play any role in the study design, analysis, interpretation of the data, writing of the paper, or the decision to submit for publication.	Ahn SH, 2009, ACS NANO, V3, P2304, DOI 10.1021/nn9003633; Amin R, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/2/022001; [Anonymous], 2011, ETHNICITY DISEASE, V21, p[S1, S1]; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 2016, CURR BIOL CB, V26, pR1258; Becker H, 2008, ANAL BIOANAL CHEM, V390, P89, DOI 10.1007/s00216-007-1692-2; Bragheri F, 2016, MICRO NANO TECHNOL, P310, DOI 10.1016/B978-0-323-35321-2.00016-9; Chen DL, 2005, J AM CHEM SOC, V127, P9672, DOI 10.1021/ja052279v; Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h; Convery N, 2019, MICRO NANO ENG, V2, P76, DOI 10.1016/j.mne.2019.01.003; Dixit CK, 2018, TRAC-TREND ANAL CHEM, V106, P37, DOI 10.1016/j.trac.2018.06.013; Duryodhan VS, 2017, EXP THERM FLUID SCI, V89, P119, DOI 10.1016/j.expthermflusci.2017.07.024; Esch MB, 2003, LAB CHIP, V3, P121, DOI 10.1039/b300730h; Fernandes AC, 2018, BIOTECHNOL ADV, V36, P1341, DOI 10.1016/j.biotechadv.2018.05.001; Gale BK, 2018, INVENTIONS-BASEL, V3, DOI 10.3390/inventions3030060; Gomez FA, 2013, BIOANALYSIS, V5, P1, DOI [10.4155/BIO.12.307, 10.4155/bio.12.307]; GOOD RJ, 1979, J COLLOID INTERF SCI, V71, P283, DOI 10.1016/0021-9797(79)90239-X; Hashmi A, 2014, JALA-J LAB AUTOM, V19, P488, DOI 10.1177/2211068214540156; Liedert R, 2012, LAB CHIP, V12, P333, DOI 10.1039/c1lc20782b; Macdonald NP, 2017, ANAL CHEM, V89, P3858, DOI 10.1021/acs.analchem.7b00136; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Mohammed MI, 2015, PROC TECH, V20, P54, DOI 10.1016/j.protcy.2015.07.010; Olanrewaju A, 2018, LAB CHIP, V18, DOI 10.1039/c8lc00458g; Oliveira AF, 2016, BIOTECHNOL PROGR, V32, P1372, DOI 10.1002/btpr.2350; Regan DP, 2019, BIOINTERPHASES, V14, DOI 10.1116/1.5114804; Romanov V, 2018, ANAL CHEM, V90, P10450, DOI 10.1021/acs.analchem.8b02356; Romao VC, 2017, ACS NANO, V11, P10659, DOI 10.1021/acsnano.7b06703; Shields CW, 2017, CYTOM PART B-CLIN CY, V92, P115, DOI 10.1002/cyto.b.21388; Sia SK, 2008, LAB CHIP, V8, P1982, DOI 10.1039/b817915h; Sivashankar S, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4954812; Stalder AF, 2010, COLLOID SURFACE A, V364, P72, DOI 10.1016/j.colsurfa.2010.04.040; Suh YK, 2010, MICROMACHINES-BASEL, V1, P82, DOI 10.3390/mi1030082; Taly V, 2017, METHODS MOL BIOL, V1547, P1, DOI 10.1007/978-1-4939-6734-6; Temiz Y, 2015, MICROELECTRON ENG, V132, P156, DOI 10.1016/j.mee.2014.10.013; Tsougeni K, 2019, SENSOR ACTUAT B-CHEM, V288, P171, DOI 10.1016/j.snb.2019.02.070; Velten T, 2011, MICROSYST TECHNOL, V17, P619, DOI 10.1007/s00542-010-1158-x; Vijayan S, 2019, RSC ADV, V9, P2822, DOI 10.1039/c8ra08686a; Volpatti LR, 2014, TRENDS BIOTECHNOL, V32, P347, DOI 10.1016/j.tibtech.2014.04.010; Vreeland WN, 2003, ANAL CHEM, V75, P6906, DOI 10.1021/ac034850j; Waheed S, 2016, LAB CHIP, V16, P1993, DOI 10.1039/c6lc00284f; Yazdi AA, 2016, MICROFLUID NANOFLUID, V20, DOI 10.1007/s10404-016-1715-4; Zheng LY, 2019, BIOSENS BIOELECTRON, V124, P143, DOI 10.1016/j.bios.2018.10.006	42	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244324	10.1371/journal.pone.0244324	http://dx.doi.org/10.1371/journal.pone.0244324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370381	gold, Green Published			2022-12-27	WOS:000603611900081
J	El-Solh, AA; Lawson, Y; Carter, M; El-Solh, DA; Mergenhagen, KA				El-Solh, Ali A.; Lawson, Yolanda; Carter, Michael; El-Solh, Daniel A.; Mergenhagen, Kari A.			Comparison of in-hospital mortality risk prediction models from COVID-19	PLOS ONE			English	Article							PROGNOSIS; WUHAN; AREA	Objective Our objective is to compare the predictive accuracy of four recently established outcome models of patients hospitalized with coronavirus disease 2019 (COVID-19) published between January 1(st) and May 1(st) 2020. Methods We used data obtained from the Veterans Affairs Corporate Data Warehouse (CDW) between January 1(st), 2020, and May 1(st) 2020 as an external validation cohort. The outcome measure was hospital mortality. Areas under the ROC (AUC) curves were used to evaluate discrimination of the four predictive models. The Hosmer-Lemeshow (HL) goodness-of-fit test and calibration curves assessed applicability of the models to individual cases. Results During the study period, 1634 unique patients were identified. The mean age of the study cohort was 68.8 +/- 13.4 years. Hypertension, hyperlipidemia, and heart disease were the most common comorbidities. The crude hospital mortality was 29% (95% confidence interval [CI] 0.27-0.31). Evaluation of the predictive models showed an AUC range from 0.63 (95% CI 0.60-0.66) to 0.72 (95% CI 0.69-0.74) indicating fair to poor discrimination across all models. There were no significant differences among the AUC values of the four prognostic systems. All models calibrated poorly by either overestimated or underestimated hospital mortality. Conclusions All the four prognostic models examined in this study portend high-risk bias. The performance of these scores needs to be interpreted with caution in hospitalized patients with COVID-19.	[El-Solh, Ali A.; Lawson, Yolanda; Carter, Michael; El-Solh, Daniel A.; Mergenhagen, Kari A.] VA Western New York Healthcare Syst, Buffalo, NY 14215 USA; [El-Solh, Ali A.] SUNY Buffalo, Jacobs Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, Buffalo, NY 14260 USA; [El-Solh, Ali A.] SUNY Buffalo, Sch Publ Hlth, Dept Epidemiol & Environm Hlth, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	El-Solh, AA (corresponding author), VA Western New York Healthcare Syst, Buffalo, NY 14215 USA.; El-Solh, AA (corresponding author), SUNY Buffalo, Jacobs Sch Med, Div Pulm Crit Care & Sleep Med, Dept Med, Buffalo, NY 14260 USA.; El-Solh, AA (corresponding author), SUNY Buffalo, Sch Publ Hlth, Dept Epidemiol & Environm Hlth, Buffalo, NY 14260 USA.	solh@buffalo.edu		El Solh, Ali/0000-0003-4237-8776	U.S. Department of Veterans Affairs [CX001656-01A2]	U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs, CX001656-01A2, Dr. Ali A. El-Solh.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Ambardekar AV, 2017, JACC-HEART FAIL, V5, P663, DOI 10.1016/j.jchf.2017.04.009; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; [Anonymous], 2020, BMJ-BRIT MED J, V369, pm2170, DOI 10.1136/bmj.m2170; Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Biagioli B, 2006, CRIT CARE, V10, DOI 10.1186/cc4951; Burton A, 2004, BRIT J CANCER, V91, P4, DOI 10.1038/sj.bjc.6601907; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chen RC, 2020, CHEST, V158, P97, DOI 10.1016/j.chest.2020.04.010; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Collins GS, 2015, ANN INTERN MED, V162, P735, DOI 10.7326/L15-5093-2; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Horwitz LI, 2021, J HOSP MED, V16, P90, DOI 10.12788/jhm.3552; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Margolis DJ, 2002, J CLIN EPIDEMIOL, V55, P518, DOI 10.1016/S0895-4356(01)00512-1; Mohamed MG C., 2020, MAYO CLIN P; Moons KGM, 2019, ANN INTERN MED, V170, pW1, DOI 10.7326/M18-1377; National Genomics Data Center M Partners, 2020, NUCLEIC ACIDS RES, V48, pD24; NYCDo H, 2020, COVID 19 DEATHS RAC; O M, 2015, J INTENSIVE CARE, V3, P42; Pan D, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100404; Riley RD, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m441; Riley RD, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3140; Safari S, 2016, EMERGENCY, V4, P48; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Seni GE J, 2010, J ENSEMBLE METHODS D; Shang YF, 2020, ECLINICALMEDICINE, V24, DOI 10.1016/j.eclinm.2020.100426; Shaw Richard E, 2003, J Invasive Cardiol, V15, P578; Sperrin M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1464; Vaid A, 2020, J MED INTERNET RES, V22, DOI 10.2196/24018; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wang K, 2020, CLIN INFECT DIS, V71, P2079, DOI 10.1093/cid/ciaa538; Yu CZ, 2020, AM J PREV MED, V59, P168, DOI 10.1016/j.amepre.2020.05.002; Zhang S, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03123-x	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244629	10.1371/journal.pone.0244629	http://dx.doi.org/10.1371/journal.pone.0244629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370409	Green Published, gold			2022-12-27	WOS:000603611900011
J	Frias, S; Van Hummelen, P; Meistrich, ML; Wyrobek, AJ				Frias, Sara; Van Hummelen, Paul; Meistrich, Marvin L.; Wyrobek, Andrew J.			Meiotic susceptibility for induction of sperm with chromosomal aberrations in patients receiving combination chemotherapy for Hodgkin lymphoma	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; MULTICOLOR FISH; STRUCTURAL-ABERRATIONS; TESTICULAR CANCER; CHILDHOOD-CANCER; X-IRRADIATION; ANEUPLOIDY; ABNORMALITIES; SPERMATOGENESIS; VINCRISTINE	Improvements in survival rates with gonad-sparing protocols for childhood and adolescence cancer have increased the optimism of survivors to become parents after treatment. Findings in rodents indicate that chromosomal aberrations can be induced in male germ cells by genotoxic exposures and transmitted to offspring and future generations with effects on development, fertility and health. Thus, there is a need for effective technologies to identify human sperm carrying chromosomal aberrations to assess the germ-line risks, especially for cancer survivors who have received genotoxic therapies. The time-dependent changes in the burden of sperm carrying structural chromosomal aberrations were assessed for the first time in a cancer setting, using the AM8 sperm FISH protocol which simultaneously detects abnormalities in chromosomal structure and number in sperm. Nine Hodgkin lymphoma (HL) patients provided 20 semen samples before, during, and after NOVP therapy (Novantrone, Oncovin, Velban and Prednisone) and radiation therapy that produced scattered gonadal doses from <0.05 to 0.6 Gy. Late meiosis was found to be the most sensitive to NOVP treatment for the production of sperm with chromosomal abnormalities, both in structure and number. Earlier stages of spermatogenesis were less sensitive and there was no evidence that therapy-exposed stem cells resulted in increased frequencies of sperm with abnormalities in chromosomal structure or number. This indicates that NOVP therapy may increase the risks for paternal transmission of chromosomal structural aberrations for sperm produced 32 to 45 days after a treatment with these drugs and implies that there are no excess risks for pregnancies conceived more than 6 months after this therapy. This clinical evaluation of the AM8 sperm FISH protocol indicates that it is a promising tool for assessing an individual's burden of sperm carrying chromosomal structural aberrations as well as aneuploidies after cancer therapy, with broad applications in other clinical and environmental situations that may pose aneugenic or clastogenic risks to human spermatogenesis.	[Frias, Sara; Van Hummelen, Paul; Wyrobek, Andrew J.] Lawrence Livermore Natl Lab, Hlth Effects Genet Div, Livermore, CA 94550 USA; [Frias, Sara] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Inst Nacl Pediat, Lab Citogenet, Mexico City, DF, Mexico; [Van Hummelen, Paul] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Meistrich, Marvin L.] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Wyrobek, Andrew J.] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Universidad Nacional Autonoma de Mexico; Stanford University; University of Texas System; UTMD Anderson Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Wyrobek, AJ (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.	ajwyrobek@lbl.gov		van hummelen, paul/0000-0002-4801-8600; Wyrobek, Andrew/0000-0002-5921-5298; Frias, Sara/0000-0002-3097-6368	U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; U.S. Department of Energy by the University of California Lawrence Livermore National Laboratory [W-7405-ENG-48]; NIH/NIEHS [R01 ES08075, P42ES04705]; Fogarty International Fellowship from NIH/Fogarty International Center [1F06TW2287-1]; NIEHS/DOE [Y01-ES-10203, Y01-ES-8016-5]; Consejo Nacional de Ciencia y Tecnologia (CONACYT) [FOSISSS 2011-1-162003, INP 003/2013]	U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy by the University of California Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Fogarty International Fellowship from NIH/Fogarty International Center; NIEHS/DOE; Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Work was performed in part under the auspices of the U.S. Department of Energy by the University of California, Lawrence Berkeley National Laboratory under contract DE-AC02-05CH11231 and under the auspices of the U.S. Department of Energy by the University of California Lawrence Livermore National Laboratory under contract W-7405-ENG-48. Specimen collection, processing and archiving were performed in the Meistrich laboratory with support from NIH/NIEHS R01 ES08075 and Fogarty International Fellowship 1F06TW2287-1 from NIH/Fogarty International Center. Specimen analyses and interpretation were performed in the Wyrobek laboratory at the Lawrence Livermore National Laboratory with funding from NIH/NIEHS Superfund Project P42ES04705 to AJW, NIEHS/DOE Interagency Agreement Y01-ES-10203 to AJW, and NIEHS/DOE Interagency Agreement Y01-ES-8016-5 to AJW. Dr. Frias was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT) FOSISSS 2011-1-162003 and INP 003/2013. These funding sources supported, in part, the preparation of this manuscript. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler ID, 1996, MUTAT RES-FUND MOL M, V372, P259, DOI 10.1016/S0027-5107(96)00145-5; Baumgartner A, 1999, ENVIRON MOL MUTAGEN, V33, P49, DOI 10.1002/(SICI)1098-2280(1999)33:1<49::AID-EM6>3.0.CO;2-F; BRANDRIFF B, 1985, HUM GENET, V70, P18, DOI 10.1007/BF00389451; BRANDRIFF B, 1984, HUM GENET, V66, P193, DOI 10.1007/BF00286600; Brandriff B.F., 1990, BIOL MAMMALIAN GERM, P183; BRANDRIFF BF, 1994, HUM GENET, V93, P295, DOI 10.1007/BF00212026; Brandriff BF, 1988, CYTOGENET CELL GENET, DOI [10.1159/000132500, DOI 10.1159/000132500]; Budgell GJ, 2001, CLIN ONCOL-UK, V13, P120, DOI 10.1007/s001740170096; Bujan L, 2014, FERTIL STERIL, V102, P667, DOI 10.1016/j.fertnstert.2014.06.008; CHANDLEY AC, 1991, J MED GENET, V28, P217, DOI 10.1136/jmg.28.4.217; da Cunha MF, 1982, CANCER, V15, P2459; Di Persio S, 2017, DEVELOPMENT, V144, P3430, DOI 10.1242/dev.150284; Dubey P, 2000, INT J RADIAT ONCOL, V46, P609, DOI 10.1016/S0360-3016(99)00338-7; EHLING WH, 1971, MUTAT RES, V11, P35, DOI 10.1016/0027-5107(71)90030-3; Evison BJ, 2016, MED RES REV, V36, P248, DOI 10.1002/med.21364; Frias S, 2003, CANCER RES, V63, P44; GENEROSO WM, 1984, MUTAT RES, V126, P177, DOI 10.1016/0027-5107(84)90060-5; HELLER CG, 1963, SCIENCE, V140, P184, DOI 10.1126/science.140.3563.184; LEONARD A, 1972, RADIAT RES, V50, P120, DOI 10.2307/3573473; LIANG JC, 1986, MUTAT RES, V163, P285, DOI 10.1016/0027-5107(86)90027-8; Liehr T, 2018, MOL CYTOGENET, V11, DOI 10.1186/s13039-018-0369-1; Lowe X, 1996, CHROMOSOMA, V105, P204; Lowe XR, 1998, ENVIRON MOL MUTAGEN, V31, P125, DOI 10.1002/(SICI)1098-2280(1998)31:2<125::AID-EM4>3.0.CO;2-L; LYON MF, 1964, GENET RES, V5, P448, DOI 10.1017/S0016672300034893; Marchetti F, 2004, BIOL REPROD, V70, P616, DOI 10.1095/biolreprod.103.023044; Marchetti F, 2006, HUM REPROD, V21, P888, DOI 10.1093/humrep/dei416; Marchetti F, 2001, P NATL ACAD SCI USA, V98, P3952, DOI 10.1073/pnas.061404598; Marchetti Francesco, 2005, Birth Defects Res C Embryo Today, V75, P112, DOI 10.1002/bdrc.20040; Marchetti F, 2012, ENVIRON HEALTH PERSP, V120, P229, DOI 10.1289/ehp.1103921; MARTIN RH, 1995, CANCER GENET CYTOGEN, V80, P29, DOI 10.1016/0165-4608(94)00162-5; Martinez G, 2017, FERTIL STERIL, V107, P341, DOI 10.1016/j.fertnstert.2016.10.001; Meistrich ML, 2020, ANDROLOGY-US, V8, P545, DOI 10.1111/andr.12740; Meistrich ML, 2013, FERTIL STERIL, V100, P1180, DOI 10.1016/j.fertnstert.2013.08.010; Meistrich ML, 1997, J CLIN ONCOL, V15, P3488, DOI 10.1200/JCO.1997.15.12.3488; Misell LM, 2006, J UROLOGY, V175, P242, DOI 10.1016/S0022-5347(05)00053-4; Muciaccia B, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111682; Neuhausler L, 2018, HUM GENET, V137, P365, DOI 10.1007/s00439-018-1888-x; Ramos S, 2018, ENVIRON MOL MUTAGEN, V59, P755, DOI 10.1002/em.22216; Rives N, 2017, FERTIL STERIL, V107, P580, DOI 10.1016/j.fertnstert.2016.11.015; ROBBINS WA, 1993, AM J HUM GENET, V52, P799; Robbins WA, 1995, REPROD FERT DEVELOP, V7, P799, DOI 10.1071/RD9950799; Robbins WA, 1997, NAT GENET, V16, P74, DOI 10.1038/ng0597-74; ROUSSEAUX S, 1993, HUM REPROD, V8, P903, DOI 10.1093/oxfordjournals.humrep.a138163; Salas C, 2012, ENVIRON MOL MUTAGEN, V53, P271, DOI 10.1002/em.21691; Schmid TE, 2004, HUM REPROD, V19, P1395, DOI 10.1093/humrep/deh278; SHEU CW, 1992, MUTAT RES, V280, P181, DOI 10.1016/0165-1218(92)90047-4; Signorello LB, 2012, J CLIN ONCOL, V30, P239, DOI 10.1200/JCO.2011.37.2938; Sloter ED, 2000, AM J HUM GENET, V67, P862, DOI 10.1086/303088; Sloter ED, 2007, FERTIL STERIL, V87, P1077, DOI 10.1016/j.fertnstert.2006.08.112; Tempest HG, 2008, HUM REPROD, V23, P251, DOI 10.1093/humrep/dem389; Templado C, 2013, MOL HUM REPROD, V19, P634, DOI 10.1093/molehr/gat039; Thomas NS, 2010, J MED GENET, V47, P112, DOI 10.1136/jmg.2009.069716; Thomson AB, 2002, LANCET, V360, P361, DOI 10.1016/S0140-6736(02)09606-X; VanHummelen P, 1997, AM J HUM GENET, V61, P651; VanHummelen P, 1996, HUM GENET, V98, P608; Willers H, 2004, BRIT J CANCER, V90, P1297, DOI 10.1038/sj.bjc.6601729; Witt KL, 1996, MUTAT RES-FUND MOL M, V355, P209, DOI 10.1016/0027-5107(96)00029-2; WYROBEK A, 1995, MOL REPROD DEV, V40, P259, DOI 10.1002/mrd.1080400216; Wyrobek AJ, 2006, P NATL ACAD SCI USA, V103, P9601, DOI 10.1073/pnas.0506468103; WYROBEK AJ, 1994, AM J MED GENET, V53, P1, DOI 10.1002/ajmg.1320530102; WYROBEK AJ, 1990, MOL REPROD DEV, V27, P200, DOI 10.1002/mrd.1080270304; Wyrobek AJ, 1996, MUTAT RES-FUND MOL M, V352, P173, DOI 10.1016/0027-5107(95)00249-9; Wyrobek AJ, 2007, ENVIRON MOL MUTAGEN, V48, P71, DOI 10.1002/em.20284	63	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242218	10.1371/journal.pone.0242218	http://dx.doi.org/10.1371/journal.pone.0242218			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370316	Green Published, gold			2022-12-27	WOS:000603611900007
J	Lavor, JR; Lacerda, RHW; Modesto, A; Vieira, AR				Lavor, Juliane R.; Lacerda, Rosa Helena W.; Modesto, Adriana; Vieira, Alexandre R.			Maxillary incisor enamel defects in individuals born with cleft lip/palate	PLOS ONE			English	Article							LIP AND/OR PALATE; DENTAL ANOMALIES; ORAL CLEFTS; DEVELOPMENTAL DEFECTS; CHILDREN; PREVALENCE; ASSOCIATION; MMP-2; TISSUES; INFANTS	Cleft lip with or without cleft palate (CLP) is considered the most frequent congenital malformations of the head and neck, with cleft individuals exhibiting more chances of presenting abnormalities such as developmental defects of enamel (DDE). Matrix metallopeptidase 2 (MMP2) is a membrane-bound protein with collagen-degrading ability and has important roles in tooth formation and mineralization. The aim of this study was to evaluate the frequency, location, severity and extent of DDE found in the maxillary incisors for groups of individuals born with CLP, as well as understanding their relationship with the cleft side. Besides, this study addresses the hypothesis that DDE can be influenced by variation in the MMP2 genes (rs9923304). Individual samples, clinical history, intraoral photographs and panoramic radiographs were obtained from 233 patients under treatment at the Cleft Lip and Palate Service of the University Hospital Lauro Wanderley at the Federal University of Paraiba. Digital images were examined by the same evaluator using the Classification of Defects According to the Modified DDE Index, and then loaded into the Image Tool software, where two measurements were made: total area of the buccal surface (SA) and the area of the DDE (DA), obtaining the percentage of the surface area affected (%SAD) (ICC = 0.99). Genomic DNA was extracted from saliva samples from 124 participants. Genotyping was carried out using TaqMan chemistry for one marker in MMP2 (rs9923304). Statistical analyses were performed by The Jamovi Project software. The Shapiro-Wilk test was applied, followed by the Student's t-test and the Mann-Whitney test. Chi-square and Fisher's exact tests, and odds ratio (OR) with 95% confidence interval (CI) calculations were used to determine Hardy-Weinberg equilibrium and statistically significant differences with an alpha of 0.05. No significant differences in the prevalence and extent of enamel defects were found between male and female individuals born with CLP (p = 0.058256). The frequency of individuals presenting teeth with DDE, in relation to the cleft and non-cleft side, was statistically different (p <0.001; OR = 7.15, CI: 4.674> 7.151> 10.942). However, the averages of %SAD were similar (p = 0.18). The highest means of the %SAD were found in individuals with bilateral cleft lip with or without cleft palate (BCLP) when compared to individuals with unilateral cleft lip with or without cleft palate (UCLP), for the teeth inside (IA) and outside the cleft area (OA) (p <0.001). Regardless of the cleft side, individuals with BCLP were 7.85 times more likely to have more than one third of the tooth surface affected, showing more frequently defects in the three thirds (OA: p <0.001) (IA: p = 0.03), as well as a higher frequency of more than one type of defect (OA: p = 0.000358) (IA: p = 0.008016), whereas in UCLP, defects were isolated and restricted to only one third, more frequently, the incisal third (OA: p = 0.009) (IA: p = 0.001), with greater frequency of milder defects, such as demarcated (p = 0.02) and diffuse (p = 0.008) opacities. A higher frequency of the T allele, less common, was observed in the group of CLP individuals who had all the affected teeth or at least two teeth with %SAD greater than 20% (p = 0.019843). Our results suggest that MMP2 may have a role in the cases that presented DDE and genotyping rs9923304 could serve as the basis for a genomic approach to define risks for individuals born with CLP. Frequency and severity of DDE is strongly related to the CLP phenotype, since the highest values were found for BCLP. However, the extent of the DDE is independent of its relationship with the side of the cleft.	[Lavor, Juliane R.; Lacerda, Rosa Helena W.; Vieira, Alexandre R.] Univ Fed Paraiba, Grad Program Dent, Joao Pessoa, Paraiba, Brazil; [Modesto, Adriana; Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Dept Pediat Dent, Pittsburgh, PA 15213 USA; [Modesto, Adriana; Vieira, Alexandre R.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15213 USA	Universidade Federal da Paraiba; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vieira, AR (corresponding author), Univ Fed Paraiba, Grad Program Dent, Joao Pessoa, Paraiba, Brazil.; Vieira, AR (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Pediat Dent, Pittsburgh, PA 15213 USA.; Vieira, AR (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15213 USA.	arv11@pitt.edu		Vieira, Alexandre/0000-0003-3392-6881				Aidar Marisi, 2007, Braz. Dent. J., V18, P148, DOI 10.1590/S0103-64402007000200012; Al Jamal GA, 2010, CLEFT PALATE-CRAN J, V47, P413, DOI 10.1597/08-275.1; Alam MK, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00656; Allam E., 2014, ANATOMY PHYSL, V4, P150, DOI [10.4172/2161-0940.1000150, DOI 10.4172/2161-0940.1000150]; Americano GCA, 2017, INT J PAEDIATR DENT, V27, P11, DOI 10.1111/ipd.12233; [Anonymous], 1982, Int Dent J, V32, P159; Bourd-Boittin K, 2005, EXP CELL RES, V304, P493, DOI 10.1016/j.yexcr.2004.11.024; Camporesi M, 2010, INT J PAEDIATR DENT, V20, P442, DOI 10.1111/j.1365-263X.2010.01063.x; Caron C, 2001, J DENT RES, V80, P1660, DOI 10.1177/00220345010800071201; Carpentier S, 2014, EUR ARCH PAEDIATR DE, V15, P159, DOI 10.1007/s40368-013-0078-8; Cavalcante BGN, 2021, CLEFT PALATE-CRAN J, V58, P597, DOI 10.1177/1055665620958569; Chen Y, 2013, J PUBLIC HEALTH DENT, V73, P204, DOI 10.1111/jphd.12014; CLARKSON J, 1989, J DENT RES, V68, P445, DOI 10.1177/00220345890680030201; Cochran JA, 2004, COMMUNITY DENT ORAL, V32, P19, DOI 10.1111/j.1600-0528.2004.00135.x; Ellwood R P, 1996, Int Dent J, V46, P69; Golkari A, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-16; Gomes AC, 2009, CLEFT PALATE-CRAN J, V46, P420, DOI 10.1597/08-044.1; HEIKINHEIMO K, 1995, J DENT RES, V74, P1226, DOI 10.1177/00220345950740051301; Hong L, 2009, CARIES RES, V43, P345, DOI 10.1159/000231571; Hudson JI, 2005, EPIDEMIOLOGY, V16, P355, DOI 10.1097/01.ede.0000158224.50593.e3; Jeremias F, 2016, CARIES RES, V50, P310, DOI 10.1159/000445726; Jeremias F, 2013, ARCH ORAL BIOL, V58, P1434, DOI 10.1016/j.archoralbio.2013.05.005; Kelly AM, 2020, J PERS MED, V10, DOI 10.3390/jpm10010005; Kobayashi TY, 2018, INT DENT J, V68, P138, DOI 10.1111/idj.12350; Konstantonis D, 2017, PROG ORTHOD, V18, DOI 10.1186/s40510-017-0169-x; Korolenkova MV, 2019, EUR ARCH PAEDIATR DE, V20, P105, DOI 10.1007/s40368-018-0397-x; Koruyucu M, 2018, OR SURG OR MED OR PA, V125, P307, DOI 10.1016/j.oooo.2018.01.007; Kuchler EC, 2011, CLEFT PALATE-CRAN J, V48, P103, DOI 10.1597/09-159; Letra A, 2007, J DENT RES, V86, P986, DOI 10.1177/154405910708601013; Lutfioglu M, 2012, CLIN ORAL INVEST, V16, P1563, DOI 10.1007/s00784-011-0652-6; Maciel SP, 2005, CLEFT PALATE-CRAN J, V42, P392, DOI 10.1597/02-152.1; Malanczuk T, 1999, J Orofac Orthop, V60, P259, DOI 10.1007/BF01299784; Menezes-Silva R, 2012, J ENDODONT, V38, P604, DOI 10.1016/j.joen.2012.02.009; Mossey PA, 2012, FRONT ORAL BIOL, V16, P1, DOI 10.1159/000337464; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Niu LN, 2011, J DENT, V39, P536, DOI 10.1016/j.jdent.2011.05.004; Pedro RD, 2012, CLEFT PALATE-CRAN J, V49, pE64, DOI 10.1597/10-067; Price SJ, 2001, J BIOL CHEM, V276, P7549, DOI 10.1074/jbc.M010242200; Ranade K, 2001, GENOME RES, V11, P1262; RANTA R, 1986, AM J ORTHOD DENTOFAC, V90, P11, DOI 10.1016/0889-5406(86)90022-3; Rice JP, 2001, ADV GENET, V42, P69, DOI 10.1016/S0065-2660(01)42015-3; Rittler M, 2011, AM J MED GENET A, V155A, P1588, DOI 10.1002/ajmg.a.34046; Robertson A J, 1999, J Audiov Media Med, V22, P63; Romualdo PC, 2019, ENVIRON TOXICOL PHAR, V66, P104, DOI 10.1016/j.etap.2018.12.016; Ruiz LA, 2013, CLEFT PALATE-CRAN J, V50, P394, DOI 10.1597/11-200; Seow W K, 1997, Int Dent J, V47, P173; Shen CA, 2019, J INT MED RES, V47, P2084, DOI 10.1177/0300060519832165; Sundell AL, 2016, ACTA ODONTOL SCAND, V74, P90, DOI 10.3109/00016357.2015.1044562; The WHO Alliance for Maternal and Newborn Health Improvement late pregnancy dating study group, 2020, LANCET GLOB HLTH, V8, pe545; Vasconcelos KR, 2019, CARIES RES, V53, P441, DOI 10.1159/000496372; Vichi M, 1995, J DENT CHILD, V62, P412; Vieira AR, 2008, AM J MED GENET A, V146A, P1406, DOI 10.1002/ajmg.a.32295; Vieira AR, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00186; Vieira AR, 2019, CARIES RES, V53, P482, DOI 10.1159/000496542; Wangsrimongkol Tasanee, 2013, Journal of the Medical Association of Thailand, V96, pS25; Wong HM, 2005, COMMUNITY DENT ORAL, V33, P438, DOI 10.1111/j.1600-0528.2005.00245.x	56	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244506	10.1371/journal.pone.0244506	http://dx.doi.org/10.1371/journal.pone.0244506			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370403	Green Published, gold			2022-12-27	WOS:000603611900059
J	Rocha, JC; Schill, C; Saavedra-Diaz, LM; Moreno, RD; Maldonado, JH				Rocha, Juan C.; Schill, Caroline; Saavedra-Diaz, Lina M.; Moreno, Rocio del Pilar; Maldonado, Jorge Higinio			Cooperation in the face of thresholds, risk, and uncertainty: Experimental evidence in fisher communities from Colombia	PLOS ONE			English	Article							REGIME SHIFTS; CLIMATE; RESOURCES; INSIGHTS	Cooperation is thought to be a necessary condition to solve collective action dilemmas such as climate change or the sustainable use of common pool resources. Yet, it is poorly understood how situations pervaded by thresholds shape the behaviour of people facing collective dilemmas. Here we provide empirical evidence that resource users facing thresholds maintain on average cooperative behaviours in the sense of maximising their individual earnings while ensuring future group opportunities. A framed field experiment in the form of a dynamic game with 256 Colombian fishers helped us investigate individual behavioural responses to the existence of thresholds, risk and uncertainty. Thresholds made fishers extract less fish compared to situation without thresholds, but risk had a stronger effect on reducing individual fishing effort. Contrary to previous expectations, cooperation did not break down. If cooperation can be maintained in the face of thresholds, then communicating uncertainty is more policy-relevant than estimating precisely where tipping points lay in social-ecological systems.	[Rocha, Juan C.; Schill, Caroline] Swedish Royal Acad Sci, Beijer Inst, Stockholm, Sweden; [Rocha, Juan C.; Schill, Caroline] Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden; [Rocha, Juan C.] Future Earth, Stockholm, Sweden; [Rocha, Juan C.] South Amer Inst Resilience & Sustainabil Studies, Maldonado, Uruguay; [Saavedra-Diaz, Lina M.] Univ Magdalena, Programa Biol, Santa Marta, Colombia; [Moreno, Rocio del Pilar; Maldonado, Jorge Higinio] Univ Los Andes, Fac Econ, Bogota, Cundinamarca, Colombia	Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; Stockholm University; Universidad del Magdalena; Universidad de los Andes (Colombia)	Rocha, JC (corresponding author), Swedish Royal Acad Sci, Beijer Inst, Stockholm, Sweden.; Rocha, JC (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Stockholm, Sweden.; Rocha, JC (corresponding author), Future Earth, Stockholm, Sweden.; Rocha, JC (corresponding author), South Amer Inst Resilience & Sustainabil Studies, Maldonado, Uruguay.	juan.rocha@su.se	Rocha, Juan Carlos/T-8188-2017; Díaz, Lina María Saavedra/AAS-2056-2021	Rocha, Juan Carlos/0000-0003-2322-5459; Saavedra-Diaz, Lina Maria/0000-0003-0511-3437	Formas [211-2013-1120, 942-2015-731]	Formas(Swedish Research Council Formas)	The research was supported by Formas (https://formas.se) grant 211-2013-1120 and 942-2015-731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the fishing communities that participated in our experiments. This work received valuable feedback on early stages of its design by Anne-Sophie Crepin, Therese Lindahl, Juan Camilo Cardenas, Maria Alejandra Velez, and Sandra Vilardy. The field work would have not been possible without the support of Nidia Vanegas, Alisson Soche, Darlin Botto, Maria de losAngeles Gonzalez, Cristhian Marrugo, Gloria de Leon, Jaime Gonzalez, and Jesus Jimenez. JCR benefit from technical advise by Joshua Abbott. The research was supported by Formas grant 211-2013-1120 and 942-2015-731.	Anderies JM, 2011, ECOL ECON, V70, P1571, DOI 10.1016/j.ecolecon.2011.01.011; Axelrod R., 2006, EVOLUTION COOPERATIO; Barrett S, 2014, NAT CLIM CHANGE, V4, P36, DOI [10.1038/nclimate2059, 10.1038/NCLIMATE2059]; Barrett S, 2012, P NATL ACAD SCI USA, V109, P17372, DOI 10.1073/pnas.1208417109; Biggs R, 2018, ECOL SOC, V23, DOI [10.5751/ES-10264-230309, 10.5751/ES-]; Breitburg D, 2018, SCIENCE, V359, P46, DOI 10.1126/science.aam7240; Cardenas JC, 2013, J DEV ECON, V103, P52, DOI 10.1016/j.jdeveco.2013.01.008; Crepin AS, 2012, ECOL ECON, V84, P15, DOI 10.1016/j.ecolecon.2012.09.003; Crepin AS, 2009, ENVIRON RESOUR ECON, V44, P29, DOI 10.1007/s10640-008-9258-0; Dannenberg A, 2014, ENV RESOUR EC DORDR, V61, P365; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; FAO, 2017, FUT FOOD AGR TRENDS; Finkbeiner EM, 2018, GLOBAL ENVIRON CHANG, V48, P151, DOI 10.1016/j.gloenvcha.2017.11.010; Gustafsson M, 1999, ACTA PSYCHOL, V103, P47, DOI 10.1016/S0001-6918(99)00024-4; Hauser OP, 2014, NATURE, V511, P220, DOI 10.1038/nature13530; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Maldonado JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148403; Hoff K, 2016, J ECON BEHAV ORGAN, V126, P25, DOI 10.1016/j.jebo.2016.01.005; Lenton TM, 2019, NATURE, V575, P592, DOI 10.1038/d41586-019-03595-0; Lindahl T, 2016, ENVIRON RESOUR ECON, V65, P657, DOI 10.1007/s10640-016-0043-1; McBride M, 2006, J PUBLIC ECON, V90, P1181, DOI 10.1016/j.jpubeco.2005.09.012; Milinski M, 2008, P NATL ACAD SCI USA, V105, P2291, DOI 10.1073/pnas.0709546105; Nowak Martin, 2013, EVOLUTION GAMES GOD; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Osborne M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225903; Ostrom, 1990, GOVERNING COMMONS; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; Polasky S, 2011, J ENVIRON ECON MANAG, V62, P229, DOI 10.1016/j.jeem.2010.09.004; Poncela-Casasnovas J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600451; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rocha JC, 2018, SCIENCE, V362, P1379, DOI 10.1126/science.aat7850; Saavedra-Diaz LM, 2016, MARIT STUD, V15, DOI 10.1186/s40152-016-0047-z; Saavedra-Diaz LM, 2015, MAR POLICY, V56, P61, DOI 10.1016/j.marpol.2014.11.026; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Schill C, 2019, UNCERTAINTY CAN HELP; Schiller CE, 2015, CNS SPECTRUMS, V20, P48, DOI 10.1017/S1092852914000480; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Vasconcelos VV, 2014, P NATL ACAD SCI USA, V111, P2212, DOI 10.1073/pnas.1323479111; Vilardy SP, 2011, HYDROLOG SCI J, V56, P1423, DOI 10.1080/02626667.2011.631497; Witt CM, 2015, SCIENCE, V347, pS50	42	5	5	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242363	10.1371/journal.pone.0242363	http://dx.doi.org/10.1371/journal.pone.0242363			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370255	Green Published, gold			2022-12-27	WOS:000603611900110
J	Suarez, ET; Granados-Falla, DS; Robledo, SM; Murillo, J; Upegui, Y; Delgado, G				Torres Suarez, Elaine; Granados-Falla, Diana Susana; Robledo, Sara Maria; Murillo, Javier; Upegui, Yulieth; Delgado, Gabriela			Antileishmanial activity of synthetic analogs of the naturally occurring quinolone alkaloid N-methyl-8-methoxyflindersin	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; IN-VITRO; CUTANEOUS LEISHMANIASIS; RESPIRATORY BURST; APOPTOSIS; INFECTION; DRUG; MACROPHAGES; DERIVATIVES; SURVIVAL	Leishmaniasis is a neglected, parasitic tropical disease caused by an intracellular protozoan from the genus Leishmania. Quinoline alkaloids, secondary metabolites found in plants from the Rutaceae family, have antiparasitic activity against Leishmania sp. N-methyl-8-methoxyflindersin (1), isolated from the leaves of Raputia heptaphylla and also known as 7-methoxy-2,2-dimethyl-2H,5H,6H-pyran[3,2-c]quinolin-5-one, shows antiparasitic activity against Leishmania promastigotes and amastigotes. This study used in silico tools to identify synthetic quinoline alkaloids having structure similar to that of compound 1 and then tested these quinoline alkaloids for their in vitro antiparasitic activity against Leishmania (Viannia) panamensis, in vivo therapeutic response in hamsters suffering from experimental cutaneous leishmaniasis (CL), and ex vivo immunomodulatory potential in healthy donors' human peripheral blood (monocyte)-derived macrophages (hMDMs). Compounds 1 (natural), 2 (synthetic), and 8 (synthetic) were effective against intracellular promastigotes (9.9, 3.4, and 1.6 mu g/mL medial effective concentration [EC50], respectively) and amastigotes (5.07, 7.94, and 1.91 mu g/mL EC50, respectively). Compound 1 increased nitric oxide production in infected hMDMs and triggered necrosis-related ultrastructural alterations in intracellular amastigotes, while compound 2 stimulated oxidative breakdown in hMDMs and caused ultrastructural alterations in the parasite 4 h posttreatment, and compound 8 failed to induce macrophage modulation but selectively induced apoptosis of infected hMDMs and alterations in the intracellular parasite ultrastructure. In addition, synthetic compounds 2 and 8 improved the health of hamsters suffering from experimental CL, without evidence of treatment-associated adverse toxic effects. Therefore, synthetic compounds 2 and 8 are potential therapeutic candidates for topical treatment of CL.	[Torres Suarez, Elaine; Granados-Falla, Diana Susana; Delgado, Gabriela] Univ Nacl Colombia, Dept Farm, Grp Invest Inmunotoxicol, Bogota, Colombia; [Granados-Falla, Diana Susana] Univ El Bosque, Vicerrectoria Invest, Bogota, Colombia; [Robledo, Sara Maria; Murillo, Javier; Upegui, Yulieth] Univ Antioquia, Fac Med, PECET, Medellin, Colombia; [Robledo, Sara Maria] Univ Antioquia, Sede Invest Univ, Programa Estudio & Control Enfermedades Trop, Medellin, Colombia; [Delgado, Gabriela] Univ Nacl Colombia, Fac Ciencias, Dept Farm, Bogota, Colombia	Universidad Nacional de Colombia; Universidad El Bosque; Universidad de Antioquia; Universidad de Antioquia; Universidad Nacional de Colombia	Delgado, G (corresponding author), Univ Nacl Colombia, Dept Farm, Grp Invest Inmunotoxicol, Bogota, Colombia.	lgdelgadom@unal.edu.co		Upegui Zapata, Yulieth Alexandra/0000-0002-9348-6227; Torres, Elaine/0000-0002-8547-2132	Colombian Ministry of Science Technology and Innovation; Colciencias-Colfuturo grant [727-2015]; Colombian Ministry of Science and Technology (MinCiencias) grant [777-2017, 110177758192]	Colombian Ministry of Science Technology and Innovation; Colciencias-Colfuturo grant; Colombian Ministry of Science and Technology (MinCiencias) grant	This study was financed by Colombian Ministry of Science Technology and Innovation, E. T: Colciencias-Colfuturo grant 727-2015 for national PhD students and Colombian Ministry of Science and Technology (MinCiencias) grant 777-2017 (project 110177758192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrews KT, 2014, INT J PARASITOL-DRUG, V4, P95, DOI 10.1016/j.ijpddr.2014.02.002; Aniszewski T., 2015, ALKALOIDS, DOI [10.1016/b978-0-444-59433-4.00002-x, DOI 10.1016/B978-0-444-59433-4.00002-X]; Antinarelli LMR, 2015, CHEM BIOL DRUG DES, V86, P704, DOI 10.1111/cbdd.12540; de Menezes JPB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/815023; Black AT, 2018, SIDE EFFECT, V40, P337, DOI 10.1016/bs.seda.2018.08.004; Bosque F, 2000, SCAND J IMMUNOL, V51, P533; Britta EA, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0236-0; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; Calixto SL, 2018, CHEM-BIOL INTERACT, V293, P141, DOI 10.1016/j.cbi.2018.08.003; Calla-Magarinos J, 2013, SCAND J IMMUNOL, V77, P30, DOI 10.1111/sji.12010; Calla-Magarinos J, 2009, SCAND J IMMUNOL, V69, P251, DOI 10.1111/j.1365-3083.2008.02219.x; Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480; Coimbra ES, 2016, CHEM-BIOL INTERACT, V260, P50, DOI 10.1016/j.cbi.2016.10.017; Barrera CAC, 2011, CHEM PHARM BULL, V59, P855, DOI 10.1248/cpb.59.855; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; de Almeida MC, 2003, MEM I OSWALDO CRUZ, V98, P861, DOI 10.1590/S0074-02762003000700001; Deschacht M, 2012, PARASITOLOGY, V139, P1429, DOI 10.1017/S003118201200073X; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Forman HJ, 2001, IUBMB LIFE, V51, P365; Getti GT, 2008, PARASITOLOGY, V135, P1391, DOI 10.1017/S0031182008004915; Ghorbani M, 2018, DRUG DES DEV THER, V12, P25, DOI 10.2147/DDDT.S146521; Guo Y, 2009, OPTIMIZATION DRUG DI, DOI 10.1385/1-59259-800-5; Holzmuller P, 2006, PARASITOLOGY, V132, pS19, DOI 10.1017/S0031182006000837; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Jorgensen I, 2017, NAT REV IMMUNOL, V17, P151, DOI 10.1038/nri.2016.147; Karimkhani C, 2016, LANCET INFECT DIS, V16, P584, DOI 10.1016/S1473-3099(16)00003-7; Lombardo M, 2014, EUR J ORG CHEM, V2014, P1607, DOI 10.1002/ejoc.201301394; Maggiora G, 2014, J MED CHEM, V57, P3186, DOI 10.1021/jm401411z; Michael JP, 2008, NAT PROD REP, V25, P166, DOI 10.1039/b612168n; Mishra BB, 2009, MINI-REV MED CHEM, V9, P107, DOI 10.2174/138955709787001758; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Natesan S, 2014, MOL PHARMACEUT, V11, P3577, DOI 10.1021/mp5003366; Oliveira LF, 2011, ACTA TROP, V118, P87, DOI 10.1016/j.actatropica.2011.02.007; Pan American Health Organization, 2019, LEISHM EP REP AM DEC; Perez-Cordero JJ, 2011, EXP PARASITOL, V129, P31, DOI 10.1016/j.exppara.2011.05.022; Perrotta I, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/282739; Podinovskaia M, 2015, FUTURE MICROBIOL, V10, P111, DOI 10.2217/fmb.14.103; Ponte-Sucre A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006052; Pulido SA, 2012, ACTA TROP, V122, P36, DOI 10.1016/j.actatropica.2011.11.015; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Silva GL, 1998, SPECIAL PROBLEMS EXT, DOI DOI 10.1007/978-1-59259-256-2_12; Singh N, 2014, BIOORGAN MED CHEM, V22, P18, DOI 10.1016/j.bmc.2013.11.048; Sousa-Franco J, 2006, MICROBES INFECT, V8, P390, DOI 10.1016/j.micinf.2005.07.007; Sundar S, 2007, THER CLIN RISK MANAG; Tempone AG, 2005, ANTIMICROB AGENTS CH, V49, P1076, DOI 10.1128/AAC.49.3.1076-1080.2005; Torres-Guerrero Edoardo, 2017, F1000Res, V6, P750, DOI 10.12688/f1000research.11120.1; Van Assche T, 2011, FREE RADICAL BIO MED, V51, P337, DOI 10.1016/j.freeradbiomed.2011.05.011; Vannier-Santos MA, 2008, MICROBIOL-SGM, V154, P3104, DOI 10.1099/mic.0.2007/013896-0; Vraka C, 2018, NUCL MED BIOL, V58, P20, DOI 10.1016/j.nucmedbio.2017.11.007; Wanderley JLM, 2010, CELL MOL LIFE SCI, V67, P1653, DOI 10.1007/s00018-010-0291-0	51	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243392	10.1371/journal.pone.0243392	http://dx.doi.org/10.1371/journal.pone.0243392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370295	Green Published, gold			2022-12-27	WOS:000603611900023
J	White, JA; Blaauw, D; Rispel, LC				White, Janine A.; Blaauw, Duane; Rispel, Laetitia C.			Social exclusion and the perspectives of health care providers on migrants in Gauteng public health facilities, South Africa	PLOS ONE			English	Article							SERVICES; BARRIERS; ATTITUDES; PEOPLE; ACCESS; GREECE	Background Universal health coverage (UHC) for all people, regardless of citizenship, is a global priority. Health care providers are central to the achievement of UHC, and their attitudes and behaviour could either advance or impede UHC for migrants. Using a social exclusion conceptual framework, this study examined the perspectives of health care providers on delivering health services to migrants in public health facilities in Gauteng Province, South Africa. Methods We used stratified, random sampling to select 13 public health facilities. All health care providers working in ambulatory care were invited to complete a self-administered questionnaire. In addition to socio-demographic information, the questionnaire asked health care providers if they had witnessed discrimination against migrants at work, and measured their perspectives on social exclusionary views and practices. Multiple regression analysis was used to identify predictors of more exclusionary perspectives for each item. Results 277 of 308 health care providers participated in the study-a response rate of 90%. The participants were predominantly female (77.6%) and nurses (51.9%), and had worked for an average of 6.8 years in their facilities. 19.2% of health care providers reported that they had witnessed discrimination against migrants, while 20.0% reported differential treatment of migrant patients. Exclusionary perspectives varied across the different items, and for different provider groups. Enrolled nurses and nursing assistants were significantly more exclusionary on a number of items, while the opposite was found for providers born outside South Africa. For some questions, female providers held more exclusionary perspectives and this was also the case for providers from higher levels of care. Conclusion Health care providers are critical to inclusive UHC. Social exclusionary views or practices must be addressed through enabling health policies; training in culture-sensitivity, ethics and human rights; and advocacy to ensure that health care providers uphold their professional obligations to all patients.	[White, Janine A.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Blaauw, Duane; Rispel, Laetitia C.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Ctr Hlth Policy, Johannesburg, South Africa; [Rispel, Laetitia C.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, South African Res Chairs Initiat, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	White, JA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.	Janine.white@wits.ac.za		White, Janine/0000-0001-8547-2012	Atlantic Philanthropies [21408]; National Research Foundation of South Africa	Atlantic Philanthropies; National Research Foundation of South Africa(National Research Foundation - South Africa)	This research was funded by the Atlantic Philanthropies (https://www.atlanticphilanthropies.org/), grant no. 21408, and Professor Rispel's Research Chair funded through the National Research Foundation of South Africa (https://www.nrf.ac.za/).The views expressed in this study are those of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Velcamp T, 2017, INT J MIGR HEALTH SO, V13, P53, DOI 10.1108/IJMHSC-04-2015-0012; Ballard R, 2019, SOCIAL COHESION GAUT; Burchill J., 2014, DIVERSITY EQUALITY H, V11, P151, DOI [10.21767/2049-5471.100010, DOI 10.21767/2049-5471.100010]; CHRI, 2019, RIGHT INF GHAN JOURN; Crush J, 2011, MED XENOPHOBIA ZIMBA; Crush J, 2014, J ETHN MIGR STUD, V40, P655, DOI 10.1080/1369183X.2013.830504; Department of Health, 2013, STRAT PLAN NURS ED T; Dhai A, 2018, SAMJ S AFR MED J, V108, P382, DOI [10.7196/SAMJ.2018.v108i5.13232, 10.7196/samj.2018.v108i5.13232]; European Union Agency for Fundamental Rights, 2013, IN MULT DISCR ACC QU; Farley R, 2014, AUST J PRIM HEALTH, V20, P85, DOI 10.1071/PY12068; Gordon S., 2020, STUDY SHEDS LIGHT S; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hassim A, 2007, HLTH DEMOCRACY GUIDE, V520; Human Rights Watch, 2009, NO HEAL HER VIOL DIS; Internal Displacement Monitoring Centre, 2016, IDMC GRID 2016 GLOB; International Organization for Migration, GLOSS MIGR 2019; International Organization for Migration, 2020, WORLD MIGR REP 2020; Lampman Robert, 1969, NOTES COMMENTS; Landau L., 2015, WASHINGTON POST; Lawrence J, 2005, HEALTH SOC CARE COMM, V13, P451, DOI 10.1111/j.1365-2524.2005.00572.x; Lori JR, 2015, NURS OUTLOOK, V63, P68, DOI 10.1016/j.outlook.2014.10.008; Lown BA, 2015, INT J HEALTH POLICY, V4, P613, DOI 10.15171/ijhpm.2015.110; Majumdar B, 2004, J NURS SCHOLARSHIP, V36, P161, DOI 10.1111/j.1547-5069.2004.04029.x; Maserumule MHM, 2019, XENOPHOBIA PUTS S AF; Mashange W, 2019, HUM RESOUR HEALTH, V17, DOI 10.1186/s12960-019-0369-1; Matlin SA, 2018, PUBLIC HEALTH REV, V39, DOI 10.1186/s40985-018-0104-9; MUNYANEZA Y., 2019, BIORXIV; NDoH, 2017, NAT HLTH INS POL UN; O'Donnell P, MEASURING SOCIAL EXC, DOI [10.1186/s12939-018-0732-1, DOI 10.1186/S12939-018-0732-1]; Papadakaki M, 2017, EUR J GEN PRACT, V23, P128, DOI 10.1080/13814788.2017.1307336; Papic O, 2012, PATIENT EDUC COUNS, V86, P205, DOI 10.1016/j.pec.2011.05.015; Peterson JC, 2020, J POLIT, V82, P600, DOI 10.1086/706889; Popay J., 2008, UNDERSTANDING TACKLI; Robertshaw L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-015981; SANC, 2019, NURS PLEDG; Scheppers E, 2006, FAM PRACT, V23, P325, DOI 10.1093/fampra/cmi113; Singapore Statement, 2010, SING STAT RES INT SI; Smith AC, 2017, CITIES RIGHTS ENSURI; South Africa Nursing Council, 2018, SANC GEOGR DISTR 201; Statistics South Africa, 2018, MID POP EST 2018; Statistics South Africa, 2011, CENS 2011 STAT REL R; Suphanchaimat R, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1065-z; Suurmond J, 2010, NURS EDUC TODAY, V30, P821, DOI 10.1016/j.nedt.2010.03.006; Teunissen E, 2016, EUR J GEN PRACT, V22, P119, DOI 10.3109/13814788.2015.1136283; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Tobin CL, 2014, INT J WOMENS HEALTH, V6, P159, DOI 10.2147/IJWH.S45579; Uiters E, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-76; United Nations, 2017, JOINT UN STAT END DI; United Nations High Commissioner for Refugees, 2019, GLOB APP 2018 2019; Vearey J, 2017, S AFRICAN HLTH REV 2; WHO, 2010, HLTH SYST CAN ADDR H; WHO, 2020, GLOB STRAT HUM RES H; WHO, 2019, 72 WORLD HLTH ASS; WHO AFRO, 2018, HLTH REF MIGR PRACT; World Health Organization, 2018, DIR GEN WORLD HLTH A; World Medical Association, 2019, DECL GEN MAY 2006; Zihindula G, 2017, J ASIAN AFR STUD, V52, P458, DOI 10.1177/0021909615595990	57	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244080	10.1371/journal.pone.0244080	http://dx.doi.org/10.1371/journal.pone.0244080			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370340	gold, Green Published			2022-12-27	WOS:000603611900033
J	Claude, SJ; Park, SJ				Jean Claude, Sivagami; Park, Seon Joo			Aster spathulifolius Maxim. a leaf transcriptome provides an overall functional characterization, discovery of SSR marker and phylogeny analysis	PLOS ONE			English	Article							SEQUENCE; PROTEIN; PLANTS; FAMILY	Aster spathulifolius Maxim. is belongs to the Asteraceae family, which is distributed only in Korea and Japan. The species is traditionally a medicinal plant and is economically valuable in the ornamental field. On the other hand, the Aster genus, among the Asteraceae family, lacks genomic resources and its molecular functions. Therefore, in our study the high-throughput RNA-sequencing transcriptome data of A. spathulifolius were obtained to identify the molecular functions and its characterization. The de novo assembly produced 98660 uniqueness with an N50 value of 1126bp. Total unigenes were procure to analyze the functional annotation against databases like non-redundant protein, Pfam, Uniprot, KEGG and Gene ontology. The overall percentage of functional annotation to the nr database (43.71%), uniprotein database (49.97%), Pfam (39.94%), KEGG (42.3%) and to GO (30.34%) were observed. Besides, 377 unigenes were found to be involved in the terpenoids pathway and 666 unigenes were actively engaged in other secondary metabolites synthesis, given that 261 unigenes were within phenylpropanoid pathway and 81 unigenes to flavonoid pathway. A further prediction of stress resistance (9,513) unigenes and transcriptional factor (3,027) unigenes in 53 types were vastly regulated in abiotic stress respectively in salt, heat, MAPK and hormone signal transduction pathway. This study discovered 29,692 SSR markers that assist the genotyping approaches and the genetic diversity perspectives. In addition, eight Asteraceae species as in-group together with one out-group were used to construct the phylogenetic relationship by employing their plastid genome and single-copy orthologs genes. Among 50 plastid protein-coding regions, A. spathulifolius is been closely related to A. annua and by 118 single copy orthologs genes, O. taihangensis is more neighboring species to A. spathulifolius. Apart from this, A. spathulifolius and O. taihangensis, genera have recently diverged from other species. Overall, this research gains new insights into transcriptome data by revealing and exposing the secondary metabolite compounds for drug development, the stress-related genes for producing resilient crops and an ortholog gene of A. spathulifolius for the robustness of phylogeny reconstruction among Asteraceae genera.	[Jean Claude, Sivagami; Park, Seon Joo] Yeungnam Univ, Dept Life Sci, Gyongsan, Gyeongbuk, South Korea	Yeungnam University	Park, SJ (corresponding author), Yeungnam Univ, Dept Life Sci, Gyongsan, Gyeongbuk, South Korea.	sjpark01@ynu.ac.kr		park, seonjoo/0000-0001-6494-3460	Yeungnam University Grant 2018 commission, South Korea [217A061011]	Yeungnam University Grant 2018 commission, South Korea	This study was supported by Yeungnam University Grant 2018 commission, South Korea, in the form of a grant awarded to SJP (217A061011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, AM J TRANSPLANT, V19, P291, DOI 10.1111/ajt.15211; Baillo EH, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100771; Beier S, 2017, BIOINFORMATICS, V33, P2583, DOI 10.1093/bioinformatics/btx198; Boeckler GA, 2011, PHYTOCHEMISTRY, V72, P1497, DOI 10.1016/j.phytochem.2011.01.038; Breitler JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep38368; Cho IJ, 2016, NUTR RES, V36, P671, DOI 10.1016/j.nutres.2016.03.001; Choi KS, 2015, GENE, V572, P214, DOI 10.1016/j.gene.2015.07.020; Debbarma J, 2019, MOL BIOTECHNOL, V61, P153, DOI 10.1007/s12033-018-0144-x; Diamantopoulos MA, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.06.10; Emms DM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1832-y; FAAIR Scientific Advisory Panel, 2002, CLIN INFECT DIS S3, V34, pS76; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Ito-Inaba Y, 2008, J EXP BOT, V59, P995, DOI 10.1093/jxb/ern024; Jang Y. D., 2008, NATURE OF DOKDO, P10; Jiang AL, 2014, PLANT MOL BIOL REP, V32, P1241, DOI 10.1007/s11105-014-0719-z; Jung SY, 2014, J ASIA-PAC BIODIVERS, V7, P197, DOI DOI 10.1016/j.japb.2014.03.011; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SJ, 2016, J PHARM PHARMACOL, V68, P107, DOI 10.1111/jphp.12485; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee C. B., 1979, ILLUSTRATED FLORA KO, P740; Lee Je-Hyuk, 2013, RES J MED PLANTS, V8, P41; Lee SO, 2005, J NAT PROD, V68, P1471, DOI 10.1021/np058044e; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu PL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-214; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; NESOM G.L., 2000, SIDA BOT MISC, V20, P1; Park JH, 2008, NATURE DOKDO, P166; Pereira A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01123; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Tribble MdC, 2016, HEART SURG FORUM, V19, pE286; Wang HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062293; Wang PF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207344; Wang YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200850; Xie CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-107; Yin XF, 2015, FOOD SCI BIOTECHNOL, V24, P301, DOI 10.1007/s10068-015-0040-0; Yin X, 2015, J MED FOOD, V18, P987, DOI 10.1089/jmf.2014.3416	38	3	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244132	10.1371/journal.pone.0244132	http://dx.doi.org/10.1371/journal.pone.0244132			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362220	Green Published, gold			2022-12-27	WOS:000603071600048
J	Tolley, EE; Zissette, S; Martinez, A; Palanee-Phillips, T; Mathebula, F; Tenza, S; Hartmann, M; Montgomery, ET				Tolley, Elizabeth E.; Zissette, Seth; Martinez, Andres; Palanee-Phillips, Thesla; Mathebula, Florence; Tenza, Siyanda; Hartmann, Miriam; Montgomery, Elizabeth T.			Development and initial validation of a simple tool to screen for partner support or opposition to HIV prevention product use	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; INFECTION; ADHERENCE; WOMEN; DISCLOSURE; SAFETY; TRIAL; PREP; GEL	In HIV prevention trials, male partners have influenced women's ability to adhere to investigational products, including antiretroviral (ARV) containing vaginal rings. Validated scales can be useful tools to systematically measure complex constructs, such as those related to male partner engagement. Although multiple scales exist to assess physical, psychological and sexual violence within intimate relationships, fewer scales focus on supportive behaviors within these relationships. Our intervention involved development of a Healthy Relationship Assessment Tool (HEART) that assessed both positive and negative aspects of male partner involvement in women's HIV prevention. We identified and refined 127 potential items, representing intimate partner violence, agency and social support. A structured survey, including potential items and other sociodemographic and behavioral variables was administered to former microbicide trial and non-trial participants. We conducted an exploratory factor analysis (EFA) to identify a reduced set of constructs and items to screen women who might experience social harms or benefits from vaginal ring use. We examined associations between constructs and with other survey variables to assess content and construct validity. In a subset of 10 women who participated in the survey and qualitative interviews, we used qualitative data to predict survey scores. We retained five constructs with theoretical relevance and good-to-strong reliability for the tool, including: Traditional Values; Partner Support; Partner Abuse & Control; Partner Resistance to HIV Prevention; and HIV Prevention Readiness. Predicted associations between HEART constructs, and correspondence between participants' qualitative data and HEART scores were generally correct, while those between constructs and other sociodemographic variables were more mixed. Initial validation of the HEART tool was promising. The tool will be used during the CHARISMA pilot study at the Johannesburg MTN 025/HOPE site and validated as part of a randomized controlled trial of CHARISMA within a PrEP demonstration project. Beyond clinical trial settings, HEART could assist PrEP or antiretroviral treatment (ART) providers with an easy-to-administer tool to identify risk and tailor risk reduction, empowerment and adherence counseling for microbicides, PrEP or ART related services.	[Tolley, Elizabeth E.; Zissette, Seth; Martinez, Andres] FHI 360, Behav Epidemiol & Clin Sci, Durham, NC USA; [Zissette, Seth] Notre Dame Univ, South Bend, IN USA; [Palanee-Phillips, Thesla; Mathebula, Florence; Tenza, Siyanda] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Hartmann, Miriam; Montgomery, Elizabeth T.] San Francisco Project Off, RTI Int, Womens Global Hlth Imperat, San Francisco, CA USA	FHI 360; University of Notre Dame; University of Witwatersrand; Research Triangle Institute	Tolley, EE (corresponding author), FHI 360, Behav Epidemiol & Clin Sci, Durham, NC USA.	btolley@fhi360.org		Montgomery, Elizabeth/0000-0002-5477-4445; Zissette, Seth/0000-0002-6502-2986; Hartmann, Miriam/0000-0001-8109-9679; Palanee-Phillips, Thesla/0000-0002-0052-5830	United States Agency for International Development (USAID) [APS-OAA-14-000076]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This study was funded by the United States Agency for International Development (USAID) under APS-OAA-14-000076, of which EM was the Principal Investigator. The funders did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amico KR, 2017, AIDS BEHAV, V21, P1361, DOI 10.1007/s10461-016-1458-y; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Clarke I, 2000, J SOC BEHAV PERS, V15, P137; Corneli A, 2014, JAIDS-J ACQ IMM DEF, V67, P555, DOI 10.1097/QAI.0000000000000362; Delany-Moretlwe S, 2018, LANCET INFECT DIS, V18, P1241, DOI 10.1016/s1473-3099(18)30428-6; DeVellis RF, 2003, SCALE DEV THEORY APP, Vviii; Doggett EG, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20536; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Hartmann M, 2019, AIDS EDUC PREV, V31, P433, DOI 10.1521/aeap.2019.31.5.433; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Karim SA, 2014, BJOG-INT J OBSTET GY, V121, P27, DOI 10.1111/1471-0528.12842; Lanham Michele, 2014, J Int AIDS Soc, V17, P19159, DOI 10.7448/IAS.17.3.19159; MAHONEY CA, 1995, HEALTH EDUC RES, V10, P1, DOI 10.1093/her/10.1.1-a; Marlow HM, 2010, CULT HEALTH SEX, V12, P899, DOI 10.1080/13691058.2010.508843; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Mngadi KT, 2014, AIDS BEHAV, V18, P849, DOI 10.1007/s10461-014-0696-0; Montgomery ET, 2015, AIDS BEHAV, V19, P784, DOI 10.1007/s10461-014-0950-5; Nanda G., 2011, FHI 360; Palanee-Phillips T, 2018, JAIDS-J ACQ IMM DEF, V79, P580, DOI 10.1097/QAI.0000000000001866; Paulhus D.L., 1991, MEASURES PERSONALITY, P17, DOI [10.1016/B978-0-12-590241-0.50006-X, DOI 10.1016/B978-0-12-590241-0.50006-X]; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Roberts ST, 2016, JAIDS-J ACQ IMM DEF, V73, P313, DOI 10.1097/QAI.0000000000001093; Sherin K M, 1998, Fam Med, V30, P508; Sidebottom D, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3463-4; Stapleton LRT, 2012, J FAM PSYCHOL, V26, P453, DOI 10.1037/a0028332; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Thompson M. P., 2006, MEASURING INTIMATE P; UN Women, 2016, FACTS FIG HIV AIDS; UN Women, 2018, FACTS FIG HIV AIDS; UNAIDS, 2019, UNAIDS DAT 2019; UNAIDS, 2019, TREND NEW HIV IN; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0242881	10.1371/journal.pone.0242881	http://dx.doi.org/10.1371/journal.pone.0242881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351805	gold, Green Published			2022-12-27	WOS:000603071400042
J	Frank, K; Abeynaike, S; Nikzad, R; Patel, RR; Roberts, AJ; Roberto, M; Paust, S				Frank, Kayla; Abeynaike, Shawn; Nikzad, Rana; Patel, Reesha R.; Roberts, Amanda J.; Roberto, Marisa; Paust, Silke			Alcohol dependence promotes systemic IFN-gamma and IL-17 responses in mice	PLOS ONE			English	Article							CHRONIC ETHANOL-CONSUMPTION; TUMOR-NECROSIS-FACTOR; PERIPHERAL-BLOOD; INTERFERON-GAMMA; T-CELLS; ALVEOLAR MACROPHAGES; KUPFFER CELLS; LIVER-DISEASE; B-LYMPHOCYTE; EXPRESSION	Alcohol use disorder (AUD) is a chronic relapsing disorder characterized by an impaired ability to stop or control alcohol use despite adverse social, occupational, or health consequences. AUD is associated with a variety of physiological changes and is a substantial risk factor for numerous diseases. We aimed to characterize systemic alterations in immune responses using a well-established mouse model of chronic intermittent alcohol exposure to induce alcohol dependence. We exposed mice to chronic intermittent ethanol vapor for 4 weeks and analyzed the expression of cytokines IFN-gamma, IL-4, IL-10, IL-12 and IL-17 by different immune cells in the blood, spleen and liver of alcohol dependent and non-dependent control mice through multiparametric flow cytometry. We found increases in IFN-gamma and IL-17 expression in a cell type- and organ-specific manner. Often, B cells and neutrophils were primary contributors to increased IFN-gamma and IL-17 levels while other cell types played a secondary role. We conclude that chronic alcohol exposure promotes systemic pro-inflammatory IFN-gamma and IL-17 responses in mice. These responses are likely important in the development of alcohol-related diseases, but further characterization is necessary to understand the initiation and effects of systemic inflammatory responses to chronic alcohol exposure.	[Frank, Kayla; Abeynaike, Shawn; Nikzad, Rana; Paust, Silke] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Patel, Reesha R.; Roberto, Marisa] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Roberts, Amanda J.] Scripps Res Inst, Anim Models Core, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Paust, S (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	paust@scripps.edu	Abeynaike, Shawn/AGR-8674-2022	Frank, Kayla/0000-0002-8150-6657	National Institute on Alcohol Abuse and Alcoholism [AA021491, AA013498, P60 AA006420, AA017447, AA015566, AA027700, F32 AA026765, T32 AA007456]; Pearson Center for Alcoholism and Addiction Research; Scripps Research Institute	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Pearson Center for Alcoholism and Addiction Research; Scripps Research Institute	t Support for this study was provided by the National Institute on Alcohol Abuse and Alcoholism grants AA021491, AA013498, P60 AA006420, AA017447, AA015566, AA027700, F32 AA026765, T32 AA007456, as well as the Pearson Center for Alcoholism and Addiction Research (all to MR) and The Scripps Research Institute's unrestricted funds (SP). The manuscript is The Scripps Research Institute's MS# 30018.	Agoglia AE, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0420-19.2020; Ballester-Lopez C, 2019, EBIOMEDICINE, V43, P562, DOI 10.1016/j.ebiom.2019.03.054; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becker HC, 2004, ALCOHOL CLIN EXP RES, V28, P1829, DOI 10.1097/01.ALC.0000149977.95306.3A; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; BLANK SE, 1993, ALCOHOL CLIN EXP RES, V17, P561, DOI 10.1111/j.1530-0277.1993.tb00800.x; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Brandon-Warner E, 2012, ALCOHOL, V46, P715, DOI 10.1016/j.alcohol.2012.08.004; Chan C, 2016, CLIN LIVER DIS, V20, P595, DOI 10.1016/j.cld.2016.02.014; Cook RT, 1996, CLIN EXP IMMUNOL, V103, P304, DOI 10.1046/j.1365-2249.1996.d01-621.x; Crews FT, 2006, ALCOHOL CLIN EXP RES, V30, P720, DOI 10.1111/j.1530-0277.2006.00084.x; Dominguez-Santalla MJ, 2001, ALCOHOL CLIN EXP RES, V25, P1198, DOI 10.1111/j.1530-0277.2001.tb02336.x; Ellis TN, 2002, J LEUKOCYTE BIOL, V72, P373; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; FUKUI H, 1993, ALCOHOL ALCOHOLISM, V28, P53, DOI 10.1093/alcalc/28.Supplement_1B.53; FULTZ MJ, 1993, INT IMMUNOL, V5, P1383, DOI 10.1093/intimm/5.11.1383; Ganapamo F, 2001, EUR J IMMUNOL, V31, P3460, DOI 10.1002/1521-4141(200112)31:12<3460::AID-IMMU3460>3.0.CO;2-X; Gjertsson I, 2003, MICROB PATHOGENESIS, V35, P119, DOI 10.1016/S0882-4010(03)00114-1; GONZALEZQUINTELA A, 1995, CLIN EXP ALLERGY, V25, P756, DOI 10.1111/j.1365-2222.1995.tb00014.x; Harris DP, 2005, J IMMUNOL, V174, P6781, DOI 10.4049/jimmunol.174.11.6781; Herman MA, 2016, J NEUROSCI, V36, P10729, DOI 10.1523/JNEUROSCI.1267-16.2016; India State Level Disease Burden Initiative Road Injury Collaborators, 2020, LANCET PUBLIC HLTH, V5, pe86; Laso FJ, 2007, CYTOM PART B-CLIN CY, V72B, P408, DOI 10.1002/cyto.b.20169; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Kaufmann U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049008; Kebir H, 2009, ANN NEUROL, V66, P390, DOI 10.1002/ana.21748; KHORUTS A, 1991, HEPATOLOGY, V13, P267, DOI 10.1016/0270-9139(91)92439-F; Kishore R, 2002, AM J PHYSIOL-GASTR L, V282, pG6, DOI 10.1152/ajpgi.00328.2001; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kono H, 2001, AM J PHYSIOL-GASTR L, V280, pG1289, DOI 10.1152/ajpgi.2001.280.6.G1289; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Laso FJ, 1999, ALCOHOL CLIN EXP RES, V23, P1306, DOI 10.1097/00000374-199908000-00003; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Loxton AG, 2012, CLIN VACCINE IMMUNOL, V19, P746, DOI 10.1128/CVI.00047-12; Ma Hsiao-Yen, 2016, Curr Pathobiol Rep, V4, P27; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Mellinger Jessica L, 2019, Clin Liver Dis (Hoboken), V13, P136, DOI 10.1002/cld.806; Pan HN, 2006, ALCOHOL CLIN EXP RES, V30, P1615, DOI 10.1111/j.1530-0277.2006.00194.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Passos ST, 2010, J IMMUNOL, V184, P1776, DOI 10.4049/jimmunol.0901843; Patel RR, 2019, BRAIN BEHAV IMMUN, V75, P208, DOI 10.1016/j.bbi.2018.10.009; Puddu P, 1997, J IMMUNOL, V159, P3490; Ratna A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030061; Roberts AJ, 2019, BRAIN BEHAV IMMUN, V82, P188, DOI 10.1016/j.bbi.2019.08.185; ROBINSON BWS, 1985, J CLIN INVEST, V75, P1488, DOI 10.1172/JCI111852; Rocco A, 2014, WORLD J GASTROENTERO, V20, P14652, DOI 10.3748/wjg.v20.i40.14652; Schlegel PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082580; Schweitzer P, 2016, NEUROPHARMACOLOGY, V107, P1, DOI 10.1016/j.neuropharm.2016.03.003; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Song KJ, 2002, J LEUKOCYTE BIOL, V72, P1109; Starkenburg S, 2001, ALCOHOL CLIN EXP RES, V25, P1221, DOI 10.1097/00000374-200108000-00019; Sturge CR, 2013, P NATL ACAD SCI USA, V110, P10711, DOI 10.1073/pnas.1307868110; Taieb J, 2000, J HEPATOL, V32, P579, DOI 10.1016/S0168-8278(00)80219-6; Varodayan FP, 2018, NEUROPHARMACOLOGY, V133, P470, DOI 10.1016/j.neuropharm.2018.02.014; Viitala K, 1997, HEPATOLOGY, V25, P1418, DOI 10.1002/hep.510250619; Vilchez D, 2014, TRENDS CELL BIOL, V24, P161, DOI 10.1016/j.tcb.2013.09.002; Warden AS, 2020, BIOL PSYCHIAT, V88, P910, DOI 10.1016/j.biopsych.2020.05.011; Yin JY, 2009, J IMMUNOL, V182, P7069, DOI 10.4049/jimmunol.0802410; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; Zhang H, 2005, J LEUKOCYTE BIOL, V78, P1070, DOI 10.1189/jlb0605-317; Zhang H, 2015, TOXICOL APPL PHARM, V282, P139, DOI 10.1016/j.taap.2014.11.013; Zhang H, 2009, ALCOHOL CLIN EXP RES, V33, P419, DOI 10.1111/j.1530-0277.2008.00852.x	63	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0239246	10.1371/journal.pone.0239246	http://dx.doi.org/10.1371/journal.pone.0239246			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347446	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071100017
J	Yang, YJ; Deng, Y; Tuo, YC; Li, J; He, TF; Chen, M				Yang, Yanjing; Deng, Yun; Tuo, Youcai; Li, Jia; He, Tianfu; Chen, Min			Study of the thermal regime of a reservoir on the Qinghai-Tibetan Plateau, China	PLOS ONE			English	Article							DEEP SUBTROPICAL RESERVOIR; CLIMATE-CHANGE; WATER-QUALITY; LAKE QIANDAOHU; STRATIFICATION; TEMPERATURE; DYNAMICS; IMPACT; RIVER; ICE	The Qinghai-Tibetan Plateau region has unique meteorological characteristics, with low air temperature, low air pressure, low humidity, little precipitation, and strong diurnal variation. A two-dimensional hydrodynamic CE-QUAL-W2 model was configured for the Pangduo Reservoir to better understand the thermal structure and diurnal variation inside the reservoir under the local climate and hydrological conditions on the Qinghai-Tibetan Plateau. Observation data were used to verify the model, and the results showed that the average error of the 6 profile measured monthly from August to December 2016 was 0.1 degrees C, and the root-mean-square error (RMSE) was 0.173 degrees C. The water temperature from August 2016 to September 2017 was simulated by inputting measured data as model inputs. The results revealed that the reservoir of the Qinghai-Tibetan Plateau was a typical dimictic reservoir and the water mixed vertically at the end of March and the end of October. During the heating period, thermal stratification occurred, with strong diurnal variation in the epilimnion. The mean variance of the diurnal water temperature was 0.10 within a 5 m water depth but 0.04 in the whole water column. The mixing mode of inflow changed from undercurrent, horizontal-invaded flow and surface layer flow in one day. In winter, the diurnal variation was weak due to the thermal protection of the ice cover, while the mean variance of diurnal water temperature was 0.00 within both 5 m and the whole water column. Compared to reservoirs in areas with low altitude but the same latitude, significant differences occurred between the temperature structure of the low-altitude reservoir and the Pangduo Reservoir (P<0.01). The Pangduo Reservoir presented a shorter stratification period and weaker stratification stability, and the annual average SI value was 26.4 kg/m(2), which was only 7.5% that of the low-altitude reservoir. The seasonal changes in the net heat flux received by the surface layers determined the seasonal cycle of stratification and mixing in reservoirs. This study provided a scientific understanding of the thermal changes in stratified reservoirs under the special geographical and meteorological conditions on the Qinghai-Tibetan Plateau. Moreover, this model can serve as a reference for adaptive management of similar dimictic reservoirs in cold and high-altitude areas.	[Yang, Yanjing; Deng, Yun; Tuo, Youcai; Li, Jia; He, Tianfu; Chen, Min] Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu, Peoples R China	Sichuan University	Deng, Y (corresponding author), Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu, Peoples R China.	dengyun@scu.edu.cn		Chen, Min/0000-0002-0212-8564; Tuo, Youcai/0000-0002-7032-0873	National Key R&D Program of China [number2016YFC0502202]; National Natural Science Foundation of China [91547211]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key R&D Program of China (grant number2016YFC0502202) and the National Natural Science Foundation of China (grant numbers 91547211).	Abdi R, 2020, J ENVIRON MANAGE, V258, DOI 10.1016/j.jenvman.2019.110023; Abdi R, 2019, WATER-SUI, V11, DOI 10.3390/w11051060; ALAVIAN V, 1992, J HYDRAUL ENG-ASCE, V118, P1464, DOI 10.1061/(ASCE)0733-9429(1992)118:11(1464); Arfi R, 2005, PHYS CHEM EARTH, V30, P432, DOI 10.1016/j.pce.2005.06.010; Becker V, 2010, WATER RES, V44, P3345, DOI 10.1016/j.watres.2010.03.018; Benyahya L, 2007, J ENVIRON ENG SCI, V6, P437, DOI [10.1139/S06-067, 10.1139/s06-067]; Boehrer B, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000210; Butcher JB, 2015, CLIMATIC CHANGE, V129, P295, DOI 10.1007/s10584-015-1326-1; Coats R, 2006, CLIMATIC CHANGE, V76, P121, DOI 10.1007/s10584-005-9006-1; Cole TM, 2003, CE QUAL W2 2 DIMENSI; DAKE JMK, 1969, WATER RESOUR RES, V5, P484, DOI 10.1029/WR005i002p00484; Debele B, 2008, ENVIRON MODEL ASSESS, V13, P135, DOI 10.1007/s10666-006-9075-1; Ding YJ, 2007, SCI CHINA SER D, V50, P936, DOI 10.1007/s11430-007-0042-8; Fischer HB, 2013, MIXING INLAND COASTA, DOI [10.1016/B978-0-08-051177-1.50005-2, DOI 10.1016/B978-0-08-051177-1.50005-2]; Foley B, 2012, FRESHWATER BIOL, V57, P278, DOI 10.1111/j.1365-2427.2011.02662.x; Han BP, 2000, ECOL MODEL, V125, P109, DOI 10.1016/S0304-3800(99)00176-3; Hayes NM, 2017, LIMNOL OCEANOGR LETT, V2, P47, DOI 10.1002/lol2.10036; He W, 2019, SCI TOTAL ENVIRON, V658, P1085, DOI 10.1016/j.scitotenv.2018.12.207; Huang L, 2017, J GEOPHYS RES-ATMOS, V122, P13095, DOI 10.1002/2017JD027379; IMBERGER J, 1985, LIMNOL OCEANOGR, V30, P737, DOI 10.4319/lo.1985.30.4.0737; Jan-Tai K, 1994, WATER SCI TECHNOL, V30, P63, DOI [10.2166/wst.1994.0029, DOI 10.2166/WST.1994.0029]; Ketabchy M, 2019, SCI TOTAL ENVIRON, V671, P215, DOI 10.1016/j.scitotenv.2019.03.248; Kraemer BM, 2015, GEOPHYS RES LETT, V42, P4981, DOI 10.1002/2015GL064097; Labaj AL, 2017, J PLANKTON RES, V39, P211, DOI 10.1093/plankt/fbw092; Lee RM, 2018, WATER-SUI, V10, DOI 10.3390/w10091284; Lerman A, 1995, PHYS CHEM LAKES, DOI [10.1002/iroh.19960810312, DOI 10.1002/IROH.19960810312]; Lewis WM, 2019, WATER RESOUR RES, V55, P1988, DOI 10.1029/2018WR023555; Li N, 2018, J HYDRODYN, V30, P267, DOI 10.1007/s42241-018-0035-4; Li XY, 2009, LAND DEGRAD DEV, V20, P69, DOI 10.1002/ldr.885; Li Y, 2018, WATER SCI TECH-W SUP, V18, P418, DOI 10.2166/ws.2017.068; Li YP, 2010, LAKE RESERV MANAGE, V26, P258, DOI 10.1080/07438141.2010.541326; Li YP, 2011, ECOL ENG, V37, P325, DOI 10.1016/j.ecoleng.2010.11.024; Liu M, 2019, SCI TOTAL ENVIRON, V651, P614, DOI 10.1016/j.scitotenv.2018.09.215; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; Ma WX, 2015, ENVIRON SCI POLLUT R, V22, P18372, DOI 10.1007/s11356-015-4764-4; MacIntyre S, 2002, LIMNOL OCEANOGR, V47, P656, DOI 10.4319/lo.2002.47.3.0656; Magee MR, 2017, HYDROL EARTH SYST SC, V21, P6253, DOI 10.5194/hess-21-6253-2017; MARTIN JL, 1988, J ENVIRON ENG-ASCE, V114, P317, DOI 10.1061/(ASCE)0733-9372(1988)114:2(317); Mi CX, 2019, ENVIRON SCI EUR, V31, DOI 10.1186/s12302-019-0202-4; Mooij WM, 2010, AQUAT ECOL, V44, P633, DOI 10.1007/s10452-010-9339-3; Norton GE, 2009, J ENVIRON MANAGE, V90, P866, DOI 10.1016/j.jenvman.2008.02.002; Oveisy A, 2012, LIMNOL OCEANOGR, V57, P43, DOI 10.4319/lo.2012.57.1.0043; OWENS EM, 1986, WATER RESOUR BULL, V22, P219; Rangel-Peraza J. G., 2012, Lakes & Reservoirs Research and Management, V17, P119, DOI 10.1111/j.1440-1770.2012.00503.x; Rogora M, 2018, HYDROBIOLOGIA, V824, P33, DOI 10.1007/s10750-018-3623-y; Rueda F, 2009, LIMNOL OCEANOGR, V54, P2003, DOI 10.4319/lo.2009.54.6.2003; Saber A, 2018, ADV WATER RESOUR, V119, P150, DOI 10.1016/j.advwatres.2018.07.006; Sahoo GB, 2016, LIMNOL OCEANOGR, V61, P496, DOI 10.1002/lno.10228; Sahoo GB, 2013, CLIMATIC CHANGE, V116, P71, DOI 10.1007/s10584-012-0600-8; Schwefel R, 2016, WATER RESOUR RES, V52, P8794, DOI 10.1002/2016WR019194; Stainsby EA, 2011, J GREAT LAKES RES, V37, P55, DOI 10.1016/j.jglr.2011.04.001; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Tuo Y, 2011, EFFECTS WATER TEMPER, P5916, DOI [10.1016/j.coldregions.2017.08.014, DOI 10.1016/J.COLDREGIONS.2017.08.014]; Tuo YC, 2018, COLD REG SCI TECHNOL, V146, P223, DOI 10.1016/j.coldregions.2017.08.014; van Emmerik THM, 2013, LIMNOL OCEANOGR-METH, V11, P79, DOI 10.4319/lom.2013.11.79; Vercauteren N, 2011, WATER RESOUR RES, V47, DOI 10.1029/2011WR010529; Vermeyen TB, 1995, WATER RESOURCES ENGINEERING, VOLS 1 AND 2, P521; Wang JB, 2020, J HYDROL, V584, DOI 10.1016/j.jhydrol.2020.124668; Wang JB, 2009, LIMNOLOGY, V10, P149, DOI 10.1007/s10201-009-0266-8; Wang XD, 2008, J ARID ENVIRON, V72, P1929, DOI 10.1016/j.jaridenv.2008.06.005; Weber M, 2017, J ENVIRON MANAGE, V197, P96, DOI 10.1016/j.jenvman.2017.03.020; Woolway RI, 2019, NAT GEOSCI, V12, P271, DOI 10.1038/s41561-019-0322-x; [谢奇珂 Xie Qike], 2019, [水力发电学报, Journal of Hydroelectric Engineering], V38, P41; Xie QK, 2017, WATER-SUI, V9, DOI 10.3390/w9080603; [徐梦珍 Xu Mengzhen], 2012, [生态学报, Acta Ecologica Sinica], V32, P2351; You QL, 2007, J GEOGR SCI, V17, P409, DOI 10.1007/s11442-007-0409-y; Zhang YL, 2015, WATER RES, V75, P249, DOI 10.1016/j.watres.2015.02.052; Zhang YL, 2014, LIMNOL OCEANOGR, V59, P1193, DOI 10.4319/lo.2014.59.4.1193; Zhu LP, 2019, SCI BULL, V64, P422, DOI 10.1016/j.scib.2019.02.016	69	4	4	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243198	10.1371/journal.pone.0243198	http://dx.doi.org/10.1371/journal.pone.0243198			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347489	gold, Green Published			2022-12-27	WOS:000603071100025
J	Chen, Y; Lin, BH; Mancino, L; Ploeg, MV; Zhen, C				Chen, Yu; Lin, Biing-Hwan; Mancino, Lisa; Ploeg, Michele Ver; Zhen, Chen			Nutritional quality of retail food purchases is not associated with participation in the Supplemental Nutrition Assistance Program for nutrition-oriented households	PLOS ONE			English	Article							DIETARY QUALITY; OBESITY; ADULTS; SNAP; INSECURITY; CHOICES; IMPACT	The Supplemental Nutrition Assistance Program (SNAP) provides millions of low-income Americans food benefits and other forms of nutrition assistance. Evidence indicates that SNAP reduces food insecurity. However, there is a concern that the food benefit may increase the demand for less healthy foods more than healthier foods, thereby reducing the overall nutritional quality of the participant's food basket. This paper aims to examine the association of SNAP participation with the nutritional quality of food-at-home purchases of low-income households and to investigate the potential heterogeneity among consumers with different levels of nutrition attitude. This analysis used food purchase data from the USDA National Household Food Acquisition and Purchase Survey (FoodAPS). Our study sample included 2,218 low-income households, of which 1,184 are SNAP participants, and 1,034 are income-eligible nonparticipants. Multivariate regressions were performed to explore the SNAP-nutritional quality association. A household's nutrition attitude was measured using its response to a question on whether the household searched for nutrition information online in the last 2 months. Households that affirmed they had an online nutrition search were treated as nutrition-oriented households (21.2% of the low-income sample), and households that did not were considered less nutrition-oriented households (78.8%). For robustness, we also created an alternative nutrition attitude measure based on reported use of the nutrition facts label. We found that among less nutrition-oriented households, SNAP participants had a statistically significant 0.097 points (p = 0.018) lower Guiding Stars rating than low-income nonparticipants. However, there was no significant SNAP-nutritional quality association among nutrition-oriented households. In conclusion, SNAP participation was associated with lower nutritional quality of food purchases among less nutrition-oriented households, but not among nutrition-oriented households. The results suggest that the intended nutritional benefits of restrictions on purchases of healthy foods may not reach the subgroup of nutrition-oriented SNAP participants.	[Chen, Yu; Zhen, Chen] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA; [Lin, Biing-Hwan; Mancino, Lisa] Econ Res Serv, USDA, Washington, DC USA; [Ploeg, Michele Ver] George Washington Univ, Milken Inst Sch Publ Hlth, Food & Hlth Policy Inst, Washington, DC USA; [Zhen, Chen] Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA	University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); George Washington University; University System of Georgia; University of Georgia	Zhen, C (corresponding author), Univ Georgia, Dept Agr & Appl Econ, Athens, GA 30602 USA.	czhen@uga.edu		Zhen, Chen/0000-0002-6087-7387	U.S. Department of Agriculture, Economic Research Service [58-4000-6-0052]	U.S. Department of Agriculture, Economic Research Service(United States Department of Agriculture (USDA))	CZ is the author who received the award. This research was supported by the intramural research program of the U.S. Department of Agriculture, Economic Research Service and cooperative agreement 58-4000-6-0052. The findings and conclusions in this publication are those of the author(s) and should not be construed to represent any official USDA or U.S. Government determination or policy. The funder website is https://www.ers.usda.gov/.The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Aggarwal A, 2014, J ACAD NUTR DIET, V114, P266, DOI 10.1016/j.jand.2013.06.006; Andreyeva T, 2015, AM J PREV MED, V49, P594, DOI 10.1016/j.amepre.2015.04.035; Andreyeva T, 2012, AM J PREV MED, V43, P411, DOI 10.1016/j.amepre.2012.06.015; [Anonymous], 2013, SAS 94 COMP SOFTW; [Anonymous], 2018, NUTR QUALITY FOODS A; [Anonymous], 2016, NUTR COD OV; Beydoun MA, 2008, EUR J CLIN NUTR, V62, P303, DOI 10.1038/sj.ejcn.1602700; Brownell KD, 2011, JAMA-J AM MED ASSOC, V306, P1370, DOI 10.1001/jama.2011.1382; Cates S, 2014, J NUTR EDUC BEHAV, V46, pS103; Chalak K, 2011, CAN J ECON, V44, P1, DOI 10.1111/j.1540-5982.2010.01622.x; Cole N., 2008, DIET QUALITY AM FOOD; Cuffey J, 2016, PUBLIC HEALTH NUTR, V19, P3216, DOI 10.1017/S1368980015003511; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Dinour LM, 2007, J AM DIET ASSOC, V107, P1952, DOI 10.1016/j.jada.2007.08.006; Fey-Yensan N, 2003, J AM DIET ASSOC, V103, P103, DOI 10.1053/jada.2003.50010; Fischer LM, 2011, AM J HLTH PROMOT, V26, pe55, DOI DOI 10.4278/AJHP.100709-QUAL-238; Fox M, 2004, 040141 EFAN USDA EC; Gregory C., 2013, Supplemental Nutrition Assistance Program (SNAP) participation leads to modest changes in diet quality; Guenther PM, 2014, J NUTR, V144, P399, DOI 10.3945/jn.113.183079; Gundersen C, 2017, AM J AGR ECON, V99, P875, DOI 10.1093/ajae/aax026; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; Harnack L, 2016, JAMA INTERN MED, V176, P1610, DOI 10.1001/jamainternmed.2016.5633; Hearty AP, 2007, APPETITE, V48, P1, DOI 10.1016/j.appet.2006.03.329; Hilmers A, 2014, PREV MED, V62, P44, DOI 10.1016/j.ypmed.2014.01.016; Leung CW, 2014, J NUTR EDUC BEHAV, V46, P68, DOI 10.1016/j.jneb.2013.10.001; Leung CW, 2013, PEDIATRICS, V131, P463, DOI 10.1542/peds.2012-0889; Leung CW, 2012, AM J CLIN NUTR, V96, P977, DOI 10.3945/ajcn.112.040014; Leung CW, 2011, PUBLIC HEALTH NUTR, V14, P645, DOI 10.1017/S1368980010002090; Levin SM, 2017, AM J PREV MED, V52, pS186, DOI 10.1016/j.amepre.2016.07.016; Mankiw N.G., 2020, PRINCIPLES MICROECON, DOI 10.1016/j.neuroimage.2019.116122; Mozaffarian D, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002661; Nguyen BT, 2014, MAYO CLIN PROC, V89, P1211, DOI 10.1016/j.mayocp.2014.05.010; Pinard CA, 2017, J HUNGER ENVIRON NUT, V12, P151, DOI 10.1080/19320248.2016.1146194; Rahkovsky I, 2013, FOOD POLICY, V43, P100, DOI 10.1016/j.foodpol.2013.08.013; Ratcliffe C, 2011, AM J AGR ECON, V93, P1082, DOI 10.1093/ajae/aar026; Rosenbaum D, 2018, FACTORS AFFECTING SN; Savoie MR, 2015, J NUTR EDUC BEHAV, V47, P81, DOI 10.1016/j.jneb.2014.08.009; Schwartz MB, 2017, AM J PREV MED, V52, pS199, DOI 10.1016/j.amepre.2016.09.022; Steele-Adjognon M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4942-z; Taylor R, 2016, AM J AGR ECON, V98, P513, DOI 10.1093/ajae/aaw009; The Lancet HIV, 2017, LANCET HIV, V4, pe51; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Ver Ploeg M., 2015, DO AM USUALLY SHOP F; Vericker TC, 2019, J SCHOOL HEALTH, V89, P907, DOI 10.1111/josh.12828; Williams PA, 2014, J ACAD NUTR DIET, V114, P1001, DOI 10.1016/j.jand.2014.01.015	46	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0240263	10.1371/journal.pone.0240263	http://dx.doi.org/10.1371/journal.pone.0240263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338058	gold, Green Published			2022-12-27	WOS:000601313500016
J	Azene, ZN; Merid, MW; Muluneh, AG; Geberu, DM; Kassa, GM; Yenit, MK; Tilahun, SY; Gelaye, KA; Mekonnen, HS; Azagew, AW; Wubneh, CA; Belay, GM; Asmamaw, NT; Agegnehu, CD; Azale, T; Tamiru, AT; Rade, BK; Taye, EB; Taddese, AA; Andualem, Z; Dagne, H; Gashaye, KT; Kabito, GG; Mekonnen, TH; Daba, S; Azanaw, J; Adane, T; Alemayeyu, M				Azene, Zelalem Nigussie; Merid, Mehari Woldemariam; Muluneh, Atalay Goshu; Geberu, Demiss Mulatu; Kassa, Getahun Molla; Yenit, Melaku Kindie; Tilahun, Sewbesew Yitayih; Gelaye, Kassahun Alemu; Mekonnen, Habtamu Sewunet; Azagew, Abere Woretaw; Wubneh, Chalachew Adugna; Belay, Getaneh Mulualem; Asmamaw, Nega Tezera; Agegnehu, Chilot Desta; Azale, Telake; Tamiru, Animut Tagele; Rade, Bayew Kelkay; Taye, Eden Bishaw; Taddese, Asefa Adimasu; Andualem, Zewudu; Dagne, Henok; Gashaye, Kiros Terefe; Kabito, Gebisa Guyasa; Mekonnen, Tesfaye Hambisa; Daba, Sintayehu; Azanaw, Jember; Adane, Tsegaye; Alemayeyu, Mekuriaw			Adherence towards COVID-19 mitigation measures and its associated factors among Gondar City residents: A community-based cross-sectional study in Northwest Ethiopia	PLOS ONE			English	Article								Background Considering its pandemicity and absence of effective treatment, authorities across the globe have designed various mitigation strategies to combat the spread of COVID-19. Although adherence towards preventive measures is the only means to tackle the virus, reluctance to do so has been reported to be a major problem everywhere. Thus, this study aimed to assess the community's adherence towards COVID-19 mitigation strategies and its associated factors among Gondar City residents, Northwest Ethiopia. Methods A community-based cross-sectional study was employed among 635 respondents from April 20-27, 2020. Cluster sampling technique was used to select the study participants. Data were collected using an interviewer-administered structured questionnaire. Epi-Data version 4.6 and STATA version 14 were used for data entry and analysis, respectively. Binary logistic regressions (Bivariable and multivariable) were performed to identify statistically significant variables. Adjusted odds ratio with 95% CI was used to declare statistically significant variables on the basis of p < 0.05 in the multivariable logistic regression model. Results The overall prevalence of good adherence towards COVID-19 mitigation measures was 51.04% (95%CI: 47.11, 54.96). Female respondents [AOR: 2.39; 95%CI (1.66, 3.45)], receiving adequate information about COVID-19 [AOR: 1.58; 95%CI (1.03, 2.43)], and favorable attitude towards COVID-19 preventive measures were significantly associated with good adherence towards COVID-19 mitigation measures. Whereas, those respondents who had high risk perception of COVID-19 were less likely to adhere towards COVID-19 mitigation measures [AOR: 0.61; 95% CI (0.41, 0.92)]. Conclusions The findings have indicated that nearly half of the study participants had poor adherence towards COVID-19 mitigation measures. Sex, level of information exposure, attitude towards COVID-19 preventive measures, and risk perception of COVID-19 were factors which significantly influenced the adherence of the community towards COVID-19 mitigation measures. Therefore, it is crucial to track adherence responses towards the COVID-19 preventive measures, scale up the community's awareness of COVID-19 prevention and mitigation strategies through appropriate information outlets, mainstream media, and rely on updating information from TV, radio, and health care workers about COVID-19.	[Azene, Zelalem Nigussie] Univ Gondar, Sch Midwifery, Dept Womens & Family Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia; [Merid, Mehari Woldemariam; Muluneh, Atalay Goshu; Kassa, Getahun Molla; Yenit, Melaku Kindie; Gelaye, Kassahun Alemu; Taddese, Asefa Adimasu] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Geberu, Demiss Mulatu] Univ Gondar, Dept Hlth Syst & Policy, Gondar, Ethiopia; [Tilahun, Sewbesew Yitayih] Univ Gondar, Dept Psychiat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Mekonnen, Habtamu Sewunet; Azagew, Abere Woretaw] Univ Gondar, Sch Nursing, Dept Med Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia; [Wubneh, Chalachew Adugna; Belay, Getaneh Mulualem; Asmamaw, Nega Tezera] Univ Gondar, Sch Nursing, Dept Pediat & Child Hlth Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia; [Agegnehu, Chilot Desta] Univ Gondar, Sch Nursing, Coll Med & Hlth Sci, Gondar, Ethiopia; [Agegnehu, Chilot Desta] Univ Gondar, Comprehens Specialized Hosp, Gondar, Ethiopia; [Azale, Telake] Univ Gondar, Inst Publ Hlth, Dept Hlth Educ & Behav Sci, Coll Med & Hlth Sci, Gondar, Ethiopia; [Tamiru, Animut Tagele; Rade, Bayew Kelkay] Univ Gondar, Sch Midwifery, Dept Gen Midwifery, Coll Med & Hlth Sci, Gondar, Ethiopia; [Taye, Eden Bishaw] Univ Gondar, Sch Midwifery, Dept Clin Midwifery, Coll Med & Hlth Sci, Gondar, Ethiopia; [Andualem, Zewudu; Dagne, Henok; Kabito, Gebisa Guyasa; Mekonnen, Tesfaye Hambisa; Daba, Sintayehu; Azanaw, Jember; Adane, Tsegaye; Alemayeyu, Mekuriaw] Univ Gondar, Coll Med & Hlth Sci, Dept Environm & Occupat Hlth, Gondar, Ethiopia; [Andualem, Zewudu; Dagne, Henok; Kabito, Gebisa Guyasa; Mekonnen, Tesfaye Hambisa; Daba, Sintayehu; Azanaw, Jember; Adane, Tsegaye; Alemayeyu, Mekuriaw] Univ Gondar, Coll Med & Hlth Sci, Safety Inst Publ Hlth, Gondar, Ethiopia; [Gashaye, Kiros Terefe] Univ Gondar, Dept Gynecol & Obstet, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Azene, ZN (corresponding author), Univ Gondar, Sch Midwifery, Dept Womens & Family Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	znigussie35@gmail.com	Mekonnen, Habtamu/GLN-7652-2022; Guyasa, Gebisa/AAU-1131-2021; Adane, Tsegaye/HGU-1897-2022; Mekonnen, Tesfaye/GQP-8197-2022; Mekonnen, Tesfaye/ABB-4922-2021; Wubneh, Chalachew Adugna/CAA-2058-2022; Dagne, Henok/AAM-6529-2021	Mekonnen, Habtamu/0000-0001-9396-7437; Adane, Tsegaye/0000-0003-3006-6169; Mekonnen, Tesfaye/0000-0002-4414-6795; Bante, Agegnehu/0000-0003-0583-6635; Yenit, Melaku Kindie/0000-0002-8982-2814; Azanaw, Jember/0000-0001-5702-1476; Bishaw, Eden/0000-0003-2904-2450; Kassa, Getahun Molla/0000-0002-9926-7797; Azene, Zelalem Nigussie/0000-0002-3511-7562; Andualem, Zewudu/0000-0002-4731-1696; Kelkay, Bayew/0000-0003-3530-6264; Derso, Henok Dagne/0000-0001-7161-0904; Kassa, Getachew Mullu/0000-0002-8095-7376	University of Gondar	University of Gondar	This study was funded by University of Gondar. However, the funder had no role in data collection, preparation of manuscript, and decision to publish.	Alfonso Medinilla BBaPA, AFR REG RESP COVID 1; Amgain K, 2020, J KARNALI ACAD HLTH, V3; [Anonymous], 2020, FACTS VS MYTHS 10 CO; Assefa D, 2020, COVID 19 PANDEMIC IT; ATAGI, 2020, GUID PRINC MAINT IMM; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Cao XT, 2020, NAT REV IMMUNOL, V20, P269, DOI 10.1038/s41577-020-0308-3; Cascella M, 2020, FEATURES EVALUATION, V1st, DOI DOI 10.1016/j.autrev.2016.07.022; CDC, 2019, DIS IMP ALL US INF; Geana Mugur V, 2020, Kans J Med, V13, P160; Harper C.A., 2020, INT J MENT HEALTH AD, P1, DOI DOI 10.1007/s11469-020-00281-5; Hirvonen K, 2020, EC IMPACTS COVID 19; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Khadka S, 2020, DRUGS THER PERSPECT, V36, P250, DOI 10.1007/s40267-020-00728-8; Klopfenstein T, 2020, INT J INFECT DIS, V100, P117, DOI 10.1016/j.ijid.2020.08.012; Kwok KO, 2020, COMMUNITY RESPONSES; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125; Liu YW, 2022, J AM STAT ASSOC, V117, P897, DOI 10.1080/01621459.2020.1831926; Malm Andreas., 2020, CORONA CLIMATE CHRON; Mansuri FMA, 2020, J TAIBAH U MED SCI; Nivette A, 2020, NONCOMPLIANCE COVID; Plohl N, 2021, PSYCHOL HEALTH MED, V26, P1, DOI 10.1080/13548506.2020.1772988; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Sarla GS., 2020, NURSING, V2, P5; Solomou I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144924; Soumya Roy, 2020, Indian Journal of Medical Sciences, V72, P5, DOI 10.25259/IJMS_26_2020; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V41, P145, DOI DOI 10.1056/NEJMcp2009249; Van Rooij B, 2020, COMPLIANCE COVID19 M; Wesseley, 2020, FACTORS AFFECTING HE; Wise T, 2020, CHANGES RISK PERCEPT; Zhou Q, 2020, AM J INFECT CONTROL, V48, P1074, DOI 10.1016/j.ajic.2020.05.043	34	21	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244265	10.1371/journal.pone.0244265	http://dx.doi.org/10.1371/journal.pone.0244265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378332	Green Published, gold			2022-12-27	WOS:000605651300074
J	Matsuyama, Y; Fujiwara, T; Sawada, Y; Yagi, J; Mashiko, H; Kawachi, I				Matsuyama, Yusuke; Fujiwara, Takeo; Sawada, Yasuyuki; Yagi, Junko; Mashiko, Hirobumi; Kawachi, Ichiro		Great East Japan	Delay discounting in children exposed to disaster	PLOS ONE			English	Article							TIME-PREFERENCES; PRESCHOOL DELAY; GRATIFICATION	Delay discounting is an important predictor of future health and academic success in children but can change in environmental uncertainty situations. Here we show that the experience of loss of housing in the Great East Japan Earthquake 2011-but not other psychological trauma such as loss of loved ones-was correlated delay discounting of children. In 2014, we assessed delay discounting in children (N = 167; mean age = 8.3 years-old), who were preschool age at the time of the earthquake (mean age at the time of disaster = 4.8 years-old) in a time-investment exercise where children allocated five tokens between rewards "now" (one candy per token on the same day) versus "one month later" (two candies per token one month later). The number of tokens allocated for "now" was higher by 0.535 (95% confidence interval: -0.012, 1.081) in children who had their housing destroyed or flooded than those with no housing damage. Other types of traumatic experiences were not associated with delay discounting.	[Matsuyama, Yusuke; Fujiwara, Takeo] Tokyo Med & Dent Univ, Dept Global Hlth Promot, Tokyo, Japan; [Sawada, Yasuyuki] Univ Tokyo, Tokyo, Japan; [Sawada, Yasuyuki] Asian Dev Bank, Mandaluyong, Philippines; [Yagi, Junko] Iwate Med Univ, Dept Psychiat, Morioka, Iwate, Japan; [Mashiko, Hirobumi] Fukushima Rehabil Ctr Children, Fukushima, Japan; [Kawachi, Ichiro] Harvard Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Tokyo Medical & Dental University (TMDU); University of Tokyo; Asian Development Bank; Iwate Medical University; Harvard University; Harvard T.H. Chan School of Public Health	Fujiwara, T (corresponding author), Tokyo Med & Dent Univ, Dept Global Hlth Promot, Tokyo, Japan.	fujiwara.hlth@tmd.ac.jp	Matsuyama, Yusuke/Q-5905-2017	Matsuyama, Yusuke/0000-0002-6114-5604	Ministry of Health, Labour and Welfare [H24jisedai-shitei-007, H25-seiiku-shitei-00x, H28sukoyaka-shitei-003, H28-kodomokosodate]; Meiji Yasuda Mental Health Fundation	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Meiji Yasuda Mental Health Fundation	This study is supported by a grant from the Ministry of Health, Labour and Welfare (H24jisedai-shitei-007, H25-seiiku-shitei-00x, H28sukoyaka-shitei-003, H28-kodomokosodate) and Meiji Yasuda Mental Health Fundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesaka M, 2019, J ECON BEHAV ORGAN, V166, P239, DOI 10.1016/j.jebo.2019.08.013; Angerer S, 2015, J ECON SCI ASSOC-JES, V1, P158, DOI 10.1007/s40881-015-0016-0; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Asgary A, 2009, INT J ENVIRON RES, V3, P379; Blair C, 2012, AM PSYCHOL, V67, P309, DOI 10.1037/a0027493; Cassar A, 2017, WORLD DEV, V94, P90, DOI 10.1016/j.worlddev.2016.12.042; Courtemanche CJ, 2015, NBER WORK PAP SER, P6; Fehr E, 2011, ECON J, V121, pF396, DOI 10.1111/j.1468-0297.2011.02478.x; Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109342; Golsteyn BHH, 2014, ECON J, V124, pF739, DOI 10.1111/ecoj.12095; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; James A, 2017, ARTEFACTUAL F EXP, P615; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kang MI, 2016, ECON HUM BIOL, V21, P122, DOI 10.1016/j.ehb.2015.09.005; Karreman A, 2006, INFANT CHILD DEV, V15, P561, DOI 10.1002/icd.478; Kidd C, 2013, COGNITION, V126, P109, DOI 10.1016/j.cognition.2012.08.004; Kuroishi Y, 2019, CIRJEF1130; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lerner JS, 2013, PSYCHOL SCI, V24, P72, DOI 10.1177/0956797612450302; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037/0022-3514.54.4.687; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Mischel W, 2011, SOC COGN AFFECT NEUR, V6, P252, DOI 10.1093/scan/nsq081; Reynolds B, 2005, PSYCHOL REC, V55, P439, DOI 10.1007/BF03395520; Sawada Y., 2015, DISASTER RISKS SOCIA, V34, P27; Sawada Y, 2018, DISASTERS AGGRAVATE; Schlam TR, 2013, J PEDIATR-US, V162, P90, DOI 10.1016/j.jpeds.2012.06.049; SHODA Y, 1990, DEV PSYCHOL, V26, P978, DOI 10.1037/0012-1649.26.6.978; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549	29	1	1	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0243994	10.1371/journal.pone.0243994	http://dx.doi.org/10.1371/journal.pone.0243994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378366	Green Published, gold			2022-12-27	WOS:000605651300027
J	Al-Rubeaan, K; Tong, C; Taylor, H; Miller, K; Thanh, TNP; Ridley, C; Steeves, S; Marsh, W				Al-Rubeaan, Khalid; Tong, Cindy; Taylor, Hannah; Miller, Karl; Nguyen Phan Thanh, Thao; Ridley, Christian; Steeves, Sara; Marsh, William			Enhanced recovery programmes versus conventional care in bariatric surgery: A systematic literature review and meta-analysis	PLOS ONE			English	Review							FAST-TRACK; CARDIOVASCULAR RISK; VARIANCE ESTIMATORS; PERIOPERATIVE CARE; METABOLIC SURGERY; OBESITY; COMPLICATIONS; FEASIBILITY; OVERWEIGHT; STATEMENT	Background With obesity prevalence projected to increase, the demand for bariatric surgery will consequently rise. Enhanced recovery programmes aim for improved recovery, earlier discharge, and more efficient use of resources following surgery. This systematic literature review aimed to evaluate the evidence available on the effects of enhanced recovery programmes after three common bariatric procedures: laparoscopic Roux-en-Y gastric bypass (LRYGB), laparoscopic sleeve gastrectomy (LSG), and one anastomosis gastric bypass (OAGB). Methods MEDLINE, Embase, the Cochrane Library and the National Health Service Economic Evaluation Database were searched for studies published in 2012-2019 comparing outcomes with enhanced recovery programmes versus conventional care after bariatric surgery in Europe, the Middle East and Africa. Data were extracted and meta-analyses or descriptive analyses performed when appropriate using R. Results Of 1152 screened articles, seven relevant studies including 3592 patients were identified. Six reported outcomes for 1434 patients undergoing LRYGB; however, as only individual studies reported on LSG and OAGB these could not be included in the analyses. The meta-analysis revealed a significantly shorter mean duration of hospital-stay for LRYGB enhanced recovery programmes than conventional care (mean difference [95% CI]: -1.34 days [-2.01, -0.67]; p<0.0001), supported by sensitivity analysis excluding retrospective studies. Meta-analysis found no significant difference in 30-day readmission rate (risk ratio [95% CI]: 1.39 [0.84, 2.28]; p = 0.2010). Complication rates were inconsistently reported by Clavien-Dindo grade, but descriptive analysis showed generally higher low-grade rates for enhanced recovery programmes; the trend reversed for high-grade complications. Reoperation rates were rarely reported; no significant differences were seen. Conclusion These results support enhanced recovery programmes allowing shorter inpatient stay without significant differences in readmission rate following LRYGB, although complication and reoperation rate comparisons were inconclusive. Further research is needed to fill current data gaps including the lack of studies on LSG and OAGB.	[Al-Rubeaan, Khalid] Sultan Bin Abdulaziz Humanitarian City, Res & Sci Ctr, Riyadh, Saudi Arabia; [Tong, Cindy] Johnson & Johnson Med Devices, Somerville, NJ USA; [Taylor, Hannah] Johnson & Johnson Med Ltd, Leeds, W Yorkshire, England; [Miller, Karl] Johnson & Johnson Middle East FZ LLC, Dubai, U Arab Emirates; [Nguyen Phan Thanh, Thao] Johnson & Johnson Med SAS, St Priest, France; [Ridley, Christian; Steeves, Sara; Marsh, William] Costello Med Consulting Ltd, Cambridge, England	Johnson & Johnson; Costello Medical Consulting	Taylor, H (corresponding author), Johnson & Johnson Med Ltd, Leeds, W Yorkshire, England.	htaylor8@its.jnj.com			Johnson & Johnson Medical NV	Johnson & Johnson Medical NV	This study was sponsored by Johnson & Johnson Medical NV. CT, HT, KM and TN are employees of Johnson & Johnson. KA, CR, SS and WMserved as paid consultants for Johnson & Johnson. The funder provided support in the form of salaries for CT, HT, KM and TN, remuneration for KA, CR, SS and WM, and contributed to the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. All authors had full access to the data, reviewed and approved the final version, and were responsible for the decision to submit for publication. A medical writing agency, employed by the funder, assisted with manuscript preparation under the authors' direction.	Abuyassin B, 2016, WORLD J DIABETES, V7, P165, DOI 10.4239/wjd.v7.i8.165; Ahmed OS, 2018, J GASTROINTEST SURG, V22, P964, DOI 10.1007/s11605-018-3709-x; Borisenko O, 2015, OBES SURG, V25, P1408, DOI 10.1007/s11695-014-1537-y; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Diabetes UK, WEIGHT LOSS SURG TYP; Dogan K, 2015, OBES SURG, V25, P28, DOI 10.1007/s11695-014-1355-2; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Elias KM, 2019, WORLD J SURG, V43, P1, DOI 10.1007/s00268-018-4753-0; Geubbels N, 2019, BJS OPEN, V3, P274, DOI 10.1002/bjs5.50143; Geubbels N, 2014, OBES SURG, V24, P390, DOI 10.1007/s11695-013-1133-6; Golay A, 2005, BEST PRACT RES CL EN, V19, P649, DOI 10.1016/j.beem.2005.07.010; GRUNDY SM, 1990, DM-DIS MON, V36, P641; Gulliford MC, 2016, COSTS OUTCOMES INCRE, DOI [10.1016/j.jval.2016.08.734, DOI 10.1016/J.JVAL.2016.08.734]; Hawkins SC, 2007, OBES SURG, V17, P434, DOI 10.1007/s11695-007-9073-7; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Holtorf AP, 2012, ADV BARIATRIC METABO, V3, P61; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Karim MA, 2013, ASIAN J ENDOSC SURG, V6, P197, DOI 10.1111/ases.12042; Klein S, 2004, CIRCULATION, V110, P2952, DOI 10.1161/01.CIR.0000145546.97738.1E; Malczak P, 2017, OBES SURG, V27, P226, DOI 10.1007/s11695-016-2438-z; Mannaerts GHH, 2019, OBES SURG, V29, P2100, DOI 10.1007/s11695-019-03841-4; Marathe PH, 2017, J DIABETES, V9, P320, DOI 10.1111/1753-0407.12524; Melnyk M, 2011, CUAJ-CAN UROL ASSOC, V5, P342, DOI 10.5489/cuaj.11002; Moher D, 2011, EPIDEMIOLOGY, V22, P128, DOI 10.1097/EDE.0b013e3181fe7825; National Institute for Health and Care Excellence, SINGL TECHN APPR US; National Institute for Health and Care Excellence, OB ID ASS MAN; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Ruiz-Tovar J, 2019, SURG OBES RELAT DIS, V15, P228, DOI 10.1016/j.soard.2018.11.002; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sidik K, 2007, STAT MED, V26, P1964, DOI 10.1002/sim.2688; Simonelli V, 2016, OBES SURG, V26, P1970, DOI 10.1007/s11695-016-2255-4; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sullivan PW, 2005, DIABETES CARE, V28, P1599, DOI 10.2337/diacare.28.7.1599; Thorell A, 2016, WORLD J SURG, V40, P2065, DOI 10.1007/s00268-016-3492-3; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Welbourn R, 2019, OBES SURG, V29, P782, DOI 10.1007/s11695-018-3593-1; Welbourn R, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1472; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization Regional Office for Europe, CHALL DIAB; Yumuk V, 2015, OBESITY FACTS, V8, P402, DOI 10.1159/000442721	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0243096	10.1371/journal.pone.0243096	http://dx.doi.org/10.1371/journal.pone.0243096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373397	Green Published, gold			2022-12-27	WOS:000603612300061
J	Hasegawa, N; Takeda, K; Mancini, M; King, LA; Horak, FB; Asaka, T				Hasegawa, Naoya; Takeda, Kenta; Mancini, Martina; King, Laurie A.; Horak, Fay B.; Asaka, Tadayoshi			Differential effects of visual versus auditory biofeedback training for voluntary postural sway	PLOS ONE			English	Article							AUGMENTED FEEDBACK; BALANCE; INFORMATION; GAIT	Augmented sensory biofeedback training is often used to improve postural control. Our previous study showed that continuous auditory biofeedback was more effective than continuous visual biofeedback to improve postural sway while standing. However, it has also been reported that both discrete visual and auditory biofeedback training, presented intermittently, improves bimanual task performance more than continuous visual biofeedback training. Therefore, this study aimed to investigate the relative effectiveness of discrete visual biofeedback versus discrete auditory biofeedback to improve postural control. Twenty-two healthy young adults were randomly assigned to either a visual or auditory biofeedback group. Participants were asked to shift their center of pressure (COP) by voluntary postural sway forward and backward in line with a hidden target, which moved in a sinusoidal manner and was displayed intermittently. Participants were asked to decrease the diameter of a visual circle (visual biofeedback) or the volume of a sound (auditory biofeedback) based on the distance between the COP and the target in the training session. The feedback and the target were given only when the target reached the inflection points of the sine curves. In addition, the perceptual magnitudes of visual and auditory biofeedback were equalized using Stevens' power law. Results showed that the mean and standard deviation of the distance between COP and the target were reduced int the test session, removing the augmented sensory biofeedback, in both biofeedback training groups. However, the temporal domain of the performance improved in the test session in the auditory biofeedback training group, but not in the visual biofeedback training group. In conclusion, discrete auditory biofeedback training was more effective for the motor learning of voluntarily postural swaying compared to discrete visual biofeedback training, especially in the temporal domain.	[Hasegawa, Naoya; Asaka, Tadayoshi] Hokkaido Univ, Dept Rehabil Sci, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Takeda, Kenta] Res Inst Natl Ctr Persons Disabil, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Mancini, Martina; King, Laurie A.; Horak, Fay B.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Hokkaido University; Oregon Health & Science University	Asaka, T (corresponding author), Hokkaido Univ, Dept Rehabil Sci, Fac Hlth Sci, Sapporo, Hokkaido, Japan.	ask-chu@hs.hokudai.ac.jp	Hasegawa, Naoya/AAN-3153-2020		Japan Society for the Promotion of Science (JSPS) [20K19371, 18K10702]; National Institutes of Health [R01AG006457]; Department of Veterans Affairs Merit Award [5I01RX001075]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs)	This study was supported by Grant-in-Aid for Early-Career Scientists (No. 20K19371, NH) and for Scientific Research (No. 18K10702, TA) from Japan Society for the Promotion of Science (JSPS), the National Institutes of Health under award (No. R01AG006457, PI: FBH), and Department of Veterans Affairs Merit Award (No. 5I01RX001075, PI: FBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhasan H, 2017, CLIN INTERV AGING, V12, P487, DOI 10.2147/CIA.S127023; Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; Carpinella I, 2017, ARCH PHYS MED REHAB, V98, P622, DOI 10.1016/j.apmr.2016.11.003; Chen HY, 2012, HUM MOVEMENT SCI, V31, P1660, DOI 10.1016/j.humov.2012.06.001; Chiou SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149221; Dozza M, 2007, EXP BRAIN RES, V178, P37, DOI 10.1007/s00221-006-0709-y; Dozza Marco, 2005, J Neuroeng Rehabil, V2, P13, DOI 10.1186/1743-0003-2-13; Dozza M, 2011, GAIT POSTURE, V34, P313, DOI 10.1016/j.gaitpost.2011.05.016; Foxe JJ, 2009, CURR BIOL, V19, pR373, DOI 10.1016/j.cub.2009.03.029; Ghai S, 2019, ANN NY ACAD SCI, V1438, P50, DOI 10.1111/nyas.13967; Ghai S, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00142; Ginis P, 2016, PARKINSONISM RELAT D, V22, P28, DOI 10.1016/j.parkreldis.2015.11.004; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Hasegawa N, 2017, GAIT POSTURE, V58, P188, DOI 10.1016/j.gaitpost.2017.08.001; Holcombe AO, 2009, TRENDS COGN SCI, V13, P216, DOI 10.1016/j.tics.2009.02.005; Hove MJ, 2013, NEUROIMAGE, V67, P313, DOI 10.1016/j.neuroimage.2012.11.032; Kim SJ, 2015, IEEE T BIO-MED ENG, V62, P2244, DOI 10.1109/TBME.2015.2420851; Lakhani B, 2015, GAIT POSTURE, V41, P499, DOI 10.1016/j.gaitpost.2014.12.003; Moore S.T., 1993, PHYSICAL THERAPY PRA, V2, P1; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Petersen H, 1996, SCAND J REHABIL MED, V28, P217; Pinsault N, 2008, ARCH PHYS MED REHAB, V89, P1772, DOI 10.1016/j.apmr.2008.02.024; POSNER MI, 1976, PSYCHOL REV, V83, P157, DOI 10.1037/0033-295X.83.2.157; Radhakrishnan SM, 2011, EXP BRAIN RES, V213, P423, DOI 10.1007/s00221-011-2792-y; Radhakrishnan SM, 2010, GAIT POSTURE, V32, P650, DOI 10.1016/j.gaitpost.2010.09.010; Ranganathan R, 2009, J MOTOR BEHAV, V41, P317, DOI 10.3200/JMBR.41.4.317-330; Ronsse R, 2011, CEREB CORTEX, V21, P1283, DOI 10.1093/cercor/bhq209; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; Schmitz G, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-32; Sienko KH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00944; Sigrist R, 2013, PSYCHON B REV, V20, P21, DOI 10.3758/s13423-012-0333-8; Sotirakis H, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9193952; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Takeda K, 2017, J PHYSIOL ANTHROPOL, V36, DOI 10.1186/s40101-017-0147-5; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Zijlstra A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-58	36	5	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244583	10.1371/journal.pone.0244583	http://dx.doi.org/10.1371/journal.pone.0244583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370408	Green Published, gold			2022-12-27	WOS:000603611900062
J	Peperkoorn, LS; Becker, DV; Balliet, D; Columbus, S; Molho, C; Van Lange, PAM				Peperkoorn, Leonard S.; Becker, D. Vaughn; Balliet, Daniel; Columbus, Simon; Molho, Catherine; Van Lange, Paul A. M.			The prevalence of dyads in social life	PLOS ONE			English	Article							SIZE; EVOLUTION; COOPERATION; RECIPROCITY; PUNISHMENT; SITUATIONS; ANXIETY; GENDER; TRUST	A salient objective feature of the social environment in which people find themselves is group size. Knowledge of group size is highly relevant to behavioural scientists given that humans spend considerable time in social settings and the number of others influences much of human behaviour. What size of group do people actually look for and encounter in everyday life? Here we report four survey studies and one experience-sampling study (total N = 4,398) which provide evidence for the predominance of the dyad in daily life. Relative to larger group sizes, dyads are most common across a wide range of activities (e.g., conversations, projects, holidays, movies, sports, bars) obtained from three time moments (past activities, present, and future activities), sampling both mixed-sex and same-sex groups, with three different methodological approaches (retrospective reports, real-time data capture, and preference measures) in the United States and the Netherlands. We offer four mechanisms that may help explain this finding: reciprocity, coordination, social exclusion, and reproduction. The present findings advance our understanding of how individuals organize themselves in everyday life.	[Peperkoorn, Leonard S.; Balliet, Daniel; Columbus, Simon; Molho, Catherine; Van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands; [Becker, D. Vaughn] Arizona State Univ, Human Syst Engn, Mesa, AZ USA; [Columbus, Simon] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Molho, Catherine] Inst Adv Study Toulouse, Toulouse, France	Vrije Universiteit Amsterdam; Arizona State University; University of Copenhagen	Peperkoorn, LS (corresponding author), Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands.	l.s.peperkoorn@gmail.com	Columbus, Simon/K-3327-2019	Columbus, Simon/0000-0003-1546-955X; Molho, Catherine/0000-0002-2846-2544; Van Lange, Paul/0000-0001-7774-6984	European Research Council [635356]	European Research Council(European Research Council (ERC)European Commission)	The third author (DB) is financially supported by a Starting Grant from the European Research Council (StG #635356; https://erc.europa.eu/).Funding was used for Study 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2017, NATURE, V544, P227, DOI 10.1038/nature21723; [Anonymous], 1965, LOGIC COLLECTIVE ACT; [Anonymous], 1981, GROUP DYNAMICS PSYCH; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BAKEMAN R, 1974, ENVIRON BEHAV, V6, P378; BAUMEISTER RF, 1990, J SOC CLIN PSYCHOL, V9, P165, DOI 10.1521/jscp.1990.9.2.165; BAUMEISTER RF, 1994, PSYCHOL BULL, V115, P243, DOI 10.1037/0033-2909.115.2.243; Bierstedt R., 1964, EXCHANGE POWER SOCIA; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Brewer M, 2015, 16 INT C SOC DIL JUN; BUSS DM, 1990, J SOC CLIN PSYCHOL, V9, P196, DOI 10.1521/jscp.1990.9.2.196; CALSYN R, 1976, PSYCHOL REP, V39, P199, DOI 10.2466/pr0.1976.39.1.199; Campbell A, 2002, MIND HER OWN EVOLUTI; Caporael L R, 1997, Pers Soc Psychol Rev, V1, P276, DOI 10.1207/s15327957pspr0104_1; Caporael LR, 1995, PSYCOLOQUY, P6; Cohen J. E., 1971, CASUAL GROUPS MONKEY; Columbus S, 2021, J PERS SOC PSYCHOL, V120, P626, DOI 10.1037/pspi0000253; Crain W., 2011, THEORIES DEV CONCEPT; Cropanzano R, 2005, J MANAGE, V31, P874, DOI 10.1177/0149206305279602; David-Barrett T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118329; Dezecache G, 2012, EVOL HUM BEHAV, V33, P775, DOI 10.1016/j.evolhumbehav.2012.07.002; Dunbar R., 2010, P BR ACAD, V158, P155, DOI [10.5871/bacad/9780197264522.001.0001, DOI 10.5871/BACAD/9780197264522.001.0001]; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; DUNBAR RIM, 1995, HUM NATURE-INT BIOS, V6, P67, DOI 10.1007/BF02734136; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; Dunbar RIM., 1998, APPROACHES EVOLUTION, P92, DOI DOI 10.1016/J.SOCNET.2013.01.003; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; EMERSON RM, 1976, ANNU REV SOCIOL, V2, P335, DOI 10.1146/annurev.so.02.080176.002003; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Fehr B, 2004, J PERS SOC PSYCHOL, V86, P265, DOI 10.1037/0022-3514.86.2.265; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fischer P, 2011, PSYCHOL BULL, V137, P517, DOI 10.1037/a0023304; Forster DE, 2017, EVOL HUM BEHAV, V38, P18, DOI 10.1016/j.evolhumbehav.2016.06.003; Gabriel S, 1999, J PERS SOC PSYCHOL, V77, P642, DOI 10.1037/0022-3514.77.3.642; Gersick A, 2014, EVOL PSYCHOL-US, V12, P549; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hofmann W, 2015, SOC SCI COMPUT REV, V33, P235, DOI 10.1177/0894439314525117; Hrdy S. B., 2007, FAM RELAT, P39, DOI DOI 10.1093/ACPROF:OSO/9780195320510.003.0003; Irwin K, 2013, SOC FORCES, V91, P1057, DOI 10.1093/sf/sos196; James J, 1951, AM SOCIOL REV, V16, P474, DOI 10.2307/2088278; Jetten J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124609; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Kerr NL, 2008, GROUP DYN-THEOR RES, V12, P39, DOI 10.1037/1089-2699.12.1.39; Klapwijk A, 2009, J PERS SOC PSYCHOL, V96, P83, DOI 10.1037/a0012823; Krems JA, 2016, EVOL HUM BEHAV, V37, P423, DOI 10.1016/j.evolhumbehav.2016.05.005; Krems JA, 2013, HUM NATURE-INT BIOS, V24, P414, DOI 10.1007/s12110-013-9177-9; Kurzban R., 2005, HDB EVOLUTIONARY PSY, P653; La Macchia ST, 2016, PERS SOC PSYCHOL B, V42, P1321, DOI 10.1177/0146167216657360; LARSON DG, 1990, J SOC CLIN PSYCHOL, V9, P439, DOI 10.1521/jscp.1990.9.4.439; Markovits H, 2006, J EXP SOC PSYCHOL, V42, P662, DOI 10.1016/j.jesp.2005.09.003; Marks MA, 2001, ACAD MANAGE REV, V26, P356, DOI 10.5465/AMR.2001.4845785; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; McCullough ME, 2013, BEHAV BRAIN SCI, V36, P1, DOI 10.1017/S0140525X11002160; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; PERPER T, 1985, SEX SIGNALS BIOL LOV; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Salas E, 2005, SMALL GR RES, V36, P555, DOI 10.1177/1046496405277134; Schwarz N., 2007, SCI REAL TIME DATA C, P11; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Spoor JR, 2007, SYD SYM SOC PSYCHOL, P279; Steiner I. D, 1972, GROUP PROCESSES PROD; Sutcliffe A, 2012, BRIT J PSYCHOL, V103, P149, DOI 10.1111/j.2044-8295.2011.02061.x; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Ten Berge MA, 1999, EUR J PERSONALITY, V13, P337, DOI 10.1002/(SICI)1099-0984(199909/10)13:5<337::AID-PER363>3.0.CO;2-F; Tooby J., 1996, P BRIT ACAD, P119, DOI DOI 10.1002/(SICI)1520-6300(1998)10:5<681::AID-; Wilkowski BM, 2012, J EXP SOC PSYCHOL, V48, P1037, DOI 10.1016/j.jesp.2012.04.005	68	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244188	10.1371/journal.pone.0244188	http://dx.doi.org/10.1371/journal.pone.0244188			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370332	Green Published, Green Accepted, gold			2022-12-27	WOS:000603611900063
J	Rahman, KMM; Tareque, MI				Rahman, K. M. Mustafizur; Tareque, Md. Ismail			Determinants of cigarette/bidi smoking among youth male in rural Mymensingh of Bangladesh: A cross-sectional study	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; TOBACCO USE; ADOLESCENTS; BEHAVIOR; PREVALENCE; PREDICTORS; INITIATION	Background Smoking cigarette/bidi, is a serious health threat, causes preventable premature morbidity and mortality. Higher prevalence of smoking among the youth hampers a country's development, as the youth are the main drivers of socio-economic development. An effective understanding of factors associated with youth smoking is precious to prevent youth smoking. This study aims to identify the determinants of smoking cigarette/bidi among the youth male of the rural areas of Mymensingh district in Bangladesh. Methods The primary data from the project "Knowledge, awareness and practices among youth smokers in Trishal Upazila under Mymensingh district: A micro-survey study", funded by the Research and Extension Center, Jatiya Kabi Kazi Nazrul Islam University, Bangladesh was utilized in the current study. The data consists of 385 youth males aged 15-24 years who were interviewed face-to-face from the rural areas of Mymensingh district in Bangladesh. Univariate distribution, chi-square tests, and binary logistic regression model were employed to identify the factors associated with smoking cigarette/bidi among the youth male. Results The prevalence of smoking cigarette/bidi among the youth male is 40.3% [95% CI: 35.0%-45.0%]. Age, occupation, monthly income, family's monthly income, cigarette/bidi smoking status of father, brother and close friends, and knowledge about harmfulness of smoking are revealed as the determinants of cigarette/bidi smoking. For instance, the odds of being smoker increases with the increase in age (Odds ratio [OR]: 1.33 [1.17-1.51]). Business owner is less likely (OR: 0.15 [0.03-0.68]) to smoke than the day labourer. Having smoker fathers (OR: 2.51 [1.39-4.53]), smoker brothers (OR: 2.88 [1.39-5.96]), smoker friends (OR: 9.85 [5.85-1.27]) are significantly associated with smoking cigarette/bidi. Conclusion As the first study, it provides the determinants of cigarette/bidi smoking among youth male of the rural areas of Mymensingh district in Bangladesh. Relevant authorities are suggested to consider the study's findings and recommendations to revise the existing smoking policies so that smoking among youth can be prevented for future development of the country.	[Rahman, K. M. Mustafizur] Jatiya Kabi Kazi Nazrul Islam Univ, Dept Populat Sci, Mymensingh, Bangladesh; [Tareque, Md. Ismail] Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh	University of Rajshahi	Tareque, MI (corresponding author), Univ Rajshahi, Dept Populat Sci & Human Resource Dev, Rajshahi, Bangladesh.	tarequemi_pops@ru.ac.bd		Tareque, Md Ismail/0000-0002-6507-1171; Rahman, K. M. Mustafizur/0000-0002-3817-9048				ABUGHOSH S, 2011, EPIDEMIOLOGY, V1, P1, DOI DOI 10.4172/2161-1165.1000102; Al-Kubaisy W, 2012, PROCD SOC BEHV, V38, P59, DOI 10.1016/j.sbspro.2012.03.324; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Bandason Tsitsi, 2010, Tob Induc Dis, V8, P12, DOI 10.1186/1617-9625-8-12; Bangladesh Bureau of Statistics, 2015, BANGL POP HOUS CENS; CDC Tobacco Free, 2019, CDC TOB FREE HLTH EF; Chan Y. H., 2004, SMJ Singapore Medical Journal, V45, P149; Chhakchhuak L, 2018, TOBACCO INDUCED D S1, V16, pA964; Nguyen CV, 2012, ECON BULL, V32, P2300; Dawood OT, 2016, J PHARM BIOALLIED SC, V8, P146, DOI 10.4103/0975-7406.171738; Doku D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-758; Duko B, 2019, TOB INDUC DIS, V17, DOI 10.18332/tid/110800; Eurobarometer S, 2015, TNS OPINION SOCIAL, P429; Fernandez E, 2001, PREV MED, V32, P218, DOI 10.1006/pmed.2000.0794; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Giovino GA, 2002, ONCOGENE, V21, P7326, DOI 10.1038/sj.onc.1205808; Ham DC, 2011, J OCCUP ENVIRON MED, V53, P1337, DOI 10.1097/JOM.0b013e3182337778; Hassan MS, 2019, INT HEALTH, V11, P306, DOI 10.1093/inthealth/ihy091; Hossain S, 2017, CENT ASIAN J GLOB HE, V6, DOI 10.5195/cajgh.2017.244; Huang GC, 2014, J ADOLESCENT HEALTH, V54, P508, DOI 10.1016/j.jadohealth.2013.07.001; Islam SMS, 2016, SOUTH ASIAN J CANCER, V5, P186, DOI 10.4103/2278-330X.195339; Johnston LD., 2021, MONITORING FUTURE NA; Escario J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018736; Kamimura Akiko, 2018, J Prev Med Public Health, V51, P51, DOI 10.3961/jpmph.17.146; Khan MMH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-149; Lalithambigai G, 2016, Asian Pac J Cancer Prev, V17, P45; Linetzky B, 2012, NICOTINE TOB RES, V14, P1092, DOI 10.1093/ntr/nts004; Mejia RM, 2012, SOCIOECONOMIC STATUS, DOI [10.1093/ntr/nts004, DOI 10.1093/NTR/NTS004]; Nargis N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141135; Nasser AMA, 2019, TOB INDUC DIS, V17, DOI 10.18332/tid/109227; Nketiah-Amponsah E, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5872-0; Perelman J, 2017, ADDICTION, V112, P2248, DOI 10.1111/add.13930; Pradhan PMS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002123; Rahman MM, 2011, J COMMUN HEALTH, V36, P831, DOI 10.1007/s10900-011-9382-6; Reda AA, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-39; Saari AJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003218; Sakore DN, 2017, INT J COMMUNITY MED, V4, P3455; Shields Margot, 2007, Health Rep, V18, P9; Smet B, 1999, TOB CONTROL, V8, P186, DOI 10.1136/tc.8.2.186; Sreeramareddy CT, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0022-0; Stanton Cassandra A, 2009, Adolesc Fam Health, V4, P95; Tareque MI, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1640-6; Ullah SMA, 2018, KILA J LOCAL GOVERNA, V5, P21; United Nations, 1981, A36215 UN; van Loon AJM, 2005, EUR J PUBLIC HEALTH, V15, P256, DOI 10.1093/eurpub/cki077; Vink JM, 2003, TWIN RES, V6, P209, DOI 10.1375/twin.6.3.209; WHO, 2020, TOB OV IMP; World Health Organization, 2009, GLOB AD TOB SURV BAN; World Health Organization, 1999, COMB TOB EP WORLD HL, P65; World Health Organization . WHO, 2013, WHO BANGL NAT TOB CO	50	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244335	10.1371/journal.pone.0244335	http://dx.doi.org/10.1371/journal.pone.0244335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370411	gold, Green Published			2022-12-27	WOS:000603611900042
J	Kotoku, J; Oyama, A; Kitazumi, K; Toki, H; Haga, A; Yamamoto, R; Shinzawa, M; Yamakawa, M; Fukui, S; Yamamoto, K; Moriyama, T				Kotoku, Jun'ichi; Oyama, Asuka; Kitazumi, Kanako; Toki, Hiroshi; Haga, Akihiro; Yamamoto, Ryohei; Shinzawa, Maki; Yamakawa, Miyae; Fukui, Sakiko; Yamamoto, Keiichi; Moriyama, Toshiki			Causal relations of health indices inferred statistically using the DirectLiNGAM algorithm from big data of Osaka prefecture health checkups	PLOS ONE			English	Article							METABOLIC SYNDROME	Causal relations among many statistical variables have been assessed using a Linear non-Gaussian Acyclic Model (LiNGAM). Using access to large amounts of health checkup data from Osaka prefecture obtained during the six fiscal years of years 2012-2017, we applied the DirectLiNGAM algorithm as a trial to extract causal relations among health indices for age groups and genders. Results show that LiNGAM yields interesting and reasonable results, suggesting causal relations and correlation among the statistical indices used for these analyses.	[Kotoku, Jun'ichi; Oyama, Asuka; Kitazumi, Kanako] Teikyo Univ, Grad Sch Med Care & Technol, Tokyo, Japan; [Kotoku, Jun'ichi; Toki, Hiroshi; Haga, Akihiro; Yamamoto, Ryohei; Yamamoto, Keiichi; Moriyama, Toshiki] Osaka Univ, Div Hlth Care, Hlth & Counseling Ctr, Osaka, Japan; [Toki, Hiroshi] Osaka Univ, Res Ctr Nucl Phys, Osaka, Japan; [Haga, Akihiro] Univ Tokushima, Grad Sch Biomed Sci, Tokushima, Japan; [Shinzawa, Maki] Osaka Univ, Grad Sch Med, Dept Nephrol, Osaka, Japan; [Yamakawa, Miyae; Fukui, Sakiko] Osaka Univ, Grad Sch Med, Div Hlth Sci, Osaka, Japan; [Yamamoto, Keiichi] Wakayama Med Univ Hosp, Dept Med Informat, Wakayama, Japan	Teikyo University; Osaka University; Osaka University; Tokushima University; Osaka University; Osaka University; Wakayama Medical University	Kotoku, J (corresponding author), Teikyo Univ, Grad Sch Med Care & Technol, Tokyo, Japan.; Kotoku, J (corresponding author), Osaka Univ, Div Hlth Care, Hlth & Counseling Ctr, Osaka, Japan.	kotoku@med.teikyo-u.ac.jp	YAMAMOTO, Ryohei/AAU-3059-2021; Yamamoto, Keiichi/AFQ-9006-2022	YAMAMOTO, Ryohei/0000-0003-2610-9824; Yamamoto, Keiichi/0000-0003-3278-5001; Kotoku, Jun'ichi/0000-0002-5233-6003	Ministry of Health, Labour and Welfare; Japan Society for the Promotion of Science (JSPS) [18K07646, 19H03871]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This project was supported by the Ministry of Health, Labour and Welfare. This work was partly supported by Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp/english/index.html) KAKENHI Grants (Nos. 18K07646 to JK and 19H03871 to TM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollen KA, 2014, WILEY SERIES PROBABI; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Cheng L, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00094; Chickering D. M., 2003, Journal of Machine Learning Research, V3, P507, DOI 10.1162/153244303321897717; Hauser A, 2012, J MACH LEARN RES, V13, P2409; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Hyvarinen A, 2013, J MACH LEARN RES, V14, P111; Kalisch M, 2012, J STAT SOFTW, V47, P1; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Nakao YM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190862; Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083; Pearl J, 2009, CAUSALITY, DOI 10.1017/CBO9780511803161; Rochlani Y, 2017, THER ADV CARDIO DIS, V11, P215, DOI 10.1177/1753944717711379; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Shimizu S, 2011, J MACH LEARN RES, V12, P1225; Spirtes P., 2000, CAUSATION PREDICTION; Thamvitayakul K, 2012, INT CONF DAT MIN WOR, P659, DOI 10.1109/ICDMW.2012.134	18	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243229	10.1371/journal.pone.0243229	http://dx.doi.org/10.1371/journal.pone.0243229			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362207	Green Published, gold			2022-12-27	WOS:000603071600007
J	Ghareghozloo, ER; Mahdavimehr, M; Meratan, AA; Nikfarjam, N; Ghasemi, A; Katebi, B; Nemat-Gorgani, M				Rostampour Ghareghozloo, Ebrahim; Mahdavimehr, Mohsen; Meratan, Ali Akbar; Nikfarjam, Nasser; Ghasemi, Atiyeh; Katebi, Bentolhoda; Nemat-Gorgani, Mohsen			Role of surface oxygen-containing functional groups of graphene oxide quantum dots on amyloid fibrillation of two model proteins	PLOS ONE			English	Article							NANOPARTICLE INTERACTIONS OPPORTUNITIES; ALZHEIMERS-DISEASE; COLLOIDAL STABILITY; CHEMICAL-REDUCTION; PEPTIDE; INHIBITION; FIBRILS; AGGREGATION; LYSOZYME; INSULIN	There are many reports demonstrating that various derivatives of carbon nanoparticles are effective inhibitors of protein aggregation. As surface structural features of nanoparticles play a key role on modulating amyloid fibrillation process, in the present in vitro study, bovine insulin and hen egg white lysozyme (HEWL) were selected as two model proteins to investigate the reducing effect of graphene oxide quantum dots (GOQDs) on their assembly under amyloidogenic conditions. GOQDs were prepared through direct pyrolysis of citric acid, and the reduction step was carried out using ascorbic acid. The prepared nanoparticles were characterized by UV-Vis, X-ray photoelectron, and FT-IR spectroscopies, transmission electron and atomic force microscopies, zeta potential measurement, and Nile red fluorescence assay. They showed the tendencies to modulate the assembly of the proteins through different mechanisms. While GOQDs appeared to have the capacity to inhibit fibrillation, the presence of reduced GOQDs (rGOQDs) was found to promote protein assembly via shortening the nucleation phase, as suggested by ThT fluorescence data. Moreover, the structures produced in the presence of GOQDs or rGOQDs were totally nontoxic. We suggest that surface properties of these particles may be part of the differences in their mechanism(s) of action.	[Rostampour Ghareghozloo, Ebrahim; Mahdavimehr, Mohsen; Meratan, Ali Akbar; Katebi, Bentolhoda] Inst Adv Studies Basic Sci IASBS, Dept Biol Sci, Zanjan, Iran; [Nikfarjam, Nasser] Inst Adv Studies Basic Sci IASBS, Dept Chem, Zanjan, Iran; [Ghasemi, Atiyeh] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Nemat-Gorgani, Mohsen] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Institute for Advanced Studies in Basic Sciences (IASBS); Institute for Advanced Studies in Basic Sciences (IASBS); University of Tehran; Stanford University	Meratan, AA (corresponding author), Inst Adv Studies Basic Sci IASBS, Dept Biol Sci, Zanjan, Iran.	a.meratan@iasbs.ac.ir		Meratan, Ali Akbar/0000-0002-1428-3254	Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran	Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran	This work was supported by grants from the Research Council of the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, Iran.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Amiri H, 2013, ACS CHEM NEUROSCI, V4, P1417, DOI 10.1021/cn4001582; Andreev I, 2008, FULLER NANOTUB CAR N, V16, P89, DOI 10.1080/15363830701885831; Azami-Movahed M, 2013, INT J BIOCHEM CELL B, V45, P299, DOI 10.1016/j.biocel.2012.10.004; Ban DK, 2018, LANGMUIR, V34, P15283, DOI 10.1021/acs.langmuir.8b02674; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Cabaleiro-Lago C, 2010, LANGMUIR, V26, P3453, DOI 10.1021/la902980d; Cabaleiro-Lago C, 2010, ACS CHEM NEUROSCI, V1, P279, DOI 10.1021/cn900027u; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chen HB, 2011, DRUG DISCOV TODAY, V16, P354, DOI 10.1016/j.drudis.2010.02.009; Chua CK, 2014, CHEM SOC REV, V43, P291, DOI 10.1039/c3cs60303b; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dong YQ, 2012, CARBON, V50, P4738, DOI 10.1016/j.carbon.2012.06.002; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fernandez-Merino MJ, 2010, J PHYS CHEM C, V114, P6426, DOI 10.1021/jp100603h; Gilead S, 2004, ANGEW CHEM INT EDIT, V43, P4041, DOI 10.1002/anie.200353565; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Gudarzi MM, 2016, LANGMUIR, V32, P5058, DOI 10.1021/acs.langmuir.6b01012; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Javed I, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11762-0; Katebi B, 2018, ARCH BIOCHEM BIOPHYS, V659, P22, DOI 10.1016/j.abb.2018.09.024; Ke PC, 2020, ADV MATER, V32, DOI 10.1002/adma.201901690; Kim D, 2018, NAT NANOTECHNOL, V13, P812, DOI 10.1038/s41565-018-0179-y; Kim JE, 2003, BIOCHEM BIOPH RES CO, V303, P576, DOI 10.1016/S0006-291X(03)00393-0; Konkena B, 2012, LANGMUIR, V28, P12432, DOI 10.1021/la3020783; Krebs MRH, 2000, J MOL BIOL, V300, P541, DOI 10.1006/jmbi.2000.3862; Laurent S, 2012, RSC ADV, V2, P5008, DOI 10.1039/c2ra01374f; Lee CC, 2016, J BIOL CHEM, V291, P2858, DOI 10.1074/jbc.M115.682336; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451; Li HY, 2011, BIOPHYS J, V101, P2267, DOI 10.1016/j.bpj.2011.09.046; Li Q, 2014, CHEM-EUR J, V20, P7236, DOI 10.1002/chem.201402022; Li SH, 2015, CHEM MATER, V27, P1764, DOI 10.1021/cm504572b; Linse S, 2007, P NATL ACAD SCI USA, V104, P8691, DOI 10.1073/pnas.0701250104; Liu YB, 2015, NANOSCALE, V7, P19060, DOI 10.1039/c5nr06282a; Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mahdavimehr M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187841; Mahmoudi M, 2013, NANOSCALE, V5, P2570, DOI 10.1039/c3nr33193h; Mahmoudi M, 2012, NANOSCALE, V4, P7322, DOI 10.1039/c2nr31657a; Mahmoudi M, 2011, CHEM REV, V111, P5610, DOI 10.1021/cr100440g; Mao XB, 2009, LANGMUIR, V25, P8849, DOI 10.1021/la901342r; Meratan AA, 2011, J MOL BIOL, V409, P826, DOI 10.1016/j.jmb.2011.04.045; Nedumpully-Govindan P, 2016, PHYS CHEM CHEM PHYS, V18, P94, DOI 10.1039/c5cp05924k; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Ou LC, 2011, J PHYS CHEM B, V115, P9813, DOI 10.1021/jp201474m; Palmal S, 2014, CHEM-EUR J, V20, P6184, DOI 10.1002/chem.201400079; PEPYS MB, 1993, NATURE, V362, P553, DOI 10.1038/362553a0; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Qi Y, 2016, ENVIRON SCI-NANO, V3, P1062, DOI 10.1039/c6en00174b; Ren XM, 2018, ENVIRON SCI-NANO, V5, P1298, DOI 10.1039/c7en01258f; Rezaeian N, 2017, ARCH BIOCHEM BIOPHYS, V634, P96, DOI 10.1016/j.abb.2017.09.015; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Szabo T, 2006, CARBON, V44, P537, DOI 10.1016/j.carbon.2005.08.005; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang XY, 2015, NANOSCALE, V7, P2034, DOI 10.1039/c4nr04136d; Xie LG, 2014, BIOPHYS J, V107, P1930, DOI 10.1016/j.bpj.2014.08.034; Yang ZX, 2015, NANOSCALE, V7, P18725, DOI 10.1039/c5nr01172h; Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a; Zhao J, 2015, ENVIRON SCI TECHNOL, V49, P2849, DOI 10.1021/es505605w; Zheng HZ, 2011, CHEM COMMUN, V47, P10650, DOI 10.1039/c1cc14741b; Zheng P, 2017, CHEM-ASIAN J, V12, P2343, DOI 10.1002/asia.201700814; Zhou X, 2014, ACS APPL MATER INTER, V6, P18475, DOI [10.1021/am506435u, 10.1021/am501341u]; Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068	68	4	4	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244296	10.1371/journal.pone.0244296	http://dx.doi.org/10.1371/journal.pone.0244296			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362209	Green Published, gold			2022-12-27	WOS:000603071600046
J	Shen, MP; Xu, HZ; Fu, JF; Wang, TL; Fu, ZZ; Zhao, XM; Zhou, GD; Jin, Q; Tong, GX				Shen, Meiping; Xu, Hongzhen; Fu, Junfen; Wang, Tianlin; Fu, Zangzang; Zhao, Xiaomei; Zhou, Gendi; Jin, Qi; Tong, Guixiu			Investigation of anxiety levels of 1637 healthcare workers during the epidemic of COVID-19	PLOS ONE			English	Article								Objective This study aimed to investigate the anxiety levels of healthcare workers and to provide guidance on potential accurate social and psychological interventions for healthcare workers during the epidemic of COVID-19 in Zhejiang Province, China. Methods Healthcare workers from five hospitals in Zhejiang Province were randomly selected into this study. Zung Self-Assessment Scale for Anxiety (SAS) was used to evaluate the anxiety status of the included 1637 healthcare workers. Results The total anxiety score of healthcare workers in Zhejiang Province was 30.85 +/- 6.89. The univariate analysis showed that the anxiety level of healthcare workers was related to gender, education, occupation, physical condition, job risk coefficient, and with family members on the first-line combating COVID-19 (P <0.05). The multivariate analysis showed that physical condition and job risk coefficient were predictors of anxiety levels of healthcare workers. Conclusions During the epidemic of COVID-19, 1637 healthcare workers generally had an increased tendency to have anxiety. Individualized assessment of the anxiety level of healthcare workers should be provided, and different interventions should be given based on the evaluation results.	[Shen, Meiping; Xu, Hongzhen; Fu, Junfen; Wang, Tianlin; Fu, Zangzang] Zhejiang Univ, Childrens Hosp, Sch Med, Natl Clin Res Ctr Child Hlth, Hangzhou, Peoples R China; [Zhao, Xiaomei] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Peoples R China; [Zhou, Gendi] Hangzhou Hosp Tradit Chinese Med, Hangzhou, Peoples R China; [Jin, Qi] Xiaoshan First Peoples Hosp, Hangzhou, Peoples R China; [Tong, Guixiu] Zhejiang Univ, Chunan Hosp Tradit Chinese Med, Sch Med, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Fu, JF (corresponding author), Zhejiang Univ, Childrens Hosp, Sch Med, Natl Clin Res Ctr Child Hlth, Hangzhou, Peoples R China.	fjf68@zju.edu.cn			Zhejiang University special research scientific research fund for COVID-19 prevention and control	Zhejiang University special research scientific research fund for COVID-19 prevention and control	This work was supported by Zhejiang University special research scientific research fund for COVID-19 prevention and control. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, SPACE RAD BIOL BIOL, V18, P200; Tran BX, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010354; Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049; Feng Jie, 2006, ACTA ACAD MED MILTAR, V28, P1111; Hao FY, 2020, BRAIN BEHAV IMMUN, V87, P100, DOI 10.1016/j.bbi.2020.04.069; Ji D, 2017, ONCOTARGET, V8, P12784, DOI 10.18632/oncotarget.14498; Li L, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0341-2; Mak WWS, 2009, PSYCHOL HEALTH, V24, P161, DOI 10.1080/08870440701447649; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Tan W., 2020, BRAIN BEHAV IMMUN; Tang Haibo, 2009, CHINESE J CLIN PSYCH, V17, P199; Tang Haibo, 2009, CHINESE J CLIN PSYCH, V17, P176; Wang C., 2020, BRAIN BEHAV IMMUN, VS0889-1591, P30511; Zhou CY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010113	14	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243890	10.1371/journal.pone.0243890	http://dx.doi.org/10.1371/journal.pone.0243890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351814	gold, Green Published			2022-12-27	WOS:000603071400049
J	Bach, P; Wallisch, C; Klein, N; Hafermann, L; Sauerbrei, W; Steyerberg, EW; Heinze, G; Rauch, G				Bach, Paul; Wallisch, Christine; Klein, Nadja; Hafermann, Lorena; Sauerbrei, Willi; Steyerberg, Ewout W.; Heinze, Georg; Rauch, Geraldine		Grp 2 STRATOS Initiative	Systematic review of education and practical guidance on regression modeling for medical researchers who lack a strong statistical background: Study protocol	PLOS ONE			English	Review							PREDICTORS; SELECTION	In the last decades, statistical methodology has developed rapidly, in particular in the field of regression modeling. Multivariable regression models are applied in almost all medical research projects. Therefore, the potential impact of statistical misconceptions within this field can be enormous Indeed, the current theoretical statistical knowledge is not always adequately transferred to the current practice in medical statistics. Some medical journals have identified this problem and published isolated statistical articles and even whole series thereof. In this systematic review, we aim to assess the current level of education on regression modeling that is provided to medical researchers via series of statistical articles published in medical journals. The present manuscript is a protocol for a systematic review that aims to assess which aspects of regression modeling are covered by statistical series published in medical journals that intend to train and guide applied medical researchers with limited statistical knowledge. Statistical paper series cannot easily be summarized and identified by common keywords in an electronic search engine like Scopus. We therefore identified series by a systematic request to statistical experts who are part or related to the STRATOS Initiative (STRengthening Analytical Thinking for Observational Studies). Within each identified article, two raters will independently check the content of the articles with respect to a predefined list of key aspects related to regression modeling. The content analysis of the topic-relevant articles will be performed using a predefined report form to assess the content as objectively as possible. Any disputes will be resolved by a third reviewer. Summary analyses will identify potential methodological gaps and misconceptions that may have an important impact on the quality of analyses in medical research. This review will thus provide a basis for future guidance papers and tutorials in the field of regression modeling which will enable medical researchers 1) to interpret publications in a correct way, 2) to perform basic statistical analyses in a correct way and 3) to identify situations when the help of a statistical expert is required.	[Bach, Paul; Wallisch, Christine; Hafermann, Lorena; Rauch, Geraldine] Free Univ Berlin, Berlin, Germany; [Bach, Paul; Wallisch, Christine; Hafermann, Lorena; Rauch, Geraldine] Humboldt Univ, Berlin, Germany; [Bach, Paul; Wallisch, Christine; Hafermann, Lorena; Rauch, Geraldine] Charite Univ Med Berlin, Berlin Inst Hlth, Inst Biometry & Clin Epidemiol, Berlin, Germany; [Bach, Paul; Wallisch, Christine; Hafermann, Lorena; Rauch, Geraldine] Berlin Inst Hlth BIH, Berlin, Germany; [Bach, Paul; Klein, Nadja] Humboldt Univ, Sch Business & Econ Appl Stat, Berlin, Berlin, Germany; [Wallisch, Christine; Heinze, Georg] Med Univ Vienna, Ctr Med Stat Informat & Intelligent Syst, Sect Clin Biometr, Vienna, Austria; [Sauerbrei, Willi] Univ Freiburg, Inst Med Biometry & Stat, Fac Med, Med Ctr, Freiburg, Germany; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands	Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Humboldt University of Berlin; Medical University of Vienna; University of Freiburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Rauch, G (corresponding author), Free Univ Berlin, Berlin, Germany.; Rauch, G (corresponding author), Humboldt Univ, Berlin, Germany.; Rauch, G (corresponding author), Charite Univ Med Berlin, Berlin Inst Hlth, Inst Biometry & Clin Epidemiol, Berlin, Germany.; Rauch, G (corresponding author), Berlin Inst Hlth BIH, Berlin, Germany.	geraldine.rauch@charite.de	Wallisch, Christine/V-2272-2019	Rauch, Geraldine/0000-0002-2451-1660; Klein, Nadja/0000-0002-5072-5347; Sauerbrei, Willi/0000-0002-6792-4123; Wallisch, Christine/0000-0003-3943-6234	Deutsche Forschungsgemeinschaft (DFG) [SA580/10-1]; German-Austrian DFG [DFG: RA-2347/8-1]; FWF project [FWF: I-4739-B]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German-Austrian DFG(German Research Foundation (DFG)); FWF project(Austrian Science Fund (FWF))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through the project [SA580/10-1] to Willi Sauerbrei and through the joint German-Austrian DFG and FWF project [DFG: RA-2347/8-1] to Geraldine Rauch and [FWF: I-4739-B] to Georg Heinze. Apart from this project, this research received no additional funding from any funding agency in the public, commercial or not-for-profit sectors. This paper was written on behalf of the topic group 2 of the STRATOS initiative (STRengthening Analytical Thinking in Observational Studies), which is a collaborative network of experts with background in many different areas of biostatistical and epidemiological methods. (http://www.stratosinitiative.org/, accessed October 2020).	Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; Hastie T., 1986, STAT SCI, V1986, P297, DOI [DOI 10.1214/SS/1177013604, 10.1214/ss/1177013604]; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Heinze G, 2017, TRANSPL INT, V30, P6, DOI 10.1111/tri.12895; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Nojima M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021129; O'Hara RB, 2009, BAYESIAN ANAL, V4, P85, DOI 10.1214/09-BA403; Perperoglou A, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0666-3; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Sauerbrei W, 1999, J R STAT SOC A STAT, V162, P71, DOI 10.1111/1467-985X.00122; Sauerbrei Willi, 2020, Diagn Progn Res, V4, P3, DOI 10.1186/s41512-020-00074-3; Sauerbrei W, 2014, STAT MED, V33, P5413, DOI 10.1002/sim.6265; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wood S.N., 2017, GEN ADDITIVE MODELS, P476, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]	20	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0241427	10.1371/journal.pone.0241427	http://dx.doi.org/10.1371/journal.pone.0241427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347441	Green Published, gold			2022-12-27	WOS:000603071100065
J	Belachew, SA; Muluneh, NY; Erku, DA; Netere, AK				Belachew, Sewunet Admasu; Muluneh, Niguse Yigzaw; Erku, Daniel Asfaw; Netere, Adeladlew Kassie			A cross sectional study on beliefs and roles of community pharmacy professionals in preventing and managing metabolic syndrome in an Ethiopian setting	PLOS ONE			English	Article							MANAGEMENT; PROGRAM; HEALTH; RISK	Introduction Metabolic syndrome (MetS) is a group of cardiovascular risk factors, and its prevalence is becoming alarmingly high in Ethiopia. Studies uncovered as community pharmacy professionals (CPPs) have not yet well integrated into public health programs and priorities. In low income setting like Ethiopia, evidence regarding the roles CPPs in preventing and management of MetS is dearth. Objective The study was aimed to assess community pharmacy professionals'(CPPs) opinions about metabolic syndrome, describe their perception level towards the effectiveness of the main interventions and explore their extent of involvement in counseling patients with the metabolic syndrome in Gondar town, Northwestern Ethiopia. Method A descriptive, cross-sectional study was conducted among pharmacists and druggists working in community medication retail outlets (CMROs) in Gondar town, northwestern Ethiopia from April 1 to May 31, 2019. Data were collected using a self-administered pre-tested questionnaire. Descriptive statistics was used to summarize different variables, and presented in tables and figure. An independent t-test and one way ANOVA (Analysis of Variance) were used to compare mean scores. A 5% level of significance was used. Result Out of the 75 CPPs approached, 65(40 pharmacists and 25 druggists) completed the survey giving a response rate of 86.7%. Smoking cessation practice was identified to be low. There were a statistically significant difference (t = 2.144, P = 0.036) in the involvement towards counseling patients between CPPs who claimed to work in pharmacy (mean = 3.96 out of 5 points Likert scale) and drug stores (mean = 3.80 out of 5 points Likert scale). Conclusion The study concluded that the overall involvement of professionals in counseling patients, opinion about metabolic syndrome, and perception towards the effectiveness of the intervention was found to be more or less positive. However, the provision of services, such as monitoring therapy, selling equipment for home blood pressure and glucose monitoring and documenting patient care services needs to be encouraged. Given proper education and training, the current study hope that community pharmacists could be an important front-line contributors to contain this emerging epidemic in Gondar town as well as in the entire nation.	[Belachew, Sewunet Admasu; Netere, Adeladlew Kassie] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia; [Muluneh, Niguse Yigzaw] Univ Gondar, Dept Psychiat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Erku, Daniel Asfaw] Griffith Univ, Sch Med, Ctr Appl Hlth Econ, Nathan, Qld, Australia; [Erku, Daniel Asfaw] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia	University of Gondar; University of Gondar; Griffith University; Griffith University	Belachew, SA (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Clin Pharm, Gondar, Ethiopia.	sewunet.admasu@gmail.com	Erku, Daniel/AAC-1508-2020	Erku, Daniel/0000-0002-8878-0317; Admasu Belachew, Sewunet/0000-0002-1050-8188				Via-Sosa MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-487; Awad A, 2010, PHARM WORLD SCI, V32, P146, DOI 10.1007/s11096-009-9360-6; Benavides S, 2011, J RURAL HEALTH, V27, P184, DOI 10.1111/j.1748-0361.2010.00329.x; Dastani HB, 2004, ANN PHARMACOTHER, V38, P1800, DOI 10.1345/aph.1E205; Eades CE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-582; Erku DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180943; Fornos JA, 2006, PHARM WORLD SCI, V28, P65, DOI 10.1007/s11096-006-9003-0; Hammad EA, 2011, J MANAGE CARE PHARM, V17, P295, DOI 10.18553/jmcp.2011.17.4.295; Hijazi MA, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05258-7; Katoue MG, 2013, INT J CLIN PHARM-NET, V35, P57, DOI 10.1007/s11096-012-9705-4; Kelliny C, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-27; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Krass I, 2007, DIABETIC MED, V24, P677, DOI 10.1111/j.1464-5491.2007.02143.x; Laliberte MC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-192; Lau R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-34; Lu B, 2006, METABOLISM, V55, P1088, DOI 10.1016/j.metabol.2006.04.003; Maguire T. A., 2001, Addiction, V96, P325, DOI 10.1046/j.1360-0443.2001.96232516.x; Malone M, 2004, ANN PHARMACOTHER, V38, P1961, DOI 10.1345/aph.1E378; Matowe L, 2003, AM J HEALTH-SYST PH, V60, P1591, DOI 10.1093/ajhp/60.15.1591; McKenney James M, 2004, J Am Pharm Assoc (2003), V44, P562, DOI 10.1331/1544-3191.44.5.562.McKenney; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Mutimura Eugene, 2008, J Cardiometab Syndr, V3, P106, DOI 10.1111/j.1559-4572.2008.07584.x; Olenak JL, 2010, J AM PHARM ASSOC, V50, P32, DOI 10.1331/JAPhA.2010.08104; PALUCK EC, 1994, CAN J PUBLIC HEALTH, V85, P389; Robinson JD, 2010, ANN PHARMACOTHER, V44, P88, DOI 10.1345/aph.1L289; Scott David M., 2016, Pharmacy Pract (Granada), V14, P836, DOI [10.18549/PharmPract.2016.04.836, 10.18549/pharmpract.2016.04.836]; Snella KA, 2006, J AM PHARM ASSOC, V46, P370, DOI 10.1331/154434506777069598; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; Trinca C E, 1995, Am Pharm, VSuppl, P13; WHO, 2008, WORLD HLTH REP PREV; World Health Organization, 2004, GLOB STRAT DIET PHYS	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244211	10.1371/journal.pone.0244211	http://dx.doi.org/10.1371/journal.pone.0244211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347490	Green Published, gold			2022-12-27	WOS:000603071100037
J	Habib, O; Sakri, RM; Ghazalli, N; Chau, D; Ling, KH; Abdullah, S				Habib, Omar; Mohd Sakri, Rozita; Ghazalli, Nadiah; Chau, De-Ming; Ling, King-Hwa; Abdullah, Syahril			Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment	PLOS ONE			English	Article							MEDIATED TRANSGENE EXPRESSION; INNATE IMMUNE-RESPONSES; GENE-EXPRESSION; CYSTIC-FIBROSIS; DNA METHYLATION; DELIVERY; VECTORS; PROMOTER; CASSETTES; THERAPY	CpG-free pDNA was reported to facilitate sustained transgene expression with minimal inflammation in vivo as compared to CpG-containing pDNA. However, the expression potential and impact of CpG-free pDNA in in vitro model have never been described. Hence, in this study, we analyzed the transgene expression profiles of CpG-free pDNA in vitro to determine the influence of CpG depletion from the transgene. We found that in contrast to the published in vivo studies, CpG-free pDNA expressed a significantly lower level of luciferase than CpG-rich pDNA in several human cell lines. By comparing novel CpG-free pDNA carrying CpG-free GFP (pZGFP: 0 CpG) to CpG-rich GFP (pRGFP: 60 CpGs), we further showed that the discrepancy was not influenced by external factors such as gene transfer agent, cell species, cell type, and cytotoxicity. Moreover, pZGFP exhibited reduced expression despite having equal gene dosage as pRGFP. Analysis of mRNA distribution revealed that the mRNA export of pZGFP and pRGFP was similar; however, the steady state mRNA level of pZGFP was significantly lower. Upon further investigation, we found that the CpG-free transgene in non-integrating CpG-free pDNA backbone acquired increased nucleosome enrichment as compared with CpG-rich transgene, which may explain the observed reduced level of steady state mRNA. Our findings suggest that nucleosome enrichment could regulate non-integrating CpG-free pDNA expression and has implications on pDNA design.	[Habib, Omar; Mohd Sakri, Rozita; Ghazalli, Nadiah; Chau, De-Ming; Ling, King-Hwa; Abdullah, Syahril] Univ Putra Malaysia UPM, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Habib, Omar; Mohd Sakri, Rozita; Ghazalli, Nadiah; Chau, De-Ming; Ling, King-Hwa; Abdullah, Syahril] Univ Putra Malaysia UPM, Genet & Regenerat Med Res Ctr, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Mohd Sakri, Rozita] Univ Teknol MARA UiTM, Fac Appl Sci, Shah Alam, Selangor, Malaysia; [Abdullah, Syahril] Univ Putra Malaysia UPM, Inst Biosci, UPM MAKNA Canc Res Lab, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Teknologi MARA; Universiti Putra Malaysia	Abdullah, S (corresponding author), Univ Putra Malaysia UPM, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia.; Abdullah, S (corresponding author), Univ Putra Malaysia UPM, Genet & Regenerat Med Res Ctr, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia.; Abdullah, S (corresponding author), Univ Putra Malaysia UPM, Inst Biosci, UPM MAKNA Canc Res Lab, Serdang, Selangor, Malaysia.	syahril@upm.edu.my	Ling, King-Hwa/M-2349-2018	Ling, King-Hwa/0000-0002-3968-7263; Habib, Omar/0000-0001-9681-6853	Ministry of Higher Education Malaysia [04-01-16-1815FR (FRGS)]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	Syahril Abdullah was funded by the Ministry of Higher Education Malaysia, project grant number: 04-01-16-1815FR (FRGS). NO -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dosari M, 2006, BIOCHEM BIOPH RES CO, V339, P673, DOI 10.1016/j.bbrc.2005.11.063; Alton EWFW, 2015, LANCET RESP MED, V3, P684, DOI 10.1016/S2213-2600(15)00245-3; Alton EWFW, 2013, BIOMATERIALS, V34, P10267, DOI 10.1016/j.biomaterials.2013.09.023; [Anonymous], 2013, ANALES CERVANTINOS, V45, P241; Bauer AP, 2010, NUCLEIC ACIDS RES, V38, P3891, DOI 10.1093/nar/gkq115; Beck S, 2018, NUCLEIC ACIDS RES, V46, P4382, DOI 10.1093/nar/gky147; Bestor TH, 2000, J CLIN INVEST, V105, P409, DOI 10.1172/JCI9459; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Capurso D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-630; Celhar T, 2012, IMMUNOL RES, V53, P58, DOI 10.1007/s12026-012-8270-1; Chen D, 2003, GENE THER, V10, P991, DOI 10.1038/sj.gt.3302031; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; Cim A, 2012, J ENDOCRINOL, V214, P277, DOI 10.1530/JOE-12-0033; Davies LA, 2012, BIOMATERIALS, V33, P5618, DOI 10.1016/j.biomaterials.2012.04.019; de Wolf HK, 2008, PHARM RES-DORDR, V25, P1654, DOI 10.1007/s11095-008-9558-7; Doerfler W, 2018, EPIGENETICS-US, V13, P1141, DOI 10.1080/15592294.2018.1549463; Dow SW, 1999, J IMMUNOL, V163, P1552; Fukunaga S, 2012, GENE THER, V19, P828, DOI 10.1038/gt.2011.127; Ghazizadeh S, 1997, J VIROL, V71, P9163, DOI 10.1128/JVI.71.12.9163-9169.1997; Ghazizadeh S, 2003, MOL THER, V7, P296, DOI 10.1016/S1525-0016(03)00013-3; Gibney ER, 2010, HEREDITY, V105, P4, DOI 10.1038/hdy.2010.54; Graf M, RATIONALES GENE DESI, P411, DOI [10.1002/9780470437988.ch12, DOI 10.1002/9780470437988.CH12]; Hebbar PB, 2008, J BIOL CHEM, V283, P4595, DOI 10.1074/jbc.M709121200; Hodges BL, 2004, MOL THER, V10, P269, DOI 10.1016/j.ymthe.2004.04.018; Hofmanova J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228010; HOLTER W, 1991, EXP CELL RES, V193, P54, DOI 10.1016/0014-4827(91)90537-5; Hong K, 2001, BIOMOL ENG, V18, P185, DOI 10.1016/S1389-0344(01)00100-9; Hsu CYM, 2012, J DRUG TARGET, V20, P301, DOI 10.3109/1061186X.2012.655247; Hyde SC, 2008, NAT BIOTECHNOL, V26, P549, DOI 10.1038/nbt1399; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; Jimenez-Useche I, 2014, BIOPOLYMERS, V101, P517, DOI 10.1002/bip.22411; Kamiya H, 2009, INT J PHARMACEUT, V376, P99, DOI 10.1016/j.ijpharm.2009.04.032; Kato M, 2012, INT J PHARMACEUT, V423, P428, DOI 10.1016/j.ijpharm.2011.12.015; Kia A, 2013, VIRUSES-BASEL, V5, P2561, DOI 10.3390/v5102561; Klausner EA, 2012, J GENE MED, V14, P100, DOI 10.1002/jgm.1634; Krinner S, 2014, NUCLEIC ACIDS RES, V42, P3551, DOI 10.1093/nar/gkt1358; Lesina E, 2010, J CONTROL RELEASE, V143, P243, DOI 10.1016/j.jconrel.2010.01.003; Lesina E, 2010, EUR J PHARM BIOPHARM, V74, P427, DOI 10.1016/j.ejpb.2009.11.013; Lieleg C, 2015, CHROMOSOMA, V124, P131, DOI 10.1007/s00412-014-0501-x; Loisel S, 2001, HUM GENE THER, V12, P685, DOI 10.1089/104303401300057405; Lui VWY, 2001, J GENE MED, V3, P384; Luu-The V, 2005, BIOTECHNIQUES, V38, P287, DOI 10.2144/05382RR05; Magnusson T, 2011, J GENE MED, V13, P382, DOI 10.1002/jgm.1585; Mercier S, 2002, J VIROL, V76, P2899, DOI 10.1128/JVI.76.6.2899-2911.2002; Mitsui M, 2009, J GENE MED, V11, P435, DOI 10.1002/jgm.1317; Nammo T, 2011, METHODS MOL BIOL, V791, P287, DOI 10.1007/978-1-61779-316-5_21; Ngai SC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/346134; Nocetti N, 2016, GENE DEV, V30, P660, DOI 10.1101/gad.274910.115; Papadakis ED, 2004, CURR GENE THER, V4, P89, DOI 10.2174/1566523044578077; Pastor DM, 2010, INT J CLIN EXP MED, V3, P69; Pelascini LPL, 2013, HUM GENE THER, V24, P78, DOI 10.1089/hum.2012.069; Pringle IA, 2012, BIOMATERIALS, V33, P6833, DOI 10.1016/j.biomaterials.2012.06.009; Prosch S, 1996, BIOL CHEM H-S, V377, P195, DOI 10.1515/bchm3.1996.377.3.195; Qin LH, 1997, HUM GENE THER, V8, P2019, DOI 10.1089/hum.1997.8.17-2019; REEVES R, 1985, NUCLEIC ACIDS RES, V13, P3599, DOI 10.1093/nar/13.10.3599; Riu ER, 2007, MOL THER, V15, P1348, DOI 10.1038/sj.mt.6300177; Schaefke B, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1485; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tavare JM, 2001, J ENDOCRINOL, V170, P297, DOI 10.1677/joe.0.1700297; Tolmachov OE, 2011, CURR GENE THER, V11, P466; Upadhyay M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142368; Vaidyanathan S, 2016, ACCOUNTS CHEM RES, V49, P1486, DOI 10.1021/acs.accounts.6b00200; Yang X, 2017, CELL RES, V27, P606, DOI 10.1038/cr.2017.55; Yew NS, 2002, MOL THER, V5, P731, DOI 10.1006/mthe.2002.0598; 2010, FOCUS CATALYSTS, V5, P3	66	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244386	10.1371/journal.pone.0244386	http://dx.doi.org/10.1371/journal.pone.0244386			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347482	Green Accepted, gold, Green Published			2022-12-27	WOS:000603071100055
J	Abraham, SB; Abdulla, N; Himratul-Aznita, WH; Awad, M; Samaranayake, LP; Ahmed, HMA				B. Abraham, Sheela; Abdulla, Nizam; Himratul-Aznita, Wan Harun; Awad, Manal; Samaranayake, Lakshman Perera; Ahmed, Hany Mohamed Aly			Antibiotic prescribing practices of dentists for endodontic infections; a cross-sectional study	PLOS ONE			English	Article							GENERAL DENTAL PRACTICE; AMERICAN-ASSOCIATION; PENICILLIN; PRESCRIPTION; PAIN; MANAGEMENT; RESISTANCE; MEMBERS	Objective The indiscriminate prescription of antibiotics has led to the emergence of resistance microbes worldwide. This study aimed to investigate the antibiotic prescribing practices amongst general dental practitioners and specialists in managing endodontic infections in the United Arab Emirates (UAE). Design General dental practitioners and specialists in the UAE were invited to participate in an online questionnaire survey which included questions on socio-demographics, practitioner's antibiotic prescribing preferences for various pulpal and periapical diseases, and their choice, in terms of the type, dose and duration of the antibiotic. The link to the survey questionnaire was sent to 250 invited dentists. Data were analyzed by descriptive statistics and chi-square tests for independence and level of significance was set at 0.05. Results A total of 174 respondents participated in the survey (response rate = 70%). The respondents who prescribed antibiotics at least once a month were 38.5% while 17.2% did so, more than three times a week; amoxicillin 500 mg was the antibiotic of choice for patients not allergic to penicillin (43.7%), and in cases of penicillin allergies, erythromycin 500 mg (21.3%). There was a significant difference in the antibiotic prescribing practices of GDPs compared to endodontists and other specialties especially in clinical cases such as acute apical abscesses with swelling and moderate to severe pre-operative symptoms and retreatment of endodontic cases (p<0.05). Approximately, three quarters of the respondents (78.7%) did not prescribe a loading dose when prescribing antibiotics. About 15% respondents prescribed antibiotics to their patients if they were not accessible to patients due to a holiday/weekend. Conclusions In general, the antibiotic prescribing practices of UAE dentists are congruent with the international norms. However, there were occasions of inappropriate prescriptions such as in patients with irreversible pulpitis, necrotic pulps with no systemic involvement and/or with sinus tracts.	[B. Abraham, Sheela; Awad, Manal] Univ Sharjah, Dept Prevent & Restorat Dent, Coll Dent Med, Sharjah, U Arab Emirates; [B. Abraham, Sheela; Ahmed, Hany Mohamed Aly] Univ Malaya, Dept Restorat Dent, Fac Dent, Kuala Lumpur, Malaysia; [Abdulla, Nizam; Samaranayake, Lakshman Perera] Univ Sharjah, Dept Oral & Craniofacial Hlth Sci, Coll Dent Med, Sharjah, U Arab Emirates; [Himratul-Aznita, Wan Harun] Univ Malaya, Dept Oral & Craniofacial Sci, Fac Dent, Kuala Lumpur, Malaysia; [Samaranayake, Lakshman Perera] Univ Hong Kong, Fac Dent, Hong Kong, Peoples R China	University of Sharjah; Universiti Malaya; University of Sharjah; Universiti Malaya; University of Hong Kong	Ahmed, HMA (corresponding author), Univ Malaya, Dept Restorat Dent, Fac Dent, Kuala Lumpur, Malaysia.	hany_endodontist@hotmail.com	HARUN, WAN HIMRATUL AZNITA WAN/C-1019-2010; /K-4947-2018	HARUN, WAN HIMRATUL AZNITA WAN/0000-0001-5792-8596; /0000-0002-9122-336X; Ahmed, Hany Mohamed Aly/0000-0003-0776-9288				Al-Ahmad A, 2014, J ENDODONT, V40, P223, DOI 10.1016/j.joen.2013.07.023; Al-Haroni M, 2007, J ANTIMICROB CHEMOTH, V59, P1161, DOI 10.1093/jac/dkm090; Alattas HA, 2017, J GLOB ANTIMICROB RE, V9, P82, DOI 10.1016/j.jgar.2017.01.012; Andersson Lars, 2016, Pediatr Dent, V38, P369; [Anonymous], 2017, J Endod, V43, P1409, DOI 10.1016/j.joen.2017.08.015; [Anonymous], 2016, J LARGE SCALE RES FA, V2, pA49; BAHAL N, 1992, ANN PHARMACOTHER, V26, P46, DOI 10.1177/106002809202600112; Bjelovucic R, 2019, INT DENT J, V69, P273, DOI 10.1111/idj.12460; Bolfoni MR, 2018, INT ENDOD J, V51, P148, DOI 10.1111/iej.12823; Cope AL, 2016, COMMUNITY DENT ORAL, V44, P145, DOI 10.1111/cdoe.12199; Dar-Odeh NS, 2010, THER CLIN RISK MANAG, V6, P301; Fincham JE, 2008, AM J PHARM EDUC, V72, DOI 10.5688/aj720243; Fouad AF, 1996, ORAL SURG ORAL MED O, V81, P590, DOI 10.1016/S1079-2104(96)80054-0; Germack M, 2017, J ENDODONT, V43, P1615, DOI 10.1016/j.joen.2017.05.009; Henry M, 2001, J ENDODONT, V27, P117, DOI 10.1097/00004770-200102000-00016; Karki AJ, 2011, BRIT DENT J, V210, DOI 10.1038/sj.bdj.2010.1179; Kuriyama T, 2007, ORAL MICROBIOL IMMUN, V22, P285, DOI 10.1111/j.1399-302X.2007.00365.x; Lewis MAO, 2008, BRIT DENT J, V205, P537, DOI 10.1038/sj.bdj.2008.984; Marra F, 2016, J AM DENT ASSOC, V147, P320, DOI 10.1016/j.adaj.2015.12.014; Maslamani M, 2018, MED PRIN PRACT, V27, P66, DOI 10.1159/000486416; Nabavizadeh Mohammad Reza, 2011, Iran Endod J, V6, P54; Nagle D, 2000, ORAL SURG ORAL MED O, V90, P636, DOI 10.1067/moe.2000.109777; Oberoi SS, 2015, INT DENT J, V65, P4, DOI 10.1111/idj.12146; Pallasch T J, 1993, J Calif Dent Assoc, V21, P46; Palmer NAO, 2000, BRIT DENT J, V188, P554, DOI 10.1038/sj.bdj.4800538a; Pickenpaugh L, 2001, J ENDODONT, V27, P53, DOI 10.1097/00004770-200101000-00019; Poeschl PW, 2011, J ENDODONT, V37, P1201, DOI 10.1016/j.joen.2011.05.029; Roche Y, 1997, J ANTIMICROB CHEMOTH, V40, P353, DOI 10.1093/jac/40.3.353; Rodriguez-Nunez A, 2009, J ENDODONT, V35, P1198, DOI 10.1016/j.joen.2009.05.031; Samaranayake L., 2018, ESSENTIAL MICROBIOLO, V5th; Sedgley CM, 2008, J ENDODONT, V34, P570, DOI 10.1016/j.joen.2008.02.014; Segura-Egea JJ, 2018, INT ENDOD J, V51, P20, DOI 10.1111/iej.12781; Shapiro DJ, 2014, J ANTIMICROB CHEMOTH, V69, P234, DOI 10.1093/jac/dkt301; Smieja M, 1998, Can J Infect Dis, V9, P22; Thornhill MH, 2019, BRIT DENT J, V227, P1044, DOI 10.1038/s41415-019-1002-3; WALTON RE, 1993, J ENDODONT, V19, P466, DOI 10.1016/S0099-2399(06)80535-2; Whitten BH, 1996, J AM DENT ASSOC, V127, P1333, DOI 10.14219/jada.archive.1996.0444; Wright AJ, 1999, MAYO CLIN PROC, V74, P290, DOI 10.4065/74.3.290; Yingling NM, 2002, J ENDODONT, V28, P396, DOI 10.1097/00004770-200205000-00012	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244585	10.1371/journal.pone.0244585	http://dx.doi.org/10.1371/journal.pone.0244585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378378	gold, Green Published			2022-12-27	WOS:000605651300076
J	Clinton, JLS; Tran, LL; Vogt, MB; Rowley, DR; Kimata, JT; Rico-Hesse, R				Spencer Clinton, Jennifer L.; Tran, Linda L.; Vogt, Megan B.; Rowley, David R.; Kimata, Jason T.; Rico-Hesse, Rebecca			IP-10 and CXCR3 signaling inhibit Zika virus replication in human prostate cells	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SEXUAL TRANSMISSION; DC-SIGN; NEURAL PROGENITORS; DENDRITIC CELLS; PATHOGENESIS; INFECTION; DIFFERENTIATION; INTERFERONS; ATTACHMENT	Our previous studies have shown that Zika virus (ZIKV) replicates in human prostate cells, suggesting that the prostate may serve as a long-term reservoir for virus transmission. Here, we demonstrated that the innate immune responses generated to three distinct ZIKV strains (all isolated from human serum) were significantly different and dependent on their passage history (in mosquito, monkey, or human cells). In addition, some of these phenotypic differences were reduced by a single additional cell culture passage, suggesting that viruses that have been passaged more than 3 times from the patient sample will no longer reflect natural phenotypes. Two of the ZIKV strains analyzed induced high levels of the IP-10 chemokine and IFN gamma in human prostate epithelial and stromal mesenchymal stem cells. To further understand the importance of these innate responses on ZIKV replication, we measured the effects of IP-10 and its downstream receptor, CXCR3, on RNA and virus production in prostate cells. Treatment with IP-10, CXCR3 agonist, or CXCR3 antagonist significantly altered ZIKV viral gene expression, depending on their passage in cells of relevant hosts (mosquito or human). We detected differences in gene expression of two primary CXCR3 isoforms (CXCR3-A and CXCR3-B) on the two cell types, possibly explaining differences in viral output. Lastly, we examined the effects of IP-10, agonist, or antagonist on cell death and proliferation under physiologically relevant infection rates, and detected no significant differences. Although we did not measure protein expression directly, our results indicate that CXCR3 signaling may be a target for therapeutics, to ultimately stop sexual transmission of this virus.	[Spencer Clinton, Jennifer L.; Kimata, Jason T.; Rico-Hesse, Rebecca] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Tran, Linda L.; Vogt, Megan B.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Tran, Linda L.; Rowley, David R.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Tran, Linda L.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Ctr, Los Angeles, CA 90048 USA; [Vogt, Megan B.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cedars Sinai Medical Center; Virginia Polytechnic Institute & State University	Rico-Hesse, R (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	Rebecca.Rico-Hesse@bcm.edu	Rico-Hesse, Rebecca/AAW-9501-2021	Clinton, Jennifer/0000-0001-5237-4395; Tran, Linda/0000-0002-2629-3994; Kimata, Jason/0000-0002-0504-0090	Baylor College of Medicine (BCM)	Baylor College of Medicine (BCM)	This study was supported by Baylor College of Medicine (BCM) in the form of internal institutional funds awarded to RRH. No other specific funding was received for this study.	Aksoy MO, 2006, AM J PHYSIOL-LUNG C, V290, pL909, DOI 10.1152/ajplung.00430.2005; Anfasa F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00817; Romero HA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01617; Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539; Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6; Bagdonaite I, 2018, GLYCOBIOLOGY, V28, P443, DOI 10.1093/glycob/cwy021; Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967; Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008; Bonin CM, 2019, CYTOKINE, V120, P92, DOI 10.1016/j.cyto.2019.04.008; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283; Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17; Chen B, 2019, TRENDS MICROBIOL, V27, P878, DOI 10.1016/j.tim.2019.06.002; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Chigbu DI, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040376; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Barros JBD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00821; Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173; Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004; Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263; Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316; Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983; Ehlert JE, 2004, J IMMUNOL, V173, P6234, DOI 10.4049/jimmunol.173.10.6234; Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferrari SM, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/5878960; Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005; Goodfellow FT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100550; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Hsieh YH, 2010, B MATH BIOL, V72, P122, DOI 10.1007/s11538-009-9440-8; Izquierdo-Suzan M, 2019, EMERG INFECT DIS, V25, P1477, DOI 10.3201/eid2508.181533; Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261; KASAHARA A, 1995, HEPATOLOGY, V21, P291, DOI 10.1016/0270-9139(95)90083-7; Khaiboullina SF, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060558; Kim W, 2014, P NATL ACAD SCI USA, V111, P16389, DOI 10.1073/pnas.1407097111; Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22747-2; Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627; Lahon A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005019; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Lei J, 2019, CYTOKINE, V115, P97, DOI 10.1016/j.cyto.2018.11.018; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005; Li L, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030093; Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019; Lima MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01928; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Magoro T, 2019, J BIOL CHEM, V294, P14591, DOI 10.1074/jbc.RA119.007555; Mansuy JM, 2019, EMERG INFECT DIS, V25, P823, DOI 10.3201/eid2504.171886; da Silva MHM, 2019, MED MICROBIOL IMMUN, V208, P703, DOI 10.1007/s00430-019-00588-8; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720; Metzemaekers M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01970; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Moser LA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006880; Moser LA, 2018, GENOME ANNOUNCEMENTS, V6, DOI [10.1128/genomea.01528-17, 10.1128/genomeA.01528-17]; Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022; Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09; Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rathi AV, 2010, VIROLOGY, V406, P202, DOI 10.1016/j.virol.2010.07.018; Raut R, 2019, P NATL ACAD SCI USA, V116, P227, DOI 10.1073/pnas.1812055115; Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Sezgin E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00616; Sgadari C, 1996, P NATL ACAD SCI USA, V93, P13791, DOI 10.1073/pnas.93.24.13791; Shimojima M, 2014, ARCH VIROL, V159, P2023, DOI 10.1007/s00705-014-2042-2; Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17; Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07; Simon D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120698; Sin JI, 2000, J VIROL, V74, P11173, DOI 10.1128/JVI.74.23.11173-11180.2000; Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436; Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2; Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7; Strumillo ST, 2019, CELL BIOL INT, V43, P574, DOI 10.1002/cbin.11111; Sung PS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06784-x; Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7; Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258; Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9; Untergasser G, 2005, PROSTATE, V64, P419, DOI 10.1002/pros.20261; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003; Vogt MB, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007837; Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16; Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383; Wu Q, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-3; Yakass MB, 2020, J INTERF CYTOK RES, V40, P1, DOI 10.1089/jir.2019.0097	96	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244587	10.1371/journal.pone.0244587	http://dx.doi.org/10.1371/journal.pone.0244587			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378361	Green Published, gold			2022-12-27	WOS:000605651300060
J	Suzuki, A; Okamura, T; Sasaki, M; Matsuoka, H; Ikeda, Y; Takahashi, A; Akiyama, S; Ono, F; Yoshihara, N				Suzuki, Akifumi; Okamura, Tomonori; Sasaki, Masahiro; Matsuoka, Hitoshi; Ikeda, Yoshinobu; Takahashi, Akira; Akiyama, Sayako; Ono, Fumiko; Yoshihara, Nariaki		Akita Study Grp	Acceleration of opportunistic atrial fibrillation screening for elderly patients in routine primary care	PLOS ONE			English	Article							RISK-FACTOR; AGED 65; STROKE; POPULATION; GUIDELINES; BURDEN	Cardio-embolic ischemic stroke caused by atrial fibrillation is more severe compared with other types of stroke, such as lacunar infarction and atherothrombotic infarction in patients without atrial fibrillation. Therefore, it is important to prevent cardio-embolic ischemic stroke by detecting atrial fibrillation early in at-risk patients and administering appropriate anticoagulation therapy. This prospective observational study aimed to evaluate the effectiveness of opportunistic atrial fibrillation screening at 12 primary clinics in Japan. The study included a 12-month pre-campaign period and a 12-month campaign period. During the campaign period, an awareness campaign was conducted to encourage physicians to be mindful of screening patients aged >= 65 years for atrial fibrillation by checking their pulses and performing subsequent electrocardiography when an irregular pulse was detected. The primary outcome was the proportion of patients with newly diagnosed atrial fibrillation. A sub-analysis focusing on first-time outpatients was performed. There were 9921 and 10,282 patients with no history of atrial fibrillation in the pre-campaign and campaign periods, respectively. In the whole population, the proportion of patients with newly diagnosed atrial fibrillation was 0.9% throughout the pre-campaign and campaign periods. In the sub-analysis limited to first-time outpatients, the detection proportion increased from 1.6% to 1.9% during the campaign period. In terms of age stratification, a large increase in detection was observed, especially among patients aged 65-74 years (detection increased from 0.9% to 1.5%) and >= 85 years (detection increased from 2.9% to 3.3%) during the campaign period. Our findings suggest the feasibility of opportunistic atrial fibrillation screening in routine primary care practice in Japan. Of note, our findings suggest that opportunistic atrial fibrillation screening targeting first-time outpatients may be of clinical value.	[Suzuki, Akifumi] Akita Prefectural Hosp Org, Local Independent Adm Inst, Akita, Japan; [Suzuki, Akifumi] Japan Stroke Assoc, Osaka, Japan; [Okamura, Tomonori] Keio Univ, Dept Prevent Med & Publ Hlth, Sch Med, Tokyo, Japan; [Sasaki, Masahiro] Akita Cerebrospinal & Cardiovasc Ctr, Akita, Japan; [Matsuoka, Hitoshi] Matsuoka Internal Med Clin, Akita, Japan; [Ikeda, Yoshinobu] Ikeda Clin, Akita, Japan; [Takahashi, Akira] Takahashi Internal Med Clin, Akita, Japan; [Akiyama, Sayako; Ono, Fumiko; Yoshihara, Nariaki] Bayer Yakuhin Ltd, Market Access, Tokyo, Japan; [Akita Study Grp] 11 Primary Care Clin Daisen & Yokote, Akita, Japan	Keio University; Bayer AG	Suzuki, A (corresponding author), Akita Prefectural Hosp Org, Local Independent Adm Inst, Akita, Japan.; Suzuki, A (corresponding author), Japan Stroke Assoc, Osaka, Japan.	akifumi240@gmail.com	Okamura, Tomonori/L-1693-2013	Okamura, Tomonori/0000-0003-0488-0351; Suzuki, Akifumi/0000-0002-9738-3698; Akiyama, Sayako/0000-0002-5673-7832	Bayer Yakuhin, Ltd.	Bayer Yakuhin, Ltd.	This study was sponsored by Bayer Yakuhin, Ltd. (https://byl.bayer.co.jp/).AS, AT, YI, MS, HM and TO received a consultation fee from Bayer Yakuhin, Ltd. and AT received a consultation fee and reimbursement as a participating general practitioner in this study from Bayer Yakuhin, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao M, 2013, J CARDIOL, V61, P260, DOI 10.1016/j.jjcc.2012.12.002; Ball J, 2013, INT J CARDIOL, V167, P1807, DOI 10.1016/j.ijcard.2012.12.093; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Esato M, 2017, CHEST, V152, P1266, DOI 10.1016/j.chest.2017.08.004; Fay MR, 2017, EUR J GEN PRACT, V23, P246, DOI 10.1080/13814788.2017.1374366; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Fitzmaurice DA, 2007, BRIT MED J, V335, P383, DOI 10.1136/bmj.39280.660567.55; Hald J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188086; Hobbs FDR, 2005, HEALTH TECHNOL ASSES, V9, P1, DOI 10.3310/hta9400; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; Inoue H, 2009, INT J CARDIOL, V137, P102, DOI 10.1016/j.ijcard.2008.06.029; Kirchhof P, 2016, EUR J CARDIO-THORAC, V50, pE1, DOI 10.1093/ejcts/ezw313; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165; Ministry of Health Labour and Welfare, OV AG ADJ MORT RAT P; Smyth B, 2016, QJM-INT J MED, V109, P539, DOI 10.1093/qjmed/hcw011; Take Action for StroKe prevention in AF (TASK-AF) steering committee, 2015, REC STROK PREV 2014; Welton NJ, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21290; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244240	10.1371/journal.pone.0244240	http://dx.doi.org/10.1371/journal.pone.0244240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378380	Green Published, gold			2022-12-27	WOS:000605651300035
J	Schulz, C; Almaas, E				Schulz, Christian; Almaas, Eivind			Genome-scale reconstructions to assess metabolic phylogeny and organism clustering	PLOS ONE			English	Article							SEQUENCE; EVOLUTION; ARCHAEA; GENES; TREE	Approaches for systematizing information of relatedness between organisms is important in biology. Phylogenetic analyses based on sets of highly conserved genes are currently the basis for the Tree of Life. Genome-scale metabolic reconstructions contain high-quality information regarding the metabolic capability of an organism and are typically restricted to metabolically active enzyme-encoding genes. While there are many tools available to generate draft reconstructions, expert-level knowledge is still required to generate and manually curate high-quality genome-scale metabolic models and to fill gaps in their reaction networks. Here, we use the tool AutoKEGGRec to construct 975 genome-scale metabolic draft reconstructions encoded in the KEGG database without further curation. The organisms are selected across all three domains, and their metabolic networks serve as basis for generating phylogenetic trees. We find that using all reactions encoded, these metabolism-based comparisons give rise to a phylogenetic tree with close similarity to the Tree of Life. While this tree is quite robust to reasonable levels of noise in the metabolic reaction content of an organism, we find a significant heterogeneity in how much noise an organism may tolerate before it is incorrectly placed in the tree. Furthermore, by using the protein sequences for particular metabolic functions and pathway sets, such as central carbon-, nitrogen-, and sulfur-metabolism, as basis for the organism comparisons, we generate highly specific phylogenetic trees. We believe the generation of phylogenetic trees based on metabolic reaction content, in particular when focused on specific functions and pathways, could aid the identification of functionally important metabolic enzymes and be of value for genome-scale metabolic modellers and enzyme-engineers.	[Schulz, Christian; Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Trondheim, Norway; [Almaas, Eivind] NTNU Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Dept Publ Hlth & Gen Practice, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Almaas, E (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Trondheim, Norway.; Almaas, E (corresponding author), NTNU Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Dept Publ Hlth & Gen Practice, Trondheim, Norway.	eivind.almaas@ntnu.no		Schulz, Christian/0000-0002-6763-6551	Norwegian Research Council [271585, 294605]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	CS and EA thank the Norwegian Research Council for funding through grants 271585 and 294605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Burleigh JG, 2011, SYST BIOL, V60, P117, DOI 10.1093/sysbio/syq072; Choe D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08888-6; de Vienne Damien M, 2016, PLoS Biol, V14, pe2001624, DOI 10.1371/journal.pbio.2001624; Edwards JS, 2002, BIOTECHNOL BIOENG, V77, P27, DOI 10.1002/bit.10047; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Felsenstein J., 2004, INFERRING PHYLOGENIE; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Gamermann D, 2014, J COMPUT BIOL, V21, P508, DOI 10.1089/cmb.2013.0150; Gupta M, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02074; Heirendt L, 2019, NAT PROTOC, V14, P639, DOI 10.1038/s41596-018-0098-2; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Holland BR, 2006, MOL BIOL EVOL, V23, P848, DOI 10.1093/molbev/msj061; Hong SH, 2004, APPL MICROBIOL BIOT, V65, P203, DOI 10.1007/s00253-004-1641-3; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Jaccard P, 1901, B SOC VAUD SCI NAT, V37, P547, DOI [DOI 10.5169/SEALS-266450, 10.5169/seals-266450]; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Karlsen E, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2472-z; Kitajima Toshihiko, 2013, Biomol Concepts, V4, P611, DOI 10.1515/bmc-2013-0033; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lee DH, 2010, APPL ENVIRON MICROB, V76, P4158, DOI 10.1128/AEM.00373-10; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Liu HX, 2019, CURR BIOL, V29, P1584, DOI 10.1016/j.cub.2019.03.054; Liu L, 2015, ANN NY ACAD SCI, V1360, P36, DOI 10.1111/nyas.12747; Matlab, MATLAB DOC; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Nancharaiah YV, 2015, MICROBIOL MOL BIOL R, V79, P61, DOI 10.1128/MMBR.00037-14; Nei M., 2000, MOL EVOLUTION PHYLOG, P352; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pitkanen E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003465; Qi M, 2016, INFECT GENET EVOL, V44, P313, DOI 10.1016/j.meegid.2016.07.022; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Sandberg TE, 2020, NAT ECOL EVOL, V4, P1402, DOI 10.1038/s41559-020-1271-x; Sharp NP, 2018, P NATL ACAD SCI USA, V115, pE5046, DOI 10.1073/pnas.1801040115; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sokal R.R., 1958, U KANS SCI B; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Szollosi GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0335; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186	48	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0240953	10.1371/journal.pone.0240953	http://dx.doi.org/10.1371/journal.pone.0240953			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373364	Green Published, gold, Green Submitted			2022-12-27	WOS:000603612300009
J	Chen, YH; Wang, TF; Chu, SC; Lin, CB; Wang, LY; Lue, KH; Liu, SH; Chan, SC				Chen, Yu-Hung; Wang, Tso-Fu; Chu, Sung-Chao; Lin, Chih-Bin; Wang, Ling-Yi; Lue, Kun-Han; Liu, Shu-Hsin; Chan, Sheng-Chieh			Incorporating radiomic feature of pretreatment F-18-FDG PET improves survival stratification in patients with EGFR-mutated lung adenocarcinoma	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; MINIMAL PLEURAL EFFUSION; TREATMENT RESPONSE; PROGNOSTIC IMPACT; TEXTURAL FEATURES; CANCER PATIENTS; 18F-FDG PET/CT; T790M MUTATION; FDG-PET; HETEROGENEITY	Background To investigate the survival prognostic value of the radiomic features of F-18-FDG PET in patients who had EGFR (epidermal growth factor receptor) mutated lung adenocarcinoma and received targeted TKI (tyrosine kinase inhibitor) treatment. Methods Fifty-one patients with stage III-IV lung adenocarcinoma and actionable EGFR mutation who received first-line TKI were retrospectively analyzed. All patients underwent pretreatment F-18-FDG PET/CT, and we calculated the PET-derived radiomic features. Cox proportional hazard model was used to examine the association between the radiomic features and the survival outcomes, including progression-free survival (PFS) and overall survival (OS). A score model was established according to the independent prognostic predictors and we compared this model to the TNM staging system using Harrell's concordance index (c-index). Results Forty-eight patients (94.1%) experienced disease progression and 41 patients (80.4%) died. Primary tumor SUV entropy > 5.36, and presence of pleural effusion were independently associated with worse OS (both p < 0.001) and PFS (p = 0.001, and 0.003, respectively). We used these two survival predictors to devise a scoring system (score 0-2). Patients with a score of 1 or 2 had a worse survival than those with a score of 0 (HR for OS: 3.6, p = 0.006 for score 1, and HR: 21.8, p < 0.001 for score 2; HR for PFS: 2.2, p = 0.027 for score 1 and HR: 8.8, p < 0.001 for score 2). Our scoring system surpassed the TNM staging system (c-index = 0.691 versus 0.574, p = 0.013 for OS, and c-index = 0.649 versus 0.517, p = 0.004 for PFS). Conclusions In this preliminary study, combining PET radiomics with clinical risk factors may improve survival stratification in stage III-IV lung adenocarcinoma with actionable EFGR mutation. Our proposed scoring system may assist with optimization of individualized treatment strategies in these patients.	[Chen, Yu-Hung; Liu, Shu-Hsin; Chan, Sheng-Chieh] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Nucl Med, Hualien, Taiwan; [Chen, Yu-Hung; Wang, Tso-Fu; Chu, Sung-Chao; Chan, Sheng-Chieh] Tzu Chi Univ, Dept Med, Coll Med, Hualien, Taiwan; [Wang, Tso-Fu; Chu, Sung-Chao] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Hematol & Oncol, Hualien, Taiwan; [Lin, Chih-Bin] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Internal Med, Hualien, Taiwan; [Wang, Ling-Yi] Tzu Chi Gen Hosp, Dept Med Res, Epidemiol & Biostat Consulting Ctr, Hualien, Taiwan; [Wang, Ling-Yi] Tzu Chi Gen Hosp, Dept Pharm, Hualien, Taiwan; [Lue, Kun-Han; Liu, Shu-Hsin] Tzu Chi Univ Sci & Technol, Dept Med Imaging & Radiol Sci, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University of Science & Technology	Chan, SC (corresponding author), Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Nucl Med, Hualien, Taiwan.; Chan, SC (corresponding author), Tzu Chi Univ, Dept Med, Coll Med, Hualien, Taiwan.	williamsm.tw@gmail.com	Chan, Sheng Chieh/AAF-9127-2019; Chen, Yu-Hung/AGC-7779-2022	Chan, Sheng Chieh/0000-0003-3236-395X; Chen, Yu-Hung/0000-0002-9227-0731; Lue, Kun-Han/0000-0001-7260-9307				[Anonymous], 2012, J OPT COMMUN NETW, V4, pB94; CAMP RL, 2004, CLIN CANCER RES, V10, P7252, DOI [10.1158/1078-0432.CCR-04-0713, DOI 10.1158/1078-0432.CCR-04-0713]; Caswell DR, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0900-y; Chen SF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067974, 10.1371/journal.pone.0054659]; Chen YH, 2019, ANN NUCL MED, V33, P657, DOI 10.1007/s12149-019-01380-7; Cheng NM, 2015, EUR J NUCL MED MOL I, V42, P419, DOI 10.1007/s00259-014-2933-1; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Cook GJR, 2015, RADIOLOGY, V276, P883, DOI 10.1148/radiol.2015141309; Cuaron J, 2013, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00208; Desseroit MC, 2017, J NUCL MED, V58, P406, DOI 10.2967/jnumed.116.180919; Gerber David E, 2014, Am Soc Clin Oncol Educ Book, pe353, DOI 10.14694/EdBook_AM.2014.34.e353; Gettinger S, 2018, J THORAC ONCOL, V13, P1363, DOI 10.1016/j.jtho.2018.05.015; Gridelli C, 2011, LUNG CANCER, V71, P249, DOI 10.1016/j.lungcan.2010.12.008; Han S, 2018, ANN NUCL MED, V32, P602, DOI 10.1007/s12149-018-1281-9; Hata A, 2018, CANCER-AM CANCER SOC, V124, P3830, DOI 10.1002/cncr.31678; Janssen-Heijnen MLG, 2001, EPIDEMIOLOGY, V12, P256, DOI 10.1097/00001648-200103000-00020; Jiang T, 2019, EUR J CANCER, V121, P98, DOI 10.1016/j.ejca.2019.08.021; Kang L, 2015, STAT MED, V34, P685, DOI 10.1002/sim.6370; Koizumi T, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-1032-0; Konert T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228793; Koyasu S, 2020, ANN NUCL MED, V34, P49, DOI 10.1007/s12149-019-01414-0; Kuiper JL, 2014, LUNG CANCER, V85, P19, DOI 10.1016/j.lungcan.2014.03.016; Kus T, 2015, ONCOTARGETS THER, V8, P3749, DOI 10.2147/OTT.S94945; Lapa P, 2017, REV ESP MED NUCL IMA, V36, P342, DOI 10.1016/j.remn.2017.04.001; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Li XF, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01062; Light RW, 1997, EUR RESPIR J, V10, P1701, DOI 10.1183/09031936.97.10081701; Lim E, 2010, J THORAC CARDIOV SUR, V139, P1441, DOI 10.1016/j.jtcvs.2009.05.048; Lindeman NI, 2013, ARCH PATHOL LAB MED, V137, P828, DOI [10.5858/arpa.2012-0720-OA, 10.1097/JTO.0b013e318290868f]; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Moon SH, 2019, EUR J NUCL MED MOL I, V46, P446, DOI 10.1007/s00259-018-4138-5; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Park SY, 2015, J NUCL MED, V56, P45, DOI 10.2967/jnumed.114.147561; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng SL, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1073-4; Pyka T, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0407-7; Ryu JS, 2016, RADIOLOGY, V278, P593, DOI 10.1148/radiol.2015142388; Ryu JS, 2014, J CLIN ONCOL, V32, P960, DOI 10.1200/JCO.2013.50.5453; Saito H, 2019, LANCET ONCOL, V20, P625, DOI 10.1016/S1470-2045(19)30035-X; Santoni-Rugiu E, 2019, CANCERS, V11, DOI 10.3390/cancers11070923; Schwartz LH, 2016, EUR J CANCER, V62, P132, DOI 10.1016/j.ejca.2016.03.081; Shea M, 2016, THER ADV RESPIR DIS, V10, P113, DOI 10.1177/1753465815617871; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song JD, 2016, IEEE ENG MED BIO, P1268, DOI 10.1109/EMBC.2016.7590937; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Steinert Hans C, 2005, Chang Gung Med J, V28, P296; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Takeda A, 2011, RADIOTHER ONCOL, V101, P291, DOI 10.1016/j.radonc.2011.08.008; Takeda K, 2017, J RADIAT RES, V58, P862, DOI 10.1093/jrr/rrx050; Tsim S, 2010, RESP MED, V104, P1767, DOI 10.1016/j.rmed.2010.08.005; van Gool MH, 2016, J THORAC DIS, V8, pE200, DOI 10.21037/jtd.2016.02.10; van Gool MH, 2014, WORLD J RADIOL, V6, P392, DOI 10.4329/wjr.v6.i7.392; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; van Velden FHP, 2016, MOL IMAGING BIOL, V18, P788, DOI 10.1007/s11307-016-0940-2; Wang TF, 2017, ASIA-PAC J CLIN ONCO, V13, P304, DOI 10.1111/ajco.12658; Yip C, 2014, RADIOLOGY, V270, P141, DOI 10.1148/radiol.13122869; Yoo IR, 2014, BIO-MED MATER ENG, V24, P3091, DOI 10.3233/BME-141131; Yu JY, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0086-2; Zhang JY, 2020, EUR J NUCL MED MOL I, V47, P1137, DOI 10.1007/s00259-019-04592-1; Zhuang MZ, 2019, J NUCL MED, V60, P600, DOI 10.2967/jnumed.118.216028; Zwanenburg A, 2019, EUR J NUCL MED MOL I, V46, P2638, DOI 10.1007/s00259-019-04391-8	62	10	10	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244502	10.1371/journal.pone.0244502	http://dx.doi.org/10.1371/journal.pone.0244502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370365	Green Published			2022-12-27	WOS:000603611900057
J	Fisher, NL; Campbell, DA; Hughes, DJ; Kuzhiumparambil, U; Halsey, KH; Ralph, PJ; Suggett, DJ				Fisher, Nerissa L.; Campbell, Douglas A.; Hughes, David J.; Kuzhiumparambil, Unnikrishnan; Halsey, Kimberly H.; Ralph, Peter J.; Suggett, David J.			Divergence of photosynthetic strategies amongst marine diatoms	PLOS ONE			English	Article							FAST REPETITION RATE; PHOTOSYSTEM-II PHOTOINACTIVATION; ALTERNATIVE ELECTRON-TRANSPORT; XANTHOPHYLL-CYCLE ACTIVITY; PHAEODACTYLUM-TRICORNUTUM; HIGH-LIGHT; CHLOROPHYLL FLUORESCENCE; DIADINOXANTHIN CYCLE; ENERGY-DISSIPATION; DYNAMIC LIGHT	Marine phytoplankton, and in particular diatoms, are responsible for almost half of all primary production on Earth. Diatom species thrive from polar to tropical waters and across light environments that are highly complex to relatively benign, and so have evolved highly divergent strategies for regulating light capture and utilization. It is increasingly well established that diatoms have achieved such successful ecosystem dominance by regulating excitation energy available for generating photosynthetic energy via highly flexible light harvesting strategies. However, how different light harvesting strategies and downstream pathways for oxygen production and consumption interact to balance excitation pressure remains unknown. We therefore examined the responses of three diatom taxa adapted to inherently different light climates (estuarine Thalassioisira weissflogii, coastal Thalassiosira pseudonana and oceanic Thalassiosira oceanica) during transient shifts from a moderate to high growth irradiance (85 to 1200 mu mol photons m(-2) s(-1)). Transient high light exposure caused T. weissflogii to rapidly downregulate PSII with substantial nonphotochemical quenching, protecting PSII from inactivation or damage, and obviating the need for induction of O-2 consuming (light-dependent respiration, LDR) pathways. In contrast, T. oceanica retained high excitation pressure on PSII, but with little change in RCII photochemical turnover, thereby requiring moderate repair activity and greater reliance on LDR. T. pseudonana exhibited an intermediate response compared to the other two diatom species, exhibiting some downregulation and inactivation of PSII, but high repair of PSII and induction of reversible PSII nonphotochemical quenching, with some LDR. Together, these data demonstrate a range of strategies for balancing light harvesting and utilization across diatom species, which reflect their adaptation to sustain photosynthesis under environments with inherently different light regimes.	[Fisher, Nerissa L.; Hughes, David J.; Kuzhiumparambil, Unnikrishnan; Ralph, Peter J.; Suggett, David J.] Univ Technol Sydney, Climate Change Cluster, Ultimo, NSW, Australia; [Campbell, Douglas A.] Mt Allison Univ, Dept Biol, Sackville, NB, Canada; [Halsey, Kimberly H.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA	University of Technology Sydney; Mount Allison University; Oregon State University	Fisher, NL (corresponding author), Univ Technol Sydney, Climate Change Cluster, Ultimo, NSW, Australia.	nerissa.fisher@uts.edu.au	Hughes, David/K-8960-2019; Campbell, Douglas/B-3768-2010; Kuzhiumparambil, Unnikrishnan/B-4842-2013; Ralph, Peter/C-5029-2009	Hughes, David/0000-0003-3778-7460; Campbell, Douglas/0000-0001-8996-5463; Kuzhiumparambil, Unnikrishnan/0000-0003-0582-6779; Ralph, Peter/0000-0002-3103-7346; Fisher, Nerissa/0000-0001-7996-8310				Allahverdiyeva Y, 2015, J EXP BOT, V66, P2427, DOI 10.1093/jxb/eru463; Alric J, 2017, CURR OPIN PLANT BIOL, V37, P78, DOI 10.1016/j.pbi.2017.03.014; Ananda MMA, 1997, STAT SINICA, V7, P631; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2016, LANCET ONCOL, V17, P1, DOI 10.1016/S1470-2045(15)00568-9; [Anonymous], 2001, NAT CELL BIOL, V3, pE199; [Anonymous], 2009, DOCUMENTATION BIBLIO, V56, P147; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Barnett A, 2015, ISME J, V9, P32, DOI 10.1038/ismej.2014.105; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Blommaert L, 2017, LIMNOL OCEANOGR, V62, P1466, DOI 10.1002/lno.10511; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; Bucciarelli E, 2013, LIMNOL OCEANOGR, V58, P1667, DOI 10.4319/lo.2013.58.5.1667; Buck JM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12043-6; Campbell DA., 2020, PHOTOSYNTHESIS ALGAE, P329, DOI DOI 10.1007/978-3-030-33397-3_13; Campbell DA, 2013, PHOTOSYNTH RES, V115, P43, DOI 10.1007/s11120-013-9809-2; Campbell DA, 2012, BBA-BIOENERGETICS, V1817, P258, DOI 10.1016/j.bbabio.2011.04.010; Cardol P, 2011, BBA-BIOENERGETICS, V1807, P912, DOI 10.1016/j.bbabio.2010.12.004; Claquin P, 2004, EUR J PHYCOL, V39, P33, DOI 10.1080/0967026032000157165; Croteau D, 2021, LIMNOL OCEANOGR, V66, pS231, DOI 10.1002/lno.11587; Derks AK, 2018, PHOTOSYNTH RES, V138, P149, DOI 10.1007/s11120-018-0558-0; Dimier C, 2007, J PHYCOL, V43, P937, DOI 10.1111/j.1529-8817.2007.00381.x; Du N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199125; Edwards KF, 2015, LIMNOL OCEANOGR, V60, P540, DOI 10.1002/lno.10033; Feikema WO, 2006, BBA-BIOENERGETICS, V1757, P829, DOI 10.1016/j.bbabio.2006.06.003; Ferron S, 2016, LIMNOL OCEANOGR-METH, V14, P610, DOI 10.1002/lom3.10116; Fisher NL, 2016, PHOTOSYNTH RES, V129, P183, DOI 10.1007/s11120-016-0282-6; Gao G, 2018, ENVIRON EXP BOT, V147, P95, DOI 10.1016/j.envexpbot.2017.11.014; Genty B, 1996, PHOTOSYNTHESIS ENV, P67, DOI DOI 10.1073/pnas.1110189108; Giordano M, 2005, NEW PHYTOL, V166, P371, DOI 10.1111/j.1469-8137.2005.01335.x; Giovagnetti V, 2017, BBA-BIOENERGETICS, V1858, P218, DOI 10.1016/j.bbabio.2016.12.005; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Grouneva I, 2006, PHYSIOL PLANTARUM, V126, P205, DOI 10.1111/j.1399-3054.2006.00613.x; Grouneva I, 2009, BBA-BIOENERGETICS, V1787, P929, DOI 10.1016/j.bbabio.2009.02.004; Guillard R.R.L., 1975, CULTURE MARINE INVER, P26, DOI DOI 10.1007/978-1-4615-8714-9_3; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; Halsey KH, 2010, PHOTOSYNTH RES, V103, P125, DOI 10.1007/s11120-009-9526-z; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; HORTON P, 1992, PHOTOSYNTH RES, V34, P375, DOI 10.1007/BF00029812; Hughes DJ, 2018, LIMNOL OCEANOGR, V63, P1891, DOI 10.1002/lno.10814; Hughes DJ, 2018, ENVIRON SCI TECHNOL, V52, P12039, DOI 10.1021/acs.est.8b03488; Joly D, 2007, BIOCHEMISTRY-US, V46, P5534, DOI 10.1021/bi602627d; KANA TM, 1994, ANAL CHEM, V66, P4166, DOI 10.1021/ac00095a009; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Klughammer C, 2008, PAM APPL NOTES, V1, P27; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; Kuzminov FI, 2016, PHOTOSYNTH RES, V127, P219, DOI 10.1007/s11120-015-0180-3; Lacour T, 2020, J PHYCOL, V56, P245, DOI 10.1111/jpy.12944; Lacour T, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00354; Larkum AWD, 2003, ADV PHOTO RESPIRAT, V14, P277; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Lavaud J, 2016, PHOTOSYNTH RES, V127, P189, DOI 10.1007/s11120-015-0172-3; Lavaud J, 2014, ADV PHOTOSYNTH RESP, V40, P421, DOI 10.1007/978-94-017-9032-1_20; Lavaud J, 2013, BBA-BIOENERGETICS, V1827, P294, DOI 10.1016/j.bbabio.2012.11.012; Laws EA, LIMNOLOGY OCEANOGRAP, V25, P457, DOI [10.4319/lo.2004.49.6.2316, DOI 10.4319/LO.2004.49.6.2316]; Lepetit B, 2017, NEW PHYTOL, V214, P205, DOI 10.1111/nph.14337; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Li G, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00218; Li G, 2015, NEW PHYTOL, V205, P533, DOI 10.1111/nph.13037; Litchman E, 2004, LIMNOL OCEANOGR, V49, P1457, DOI 10.4319/lo.2004.49.4_part_2.1457; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lomas MW, 2004, MAR BIOL, V144, P37, DOI 10.1007/s00227-003-1181-x; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Malviya S, 2016, P NATL ACAD SCI USA, V113, pE1516, DOI 10.1073/pnas.1509523113; McKew BA, 2013, NEW PHYTOL, V200, P74, DOI 10.1111/nph.12373; Milligan AJ, 2012, MAR ECOL PROG SER, V448, P67, DOI 10.3354/meps09544; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Miyake C, 2012, SOIL SCI PLANT NUTR, V58, P718, DOI 10.1080/00380768.2012.736078; Murik O, 2019, NEW PHYTOL, V221, P1303, DOI 10.1111/nph.15479; Nawrocki WJ, 2015, ANNU REV PLANT BIOL, V66, P49, DOI 10.1146/annurev-arplant-043014-114744; Oliver RL, 2013, J PLANKTON RES, V35, P927, DOI 10.1093/plankt/fbt043; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Perkins R, 2018, PHOTOSYNTH RES, V137, P377, DOI 10.1007/s11120-018-0508-x; Prihoda J, 2012, J EXP BOT, V63, P1543, DOI 10.1093/jxb/err441; R Core Team, R LANG ENV STAT COMP; Raven JA, 2000, J MAR BIOL ASSOC UK, V80, P1, DOI 10.1017/S0025315499001526; Raven JA, 2011, PHYSIOL PLANTARUM, V142, P87, DOI 10.1111/j.1399-3054.2011.01465.x; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; RStudio Team, RSTUDIO INT DEV R; Rusch Douglas B, 2010, Proc Natl Acad Sci U S A, V107, P16184, DOI 10.1073/pnas.1009513107; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Serodio J, 2005, J EXP MAR BIOL ECOL, V326, P157, DOI 10.1016/j.jembe.2005.05.011; STRANSKY H, 1970, ARCH MIKROBIOL, V72, P84, DOI 10.1007/BF00411017; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett DJ, 2015, NEW PHYTOL, V208, P370, DOI 10.1111/nph.13483; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Suggett DJ, 2003, EUR J PHYCOL, V38, P371, DOI 10.1080/09670260310001612655; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; Taddei L, 2018, PLANT PHYSIOL, V177, P953, DOI 10.1104/pp.18.00448; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; Wagner H, 2016, PHOTOSYNTH RES, V128, P151, DOI 10.1007/s11120-015-0209-7; Walter B, 2015, ICES J MAR SCI, V72, P2061, DOI 10.1093/icesjms/fsu218; Waring J, 2010, J PHYCOL, V46, P1206, DOI 10.1111/j.1529-8817.2010.00919.x; WEGER HG, 1989, LIMNOL OCEANOGR, V34, P1153, DOI 10.4319/lo.1989.34.7.1153; Westberry T, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003078; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Wilhelm C, 2014, MAR GENOM, V16, P5, DOI 10.1016/j.margen.2013.12.003; Wu HY, 2012, PLANT PHYSIOL, V160, P464, DOI 10.1104/pp.112.203067; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	117	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244252	10.1371/journal.pone.0244252	http://dx.doi.org/10.1371/journal.pone.0244252			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370327	Green Published, gold			2022-12-27	WOS:000603611900102
J	Karuppusami, R; Antonisami, B; Vasan, SK; Gowri, M; Selliah, HY; Arulappan, G; Jebasingh, F; Thomas, N; Paul, TV				Karuppusami, Reka; Antonisami, Belavendra; Vasan, Senthil K.; Gowri, Mahasampath; Selliah, Hepsy Y.; Arulappan, Geethanjali; Jebasingh, Felix; Thomas, Nihal; Paul, Thomas V.			Association of serum 25-Hydroxy vitamin D with total and regional adiposity and cardiometabolic traits	PLOS ONE			English	Article							D DEFICIENCY; HYPOVITAMINOSIS-D; D SUPPLEMENTATION; INSULIN-RESISTANCE; DIETARY CALCIUM; HIGH PREVALENCE; ASIAN INDIANS; HEALTHY; OBESITY; METAANALYSIS	Background Lower serum 25-hydroxyvitamin D [25(OH)D] is associated with greater adiposity and adverse cardiometabolic risk profile. The evidence is inconsistent among South Asian Indians. We aimed to examine associations between 25(OH)D and cardiovascular (CVD) risk markers in a rural and urban cohort from South India. Subjects/Methods In this cross sectional study, 373 individuals (men, n = 205) underwent detailed CVD risk marker assessment including anthropometry [body mass index (BMI), waist, (WC) and hip circumferences (HC)], body composition analysis using dual energy x-ray absorptiometry (DXA), blood pressure and biochemical analysis (glucose, insulin and lipids). The distribution of CVD risk factors were compared across serum 25(OH)D levels, stratified as deficiency (<20 ng/ml), insufficiency (20 to 29 ng/ml) and normal (>= 30 ng/ml) levels. Multiple regression analysis, adjusting for potential confounders, was used to study associations of 25(OH)D with adiposity and cardiometabolic traits. Results The mean and standard deviation (SD) of age, BMI and 25(OH)D levels were 41.4 (1.1) years, 25.5 (4.8) kg/m(2) and 23.4 (10.4) ng/ml respectively. The prevalence of 25(OH)D deficiency was 39.9% in this cohort. Individuals in the 25(OH)D deficiency category had significantly higher mean (SD) BMI [26.6 (5.1) kg/m(2)], waist circumference [89.9 (12.5) cm] and total fat mass [20.6 (7.9) kg] compared with the Vitamin D sufficient group [BMI: 24.0 (4.4); WC 84.7 (12.0); total fat mass: 15.2 (6.8)]. Significantly inverse associations were observed with DXA measured total and regional fat depots with 25(OH)D levels, while anthropometric indices of adiposity showed significant inverse association only in women. After adjusting for total fat mass, no significant associations were observed between 25(OH)D and the cardiometabolic traits. Conclusions Our results confirm that lower 25(OH)D is independently associated with both total and regional adiposity, but not with cardiometabolic traits, in this population.	[Karuppusami, Reka; Antonisami, Belavendra; Gowri, Mahasampath; Selliah, Hepsy Y.] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Vasan, Senthil K.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Arulappan, Geethanjali] Christian Med Coll & Hosp, Dept Clin Biochem, Vellore, Tamil Nadu, India; [Jebasingh, Felix; Thomas, Nihal; Paul, Thomas V.] Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; University of Oxford; Christian Medical College & Hospital (CMCH) Vellore; Christian Medical College & Hospital (CMCH) Vellore	Paul, TV (corresponding author), Christian Med Coll & Hosp, Dept Endocrinol Diabet & Metab, Vellore, Tamil Nadu, India.	thomasvpaul@yahoo.com		jebasingh, felix/0000-0001-5903-6110; PAUL, THOMAS/0000-0003-3315-341X	Indian Institute of Public Health, Hyderabad [09-2012]; Christian Medical College, Vellore	Indian Institute of Public Health, Hyderabad; Christian Medical College, Vellore	The study was jointly funded by the Indian Institute of Public Health, Hyderabad (WTP Project grant/09-2012) and internal research funds from Christian Medical College, Vellore.	Antonisamy B, 2009, INT J EPIDEMIOL, V38, P663, DOI 10.1093/ije/dyn159; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Awumey EMK, 1998, J CLIN ENDOCR METAB, V83, P169, DOI 10.1210/jc.83.1.169; Baker CP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129468; Beloyartseva Maria, 2012, Arch Osteoporos, V7, P187, DOI 10.1007/s11657-012-0096-x; Chandler PD, 2015, NUTR REV, V73, P577, DOI 10.1093/nutrit/nuv012; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285; Gangloff A, 2015, INT J OBESITY, V39, P1638, DOI 10.1038/ijo.2015.118; Geleijnse JM, 2011, AM J HYPERTENS, V24, P253, DOI 10.1038/ajh.2010.199; Gepner AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036617; Harinarayan CV, 2007, AM J CLIN NUTR, V85, P1062, DOI 10.1093/ajcn/85.4.1062; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kelly TLWK, 2011, US patent application, Patent No. [US2011-02358812011, 201102358812011]; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Majumdar V, 2011, INT J OBESITY, V35, P1131, DOI 10.1038/ijo.2010.232; Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991; Misra A, 2009, J Assoc Physicians India, V57, P163; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Mitri J, 2011, EUR J CLIN NUTR, V65, P1005, DOI 10.1038/ejcn.2011.118; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Ock SY, 2016, DIABETES METAB J, V40, P367, DOI 10.4093/dmj.2016.40.5.367; Pelczynska M, 2016, ANN AGR ENV MED, V23, P403, DOI 10.5604/12321966.1219177; Ponda MP, 2012, CIRCULATION, V126, P270, DOI 10.1161/CIRCULATIONAHA.111.077875; Saneei P, 2013, OBES REV, V14, P393, DOI 10.1111/obr.12016; Savastano S, 2017, REV ENDOCR METAB DIS, V18, P215, DOI 10.1007/s11154-017-9410-7; Shivane VK, 2011, POSTGRAD MED J, V87, P514, DOI 10.1136/pgmj.2010.113092; Snijder MB, 2005, J CLIN ENDOCR METAB, V90, P4119, DOI 10.1210/jc.2005-0216; Sulistyoningrum DC, 2013, METABOLISM, V62, P1795, DOI 10.1016/j.metabol.2013.07.009; Sulistyoningrum DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043159; Vasan SK, 2018, INT J OBESITY, V42, P850, DOI 10.1038/ijo.2017.289; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Wamberg L, 2013, INT J OBESITY, V37, P651, DOI 10.1038/ijo.2012.112; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wright CS, 2015, J NUTR, V145, P2683, DOI 10.3945/jn.115.220541; Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212; Zhang J, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1794894	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243850	10.1371/journal.pone.0243850	http://dx.doi.org/10.1371/journal.pone.0243850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370344	Green Published, gold			2022-12-27	WOS:000603611900109
J	Afaa, TJ; Amegan-Aho, KH; Dono, MT; Odei, E; Awuku, YA				Afaa, Taiba Jibril; Amegan-Aho, Kokou Hefoume; Dono, Matilda Tierenye; Odei, Eric; Awuku, Yaw Asante			Clinical characteristics of paediatric autoimmune hepatitis at a referral hospital in Sub Saharan Africa	PLOS ONE			English	Article							LIVER-DISEASE; MANAGEMENT; DIAGNOSIS	Background Autoimmune hepatitis (AIH) is a progressive inflammatory liver disease of unknown aetiology. The number of reported AIH cases is increasing in the developed countries but the same cannot be said about sub Saharan Africa (SSA). Paediatric AIH diagnosis is usually missed and patients present with decompensated liver disease. Our study highlights the clinical profile of paediatric AIH cases at a referral hospital in Ghana. Methods This is a retrospective review of all cases of children diagnosed with autoimmune hepatitis at the gastroenterology clinic in Korle Bu Teaching Hospital, Accra, Ghana. Data was extracted from the patients' records from April 2016 to October 2019. These children were diagnosed based on the presence of autoantibodies, elevated immunoglobulin G and histologic presence of interphase hepatitis with the exclusion of hepatitis A, B, C and E depending on their clinical presentation, Wilson's disease, HIV, Schistosomiasis and sickle cell disease. Results Thirteen patients aged between 5 years to 13 years with a mean age of 10 years were diagnosed with AIH. All the patients had type 1 AIH with majority 8 (61.5%) being females. Most of the children presented with advanced liver disease with complications. Three patients had other associated autoimmune diseases. The patients were treated with prednisolone with or without azathioprine depending on the severity of the liver disease. Conclusion Majority of paediatric AIH presents with advanced liver disease. There is the need for early detection to change the natural history of AIH in SSA.	[Afaa, Taiba Jibril] Univ Ghana, Med Sch, Dept Child Hlth, Coll Hlth Sci, Accra, Ghana; [Amegan-Aho, Kokou Hefoume] Univ Hlth & Allied Sci, Dept Paediat & Child Hlth, Ho, Ghana; [Dono, Matilda Tierenye] Korle Bu Teaching Hosp, Dept Child Hlth, Accra, Ghana; [Odei, Eric] Korle Bu Teaching Hosp, Dept Publ Hlth, Accra, Ghana; [Awuku, Yaw Asante] Univ Hlth & Allied Sci, Dept Med & Therapeut, Ho, Ghana	University of Ghana	Afaa, TJ (corresponding author), Univ Ghana, Med Sch, Dept Child Hlth, Coll Hlth Sci, Accra, Ghana.	taibaafaa@yahoo.com		Amegan-Aho, Kokou/0000-0001-7982-9222				Behairy OGA, 2017, EGYPT PEDIATR ASSO, V65, P108, DOI 10.1016/j.epag.2017.11.002; Bjornsson E, 2011, CLIN GASTROENTEROL H, V9, P57, DOI 10.1016/j.cgh.2010.07.016; Czaja AJ, 2019, WORLD J GASTROENTERO, V25, P6579, DOI 10.3748/wjg.v25.i45.6579; Czaja AJ, 2016, GUT LIVER, V10, P177, DOI 10.5009/gnl15352; El-Koofy N, 2010, MED J CAIRO U, V78, P107; Ferri PM, 2012, WORLD J GASTROENTERO, V18, P4470, DOI 10.3748/wjg.v18.i33.4470; Gregorio GV, 1997, HEPATOLOGY, V25, P541, DOI 10.1002/hep.510250308; Guo LP, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/2376231; Jimenez-Rivera C, 2015, PEDIATRICS, V136, pE1237, DOI 10.1542/peds.2015-0578; Kerkar N, 2015, ANN PEDIAT CHILD HLT, V3, P1045; Liberal R, 2013, J AUTOIMMUN, V41, P126, DOI 10.1016/j.jaut.2012.11.002; Lim KN, 2001, AM J GASTROENTEROL, V96, P3390, DOI 10.1111/j.1572-0241.2001.05272.x; Lohse AW, 2015, J HEPATOL, V63, P971, DOI 10.1016/j.jhep.2015.06.030; Maggiore G, 2014, WORLD J HEPATOL, V6, P464, DOI 10.4254/wjh.v6.i7.464; MCFARLANE IG, 1990, LANCET, V335, P754, DOI 10.1016/0140-6736(90)90870-B; Mieli-Vergani G, 2018, J PEDIATR GASTR NUTR, V66, P345, DOI 10.1097/MPG.0000000000001801; Mieli-Vergani G, 2013, ARCH DIS CHILD, V98, P1012, DOI 10.1136/archdischild-2013-303848; Muratori P, 2015, EUR J GASTROEN HEPAT, V27, P1175, DOI 10.1097/MEG.0000000000000424; Pathak S, 2018, PEDIATR ANN, V47, pE81, DOI 10.3928/19382359-20180126-01; Price JC, 2010, CLIN GASTROENTEROL H, V8, P1002, DOI 10.1016/j.cgh.2010.08.024; Sebode M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00609; Shah Rushikesh, 2017, World J Gastrointest Pathophysiol, V8, P108, DOI 10.4291/wjgp.v8.i3.108; Shaker Y, 2014, J CLIN TRANSL HEPATO, V2, P212, DOI 10.14218/JCTH.2014.00018; Wong GW, 2015, DIGEST DIS, V33, P25, DOI 10.1159/000440707	24	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0239964	10.1371/journal.pone.0239964	http://dx.doi.org/10.1371/journal.pone.0239964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362271	Green Published, gold			2022-12-27	WOS:000603071600021
J	Chen, CK; Chan, YL; Su, TH				Chen, Chun-Kuei; Chan, Yi-Ling; Su, Tse-Hsuan			Incidence of intoxication events and patient outcomes in Taiwan: A nationwide population-based observational study	PLOS ONE			English	Article							AMERICAN-ASSOCIATION; ACUTE POISONINGS; SELF-HARM; ATTEMPTED-SUICIDE; OLDER-ADULTS; REPETITION; MULTICENTER; MORTALITY; HOSPITALS; SURVIVAL	Background Intoxicated patients were frequently managed in the emergency departments (ED) with few studies at national level. The study aimed to reveal the incidence, outcomes of intoxications and trend in Taiwan. Methods Adults admitted to an ED due to an intoxication event between 2006 and 2013 were identified using the Taiwan National Health Insurance Research Database. The rate of intoxication and severe intoxication events, mortality rate, hospital length of stay (LOS), and daily medical costs of these patients were analyzed. Changes over time were analyzed using Joinpoint models. Multivariable generalized regressions with GEE were used to assess the effect of sex, age, and presence of prior psychiatric illness. Results A total of 20,371 ED admissions due to intoxication events were identified during the study period, and the incidence decreased with annual percentage change of 4.7% from 2006 to 2013. The mortality rate, hospital LOS, and daily medical costs were not decreased over time. Males and geriatric patients had more severe intoxication events, greater mortality rates, and greater daily medical costs. Patients with psychiatric illnesses had higher mortality rates and a longer hospital LOS, but lower daily medical expenses. Conclusion From 2006 to 2013, there was a decline in the incidence of ED admission for intoxication events in Taiwan. Males, geriatric patients, and those with psychiatric illnesses had greater risks for severe intoxication and mortality.	[Chen, Chun-Kuei; Chan, Yi-Ling; Su, Tse-Hsuan] Chang Gung Mem Hosp, Dept Emergency Med, Taoyuan, Taiwan; [Chen, Chun-Kuei; Chan, Yi-Ling; Su, Tse-Hsuan] Chang Gung Univ, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Su, TH (corresponding author), Chang Gung Mem Hosp, Dept Emergency Med, Taoyuan, Taiwan.; Su, TH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	Hsuan.ths@gmail.com	CHEN, Chun Kuei/ABB-1653-2021	Su, Tse-Hsuan/0000-0003-0619-0282				Andrew E, 2008, CLIN TOXICOL, V46, P310, DOI 10.1080/15563650701378712; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2008, JT COMM PERSPECT PAT, V8, P7; Azizpour Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3585-9; Brandenburg R, 2014, CRIT CARE MED, V42, P1471, DOI 10.1097/CCM.0000000000000245; Bronstein AC, 2007, CLIN TOXICOL, V45, P815, DOI 10.1080/15563650701754763; Bronstein AC, 2012, CLIN TOXICOL, V50, P911, DOI 10.3109/15563650.2012.746424; Bronstein AC, 2011, CLIN TOXICOL, V49, P910, DOI 10.3109/15563650.2011.635149; Bronstein AC, 2010, CLIN TOXICOL, V48, P979, DOI 10.3109/15563650.2010.543906; Bronstein AC, 2009, CLIN TOXICOL, V47, P911, DOI 10.3109/15563650903438566; Bronstein AC, 2008, CLIN TOXICOL, V46, P927, DOI 10.1080/15563650802559632; Burillo-Putze G, 2003, EUR J EMERG MED, V10, P101, DOI 10.1097/00063110-200306000-00006; Chen CF, 2015, EMERG MED J, V32, P226, DOI 10.1136/emermed-2013-203238; Chien WC, 2013, INT J INJ CONTROL SA, V20, P295, DOI 10.1080/17457300.2012.724689; Chien WC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-703; Christiansen E, 2007, AUST NZ J PSYCHIAT, V41, P257, DOI 10.1080/00048670601172749; Chung JY, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5918-3; Erlangsen A, 2015, SOC PSYCH PSYCH EPID, V50, P1427, DOI 10.1007/s00127-015-1051-0; Gummin DD, 2019, CLIN TOXICOL, V57, P1220, DOI 10.1080/15563650.2019.1677022; Gummin DD, 2018, CLIN TOXICOL, V56, P1213, DOI 10.1080/15563650.2018.1533727; Harnod D, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193524; Hedegaard Holly, 2018, NCHS Data Brief, P1; Heyerdahl F, 2008, CLIN TOXICOL, V46, P42, DOI [10.1080/15563650701210048, 10.3109/15563650701210048]; Hovda KE, 2008, CLIN TOXICOL, V46, P35, DOI 10.1080/15563650601185969; Hu YH, 2010, J CHIN MED ASSOC, V73, P78, DOI 10.1016/S1726-4901(10)70006-X; Huang CC, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0416-7; Huang HS, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-017-0468-8; Kordrostami R, 2017, DARU, V25, DOI 10.1186/s40199-017-0181-1; Kristinsson J, 2008, CLIN TOXICOL, V46, P126, DOI 10.1080/15563650701438268; Kumpula EK, 2017, AUST NZ J PUBL HEAL, V41, P535, DOI 10.1111/1753-6405.12702; Kwok CL, 2014, BRIT J PSYCHIAT, V204, P376, DOI 10.1192/bjp.bp.113.130179; Lam SM, 2010, HUM EXP TOXICOL, V29, P757, DOI 10.1177/0960327110361753; Lee HL, 2008, HUM EXP TOXICOL, V27, P373, DOI 10.1177/0960327108094609; Liang HF, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2261-2; Lilley R, 2008, BRIT J PSYCHIAT, V192, P440, DOI 10.1192/bjp.bp.107.043380; Lin CM, 2018, PSYCHOL RES BEHAV MA, V11, P323, DOI 10.2147/PRBM.S167621; Lung FW, 2017, PUBLIC HEALTH, V147, P136, DOI 10.1016/j.puhe.2017.01.030; Mowry JB, 2014, CLIN TOXICOL, V52, P1032, DOI 10.3109/15563650.2014.987397; Mowry JB, 2013, CLIN TOXICOL, V51, P949, DOI 10.3109/15563650.2013.863906; Murphy E, 2012, BRIT J PSYCHIAT, V200, P399, DOI 10.1192/bjp.bp.111.094177; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Shaw FFT, 2019, J AFFECT DISORDERS, V244, P16, DOI 10.1016/j.jad.2018.09.050; van Beusekom I, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0224-7; Wong CS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215878; Wong CS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002549; Wu WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087568; Wu ZT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001435; Yang CC, 1996, J TOXICOL-CLIN TOXIC, V34, P651, DOI 10.3109/15563659609013825; Yang WS, 2019, NEUROPSYCH DIS TREAT, V15, P397, DOI 10.2147/NDT.S192943; Zeppegno P, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0392-2	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244438	10.1371/journal.pone.0244438	http://dx.doi.org/10.1371/journal.pone.0244438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362242	gold, Green Published, Green Submitted			2022-12-27	WOS:000603071600005
J	Stevens, CR; Berenson, J; Sledziona, M; Moore, TP; Dong, L; Cheetham, J				Stevens, Courtney R.; Berenson, Josh; Sledziona, Michael; Moore, Timothy P.; Dong, Lynn; Cheetham, Jonathan			Approach for semi-automated measurement of fiber diameter in murine and canine skeletal muscle	PLOS ONE			English	Article							SEGMENTATION; HYPERTROPHY	Currently available software tools for automated segmentation and analysis of muscle cross-section images often perform poorly in cases of weak or non-uniform staining conditions. To address these issues, our group has developed the MyoSAT (Myofiber Segmentation and Analysis Tool) image-processing pipeline. MyoSAT combines several unconventional approaches including advanced background leveling, Perona-Malik anisotropic diffusion filtering, and Steger's line detection algorithm to aid in pre-processing and enhancement of the muscle image. Final segmentation is based upon marker-based watershed segmentation. Validation tests using collagen V labeled murine and canine muscle tissue demonstrate that MyoSAT can determine mean muscle fiber diameter with an average accuracy of similar to 92.4%. The software has been tested to work on full muscle cross-sections and works well even under non-optimal staining conditions. The MyoSAT software tool has been implemented as a macro for the freely available ImageJ software platform. This new segmentation tool allows scientists to efficiently analyze large muscle cross-sections for use in research studies and diagnostics.	[Stevens, Courtney R.; Berenson, Josh; Sledziona, Michael; Moore, Timothy P.; Dong, Lynn; Cheetham, Jonathan] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Cornell University	Cheetham, J (corresponding author), Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA.	jc485@cornell.edu		Cheetham, Jonathan/0000-0001-9309-5261	National Institute of Deafness and Communication Disorders [1R01DC017171]	National Institute of Deafness and Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an award from the National Institute of Deafness and Communication Disorders (received award 1R01DC017171).	[Anonymous], 2014, LANCET INFECT DIS, V14, P1, DOI 10.1016/S1473-3099(13)70368-2; Bergmeister KD, 2016, MUSCLE NERVE, V54, P292, DOI 10.1002/mus.25033; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; Brox T, 2006, FULLY AUTOMATED ANAL, P86; Jain A. K., 1989, FUNDAMENTALS DIGITAL; Klemencic A, 1998, CYTOMETRY, V32, P317, DOI 10.1002/(SICI)1097-0320(19980801)32:4<317::AID-CYTO9>3.0.CO;2-E; Legland D, 2016, BIOINFORMATICS, V32, P3532, DOI 10.1093/bioinformatics/btw413; Liu F, 2013, J MICROSC-OXFORD, V252, P275, DOI 10.1111/jmi.12090; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Meunier B, 2010, HISTOCHEM CELL BIOL, V134, P307, DOI 10.1007/s00418-010-0733-7; Miazaki M, 2015, COMPUT BIOL MED, V63, P28, DOI 10.1016/j.compbiomed.2015.04.020; Mula J, 2013, J APPL PHYSIOL, V114, P148, DOI 10.1152/japplphysiol.01022.2012; NICKS DK, 1989, J ANAT, V163, P1; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Roorda BD, 2005, J LIPID RES, V46, P230, DOI 10.1194/jlr.M400416-JLR200; Sacha J, 2017, IJ PLUGINS TOOLKIT V; Saez A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-77; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Soille P, 1990, DETERMINING WATERSHE, P240, DOI [10.1117/12.24211, DOI 10.1117/12.24211]; Spiegel, 1984, SPIEGEL, V9, P101; Steger C, 1996, UNBIASED DETECTOR CU; TAYLOR NAS, 1986, SPORTS MED, V3, P190, DOI 10.2165/00007256-198603030-00003; Wagner T, 2017, RIDGE DETECTION V1 4; Wen Y, 2018, J APPL PHYSIOL, V124, P40, DOI 10.1152/japplphysiol.00762.2017; Zuravin S.J., 1986, J FAM VIOLENCE, V1, P307, DOI DOI 10.1007/BF00978275; Zygelyte E, 2016, J NEUROSCI METH, V271, P34, DOI 10.1016/j.jneumeth.2016.05.017	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243163	10.1371/journal.pone.0243163	http://dx.doi.org/10.1371/journal.pone.0243163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362264	gold, Green Published, Green Submitted			2022-12-27	WOS:000603071600047
J	Wu, M; Whittemore, K; Huang, CC; Corrado, RE; Culp, GM; Lim, S; Schluger, NW; Daskalakis, DC; Lucero, DE; Vora, NM				Wu, Melody; Whittemore, Katherine; Huang, Chaorui C.; Corrado, Rachel E.; Culp, Gretchen M.; Lim, Sungwoo; Schluger, Neil W.; Daskalakis, Demetre C.; Lucero, David E.; Vora, Neil M.			Community-setting pneumonia-associated hospitalizations by level of urbanization-New York City versus other areas of New York State, 2010-2014	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; ACQUIRED PNEUMONIA; HEALTH; DIAGNOSIS; BURDEN; ADULTS; IMPACT; URBAN; RISK	Background New York City (NYC) reported a higher pneumonia and influenza death rate than the rest of New York State during 2010-2014. Most NYC pneumonia and influenza deaths are attributed to pneumonia caused by infection acquired in the community, and these deaths typically occur in hospitals. Methods We identified hospitalizations of New York State residents aged >= 20 years discharged from New York State hospitals during 2010-2014 with a principal diagnosis of community-setting pneumonia or a secondary diagnosis of community-setting pneumonia if the principal diagnosis was respiratory failure or sepsis. We examined mean annual age-adjusted community-setting pneumonia-associated hospitalization (CSPAH) rates and proportion of CSPAH with in-hospital death, overall and by sociodemographic group, and produced a multivariable negative binomial model to assess hospitalization rate ratios. Results Compared with non-NYC urban, suburban, and rural areas of New York State, NYC had the highest mean annual age-adjusted CSPAH rate at 475.3 per 100,000 population and the highest percentage of CSPAH with in-hospital death at 13.7%. NYC also had the highest proportion of CSPAH patients residing in higher-poverty-level areas. Adjusting for age, sex, and area-based poverty, NYC residents experienced 1.3 (95% confidence interval [CI], 1.2-1.4), non-NYC urban residents 1.4 (95% CI, 1.3-1.6), and suburban residents 1.2 (95% CI, 1.1-1.3) times the rate of CSPAH than rural residents. Conclusions In New York State, NYC as well as other urban areas and suburban areas had higher rates of CSPAH than rural areas. Further research is needed into drivers of CSPAH deaths, which may be associated with poverty.	[Wu, Melody] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Wu, Melody; Whittemore, Katherine; Huang, Chaorui C.; Corrado, Rachel E.; Daskalakis, Demetre C.; Lucero, David E.; Vora, Neil M.] New York City Dept Hlth & Mental Hyg, Div Dis Control, Queens, NY 10013 USA; [Culp, Gretchen M.; Lim, Sungwoo] New York City Dept Hlth & Mental Hyg, Div Epidemiol, Queens, NY USA; [Schluger, Neil W.] Columbia Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, New York, NY USA; [Schluger, Neil W.] Columbia Univ, Dept Med, Vagelos Coll Phys & Surg, New York, NY USA; [Schluger, Neil W.] Columbia Univ, Dept Epidemiol, Vagelos Coll Phys & Surg, New York, NY USA; [Schluger, Neil W.] Columbia Univ, Dept Environm Hlth Sci, Vagelos Coll Phys & Surg, New York, NY USA; [Schluger, Neil W.] Mailman Sch Publ Hlth, New York, NY USA; [Vora, Neil M.] Ctr Dis Control & Prevent, Career Epidemiol Field Officer Program, Ctr Preparedness & Response, Atlanta, GA USA	Columbia University; New York City Department of Health & Mental Hygiene; New York City Department of Health & Mental Hygiene; Columbia University; Columbia University; Columbia University; Columbia University; Centers for Disease Control & Prevention - USA	Wu, M (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.; Wu, M (corresponding author), New York City Dept Hlth & Mental Hyg, Div Dis Control, Queens, NY 10013 USA.	mw2893@caa.columbia.edu	Schluger, Neil/ABA-1793-2021; Vora, Neil Manhar/AAJ-7269-2021	Vora, Neil Manhar/0000-0002-4989-3108; Wu, Melody/0000-0002-7928-0126	Epi Scholars program, New York City Department of Health and Mental Hygiene	Epi Scholars program, New York City Department of Health and Mental Hygiene	MW was supported by the Epi Scholars program, New York City Department of Health and Mental Hygiene (https://www1.nyc.gov/site/doh/about/employment/epi-scholar.page).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSINFO, 2019, GUID PREV TREATM OPP; American Lung Association, 2019, 2019 STAT AIR, DOI [10.1702/3169.31501, DOI 10.1702/3169.31501]; AMJS, 2020, MIN FAT; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Beninca E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180797; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Bureau of Health Informatics, 2014, SPARCS INP OUTP DAT; Calvillo-King L, 2013, J GEN INTERN MED, V28, P269, DOI 10.1007/s11606-012-2235-x; Cordoba E, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy020; Corrado RE, 2017, CHEST, V152, P930, DOI 10.1016/j.chest.2017.04.162; Ehrlich SF, 2010, DIABETES CARE, V33, P55, DOI 10.2337/dc09-0880; Flanders WD, 1999, J GEN INTERN MED, V14, P333, DOI 10.1046/j.1525-1497.1999.00351.x; Gross AE, 2014, ANTIMICROB AGENTS CH, V58, P5262, DOI 10.1128/AAC.02582-14; Gu CH, 2018, PUBLIC HEALTH REP, V133, P584, DOI 10.1177/0033354918792009; Hall MJ, 2014, NCHS DATA BRIEF, V17, P12; Hayes BH, 2018, CHEST, V153, P427, DOI 10.1016/j.chest.2017.09.041; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Karpati A., 2004, HLTH DISPARITIES NEW; Klein RJ, 2001, HLTH PEOPLE 2010 STA, V20, P1; Knox EG, 2008, J EPIDEMIOL COMMUN H, V62, P442, DOI 10.1136/jech.2007.065862; Krieger J, 2002, AM J PUBLIC HEALTH, V92, P758, DOI 10.2105/AJPH.92.5.758; Lave JR, 1996, J GEN INTERN MED, V11, P415, DOI 10.1007/BF02600189; Loeb MB, 2004, CLIN INFECT DIS, V38, P1293, DOI 10.1086/383469; Lutfiyya MN, 2007, INT J QUAL HEALTH C, V19, P141, DOI 10.1093/intqhc/mzm010; Lutfiyya MN, 2006, AM FAM PHYSICIAN, V73, P442; Medicaid and CHIP Payment and Access Commission, 2018, ACC BRIEF RURU URB H; Metlay JP, 2019, AM J RESP CRIT CARE, V200, pE45, DOI 10.1164/rccm.201908-1581ST; National Center for Health Statistics  Centers for Disease Control and Prevention, 2018, INFL PNEUM MORT STAT; New York City Department of Health and Mental Hygiene, 2020, COVID 19 DAT; New York State Department of Health, 2020, END AIDS EP NEW YORK; New York State Department of Health, 2014, SPARCS FAC RAC ETHN; New York State Department of Health, STAT PLANN RES COOP; New York State Department of Health, 2014, 1603 NY STAT DEP HLT; New York State Department of Health, 2018, LEAD CAUS DEATH NEW; Office on Smoking and Health  National Center for Chronic Disease Prevention and Health Promotion Centers for Disease Control and Prevention, 2019, SMOK COPD; Remington PL, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0044-2; Shirey L., RURAL URBAN HLTH; Stringer SM, 2015, HIDDEN HOUSEHOLDS; Torres A, 2015, THORAX, V70, P984, DOI 10.1136/thoraxjnl-2015-206780; United States Census Bureau, 2018, COMP ACS DAT; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244367	10.1371/journal.pone.0244367	http://dx.doi.org/10.1371/journal.pone.0244367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362262	Green Published, gold			2022-12-27	WOS:000603071600023
J	Goyal, N; Rongsen-Chandola, T; Sood, M; Sinha, B; Kumar, A; Qazi, SA; Aboubaker, S; Nisar, YB; Bahl, R; Bhan, MK; Bhandari, N				Goyal, Nidhi; Rongsen-Chandola, Temsunaro; Sood, Mangla; Sinha, Bireshwar; Kumar, Amit; Qazi, Shamim Ahmad; Aboubaker, Samira; Nisar, Yasir Bin; Bahl, Rajiv; Bhan, Maharaj Kishan; Bhandari, Nita			Management of possible serious bacterial infection in young infants closer to home when referral is not feasible: Lessons from implementation research in Himachal Pradesh, India	PLOS ONE			English	Article							INJECTABLE PROCAINE BENZYLPENICILLIN; COMMUNITY-HEALTH WORKERS; CLINICAL SIGNS; OPEN-LABEL; GENTAMICIN; MORTALITY; NEWBORNS; CARE	Background Government of India and the World Health Organization have guidelines for outpatient management of young infants 0-59 days with signs of Possible Serious Bacterial Infection (PSBI), when referral is not feasible. Implementation research was conducted to identify facilitators and barriers to operationalizing these guidelines. Methods Himachal Pradesh government implemented the guidelines in program settings supported by Centre for Health Research and Development, Society for Applied Studies. The strategy included community sensitization, skill enhancement of Accredited Social Health Activists (ASHA), Auxiliary Nurse Midwives (ANMs) and Medical Officers (MOs) to identify PSBI and treat when referral was not feasible. The research team collected information on facilitators and barriers. A technical support unit provided training and oversight. Findings Among 1997 live births from June 2017 to January 2019, we identified 160 cases of PSBI in young infants resulting in a coverage of 80%, assuming an incidence of 10%. Of these,29(18.1%) had signs of critical illness (CI), 92 (57.5%) had clinical severe infection (CSI), 5 (3.1%)had severe pneumonia (only fast breathing in young infants 0-6 days), while 34 (21%) had pneumonia (only fast breathing in young infants 7-59 days). Hospital referral was accepted by 48/160 (30%), whereas 112/160 (70%) were treated with the simplified treatment regimens at primary level facilities. Of the 29 infants with CI, 18 (62%) accepted referral; 26 (90%) recovered while 3 (10%) who had accepted referral, died. Of the 92 infants who had CSI, 86 (93%) recovered, 65 (71%) received simplified treatment and one infant who had accepted referral, died. All the five infants who had severe pneumonia, recovered; 3 (60%) had received simplified treatment. Of the 34 pneumonia cases, 33 received simplified treatment of which 5 (15%) failed treatment; two out of these 5 died. Overall, 6/160 infants died (case-fatality-rate 3.4%); 2 in the simplified treatment (case-fatality-rate 1.8%) and 4 in the hospital group (case-fatality-rate 8.3%). Delayed identification and care-seeking by families and health system weaknesses like manpower gaps and interrupted supplies were challenges in implementation. Conclusions Implementation of the guidelines in program settings is possible and acceptable. Scaling up would require creating community awareness, early identification and appropriate care-seeking, strengthening ASHA home-visitation program, building skills and confidence of MOs and ANMs, uninterrupted supplies and a dependable referral system.	[Goyal, Nidhi; Rongsen-Chandola, Temsunaro; Sinha, Bireshwar; Kumar, Amit; Bhandari, Nita] Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India; [Sood, Mangla] Indira Gandhi Med Coll, Dept Pediat, Shimla, Himachal Prades, India; [Sood, Mangla] Natl Hlth Mission, Child Hlth, Shimla, Himachal Prades, India; [Qazi, Shamim Ahmad; Aboubaker, Samira; Nisar, Yasir Bin; Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth & A, Geneva, Switzerland; [Bhan, Maharaj Kishan] Indian Inst Technol Delhi, New Delhi, India; [Bhan, Maharaj Kishan] Biotechnol Ind Res Assistance Council BIRAC, Knowledge Integrat & Translat Platform KnIT, New Delhi, India	Indira Gandhi Medical College & Hospital Shimla; World Health Organization; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Biotechnology Industry Research Assistance Council (BIRAC)	Rongsen-Chandola, T (corresponding author), Soc Appl Studies, Ctr Hlth Res & Dev, New Delhi, India.	naro@sas.org.in	Sood, Mangla/AAO-2493-2020; Sinha, Bireshwar/AEA-9974-2022; Nisar, Yasir Bin/AFO-2407-2022	Sood, Mangla/0000-0002-9616-5410; Sinha, Bireshwar/0000-0002-7408-7474; 	Bill and Melinda Gates Foundation (BMGF) through the Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland [OPP1114815]; Technical Service Agreement with WHO [2016/640408-0]	Bill and Melinda Gates Foundation (BMGF) through the Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland; Technical Service Agreement with WHO	The study was supported by a grant from the Bill and Melinda Gates Foundation (BMGF Grant No. OPP1114815) through the Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland. TRC received funds through a Technical Service Agreement with WHO, (WHO Reference 2016/640408-0). URL of funder website: www.gatesfoundation.org.The funder, BMGF had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. SAQ, SA, YBN and RB from WHO were involved in study design, decision to publish and preparation of the manuscript.	[Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; Applegate JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229988; Applegate JA, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001643; Awasthi S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234212; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Bhandari N, 1996, LANCET, V347, P1774, DOI 10.1016/S0140-6736(96)90856-9; Bhura M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240688; Fadel SA, 2017, LANCET, V390, P1972, DOI 10.1016/S0140-6736(17)32162-1; [GOI MOHFW], 2014, OP GUID US GENT ANMS; [GOI MoHFW], 2017, ADD OP GUID US GENT; [GOI MoHFW], 2011, HOM BAS NEWB CAR OP; Government of India, 2018, NAVJ SHISH SUR KAR B; Guenther T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229248; Harden SM, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00071; Khanal S, 2011, J HEALTH POPUL NUTR, V29, P255, DOI 10.3329/jhpn.v29i3.7873; Kozuki N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2330-0; Kumar Pratyush, 2018, J Family Med Prim Care, V7, P1157, DOI 10.4103/jfmpc.jfmpc_254_18; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; National Health Authority, 2018, AYS BHAR PRADH MANTR; NFHS4-Telangana, 2015, NATL FAMILY HLTH SUR; Owais A, 2011, J PERINATOL, V31, P586, DOI 10.1038/jp.2010.191; Rahman AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232675; Roy S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236355; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Taneja S, 2018, ACTA PAEDIATR, V107, P80, DOI 10.1111/apa.14428; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; Wammanda RD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228718; World Health Organization, 2015, GUID MAN POSS SER BA; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zaidi AKM, 2012, PEDIATR INFECT DIS J, V31, P667, DOI 10.1097/INF.0b013e318256f86c	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243724	10.1371/journal.pone.0243724	http://dx.doi.org/10.1371/journal.pone.0243724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351810	Green Published, gold			2022-12-27	WOS:000603071400033
J	Schneider, C; Wiewelhove, T; McLaren, SJ; Roleke, L; Kasbauer, H; Hecksteden, A; Kellmann, M; Pfeiffer, M; Ferrauti, A				Schneider, Christoph; Wiewelhove, Thimo; McLaren, Shaun J.; Roeleke, Lucas; Kaesbauer, Hannes; Hecksteden, Anne; Kellmann, Michael; Pfeiffer, Mark; Ferrauti, Alexander			Monitoring training and recovery responses with heart rate measures during standardized warm-up in elite badminton players	PLOS ONE			English	Article							RUNNING PERFORMANCE; FATIGUE; EXERCISE; FITNESS; MARKERS; CAMP; TOOL	Purpose To investigate short-term training and recovery-related effects on heart rate during a standardized submaximal running test. Methods Ten elite badminton players (7 females and 3 males) were monitored during a 12-week training period in preparation for the World Championships. Exercise heart rate (HRex) and perceived exertion were measured in response to a 5-min submaximal shuttle-run test during the morning session warm-up. This test was repeatedly performed on Mondays after 1-2 days of pronounced recovery ('recovered' state; reference condition) and on Fridays following 4 consecutive days of training ('strained' state). In addition, the serum concentration of creatine kinase and urea, perceived recovery-stress states, and jump performance were assessed before warm-up. Results Creatine kinase increased in the strained compared to the recovered state and the perceived recovery-stress ratings decreased and increased, respectively (range of average effects sizes: |d| = 0.93-2.90). The overall HRex was 173 bpm and the observed within-player variability (i.e., standard deviation as a coefficient of variation [CV]) was 1.3% (90% confidence interval: 1.2% to 1.5%). A linear reduction of -1.4% (-3.0% to 0.3%) was observed in HRex over the 12-week observational period. HRex was -1.5% lower (-2.2% to -0.9%) in the strained compared to the recovered state, and the standard deviation (as a CV) representing interindividual variability in this response was 0.7% (-0.6% to 1.2%). Conclusions Our findings suggest that HRex measured during a standardized warm-up can be sensitive to short-term accumulation of training load, with HRex decreasing on average in response to consecutive days of training within repeated preparatory weekly microcycles. From a practical perspective, it seems advisable to determine intra-individual recovery-strain responses by repeated testing, as HRex responses may vary substantially between and within players.	[Schneider, Christoph; Wiewelhove, Thimo; Ferrauti, Alexander] Ruhr Univ Bochum, Fac Sport Sci, Dept Training & Exercise Sci, Bochum, Germany; [McLaren, Shaun J.] Univ Durham, Dept Sport & Exercise Sci, Durham, England; [Roeleke, Lucas] Philipps Univ Marburg, Inst Sport Sci & Motol, Dept Med Training & Hlth, Marburg, Germany; [Kaesbauer, Hannes] German Badminton Assoc, Saarbrucken, Germany; [Hecksteden, Anne] Saarland Univ, Inst Sports & Prevent Med, Saarbrucken, Germany; [Kellmann, Michael] Ruhr Univ Bochum, Fac Sport Sci, Unit Sport Psychol, Bochum, Germany; [Kellmann, Michael] Univ Queensland, Sch Human Movement & Nutr Sci, St Lucia, Qld, Australia; [Pfeiffer, Mark] Johannes Gutenberg Univ Mainz, Inst Sport Sci, Dept Theory & Practice Sports, Mainz, Germany	Ruhr University Bochum; Durham University; Philipps University Marburg; Saarland University; Ruhr University Bochum; University of Queensland; Johannes Gutenberg University of Mainz	Schneider, C (corresponding author), Ruhr Univ Bochum, Fac Sport Sci, Dept Training & Exercise Sci, Bochum, Germany.	christoph.schneider-a5c@ruhr-uni-bochum.de	Schneider, Christoph/E-6624-2019; Kellmann, Michael/J-3508-2014	Schneider, Christoph/0000-0003-3760-7001; Kellmann, Michael/0000-0003-1699-9624; Pfeiffer, Mark/0000-0002-9287-5343; Roleke, Lucas/0000-0002-4611-7330; Alexander, Ferrauti/0000-0001-9807-2755; McLaren, Shaun/0000-0003-0480-3209	German Federal Institute of Sport Science; project REGman-Optimization of Training and Competition: Management of Regeneration in Elite Sports [IIA1-081901/17-20]; DFG Open Access Publication Funds of Ruhr-Universitat Bochum	German Federal Institute of Sport Science; project REGman-Optimization of Training and Competition: Management of Regeneration in Elite Sports; DFG Open Access Publication Funds of Ruhr-Universitat Bochum	The current study was funded by the German Federal Institute of Sport Science (http://www.bisp.de).The research was realized in the project REGman-Optimization of Training and Competition: Management of Regeneration in Elite Sports (IIA1-081901/17-20). Funding were received by MK MP AF. We further acknowledge support by the DFG Open Access Publication Funds of the Ruhr-Universitat Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Aisbett J., 2020, MAGNITUDE BASED INFE, DOI [10.31236/osf.io/pn9s3, DOI 10.31236/OSF.IO/PN9S3]; [Anonymous], 2019, JAM VERS 1 2 16 COMP; Atkinson G, 2019, EXP PHYSIOL, V104, P1215, DOI 10.1113/EP087712; Bangsbo J, 2008, SPORTS MED, V38, P37, DOI 10.2165/00007256-200838010-00004; Barker J, 2011, CASE REP MED, DOI DOI 10.1155/2011/806723; Barth V, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00778; Bellenger CR, 2016, SPORTS MED, V46, P1461, DOI 10.1007/s40279-016-0484-2; Billat VL, 1999, MED SCI SPORT EXER, V31, P156, DOI 10.1097/00005768-199901000-00024; Borresen J, 2008, SPORTS MED, V38, P633, DOI 10.2165/00007256-200838080-00002; Bosquet L, 2008, BRIT J SPORT MED, V42, P709, DOI 10.1136/bjsm.2007.042200; Bradley PS, 2011, EUR J APPL PHYSIOL, V111, P969, DOI 10.1007/s00421-010-1721-2; Buchheit M, 2013, J SCI MED SPORT, V16, P550, DOI 10.1016/j.jsams.2012.12.003; Buchheit M, 2009, EUR J APPL PHYSIOL, V105, P471, DOI 10.1007/s00421-008-0925-1; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; COSTILL DL, 1988, MED SCI SPORT EXER, V20, P249, DOI 10.1249/00005768-198806000-00006; Coutts A.J., 2018, SPORT RECOVERY PERFO, P19; Daanen HAM, 2012, INT J SPORT PHYSIOL, V7, P251, DOI 10.1123/ijspp.7.3.251; Decroix L, 2018, INT J SPORT PHYSIOL, V13, P23, DOI 10.1123/ijspp.2016-0685; FELLMANN N, 1992, SPORTS MED, V13, P37, DOI 10.2165/00007256-199213010-00004; Goltz FR, 2018, MED SCI SPORT EXER, V50, P758, DOI 10.1249/MSS.0000000000001504; Halson SL, 2002, J APPL PHYSIOL, V93, P947, DOI 10.1152/japplphysiol.01164.2001; Hammes D, 2016, INT J SPORT PHYSIOL, V11, P328, DOI 10.1123/ijspp.2015-0119; Hecksteden A, 2017, INT J SPORT PHYSIOL, V12, P1137, DOI 10.1123/ijspp.2016-0120; Hecksteden A, 2015, J APPL PHYSIOL, V118, P1450, DOI 10.1152/japplphysiol.00714.2014; Hedelin R, 2000, MED SCI SPORT EXER, V32, P1480, DOI 10.1097/00005768-200008000-00017; Hitzschke B., 2017, PERFORM ENHANC HLTH, V5, P147, DOI [10.1016/j.peh.2017.08.001, DOI 10.1016/J.PEH.2017.08.001]; Hopkins W.G., 2018, SPORTSCIENCE, V22, P39; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; JEUKENDRUP AE, 1992, INT J SPORTS MED, V13, P534, DOI 10.1055/s-2007-1021312; Kellmann M, 2019, RECOVERY STRESS SPOR; Kellmann M, 2020, AKUTMA KURZSKALA ERF, V1st; Kellmann M, 2018, INT J SPORT PHYSIOL, V13, P240, DOI 10.1123/ijspp.2017-0759; Lamberts RP, 2010, EUR J APPL PHYSIOL, V108, P183, DOI 10.1007/s00421-009-1291-3; Le Meur Y, 2013, MED SCI SPORT EXER, V45, P2061, DOI 10.1249/MSS.0b013e3182980125; LEHMANN M, 1991, INT J SPORTS MED, V12, P444, DOI 10.1055/s-2007-1024711; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; Majumdar P, 1997, BRIT J SPORT MED, V31, P342, DOI 10.1136/bjsm.31.4.342; Malone S, 2017, SCI MED FOOTBALL, V1, P229, DOI 10.1080/24733938.2017.1361040; Mann TN, 2015, J STRENGTH COND RES, V29, P3343, DOI 10.1519/JSC.0000000000001004; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Murphy KR, 1999, J APPL PSYCHOL, V84, P234, DOI 10.1037/0021-9010.84.2.234; Ross R, 2019, BRIT J SPORT MED, V53, P1141, DOI 10.1136/bjsports-2018-100328; Saw AE, 2016, BRIT J SPORT MED, V50, P281, DOI 10.1136/bjsports-2015-094758; Schneider C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00639; Senn Stephen, 2011, Stat Methods Med Res, V20, P657, DOI 10.1177/0962280210379174; Siegl A, 2017, INT J SPORTS MED, V38, P675, DOI 10.1055/s-0043-110226; SNYDER AC, 1995, MED SCI SPORT EXER, V27, P1063, DOI 10.1249/00005768-199507000-00016; Swinton PA, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00041; Team JASP, 2019, JASP VERS 0 12 0 COM, DOI 10.1002/spe.2678; ten Haaf T, 2019, EUR J SPORT SCI, V19, P1082, DOI 10.1080/17461391.2019.1571112; Urhausen A, 1998, INT J SPORTS MED, V19, P114, DOI 10.1055/s-2007-971892; White DW, 2014, J PHYSIOL-LONDON, V592, P2491, DOI 10.1113/jphysiol.2014.271858; Wiewelhove T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139801; **DATA OBJECT**, DOI DOI 10.17605/OSF.IO/ZNKGE	56	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244412	10.1371/journal.pone.0244412	http://dx.doi.org/10.1371/journal.pone.0244412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347512	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000603071100028
J	Sun, ZM; Chen, XL; Xing, HF; Ma, HT; Meng, Y				Sun, Zhiming; Chen, Xianglong; Xing, Hanfa; Ma, Hongtao; Meng, Yuan			Regional differences in socioeconomic trends: The spatiotemporal evolution from individual cities to a megacity region over a long time series	PLOS ONE			English	Article							CHINA; POPULATION; GDP	Regional differences in socioeconomic factors are important for assessing the regional development of an area. While much research has focused on the overall patterns of regional differences within independent cities and areas, the hierarchical spatiotemporal structures of megacity regions have seldom been discussed. To fill this gap, this paper investigates the multilevel regional differences within megacity regions. Employing GDP, population and total retail sales as socioeconomic indicators, the spatiotemporal patterns of socioeconomic trends are identified. A hierarchical clustering approach that utilizes socioeconomic similarities is proposed for the identification of the spatiotemporal patterns of individual cities. At the megacity regional level, gravity centers and pathways are constructed to evaluate spatial imbalances and temporal change intensities. Taking the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) as its study area, this research produces results that show diverse spatiotemporal patterns among the individual cities, revealing high/low starting point and high/low growth rate modes in terms of city interactions. From the perspective of the entire GBA, the spatial imbalance of GDP is the highest of the factors, followed by the spatial imbalance of the total retail sales of the region and, finally, by that of its population. Total retail sales exhibit the highest level of temporal change intensity, followed by GDP and population. In terms of the contribution of the various cities to the overall regional changes, Guangzhou, Shenzhen and Hong Kong dominate the spatiotemporal changes in the gravity centers, while Foshan and Dongguan show significant potential to contribute to these socioeconomic patterns. These results provide effective guidance for the sustainable development of megacity regions.	[Sun, Zhiming; Ma, Hongtao] Yunnan Normal Univ, Sch Geog, Kunming, Yunnan, Peoples R China; [Sun, Zhiming] Yunnan Normal Univ, Ctr Myanmar Studies, Kunming, Yunnan, Peoples R China; [Chen, Xianglong; Xing, Hanfa] South China Normal Univ, Sch Geog, Guangzhou, Guangdong, Peoples R China; [Xing, Hanfa] SCNU Qingyuan Inst Sci & Technol Innovat Co Ltd, Qingyuan, Guangdong, Peoples R China; [Xing, Hanfa] Guangdong Normal Univ Weizhi Informat Technol Co, Qingyuan, Guangdong, Peoples R China; [Meng, Yuan] Hong Kong Polytech Univ, Dept Land Surveying & Geoinformat, Kowloon, Hong Kong, Peoples R China	Yunnan Normal University; Yunnan Normal University; South China Normal University; Hong Kong Polytechnic University	Ma, HT (corresponding author), Yunnan Normal Univ, Sch Geog, Kunming, Yunnan, Peoples R China.; Meng, Y (corresponding author), Hong Kong Polytech Univ, Dept Land Surveying & Geoinformat, Kowloon, Hong Kong, Peoples R China.	354626572@qq.com; mengyuan@stu.sdnu.edu.cn	MENG, Yuan/GWM-7988-2022	MENG, Yuan/0000-0002-0963-0581				[Anonymous], 2008, WORKSH VER VAL SHIP, V1, pB7; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; Bai X, 2015, TROPICAL GEOGRAPHY, V35, P762; Bakos Y, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.1.69; Bie JB, 2015, J URBAN TECHNOL, V22, P103, DOI 10.1080/10630732.2014.971575; CAMAGNI RP, 1993, URBAN STUD, V30, P1053, DOI 10.1080/00420989320080941; Cheng FF, 2013, TIJDSCHR ECON SOC GE, V104, P261, DOI 10.1111/j.1467-9663.2012.00741.x; Huang X, 2017, REMOTE SENS ENVIRON, V196, P56, DOI 10.1016/j.rse.2017.05.001; Jie Fan, 1996, ACTAGEOGRAPHICA SINI, V5, P398; Keidel A, 2001, CHINA ECON REV, V12, P355, DOI 10.1016/S1043-951X(01)00073-6; Krausmann F, 2009, ECOL ECON, V68, P2696, DOI 10.1016/j.ecolecon.2009.05.007; Lee HO, 2018, MOL GENET METAB REP, V15, P15, DOI 10.1016/j.ymgmr.2018.01.002; Li C, 2019, ASIA PAC POLICY STUD, V6, P170, DOI 10.1002/app5.272; Li CQ, 2016, J HENAN U TECHNOLOGY, V12, P57; Li RY, 2015, AREAL RES DEV, V34, P93; Li RY, 2015, AREAL RES DEV, V34, P116; Li Z, 2019, J GEOGR SCI, V29, P1363, DOI 10.1007/s11442-019-1664-5; Lian X., 2007, POPUL J, V8, P23, DOI [10.16405/j.cnki.1004-129x.2007.03.005, DOI 10.16405/J.CNKI.1004-129X.2007.03.005]; Lin ZR, 2017, TAIWAN STUDIES, P53; Liu B., 1970, J AM STAT ASSOC, V65, P1460; [刘华军 Liu Huajun], 2019, [数量经济技术经济研究, Quantitative & Technical Economics], V36, P99; Lozano S, 2008, ECOL ECON, V66, P687, DOI 10.1016/j.ecolecon.2007.11.003; Lu ZG, 2015, SCI TECHNOLOGY PROGR, V32, P112; Luo Y, 2019, SUSTAINABILITY, V11, P16; [孟广文 Meng Guangwen], 2017, [经济地理, Economic Geography], V37, P87; Nguyen MN, 2010, PLOS ONE, V5, pe9907; Ni W, 2020, SHANGHAI J EC, P33; [聂雷 Nie Lei], 2015, [农业现代化研究, Research of Agricultural Modernization], V36, P380; Peng DX, 2015, INNOVATION, V9, P87; Peterson EWF, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017736094; Ramon-Berjano CB, 2011, ASIAN SURV, V51, P584, DOI 10.1525/as.2011.51.4.584; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Smith A., 1963, INQUIRY NATURE CAUSE; Suguitan Jr AL, 2011, PLOS ONE, V6; [王彬 Wang Bin], 2011, [地理研究, Geographical Research], V30, P1882; Wang YX, 2019, CITIES, V86, P167, DOI 10.1016/j.cities.2018.09.016; Wen SB, 2019, CHINA J COMMERCE, P185; Wu J, 2017, INQUIRY EC ISSUES, V12, P18; Wu J, 2017, INQUIRY EC ISSUES, P180; Xiong HH, 2020, SUSTAINABILITY, V12, P18; Yan D, 2020, PROCEEDINGS OF THE 25TH ACM SIGPLAN SYMPOSIUM ON PRINCIPLES AND PRACTICE OF PARALLEL PROGRAMMING (PPOPP '20), P32, DOI 10.1145/3332466.3374520; Yang XH, 2009, INT J ENV RES PUB HE, V6, P3025, DOI 10.3390/ijerph6123025; Yu YW, 2016, ECOLOGICAL EC, V32, P117; Yuan QF, 2020, NEW ARCHITECTURE, P16; Zhang AQ, 2021, ENVIRON PLAN B-URBAN, V48, P1245, DOI 10.1177/2399808320924425; [张洪 Zhang Hong], 2015, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V29, P216; Zhang J, 2018, INT ELECTR DRIVE PRO; Zhao Hai-xia, 2013, China Environmental Science, V33, P1911; Zhong J.T., 2014, ECON GEOGR, V34, P14; Zhong JT, 2014, ECON GEOGR, V34, P47; Zhou C.S., 2017, TROP GEOGR, V37, P802, DOI [10.13284/j.cnki.rddl.003011, DOI 10.13284/J.CNKI.RDDL.003011]	53	1	1	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244084	10.1371/journal.pone.0244084	http://dx.doi.org/10.1371/journal.pone.0244084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347454	Green Published, gold			2022-12-27	WOS:000603071100022
J	Deren, K; Wyszynska, J; Nyankovskyy, S; Nyankovska, O; Yatsula, M; Luszczki, E; Sobolewski, M; Mazur, A				Deren, Katarzyna; Wyszynska, Justyna; Nyankovskyy, Serhiy; Nyankovska, Olena; Yatsula, Marta; Luszczki, Edyta; Sobolewski, Marek; Mazur, Artur			Assessment of body mass index in a pediatric population aged 7-17 from Ukraine according to various international criteria-A cross-sectional study	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; OBESITY TASK-FORCE; CLASSIFICATION SYSTEMS; PRESCHOOL-CHILDREN; CHILDHOOD OBESITY; OVERWEIGHT; PREVALENCE; REFERENCES; REGION	Childhood obesity is one of the most serious public health problems. The prevalence of obesity among children is increasing and may negatively affect their immediate health, but it can also lead to obesity in adulthood. The aim of the study was to compare BMI cut-off points by examining three main international references: the World Health Organization (WHO), the International Task Force Obesity (IOTF) and the US Center for Disease Control and Prevention (CDC). Ultimately, the study group consisted of 18,144 children and adolescents aged 6.5-17.5 years. Body mass was measured on medical scales with an accuracy of +/- 100 g and height measurement was taken using a height meter with an accuracy of +/- 0.1 cm three times. Underweight, overweight and obesity were calculated according to WHO, IOTF and CDC BMI international references. There were differences in the incidence of underweight between the classifications: 16.8% according to IATF, 5.3% according to WHO and 9.9% according to CDC. There were also differences in the incidence of overweight and obesity between the classifications: 13% according to IOTF, 19.7% according to WHO and 14.1% according to CDC. In the CDC and WHO studies, a significantly higher prevalence of childhood obesity (4.0% and 4.7%, respectively) was observed compared with IOTF (2.1%). The prevalence of overweight and obesity in this study was higher among boys compared to girls. However, estimates of prevalence of overweight and obesity differ in methods and reference cut-off points. Higher prevalence was obtained in IOTF classification, followed by the WHO and CDC classification.	[Deren, Katarzyna; Wyszynska, Justyna; Nyankovskyy, Serhiy; Luszczki, Edyta] Rzeszow Univ, Med Coll, Inst Hlth Sci, Rzeszow, Poland; [Deren, Katarzyna; Wyszynska, Justyna; Nyankovskyy, Serhiy; Yatsula, Marta] Danylo Halytsky Lviv Natl Med Univ, Pediat Dept 1, Lvov, Ukraine; [Nyankovska, Olena] Danylo Halytsky Lviv Natl Med Univ, Dept Pediat & Neonatol, Lvov, Ukraine; [Sobolewski, Marek] Rzeszow Univ Technol, Fac Management, Rzeszow, Poland; [Mazur, Artur] Rzeszow Univ, Inst Med Sci, Med Coll, Rzeszow, Poland	University of Rzeszow; Danylo Halytsky Lviv National Medical University; Danylo Halytsky Lviv National Medical University; Rzeszow University of Technology; University of Rzeszow	Deren, K (corresponding author), Rzeszow Univ, Med Coll, Inst Hlth Sci, Rzeszow, Poland.; Deren, K (corresponding author), Danylo Halytsky Lviv Natl Med Univ, Pediat Dept 1, Lvov, Ukraine.	kderen@ur.edu.pl	Łuszczki, Edyta/AAP-1883-2020; Wyszynska, Justyna/L-5315-2016	Łuszczki, Edyta/0000-0002-4619-7705; Sobolewski, Marek/0000-0001-6564-8877; Wyszynska, Justyna/0000-0002-5786-6214; Deren, Katarzyna/0000-0002-0977-5844; Mazur, Artur/0000-0001-5393-3515				[Anonymous], 2000, EUR J INT LAW, V11, P1; Center for Disease Control and Prevention, DEF CHILDH OV OB; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Deren K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21773-4; Rios MIE, 2013, AN PEDIATR, V78, P374, DOI 10.1016/j.anpedi.2012.09.007; Lopez-Sanchez GF, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00130; Goldfield GS, 2006, J SPORT MED PHYS FIT, V46, P447; Haq I, 2017, ANN TROP MED PUBLIC, V10, P1814, DOI [10.4103/ATMPH.ATMPH_98_17, 10.4103/atmph.atmph_98_17]; Hassapidou M, 2015, HORM-INT J ENDOCRINO, V14, P615, DOI 10.14310/horm.2002.1601; Keke LM, 2015, REV EPIDEMIOL SANTE, V63, P173, DOI 10.1016/j.respe.2014.11.003; Kim S, 2017, CHILD YOUTH SERV REV, V79, P309, DOI 10.1016/j.childyouth.2017.06.028; Lemelin L, 2013, SANTE PUBLIQUE, V25, P571, DOI 10.3917/spub.135.0571; Medehouenou TCM, 2015, J ADOLESCENT HEALTH, V57, P31, DOI 10.1016/j.jadohealth.2015.03.022; Moreno LA, 2003, NUTRITION, V19, P481, DOI 10.1016/S0899-9007(03)00040-6; MPhil UP, 2017, J PEDIAT, V190; Partap U, 2017, J PEDIAT, V190; Pattinson CL, 2017, OBES REV, V18, P1, DOI 10.1111/obr.12581; Pelegrini A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-5; Ramirez E, 2006, ARCH LATINOAM NUTR, V56, P251; Shields M, 2010, INT J PEDIATR OBES, V5, P265, DOI 10.3109/17477160903268282; Twells LK, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-21; World Health Organisation, 2020, OV OB; World Health Organization, GROWTH REF 5 19 YEAR	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244300	10.1371/journal.pone.0244300	http://dx.doi.org/10.1371/journal.pone.0244300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338085	Green Published, gold			2022-12-27	WOS:000601313500045
J	Lopez-Incera, A; Ried, K; Muller, T; Briegel, HJ				Lopez-Incera, Andrea; Ried, Katja; Mueller, Thomas; Briegel, Hans J.			Development of swarm behavior in artificial learning agents that adapt to different foraging environments	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; COLLECTIVE MOTION; MULTIMODEL INFERENCE; PHASE-TRANSITION; LEVY WALKS; PREY; STOCHASTICITY; SELECTION; MOVEMENT; ECOLOGY	Collective behavior, and swarm formation in particular, has been studied from several perspectives within a large variety of fields, ranging from biology to physics. In this work, we apply Projective Simulation to model each individual as an artificial learning agent that interacts with its neighbors and surroundings in order to make decisions and learn from them. Within a reinforcement learning framework, we discuss one-dimensional learning scenarios where agents need to get to food resources to be rewarded. We observe how different types of collective motion emerge depending on the distance the agents need to travel to reach the resources. For instance, strongly aligned swarms emerge when the food source is placed far away from the region where agents are situated initially. In addition, we study the properties of the individual trajectories that occur within the different types of emergent collective dynamics. Agents trained to find distant resources exhibit individual trajectories that are in most cases best fit by composite correlated random walks with features that resemble Levy walks. This composite motion emerges from the collective behavior developed under the specific foraging selection pressures. On the other hand, agents trained to reach nearby resources predominantly exhibit Brownian trajectories.	[Lopez-Incera, Andrea; Ried, Katja; Briegel, Hans J.] Univ Innsbruck, Inst Theoret Phys, Innsbruck, Austria; [Mueller, Thomas; Briegel, Hans J.] Univ Konstanz, Fachbereich Philosophie, Constance, Germany	University of Innsbruck; University of Konstanz	Lopez-Incera, A (corresponding author), Univ Innsbruck, Inst Theoret Phys, Innsbruck, Austria.	andrea.lopez-incera@uibk.ac.at		Muller, Thomas/0000-0003-1225-1483	Austrian Science Fund (FWF) [SFB BeyondC F7102]; Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg [AZ:33-7533-30-10/41/1]; Volkswagen Foundation [Az:97721]; BlueSky project of the University of Konstanz	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg; Volkswagen Foundation(Volkswagen); BlueSky project of the University of Konstanz	AL, KR and HJB were supported by the Austrian Science Fund (FWF) through grant SFB BeyondC F7102. HJB was supported by the Ministerium fur Wissenschaft, Forschung, und Kunst Baden-Wurttemberg (AZ:33-7533-30-10/41/1). HJB and TM were supported by Volkswagen Foundation (Az:97721) and a BlueSky project of the University of Konstanz.	Ariel G, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004522; Auger-Methe M, 2015, METHODS ECOL EVOL, V6, P1179, DOI 10.1111/2041-210X.12412; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Bilecenoglu Murat, 2005, Zoology in the Middle East, V35, P29; Bode NWF, 2010, J THEOR BIOL, V267, P292, DOI 10.1016/j.jtbi.2010.08.034; Briegel HJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00400; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Combes SA, 2012, J EXP BIOL, V215, P903, DOI 10.1242/jeb.059394; Czirok A, 1999, PHYSICA A, V264, P299, DOI 10.1016/S0378-4371(98)00468-3; Czirok A, 1999, PHYS REV LETT, V82, P209, DOI 10.1103/PhysRevLett.82.209; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Durve M, 2019, ARXIV191101697; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Edwards AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045174; Edwards AM, 2011, ECOLOGY, V92, P1247, DOI 10.1890/10-1182.1; Eifler D, 2014, AMPHIBIA-REPTILIA, V35, P383, DOI 10.1163/15685381-00002963; Gautestad AO, 2012, J R SOC INTERFACE, V9, P2332, DOI 10.1098/rsif.2012.0059; Holland J.H., 1975, ADAPTATION NATURAL A, DOI DOI 10.7551/MITPRESS/1090.001.0001; HUMPHRIE.DA, 1970, OECOLOGIA, V5, P285, DOI 10.1007/BF00815496; Humphries NE, 2013, METHODS ECOL EVOL, V4, P930, DOI 10.1111/2041-210X.12096; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Jansen VAA, 2012, SCIENCE, V335, DOI 10.1126/science.1215747; Jones KA, 2011, BEHAV ECOL, V22, P831, DOI 10.1093/beheco/arr062; Kolpas A, 2007, P NATL ACAD SCI USA, V104, P5931, DOI 10.1073/pnas.0608270104; Levy P, 1954, THEORIE ADDITION VAR, V1; Makmal A, 2016, IEEE ACCESS, V4, P2110, DOI 10.1109/ACCESS.2016.2556579; Martinez-Gil F, 2017, SIMUL MODEL PRACT TH, V74, P117, DOI 10.1016/j.simpat.2017.03.003; Mautner J, 2015, NEW GENERAT COMPUT, V33, P69, DOI 10.1007/s00354-015-0102-0; Melnikov AA, 2018, IEEE ACCESS, V6, P64639, DOI 10.1109/ACCESS.2018.2876494; Melnikov AA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14740-y; Morales JM, 2005, LANDSCAPE ECOL, V20, P301, DOI 10.1007/s10980-005-0061-9; Mueller T, 2011, THEOR ECOL-NETH, V4, P341, DOI 10.1007/s12080-010-0081-1; O'Loan OJ, 1999, J PHYS A-MATH GEN, V32, pL99, DOI 10.1088/0305-4470/32/8/002; Pener MP, 2009, ADV INSECT PHYSIOL, V36, P1, DOI 10.1016/S0065-2806(08)36001-9; Plank MJ, 2008, J R SOC INTERFACE, V5, P1077, DOI 10.1098/rsif.2008.0006; Plank MJ, 2009, ECOLOGY, V90, P3546, DOI 10.1890/09-0079.1; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Pyke GH, 2015, METHODS ECOL EVOL, V6, P1, DOI 10.1111/2041-210X.12298; Raposo EP, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434003; Reynolds AM, 2013, J THEOR BIOL, V332, P117, DOI 10.1016/j.jtbi.2013.04.035; Reynolds AM, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/18001; Reynolds AM, 2012, ECOLOGY, V93, P1228, DOI 10.1890/11-1815.1; Reynolds AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30515; Richardson G, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1112; Ried K, 2019, ARXIV191006985V1; Ried K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212044; Santos MC, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434017; Shimada K, 2018, P GEN EV COMP C COMP, P169, DOI [10.1145/3205651.3205770, DOI 10.1145/3205651.3205770]; Shlesinger MF, 1986, GROWTH AND FORM; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sinervo B., 1997, OPTIMAL FORAGING THE; Stephens D., 2007, FORAGING BEHAV ECOLO; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Viswanathan G. M., 2011, PHYS FORAGING; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wosniack ME, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005774; YAGER DD, 1990, J EXP BIOL, V152, P17; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	65	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243628	10.1371/journal.pone.0243628	http://dx.doi.org/10.1371/journal.pone.0243628			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338066	Green Published, Green Submitted, gold			2022-12-27	WOS:000601313500038
J	Neysanian, M; Iranbakhsh, A; Ahmadvand, R; Ardebili, ZO; Ebadi, M				Neysanian, Maryam; Iranbakhsh, Alireza; Ahmadvand, Rahim; Ardebili, Zahra Oraghi; Ebadi, Mostafa			Comparative efficacy of selenate and selenium nanoparticles for improving growth, productivity, fruit quality, and postharvest longevity through modifying nutrition, metabolism, and gene expression in tomato; potential benefits and risk assessment	PLOS ONE			English	Article							RICE; ALLEVIATION; OXIDE	This study attempted to address molecular, developmental, and physiological responses of tomato plants to foliar applications of selenium nanoparticles (nSe) at 0, 3, and 10 mgl(-1) or corresponding doses of sodium selenate (BSe). The BSe/nSe treatment at 3 mgl(-1) increased shoot and root biomass, while at 10 mgl(-1) moderately reduced biomass accumulation. Foliar application of BSe/nSe, especially the latter, at the lower dose enhanced fruit production, and postharvest longevity, while at the higher dose induced moderate toxicity and restricted fruit production. In leaves, the BSe/nSe treatments transcriptionally upregulated miR172 (mean = 3.5-folds). The Se treatments stimulated the expression of the bZIP transcription factor (mean = 9.7-folds). Carotene isomerase (CRTISO) gene was transcriptionally induced in both leaves and fruits of the nSe-treated seedlings by an average of 5.5 folds. Both BSe or nSe at the higher concentration increased proline concentrations, H2O2 accumulation, and lipid peroxidation levels, suggesting oxidative stress and impaired membrane integrity. Both BSe or nSe treatments also led to the induction of enzymatic antioxidants (catalase and peroxidase), an increase in concentrations of ascorbate, non-protein thiols, and soluble phenols, as well as a rise in the activity of phenylalanine ammonia-lyase enzyme. Supplementation at 3 mgl(-1) improved the concentration of mineral nutrients (Mg, Fe, and Zn) in fruits. The bioaccumulated Se contents in the nSe-treated plants were much higher than the corresponding concentration of selenate, implying a higher efficacy of the nanoform towards biofortification programs. Se at 10 mgl(-1), especially in selenate form, reduced both size and density of pollen grains, indicating its potential toxicity at the higher doses. This study provides novel molecular and physiological insights into the nSe efficacy for improving plant productivity, fruit quality, and fruit post-harvest longevity.	[Neysanian, Maryam; Iranbakhsh, Alireza] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran; [Ahmadvand, Rahim] Dept Seed & Plant Res Improvement Inst, Karaj, Iran; [Ardebili, Zahra Oraghi] Islamic Azad Univ, Garmsar Branch, Dept Biol, Garmsar, Iran; [Ebadi, Mostafa] Islamic Azad Univ, Damghan Branch, Dept Biol, Damghan, Iran	Islamic Azad University; Islamic Azad University; Islamic Azad University	Iranbakhsh, A (corresponding author), Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran.	iranbakhsh@iau.ac.ir	iranbakhsh, alireza/L-6903-2019; Ahmadvand, Rahim/AAW-6224-2021	iranbakhsh, alireza/0000-0001-5879-0613; 				Abedi S, 2021, ENVIRON SCI POLLUT R, V28, P3136, DOI 10.1007/s11356-020-10706-2; Alam MZ, 2019, FRONT PHYSIOL, P10, DOI [10.3389/fphys.2019.00010, DOI 10.3389/FPHYS.2019.00010]; Amirabad SA, 2020, ENVIRON SCI POLLUT R, V27, P12476, DOI 10.1007/s11356-020-07751-2; [Anonymous], 2018, DIABETES CARE, V40, pS1; [Anonymous], 2019, CANCER DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Babajani A, 2019, ENVIRON SCI POLLUT R, V26, P24430, DOI 10.1007/s11356-019-05676-z; Babajani A, 2019, PLASMA CHEM PLASMA P, V39, P21, DOI 10.1007/s11090-018-9934-y; Balanza V, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01622; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUDOINEAGAN LD, 1985, PLANT PHYSIOL, V78, P438, DOI 10.1104/pp.78.3.438; Das P, 2019, RICE, V12, DOI 10.1186/s12284-019-0316-8; de Pinto MC, 1999, PROTOPLASMA, V209, P90, DOI 10.1007/BF01415704; DELLONGO OT, 1993, PLANT CELL PHYSIOL, V34, P1023; Djanaguiraman M, 2018, ACS OMEGA, V3, P2479, DOI 10.1021/acsomega.7b01934; Ds A., 2020, PLANT SMALL RNA, P209, DOI [10.1016/B978-0-12-817112-7.00011-0, DOI 10.1016/B978-0-12-817112-7.00011-0]; Elkelish AA, 2019, PLANT PHYSIOL BIOCH, V137, P144, DOI 10.1016/j.plaphy.2019.02.004; Farinati S., 2020, PLANT MICRORNAS, P75; Hu T, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00597; Joo H, 2019, PLANT J, V100, P399, DOI 10.1111/tpj.14451; Khan SA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061634; Li C, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00119; Li XY, 2019, J ZHEJIANG UNIV-SC B, V20, P322, DOI 10.1631/jzus.B1800003; Li YX, 2020, ECOTOX ENVIRON SAFE, V189, DOI 10.1016/j.ecoenv.2019.109955; Liang MH, 2020, SCI HORTIC-AMSTERDAM, V263, DOI 10.1016/j.scienta.2019.109072; Lilay GH, 2020, J EXP BOT, V71, P3664, DOI 10.1093/jxb/eraa115; Moghanloo M, 2019, ACTA PHYSIOL PLANT, V41, DOI 10.1007/s11738-019-2846-5; Nazerieh H., 2018, Acta Agriculturae Slovenica, V111, P357, DOI 10.14720/aas.2018.111.2.11; Behbahani SR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235556; Salah SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14278; Seddighinia FS, 2020, J PLANT GROWTH REGUL, V39, P87, DOI 10.1007/s00344-019-09965-2; Sheteiwy MS, 2016, ENVIRON SCI POLLUT R, V23, P19989, DOI 10.1007/s11356-016-7170-7; Soleymanzadeh R, 2020, ACTA BIOL CRACOV BOT, V62, P33, DOI 10.24425/abcsb.2019.127751; Sotoodehnia-Korani S, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114727; Wang R., 2019, SCI REP, V9, P1, DOI DOI 10.1038/S41598-019-43885-1; Wisutiamonkul A, 2017, SCI HORTIC-AMSTERDAM, V220, P233, DOI 10.1016/j.scienta.2017.03.048; Yin HQ, 2019, ECOTOX ENVIRON SAFE, V169, P911, DOI 10.1016/j.ecoenv.2018.11.080; Zahedi SM, 2019, ENVIRON POLLUT, V253, P246, DOI 10.1016/j.envpol.2019.04.078	37	30	30	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244207	10.1371/journal.pone.0244207	http://dx.doi.org/10.1371/journal.pone.0244207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338077	Green Published, gold			2022-12-27	WOS:000601313500036
J	Abrahim, SA; Tessema, M; Defar, A; Hussen, A; Ejeta, E; Demoz, G; Tereda, AB; Dillnessa, E; Feleke, A; Amare, M; Nigatu, F; Fufa, Y; Refera, H; Aklilu, A; Kassa, M; Kifle, T; Whiting, S; Tollera, G; Abate, E				Abrahim, Saro Abdella; Tessema, Masresha; Defar, Atkure; Hussen, Alemayehu; Ejeta, Eshetu; Demoz, Getachew; Tereda, Addisu Birhanu; Dillnessa, Enatenesh; Feleke, Altaye; Amare, Misiker; Nigatu, Frehiwot; Fufa, Yaregal; Refera, Hailu; Aklilu, Ayalew; Kassa, Munir; Kifle, Tsigereda; Whiting, Susan; Tollera, Getachew; Abate, Ebba			Time to recovery and its predictors among adults hospitalized with COVID-19: A prospective cohort study in Ethiopia	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; SEX; AGE; INFECTION	Background Various factors may determine the duration of viral shedding (the time from infection to viral RNA-negative conversion or recovery) in COVID-19 patients. Understanding the average duration of recovery and its predictors is crucial in formulating preventive measures and optimizing treatment options. Therefore, evidence showing the duration of recovery from COVID-19 in different contexts and settings is necessary for tailoring appropriate treatment and prevention measures. This study aimed to investigate the average duration and the predictors of recovery from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection among COVID-19 patients. Method A hospital-based prospective cohort study was conducted at Eka Kotebe General Hospital, COVID-19 Isolation and Treatment Center from March 18 to June 27, 2020. The Center was the first hospital designated to manage COVID-19 cases in Ethiopia. The study participants were all COVID-19 adult patients who were admitted to the center during the study period. Follow up was done for the participants from the first date of diagnosis to the date of recovery (negative Real-time Reverse Transcriptase Polymerase Chain Reaction (rRT-PCT) test of throat swab). Result A total of 306 COVID-19 cases were followed up to observe the duration of viral clearance by rRT-PCR. Participants' mean age was 34 years (18-84 years) and 69% were male. The median duration of viral clearance from each participant's body was 19 days, but the range was wide: 2 to 71 days. Cough followed by headache was the leading sign of illness among the 67 symptomatic COVID-19 patients; and nearly half of those with comorbidities were known cancer and HIV/AIDS patients on clinical follow up. The median duration of recovery from COVID-19 was different for those with and without previous medical conditions or comorbidities. The rate of recovery from SARS-CoV-2 infection was 36% higher in males than in females (p = 0.043, CI: 1.01, 1.85). The rate of recovery was 93% higher in those with at least one comorbidity than in those without any comorbidity. The risk of delayed recovery was not influenced by blood type, BMI and presence of signs or symptoms. The findings showed that study participants without comorbidities recovered more quickly than those with at least one comorbidity. Therefore, isolation and treatment centers should be prepared to manage the delayed stay of patients having comorbidity.	[Abrahim, Saro Abdella; Tessema, Masresha; Defar, Atkure; Hussen, Alemayehu; Ejeta, Eshetu; Dillnessa, Enatenesh; Feleke, Altaye; Amare, Misiker; Fufa, Yaregal; Refera, Hailu; Tollera, Getachew; Abate, Ebba] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Demoz, Getachew; Tereda, Addisu Birhanu] Eka Kotebe Gen Hosp, COVID 19 Isolat & Treatment Ctr, Addis Ababa, Ethiopia; [Nigatu, Frehiwot] Int Inst Primary Hlth Care Ethiopia, Addis Ababa, Ethiopia; [Aklilu, Ayalew] ICAP Ethiopia, Addis Ababa, Ethiopia; [Kassa, Munir; Kifle, Tsigereda] Fed Minist Hlth, Addis Ababa, Ethiopia; [Whiting, Susan] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada	Federal Ministry of Health - Ethiopia (FMOH); University of Saskatchewan	Abrahim, SA (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	saroabrahim@gmail.com	Ejeta, Eshetu/AFU-1135-2022	Ejeta, Eshetu/0000-0002-4662-9125; Abrahim, Saro Abdella/0000-0001-7167-4043				Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Chen XD, 2020, INT J INFECT DIS, V98, P252, DOI 10.1016/j.ijid.2020.06.091; Dzik S, 2020, TRANSFUSION, V60, P1883, DOI 10.1111/trf.15946; Fu Y, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01190-2020; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Goronzy JJ, 2007, EXP GERONTOL, V42, P400, DOI 10.1016/j.exger.2006.11.016; Hu XW, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138812; Kampen JJAvan, 2020, SHEDDING INFECT VIRU; Latz CA, 2020, ANN HEMATOL, V99, P2113, DOI 10.1007/s00277-020-04169-1; Li JY, 2020, BRIT J HAEMATOL, V190, P24, DOI 10.1111/bjh.16797; Li TZ, 2021, J MED VIROL, V93, P506, DOI 10.1002/jmv.26280; Mendy Angelico, 2020, medRxiv, DOI 10.1101/2020.08.11.20172676; Moriconi D, 2020, OBES RES CLIN PRACT, V14, P205, DOI 10.1016/j.orcp.2020.05.009; Qi L, 2020, INT J INFECT DIS, V96, P531, DOI 10.1016/j.ijid.2020.05.045; Sattar N, 2020, DIABETES METAB SYND, V14, P1149, DOI 10.1016/j.dsx.2020.06.060; Shi D, 2020, J INFECT DIS, V222, P910, DOI 10.1093/infdis/jiaa388; Udugama B, 2020, ACS NANO, V14, P3822, DOI 10.1021/acsnano.0c02624; Voinsky I, 2020, J INFECTION, V81, pE102, DOI 10.1016/j.jinf.2020.05.026; Wang K, 2020, CHEST, V158, P1876, DOI 10.1016/j.chest.2020.06.015; Warabi Y, 2020, SPEC CARE DENT, V40, P470, DOI 10.1111/scd.12498; Webster RG, 2000, VACCINE, V18, P1686, DOI 10.1016/S0264-410X(99)00507-1; Wu BB, 2020, INFECT GENET EVOL, V84, DOI 10.1016/j.meegid.2020.104485; Wu J, 2020, J INTERN MED, V288, P128, DOI 10.1111/joim.13063; Xu KJ, 2020, CLIN INFECT DIS, V71, P799, DOI 10.1093/cid/ciaa351; Xu K, 2021, CONNECT TISSUE RES, V62, P475, DOI 10.1080/03008207.2020.1778679; Yan D, 2020, TAKE HOME MESSAGE; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Zaidi FZ, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102838; Zheng XC, 2021, J MED VIROL, V93, P952, DOI 10.1002/jmv.26367; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zietz Michael, 2020, medRxiv, DOI 10.1101/2020.04.08.20058073	32	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244269	10.1371/journal.pone.0244269	http://dx.doi.org/10.1371/journal.pone.0244269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378367	Green Published, gold			2022-12-27	WOS:000605651300061
J	Fu, HB; Mu, XP; Wang, PF; Zhang, JC; Fu, BC; Du, JJ				Fu, Hongbo; Mu, Xiaopeng; Wang, Pengfei; Zhang, Jiancheng; Fu, Baochun; Du, Junjie			Fruit quality and antioxidant potential of Prunus humilis Bunge accessions	PLOS ONE			English	Article							BGE. SOK.; CHERRY	In this study, we aimed to evaluate the fruit quality of Prunus humilis and identify cultivars that could provide superior human health benefits. We measured the basic characteristics, bioactive compounds, and antioxidant capacities of 137 P. humilis accessions. Flavonoid and phenol content were determined via colorimetry and ultrahigh performance liquid chromatography. Single fruit and stone weights varied widely and were genetically diverse among accessions. The variation in soluble solid content was comparatively narrow. Total flavonoid content (TFC) ranged from 3.90 to 28.37 mg/g FW, with an average of 10.58 mg/g FW in 2019. Significant differences between accessions in terms of TFC, total phenol content, and antioxidant capacity were found. TFC in the accessions was normally distributed and predominantly in the medium range (9.57-15.23 mg/g FW). Red was the predominant peel color over all other phenotypes (i.e., dark red, red, light red, red-orange, and yellow). There was no obvious correlation between peel color and TFC. Catechin was the major flavonoid component in the fruit. Principal component analysis showed that TFC, ABTS, single fruit weight, and vertical and horizontal diameter contributed to the first two principal components for each accession. Accessions 10-02, 3-17-2, 3-17-4, and JD1-6-7-37 were characterized by high TFC, ABTS, and large fruit. We believe that our results will aid in the breeding and functional food processing of Prunus humilis.	[Fu, Hongbo; Mu, Xiaopeng; Wang, Pengfei; Zhang, Jiancheng; Du, Junjie] Shanxi Agr Univ, Coll Hort, Taigu, Shanxi, Peoples R China; [Fu, Hongbo] Heilongjiang Acad Agr Sci, Rural Revitalizat Inst Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Fu, Hongbo; Fu, Baochun] Shanxi Agr Univ, Res Inst Pomol, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University; Heilongjiang Academy of Agricultural Sciences; Shanxi Agricultural University	Du, JJ (corresponding author), Shanxi Agr Univ, Coll Hort, Taigu, Shanxi, Peoples R China.	djj738@163.com		fu, dou dou/0000-0002-7401-2966	Key Research and Development Projects of Shanxi Province [201703D221028-4]; Key Projects of Key Research and Development of Shanxi Province [201703D211001-0404]; Applied Basic Research Project of Shanxi Province [201801D121251]	Key Research and Development Projects of Shanxi Province; Key Projects of Key Research and Development of Shanxi Province; Applied Basic Research Project of Shanxi Province	This work was supported by the Key Research and Development Projects of Shanxi Province (Grant No. 201703D221028-4), the Key Projects of Key Research and Development of Shanxi Province (Grant No. 201703D211001-0404), and the Applied Basic Research Project of Shanxi Province (Grant No. 201801D121251).	Agati G, 2008, FUNCT PLANT BIOL, V35, P77, DOI 10.1071/FP07178; [Anonymous], 2018, CONSCIENCE, V39, P20; Bai DH, 2015, EXTRACTION COMPONENT; [蔡文国 Cai Wenguo], 2010, [食品科学, Food Science], V31, P201; Cao YF, 2011, ANAL GENETIC RELATIO; Celli GB, 2011, FOOD RES INT, V44, P2442, DOI 10.1016/j.foodres.2010.12.036; [常虹 CHANG Hong], 2011, [食品科学, Food Science], V32, P59; [陈学森 Chen Xuesen], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P2193; [程霜 CHENG Shuang], 2007, [食品科学, Food Science], V28, P57; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; Guo JM, 2019, NONWOOD FOREST RES, V37, P198; Hao YJ, 2000, IN VITRO CONSERVATIO; Huang ChunHui, 2019, Journal of Fruit Science, V36, P174; [姜凤超 Jiang Fengchao], 2016, [湖南农业大学学报. 自然科学版, Journal of Hunan Agricultural University. Natural Sciences], V42, P157; Jiang Y, 2016, QUALITY EVALUATION M; [李富华 Li Fuhua], 2014, [食品科学, Food Science], V35, P58; Li WD, 2014, SCI HORTIC-AMSTERDAM, V175, P208, DOI 10.1016/j.scienta.2014.06.015; Liu L, 2018, NONWOOD FOREST RES, V36, P151; Liu N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239076; Liu SW, 2018, J FOOD QUALITY, DOI 10.1155/2018/5479565; Lu Y, 2015, IDENTIFICATION FLAVO; Lunet N, 2005, NUTR CANCER, V53, P1, DOI 10.1207/s15327914nc5301_1; Meng R, 2017, ANAL GENETICS APPLE; Mirto A, 2018, FOOD CHEM, V240, P559, DOI 10.1016/j.foodchem.2017.07.162; Morimoto M, 2003, J AGR FOOD CHEM, V51, P389, DOI 10.1021/jf025627a; Mu XP, 2015, J HORTIC SCI BIOTECH, V90, P525, DOI 10.1080/14620316.2015.11668709; Qin LN, 2013, NEUROSCI LETT, V534, P285, DOI 10.1016/j.neulet.2012.12.023; Srednicka-Tober D, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110534; Su MingShen, 2017, Acta Agriculturae Shanghai, V33, P93; Sun J, 2019, NONWOOD FOREST RES, V37, P95; Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054; Wang PF, 2018, J FORESTRY RES, V29, P55, DOI 10.1007/s11676-017-0418-3; Wang S, 2017, CLIN EXP OPHTHALMOL, V45, P33; Wang YanQiu, 2008, Scientia Agricultura Sinica, V41, P2063; Wu Hui, 2011, Journal of Fruit Science, V28, P1045; Wu Q, 2019, NAT PROD COMMUN, V14, DOI 10.1177/1934578X19856509; Xia LH, 2019, NONWOOD FOREST RES, V37, P125; Xu Z, 2006, CHIN J ANIM NUTR, P1; Ye LQ, 2017, FOOD CHEM, V217, P389, DOI 10.1016/j.foodchem.2016.08.122; Yin ZP, 2017, PROTEOME SCI, V15, DOI 10.1186/s12953-017-0117-1; [余晓红 Yu Xiaohong], 2015, [食品科学, Food Science], V36, P209; Zhang DW, 2012, SOIL WATER CONSERVAT, P45; Zhang WJ, 2015, EXTRACTION ANAL FUNC; Zhou JJ, 2018, SCI REP, P7, DOI [10.1038/s41598-017-18310-0, DOI 10.1038/S41598-017-18310-0]	44	7	7	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244445	10.1371/journal.pone.0244445	http://dx.doi.org/10.1371/journal.pone.0244445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378359	Green Published, gold			2022-12-27	WOS:000605651300026
J	Nepal, V; Fabrizio, MC				Nepal, Vaskar; Fabrizio, Mary C.			Sublethal effects of salinity and temperature on non-native blue catfish: Implications for establishment in Atlantic slope drainages	PLOS ONE			English	Article							ICTALURUS-FURCATUS; FOOD-CONSUMPTION; BODY-COMPOSITION; CHANNEL CATFISH; BRACKISH-WATER; CHESAPEAKE BAY; NILE TILAPIA; GROWTH-RATE; TOLERANCE; FISH	The distribution and further range expansion of non-native blue catfish Ictalurus furcatus in coastal waters throughout the United States Atlantic slope depend, in part, on the salinity tolerance of the fish. However, temperature-mediated sublethal effects of increased salinities on blue catfish biology are not yet known. We assessed the effects of salinity and temperature on growth, body condition, body composition and food consumption of juvenile blue catfish in a controlled laboratory experiment. Temperature and salinity had an interactive effect on blue catfish biology, although most fish survived 112 days in salinities up to 10 psu. At salinities <= 7 psu, mean growth rate, body condition and consumption rates were higher at 22 degrees C than at 12 degrees C. Mean consumption rates declined significantly with increasing salinities, yet, salinities <= 7 psu were conducive to rapid growth and high body condition, with highest growth and body condition at 4 psu. Fish at 10 psu exhibited low consumption rates, slow growth, low body condition and lower proportions of lipids. Habitats with hyperosmotic salinities (>9 psu) likely will not support the full lifecycle of blue catfish, but the fish may use salinities up to 10 psu for foraging, dispersal and even growth. Many oligohaline and mesohaline habitats in U.S. Atlantic slope drainages may thus be vulnerable to establishment of invasive blue catfish, particularly given the increasing temperatures as a result of climate warming.	[Nepal, Vaskar; Fabrizio, Mary C.] Virginia Inst Marine Sci, William & Mary, Gloucester Point, VA 23062 USA	William & Mary; Virginia Institute of Marine Science	Nepal, V (corresponding author), Virginia Inst Marine Sci, William & Mary, Gloucester Point, VA 23062 USA.	vnepalkc@vims.edu		Fabrizio, Mary/0000-0002-6115-5490; Nepal, Vaskar/0000-0001-9155-7768	Virginia Institute of Marine Science (VIMS); Virginia Sea Grant; Virginia Marine Resources Commission; U.S. Fish and Wildlife Service	Virginia Institute of Marine Science (VIMS); Virginia Sea Grant; Virginia Marine Resources Commission; U.S. Fish and Wildlife Service(US Fish & Wildlife Service)	Financial assistance was provided by a Virginia Institute of Marine Science (VIMS) student research grant and Virginia Sea Grant graduate fellowship to VN, and by the Virginia Marine Resources Commission and the U.S. Fish and Wildlife Service to MF. The funder provided support in the form of salaries for authors [VN; MCF], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abass NY, 2017, AQUACULTURE, V471, P28, DOI 10.1016/j.aquaculture.2016.12.029; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Allen K. O., 1970, P SE ASS GAME FISH C, V23, P319; Altinok I, 2001, J FISH BIOL, V59, P1142, DOI [10.1006/jfbi.2001.1722, 10.1111/j.1095-8649.2001.tb00181.x]; [Anonymous], 2011, FISH DIS DIAGNOSIS T; ARUNACHALAM S, 1979, AQUACULTURE, V16, P163, DOI 10.1016/0044-8486(79)90147-9; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Bringolf RB, 2005, T AM FISH SOC, V134, P927, DOI 10.1577/T04-195.1; Capps KA, 2011, AQUAT CONSERV, V21, P528, DOI 10.1002/aqc.1210; Collins C, 1988, AQUACULTURE MAG, P81; Copp GH, 2009, FISH FISH, V10, P252, DOI 10.1111/j.1467-2979.2008.00321.x; Dubey Sourabh Kumar, 2016, Zoology and Ecology, V26, P282, DOI 10.1080/21658005.2016.1225867; Efron B., 1994, MONOGRAPHS STAT APPL; Egozcue JJ, 2003, MATH GEOL, V35, P279, DOI 10.1023/A:1023818214614; Fabrizio MC, 2018, ESTUAR COAST, V41, P827, DOI 10.1007/s12237-017-0307-1; Fabrizio MC, N AM J FISH MANAG; Fagbenro O. A., 1993, Tropical Zoology, V6, P67; Fuller P., 2020, US GEOLOGICAL SURVEY; Gao F, 2006, ANAL MULTIVARIATE LO, P1; Goudswaard PC, 2002, J FISH BIOL, V60, P838, DOI [10.1006/jfbi.2002.1888, 10.1111/j.1095-8649.2002.tb02413.x]; Herath SS, 2018, AQUAC RES, V49, P2128, DOI 10.1111/are.13667; Hill RW, 2008, ANIMAL PHYSL; HOLDWAY DA, 1984, J EXP MAR BIOL ECOL, V81, P147, DOI 10.1016/0022-0981(84)90003-0; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; KILAMBI RV, 1980, J FISH BIOL, V16, P171, DOI 10.1111/j.1095-8649.1980.tb03696.x; Kooijman S. A. L. M., 2010, DYNAMIC ENERGY BUDGE; Kultz D, 2015, J EXP BIOL, V218, P1907, DOI 10.1242/jeb.118695; LAMBERT Y, 1994, CAN J FISH AQUAT SCI, V51, P1569, DOI 10.1139/f94-155; LECREN ED, 1951, J ANIM ECOL, V20, P201, DOI 10.2307/1540; Lloret J, 2013, CONDITION HLTH INDIC; Lockwood JL., 2013, INVASION ECOLOGY; Marshall William S., 2006, P177; MCENROE M, 1985, ENVIRON BIOL FISH, V14, P23, DOI 10.1007/BF00001573; Gutierre SMM, 2014, MAR FRESHWATER RES, V65, P425, DOI 10.1071/MF13161; Moeller S, 2019, ECOL FRESHW FISH, V28, P602, DOI 10.1111/eff.12478; Nepal V, 2020, THESIS; Nepal V, 2020, FISH RES, V230, DOI 10.1016/j.fishres.2020.105650; Nepal V, 2020, T AM FISH SOC, V149, P108, DOI 10.1002/tafs.10217; Nepal V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224770; New JG, 1999, AM FISH S S, V24, P125; Pedersen PBM, 2014, AQUAC RES, V45, P427, DOI 10.1111/j.1365-2109.2012.03244.x; Perry Jr. W.G., 1968, P SE ASS GAM FISH CO, V21, P436; PERRY WG, 1973, PROG FISH CULT, V35, P164, DOI 10.1577/1548-8659(1973)35[164:NOTSOB]2.0.CO;2; Roloson SD, 2020, CAN J FISH AQUAT SCI, V77, P1117, DOI 10.1139/cjfas-2019-0229; Sahoo S.K., 2003, Indian Journal of Fisheries, V50, P119; Schloesser RW, 2011, AM FISH S S, V77, P369; Schmitt JD, 2019, FISH B-NOAA, V117, P277, DOI 10.7755/FB.117.4.1; Schmitt JD, 2019, ENVIRON BIOL FISH, V102, P443, DOI 10.1007/s10641-018-0783-6; Schofield PJ, 2011, MAR FRESHWATER RES, V62, P439, DOI 10.1071/MF10207; Shikano T, 1998, FISHERIES SCI, V64, P10, DOI 10.2331/fishsci.64.10; St Mary CM, 2001, ETHOLOGY, V107, P1035, DOI 10.1046/j.1439-0310.2001.00747.x; Stroup W.W., 2018, SAS MIXED MODELS INT; Templ M, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P341; Tuckey TD, 2019, 2019 ANN REPORT ESTI, P149, DOI [10.25773/8znm-db81, DOI 10.25773/8ZNM-DB81]; Wang JQ, 1997, AQUACULTURE, V148, P115, DOI 10.1016/S0044-8486(96)01334-8; WATANABE WO, 1993, AQUACULTURE, V112, P309, DOI 10.1016/0044-8486(93)90392-C; Whitfield AK, 2015, J FISH BIOL, V86, P1227, DOI 10.1111/jfb.12641	58	6	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244392	10.1371/journal.pone.0244392	http://dx.doi.org/10.1371/journal.pone.0244392			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373393	Green Published, gold			2022-12-27	WOS:000603612300010
J	Bell, S; Clarke, R; Paterson, P; Mounier-Jack, S				Bell, Sadie; Clarke, Richard; Paterson, Pauline; Mounier-Jack, Sandra			Parents' and guardians' views and experiences of accessing routine childhood vaccinations during the coronavirus (COVID-19) pandemic: A mixed methods study in England	PLOS ONE			English	Article							COVERAGE	Objective To explore parents' and guardians' views and experiences of accessing National Health Service (NHS) general practices for routine childhood vaccinations during the coronavirus (COVID-19) pandemic in England. Design Mixed methods approach involving an online cross-sectional survey (conducted between 19(th) April and 11(th) May 2020) and semi-structured telephone interviews (conducted between 27(th) April and 27(th) May 2020). Participants 1252 parents and guardians (aged 16+ years) who reported living in England with a child aged 18 months or under completed the survey. Nineteen survey respondents took part in follow-up interviews. Results The majority of survey respondents (85.7%) considered it important for their children to receive routine vaccinations on schedule during the COVID-19 pandemic; however, several barriers to vaccination were identified. These included a lack of clarity around whether vaccination services were operating as usual, particularly amongst respondents from lower income households and those self-reporting as Black, Asian, Chinese, Mixed or Other ethnicity; difficulties in organising vaccination appointments; and fears around contracting COVID-19 while attending general practice. Concerns about catching COVID-19 while accessing general practice were weighed against concerns about children acquiring a vaccine-preventable disease if they did not receive scheduled routine childhood vaccinations. Many parents and guardians felt their child's risk of acquiring a vaccine-preventable disease was low as the implementation of stringent physical distancing measures (from March 23(rd) 2020) meant they were not mixing with others. Conclusion To promote routine childhood vaccination uptake during the current COVID-19 outbreak, further waves of COVID-19 infection, and future pandemics, prompt and sustained national and general practice level communication is needed to raise awareness of vaccination service continuation and the importance of timely vaccination, and invitation-reminder systems for vaccination need to be maintained. To allay concerns about the safety of accessing general practice, practices should communicate the measures being implemented to prevent COVID-19 transmission.	[Bell, Sadie; Mounier-Jack, Sandra] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London, England; [Clarke, Richard] Newcastle Univ London, Newcastle Univ Business Sch, London, England; [Paterson, Pauline] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bell, S (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London, England.	sadie.bell@lshtm.ac.uk		Bell, Sadie/0000-0003-4381-0030	National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation at the London School of Hygiene & Tropical Medicine; Public Health England	National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation at the London School of Hygiene & Tropical Medicine; Public Health England	The research was funded by the National Institute for Health Research (NIHR) Health Protection Research Unit in Immunisation at the London School of Hygiene & Tropical Medicine in partnership with Public Health England. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.	Bramer CA, 2020, MMWR-MORBID MORTAL W, V69, P630, DOI 10.15585/mmwr.mm6920e1; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Dann L, 2020, ARCH DIS CHILD, V105, P810, DOI 10.1136/archdischild-2020-319654; Habersaat KB, 2020, BUNDESGESUNDHEITSBLA, V63, P32, DOI 10.1007/s00103-019-03063-0; Joint Committee on Vaccination and Immunisation, 2020, STAT JCVI IMM PRIOR; Kleinman Z, 2020, BBC NEWS; McDonald HI, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.19.2000848; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Nelson R, 2020, LANCET INFECT DIS, V20, P546, DOI 10.1016/S1473-3099(20)30304-2; NHS England, 2020, NHS URG PUBL GET ESS; Public Health England, 2020, NFDA NEWS 0401; Public Health England, 2020, EM DEP SYNDR SURV SY; Royal College of General Practitioners (RCGP), 2020, RCGP GUID WORKL PRIO; Royal Society for Public Health, 2020, MOV NEEDL PROM VACC; Santoli JM, 2020, MMWR-MORBID MORTAL W, V69, P591, DOI 10.15585/mmwr.mm6919e2; SAXENA S, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2392; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; The Rt Hon Boris Johnson MP, 2020, PRIME MINISTERS STAT; THORNTON J, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1401; Tiley KS, 2018, VACCINE, V36, P6726, DOI 10.1016/j.vaccine.2018.09.032; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; Wagner KS, 2014, ARCH DIS CHILD, V99, P348, DOI 10.1136/archdischild-2013-304388; WHO, 2020, WHO UNICEF WARN DECL; Williams Nia, 2011, JRSM Short Rep, V2, P81, DOI 10.1258/shorts.2011.011112; World Health Organisation, 2020, LEAST 8000000 CHILDR; World Health Organization, 2020, GUID PRINC IMM ACT C	26	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244049	10.1371/journal.pone.0244049	http://dx.doi.org/10.1371/journal.pone.0244049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370323	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000603611900080
J	Chekol, D; Bedimo, M; Mulugeta, Y; Bantie, GM				Chekol, Dessalegn; Bedimo, Melkamu; Mulugeta, Yihun; Bantie, Getasew Mulat			Determinants of non-Hodgkin's lymphoma at Felegehiwot specialized hospital, North West Ethiopia: A case-control study	PLOS ONE			English	Article							RISK-FACTORS; OBESITY	Background The global burden of cancer continues to increase largely because of the aging and growth of the world population alongside an increasing adoption of cancer-causing behaviors. Hence, the purpose of this study was to identify determinants of Non-Hodgkin lymphoma cancer among individuals who diagnosed at the Felegehiwot specialized hospital, North West Ethiopia, 2019. Methods An institution-based unmatched case-control study was conducted at the Felegehiwot Specialized hospital from December 2018 up to June 2019. The sample size calculated using the two-population proportion formula. The final sample size was 486, (162 cases and 324 controls). The simple random sampling method was employed to catch up with the estimated samples. The collected data entered into the Epi-data version 3.1 software and analyzed using SPSS version 21 software. Descriptive statistics computed. Simple logistic analysis was run (at 95% CI and p-value < 0.05) to identify the determinants of non-Hodgkin's lymphoma. Result A total of 486 patients participated. Nearly one-third of the cases and controls were in the age group of 46-60 years. About 90% of cases and 91% of controls were orthodox Christian. Monthly income of <= 28 dollars (AOR = 2. 73, 95%CI: 1. 8, 4.2), male sex (AOR = 1. 8, 95%CI: 1.2, 2.8), ever had chemical exposure, (AOR = 11. 9, 95%CI: 7.6, 18.8), no regular physical exercise (AOR = 15. 5, 95%CI: 5.7, 42.3), and having hypertension [AOR = 0. 03; 95%CI:0.005, 0.2), lung disease (AOR = 0. 2; 95%CI: 0.06, 0.7), and chronic kidney and cardiac diseases (AOR = 0. 06; 95%CI: 0.01, 0.2) were the determinants of non-Hodgkin's lymphoma. Conclusions The findings in this study suggest that having a low monthly income, being male sex, ever had chemical exposure, not engaged in regular physical exercise, and being diabetic were the determinants of non-Hodgkin's lymphoma.	[Chekol, Dessalegn] Felegehiwot Comprehens Specialized Hosp, Dept Nursing, Bahir Dar, Ethiopia; [Bedimo, Melkamu; Mulugeta, Yihun] Bahir Dar Univ, Dept Biostat & Epidemiol, Bahir Dar, Ethiopia; [Bantie, Getasew Mulat] Alkan Hlth Sci Business & Technol Coll, Fac Community Hlth, Dept Publ Hlth, Bahir Dar, Ethiopia	Bahir Dar University	Bantie, GM (corresponding author), Alkan Hlth Sci Business & Technol Coll, Fac Community Hlth, Dept Publ Hlth, Bahir Dar, Ethiopia.	getasewmulat@gmail.com	Bantie, Getasew/ABZ-4323-2022; Fazli, Ghazal/AAE-8320-2022	Bantie, Getasew/0000-0002-5073-6767; Beyene, Melkamu Bedimo/0000-0003-4349-9887				[Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Balasubramaniam G, 2013, ASIAN PAC J CANCER P, V14, P775, DOI 10.7314/APJCP.2013.14.2.775; Cerhan JR, 1997, J NATL CANCER I, V89, P314, DOI 10.1093/jnci/89.4.314; Fabbro-Peray P, 2001, CANCER CAUSE CONTROL, V12, P201, DOI 10.1023/A:1011274922701; Frederiksen BL, 2012, BRIT J CANCER, V106, P988, DOI 10.1038/bjc.2012.3; GLOBOCAN, 2018, GLOBOCAN 2018; Hardell L, 1999, CANCER, V85, P1353, DOI 10.1002/(SICI)1097-0142(19990315)85:6&lt;1353::AID-CNCR19&gt;3.0.CO;2-1; Luo D, 2016, SCI REP-UK, V6, DOI 10.1038/srep25768; Mitri J, 2008, DIABETES CARE, V31, P2391, DOI 10.2337/dc08-1034; Naresh KN, 2011, BRIT J HAEMATOL, V154, P696, DOI 10.1111/j.1365-2141.2011.08772.x; Pan SY, 2005, AM J EPIDEMIOL, V162, P1162, DOI 10.1093/aje/kwi342; Skibola CF, 2007, CANCER EPIDEM BIOMAR, V16, P392, DOI 10.1158/1055-9965.EPI-06-1081; Zebrack BJ, 2002, PEDIATRICS, V110, P42, DOI 10.1542/peds.110.1.42; Zhang Yawei, 2011, Expert Opin Med Diagn, V5, P539	15	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243561	10.1371/journal.pone.0243561	http://dx.doi.org/10.1371/journal.pone.0243561			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370329	Green Submitted, Green Published, gold			2022-12-27	WOS:000603611900104
J	Guenther, SK; Shanahan, EA				Guenther, Sara K.; Shanahan, Elizabeth A.			Communicating risk in human-wildlife interactions: How stories and images move minds	PLOS ONE			English	Article							CLIMATE-CHANGE; PERCEPTION; NARRATIVES; ATTITUDES; CONFLICT; MESSAGES; SCIENCE; PROTECT; BATS; CONSERVATION	Effectively communicating risk is critical to reducing conflict in human-wildlife interactions. Using a survey experiment fielded in the midst of contentious public debate over flying fox management in urban and suburban areas of Australia, we find that stories with characters (i.e., narratives) are more effective than descriptive information at mobilizing support for different forms of bat management, including legal protection, relocation, and habitat restoration. We use conditional process analysis to show that narratives, particularly with accompanying images, are effective because they cause emotional reactions that influence risk perception, which in turn drives public opinion about strategies for risk mitigation. We find that prior attitudes towards bats matter in how narrative messages are received, in particular in how strongly they generate shifts in affective response, risk perception, and public opinion. Our results suggest that those with warm prior attitudes towards bats report greater support for bat dispersal when they perceive impacts from bats to be more likely, while those with cool priors report greater support for bat protection when they perceive impacts from bats to be more positive, revealing 1) potential opportunities for targeted messaging to boost public buy-in of proposals to manage risks associated with human-wildlife interactions, and 2) potential vulnerabilities to disinformation regarding risk.	[Guenther, Sara K.; Shanahan, Elizabeth A.] Montana State Univ, Dept Polit Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Guenther, SK (corresponding author), Montana State Univ, Dept Polit Sci, Bozeman, MT 59717 USA.	sara.guenther@montana.edu		Guenther, Sara/0000-0002-9964-5823	National Science Foundation CNH-L [1716698]; National Science Foundation RAPID [1914601]	National Science Foundation CNH-L; National Science Foundation RAPID	EAS awarded and SKG funded through National Science Foundation CNH-L grant number 1716698, https://www.nsf.gov/. EAS and SKG both awarded National Science Foundation RAPID grant number 1914601, https://www.nsf.gov/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; ALHAKAMI AS, 1994, RISK ANAL, V14, P1085, DOI 10.1111/j.1539-6924.1994.tb00080.x; [Anonymous], 2001, RESOLVING HUMAN WILD; Aziz SA, 2017, HUM ECOL, V45, P377, DOI 10.1007/s10745-017-9905-6; Baruch-Mordo S., 2009, Human Dimensions of Wildlife, V14, P219, DOI 10.1080/10871200902839324; Currey K, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10020039; Dahlstrom MF, 2014, P NATL ACAD SCI USA, V111, P13614, DOI 10.1073/pnas.1320645111; Dahlstrom MF, 2018, SCI COMMUN, V40, P340, DOI 10.1177/1075547018766556; Entman RM, 1995, MEDIA RES READINGS M, P55; Espinosa S, 2012, J ENVIRON EDUC, V43, P55, DOI 10.1080/00958964.2011.579642; Fagan KE, 2018, BIOL CONSERV, V220, P132, DOI 10.1016/j.biocon.2018.02.004; Finucane ML, 2000, J BEHAV DECIS MAKING, V13, P1, DOI 10.1002/(SICI)1099-0771(200001/03)13:1<1::AID-BDM333>3.0.CO;2-S; Fischhoff B, 2019, P NATL ACAD SCI USA, V116, P7632, DOI 10.1073/pnas.1902256116; Florens FBV, 2018, SCIENCE, V362, P409, DOI 10.1126/science.aav5161; Ge J, 2018, J MARKET MANAG-UK, V34, P1272, DOI 10.1080/0267257X.2018.1483960; Green MC, 2000, J PERS SOC PSYCHOL, V79, P701, DOI 10.1037/0022-3514.79.5.701; Gunnthorsdottir A, 2001, ANTHROZOOS, V14, P204, DOI 10.2752/089279301786999355; Han BA, 2016, TRENDS PARASITOL, V32, P565, DOI 10.1016/j.pt.2016.04.007; Hayes A., 2017, INTRO MEDIATION MODE; Hinyard LJ, 2007, HEALTH EDUC BEHAV, V34, P777, DOI 10.1177/1090198106291963; Joo J, 2014, PROC CVPR IEEE, P216, DOI 10.1109/CVPR.2014.35; Kahan D. M., 2007, J EMPIR LEGAL STUD, V4, P465, DOI DOI 10.1111/J.1740-1461.2007.00097.X; Kahlor LA, 2020, ENVIRON COMMUN, V14, P555, DOI 10.1080/17524032.2019.1699136; Kaplan S., 1981, RISK ANAL, V1, P11, DOI [DOI 10.1111/J.1539-6924.1981.TB01350.X, 10.1111/j.1539-6924.1981.tb01350.x]; Konig HJ, 2020, CONSERV BIOL, V34, P786, DOI 10.1111/cobi.13513; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Law B.S., 1995, PACIFIC CONSERVATION, V2, P363, DOI [10.1071/PC960363, DOI 10.1071/PC960363]; Lodge M, 2005, POLIT PSYCHOL, V26, P455, DOI 10.1111/j.1467-9221.2005.00426.x; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lopez-Baucells A, 2018, MAMMAL REV, V48, P62, DOI 10.1111/mam.12110; Lu H, 2018, SOC SCI J, V55, P182, DOI 10.1016/j.soscij.2017.05.002; Lu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156205; Lujala P, 2015, LOCAL ENVIRON, V20, P489, DOI 10.1080/13549839.2014.887666; Musila S, 2018, ANTHROZOOS, V31, P247, DOI 10.1080/08927936.2018.1434065; Muter B. A., 2009, Human Dimensions of Wildlife, V14, P366, DOI 10.1080/10871200903045210; Nyhus PJ, 2016, ANNU REV ENV RESOUR, V41, P143, DOI 10.1146/annurev-environ-110615-085634; Peters EM, 2004, RISK ANAL, V24, P1349, DOI 10.1111/j.0272-4332.2004.00531.x; Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Prokop P, 2017, EURASIA J MATH SCI T, V13, P6069, DOI 10.12973/eurasia.2017.01000a; Prokop P, 2009, ANTHROZOOS, V22, P19, DOI 10.2752/175303708X390446; Roh S, 2015, SCI COMMUN, V37, P340, DOI 10.1177/1075547015575181; Schmelitschek E, 2009, WILDLIFE RES, V36, P592, DOI 10.1071/WR08169; Shanahan EA, 2017, THEORIES POLICY PROC, P173, DOI DOI 10.4324/9780429494284-6; Shanahan EA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225968; Shanahan EA, 2013, POLICY STUD J, V41, P453, DOI 10.1111/psj.12025; Shapiro HG, 2020, HUM-WILDL INTERACT, V14, P5; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Soulsbury CD, 2015, WILDLIFE RES, V42, P541, DOI 10.1071/WR14229; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; Tait J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109810; Vainio A, 2018, APPETITE, V125, P217, DOI 10.1016/j.appet.2018.02.002; Vincenot CE, 2017, SCIENCE, V355, P1368, DOI 10.1126/science.aam7582; Vincenot CE, 2015, GLOB ECOL CONSERV, V3, P526, DOI 10.1016/j.gecco.2015.02.005; Wachinger G, 2013, RISK ANAL, V33, P1049, DOI 10.1111/j.1539-6924.2012.01942.x; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Webster SW, 2017, AM POLIT RES, V45, P621, DOI 10.1177/1532673X17703132; White MP, 2003, RISK ANAL, V23, P717, DOI 10.1111/1539-6924.00350; Wilson RS, 2019, RISK ANAL, V39, P777, DOI 10.1111/risa.13207; Woodroffe R., 2005, CONSERV BIOL; Zillmann D., 2013, SELECTIVE EXPOSURE C; 2018, CURR OPIN TOXICOL, V10	63	6	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244440	10.1371/journal.pone.0244440	http://dx.doi.org/10.1371/journal.pone.0244440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370410	gold, Green Published			2022-12-27	WOS:000603611900088
J	Liu, Q; Brookbank, L; Ho, A; Coffey, J; Brennan, AB; Jones, CJ				Liu, Qi; Brookbank, Lindsey; Ho, Angela; Coffey, Jenna; Brennan, Anthony B.; Jones, Christopher J.			Surface texture limits transfer of S. aureus, T4 bacteriophage, influenza B virus and human coronavirus	PLOS ONE			English	Article							VIRAL-INFECTIONS; TRANSMISSION; ATTACHMENT; SPREAD; PREVENTION; BACTERIA; ADHESION; FOMITES	Spread of pathogens on contaminated surfaces plays a key role in disease transmission. Surface technologies that control pathogen transfer can help control fomite transmission and are of great interest to public health. Here, we report a novel bead transfer method for evaluating fomite transmission in common laboratory settings. We show that this method meets several important criteria for quantitative test methods, including reasonableness, relevancy, resemblance, responsiveness, and repeatability, and therefore may be adaptable for standardization. In addition, this method can be applied to a wide variety of pathogens including bacteria, phage, and human viruses. Using the bead transfer method, we demonstrate that an engineered micropattern limits transfer of Staphylococcus aureus by 97.8% and T4 bacteriophage by 93.0% on silicone surfaces. Furthermore, the micropattern significantly reduces transfer of influenza B virus and human coronavirus on silicone and polypropylene surfaces. Our results highlight the potential of using surface texture as a valuable new strategy in combating infectious diseases.	[Liu, Qi; Brookbank, Lindsey; Ho, Angela; Coffey, Jenna; Brennan, Anthony B.; Jones, Christopher J.] Sharklet Technol Inc, Aurora, CO 80045 USA		Jones, CJ (corresponding author), Sharklet Technol Inc, Aurora, CO 80045 USA.	cjones@sharklet.com	Jones, Christopher J/AGI-4256-2022	Jones, Christopher/0000-0001-8113-7831; Coffey, Jenna/0000-0001-9249-5191; Liu, Qi/0000-0003-2106-7231	Sharklet Technologies, Inc.	Sharklet Technologies, Inc.	This work was funded by internal Sharklet Technologies, Inc. funding. All authors were employees of Sharklet Technologies, Inc. while contributing to this study. The funder provided support in the form of salaries for authors [QL, LB, AH, JC, AB, and CJ] and test materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almand EA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030058; [Anonymous], 2019, NAT METHODS, V16, P1, DOI 10.1038/s41592-018-0292-8; [Anonymous], 2020, E3515 ATM INT; [Anonymous], 2015, DABIQ, V4, P9; [Anonymous], 2014, FUEL CELLS B; [Anonymous], 2007, ENV HLTH NEWS, V22, P11; ANSARI SA, 1991, J CLIN MICROBIOL, V29, P2115, DOI 10.1128/JCM.29.10.2115-2119.1991; Armanious A, 2016, ENVIRON SCI TECHNOL, V50, P732, DOI 10.1021/acs.est.5b04644; ASTM, 2020, SUBC E35 15 ANT AG; Barker J, 2001, J APPL MICROBIOL, V91, P7, DOI 10.1046/j.1365-2672.2001.01364.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bonilla N, 2016, PEERJ, V4, DOI 10.7717/peerj.2261; Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; DANN JR, 1970, J COLLOID INTERF SCI, V32, P302, DOI 10.1016/0021-9797(70)90054-8; Desai R, 2011, AM J INFECT CONTROL, V39, P219, DOI 10.1016/j.ajic.2010.07.005; ECKMANN BH, 1964, AM REV RESPIR DIS, V89, P175; Gangadoo S, 2016, J MATER CHEM B, V4, P5747, DOI 10.1039/c6tb01642a; Hamilton MA, 2010, KSA SM 03 TESTING SU; Hanada S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02640; Jiang RJ, 2020, CHEM ENG J, V398, DOI 10.1016/j.cej.2020.125609; Julian TR, 2010, J APPL MICROBIOL, V109, P1868, DOI 10.1111/j.1365-2672.2010.04814.x; Karakus U, 2018, METHODS MOL BIOL, V1836, P59, DOI 10.1007/978-1-4939-8678-1_4; Kraay ANM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3425-x; Kurgat EK, 2019, INT J HYG ENVIR HEAL, V222, P479, DOI 10.1016/j.ijheh.2019.01.001; Lei H, 2018, INDOOR AIR, V28, P394, DOI 10.1111/ina.12445; Lopez GU, 2013, APPL ENVIRON MICROB, V79, P5728, DOI 10.1128/AEM.01030-13; Mann EE, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-28; Nascimento-Carvalho AC, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0645-3; Parker AE, 2011, KSA SM 10 ASSESSING; R Development Core Team, 2009, R LANG ENV STAT COMP; Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530; Reed LJ., 1938, AM J HYG, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Rios PF, 2007, J ADHES SCI TECHNOL, V21, P227, DOI 10.1163/156856107780684567; Salgado CD, 2013, INFECT CONT HOSP EP, V34, P479, DOI 10.1086/670207; Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v; Shahali H, 2019, J MATER CHEM B, V7, P1300, DOI 10.1039/c8tb03295e; Stephens B, 2019, CURR POLLUT REP, V5, P198, DOI 10.1007/s40726-019-00123-6; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Truong VK, 2012, BIOFOULING, V28, P539, DOI 10.1080/08927014.2012.694426; Vega E, 2005, J FOOD PROTECT, V68, P2112, DOI 10.4315/0362-028X-68.10.2112; Watson GS, 2017, ACS APPL MATER INTER, V9, P24381, DOI 10.1021/acsami.7b08368; Xiao SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181558	42	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244518	10.1371/journal.pone.0244518	http://dx.doi.org/10.1371/journal.pone.0244518			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370781	gold, Green Published, Green Submitted			2022-12-27	WOS:000603611900035
J	Bezerra, CRF; Borges, KRA; Alves, RDS; Teles, AM; Rodrigues, IVP; da Silva, MACN; Nascimento, MDSB; Bezerra, GFD				Bezerra, Carolina Rabelo Falcao; Assuncao Borges, Katia Regina; Alves, Rita de Nazare Silva; Teles, Amanda Mara; Pimentel Rodrigues, Igor Vinicius; da Silva, Marcos Antonio Custodio Neto; Nascimento, Maria do Desterro Soares Brandao; Bezerra, Geusa Felipa de Barros			Highly efficient antibiofilm and antifungal activity of green propolis against Candida species in dentistry materials	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; CHEMICAL-COMPOSITION; NATURAL-PRODUCTS; EXTRACT; COLONIZATION	This study evaluated the effect of green propolis extract on the adhesion and biofilm formation of Candida species in dentistry materials. Phytochemical analysis of green propolis extract was performed by high-performance liquid chromatography. Adhesion was quantified by counting the number of yeast cells adherent to dental material fragments in a Neubauer chamber. Biofilm formation was determined by counting colony-forming units recovered from dental material fragments. The intensity of biofilm adhesion was classified as negative, weak, moderate, strong, or very strong. Fifteen compounds, mainly flavonoids, were identified in green propolis extract. All strains adhered to and formed biofilms on the surfaces of the orthodontic materials studied. On steel and resin, yeast cell adhesion intensities were weak at all incubation times, except for those of Candida parapsilosis and C. tropicalis, which were moderate at 12 h. At 24 and 48 h, C. albicans formed biofilms on steel with moderate adhesion affinities; at 24 and 48 h, C. parapsilosis formed biofilms with very strong affinities. C. tropicalis formed biofilms with strong and very strong affinities at 24 and 48 h, respectively. On resin, all species displayed strong affinity for biofilm formation at 24 and 48 h, except for C. tropicalis, which displayed very strong affinity at only 48 h. Green propolis extract displayed antifungal activity and inhibited both adhesion and biofilm formation at 2.5 mu g/mL. This study reinforces the idea that green propolis has antifungal activity and interferes with the virulence of Candida species.	[Bezerra, Carolina Rabelo Falcao] Fed Univ Maranhao UFMA, Postgrad Program Adult Hlth, Sao Luis, Maranhao, Brazil; [Assuncao Borges, Katia Regina; Alves, Rita de Nazare Silva; Pimentel Rodrigues, Igor Vinicius; Nascimento, Maria do Desterro Soares Brandao; Bezerra, Geusa Felipa de Barros] Fed Univ Maranhao UFMA, Postgrad Program Adult Hlth Basic & Appl Immunol, Sao Luis, Maranhao, Brazil; [Teles, Amanda Mara] Fed Univ Maranhao UFMA, Postgrad Program Biotechnol, Sao Luis, Maranhao, Brazil; [da Silva, Marcos Antonio Custodio Neto] State Univ Campinas UNICAMP, Postgrad Program Internal Med, Campinas, Brazil	Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Federal do Maranhao; Universidade Estadual de Campinas	Bezerra, GFD (corresponding author), Fed Univ Maranhao UFMA, Postgrad Program Adult Hlth Basic & Appl Immunol, Sao Luis, Maranhao, Brazil.	geusabezerra@gmail.com	Teles, Amanda Mara/AAE-4264-2021; Nascimento, Maria do Desterro/S-7024-2019	Custodio Neto da Silva, Marcos Antonio/0000-0003-2748-1564; Nascimento, Maria do Desterro/0000-0003-2783-362X	Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Estado do Maranhao (FAPEMA)	Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Estado do Maranhao (FAPEMA)(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA))	GFBB receveid financial support by Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Estado do Maranhao (FAPEMA). Notice 31/2016 for accquiring equipments and reagents.	Afrouzan Houshang, 2018, Iranian Biomedical Journal, V22, P50, DOI 10.22034/ibj.22.1.50; Alaa Ahmed M, 2019, PLoS One, V14, pe0213653, DOI 10.1371/journal.pone.0213653; [Anonymous], 2017, FUEL CELLS B, V2017, P7, DOI [10.1016/S1464-2859(17)30385-1, DOI 10.1016/S1464-2859(17)30385-1]; [Anonymous], 2016, FUEL CELLS B, V2016, P11; [Anonymous], 2017, PEDIAT RADIOL S2, V47, pS303; Borges KRA, 2018, REV INST MED TROP SP, V60, DOI [10.1590/s1678-9946201860059, 10.1590/S1678-9946201860059]; Bankova V, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-28; Bhargava P, 2018, INT J ONCOL, V52, P925, DOI 10.3892/ijo.2018.4249; CANNON RD, 1995, J DENT RES, V74, P1152, DOI 10.1177/00220345950740050301; CLSI, 2010, METHOD ANTIFUNGAL DI; D'Auria FD, 2003, J CHEMOTHERAPY, V15, P454, DOI 10.1179/joc.2003.15.5.454; de A Matos FJ, 2009, INTRO FITOQUIMICA EX, V3rd; de Moura RS, 2011, FOOD CHEM TOXICOL, V49, P855, DOI 10.1016/j.fct.2010.12.007; De-Carli AD, 2011, REV ODONTOL BRAS CEN, V9, P310; Devequi-Nunes D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207676; Ferreira JM, 2017, J SCI FOOD AGR, V97, P3552, DOI 10.1002/jsfa.8210; Franchin M, 2018, EUR J MED CHEM, V153, P49, DOI 10.1016/j.ejmech.2017.06.050; Galletti J, 2017, FUTURE MICROBIOL, V12, P1311, DOI 10.2217/fmb-2017-0052; Ghazal ARA, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0765-x; Capoci IRG, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/287693; Herrera CL, 2010, CIENC INVESTIG AGRAR, V37, P75; Khurshid Zohaib, 2017, J Dent Res Dent Clin Dent Prospects, V11, P265, DOI 10.15171/joddd.2017.046; Koo H, 2000, CURR MICROBIOL, V41, P192, DOI 10.1007/s0028400101170; Koya-Miyata S, 2009, BIOL PHARM BULL, V32, P2022, DOI 10.1248/bpb.32.2022; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Maruyama H, 2009, BIOL PHARM BULL, V32, P1244, DOI 10.1248/bpb.32.1244; Maureira Natalia, 2017, Int. J. Odontostomat., V11, P295; Miguel MG, 2010, FOOD CHEM TOXICOL, V48, P3418, DOI 10.1016/j.fct.2010.09.014; Morawiec T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/869575; Mystkowska J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030743; Okada H, 2019, CLIN EXP NEPHROL, V23, P1, DOI 10.1007/s10157-018-1648-1; Oliveira-Junior JK, 2018, REV UNINGA REV, V30, P45; Ota C, 2001, MYCOSES, V44, P375, DOI 10.1046/j.1439-0507.2001.00671.x; Packer Janaina F., 2007, Rev. bras. farmacogn., V17, P102, DOI 10.1590/S0102-695X2007000100019; Paulino N, 2006, PLANTA MED, V72, P899, DOI 10.1055/s-2006-947185; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pina GDS, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8971746; Oliveira ACP, 2006, MEM I OSWALDO CRUZ, V101, P493, DOI 10.1590/S0074-02762006000500002; Andrade JKS, 2017, FOOD RES INT, V101, P129, DOI 10.1016/j.foodres.2017.08.066; Sayyadi F, 2020, CASP J INTERN MED, V11, P62, DOI 10.22088/cjim.11.1.62; Sforcin J. M., 2001, Journal of Venomous Animals and Toxins, V7, P139, DOI 10.1590/S0104-79302001000100009; Silici S, 2006, LETT APPL MICROBIOL, V43, P318, DOI 10.1111/j.1472-765X.2006.01949.x; Silva S, 2010, J MED MICROBIOL, V59, P747, DOI 10.1099/jmm.0.017517-0; Silva-Carvalho R, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/206439; Singla RK, 2019, CURR TOP MED CHEM, V19, P2567, DOI 10.2174/1568026619666191025154834; Siqueira ABS, 2015, BRAZ ORAL RES, V29, DOI 10.1590/1807-3107BOR-2015.vol29.0083; Machado BAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145954; Stefanakis, 2015, INT J GEOGRAPHICAL I, V29, P1; Tobaldini-Valerio FK, 2016, FUTURE MICROBIOL, V11, P1035, DOI 10.2217/fmb-2015-0016; Waterhouse A., 2012, AM J ECOL VITIC, P357; Yen GC, 1999, FOOD CHEM, V65, P375, DOI 10.1016/S0308-8146(98)00239-8	51	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0228828	10.1371/journal.pone.0228828	http://dx.doi.org/10.1371/journal.pone.0228828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362254	Green Published, gold			2022-12-27	WOS:000603071600003
J	Kim, D; Lee, JH; Kim, HY; Shin, J; Kim, K; Lee, S; Park, J; Kim, J; Kim, Y				Kim, DaWon; Lee, Jeong Hwa; Kim, Hye Yun; Shin, Jisu; Kim, Kyeonghwan; Lee, Sejin; Park, Jinwoo; Kim, JinIkyon; Kim, YoungSoo			Fluorescent indolizine derivative YI-13 detects amyloid-beta monomers, dimers, and plaques in the brain of 5XFAD Alzheimer transgenic mouse model	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; PROTEIN-PRECURSOR; DISEASE; OLIGOMERS; NEURODEGENERATION; MICE; PET	Alzheimer disease (AD) is a neurodegenerative disorder characterized by the aberrant production and accumulation of amyloid-beta (A beta) peptides in the brain. Accumulated A beta in soluble oligomer and insoluble plaque forms are considered to be a pathological culprit and biomarker of the disorder. Here, we report a fluorescent universal A beta-indicator YI-13, 5-(4-fluorobenzoyl)-7,8-dihydropyrrolo[1,2-b]isoquinolin-9(6H)-one, which detects A beta monomers, dimers, and plaques. We synthesized a library of 26 fluorescence chemicals with the indolizine core and screen them through a series of in vitro tests utilizing A beta as a target and YI-13 was selected as the final imaging candidate. YI-13 was found to stain and visualize insoluble A beta plaques in the brain tissue, of a transgenic mouse model with five familial AD mutations (5XFAD), by a histochemical approach and to label soluble A beta oligomers within brain lysates of the mouse model under a fluorescence plate reader. Among oligomers aggregated from monomers and synthetic dimers from chemically conjugated monomers, YI-13 preferred the dimeric A beta.	Yonsei Univ, Dept Pharm, Coll Pharm, Incheon, South Korea; [Kim, DaWon; Lee, Jeong Hwa; Kim, Hye Yun; Shin, Jisu; Kim, Kyeonghwan; Lee, Sejin; Kim, JinIkyon; Kim, YoungSoo] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea; [Park, Jinwoo] BioActs, Incheon, South Korea	Yonsei University; Yonsei University	Kim, J; Kim, Y (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea.	ikyonkim@yonsei.ac.kr; y.kim@yonsei.ac.kr	Kim, YoungSoo/AAO-1970-2020	Kim, YoungSoo/0000-0001-5029-7082; Kim, Hye Yun/0000-0003-3757-5652	Korea Health Industry Development Institute [HI18C0836]; National Research Foundation of Korea (Basic Science Research Program) [NRF-2018R1A6A1A03023718, NRF-2018M3C7A1021858]; National Research Foundation of Korea [NRF-2020R1A2C2005961]; POSCO TJ Park Foundation (POSCO Science Fellowship)	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); National Research Foundation of Korea (Basic Science Research Program); National Research Foundation of Korea(National Research Foundation of Korea); POSCO TJ Park Foundation (POSCO Science Fellowship)	Korea Health Industry Development Institute (HI18C0836)(URL:https://www.khidi.or.kr) awarded to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Research Foundation of Korea (Basic Science Research Program NRF-2018R1A6A1A03023718, Original Technology Research Program for Brain Science NRF-2018M3C7A1021858)(URL:http://www.nrf.re.kr) awarded to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Research Foundation of Korea (NRF-2020R1A2C2005961)(URL:http://www.nrf.re.kr) awarded to IK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. -POSCO TJ Park Foundation (POSCO Science Fellowship) (URL:https://www.postf.org) awarded to YK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. -The funder, BioActs, provided support in the form of salaries for author J. Park, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aho L, 2010, J ALZHEIMERS DIS, V20, P1015, DOI 10.3233/JAD-2010-091681; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Geerts H, 2020, ALZHEIMERS DEMENT, V16, P862, DOI 10.1002/alz.12082; Gorman AM, 2008, J CELL MOL MED, V12, P2263, DOI 10.1111/j.1582-4934.2008.00402.x; Herzog B, 2018, PHOTOCHEM PHOTOBIOL, V94, P384, DOI 10.1111/php.12861; Hudson SA, 2009, FEBS J, V276, P5960, DOI 10.1111/j.1742-4658.2009.07307.x; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KARSTENS T, 1980, J PHYS CHEM-US, V84, P1871, DOI 10.1021/j100451a030; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim M, 2013, J ORG CHEM, V78, P10395, DOI 10.1021/jo401801j; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lazarov O, 2002, J NEUROSCI, V22, P9785; Lee D, 2019, ACS CHEM NEUROSCI, V10, P2647, DOI 10.1021/acschemneuro.9b00199; Lee JC, 2020, ANGEW CHEM INT EDIT, V59, P11491, DOI 10.1002/anie.202002574; Lee S, 2015, B KOREAN CHEM SOC, V36, P2147, DOI 10.1002/bkcs.10391; Liu X, 2019, SYNLETT, V30, P1026, DOI 10.1055/s-0037-1611476; Moon SH, 2016, BIOORG MED CHEM LETT, V26, P110, DOI 10.1016/j.bmcl.2015.11.021; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Ng S, 2007, J NUCL MED, V48, P547, DOI 10.2967/jnumed.106.037762; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Park S, 2018, EUR J MED CHEM, V144, P435, DOI 10.1016/j.ejmech.2017.12.056; Rahimi Farid, 2009, J Vis Exp, DOI 10.3791/1071; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Sharma V, 2014, MED CHEM RES, V23, P3593, DOI 10.1007/s00044-014-0940-1; Shin NN, 2019, ACS CHEM NEUROSCI, V10, P3031, DOI 10.1021/acschemneuro.9b00093; Storey E, 1999, NEUROPATH APPL NEURO, V25, P81; Vemula V, 2011, INT J PHARM SCI REV, V11, P159; Watt AD, 2013, ACTA NEUROPATHOL, V125, P549, DOI 10.1007/s00401-013-1083-z; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107	37	4	4	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243041	10.1371/journal.pone.0243041	http://dx.doi.org/10.1371/journal.pone.0243041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362250	Green Published, gold			2022-12-27	WOS:000603071600043
J	Lu, YF; Xu, P; Li, QW; Wang, YK; Wu, C				Lu, Yafeng; Xu, Pei; Li, Qinwen; Wang, Yukuan; Wu, Cheng			Planning priority conservation areas for biodiversity under climate change in topographically complex areas: A case study in Sichuan province, China	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; LAND-USE; PHENOLOGY; RANGE	Identifying priority conservation areas plays a significant role in conserving biodiversity under climate change, but uncertainties create challenges for conservation planning. To reduce uncertainties in the conservation planning framework, we developed an adaptation index to assess the effect of topographic complexity on species adaptation to climate change, which was incorporated into the conservation framework as conservation costs. Meanwhile, the species distributions were predicted by the Maxent model, and the priority conservation areas were optimized during different periods in Sichuan province by the Marxan model. Our results showed that the effect of topographic complexity was critical for species adaptation, but the adaptation index decreased with the temperature increase. Based on the conservation targets and costs, the distributions of priority conservation areas were mainly concentrated in mountainous areas around the Sichuan Basin where may be robust to the adaptation to climate change. In the future, the distributions of priority conservation areas had no evident changes, accounting for about 26% and 28% of the study areas. Moreover, most species habitats could be conserved in terms of conservation targets in these priority conservation areas. Therefore, our approach could achieve biodiversity conservation goals and be highly practical. More importantly, quantifying the effect of topography also is critical for options for planning conservation areas in response to climate change.	[Lu, Yafeng; Xu, Pei; Li, Qinwen; Wang, Yukuan] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Lu, Yafeng; Xu, Pei; Li, Qinwen; Wang, Yukuan] Minist Water Resources, Chengdu, Peoples R China; [Wu, Cheng] Power China Kunming Engn Corp Ltd, Kuming, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS	Xu, P (corresponding author), Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Peoples R China.; Xu, P (corresponding author), Minist Water Resources, Chengdu, Peoples R China.	xupei@imde.ac.cn			Youth Program of National Natural Science Foundation of China [41701114]; West Light Foundation of The Chinese Academy of Sciences [Y7R280080]; General Program of Beijing Natural Science Foundation [8182018]	Youth Program of National Natural Science Foundation of China; West Light Foundation of The Chinese Academy of Sciences(Chinese Academy of Sciences); General Program of Beijing Natural Science Foundation	This work was supported by a Youth Program of National Natural Science Foundation of China (http://www.nsfc.gov.cn/) Project Grant (41701114) and by the West Light Foundation of The Chinese Academy of Sciences (http://www.cas.cn) Project Grant (Y7R280080) to Yafeng Lu, Pei Xu, Yukuan Wang. Additionally, the General Program of Beijing Natural Science Foundation (http://kw.beijing.gov.cn/) Project Grant (8182018) provided support in the form of salary for authors [Qinwen Li and Cheng Wu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Alagador D, 2014, J APPL ECOL, V51, P703, DOI 10.1111/1365-2664.12230; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Baker B, 2010, CLIMATIC CHANGE, V98, P113, DOI 10.1007/s10584-009-9622-2; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Bertolino S, 2020, MAMMAL REV, V50, P187, DOI 10.1111/mam.12185; Brown CJ, 2016, GLOBAL CHANGE BIOL, V22, P1548, DOI 10.1111/gcb.13184; Chaudhary A, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10082764; Crossman ND, 2007, BIODIVERS CONSERV, V16, P3781, DOI 10.1007/s10531-007-9180-8; Desmet P, 2004, ECOL SOC, V9; Di Pasquale G, 2020, FORESTS, V11, DOI 10.3390/f11060673; Dobson AP, 1996, CONSERVATION BIODIVE; Geiger R., 2003, CLIMATE NEAR GROUND; Hallfors MH, 2016, ECOL APPL, V26, P1154, DOI 10.1890/15-0926; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho SP, 2020, B AM METEOR SOC, V101, pE1107, DOI 10.1175/BAMS-D-18-0290.1; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Hui Y, 2015, ENVIRON EARTH SCI, V74, P4335, DOI 10.1007/s12665-015-4443-2; Jones KR, 2016, BIOL CONSERV, V194, P121, DOI 10.1016/j.biocon.2015.12.008; Kareiva P, 2017, SCIENCE; Li J, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/706713; Mathevet R, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10114171; Miller KM, 2018, GLOBAL ECOL BIOGEOGR, V27, P57, DOI 10.1111/geb.12671; Moradi S, 2019, ECOL INDIC, V97, P159, DOI 10.1016/j.ecolind.2018.10.003; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Newman TP, 2017, PUBLIC UNDERST SCI, V26, P815, DOI 10.1177/0963662516628477; Nunez TA, 2013, CONSERV BIOL, V27, P407, DOI 10.1111/cobi.12014; Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Qu H, 2018, NAT CONSERV-BULGARIA, P89, DOI 10.3897/natureconservation.25.20063; Raffini F, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12114508; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Sarkar S., 2005, BIODIVERSITY ENV PHI, DOI DOI 10.1017/CBO9780511498558; Sittaro F, 2017, GLOBAL CHANGE BIOL, V23, P3292, DOI 10.1111/gcb.13622; Andrade-Diaz MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221901; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Tang CC, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00440; Tang CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep43822; Trigas P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059425; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Wang JJ, 2018, CONSERV BIOL, V32, P1266, DOI 10.1111/cobi.13147; Wang WJ, 2018, J BIOGEOGR, V45, P2766, DOI 10.1111/jbi.13467; Wang WJ, 2017, LANDSCAPE ECOL, V32, P1399, DOI 10.1007/s10980-016-0429-z; Weiss A., 2001, ESR INT USER C; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Yang J, 2020, BIOL CONSERV, V244, DOI 10.1016/j.biocon.2020.108535; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x; Zhang MG, 2012, BIOL CONSERV, V153, P257, DOI 10.1016/j.biocon.2012.04.023; Zhang WJ, 2008, SCI CHINA SER D, V51, P748, DOI 10.1007/s11430-008-0037-0	55	1	1	9	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243425	10.1371/journal.pone.0243425	http://dx.doi.org/10.1371/journal.pone.0243425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362279	gold, Green Published			2022-12-27	WOS:000603071600004
J	Jalenques, I; Cyrille, D; Derost, P; Hartmann, A; Lauron, S; Jameux, C; Tauveron-Jalenques, U; Guiguet-Auclair, C; Rondepierre, F				Jalenques, Isabelle; Cyrille, Diane; Derost, Philippe; Hartmann, Andreas; Lauron, Sophie; Jameux, Clara; Tauveron-Jalenques, Urbain; Guiguet-Auclair, Candy; Rondepierre, Fabien		Syndrome de Gilles de La Tourette	Cross-cultural adaptation and psychometric evaluation of the French version of the Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL)	PLOS ONE			English	Article							HEALTH-STATUS QUESTIONNAIRES; IMPACT; ADULTS; ADOLESCENTS; POPULATION; PREVALENCE; GUIDELINES; MOVES; TICS	Introduction The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL) is a self-rated disease-specific questionnaire to assess health-related quality of life of subjects with GTS. Our aim was to perform the cross-cultural adaptation of the GTS-QOL into French and to assess its psychometric properties. Methods The GTS-QOL was cross-culturally adapted by conducting forward and backward translations, following international guidelines. The psychometric properties of the GTS-QOL-French were assessed in 109 participants aged 16 years and above with regard to factor structure, internal consistency, reliability and convergent validity with the MOVES (Motor tic, Obsessions and compulsions, Vocal tic Evaluation Survey) and the WHOQOL-BREF (World Health Organization Quality of Life Brief). Results Exploratory factor analysis of the GTS-QOL-French resulted in a 6-factor solution and did not replicate the original structure in four subscales. The results showed good acceptability (missing values per subscale ranging from 0% to 0.9%), good internal consistency (Cronbach's alpha ranging from 0.68 to 0.94) and good test-retest reliability (intraclass correlation coefficients ranging from 0.70 to 0.81). Convergent validity with the MOVES and WHOQOL-BREF scales showed high correlations. Discussion Our study provides evidence of the good psychometric properties of the GTS-QOL-French. The cross-cultural adaptation and validation of this specific instrument will make it possible to assess health-related quality of life in French-speaking subjects with GTS. The GTS-QOL-French could be recommended for use in future research.	[Jalenques, Isabelle; Cyrille, Diane; Lauron, Sophie; Jameux, Clara; Tauveron-Jalenques, Urbain; Rondepierre, Fabien] Univ Clermont Auvergne, CHU Clermont Ferrand, Ctr Competence Gilles Tourette, Serv Psychiat Adulte & Psychol Med A, Clermont Ferrand, France; [Derost, Philippe] CHU Clermont Ferrand, Serv Neurol, Clermont Ferrand, France; [Hartmann, Andreas] Hop La Pitie Salpetriere, AP HP, Natl Reference Ctr Tourette Syndrome, Paris, France; [Guiguet-Auclair, Candy] Univ Clermont Auvergne, CHU Clermont Ferrand, CNRS, Inst Pascal,SIGMA Clermont, Clermont Ferrand, France	CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA)	Jalenques, I (corresponding author), Univ Clermont Auvergne, CHU Clermont Ferrand, Ctr Competence Gilles Tourette, Serv Psychiat Adulte & Psychol Med A, Clermont Ferrand, France.	ijalenques@chu-clermontferrand.fr		Rondepierre, Fabien/0000-0002-8998-1559; Guiguet-Auclair, Candy/0000-0002-0782-2889	University Hospital of Clermont-Ferrand (AOI); Association Francaise Syndrome Gilles de la Tourette (AO AFSGT)	University Hospital of Clermont-Ferrand (AOI); Association Francaise Syndrome Gilles de la Tourette (AO AFSGT)	IJ received a grant from the University Hospital of Clermont-Ferrand (AOI 2012) and the Association Francaise Syndrome Gilles de la Tourette (AO AFSGT 2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2005, NEPHROL CARLT, V10, pS157; [Anonymous], COSMIN IMPR SEL OUTC; [Anonymous], 2011, PRESCRIRE INT, V20, P173; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Blazquez A, 2019, COMPR PSYCHIAT, V89, P33, DOI 10.1016/j.comppsych.2018.11.011; Bullinger M, 1998, J CLIN EPIDEMIOL, V51, P913, DOI 10.1016/S0895-4356(98)00082-1; Cath DC, 2011, EUR CHILD ADOLES PSY, V20, P155, DOI 10.1007/s00787-011-0164-6; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cavanna AE, 2008, NEUROLOGY, V71, P1410, DOI 10.1212/01.wnl.0000327890.02893.61; Cavanna AE, 2018, REV NEUROL-FRANCE, V174, P621, DOI 10.1016/j.neurol.2018.06.006; Cavanna AE, 2012, EUR J PAEDIATR NEURO, V16, P605, DOI 10.1016/j.ejpn.2012.02.004; Cavanna AE, 2009, J NEUROPSYCH CLIN N, V21, P13, DOI 10.1176/appi.neuropsych.21.1.13; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Conelea CA, 2013, COMMUNITY MENT HLT J, V49, P110, DOI 10.1007/s10597-011-9465-y; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crossley E, 2013, PSYCHIAT RES, V209, P705, DOI 10.1016/j.psychres.2013.04.019; Eapen V, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00097; Eddy CM, 2014, BEHAV MODIF, V38, P264, DOI 10.1177/0145445513504432; Eddy CM, 2013, J PSYCHIATR RES, V47, P1259, DOI 10.1016/j.jpsychires.2013.05.019; Elstner K, 2001, ACTA PSYCHIAT SCAND, V103, P52, DOI 10.1034/j.1600-0447.2001.00147.x; Evans J, 2016, EUR CHILD ADOLES PSY, V25, P939, DOI 10.1007/s00787-016-0823-8; Freeman RD, 2009, DEV MED CHILD NEUROL, V51, P218, DOI 10.1111/j.1469-8749.2008.03135.x; GAFFNEY GR, 1994, J CHILD ADOL PSYCHOP, V4, P269, DOI 10.1089/cap.1994.4.269; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P953, DOI 10.1016/S0895-4356(98)00086-9; Guyatt GH, 1997, CANADIAN RESP J HIND, V4, pe271269; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Hinkle DEJS, 2002, APPL STAT BEHAV SCI; Huisman-van Dijk HM, 2019, ACTA NEUROL SCAND, V140, P390, DOI 10.1111/ane.13155; Jalenques I, 2020, MENDELEY DATA V3; Jalenques I, 2018, J NEUROL, V265, P678, DOI 10.1007/s00415-018-8769-z; Jalenques I, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-109; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; Kobierska M, 2014, NEUROL NEUROCHIR POL, V48, P1, DOI 10.1016/j.pjnns.2013.03.001; Leplege A, 2000, ENCEPHALE, V26, P13; Martino D, 2017, MOVEMENT DISORD, V32, P467, DOI 10.1002/mds.26891; McHorney CA, 1998, MED CARE, V36, P445, DOI 10.1097/00005650-199804000-00001; Muller-Vahl K, 2010, MOVEMENT DISORD, V25, P309, DOI 10.1002/mds.22900; Nunnally J.C., 1978, PSYCHOMETRIC THEORY, DOI DOI 10.1037/018882; Pringsheim T, 2019, NEUROLOGY, V92, P896, DOI 10.1212/WNL.0000000000007466; Puett M, 2013, CRIT RES RELIG, V1, P95, DOI 10.1177/2050303213476115; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Robertson MM, 2008, J PSYCHOSOM RES, V65, P461, DOI 10.1016/j.jpsychores.2008.03.006; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Su MT, 2017, J CHILD NEUROL, V32, P76, DOI 10.1177/0883073816670083; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Trillini MO, 2015, PSYCHIAT RES, V228, P765, DOI 10.1016/j.psychres.2015.04.043; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P945, DOI 10.1016/S0895-4356(98)00085-7; Ware JE, 1980, MODEL HLTH METHODOLO, VI; Worbe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012959; Yang J, 2016, MOVEMENT DISORD, V31, P1658, DOI 10.1002/mds.26766	52	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243912	10.1371/journal.pone.0243912	http://dx.doi.org/10.1371/journal.pone.0243912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351837	Green Published, gold			2022-12-27	WOS:000603071400021
J	Wei, YL; Silke, JR; Aris, P; Xia, XH				Wei, Yulong; Silke, Jordan R.; Aris, Parisa; Xia, Xuhua			Coronavirus genomes carry the signatures of their habitats	PLOS ONE			English	Article							INHIBITS HIV-1 INFECTION; APOBEC3 PROTEINS; ANTIRETROVIRAL FACTOR; DEAMINATION HOTSPOTS; CYTOSINE DEAMINATION; CYTIDINE DEAMINASES; RESTRICTION FACTOR; VIRUS-REPLICATION; SEQUENCE CONTEXT; FAMILY-MEMBERS	Coronaviruses such as SARS-CoV-2 regularly infect host tissues that express antiviral proteins (AVPs) in abundance. Understanding how they evolve to adapt or evade host immune responses is important in the effort to control the spread of infection. Two AVPs that may shape viral genomes are the zinc finger antiviral protein (ZAP) and the apolipoprotein B mRNA editing enzyme-catalytic polypeptide-like 3 (APOBEC3). The former binds to CpG dinucleotides to facilitate the degradation of viral transcripts while the latter frequently deaminates C into U residues which could generate notable viral sequence variations. We tested the hypothesis that both APOBEC3 and ZAP impose selective pressures that shape the genome of an infecting coronavirus. Our investigation considered a comprehensive number of publicly available genomes for seven coronaviruses (SARS-CoV-2, SARS-CoV, and MERS infecting Homo sapiens, Bovine CoV infecting Bos taurus, MHV infecting Mus musculus, HEV infecting Sus scrofa, and CRCoV infecting Canis lupus familiaris). We show that coronaviruses that regularly infect tissues with abundant AVPs have CpG-deficient and U-rich genomes; whereas those that do not infect tissues with abundant AVPs do not share these sequence hallmarks. Among the coronaviruses surveyed herein, CpG is most deficient in SARS-CoV-2 and a temporal analysis showed a marked increase in C to U mutations over four months of SARS-CoV-2 genome evolution. Furthermore, the preferred motifs in which these C to U mutations occur are the same as those subjected to APOBEC3 editing in HIV-1. These results suggest that both ZAP and APOBEC3 shape the SARS-CoV-2 genome: ZAP imposes a strong CpG avoidance, and APOBEC3 constantly edits C to U. Evolutionary pressures exerted by host immune systems onto viral genomes may motivate novel strategies for SARS-CoV-2 vaccine development.	[Wei, Yulong; Silke, Jordan R.; Aris, Parisa; Xia, Xuhua] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Xia, Xuhua] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Xia, XH (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.; Xia, XH (corresponding author), Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada.	Xuhua.Xia@uottawa.ca	Xia, Xuhua/E-5264-2010	Xia, Xuhua/0000-0002-3092-7566; Wei, Yulong/0000-0003-1218-2086; Aris, Parisa/0000-0003-2774-7035; Silke, Jordan/0000-0002-1578-1933	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/2018-03878]; NSERC Doctoral Scholarship [CGSD/2019-535291]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Doctoral Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC, https://www.nserc-crsng.gc.ca/) Discovery Grant to X.X. [RGPIN/2018-03878], and NSERC Doctoral Scholarship to Y.W. [CGSD/2019-535291]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph MB, 2018, ACS INFECT DIS, V4, P224, DOI 10.1021/acsinfecdis.7b00221; Adolph MB, 2017, NUCLEIC ACIDS RES, V45, P3378, DOI 10.1093/nar/gkx066; Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; [Anonymous], 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1494; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Antzin-Anduetza I, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0374-1; Armitage AE, 2008, J VIROL, V82, P8743, DOI 10.1128/JVI.00584-08; Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519; Briggs J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017107; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chen J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005471; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Desimmie BA, 2016, NUCLEIC ACIDS RES, V44, P7848, DOI 10.1093/nar/gkw653; Di Gioacchino Andrea, 2020, bioRxiv, DOI 10.1101/2020.05.06.074039; Di Giorgio S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5813; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Duff MO, 2015, NATURE, V521, P376, DOI 10.1038/nature14475; Ebrahimi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087679; Eckerle LD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000896; Eisenberg E, 2018, NAT REV GENET, V19, P473, DOI 10.1038/s41576-018-0006-1; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Ficarelli M, 2020, J VIROL, V94, DOI 10.1128/JVI.01337-19; Fros JJ, 2017, ELIFE, V6, DOI 10.7554/eLife.29112; Gillick K, 2013, J VIROL, V87, P1508, DOI 10.1128/JVI.02587-12; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hayward JA, 2018, MOL BIOL EVOL, V35, P1626, DOI 10.1093/molbev/msy048; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Holtz CM, 2013, NUCLEIC ACIDS RES, V41, P6139, DOI 10.1093/nar/gkt246; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jiang W, 2020, 2020040335 PREPR; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Kohli RM, 2009, J BIOL CHEM, V284, P22898, DOI 10.1074/jbc.M109.025536; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1016/j.gastro.2003.08.001, 10.1053/S0016-5085(03)01215-0]; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Liu P, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008421; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Luo X, 2020, CELL REP, V30, P46, DOI 10.1016/j.celrep.2019.11.116; Martinez T, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vey040; McDaniel YZ, 2020, NUCLEIC ACIDS RES, V48, P1353, DOI 10.1093/nar/gkz1164; Meagher JL, 2019, P NATL ACAD SCI USA, V116, P24303, DOI 10.1073/pnas.1913232116; Milewska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24448-2; Mitra M, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0130-8; Nabel CS, 2013, P NATL ACAD SCI USA, V110, P14225, DOI 10.1073/pnas.1306345110; Nchioua R, 2020, MBIO, V11, DOI 10.1128/mBio.01930-20; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; O'Connell MA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005687; Odon V, 2019, NUCLEIC ACIDS RES, V47, P8061, DOI 10.1093/nar/gkz581; Okeoma CM, 2010, CELL HOST MICROBE, V8, P534, DOI 10.1016/j.chom.2010.11.003; Ooms M, 2013, CELL HOST MICROBE, V14, P411, DOI 10.1016/j.chom.2013.09.006; Palasca O, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay003; Pauli EK, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-38; Pimentel H, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1357-2; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rodriguez-Frias F, 2013, WORLD J GASTROENTERO, V19, P6995, DOI 10.3748/wjg.v19.i41.6995; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Saraconi G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0417-z; Shamimuzzaman M, 2020, NUCLEIC ACIDS RES, V48, pD676, DOI 10.1093/nar/gkz944; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Sharma S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1651-1; Sharma S, 2017, PEERJ, V5, DOI 10.7717/peerj.4136; Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39100; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Silvas TV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25881-z; Simmonds P., 2020, RAMPANT C U HYPERMUT, DOI [10.1101/2020.05.01.072330, DOI 10.1101/2020.05.01.072330]; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Suspene R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063461; Suspene R, 2011, J VIROL, V85, P2458, DOI 10.1128/JVI.02138-10; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Theys K, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007420; Trus I, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03077; Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Victorovich KV, 2020, TRANSLATION ASS MUTA, DOI [10.1101/2020.05.05.078238, DOI 10.1101/2020.05.05.078238]; Wan L, 2018, PHYS CHEM CHEM PHYS, V20, P3109, DOI 10.1039/c7cp04477a; Wang SM, 2009, VIROLOGY, V388, P112, DOI 10.1016/j.virol.2009.03.010; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Wasson MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08716-1; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xia XH, 2020, MOL BIOL EVOL, V37, P2699, DOI 10.1093/molbev/msaa094; Xia XH, 2018, MOL BIOL EVOL, V35, P1550, DOI 10.1093/molbev/msy073; Yao XH, 2020, CELL RES, V30, P541, DOI 10.1038/s41422-020-0318-5; Yap YL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-43; Yi L, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1419-z; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhao ZM, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-21; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	112	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244025	10.1371/journal.pone.0244025	http://dx.doi.org/10.1371/journal.pone.0244025			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351847	gold, Green Published, Green Submitted			2022-12-27	WOS:000603071400053
J	Theart, RP; Kriel, J; du Toit, A; Loos, B; Niesler, TR				Theart, Rensu P.; Kriel, Jurgen; du Toit, Andre; Loos, Ben; Niesler, Thomas R.			Mitochondrial event localiser (MEL) to quantitativelydescribe fission, fusion and depolarisation in the three-dimensional space	PLOS ONE			English	Article							QUALITY-CONTROL; MORPHOLOGY; CELLS; AUTOPHAGY; PARKIN; FRAGMENTATION; ACTIVATION; MITOPHAGY; DYNAMICS	Mitochondrial fission and fusion play an important role not only in maintaining mitochondrial homeostasis but also in preserving overall cellular viability. However, quantitative analysis based on the three-dimensional localisation of these highly dynamic mitochondrial events in the cellular context has not yet been accomplished. Moreover, it remains largely uncertain where in the mitochondrial network depolarisation is most likely to occur. We present the mitochondrial event localiser (MEL), a method that allows high-throughput, automated and deterministic localisation and quantification of mitochondrial fission, fusion and depolarisation events in large three-dimensional microscopy time-lapse sequences. In addition, MEL calculates the number of mitochondrial structures as well as their combined and average volume for each image frame in the time-lapse sequence. The mitochondrial event locations can subsequently be visualised by superposition over the fluorescence micrograph z-stack. We apply MEL to both control samples as well as to cells before and after treatment with hydrogen peroxide (H2O2). An average of 9.3/7.2/2.3 fusion/fission/depolarisation events per cell were observed respectively for every 10 sec in the control cells. With peroxide treatment, the rate initially shifted toward fusion with and average of 15/6/3 events per cell, before returning to a new equilibrium not far from that of the control cells, with an average of 6.2/6.4/3.4 events per cell. These MEL results indicate that both pre-treatment and control cells maintain a fission/fusion equilibrium, and that depolarisation is higher in the post-treatment cells. When individually validating mitochondrial events detected with MEL, for a representative cell for the control and treated samples, the true-positive events were 47%/49%/14% respectively for fusion/fission/depolarisation events. We conclude that MEL is a viable method of quantitative mitochondrial event analysis.	[Theart, Rensu P.; Niesler, Thomas R.] Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa; [Kriel, Jurgen; du Toit, Andre; Loos, Ben] Stellenbosch Univ, Dept Physiol Sci, Stellenbosch, Western Cape, South Africa	Stellenbosch University; Stellenbosch University	Theart, RP (corresponding author), Stellenbosch Univ, Dept Elect & Elect Engn, Stellenbosch, Western Cape, South Africa.	rptheart@sun.ac.za		Kriel, Jurgen/0000-0001-7558-7916; du Toit, Andre/0000-0002-3936-6013; Theart, Rensu/0000-0003-0508-1690	South African Medical Research Council (SAMRC); Cancer Association of South Africa (CANSA); Telkom South Africa; South African National Research Foundation (NRF); Nvidia corporation	South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Association of South Africa (CANSA); Telkom South Africa; South African National Research Foundation (NRF)(National Research Foundation - South Africa); Nvidia corporation	The authors received no specific funding for this work. This work was supported by the South African Medical Research Council (SAMRC), the Cancer Association of South Africa (CANSA), and Telkom South Africa and the South African National Research Foundation (NRF). Nvidia corporation, as a commercial funder, sponsored the GPU that was used in this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Benard G, 2010, BBA-BIOENERGETICS, V1797, P698, DOI 10.1016/j.bbabio.2010.02.030; Berman SB, 2008, CELL DEATH DIFFER, V15, P1147, DOI 10.1038/cdd.2008.57; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Dalmasso G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168198; Diot A, 2015, PHARMACOL RES, V100, P24, DOI 10.1016/j.phrs.2015.07.014; Fan XY, 2010, FREE RADICAL BIO MED, V49, P1646, DOI 10.1016/j.freeradbiomed.2010.08.024; Figge MT, 2013, BIOESSAYS, V35, P314, DOI 10.1002/bies.201200125; Figge MT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002576; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Gilkerson RW, 2012, HUM MOL GENET, V21, P978, DOI 10.1093/hmg/ddr529; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Kriel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28590-9; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Leonard AP, 2015, BBA-MOL CELL RES, V1853, P348, DOI 10.1016/j.bbamcr.2014.11.002; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; McCarron JG, 2013, J VASC RES, V50, P357, DOI 10.1159/000353883; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ntsapi C, 2016, AUTOPHAGY IN CURRENT TRENDS IN CELLULAR PHYSIOLOGY AND PATHOLOGY, P157, DOI 10.5772/64197; Otani K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30689; Patel PK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003108; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reis Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028694; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Theart RP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225141; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Twig G, 2010, AM J PHYSIOL-CELL PH, V299, pC477, DOI 10.1152/ajpcell.00427.2009; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Valente AJ, 2017, ACTA HISTOCHEM, V119, P315, DOI 10.1016/j.acthis.2017.03.001; Vidoni S, 2013, ANTIOXID REDOX SIGN, V19, P379, DOI 10.1089/ars.2012.4800; Wang SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0019879; Westrate LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095265; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0229634	10.1371/journal.pone.0229634	http://dx.doi.org/10.1371/journal.pone.0229634			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378337	Green Published, gold, Green Submitted			2022-12-27	WOS:000605651300015
J	Croucher, K; Buster, L; Dayes, J; Green, L; Raynsford, J; Boyes, LC; Faull, C				Croucher, Karina; Buster, Lindsey; Dayes, Jennifer; Green, Laura; Raynsford, Justine; Comerford Boyes, Louise; Faull, Christina			Archaeology and contemporary death: Using the past to provoke, challenge and engage	PLOS ONE			English	Article							TERMINALLY-ILL PATIENTS; CARE; ATTITUDES; PEOPLE; HEALTH; PLACE; FRAIL	While death is universal, reactions to death and ways of dealing with the dead body are hugely diverse, and archaeological research reveals numerous ways of dealing with the dead through time and across the world. In this paper, findings are presented which not only demonstrate the power of archaeology to promote and aid discussion around this difficult and challenging topic, but also how our approach resulted in personal growth and professional development impacts for participants. In this interdisciplinary pilot study, archaeological case studies were used in 31 structured workshops with 187 participants from health and social care backgrounds in the UK, to explore their reactions to a diverse range of materials which documented wide and varied approaches to death and the dead. Our study supports the hypothesis that the past is a powerful instigator of conversation around challenging aspects of death, and after death care and practices: 93% of participants agreed with this. That exposure to archaeological case studies and artefacts stimulates multifaceted discourse, some of it difficult, is a theme that also emerges in our data from pre, post and follow-up questionnaires, and semi-structured interviews. The material prompted participants to reflect on their biases, expectations and norms around both treatment of the dead, and of bereavement, impacting on their values, attitudes and beliefs. Moreover, 87% of participants believed the workshop would have a personal effect through thinking differently about death and bereavement, and 57% thought it would impact on how they approached death and bereavement in their professional practice. This has huge implications today, where talk of death remains troublesome, and for some, has a near-taboo status-'taboo' being a theme evident in some participants' own words. The findings have an important role to play in facilitating and normalising discussions around dying and bereavement and in equipping professionals in their work with people with advanced illness.	[Croucher, Karina; Buster, Lindsey] Univ Bradford, Sch Archaeol & Forens Sci, Fac Life Sci, Bradford, W Yorkshire, England; [Buster, Lindsey] Univ York, Dept Archaeol, York, N Yorkshire, England; [Dayes, Jennifer] Manchester Metropolitan Univ, Dept Psychol, Fac Hlth Psychol & Social Care, Manchester, Lancs, England; [Green, Laura] Univ Manchester, Fac Biol Med & Hlth, Nursing Midwifery & Social Work, Manchester, Lancs, England; [Raynsford, Justine] Univ Bradford, Fac Hlth Studies, Bradford, W Yorkshire, England; [Comerford Boyes, Louise] Univ Bradford, Div Psychol, Sch Social Sci, Fac Management Law & Social Sci, Bradford, W Yorkshire, England; [Faull, Christina] LOROS Hosp, Leicester, Leics, England	University of Bradford; University of York - UK; Manchester Metropolitan University; University of Manchester; University of Bradford; University of Bradford	Croucher, K (corresponding author), Univ Bradford, Sch Archaeol & Forens Sci, Fac Life Sci, Bradford, W Yorkshire, England.	k.croucher@bradford.ac.uk	Croucher, Karina/U-9851-2018	Croucher, Karina/0000-0002-3040-9304	Arts and Humanities Research Council [AH/M008266/1]; AHRC [AH/M008266/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	The project `Continuing Bonds: Exploring the meaning and legacy of death through past and contemporary practice' was funded by the Arts and Humanities Research Council, Grant Number AH/M008266/1. The Principal Investigator was Karina Croucher, and Co-Investigators were Christina Faull and Laura Green. https://ahrc.ukri.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan HT, 2010, NURS EDUC TODAY, V30, P476, DOI 10.1016/j.nedt.2009.10.011; Bardsley M, 2019, BMJ SUPPORT PALLIAT, V9, P167, DOI 10.1136/bmjspcare-2015-000936; Bauman Zygmunt, 2006, LIQUID MODERNITY; Bloomer MJ, 2011, J NURS HEALTHC CHRON, V3, P165; Boniol M, 2019, WHO GENDER EQUITY HL; Booth J, 2021, VOLUNT SECT REV, V12, P333, DOI 10.1332/204080520X16014085811284; Braun RP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-54; British Psychological Society, 2014, BPS COD HUM RES ETH, V2nd; Brooks L., 2020, GUARDIAN; Buster L., 2018, AP ONLINE J PUBLIC A, P249, DOI 10.23914/ap.v8i2.147; Chatterjee H, 2013, MUSEUMS, HEALTH AND WELL-BEING, P1; Co-op Funeral Care, 2018, MAK PEAC DEATH NAT A; Cox K, 2013, BMJ SUPPORT PALLIAT, V3, P37, DOI 10.1136/bmjspcare-2012-000203; Crossick G., 2016, ARTS HUMANIT RES COU; Croucher K., 2019, LIVING DEAD CREATIVE; Cuypers K, 2012, J EPIDEMIOL COMMUN H, V66, P698, DOI 10.1136/jech.2010.113571; Department of Health, 2008, END LIF CAR STRAT PR; Desmarais S., 2018, MUSEUMS SPACES WELLB; Directorates SSGH, 2019, LIV DYING WELL NAT A; Ela S, 2014, J PALLIAT MED, V17, P385, DOI 10.1089/jpm.2013.0203; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Evans A., 2020, ZENODO, DOI [10.5281/zenodo.3950360, DOI 10.5281/ZENODO.3950360]; Everill P, 2020, ANTIQUITY, V94, P212, DOI 10.15184/aqy.2019.85; Garrow D., 2020, GRAVE GOODS OBJECTS; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Green L., 2020, EXCITING NOT ALL GET; Henoch I., 2016, PALLIATIVE MED, DOI [10.1177/0269216316646056, DOI 10.1177/0269216316646056]; Hoare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142723; Holdsworth L, 2010, INT J PALLIAT NURS, V16, P424, DOI 10.12968/ijpn.2010.16.9.78634; Holloway M., 2019, REMEMBER ME CHANGING; HOLTER IM, 1993, J ADV NURS, V18, P298, DOI 10.1046/j.1365-2648.1993.18020298.x; Hospice UK, 2013, DYING MATTERS RAISIN; Ipsos MORI, 2019, DEP LOUNG PUBL ATT D; Macmillan, 2017, NO REGRETS TALKING D; Mannix K., 2019, END MIND DYING DEATH; Mazzanti M, 2002, J SOCIO-ECON, V31, P529, DOI DOI 10.1016/S1053-5357(02)00133-6; McCleery I, 2017, IMAGO TEMPORIS, V11, P385, DOI 10.21001/itma.2017.11.15; Munday D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2391; Nairn S, 2012, NURS PHILOS, V13, P189, DOI 10.1111/j.1466-769X.2011.00530.x; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; NCPC, 2003, PRIOR REF END LIF CA; Neimeyer RA, 2006, DEATH STUD, V30, P715, DOI 10.1080/07481180600848322; Neuberger J., 2013, MORE CARE LESS PATHW; Nickman S., 2014, CONTINUING BONDS NEW; Onwuegbuzie A. J., 2009, QUALITATIVE FRAMEWOR, P1; Peters L, 2013, Open Nurs J, V7, P14, DOI 10.2174/1874434601307010014; Public Health England, 2018, REV REC TRENDS MORT; Reilly S., 2018, WELLBEING HIST ENV; Rodenbach RA, 2016, PATIENT EDUC COUNS, V99, P356, DOI 10.1016/j.pec.2015.10.010; Royal College of Physicians, 2018, OUR FUTUR HLTH, P18; Sallnow L., 2012, ROUTLEDGE STUDIES PU; Sayer D, 2010, WORLD ARCHAEOL, V42, P481, DOI 10.1080/00438243.2010.498665; Schon D. A., 1983, DESIGN, DOI [10.1542/peds.2005-0209, DOI 10.1542/PEDS.2005-0209]; Sharp T, 2018, BRIT J GEN PRACT, V68, pE44, DOI 10.3399/bjgp17X694145; Sharp T, 2013, BRIT J GEN PRACT, V63, pE657, DOI 10.3399/bjgp13X673667; Shaw J, 2017, WORLD ARCHAEOL, V48, P449, DOI 10.1080/00438243.2016.1326754; Skorstengaard MH, 2017, J PALLIAT MED, V20, P1217, DOI 10.1089/jpm.2017.0082; Stephen A., 2006, BEREAVEMENT BEREAVEM; Swain H., 2016, ARCHAEOLOGISTS DEAD, DOI [10.1093/oso/9780198753537.001.0001/isbn-9780198753537-book-part-16, DOI 10.1093/OSO/9780198753537.001.0001/ISBN-9780198753537-BOOK-PART-16]; Swift J., 2011, PSYCHOTHERAPY RELATI, P152; Tarlow S., 2013, OXFORD HDB ARCHAEOLO, P617; Thiemann P., 2014, BMJ SUPPORT PALLIAT, V4, pA31, DOI [10.1136/bmjspcare-2014-000654.87, DOI 10.1136/BMJSPCARE-2014-000654.87]; Underwood J, 2016, DEATH CAFE; Walter T, 2017, WHAT DEATH MEANS NOW: THINKING CRITICALLY ABOUT DYING AND GRIEVING, P1, DOI 10.2307/j.ctt22p7kcp; WALTER T, 1991, SOCIOLOGY, V25, P293, DOI 10.1177/0038038591025002009; Walter T., 1996, MORTALITY, V1, P7, DOI [10.1080/713685822, DOI 10.1080/713685822]; Zibaite S, 2020, ROLE ONLINE DEATH CA	67	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244058	10.1371/journal.pone.0244058	http://dx.doi.org/10.1371/journal.pone.0244058			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373412	Green Accepted, Green Published, gold			2022-12-27	WOS:000603612300051
J	Hwang, IC; Kim, KK; Lee, KR				Hwang, In Cheol; Kim, Kyoung Kon; Lee, Kyu Rae			Cryolipolysis-induced abdominal fat change: Split-body trials	PLOS ONE			English	Article							SUBCUTANEOUS FAT; ADIPOSE-TISSUE; RISK-FACTORS; LIPOSUCTION; DEPOTS	Cryolipolysis has been considered as a noninvasive alternative to surgical procedures for reducing subcutaneous fat without affecting the surrounding tissues. However, no clinical trial has investigated changes in the abdominal fat tissue by 12 weeks after cryolipolysis. Therefore, in this split-body trial, we explored whether a single session of unilateral cryolipolysis could change visceral and subcutaneous adipose tissue over a period of 12 weeks. We compared the cross-sectional areas of the abdominal adipose tissue of 15 subjects (9 women; 38.3 [10.8] years) by computed tomography before and at 12 weeks after a single treatment of cryolipolysis to the left abdomen and used the right abdomen as untreated control. In addition, we measured participants' waist circumference, percentage of body fat (by bioelectrical impedance analysis) at baseline and at 6- and 12-weeks post-treatment. Single unilateral cryolipolysis tended to reduce the cross-sectional areas of visceral adipose tissue, by 8.4 cm(2) (9.9%), the waist circumferences, and the percent body fat, by 2.8 cm(2) (0.6%), overall. The cross-sectional area of visceral adipose tissues on the treated side significantly decreased, by 6.8 cm(2) (15.6%; P = 0.003), and that of the untreated side tended to decrease by 1.2 cm(2) (3.6%). Thus, a single unilateral session of noninvasive selective cryolipolysis can be considered as a safe and effective treatment for reduction of visceral adipose tissue over a period of 12 weeks, which should result in metabolic improvement.	[Hwang, In Cheol; Kim, Kyoung Kon; Lee, Kyu Rae] Gachon Univ, Family Med, Incheon, South Korea	Gachon University	Lee, KR (corresponding author), Gachon Univ, Family Med, Incheon, South Korea.	baria07@daum.net	Kim, Kyoung-Kon/GXV-1730-2022	Kim, Kyoung-Kon/0000-0003-0374-2571; lee, kyu rae/0000-0003-2178-0459	Gachon University [GCU-2018-5258]	Gachon University	This study was fully supported by a grant from the Gachon University research fund of 2018. (GCU-2018-5258). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TM, 2015, CIRCULATION, V132, P1639, DOI 10.1161/CIRCULATIONAHA.114.015000; Avram MM, 2009, LASER SURG MED, V41, P703, DOI 10.1002/lsm.20864; BEACHAM BE, 1980, ARCH DERMATOL, V116, P1025, DOI 10.1001/archderm.116.9.1025; Bellini E, 2017, ANN MED SURG, V24, P53, DOI 10.1016/j.amsu.2017.10.024; BELLISARI A, 1993, INT J OBESITY, V17, P475; Berry MG, 2011, J PLAST RECONSTR AES, V64, P985, DOI 10.1016/j.bjps.2010.11.018; Chang JC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45354-1; Coleman SR, 2009, AESTHET PLAST SURG, V33, P482, DOI 10.1007/s00266-008-9286-8; Efremova A, 2020, J PHYSIOL BIOCHEM, V76, P185, DOI 10.1007/s13105-019-00721-4; EPSTEIN EH, 1970, NEW ENGL J MED, V282, P966, DOI 10.1056/NEJM197004232821709; Faull F, 2013, G POWER VERSION 3 1; Garibyan L, 2020, PLAST RECONSTR SURG, V145, p725E, DOI 10.1097/PRS.0000000000006658; Hu F., 2008, OBESITY EPIDEMIOLOGY, P53, DOI DOI 10.1093/ACPROF:OSO/9780195312911; Jalian HR, 2014, JAMA DERMATOL, V150, P317, DOI 10.1001/jamadermatol.2013.8071; Juhasz M, 2020, DERMATOL SURG, V46, P1461, DOI 10.1097/DSS.0000000000002135; Kaess BM, 2012, DIABETOLOGIA, V55, P2622, DOI 10.1007/s00125-012-2639-5; Karow Jr AM, 1960, CRYOBIOLOGY, V2, P99; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Lee D, 2018, J BIOSCIENCES MED, V6, P44, DOI [10.1080/14764172.2018.1525742, DOI 10.1080/14764172.2018.1525742]; Manstein D, 2008, LASER SURG MED, V40, P595, DOI 10.1002/lsm.20719; MATSUZAWA Y, 1995, OBES RES, V3, pS187, DOI 10.1002/j.1550-8528.1995.tb00462.x; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; Mohammed BS, 2008, OBESITY, V16, P2648, DOI 10.1038/oby.2008.418; Oh CH, 2020, ARCH PLAST SURG-APS, V47, P62, DOI 10.5999/aps.2019.01305; Rosenquist KJ, 2013, JACC-CARDIOVASC IMAG, V6, P762, DOI 10.1016/j.jcmg.2012.11.021; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Stewart KJ, 2006, J PLAST RECONSTR AES, V59, P1152, DOI 10.1016/j.bjps.2005.12.060; Weiner J, 2017, MOL METAB, V6, P482, DOI 10.1016/j.molmet.2017.03.004; Zelickson B, 2009, DERMATOL SURG, V35, P1462, DOI 10.1111/j.1524-4725.2009.01259.x	29	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0242782	10.1371/journal.pone.0242782	http://dx.doi.org/10.1371/journal.pone.0242782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373395	Green Published, gold			2022-12-27	WOS:000603612300014
J	Kaufmann, S; Glass, A; Kropp, P; Muller-Hilke, B				Kaufmann, Sabrina; Glass, Anne; Kropp, Peter; Mueller-Hilke, Brigitte			Semantic fluency including task switching predicts academic success in medical school	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; EXECUTIVE FUNCTIONS; SELECTION; ACHIEVEMENT; EDUCATION; STUDENTS; TESTS	Objectives The future state treaty on the admission of students to German medical schools calls for a variety of selection criteria among which at least two are required to be independent of school leaving grades. Against this background, the present study investigated achievement motivation and executive functions as predictors of academic success in medical school. Material and methods Second year medical students were assessed for executive functioning by using the Tower of London Test (ToL), a German version of the Controlled Oral Word Association Test (COWAT), the Trail Making Test (TMT-A) and for motivation by using the Achievement Motivation Inventory (AMI). Academic success was evaluated twofold, i) whether the first state exam (M1) was passed at the earliest possible, after completion of the second year and ii) via the grades obtained. Results 81 out of 226 students enrolled participated in our study. Passing the M1 was best explained by semantic fluency including task switching. Moreover, academically successful students achieved significantly higher levels in the AMI-facets "compensatory effort" and "engagement". All students scored above average in the TMT-A and average in the ToL. Conclusion Alternating semantic fluency-requiring simultaneously inhibition, updating and task shifting-turned out highly predictive of academic success in medical school. Moreover, higher levels in "compensatory effort" and "engagement" suggested that both, increased energy expenditure as response to fear of failure and elevated readiness to exert effort also impacted positively on success.	[Kaufmann, Sabrina; Mueller-Hilke, Brigitte] Univ Med Ctr Rostock, Core Facil Cell Sorting & Cell Anal, Rostock, Germany; [Glass, Anne] Univ Med Rostock, Inst Biostat & Informat Med, Rostock, Germany; [Kropp, Peter] Univ Med Ctr Rostock, Inst Med Psychol & Sociol, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Muller-Hilke, B (corresponding author), Univ Med Ctr Rostock, Core Facil Cell Sorting & Cell Anal, Rostock, Germany.	Brigitte.mueller-hilke@med.uni-rostock.de						ATKINSON JW, 1957, PSYCHOL REV, V64, P359, DOI 10.1037/h0043445; Baddeley A.D., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI DOI 10.1016/S0079-7421(08)60452-1; BANGERTDROWNS RL, 1991, J EDUC RES, V85, P89, DOI 10.1080/00220671.1991.10702818; Barrett LF, 2004, PSYCHOL BULL, V130, P553, DOI 10.1037/0033-2909.130.4.553; Becker N, 2019, ARCH CLIN NEUROPSYCH, V34, P1217, DOI 10.1093/arclin/acz022; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Brunstein JoachimC., 2018, MOTIVATION ACTION, P221, DOI DOI 10.1007/978-3-319-65094-4_6; Casuso-Holgado MJ, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-33; Covington MV, STUDENT MOTIVATION C, P157; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Ferguson E, 2002, BMJ-BRIT MED J, V324, P952, DOI 10.1136/bmj.324.7343.952; Fossati P, 2003, PSYCHIAT RES, V117, P17, DOI 10.1016/S0165-1781(02)00300-1; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Hahn H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171220; Kadmon Guni, 2014, GMS Z Med Ausbild, V31, pDoc21, DOI 10.3205/zma000913; Lange K.W., 2000, RWT REGENSBURGER WOR; Lehto JH, 1996, Q J EXP PSYCHOL-A, V49, P29, DOI 10.1080/027249896392793; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Niessen ASM, 2016, CLIN MED, V16, P339, DOI 10.7861/clinmedicine.16-4-339; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Oberer N, 2018, HUM MOVEMENT SCI, V58, P69, DOI 10.1016/j.humov.2018.01.003; Oswald WD., 2016, ZVT ZAHLEN VERBINDUN; Patterson F, 2016, MED TEACH, V38, P3, DOI 10.3109/0142159X.2015.1072619; Patterson F, 2016, MED EDUC, V50, P36, DOI 10.1111/medu.12817; Patterson F, 2008, MED EDUC, V42, P1195, DOI 10.1111/j.1365-2923.2008.03174.x; Pau A, 2013, MED TEACH, V35, P1027, DOI 10.3109/0142159X.2013.829912; Pekrun R, 2006, EDUC PSYCHOL REV, V18, P315, DOI 10.1007/s10648-006-9029-9; Richman WL, 1999, J APPL PSYCHOL, V84, P754, DOI 10.1037/0021-9010.84.5.754; Rosen VM, 1998, J MEM LANG, V39, P418, DOI 10.1006/jmla.1998.2590; Schuler, 2001, LMI LEISTUNGSMOTIVAT; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Titz C, 2014, PSYCHOL RES-PSYCH FO, V78, P852, DOI 10.1007/s00426-013-0537-1; Tucha O, 2004, J NEUROPSYCHOL; Walter SR, 2014, BMJ QUAL SAF, V23, P231, DOI 10.1136/bmjqs-2013-002097; Yeh YC, 2007, KAOHSIUNG J MED SCI, V23, P379, DOI 10.1016/S0257-5655(07)70001-9	39	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244456	10.1371/journal.pone.0244456	http://dx.doi.org/10.1371/journal.pone.0244456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373421	Green Published, gold			2022-12-27	WOS:000603612300031
J	Li, GL; Zhou, ZY; Liang, LR; Song, Z; Hu, YF; Cui, JJ; Chen, WL; Hu, KL; Cheng, JW				Li, Guanliang; Zhou, Ziyan; Liang, Lingrui; Song, Zhao; Hu, Yafei; Cui, Junjie; Chen, Weili; Hu, Kailin; Cheng, Jiaowen			Genome-wide identification and analysis of highly specific CRISPR/Cas9 editing sites in pepper (Capsicum annuum L.)	PLOS ONE			English	Article							PROVIDES INSIGHTS; GUIDE RNA; EVOLUTION; SOFTWARE; SEQUENCE; SEARCH	The CRISPR/Cas9 system is an efficient genome editing tool that possesses the outstanding advantages of simplicity and high efficiency. Genome-wide identification and specificity analysis of editing sites is an effective approach for mitigating the risk of off-target effects of CRISPR/Cas9 and has been applied in several plant species but has not yet been reported in pepper. In present study, we first identified genome-wide CRISPR/Cas9 editing sites based on the 'Zunla-1' reference genome and then evaluated the specificity of CRISPR/Cas9 editing sites through whole-genome alignment. Results showed that a total of 603,202,314 CRISPR/Cas9 editing sites, including 229,909,837 (similar to 38.11%) NGG-PAM sites and 373,292,477 (similar to 61.89%) NAG-PAM sites, were detectable in the pepper genome, and the systematic characterization of their composition and distribution was performed. Furthermore, 29,623,855 highly specific NGG-PAM sites were identified through whole-genome alignment analysis. There were 26,699,38 (similar to 90.13%) highly specific NGG-PAM sites located in intergenic regions, which was 9.13 times of the number in genic regions, but the average density in genic regions was higher than that in intergenic regions. More importantly, 34,251 (similar to 96.93%) out of 35,336 annotated genes exhibited at least one highly specific NGG-PAM site in their exons, and 90.50% of the annotated genes exhibited at least 4 highly specific NGG- PAM sites, indicating that the set of highly specific CRISPR/Cas9 editing sites identified in this study was widely applicable and conducive to the minimization of the off-target effects of CRISPR/Cas9 in pepper.	[Li, Guanliang; Zhou, Ziyan; Liang, Lingrui; Song, Zhao; Hu, Yafei; Chen, Weili; Hu, Kailin; Cheng, Jiaowen] South China Agr Univ, Coll Hort, Guangzhou, Peoples R China; [Li, Guanliang; Zhou, Ziyan; Liang, Lingrui; Song, Zhao; Hu, Yafei; Chen, Weili; Hu, Kailin; Cheng, Jiaowen] Minist Agr & Rural Affairs, South China Key Lab Urban Agr, Guangzhou, Peoples R China; [Li, Guanliang; Zhou, Ziyan; Liang, Lingrui; Song, Zhao; Hu, Yafei; Chen, Weili; Hu, Kailin; Cheng, Jiaowen] Minist Agr & Rural Affairs, Key Lab Biol & Genet Improvement Hort Crops South, Guangzhou, Peoples R China; [Cui, Junjie] Foshan Univ, Dept Hort, Coll Food Sci & Engn, Foshan, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; Foshan University	Cheng, JW (corresponding author), South China Agr Univ, Coll Hort, Guangzhou, Peoples R China.; Cheng, JW (corresponding author), Minist Agr & Rural Affairs, South China Key Lab Urban Agr, Guangzhou, Peoples R China.; Cheng, JW (corresponding author), Minist Agr & Rural Affairs, Key Lab Biol & Genet Improvement Hort Crops South, Guangzhou, Peoples R China.	jiaolong1015@126.com			Guangzhou Science and Technology Plan Project [201704020019]; National Natural Science Foundation of China [31701921, 31672162]; Guangdong Basic and Applied Basic Research Foundation [2019A1515011784]	Guangzhou Science and Technology Plan Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation	This work was supported by the Guangzhou Science and Technology Plan Project (201704020019), the National Natural Science Foundation of China (31701921, 31672162) and the Guangdong Basic and Applied Basic Research Foundation (2019A1515011784). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cheng JW, 2020, THEOR APPL GENET, V133, P889, DOI 10.1007/s00122-019-03513-y; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Concordet JP, 2018, NUCLEIC ACIDS RES, V46, pW242, DOI 10.1093/nar/gky354; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaur K, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav055; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kothari SL, 2010, BIOTECHNOL ADV, V28, P35, DOI 10.1016/j.biotechadv.2009.08.005; Liu YaoGuang, 2019, Journal of South China Agricultural University, V40, P38; Makarova Kira S, 2015, Methods Mol Biol, V1311, P47, DOI 10.1007/978-1-4939-2687-9_4; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Park J, 2015, BIOINFORMATICS, V31, P4014, DOI 10.1093/bioinformatics/btv537; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pozueta-Romero J, 2001, PLANT CELL TISS ORG, V67, P173, DOI 10.1023/A:1011997926381; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rizk G, 2010, BIOINFORMATICS, V26, P2534, DOI 10.1093/bioinformatics/btq485; Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184; Wang MG, 2018, J INTEGR PLANT BIOL, V60, P626, DOI 10.1111/jipb.12667; Wang Y, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0787-3; Xie KB, 2014, MOL PLANT, V7, P923, DOI 10.1093/mp/ssu009; Yan WX, 2019, SCIENCE, V363, P88, DOI 10.1126/science.aav7271; Yao X, 2017, CELL RES, V27, P801, DOI 10.1038/cr.2017.76	29	2	2	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244515	10.1371/journal.pone.0244515	http://dx.doi.org/10.1371/journal.pone.0244515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373406	Green Published, gold			2022-12-27	WOS:000603612300008
J	Cho, JH; Namazi, A; Shelton, R; Ramireddy, A; Ehdaie, A; Shehata, M; Wang, XZ; Marban, E; Chugh, SS; Cingolani, E				Cho, Jae Hyung; Namazi, Ali; Shelton, Richard; Ramireddy, Archana; Ehdaie, Ashkan; Shehata, Michael; Wang, Xunzhang; Marban, Eduardo; Chugh, Sumeet S.; Cingolani, Eugenio			Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States	PLOS ONE			English	Article							PNEUMONIA; WUHAN	Arrhythmias have been reported frequently in COVID-19 patients, but the incidence and nature have not been well characterized. Patients admitted with COVID-19 and monitored by telemetry were prospectively enrolled in the study. Baseline characteristics, hospital course, treatment and complications were collected from the patients' medical records. Telemetry was monitored to detect the incidence of cardiac arrhythmias. The incidence and types of cardiac arrhythmias were analyzed and compared between survivors and non-survivors. Among 143 patients admitted with telemetry monitoring, overall in-hospital mortality was 25.2% (36/143 patients) during the period of observation (mean follow-up 23.7 days). Survivors were less tachycardic on initial presentation (heart rate 90.6 +/- 19.6 vs. 99.3 +/- 23.1 bpm, p = 0.030) and had lower troponin (peak troponin 0.03 vs. 0.18 ng/ml. p = 0.004), C-reactive protein (peak C-reactive protein 97 vs. 181 mg/dl, p = 0.029), and interleukin-6 levels (peak interleukin-6 30 vs. 246 pg/ml, p = 0.003). Sinus tachycardia, the most common arrhythmia (detected in 39.9% [57/143] of patients), occurred more frequently in non-survivors (58.3% vs. 33.6% in survivors, p = 0.009). Premature ventricular complexes occurred in 28.7% (41/143), and non-sustained ventricular tachycardia in 15.4% (22/143) of patients, with no difference between survivors and non-survivors. Sustained ventricular tachycardia and ventricular fibrillation were not frequent (seen only in 1.4% and 0.7% of patients, respectively). Contrary to reports from other regions, overall mortality was higher and ventricular arrhythmias were infrequent in this hospitalized and monitored COVID-19 population. Either disease or management-related factors could explain this divergence of clinical outcomes, and should be urgently investigated.	[Cho, Jae Hyung; Namazi, Ali; Shelton, Richard; Ramireddy, Archana; Ehdaie, Ashkan; Shehata, Michael; Wang, Xunzhang; Marban, Eduardo; Chugh, Sumeet S.; Cingolani, Eugenio] Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Cingolani, E (corresponding author), Cedars Sinai Med Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA.	Eugenio.Cingolani@csmc.edu	Marban, Eduardo/GWC-8514-2022		National Institutes of Health [RO1 HL135866]; US Department of Defense [PR150620]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense)	This study was funded by the National Institutes of Health (RO1 HL135866 to EC and EM) and the Peer-Reviewed Medical Research Program of the US Department of Defense (PR150620 to EM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmerov A, 2020, CIRC RES, V126, P1443, DOI 10.1161/CIRCRESAHA.120.317055; Baksi A John, 2015, Card Electrophysiol Clin, V7, P269, DOI 10.1016/j.ccep.2015.03.009; Bhatla A, 2020, HEART RHYTHM, V17, P1439, DOI 10.1016/j.hrthm.2020.06.016; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Mesnier J, 2020, LANCET PUBLIC HEALTH, V5, pE536, DOI 10.1016/S2468-2667(20)30188-2; Peretto G, 2020, J AM COLL CARDIOL, V75, P1046, DOI 10.1016/j.jacc.2020.01.036; Peretto G, 2019, HEART RHYTHM, V16, P793, DOI 10.1016/j.hrthm.2018.11.024; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Shao F, 2020, RESUSCITATION, V151, P18, DOI 10.1016/j.resuscitation.2020.04.005; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585	13	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244533	10.1371/journal.pone.0244533	http://dx.doi.org/10.1371/journal.pone.0244533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370347	Green Published, gold			2022-12-27	WOS:000603611900096
J	Eligio, RB; Kaschak, MP				Eligio, Rachel B.; Kaschak, Michael P.			Gaming experience affects the interpretation of ambiguous words	PLOS ONE			English	Article							FIXATION TIMES; MEANINGS; KNOWLEDGE; ACCESS	Rodd et al. (2016) report that recreational rowers' acquisition of sport-related terminology affected their interpretation of words that have both rowing-related and non-rowing-related meanings (e.g., crab). The extent to which the rowing- and non-rowing-related meanings were accessible to the participants depended on experiential factors, such as how long the participant had been a rower, and how long it had been since they last rowed. We present two experiments that attempt to replicate these findings with another group of hobbyists, namely video game players. Experiment 1 examined the differences in word meaning choice between gamers and non-gamers. Participation in video-gaming lead to participants generating more gaming-related word meanings in a word association task. Experiment 2 further examined the effects of video gaming experience on the lexical representation of gaming-related words. Participants who had spent more years as gamers were more likely to produce gaming-related word meanings in a word association task. The effect of time spent gaming was no longer significant when we took into account whether the participant engaged with video-game related media (such as YouTube channels or gaming-related message boards). This finding helps us to refine our understanding of the results reported by Rodd et al. (2016), suggesting that it may not be the time spent in an activity that affects the interpretation of ambiguous words, but rather the specific exposure to activity-related vocabulary.	[Eligio, Rachel B.; Kaschak, Michael P.] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Eligio, RB (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	eligio@psy.fsu.edu		Kaschak, Michael/0000-0002-7704-4904				[Anonymous], 2020, DICT COMM GAM TERMS; Betts HN, 2018, J EXP PSYCHOL LEARN, V44, P1130, DOI 10.1037/xlm0000507; Clark HH, 1997, DISCOURSE PROCESS, V23, P567, DOI 10.1080/01638539709545003; Coane JH, 2011, EXP PSYCHOL, V58, P62, DOI 10.1027/1618-3169/a000068; Cobbett R, 2015, PC GAMER; Colbert-Getz J, 2013, MEM COGNITION, V41, P1172, DOI 10.3758/s13421-013-0328-3; DUFFY SA, 1988, J MEM LANG, V27, P429, DOI 10.1016/0749-596X(88)90066-6; FINCHERKIEFER R, 1988, J MEM LANG, V27, P416, DOI 10.1016/0749-596X(88)90065-4; Fokkema M, 2018, BEHAV RES METHODS, V50, P2016, DOI 10.3758/s13428-017-0971-x; [Game Genius. Genius], 2009, LIST GAM TERMS; Gilbert RA, 2018, J EXP PSYCHOL LEARN, V44, P1533, DOI 10.1037/xlm0000532; Hulme RC, 2019, LANG LEARN, V69, P18, DOI 10.1111/lang.12313; Kaschak MP, 2004, J EXP PSYCHOL GEN, V133, P450, DOI 10.1037/0096-3445.133.3.450; Kraljic T, 2005, COGNITIVE PSYCHOL, V51, P141, DOI 10.1016/j.cogpsych.2005.05.001; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; Ricks TR, 2009, J MEM LANG, V61, P519, DOI 10.1016/j.jml.2009.07.007; Rodd J, 2002, J MEM LANG, V46, P245, DOI 10.1006/jmla.2001.2810; Rodd JM, 2020, PERSPECT PSYCHOL SCI, V15, P411, DOI 10.1177/1745691619885860; Rodd JM, 2016, J MEM LANG, V87, P16, DOI 10.1016/j.jml.2015.10.006; Rodd JM, 2013, J MEM LANG, V68, P180, DOI 10.1016/j.jml.2012.08.002; Rodd JM, 2012, MEM COGNITION, V40, P1095, DOI 10.3758/s13421-012-0209-1; RStudio, 2021, RSTUDIO INT DEV ENV; SIMPSON GB, 1985, J EXP PSYCHOL HUMAN, V11, P28, DOI 10.1037/0096-1523.11.1.28; Wells JB, 2009, COGNITIVE PSYCHOL, V58, P250, DOI 10.1016/j.cogpsych.2008.08.002; Wiley J, 2018, Q J EXP PSYCHOL, V71, P93, DOI 10.1080/17470218.2016.1251470; Wowpedia, 2017, MUL GAM TERM 2017 AU	27	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243512	10.1371/journal.pone.0243512	http://dx.doi.org/10.1371/journal.pone.0243512			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370334	gold, Green Published			2022-12-27	WOS:000603611900083
J	Trounson, KM; Busch, A; Collier, NF; Robertson, S				Trounson, Karl M.; Busch, Aglaja; French Collier, Neil; Robertson, Sam			Effects of acute wearable resistance loading on overground running lower body kinematics	PLOS ONE			English	Article							MOVEMENT PATTERNS; EXTERNAL PERTURBATIONS; AUSTRALIAN-FOOTBALL; PERFORMANCE; VARIABILITY; COORDINATION; FREEDOM; LEG; IDENTIFICATION; ADAPTATIONS	Field-based sports require athletes to run sub-maximally over significant distances, often while contending with dynamic perturbations to preferred coordination patterns. The ability to adapt movement to maintain performance under such perturbations appears to be trainable through exposure to task variability, which encourages movement variability. The aim of the present study was to investigate the extent to which various wearable resistance loading magnitudes alter coordination and induce movement variability during running. To investigate this, 14 participants (three female and 11 male) performed 10 sub-maximal velocity shuttle runs with either no weight, 1%, 3%, or 5% of body weight attached to the lower limbs. Sagittal plane lower limb joint kinematics from one complete stride cycle in each run were assessed using functional data analysis techniques, both across the participant group and within-individuals. At the group-level, decreases in ankle plantarflexion following toe-off were evident in the 3% and 5% conditions, while increased knee flexion occurred during weight acceptance in the 5% condition compared with unloaded running. At the individual-level, between-run joint angle profiles varied, with six participants exhibiting increased joint angle variability in one or more loading conditions compared with unloaded running. Loading of 5% decreased between-run ankle joint variability among two individuals, likely in accordance with the need to manage increased system load or the novelty of the task. In terms of joint coordination, the most considerable alterations to coordination occurred in the 5% loading condition at the hip-knee joint pair, however, only a minority of participants exhibited this tendency. Coaches should prescribe wearable resistance individually to perturb preferred coordination patterns and encourage movement variability without loading to the extent that movement options become limited.	[Trounson, Karl M.; French Collier, Neil; Robertson, Sam] Victoria Univ, Inst Hlth & Sport, Footscray, Vic, Australia; [Trounson, Karl M.] Western Bulldogs Football Club, Footscray, Vic, Australia; [Busch, Aglaja] Univ Potsdam, Univ Outpatient Clin Sports Med & Sports Orthoped, Potsdam, Germany	Victoria University; University of Potsdam	Trounson, KM (corresponding author), Victoria Univ, Inst Hlth & Sport, Footscray, Vic, Australia.; Trounson, KM (corresponding author), Western Bulldogs Football Club, Footscray, Vic, Australia.	karl.trounson@live.vu.edu.au		Trounson, Karl/0000-0002-8328-2167; Robertson, Samuel/0000-0002-8330-0011				Alfonso M, 2019, EUR J HUM MOV, V43, P86; Andrzejewski M, 2016, INT J PERF ANAL SPOR, V16, P817, DOI 10.1080/24748668.2016.11868930; Apps C, 2014, J FOOT ANKLE RES, P7, DOI [10.1186/1757-1146-7-7, DOI 10.1186/1757-1146-7-7]; Apps C, 2017, FOOTWEAR SCI, V9, P65, DOI 10.1080/19424280.2017.1293175; Araujo D, 2006, PSYCHOL SPORT EXERC, V7, P653, DOI 10.1016/j.psychsport.2006.07.002; Barris S, 2014, RES Q EXERCISE SPORT, V85, P97, DOI 10.1080/02701367.2013.872220; Bernstein NA., 1967, CONTROL REGULATION M; Bezodis I, 2007, 25 INT S BIOM SPORTS, DOI [10.1080/14763140701324487, DOI 10.1080/14763140701324487]; Bishop DJ, 2012, CLIN EXP PHARMACOL P, V39, P836, DOI 10.1111/j.1440-1681.2012.05735.x; Bustos A, 2020, J STRENGTH COND RES, V34, P1220, DOI 10.1519/JSC.0000000000003498; Carling C, 2012, J SPORT SCI, V30, P325, DOI 10.1080/02640414.2011.652655; Chmielewski TL, 2005, PHYS THER, V85, P740, DOI 10.1093/ptj/85.8.740; Chmielewski TL, 2005, PHYS THER, V85, P50; Chow JY, 2006, INT J SPORT PSYCHOL, V37, P207; Chow JY, 2011, NEW IDEAS PSYCHOL, V29, P189, DOI 10.1016/j.newideapsych.2010.10.001; Chow J, 2007, J MOTOR BEHAV, V39, P463, DOI 10.3200/JMBR.39.6.463-480; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; Davids K., 2003, INT J COMPUT SCI SPO, V2, P31; Davids K., 2008, COORDINATION CONTROL; Dawson B, 2004, J SCI MED SPORT, V7, P278, DOI 10.1016/S1440-2440(04)80023-9; Di Nardo F, 2016, GAIT POSTURE, V46, P161, DOI 10.1016/j.gaitpost.2016.03.002; Domingo A, 2010, EXP BRAIN RES, V206, P359, DOI 10.1007/s00221-010-2409-x; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Field AP, 2019, SPORTS, V7, DOI 10.3390/sports7080187; Folland JP, 2017, MED SCI SPORT EXER, V49, P1412, DOI 10.1249/MSS.0000000000001245; Frank NS, 2013, FOOTWEAR SCI, V5, P171, DOI 10.1080/19424280.2013.797505; Gabbe B, 2002, J SCI MED SPORT, V5, P149, DOI 10.1016/S1440-2440(02)80036-6; Garcia-Herrero JA, 2016, INT J SPORTS SCI COA, V11, P648, DOI 10.1177/1747954116667101; Harbourne RT, 2009, PHYS THER, V89, P284, DOI 10.2522/ptj.20080130.ar; Harrison AJ, 2007, SPORT BIOMECH, V6, P199, DOI 10.1080/14763140701323042; Haudum A, 2014, HUM MOVEMENT SCI, V36, P246, DOI 10.1016/j.humov.2014.02.004; Haudum A, 2012, J SPORT SCI MED, V11, P582; Haudum A, 2012, J SPORT SCI MED, V11, P459; Hernandez-Davo H, 2014, J SPORT SCI, V32, P1383, DOI 10.1080/02640414.2014.891290; Higuchi T, 2002, HUM MOVEMENT SCI, V21, P831, DOI 10.1016/S0167-9457(02)00174-4; Jeffreys I, 2016, STRENGTH CONDITIONIN; JUARRERO ALICIA, 2000, EMERGENCE, V2, P24, DOI DOI 10.1207/S15327000EM0202_03; Kelso JAS, 2012, PHILOS T R SOC B, V367, P906, DOI 10.1098/rstb.2011.0351; Kelso S., 1995, DYNAMIC PATTERNS SEL; Komar J., 2015, MOV SPORT SCI, V36, P65, DOI [10.1051/sm/2015020, DOI 10.1051/SM/2015020]; Kostrubiec V, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00222; Lee MD, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096431, 10.1371/journal.pone.0104744]; Liew B, 2017, J APPL BIOMECH, V33, P347, DOI 10.1123/jab.2016-0226; Macadam P, 2019, STRENGTH COND J, V41, P79, DOI 10.1519/SSC.0000000000000444; Macadam P, 2017, EUR J SPORT SCI, V17, P555, DOI 10.1080/17461391.2017.1298672; MARRAS WS, 1987, ERGONOMICS, V30, P551, DOI 10.1080/00140138708969744; MARTIN PE, 1990, J BIOMECH, V23, P529, DOI 10.1016/0021-9290(90)90046-6; Moore IS, 2016, SPORTS MED, V46, P793, DOI 10.1007/s40279-016-0474-4; Morel B, 2015, INT J SPORTS SCI COA, V10, P11, DOI 10.1260/1747-9541.10.1.11; MORGAN DW, 1989, MED SCI SPORT EXER, V21, P78, DOI 10.1249/00005768-198902000-00014; Nagahara R., 2013, INT J SPORT HLTH SCI, V11, P96, DOI [10.5432/ijshs.201318, DOI 10.5432/IJSHS.201318]; Nakamoto H, 2012, HUM MOVEMENT SCI, V31, P1529, DOI 10.1016/j.humov.2012.04.005; Newell K.M., 1989, PERSPECTIVES COORDIN, P85, DOI DOI 10.1016/S0166-4115(08)60019-9; Newell KM, 1991, VARIABILITY MOTOR CO; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Savelsbergh GJP, 2010, INT J SPORT PSYCHOL, V41, P415; Schache AG, 2001, CLIN BIOMECH, V16, P667, DOI 10.1016/S0268-0033(01)00061-4; Schollhorn W.I., 1998, ISBS C P ARCHIVE, V1; Schollhorn WI, 2002, GAIT POSTURE, V15, P180, DOI 10.1016/S0966-6362(01)00193-X; Schollhorn WI, 2010, STOCHASTIC PERTURBAT; Schorer J, 2007, J MOTOR BEHAV, V39, P409, DOI 10.3200/JMBR.39.5.409-422; Seagrave L, 2009, NEW STUD ATHL, V24, P19; Simperingham K, 2016, P 34 INT C BIOM SPOR; Simperingham K., 2014, J AUSTR STRENGTH CON, V22, P69; Slider A, 2015, J BIOMECH, V48, P1003, DOI 10.1016/j.jbiomech.2015.01.051; SOUTHARD D, 1987, RES Q EXERCISE SPORT, V58, P77, DOI 10.1080/02701367.1987.10605424; Suarez-Arrones LJ, 2012, J STRENGTH COND RES, V26, P3155, DOI 10.1519/JSC.0b013e318243fff7; Suarez-Arrones LJ, 2012, ISOKINET EXERC SCI, V20, P77, DOI 10.3233/IES-2012-0444; Thompson D, 1999, J SPORT SCI, V17, P387, DOI 10.1080/026404199365902; van Emmerik REA, 2016, J SPORT HEALTH SCI, V5, P3, DOI 10.1016/j.jshs.2016.01.013; Varley MC, 2014, J SPORT SCI, V32, P1858, DOI 10.1080/02640414.2013.823227; VEREIJKEN B, 1992, J MOTOR BEHAV, V24, P133, DOI 10.1080/00222895.1992.9941608; Walker C, 2019, SPORT BIOMECH, V18, P146, DOI 10.1080/14763141.2019.1574887; Warmenhoven J, 2019, SPORT BIOMECH, V18, P10, DOI 10.1080/14763141.2017.1384050; Warmenhoven J, 2018, J SCI MED SPORT, V21, P1100, DOI 10.1016/j.jsams.2018.03.009; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wood SN, 2015, J R STAT SOC C-APPL, V64, P139, DOI 10.1111/rssc.12068	79	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244361	10.1371/journal.pone.0244361	http://dx.doi.org/10.1371/journal.pone.0244361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370355	Green Accepted, gold, Green Published			2022-12-27	WOS:000603611900024
J	Uddin, MM; Chen, ZF; Huang, LF				Uddin, Mohammad Mazbah; Chen, Zhenfang; Huang, Lingfeng			Cadmium accumulation, subcellular distribution and chemical fractionation in hydroponically grown Sesuvium portulacastrum [Aizoaceae]	PLOS ONE			English	Article							CD ACCUMULATION; HEAVY-METALS; FORMS; TOLERANCE; L.; HALOPHYTE; PLANTS; TOXICITY; ZN; HYPERACCUMULATOR	Sesuvium portulacastrum is a well-known halophyte with considerable Cd accumulation and tolerance under high Cd stress. This species is also considered as a good candidate of Cd phytoremediation in the polluted soils. However, the mechanism of Cd accumulation, distribution and fractionation in different body parts still remain unknown. Seedlings of Sesuvium portulacastrum were studied hydroponically under exposure to a range of Cd concentrations (50 mu M or mu mol/L to 600 mu M or mu mol/L) for 28 days to investigate the potential accumulation capability and tolerance mechanisms of this species. Cd accumulation in roots showed that the bio-concentration factor was > 10, suggesting a strong ability to absorb and accumulate Cd. Cd fractionation in the aboveground parts showed the following order of distribution: soluble fraction > cell wall > organelle > cell membrane. In roots, soluble fraction was mostly predominant than other fractions. Cd speciation in leaves and stems was mainly contained of sodium chloride and deionised water extracted forms, suggesting a strong binding ability with pectin and protein as well as with organic acids. In the roots, inorganic form of Cd was dominant than other forms of Cd. It could be suggested that sodium chloride, deionised water and inorganic contained form of Cd are mainly responsible for the adaption of this plant in the Cd stress environment and alleviating Cd toxicity.	[Uddin, Mohammad Mazbah; Chen, Zhenfang; Huang, Lingfeng] Xiamen Univ, Coll Environm & Ecol, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China	Xiamen University	Huang, LF (corresponding author), Xiamen Univ, Coll Environm & Ecol, Key Lab, Minist Educ Coastal & Wetland Ecosyst, Xiamen, Peoples R China.	huanglf@xmu.edu.cn	Uddin, Mohammad Mazbah/ABC-9557-2020	Uddin, Mohammad Mazbah/0000-0003-2318-8002; Huang, Lingfeng/0000-0002-2428-8147	National Key Research and Development Program of China [2018YFC1406306, 2016YFC0502904]	National Key Research and Development Program of China	This work was supported by the National Key Research and Development Program of China (No. 2018YFC1406306 and No. 2016YFC0502904).	Appenroth KJ, 2010, ACTA PHYSIOL PLANT, V32, P615, DOI 10.1007/s11738-009-0455-4; Ayyappan D, 2016, INT J PHYTOREMEDIAT, V18, P453, DOI 10.1080/15226514.2015.1109606; Boominathan R, 2003, BIOTECHNOL BIOENG, V83, P158, DOI 10.1002/bit.10656; Cai YM, 2019, ENVIRON POLLUT, V253, P959, DOI 10.1016/j.envpol.2019.07.077; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Fang T, 2019, CHEMOSPHERE, V218, P1122, DOI 10.1016/j.chemosphere.2018.10.107; Feng JX, 2018, ECOTOX ENVIRON SAFE, V147, P306, DOI 10.1016/j.ecoenv.2017.08.056; Fu XP, 2011, J HAZARD MATER, V186, P103, DOI 10.1016/j.jhazmat.2010.10.122; Ghnaya T, 2005, J PLANT PHYSIOL, V162, P1133, DOI 10.1016/j.jplph.2004.11.011; Ghori NH, 2019, INT J ENVIRON SCI TE, V16, P1807, DOI 10.1007/s13762-019-02215-8; Hao XQ, 2015, ENVIRON SCI POLLUT R, V22, P7461, DOI 10.1007/s11356-015-4379-9; He JY, 2008, PEDOSPHERE, V18, P371, DOI 10.1016/S1002-0160(08)60027-2; Huang GY, 2010, J HAZARD MATER, V182, P848, DOI 10.1016/j.jhazmat.2010.06.121; Huang LF, 2013, MAR POLLUT BULL, V71, P74, DOI 10.1016/j.marpolbul.2013.03.032; Kumar S. D., 2013, Journal of Biological Sciences, V13, P400; Kupper H, 2000, PLANTA, V212, P75, DOI 10.1007/s004250000366; Lagriffoul A, 1998, PLANT SOIL, V200, P241, DOI 10.1023/A:1004346905592; Lai HY, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-014-2246-9; Li DD, 2011, ECOTOX ENVIRON SAFE, V74, P874, DOI 10.1016/j.ecoenv.2010.12.006; Lokhande VH, 2013, AGRON SUSTAIN DEV, V33, P329, DOI 10.1007/s13593-012-0113-x; Manousaki E, 2009, J CHEM TECHNOL BIOT, V84, P877, DOI 10.1002/jctb.2177; Pandey VC, 2014, ECOL ENG, V71, P722, DOI 10.1016/j.ecoleng.2014.08.002; Pandey VC, 2012, ECOTOX ENVIRON SAFE, V82, P8, DOI 10.1016/j.ecoenv.2012.05.002; Pietrini F, 2016, J HAZARD MATER, V309, P77, DOI 10.1016/j.jhazmat.2016.01.079; Qiao K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37352-6; Qiu Q, 2011, FOOD CHEM TOXICOL, V49, P2260, DOI 10.1016/j.fct.2011.06.024; Ramos I, 2002, PLANT SCI, V162, P761, DOI 10.1016/S0168-9452(02)00017-1; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Song Y, 2017, INT J PHYTOREMEDIAT, V19, P133, DOI 10.1080/15226514.2016.1207598; Sruthi P, 2017, WETL ECOL MANAG, V25, P129, DOI 10.1007/s11273-016-9513-z; Su Y, 2014, ENVIRON EXP BOT, V97, P40, DOI 10.1016/j.envexpbot.2013.10.001; Taamalli M, 2014, ECOL ENG, V71, P623, DOI 10.1016/j.ecoleng.2014.08.013; Uddin M. M., 2019, Journal of Biological Sciences, V19, P314, DOI 10.3923/jbs.2019.314.322; Uddin MM, 2021, HUM ECOL RISK ASSESS, V27, P465, DOI 10.1080/10807039.2020.1731679; Wali M, 2016, PLANTA, V244, P333, DOI 10.1007/s00425-016-2515-5; Wali M, 2015, ENVIRON SCI POLLUT R, V22, P10769, DOI 10.1007/s11356-015-4298-9; Wali M, 2014, CHEMOSPHERE, V117, P243, DOI 10.1016/j.chemosphere.2014.07.041; Wang SL, 2013, MAR POLLUT BULL, V76, P7, DOI 10.1016/j.marpolbul.2013.08.025; Wang SF, 2016, ECOL ENG, V90, P347, DOI 10.1016/j.ecoleng.2015.11.044; Wang WX, 2002, MAR ECOL PROG SER, V243, P295, DOI 10.3354/meps243295; Wang X, 2008, ENVIRON EXP BOT, V62, P389, DOI 10.1016/j.envexpbot.2007.10.014; Weng BS, 2012, MAR POLLUT BULL, V64, P2453, DOI 10.1016/j.marpolbul.2012.07.047; Wu FB, 2005, CHEMOSPHERE, V60, P1437, DOI 10.1016/j.chemosphere.2005.01.071; Xin JL, 2014, J AGR FOOD CHEM, V62, P508, DOI 10.1021/jf4044524; Xu XX, 2018, INT J PHYTOREMEDIAT, V20, P973, DOI 10.1080/15226514.2017.1365351; Xu ZM, 2017, ENVIRON POLLUT, V224, P89, DOI 10.1016/j.envpol.2016.12.067; Yoon J, 2006, SCI TOTAL ENVIRON, V368, P456, DOI 10.1016/j.scitotenv.2006.01.016; Zaier H, 2010, J HAZARD MATER, V183, P609, DOI 10.1016/j.jhazmat.2010.07.068; Zhang SJ, 2014, INT J ENVIRON SCI TE, V11, P757, DOI 10.1007/s13762-013-0384-z; Zhao FJ, 2006, NEW PHYTOL, V172, P646, DOI 10.1111/j.1469-8137.2006.01867.x; Zhao YF, 2015, FOOD CHEM, V168, P48, DOI 10.1016/j.foodchem.2014.07.054; Zhong H T, 2013, ENV PROTECTION SCI, V39, P50	52	6	6	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244085	10.1371/journal.pone.0244085	http://dx.doi.org/10.1371/journal.pone.0244085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370774	gold, Green Published			2022-12-27	WOS:000603611900022
J	Zaugg, TL; Thielman, EJ; Carlson, KF; Tuepker, A; Elnitsky, C; Drummond, KL; Schmidt, CJ; Newell, S; Kaelin, C; Choma, C; Henry, JA				Zaugg, Tara L.; Thielman, Emily J.; Carlson, Kathleen F.; Tuepker, Anais; Elnitsky, Christine; Drummond, Karen L.; Schmidt, Caroline J.; Newell, Summer; Kaelin, Christine; Choma, Christie; Henry, James A.			Factors affecting the implementation of evidence-based Progressive Tinnitus Management in Department of Veterans Affairs Medical Centers	PLOS ONE			English	Article							AUDIOLOGICAL TINNITUS; SUPPORTED EMPLOYMENT; COLLABORATIVE CARE; SKILLS EDUCATION; HEALTH; PROGRAM; SYSTEM	Purpose Progressive Tinnitus Management (PTM) is an evidence-based interdisciplinary stepped-care approach to improving quality of life for patients with tinnitus. PTM was endorsed by Department of Veterans Affairs (VA) Audiology leadership in 2009. Factors affecting implementation of PTM are unknown. We conducted a study to: 1) estimate levels of PTM program implementation in VA Audiology and Mental Health clinics across the country; and 2) identify barriers and facilitators to PTM implementation based on the experiences of VA audiologists and mental health providers. Method We conducted an anonymous, web-based survey targeting Audiology and Mental Health leaders at 144 major VA facilities. Quantitative analyses summarized respondents' facility characteristics and levels of program implementation (full PTM, partial PTM, or no PTM). Qualitative analyses identified themes in factors influencing the implementation of PTM across VA sites. Results Surveys from 87 audiologists and 66 mental health clinicians revealed that few facilities offered full PTM; the majority offered partial or no PTM. Inductive analysis of the open-ended survey responses identified seven factors influencing implementation of PTM: 1) available resources, 2) service collaboration, 3) prioritization, 4) Veterans' preferences and needs, 5) clinician training, 6) awareness of (evidence-based) options, and 7) perceptions of scope of practice. Conclusion Results suggest wide variation in services provided, a need for greater engagement of mental health providers in tinnitus care, and an interest among both audiologists and mental health providers in receiving tinnitus-related training. Future research should address barriers to PTM implementation, including methods to: 1) improve understanding among mental health providers of their potential role in tinnitus management; 2) enhance coordination of tinnitus-related care between health care disciplines; and 3) collect empirical data on Veterans' need for and interest in PTM, including delivery by telehealth modalities.	[Zaugg, Tara L.; Thielman, Emily J.; Carlson, Kathleen F.; Kaelin, Christine; Choma, Christie; Henry, James A.] VA Portland Hlth Care Syst, VA RR&D Natl Ctr Rehabil Auditory Res NCRAR, Portland, OR 97239 USA; [Carlson, Kathleen F.; Tuepker, Anais; Newell, Summer; Choma, Christie] VA Portland Hlth Care Syst, VA HSR&D Ctr Improve Veteran Involvement Care CIV, Portland, OR USA; [Carlson, Kathleen F.] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Tuepker, Anais] Oregon Hlth & Sci Univ OHSU, Div Gen Internal Med & Geriatr, Portland, OR USA; [Elnitsky, Christine] Univ N Carolina, Coll Hlth & Human Serv, Charlotte, NC USA; [Drummond, Karen L.] Cent Arkansas Vet Healthcare Syst, VA Ctr Mental Healthcare & Outcomes Res, North Little Rock, AR USA; [Drummond, Karen L.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA; [Schmidt, Caroline J.] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Henry, James A.] Oregon Hlth & Sci Univ OHSU, Dept Otolaryngol Head & Neck Surg, Portland, OR USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Portland State University; Oregon Health & Science University; University of North Carolina; University of North Carolina Charlotte; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; Yale University; Oregon Health & Science University	Zaugg, TL (corresponding author), VA Portland Hlth Care Syst, VA RR&D Natl Ctr Rehabil Auditory Res NCRAR, Portland, OR 97239 USA.	tara.zaugg@va.gov			Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI) [RRP 13-440/IRB3295]	Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI)(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Health Services Research and Development (HSR&D) Service Quality Enhancement Research Initiative (QUERI) through a Rapid Response Project mechanism (RRP 13-440/IRB3295) (JAH). https://www.queri.research.va.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, CANC DISCOV, V10, pOF8; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Bach-Mortensen AM, 2018, IMPLEMENT SCI, V13, DOI 10.1186/s13012-018-0789-7; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Beck JE, 2019, AM J AUDIOL, V28, P162, DOI 10.1044/2018_AJA-TTR17-18-0040; Bhatt JM, 2017, LARYNGOSCOPE, V127, P466, DOI 10.1002/lary.26107; Carlson KF, 2019, AM J AUDIOL, V28, P181, DOI 10.1044/2018_AJA-TTR17-18-0042; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; EC, 2000, OFF J EUR UNION; Edmonds CM, 2017, AM J AUDIOL, V26, P242, DOI 10.1044/2017_AJA-16-0085; Fuller TE, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00206; Gaudet T, 2019, J ALTERN COMPLEM MED, V25, pS7, DOI 10.1089/acm.2018.29061.gau; Henry JA, 2020, HEAR J, V73, P32; Henry JA, 2019, EAR HEARING, V40, P227, DOI 10.1097/AUD.0000000000000609; Henry JA, 2017, J SPEECH LANG HEAR R, V60, P1378, DOI 10.1044/2016_JSLHR-H-16-0126; Henry JA, 2016, OTOL NEUROTOL, V37, pE276, DOI 10.1097/MAO.0000000000001070; Henry JA, 2009, NOISE HEALTH, V11, P33, DOI 10.4103/1463-1741.45311; Martin WH, 2017, AM J PREV MED, V52, pS268, DOI 10.1016/j.amepre.2016.10.031; Martinez-Devesa P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005233.pub3; McIntosh N, 2014, HEALTH CARE MANAGE R, V39, P279, DOI 10.1097/HMR.0000000000000004; Moller AR, 2007, PROG BRAIN RES, V166, P47, DOI 10.1016/S0079-6123(07)66004-X; Myers PJ, 2014, J REHABIL RES DEV, V51, P609, DOI 10.1682/JRRD.2013.08.0189; Pearce J, 2012, J CONTIN EDUC HEALTH, V32, P215, DOI 10.1002/chp.21148; Peker S, 2016, MED HYPOTHESES, V91, P95, DOI 10.1016/j.mehy.2016.04.023; Pogoda TK, 2018, ARCH PHYS MED REHAB, V99, pS14, DOI 10.1016/j.apmr.2017.06.029; Pugh MJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-44; Pyne JM, 2011, ARCH INTERN MED, V171, P23, DOI 10.1001/archinternmed.2010.395; Pyne JM, 2010, ARCH GEN PSYCHIAT, V67, P812, DOI 10.1001/archgenpsychiatry.2010.82; Resnick SG, 2007, J REHABIL RES DEV, V44, P867, DOI 10.1682/JRRD.2007.02.0043; Schmidt Caroline J, 2017, Fed Pract, V34, P6; Sharma U, 2014, INDIAN J CLIN BIOCHE, V29, P269, DOI 10.1007/s12291-013-0408-y; Sherlock LP, 2019, MIL MED; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Taylor SL, 2019, J ALTERN COMPLEM MED, V25, pS52, DOI 10.1089/acm.2018.0445; Tuepker A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196105; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Ubbink DT, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001881; Westin VZ, 2011, BEHAV RES THER, V49, P737, DOI 10.1016/j.brat.2011.08.001; Williams KM, 2017, TELEMED E-HEALTH, V23, P577, DOI 10.1089/tmj.2016.0166; Wyse JJ, 2018, SUBST ABUS, V39, P139, DOI 10.1080/08897077.2018.1452327	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242007	10.1371/journal.pone.0242007	http://dx.doi.org/10.1371/journal.pone.0242007			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370307	gold, Green Published			2022-12-27	WOS:000603611900123
J	Jones, LK; Sturm, AC; Seaton, TL; Gregor, C; Gidding, SS; Williams, MS; Rahm, AK				Jones, Laney K.; Sturm, Amy C.; Seaton, Terry L.; Gregor, Christina; Gidding, Samuel S.; Williams, Marc S.; Rahm, Alanna Kulchak			Barriers, facilitators, and solutions to familial hypercholesterolemia treatment	PLOS ONE			English	Article							PREVALENCE; STATINS; DISEASE	Background Familial hypercholesterolemia (FH) is an inherited lipid disorder that confers high risk for premature cardiovascular disease but remains undertreated. Causes are multifactorial and multilevel, ranging from underprescribing (at the clinician-level) to medication nonadherence (at the patient-level). We evaluated patient and clinician stakeholder barriers and facilitators for treatment of FH to explore possible solutions to the problem. Methods and results Semi-structured interviews and focus groups guided by the Practical, Robust, Implementation and Sustainability Model (PRISM), were conducted with 33 patients and 17 clinician stakeholders across three healthcare systems. A total of14 patients and 9 clinician stakeholders participated in on-site focus groups and the remainder were individual interviews. Transcripts were coded using an iterative process to create a static codebook. We characterized patient and clinician stakeholder barriers into three categories: medical care-, medication-, and life-related. Feasibility of brainstormed solutions varied and was not always representative of the needs of all stakeholders. Patients suggested a need for childhood screening for FH and doctors being persistent about the importance of treating FH, creation of a patient peer group, data transparency, advocacy, and policy changes that would enable patients to receive better treatment. Clinician stakeholders suggested the need for clinical champions. Both groups of stakeholders discussed the need for education about FH. Conclusions Proposed solutions to improve treatment of FH proffered by participants in this study included resources for both patients and clinician stakeholders that clarify cardiovascular disease risks from FH, develop programs to screen for and identify FH at younger ages, and foster open conversations between patients and clinicians about treatment.	[Jones, Laney K.; Sturm, Amy C.; Gidding, Samuel S.; Williams, Marc S.; Rahm, Alanna Kulchak] Geisinger, Genom Med Inst, Danville, PA 17822 USA; [Jones, Laney K.; Gregor, Christina] Geisinger, Ctr Pharm Innovat & Outcomes, Danville, PA 17822 USA; [Seaton, Terry L.] Univ Hlth Sci & Pharm St Louis, St Louis, MO USA; [Seaton, Terry L.] Mercy Clin East Communities, St Louis, MO USA		Jones, LK (corresponding author), Geisinger, Genom Med Inst, Danville, PA 17822 USA.; Jones, LK (corresponding author), Geisinger, Ctr Pharm Innovat & Outcomes, Danville, PA 17822 USA.	ljones14@geisinger.edu	Rahm, Alanna Kulchak/AAG-1967-2021	Rahm, Alanna Kulchak/0000-0003-2513-9298; Jones, Laney/0000-0002-6182-5634	National Heart, Lung, and Blood Institute of the National Institutes of Health [K12HL137942]	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number K12HL137942 (LKJ, MSW).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2019, CIRCULATION, V139, pe42; Banerjee A, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000438; Barkas F., 2016, HELLENIC J ATHEROSCL, V7, P120; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Clough JD, 2019, J AM HEART ASSOC, V8, DOI [10.1161/jaha.118.010241, 10.1161/JAHA.118.010241]; deGoma EM, 2016, CIRC-CARDIOVASC GENE, V9, P240, DOI 10.1161/CIRCGENETICS.116.001381; Glasgow RE, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00064; Hope HF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0201196; Jones LK, 2020, RES SOC ADMIN PHARM, V16, P390, DOI 10.1016/j.sapharm.2019.06.006; Kedward J, 2003, BRIT J GEN PRACT, V53, P684; Khera AV, 2016, J AM COLL CARDIOL, V67, P2578, DOI 10.1016/j.jacc.2016.03.520; Khoury M, 2019, CTR DIS CONTR PREV; Kinnear FJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030290; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Martin-Ruiz E, 2018, J CARDIOVASC PHARM T, V23, P200, DOI 10.1177/1074248417745357; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Patton M. Q., 1990, QUALITATIVE EVALUATI; Powell BJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0209-1; Proctor EK, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-105; Shi ZM, 2014, INT J CARDIOL, V174, P834, DOI 10.1016/j.ijcard.2014.04.165; Strauss A., 1998, BASICS QUALITATIVE R	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244193	10.1371/journal.pone.0244193	http://dx.doi.org/10.1371/journal.pone.0244193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362269	gold, Green Published			2022-12-27	WOS:000603071600019
J	Feybesse, C; Lubart, T; Rasa, L; Ossom, C; Cavasino, V; Jacob, J; Lemonnier, T				Feybesse, Cyrille; Lubart, Todd; Rasa, Leela; Ossom, Charlotte; Cavasino, Victor; Jacob, Julien; Lemonnier, Thibaud			Social representation of fair price among professional photographers	PLOS ONE			English	Article								We investigated the social representation of fair price of French and English-speaking photographers using the free association method. In two independent studies, we performed a factorial analysis of correspondence of the words provided by the participants as well as a similitude analysis. The results indicated that "fair price" was mainly associated with time, effort and experience level of photographers. Both French- and English-speaking samples made similar associations around the concept of fair price but the order of importance varied. We observed some gender-related differences in both samples, although the relative number of male and female participants must be taken into consideration.	[Feybesse, Cyrille; Lubart, Todd] Univ Paris, LAPEA, Boulogne Billancourt, France; [Feybesse, Cyrille; Lubart, Todd] Univ Gustave Eiffel, Versailles, France; [Rasa, Leela; Ossom, Charlotte] Univ Paris, Boulogne Billancourt, France; [Rasa, Leela; Ossom, Charlotte; Cavasino, Victor; Jacob, Julien; Lemonnier, Thibaud] OCUS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; UDICE-French Research Universities; Universite Paris Cite	Feybesse, C (corresponding author), Univ Paris, LAPEA, Boulogne Billancourt, France.; Feybesse, C (corresponding author), Univ Gustave Eiffel, Versailles, France.	psicy@yahoo.com.br		Cyrille, Feybesse/0000-0001-7795-568X	 [Erganeo-Q84]		Funded study This research was financed by Julien Jacob and Thibaud Lemonnier who own the OCS company. URL: https://www.ocus.com/en/They also played a role in the design and in the decision of publishing the results. They did not have had any influence in the analysis, discussion or the discussion of the results. The following coauthors received grant to do this research: CF,TL, LR, CO, VC. The grant number: Erganeo-Q84. Here are the contributions and role played by each author: Ideas, formulation or evolution of overarching research goals and aims: TL, CF, VC, TL and JJ. Data Curation, management activities to annotate (produce metadata), scrub data and maintain research data (including software code, where it is necessary for interpreting the data itself) for initial use and later reuse: CF. Formal Analysis Application of statistical, mathematical, computational, or other formal techniques to analyze or synthesize study data: CF. Funding Acquisition, acquisition of the financial support for the project leading to this publication. TL, JJ. Investigation, conducting a research and investigation process, specifically performing the experiments, or data/evidence collection: LR, CO and VC. Methodology Development or design of methodology; creation of models: CF. Project Administration, management and coordination responsibility for the research activity planning and execution, TL. Resources, provision of study materials, reagents, materials, patients, laboratory samples, animals, instrumentation, computing resources, or other analysis tools: TL and VC. Software, programming, software development; designing computer programs; implementation of the computer code and supporting algorithms; testing of existing code components: CF. Supervision, oversight and leadership responsibility for the research activity planning and execution, including mentorship external to the core team: TL. Validation, verification, whether as a part of the activity or separate, of the overall replication/reproducibility of results/experiments and other research outputs. CYRILLE Visualization PreparatiYon, creation and/or presentation of the published work, specifically visualization/data presentation: CF. Writing -Original Draft Preparation Creation and/or presentation of the published work, specifically writing the initial draft (including substantive translation). CL, CO, LR. Writing -Review & Editing Preparation, creation and/or presentation of the published work by those from the original research group, specifically critical review, commentary or revision -including pre-or post-publication stages. CF, LR, CO, JJ, TL, TL.	Balineau G, 2012, DICT COMMERCE EQUITA; Bolton LE, 2003, J CONSUM RES, V29, P474, DOI 10.1086/346244; Dex S, 2000, WORK EMPLOY SOC, V14, P283, DOI 10.1177/09500170022118419; Doise W, 1992, REPRESENTATIONS SOCI; Europe W, 2013, 10 PRINCIPLES FAIR T; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Finkel N. J., 2001, NOT FAIR TYPOLOGY CO; Galand C., 2009, CAH INT PSYCHOL SOC, V84, P125, DOI 10.3917/cips.084.0125; Jodelet D., 1984, PSYCHOL SOCIALE, P357; Jolls C, 2002, NEW YORK U LAW REV, V77, P47; KAHNEMAN D, 1986, AM ECON REV, V76, P728; Manyika J., 2016, DIGITAL FINANCE ALL; Pouchain D, 2016, EC POLITIQUE, V70, P66; Vitaud L, 2019, FREELANCING FRANCE 2; World Economic Forum,, 2016, FUTURE JOBS EMPLOYME; Xia L, 2004, J MARKETING, V68, P1, DOI 10.1509/jmkg.68.4.1.42733	16	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243547	10.1371/journal.pone.0243547	http://dx.doi.org/10.1371/journal.pone.0243547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351796	Green Published, gold			2022-12-27	WOS:000603071400006
J	Anagnostopoulos, G; Moosavi, V				Anagnostopoulos, Georg; Moosavi, Vahid			StationRank: Aggregate dynamics of the Swiss railway	PLOS ONE			English	Article							NETWORK ANALYSIS; URBAN STREETS; ROAD; MODEL	Increasing availability and quality of actual, as opposed to scheduled, open transport data offers new possibilities for capturing the spatiotemporal dynamics of railway and other networks of social infrastructure. One way to describe such complex phenomena is in terms of stochastic processes. At its core, a stochastic model is domain-agnostic and algorithms discussed here have been successfully used in other applications, including Google's PageRank citation ranking. Our key assumption is that train routes constitute meaningful sequences analogous to sentences of literary text. A corpus of routes is thus susceptible to the same analytic tool-set as a corpus of sentences. With our experiment in Switzerland, we introduce a method for building Markov Chains from aggregated daily streams of railway traffic data. The stationary distributions under normal and perturbed conditions are used to define systemic risk measures with non-evident, valuable information about railway infrastructure.	[Anagnostopoulos, Georg; Moosavi, Vahid] Swiss Fed Inst Technol, Dept Architecture, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Anagnostopoulos, G (corresponding author), Swiss Fed Inst Technol, Dept Architecture, Zurich, Switzerland.	mail@anagno.com		Anagnostopoulos, Georg/0000-0001-7662-1178				[Anonymous], 2019, 1 DAT ACT DAT; Bartschi HP., 2011, SCHWEIZERISCHE CENTR; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Bellman R.E, 2015, ADAPTIVE CONTROL PRO; Berche B., 2010, PUBLIC TRANSPORT NET; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Buchel B, 2019, 8 INT C RAILW OP MOD, V69, P221; Crisostomi E, 2011, INT J CONTROL, V84, P633, DOI 10.1080/00207179.2011.568005; Dorbritz R, 2012, METHODOLOGY ASSESSIN; Doytchinov B., 2010, PI MU EPSILON J, V13, P69; Erath A, 2009, NETW SPAT ECON, V9, P379, DOI 10.1007/s11067-008-9074-7; Froyland G, 2001, NONLINEAR DYNAMICS AND STATISTICS, P281; Gleich DF, 2015, SIAM REV, V57, P321, DOI 10.1137/140976649; Graser A., 2020, KN J CARTOGR GEOGR I, V70, P3, DOI [10.1007/s42489-020-00039-y, DOI 10.1007/S42489-020-00039-Y]; Hackl J, 2019, APPL NETWORK SCI, V4, P1; Hunter J, 2002, RES LETT INF MATH SC, V3, P99; Kurant M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036114; Liu N., 2010, PERFORMANCE EVALUATI, P87, DOI [10.1007/978-3-642-25575-5_8, DOI 10.1007/978-3-642-25575-5_8]; Manser P, 2020, TRANSPORT RES A-POL, V137, P1, DOI 10.1016/j.tra.2020.04.011; Markov AA, 2006, SCI CONTEXT, V19, P591, DOI 10.1017/S0269889706001074; Moosavi V, 2017, ABS170903136 CORR; Moosavi V, 2013, P 2 ACM SIGKDD INT W, P10; Moosavi V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186746; Page L., 1999, 199966 STANF INFOLAB, P1999; Pearce DJ, 2005, IMPROVED ALGORITHM F; Porta S, 2006, ENVIRON PLANN B, V33, P705, DOI 10.1068/b32045; Porta S, 2006, PHYSICA A, V369, P853, DOI 10.1016/j.physa.2005.12.063; Sahin I, 2017, J RAIL TRANSPORT PLA, V7, P101, DOI 10.1016/j.jrtpm.2017.08.006; Salman S, 2018, COMPUT OPER RES, V99, P191, DOI 10.1016/j.cor.2018.06.015; von Ferber C, 2009, EUR PHYS J B, V68, P261, DOI 10.1140/epjb/e2009-00090-x; Wei S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211052	31	0	0	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244206	10.1371/journal.pone.0244206	http://dx.doi.org/10.1371/journal.pone.0244206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347493	gold, Green Published, Green Submitted			2022-12-27	WOS:000603071100020
J	Georges, JL; Gilles, F; Cochet, H; Bertrand, A; De Tournemire, M; Monguillon, V; Pasqualini, M; Prevot, A; Roger, G; Saba, J; Soltani, J; Koukabi-Fradelizi, M; Beressi, JP; Laureana, C; Prost, JF; Livarek, B				Georges, Jean-Louis; Gilles, Floriane; Cochet, Helene; Bertrand, Alisson; De Tournemire, Marie; Monguillon, Victorien; Pasqualini, Maeva; Prevot, Alix; Roger, Guillaume; Saba, Joseph; Soltani, Josephine; Koukabi-Fradelizi, Mehrsa; Beressi, Jean-Paul; Laureana, Cecile; Prost, Jean-Francois; Livarek, Bernard			Positive association of angiotensin II receptor blockers, not angiotensin-converting enzyme inhibitors, with an increased vulnerability to SARS-CoV-2 infection in patients hospitalized for suspected COVID-19 pneumonia	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; ACE2; HYPERTENSION; PROTECTS	Background Angiotensin-converting enzyme 2 is the receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses for entry into lung cells. Because ACE-2 may be modulated by angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), there is concern that patients treated with ACEIs and ARBs are at higher risk of coronavirus disease 2019 (COVID-19) pneumonia. Aim This study sought to analyze the association of COVID-19 pneumonia with previous treatment with ACEIs and ARBs. Materials and methods We retrospectively reviewed 684 consecutive patients hospitalized for suspected COVID-19 pneumonia and tested by polymerase chain reaction assay. Patients were split into two groups, according to whether (group 1, n = 484) or not (group 2, n = 250) COVID-19 was confirmed. Multivariable adjusted comparisons included a propensity score analysis. Results The mean age was 63.6 +/- 18.7 years, and 302 patients (44%) were female. Hypertension was present in 42.6% and 38.4% of patients in groups 1 and 2, respectively (P = 0.28). Treatment with ARBs was more frequent in group 1 than group 2 (20.7% vs. 12.0%, respectively; odds ratio [OR] 1.92, 95% confidence interval [CI] 1.23-2.98; P = 0.004). No difference was found for treatment with ACEIs (12.7% vs. 15.7%, respectively; OR 0.81, 95% CI 0.52-1.26; P = 0.35). Propensity score-matched multivariable logistic regression confirmed a significant association between COVID-19 and previous treatment with ARBs (adjusted OR 2.36, 95% CI 1.38-4.04; P = 0.002). Significant interaction between ARBs and ACEIs for the risk of COVID-19 was observed in patients aged > 60 years, women, and hypertensive patients. Conclusions This study suggests that ACEIs and ARBs are not similarly associated with COVID-19. In this retrospective series, patients with COVID-19 pneumonia more frequently had previous treatment with ARBs compared with patients without COVID-19.	[Georges, Jean-Louis; Gilles, Floriane; Cochet, Helene; Bertrand, Alisson; De Tournemire, Marie; Monguillon, Victorien; Pasqualini, Maeva; Prevot, Alix; Roger, Guillaume; Saba, Joseph; Soltani, Josephine; Prost, Jean-Francois; Livarek, Bernard] Ctr Hosp Versailles, Dept Cardiol, Le Chesnay, France; [Koukabi-Fradelizi, Mehrsa] Ctr Hosp Versailles, Emergency Dept, Le Chesnay, France; [Beressi, Jean-Paul] Ctr Hosp Versailles, Dept Diabetol, Le Chesnay, France; [Laureana, Cecile] Ctr Hosp Versailles, Dept Med Informat, Le Chesnay, France	Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay	Georges, JL (corresponding author), Ctr Hosp Versailles, Dept Cardiol, Le Chesnay, France.	jgeorges@ch-versailles.fr		Georges, Jean-Louis/0000-0003-4728-2220; ROGER, Guillaume/0000-0001-8310-7919				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, CELL, V181, DOI DOI 10.1016/j.cell.2020.02.052; [Anonymous], 2020, EUR HEART J, DOI DOI 10.1093/eurheartj/ehaa373; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Caldeira D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4260; De Simone G, POSITION STATEMENT E; Deborde T, 2018, J HYPERTENS, V36, P939, DOI 10.1097/HJH.0000000000001607; Ferrario CM, 2011, CURR OPIN NEPHROL HY, V20, P1, DOI 10.1097/MNH.0b013e3283406f57; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ishiyama Y, 2004, HYPERTENSION, V43, P970, DOI 10.1161/01.HYP.0000124667.34652.1a; Kaparianos A, 2011, CURR MED CHEM, V18, P3506, DOI 10.2174/092986711796642562; Kreutz R, 2020, CARDIOVASC RES, V116, P1688, DOI 10.1093/cvr/cvaa097; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mackey K, 2020, ANN INTERN MED, V173, P195, DOI 10.7326/M20-1515; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Mehta N, 2020, JAMA CARDIOL, V5, P1020, DOI 10.1001/jamacardio.2020.1855; Meng J, 2020, EMERG MICROBES INFEC, V9, P757, DOI 10.1080/22221751.2020.1746200; Meng Y, 2014, AM J RESP CELL MOL, V50, P723, DOI 10.1165/rcmb.2012-0451OC; Murray E, 2020, CARDIOVASC RES, V116, pE87, DOI 10.1093/cvr/cvaa096; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Rossi GP, 2020, ELIFE, V9, DOI 10.7554/eLife.57278; Wosten-van Asperen RM, 2011, J PATHOL, V225, P618, DOI 10.1002/path.2987	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244349	10.1371/journal.pone.0244349	http://dx.doi.org/10.1371/journal.pone.0244349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347477	gold, Green Published, Green Submitted			2022-12-27	WOS:000603071100047
J	Issimov, A; Taylor, DB; Zhugunissov, K; Kutumbetov, L; Zhanabayev, A; Kazhgaliyev, N; Akhmetaliyeva, A; Nurgaliyev, B; Shalmenov, M; Absatirov, G; Dushayeva, L; White, PJ				Issimov, Arman; Taylor, David B.; Zhugunissov, Kuandyk; Kutumbetov, Lespek; Zhanabayev, Assylbek; Kazhgaliyev, Nurlybay; Akhmetaliyeva, Aliya; Nurgaliyev, Birzhan; Shalmenov, Malik; Absatirov, Gaisa; Dushayeva, Laura; White, Peter J.			The combined effects of temperature and relative humidity parameters on the reproduction of Stomoxys species in a laboratory setting	PLOS ONE			English	Article							STABLE FLIES DIPTERA; NIGER-NIGER DIPTERA; MECHANICAL TRANSMISSION; FLY DIPTERA; CALCITRANS DIPTERA; FEVER VIRUS; MUSCIDAE; ABUNDANCE; MOSQUITOS; AEGYPTI	In this study, Stomoxys species (S. calcitrans, S. sitiens and S. indica) were examined to improve on the current technique for mass rearing using a method of combined incubation parameters. Moreover, the reproductive potential of immature forms at various stages of development was defined. Immature forms of stable flies were incubated according to species. There was no significant difference in the number of immature forms obtained among species incubated under the same conditions. Six incubation parameters were used in combination, at temperatures (T) of 32 degrees C, 27 degrees C and 22 degrees C and relative humidity (RH) of 90% and 70% RH. The combined method resulted in a higher number of eggs hatching at 32 degrees C and 90% humidity as well as an increase in the number of larva pupated and emergence of imago at 27 degrees C and 70% humidity.	[Issimov, Arman; White, Peter J.] Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Sydney, NSW, Australia; [Taylor, David B.] ARS, Agroecosyst Management Res Unit, USDA, Lincoln, NE USA; [Zhugunissov, Kuandyk; Kutumbetov, Lespek] Minist Educ & Sci Republ Kazakhstan, RGE Res Inst Biol Safety Problems, Comm Sci, Nur Sultan, Kazakhstan; [Zhanabayev, Assylbek; Kazhgaliyev, Nurlybay] Saken Seifullin Kazakh Agrotech Univ, Dept Vet Med, Nur Sultan, Kazakhstan; [Akhmetaliyeva, Aliya; Nurgaliyev, Birzhan; Shalmenov, Malik; Absatirov, Gaisa; Dushayeva, Laura] Zhangir Khan West Kazakhstan Agr Tech Univ, Dept Vet Med, Uralsk, Kazakhstan	University of Sydney; United States Department of Agriculture (USDA); Saken Seifullin Kazakh Agrotechnical University; Zhangir Khan West Kazakhstan Agrarian Technical University	Issimov, A (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Fac Sci, Sydney, NSW, Australia.	issimovarman@gmail.com	Жанабаев, Асылбек/AAE-1050-2021; Zhugunissov, Kuandyk/G-2087-2015; Issimov, Arman/HCI-0729-2022; Zhugunissov, Kuandyk/N-9990-2019; Nurgaliyev, Birzhan/AAI-9982-2021	Жанабаев, Асылбек/0000-0002-1267-3814; Nurgaliyev, Birzhan/0000-0001-5998-8250; White, Peter/0000-0002-9742-4939; Zhugunissov, Kuandyk/0000-0003-4238-5116; Issimov, Arman/0000-0002-0486-0054	Science Committee/Ministry of Education and Science/Republic of Kazakhstan [AP05135323]	Science Committee/Ministry of Education and Science/Republic of Kazakhstan(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	Issimov, A. This study was funded by research project #AP05135323 of the Science Committee/Ministry of Education and Science/Republic of Kazakhstan.	Baldacchino F, 2013, PARASITE, V20, DOI 10.1051/parasite/2013026; BERKEBILE DR, 1994, J ECON ENTOMOL, V87, P1555, DOI 10.1093/jee/87.6.1555; BRUCE WN, 1958, J ECON ENTOMOL, V51, P269, DOI 10.1093/jee/51.3.269; CAMPBELL JB, 1987, J ECON ENTOMOL, V80, P117, DOI 10.1093/jee/80.1.117; Campbell JB, 2001, J ECON ENTOMOL, V94, P780, DOI 10.1603/0022-0493-94.3.780; Chihota CM, 2001, EPIDEMIOL INFECT, V126, P317, DOI 10.1017/S0950268801005179; Cruz-Vazquez Carlos, 2004, Parasitologia Latinoamericana, V59, P99; Desquesnes M, 2004, VET PARASITOL, V119, P9, DOI 10.1016/j.vetpar.2003.10.015; Florez-Cuadros M, 2019, INSECTS, V10, DOI 10.3390/insects10070207; FOIL LD, 1983, AM J VET RES, V44, P155; Friesen K, 2018, JOVE-J VIS EXP, DOI 10.3791/57341; Gilles J, 2005, J MED ENTOMOL, V42, P959, DOI 10.1603/0022-2585(2005)042[0959:EOTOTR]2.0.CO;2; Gilles J, 2005, J MED ENTOMOL, V42, P260, DOI 10.1603/0022-2585(2005)042[0260:TEODAS]2.0.CO;2; Issimov A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030477; KUNZ SE, 1977, ANN ENTOMOL SOC AM, V70, P169, DOI 10.1093/aesa/70.2.169; Lysyk TJ, 1999, J MED ENTOMOL, V36, P382, DOI 10.1093/jmedent/36.3.382; Lysyk TJ, 1998, J MED ENTOMOL, V35, P107, DOI 10.1093/jmedent/35.2.107; LYSYK TJ, 1993, J MED ENTOMOL, V30, P888, DOI 10.1093/jmedent/30.5.888; Masmeatathip Roungthip, 2006, Kasetsart Journal Natural Sciences, V40, P872; McPheron LJ, 1996, ENVIRON ENTOMOL, V25, P665, DOI 10.1093/ee/25.3.665; MELLOR PS, 1987, RES VET SCI, V43, P109, DOI 10.1016/S0034-5288(18)30753-7; Mohamed Z., 2014, JURNAL TEKNOLOGI DYN, V5, P9; PARR H. C. M., 1959, BULL ENT RES, V50, P165, DOI 10.1017/S0007485300054481; RAMSAMY M, 1979, B ENTOMOL RES, V69, P477, DOI 10.1017/S0007485300018988; RASMUSSEN RL, 1981, ENVIRON ENTOMOL, V10, P798, DOI 10.1093/ee/10.5.798; Romero A, 2006, MED VET ENTOMOL, V20, P115, DOI 10.1111/j.1365-2915.2006.00602.x; Sohier C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56605-6; SUTHERLAND B, 1979, ONDERSTEPOORT J VET, V46, P223; Talley J, 2009, J MED ENTOMOL, V46, P1310, DOI 10.1603/033.046.0609; TURELL MJ, 1987, INFECT IMMUN, V55, P1859, DOI 10.1128/IAI.55.8.1859-1861.1987; TURELL MJ, 1990, AM J TROP MED HYG, V43, P677, DOI 10.4269/ajtmh.1990.43.677; WANG YHE, 1970, J ECON ENTOMOL, V63, P1666, DOI 10.1093/jee/63.5.1666; Zumpt F., 1973, TAXONOMY BIOL EC IMP	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0242794	10.1371/journal.pone.0242794	http://dx.doi.org/10.1371/journal.pone.0242794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347453	Green Published, gold			2022-12-27	WOS:000603071100039
J	Cassola, FM; Henaut, Y; Cedeno-Vazquez, JR; de la Cruz, FRM; Morales-Vela, B				Cassola, Francesca Maura; Henaut, Yann; Cedeno-Vazquez, Jose Rogelio; de la Cruz, Fausto Roberto; Morales-Vela, Benjamin			Temperament and sexual behaviour in the Furrowed Wood Turtle Rhinoclemmys areolata	PLOS ONE			English	Article							RHINOCEROS DICEROS-BICORNIS; ANIMAL TEMPERAMENT; GIANT PANDAS; US ZOOS; PERSONALITY; BOLDNESS; SUCCESS; CONSEQUENCES; CONSERVATION; POPULATIONS	The variation in temperament among animals has consequences for evolution and ecology. One of the primary effects of consistent behavioral differences is on reproduction. In chelonians some authors have focused on the study of temperament using different methods. In our research our first aim was i) establish a methodology to determine the degree of boldness among individuals Rhinoclemmys areolata. Our second aim was to ii) determine the role boldness plays during reproduction, with emphasis on courtship and copulation, considering a) the interactions between males and females, and b) competition between males. We used 16 sexually mature individuals of each sex. Males were observed in four different situations and 17 behavioral traits were recorded. We selected 12 traits that allowed us distinguish between the bolder and the shier individuals and found that five behavioral traits were specific for bolder individuals and five others for shier individuals. In a second step, we observed a male in presence of a female and recorded courtship behaviors and breeding attempts. Bolder individuals did not display courtship behaviors and just attempted to copulate. Shier individuals displayed courtship behaviors and copulation attempts were rarely observed. Finally, in the simulations that compared two males in the presence of a female we noticed that bolder individuals displayed courtship behaviors while the shier ones simply ignored the female. Our results first allowed us to determine which methodology is the best to determine temperament in turtles. Secondly, temperament seems to be an important factor in modulating interaction between males and females. Bolder individuals have an advantage during competition and display courtship behaviours only if other males are present. Shier males displayed courtship behaviors and only try to copulate when no competitors were present. These two different temperament-dependant strategies are discussed in terms of ecology, evolution and management.	[Cassola, Francesca Maura; Henaut, Yann; Cedeno-Vazquez, Jose Rogelio; Morales-Vela, Benjamin] El Colegio Frontera Sur, Unidad Chetumal, Chetmal, Quintana Roo, Mexico; [de la Cruz, Fausto Roberto] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Lab Herpetol, Mexico City, DF, Mexico	El Colegio de la Frontera Sur (ECOSUR); Universidad Nacional Autonoma de Mexico	Henaut, Y (corresponding author), El Colegio Frontera Sur, Unidad Chetumal, Chetmal, Quintana Roo, Mexico.	yhenaut@ecosur.mx	Mendez, Fausto/HGD-1205-2022; Cassola, Francesca/GMW-7657-2022; Cedeño, José/T-4737-2019	Cedeño, José/0000-0001-7763-902X; Henaut, Yann/0000-0002-8805-1739	Colegio de la Frontera del Sur; CONACYT-OEA-AMEXCID scholarship program	Colegio de la Frontera del Sur; CONACYT-OEA-AMEXCID scholarship program	CFM and CVJR. El Colegio de la Frontera del Sur and CONACYT-OEA-AMEXCID scholarship program for the funds needed to cover expenses for data collection and specimen maintenance.	Ah-King M, 2016, ECOL EVOL, V6, P4607, DOI 10.1002/ece3.2197; Ahtiainen JJ, 2004, P ROY SOC B-BIOL SCI, V271, P1839, DOI 10.1098/rspb.2004.2791; Angeloni L, 2010, ENCY ANIMAL BEHAV, P377; Artner H., 2009, EMYS, V16, P4; AUFFENBERG WALTER, 1966, HERPETOLOGICA, V22, P113; BEACH FA, 1967, ANIM BEHAV, V15, P546, DOI 10.1016/0003-3472(67)90057-7; Bremner-Harrison S, 2004, ANIM CONSERV, V7, P313, DOI 10.1017/S1367943004001490; Carlstead K, 1999, ZOO BIOL, V18, P17, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;17::AID-ZOO4&gt;3.0.CO;2-K; Carlstead K, 1999, ZOO BIOL, V18, P35, DOI 10.1002/(SICI)1098-2361(1999)18:1&lt;35::AID-ZOO5&gt;3.0.CO;2-L; Caro T, 2011, TRENDS ECOL EVOL, V26, P111, DOI 10.1016/j.tree.2010.12.008; Carter AW, 2016, PHYSIOL BEHAV, V155, P46, DOI 10.1016/j.physbeh.2015.11.034; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; CLARKE AS, 1995, AM J PRIMATOL, V37, P103, DOI 10.1002/ajp.1350370205; Cole EF, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0178; Cooper WE, 1999, BEHAV ECOL SOCIOBIOL, V47, P54, DOI 10.1007/s002650050649; Cicero VC, 2019, ESTUD CULT MAYA, V54, P285, DOI 10.19130/iifl.ecm.2019.54.994; Dingemanse NJ, 2015, TRENDS ECOL EVOL, V30, P88, DOI 10.1016/j.tree.2014.12.002; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Duckworth RA, 2007, P NATL ACAD SCI USA, V104, P15017, DOI 10.1073/pnas.0706174104; Dyer JRG, 2009, BEHAV ECOL, V20, P165, DOI 10.1093/beheco/arn129; Fox RA, 2014, ZOO BIOL, V33, P166, DOI 10.1002/zoo.21121; Freeman EW, 2009, ZOO BIOL, V28, P1, DOI 10.1002/zoo.20187; Germano JM, 2017, BEHAV ECOL, V28, P1075, DOI 10.1093/beheco/arx064; Gharnit E, 2020, BEHAV ECOL; Gowaty PA, 2003, ANIM BEHAV, V65, P95, DOI 10.1006/anbe.2002.2026; Ibanez A, 2018, BEHAV PROCESS, V157, P142, DOI 10.1016/j.beproc.2018.08.011; Ibanez A, 2014, NATURWISSENSCHAFTEN, V101, P803, DOI 10.1007/s00114-014-1219-6; Ibanez A, 2013, BEHAV ECOL SOCIOBIOL, V67, P541, DOI 10.1007/s00265-012-1473-6; Kashon EAF, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-017-2428-8; Kelleher SR, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2493-7; KLEIMAN DG, 1994, ZOO BIOL, V13, P411, DOI 10.1002/zoo.1430130503; Lees C. M., 2009, International Zoo Yearbook, V43, P6, DOI 10.1111/j.1748-1090.2008.00066.x; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V51, P461, DOI 10.1007/s00265-001-0447-x; MacKay JRD, 2015, ANIMALS, V5, P455, DOI 10.3390/ani5030366; Mafli A, 2011, ANIM BEHAV, V81, P859, DOI 10.1016/j.anbehav.2011.01.025; Martin-Wintle MS, 2017, BIOL CONSERV, V207, P27, DOI 10.1016/j.biocon.2017.01.010; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; McLelland GL, 2018, CURR OPIN PHYSIOL, V3, P25, DOI 10.1016/j.cophys.2018.02.005; Merrick MJ, 2017, BIOL CONSERV, V209, P34, DOI 10.1016/j.biocon.2017.01.021; Michelangeli M, 2019, BEHAV ECOL, V30, P393, DOI 10.1093/beheco/ary178; Michelangeli M, 2018, FUNCT ECOL, V32, P970, DOI 10.1111/1365-2435.13034; Miller W, 2010, BIOCOMPUT-PAC SYM, P43; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; PEREZ-HIGAREDA G, 1988, Great Basin Naturalist, V48, P263; Pervin L, 1999, HDB PERSONALITY THEO, DOI [10.1161/01.res.85.4.377, DOI 10.1161/01.RES.85.4.377]; Powell David, 2008, Acta Zoologica Sinica, V54, P169; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rhodin AGJ, 2018, CHELONIAN CONSERV BI, V17, P135, DOI 10.2744/CCB-1348.1; Saidenberg ABS, 2015, J ZOO WILDLIFE MED, V46, P704, DOI 10.1638/2013-0152.1; Sanchez-Macouzet O, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2843; Sasaki T, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0038; Schuett W, 2011, ANIM BEHAV, V81, P609, DOI 10.1016/j.anbehav.2010.12.006; Schwartz, 2005, EU LIFE NATURE PROJE, P51; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Tetley CL, 2012, ANIM WELFARE, V21, P463, DOI 10.7120/09627286.21.4.463; Teyssier A, 2014, BEHAV ECOL, V25, P723, DOI 10.1093/beheco/aru049; van Dijk PP, 2007, IUCN RED LIST THREAT; Vogt R.C, 2009, CHELONIAN RES MONOGR, V5, P22; White SJ, 2020, BEHAV ECOL, V31, P340, DOI 10.1093/beheco/arz198; Wilson ADM, 2009, BEHAV ECOL, V20, P231, DOI 10.1093/beheco/arp018; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	62	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244561	10.1371/journal.pone.0244561	http://dx.doi.org/10.1371/journal.pone.0244561			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378375	Green Published, gold			2022-12-27	WOS:000605651300038
J	Lemieux, J; Abdollah, V; Powelske, B; Kawchuk, G				Lemieux, James; Abdollah, Vahid; Powelske, Brandyn; Kawchuk, Greg			Comparing the effectiveness of group-based exercise to other non-pharmacological interventions for chronic low back pain: A systematic review	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; FITNESS PROGRAM; THERAPY; PHYSIOTHERAPY; DISABILITY	Background Low back pain (LBP) is the leading cause of disability worldwide with a substantial financial burden on individuals and health care systems. To address this, clinical practice guidelines often recommend non-pharmacological, non-invasive management approaches. One management approach that has been recommended and widely implemented for chronic LBP is group-based exercise programs, however, their clinical value compared with other non-pharmacological interventions has not been investigated systematically. Objective To compare the effectiveness of group-based exercise with other non-pharmacological interventions in people with chronic LBP. Methods Four electronic databases were searched by two independent reviewers. Only randomized controlled trials that compared group-based exercise with other non-pharmacological interventions for chronic LBP were eligible. Study quality was assessed using the Cochrane Handbook for systematic reviews of Interventions by two independent reviewers. Results Eleven studies were eligible. We identified strong evidence of no difference between group exercise and other non-pharmacologic interventions for disability level and pain scores 3-month post-intervention in people with chronic LBP. We could not find any strong or moderate evidence for or against the use of group-based exercise in the rehabilitation of people with chronic LBP for other time-points and health measurement outcomes. We found no statistically significant differences in disability and quality of life and pain between the group and individual non-pharmacological interventions that included exercise. Conclusion With this equivocal finding, group-based exercise may be a preferred choice given potential advantages in other domains not reviewed here such as motivation and cost. Further research in this area is needed to evaluate this possibility.	[Lemieux, James; Abdollah, Vahid; Powelske, Brandyn; Kawchuk, Greg] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada	University of Alberta	Kawchuk, G (corresponding author), Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada.	greg.kawchuk@ualberta.ca		Lemieux, James/0000-0001-9879-4766; Abdollah, Vahid/0000-0003-0672-8265				Bernstein IA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6748; Bialocerkowski A, 2010, INT J THER REHABIL, V17, P114, DOI 10.12968/ijtr.2010.17.3.46743; Bussieres AE, 2018, J MANIP PHYSIOL THER, V41, P265, DOI 10.1016/j.jmpt.2017.12.004; Carr JL, 2005, DISABIL REHABIL, V27, P929, DOI 10.1080/09638280500030639; Cornelius LR, 2011, J OCCUP REHABIL, V21, P259, DOI 10.1007/s10926-010-9261-5; Daulat, 2016, INT MUSCULOSKELET ME, V38, P97, DOI [10.1080/17536146.2016.1261234, DOI 10.1080/17536146.2016.1261234]; Francisco-Fernandez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147505; Frost H, 1998, PAIN, V75, P273, DOI 10.1016/S0304-3959(98)00005-0; FROST H, 1995, BRIT MED J, V310, P151, DOI 10.1136/bmj.310.6973.151; Froud R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164573; Harris A, 2017, EUR J PAIN, V21, P1397, DOI 10.1002/ejp.1041; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hurley DA, 2015, PAIN, V156, P131, DOI 10.1016/j.pain.0000000000000013; Jerosch-Herold C., 2005, BRIT J OCCUP THER, V68, P347, DOI [10.1177/030802260506800803, DOI 10.1177/030802260506800803]; Johnson RE, 2007, SPINE, V32, P1578, DOI 10.1097/BRS.0b013e318074f890; Lewis JS, 2005, SPINE, V30, P711, DOI 10.1097/01.brs.0000157469.27779.de; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Masharawi Y, 2013, J BACK MUSCULOSKELET, V26, P353, DOI 10.3233/BMR-130391; Moffett JAK, 2004, SPINE, V29, P1167, DOI 10.1097/00007632-200406010-00002; Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI 10.1016/j.jclinepi.2010.02.006; O'Keeffe M, 2020, BRIT J SPORT MED, V54, P782, DOI 10.1136/bjsports-2019-100780; O'Keeffe M, 2017, BRIT J SPORT MED, V51, P126, DOI 10.1136/bjsports-2015-095410; Reme SE, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-152; Ryan CG, 2010, MANUAL THER, V15, P382, DOI 10.1016/j.math.2010.03.003; Sahin N, 2011, J REHABIL MED, V43, P224, DOI 10.2340/16501977-0650; Sherman KJ, 2005, ANN INTERN MED, V143, P849, DOI 10.7326/0003-4819-143-12-200512200-00003; Stochkendahl MJ, 2018, EUR SPINE J, V27, P60, DOI 10.1007/s00586-017-5099-2; Underwood M, 2004, BMJ-BRIT MED J, V329, P1377, DOI 10.1136/bmj.38282.669225AE; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Wong JJ, 2017, EUR J PAIN, V21, P201, DOI 10.1002/ejp.931	32	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244588	10.1371/journal.pone.0244588	http://dx.doi.org/10.1371/journal.pone.0244588			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378346	gold, Green Published			2022-12-27	WOS:000605651300063
J	Schote, AB; Schiel, F; Schmitt, B; Winnikes, U; Frank, N; Gross, K; Croye, MA; Tarragon, E; Bekhit, A; Bobbili, DR; May, P; Schick, C; Meyer, J				Schote, Andrea B.; Schiel, Florian; Schmitt, Benedikt; Winnikes, Ulrike; Frank, Nicole; Gross, Katharina; Croye, Marie-Anne; Tarragon, Ernesto; Bekhit, Adam; Bobbili, Dheeraj Reddy; May, Patrick; Schick, Christoph; Meyer, Jobst			Genome-wide linkage analysis of families with primary hyperhidrosis	PLOS ONE			English	Article							TOXIN TYPE-A; PALMAR HYPERHIDROSIS; SWEAT GLANDS; PREVALENCE; FRAMEWORK; BURDEN; LOCUS; DNA	Primary focal hyperhidrosis (PFH, OMIM %144110) is a genetically influenced condition characterised by excessive sweating. Prevalence varies between 1.0-6.1% in the general population, dependent on ethnicity. The aetiology of PFH remains unclear but an autosomal dominant mode of inheritance, incomplete penetrance and variable phenotypes have been reported. In our study, nine pedigrees (50 affected, 53 non-affected individuals) were included. Clinical characterisation was performed at the German Hyperhidrosis Centre, Munich, by using physiological and psychological questionnaires. Genome-wide parametric linkage analysis with GeneHunter was performed based on the Illumina genome-wide SNP arrays. Haplotypes were constructed using easyLINKAGE and visualised via HaploPainter. Whole-exome sequencing (WES) with 100x coverage in 31 selected members (24 affected, 7 non-affected) from our pedigrees was achieved by next generation sequencing. We identified four genome-wide significant loci, 1q41-1q42.3, 2p14-2p13.3, 2q21.2-2q23.3 and 15q26.3-15q26.3 for PFH. Three pedigrees map to a shared locus at 2q21.2-2q23.3, with a genome-wide significant LOD score of 3.45. The chromosomal region identified here overlaps with a locus at chromosome 2q22.1-2q31.1 reported previously. Three families support 1q41-1q42.3 (LOD = 3.69), two families share a region identical by descent at 2p14-2p13.3 (LOD = 3.15) and another two families at 15q26.3 (LOD = 3.01). Thus, our results point to considerable genetic heterogeneity. WES did not reveal any causative variants, suggesting that variants or mutations located outside the coding regions might be involved in the molecular pathogenesis of PFH. We suggest a strategy based on whole-genome or targeted next generation sequencing to identify causative genes or variants for PFH.	[Schote, Andrea B.; Schiel, Florian; Schmitt, Benedikt; Winnikes, Ulrike; Frank, Nicole; Gross, Katharina; Croye, Marie-Anne; Tarragon, Ernesto; Meyer, Jobst] Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany; [Bekhit, Adam] Saarland Univ, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Bobbili, Dheeraj Reddy; May, Patrick] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Bioinformat Core, Esch Sur Alzette, Luxembourg; [Bobbili, Dheeraj Reddy] Megeno, Esch Sur Alzette, Luxembourg; [Schick, Christoph] German Hyperhidrosis Ctr, Munich, Germany	Universitat Trier; Universitatsklinikum des Saarlandes; University of Luxembourg	Meyer, J (corresponding author), Univ Trier, Inst Psychobiol, Dept Neurobehav Genet, Trier, Germany.	meyerjo@uni-trier.de	E, Tarragon/C-9342-2015; May, Patrick/N-1019-2019	E, Tarragon/0000-0001-9575-5585; May, Patrick/0000-0001-8698-3770; Schiel, Florian/0000-0003-3708-1927; Bobbili, Dheeraj/0000-0002-1368-9623; Croye, Marie-Anne/0000-0001-6077-0582	Luxembourg National Research Fund (FNR) within the National Centre for Excellence in Research on Parkinson's disease (NCER-PD); EU; European Union [692320]; Research Fund of the University of Trier; Alexander von Humboldt Postdoctoral Fellowship programme; State Graduate Sponsorship Program of the State Rhineland Palatinate; University Research Priority Program "Psychobiology of Stress" - State Rhineland-Palatinate; Open Access Fund of Trier University; German Research Foundation (DFG)	Luxembourg National Research Fund (FNR) within the National Centre for Excellence in Research on Parkinson's disease (NCER-PD); EU(European Commission); European Union(European Commission); Research Fund of the University of Trier; Alexander von Humboldt Postdoctoral Fellowship programme(Alexander von Humboldt Foundation); State Graduate Sponsorship Program of the State Rhineland Palatinate; University Research Priority Program "Psychobiology of Stress" - State Rhineland-Palatinate; Open Access Fund of Trier University; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Luxembourg National Research Fund (FNR) within the National Centre for Excellence in Research on Parkinson's disease (NCER-PD to DRB, PM), the EU Joint ProgramNeurodegenerative Diseases (JPND; COURAGE-PD to DRB, PM), by the European Union's Horizon2020 research and innovation program under grant agreement No 692320 (WIDESPREAD; CENTRE-PD to PM). The Research Fund of the University of Trier provided initial funding of the study to JM. Parts of the computational work in this study were performed on the highperformance cluster of the University of Luxembourg (https://hpc.uni.lu).Further funding was provided by the Alexander von Humboldt Postdoctoral Fellowship programme to ET, and the State Graduate Sponsorship Program of the State RhinelandPalatinate to KG. JM and ABS were supported by the University Research Priority Program "Psychobiology of Stress" funded by the State Rhineland-Palatinate. The APC was funded by the Open Access Fund of Trier University and the German Research Foundation (DFG) within the Open Access Publishing funding program. DRB is an employee of Megeno S.A. Megeno S.A. provided support in the form of salaries for authors [DRB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; [Anonymous], 2018, DIAB PRAKT, V4, P1, DOI DOI 10.1186/s40798-017-0116-x; Aoki KR, 2001, EUR J NEUROL, V8, P21, DOI 10.1046/j.1468-1331.2001.00035.x; Arvaniti M, 2016, J NEUROCHEM, V138, P806, DOI 10.1111/jnc.13718; Augustin M, 2013, DERMATOLOGY, V227, P10, DOI 10.1159/000351292; Bajaj V, 2007, BRIT J DERMATOL, V157, P118, DOI 10.1111/j.1365-2133.2007.07884.x; Bobbili DR, 2018, EUR J HUM GENET, V26, P258, DOI 10.1038/s41431-017-0034-x; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen J, 2015, BRIT J DERMATOL, V172, P1150, DOI 10.1111/bjd.13383; Darvas M, 2009, EUR NEUROPSYCHOPHARM, V19, P670, DOI 10.1016/j.euroneuro.2009.03.007; de Moura NB, 2013, ANN THORAC SURG, V95, P465, DOI 10.1016/j.athoracsur.2012.10.068; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doolittle J, 2016, ARCH DERMATOL RES, V308, P743, DOI 10.1007/s00403-016-1697-9; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greotti E, 2019, CELL CALCIUM, V79, P44, DOI 10.1016/j.ceca.2019.02.005; Gross KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092412; Harker M, 2013, SKIN PHARMACOL PHYS, V26, P92, DOI 10.1159/000346930; Higashimoto I, 2006, AM J MED GENET A, V140A, P567, DOI 10.1002/ajmg.a.31127; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Kaufmann H, 2003, CLIN AUTON RES, V13, P96, DOI 10.1007/s10286-003-0082-x; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kowalski JW, 2004, J AM ACAD DERMATOL, V50, pP51, DOI 10.1016/j.jaad.2003.10.202; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lewis V, 2004, J INVEST DERM SYMP P, V9, P169, DOI 10.1111/j.1087-0024.2004.09113.x; Liu YD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153719; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Naumann MK, 2002, BRIT J DERMATOL, V147, P1218, DOI 10.1046/j.1365-2133.2002.05059.x; Noppen M, 1997, EUR J CLIN INVEST, V27, P202, DOI 10.1046/j.1365-2362.1997.870647.x; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Ochoa V, 2016, FASEB J, V30, P1109, DOI 10.1096/fj.15-274548; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Ro KM, 2002, J VASC SURG, V35, P382, DOI 10.1067/mva.2002.119507; Ruchinskas RA, 2002, BRIT J DERMATOL, V147, P733, DOI 10.1046/j.1365-2133.2002.04857.x; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; Schlereth T, 2009, DTSCH ARZTEBL INT, V106, P32, DOI 10.3238/arztebl.2009.0032; Shayesteh A, 2016, DERMATOLOGY, V232, P586, DOI 10.1159/000448032; Simes BC, 2018, CLIN COSMET INV DERM, V11, P477, DOI 10.2147/CCID.S176842; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sonntag M, 2004, ZFA Z F R ALLGEMEINM, V80, P289, DOI [10.1055/s-2004-822835, DOI 10.1055/S-2004-822835]; Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; UNO H, 1977, J INVEST DERMATOL, V69, P112, DOI 10.1111/1523-1747.ep12497915; Vervloessem T, 2015, BBA-MOL CELL RES, V1853, P1992, DOI 10.1016/j.bbamcr.2014.12.006; Walling HW, 2012, J AM ACAD DERMATOL, V66, P387, DOI 10.1016/j.jaad.2011.01.023; Wechter Todd, 2019, Skin Therapy Lett, V24, P1; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105	48	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244565	10.1371/journal.pone.0244565	http://dx.doi.org/10.1371/journal.pone.0244565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378362	Green Published, gold			2022-12-27	WOS:000605651300025
J	Contijoch, F; Han, YC; Iyer, SK; Kellman, P; Gualtieri, G; Elliott, MA; Berisha, S; Gorman, JH; Gorman, RC; Pilla, JJ; Witschey, WRT				Contijoch, Francisco; Han, Yuchi; Kamesh Iyer, Srikant; Kellman, Peter; Gualtieri, Gene; Elliott, Mark A.; Berisha, Sebastian; Gorman, Joseph H., III; Gorman, Robert C.; Pilla, James J.; Witschey, Walter R. T.			Closed-loop control of k-space sampling via physiologic feedback for cine MRI	PLOS ONE			English	Article							NAVIGATOR ECHOES; ADAPTIVE TECHNIQUE; RECONSTRUCTION; ARTIFACTS	Background Segmented cine cardiac MRI combines data from multiple heartbeats to achieve high spatiotemporal resolution cardiac images, yet predefined k-space segmentation trajectories can lead to suboptimal k-space sampling. In this work, we developed and evaluated an autonomous and closed-loop control system for radial k-space sampling (ARKS) to increase sampling uniformity. Methods The closed-loop system autonomously selects radial k-space sampling trajectory during live segmented cine MRI and attempts to optimize angular sampling uniformity by selecting views in regions of k-space that were not previously well-sampled. Sampling uniformity and the ability to detect cardiac phase in vivo was assessed using ECG data acquired from 10 normal subjects in an MRI scanner. The approach was then implemented with a fast gradient echo sequence on a whole-body clinical MRI scanner and imaging was performed in 4 healthy volunteers. The closed-loop k-space trajectory was compared to random, uniformly distributed and golden angle view trajectories via measurement of k-space uniformity and the point spread function. Lastly, an arrhythmic dataset was used to evaluate a potential application of the approach. Results The autonomous trajectory increased k-space sampling uniformity by 15 +/- 7%, main lobe point spread function (PSF) signal intensity by 6 +/- 4%, and reduced ringing relative to golden angle sampling. When implemented, the autonomous pulse sequence prescribed radial view angles faster than the scan TR (0.98 +/- 0.01 ms, maximum = 1.38 ms) and increased k-space sampling mean uniformity by 10 +/- 11%, decreased uniformity variability by 44 +/- 12%, and increased PSF signal ratio by 6 +/- 6% relative to golden angle sampling. Conclusion The closed-loop approach enables near-uniform radial sampling in a segmented acquisition approach which was higher than predetermined golden-angle radial sampling. This can be utilized to increase the sampling or decrease the temporal footprint of an acquisition and the closed-loop framework has the potential to be applied to patients with complex heart rhythms.	[Contijoch, Francisco] Univ Calif San Diego, Dept Bioengn, Jacobs Sch Engn, San Diego, CA 92103 USA; [Contijoch, Francisco] Univ Calif San Diego, Dept Radiol, Sch Med, San Diego, CA 92103 USA; [Han, Yuchi] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kamesh Iyer, Srikant; Elliott, Mark A.; Berisha, Sebastian; Pilla, James J.; Witschey, Walter R. T.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kellman, Peter] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA; [Gualtieri, Gene] AJO, Philadelphia, PA USA; [Gorman, Joseph H., III; Gorman, Robert C.] Univ Penn, Dept Surg, Perelman Sch Med, Philadelphia, PA 19104 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Pennsylvania; Pennsylvania Medicine	Contijoch, F (corresponding author), Univ Calif San Diego, Dept Bioengn, Jacobs Sch Engn, San Diego, CA 92103 USA.; Contijoch, F (corresponding author), Univ Calif San Diego, Dept Radiol, Sch Med, San Diego, CA 92103 USA.	fcontijoch@ucsd.edu	Contijoch, Francisco/H-6279-2019; Iyer, Srikant Kamesh/AAK-5907-2021	Contijoch, Francisco/0000-0001-9616-3274; 	NIH [F31 HL120580, R00 HL108157, R01 HL063954]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grants F31 HL120580, R00 HL108157, R01 HL063954. The funder provided support in the form of salaries for authors FC, SKI, SB, RCG, and WRTW but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. GG is currently employed at AJO but AJO did not play a role in the study as GG was previously employed at Drexel University.	AHN CB, 1986, IEEE T MED IMAGING, V5, P2, DOI 10.1109/TMI.1986.4307732; BAILES DR, 1985, J COMPUT ASSIST TOMO, V9, P835, DOI 10.1097/00004728-198507010-00039; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; BERGIN CJ, 1991, RADIOLOGY, V180, P845, DOI 10.1148/radiology.180.3.1871305; Chava R, 2019, MAGN RESON MED, V81, P1726, DOI 10.1002/mrm.27533; Contijoch F, 2015, J CARDIOVASC MAGN R, V17, P37, DOI [10.1186/1532-429X-17-S1-P37, DOI 10.1186/1532-429X-17-S1-P37]; Contijoch F, 2017, MAGN RESON MED, V78, P678, DOI 10.1002/mrm.26381; Contijoch F, 2015, J CARDIOVASC MAGN R, V17, DOI 10.1186/s12968-015-0146-9; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; Feinberg DA, 2010, MAGN RESON MED, V63, P290, DOI 10.1002/mrm.22250; FU ZW, 1995, MAGNET RESON MED, V34, P746, DOI 10.1002/mrm.1910340514; Glover G H, 1988, Magn Reson Annu, P299; GLOVER GH, 1992, MAGNET RESON MED, V28, P275, DOI 10.1002/mrm.1910280209; Han F, 2016, MAGN RESON MED, V76, P94, DOI 10.1002/mrm.25861; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24743, 10.1002/mrm.24389]; Hundley WG, 2010, CIRCULATION, V121, P2462, DOI 10.1161/CIR.0b013e3181d44a8f; Iyer SK, 2016, MED PHYS, V43, P1969, DOI 10.1118/1.4943643; Jackson C, 2003, LECT NOTES COMPUT SC, V2878, P541; KORIN HW, 1990, RADIOLOGY, V177, P217, DOI 10.1148/radiology.177.1.2399320; LAUTERBUR PC, 1989, CLIN ORTHOP RELAT R, P3; Lauzon ML, 1996, MAGNET RESON MED, V36, P940, DOI 10.1002/mrm.1910360617; Lelieveldt BPF, 2001, RADIOLOGY, V221, P537, DOI 10.1148/radiol.2212010177; LENZ GW, 1989, MAGN RESON IMAGING, V7, P445, DOI 10.1016/0730-725X(89)90399-8; Lu XG, 2011, LECT NOTES COMPUT SC, V6893, P479, DOI 10.1007/978-3-642-23626-6_59; Markl M, 2007, J MAGN RESON IMAGING, V25, P824, DOI 10.1002/jmri.20871; MEYER CH, 1992, MAGNET RESON MED, V28, P202, DOI 10.1002/mrm.1910280204; Moenninghoff C, 2013, ACAD RADIOL, V20, P721, DOI 10.1016/j.acra.2013.01.004; Narayanan S, 2004, J ACOUST SOC AM, V115, P1771, DOI 10.1121/1.1652588; Nitta S, 2013, MAGN RESON MATER PHY, V26, P451, DOI 10.1007/s10334-012-0361-4; Norris DG, 2001, MAGNET RESON MED, V45, P729, DOI 10.1002/mrm.1099; Ooi MB, 2009, MAGN RESON MED, V62, P943, DOI 10.1002/mrm.22082; Peters DC, 2006, MAGN RESON MED, V55, P396, DOI 10.1002/mrm.20782; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; Scheffler K, 1998, MAGNET RESON MED, V40, P474, DOI 10.1002/mrm.1910400319; Schulz J, 2012, MAGN RESON MATER PHY, V25, P443, DOI 10.1007/s10334-012-0320-0; Seiberlich N, 2007, MAGN RESON MED, V58, P1257, DOI 10.1002/mrm.21435; Uribe S, 2007, MAGN RESON MED, V57, P606, DOI 10.1002/mrm.21156; Walsh DO, 2000, MAGNET RESON MED, V43, P682, DOI 10.1002/(SICI)1522-2594(200005)43:5<682::AID-MRM10>3.0.CO;2-G; Welch EB, 2002, MAGN RESON MED, V47, P32, DOI 10.1002/mrm.10012; Winkelmann S, 2007, IEEE T MED IMAGING, V26, P68, DOI 10.1109/TMI.2006.885337; Witschey WRT, 2014, ANN THORAC SURG, V97, P1597, DOI 10.1016/j.athoracsur.2014.01.010; Zhang S, 2010, J MAGN RESON IMAGING, V31, P101, DOI 10.1002/jmri.21987	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244286	10.1371/journal.pone.0244286	http://dx.doi.org/10.1371/journal.pone.0244286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373391	Green Submitted, Green Published, gold			2022-12-27	WOS:000603612300019
J	Durmo, F; Rydhog, A; Testud, F; Latt, J; Schmitt, B; Rydelius, A; Englund, E; Bengzon, J; van Zijl, P; Knutsson, L; Sundgren, PC				Durmo, Faris; Rydhog, Anna; Testud, Frederik; Latt, Jimmy; Schmitt, Benjamin; Rydelius, Anna; Englund, Elisabet; Bengzon, Johan; van Zijl, Peter; Knutsson, Linda; Sundgren, Pia C.			Assessment of Amide proton transfer weighted (APTw) MRI for pre-surgical prediction of final diagnosis in gliomas	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; CONTRAST ENHANCEMENT; ENDOGENOUS PROTEIN; DIFFUSE GLIOMAS; MANN-WHITNEY; IDH MUTATION; BRAIN-TUMORS; T-TEST; DIFFERENTIATION; GLIOBLASTOMA	Purpose Radiological assessment of primary brain neoplasms, both high (HGG) and low grade tumors (LGG), based on contrast-enhancement alone can be inaccurate. We evaluated the radiological value of amide proton transfer weighted (APTw) MRI as an imaging complement for pre-surgical radiological diagnosis of brain tumors. Methods Twenty-six patients were evaluated prospectively; (22 males, 4 females, mean age 55 years, range 26-76 years) underwent MRI at 3T using T1-MPRAGE pre- and post-contrast administration, conventional T2w, FLAIR, and APTw imaging pre-surgically for suspected primary/secondary brain tumor. Assessment of the additional value of APTw imaging compared to conventional MRI for correct pre-surgical brain tumor diagnosis. The initial radiological pre-operative diagnosis was based on the conventional contrast-enhanced MR images. The range, minimum, maximum, and mean APTw signals were evaluated. Conventional normality testing was performed; with boxplots/outliers/skewness/kurtosis and a Shapiro-Wilk's test. Mann-Whitney U for analysis of significance for mean/max/min and range APTw signal. A logistic regression model was constructed for mean, max, range and Receiver Operating Characteristic (ROC) curves calculated for individual and combined APTw signals Results Conventional radiological diagnosis prior to surgery/biopsy was HGG (8 patients), LGG (12 patients), and metastasis (6 patients). Using the mean and maximum: APTw signal would have changed the pre-operative evaluation the diagnosis in 8 of 22 patients (two LGGs excluded, two METs excluded). Using a cut off value of >2.0% for mean APTw signal integral, 4 of the 12 radiologically suspected LGG would have been diagnosed as high grade glioma, which was confirmed by histopathological diagnosis. APTw mean of >2.0% and max >2.48% outperformed four separate clinical radiological assessments of tumor type, P-values = .004 and = .002, respectively. Conclusions Using APTw-images as part of the daily clinical pre-operative radiological evaluation may improve diagnostic precision in differentiating LGGs from HGGs, with potential improvement of patient management and treatment.	[Durmo, Faris; Sundgren, Pia C.] Lund Univ, Dept Clin Sci, Div Radiol, Lund, Sweden; [Rydhog, Anna; Latt, Jimmy; Sundgren, Pia C.] Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden; [Testud, Frederik] Siemens Healthcare AB, Malmo, Sweden; [Schmitt, Benjamin] Siemens Healthcare Pty Ltd, Bayswater, Australia; [Rydelius, Anna] Lund Univ, Dept Clin Sci, Div Neurol, Lund, Sweden; [Englund, Elisabet] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; [Bengzon, Johan] Lund Univ, Dept Clin Sci, Div Neurosurg, Lund, Sweden; [van Zijl, Peter; Knutsson, Linda] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [van Zijl, Peter] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA; [Knutsson, Linda] Lund Univ, Dept Med Radiat Phys, Lund, Sweden; [Sundgren, Pia C.] Lund Univ, Bioimaging Ctr, LBIC, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Siemens AG; Lund University; Lund University; Lund University; Johns Hopkins University; Kennedy Krieger Institute; Lund University; Lund University	Sundgren, PC (corresponding author), Lund Univ, Dept Clin Sci, Div Radiol, Lund, Sweden.; Sundgren, PC (corresponding author), Skane Univ Hosp, Ctr Med Imaging & Physiol, Lund, Sweden.; Sundgren, PC (corresponding author), Lund Univ, Bioimaging Ctr, LBIC, Lund, Sweden.	pia.sundgren@med.lu.se	Knutsson, Linda/F-8554-2011	Knutsson, Linda/0000-0002-4263-113X; Durmo, Faris/0000-0001-7364-5991; Sundgren, Pia/0000-0001-9237-1236	Swedish Research Council [2015-04170, 2019-03637, 2016-02199-3, 201901162]; Swedish Cancer Society [CAN 2015/251, CAN 2018/550, CAN 2018/468, CAN 2016/365]; Swedish Brain Foundation [FO2017-0236]; ALF Regional Research Funds [F 2018/1490]; NIH [P41EB015909, EB015032]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Brain Foundation; ALF Regional Research Funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following funders: Swedish Research Council grants (Grant No. 2015-04170 and Grant No. 2019-03637 to LK; Grant No. 2016-02199-3 and Grant No. 201901162 to PCS), Swedish Cancer Society grants (Grant No. CAN 2015/251 and Grant No. CAN 2018/550 to LK; Grant No. CAN 2018/468 and Grant No. CAN 2016/365 to PCS), Swedish Brain Foundation (Grant No. FO2017-0236 to LK), ALF Regional Research Funds (F 2018/1490 to PCS), and NIH grants (Grant No. P41EB015909 and Grant No. EB015032 to PvZ). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial vendor Siemens Healthcare provided support in the form of salaries for authors FT and BS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agnihotri S, 2013, ARCH IMMUNOL THER EX, V61, P25, DOI 10.1007/s00005-012-0203-0; Bai Y, 2017, ONCOTARGET, V8, P5834, DOI 10.18632/oncotarget.13970; Batash R, 2017, CURR MED CHEM, V24, P3002, DOI 10.2174/0929867324666170516123206; Choi S, 2018, NEURO-ONCOLOGY, V20, P1300, DOI 10.1093/neuonc/noy016; Choi YS, 2017, EUR RADIOL, V27, P3181, DOI 10.1007/s00330-017-4732-0; Christensen HC, 2003, NEUROSURGERY, V52, P1327, DOI 10.1227/01.NEU.0000064802.46759.53; Dobes Martin, 2011, Surg Neurol Int, V2, P176, DOI 10.4103/2152-7806.90696; Fang XP, 2012, J PROTEOME RES, V11, P3937, DOI 10.1021/pr300303t; Fay MP, 2010, STAT SURV, V4, P1, DOI 10.1214/09-SS051; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fouke SJ, 2015, J NEURO-ONCOL, V125, P457, DOI 10.1007/s11060-015-1908-9; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Ginsberg LE, 1998, SURG NEUROL, V49, P436, DOI 10.1016/S0090-3019(97)00360-1; Halligan S, 2015, EUR RADIOL, V25, P932, DOI 10.1007/s00330-014-3487-0; Heo HY, 2019, MAGN RESON MED, V82, P1812, DOI 10.1002/mrm.27875; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Hoshide R, 2016, WORLD NEUROSURG, V94, P561, DOI 10.1016/j.wneu.2016.07.082; Jiang SS, 2019, CLIN CANCER RES, V25, P552, DOI 10.1158/1078-0432.CCR-18-1233; Jiang SS, 2018, EUR RADIOL, V28, P2115, DOI 10.1007/s00330-017-5182-4; Jiang SS, 2017, MAGN RESON MED, V78, P1100, DOI 10.1002/mrm.26820; Jiang SS, 2017, EUR J CANCER, V83, P9, DOI 10.1016/j.ejca.2017.06.009; Jiang SS, 2016, EUR RADIOL, V26, P64, DOI 10.1007/s00330-015-3805-1; Joo B, 2018, EUR RADIOL, V28, P331, DOI 10.1007/s00330-017-4962-1; Kattar MM, 1997, HUM PATHOL, V28, P1166, DOI 10.1016/S0046-8177(97)90255-0; Kim MJ, 2008, ACTA RADIOL, V49, P450, DOI 10.1080/02841850701881820; KONDZIOLKA D, 1993, J NEUROSURG, V79, P533, DOI 10.3171/jns.1993.79.4.0533; Law M, 2003, AM J NEURORADIOL, V24, P1989; MILTON C, 1964, J AM STAT ASSOC, V59, P925; Nguyen TB, 2012, AM J NEURORADIOL, V33, P1539, DOI 10.3174/ajnr.A3012; Odreman F, 2005, J PROTEOME RES, V4, P698, DOI 10.1021/pr0498180; Paech D, 2019, EUR RADIOL, V29, P4957, DOI 10.1007/s00330-019-06066-2; Paech D, 2018, NEURO-ONCOLOGY, V20, P1661, DOI 10.1093/neuonc/noy073; Sakata A, 2015, J NEURO-ONCOL, V122, P339, DOI 10.1007/s11060-014-1715-8; Schure JR, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4125; Shapiro ASS, 2017, AM SOC QUALITY ANAL, V14, P355; Suh CH, 2019, NEURORADIOLOGY, V61, P525, DOI 10.1007/s00234-018-02152-2; Togao O, 2017, EUR RADIOL, V27, P578, DOI 10.1007/s00330-016-4328-0; Togao O, 2014, NEURO-ONCOLOGY, V16, P441, DOI 10.1093/neuonc/not158; Urhie O, 2018, WORLD NEUROSURG, V115, pE59, DOI 10.1016/j.wneu.2018.03.163; van Zijl PCM, 2018, NEUROIMAGE, V168, P222, DOI 10.1016/j.neuroimage.2017.04.045; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Wen ZB, 2010, NEUROIMAGE, V51, P616, DOI 10.1016/j.neuroimage.2010.02.050; Woehrer A, 2014, CURR OPIN NEUROL, V27, P666, DOI 10.1097/WCO.0000000000000144; Zhang JX, 2018, MOL IMAGING BIOL, V20, P623, DOI 10.1007/s11307-017-1154-y; Zhang Y, 2019, MAGN RESON MED, V82, P2046, DOI 10.1002/mrm.27881; Zhao XN, 2013, MOL IMAGING BIOL, V15, P114, DOI 10.1007/s11307-012-0563-1; Zhou J, 2019, J MAGN RESON IMAGING; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; ZIMMERMAN DW, 1987, J EXP EDUC, V55, P171, DOI 10.1080/00220973.1987.10806451	50	6	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244003	10.1371/journal.pone.0244003	http://dx.doi.org/10.1371/journal.pone.0244003			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373375	Green Published, gold			2022-12-27	WOS:000603612300024
J	Mfarej, MG; Skibbens, RV				Mfarej, Michael G.; Skibbens, Robert V.			DNA damage induces Yap5-dependent transcription of ECO1/CTF7 in Saccharomyces cerevisiae	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; S-PHASE; OXIDATIVE STRESS; ROBERTS-SYNDROME; SYSTEMS-APPROACH; ATM ACTIVATION; CELL-CYCLE; ESTABLISHMENT; REPLICATION	Yeast Eco1 (ESCO2 in humans) acetyltransferase converts chromatin-bound cohesins to a DNA tethering state, thereby establishing sister chromatid cohesion. Eco1 establishes cohesion during DNA replication, after which Eco1 is targeted for degradation by SCF E3 ubiquitin ligase. SCF E3 ligase, and sequential phosphorylations that promote Eco1 ubiquitination and degradation, remain active throughout the M phase. In this way, Eco1 protein levels are high during S phase, but remain low throughout the remaining cell cycle. In response to DNA damage during M phase, however, Eco1 activity increases-providing for a new wave of cohesion establishment (termed Damage-Induced Cohesion, or DIC) which is critical for efficient DNA repair. To date, little evidence exists as to the mechanism through which Eco1 activity increases during M phase in response to DNA damage. Possibilities include that either the kinases or E3 ligase, that target Eco1 for degradation, are inhibited in response to DNA damage. Our results reveal instead that the degradation machinery remains fully active during M phase, despite the presence of DNA damage. In testing alternate models through which Eco1 activity increases in response to DNA damage, the results reveal that DNA damage induces new transcription of ECO1 and at a rate that exceeds the rate of Eco1 turnover, providing for rapid accumulation of Eco1 protein. We further show that DNA damage induction of ECO1 transcription is in part regulated by Yap5-a stress-induced transcription factor. Given the role for mutated ESCO2 (homolog of ECO1) in human birth defects, this study highlights the complex nature through which mutation of ESCO2, and defects in ESCO2 regulation, may promote developmental abnormalities and contribute to various diseases including cancer.	[Mfarej, Michael G.; Skibbens, Robert V.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	Lehigh University	Skibbens, RV (corresponding author), Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA.	rvs3@lehigh.edu		Skibbens, Robert/0000-0003-4216-8306	National Institutes of Health [R15GM110631]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an award to R.V.S. from the National Institutes of Health [R15GM110631] and a research fellowship award to MGM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi HH, 2016, CONGENIT ANOM, V56, P154, DOI 10.1111/cga.12151; Banerji R, 2017, BIOL OPEN, V6, P1802, DOI 10.1242/bio.026013; Banerji R, 2017, DEV DYNAM, V246, P881, DOI 10.1002/dvdy.24510; Banerji R, 2016, DEV DYNAM, V245, P7, DOI [10.1002/DVDY.24354, 10.1002/dvdy.24354]; Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bender D, 2020, P NATL ACAD SCI USA, V117, P1081, DOI 10.1073/pnas.1911936117; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Carson DR, 2001, P NATL ACAD SCI USA, V98, P8270, DOI 10.1073/pnas.131022798; Carter CD, 2005, MOL CELL BIOL, V25, P10273, DOI 10.1128/MCB.25.23.10273-10285.2005; Choi JE, 2019, J MICROBIOL, V57, P9, DOI 10.1007/s12275-019-8475-2; Choi JE, 2018, FREE RADICAL BIO MED, V129, P97, DOI 10.1016/j.freeradbiomed.2018.09.015; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Columbo EA, 2019, FRONT PEDIATR, V7, P2010; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; Evert BA, 2004, J BIOL CHEM, V279, P22585, DOI 10.1074/jbc.M400468200; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Gordillo M, 2008, HUM MOL GENET, V17, P2172, DOI 10.1093/hmg/ddn116; Guacci V, 2012, MOL BIOL CELL, V23, P729, DOI 10.1091/mbc.E11-08-0696; Guo Z, 2010, CELL CYCLE, V9, P4805, DOI 10.4161/cc.9.24.14323; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Heidinger-Pauli JM, 2008, MOL CELL, V31, P47, DOI 10.1016/j.molcel.2008.06.005; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; Kenna MA, 2003, MOL CELL BIOL, V23, P2999, DOI 10.1128/MCB.23.8.2999-3007.2003; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SA, 2010, CELL CYCLE, V9, P3315, DOI 10.4161/cc.9.16.12673; Luedeke M, 2009, CANCER EPIDEM BIOMAR, V18, P3030, DOI 10.1158/1055-9965.EPI-09-0772; Lyons NA, 2013, NAT STRUCT MOL BIOL, V20, P194, DOI 10.1038/nsmb.2478; Lyons NA, 2011, MOL CELL, V42, P378, DOI 10.1016/j.molcel.2011.03.023; Maradeo ME, 2010, CELL CYCLE, V9, P4370, DOI 10.4161/cc.9.21.13634; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; McKay MJ, 2019, INT J RADIAT ONCOL, V103, P1194, DOI 10.1016/j.ijrobp.2018.11.047; Minamino M, 2018, CURR BIOL, V28, P2665, DOI 10.1016/j.cub.2018.06.037; Moldovan GL, 2006, MOL CELL, V23, P723, DOI 10.1016/j.molcel.2006.07.007; Morita A, 2012, DEV GROWTH DIFFER, V54, P588, DOI 10.1111/j.1440-169X.2012.01362.x; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Parnas O, 2010, CELL CYCLE, V9, P4615, DOI 10.4161/cc.9.23.13961; Percival SM, 2015, DIS MODEL MECH, V8, P941, DOI 10.1242/dmm.019059; Pimentel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037434; Ragu S, 2007, P NATL ACAD SCI USA, V104, P9747, DOI 10.1073/pnas.0703192104; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Rowe LA, 2012, MECH AGEING DEV, V133, P147, DOI 10.1016/j.mad.2012.03.009; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Salmon' TB, 2004, NUCLEIC ACIDS RES, V32, P3712, DOI 10.1093/nar/gkh696; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seoane AI, 2017, CURR BIOL, V27, P2849, DOI 10.1016/j.cub.2017.07.070; Skibbens RV, 2009, CURR BIOL, V19, pR1126, DOI 10.1016/j.cub.2009.10.067; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; SPENCER F, 1990, GENETICS, V124, P237; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Strom L, 2004, MOL CELL, V16, P1003, DOI 10.1016/j.molcel.2004.11.026; Takeda T, 2001, MOL BIOL CELL, V12, P1257, DOI 10.1091/mbc.12.5.1257; Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Tong K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100470; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 2009, EMBO REP, V10, P1095, DOI 10.1038/embor.2009.207; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; van der Lelij P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006936; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yan S, 2014, CELL MOL LIFE SCI, V71, P3951, DOI 10.1007/s00018-014-1666-4; Yi DG, 2016, FREE RADICAL BIO MED, V101, P424, DOI 10.1016/j.freeradbiomed.2016.11.005; Zhang JJ, 2017, EMBO REP, V18, P1294, DOI 10.15252/embr.201643807; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang W, 2017, ELIFE, V6, DOI 10.7554/eLife.28231; Zhou J, 2018, EXP THER MED, V15, P1702, DOI 10.3892/etm.2017.5592	83	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0242968	10.1371/journal.pone.0242968	http://dx.doi.org/10.1371/journal.pone.0242968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373396	Green Published, gold			2022-12-27	WOS:000603612300012
J	Shane, HL; Othumpangat, S; Marshall, NB; Blachere, F; Lukomska, E; Weatherly, LM; Baur, R; Noti, JD; Anderson, SE				Shane, Hillary L.; Othumpangat, Sreekumar; Marshall, Nikki B.; Blachere, Francoise; Lukomska, Ewa; Weatherly, Lisa M.; Baur, Rachel; Noti, John D.; Anderson, Stacey E.			Topical exposure to triclosan inhibits Th1 immune responses and reduces T cells responding to influenza infection in mice	PLOS ONE			English	Article							HEALTH-CARE WORKERS; TRANSCRIPTION FACTOR; VIRUS; BET; ANTIMICROBIALS; VACCINATION; METABOLISM; TOXICITY; AUGMENTS	Healthcare workers concurrently may be at a higher risk of developing respiratory infections and allergic disease, such as asthma, than the general public. Increased incidence of allergic diseases is thought to be caused, in part, due to occupational exposure to chemicals that induce or augment Th2 immune responses. However, whether exposure to these chemical antimicrobials can influence immune responses to respiratory pathogens is unknown. Here, we use a BALB/c murine model to test if the Th2-promoting antimicrobial chemical triclosan influences immune responses to influenza A virus. Mice were dermally exposed to 2% triclosan for 7 days prior to infection with a sub-lethal dose of mouse adapted PR8 A(H1N1) virus (50 pfu); triclosan exposure continued until 10 days post infection (dpi). Infected mice exposed to triclosan did not show an increase in morbidity or mortality, and viral titers were unchanged. Assessment of T cell responses at 10 dpi showed a decrease in the number of total and activated (CD44(hi)) CD4+ and CD8+ T cells at the site of infection (BAL and lung) in triclosan exposed mice compared to controls. Influenza-specific CD4+ and CD8+ T cells were assessed using MHCI and MHCII tetramers, with reduced populations, although not reaching statistical significance at these sites following triclosan exposure. Reductions in the Th1 transcription factor T-bet were seen in both activated and tetramer+ CD4+ and CD8+ T cells in the lungs of triclosan exposed infected mice, indicating reduced Th1 polarization and providing a potential mechanism for numerical reduction in T cells. Overall, these results indicate that the immune environment induced by triclosan exposure has the potential to influence the developing immune response to a respiratory viral infection and may have implications for healthcare workers who may be at an increased risk for developing infectious diseases.	[Shane, Hillary L.; Othumpangat, Sreekumar; Marshall, Nikki B.; Blachere, Francoise; Lukomska, Ewa; Weatherly, Lisa M.; Baur, Rachel; Noti, John D.; Anderson, Stacey E.] Ctr Dis Control & Prevent, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, NIOSH, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Shane, HL (corresponding author), Ctr Dis Control & Prevent, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, NIOSH, Morgantown, WV 26505 USA.	hshane@cdc.gov		Othumpangat, Sreekumar/0000-0002-6563-611X; Baur, Rachel/0000-0002-4874-440X; Shane, Hillary/0000-0002-8584-2818	Health Effects Laboratory Division of the National Institute for Occupational Safety and Health	Health Effects Laboratory Division of the National Institute for Occupational Safety and Health	This work was supported by internal funds from the Health Effects Laboratory Division of the National Institute for Occupational Safety and Health.	ACTOR JK, 1993, P NATL ACAD SCI USA, V90, P948, DOI 10.1073/pnas.90.3.948; [Administration OSaH. OSHA], 2013, CAR OUR CAR FACTS HO; Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Anderson SE, 2019, CURR OPIN IMMUNOL, V60, P91, DOI 10.1016/j.coi.2019.05.003; Anderson SE, 2016, J IMMUNOTOXICOL, V13, P165, DOI 10.3109/1547691X.2015.1029146; Anderson SE, 2013, TOXICOL SCI, V132, P96, DOI 10.1093/toxsci/kfs328; Anderson SE, 2010, TOXICOL SCI, V115, P435, DOI 10.1093/toxsci/kfq054; Azadi S, 2004, TOXICOL APPL PHARM, V197, P1, DOI 10.1016/j.taap.2004.01.017; Balish A.L., 2013, CURR PROTOC MICROBIO, V29, p15G.1.1, DOI [10.1002/9780471729259.mc15g01s29, DOI 10.1002/9780471729259.MC15G01S29]; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Bernard H, 2009, EMERG INFECT DIS, V15, P1438, DOI 10.3201/eid1509.081475; Black CL, 2018, MMWR-MORBID MORTAL W, V67, P1050, DOI 10.15585/mmwr.mm6738a2; Clayton EMR, 2011, ENVIRON HEALTH PERSP, V119, P390, DOI 10.1289/ehp.1002883; Crinnion WJ, 2010, ALTERN MED REV, V15, P101; Dhillon GS, 2015, INT J ENV RES PUB HE, V12, P5657, DOI 10.3390/ijerph120505657; Dhume K, 2019, MUCOSAL IMMUNOL, V12, P1220, DOI 10.1038/s41385-019-0183-z; Epstein SL, 1998, J IMMUNOL, V160, P322; Fang JL, 2010, J ENVIRON SCI HEAL C, V28, P147, DOI 10.1080/10590501.2010.504978; Food and Drug Adminnistration HHS, 2016, Fed Regist, V81, P61106; Frank K, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00425; Gazzinelli-Guimaraes PH, 2017, INT J PARASITOL, V47, P1, DOI 10.1016/j.ijpara.2016.08.007; GRAHAM MB, 1994, J EXP MED, V180, P1273, DOI 10.1084/jem.180.4.1273; HHS, 2019, HOUS PROD DAT NAT LI; Hufford MM, 2015, CURR TOP MICROBIOL, V386, P423, DOI 10.1007/82_2014_397; Kallies A, 2017, TRENDS IMMUNOL, V38, P287, DOI 10.1016/j.it.2017.02.003; KANETOSHI A, 1992, ARCH ENVIRON CON TOX, V23, P91; Kendal AP, 1982, CONCEPTS PROCEDURES; Lauder SN, 2013, EUR J IMMUNOL, V43, P2613, DOI 10.1002/eji.201243018; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Lietz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162061; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Mabbott NA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02579; MacIsaac JK, 2014, J OCCUP ENVIRON MED, V56, P834, DOI 10.1097/JOM.0000000000000183; Marshall NB, 2017, J IMMUNOTOXICOL, V14, P50, DOI 10.1080/1547691X.2016.1258094; Marshall NB, 2015, TOXICOL SCI, V147, P127, DOI 10.1093/toxsci/kfv113; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Meisel JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0404-9; Moss T, 2000, FOOD CHEM TOXICOL, V38, P361, DOI 10.1016/S0278-6915(99)00164-7; Ng ANM, 2011, J HOSP INFECT, V79, P279, DOI 10.1016/j.jhin.2011.08.004; Nukui Y, 2012, INFECT CONT HOSP EP, V33, P58, DOI 10.1086/663208; REED L. J., 1938, AMER JOUR HYG, V27, P493; Riner DK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005180; SanMiguel AJ, 2018, J INVEST DERMATOL, V138, P2234, DOI 10.1016/j.jid.2018.04.022; SanMiguel AJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00774-17; Savage JH, 2014, ANN ALLERG ASTHMA IM, V112, P179, DOI 10.1016/j.anai.2013.11.017; Savage JH, 2012, J ALLERGY CLIN IMMUN, V130, P453, DOI 10.1016/j.jaci.2012.05.006; Sepkowitz KA, 2005, EMERG INFECT DIS, V11, P1003, DOI 10.3201/eid1107.401038; Shane HL, 2020, TOXICOL SCI, V178, P127, DOI 10.1093/toxsci/kfaa112; Shane HL, 2019, TOXICOL SCI, V168, P508, DOI 10.1093/toxsci/kfz002; Shane HL, 2017, J IMMUNOTOXICOL, V14, P204, DOI 10.1080/1547691X.2017.1397826; Spanier AJ, 2014, ALLERGY ASTHMA PROC, V35, P475, DOI 10.2500/aap.2014.35.3803; Sullivan BM, 2003, P NATL ACAD SCI USA, V100, P15818, DOI 10.1073/pnas.2636938100; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Utsumi M, 2010, AGE AGEING, V39, P299, DOI 10.1093/ageing/afq029; Velazquez-Salinas L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01057; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007	56	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244436	10.1371/journal.pone.0244436	http://dx.doi.org/10.1371/journal.pone.0244436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373420	Green Published, gold			2022-12-27	WOS:000603612300005
J	Zhou, P; Liu, Z; Wu, H; Wang, YL; Lei, Y; Abbaszadeh, S				Zhou, Peng; Liu, Zheng; Wu, Hemmings; Wang, Yuli; Lei, Yong; Abbaszadeh, Shiva			Automatically detecting bregma and lambda points in rodent skull anatomy images	PLOS ONE			English	Article								Currently, injection sites of probes, cannula, and optic fibers in stereotactic neurosurgery are typically located manually. This step involves location estimations based on human experiences and thus introduces errors. In order to reduce localization error and improve repeatability of experiments and treatments, we investigate an automated method to locate injection sites. This paper proposes a localization framework, which integrates a region-based convolutional network and a fully convolutional network, to locate specific anatomical points on skulls of rodents. Experiment results show that the proposed localization framework is capable of identifying and locatin bregma and lambda in rodent skull anatomy images with mean errors less than 300 mu m. This method is robust to different lighting conditions and mouse orientations, and has the potential to simplify the procedure of locating injection sites.	[Zhou, Peng; Wang, Yuli; Abbaszadeh, Shiva] Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA; [Liu, Zheng] Univ Illinois, Dept Nucl Plasma & Radiol Engn, Urbana, IL USA; [Wu, Hemmings] Stanford Univ, Dept Neurosurg, Palo Alto, CA 94304 USA; [Lei, Yong] Zhejiang Univ, Sch Mech Engn, State Key Lab Fluid Power & Mechatron Syst, Hangzhou, Peoples R China	University of California System; University of California Santa Cruz; University of Illinois System; University of Illinois Urbana-Champaign; Stanford University; Zhejiang University	Abbaszadeh, S (corresponding author), Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA.	sabbasza@ucsc.edu	Wang, Yuli/AAD-1244-2021	Wang, Yuli/0000-0003-3311-2810	Zhejiang University-University of Illinois at Urbana-Champaign Institute	Zhejiang University-University of Illinois at Urbana-Champaign Institute	Yes-Shiva Abbaszadeh received funding from Zhejiang University-University of Illinois at Urbana-Champaign Institute Research Programhttps://zjui.illinois.edu/research The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadeh S, 2017, PROC SPIE, V10135, DOI 10.1117/12.2254722; Chen D. Z., 2017, INT C MEDICAL IMAGE, P399; Gao DD, 2016, J MANUF SCI E-T ASME, V138, DOI 10.1115/1.4034134; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; Grange P, 2011, ARXIV11042616; Grange P, 2010, M SOC NEUR; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Henderson M, 2014, ARXIV14105914; IOFFE S, 2015, ARXIV 1502 03167, V1502, P3167, DOI DOI 10.1007/S13398-014-0173-7.2; Krizhevsky A., P 25 INT C NEUR INF, P1097; LAITINEN LV, 1992, J NEUROSURG, V76, P53, DOI 10.3171/jns.1992.76.1.0053; Liu W, 2016, LECT NOTES COMPUT SC, V9905, P21, DOI 10.1007/978-3-319-46448-0_2; Liu Z, 2018, PROC SPIE, V10576, DOI 10.1117/12.2293715; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Rangarajan JR, 2016, SCI REP-UK, V6, DOI 10.1038/srep38058; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Uthoff RD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207493; Wang J, 2018, ENVIRON TECHNOL, V39, P3055, DOI 10.1080/09593330.2017.1371797; Wu H, 2018, P NATL ACAD SCI USA, V115, P192, DOI 10.1073/pnas.1712214114; Yang A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007577	23	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244378	10.1371/journal.pone.0244378	http://dx.doi.org/10.1371/journal.pone.0244378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373400	Green Published, gold			2022-12-27	WOS:000603612300030
J	Minicuci, N; Giorato, C; Rocco, I; Lloyd-Sherlock, P; Avruscio, G; Cardin, F				Minicuci, Nadia; Giorato, Cinzia; Rocco, Ilaria; Lloyd-Sherlock, Peter; Avruscio, Giampiero; Cardin, Fabrizio			Survey of doctors' perception of professional values	PLOS ONE			English	Article							HUMANISM; LINKING	Background New challenges in the medical field of the third millennium emphasise the "humanization of medicine" leading to a redefinition of doctors' values, limits and roles. The study aims to assess whether there are different personality dimensions of physicians in relation to their perception of professional values and public expectations. Methods A questionnaire on the perception of professional values and the opinion on work in the medical field, work relationships and public expectations was administered to 374 doctors attending Continuing Medical Education courses. Results Two personality dimensions were identified: the first dimension (which we termed "Performance Attainment") is associated preeminently with values of competence, advocacy, confidentiality, spirit of enquiry, integrity, responsibility and commitment; the second dimension (which we called "Personal Involvement") focuses on concern and compassion. The doctors that have more difficulty accepting judgements on their activity are those who think that "Performance attainment" is less important (beta = 6.01; p-value = 0.007). Instead, the doctors who believe "public expectation of the health system" is not high enough, tend to think that "Performance Attainment" is more important (beta = -6.08; p-value = 0.024). The less importance is given to the values of "Personal Involvement", the less is the doctor's perception of having a leading role in respect to other health professionals (beta = -2.37; p-value = 0.018). Conclusions Our results demonstrate that there are two different attitudes in terms of recognition and selection of the essential values to better practice the medical profession. Whether the doctors attach more importance to one dimension or the other, they do not differ in our analysis for how they answered the questions about relationships with patients, colleagues or family commitments in the questionnaire, even if they work in different areas. This suggests that in our research there is no single personal attitude that characterizes "a good doctor".	[Minicuci, Nadia; Rocco, Ilaria] CNR, Neurosci Inst, Padua, Italy; [Giorato, Cinzia; Cardin, Fabrizio] Dept Surg Oncol & Gastroenterol, Padua, Italy; [Lloyd-Sherlock, Peter] Univ East Anglia, Sch Int Dev, Norwich, Norfolk, England; [Avruscio, Giampiero] Univ Hosp Padua, Dept Cardiac, Angiol Unit, Thorac & Vasc Sci, Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); University of East Anglia; University of Padua; Azienda Ospedaliera - Universita di Padova	Rocco, I (corresponding author), CNR, Neurosci Inst, Padua, Italy.	Ilaria.rocco@in.cnr.it	cardin, fabrizio/ABH-1338-2021	Lloyd-Sherlock, Peter/0000-0002-1367-0703				American Board of Internal Medicine, 1995, PROJ PROF; British Medical Association, 2015, COH STUD 2006 MED GR; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Cohen JJ, 2007, ACAD MED, V82, P1029, DOI 10.1097/01.ACM.0000285307.17430.74; Cooke L, 2001, MED EDUC, V35, P735, DOI 10.1046/j.1365-2923.2001.01011.x; DeAngelis CD, 2015, JAMA-J AM MED ASSOC, V313, P1837, DOI 10.1001/jama.2015.3597; Feinmann J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d876; Fernando AT, 2014, POSTGRAD MED J, V90, P388, DOI 10.1136/postgradmedj-2013-132127; Fuchs VR, 2015, JAMA-J AM MED ASSOC, V313, P1821, DOI 10.1001/jama.2015.2915; Glicksman Eve, 2013, WANTING IT ALL NEW G; Goitein L, 2017, JAMA INTERN MED, V177, P164, DOI 10.1001/jamainternmed.2016.7688; Gordon J, 2005, MED J AUSTRALIA, V182, P5, DOI 10.5694/j.1326-5377.2005.tb06543.x; Livingston EH, 2016, JAMA-J AM MED ASSOC, V316, P720, DOI 10.1001/jama.2016.9854; Lombarts KMJMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097069; Montgomery L, 2017, FAM MED, V49, P378; O'Tuathaigh CMP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215675; Paice E, 2002, BMJ-BRIT MED J, V325, P707, DOI 10.1136/bmj.325.7366.707; Pettersen T, 2011, HEALTH CARE ANAL, V19, P51, DOI 10.1007/s10728-010-0163-7; Pfifferling J -H, 2000, FAM PRACT MANAG, V7, P39; Rizo CA, 2002, BRIT MED J, V325, P711, DOI 10.1136/bmj.325.7366.711; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; Sabitova A, 2020, JAMA NETW OPEN, V3, P1; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	23	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244303	10.1371/journal.pone.0244303	http://dx.doi.org/10.1371/journal.pone.0244303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370373	Green Accepted, Green Published, gold			2022-12-27	WOS:000603611900113
J	van de Louw, A; Cohrs, A; Leslie, D				van de Louw, Andry; Cohrs, Austin; Leslie, Douglas			Incidence of sepsis and associated mortality within the first year after cancer diagnosis in middle aged adults: A US population based study	PLOS ONE			English	Article							SEPTIC SHOCK; EPIDEMIOLOGY; BACTEREMIA	Background The incidence of sepsis has been rising overall but updated data in cancer patients are lacking. After a cancer diagnosis, incidence of sepsis and overall mortality peak within the first year. However, how much sepsis contributes to mortality remains unclear. We used a multistate model approach to analyze the incidence, risk factors and associated mortality of sepsis within 1 year of cancer diagnosis in middle aged adults. Methods Analysis of a large US health insurance claims database (Marketscan) between 2005 and 2014. Patients with a new diagnosis of cancer who received chemotherapy were included. Within a year of diagnosis, we assessed inpatient admissions for sepsis based on ICD-9 codes and survival using hospitalizations, outpatient visits and prescriptions filled. Competing risk and multistate models were used to assess the incidence of sepsis and transition probabilities between cancer, sepsis and death. Results 119,379 patients (38.9% males), aged 55 (50-60) years, were included; 2,560 developed isolated sepsis, 477 severe sepsis and 1331 septic shock within 1 year, with associated hospital mortality of 14.8%, 30% and 46% respectively. The probability of sepsis increased between 2005 and 2014; at 1 year, its cumulative incidence was 3.7% with a probability of mortality after sepsis of 35.5% (95% CI 21.6%-50.9%). Age, male gender, Charlson comorbidity index, hematological malignancies and metastases at diagnosis were associated with sepsis and mortality. Conclusions Incidence and mortality of sepsis were 3.7% and 35.5% at 1 year after cancer diagnosis and were both associated with baseline patient and cancer characteristics.	[van de Louw, Andry] Penn State Hlth Milton S Hershey Med Ctr, Div Pulm & Crit Care Med, Hershey, PA 17033 USA; [Cohrs, Austin; Leslie, Douglas] Penn State Hlth Milton S Hershey Med Ctr, Dept Publ Hlth Sci, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	van de Louw, A (corresponding author), Penn State Hlth Milton S Hershey Med Ctr, Div Pulm & Crit Care Med, Hershey, PA 17033 USA.	avandelouw@pennstatehealth.psu.edu		Cohrs, Austin/0000-0002-4952-0045	Department of Medicine of the Penn State Health Milton S Hershey Medical Center	Department of Medicine of the Penn State Health Milton S Hershey Medical Center	AV and DL received an internal grant from the Department of Medicine of the Penn State Health Milton S Hershey Medical Center to fund this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONE RC, 1992, CHEST, V101, P1481, DOI 10.1378/chest.101.6.1481; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Heron Melonie, 2015, Natl Vital Stat Rep, V64, P1; Lemiale V, 2020, CRIT CARE MED, V48, P822, DOI 10.1097/CCM.0000000000004322; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Meira-Machado L, 2009, STAT METHODS MED RES, V18, P195, DOI 10.1177/0962280208092301; Montassier E, 2013, EUR J CLIN MICROBIOL, V32, P841, DOI 10.1007/s10096-013-1819-7; Ngoma T, 2006, ANN ONCOL, V17, P9, DOI [10.1093/annonc.mdl983, 10.1093/annonc/mdl982]; Rhee C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7571; Roberts SCM, 2018, JAMA-J AM MED ASSOC, V319, P2497, DOI 10.1001/jama.2018.7675; Schelenz S, 2013, J ANTIMICROB CHEMOTH, V68, P1431, DOI 10.1093/jac/dkt002; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; De La Rica AS, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.59; te Marvelde L, 2020, AUST NZ J PUBL HEAL, V44, P53, DOI 10.1111/1753-6405.12935; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Wren AA, 2018, INFLAMM BOWEL DIS, V24, P2093, DOI 10.1093/ibd/izy222; Yadegarynia D, 2003, CLIN INFECT DIS, V37, P1144, DOI 10.1086/378305; Zaorsky NG, 2017, ANN ONCOL, V28, P400, DOI 10.1093/annonc/mdw604	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243449	10.1371/journal.pone.0243449	http://dx.doi.org/10.1371/journal.pone.0243449			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370330	Green Published, gold			2022-12-27	WOS:000603611900100
J	Ibrahim, R; Gleich, DF				Ibrahim, Rania; Gleich, David F.			Local hypergraph clustering using capacity releasing diffusion	PLOS ONE			English	Article								Local graph clustering is an important machine learning task that aims to find a well-connected cluster near a set of seed nodes. Recent results have revealed that incorporating higher order information significantly enhances the results of graph clustering techniques. The majority of existing research in this area focuses on spectral graph theory-based techniques. However, an alternative perspective on local graph clustering arises from using max-flow and min-cut on the objectives, which offer distinctly different guarantees. For instance, a new method called capacity releasing diffusion (CRD) was recently proposed and shown to preserve local structure around the seeds better than spectral methods. The method was also the first local clustering technique that is not subject to the quadratic Cheeger inequality by assuming a good cluster near the seed nodes. In this paper, we propose a local hypergraph clustering technique called hypergraph CRD (HG-CRD) by extending the CRD process to cluster based on higher order patterns, encoded as hyperedges of a hypergraph. Moreover, we theoretically show that HG-CRD gives results about a quantity called motif conductance, rather than a biased version used in previous experiments. Experimental results on synthetic datasets and real world graphs show that HG-CRD enhances the clustering quality.	[Ibrahim, Rania; Gleich, David F.] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ibrahim, R (corresponding author), Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA.	ibrahimr@purdue.edu			NSF [IIS-1546488, CCF-1909528]; NASA; Sloan Foundation; NSF Center for Science of Information STC [CCF-0939370, DE-SC0014543]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Sloan Foundation(Alfred P. Sloan Foundation); NSF Center for Science of Information STC	This work is supported by NSF awards IIS-1546488, CCF-1909528 NSF Center for Science of Information STC, CCF-0939370, DE-SC0014543, NASA, and the Sloan Foundation.	Agarwal S., 2006, P 23 INT C MACH LEAR, P17, DOI DOI 10.1145/1143844.1143847; Andersen R, 2006, ANN IEEE SYMP FOUND, P475; Andersen R, 2008, PROCEEDINGS OF THE NINETEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P651; [Anonymous], 2020, ZENODO, V21, P1; Benson AR, 2018, P NATL ACAD SCI USA, V115, pE11221, DOI 10.1073/pnas.1800683115; Benson AR, 2016, SCIENCE, V353, P163, DOI 10.1126/science.aad9029; Chung F, 2007, LINEAR ALGEBRA APPL, V423, P22, DOI 10.1016/j.laa.2006.07.018; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Fountoulakis K, 2017, P IEEE, V105, P256, DOI 10.1109/JPROC.2016.2637349; Ghahramani Z., 2003, INT C MACH LEARN, P912, DOI DOI 10.1/1/14/4312; Gleich D. F., 2016, HDB MODERN STAT METH, P191, DOI [10.1201/b19567-17, DOI 10.1201/B19567-17]; Gleich DF, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P359, DOI 10.1145/2783258.2783376; GOLDBERG AV, 1988, J ACM, V35, P921, DOI 10.1145/48014.61051; Guo XD, 2018, DESTECH TRANS ENVIR, P223; Hein M., 2013, ADV NEURAL INFORM PR, P2427, DOI DOI 10.5555/2999792.2999883; Kloumann IM, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1366, DOI 10.1145/2623330.2623621; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lang K, 2004, LECT NOTES COMPUT SC, V3064, P325; Lang K., 2005, ADV NEURAL INFORM PR, P715; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Li P, 2017, ADV NEUR IN, V30; Mahoney MW, 2012, J MACH LEARN RES, V13, P2339; Orecchia L., 2014, PROC 25 ANN ACM SIAM, P1267; Pan J-Y, 2004, P 10 ACM SIGKDD INT, P653, DOI 10.1145/1014052.1014135; Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001; Spielman DA, 2013, SIAM J COMPUT, V42, P1, DOI 10.1137/080744888; Tsourkakis CE, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1451, DOI 10.1145/3038912.3052653; Veldt N, 2020, HYPERGRAPH CUTS GEN; Veldt N, 2018, ARXIV181112280; Veldt N, 2020, ARXIV200209441; Veldt N, 2016, PR MACH LEARN RES, V48; Wang D, 2017, PR MACH LEARN RES, V70; Yin H, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P555, DOI 10.1145/3097983.3098069; Zhou D, 2007, 2007 IEEE NORTH-EAST WORKSHOP ON CIRCUITS AND SYSTEMS, P167, DOI 10.1109/CADCG.2007.4407875; Zhu Z. A., 2013, PROC INT C MACH LEAR, P396	35	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243485	10.1371/journal.pone.0243485	http://dx.doi.org/10.1371/journal.pone.0243485			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362247	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071600051
J	Bitew, MS; Zewde, MF; Wubetu, M; Alemu, AA				Bitew, Mezinew Sintayehu; Zewde, Maereg Fekade; Wubetu, Muluken; Alemu, Addisu Alehegn			Consumption of alcohol and binge drinking among pregnant women in Addis Ababa, Ethiopia: Prevalence and determinant factors	PLOS ONE			English	Article							SPECTRUM DISORDERS; CHILDBEARING AGE; SOCIAL SUPPORT; SUBSTANCE USE; RISK; EXPOSURE; HEALTH; OUTCOMES; SMOKING; 1ST	Introduction People in Ethiopia, including pregnant women, highly consume both home-made and manufactured alcohol beverages due to lack of awareness about the harmful effect of risky alcohol use, and cultural acceptance of alcohol consumption. Alcohol consumption and other hazardous patterns of use like binge drinking have tremendous adverse effects on fetus and mothers. Therefore, this study aimed to assess the magnitude of alcohol consumption, binge drinking and its determinants among pregnant women residing in Kolfe sub-city, Addis Ababa, Ethiopia. Methods Institutional based cross-sectional study was conducted among a total of 367 pregnant women. The participants were selected using a systematic random sampling method. Data were collected through a structured questionnaire. A binary logistic regression was conducted using SPSS version 20 software to identify determinants of alcohol consumption and binge drinking. A p-value < 0.05 was used to declare a statistical significance in multiple logistic regression. The results were described using adjusted odds ratio with a 95% confidence interval. Results This study revealed that the prevalence of alcohol consumption, binge drinking, and weekly alcohol consumption of four or more units among pregnant women was 39.78%, 3.54% and 4.9%, respectively. Not having formal education [AOR 95% CI = 8.47 (2.42, 29.62), having primary education [AOR 95% CI = 4.26 (1.23, 14.74), being a housewife [AOR 95% CI = 4.18 (2.13, 8.22), having an unplanned pregnancy [AOR 95% CI = 2.47(1.33, 4.60), having a history of abortion [AOR 95% CI = 3.33 (1.33, 6.05)], not having awareness about the harmful effect of alcohol consumption [AOR 95% CI = 4.66 (2.53, 8.61)], and not having family social support [AOR 95% CI = 2(1.14,3.53) were determinants of alcohol consumption among pregnant women. Conclusions This study found a high level of alcohol consumption among pregnant women. Interventions to create awareness on the harmful effects of alcohol are needed. Moreover, strengthening social support during pregnancy and family planning services to reduce unplanned pregnancy and abortion should be considered.	[Bitew, Mezinew Sintayehu] Debre Markos Univ, Dept Mental Hlth, Debre Markos, Amhara, Ethiopia; [Zewde, Maereg Fekade] Addis Ababa City Adm Hlth Bur, Dept Maternal & Child Hlth, Addis Ababa, Ethiopia; [Wubetu, Muluken] Debre Markos Univ, Dept Pharm, Debre Markos, Amhara, Ethiopia; [Alemu, Addisu Alehegn] Debre Markos Univ, Dept Midwifery, Debre Markos, Amhara, Ethiopia		Bitew, MS (corresponding author), Debre Markos Univ, Dept Mental Hlth, Debre Markos, Amhara, Ethiopia.	sintayehume@gmail.com	Alemu, Addisu Alehegn/AFP-1663-2022	Alemu, Addisu Alehegn/0000-0001-6415-6635; Sintayehu Bitew, Mezinew/0000-0002-4134-8543				Abebe H, 2011, ISOLATION CHARACTERI; Adusi-Poku Y, 2012, AFR J REPROD HEALTH, V16, P1; Alati R, 2006, ARCH GEN PSYCHIAT, V63, P1009, DOI 10.1001/archpsyc.63.9.1009; [Anonymous], 2009, AM J TRANSPLANTAT S3, V9, pS1; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Anteab K, 2014, ASSESSMENT PREVALENC, V2014; Bailey BN, 2004, AM J OBSTET GYNECOL, V191, P1037, DOI 10.1016/j.ajog.2004.05.048; BARNET B, 1995, PEDIATRICS, V96, P659; Barthelemy T-U, 2011, OPEN J OBSTET GYNECO, V1, P208, DOI DOI 10.4236/ojog.2011.14040; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Butt P., 2011, ALCOHOL HLTH CANADA; Coleman PK, 2005, BRIT J HEALTH PSYCH, V10, P255, DOI 10.1348/135910705X25499; Coles CD, 2006, J PEDIATR PSYCHOL, V31, P1, DOI 10.1093/jpepsy/jsj036; Demographic N, 2012, HLTH SURV 2011; Dupraz J, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13795; English L, 2015, J OBSTET GYNAECOL CA, V37, P901, DOI 10.1016/S1701-2163(16)30027-5; Goldschmidt L, 2004, NEUROTOXICOL TERATOL, V26, P521, DOI 10.1016/j.ntt.2004.04.003; HARLAP S, 1980, LANCET, V2, P173, DOI 10.1016/S0140-6736(80)90061-6; Haynes G, 2003, NEUROTOXICOL TERATOL, V25, P659, DOI 10.1016/j.ntt.2003.07.003; Isaksen AB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0630-0; Jr IW, 2009, AM J MED S, V122, pS3; Kalberg WO, 2006, ALCOHOL CLIN EXP RES, V30, P2037, DOI 10.1111/j.1530-0277.2006.00250.x; Kesmodel U, 2002, AM J EPIDEMIOL, V155, P305, DOI 10.1093/aje/155.4.305; Kesmodel U, 2002, ALCOHOL ALCOHOLISM, V37, P87, DOI 10.1093/alcalc/37.1.87; Kesmodel U, 2001, AM J EPIDEMIOL, V154, P777, DOI 10.1093/aje/154.8.777; Lekettey JD, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0384-4; Linell A, 2013, SCAND J PUBLIC HEALT, V41, P3, DOI 10.1177/1403494812466989; Manning MA, 2007, NEUROSCI BIOBEHAV R, V31, P230, DOI 10.1016/j.neubiorev.2006.06.016; Mardby AC, 2017, WOMEN BIRTH, V30, pE207, DOI 10.1016/j.wombi.2017.01.003; McGee CL, 2009, NEUROTOXICOL TERATOL, V31, P71, DOI 10.1016/j.ntt.2008.09.004; McNamara TK, 2006, J WOMENS HEALTH, V15, P70, DOI 10.1089/jwh.2006.15.70; MOHAMMED MA, 2013, J APP PHARM SCI, V3, P116, DOI DOI 10.7324/JAPS.2013.3421; Muckle G, 2011, ALCOHOL CLIN EXP RES, V35, P1081, DOI 10.1111/j.1530-0277.2011.01441.x; Namagembe I, 2010, MATERN CHILD HLTH J, V14, P492, DOI 10.1007/s10995-009-0500-3; Nykjaer C, 2014, J EPIDEMIOL COMMUN H, V68, P542, DOI 10.1136/jech-2013-202934; Odejide AO, 2006, INT J MENT HEALTH AD, V4, P87, DOI DOI 10.1007/S11469-006-9015-Y; Onah MN, 2016, INT J MENT HEALTH SY, V10, DOI 10.1186/s13033-016-0070-x; Onwuka CI, 2016, J CLIN DIAGN RES, V10, pQC10, DOI 10.7860/JCDR/2016/21036.8449; Ordinioha B, 2015, NIGER J CLIN PRACT, V18, P13, DOI 10.4103/1119-3077.146966; Popova S, 2017, EUR J MED GENET, V60, P32, DOI 10.1016/j.ejmg.2016.09.010; Popova S, 2016, TROP MED INT HEALTH, V21, P1209, DOI 10.1111/tmi.12755; Poznyak V, 2015, TACKLING HARMFUL ALC, V81; Rasch V, 2003, ACTA OBSTET GYN SCAN, V82, P182, DOI 10.1034/j.1600-0412.2003.00078.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x; Seiler NK, 2016, PUBLIC HEALTH REP, V131, P623, DOI 10.1177/0033354916662222; Seyoum G, 1995, RAPID ASSESSMENT SIT, P9; Skeen S, 2010, INT REV PSYCHIATR, V22, P624, DOI 10.3109/09540261.2010.535509; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Statistical Agency C International I. Ethiopia, 2011, ETHIOPIA; Sudhinaraset M, 2016, ALCOHOL RES CURR REV; Tan CH, 2015, MMWR-MORBID MORTAL W, V64, P1042, DOI 10.15585/mmwr.mm6437a3; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; WHO, 2010, ATL SUBST US 2010 RE; Williams AD, 2013, BIRTH DEFECTS RES A, V97, P489, DOI 10.1002/bdra.23127; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	56	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243784	10.1371/journal.pone.0243784	http://dx.doi.org/10.1371/journal.pone.0243784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351815	Green Published, gold			2022-12-27	WOS:000603071400001
J	Chotiprasitsakul, D; Pewloungsawat, P; Setthaudom, C; Santanirand, P; Pornsuriyasak, P				Chotiprasitsakul, Darunee; Pewloungsawat, Pataraporn; Setthaudom, Chavachol; Santanirand, Pitak; Pornsuriyasak, Prapaporn			Performance of real-time PCR and immunofluorescence assay for diagnosis of Pneumocystis pneumonia in real-world clinical practice	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; JIROVECII PNEUMONIA; CARINII-PNEUMONIA; INDUCED SPUTUM; QUANTITATIVE PCR; COLONIZATION	Background PCR is more sensitive than immunofluorescence assay (IFA) for detection of Pneumocystis jirovecii. However, PCR cannot always distinguish infection from colonization. This study aimed to compare the performance of real-time PCR and IFA for diagnosis of P. jirovecii pneumonia (PJP) in a real-world clinical setting. Methods A retrospective cohort study was conducted at a 1,300-bed hospital between April 2017 and December 2018. Patients whose respiratory sample (bronchoalveolar lavage or sputum) were tested by both Pneumocystis PCR and IFA were included. Diagnosis of PJP was classified based on multicomponent criteria. Sensitivity, specificity, 95% confidence intervals (CI), and Cohen's kappa coefficient were calculated. Results There were 222 eligible patients. The sensitivity and specificity of PCR was 91.9% (95% CI, 84.0%-96.7%) and 89.7% (95% CI, 83.3%-94.3%), respectively. The sensitivity and specificity of IFA was 7.0% (95% CI, 2.6%-14.6%) and 99.2% (95% CI, 95.6%-100.0%), respectively. The percent agreement between PCR and IFA was 56.7% (Cohen's kappa -0.02). Among discordant PCR-positive and IFA-negative samples, 78% were collected after PJP treatment. Clinical management would have changed in 14% of patients using diagnostic information, mainly based on PCR results. Conclusions PCR is highly sensitive compared with IFA for detection of PJP. Combining clinical, and radiological features with PCR is useful for diagnosis of PJP, particularly when respiratory specimens cannot be promptly collected before initiation of PJP treatment.	[Chotiprasitsakul, Darunee] Mahidol Univ, Ramathibodi Hosp, Div Infect Dis, Dept Med,Fac Med, Bangkok, Thailand; [Pewloungsawat, Pataraporn] Mahidol Univ, Ramathibodi Hosp, Dept Med, Fac Med, Bangkok, Thailand; [Setthaudom, Chavachol; Santanirand, Pitak] Mahidol Univ, Ramathibodi Hosp, Dept Pathol, Fac Med, Bangkok, Thailand; [Pornsuriyasak, Prapaporn] Mahidol Univ, Ramathibodi Hosp, Div Pulm & Crit Care, Dept Med,Fac Med, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Chotiprasitsakul, D (corresponding author), Mahidol Univ, Ramathibodi Hosp, Div Infect Dis, Dept Med,Fac Med, Bangkok, Thailand.	darunee.cho@mahidol.ac.th		Chotiprasitsakul, Darunee/0000-0003-2669-0372; Pornsuriyasak, Prapaporn/0000-0003-1057-4422; Santanirand, Pitak/0000-0002-3914-1367				Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Bossart S, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05075-5; Caliendo AM, 1998, J CLIN MICROBIOL, V36, P979, DOI 10.1128/JCM.36.4.979-982.1998; Choukri F, 2010, CLIN INFECT DIS, V51, P259, DOI 10.1086/653933; Cruciani M, 2002, EUR RESPIR J, V20, P982, DOI 10.1183/09031936.02.01372002; ELSADR W, 1986, ANN INTERN MED, V105, P889, DOI 10.7326/0003-4819-105-6-889; Enomoto T, 2010, RESPIROLOGY, V15, P126, DOI 10.1111/j.1440-1843.2009.01660.x; Fauchier T, 2016, J CLIN MICROBIOL, V54, P1487, DOI 10.1128/JCM.03174-15; FORTUN J, 1992, EUR RESPIR J, V5, P665; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Helweg-Larsen J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-28; Jayaram L, 2000, EUR RESPIR J, V16, P150, DOI 10.1034/j.1399-3003.2000.16a27.x; Khan MA, 1999, J INFECTION, V39, P77, DOI 10.1016/S0163-4453(99)90106-8; Kiska DL, 1998, AM J CLIN PATHOL, V109, P335, DOI 10.1093/ajcp/109.3.335; Lu Y, 2011, J CLIN MICROBIOL, V49, P4361, DOI 10.1128/JCM.06066-11; Maillet M, 2014, EUR J CLIN MICROBIOL, V33, P331, DOI 10.1007/s10096-013-1960-3; Medrano FJ, 2005, EMERG INFECT DIS, V11, P245, DOI 10.3201/eid1102.040487; Montesinos I, 2015, DIAGN MICR INFEC DIS, V82, P143, DOI 10.1016/j.diagmicrobio.2015.03.006; Moodley B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180589; Morris A, 2012, CLIN MICROBIOL REV, V25, P297, DOI 10.1128/CMR.00013-12; Ogawa Jun, 2005, Mod Rheumatol, V15, P91; Reid AB, 2011, CURR OPIN INFECT DIS, V24, P534, DOI 10.1097/QCO.0b013e32834cac17; Robberts FJL, 2007, DIAGN MICR INFEC DIS, V58, P385, DOI 10.1016/j.diagmicrobio.2007.02.014; Robert-Gangneux F, 2014, J CLIN MICROBIOL, V52, P3370, DOI 10.1128/JCM.01480-14; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; Slaoui M, 2011, METHODS MOL BIOL, V691, P69, DOI 10.1007/978-1-60761-849-2_4; Sokulska M, 2015, PARASITOL RES, V114, P3577, DOI 10.1007/s00436-015-4678-6; Tasaka S, 2015, CLIN MED INSIGHTS-CI, V9, P19, DOI [10.4137/CCRPM.S23324, 10.4137/CCRPRPM.S23324]; Tasaka S, 2012, J INFECT CHEMOTHER, V18, P793, DOI 10.1007/s10156-012-0453-0; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Unnewehr M, 2016, RESPIRATION, V92, P144, DOI 10.1159/000448626; VERSI E, 1992, BRIT MED J, V305, P187, DOI 10.1136/bmj.305.6846.187-b	32	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244023	10.1371/journal.pone.0244023	http://dx.doi.org/10.1371/journal.pone.0244023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347478	Green Published, gold			2022-12-27	WOS:000603071100056
J	Krzyminska-Siemaszko, R; Deskur-Smielecka, E; Kaluzniak-Szymanowska, A; Styszynski, A; Wieczorowska-Tobis, K				Krzyminska-Siemaszko, Roma; Deskur-Smielecka, Ewa; Kaluzniak-Szymanowska, Aleksandra; Styszynski, Arkadiusz; Wieczorowska-Tobis, Katarzyna			Polish version of SARC-F to assess sarcopenia in older adults: An examination of reliability and validity	PLOS ONE			English	Article							QUESTIONNAIRE; VALIDATION; TRANSLATION; CONSENSUS; TOOL	Introduction SARC-F is a quick questionnaire recommended as a screening tool for sarcopenia. The aim of the study was to translate, adapt, and validate the Polish version of the SARC-F for community-dwelling older adults in Poland. Materials and methods We included 160 Polish volunteers aged >= 60 years (44% of men). The Polish version of SARC-F was adapted following standardized forward-backward translation procedure. SARC-F was validated against the six sets of diagnostic criteria as the reference standards [developed independently by European Working Group on Sarcopenia in Older People1 (EWGSOP1), European Working Group on Sarcopenia in Older People2 (EWGSOP2), Foundation for the National Institutes of Health (FNIH) Sarcopenia Project, Asia Working Group for Sarcopenia (AWGS), the International Working Group for Sarcopenia (IWGS), and Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD)]. Results SARC-F score >= 4 points was observed in 18.8% of the study population. Cronbach's alpha was 0.70. The sensitivity of SARC-F varied from 33.3% to 50.0% depending on the diagnostics criteria used, while the specificity was about 85%. Positive predictive value (PPV) was low (about 30%) for five out of six sets of the diagnostic criteria used (EWGSOP2, IWGS, AWGS, FNIH, and SCWD), while the negative predictive value (NPV) was generally high (>88%). The area under the ROC curves (AUC) was 0.652-0.728. SARC-F had the largest AUC against FNIH criteria (0.728), indicating a moderate diagnostic accuracy. Similar results were found for EWGSOP2 and IWGS criteria. The AUC values were below 0.7 for AWGS, SCWD, and EWGSOP1 criteria. Conclusion Based on the results, the Polish version of SARC-F shows excellent reliability and good internal consistency. High specificity and high NPV make SARC-F a useful tool to rule-out sarcopenia with high accuracy in community-dwelling older adults, independently of the diagnostic criteria used.	[Krzyminska-Siemaszko, Roma; Deskur-Smielecka, Ewa; Kaluzniak-Szymanowska, Aleksandra; Styszynski, Arkadiusz; Wieczorowska-Tobis, Katarzyna] Poznan Univ Med Sci, Dept Palliat Med, Poznan, Poland	Poznan University of Medical Sciences	Krzyminska-Siemaszko, R (corresponding author), Poznan Univ Med Sci, Dept Palliat Med, Poznan, Poland.	krzyminskasiemaszko@ump.edu.pl	Styszyński, Arkadiusz/AAH-7497-2021	Styszynski, Arkadiusz/0000-0001-5515-9826; Krzyminska-Siemaszko, Roma/0000-0002-6770-7321	Poznan University of Medical Sciences [502-14-11141570-10595]	Poznan University of Medical Sciences	This study was funded by Poznan University of Medical Sciences (grant number 502-14-11141570-10595). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Bahat G, 2018, J NUTR HEALTH AGING, V22, P898, DOI 10.1007/s12603-018-1067-8; Bahat G, 2018, EUR GERIATR MED, V9, P23, DOI 10.1007/s41999-017-0003-5; Barbosa-Silva TG, 2016, J AM MED DIR ASSOC, V17, P1136, DOI 10.1016/j.jamda.2016.08.004; Beaudart C, 2018, EUR GERIATR MED, V9, P29, DOI 10.1007/s41999-017-0007-1; Beaudart C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169548; Cederholm T, 2019, CLIN NUTR, V38, P1, DOI [10.1016/j.clnu.2018.08.002, 10.1002/jpen.1440]; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Drey M, 2020, J AM MED DIR ASSOC, V21, P747, DOI 10.1016/j.jamda.2019.12.011; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Ida S, 2018, J AM MED DIR ASSOC, V19, P685, DOI 10.1016/j.jamda.2018.04.001; Ida S, 2017, AGING CLIN EXP RES, V29, P935, DOI 10.1007/s40520-016-0668-5; Ishii S, 2014, GERIATR GERONTOL INT, V14, P93, DOI 10.1111/ggi.12197; Kera T, 2019, GERIATR GERONTOL INT, V19, P1172, DOI 10.1111/ggi.13768; Kim S, 2018, J AM MED DIR ASSOC, V19, P40, DOI 10.1016/j.jamda.2017.07.006; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Krzyminska-Siemaszko R, 2019, EUR REV MED PHARMACO, V23, P4321, DOI 10.26355/eurrev_201905_17938; Krzyminska-Siemaszko R, 2020, CLIN INTERV AGING, V15, P583, DOI 10.2147/CIA.S250508; Lanza E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232371; Linden A, 2006, J EVAL CLIN PRACT, V12, P132, DOI 10.1111/j.1365-2753.2005.00598.x; Malmstrom TK, 2016, J CACHEXIA SARCOPENI, V7, P28, DOI 10.1002/jcsm.12048; Malmstrom TK, 2013, J AM MED DIR ASSOC, V14, P531, DOI 10.1016/j.jamda.2013.05.018; Marra M, 2019, CONTRAST MEDIA MOL I, DOI 10.1155/2019/3548284; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Parra-Rodriguez L, 2016, J AM MED DIR ASSOC, V17, P1142, DOI 10.1016/j.jamda.2016.09.008; Piotrowicz K, 2020, EUR GERIATR MED, V11, P343, DOI 10.1007/s41999-020-00295-1; Rossi AP, 2017, J NUTR HEALTH AGING, V21, P743, DOI 10.1007/s12603-017-0921-4; Sanchez-Rodriguez D, 2019, J NUTR HEALTH AGING, V23, P518, DOI 10.1007/s12603-019-1204-z; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Nguyen TN, 2020, CLIN INTERV AGING, V15, P879, DOI 10.2147/CIA.S254397; Tavakol M, 2011, INT J MED EDUC, V2, P1, DOI 10.5116/ijme.4d27.32ff; Walowski CO, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030755; Woo J, 2014, J AM MED DIR ASSOC, V15, P630, DOI 10.1016/j.jamda.2014.04.021; World Health Organization, PROC TRANSL AD INSTR; Yang M, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.016; Zasadzka E, 2020, CLIN INTERV AGING, V15, P567, DOI 10.2147/CIA.S245074	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244001	10.1371/journal.pone.0244001	http://dx.doi.org/10.1371/journal.pone.0244001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347486	Green Published, gold			2022-12-27	WOS:000603071100024
J	Christensen, BR; Becnel, CM; Chan, LP; Minetos, PD; Clarke, JF; Kahn, MJ				Christensen, Bryce R.; Becnel, Chad M.; Chan, Leland P.; Minetos, Paul D.; Clarke, John F.; Kahn, Marc J.			A comparison of match outcomes between traditional medical degree and dual-degree applicants	PLOS ONE			English	Article								Background Dual degrees combining and MD with another professional degree (MPH, MBA, or PhD) are becoming more common in an attempt to increase an applicant's competitivity for a residency. Objective This study was designed to assess differences in MD-only and dual degree MD applicants with respect to applicant characteristics and match outcomes. Methods Utilizing the voluntarily-reported publicly available 2017-2019 Texas STAR database, we assessed applicants from 115 medical schools. Texas STAR indicates that over this time period, there were 18,224 responses for a response rate of 43.8%. Comparisons were made between groups using student's t-test and chi-squared analysis. Results Compared to MD only students, MD/MPH applicants had a higher propensity towards primary care specialties. MD/PhD applicants did not differ versus MD only applicants in their selection of primary care specialties, or of competitive specialties. MD/MBA applicants chose more competitive specialties and less primary care specialties. Despite all these differences, match rates were not different comparing MD only and dual-degree students. Conclusions Despite the growing popularity of combined MD programs, such programs do not appear to increase applicant match competitivity.	[Christensen, Bryce R.; Becnel, Chad M.; Chan, Leland P.; Minetos, Paul D.; Clarke, John F.; Kahn, Marc J.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Christensen, Bryce R.; Becnel, Chad M.; Chan, Leland P.; Minetos, Paul D.; Clarke, John F.] Tulane Univ, AB Freeman Sch Business, New Orleans, LA 70118 USA; [Christensen, Bryce R.] Brooke Army Med Ctr, Dept Internal Med, San Antonio, TX USA; [Becnel, Chad M.] Tulane Univ, Med Ctr, Dept Surg, New Orleans, LA 70118 USA; [Chan, Leland P.] NYU, Grossman Sch Med, Dept Emergency Med, New York, NY USA; [Kahn, Marc J.] Univ Nevada, Sch Med, Las Vegas Sch Med, Dept Med, Las Vegas, NV 89154 USA	Tulane University; Tulane University; San Antonio Military Medical Center; United States Department of Defense; United States Army; Tulane University; New York University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Kahn, MJ (corresponding author), Univ Nevada, Sch Med, Las Vegas Sch Med, Dept Med, Las Vegas, NV 89154 USA.	marc.kahn@unlv.edu	Kahn, Marc/AAF-7547-2021; Minetos, Paul/AAM-1969-2021	KAHN, MARC/0000-0002-9781-9316; Christensen, Bryce/0000-0002-9699-6652				Andriole DA, 2016, PUBLIC HEALTH REP, V131, P637, DOI 10.1177/0033354916662224; Brass LF, 2018, MOL BIOL CELL, V29, P881, DOI 10.1091/mbc.E17-12-0721; Krousel-Wood M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039020; Krupat E, 2017, EVAL HEALTH PROF, V40, P203, DOI 10.1177/0163278715620831; Larson DB, 2003, ACAD MED, V78, P335, DOI 10.1097/00001888-200303000-00021; Sherrill Windsor Westbrook, 2004, Med Educ Online, V9, P4353, DOI 10.3402/meo.v9i.4353	6	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244147	10.1371/journal.pone.0244147	http://dx.doi.org/10.1371/journal.pone.0244147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338062	Green Published, gold			2022-12-27	WOS:000601313500043
J	Paz, S; Mauer, C; Ritchie, A; Robishaw, JD; Caputi, M				Paz, Sean; Mauer, Christopher; Ritchie, Anastasia; Robishaw, Janet D.; Caputi, Massimo			A simplified SARS-CoV-2 detection protocol for research laboratories	PLOS ONE			English	Article								Widespread testing is required to limit the current public health crisis caused by the COVID-19 pandemic. Multiple tests protocols have been authorized by the food and drugs administration (FDA) under an emergency use authorization (EUA). The majority of these protocols are based on the gold-standard RT-qPCR test pioneered by the U.S. Centers for Disease Control and Prevention (CDC). However, there is still a widespread lack of testing in the US and many of the clinical diagnostics protocols require extensive human labor and materials that could face supply shortages and present biosafety concerns. Given the need to develop alternative reagents and approaches to provide nucleic-acid testing in the face of heightened demand and potential shortages, we have developed a simplified SARS-CoV-2 testing protocol adapted for its use in research laboratories with minimal molecular biology equipment and expertise. The protocol utilizes TRIzol to purify the viral RNA from different types of clinical specimens, requires minimal BSL-1 precautions and, given its high sensitivity, can be easily adapted to pooling samples strategies.	[Paz, Sean; Mauer, Christopher; Ritchie, Anastasia; Robishaw, Janet D.; Caputi, Massimo] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Caputi, M (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.	mcaputi@health.fau.edu		Caputi, Massimo/0000-0002-4926-9700; Mauer, Christopher/0000-0001-6092-4385; Ritchie, Anastasia/0000-0001-5761-2663	Florida Blue foundation	Florida Blue foundation	This work was supported by the Florida Blue foundation grant "Developing Predictive Algorithms for COVID-19 Infection in FAU Health Care Workers". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, STRATEG COMMENTS, V26, pX, DOI 10.1080/13567888.2020.1762348; [Anonymous], 2020, 1POINT3ACRES; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Azzi L, 2020, J INFECTION, V81, pE45, DOI 10.1016/j.jinf.2020.04.005; Basu A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01136-20; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Jones T.C., 2020, ANAL SARS COV 2 VIRA, DOI [DOI 10.1101/2020.06.08.20125484, 10.1101/2020.06.08.20125484]; Ketchum K, 2020, SARS COV 2 TESTING P; Klebe RJ, 1996, BIOTECHNIQUES, V21, P1094; Noriega R., 2020, INCREASING TESTING T, DOI [10.1101/2020.04.03.024216v1.full.pdf, DOI 10.1101/2020.04.03.024216V1.FULL.PDF]; Pere H, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00721-20; Sinnott-Armstrong N, 2020, EVALUATION GROUP TES, DOI [DOI 10.1101/2020.03.27.20043968, 10.1101/2020.03.27.20043968]; To KKW, 2019, CLIN MICROBIOL INFEC, V25, P372, DOI 10.1016/j.cmi.2018.06.009; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wyllie A.L., 2020, SALIVA IS MORE SENSI, V8, P12, DOI [10.1101/2020.04.16.20067835, DOI 10.1101/2020.04.16.20067835]; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Xu RB, 2020, IEEE PHOTONICS J, V12, DOI [10.1109/JPHOT.2020.2979564, 10.1038/s41368-020-0080-z]	19	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244271	10.1371/journal.pone.0244271	http://dx.doi.org/10.1371/journal.pone.0244271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338082	Green Published, Green Submitted, gold			2022-12-27	WOS:000601313500029
J	Ganss, C; Klein, P; Giese-Kraft, K; Meyners, M				Ganss, Carolina; Klein, Patrick; Giese-Kraft, Katja; Meyners, Michael			Validation of motion tracking as tool for observational toothbrushing studies	PLOS ONE			English	Article							BRUSHING EXERCISE; CHILDREN; BEHAVIOR; EFFICACY	Video observation (VO) is an established tool for observing toothbrushing behaviour, however, it is a subjective method requiring thorough calibration and training, and the toothbrush position is not always clearly visible. As automated tracking of motions may overcome these disadvantages, the study aimed to compare observational data of habitual toothbrushing as well as of post-instruction toothbrushing obtained from motion tracking (MT) to observational data obtained from VO. One-hundred-three subjects (37.4 +/- 14.7 years) were included and brushed their teeth with a manual (MB; n = 51) or a powered toothbrush (PB; n = 52) while being simultaneously video-filmed and tracked. Forty-six subjects were then instructed how to brush their teeth systematically and were filmed/tracked for a second time. Videos were analysed with INTERACT (Mangold, Germany); parameters of interest were toothbrush position, brushing time, changes between areas (events) and the Toothbrushing Systematic Index (TSI). Overall, the median proportion (min; max) of identically classified toothbrush positions (both sextant/surface correct) in a brushing session was 87.8% (50.0; 96.9), which was slightly higher for MB compared to PB (90.3 (50.0; 96.9) vs 86.5 (63.7; 96.5) resp.; p = 0.005). The number of events obtained from MT was higher than from VO (p < 0.001) with a moderate to high correlation between them (MB: rho = 0.52, p < 0.001; PB: rho = 0.87; p < 0.001). After instruction, both methods revealed a significant increase of the TSI regardless of the toothbrush type (p < 0.001 each). Motion tracking is a suitable tool for observing toothbrushing behaviour, is able to measure improvements after instruction, and can be used with both manual and powered toothbrushes.	[Ganss, Carolina; Klein, Patrick; Giese-Kraft, Katja] Justus Liebig Univ Giessen, Dent Clin, Dept Conservat & Prevent Dent, Giessen, Germany; [Meyners, Michael] Procter & Gamble Serv GmbH, Kronberg, Germany	Justus Liebig University Giessen; Procter & Gamble	Ganss, C (corresponding author), Justus Liebig Univ Giessen, Dent Clin, Dept Conservat & Prevent Dent, Giessen, Germany.	Carolina.ganss@dentist.med.uni-giessen.de		Meyners, Michael/0000-0002-6786-3607	Procter Gamble	Procter Gamble(Procter & Gamble)	The study was a joint research project between CG, PK and KGK and Procter & Gamble who provided financial and research resources. Procter & Gamble contributed to the study design, to data collection and analysis and preparation of the manuscript.	[Anonymous], 2020, J GYNECOL ONCOL, V31, pe69; Bakeman R., 1997, OBSERVING INTERACTIO; Ganss C, 2018, CLIN ORAL INVEST, V22, P715, DOI 10.1007/s00784-017-2146-7; Ganss C, 2009, CLIN ORAL INVEST, V13, P203, DOI 10.1007/s00784-008-0230-8; Grischke J, 2020, DENT MATER, V36, P765, DOI 10.1016/j.dental.2020.03.021; Heydarian H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051168; Inada E, 2015, CLIN ORAL INVEST, V19, P1451, DOI 10.1007/s00784-014-1367-2; Knippenberg E, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0270-x; MACGREGOR IDM, 1979, COMMUNITY DENT ORAL, V7, P297, DOI 10.1111/j.1600-0528.1979.tb01235.x; MACGREGOR IDM, 1979, J PERIODONTAL RES, V14, P225, DOI 10.1111/j.1600-0765.1979.tb00227.x; Marcon M, 2016, COMPUT VIS IMAGE UND, V148, P34, DOI 10.1016/j.cviu.2016.03.009; Muller-Bolla M, 2011, REV ODONT STOMAT, V40, P239; Muller-Bolla M, 2013, ORAL HLTH PREV DENT, V11, P341, DOI 10.3290/j.ohpd.a30602; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rateitschak HF, 2004, PERIODONTOLOGY; Rosema NAM, 2016, INT J DENT HYG, V14, P29, DOI 10.1111/idh.12115; RUGGGUNN AJ, 1978, J PERIODONTAL RES, V13, P382, DOI 10.1111/j.1600-0765.1978.tb00193.x; RUGGGUNN AJ, 1979, J PERIODONTAL RES, V14, P231, DOI 10.1111/j.1600-0765.1979.tb00228.x; Schlueter N, 2010, CLIN ORAL INVEST, V14, P99, DOI 10.1007/s00784-009-0269-1; Schlueter N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196497; Shan, 2016, SENSYS 16; Slot DE, 2012, INT J DENT HYG, V10, P187, DOI 10.1111/j.1601-5037.2012.00557.x; Springer, 2010, OBSERVATIONAL SAMPLI; Sweetman, 1988, RES PAP EDUC, V3, P42; Wainwright J, 2014, BRIT DENT J, V217, DOI 10.1038/sj.bdj.2014.651; Winterfeld T, 2015, CLIN ORAL INVEST, V19, P851, DOI 10.1007/s00784-014-1306-2; Yaacob M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002281.pub3	27	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244678	10.1371/journal.pone.0244678	http://dx.doi.org/10.1371/journal.pone.0244678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378368	Green Published, gold			2022-12-27	WOS:000605651300006
J	Kasozi, S; Kirirabwa, NS; Kimuli, D; Luwaga, H; Kizito, E; Turyahabwe, S; Lukoye, D; Byaruhanga, R; Chen, LS; Suarez, P				Kasozi, Samuel; Kirirabwa, Nicholas Sebuliba; Kimuli, Derrick; Luwaga, Henry; Kizito, Enock; Turyahabwe, Stavia; Lukoye, Deus; Byaruhanga, Raymond; Chen, Lisa; Suarez, Pedro			Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda	PLOS ONE			English	Article							HIGH TREATMENT SUCCESS; SEX-DIFFERENCES; MDR-TB; HIV; PREVALENCE; DIAGNOSIS; AFRICA	Worldwide, Drug-resistant Tuberculosis (DR-TB) remains a big problem; the diagnostic capacity has superseded the clinical management capacity thereby causing ethical challenges. In Sub-Saharan Africa, treatment is either inadequate or lacking and some diagnosed patients are on treatment waiting lists. In Uganda, various health system challenges impeded scale-up of DR-TB care in 2012; only three treatment initiation facilities existed, with only 41 of the estimated 1010 RR-TB/MDR-TB cases enrolled on treatment yet 300 were on the waiting list and there was no DR-TB treatment scale-up plan. To scale up care, the National TB and leprosy Program (NTLP) with partners rolled out a DR-TB mixed model of care. In this paper, we share achievements and outcomes resulting from the implementation of this mixed Model of DR-TB care. Routine NTLP DR-TB program data on treatment initiation site, number of patients enrolled, their demographic characteristics, patient category, disease classification (based on disease site and human immunodeficiency virus (HIV) status), on co-trimoxazole preventive therapy (CPT) and antiretroviral therapy (ART) statuses, culture results, smear results and treatment outcomes (6, 12, and 24 months) from 2012 to 2017 RR-TB/MDR-TB cohorts were collected from all the 15 DR-TB treatment initiation sites and descriptive analysis was done using STATA version 14.2. We presented outcomes as the number of patient backlog cleared, DR-TB initiation sites, RR-TB/DR-TB cumulative patients enrolled, percentage of co-infected patients on the six, twelve interim and 24 months treatment outcomes as per the Uganda NTLP 2016 Programmatic Management of drug-resistant Tuberculosis (PMDT) guidelines (NTLP, 2016). Over the period 2013-2015, the RR-TB/MDR-TB Treatment success rate (TSR) was sustained between 70.1% and 74.1%, a performance that is well above the global TSR average rate of 50%. Additionally, the cure rate increased from 48.8% to 66.8% (P = 0.03). The Uganda DR-TB mixed model of care coupled with early application of continuous improvement approaches, enhanced cohort reviews and use of multi-disciplinary teams allowed for rapid DR-TB program expansion, rapid clearance of patient backlog, attainment of high cumulative enrollment and high treatment success rates. Sustainability of these achievements is needed to further reduce the DR-TB burden in the country. We highly recommend this mixed model of care in settings with similar challenges.	[Kasozi, Samuel; Kirirabwa, Nicholas Sebuliba; Kimuli, Derrick; Luwaga, Henry; Kizito, Enock; Lukoye, Deus; Byaruhanga, Raymond] TRACK TB Project, Management Sci Hlth, Kampala, Uganda; [Turyahabwe, Stavia] Minist Hlth, Natl TB & Leprosy Program, Kampala, Uganda; [Chen, Lisa] Univ Calif San Francisco, Curry Int TB Ctr UCSF CITC, San Francisco, CA 94143 USA; [Suarez, Pedro] Management Sci Hlth, Arlington, VA USA	University of California System; University of California San Francisco	Kimuli, D (corresponding author), TRACK TB Project, Management Sci Hlth, Kampala, Uganda.	derrickkimuli@gmail.com	Chen, Lisa/GXN-0315-2022; Suarez, Pedro G/AAD-2278-2019	Suarez, Pedro G/0000-0001-9825-1761; Kimuli, Derrick/0000-0002-5302-7077	United States Agency for International Development (USAID); PEPFAR [623-A-13-00003]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); PEPFAR	Funding for TRACK TB Project is provided by the United States Agency for International Development (USAID) and PEPFAR under cooperative agreement 623-A-13-00003.	[Anonymous], 2016, GLOBAL REPORT DIABET; Bieh KL, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2114-x; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Brust JCM, 2012, INT J TUBERC LUNG D, V16, P998, DOI 10.5588/ijtld.11.0713; Daou NadineAbiZeid., 2015, ROLE WOMEN NGOS EMPO, V22, P1; Eshetie S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2323-y; Fernandez N, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.598.8972; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Heysell SK, 2016, INT J TUBERC LUNG D, V20, P187, DOI 10.5588/ijtld.14.0961; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Horter S, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-81; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Kapata N, 2013, TROP MED INT HEALTH, V18, P1386, DOI 10.1111/tmi.12183; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Meressa D, 2015, THORAX, V70, P1181, DOI 10.1136/thoraxjnl-2015-207374; MoH, 2017, REV NAT STRAT PLAN 2, P1; MSH, 2014, TRACK TB PROJ BAS AS, P1; MSH, 2016, TRACK TB ANN REP PRO; NTLP, 2015, REP POP BAS SURV PRE; NTLP, 2012, UG EXP LAN 2012 2016; Oladimeji O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094393; Palacios E, 2012, INT J TUBERC LUNG D, V16, P568, DOI 10.5588/ijtld.11.0473-e; Phuong NTM, 2016, PUBLIC HEALTH ACTION, V6, P25, DOI 10.5588/pha.15.0068; Rhines AS, 2013, TUBERCULOSIS, V93, P104, DOI 10.1016/j.tube.2012.10.012; Rocha C, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P50, DOI 10.5588/ijtld.10.0447; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Selgelid M J, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P9, DOI 10.5588/ijtld.10.0434; Sharma A, 2017, LANCET INFECT DIS, V17, P707, DOI 10.1016/S1473-3099(17)30247-5; Shin SS, 2017, JAIDS-J ACQ IMM DEF, V74, P65, DOI 10.1097/QAI.0000000000001169; Steingart KR, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009593.pub2, 10.1002/14651858.CD009593.pub3]; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; UBOS, 2016, NAT POP HOUS CENS 20, P1; USAID/UGANDA MONITORING EVALUATION AND LEARNING PROGRAM, 2016, TRACK TB MIX METH AS, P1; Van den Hof S, 2010, REPORT PREPARED TUBE; van der Walt M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144249; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; WHO, 2008, GUID PROGR MAN DRUG, pi; World Health Organisation, 2015, CONST WHO ENT FORC 7, P1; World Health Organization, 2017, GLOB TUB REP, V2017, P1	40	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244451	10.1371/journal.pone.0244451	http://dx.doi.org/10.1371/journal.pone.0244451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373997	Green Published, gold, Green Submitted			2022-12-27	WOS:000603612300045
J	Al-Kahtani, SN; Taha, E; Khan, KA; Ansari, MJ; Farag, SA; Shawer, DMB; Elnabawy, EM				Al-Kahtani, Saad N.; Taha, El-Kazafy; Khan, Khalid Ali; Ansari, Mohammad Javed; Farag, Soha A.; Shawer, Dalia M. B.; Elnabawy, El-Said Mohamed			Effect of harvest season on the nutritional value of bee pollen protein	PLOS ONE			English	Article							NATURAL ANTIOXIDANT SOURCE; PREVENT LIPID OXIDATION; CHEMICAL-COMPOSITION; BOTANICAL ORIGIN; AMINO-ACID; AL-AHSA; QUALITY; HONEYBEE; BREAD	Bee pollen is a natural product that has valuable nutritional and medicinal characteristics and has recently garnered increasing attention in the food industry due to its nutritive value. Here, we harvested pollen loads from the Al-Ahsa oasis in eastern Saudi Arabia during spring, summer, autumn, and winter in 2018/2019 to compare the nutritional value of bee pollen protein with the amino acid requirements of honeybees and adult humans. Based on the nutritional value of bee pollen protein, the optimal season for harvesting bee pollen was determined. The composition of the bee pollen showed the highest contents of crude protein, total amino acids, leucine, glutamic acid, valine, isoleucine, threonine, and glycine in samples collected in spring. The highest contents of lysine, phenylalanine, threonine, tryptophan, arginine, tyrosine, and cysteine were observed in samples collected in winter. The highest contents of histidine, methionine, and serine were in samples collected in autumn. Moreover, the highest levels of aspartic acid, proline, and alanine were in samples collected in summer. Leucine, valine, lysine, histidine, threonine, and phenylalanine (except in autumn bee pollen) contents in pollen from all four seasons were above the requirements of honeybees. Leucine, valine, histidine, isoleucine (except in autumn bee pollen), lysine (except in spring and summer bee pollen), and threonine (except in winter and spring bee pollen) in all tested samples were above the requirements of adult humans. In comparison with the minimal amino acid requirements of adult humans and honeybees, the 1(st) limiting amino acid in bee pollen collected during the different seasons was methionine. Bee pollen collected during spring (March-May) and winter (December-February) can be considered a nutritive food source for adult humans and honeybees.	[Al-Kahtani, Saad N.; Taha, El-Kazafy] King Faisal Univ, Arid Land Agr Dept, Coll Agr Sci & Foods, Al Hasa, Saudi Arabia; [Taha, El-Kazafy; Shawer, Dalia M. B.] Kafrelsheikh Univ, Fac Agr, Econ Entomol Dept, Kafrelsheikh, Egypt; [Khan, Khalid Ali] King Khalid Univ, Res Ctr Adv Mat Sci RCAMS, Abha, Saudi Arabia; [Khan, Khalid Ali] King Khalid Univ, Fac Sci, Unit Bee Res & Honey Prod, Abha, Saudi Arabia; [Khan, Khalid Ali] King Khalid Univ, Fac Sci, Biol Dept, Abha, Saudi Arabia; [Ansari, Mohammad Javed] Hindu Coll Moradabad, Dept Bot, Moradabad, Uttar Pradesh, India; [Farag, Soha A.; Elnabawy, El-Said Mohamed] Univ Tanta, Fac Agr, Dept Anim & Poultry Prod, Tanta, Egypt	King Faisal University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; King Khalid University; King Khalid University; King Khalid University; Egyptian Knowledge Bank (EKB); Tanta University	Al-Kahtani, SN (corresponding author), King Faisal Univ, Arid Land Agr Dept, Coll Agr Sci & Foods, Al Hasa, Saudi Arabia.	salkahtani@kfu.edu.sa	Taha, El-Kazafy/P-6346-2016; Ansari, Muhammad/GQI-1517-2022; Ansari, Mohammad Javed/E-9303-2014; Khan, Khalid Ali/AAR-5403-2020	Taha, El-Kazafy/0000-0003-2010-4838; Ansari, Mohammad Javed/0000-0002-8718-3078; Khan, Khalid Ali/0000-0002-4734-6338; Elnabawy, Elsaid/0000-0001-5456-8548; Farag, Soha/0000-0002-9118-1470	Cooperative association for development of bees industry in Riyadh (NAHAL), Saudi Arabia	Cooperative association for development of bees industry in Riyadh (NAHAL), Saudi Arabia	Cooperative association for development of bees industry in Riyadh (NAHAL), Saudi Arabia.	Abdelnour SA, 2019, J ANIM PHYSIOL AN N, V103, P477, DOI 10.1111/jpn.13049; Almeida JD, 2017, LWT-FOOD SCI TECHNOL, V76, P299, DOI 10.1016/j.lwt.2016.06.017; Anjos O, 2019, LWT-FOOD SCI TECHNOL, V111, P869, DOI 10.1016/j.lwt.2019.05.105; [Anonymous], 2006, PHARM CHEM J; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Ares AM, 2018, J PHARMACEUT BIOMED, V147, P110, DOI 10.1016/j.jpba.2017.08.009; Bridi R, 2019, J NAT PROD, V82, P559, DOI 10.1021/acs.jnatprod.8b00945; Conte P, 2018, LWT-FOOD SCI TECHNOL, V90, P1, DOI 10.1016/j.lwt.2017.12.002; Demir Z, 2020, PAK J ZOOL, V52, P549, DOI 10.17582/journal.pjz/20181119101139; Duman M, CROPS, V16, P26; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; FAO, 2007, COD AL COMM PROC MAN; Farag S. A., 2016, ASIAN J ANIM VET ADV, V11, P168, DOI [10.3923/ajava.2016.168.177, DOI 10.3923/AJAVA.2016.168.177]; Gardana C, 2018, J FOOD COMPOS ANAL, V73, P29, DOI 10.1016/j.jfca.2018.07.009; Ghosh S, 2017, J ASIA-PAC ENTOMOL, V20, P245, DOI 10.1016/j.aspen.2017.01.009; Groot A. P. de, 1953, PROTEIN AMINO ACID R; Hassan H. M. M., 2011, Global Journal of Biotechnology & Biochemistry, V6, P1; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P393, DOI 10.1016/S0022-1910(98)00022-5; Joint FAO/WHO Ad Hoc Expert Committee on Energy and Protein Requirements World Health Organization & Food and Agriculture Organization of the United Nations, 1973, REPORT SERIES, V52; Kieliszek M, 2018, TRENDS FOOD SCI TECH, V71, P170, DOI 10.1016/j.tifs.2017.10.021; Komosinska-Vassev K, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/297425; MITCHELL HH, 1946, J BIOL CHEM, V163, P599; Negrao AF, 2018, AN ACAD BRAS CIENC, V90, P325, DOI 10.1590/0001-3765201720150192; Nicolson SW, 2013, APIDOLOGIE, V44, P144, DOI 10.1007/s13592-012-0166-5; OSER BERNARD L., 1951, JOUR AMER DIETETIC ASSOC, V27, P396; RABIE AL, 1983, J APICULT RES, V22, P119, DOI 10.1080/00218839.1983.11100572; Rogala R., 2004, J APIC SCI, V48, P29; Sas S, 2003, SAS S GUID SUS VERS; de Arruda VAS, 2017, J APICULT RES, V56, P231, DOI 10.1080/00218839.2017.1307715; Spulber R, 2018, ROM BIOTECH LETT, V23, P13357; Szcz^esna, 2006, J APIC SCI, V50, P91; Szczesna T, 2006, J APIC SCI, V50, P81, DOI DOI 10.1016/J.SJBS.2017.06.003; Taha EKA, 2020, J KANS ENTOMOL SOC A; Taha EA, 2019, SAUDI J BIOL SCI, V26, P232, DOI 10.1016/j.sjbs.2017.06.003; Taha El-Kazafy Abdou, 2015, Journal of Entomology and Zoology Studies, V3, P272; Taha EKA, 2015, J APIC SCI, V59, P75, DOI 10.1515/JAS-2015-0008; Thakur M, 2020, TRENDS FOOD SCI TECH, V98, P82, DOI 10.1016/j.tifs.2020.02.001; Thakur M, 2018, J FOOD NUTR RES-SLOV, V57, P328; Themelis T, 2019, J PHARMACEUT BIOMED, V173, P144, DOI 10.1016/j.jpba.2019.05.031; Yang K, 2013, J AGR FOOD CHEM, V61, P708, DOI 10.1021/jf304056b; Yerlikaya O, 2014, MLJEKARSTVO, V64, P268	41	20	20	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0241393	10.1371/journal.pone.0241393	http://dx.doi.org/10.1371/journal.pone.0241393			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370277	Green Published, gold			2022-12-27	WOS:000603611900115
J	Birowo, P; Rangganata, E; Rasyid, N; Atmoko, W				Birowo, Ponco; Rangganata, Ervandy; Rasyid, Nur; Atmoko, Widi			Efficacy and safety of extracorporeal shockwave therapy for the treatment of chronic non-bacterial prostatitis: A systematic review and meta-analysis	PLOS ONE			English	Review							PELVIC-PAIN-SYNDROME; WAVE-THERAPY; MANAGEMENT; ESWT	Purpose Chronic pelvic pain syndrome (CPPS) is one of the most common outpatient urological diagnoses, and its incidence is increasing. Extracorporeal shockwave therapy (ESWT) has been suggested for relieving local perineal symptoms associated with chronic prostatitis/CPPS. Despite several treatment methods, no causal or standardized treatment is available for CPPS. This study aimed to investigate the efficacy and safety profile of ESWT for the treatment of chronic non-bacterial prostatitis. Materials and methods Studies were collected using four search engines (Pubmed, Cochrane, ScienceDirect, and EBSCOHost), on May 16, 2020; and assessed based on predetermined inclusion and exclusion criteria. Two reviewers performed study selection. Studies were then analyzed using Review Manager 5.3 for the meta-analysis. Results Seventy-four publications were initially retrieved, and three studies were considered for both qualitative and quantitative analyses. From these studies, we found that the use of ESWT was significantly associated with decreased pain domain (mean difference: -3.93; 95% confidence interval [CI] -5.13, -2.73; p<0.001), improved urinary score (mean difference: -1.79; 95% CI -2.38, -1.21; p<0.001), improved quality of life (mean difference: -1.71; 95% CI -2.12, -1.31; p<0.001), and improved National Institutes of Health chronic prostatitis symptom index (NIH-CPSI) score (mean difference: -5.45; 95% CI -5.74, -5.16; p<0.001) after 12 weeks of treatment. Conclusion ESWT is efficacious and safe in reducing pain and improving urinary condition, NIH-CPSI score, and quality of life in patients with chronic non-bacterial prostatitis.	[Birowo, Ponco; Rangganata, Ervandy; Rasyid, Nur; Atmoko, Widi] Univ Indonesia, Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Urol, Jakarta, Indonesia	University of Indonesia	Birowo, P (corresponding author), Univ Indonesia, Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Urol, Jakarta, Indonesia.	ponco.birowo@gmail.com	Atmoko, Widi/AGD-1105-2022; Atmoko, Widi/GVS-5551-2022	Atmoko, Widi/0000-0002-7793-7083; 	International Publication Research Grant Universitas Indonesia [NKB-1520/UN2.RST/HKP.05.00/2020]	International Publication Research Grant Universitas Indonesia	Ponco Birowo NKB-1520/UN2.RST/HKP.05.00/2020 International Publication Research Grant Universitas Indonesia www.ui.ac.id.	Al Edwan GM, 2017, ANN MED SURG, V14, P12, DOI 10.1016/j.amsu.2016.12.051; Berghuis JP, 1996, J PSYCHOSOM RES, V41, P313, DOI 10.1016/S0022-3999(96)00157-2; Brede CM, 2011, NAT REV UROL, V8, P207, DOI 10.1038/nrurol.2011.22; Collins MM, 2000, ANN INTERN MED, V133, P367, DOI 10.7326/0003-4819-133-5-200009050-00013; Collins MM, 1998, J UROLOGY, V159, P1224, DOI 10.1016/S0022-5347(01)63564-X; Delavierre D, 2010, PROG UROL, V20, P940, DOI 10.1016/j.purol.2010.09.018; Fall M, 2008, GEN TREATMENT CHRONI, P84; Grabe M, 2008, PROSTATITIS CHRONIC, P79; Habermacher GM, 2006, ANNU REV MED, V57, P195, DOI 10.1146/annurev.med.57.011205.135654; Hartling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017242; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Le BV, 2009, UROL CLIN N AM, V36, P527, DOI 10.1016/j.ucl.2009.08.005; Letizia P, 2017, J SEX MED, V14, pE150, DOI 10.1016/j.jsxm.2017.03.042; Magri V, 2015, EXP THER MED, V9, P658, DOI 10.3892/etm.2014.2152; Moayednia A, 2014, J RES MED SCI, V19, P293; Murphy AB, 2009, DRUGS, V69, P71, DOI 10.2165/00003495-200969010-00005; Nickel JC, 2004, J UROLOGY, V172, P551, DOI 10.1097/01.ju.0000131592.98562.16; Nickel JC, 2016, Campbell-walsh urology, Veleventh, P304; Schaeffer AJ, 2006, NEW ENGL J MED, V355, P1690, DOI 10.1056/NEJMcp060423; Vahdatpour Babak, 2013, ISRN Urol, V2013, P972601, DOI 10.1155/2013/972601; von Hippel PT, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0024-z; Zhang JZ, 2019, AM J MENS HEALTH, V13, P1, DOI 10.1177/1557988319865380; Zimmermann R, 2008, BJU INT, V102, P976, DOI 10.1111/j.1464-410X.2008.07742.x; Zimmermann R, 2009, EUR UROL, V56, P418, DOI 10.1016/j.eururo.2009.03.043	24	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244295	10.1371/journal.pone.0244295	http://dx.doi.org/10.1371/journal.pone.0244295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370372	Green Published, gold			2022-12-27	WOS:000603611900047
J	Buja, A; Paganini, M; Cocchio, S; Scioni, M; Rebba, V; Baldo, V				Buja, Alessandra; Paganini, Matteo; Cocchio, Silvia; Scioni, Manuela; Rebba, Vincenzo; Baldo, Vincenzo			Demographic and socio-economic factors, and healthcare resource indicators associated with the rapid spread of COVID-19 in Northern Italy: An ecological study	PLOS ONE			English	Article								Background COVID-19 rapidly escalated into a pandemic, threatening 213 countries, areas, and territories the world over. We aimed to identify potential province-level socioeconomic determinants of the virus's dissemination, and explain between-province differences in the speed of its spread, based on data from 36 provinces of Northern Italy. Methods This is an ecological study. We included all confirmed cases of SARS-CoV-2 reported between February 24th and March 30th, 2020. For each province, we calculated the trend of contagion as the relative increase in the number of individuals infected between two time endpoints, assuming an exponential growth. Pearson's test was used to correlate the trend of contagion with a set of healthcare-associated, economic, and demographic parameters by province. The virus's spread was input as a dependent variable in a stepwise OLS regression model to test the association between rate of spread and province-level indicators. Results Multivariate analysis showed that the spread of COVID-19 was correlated negatively with aging index (p-value = 0.003), and positively with public transportation per capita (p-value = 0.012), the % of private long-term care hospital beds and, to a lesser extent (p-value = 0.070), the % of private acute care hospital beds (p-value = 0.006). Conclusion Demographic and socioeconomic factors, and healthcare organization variables were found associated with a significant difference in the rate of COVID-19 spread in 36 provinces of Northern Italy. An aging population seemed to naturally contain social contacts. The availability of healthcare resources and their coordination could play an important part in spreading infection.	[Buja, Alessandra; Cocchio, Silvia; Baldo, Vincenzo] Univ Padua, Dept Cardiol Vasc & Thorac Sci, Padua, Italy; [Buja, Alessandra; Cocchio, Silvia; Baldo, Vincenzo] Univ Padua, Publ Hlth, Padua, Italy; [Paganini, Matteo] Univ Padua, Dept Biomed Sci, Padua, Italy; [Scioni, Manuela] Univ Padua, Dept Stat, Padua, Italy; [Rebba, Vincenzo] Univ Padua, Marco Fanno Dept Econ & Management, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua; University of Padua	Paganini, M (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	matteo.paganini@unipd.it	Paganini, Matteo/GQQ-0223-2022; Buja, Alessandra/AAN-8141-2020; Baldo, Vincenzo/D-7822-2018	Buja, Alessandra/0000-0003-2216-3807; Baldo, Vincenzo/0000-0001-6012-9453; Paganini, Matteo/0000-0002-7556-6928				Cohen HW, 2005, AM J HYPERTENS, V18, P750, DOI 10.1016/j.amjhyper.2005.04.002; Fauci AS, 2006, EMERG INFECT DIS, V12, P73; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; International Labour Organization, 2020, GUID MENT HLTH PROM; Istituto Superiore di Sanita, 2020, CHAR SARS COV 2 PAT; Italian Civil Protection, 2020, COR DIS 2019 COVID 1; Italian Civil Protection, 2020, CONT RAT; Italian Ministry of Health, 2018, AN STAT SERV SAN NAZ; Italian Ministry of Health, 2020, COVID 19 IT SIT; Italian National Olympic Committee (CONI), 2020, REG SPORTS ASS; Leung K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08241-1; Marcum CS, 2013, RES AGING, V35, P612, DOI 10.1177/0164027512453468; Mollenkopf H, 2017, KNOWL SPACE, V9, P267, DOI 10.1007/978-3-319-44588-5_15; National Institute of Statistics (ISTAT), 2020, MAIN DAT; National Institute of Statistics (ISTAT), 2020, HLTH ALL DAT; The Prime Minister of the Italian Republic, 2020, URG MEAS CONT MAN EP; WHO, 2007, INF PREV CONTR EP PA, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/s41598-019-38808-z]; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; World Health Organization, 2020, DIS OUTBR NEWS UPD J; Wu X, 2020, MANAGEMENT TRANSFORMATION OF HUAWEI, P1, DOI 10.1017/9781108550987; Zhao S, 2020, TRAVEL MED INFECT DI, V33, DOI 10.1016/j.tmaid.2020.101568; Zheng RZ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101626	22	26	26	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244535	10.1371/journal.pone.0244535	http://dx.doi.org/10.1371/journal.pone.0244535			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370383	gold, Green Published, Green Submitted			2022-12-27	WOS:000603611900099
J	Ruan, GP; Yao, X; Lin, QK; Li, ZA; Cai, XM; Pang, RQ; Pan, XH				Ruan, Guang-ping; Yao, Xiang; Lin, Qing-keng; Li, Zi-an; Cai, Xue-min; Pang, Rong-qing; Pan, Xing-hua			Transplantation of chicken egg white extract-induced rabbit PBMCs as a treatment for renal ischemia-reperfusion injury in rabbits	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SOMATIC-CELLS; EXPRESSION; SURVIVAL	Ischemia-reperfusion injury is an important contributor to acute kidney injury and a major factor affecting early functional recovery after kidney transplantation. We conducted this experiment to investigate the protective effect of induced multipotent stem cell transplantation on renal ischemia-reperfusion injury. Forty rabbits were divided into four groups of 10 rabbits each. Thirty rabbits were used to establish the renal ischemia-reperfusion injury model, and ten rabbits served as the model group and were not treated. Among the 30 rabbits with renal ischemia-reperfusion injury, 10 rabbits were treated with induced peripheral blood mononuclear cells (PBMCs), and 10 other rabbits were treated with noninduced PBMCs. After three weekly treatments, the serum creatinine levels, urea nitrogen levels and urine protein concentrations were quantified. The kidneys were stained with hematoxylin-eosin (HE), periodic acid-Schiff (PAS) and Masson's trichrome and then sent for commercial metabolomic testing. The kidneys of the rabbits in the model group showed different degrees of pathological changes, and the recovery of renal function was observed in the group treated with induced cells. The results indicate that PBMCs differentiate into multipotent stem cells after induction and exert a therapeutic effect on renal ischemia-reperfusion injury.	[Ruan, Guang-ping; Yao, Xiang; Lin, Qing-keng; Li, Zi-an; Cai, Xue-min; Pang, Rong-qing; Pan, Xing-hua] 920th Hosp Joint Logist Support Force PLA, Kunming Key Lab Stem Cell & Regenerat Med, Kunming, Yunnan, Peoples R China; [Ruan, Guang-ping; Yao, Xiang; Lin, Qing-keng; Li, Zi-an; Cai, Xue-min; Pang, Rong-qing; Pan, Xing-hua] Stem Cell & Immune Cell Biomed Tech Integrated En, Kunming, Yunnan, Peoples R China; [Ruan, Guang-ping; Yao, Xiang; Lin, Qing-keng; Li, Zi-an; Cai, Xue-min; Pang, Rong-qing; Pan, Xing-hua] Cell Therapy Technol Transfer Med Key Lab Yunnan, Kunming, Yunnan, Peoples R China		Ruan, GP; Pan, XH (corresponding author), 920th Hosp Joint Logist Support Force PLA, Kunming Key Lab Stem Cell & Regenerat Med, Kunming, Yunnan, Peoples R China.; Ruan, GP; Pan, XH (corresponding author), Stem Cell & Immune Cell Biomed Tech Integrated En, Kunming, Yunnan, Peoples R China.; Ruan, GP; Pan, XH (corresponding author), Cell Therapy Technol Transfer Med Key Lab Yunnan, Kunming, Yunnan, Peoples R China.	ruangp@126.com; xinghuapan@aliyun.com		Ruan, Guangping/0000-0002-3784-7040	Yunnan Science and Technology Plan Project Major Science and Technology Project [2018ZF007]; Yunnan Province Applied Basic Research Program Key Project [2018FA041, 2017FA040]; National Natural Science Foundation [31970515]; 920th Hospital of the PLA Joint Logistics Support Force Inhospital technology plans [2019YGB17, 2019YGA05]	Yunnan Science and Technology Plan Project Major Science and Technology Project; Yunnan Province Applied Basic Research Program Key Project; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 920th Hospital of the PLA Joint Logistics Support Force Inhospital technology plans	This work was supported by grants from Yunnan Science and Technology Plan Project Major Science and Technology Project (2018ZF007) and the Yunnan Province Applied Basic Research Program Key Project (2018FA041, 2017FA040). National Natural Science Foundation (31970515), 920th Hospital of the PLA Joint Logistics Support Force Inhospital technology plans (2019YGB17, 2019YGA05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio R, 2005, EXP CELL RES, V307, P131, DOI 10.1016/j.yexcr.2005.02.028; Alzahrani FA, 2019, AM J TRANSL RES, V11, P2887; [Anonymous], 2017, ACOMA, V12, P183; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; [Anonymous], 2016, THE TOTAL AUDIENCE R; Bi LY, 2015, GENET MOL RES, V14, P4102, DOI 10.4238/2015.April.27.25; Bruno S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt205; Cal JR, 2014, AM J NEPHROL, V39, P466, DOI 10.1159/000362623; Fahmy SR, 2017, TISSUE CELL, V49, P369, DOI 10.1016/j.tice.2017.04.006; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Jang HR, 2014, AM J PHYSIOL-RENAL, V307, pF1149, DOI 10.1152/ajprenal.00555.2013; Miyamoto K, 2009, BIOL REPROD, V80, P935, DOI 10.1095/biolreprod.108.073676; Qi YZ, 2014, YONSEI MED J, V55, P1130, DOI 10.3349/ymj.2014.55.4.1130; Ruan GP, 2017, CELL MOL BIOL, V63, P59, DOI 10.14715/cmb/2017.63.7.10; Ruan GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083507; Ruan GP, 2012, CYTOTECHNOLOGY, V64, P541, DOI 10.1007/s10616-012-9431-8; Si XY, 2015, INT J CLIN EXP PATHO, V8, P12368; Tan XH, 2015, J NEPHROL, V28, P289, DOI 10.1007/s40620-015-0171-7; Tao Yu-Hong, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P157; Xie LB, 2019, RENAL FAILURE, V41, P175, DOI 10.1080/0886022X.2019.1588131; Ying M K, 2016, Zhonghua Yi Xue Za Zhi, V96, P1573, DOI 10.3760/cma.j.issn.0376-2491.2016.20.006; Yuan XD, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0041-4; Zhou LH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44058; Zhu GM, 2019, J CELL PHYSIOL, V234, P23736, DOI 10.1002/jcp.28941; 2014, REG ANESTH PAIN MED, V9	26	0	0	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244160	10.1371/journal.pone.0244160	http://dx.doi.org/10.1371/journal.pone.0244160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370374	Green Published, gold			2022-12-27	WOS:000603611900091
J	Vu, L; Burnett-Zieman, B; Stoman, L; Luu, M; Mdala, J; Granger, K; Forsythe, S; Zegeye, A; Geibel, S				Vu, Lung; Burnett-Zieman, Brady; Stoman, Lizl; Luu, Minh; Mdala, Johnface; Granger, Krista; Forsythe, Steven; Zegeye, Abeje; Geibel, Scott			Effects of the implementation of the HIV Treat All guidelines on key ART treatment outcomes in Namibia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; INITIATION	Background This study aimed to help the Namibian government understand the impact of Treat All implementation (started on April 1, 2017) on key antiretroviral therapy (ART) outcomes, and how this transition impacts progress toward the UNAIDS's 90-90-90 HIV targets. Methods We collected clinical records from two separate cohorts (before and after treat-all) of ART patients in 10 high- and medium-volume facilities in 6 northern Namibia districts. Each cohort contains 12-month data on patients' scheduled appointments and visits, health status, and viral load results. We also measured patients' wait time and perceptions of service quality using exit interviews with 300 randomly selected patients (per round). We compared ART outcomes of the two cohorts: ART initiation within 7 days from diagnosis, loss to follow-up (LTFU), missed scheduled appointments for at least 30 days, and viral suppression using unadjusted and adjusted analyses. Results Among new ART clients (on ART for less than 3 months or had not yet initiated treatment as of the start date for the ART record review period), rapid ART initiation (within 7 days from diagnosis) was 5.2 times higher after Treat All than that among clients assessed before the policy took effect [AOR: 5.2 (3.8-6.9)]. However, LTFU was higher after Treat All roll-out compared to before Treat All [AOR: 1.9 (1.3-2.8)]. Established ART clients (on ART treatment for at least three months at the start date of the ART record review period) had over 3 times greater odds of achieving viral suppression after Treat All roll-out compared to established ART clients assessed before Treat All [AOR: 3.1 (1.6-5.9)]. Conclusions and recommendations The findings indicate positive effect of the "Treat All" implementation on ART initiation and viral suppression, and negative effect on LTFU. Additionally, by April 2018, Namibia seems to have reached the UNAIDS's 90-90-90 targets.	[Vu, Lung; Burnett-Zieman, Brady; Granger, Krista; Geibel, Scott] Populat Council, Washington, DC USA; [Stoman, Lizl] Survey Warehouse, Windhoek, Namibia; [Luu, Minh] Emory Univ, Atlanta, GA 30322 USA; [Mdala, Johnface] IntraHlth Int, Windhoek, Namibia; [Forsythe, Steven] Avenir Hlth, Glastonbury, CT USA; [Zegeye, Abeje] USAID, Windhoek, Namibia	Population Council; Emory University; United States Agency for International Development (USAID)	Vu, L (corresponding author), Populat Council, Washington, DC USA.	lvu8@worldbank.org	; Vu, Lung/M-3043-2014	Forsythe, Steven/0000-0002-4409-5991; Vu, Lung/0000-0001-9088-7407	United States President's Emergency Plan for AIDS Relief (PEPFAR) [AID-OAA-A-14-00060]; United States Agency for International Development (USAID) [AID-OAA-A-14-00060]	United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This work was supported by Project SOAR (Cooperative agreement AID-OAA-A-14-00060), made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR) and United States Agency for International Development (USAID). The contents of this paper are the sole responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, or the United States Government. In addition, we would like to declare that the funder has never paid direct salaries to any authors, including Lizl Stoman from Survey Warehouse, for working on this manuscript.	Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Brennan AT, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-49; CDC, CDC NAM JAN; Chandiwana N, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010901, 10.1097/md.0000000000010901]; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Ford N, 2018, AIDS, V32, P17, DOI [10.1097/QAD.0000000000001671, 10.1097/qad.0000000000001671]; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Havlir DV, 2019, NEW ENGL J MED, V381, P219, DOI 10.1056/NEJMoa1809866; Hayes RJ, 2019, NEW ENGL J MED, V381, P207, DOI 10.1056/NEJMoa1814556; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Kelly JD, 2018, SAHARA J-J SOC ASP H, V15, P138, DOI 10.1080/17290376.2018.1527244; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Makhema J, 2019, NEW ENGL J MED, V381, P230, DOI 10.1056/NEJMoa1812281; Ministry of Health and Social Services Directorate of Special Programmes, 2017, NAT STRAT FRAM HIV A; Ministry of Health and Social Services Namibia Centers for Disease Control and Prevention (CDC) University of California San Francisco and ICAP at Columbia University, 2018, NAM POP BAS HIV IMP; Mukherjee JS, 2016, CURR HIV-AIDS REP, V13, P359, DOI 10.1007/s11904-016-0335-7; Namibia Ministry of Health and Social Services, 2017, NAM 2014 15 HLTH ACC; PEPFAR, 2016, FY 2016 NAM COUNTR O; Schutte C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228135; Song AX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00212; Susman Ed, 2018, MEDPAGE TODAY; Thayaparan AJ, 2013, MED EDUC ONLINE, V18, DOI 10.3402/meo.v18i0.21747; The Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK END AIDS; UNAIDS, 2020, UNAIDS DAT; Walsh F, 2020, CURR HIV-AIDS REP, V17, P324, DOI 10.1007/s11904-020-00501-6; Warstrom, 2014, MENTIMETER; World Health Organization, 2015, GUID START ANT THER; World Health Organization (WHO), 2017, GUIDELINES MANAGING	29	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243749	10.1371/journal.pone.0243749	http://dx.doi.org/10.1371/journal.pone.0243749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370313	Green Published, gold			2022-12-27	WOS:000603611900092
J	Glance, LG; Thirukumaran, CP; Shippey, E; Lustik, SJ; Dick, AW				Glance, Laurent G.; Thirukumaran, Caroline P.; Shippey, Ernie; Lustik, Stewart J.; Dick, Andrew W.			Impact of medicaid expansion on disparities in revascularization in patients hospitalized with acute myocardial infarction	PLOS ONE			English	Article							ASSOCIATION TASK-FORCE; HEART-DISEASE; CARDIOVASCULAR HEALTH; AMERICAN-COLLEGE; MANAGEMENT; GUIDELINE; INSURANCE; UPDATE; CARE; MORTALITY	Introduction Blacks are more likely to live in poverty and be uninsured, and are less likely to undergo revascularization after am acute myocardial infarction compared to whites. The objective of this study was to determine whether Medicaid expansion was associated with a reduction in revascularization disparities in patients admitted with an acute myocardial infarction. Methods Retrospective analysis study using data (2010-2018) from hospitals participating in the University Health Systems Consortium, now renamed the Vizient Clinical Database. Comparative interrupted time series analysis was used to compare changes in the use of revascularization therapies (PCI and CABG) in white versus non-Hispanic black patients hospitalized with either ST-segment elevation (STEMI) or non-ST-segment elevation acute myocardial infarctions (NSTEMI) after Medicaid expansion. Results The analytic cohort included 68,610 STEMI and 127,378 NSTEMI patients. The percentage point decrease in the uninsured rate for STEMIs and NSTEMIs was greater for blacks in expansion states compared to whites in expansion states. For patients with STEMIs, differences in black versus white revascularization rates decreased by 2.09 percentage points per year (95% CI, 0.29-3.88, P = 0.023) in expansion versus non-expansion states after adjusting for patient and hospital characteristics. Black patients hospitalized with STEMI in non-expansion states experienced a 7.24 percentage point increase in revascularization rate in 2014 (95% CI, 2.83-11.7, P < 0.001) but did not experience significant annual percentage point increases in the rate of revascularization in subsequent years (1.52; 95% CI, -0.51-3.55, P = 0.14) compared to whites in non-expansion states. Medicaid expansion was not associated with changes in the revascularization rate for either blacks or whites hospitalized with NSTEMIs. Conclusion Medicaid expansion was associated with greater reductions in the number of uninsured blacks compared to uninsured whites. Medicaid expansion was not associated, however, with a reduction in revascularization disparities between black and white patients admitted with acute myocardial infarctions.	[Glance, Laurent G.; Lustik, Stewart J.] Univ Rochester, Sch Med, Dept Anesthesiol & Perioperat Med, Rochester, NY 14627 USA; [Glance, Laurent G.] Univ Rochester, Sch Med, Dept Publ Hlth Sci, Rochester, NY 14627 USA; [Glance, Laurent G.; Dick, Andrew W.] RAND, RAND Hlth, Boston, MA 02116 USA; [Thirukumaran, Caroline P.] Univ Rochester, Dept Orthoped, Sch Med, Rochester, NY 14642 USA; [Shippey, Ernie] Vizient, Irving, TX USA	University of Rochester; University of Rochester; RAND Corporation; University of Rochester	Glance, LG (corresponding author), Univ Rochester, Sch Med, Dept Anesthesiol & Perioperat Med, Rochester, NY 14627 USA.; Glance, LG (corresponding author), Univ Rochester, Sch Med, Dept Publ Hlth Sci, Rochester, NY 14627 USA.; Glance, LG (corresponding author), RAND, RAND Hlth, Boston, MA 02116 USA.	Laurent_Glance@urmc.rochester.edu		Thirukumaran, Caroline/0000-0003-3316-0951; Glance, Laurent/0000-0003-3381-699X	NIH [R01 MD012422]; Department of Anesthesiology and Perioperative Medicine at the University of Rochester School of Medicine and Dentistry, RAND Health	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Anesthesiology and Perioperative Medicine at the University of Rochester School of Medicine and Dentistry, RAND Health	This work was supported by NIH grant R01 MD012422, and by the Department of Anesthesiology and Perioperative Medicine at the University of Rochester School of Medicine and Dentistry, RAND Health, and Vizient. The funder provided support in the form of salaries for authors [LGG, ES, SJL, AWD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Akhabue E, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1296; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; [Anonymous], 2018, POVERTY RATE RACE ET; Baicker K, 2004, HEALTH AFFAIR, V23, pVAR33, DOI 10.1377/hlthaff.var.33; Braunwald E, 2002, J AM COLL CARDIOL, V40, P1366, DOI 10.1016/S0735-1097(02)02336-7; Buchmueller TC, 2016, AM J PUBLIC HEALTH, V106, P1416, DOI 10.2105/AJPH.2016.303155; Bureau USC,, 2018, ICONCOME POVERTYU US; Bydon M, 2020, CLIN NEUROL NEUROSUR, V188, DOI 10.1016/j.clineuro.2019.105585; Carnethon MR, 2017, CIRCULATION, V136, pE393, DOI 10.1161/CIR.0000000000000534; Cromwell J, 2005, MED CARE, V43, P330, DOI 10.1097/01.mlr.0000156864.80880.aa; Damico A, 2020, CHANGES HLTH COVERAG; Eagle Kim A, 2004, Circulation, V110, pe340; Eguia E, 2018, ANN SURG, V268, P584, DOI 10.1097/SLA.0000000000002952; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Eltorai AEM, 2017, JAMA-J AM MED ASSOC, V317, P1407, DOI 10.1001/jama.2017.2042; Etzioni DA, 2015, JAMA-J AM MED ASSOC, V313, P505, DOI 10.1001/jama.2015.90; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Kahn JM, 2019, JAMA-J AM MED ASSOC, V322, P240, DOI 10.1001/jama.2019.9021; Khatana SAM, 2019, JAMA CARDIOL, V4, P671, DOI 10.1001/jamacardio.2019.1651; Li SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069855; Loehrer AP, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2017.5568; McWilliams JM, 2018, NEW ENGL J MED, V379, P1139, DOI 10.1056/NEJMsa1803388; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Qian F, 2012, ANN SURG; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Simorov A, 2012, ANN SURG, V256, P462, DOI 10.1097/SLA.0b013e3182657ec5; Sommers BD, 2017, AM J HEALTH ECON, V3, P392, DOI 10.1162/ajhe_a_00080; Soni A, 2020, HEALTH AFFAIR, V39, P371, DOI 10.1377/hlthaff.2019.01436; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wadhera RK, 2019, JAMA CARDIOL, V4, P120, DOI 10.1001/jamacardio.2018.4577; Wadhera RK, 2017, CIRCULATION, V135, P1988, DOI 10.1161/CIRCULATIONAHA.117.028618; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Xu J, DEATHS FINAL DATA 20; Yong CM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001029	36	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243385	10.1371/journal.pone.0243385	http://dx.doi.org/10.1371/journal.pone.0243385			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362198	Green Published, gold			2022-12-27	WOS:000603071600013
J	Kiss, HJ; Rosa-Garcia, A; Zhukova, V				Kiss, Hubert Janos; Rosa-Garcia, Alfonso; Zhukova, Vita			Conditional cooperation in group contests	PLOS ONE			English	Article							PAROCHIAL ALTRUISM; COGNITIVE REFLECTION; COLLECTIVE ACTION; INFORMATION; COMMUNICATION; COMPETITION; FAIRNESS; FEEDBACK	In this paper we show experimentally that conditional cooperation, a phenomenon described in the private provision of public goods, is also present in group contests, where participants' contributions to their group performance partially determines if they overcome a rival group. This environment allows us to identify new determinants of conditional cooperation. We observe conditional cooperation in successful groups and in groups where members contribute more than rivals (even if they lose), but it vanishes in those groups that lose the contest due to low group performance. A random-effect linear panel regression analysis with an extensive set of controls confirms the findings.	[Kiss, Hubert Janos] Inst Econ KRTK KTI, Ctr Econ & Reg Studies, Budapest, Hungary; [Kiss, Hubert Janos] Corvinus Univ Budapest, Dept Econ, Budapest, Hungary; [Rosa-Garcia, Alfonso] Univ Murcia, Dept Fundamentos Anal Econ, Murcia, Spain; [Zhukova, Vita] Univ Catolica San Antonio Murcia, Dept Business, Murcia, Spain	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Economic & Regional Studies; Corvinus University Budapest; University of Murcia; Universidad Catolica de Murcia	Kiss, HJ (corresponding author), Inst Econ KRTK KTI, Ctr Econ & Reg Studies, Budapest, Hungary.; Kiss, HJ (corresponding author), Corvinus Univ Budapest, Dept Econ, Budapest, Hungary.	kiss.hubert.janos@krtk.mta.hu	Kiss, Hubert János/C-6313-2016; Rosa Garcia, Alfonso/C-3224-2016	Kiss, Hubert János/0000-0003-3666-9331; Rosa Garcia, Alfonso/0000-0003-2223-007X	National Research, Development Innovation (NKFIH) [ECO2017-82449-P]; Spanish Ministry of Economy, Industry and Competitiveness [20764-3/2018/FEKUTSRTAT, PID2019-107192GB-I00 (AEI/10.13039/501100011033)]; Higher Education Institutional Excellence Program of the Ministry of Human Capacities;  [K 119683];  [ECO2016-76178-P]	National Research, Development Innovation (NKFIH); Spanish Ministry of Economy, Industry and Competitiveness; Higher Education Institutional Excellence Program of the Ministry of Human Capacities; ; 	This study was funded by the following: HJK - K 119683, the National Research, Development Innovation (NKFIH) HJK - ECO2017-82449-P, Spanish Ministry of Economy, Industry and Competitiveness HJK - 20764-3/2018/FEKUTSRTAT, Higher Education Institutional Excellence Program of the Ministry of Human Capacities in the framework of the 'Financial and Public Services' at Corvinus University of Budapest. ARG - ECO2016-76178-P, Spanish Ministry of Economy, Industry and Competitiveness ARG - PID2019-107192GB-I00 (AEI/10.13039/501100011033), Spanish Ministry of Economy, Industry and Competitiveness The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink K, 2012, ECON LETT, V117, P45, DOI 10.1016/j.econlet.2012.04.083; Abbink K, 2010, AM ECON REV, V100, P420, DOI 10.1257/aer.100.1.420; ANDREONI J, 1989, J POLIT ECON, V97, P1447, DOI 10.1086/261662; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bhattacharya P, 2016, J ECON BEHAV ORGAN, V132, P157, DOI 10.1016/j.jebo.2016.09.004; Brookins P, 2015, LABOUR ECON, V35, P16, DOI 10.1016/j.labeco.2015.03.011; Cason T. N., 2018, J EC BEHAV ORG; Cason TN, 2017, EXP ECON, V20, P946, DOI 10.1007/s10683-017-9519-2; Cason TN, 2012, GAME ECON BEHAV, V76, P26, DOI 10.1016/j.geb.2012.05.001; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; Chowdhury SM, 2016, EUR ECON REV, V90, P107, DOI 10.1016/j.euroecorev.2016.02.003; Chowdhury SM, 2014, GAME ECON BEHAV, V87, P224, DOI 10.1016/j.geb.2014.05.004; Crosetto P, 2013, J RISK UNCERTAINTY, V47, P31, DOI 10.1007/s11166-013-9170-z; Croson R, 2005, ECON LETT, V87, P95, DOI 10.1016/j.econlet.2004.10.007; Cueva C, 2016, J BEHAV EXP ECON, V64, P81, DOI 10.1016/j.socec.2015.09.002; Eisenkopf G, 2014, EUR ECON REV, V67, P42, DOI 10.1016/j.euroecorev.2014.01.003; Fallucchi F, 2019, J ECON SCI ASSOC-JES, V5, P238, DOI 10.1007/s40881-018-0060-7; Fallucchi F, 2013, EUR ECON REV, V64, P223, DOI 10.1016/j.euroecorev.2013.09.003; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fernandez Domingos E, 2020, ARXIV200307317; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Flamand S., 2015, COMPANION POLITICAL, P92; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gavrilets S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0016; GUTTMAN JM, 1986, J ECON BEHAV ORGAN, V7, P171, DOI 10.1016/0167-2681(86)90004-1; Keser C, 2000, SCAND J ECON, V102, P23, DOI 10.1111/1467-9442.00182; Kocher MG, 2008, ECON LETT, V101, P175, DOI 10.1016/j.econlet.2008.07.015; Konrad K. A., 2009, STRATEGY DYNAMICS CO; Kuhnen CM, 2012, MANAGE SCI, V58, P94, DOI 10.1287/mnsc.1110.1379; Lim W, 2014, J ECON BEHAV ORGAN, V99, P155, DOI 10.1016/j.jebo.2013.12.010; Liu LJ, 2019, MATH MOD METH APPL S, V29, P2127, DOI 10.1142/S0218202519500428; Ludwig S, 2012, J ECON PSYCHOL, V33, P166, DOI 10.1016/j.joep.2011.09.011; Mago SD, 2016, J CONFLICT RESOLUT, V60, P459, DOI 10.1177/0022002714545333; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Price CR, 2015, J ECON MANAGE STRAT, V24, P597, DOI 10.1111/jems.12108; Price CR, 2011, ECON LETT, V111, P217, DOI 10.1016/j.econlet.2011.02.003; RABIN M, 1993, AM ECON REV, V83, P1281; Sen Amartya, 2007, IDENTITY VIOLENCE IL; Sheremeta RM, 2018, J ECON SURV, V32, P683, DOI 10.1111/joes.12208; Sheremeta RM, 2011, KOREAN ECON REV, V27, P5; Sheremeta RM, 2010, GAME ECON BEHAV, V68, P731, DOI 10.1016/j.geb.2009.08.001; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Thoni C, 2018, ECON LETT, V171, P37, DOI 10.1016/j.econlet.2018.06.022; Toplak ME, 2014, THINK REASONING, V20, P147, DOI 10.1080/13546783.2013.844729	47	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244152	10.1371/journal.pone.0244152	http://dx.doi.org/10.1371/journal.pone.0244152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362281	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000603071600009
J	Pereira, RAD; da Silva, GR; Barcelos, LM; Cavalcanti, KGBA; Herval, AM; Ardenghi, TM; Soares, CJ				da Silva Pereira, Renata Afonso; da Silva, Gisele Rodrigues; Barcelos, Luciana Mendes; Cavalcanti, Karoline Guara Brusaca Almeida; Herval, Alex Moreira; Ardenghi, Thiago Machado; Soares, Carlos Jose			Practice-based analysis of direct posterior dental restorations performed in a public health service: Retrospective long-term survival in Brazil	PLOS ONE			English	Article							RESIN COMPOSITE RESTORATIONS; MERGE MINAMATA CONVENTION; ORAL-HEALTH; CLINICAL-EVALUATION; PERMANENT TEETH; LONGEVITY; AMALGAM; INTERVENTION; PLACEMENT; ACCESS	The aim of this retrospective study was to evaluate the survival and associated factors for the longevity of direct posterior restorations and to verify whether the geographic location of public health units could influence the long-term survival of such restorations. Data were extracted from electronic patient files of the Brazilian public oral health services. The sample comprised 2,405 class I and II restorations performed 4 to 24 years ago (mean, 8.9 years) in 351 patients (6.8 teeth/patient) across 12 public health units located in different city regions (42 professionals-55 restorations). The restoration was considered successful if it had not been repaired or replaced at the time of evaluation; failure was defined as replacement of the restoration, the need for endodontic treatment, tooth/restoration fracture or tooth extraction. Data were analyzed using the Kaplan-Meier test for restoration survival and Cox regression to evaluate the factors associated with failure. The majority of the restorations involved the use of amalgam (85%), involved a single face (70%), and were without pulp/dentin capping (85%). The overall survival rate was 95%, and the mean observation time was 8.9 years. The restoration survival was 79% (95% CI: 60.6-89.5) over 24 years, and the mean survival time was 22.2 years (95% CI: 21.9-22.6 years). The annual failure rate up to 24 years was 0.9%. After the adjustment, only the number of restored faces and the geographic location where the restoration was performed remained associated with failure of the restoration. The direct posterior restorations performed at the evaluated public health service units presented high survival rates. The restorations of people with lower access to POHS had lower survival rates. Class I restorations presented higher survival rates than class II restorations with two or more faces, regardless of the restorative material used.	[da Silva Pereira, Renata Afonso; da Silva, Gisele Rodrigues; Barcelos, Luciana Mendes; Soares, Carlos Jose] Univ Fed Uberlandia, Sch Dent, Dept Operat Dent & Dent Mat, Uberlandia, MG, Brazil; [Cavalcanti, Karoline Guara Brusaca Almeida] Univ Ceuma, Dept Postgrad Program Dent, Sao Luis, Maranhao, Brazil; [Herval, Alex Moreira] Univ Fed Uberlandia, Sch Dent, Dept Social & Prevent Dent, Uberlandia, MG, Brazil; [Ardenghi, Thiago Machado] Univ Fed Santa Maria, Dept Stomatol, Santa Maria, RS, Brazil	Universidade Federal de Uberlandia; Universidade Ceuma; Universidade Federal de Uberlandia; Universidade Federal de Santa Maria (UFSM)	Soares, CJ (corresponding author), Univ Fed Uberlandia, Sch Dent, Dept Operat Dent & Dent Mat, Uberlandia, MG, Brazil.	carlosjsoares@ufu.br	da Silva GR Silva, Gisele Rodrigues/G-5227-2015; Soares, Carlos/D-2126-2013	Herval, Alex Moreira/0000-0001-6649-2616; Soares, Carlos/0000-0002-8830-605X	CNPq; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	We did not have any financial support for this specific study. Only the students that performed this study received the scholarship from CNPq and FAPEMIG.	Accounting Today, 2009, ACCOUNTING TODAY, V23, P9; Afrashtehfar KI, 2017, J PROSTHET DENT, V117, P345, DOI 10.1016/j.prosdent.2016.08.003; Alexander G, 2014, AUST DENT J, V59, P408, DOI 10.1111/adj.12209; [Anonymous], 2018, LUBES N GREASES, V23, P1; Rossi TRA, 2019, CIENC SAUDE COLETIVA, V24, P4427, DOI 10.1590/1413-812320182412.25582019; Astvaldsdottir A, 2015, J DENT, V43, P934, DOI 10.1016/j.jdent.2015.05.001; Ben-Gal G, 2011, J DENT EDUC, V75, P1590; Blum Igor R, 2014, Prim Dent J, V3, P62; Burke FJT, 2018, BRIT DENT J, V224, P789, DOI 10.1038/sj.bdj.2018.354; By CC, 2014, PEDIAT DERMATOL, V31, pe152; Cardoso DF., 2015, PLANEJ POLIT, V45, P347; Como DH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050710; Correa MB, 2012, J DENT, V40, P703, DOI 10.1016/j.jdent.2012.04.020; Correa MB, 2013, J DENT, V41, P960, DOI 10.1016/j.jdent.2013.02.010; Rodolpho PAD, 2011, DENT MATER, V27, P955, DOI 10.1016/j.dental.2011.06.001; Goldstein Gary R, 2010, J Evid Based Dent Pract, V10, P30, DOI 10.1016/j.jebdp.2009.11.015; Heaven TJ, 2013, J DENT, V41, P718, DOI 10.1016/j.jdent.2013.05.014; Hurst Dominic, 2014, Evid Based Dent, V15, P50, DOI 10.1038/sj.ebd.6401026; Kidd E A, 1990, Adv Dent Res, V4, P10; Kielbassa AM, 2017, QUINTESSENCE INT, V48, P9, DOI 10.3290/j.qi.a37211; Kielbassa AM, 2016, QUINTESSENCE INT, V47, P813, DOI 10.3290/j.qi.a36884; Kielbassa AM, 2014, QUINTESSENCE INT, V45, P547, DOI 10.3290/j.qi.a32032; Kohler B, 2000, J DENT, V28, P111, DOI 10.1016/S0300-5712(99)00059-7; Kopperud SE, 2012, EUR J ORAL SCI, V120, P539, DOI 10.1111/eos.12004; Lubisich EB, 2011, J DENT, V39, P302, DOI 10.1016/j.jdent.2011.01.007; Lynch CD, 2013, BRIT DENT J, V215, P109, DOI 10.1038/sj.bdj.2013.737; Lynch CD, 2010, J ORAL REHABIL, V37, P916, DOI 10.1111/j.1365-2842.2010.02119.x; Lynch CD, 2011, J AM DENT ASSOC, V142, P612, DOI 10.14219/jada.archive.2011.0243; McCracken MS, 2013, J AM DENT ASSOC, V144, P583, DOI 10.14219/jada.archive.2013.0169; Mendes SR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217249; Mjor IA, 2002, OPER DENT, V27, P117; Nunes ED, 2006, TRATADO SAUDE COLETI, P295; Opdam NJM, 2014, J DENT RES, V93, P943, DOI 10.1177/0022034514544217; Pallesen U, 2014, CLIN ORAL INVEST, V18, P819, DOI 10.1007/s00784-013-1052-x; Pallesen U, 2013, J DENT, V41, P297, DOI 10.1016/j.jdent.2012.11.021; Palotie U, 2017, J DENT, V62, P13, DOI 10.1016/j.jdent.2017.05.012; Pucca GA, 2015, J DENT RES, V94, P1333, DOI 10.1177/0022034515599979; Raedel M, 2017, CLIN ORAL INVEST, V21, P2819, DOI 10.1007/s00784-017-2084-4; Ramesh KK, 2019, J PHARM BIOALLIED SC, V11, pS151, DOI [10.4103/JPBS.JPBS_280_18, 10.4103/jpbs.JPBS_280_18]; Rechmann Peter, 2019, J Calif Dent Assoc, V47, P15; Rey R, 2015, J DENT EDUC, V79, P331; Shariff JA, 2016, HEALTH AFFAIR, V35, P2259, DOI 10.1377/hlthaff.2016.0583; van de Sande FH, 2013, J DENT RES, V92, pS78, DOI 10.1177/0022034513484337; Versluis Antheunis, 2011, J Tenn Dent Assoc, V91, P36; Wallace BB, 2012, J COMMUN HEALTH, V37, P32, DOI 10.1007/s10900-011-9412-4; Zabrovsky A, 2018, OPER DENT, V43, pE273, DOI 10.2341/17-361-C	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243288	10.1371/journal.pone.0243288	http://dx.doi.org/10.1371/journal.pone.0243288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351807	Green Published, gold			2022-12-27	WOS:000603071400039
J	Wu, ZH; Hai, EH; Di, ZY; Ma, R; Shang, FZ; Wang, Y; Wang, M; Liang, LL; Rong, YJ; Pan, JF; Wu, WB; Su, R; Wang, ZY; Wang, RJ; Zhang, YJ; Li, JQ				Wu, Zhihong; Hai, Erhan; Di, Zhengyang; Ma, Rong; Shang, Fangzheng; Wang, Yu; Wang, Min; Liang, Lili; Rong, Youjun; Pan, Jianfeng; Wu, Wenbin; Su, Rui; Wang, Zhiying; Wang, Ruijun; Zhang, Yanjun; Li, Jinquan			Using WGCNA (weighted gene co-expression network analysis) to identify the hub genes of skin hair follicle development in fetus stage of Inner Mongolia cashmere goat	PLOS ONE			English	Article							CELL POLARITY; WNT; ACTIVATION; GASTRULATION; SUPPRESSION; MECHANISMS; BUD	Objective Mature hair follicles represent an important stage of hair follicle development, which determines the stability of hair follicle structure and its ability to enter the hair cycle. Here, we used weighted gene co-expression network analysis (WGCNA) to identify hub genes of mature skin and hair follicles in Inner Mongolian cashmere goats. Methods We used transcriptome sequencing data for the skin of Inner Mongolian cashmere goats from fetal days 45-135 days, and divided the co expressed genes into different modules by WGCNA. Characteristic values were used to screen out modules that were highly expressed in mature skin follicles. Module hub genes were then selected based on the correlation coefficients between the gene and module eigenvalue, gene connectivity, and Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The results were confirmed by quantitative polymerase chain reaction (qPCR). Results Ten modules were successfully defined, of which one, with a total of 3166 genes, was selected as a specific module through sample and gene expression pattern analyses. A total of 584 candidate hub genes in the module were screened by the correlation coefficients between the genes and module eigenvalue and gene connectivity. Finally, GO/KEGG functional enrichment analyses detected WNT10A as a key gene in the development and maturation of skin hair follicles in fetal Inner Mongolian cashmere goats. qPCR showed that the expression trends of 13 genes from seven fetal skin samples were consistent with the sequencing results, indicating that the sequencing results were reliable.n	[Wu, Zhihong; Hai, Erhan; Di, Zhengyang; Ma, Rong; Shang, Fangzheng; Wang, Min; Liang, Lili; Rong, Youjun; Pan, Jianfeng; Su, Rui; Wang, Zhiying; Wang, Ruijun; Zhang, Yanjun; Li, Jinquan] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China; [Li, Jinquan] Key Lab Anim Genet Breeding & Reprod, Hohhot, Inner Mongolia, Peoples R China; [Li, Jinquan] Minist Agr, Key Lab Mutton Sheep Genet & Breeding, Hohhot, Peoples R China; [Zhang, Yanjun; Li, Jinquan] Engn Res Ctr Goat Genet & Breeding, Hohhot, Inner Mongolia, Peoples R China; [Wang, Yu] Inner Mongolia Agr Univ, Coll Vet Med, Hohhot, Inner Mongolia, Peoples R China; [Wu, Wenbin] Zhenlai Hehe Anim Husb Dev Co Ltd, Baicheng, Peoples R China	Inner Mongolia Agricultural University; Ministry of Agriculture & Rural Affairs; Inner Mongolia Agricultural University	Zhang, YJ; Li, JQ (corresponding author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China.; Li, JQ (corresponding author), Key Lab Anim Genet Breeding & Reprod, Hohhot, Inner Mongolia, Peoples R China.; Li, JQ (corresponding author), Minist Agr, Key Lab Mutton Sheep Genet & Breeding, Hohhot, Peoples R China.; Zhang, YJ; Li, JQ (corresponding author), Engn Res Ctr Goat Genet & Breeding, Hohhot, Inner Mongolia, Peoples R China.	imauzyj@163.com; lijinquan_nd@126.com	wu, zhi/GXH-3041-2022		National Natural Science Foundation of China [31860627]; Plan Project of Science and Technology in Inner Mongolia [2019GG243]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan Project of Science and Technology in Inner Mongolia	This work was supported by National Natural Science Foundation of China in the form of a grant awarded to YZ (31860627) and Plan Project of Science and Technology in Inner Mongolia in the form of a grant awarded to YZ (2019GG243).	Ahn S, 2020, BIOMATERIALS, V255, DOI 10.1016/j.biomaterials.2020.120149; An JA, 2015, BIOCHEM BIOPH RES CO, V461, P142, DOI 10.1016/j.bbrc.2015.03.182; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; [Anonymous], 2020, CANC DISCOV, V10, pOF8; Anyabolu Ernest Ndukaife, 2017, CLIN MED DIAGN, V7, P8, DOI DOI 10.5923/J.CMD.20170701.02; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Basler K, 2016, J CONTROL RELEASE, V242, P105, DOI 10.1016/j.jconrel.2016.08.007; Bai JY, 2006, ASIAN AUSTRAL J ANIM, V19, P13; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Bray MA, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw014; Chamcheu JC, 2011, ARCH BIOCHEM BIOPHYS, V508, P123, DOI 10.1016/j.abb.2010.12.019; Deng ZL, 2015, J MOL CELL BIOL, V7, P62, DOI 10.1093/jmcb/mjv005; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Feltrin AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210431; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Han WJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60351-5; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hoefert JE, 2018, J CELL BIOL, V217, P2185, DOI 10.1083/jcb.201708173; Kim HS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225511; Klufa J, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax2693; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee J, 2018, CELL REP, V22, P242, DOI 10.1016/j.celrep.2017.12.007; Lefever T, 2010, J CELL SCI, V123, P128, DOI 10.1242/jcs.053835; Li J, 2019, ONCOL LETT, V17; Liu X, 2020, GENE, V733, DOI 10.1016/j.gene.2019.144242; Manli Yang, 2020, J COSMET DERMATOL; Marques M, 2002, J INVEST DERMATOL, V119, P913, DOI 10.1046/j.1523-1747.2002.01859.x; Mikkola ML, 2006, J MAMMARY GLAND BIOL, V11, P187, DOI 10.1007/s10911-006-9029-x; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Noramly S, 1999, DEVELOPMENT, V126, P3509; Petridis C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07459-5; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reyes CC, 2014, CURR BIOL, V24, P1263, DOI 10.1016/j.cub.2014.04.021; Roy E, 2016, EMBO J, V35, P2658, DOI 10.15252/embj.201693806; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sennett R, 2015, DEV CELL, V34, P577, DOI 10.1016/j.devcel.2015.06.023; Shin W, 2020, DEV CELL, V53, P185, DOI 10.1016/j.devcel.2020.03.019; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Suen WJ, 2020, STEM CELLS, V38, P301, DOI 10.1002/stem.3117; Tiskinformation, 2006, TISKINFORMATION, V25, P2; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Xiong Y, 2019, J DENT RES, V98, P580, DOI 10.1177/0022034519835194; Xu XG, 2018, ACTA DERM-VENEREOL, V98, P318, DOI 10.2340/00015555-2843; Yang L, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.27266; Yu M, 2020, J DENT RES, V99, P311, DOI 10.1177/0022034519897607; Yu Miao, 2019, AM J MED GENETICS A, V179; Zhang Yanjun, 2007, INNER MONGOLIA CASHM; Zhou T, 2016, CELL PHYSIOL BIOCHEM, V38, P959, DOI 10.1159/000443048; Zorn-Kruppa M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30341-9; 2018, CURR OPIN TOXICOL, V10; 2019, J CROHNS COLITIS S1, V13	59	5	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243507	10.1371/journal.pone.0243507	http://dx.doi.org/10.1371/journal.pone.0243507			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351808	gold, Green Published			2022-12-27	WOS:000603071400028
J	Barakat, M; Al-Qudah, R; Akour, A; Al-Qudah, N; Bashi, YDH				Barakat, Muna; Al-Qudah, Raja'a; Akour, Amal; Al-Qudah, Najem; Dallal Bashi, Yahya H.			Unforeseen uses of oral contraceptive pills: Exploratory study in Jordanian community pharmacies	PLOS ONE			English	Article							KNOWLEDGE; MISUSE; WOMEN; PRESCRIPTION; ATTITUDE; IMPACT; ABUSE	Background The use of oral contraceptive pills (OCPs) as a birth control method is very common worldwide. OCPs have many other labeled non-contraceptive indications, and as a result there is an associated risk of improper use, as with any other medications. This study was designed to assess the unforeseen improper uses of OCPs observed by community pharmacists in Jordan. Method A cross-sectional study design was conducted using a self-administered survey. A convenience sample (n = 380) of Jordanian community pharmacists, were recruited through social media resources. The survey included multiple-choice and open-ended questions. Descriptive statistics and correlation analyses were completed using SPSS. Results More than half of the recruited pharmacists (55.3%) were female, and the mean age of the participants was 32.58 +/- 9.94. The majority of the pharmacists (85%) had good knowledge about the non-contraceptive indications of OCPs. About 53% of them confirmed their exposure to cases of the improper use of OCPs. About 67.5% of the pharmacists who confirmed exposure to such cases, reported the topical use of OCPs for the enhancement of hair growth. Around 15% of those pharmacists stated that OCPs were used to give negative results for addictive drug screening tests. In the event that the pharmacists suspected improper use, more than 90% suggested they would refrain from dispensing the pills. Conclusion This study has spotlighted many unforeseen uses of OCPs in Jordan and highlighted the need for restricted national regulations on the monitoring of OCP prescription/selling patterns in Jordan by policymakers. Moreover, there is a need for the establishment of national educational programs for the Jordanian community regarding the safe proper use of OCPs.	[Barakat, Muna; Al-Qudah, Raja'a] Appl Sci Private Univ, Fac Pharm, Amman, Jordan; [Akour, Amal] Al Zaytoonah Univ Jordan, Dept Pharm, Fac Pharm, Amman, Jordan; [Akour, Amal] Univ Jordan, Dept Biopharmaceut & Clin Pharm, Sch Pharm, Amman, Jordan; [Al-Qudah, Najem] Al Balqa Appl Univ, Fac Med, Al Salt, Jordan; [Dallal Bashi, Yahya H.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland	Al-Zaytoonah University of Jordan; University of Jordan; Al-Balqa Applied University; Queens University Belfast	Barakat, M (corresponding author), Appl Sci Private Univ, Fac Pharm, Amman, Jordan.	m_barakat@asu.edu.jo	Barakat, Muna/AAN-8778-2020	Barakat, Muna/0000-0002-7966-1172; Dallal Bashi, Yahya H/0000-0002-8480-9776				Akour A, 2017, EUR J CONTRACEP REPR, V22, P459, DOI 10.1080/13625187.2017.1412425; Albsoul-Younes A, 2010, SUBST USE MISUSE, V45, P1319, DOI 10.3109/10826080802490683; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; [Anonymous], 2018, GLOBAL NEWS; [Anonymous], 2007, DIABETES CARE S1, V30, pS4; Bardaweel SK, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0770-x; Bardaweel SK, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0275-1; Boynton PM, 2004, BRIT MED J, V328, P1312, DOI 10.1136/bmj.328.7451.1312; Cundill Pauline, 2020, Aust J Gen Pract, V49, P385, DOI 10.31128/AJGP-01-20-5197; Daniels Kimberly, 2014, NCHS Data Brief, P1; El-Mowafi IM, 2020, CONTRACEPTION, V101, P261, DOI 10.1016/j.contraception.2019.10.002; Foroutan Nazanin, 2016, Pharmacy Pract (Granada), V14, P745, DOI [10.18549/PharmPract.2016.04.745, 10.18549/pharmpract.2016.04.745]; Francis A, 2018, Womens Midlife Health, V4, P12, DOI 10.1186/s40695-018-0042-1; Fu S, 2016, ADV CLIN CHEM, V76, P123, DOI 10.1016/bs.acc.2016.05.003; Gardner JS, 2008, J AM PHARM ASSOC, V48, P212, DOI 10.1331/JAPhA.2008.07138; GOLDSTUCK N D, 1987, Advances in Contraception, V3, P335, DOI 10.1007/BF01849291; Hajhashemi V, 2007, PHYSIOL PHARMACOL, V11, P68; Health WHOR, 2018, FAM PLANN GLOB HDB P; Huang QL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016440; Ibrahim OM, 2017, TROP J PHARM RES, V16, P947, DOI 10.4314/tjpr.v16i4.29; Ilardo ML, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020536; Irwin AN, 2019, RES SOC ADMIN PHARM, V15, P650, DOI 10.1016/j.sapharm.2018.08.003; Jager J, 2017, MONOGR SOC RES CHILD, V82, P13, DOI 10.1111/mono.12296; Jordan Food and Drug Administration (JFDA)., 2018, LIST NONPR MED; Jordanian pharmacist's association (JPA), 2019, JPA STAT NUMB PHARM; Kennedy CE, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001402; Kirkpatrick K., 2015, WHAT MAN TAKES BIRTH; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Mahmoud MA, 2018, COMMUNITY PHARM PERS; McIntosh J, 2011, PHARMACOTHERAPY, V31, P424, DOI 10.1592/phco.31.4.424; Mobark DM, 2019, PHARM PRACT-GRANADA, V17, DOI [10.18549/pharmpract.2019.2.1465, 10.18549/PharmPract.2019.2.1465]; Obreli-Neto PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079875; Pazol K, 2018, AM J PREV MED, V55, P703, DOI 10.1016/j.amepre.2018.07.012; Rafie S, 2019, PHARMACY-BASEL, V7, DOI 10.3390/pharmacy7030096; Ratanajamit C, 2001, PHARMACOEPIDEM DR S, V10, P149, DOI 10.1002/pds.573; ROSENBERG MJ, 1995, CONTRACEPTION, V51, P283, DOI 10.1016/0010-7824(95)00074-K; Saadatnia M, 2012, J RES MED SCI, V17, P344; Sattari M, 2013, E MEDITERR HEALTH J, V19, P547, DOI 10.26719/2013.19.6.547; Schindler AE, 2013, INT J ENDOCRINOL MET, V11, P41, DOI 10.5812/ijem.4158; Skouby SO, 2004, EUR J CONTRACEP REPR, V9, P57, DOI 10.1080/13625180410001715681; Smith SM, 2013, PAIN, V154, P2287, DOI 10.1016/j.pain.2013.05.053; Spooner C., 2005, SOCIAL DETERMINANTS; Tahaineh L, 2020, J PHARM HEALTH SERV, V11, P33, DOI 10.1111/jphs.12337; Taherdoost H., 2017, INT J EC MANAGEMENT, V2, P237, DOI DOI 10.1016/J.JTH.2017.07.005; The United States Agency for International Development (USAID), 2015, JORD PROGR PROF; Weerasinghe M, 2017, J FAM PLAN REPROD H, V43, P147, DOI 10.1136/jfprhc-2015-101171	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244373	10.1371/journal.pone.0244373	http://dx.doi.org/10.1371/journal.pone.0244373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347511	Green Published, gold			2022-12-27	WOS:000603071100032
J	de Lemos, APS; Sacchi, CT; Goncalves, CR; Camargo, CH; Andrade, AL				de Lemos, Ana Paula Silva; Sacchi, Claudio Tavares; Goncalves, Claudia Regina; Camargo, Carlos Henrique; Andrade, Ana Lucia			Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; MOLECULAR EPIDEMIOLOGY; MULTICOMPONENT VACCINE; 4CMENB VACCINE; RESISTANCE; CANDIDATE; VARIANTS; COVERAGE; PREVALENCE; CIPROFLOXACIN	Background Neisseria meningitidis serogroup B remains a prominent cause of invasive meningococcal disease (IMD) in Brazil. Because two novel protein-based vaccines against serogroup B are available, the main purpose of this study was to provide data on the diversity and distribution of meningococcal vaccine antigen types circulating in Brazil. Methodology Genetic lineages, vaccine antigen types, and allele types of antimicrobial-associated resistance genes based on whole-genome sequencing of a collection of 145 Neisseria meningitidis serogroup B invasive strains recovered in Brazil from 2016 to 2018 were collected. Results A total of 11 clonal complexes (ccs) were identified among the 145 isolates, four of which were predominant, namely, cc461, cc35, cc32, and cc213, accounting for 72.0% of isolates. The most prevalent fHbp peptides were 24 (subfamily A/variant 2), 47 (subfamily A/variant 3), 1 (subfamily B/variant 1) and 45 (subfamily A/variant 3), which were predominantly associated with cc35, cc461, cc32, and cc213, respectively. The NadA peptide was detected in only 26.2% of the isolates. The most frequent NadA peptide 1 was found almost exclusively in cc32. We found seven NHBA peptides that accounted for 74.5% of isolates, and the newly described peptide 1390 was the most prevalent peptide exclusively associated with cc461. Mutated penA alleles were detected in 56.5% of the isolates, whereas no rpoB and gyrA mutant alleles were found. Conclusion During the study period, changes in the clonal structure of circulating strains were observed, without a predominance of a single hyperinvasive lineage, indicating that an epidemiologic shift has occurred that led to a diversity of vaccine antigen types in recent years in Brazil.	[de Lemos, Ana Paula Silva; Camargo, Carlos Henrique] Inst Adolfo Lutz IAL, Ctr Bacteriol, Sao Paulo, Brazil; [Sacchi, Claudio Tavares; Goncalves, Claudia Regina] Inst Adolfo Lutz IAL, Strateg Lab, Sao Paulo, Brazil; [Andrade, Ana Lucia] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil	Universidade Federal de Goias	de Lemos, APS (corresponding author), Inst Adolfo Lutz IAL, Ctr Bacteriol, Sao Paulo, Brazil.	ana.lemos@ial.sp.gov.br			Pfizer	Pfizer(Pfizer)	This research was supported by an Investigator-Initiated Research award from Pfizer. The authors were responsible for the content of the manuscript and the decision to submit for publication. Pfizer had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abad R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150721; Andrade AL, 2017, VACCINE, V35, P2025, DOI 10.1016/j.vaccine.2017.03.010; [Anonymous], 2012, Regen Med, V7, pS14, DOI 10.2217/rme.12.38; [Anonymous], 1983, HIST EC SOC, V2, P355; Argimon S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093; Bambini S, 2014, CLIN VACCINE IMMUNOL, V21, P966, DOI 10.1128/CVI.00825-13; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Bennett DE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228629; Brehony C, 2016, VACCINE, V34, P4690, DOI 10.1016/j.vaccine.2016.08.015; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Brik A, 2020, INT J INFECT DIS, V91, P73, DOI 10.1016/j.ijid.2019.11.013; Caugant DA, 1998, APMIS, V106, P505, DOI 10.1111/j.1699-0463.1998.tb01379.x; Ceyhan M, 2020, VACCINE, V38, P3545, DOI 10.1016/j.vaccine.2020.03.024; Chang HY, 2019, J INFECTION, V79, P426, DOI 10.1016/j.jinf.2019.09.001; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Christodoulides M, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx033; Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407; Deceuninck G, 2019, VACCINE, V37, P4243, DOI 10.1016/j.vaccine.2019.06.021; Chicuto LAD, 2020, HUM VACC IMMUNOTHER, V16, P1945, DOI 10.1080/21645515.2019.1700710; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Enriquez R, 2008, J ANTIMICROB CHEMOTH, V61, P286, DOI 10.1093/jac/dkm452; Leon ME, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.10; European Centre for Disease Prevention and Control (ECDC), EXP OP INTR MEN B 4C; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Gorla Maria Cecilia, 2020, Access Microbiol, V2, pacmi000079, DOI 10.1099/acmi.0.000079; Gorla MC, 2018, J MED MICROBIOL, V67, P286, DOI 10.1099/jmm.0.000685; Government of South Australia South Australian Meningococcal B expert working group, 2018, S AUSTR MEN B EXP WO; Green UR, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00204-18, 10.1128/jcm.00204-18]; Harcourt BH, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv117; Hoiseth SK, 2013, PEDIATR INFECT DIS J, V32, P1096, DOI 10.1097/INF.0b013e31829aa63b; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Lemos A., 2012, 18 INT PATH NEISS C; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P194, DOI 10.1128/CVI.00401-10; MacNeil JR, 2015, MMWR-MORBID MORTAL W, V64, P1171, DOI 10.15585/mmwr.mm6441a3; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McNeil LK, 2018, MBIO, V9, DOI 10.1128/mBio.00036-18; Ministerio da Saude, DAT; Moreno J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234475; Mothibeli KM, 2011, VACCINE, V29, P2187, DOI 10.1016/j.vaccine.2010.11.072; Mowlaboccus S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158315; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Muzzi A, 2019, VACCINE, V37, P991, DOI 10.1016/j.vaccine.2018.12.061; Ohyama Yoshiaki, 2013, J Cardiol Cases, V8, pe13, DOI 10.1016/j.jccase.2013.02.015; Orus P, 2001, INT J ANTIMICROB AG, V18, P113, DOI 10.1016/S0924-8579(01)00362-4; Parikh SR, 2017, LANCET INFECT DIS, V17, P754, DOI 10.1016/S1473-3099(17)30170-6; Parikh SR, 2016, LANCET, V388, P2775, DOI 10.1016/S0140-6736(16)31921-3; Perez-Trallero E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116024; Rodrigues CMC, 2018, EMERG INFECT DIS, V24, P673, DOI 10.3201/eid2404.171480; Rodrigues CMS, MENINGOCOCCAL DEDUCE, DOI 10.1101/2020.08.18.256834v1; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Russell JE, 2008, MICROBIOL-SGM, V154, P1170, DOI 10.1099/mic.0.2007/014761-0; SACCHI CT, 1992, J CLIN MICROBIOL, V30, P1734, DOI 10.1128/JCM.30.7.1734-1738.1992; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Shi FL, 2017, VACCINE, V35, P2343, DOI 10.1016/j.vaccine.2017.03.057; Shultz TR, 2000, ANTIMICROB AGENTS CH, V44, P1116, DOI 10.1128/AAC.44.4.1116-1116.2000; Silva LA, 2018, INFECT DIS-NOR, V50, P697, DOI 10.1080/23744235.2018.1459829; SPRATT BG, 1994, SCIENCE, V264, P388, DOI 10.1126/science.8153626; Taha MK, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05241-9; Taha MK, 2010, ANTIMICROB AGENTS CH, V54, P3651, DOI 10.1128/AAC.00315-10; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Tsang RSW, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00883-19; Tsang RSW, 2017, CAN J MICROBIOL, V63, P265, DOI 10.1139/cjm-2016-0716; Tzanakaki G, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-111; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Vacca P, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00207-18; Vogel U, 2013, LANCET INFECT DIS, V13, P416, DOI 10.1016/S1473-3099(13)70006-9; Wang X, 2011, VACCINE, V29, P4739, DOI 10.1016/j.vaccine.2011.04.092; Wasko I, 2020, VACCINE, V38, P1943, DOI 10.1016/j.vaccine.2020.01.021; Zlotnick GW, 2015, HUM VACC IMMUNOTHER, V11, P5, DOI 10.4161/hv.34293	72	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243375	10.1371/journal.pone.0243375	http://dx.doi.org/10.1371/journal.pone.0243375			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347452	Green Published, gold			2022-12-27	WOS:000603071100057
J	Hatabu, A; Mao, XH; Zhou, Y; Kawashita, N; Wen, Z; Ueda, M; Takagi, T; Tian, YS				Hatabu, Asuka; Mao, Xinhua; Zhou, Yi; Kawashita, Norihito; Wen, Zheng; Ueda, Mikiko; Takagi, Tatsuya; Tian, Yu-Shi			Knowledge, attitudes, and practices toward COVID-19 among university students in Japan and associated factors: An online cross-sectional survey	PLOS ONE			English	Article							SELF-CONSCIOUSNESS; OUTBREAK	The coronavirus disease (COVID-19) pandemic has greatly altered peoples' daily lives, and it continues spreading as a crucial concern globally. Knowledge, attitudes, and practices (KAP) toward COVID-19 are related to individuals' adherence to government measures. This study evaluated KAP toward COVID-19 among university students in Japan between May 22 and July 16, 2020, via an online questionnaire, and it further investigated the associated determining KAP factors. Among the eligible respondents (n = 362), 52.8% were female, 79.0% were undergraduate students, 32.9% were students whose major university subjects were biology-related, 35.4% were from the capital region, and 83.7% were Japanese. The overall KAP of university students in Japan was high. All respondents (100%) showed they possessed knowledge on avoiding enclosed spaces, crowded areas, and close situations. Most respondents showed a moderate or higher frequency of washing their hands or wearing masks (both at 96.4%). In addition, 68.5% of respondents showed a positive attitude toward early drug administration. In the logistic regressions, gender, major subjects, education level, nationality, residence, and psychological factors (private self-consciousness and extroversion) were associated with knowledge or attitudes toward COVD-19 (p < 0.05). In the logistic and multiple linear regressions, capital regions, high basic knowledge, high information acquisition, correct information explanations contributed positively to preventative action (p < 0.05). Non-capital regions, male gender, non-bio-backgrounds, high public self-consciousness, high advanced knowledge, incorrect information explanations, and high extroversion contributed negatively to self-restraint (p < 0.05). Moreover, self-restraint was decreasing over time. These findings clarify the Japanese university students' KAP and the related factors in the early period of the COVID-19 pandemic, and they may help university managers, experts, and policymakers control the future spread of COVID-19 and other emerging infections.	[Hatabu, Asuka; Zhou, Yi; Ueda, Mikiko; Takagi, Tatsuya; Tian, Yu-Shi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Mao, Xinhua] Kobe Gakuin Univ, Fac Psychol, Kobe, Hyogo, Japan; [Kawashita, Norihito] Kindai Univ, Grad Sch Sci & Engn Res, Higashiosaka, Osaka, Japan; [Wen, Zheng] Waseda Univ, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan	Osaka University; Kobe Gakuin University; Kindai University (Kinki University); Waseda University	Tian, YS (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan.	yushi-tian@phs.osaka-u.ac.jp	wen, zheng/AGG-3620-2022; wen, zheng/HII-3705-2022; Zhou, Yi/GQQ-3081-2022; Tian, Yu-Shi/AAM-2780-2021	wen, zheng/0000-0002-9942-8431; Zhou, Yi/0000-0001-9254-3245; Tian, Yu-Shi/0000-0002-8988-9453; TAKAGI, Tatsuya/0000-0002-0044-0722				Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969; Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04; Amazaki Mitsuhiro, 2008, Nihon Koshu Eisei Zasshi, V55, P306; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Babalola S., 2020, KAP COVID DASHBOARD; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Bhatti JS, 2020, MOL NEUROBIOL, V57, P4856, DOI 10.1007/s12035-020-02074-2; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; CSSE. Center For Systems Science and Engineering at JHU, 2020, COVID 19 MAP J HOPK; Erikson E.H., 1963, CHILDHOOD SOC; FENIGSTEIN A, 1975, J CONSULT CLIN PSYCH, V43, P522, DOI 10.1037/h0076760; Fetzer T. R., 2020, 27082 NBER, DOI DOI 10.31234/OSF; Fujimoto J, NOTICE URGENT SURVEY; Gupta S, 2020, JAMA INTERN MED, V15, P2020, DOI [10.1001/jamainternmed.2020.3596, DOI 10.1001/JAMAINTERNMED.2020.359632667668]; Iwasaki A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012481; Jung C.G., 1921, PSYCHOL TYPEN; Katz MH, 2021, JAMA INTERN MED, V181, P381, DOI 10.1001/jamainternmed.2020.5415; Kooka A, RELATIONSHIP U STUDE; Liu C, 2020, ACS CENTRAL SCI, V6, P315, DOI 10.1021/acscentsci.0c00272; Machida M, 2020, INT J INFECT DIS, V94, P139, DOI 10.1016/j.ijid.2020.04.014; Ministry of Education Culture Sports Science and Technology of Japan, SCH BAS SURV; Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2; Muto K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234292; Namikawa Tsutomu, 2012, Shinrigaku Kenkyu, V83, P91; Ningthoujam R, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.109896; Odriozola-Gonzalez P, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113108; Olaimat AN, 2020, AM J TROP MED HYG, V103, P1177, DOI 10.4269/ajtmh.20-0418; Pagnini F, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.15821; Peng YL, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09392-z; Saefi M, 2020, DATA BRIEF, V31, DOI 10.1016/j.dib.2020.105855; Sakakibara R, 2020, PSYCHOL BEHAV SURVEY, DOI [10.31234/osf.io/635zk, DOI 10.31234/OSF.I0/635ZK]; SUGAWARA K, 1984, JPN J PSYCHOL, V55, P184, DOI 10.4992/jjpsy.55.184; Sugawara K., 2004, SELF OTHER PERSONS E; Sutin AR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237056; Takahashi R., 2020, JAPAN TIMES; World Health Organization, COR DIS COVID 19; Zhao B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186671; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhou Y, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3494-x	39	42	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244350	10.1371/journal.pone.0244350	http://dx.doi.org/10.1371/journal.pone.0244350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347488	gold, Green Published			2022-12-27	WOS:000603071100009
J	Machado-Alba, JE; Jimenez-Morales, AL; Moran-Yela, YC; Parrado-Fajardo, IY; Valladales-Restrepo, LF				Enrique Machado-Alba, Jorge; Liliana Jimenez-Morales, Anyi; Carolina Moran-Yela, Yulieth; Yadira Parrado-Fajardo, Ilsa; Fernando Valladales-Restrepo, Luis			Adverse drug reactions associated with the use of biological agents	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; RHEUMATOID-ARTHRITIS; EVENTS; SAFETY; SURVEILLANCE	Introduction Biological drugs open new possibilities to treat diseases for which drug therapy is limited, but they may be associated with adverse drug reactions (ADRs). Objective To identify the ADRs associated with the use of biological drugs in Colombia. Methods This was a retrospective study of ADR reports from 2014 to 2019, contained in the database of Audifarma SA pharmacovigilance program. The ADRs, groups of associated drugs, and affected organs were classified. Results In total, 5,415 reports of ADRs associated with biological drugs were identified in 78 Colombian cities. A total of 76.1% of the cases corresponded to women. The majority were classified as type A (55.0%) and B (28.9%), and 16.7% were serious cases. The respiratory tract was the most affected organ system (16.8%), followed by the skin and appendages (15.6%). Antineoplastic and immunomodulatory drugs accounted for 70.6% of the reports, and the drugs related to the greatest number of ADRs were adalimumab (12.2%) and etanercept (11.6%). Conclusions The reporting of ADRs has increased in recent years and these reactions are mostly classified as tyoe A or B, categorized as serious in almost one-fifth of the reported cases and associated mainly with immunomodulators and antineoplastic agents. This type of study can support decision makers in ways that benefit patient safety and interaction with health systems.	[Enrique Machado-Alba, Jorge; Fernando Valladales-Restrepo, Luis] Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Risaralda, Colombia; [Enrique Machado-Alba, Jorge; Liliana Jimenez-Morales, Anyi; Carolina Moran-Yela, Yulieth] Univ Tecnol Pereira Audifarma SA, Pereira, Risaralda, Colombia; [Yadira Parrado-Fajardo, Ilsa] Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Bogota, Colombia; [Fernando Valladales-Restrepo, Luis] Fundac Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Colombia	Universidad Tecnologica de Pereira; Universidad Tecnologica de Pereira; Universidad Tecnologica de Pereira	Machado-Alba, JE (corresponding author), Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Pereira, Risaralda, Colombia.	machado@utp.edu.co		Valladales Restrepo, Luis Fernando/0000-0002-4245-0101; Machado-Alba, Jorge Enrique/0000-0002-8455-0936				Abasolo L, 2015, SEMIN ARTHRITIS RHEU, V44, P506, DOI 10.1016/j.semarthrit.2014.11.003; Al-Ahmad Mona, 2018, Open Access Maced J Med Sci, V6, P1839, DOI 10.3889/oamjms.2018.394; [Anonymous], 2008, J EARTHQUAKE ENG ENG, V5, P119; Aspden P, 2004, PATIENT SAFETY ACHIE, P200; Barbieri MA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041227; Cutroneo PM, 2014, DRUG SAFETY, V37, P961, DOI 10.1007/s40264-014-0224-1; de Camargo MC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00965; Durand Z, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7222; Machado-Alba JE, 2014, REV PANAM SALUD PUBL, V36, P396; Food US  Administration D, 2020, GUIDELINE IND CLIN S, P1995; Gabay Michael, 2013, Hosp Pharm, V48, P473, DOI 10.1310/hpj4806-473; Giezen TJ, 2009, DRUG SAFETY, V32, P811, DOI 10.2165/11316550-000000000-00000; Ha D, 2020, CLIN RHEUMATOL, V39, P347, DOI 10.1007/s10067-019-04802-z; Heather EM, 2014, PHARMACOECONOMICS, V32, P109, DOI 10.1007/s40273-013-0120-z; Klein K, 2016, DRUG SAFETY, V39, P185, DOI 10.1007/s40264-015-0383-8; Koike T, 2009, J RHEUMATOL, V36, P898, DOI 10.3899/jrheum.080791; Leon L, 2018, CLIN EXP RHEUMATOL, V36, P29; Machado-Alba Jorge E, 2006, Rev. salud pública, V8, P200, DOI 10.1590/S0124-00642006000200008; Mendoza-Sassi R, 2001, Cad Saude Publica, V17, P819, DOI 10.1590/S0102-311X2001000400016; Narongroeknawin P, 2018, INT J RHEUM DIS, V21, P169, DOI 10.1111/1756-185X.12937; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; O'Callaghan J, 2018, BIODRUGS, V32, P267, DOI 10.1007/s40259-018-0281-6; Ortona Elena, 2016, Ann Ist Super Sanita, V52, P205, DOI 10.4415/ANN_16_02_12; Palleria C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205134; Pryymachenko Y, 2020, J ARTHROPLASTY, V35, P3099, DOI 10.1016/j.arth.2020.06.040; Ringold S, 2015, ARTHRIT CARE RES, V67, P529, DOI 10.1002/acr.22487; Roberti R, 2020, CURR MED RES OPIN, V36, P1457, DOI 10.1080/03007995.2020.1786681; Rojas K, 2016, CLIN OBSTET GYNECOL, V59, P651, DOI 10.1097/GRF.0000000000000239; Sim DW, 2016, PHARMACOEPIDEM DR S, V25, P1279, DOI 10.1002/pds.4049; Sousa J, 2020, EXPERT OPIN DRUG SAF, V19, P99, DOI 10.1080/14740338.2020.1686481; Sultana J, 2013, J PHARMACOL PHARMACO, V4, pS73, DOI 10.4103/0976-500X.120957; Vermeer NS, 2019, CLIN PHARMACOL THER, V105, P962, DOI 10.1002/cpt.1310; Yamanaka H, 2019, MOD RHEUMATOL, V29, P737, DOI 10.1080/14397595.2018.1510759	33	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0240276	10.1371/journal.pone.0240276	http://dx.doi.org/10.1371/journal.pone.0240276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338057	Green Published, Green Submitted, gold			2022-12-27	WOS:000601313500005
J	Assefa, Y; Hill, PS; Gilks, CF; Van Damme, W; van de Pas, R; Woldeyohannes, S; Reid, S				Assefa, Yibeltal; Hill, Peter S.; Gilks, Charles F.; Damme, Wim Van; Pas, Remco van de; Woldeyohannes, Solomon; Reid, Simon			Global health security and universal health coverage: Understanding convergences and divergences for a synergistic response	PLOS ONE			English	Article							DEMONSTRATION PROJECT; SURVEILLANCE; REGULATIONS; CAPACITY; LESSONS; SYSTEMS; WORLD; EBOLA; CARE	Background Global health security (GHS) and universal health coverage (UHC) are key global health agendas which aspire for a healthier and safer world. However, there are tensions between GHS and UHC strategy and implementation. The objective of this study was to assess the relationship between GHS and UHC using two recent quantitative indices. Methods We conducted a macro-analysis to determine the presence of relationship between GHS index (GHSI) and UHC index (UHCI). We calculated Pearson's correlation coefficient and the coefficient of determination. Analyses were performed using IBM SPSS Statistics Version 25 with a 95% level of confidence. Findings There is a moderate and significant relationship between GHSI and UHCI (r = 0.662, p<0.001) and individual indices of UHCI (maternal and child health and infectious diseases: r = 0.623 (p<0.001) and 0.594 (p<0.001), respectively). However, there is no relationship between GHSI and the non-communicable diseases (NCDs) index (r = 0.063, p>0.05). The risk of GHS threats a significant and negative correlation with the capacity for GHS (r = -0.604, p<0.001) and the capacity for UHC (r = -0.792, p<0.001). Conclusion The aspiration for GHS will not be realized without UHC; hence, the tension between these two global health agendas should be transformed into a synergistic solution. We argue that strengthening the health systems, in tandem with the principles of primary health care, and implementing a "One Health" approach will progressively enable countries to achieve both UHC and GHS towards a healthier and safer world that everyone aspires to live in.	[Assefa, Yibeltal; Hill, Peter S.; Gilks, Charles F.; Woldeyohannes, Solomon; Reid, Simon] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Damme, Wim Van; Pas, Remco van de] Inst Trop Med, Antwerp, Belgium	University of Queensland; Institute of Tropical Medicine (ITM)	Assefa, Y (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia.	y.alemu@uq.edu.au	Assefa, Yibeltal/N-5984-2016; Reid, Simon/E-9884-2011; Van Damme, Wim/F-7404-2011	Assefa, Yibeltal/0000-0003-2393-1492; Reid, Simon/0000-0002-6103-4429; Van Damme, Wim/0000-0002-6344-3007; Woldeyohannes, Solomon/0000-0003-2431-2730	University of Queensland	University of Queensland(University of Queensland)	The research was funded by the University of Queensland. The University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldis W, 2008, HEALTH POLICY PLANN, V23, P369, DOI 10.1093/heapol/czn030; [Anonymous], 2014, REG ANESTH PAIN MED; Assefa Y, 2018, LANCET, V392, P1473, DOI 10.1016/S0140-6736(18)32215-3; Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015; Bali S, 2017, J PUBLIC HEALTH POL, V38, P257, DOI 10.1057/s41271-016-0058-4; Ben Oppenheim, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001157; Binagwaho A, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2391; Bloom G, 2017, INT J HEALTH POLICY, V6, P229, DOI 10.15171/ijhpm.2016.120; Borchert JN, 2014, MMWR-MORBID MORTAL W, V63, P73; Brim B, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5719; Brown T, 2011, SOC SCI MED, V72, P319, DOI 10.1016/j.socscimed.2010.09.010; Chen L., 2003, J HUMAN DEV, V4, P181, DOI [10.1080/1464988032000087532, DOI 10.1080/1464988032000087532]; David PF., 2005, CHIN J INT LAW, V4, P325, DOI 10.1093/chinesejil/jmi029; El Zowalaty ME, 2020, ONE HEALTH-AMSTERDAM, V9, DOI 10.1016/j.onehlt.2020.100124; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Erondu NA, 2018, LANCET, V392, P1482, DOI 10.1016/S0140-6736(18)32332-8; Etienne CF, 2018, REV PANAM SALUD PUBL, V42, DOI 10.26633/RPSP.2018.145; Evans T. G., 2012, INDEPENDENT ASSESSME, V10, P2001; Feldbaum Harley, 2006, Med Confl Surviv, V22, P192, DOI 10.1080/13623690600772501; Forzley Michele, 2017, Health Secur, V15, P312, DOI 10.1089/hs.2017.0013; Frieden TR, 2014, LANCET, V383, P764, DOI 10.1016/S0140-6736(14)60189-6; Global Health Security Agenda (GHSA), 2018, GLOB HLTH SEC AG GHS; Gordy K, 2009, ALTERNATIVES, V34, P229, DOI 10.1177/030437540903400301; Gostin LO, 2016, MILBANK Q, V94, P264, DOI 10.1111/1468-0009.12186; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3; Hogan D, 2016, DEV INDEX COVERAGE E; Horton R, 2017, LANCET, V390, P346, DOI 10.1016/S0140-6736(17)31919-0; Johns Hopkins Center for Health Security, 2019, GLOB HLTH SEC IND 20; Kandel N, 2020, REV HLTH SECURITY CA; Karesh WB, 2009, CLIN MED, V9, P259, DOI 10.7861/clinmedicine.9-3-259; Katz R, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6789-y; Kelly TR, 2017, PREV VET MED, V137, P112, DOI 10.1016/j.prevetmed.2016.11.023; Kieny MP, 2017, B WORLD HEALTH ORGAN, V95, P537, DOI 10.2471/BLT.16.187476; Kluge H, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000656; Kostova D, 2017, EMERG INFECT DIS, V23, pS40, DOI 10.3201/eid2313.170581; Kutzin J, 2016, B WORLD HEALTH ORGAN, V94, P2, DOI 10.2471/BLT.15.165050; Mahjour J, 2018, E MEDITERR HEALTH J, V24, P323, DOI 10.26719/2018.24.4.323; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; McInnes C, 2006, REV INT STUD, V32, P5, DOI 10.1017/S0260210506006905; McMurray C, 2013, DIS GLOBALIZATION SO; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; O'Connell T, 2014, LANCET, V383, P277, DOI 10.1016/S0140-6736(13)60955-1; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Ooms G, 2018, LANCET, V392, P1098, DOI 10.1016/S0140-6736(18)32072-5; Ooms G, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000217; Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135; Rodier G, 2007, EMERG INFECT DIS, V13, P1447, DOI 10.3201/eid1310.070732; Rose DA, 2017, AM J PUBLIC HEALTH, V107, pS126, DOI [10.2105/AJPH.2017.303947, 10.2105/ajph.2017.303947]; Rushton S, 2011, POLIT STUD-LONDON, V59, P779, DOI 10.1111/j.1467-9248.2011.00919.x; Sinclair JR, 2019, REV SCI TECH OIE, V38, P145, DOI 10.20506/rst.38.1.2949; Stevenson MA, 2014, ROUTLEDGE HDB GLOBAL, P344; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Phu TD, 2014, MMWR-MORBID MORTAL W, V63, P77; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wenham C, 2019, INT AFF, V95, P1093, DOI 10.1093/ia/iiz170; Wenham C, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001145; WHO, 2018, P 71 SESSION WORLD H; Wilson K, 2008, CAN MED ASSOC J, V179, P44, DOI 10.1503/cmaj.080516; Wolicki SB, 2016, HEALTH SECUR, V14, P185, DOI 10.1089/hs.2016.0002; World Health Organization, HUM HLTH ACT DEF EM; World Health Organization (WHO), 2015, GUIN EB VIR SHOWS IT; World Health Organization (WHO), 2017, UNIVERSAL HLTH COVER; Yu M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162813; Yunpeng Ji, 2020, LANCET GLOBAL HLTH; Zimmet PZ, 2006, OBESITY, V14, P1, DOI 10.1038/oby.2006.1; Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003	67	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244555	10.1371/journal.pone.0244555	http://dx.doi.org/10.1371/journal.pone.0244555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378383	Green Published, gold			2022-12-27	WOS:000605651300002
J	Glandorf, J; Klimes, F; Voskrebenzev, A; Gutberlet, M; Behrendt, L; Crisosto, C; Wacker, F; Ciet, P; Wild, JM; Vogel-Claussen, J				Glandorf, Julian; Klimes, Filip; Voskrebenzev, Andreas; Gutberlet, Marcel; Behrendt, Lea; Crisosto, Cristian; Wacker, Frank; Ciet, Pierluigi; Wild, Jim M.; Vogel-Claussen, Jens			Comparison of phase-resolved functional lung (PREFUL) MRI derived perfusion and ventilation parameters at 1.5T and 3T in healthy volunteers	PLOS ONE			English	Article							QUANTITATIVE REGIONAL VENTILATION; FOURIER DECOMPOSITION; SIGNAL INTENSITY; RELAXATION; VOLUME; REPRODUCIBILITY; T-2-ASTERISK; DEPENDENCE; DENSITY; TISSUE	Purpose The purpose of this study is to evaluate the influence of different field strengths on perfusion and ventilation parameters, SNR and CNR derived by PREFUL MRI using predefined sequence parameters. Methods Data sets of free breathing 2d FLASH lung MRI were acquired from 15 healthy subjects at 1.5T and 3T (Magnetom Avanto and Skyra, Siemens Healthcare, Erlangen, Germany) with a maximum period of 3 days in between. The processed functional parameters regional ventilation (RVent), perfusion (Q), quantified perfusion (Q(Quant)), perfusion defect percentage (QDP), ventilation defect percentage (VDP) and ventilation-perfusion match (VQM) were compared for systematic differences. Signal- and contrast-to-noise ratio (SNR and CNR) of both acquisitions were analyzed. Results RVent, Q, VDP, SNR and CNR presented no significant differences between 1.5T and 3T. Q(Quant) (1.5T vs. 3T, P = 0.04), and QDP (1.5T vs. 3T, P <= 0.01) decreased significantly at 3T. Consequently, VQM increased significantly (1.5T vs. 3T, P <= 0.01). Skewness and kurtosis of the Q-values increased significantly at 3T (P <= 0.01). The mean Sorensen-Dice coefficients between both series were 0.91 for QDP and 0.94 for VDP. The Bland-Altman analysis of both series showed mean differences of 4.29% for QDP, 1.23% for VDP and -5.15% for VQM. Using the above-mentioned parameters for three-day repeatability at two different scanners and field strengths, the retrospective power calculation showed, that a sample size of 15 can detect differences of 3.7% for QDP, of 2.9% for VDP and differences of 2.6% for VQM. Conclusion Significant differences in QDP may be related to field inhomogeneities, which is expressed by increasing skewness and kurtosis at 3T. Q(Quant) reveals only poor reproducibility between 1.5T and 3T. RVent, Q, VDP, SNR and CNR were not altered significantly at the used sequence parameters. Healthy participants with minimal defects present high spatial agreement of QDP and VDP.	[Glandorf, Julian; Klimes, Filip; Voskrebenzev, Andreas; Gutberlet, Marcel; Behrendt, Lea; Crisosto, Cristian; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Glandorf, Julian; Klimes, Filip; Voskrebenzev, Andreas; Gutberlet, Marcel; Behrendt, Lea; Crisosto, Cristian; Wacker, Frank; Vogel-Claussen, Jens] Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Glandorf, Julian; Klimes, Filip; Voskrebenzev, Andreas; Gutberlet, Marcel; Behrendt, Lea; Crisosto, Cristian; Wacker, Frank; Vogel-Claussen, Jens] German Ctr Lung Res DZL, Hannover, Germany; [Ciet, Pierluigi] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Wild, Jim M.] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England	Hannover Medical School; Erasmus University Rotterdam; Erasmus MC; University of Sheffield	Vogel-Claussen, J (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.; Vogel-Claussen, J (corresponding author), Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany.; Vogel-Claussen, J (corresponding author), German Ctr Lung Res DZL, Hannover, Germany.	vogel-claussen.jens@mh-hannover.de		Glandorf, Julian Magnus Wilhelm/0000-0003-1927-9876; Wild, Jim/0000-0002-7246-8660; Vogel-Claussen, Jens/0000-0001-5595-6948	German Center for Lung Research (DZL); Cystic Fibrosis Foundation (CFF); MRC [MR/M008894/1] Funding Source: UKRI	German Center for Lung Research (DZL); Cystic Fibrosis Foundation (CFF)(Italian Cystic Fibrosis Research Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by the German Center for Lung Research (DZL) and by the Cystic Fibrosis Foundation (CFF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bankier AA, 2004, J MAGN RESON IMAGING, V20, P961, DOI 10.1002/jmri.20198; Barth MM, 2007, RADIOGRAPHICS, V27, DOI 10.1148/rg.275065204; Bauman G, 2019, MAGN RESON MED, V81, P1915, DOI 10.1002/mrm.27535; Behrendt L, 2020, J MAGN RESON IMAGING, V52, P103, DOI 10.1002/jmri.27027; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; Bydder GM, 2011, BRIT J RADIOL, V84, P1067, DOI 10.1259/bjr/74368403; Cha MJ, 2019, RADIOLOGY, V293, P117, DOI 10.1148/radiol.2019190485; Constantinides CD, 1997, MAGNET RESON MED, V38, P852, DOI 10.1002/mrm.1910380524; Couch MJ, 2019, J MAGN RESON IMAGING, V49, P343, DOI 10.1002/jmri.26292; Ebert M, 1996, LANCET, V347, P1297, DOI 10.1016/S0140-6736(96)90940-X; Enright PL, 2004, AM J RESP CRIT CARE, V169, P235, DOI 10.1164/rccm.200204-347OC; Forum of International Respiratory Societies, 2017, GLOB IMP RESP DIS, VSecond; Gai ND, 2017, J MAGN RESON IMAGING, V45, P1097, DOI 10.1002/jmri.25487; Glandorf J, 2020, MAGN RESON MED, V83, P1045, DOI 10.1002/mrm.27991; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Guo FM, 2019, MAGN RESON MED, V81, P2135, DOI 10.1002/mrm.27527; Hatabu H, 1999, EUR J RADIOL, V29, P245, DOI 10.1016/S0720-048X(98)00169-7; He KM, 2013, IEEE T PATTERN ANAL, V35, P1397, DOI 10.1109/TPAMI.2012.213; Hopkins SR, 2012, J APPL PHYSIOL, V113, P328, DOI 10.1152/japplphysiol.00320.2012; Kaireit TF, 2018, J MAGN RESON IMAGING, V47, P1534, DOI 10.1002/jmri.25902; Kauczor Hans-Ulrich, 2003, Top Magn Reson Imaging, V14, P223, DOI 10.1097/00002142-200306000-00002; Kauczor HU, 2000, EUR J RADIOL, V34, P196, DOI 10.1016/S0720-048X(00)00199-6; Kern AL, 2020, J MAGN RESON IMAGING, V51, P1669, DOI 10.1002/jmri.27000; Kjorstad A, 2014, MAGN RESON MED, V72, P558, DOI 10.1002/mrm.24930; Klimes F, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4088; Lederlin M, 2013, EUR J RADIOL, V82, P1015, DOI 10.1016/j.ejrad.2012.12.003; Mulkern R, 2014, CONCEPT MAGN RESON A, V43, P29, DOI 10.1002/cmr.a.21297; Roturmel A., 2018, P INT SOC MAG RESON, P2, DOI DOI 10.1002/NBM.3134.8; Schoenfeld C, 2016, RADIOLOGY, V279, P925, DOI 10.1148/radiol.2015150765; Soher Brian J, 2007, Magn Reson Imaging Clin N Am, V15, P277, DOI 10.1016/j.mric.2007.06.002; Sourbron S, 2009, MAGN RESON MED, V62, P205, DOI 10.1002/mrm.22005; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Theilmann RJ, 2009, J MAGN RESON IMAGING, V30, P527, DOI 10.1002/jmri.21866; Triphan SMF, 2015, J MAGN RESON IMAGING, V42, P610, DOI 10.1002/jmri.24840; Veldhoen S, 2017, RADIOLOGY, V283, P242, DOI 10.1148/radiol.2016160355; Vogel-Claussen J, 2019, AM J RESP CRIT CARE, V199, P1086, DOI 10.1164/rccm.201805-0995OC; Voskrebenzev A, 2018, AM J TRANSPLANT, V18, P2050, DOI 10.1111/ajt.14759; Voskrebenzev A, 2018, MAGN RESON MED, V79, P2306, DOI 10.1002/mrm.26893; Voskrebenzev A, 2017, MAGN RESON MED, V78, P1496, DOI 10.1002/mrm.26526; Voskrebenzev A, 2016, MAGN RESON MED, V76, P1542, DOI 10.1002/mrm.26047; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; World Health Organization, 2008, World health statistics 2008; Yu JS, 2011, MAGN RESON MED, V66, P248, DOI 10.1002/mrm.22829; Zapke M, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-106; Zhang X, 2013, MAGN RESON MED, V70, P1082, DOI 10.1002/mrm.24550	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244638	10.1371/journal.pone.0244638	http://dx.doi.org/10.1371/journal.pone.0244638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378373	Green Published, gold, Green Accepted			2022-12-27	WOS:000605651300012
J	Thomas, M; Hughes, TE				Thomas, Merrilee; Hughes, Thomas E.			Optically activated, customizable, excitable cells	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; ADENYLYL-CYCLASE; DRUG DISCOVERY; CAMP; CA2+; EVOLUTION; MEMBRANE; SENSORS	Genetically encoded fluorescent biosensors are powerful tools for studying complex signaling in the nervous system, and now both Ca2+ and voltage sensors are available to study the signaling behavior of entire neural circuits. There is a pressing need for improved sensors, but improving them is challenging because testing them involves a low throughput, labor-intensive processes. Our goal was to create synthetic, excitable cells that can be activated with brief pulses of blue light and serve as a medium throughput platform for screening the next generation of sensors. In this live cell system, blue light activates an adenylyl cyclase enzyme (bPAC) that increases intracellular cAMP (Stierl M et al. 2011). In turn, the cAMP opens a cAMP-gated ion channel. This produces slow, whole-cell Ca2+ transients and voltage changes. To increase the speed of these transients, we add the inwardly rectifying potassium channel Kir2.1, the bacterial voltage-gated sodium channel NAVROSD, and Connexin-43. The result is a highly reproducible, medium-throughput, live cell system that can be used to screen voltage and Ca2+ sensors.	[Thomas, Merrilee; Hughes, Thomas E.] Montana State Univ, Dept Neurosci & Cell Biol, Bozeman, MT 59717 USA; [Hughes, Thomas E.] Montana Mol, Bozeman, MT USA	Montana State University System; Montana State University Bozeman	Thomas, M (corresponding author), Montana State Univ, Dept Neurosci & Cell Biol, Bozeman, MT 59717 USA.	Merrileethomas1@gmail.com		Thomas, Merrilee/0000-0002-3430-0912	NIH/NINDS BRAIN initiative grant [1U01NS099691]; NIH	NIH/NINDS BRAIN initiative grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a NIH/NINDS BRAIN initiative grant (grant number 1U01NS099691) to Montana State University. Dr. Hughes works for both Montana State University and Montana Molecular, where he is PI on NIH grants to both institutions. Montana Molecular provided BacMam packaging for the viruses described here as a fee-for service, and this work was done under an approved Conflict of Interest management plan supervised by Montana State University. Montana Molecular also provided materials for the study including HEK293 cells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section	Abdelfattah AS, 2019, SCIENCE, V365, P699, DOI 10.1126/science.aav6416; Agetsuma M, 2017, CELL CALCIUM, V64, P12, DOI 10.1016/j.ceca.2016.12.002; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Alford SC, 2012, CHEM BIOL, V19, P353, DOI 10.1016/j.chembiol.2012.01.006; Bruton J, 2020, ADV EXP MED BIOL, V1131, P7, DOI 10.1007/978-3-030-12457-1_2; BUTTERWECK A, 1994, J MEMBRANE BIOL, V141, P247; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Capel RA, 2019, BIORXIV, P694349, DOI [10.1101/694349, DOI 10.1101/694349]; Chen KH, 2018, FASEB J, V32, P3047, DOI 10.1096/fj.201701260R; Dana H, 2019, NAT METHODS, V16, P649, DOI 10.1038/s41592-019-0435-6; Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440; Ding YD, 2015, NAT METHODS, V12, P195, DOI 10.1038/nmeth.3261; Edelstein Arthur D, 2014, J Biol Methods, V1; Fahrenbach JP, 2007, J PHYSIOL-LONDON, V585, P565, DOI 10.1113/jphysiol.2007.144121; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Hille B., 2001, IONIC CHANNELS EXCIT, P814; HSU HO, 1993, BIOPHYS J, V65, P1196, DOI 10.1016/S0006-3495(93)81153-6; Huang H, 2019, RES POLITICS, V6; Ibraheem A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-105; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kerruth S, 2019, J BIOL CHEM, V294, P3934, DOI 10.1074/jbc.RA118.004543; Khan KH, 2013, ADV PHARM BULL, V3, P257, DOI 10.5681/apb.2013.042; Kim D, 2019, US Patent, Patent No. [20190153067:A1, 20190153067]; Kirkton RD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1302; Kost TA, 2007, DRUG DISCOV TODAY, V12, P396, DOI 10.1016/j.drudis.2007.02.017; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Nguyen HX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13132; Park J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085221; Podgorski K, 2016, J NEUROPHYSIOL, V116, P1012, DOI 10.1152/jn.00275.2016; Qian Y, 2019, NAT METHODS, V16, P171, DOI 10.1038/s41592-018-0294-6; Rich TC, 2000, J GEN PHYSIOL, V116, P147, DOI 10.1085/jgp.116.2.147; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rodin SN, 2003, J MOL EVOL, V56, P718, DOI 10.1007/s00239-002-2446-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shah BS, 2004, J NEUROSCI, V24, P7387, DOI 10.1523/JNEUROSCI.0322-04.2004; Shen Y, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0480-0; Sierra YAB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07038-8; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Storace D, 2016, TRENDS NEUROSCI, V39, P277, DOI 10.1016/j.tins.2016.02.005; Tewson PH, 2016, J BIOMOL SCREEN, V21, P298, DOI 10.1177/1087057115618608; Woehler A, 2010, BIOPHYS J, V99, P2344, DOI 10.1016/j.bpj.2010.07.053; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang HK, 2017, TRENDS BIOTECHNOL, V35, P625, DOI 10.1016/j.tibtech.2017.04.002; Zhang HK, 2016, ELIFE, V5, DOI 10.7554/eLife.15202; Zhao YX, 2014, INTEGR BIOL-UK, V6, P714, DOI 10.1039/c4ib00039k; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	48	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0229051	10.1371/journal.pone.0229051	http://dx.doi.org/10.1371/journal.pone.0229051			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378334	gold, Green Published			2022-12-27	WOS:000605651300058
J	Goupell, MJ; Draves, GT; Litovsky, RY				Goupell, Matthew J.; Draves, Garrison T.; Litovsky, Ruth Y.			Recognition of vocoded words and sentences in quiet and multi-talker babble with children and adults	PLOS ONE			English	Article							SPEECH RECOGNITION; NORMAL-HEARING; TEMPORAL ENVELOPE; COCHLEAR IMPLANTS; SPECTRAL CUES; SINE-WAVE; NOISE; INTELLIGIBILITY; CHANNELS; NUMBER	A vocoder is used to simulate cochlear-implant sound processing in normal-hearing listeners. Typically, there is rapid improvement in vocoded speech recognition, but it is unclear if the improvement rate differs across age groups and speech materials. Children (8-10 years) and young adults (18-26 years) were trained and tested over 2 days (4 hours) on recognition of eight-channel noise-vocoded words and sentences, in quiet and in the presence of multi-talker babble at signal-to-noise ratios of 0, +5, and +10 dB. Children achieved poorer performance than adults in all conditions, for both word and sentence recognition. With training, vocoded speech recognition improvement rates were not significantly different between children and adults, suggesting that improvement in learning how to process speech cues degraded via vocoding is absent of developmental differences across these age groups and types of speech materials. Furthermore, this result confirms that the acutely measured age difference in vocoded speech recognition persists after extended training.	[Goupell, Matthew J.] Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA; [Draves, Garrison T.; Litovsky, Ruth Y.] Univ Wisconsin, Waisman Ctr, Madison, WI USA; [Litovsky, Ruth Y.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA	University System of Maryland; University of Maryland College Park; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Goupell, MJ (corresponding author), Univ Maryland, Dept Hearing & Speech Sci, College Pk, MD 20742 USA.	goupell@umd.edu		Goupell, Matthew/0000-0003-2662-3057	NIH [R01 DC014948, R01 DC003083, R01 DC008365, P30 HD03352]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH Grant R01 DC014948 (M. J. Goupell), R01 DC003083 (R. Y. Litovsky), R01 DC008365 (R.Y. Litovsky), and P30 HD03352 (Waisman Center core grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1969, IEEE T ACOUST SPEECH, VAU17, P225; Bertoncini J, 2009, J SPEECH LANG HEAR R, V52, P682, DOI 10.1044/1092-4388(2008/07-0273); Blamey P, 2013, AUDIOL NEURO-OTOL, V18, P36, DOI 10.1159/000343189; Chatterjee M, 2015, HEARING RES, V322, P151, DOI 10.1016/j.heares.2014.10.003; Conway CM, 2010, COGNITION, V114, P356, DOI 10.1016/j.cognition.2009.10.009; Davis MH, 2005, J EXP PSYCHOL GEN, V134, P222, DOI 10.1037/0096-3445.134.2.222; Dorman MF, 1997, J ACOUST SOC AM, V102, P2403, DOI 10.1121/1.419603; Dorman MF, 2000, EAR HEARING, V21, P590, DOI 10.1097/00003446-200012000-00006; Eisenberg LS, 2000, J ACOUST SOC AM, V107, P2704, DOI 10.1121/1.428656; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Fu QJ, 1998, J ACOUST SOC AM, V104, P3586, DOI 10.1121/1.423941; Gifford RH, 2008, AUDIOL NEURO-OTOL, V13, P193, DOI 10.1159/000113510; Goupell MJ, 2008, J ACOUST SOC AM, V123, P2295, DOI 10.1121/1.2831738; Goupell MJ, 2017, EAR HEARING, V38, pE335, DOI 10.1097/AUD.0000000000000447; Hervais-Adelman A, 2008, J EXP PSYCHOL HUMAN, V34, P460, DOI 10.1037/0096-1523.34.2.460; Hervais-Adelman AG, 2011, J EXP PSYCHOL HUMAN, V37, P283, DOI 10.1037/a0020772; Huyck JJ, 2018, J SPEECH LANG HEAR R, V61, P1012, DOI 10.1044/2018_JSLHR-H-17-0252; Huyck JJ, 2017, J SPEECH LANG HEAR R, V60, P3334, DOI 10.1044/2017_JSLHR-H-16-0300; Li TH, 2007, JARO-J ASSOC RES OTO, V8, P32, DOI 10.1007/s10162-006-0059-2; Litovsky RY, 2012, J AM ACAD AUDIOL, V23, P476, DOI 10.3766/jaaa.23.6.9; Loizou Philipos C, 2006, Adv Otorhinolaryngol, V64, P109, DOI 10.1159/000094648; Lowenstein JH, 2012, J ACOUST SOC AM, V132, pEL443, DOI 10.1121/1.4763554; Newman R, 2013, J ACOUST SOC AM, V133, P483, DOI 10.1121/1.4770241; Newman RS, 2020, J ACOUST SOC AM, V147, P2432, DOI 10.1121/10.0001129; Newman RS, 2015, J ACOUST SOC AM, V138, pEL311, DOI 10.1121/1.4929731; Nittrouer S, 2009, J EXP PSYCHOL HUMAN, V35, P1245, DOI 10.1037/a0015020; PETERSON GE, 1962, J SPEECH HEAR DISORD, V27, P62, DOI 10.1044/jshd.2701.62; Roman AS, 2017, EAR HEARING, V38, P344, DOI 10.1097/AUD.0000000000000393; Rosen S, 1999, J ACOUST SOC AM, V106, P3629, DOI 10.1121/1.428215; Schvartz KC, 2008, J ACOUST SOC AM, V124, P3972, DOI 10.1121/1.2997434; Shader MJ, 2020, EAR HEARING, V41, P1226, DOI 10.1097/AUD.0000000000000840; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sheldon S, 2008, J ACOUST SOC AM, V123, P476, DOI 10.1121/1.2805676; Souza P, 2009, J ACOUST SOC AM, V126, P792, DOI 10.1121/1.3158835; Stilp CE, 2010, J ACOUST SOC AM, V128, P2112, DOI 10.1121/1.3483719; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; Tinnemore AR, 2018, EAR HEARING, V39, P874, DOI 10.1097/AUD.0000000000000546; Waked A, 2017, J ACOUST SOC AM, V141, pEL45, DOI 10.1121/1.4973649	39	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244632	10.1371/journal.pone.0244632	http://dx.doi.org/10.1371/journal.pone.0244632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373427	gold, Green Published			2022-12-27	WOS:000603612300003
J	Parkes, RSV; Pfau, T; Weller, R; Witte, TH				Parkes, Rebecca S. V.; Pfau, Thilo; Weller, Renate; Witte, Thomas H.			The effect of curve running on distal limb kinematics in the Thoroughbred racehorse	PLOS ONE			English	Article							BODY LEAN ANGLE; RISK-FACTORS; HORSES; INJURIES; FORELIMB; FORCE; SPEED; PARAMETERS; RACETRACK; MOVEMENT	During racing, injury is more likely to occur on a bend than on a straight segment of track. This study aimed to quantify the effects of galloping at training speeds on large radius curves on stride parameters and limb lean angle in order to assess estimated consequences for limb loading. Seven Thoroughbred horses were equipped with a sacrum-mounted inertial measurement unit with an integrated GPS, two hoof-mounted accelerometers and retro-reflective markers on the forelimbs. Horses galloped 2-4 circuits anticlockwise around an oval track and were filmed at 120 frames per second using an array of ten cameras. Speed and curve radius were derived from GPS data and used to estimate the centripetal acceleration necessary to navigate the curve. Stride, stance and swing durations and duty factor (DF) were derived from accelerometer data. Limb markers were tracked and whole limb and third metacarpus (MCIII) angles were calculated. Data were analysed using mixed effects models with a significance level of p < 0.05. For horses galloping on the correct lead, DF was higher for the inside (lead) leg on the straight and on the curve. For horses galloping on the incorrect lead, there was no difference in DF between inside and outside legs on the straight or on the curve. DF decreased by 0.61% of DF with each 1 m s(-2) increase in centripetal acceleration (p < 0.001). Whole limb inclination angle increased by 1.5 degrees per 1 m s(-1) increase in speed (p = 0.002). Limb lean angles increase as predicted, and lead limb function mirrors the functional requirements for curve running. A more comprehensive understanding of the effects of lean and torque on the distal limb is required to understand injury mechanisms.	[Parkes, Rebecca S. V.] City Univ Hong Kong, Dept Vet Clin Sci, Kowloon, Hong Kong, Peoples R China; [Parkes, Rebecca S. V.; Pfau, Thilo; Weller, Renate; Witte, Thomas H.] Royal Vet Coll, Dept Clin Sci & Serv, South Mimms, Herts, England; [Parkes, Rebecca S. V.; Pfau, Thilo; Weller, Renate; Witte, Thomas H.] Royal Vet Coll, Struct & Mot Lab, South Mimms, Herts, England	City University of Hong Kong; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Parkes, RSV (corresponding author), City Univ Hong Kong, Dept Vet Clin Sci, Kowloon, Hong Kong, Peoples R China.; Parkes, RSV (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, South Mimms, Herts, England.; Parkes, RSV (corresponding author), Royal Vet Coll, Struct & Mot Lab, South Mimms, Herts, England.	reparkes@cityu.edu.hk		PARKES, Rebecca Sarah Victoria/0000-0001-5465-8578	Horserace Betting Levy Board (HBLB); RSVP's PhD [VET/RS/245]	Horserace Betting Levy Board (HBLB); RSVP's PhD	This research was funded by The Horserace Betting Levy Board (HBLB), https://www.hblb.org.uk.The HBLB funded RSVP's PhD, grant number VET/RS/245. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur RM, 2003, DIAGNOSIS MANAGEMENT, DOI [10.1016/B978-0-7216-8342-3.50114-5, DOI 10.1016/B978-0-7216-8342-3.50114-5]; Bakhtiari J, 2009, LIVEST SCI, V123, P116, DOI 10.1016/j.livsci.2008.10.014; Bertram JEA, 2013, VET J, V198, pE3, DOI 10.1016/j.tvjl.2013.09.025; BroCklehurst C, 2014, VET J, V199, P258, DOI 10.1016/j.tvjl.2013.11.009; Chang YH, 2007, J EXP BIOL, V210, P971, DOI 10.1242/jeb.02728; Chateau H, 2005, EQUINE VET J, V37, P12, DOI 10.2746/0425164054406946; Chateau H, 2013, VET J, V198, pE20, DOI 10.1016/j.tvjl.2013.09.028; Cogger N, 2006, PREV VET MED, V74, P36, DOI 10.1016/j.prevetmed.2006.01.005; Dyson PK, 2008, EQUINE VET J, V40, P650, DOI 10.2746/042516408X363242; Ely ER, 2009, EQUINE VET J, V41, P372, DOI 10.2746/042516409X371224; Evans DL, 1997, AUST VET J, V75, P751, DOI 10.1111/j.1751-0813.1997.tb12261.x; Fredricson I., 1975, Equine Veterinary Journal, V7, P91, DOI 10.1111/j.2042-3306.1975.tb03240.x; Gnagey L, 2006, EQUINE VET J, V38, P628, DOI 10.2746/042516406X159043; GREENE PR, 1987, J BIOMECH, V20, P667, DOI 10.1016/0021-9290(87)90033-9; Greve L, 2018, VET J, V239, P1, DOI 10.1016/j.tvjl.2018.07.006; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Heim C, 2016, EQUINE VET J, V48, P509, DOI 10.1111/evj.12455; Hobbs SJ, 2011, EQUINE VET J, V43, P686, DOI 10.1111/j.2042-3306.2010.00334.x; McGuigan MP, 2003, J EXP BIOL, V206, P1325, DOI 10.1242/jeb.00254; Moreno C, 2009, COMP BIOCHEM PHYS A, V153A, pS118, DOI 10.1016/j.cbpa.2009.04.183; OIKAWA M, 1994, J EQUINE VET SCI, V14, P262, DOI 10.1016/S0737-0806(06)81951-9; Parkes RS, 2013, VET J, V196, P218, DOI 10.1016/j.tvjl.2012.09.006; Parkes RSV, 2019, ANIMALS, P1; Parkin TDH, 2006, PREV VET MED, V74, P44, DOI 10.1016/j.prevetmed.2006.01.006; Pearce GP, 2005, AUST VET J, V83, P367, DOI 10.1111/j.1751-0813.2005.tb15636.x; Pfau T, 2006, J EXP BIOL, V209, P3742, DOI 10.1242/jeb.02439; Pfau T, 2012, AM J VET RES, V73, P1890, DOI 10.2460/ajvr.73.12.1890; Pilsworth RC, 2003, DIAGNOSIS MANAGEMENT, DOI [10.1016/B978-0-7216-8342-3.50115-7, DOI 10.1016/B978-0-7216-8342-3.50115-7]; ROSSDALE PD, 1985, VET REC, V116, P66, DOI 10.1136/vr.116.3.66; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Schamhardt HC, 1996, MEASURING MOVEMENT L; Schneider R K, 1988, Equine Vet J Suppl, P33; Tan HL, 2011, P ROY SOC B-BIOL SCI, V278, P2105, DOI 10.1098/rspb.2010.2395; UEDA Y, 1993, J EQUINE VET SCI, V13, P707, DOI 10.1016/S0737-0806(06)81572-8; Unt VE, 2010, EQUINE VET J, V42, P444, DOI 10.1111/j.2042-3306.2010.00192.x; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; Walter RM, 2003, J EXP BIOL, V206, P1739, DOI 10.1242/jeb.00349; Whitton RC, 1997, VET SURG, V26, P367, DOI 10.1111/j.1532-950X.1997.tb01695.x; Williams DE, 2007, ANIM BEHAV, V74, P941, DOI 10.1016/j.anbehav.2007.01.014; Wills, 2013, LIM TURN PERF DOM DO; Wilson AM, 2003, NATURE, V421, P35, DOI 10.1038/421035a; Witte TH, 2006, J EXP BIOL, V209, P4389, DOI 10.1242/jeb.02518; Witte TH, 2004, J EXP BIOL, V207, P3639, DOI 10.1242/jeb.01182	43	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244105	10.1371/journal.pone.0244105	http://dx.doi.org/10.1371/journal.pone.0244105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373408	gold, Green Published			2022-12-27	WOS:000603612300056
J	Wiesent, L; Schultheiss, U; Lulla, P; Noster, U; Schratzenstaller, T; Schmid, C; Nonn, A; Spear, A				Wiesent, Lisa; Schultheiss, Ulrich; Lulla, Philipp; Noster, Ulf; Schratzenstaller, Thomas; Schmid, Christof; Nonn, Aida; Spear, Ashley			Computational analysis of the effects of geometric irregularities and post-processing steps on the mechanical behavior of additively manufactured 316L stainless steel stents	PLOS ONE			English	Article							COMPRESSIVE PROPERTIES; RESIDUAL-STRESS; HEAT-TREATMENT; LASER; PREDICTION; DESIGN; STRUTS	Advances in additive manufacturing enable the production of tailored lattice structures and thus, in principle, coronary stents. This study investigates the effects of process-related irregularities, heat and surface treatment on the morphology, mechanical response, and expansion behavior of 316L stainless steel stents produced by laser powder bed fusion and provides a methodological approach for their numerical evaluation. A combined experimental and computational framework is used, based on both actual and computationally reconstructed laser powder bed fused stents. Process-related morphological deviations between the as-designed and actual laser powder bed fused stents were observed, resulting in a diameter increase by a factor of 2-2.6 for the stents without surface treatment and 1.3-2 for the electropolished stent compared to the as-designed stent. Thus, due to the increased geometrically induced stiffness, the laser powder bed fused stents in the as-built (7.11 +/- 0.63 N) or the heat treated condition (5.87 +/- 0.49 N) showed increased radial forces when compressed between two plates. After electropolishing, the heat treated stents exhibited radial forces (2.38 +/- 0.23 N) comparable to conventional metallic stents. The laser powder bed fused stents were further affected by the size effect, resulting in a reduced yield strength by 41% in the as-built and by 59% in the heat treated condition compared to the bulk material obtained from tensile tests. The presented numerical approach was successful in predicting the macroscopic mechanical response of the stents under compression. During deformation, increased stiffness and local stress concentration were observed within the laser powder bed fused stents. Subsequent numerical expansion analysis of the derived stent models within a previously verified numerical model of stent expansion showed that electropolished and heat treated laser powder bed fused stents can exhibit comparable expansion behavior to conventional stents. The findings from this work motivate future experimental/numerical studies to quantify threshold values of critical geometric irregularities, which could be used to establish design guidelines for laser powder bed fused stents/lattice structures.	[Wiesent, Lisa; Nonn, Aida] Ostbayer Tech Hsch OTH Regensburg, Dept Mech Engn, Computat Mech & Mat Lab, Regensburg, Germany; [Wiesent, Lisa; Nonn, Aida] OTH Regensburg, Dept Mech Engn, Technol Campus Neustadt Ad Donau, Regensburg, Germany; [Schultheiss, Ulrich; Noster, Ulf] OTH Regensburg, Dept Mech Engn, Mat Sci & Surface Analyt Lab, Regensburg, Germany; [Lulla, Philipp] FIT Prod GmbH, Lupburg, Germany; [Schmid, Christof] Univ Regensburg, Univ Hosp Regensburg, Regensburg, Germany; [Schratzenstaller, Thomas] OTH Regensburg, Dept Mech Engn, Med Device Lab, Regensburg, Germany; [Schratzenstaller, Thomas] Regensburg Ctr Biomed Engn RCBE, Regensburg, Germany; [Spear, Ashley] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA	University of Regensburg; Utah System of Higher Education; University of Utah	Wiesent, L (corresponding author), Ostbayer Tech Hsch OTH Regensburg, Dept Mech Engn, Computat Mech & Mat Lab, Regensburg, Germany.; Wiesent, L (corresponding author), OTH Regensburg, Dept Mech Engn, Technol Campus Neustadt Ad Donau, Regensburg, Germany.	lisa.wiesent@oth-regensburg.de	Wiesent, Lisa/AAS-1633-2021	Wiesent, Lisa/0000-0001-8094-4930; Nonn, Aida/0000-0003-1522-224X	Fulbright doctoral fellowship; German-American Fulbright Program; Bavarian State Ministry of Science and Arts [AZ-1221-16]; Bayerischen Forschungsstiftung [CMMI1752400]; National Science Foundation [INST 102/11-1 FUGG]; Deutsche Forschungsgemeinschaft (DFG); Center for High Performance Computing at the University of Utah; Technology Campus Neustadt a. d. Donau and the Regensburg Center of Biomedical Engineering (RCBE)	Fulbright doctoral fellowship; German-American Fulbright Program; Bavarian State Ministry of Science and Arts; Bayerischen Forschungsstiftung; National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Center for High Performance Computing at the University of Utah; Technology Campus Neustadt a. d. Donau and the Regensburg Center of Biomedical Engineering (RCBE)	L.W.: Fulbright doctoral fellowship (no grant number), German-American Fulbright Program, https://www.fulbright.de/L.W: Bavarian Academic Forum (BayWISS) - Doctoral Consortium `Health Research', Bavarian State Ministry of Science and Arts, https://www.baywiss.de/L.W: doctoral scholarship, LaKoF (State Conference of Women's and Equal Opportunities Representatives at Bavarian Universities), https://www.lakof-bayern.de/foerderung/HAW/pst U. N.: grant number AZ-1221-16, Bayerischen Forschungsstiftung, https://www.forschungsstiftung.de/A.S.: Grant No. CMMI1752400, National Science Foundation, https://www.nsf.gov/RCBE: grand number INST 102/11-1 FUGG, Deutsche Forschungsgemeinschaft (DFG), https://www.dfg.de/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would further like to thank the Center for High Performance Computing at the University of Utah, the Technology Campus Neustadt a. d. Donau and the Regensburg Center of Biomedical Engineering (RCBE) for providing support and resources. Particular thanks goes to Birgit Striegl of the RCBE for performing all mu-CT scans.	[Anonymous], 2013, SYSTEMES 6 13 DOCUME, P1138; Bae IH, 2015, J IND ENG CHEM, V21, P1295, DOI 10.1016/j.jiec.2014.05.045; Banhart J, 1998, J MATER SCI, V33, P1431, DOI 10.1023/A:1004383222228; Barba D, 2020, MATER DESIGN, V186, DOI 10.1016/j.matdes.2019.108235; Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071; Charles A, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9061256; Chen HY, 2009, J APPL PHYSIOL, V106, P1686, DOI 10.1152/japplphysiol.91519.2008; Chen W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12265-8; Demir AG, 2017, MATER DESIGN, V119, P338, DOI 10.1016/j.matdes.2017.01.091; Deutsches Intitute fur Normung e V, 2016, 50125201612 DIN; Deutsches Intitute fur Normung e V, 2012, 255392201305 DIN EN, P2013; Dong ZC, 2018, MATERIALS, V11, DOI 10.3390/ma11122463; du Plessis A, 2018, 3D PRINT ADDIT MANUF, V5, P227, DOI 10.1089/3dp.2018.0060; Finazzi V, 2020, J MANUF PROCESS, V55, P161, DOI 10.1016/j.jmapro.2020.03.060; Finazzi V, 2019, PROCEDIA STRUCT INTE, V15, P16, DOI 10.1016/j.prostr.2019.07.004; Frazier WE, 2014, J MATER ENG PERFORM, V23, P1917, DOI 10.1007/s11665-014-0958-z; Geng LC, 2019, EXP MECH, V59, P913, DOI 10.1007/s11340-019-00489-0; Gumruk R, 2013, INT J MECH SCI, V68, P125, DOI 10.1016/j.ijmecsci.2013.01.006; Gumruk R, 2018, J MATER ENG PERFORM, V27, P1016, DOI 10.1007/s11665-018-3208-y; Gundert TJ, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005542; Hocheng H, 2001, J MATER ENG PERFORM, V10, P414, DOI 10.1361/105994901770344827; Hufenbach J, 2020, ADV ENG MATER, V22, DOI 10.1002/adem.202000182; Kaya AC, 2014, MAT SCI ENG A-STRUCT, V615, P447, DOI 10.1016/j.msea.2014.07.098; Khairallah SA, 2016, ACTA MATER, V108, P36, DOI 10.1016/j.actamat.2016.02.014; Kong DC, 2019, J MATER SCI TECHNOL, V35, P1499, DOI 10.1016/j.jmst.2019.03.003; Kurzynowski T, 2018, MAT SCI ENG A-STRUCT, V718, P64, DOI 10.1016/j.msea.2018.01.103; Lei HS, 2019, MATER DESIGN, V169, DOI 10.1016/j.matdes.2019.107685; Li HX, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-016-0307-6; Liu L, 2017, J MECH PHYS SOLIDS, V107, P160, DOI 10.1016/j.jmps.2017.07.003; Mahmoud D, 2017, J MANUF MATER PROC, V1, DOI 10.3390/jmmp1020013; Matheson KE, 2017, MAT SCI ENG A-STRUCT, V707, P181, DOI 10.1016/j.msea.2017.08.102; Nagarajan B, 2019, ENGINEERING-PRC, V5, P702, DOI 10.1016/j.eng.2019.07.002; Nandishwarsteel, 2010, ASME SA 240 STAINL S; Parthasarathy J., 2011, J MANUF PROCESS, V13, P160, DOI [10.1016/j.jmapro.2011.01.004, DOI 10.1016/J.JMAPRO.2011.01.004, DOI 10.1016/j.jmapro.2011.01.004]; Polishetty Ashwin, 2019, International Journal of Materials, Mechanics and Manufacturing, V7, P114, DOI 10.18178/ijmmm.2019.7.2.442; Qiu CL, 2015, MAT SCI ENG A-STRUCT, V628, P188, DOI 10.1016/j.msea.2015.01.031; Gonzalez FJQ, 2016, BIOMATER BIOMECH BIO, V3, P1, DOI 10.12989/bme.2016.3.1.001; Ravari MRK, 2015, J MATER ENG PERFORM, V24, P245, DOI 10.1007/s11665-014-1281-4; Sarkar S, 2019, MAT SCI ENG A-STRUCT, V762, DOI 10.1016/j.msea.2019.138109; Shen Y, 2010, J SANDW STRUCT MATER, V12, P159, DOI 10.1177/1099636209104536; Shiomi M, 2004, CIRP ANN-MANUF TECHN, V53, P195, DOI 10.1016/S0007-8506(07)60677-5; Simson T, 2017, ADDIT MANUF, V17, P183, DOI 10.1016/j.addma.2017.07.007; Sing SL, 2020, VIRTUAL PHYS PROTOTY, V15, P359, DOI 10.1080/17452759.2020.1779999; Smith M, 2013, INT J MECH SCI, V67, P28, DOI 10.1016/j.ijmecsci.2012.12.004; Solberg K, 2019, FATIGUE FRACT ENG M, V42, P2043, DOI 10.1111/ffe.13077; Stoeckel D, 2002, MINIM INVASIV THER, V11, P137, DOI 10.1080/136457002760273340; Strano G, 2013, J MATER PROCESS TECH, V213, P589, DOI 10.1016/j.jmatprotec.2012.11.011; Suard Mathieu, 2021, Material Design & Processing Communications, V3, DOI 10.1002/mdp2.140; Suard M, 2015, ADDIT MANUF, V8, P124, DOI 10.1016/j.addma.2015.10.002; Tsopanos S, 2010, J MANUF SCI E-T ASME, V132, DOI 10.1115/1.4001743; Ushijima K, 2011, J SANDW STRUCT MATER, V13, P303, DOI 10.1177/1099636210380997; Van Bael S, 2011, MAT SCI ENG A-STRUCT, V528, P7423, DOI 10.1016/j.msea.2011.06.045; Wang YM, 2018, NAT MATER, V17, P63, DOI [10.1038/NMAT5021, 10.1038/nmat5021]; Waqar S, 2020, RAPID PROTOTYPING J, V26, P1739, DOI 10.1108/RPJ-12-2019-0320; Wiesent L, 2020, MATERIALWISS WERKST, V51, P1615, DOI 10.1002/mawe.202000038; Wiesent L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224026; Wustenhagen Carolin, 2018, Current Directions in Biomedical Engineering, V4, P93, DOI 10.1515/cdbme-2018-0024; Yadollahi A, 2015, MAT SCI ENG A-STRUCT, V644, P171, DOI 10.1016/j.msea.2015.07.056; Yan CZ, 2014, MATER DESIGN, V55, P533, DOI 10.1016/j.matdes.2013.10.027; Yavari SA, 2015, J MECH BEHAV BIOMED, V43, P91, DOI 10.1016/j.jmbbm.2014.12.015; Zhao H, 2002, J MATER SCI-MATER M, V13, P911, DOI 10.1023/A:1019831808503	61	3	3	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244463	10.1371/journal.pone.0244463	http://dx.doi.org/10.1371/journal.pone.0244463			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373392	Green Published, gold			2022-12-27	WOS:000603612300062
J	Botham, CM; Brawn, S; Steele, L; Barron, CB; Kleppner, SR; Herschlag, D				Botham, Crystal M.; Brawn, Shay; Steele, Latishya; Barron, Cisco B.; Kleppner, Sofie R.; Herschlag, Daniel			Biosciences Proposal Bootcamp: Structured peer and faculty feedback improves trainees' proposals and grantsmanship self-efficacy	PLOS ONE			English	Article							FORMATIVE ASSESSMENT; REVIEWERS; REVISION; STUDENTS	Grant writing is an essential skill to develop for academic and other career success but providing individual feedback to large numbers of trainees is challenging. In 2014, we launched the Stanford Biosciences Grant Writing Academy to support graduate students and postdocs in writing research proposals. Its core program is a multi-week Proposal Bootcamp designed to increase the feedback writers receive as they develop and refine their proposals. The Proposal Bootcamp consisted of two-hour weekly meetings that included mini lectures and peer review. Bootcamp participants also attended faculty review workshops to obtain faculty feedback. Postdoctoral trainees were trained and hired as course teaching assistants and facilitated weekly meetings and review workshops. Over the last six years, the annual Bootcamp has provided 525 doctoral students and postdocs with multi-level feedback (peer and faculty). Proposals from Bootcamp participants were almost twice as likely to be funded than proposals from non-Bootcamp trainees. Overall, this structured program provided opportunities for feedback from multiple peer and faculty reviewers, increased the participants' confidence in developing and submitting research proposals, while accommodating a large number of participants.	[Botham, Crystal M.] Stanford Univ, Stanford Biosci Grant Writing Acad, Stanford, CA 94305 USA; [Brawn, Shay] Stanford Univ, Program Writing & Rhetor, Stanford, CA 94305 USA; [Steele, Latishya; Barron, Cisco B.] Stanford Univ, Off Grad Educ, Stanford, CA 94305 USA; [Kleppner, Sofie R.] Stanford Univ, Off Postdoctoral Affairs, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Dept Chem, ChEM H Inst, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Botham, CM (corresponding author), Stanford Univ, Stanford Biosci Grant Writing Acad, Stanford, CA 94305 USA.	cbotham@stanford.edu		Botham, Crystal/0000-0002-7510-6112				Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Ambrose S.A., 2010, HOW LEARNING WORKS; Bieschke KJ, 1996, J CAREER ASSESSMENT, V4, P59, DOI 10.1177/106907279600400104; Boud D, 2000, STUDIES CONT ED, V22, P151, DOI [DOI 10.1080/713695728, 10.1080/]; Cho K, 2006, WRIT COMMUN, V23, P260, DOI 10.1177/0741088306289261; Cho K, 2007, COMPUT EDUC, V48, P409, DOI 10.1016/j.compedu.2005.02.004; Cho K, 2010, LEARN INSTR, V20, P328, DOI 10.1016/j.learninstruc.2009.08.006; Clark SL, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-01-0036; Dumanis SB, 2013, CBE-LIFE SCI EDUC, V12, P419, DOI 10.1187/cbe.12-05-0058; Forbes D, 1991, INNOVATIONS ENG ED, P971; Gielen S, 2010, LEARN INSTR, V20, P304, DOI 10.1016/j.learninstruc.2009.08.007; Harwood EM, 2019, ANN NY ACAD SCI, V1445, P17, DOI 10.1111/nyas.13995; Hollenbach AD, 2014, PRACTICAL GUIDE WRIT, DOI [10.1016/B978-0-12-420187-3.00008-9, DOI 10.1016/B978-0-12-420187-3.00008-9]; Inouye SK, 2005, ANN INTERN MED, V142, P274, DOI 10.7326/0003-4819-142-4-200502150-00009; Irons A., 2007, ENHANCING LEARNING F, DOI [10.4324/9780203934333, DOI 10.4324/9780203934333]; Isaacs G., 2001, HIGHER ED RES DEV, V20, P53, DOI [10.1080/07924360120043658, DOI 10.1080/07294360123776]; James W., 1997, ASSESS EDUC, V4, P365, DOI [10.1080/0969594970040304, DOI 10.1080/0969594970040304]; Kahn RA, 2016, TRAFFIC, V17, P803, DOI 10.1111/tra.12398; Kovac J, 2003, ANN NY ACAD SCI, V988, P233, DOI 10.1111/j.1749-6632.2003.tb06103.x; Larose S, 2006, EDUC RES EVAL, V12, P373, DOI 10.1080/13803610600765836; Lee S, 2014, REQUESTING GIVING AC; Lundstrom K, 2009, J SECOND LANG WRIT, V18, P30, DOI 10.1016/j.jslw.2008.06.002; Mackert M, 2017, HEALTH COMMUN, V32, P247, DOI 10.1080/10410236.2015.1110686; Marra RM, 2009, J ENG EDUC, V98, P27, DOI 10.1002/j.2168-9830.2009.tb01003.x; Min H. T., 2005, SYSTEM, V33, P293, DOI [DOI 10.1016/J.SYSTEM.2004.11.003, 10.1016/j.system.2004.11.003]; Min HT, 2006, J SECOND LANG WRIT, V15, P118, DOI 10.1016/j.jslw.2006.01.003; Nicol DJ, 2006, STUD HIGH EDUC, V31, P199, DOI 10.1080/03075070600572090; NIH Confidentiality and Nondisclosure Rules: Information for Reviewers of NIH Grant Applications and R&D Contract Proposals, 2015, NIH CONF NOND RUL IN; Panadero E, 2013, EDUC RES REV-NETH, V9, P129, DOI 10.1016/j.edurev.2013.01.002; Poe M., 2010, LEARNING COMMUNICATE; Quitadamo Ian J, 2007, CBE Life Sci Educ, V6, P140, DOI 10.1187/cbe.06-11-0203; Rushton A, 2005, MED TEACH, V27, P509, DOI 10.1080/01421590500129159; Russell SW, 2017, GRANT APPL WRITERS W; SOMMERS N, 1982, COLL COMPOS COMMUN, V33, P148, DOI 10.2307/357622; van Zundert M, 2010, LEARN INSTR, V20, P270, DOI 10.1016/j.learninstruc.2009.08.004	35	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243973	10.1371/journal.pone.0243973	http://dx.doi.org/10.1371/journal.pone.0243973			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370337	Green Published, gold			2022-12-27	WOS:000603611900114
J	Jang, JY; Chun, BC				Jang, Jin Young; Chun, Byung Chul			Association of Anopheles sinensis average abundance and climate factors: Use of mosquito surveillance data in Goyang, Korea	PLOS ONE			English	Article							EPIDEMIOLOGIC CHARACTERISTICS; VIVAX MALARIA	Malaria is a vector-borne disease transmitted by Anopheline mosquitoes. In Korea, Plasmodium vivax malaria is an endemic disease and the main vector is Anopheles sinensis. Plasmodium vivax malaria is common in the northwestern part of South Korea, including in the city of Goyang in regions near the demilitarized zone. This study aimed to identify the best time-series model for predicting mosquito average abundance in Goyang, Korea. Mosquito data were obtained from the Mosquito Surveillance Program of the Goyang Ilsanseogu Public Health Center for the period 2008-2012. Black light traps were set up periodically in a park, a senior community center, and a village community center, public health center, drainage pumping station, cactus research center, restaurant near forest, in which many activities occur at night. In total, 9,512 female mosquitoes were collected at 12 permanent trapping sites during the mosquito season in the study period. Weekly An. sinensis average abundance was positively correlated with minimum grass temperature (r = 0.694, p < 0.001), precipitation (r = 0.326, p = 0.001). The results showed that seasonal autoregressive integrated moving average (SARIMA) (1,0,0)(0,0,1)(21) with minimum grass temperature variable at time lag0 weeks and the precipitation variable at time lag1 weeks provided that best model of mosquito average abundance. The multivariate model accounted for about 54.1% of the mosquito average abundance variation. Time-series analysis of mosquito average abundance and climate factors provided basic information for predicting the occurrence of malaria mosquitoes.	[Jang, Jin Young; Chun, Byung Chul] Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Chun, Byung Chul] Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine)	Chun, BC (corresponding author), Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea.; Chun, BC (corresponding author), Korea Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	chun@korea.ac.kr	Chun, Byung Chul/AGO-1390-2022; Chun, Byung Chul/AGO-1458-2022	Chun, Byung Chul/0000-0001-6576-8916; Chun, Byung Chul/0000-0001-6576-8916				[Anonymous], 2013, J CARDIOLOGY CASES, V8, pe13; [Anonymous], 2013, J CARDIOLOGY CASES, V8, pe13; Bahk YY, 2018, KOREAN J PARASITOL, V56, P531, DOI 10.3347/kjp.2018.56.6.531; Becking LE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075996, 10.1371/journal.pone.0079276]; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Foley DH, 2017, J VECTOR ECOL, V42, P335, DOI 10.1111/jvec.12274; Jarraud M., 2008, 8 WMO; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Korea Centers for Disease Control and Prevention, 2019, MAL MAN GUID; Korea Centers for Disease Control and Prevention, 2012, MAJ INF DIS MED MOSQ; Liu H, 2009, ENVIRON MONIT ASSESS, V159, P143, DOI 10.1007/s10661-008-0618-6; Medlock JM, 2015, LANCET INFECT DIS, V15, P721, DOI 10.1016/S1473-3099(15)70091-5; Organization WH, 2018, WORLD MAL REP 2018, P3; Park JW, 2009, KOREAN J PARASITOL, V47, pS39, DOI 10.3347/kjp.2009.47.S.S39; Ranco DJ, 2011, ENVIRON JUSTICE, V4, P221, DOI 10.1089/env.2010.0036; REE Han-Il, 2005, Korean Journal of Parasitology, V43, P75, DOI 10.3347/kjp.2005.43.3.75; Zhao XF, 2013, TROP BIOMED, V30, P267; Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244479	10.1371/journal.pone.0244479	http://dx.doi.org/10.1371/journal.pone.0244479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370376	gold, Green Published			2022-12-27	WOS:000603611900003
J	Ngaage, LM; Harris, C; Landford, W; Knighton, BJ; Stewart, T; Ge, S; Silverman, RP; Slezak, S; Rasko, YM				Ngaage, Ledibabari M.; Harris, Chelsea; Landford, Wilmina; Knighton, Brooks J.; Stewart, Talia; Ge, Shealinna; Silverman, Ronald P.; Slezak, Sheri; Rasko, Yvonne M.			Follow the money: Investigating gender disparity in industry payments among senior academics and leaders in plastic surgery	PLOS ONE			English	Article							CONFLICTS-OF-INTEREST; ASSOCIATION; IMPACT; INDEX; WOMEN; PRODUCTIVITY; PHYSICIANS	Introduction Differences in academic qualifications are cited as the reason behind the documented gender gap in industry sponsorship to academic plastic surgeons. Gendered imbalances in academic metrics narrow among senior academic plastic surgeons. However, it is unknown whether this gender parity translates to industry payments. Methods We conducted a cross-sectional analysis of industry payments disbursed to plastic surgeons in 2018. Inclusion criteria encompassed (i) faculty with the rank of professor or a departmental leadership position. Exclusion criteria included faculty (i) who belonged to a speciality besides plastic surgery; (ii) whose gender could not be determined; or (iii) whose name could not be located on the Open Payment Database. Faculty and title were identified using departmental listings of ACGME plastic surgery residency programs. We extracted industry payment data through the Open Payment Database. We also collected details on H-index and time in practice. Statistical analysis included odds ratios (OR) and Pearson's correlation coefficient (R). Results We identified 316 senior academic plastic surgeons. The cohort was predominately male (88%) and 91% held a leadership role. Among departmental leaders, women were more likely to be an assistant professor (OR 3.9, p = 0.0003) and heads of subdivision (OR 2.1, p = 0.0382) than men. Industry payments were distributed equally to male and female senior plastic surgeons except for speakerships where women received smaller amounts compared to their male counterparts (median payments of $3,675 vs $7,134 for women and men respectively, p<0.0001). Career length and H-index were positively associated with dollar value of total industry payments (R = 0.17, p = 0.0291, and R = 0.14, p = 0.0405, respectively). Conclusion Disparity in industry funding narrows at senior levels in academic plastic surgery. At higher academic levels, industry sponsorship may preferentially fund individuals based on academic productivity and career length. Increased transparency in selection criteria for speakerships is warranted.	[Ngaage, Ledibabari M.; Knighton, Brooks J.; Ge, Shealinna; Silverman, Ronald P.; Slezak, Sheri; Rasko, Yvonne M.] Univ Maryland, Dept Surg, Med Ctr, Div Plast Surg, Baltimore, MD 21201 USA; [Harris, Chelsea] Univ Maryland, Dept Surg, Med Ctr, Baltimore, MD 21201 USA; [Landford, Wilmina] Johns Hopkins Univ, Dept Plast & Reconstruct Surg, Sch Med, Baltimore, MD USA; [Stewart, Talia] Geisel Sch Med Dartmouth, Hanover, NH USA; [Silverman, Ronald P.] Acelity Corp, San Antonio, TX USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Dartmouth College	Rasko, YM (corresponding author), Univ Maryland, Dept Surg, Med Ctr, Div Plast Surg, Baltimore, MD 21201 USA.	yrasko@som.umaryland.edu		Ngaage, Ledibabari/0000-0001-5802-779X; Knighton, Brooks/0000-0002-6203-3364				Ahmed R, 2017, ANN PLAS SURG, V78, P315, DOI 10.1097/SAP.0000000000000874; American Association of Medical Colleges, 2018, 2018 PHYS SPEC DAT R; [Anonymous], 2018, VOX             0919; Buckley LM, 2000, ACAD MED, V75, P283, DOI 10.1097/00001888-200003000-00021; Centers for Medicare & Medicaid Services, NAT PAYM; Eloy JA, 2017, JAMA OTOLARYNGOL, V143, P796, DOI 10.1001/jamaoto.2017.0276; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Kutner M., 2004, APPL LINEAR STAT MOD; LEXCHIN J, 1993, CAN MED ASSOC J, V149, P1401; Lopez J, 2016, ANN PLAS SURG, V77, P226, DOI 10.1097/SAP.0000000000000834; Lopez J, 2015, PLAST RECONSTR SURG, V136, p690E, DOI 10.1097/PRS.0000000000001718; Luce EA, 2017, PLAST RECONSTR SURG, V140, P635, DOI 10.1097/PRS.0000000000003598; Moses H, 2012, JAMA-J AM MED ASSOC, V308, P2341, DOI 10.1001/jama.2012.14846; Myers SP, 2019, J SURG RES, V236, P22, DOI 10.1016/j.jss.2018.10.015; Ngaage LM, 2020, ANN PLAS SURG, V84, P201, DOI 10.1097/SAP.0000000000001989; Ngaage LM, 2019, WORLD NEUROSURG, V130, P516, DOI 10.1016/j.wneu.2019.06.145; Paik AM, 2014, J SURG EDUC, V71, P593, DOI 10.1016/j.jsurg.2014.01.010; Plana NM, 2018, PLAST RECONSTR SURG, V141, P1304, DOI 10.1097/PRS.0000000000004337; Ruan QZ, 2018, J SURG RES, V224, P185, DOI 10.1016/j.jss.2017.12.025; Ruel E, 2013, DEMOGRAPHY, V50, P1155, DOI 10.1007/s13524-012-0182-0; Santosa KB, 2019, PLAST RECONSTR SURG, V143, P1798, DOI 10.1097/PRS.0000000000005672; Sasor SE, 2018, J SURG RES, V229, P332, DOI 10.1016/j.jss.2018.04.031; Seemann NM, 2016, AM J SURG, V211, P343, DOI 10.1016/j.amjsurg.2015.08.036; Sheather SJ, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-09608-7_1; Silvestre J, 2016, PLAST RECONSTR SURG, V138, p136E, DOI 10.1097/PRS.0000000000002308; Silvestre J, 2016, PLAST RECONSTR SURG, V137, P690, DOI 10.1097/01.prs.0000475798.69478.ea; Sismondo S, 2013, J LAW MED ETHICS, V41, P635, DOI 10.1111/jlme.12073; Sugimoto CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128000; Therattil PJ, 2016, ANN PLAS SURG, V76, P545, DOI 10.1097/SAP.0000000000000382; Tringale KR, 2017, JAMA-J AM MED ASSOC, V317, P1774, DOI 10.1001/jama.2017.3091; Wietsma AC, 2014, J COMMUNITY HOSP INT, V4, DOI 10.3402/jchimp.v4.24665; Zhu EY, 2017, BULL HOSP JT DIS, V75, P257	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0235058	10.1371/journal.pone.0235058	http://dx.doi.org/10.1371/journal.pone.0235058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370290	gold, Green Published			2022-12-27	WOS:000603611900093
J	Zhou, B; Wu, J; Guo, SD; Hu, MX; Wang, J				Zhou, Bing; Wu, Jing; Guo, Sidai; Hu, Mingxia; Wang, Jing			Environmental regulation and financial performance of Chinese listed companies	PLOS ONE			English	Article								Objective The answer to this article lies in: Does the financial activities of physical enterprises have an adverse impact on their main business? Is it conducive to the sustainable development of the national economy? However, when most scholars study the impact of environmental regulations on companies performance, they have not classified companies performance. This article will study the relationship between environmental regulations and performance levels based on the classification of companies performance, and then divide the nature of industry pollution, companies location and nature of property for in-depth research. Methods First, this article uses a random effect variable-intercept model to measure companies financial performance and non-financial performance. Then, the variables are divided into two variable groups: light pollution and heavy pollution according to the nature of industry pollution. Next, the companies are divided into three variable groups: the eastern region, the central region, and the western region. Finally, the company is divided into two variable groups: state-owned and non-state-owned according to the nature of property. Conclusions The study found that: (1) Environmental regulations have inhibited companies financial activities. And the inhibitory effect of environmental regulations on the financial performance of enterprises is more obvious in the heavily polluting industries and enterprises in central and eastern regions. (2) Environmental regulations and companies non-financial performance are also negatively related, environmental regulations have also inhibited the non-financial performance of companies, this effect is more pronounced in heavily polluting industries and enterprises in western regions. (3) Income crowding effect brought by China's environmental regulations is greater than the income compensation effect brought by stimulating technological innovation.	[Zhou, Bing; Wu, Jing] Chongqing Technol & Business Univ, Sch Accounting, Res Ctr Econ Upper Reaches Yangtse River, Chongqing, Peoples R China; [Guo, Sidai] Southwest Univ Sci & Technol, Sichuan Prov Circular Econ Res Ctr, Mianyang, Sichuan, Peoples R China; [Hu, Mingxia] Beijing Natl Accounting Inst, Accounting Res & Dev Ctr, Beijing, Peoples R China; [Wang, Jing] Lanzhou Univ Technol, Sch Law, Lanzhou, Peoples R China	Chongqing Technology & Business University; Southwest University of Science & Technology - China; Lanzhou University of Technology	Hu, MX (corresponding author), Beijing Natl Accounting Inst, Accounting Res & Dev Ctr, Beijing, Peoples R China.	humx@mail.nai.edu.cn	Sidai, Guo/GLV-2648-2022	Wang, Jing/0000-0003-0357-9348				Ar I M, 1998, EUROPEAN J INNOVATIO, V14, P172; Bin Li, 2013, CHINA IND EC, P56; Changlong Lou, 2015, SCI TECHNOLOGY PROGR, V32, P66; Eiadat Yousef, 2007, J WORLD BUSINESS, V43; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Feng X, 2007, INT GEOSCI REMOTE SE, P571, DOI 10.1109/IGARSS.2007.4422858; [胡樱凡 Hu Yingfan], 2019, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V25, P54; Jaffe AB, 1997, REV ECON STAT, V79, P610, DOI 10.1162/003465397557196; Jihong Lin, 2013, CHINA POPULATION RES, V23, P13; Jingyan F., 2010, MANAG WORLD, V10, P87; Ke Jiang, 2014, ECOLOGICAL EC, V30, P90; Kneller Richard, RESOURCE ENERGY EC, V34, P235; Neng Shen, 2012, CHINA SOFT SCI, P49; Peng C., 2018, J YUNNAN U FIN EC, V34, P37, DOI [10.16537/j.cnki.jynufe.000353, DOI 10.16537/J.CNKI.JYNUFE.000353]; Rassier DG, 2010, ENVIRON RESOUR ECON, V45, P353, DOI 10.1007/s10640-009-9318-0; Shuting Yang, 2018, ECOLOGICAL EC, V34, P41; Wei Yu, 2017, SCI RES MANAGEMENT, V38, P18; Weihong Li, 2018, AUDITING EC RES, V33, P103; Xiaojian Yao, 2018, STAT DECISION, V34, P78; Xin Yang, 2014, RES ENV REGULATION E, P36; Yue Zheng, 2015, IMPACT ENV REGULATIO; Yuxia Feng, 2013, ECOLOGICAL EC, P66	22	6	6	9	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244083	10.1371/journal.pone.0244083	http://dx.doi.org/10.1371/journal.pone.0244083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370326	Green Published, gold			2022-12-27	WOS:000603611900034
J	Belovsky, GE; Slade, JB				Belovsky, Gary E.; Slade, Jennifer B.			Climate change and primary production: Forty years in a bunchgrass prairie	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; UNITED-STATES; GRASSLAND; TERRESTRIAL; PRECIPITATION; RESPONSES; FORESTS; VARIABILITY; PERSPECTIVE; INCREASES	Over the past 109 years, a Montana intermountain bunchgrass prairie annually became warmer (0.7 degrees C) and drier (27%). The temperature and precipitation trends continued since 1978, as we studied nitrogen availability, annual aboveground primary production (ANPP), plant phenology and species composition. Given the annual increase in temperature and decrease in precipitation, ANPP might be expected to decline; however, it increased by 110%, as the period of greatest production (late-May-June) became wetter and cooler, counter to the annual pattern, and this was strongest at lower elevations. Grass production increased by 251%, while dicot production declined by 65%, which increased grass relative abundance by 54%. Summer temperatures increased 12.5% which increased plant senescence by 119% and decreased fall plant regrowth by 68%. More intense summer senescence changed plant species composition in favor of more drought tolerant species. The greater ANPP and summer senescence may increase susceptibility for fire, but fire tolerance of the plant species composition did not change. Invasive plant species increased 108% over the study with annual grasses accounting for >50% of this increase, which further increased summer plant senescence. Therefore, seasonal climate changes at a smaller geographical scale (local), rather than average annual climate changes over a larger geographical scale (regional), may better reflect plant community responses, and this makes ecological forecasting of climate change more difficult.	[Belovsky, Gary E.] Univ Notre Dame, Environm Res Ctr, Notre Dame, IN 46556 USA; [Belovsky, Gary E.; Slade, Jennifer B.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Belovsky, GE (corresponding author), Univ Notre Dame, Environm Res Ctr, Notre Dame, IN 46556 USA.; Belovsky, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	belovsky.1@nd.edu			National Science Foundation: NSF [NSF DEB78-02069, NSF BSR-83-07352, NSF DEB-9317984, NSF DEB-97-07564, NSF DEB-04-15390, NSF DEB-09-18306, NSF DEB-1456511]; National Geographic Society [FY79]; University of Michigan Rackham Graduate School; University of Michigan Vice-President of Research Grant; USDA/GHIPM (1989-1994); Utah State University Agricultural Experiment Station; USDA/ARS; USDA-CSREES/NRICGP [00-35101-9267]	National Science Foundation: NSF(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); University of Michigan Rackham Graduate School(University of Michigan System); University of Michigan Vice-President of Research Grant(University of Michigan System); USDA/GHIPM (1989-1994); Utah State University Agricultural Experiment Station; USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA-CSREES/NRICGP(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	Funding to 1st author GEB: National Science Foundation: NSF -www.nsf.gov NSF DEB78-02069, NSF BSR-83-07352, NSF DEB-9317984, NSF DEB-97-07564, NSF DEB-04-15390, NSF DEB-09-18306, NSF DEB-1456511 National Geographic Society Grant FY79 -https://www.nationalgeographic.org; University of Michigan Rackham Graduate School -https://rackham.umich.edu/; University of Michigan Vice-President of Research Grant -https://www.research.umich.edu; USDA/GHIPM (1989-1994) -www.ars.usda.gov (GHIPM program ended in 1994); Utah State University Agricultural Experiment Station (1992-1996) -https://uaes.usu.edu/; USDA/ARS and USDA-CSREES/NRICGP (00-35101-9267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; ANTOS JA, 1983, AM MIDL NAT, V110, P354, DOI 10.2307/2425275; Baer SG, 2008, ECOLOGY, V89, P1859, DOI 10.1890/07-0417.1; Belovsky Gary E., 2002, Journal of Orthoptera Research, V11, P29, DOI 10.1665/1082-6467(2002)011[0029:AEPOGC]2.0.CO;2; BELOVSKY GE, 1995, OECOLOGIA, V101, P383, DOI 10.1007/BF00328826; Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Belovsky GE, 2000, NATO ASI 2, V73, P7; Binkley D., 1989, Advances in Soil Science, V10, P57; Blair J. M., 1998, GRASSLAND DYNAMICS L, P222; Booth ELJ, 2012, INT J CLIMATOL, V32, P2283, DOI 10.1002/joc.3401; Bragg Thomas B., 1995, P49; Branson DH, 2001, THESIS; Briske DD, 2015, FRONT ECOL ENVIRON, V13, P249, DOI 10.1890/140266; Burke IC, 1997, ECOLOGY, V78, P1330, DOI 10.1890/0012-9658(1997)078[1330:RATVIN]2.0.CO;2; Clark DA, 2001, ECOL APPL, V11, P356, DOI 10.1890/1051-0761(2001)011[0356:MNPPIF]2.0.CO;2; Cleland EE, 2013, ECOLOGY, V94, P1687, DOI 10.1890/12-1006.1; Collins Scott L., 1995, P128; Conroy JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039558; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; Craine JM, 2011, OECOLOGIA, V165, P1109, DOI 10.1007/s00442-011-1938-8; Craine JM, 2010, ECOLOGY, V91, P2132, DOI 10.1890/09-1242.1; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; DAUBENMIRE R, 1956, ECOL MONOGR, V26, P131, DOI 10.2307/1943287; DAUBENMIRE R. F., 1942, ECOL MONOGR, V12, P53, DOI 10.2307/1948422; Daubenmire RF, 1947, PANTS ENV TXB PLANT; Daubenmire RF, 1970, WASH AGR STA TECH B, P62; Del Grosso S, 2008, ECOLOGY, V89, P2117, DOI 10.1890/07-0850.1; Dice LR, 1962, NATURAL COMMUNITIES; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dorn R. D., 1984, VASCULAR PLANTS MONT; Everard K, 2010, AM NAT, V175, P85, DOI 10.1086/648557; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Finch DM, RMRSGTR285, DOI 10.2737/RMRS-GTR-285; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Garcia A, 1976, TOUGH TRIP PARADISE; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Harte J, 2015, GLOBAL CHANGE BIOL, V21, P2349, DOI 10.1111/gcb.12831; Hautier Y, 2015, SCIENCE, V348, P336, DOI 10.1126/science.aaa1788; Heyerdahl EK, 2008, ECOLOGY, V89, P705, DOI 10.1890/06-2047.1; Hitchcock A. S., 1971, MANUAL GRASSES US; Hitchcock C.L., 1973, FLORA PACIFIC NW; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; JOERN A, 1995, CHANGING PRAIRIE N A; Johnson D., 2001, WILDLIFE HABITAT REL; Johnson SE, 1930, U MONTANA BULLETIN, V237; Kennedy PL, 2009, RESTOR ECOL, V17, P515, DOI 10.1111/j.1526-100X.2008.00402.x; Kerr JT, 2007, SCIENCE, V316, P1581, DOI 10.1126/science.1133267; Knapp A.K., 1998, GRASSLAND DYNAMICS L, V1st; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Knapp AK, 2015, OECOLOGIA, V177, P949, DOI 10.1007/s00442-015-3233-6; Lackschewitz K, 1991, INT277 USDA FOR SERV; Lauenroth WK, 2006, ECOSYSTEMS, V9, P843, DOI 10.1007/s10021-005-0072-z; Lauenroth W. K., 1979, Perspectives in grassland ecology., P3; LAUENROTH WK, 1992, ECOL APPL, V2, P397, DOI 10.2307/1941874; Lavin M, 2011, GRASSES MONTANA; Lesica P, 2010, J ARID ENVIRON, V74, P1013, DOI 10.1016/j.jaridenv.2010.02.002; LONG SP, 1991, ECOL APPL, V1, P139, DOI 10.2307/1941807; Manske LL, 2001, N DAKOTA STATE U 200; McDougall W. B., 1956, PLANTS YELLOWSTONE N; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; MILTON EJ, 1987, INT J REMOTE SENS, V8, P1807, DOI 10.1080/01431168708954818; Moran MS, 2014, ECOLOGY, V95, P2121, DOI 10.1890/13-1687.1; MORRIS MELVIN S., 1957, JOUR WILDLIFE MANAGEMENT, V21, P189, DOI 10.2307/3797584; MOULTON G, 1988, J LEWIS CLARK EXPEDI; National Atmospheric Deposition Program (NADP), 2009, NADP C OCT 6 8; Nelson R. A., 1992, HDB ROCKY MOUNTAIN P; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Ortiz R. D. C., AM J BOT, V94, P1425, DOI [10.3732/ajb.94.8.1425, DOI 10.3732/AJB.94.8.1425, DOI 10.3732/AJB.94.4.55121636425]; Overpeck J, 2010, SCIENCE, V328, P1642, DOI 10.1126/science.1186591; PEARSON LC, 1965, ECOLOGY, V46, P278, DOI 10.2307/1936331; PEARSON RL, 1976, APPL OPTICS, V15, P416, DOI 10.1364/AO.15.000416; Pederson GT, 2011, SCIENCE, V333, P332, DOI 10.1126/science.1201570; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Peng J, 2012, ADV ATMOS SCI, V29, P1063, DOI 10.1007/s00376-012-1172-2; Pohl RW, 1976, KNOW GRASSES; Polley HW, 2013, RANGELAND ECOL MANAG, V66, P493, DOI 10.2111/REM-D-12-00068.1; Price C., 2009, LIGHTNING PRINCIPLES, P521, DOI [10.1007/978-1-4020-9079-0_24, DOI 10.1007/978-1-4020-9079-0_24]; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; RICKARD WH, 1985, NORTHWEST SCI, V59, P126; Robertson G.P, 1999, LONG TERM ECOLOGICAL; Romps DM, 2014, SCIENCE, V346, P851, DOI 10.1126/science.1259100; Sala OE, 2012, PHILOS T R SOC B, V367, P3135, DOI 10.1098/rstb.2011.0347; SCHMITZ OJ, 1993, OECOLOGIA, V93, P327, DOI 10.1007/BF00317874; Seager R, 2009, J CLIMATE, V22, P5021, DOI 10.1175/2009JCLI2683.1; Seastedt Timothy R., 1995, P157; Seastedt TR, 1998, GRASSLAND DYNAMICS L, P283; SHELFORD VE, 1963, ECOLOGY N AM; SMOLIAK S, 1986, J RANGE MANAGE, V39, P100, DOI 10.2307/3899276; Steinman BA, 2015, SCIENCE, V347, P988, DOI 10.1126/science.1257856; Stuart G, 2004, 40 YEARS FRONTIER; Volenec ZM, 2018, OECOLOGIA, V188, P913, DOI 10.1007/s00442-018-4247-7; West N.E., 1983, P351; Western Regional Climate Center (WRCC), DIV ATM SCI; WHITE KL, 1967, ECOLOGY, V48, P949, DOI 10.2307/1934539; Wu ZT, 2017, GLOBAL CHANGE BIOL, V17, P927; Ye JS, 2014, ECOLOGY, V95, P2109, DOI 10.1890/13-1014.1; Zhang YH, 2018, OECOLOGIA, V188, P183, DOI 10.1007/s00442-018-4208-1	98	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243496	10.1371/journal.pone.0243496	http://dx.doi.org/10.1371/journal.pone.0243496			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362217	Green Published, gold			2022-12-27	WOS:000603071600069
J	Lee, Y; Oh, D; Han, JH; Gong, HS; Lee, WW				Lee, Yohan; Oh, Dongkyu; Han, Jeong Hee; Gong, Hyun Sik; Lee, Won Woo			Semiquantitative single-photon-emission computed tomography /computed tomography study to evaluate concomitant ulnar impaction syndrome in patients presenting with triangular fibrocartilage complex tears	PLOS ONE			English	Article							STANDARDIZED UPTAKE VALUE; WRIST; SPECT/CT; REPAIR; OSTEOARTHRITIS	Introduction Patients presenting with tears of the triangular fibrocartilage complex (TFCC) can have ulnar positive variance, for which the clinical relevance to concomitant ulnar impaction syndrome (UIS) may be unclear. We hypothesized that maximum standardized uptake value (SUVmax), a semiquantitative single-photon-emission computed tomography/computed tomography (SPECT/CT) value, would distinguish between the traumatic TFCC tear and degenerative TFCC tear associated with the UIS. This study aimed to compare SUVmax between patients with TFCC tear only and patients with TFCC tear and UIS. Methods A total of 26 patients presenting with TFCC tears on magnetic resonance imaging (MRI) underwent semiquantitative SPECT/CT examinations. The diagnosis of concomitant UIS was made based on positive ulnar impaction tests and MRI findings. We compared the SUVmax between patients with and without concomitant UIS. We also calculated the cutoff value for the diagnosis of UIS using receiver operating characteristic curve analysis. Results Of 26 patients, 14 had concomitant UIS, and 12 had TFCC tears only. The SUVmax was significantly higher in patients with concomitant UIS than in those without UIS (p = 0.048). With a SUVmax cutoff value of 4.09 for UIS, sensitivity of 67% and specificity of 82% were obtained. Conclusions In the semiquantitative SPECT/CT examinations of patients with TFCC tears, those with concomitant UIS had a higher SUVmax than those without UIS. Semiquantitative SPECT/CT can be helpful in confirming concomitant UIS in patients with TFCC tears.	[Lee, Yohan] Seoul Natl Univ, Boramae Hosp, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Oh, Dongkyu; Han, Jeong Hee; Lee, Won Woo] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Nucl Med, Seoul, South Korea; [Gong, Hyun Sik] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Orthopaed Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Lee, WW (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Nucl Med, Seoul, South Korea.; Gong, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Orthopaed Surg, Seoul, South Korea.	hsgong@snu.ac.kr; wwlee@snu.ac.kr			National Research Foundation of Korea - Ministry of Education [2018R1D1A1A09081961]; Korean Society of Nuclear Medicine Clinical Trial Network (KSNM CTN) working group - Korean Society of Nuclear Medicine [KSNM-CTN-2017-0101]	National Research Foundation of Korea - Ministry of Education; Korean Society of Nuclear Medicine Clinical Trial Network (KSNM CTN) working group - Korean Society of Nuclear Medicine	This study was supported in part by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2018R1D1A1A09081961) and by the Korean Society of Nuclear Medicine Clinical Trial Network (KSNM CTN) working group funded by the Korean Society of Nuclear Medicine (KSNM-CTN-2017-0101).	[Anonymous], 2016, MEDICINE BALTIMORE, V95, pe3187; Bae S, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014022; COLEMAN DA, 1987, J BONE JOINT SURG AM, V69A, P385; DaSilva MF, 2017, J AM ACAD ORTHOP SUR, V25, pE150, DOI 10.5435/JAAOS-D-16-00407; FRIEDMAN SL, 1991, HAND CLIN, V7, P295; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Huellner MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085359; Iordache SD, 2012, J HAND SURG-AM, V37A, P98, DOI 10.1016/j.jhsa.2011.10.006; Kim J, 2017, CLIN RADIOL, V72, P580, DOI 10.1016/j.crad.2017.03.009; Meier R, 2005, Handchir Mikrochir Plast Chir, V37, P85, DOI 10.1055/s-2004-830376; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; PALMER AK, 1989, J HAND SURG-AM, V14A, P594, DOI 10.1016/0363-5023(89)90174-3; Porteous R, 2012, CAN ASSOC RADIOL J, V63, P18, DOI 10.1016/j.carj.2010.07.007; Reiter A, 2008, ARTHROSCOPY, V24, P1244, DOI 10.1016/j.arthro.2008.06.022; Ruch DS, 2005, ARTHROSCOPY, V21, P1126, DOI 10.1016/j.arthro.2005.05.024; Saha S, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120519; Schleich FS, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-53; Schmauss D, 2016, ARCH ORTHOP TRAUM SU, V136, P873, DOI 10.1007/s00402-016-2441-9; Shirley RA, 2016, J PLAST RECONSTR AES, V69, P1424, DOI 10.1016/j.bjps.2016.04.011; Strobel K, 2014, EUR J NUCL MED MOL I, V41, P548, DOI 10.1007/s00259-013-2584-7; Strzelczyk Jadwiga Jodi, 2007, J Am Coll Radiol, V4, P32, DOI 10.1016/j.jacr.2006.07.010; Suh MS, 2016, RADIOLOGY, V280, P890, DOI 10.1148/radiol.2016152294; Tatebe M, 2007, J HAND SURG-AM, V32A, P445, DOI 10.1016/j.jhsa.2007.01.013	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244256	10.1371/journal.pone.0244256	http://dx.doi.org/10.1371/journal.pone.0244256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362280	Green Published, gold			2022-12-27	WOS:000603071600053
J	Paramita, RI; Nelwan, EJ; Fadilah, F; Renesteen, E; Puspandari, N; Erlina, L				Paramita, Rafika Indah; Nelwan, Erni Juwita; Fadilah, Fadilah; Renesteen, Editha; Puspandari, Nelly; Erlina, Linda			Genome-based characterization of Escherichia coli causing bloodstream infection through next-generation sequencing	PLOS ONE			English	Article							VIRULENCE FACTORS; SPECTRUM; ST131; ENTEROBACTERIACEAE; PREVALENCE; RESISTANCE; GENE; EPIDEMIOLOGY; SURVEILLANCE; DIVERSITY	Escherichia coli are one of the commonest bacteria causing bloodstream infection (BSI). The aim of the research was to identify the serotypes, MLST (Multi Locus Sequence Type), virulence genes, and antimicrobial resistance of E. coli isolated from bloodstream infection hospitalized patients in Cipto Mangunkusumo National Hospital Jakarta. We used whole genome sequencing methods rather than the conventional one, to characterized the serotypes, MLST (Multi Locus Sequence Type), virulence genes, and antimicrobial resistance (AMR) of E. coli. The composition of E. coli sequence types (ST) was as follows: ST131 (n = 5), ST38 (n = 3), ST405 (n = 3), ST69 (n = 3), and other STs (ST1057, ST127, ST167, ST3033, ST349, ST40, ST58, ST6630). Enteroaggregative E. coli (EAEC) and Extra-intestinal pathogenic E. coli (ExPEC) groups were found dominant in our samples. Twenty isolates carried virulence genes for host cells adherence and 15 for genes that encourage E. coli immune evasion by enhancing survival in serum. ESBL-genes were present in 17 E. coli isolates. Other AMR genes also encoded resistance against aminoglycosides, quinolones, chloramphenicol, macrolides and trimethoprim. The phylogeny analysis showed that phylogroup D is dominated and followed by phylogroup B2. The E. coli isolated from 22 patients in Cipto Mangunkusumo National Hospital Jakarta showed high diversity in serotypes, sequence types, virulence genes, and AMR genes. Based on this finding, routinely screening all bacterial isolates in health care facilities can improve clinical significance. By using Whole Genome Sequencing for laboratory-based surveillance can be a valuable early warning system for emerging pathogens and resistance mechanisms.	[Paramita, Rafika Indah; Fadilah, Fadilah; Erlina, Linda] Univ Indonesia, Fac Med, Dept Med Chem, Dki Jakarta, Indonesia; [Paramita, Rafika Indah; Fadilah, Fadilah; Erlina, Linda] Univ Indonesia, Fac Med, Bioinformat Core Facil IMERI, Dki Jakarta, Indonesia; [Paramita, Rafika Indah; Fadilah, Fadilah; Erlina, Linda] Univ Indonesia, Fac Med, Masters Programme Biomed Sci, Dki Jakarta, Indonesia; [Nelwan, Erni Juwita] Univ Indonesia, Fac Med, Dept Internal Med, Dki Jakarta, Indonesia; [Nelwan, Erni Juwita; Renesteen, Editha] Univ Indonesia, Fac Med, Infect Dis & Immunol Res Ctr IMERI, Dki Jakarta, Indonesia; [Puspandari, Nelly] Minist Hlth, Natl Inst Hlth Res & Dev, Ctr Res & Dev Biomed & Basic Hlth Technol, Dki Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia; University of Indonesia; University of Indonesia; National Institute of Health Research & Development - Indonesia	Erlina, L (corresponding author), Univ Indonesia, Fac Med, Dept Med Chem, Dki Jakarta, Indonesia.; Erlina, L (corresponding author), Univ Indonesia, Fac Med, Bioinformat Core Facil IMERI, Dki Jakarta, Indonesia.; Erlina, L (corresponding author), Univ Indonesia, Fac Med, Masters Programme Biomed Sci, Dki Jakarta, Indonesia.	linda.erlina22@ui.ac.id		Renesteen, Editha/0000-0003-1635-528X; Erlina, Linda/0000-0003-1108-0600	Universitas Indonesia (Q1Q2 Grant) [NBK-0220/UN2.R3.1/HKP.05.00/2019]	Universitas Indonesia (Q1Q2 Grant)	This research was funded by Universitas Indonesia (Q1Q2 Grant; grant number NBK-0220/UN2.R3.1/HKP.05.00/2019).	Aibinu I, 2012, CLIN MICROBIOL INFEC, V18, pE49, DOI 10.1111/j.1469-0691.2011.03730.x; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; Boisen N, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008613; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boll EJ, 2013, INFECT IMMUN, V81, P1164, DOI 10.1128/IAI.01376-12; Cha MK, 2016, DIAGN MICR INFEC DIS, V84, P102, DOI 10.1016/j.diagmicrobio.2015.10.015; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Frieri M, 2017, J INFECT PUBLIC HEAL, V10, P369, DOI 10.1016/j.jiph.2016.08.007; Habouria H, 2019, VIRULENCE, V10, P568, DOI 10.1080/21505594.2019.1624102; Havt A, 2017, DIAGN MICR INFEC DIS, V89, P98, DOI 10.1016/j.diagmicrobio.2017.06.024; Herzog K, 2014, INFECTION, V42, P441, DOI 10.1007/s15010-013-0569-x; Huang WC, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00677-4; Joensen KG, 2015, J CLIN MICROBIOL, V53, P2410, DOI 10.1128/JCM.00008-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson JR, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx089; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Johnson JR, 2001, J INFECT DIS, V183, P78, DOI 10.1086/317656; Kaye KS, 2015, PHARMACOTHERAPY, V35, P949, DOI 10.1002/phar.1636; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Mandomando I, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008274; Manyahi J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2395-8; Nelwan EJ, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105631; Nguyen MCP, 2009, EMERG INFECT DIS, V15, P1648, DOI 10.3201/eid1510.090696; Noguchi N, 2000, J BACTERIOL, V182, P5052, DOI 10.1128/JB.182.18.5052-5058.2000; Olesen B, 2012, J CLIN MICROBIOL, V50, P3703, DOI 10.1128/JCM.01909-12; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Peirano G, 2010, INT J ANTIMICROB AG, V36, P19, DOI 10.1016/j.ijantimicag.2010.02.016; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2012, INFECT GENET EVOL, V12, P883, DOI 10.1016/j.meegid.2012.02.008; Roer L, 2017, J ANTIMICROB CHEMOTH, V72, P1922, DOI 10.1093/jac/dkx092; Sarowska J, 2019, GUT PATHOG, V11, DOI 10.1186/s13099-019-0290-0; Seki LM, 2013, BRAZ J INFECT DIS, V17, P640, DOI 10.1016/j.bjid.2013.03.012; Shakya M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58356-1; Sonda T, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0361-x; Storberg Viktor, 2014, Infection Ecology & Epidemiology, V4, P20342, DOI 10.3402/iee.v4.20342; Torres AG, 2009, J CLIN MICROBIOL, V47, P2442, DOI 10.1128/JCM.00566-09; Trecarichi EM, 2016, AM J HEMATOL, V91, P1076, DOI 10.1002/ajh.24489; Valenza G, 2017, VET MICROBIOL, V200, P138, DOI 10.1016/j.vetmic.2015.10.008; Xiong YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036144; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	44	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244358	10.1371/journal.pone.0244358	http://dx.doi.org/10.1371/journal.pone.0244358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362261	Green Published, gold			2022-12-27	WOS:000603071600002
J	Hayashi, T; Shibata, M; Oe, S; Miyagawa, K; Honma, Y; Harada, M				Hayashi, Tsuguru; Shibata, Michihiko; Oe, Shinji; Miyagawa, Koichiro; Honma, Yuichi; Harada, Masaru			C-reactive protein can predict dose intensity, time to treatment failure and overall survival in HCC treated with lenvatinib	PLOS ONE			English	Article							ADVANCED HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; PREOPERATIVE ELEVATION; LIVER-TRANSPLANTATION; SORAFENIB; CANCER; INTERLEUKIN-6; INFLAMMATION; EXPRESSION; PROGNOSIS	Background and aim Lenvatinib has become a first line treatment for unresectable hepatocellular carcinoma (HCC). However, continued administration is impossible in many patients due to treatment resistance and severe adverse events. This study aimed to identify predicting factors to select patients likely to benefit from lenvatinib treatment. Methods We retrospectively analyzed 53 patients who were treated with lenvatinib for unresectable HCC. They were divided to two groups; low C-reactive protein (CRP) group with pretreatment serum CRP level < 1.0 mg/dL and high CRP group with serum CRP level >= 1.0 mg/dl. Overall survival (OS), total amount administered, and period of treatment were compared between the two groups. Results The high CRP group showed a significantly poorer OS than the low CRP group (0.0% vs 71.5%/ 1year, p < 0.01). Multivariate analyses revealed that high CRP was a significant negative factor for OS (HR: 7.69, 95% confidence interval: 2.43-24.3, p < 0.001), and this result was independent of Child-Pugh score and existing tumor factors. Relative dose intensity at 8 weeks was lower (p = 0.01) and time to treatment failure was shorter (P < 0.001) in the high CRP group. Conclusions CRP level was associated with OS in HCC patients treated with lenvatinib. CRP could be a useful marker to identify patients most likely to benefit from lenvatinib treatment.	[Hayashi, Tsuguru; Shibata, Michihiko; Oe, Shinji; Miyagawa, Koichiro; Honma, Yuichi; Harada, Masaru] Univ Occupat & Environm Hlth, Dept Internal Med 3, Fukuoka, Japan	University of Occupational & Environmental Health - Japan	Hayashi, T (corresponding author), Univ Occupat & Environm Hlth, Dept Internal Med 3, Fukuoka, Japan.	haya033185@med.uoeh-u.ac.jp						Abou-Alfa GK, 2018, NEW ENGL J MED, V379, P54, DOI 10.1056/NEJMoa1717002; An HJ, 2012, LIVER TRANSPLANT, V18, P1406, DOI 10.1002/lt.23512; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bertuzzo VR, 2011, TRANSPLANTATION, V91, P1279, DOI 10.1097/TP.0b013e3182187cf0; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Bruix J, 2016, GASTROENTEROLOGY, V150, P835, DOI 10.1053/j.gastro.2015.12.041; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Fujikawa K, 1999, J UROLOGY, V162, P1934, DOI 10.1016/S0022-5347(05)68072-X; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hiraoka A, 2019, CANCER MED-US, V8, P137, DOI 10.1002/cam4.1909; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Hucke F, 2014, J HEPATOL, V61, P1287, DOI 10.1016/j.jhep.2014.07.002; Ishizuka M, 2012, AM J SURG, V203, P101, DOI 10.1016/j.amjsurg.2010.09.030; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kinoshita A, 2012, MED ONCOL, V29, P2800, DOI 10.1007/s12032-012-0220-1; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Morris-Stiff G, 2008, EJSO-EUR J SURG ONC, V34, P727, DOI 10.1016/j.ejso.2008.01.016; Nakanishi H, 2016, LIVER CANCER, V5, P257, DOI 10.1159/000449337; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Nozoe T, 2001, AM J SURG, V182, P197, DOI 10.1016/S0002-9610(01)00684-5; Nozoe T, 2003, CANCER LETT, V192, P89, DOI 10.1016/S0304-3835(02)00630-4; O'Hanlon DM, 2002, ANTICANCER RES, V22, P1289; Obi S, 2019, HEPATOL INT, V13, P199, DOI 10.1007/s12072-019-09929-4; Quintanilla-Martinez L, 2003, AM J PATHOL, V162, P1449, DOI 10.1016/S0002-9440(10)64278-2; Sasaki R, 2019, CANCERS, V11, DOI 10.3390/cancers11111769; Scott HR, 2002, BRIT J CANCER, V87, P264, DOI 10.1038/sj.bjc.6600466; Sieghart W, 2013, HEPATOLOGY, V57, P2224, DOI 10.1002/hep.26057; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Tamaki N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00357-8; Tamaki N, 2015, HEPATOL RES, V45, pE82, DOI 10.1111/hepr.12466; Tsuchiya K, 2014, CANCER-AM CANCER SOC, V120, P229, DOI 10.1002/cncr.28384; Ueno H, 2000, ONCOLOGY-BASEL, V59, P296, DOI 10.1159/000012186; Xie TX, 2006, CANCER RES, V66, P3188, DOI 10.1158/0008-5472.CAN-05-2674; Zhang M, 2018, ONCOL LETT, V16, P7158, DOI 10.3892/ol.2018.9557; Zhu AX, 2019, LANCET ONCOL, V20, P282, DOI 10.1016/S1470-2045(18)30937-9	41	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244370	10.1371/journal.pone.0244370	http://dx.doi.org/10.1371/journal.pone.0244370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351844	Green Published, gold			2022-12-27	WOS:000603071400035
J	Ishiyama, Y; Shimbo, M; Iizuka, J; Deshpande, G; Tanabe, K; Hattori, K				Ishiyama, Yudai; Shimbo, Masaki; Iizuka, Junpei; Deshpande, Gautam; Tanabe, Kazunari; Hattori, Kazunori			Association between prostate cancer characteristics and BRCA1/2-associated family cancer history in a Japanese cohort	PLOS ONE			English	Article							BREAST-CANCER; RISK; SURVIVAL; OBESITY; BRCA1	In addition to breast, ovarian, and pancreatic cancers, BRCA1/2 genes have been associated with prostate cancer (PC). However, the role of BRCA1/2-associated family cancer history (FCH) has remained unexplored in treating these four cancer types as a homogenous pathophysiological group. We aimed to clarify the relationship between BRCA1/2-associated FCH and PC, and to assess its relationship with cancer aggressiveness. Patient characteristics, positive family history of BRCA1/2-associated cancer, and cancer characteristics (Gleason score, prostate specific antigen level at diagnosis, and clinical tumor stage) were analyzed. Among the 1,985 eligible candidates, 473 (23.83%) patients had adequately detailed FCH, obtained via questionnaire, and were thus included in the study. BRCA1/2-associated FCH was observed in 135 (28.54%) patients with PC (68, 14.38%), breast (44, 9.30%), pancreatic (31, 6.55%), or ovarian (8, 1.69%) cancers. BRCA1/2-associated FCH was not significantly associated with high Gleason score (>= 8). Patients with BRCA-associated FCH were less likely to present with high clinical tumor stage, and no difference was observed in prostate-specific antigen level, presence of metastatic lesions at diagnosis, or likelihood of high-risk classification between patients with and without BRCA-associated FCH. This is the first report of BRCA1/2-associated FCH in Japanese men, indicating that family history did not affect the severity or aggressiveness of PC.	[Ishiyama, Yudai; Shimbo, Masaki; Hattori, Kazunori] St Lukes Int Hosp, Dept Urol, Tokyo, Japan; [Ishiyama, Yudai; Iizuka, Junpei; Tanabe, Kazunari] Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan; [Deshpande, Gautam] St Lukes Int Univ, Support Unit Conducting Clinically Essential Stud, Tokyo, Japan; [Deshpande, Gautam] St Lukes Int Hosp, Dept Gen Internal Med, Tokyo, Japan	St. Luke's International Hospital; Tokyo Women's Medical University; St. Luke's International Hospital; St. Luke's International Hospital	Ishiyama, Y (corresponding author), St Lukes Int Hosp, Dept Urol, Tokyo, Japan.; Ishiyama, Y (corresponding author), Tokyo Womens Med Univ, Dept Urol, Tokyo, Japan.	yuishi0831@gmail.com	Ishiyama, Yudai/AAM-7002-2021; Shimbo, Masaki/AAQ-9862-2021	Ishiyama, Yudai/0000-0002-8440-6264; 				Allott EH, 2013, EUR UROL, V63, P800, DOI 10.1016/j.eururo.2012.11.013; BASTACKY SI, 1995, J UROLOGY, V153, P987, DOI 10.1016/S0022-5347(01)67619-5; Beger C, 2004, CLIN CANCER RES, V10, P3780, DOI 10.1158/1078-0432.CCR-0992-3; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Calvocoressi L, 2018, J INVEST MED, V66, P1142, DOI 10.1136/jim-2018-000804; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; Castro E, 2015, EUR UROL, V68, P186, DOI 10.1016/j.eururo.2014.10.022; Castro E, 2013, J CLIN ONCOL, V31, P1748, DOI 10.1200/JCO.2012.43.1882; Chen YC, 2008, PROSTATE, V68, P1582, DOI 10.1002/pros.20825; de Bono J, 2020, NEW ENGL J MED, V382, P2091, DOI 10.1056/NEJMoa1911440; Epstein JI, 2014 INT SOC UR PATH; Hemminki K, 2008, J CLIN ONCOL, V26, P1705, DOI 10.1200/JCO.2007.13.3355; Hemminki K, 2012, WORLD J UROL, V30, P143, DOI 10.1007/s00345-011-0801-1; Imamoto T, 2010, UROLOGY, V76, P404, DOI 10.1016/j.urology.2009.05.084; Jeong IG, 2017, J UROLOGY, V198, P71, DOI 10.1016/j.juro.2017.01.073; Kimura T, 2018, INT J UROL, V25, P524, DOI 10.1111/iju.13593; Maier C, 2014, PROSTATE, V74, P1444, DOI 10.1002/pros.22860; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mori M, 2011, ASIAN PAC J CANCER P, V12, P743; Network N. C. C, GEN FAM HIGH RISK AS; Network NCC, 2020, PROST CANC VERS 2 20; Rodriguez C, 1998, EPIDEMIOLOGY, V9, P525, DOI 10.1097/00001648-199809000-00009; Services NCCJCfCCaI, SERV NCCJCFCCAI; Shiga Y, 2003, JPN J UROL SURG, V16, P867; Thomas JA, 2012, J INTERN MED, V272, P85, DOI 10.1111/j.1365-2796.2011.02504.x; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Yadav SS, 2018, UROL ONCOL-SEMIN ORI, V36, P349, DOI 10.1016/j.urolonc.2018.05.008	27	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244149	10.1371/journal.pone.0244149	http://dx.doi.org/10.1371/journal.pone.0244149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351846	gold, Green Published			2022-12-27	WOS:000603071400044
J	Emina, JBO; Gahungu, P; Iyese, F; Etinkum, R; Kini, B; Mobolua, JF; Boboeva, M; Kobeissi, L				Emina, Jacques B. O.; Gahungu, Parfait; Iyese, Francis; Etinkum, Rinelle; Kini, Brigitte; Mobolua, Joseph Fataki; Boboeva, Mohira; Kobeissi, Loulou			Situation analysis for delivering integrated comprehensive sexual and reproductive health services for displaced population of Kasai, Democratic Republic of Congo: Protocol for a mixed method study	PLOS ONE			English	Article								Introduction Delivering integrated sexual and reproductive health services (SRHS) in emergencies is important in order to save lives of the most vulnerable as well as to combat poverty, reduce inequities and social injustice. More than 60% of preventable maternal deaths occur in conflict areas and especially among the internally displaced persons (IDP). Between 2016 and 2018, unprecedented violence erupted in the Kasai's region, in the Democratic Republic of Congo (DRC), called the Kamuina Nsapu Insurgency. During that period, an estimated three million of adolescent girls and women were forced to flee; and have faced growing threat to their health, safety, security, and well-being including significant sexual and reproductive health challenges. Between August 2016 and May 2017, the "Sous-Cluster sur les violences basees sur le genre (SC-VBG)" in DRC (2017) reported 1,429 Gender Based Violence (GBV) incidents in the 49 service delivery points in the provinces of Kasai, Kasai Central and Kasai Oriental. Rape cases represented 79% of reported incidents whereas sexual assault and forced marriage accounted for respectively 11% and 4% of Gender Based Violence (GBV) among women and adolescent girls. This study aims to assess the availability of SRHS in the displaced camps in Kasai; to evaluate the SRHS needs of young girls and women in the reproductive age (12-49). Studies of sexual and reproductive health (SRH) in the Democratic Republic of Congo (DRC) have often included adolescent girls under the age of 15 because of high prevalence of child marriage and early onset of childbearing, especially in the humanitarian context. According to the 2013 Demographic and Health Survey (DHS), about 16% of surveyed women got married by age 14 while the prevalence of early child marriage (marriage by 15) was estimated at 30%; to assess the use of SRHS services and identify barriers as well as challenges for SRH service delivery and use. Findings from this study will help provide evidence to inform towards more needs-based and responsive SRH service delivery. This is hoped for ultimately improve the quality and effectiveness of services, when considering service delivery and response in humanitarian settings. Data and methods We will conduct a mixed-methods study design, which will combine quantitative and qualitative approaches. Based on the estimation of the sample size, quantitative data will be drawn from the community-based survey (500 women of reproductive age per site) and health facility assessments will include assessments of 45 health facilities and 135 health providers' interviews. Qualitative data will comprise materials from 30 Key Informant Interviews (KII) and 24 Focus Group Discussions (FGDs), which are believed to achieve the needed saturation levels. Data analysis will include thematic and content analysis for the KIIs and FGDs using ATLAS.ti software for the qualitative arm. For the quantitative arm, data analysis will combine frequency and bivariate chi-square analysis, coupled with multi-level regression models, using Stata 15 software. Statistic differences will be established at the significance level of 0.05. We submitted this protocol to the national ethical committee of the ministry of health in September 2019 and it was approved in January 2020. It needs further approval from the Scientific Oversee Committee (SOC) and the Provincial Ministry of Health. Prior to data collection, informed consents will be obtained from all respondents.	[Emina, Jacques B. O.; Iyese, Francis; Etinkum, Rinelle] Populat & Hlth Res Inst, Kinshasa, DEM REP CONGO; [Emina, Jacques B. O.] Univ Kinshasa, Dept Populat & Dev Studies, Kinshasa, DEM REP CONGO; [Gahungu, Parfait] Programme Natl Sante Adolescents PNSA, Kinshasa, DEM REP CONGO; [Kini, Brigitte] WHO Natl Off, Kinshasa, DEM REP CONGO; [Mobolua, Joseph Fataki] WHO DRC, Projet SR Situat Urgence Reg Kasai, Kinshasa, DEM REP CONGO; [Boboeva, Mohira] World Hlth Org HQ, Hlth Emergencies Program, Emergency Operat Dept, Global Hlth Cluster, Geneva, Switzerland; [Kobeissi, Loulou] World Hlth Org HQ, Dept Sexual & Reprod Hlth & Res SRH, UNDP UNFPA UNICEF WHO World Bank Special Program, Geneva, Switzerland	Universite de Kinshasa; World Health Organization; The World Bank; United Nations Population Fund; World Health Organization	Emina, JBO (corresponding author), Populat & Hlth Res Inst, Kinshasa, DEM REP CONGO.; Emina, JBO (corresponding author), Univ Kinshasa, Dept Populat & Dev Studies, Kinshasa, DEM REP CONGO.	Jacques.emina@gmail.com		Emina, Jacques/0000-0003-3709-1121	Department of Reproductive Health and Research (RHR), including the UNDP/UNFPA/UNICEF/WHO/World/Bank Special programme of research, development and research training in human reproduction (HRP)	Department of Reproductive Health and Research (RHR), including the UNDP/UNFPA/UNICEF/WHO/World/Bank Special programme of research, development and research training in human reproduction (HRP)	This work was funded by the Department of Reproductive Health and Research (RHR), including the UNDP/UNFPA/UNICEF/WHO/World/Bank Special programme of research, development and research training in human reproduction (HRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, ENQ DEM SANT REP DEM; Ecole de Sante Publique de Kishasa ESPK/Republique Demogratique du Congo Kinshasa/ICF, 2019, REP DEM CONG EV PRES; Hennink MM, 2019, QUAL HEALTH RES, V29, P1483, DOI 10.1177/1049732318821692; Miller Kate, 1998, CLIN BASED FAMILY PL; Republique Democratique du Congo Ministere de la Sante Publique, 2016, PLAN NAT DEV SAN 201; Sous-Cluster sur les violences basees sur le genre (SC-VBG) en Republique Democratique du Congo, 2017, RAPP EV VIOL BAS GEN; World Health Organization, HUM HLTH ACT; World Health Organization (WHO), 2019, HLTH EM DISPL POP	8	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0242046	10.1371/journal.pone.0242046	http://dx.doi.org/10.1371/journal.pone.0242046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347460	Green Published, gold			2022-12-27	WOS:000603071100063
J	Tuot, S; Teo, AKJ; Chhoun, P; Mun, P; Prem, K; Yi, SY				Tuot, Sovannary; Teo, Alvin Kuo Jing; Chhoun, Pheak; Mun, Phalkun; Prem, Kiesha; Yi, Siyan			Risk factors of HIV infection among female entertainment workers in Cambodia: Findings of a national survey	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SEX WORKERS; PHNOM-PENH; STIMULANT USE; BEHAVIORS	Background Cambodia has been well recognized for its success in the fight against the HIV epidemic. However, challenges remain in eliminating HIV infections in key populations, including women working in entertainment establishments, such as massage parlors, karaoke bars, or beer gardens. This study explored the prevalence of HIV and identified factors associated with HIV infection among female entertainment workers (FEWs) in Cambodia. Methods This national biological and behavioral survey was conducted in 2016 in Phnom Penh and 17 provinces. We used a two-stage cluster sampling method to recruit FEWs for HIV testing performed on-site and face-to-face interviews using a structured questionnaire. We investigated factors associated with HIV infection using multiple logistic regression. Results This study included 3149 FEWs with a mean age of 26.2 years (SD 5.7). The adjusted prevalence of HIV was 3.2% (95% CI 1.76-5.75). In the multiple logistic regression model, the odds of HIV infection were significantly higher among FEWs in the age group of 31 to 35 (AOR 2.72, 95% CI 1.36-8.25) and 36 or older (AOR 3.62, 95% CI 1.89-10.55); FEWs who were not married but living with a sexual partner (AOR 3.00, 95% CI 1.16-7.79); FEWs who had at least ten years of formal education (AOR 0.32, 95% CI 0.17-0.83); FEWs who reported having abnormal vaginal discharge (AOR 3.51, 95% CI 1.12-9.01), genital ulcers or sores (AOR 2.06, 95% CI 1.09-3.17), and genital warts (AOR 2.89, 95% CI 1.44-6.33) in the past three months; and FEWs who reported using illicit drugs (AOR 3.28, 95% CI 1.20-4.27) than their respective reference group. The odds of HIV infection were significantly lower among FEWs working in karaoke bars (AOR 0.26, 95% CI 0.14-0.50) and beer gardens (AOR 0.17, 95% CI 0.09-0.54) than among freelance FEWs. Conclusions The prevalence of HIV among FEWs in Cambodia remains much higher than that in the general population. These findings indicate that differentiated strategies to address HIV and other sexually transmitted infections should be geared towards FEWs working as freelancers or in veiled entertainment venues such as massage parlors and freelance sex workers. Prevention efforts among venue-based FEWs should be sustained.	[Tuot, Sovannary; Chhoun, Pheak; Yi, Siyan] KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia; [Teo, Alvin Kuo Jing; Prem, Kiesha; Yi, Siyan] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Teo, Alvin Kuo Jing; Prem, Kiesha; Yi, Siyan] Natl Univ Hlth Syst, Singapore, Singapore; [Mun, Phalkun] Natl Ctr HIV AIDS Dermatol & STD, Phnom Penh, Cambodia; [Prem, Kiesha] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England; [Yi, Siyan] Touro Univ Calif, Ctr Global Hlth Res, Vallejo, CA 94592 USA	National University of Singapore; National University of Singapore; University of London; London School of Hygiene & Tropical Medicine; Touro University California	Yi, SY (corresponding author), KHANA Ctr Populat Hlth Res, Phnom Penh, Cambodia.; Yi, SY (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Yi, SY (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.; Yi, SY (corresponding author), Touro Univ Calif, Ctr Global Hlth Res, Vallejo, CA 94592 USA.	ephsyi@nus.edu.sg	Chhoun, Pheak/AAR-3361-2021; Teo, Alvin/AAH-4516-2020	Chhoun, Pheak/0000-0001-6369-0190; Teo, Alvin/0000-0002-0569-3518	Global Fund to Fight AIDS, Tuberculosis, and Malaria through the National Center for HIV/AIDS, Dermatology, and STD; GF-New Funding Model grant (GF-NFM)	Global Fund to Fight AIDS, Tuberculosis, and Malaria through the National Center for HIV/AIDS, Dermatology, and STD; GF-New Funding Model grant (GF-NFM)	This study was funded by the Global Fund to Fight AIDS, Tuberculosis, and Malaria through the National Center for HIV/AIDS, Dermatology, and STD. The funding was part of the GF-New Funding Model grant (GF-NFM 2015-2017). KHANA Center for Population Health Research provided technical support to the study design, data collection, data analyses, and report writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received a salary from the funder.	[Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2016, J IMMUNOTHERAPY CA S, V4, P91; [Anonymous], 2014, JURNAL ILMIAH PEURAD, V2, P211; [Anonymous], 2017, B DE LIAISON, V17, P20; Bell BA, 2012, AM J PUBLIC HEALTH, V102, P1399, DOI 10.2105/AJPH.2011.300398; Brody C, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2814-6; Couture MC, 2012, DRUG ALCOHOL DEPEN, V120, P119, DOI 10.1016/j.drugalcdep.2011.07.005; Couture MC, 2011, SEX TRANSM DIS, V38, P33, DOI 10.1097/OLQ.0b013e3182000e47; Dean AG, OPENEPI OPEN SOURCE; Kim AA, 2005, SEX TRANSM DIS, V32, P745, DOI 10.1097/01.olq.0000175384.44106.be; Maher L, 2011, INT J DRUG POLICY, V22, P203, DOI 10.1016/j.drugpo.2011.01.003; Maher L, 2011, HARM REDUCT J, V8, DOI 10.1186/1477-7517-8-30; Ministry of Health, 2012, STAND OP PROC HIV TE; Ministry of Justice, 2011, LAW SUPPR HUM TRAFF; Moret JED, 2016, DRUG ALCOHOL DEPEN, V161, P171, DOI 10.1016/j.drugalcdep.2016.01.028; Mun P, 2016, NATL HIV SENTINEL SU; National Center for HIV/AIDS, 2013, ANN REP 2012; National Center for HIV/AIDS Dermatology and STD, 2014, ANN REP 2013; National Center for HIV/AIDS Dermatology and STD, 2016, ANN REP 2015; National Center for HIV/AIDS Dermatology and STD., 2011, DERM STD EST HIV PRE; National Center for HIV/AIDS Dermatology and STD (NCHADS), 2013, BEH SENT SURV BSS 20; Needle R, 2008, SOC SCI MED, V67, P1447, DOI 10.1016/j.socscimed.2008.06.031; Parcesepe AM, 2016, SEX TRANSM INFECT, V92, P593, DOI 10.1136/sextrans-2016-052549; Remple VP, 2007, SEX TRANSM DIS, V34, P754, DOI 10.1097/01.olq.0000261327.78674.cb; Sopheab H, 2003, SEX TRANSM INFECT, V79, DOI 10.1136/sti.79.4.e2; Sopheab H, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0075-y; UNAIDS and World Health Organization, 2010, GUID EST SIZ POP MOS; Vun MC, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18905; World Bank Group, 2016, NEW COUNTR CLASS INC; Yi SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198095; Yi SY, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0122-6; Yi SY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007947; Yi SY, 2015, BMC INFECT DIS, V15, DOI [10.1186/s12879-015-0954-4, 10.1186/s12889-015-2096-4]	33	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244357	10.1371/journal.pone.0244357	http://dx.doi.org/10.1371/journal.pone.0244357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347494	gold, Green Published			2022-12-27	WOS:000603071100002
J	Vojnovic, I; Ligmann-Zielinska, A; LeDoux, TF				Vojnovic, Igor; Ligmann-Zielinska, Arika; LeDoux, Timothy F.			The dynamics of food shopping behavior: Exploring travel patterns in low-income Detroit neighborhoods experiencing extreme disinvestment using agent-based modeling	PLOS ONE			English	Article							URBAN FORM; ACCESSIBILITY; INEQUALITIES; EXPLORATION; ENVIRONMENT; RESIDENTS; BURDENS	Only a handful of studies have leveraged agent-based models (ABMs) to examine public health outcomes and policy interventions associated with uneven urban food environments. While providing keen insights about the role of ABMs in studying urban food environments, these studies underutilize real-world data on individual behavior in their models. This study provides a unique contribution to the ABM and food access literature by utilizing survey data to develop an empirically-rich spatially-explicit ABM of food access. This model is used to simulate and scrutinize individual travel behavior associated with accessing food in low-income neighborhoods experiencing disinvestment in Detroit (Michigan), U.S. In particular, the relationship between trip frequencies, mode of travel, store choice, and distances traveled among individuals grouped into strata based on selected sociodemographic characteristics, including household income and age, is examined. Results reveal a diversified picture of not only how income and age shape food shopping travel but also the different thresholds of tolerance for non-motorized travel to stores. Younger and poorer population subgroups have a higher propensity to utilize non-motorized travel for shopping than older and wealthier subgroups. While all groups tend to travel considerable distances outside their immediate local food environment, different sociodemographic groups maintain unique spatial patterns of grocery-shopping behavior throughout the city and the suburbs. Overall, these results challenge foundational tenets in urban planning and design, regarding the specific characteristics necessary in the built environment to facilitate accessibility to urban amenities, such as grocery stores. In neighborhoods experiencing disinvestment, sociodemographic conditions play a more important role than the built environment in shaping food accessibility and ultimately travel behavior.	[Vojnovic, Igor] Michigan State Univ, Global Urban Studies Program, Dept Geog Environm & Spatial Sci, Sch Planning Design & Construct, E Lansing, MI 48824 USA; [Ligmann-Zielinska, Arika] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA; [LeDoux, Timothy F.] Westfield State Univ, Geog Planning & Sustainabil, Westfield, MA USA	Michigan State University; Michigan State University; Massachusetts System of Public Higher Education; Westfield State University	Vojnovic, I (corresponding author), Michigan State Univ, Global Urban Studies Program, Dept Geog Environm & Spatial Sci, Sch Planning Design & Construct, E Lansing, MI 48824 USA.	vojnovic@msu.edu	LeDoux, Timothy/ABB-9859-2021	LeDoux, Timothy/0000-0002-5556-3105	U.S. National Science Foundation, Human and Social Dynamics Program [SES 0624263]; U.S. National Science Foundation [SMA 1416730]	U.S. National Science Foundation, Human and Social Dynamics Program(National Science Foundation (NSF)); U.S. National Science Foundation(National Science Foundation (NSF))	Igor Vojnovic-U.S. National Science Foundation, Human and Social Dynamics Program Grant SES 0624263 https://urldefense.com/v3/__ https://www.nsf.gov/awardsearch/showAward? AWD_ID=0624263&HistoricalAwards=false__;!! HXCxUKc!lMcPEDM0x4hHyO4tMO8Z1PABv2IV YmTceRgSmFBB21uwakI1nGYGVFKOygs4ztGb$ The sponsors or funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Arika Ligmann-Zielinska-U.S. National Science Foundation under Grant No. SMA 1416730 https://urldefense.com/v3/__https://www.nsf.gov/awardsearch/showAward?AWD_ID=1416730__;!! HXCxUKc!lMcPEDM0x4hHyO4tMO8Z1PABv2IVY mTceRgSmFBB21uwakI1nGYGVFKOyil-R9Mb$ The sponsors or funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel KC, 2020, SUSTAIN CITIES SOC, V52, DOI 10.1016/j.scs.2019.101795; [Anonymous], 2018, EFSA J, V3, P4; [Anonymous], 2002, APPL DEMOGRAPHY; Auchincloss AH, 2011, AM J PREV MED, V40, P303, DOI 10.1016/j.amepre.2010.10.033; Badland H, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-58; Blok DJ, 2015, AM J PREV MED, V49, P605, DOI 10.1016/j.amepre.2015.03.042; Census 2010 Census Redistricting Data, 2011, CENS 2010 CEN RED DA; Census American Community Survey 2006-2010 (5-year estimates), 2010, CENS AM COMM SURV 20; Census Census, 2000, SUMM FIL 1; Census Census of Population: 1950, 1950, CENS CENS POP 1950; Census Census of Wholesale Trade, 1967, CENS CENS WHOL TRAD; Census Selected Economic Characteristics  2014-2018 American Community 5-Year Estimates Table DP03, 2018, CENS SEL EC CHAR 201; Center for Shared Solutions, 2020, MICH OPEN GIS DAT PO; Eckert J, 2017, APPL GEOGR, V89, P41, DOI 10.1016/j.apgeog.2017.09.011; Edmonds B., 2003, JASSS-J ARTIF SOC S, V6, P4; Farrell D., 2020, EARLY IMPACT COVID 1; Giabbanelli PJ, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/5742629; Grimm V., 2017, DOCUMENTING SOCIAL S, P349; Grimm V, 2020, JASSS-J ARTIF SOC S, V23, DOI 10.18564/jasss.4259; Groves R. M., 2012, NONRESPONSE HOUSEHOL; Hollander J, 2019, ENVIRON PLAN B-URBAN, V46, P963, DOI 10.1177/2399808317743971; Johnston J, 2008, THEOR SOC, V37, P229, DOI 10.1007/s11186-007-9058-5; Koh K, 2019, FOOD SECUR, V11, P317, DOI 10.1007/s12571-019-00900-7; Kotval-K Z, 2016, ECOL ECON, V128, P87, DOI 10.1016/j.ecolecon.2016.04.009; Kotval-K Z, 2015, TRANSPORT RES D-TR E, V41, P477, DOI 10.1016/j.trd.2015.10.017; Kurth J., 2013, THE DETROIT NEWS; Laitner B., 2015, HEART SOLE DETROITER; Lawrence Craig., 2020, GURKHA 25 YEARS ROYA; Ledoux TF, 2017, TIJDSCHR ECON SOC GE, V108, P605, DOI 10.1111/tesg.12227; LeDoux TF, 2013, HEALTH PLACE, V19, P1, DOI 10.1016/j.healthplace.2012.09.010; Lee J, 2018, URBAN STUD, V55, P2470, DOI 10.1177/0042098017730521; Ligmann-Zielinska A G.S., 2016, HDB APPL SYSTEM SCI, P49, DOI 10.1080/1747423X.2015.1030463; Mehryar S., 2020, ADV SOCIAL SIMULATIO, P307; Michas S, 2020, ENERG POLICY, V139, DOI 10.1016/j.enpol.2020.111350; Mui Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216985; Nianogo RA, 2015, AM J PUBLIC HEALTH, V105, pE20, DOI 10.2105/AJPH.2014.302426; Rouchier J, 2008, JASSS-J ARTIF SOC S, V11; Smajgl A, 2011, ENVIRON MODELL SOFTW, V26, P837, DOI 10.1016/j.envsoft.2011.02.011; Sohi I, 2014, J NUTR EDUC BEHAV, V46, P241, DOI 10.1016/j.jneb.2013.12.006; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Steven Manson, 2020, PUMS NATL HIST GEOGR, DOI 10.18128/D050.V15.0; Tracy M, 2018, ANNU REV PUBL HEALTH, V39, P77, DOI 10.1146/annurev-publhealth-040617-014317; U.S. Bureau of the Census, 2020, ANN 2019 CHARCT NEW; United States Census Bureau, 2010, SUMM FIL 1; Vojnovic I, 2000, ENVIRON PLANN B, V27, P197, DOI 10.1068/b2620; Vojnovic I, 2006, GEOGR ANN B, V88B, P67, DOI 10.1111/j.0435-3684.2006.00206.x; Vojnovic I., 2019, HDB GLOBAL URBAN HLT; Vojnovic I., 2013, URBAN SUSTAINABILITY; Vojnovic I, 2013, J URBAN DES, V18, P1, DOI 10.1080/13574809.2012.683403; Vojnovic I, 2014, J URBAN AFF, V36, P225, DOI 10.1111/juaf.12031; Vojnovic I, 2013, ECOL ECON, V96, P88, DOI 10.1016/j.ecolecon.2013.10.007; Walker RE, 2010, HEALTH PLACE, V16, P876, DOI 10.1016/j.healthplace.2010.04.013; Widener MJ, 2013, APPL GEOGR, V40, P1, DOI 10.1016/j.apgeog.2013.01.003; Yang Y, 2019, TRANSL BEHAV MED, V9, P1065, DOI 10.1093/tbm/iby132; Yang Y, 2012, AM J PREV MED, V43, P11, DOI 10.1016/j.amepre.2012.03.015; Yang Y, 2012, HEALTH PLACE, V18, P96, DOI 10.1016/j.healthplace.2011.08.010; Zimowski M., 1997, NONRESPONSE HOUSEHOL	57	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243501	10.1371/journal.pone.0243501	http://dx.doi.org/10.1371/journal.pone.0243501			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347464	gold, Green Published			2022-12-27	WOS:000603071100006
J	Werner, A; Molling, P; Fagerstrom, A; Dyrkell, F; Arnellos, D; Johansson, K; Sundqvist, M; Noren, T				Werner, Anders; Molling, Paula; Fagerstrom, Anna; Dyrkell, Fredrik; Arnellos, Dimitrios; Johansson, Karin; Sundqvist, Martin; Noren, Torbjorn			Whole genome sequencing of Clostridioides difficile PCR ribotype 046 suggests transmission between pigs and humans	PLOS ONE			English	Article							INFECTION; EVOLUTION; BURDEN	Background A zoonotic association has been suggested for several PCR ribotypes (RTs) of Clostridioides difficile. In central parts of Sweden, RT046 was found dominant in neonatal pigs at the same time as a RT046 hospital C. difficile infection (CDI) outbreak occurred in the southern parts of the country. Objective To detect possible transmission of RT046 between pig farms and human CDI cases in Sweden and investigate the diversity of RT046 in the pig population using whole genome sequencing (WGS). Methods WGS was performed on 47 C. difficile isolates from pigs (n = 22), the farm environment (n = 7) and human cases of CDI (n = 18). Two different core genome multilocus sequencing typing (cgMLST) schemes were used together with a single nucleotide polymorphisms (SNP) analysis and the results were related to time and location of isolation of the isolates. Results The pig isolates were closely related (<= 6 cgMLST alleles differing in both cgMLST schemes) and conserved over time and were clearly separated from isolates from the human hospital outbreak (>= 76 and >= 90 cgMLST alleles differing in the two cgMLST schemes). However, two human isolates were closely related to the pig isolates, suggesting possible transmission. The SNP analysis was not more discriminate than cgMLST. Conclusion No general pattern suggesting zoonotic transmission was apparent between pigs and humans, although contrasting results from two isolates still make transmission possible. Our results support the need for high resolution WGS typing when investigating hospital and environmental transmission of C. difficile.	[Werner, Anders] Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Region Vastra G, Sweden; [Molling, Paula; Fagerstrom, Anna; Johansson, Karin; Sundqvist, Martin; Noren, Torbjorn] Orebro Univ, Fac Med & Hlth, Natl Reference Lab Clostridioides Difficile, Dept Lab Med,Clin Microbiol, Orebro, Sweden; [Dyrkell, Fredrik; Arnellos, Dimitrios] 1928 Diagnost, Gothenburg, Sweden	Sahlgrenska University Hospital; Orebro University	Werner, A (corresponding author), Sahlgrens Univ Hosp, Dept Clin Microbiol, Gothenburg, Region Vastra G, Sweden.	anders.e.werner@gmail.com			Research Committee of Region Orebro County [OLL-674241]	Research Committee of Region Orebro County	K.J., P.M., T.N. and M.S. has received funding for this study from the Research Committee of Region Orebro County (grant OLL-674241). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript. D.A. and F.D. employees of 1928 Diagnostics. 1928 Diagnostics provided support in the form of salaries for D.A. and F.D. and made the analysis available for free, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Balsells E, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010407; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bletz S, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01987-17, 10.1128/jcm.01987-17]; Cairns MD, 2017, J CLIN MICROBIOL, V55, P865, DOI 10.1128/JCM.01296-16; de Been M, 2015, J CLIN MICROBIOL, V53, P3788, DOI 10.1128/JCM.01946-15; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Dominguez SR, 2016, J PEDIAT INF DIS SOC, V5, P329, DOI 10.1093/jpids/piv020; Eyre DW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01037-19; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Eyre DW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001124; Garrison E, 2012, HAPLOTYPE BASED VARI; Knetsch CW, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01384-17; Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954; Knetsch CW, 2013, EUROSURVEILLANCE, V18, P57; Knight DR, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02138; Knight DR, 2015, CLIN MICROBIOL REV, V28, P721, DOI 10.1128/CMR.00127-14; Koene MGJ, 2012, CLIN MICROBIOL INFEC, V18, P778, DOI 10.1111/j.1469-0691.2011.03651.x; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Li H., 2013, ARXIV13033997 Q BIO; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linkevicius M, 2019, EUROSURVEILLANCE, V24, P7, DOI 10.2807/1560-7917.ES.2019.24.49.1900681; Munoz M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47688-2; Noren T, 2014, CLIN MICROBIOL INFEC, V20, pO2, DOI 10.1111/1469-0691.12296; Obuch-Woszczatynski P, 2013, EUR J CLIN MICROBIOL, V32, P1027, DOI 10.1007/s10096-013-1845-5; Pearce ME, 2018, INT J FOOD MICROBIOL, V274, P1, DOI 10.1016/j.ijfoodmicro.2018.02.023; Plaza-Garrido A, 2016, EPIDEMIOL INFECT, V144, P976, DOI 10.1017/S0950268815002459; Rizzardi K, 2018, EMERG INFECT DIS, V24, P1617, DOI 10.3201/eid2409.171658; Schurch AC, 2018, CLIN MICROBIOL INFEC, V24, P350, DOI 10.1016/j.cmi.2017.12.016; Tian TT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151964; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Yaeger M, 2002, J VET DIAGN INVEST, V14, P281, DOI 10.1177/104063870201400402; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244227	10.1371/journal.pone.0244227	http://dx.doi.org/10.1371/journal.pone.0244227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347506	Green Published, gold			2022-12-27	WOS:000603071100046
J	Wagner, A; Zuniga, F; Ruesch, P; Schaffert, R; Dratva, J				Wagner, Aylin; Zuniga, Franziska; Ruesch, Peter; Schaffert, Rene; Dratva, Julia		HCD Res Grp	Selecting home care quality indicators based on the Resident Assessment Instrument-Home Care (RAI-HC) for Switzerland: A public health and healthcare providers' perspective	PLOS ONE			English	Article							URGENCY URINARY-INCONTINENCE; CLINICAL INDICATORS; ECONOMIC BURDEN; OF-CARE; GUIDE	Background Despite an increasing importance of home care, quality assurance in this healthcare sector in Switzerland is hardly established. In 2010, Swiss home care quality indicators (QIs) based on the Resident Assessment Instrument-Home Care (RAI-HC) were developed. However, these QIs have not been revised since, although internationally new RAI-HC QIs have emerged. The objective of this study was to assess the appropriateness of RAI-HC QIs to measure quality of home care in Switzerland from a public health and healthcare providers' perspective. Methods First, the appropriateness of RAI-HC QIs, identified in a recent systematic review, was assessed by a multidisciplinary expert panel based on the RAND/UCLA Appropriateness Method taking into account indicators' public health relevance, potential of influence, and comprehensibility. Second, the QIs selected by the experts were afterwards rated regarding their relevance, potential of influence, and practicability from a healthcare providers' perspective in focus groups with home care nurses based on the Nominal-Group-Technique. Data were analyzed using median scores and the Disagreement Index. Results 18 of 43 RAI-HC QIs were rated appropriate by the experts from a public health perspective. The 18 QIs cover clinical, psychosocial, functional and service use aspects. Seven of the 18 QIs were subsequently rated appropriate by home care nurses from a healthcare providers' perspective. The focus of these QIs is narrow, because three of seven QIs are pain-related. From both perspectives, the majority of RAI-HC QIs were rated inappropriate because of insufficient potential of influence, with healthcare providers rating them more critically. Conclusions The study shows that the appropriateness of RAI-HC QIs differs according to the stakeholder perspective and the intended use of QIs. The findings of this study can guide policy-makers and home care organizations on selecting QIs and to critically reflect on their appropriate use.	[Wagner, Aylin; Ruesch, Peter; Schaffert, Rene; Dratva, Julia] ZHAW Zurich Univ Appl Sci, Inst Hlth Sci, Sch Hlth Profess, Winterthur, Switzerland; [Wagner, Aylin] Univ Lucerne, Dept Hlth Sci & Med, Luzern, Switzerland; [Zuniga, Franziska] Univ Basel, Inst Nursing Sci, Dept Publ Hlth, Basel, Switzerland; [Dratva, Julia] Univ Basel, Med Fac, Basel, Switzerland	Zurich University of Applied Sciences; University of Lucerne; University of Basel; University of Basel	Wagner, A (corresponding author), ZHAW Zurich Univ Appl Sci, Inst Hlth Sci, Sch Hlth Profess, Winterthur, Switzerland.; Wagner, A (corresponding author), Univ Lucerne, Dept Hlth Sci & Med, Luzern, Switzerland.	aylin.wagner@zhaw.ch	Zúñiga, Franziska/AFH-1194-2022	Zúñiga, Franziska/0000-0002-8844-4903; Wagner, Aylin/0000-0002-6683-5671	Swiss National Science Foundation (SNSF) [167499]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation (SNSF), National Research Program 74 "Smarter Health Care", Project "Swiss Home Care Data: patient profiles and quality measures for home care" (No. 167499). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai SMH, 2005, CAN MED ASSOC J, V172, P773, DOI 10.1503/cmaj.1031527; Anliker M, 2015, Z GERONTOL GERIATR, V48, P114, DOI 10.1007/s00391-015-0864-5; [Anonymous], 2018, LANCET DIABETES ENDO, V6, P1, DOI DOI 10.1080/08927022.2018.1510179; Attree M, 1996, INT J NURS STUD, V33, P13, DOI 10.1016/0020-7489(95)00049-6; Becker M, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0918-y; Bitton A, 2019, INFLAMM BOWEL DIS, V25, P403, DOI 10.1093/ibd/izy259; Blumenthal D, 1996, NEW ENGL J MED, V335, P891, DOI 10.1056/NEJM199609193351213; Borglin G, 2020, INT J OLDER PEOPLE N, V15, DOI 10.1111/opn.12275; Burla L, 2010, GESUNDHEITSWESEN, V72, P106, DOI 10.1055/s-0029-1233474; Campbell SM, 2002, QUAL SAF HEALTH CARE, V11, P358, DOI 10.1136/qhc.11.4.358; Center for Health Policy/Center for Primary Care and Outcomes Research and Battelle Memorial Institute, 2011, AG HEALTHC RES QUAL; Coyne KS, 2014, J MANAGE CARE PHARM, V20, P130, DOI 10.18553/jmcp.2014.20.2.130; Dalby DM, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-7; de Boer ME, 2007, INT PSYCHOGERIATR, V19, P1021, DOI 10.1017/S1041610207005765; Delbecq AL, 1975, J HUMAN SCI; Derose SF, 2002, ANNU REV PUBL HEALTH, V23, P1, DOI 10.1146/annurev.publhealth.23.092601.095644; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Donnelly C, 2019, PRIM HEALTH CARE RES, V20, DOI 10.1017/S1463423619000409; El-Hayek YH, 2019, J ALZHEIMERS DIS, V70, P321, DOI 10.3233/JAD-190426; Federal Statistical Office (FSO), 2020, HILF PFLEG HAUS 2019; Fitch K., 2001, RAND UCLA APPROPRIAT; Florence CS, 2018, J AM GERIATR SOC, V66, P693, DOI 10.1111/jgs.15304; Hirdes JP, 2004, GERONTOLOGIST, V44, P665, DOI 10.1093/geront/44.5.665; Hughes, 2008, PATIENT SAFETY QUALI; Hunter KF, 2018, NURSING-RES REV, V8, P1, DOI 10.2147/NRR.S144356; Institute of Medicine (US) Committee to Design a Strategy for Quality Review and Assurance in Medicare, 1990, COMM DES STRAT QUAL, DOI [10.17226/1547, DOI 10.17226/1547]; Jones RN, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-96; Junger S, 2017, PALLIATIVE MED, V31, P684, DOI 10.1177/0269216317690685; KANE RA, 1994, HEALTH CARE FINANC R, V16, P69; Koenders N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032208; Kotter T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-21; Kredo T, 2016, INT J QUAL HEALTH C, V28, P122, DOI 10.1093/intqhc/mzv115; Lehnert T, 2019, AGEING SOC, V39, P1873, DOI 10.1017/S0144686X18000314; Lorini C, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2828-0; Lynn MR, 2007, J NURS CARE QUAL, V22, P328, DOI 10.1097/01.NCQ.0000290414.42640.c0; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; Marshall MN, 2003, QUAL SAF HEALTH CARE, V12, P8, DOI 10.1136/qhc.12.1.8; McCorry NK, 2019, PALLIATIVE MED, V33, P197, DOI 10.1177/0269216318810601; Milsom I, 2014, EUR UROL, V65, P79, DOI 10.1016/j.eururo.2013.08.031; Morris JN, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-127; Mosadeghrad AM, 2013, INT J HEALTH CARE Q, V26, P203, DOI 10.1108/09526861311311409; Mundi MS, 2018, CLIN INTERV AGING, V13, P1353, DOI 10.2147/CIA.S134919; National Guideline Alliance (UK), 2019, UR INC PELV ORG PROL; Orrell A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002926; Parast L, 2015, J GEN INTERN MED, V30, P359, DOI 10.1007/s11606-014-3150-0; Reeves S, 2010, J INTERPROF CARE, V24, P230, DOI 10.3109/13561820903163405; Reinhard, 2008, PATIENT SAFETY QUALI; Spackman E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210794; Spitex Schweiz, 2020, EINS SPIT; Staines A, 2019, ENHANCING QUALITY SA, DOI [10.13140/RG.2.2.22966.04160, DOI 10.13140/RG.2.2.22966.04160]; Stelfox HT, 2013, J CLIN EPIDEMIOL, V66, P1320, DOI 10.1016/j.jclinepi.2013.05.018; Suhr R, 2018, AGING CLIN EXP RES, V30, P589, DOI 10.1007/s40520-017-0816-6; Supper I, 2015, J PUBLIC HEALTH-UK, V37, P716, DOI 10.1093/pubmed/fdu102; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tsakitzidis G, 2016, INT J INTEGR CARE, V16, DOI 10.5334/ijic.2017; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Wagner A, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05238-x; Wollersheim H, 2007, NETH J MED, V65, P15; Woolf S, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-61; Yajima N, 2020, MOD RHEUMATOL, V30, P525, DOI 10.1080/14397595.2019.1621419	60	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244577	10.1371/journal.pone.0244577	http://dx.doi.org/10.1371/journal.pone.0244577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378348	gold, Green Accepted, Green Published			2022-12-27	WOS:000605651300047
J	Wetzel, M; Vanhoutte, B				Wetzel, Martin; Vanhoutte, Bram			Putting cumulative (dis)advantages in context: Comparing the role of educational inequality in later-life functional health trajectories in England and Germany	PLOS ONE			English	Article							SELF-RATED HEALTH; SOCIOECONOMIC INEQUALITIES; DEPRESSIVE SYMPTOMS; EUROPEAN COUNTRIES; COHORT VARIATIONS; ADULT DEVELOPMENT; AGE-TRAJECTORIES; OLDER-PEOPLE; SOCIAL-CLASS; DISPARITIES	Background The cumulative (dis)advantage (CAD) perspective more and more is examined in a comparative way, to highlight the role of context in generating inequality over the life course. This study adds to this field of research by examining trajectories of activities of daily living (ADL) in later life by educational level in a country comparison of England and Germany, emphasizing differing institutional conditions. Method Data used are the English Longitudinal Study of Ageing (ELSA; 11,352 individuals) and the German subsample of the Survey of Health and Retirement in Europe (SHARE; 5,573 individuals). Using population averaged Poisson panel regression models, 12-year trajectories of six birth cohorts are investigated, covering the age range of 50 to 90 years. Results Respondents in England have a higher level of limitations at age 50, and more limited increases over age than in Germany. An educational gradient exists in both countries at age 50. Notably, the educational gradient increases for more recently born cohorts, but declines with increasing age in England, while in Germany educational differences increase for more recently born cohort only. Discussion The current study indicates that CAD processes between educational groups are context sensitive. While England showed convergence of disparities with increasing age, in Germany no differential development was found.	[Wetzel, Martin] Univ Cologne, Cologne, Germany; [Vanhoutte, Bram] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Vanhoutte, Bram] Univ Manchester, Dept Sociol, Manchester, Lancs, England	University of Cologne; Universite Libre de Bruxelles; University of Manchester	Wetzel, M (corresponding author), Univ Cologne, Cologne, Germany.	wetzel@wiso.uni-koeln.de		Wetzel, Martin/0000-0002-9206-0224	Excellence Initiative of University of Cologne; fRaill project as part of the cross research council Life Long Health and Wellbeing programme [MRC G1001375/1]; Simon Fellowship of the University of Manchester; Derby Fellowship of the University of Liverpool; German Research Foundation (DFG)	Excellence Initiative of University of Cologne; fRaill project as part of the cross research council Life Long Health and Wellbeing programme; Simon Fellowship of the University of Manchester; Derby Fellowship of the University of Liverpool; German Research Foundation (DFG)(German Research Foundation (DFG))	Major parts of this work originated during a research stay of Martin Wetzel at the Cathie Marsh Institute of the University of Manchester which was supported by a mobility grant of the Excellence Initiative of University of Cologne. Martin Wetzel is currently working in the pairfamproject which is funded by the German Research Foundation (DFG). Bram Vanhoutte was funded by the fRaill project (grant MRC G1001375/1) as part of the cross research council Life Long Health and Wellbeing programme, and was supported by a Simon Fellowship of the University of Manchester, as well as a Derby Fellowship of the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, DAT EXPL VERS 2 0; Bambra C, 2007, J EPIDEMIOL COMMUN H, V61, P1098, DOI 10.1136/jech.2007.064295; Bambra C, 2005, SOC POLICY SOC, V4, P31, DOI 10.1017/S1474746404002143; Bambra C, 2010, INT J HEALTH SERV, V40, P399, DOI 10.2190/HS.40.3.b; Bank TW, 2020, PHYS PER 1 000 PEOPL; Beckfield J, 2013, ANNU REV SOCIOL, V39, P127, DOI 10.1146/annurev-soc-071312-145609; Bell A, 2014, SOC SCI MED, V120, P21, DOI 10.1016/j.socscimed.2014.09.008; Bell DNF, 2011, OXFORD REV ECON POL, V27, P241, DOI 10.1093/oxrep/grr011; Bergmann M, 2019, SHARE WORKING PAPER; Blossfeld PN, 2015, EUR SOCIOL REV, V31, P144, DOI 10.1093/esr/jcv017; Boen C, 2016, SOC SCI MED, V170, P63, DOI 10.1016/j.socscimed.2016.10.008; Borsch-Supan A, 2013, INT J EPIDEMIOL, V42, P992, DOI 10.1093/ije/dyt088; Brailean A, 2018, J GERONTOL B-PSYCHOL, V73, P1214, DOI 10.1093/geronb/gbw129; Brault MC, 2012, SOC PSYCH PSYCH EPID, V47, P903, DOI 10.1007/s00127-011-0398-0; Broadberry S, 2007, WORK PAY 20 CENTURY, P301; Brown TH, 2012, J HEALTH SOC BEHAV, V53, P359, DOI 10.1177/0022146512455333; Cambois E, 2016, J EPIDEMIOL COMMUN H, V70, P331, DOI 10.1136/jech-2015-205978; Chen FN, 2010, AM SOCIOL REV, V75, P126, DOI 10.1177/0003122409359165; Cheng SW, 2014, AM J SOCIOL, V120, P633, DOI 10.1086/679103; Cheshire H, 2011, LONGITUD LIFE COURSE, V2, P127; Conti G, 2010, AM ECON REV, V100, P234, DOI 10.1257/aer.100.2.234; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P75, DOI 10.1093/geronb/gbq088; Cullati S, 2015, SOCIOL HEALTH ILL, V37, P745, DOI 10.1111/1467-9566.12232; Dannefer D, 2003, J GERONTOL B-PSYCHOL, V58, pS327, DOI 10.1093/geronb/58.6.S327; DANNEFER D, 1984, AM SOCIOL REV, V49, P100, DOI 10.2307/2095560; Salinas-Jimenez MD, 2011, SOC INDIC RES, V103, P409, DOI 10.1007/s11205-010-9709-1; Dewilde C, 2017, INT J SOC WELF, V26, P384, DOI 10.1111/ijsw.12261; Drewelies J, 2019, PSYCHOL AGING, V34, P1021, DOI 10.1037/pag0000423; Elder GH, 2003, HDB LIFE COURSE, P3, DOI DOI 10.1007/978-0-306-48247-2_1; Elo IT, 2009, ANNU REV SOCIOL, V35, P553, DOI 10.1146/annurev-soc-070308-115929; Esping-Andersen G., 1990, 3 WORLDS WELFARE CAP; Eurostat, 2020, HEALTHC EXP STAT; Ferraro KF, 2016, AM SOCIOL REV, V81, P107, DOI 10.1177/0003122415619617; Ferraro KennethF., 2009, HDB THEORIES AGING, V2nd ed, P413; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Haas S, 2010, SOC SCI MED, V70, P240, DOI 10.1016/j.socscimed.2009.10.003; Haas SA, 2018, SOC SCI MED, V213, P123, DOI 10.1016/j.socscimed.2018.07.047; Haas SA, 2017, DEMOGRAPHY, V54, P2043, DOI 10.1007/s13524-017-0624-9; Hu Y, 2016, J EPIDEMIOL COMMUN H, V70, P1128, DOI 10.1136/jech-2015-206548; Huisman M, 2003, SOC SCI MED, V57, P861, DOI 10.1016/S0277-9536(02)00454-9; Jackson MI, 2015, J HEALTH SOC BEHAV, V56, P262, DOI 10.1177/0022146515581857; Jivraj S, 2014, J GERONTOL B-PSYCHOL, V69, P930, DOI 10.1093/geronb/gbu006; Jurges H, 2010, APPL ECON LETT, V17, P87, DOI 10.1080/13504850701719835; KALMIJN M, 1991, AM J SOCIOL, V97, P496, DOI 10.1086/229786; Leopold L, 2019, DEMOGRAPHY, V56, P763, DOI 10.1007/s13524-019-00761-x; Leopold L, 2018, DEMOGRAPHY, V55, P901, DOI 10.1007/s13524-018-0674-7; Leopold L, 2018, J HEALTH SOC BEHAV, V59, P94, DOI 10.1177/0022146517751206; Leopold L, 2016, J HEALTH SOC BEHAV, V57, P257, DOI 10.1177/0022146516645926; Leopold L, 2013, INT J PUBLIC HEALTH, V58, P23, DOI 10.1007/s00038-012-0399-0; Liang J, 2010, J AGING HEALTH, V22, P3, DOI 10.1177/0898264309348877; Lin JL, 2020, J GERONTOL B-PSYCHOL, V75, P1082, DOI 10.1093/geronb/gby156; Lu WT, 2021, AGEING SOC, V41, P1495, DOI 10.1017/S0144686X19001740; Lynch SM, 2003, DEMOGRAPHY, V40, P309, DOI 10.2307/3180803; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Marmot M, 2017, UK DATA SERVICE; Marshall A, 2015, J EPIDEMIOL COMMUN H, V69, P316, DOI 10.1136/jech-2014-204655; McDonough P, 2015, ADV LIFE COURSE RES, V25, P49, DOI 10.1016/j.alcr.2015.05.004; McDonough P, 2010, SOC SCI MED, V70, P251, DOI 10.1016/j.socscimed.2009.10.001; Mirowsky J, 2008, RES AGING, V30, P93, DOI 10.1177/0164027507309649; Mirowsky J, 2007, SOCIOL METHOD RES, V35, P497, DOI 10.1177/0049124106296015; Muthen L. K., 2010, MPLUS USERS GUIDE 6; OECD.Stat, 2020, OECD STAT DAT; Pais J, 2014, DEMOGRAPHY, V51, P1729, DOI 10.1007/s13524-014-0330-9; Palier B, 2007, SOC POLICY ADMIN, V41, P535, DOI 10.1111/j.1467-9515.2007.00571.x; Palier B, 2010, CHANG WELF STATE, P333; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; RILEY MW, 1987, AM SOCIOL REV, V52, P1, DOI 10.2307/2095388; RYDER NB, 1965, AM SOCIOL REV, V30, P843, DOI 10.2307/2090964; Sacker A, 2011, J EPIDEMIOL COMMUN H, V65, P130, DOI 10.1136/jech.2009.091199; Salata A, 2019, BRIT J SOCIOL EDUC, V40, P410, DOI 10.1080/01425692.2018.1552846; Schaan B, 2014, SOC SCI MED, V102, P94, DOI 10.1016/j.socscimed.2013.11.049; Schollgen I, 2010, EUR J AGEING, V7, P17, DOI 10.1007/s10433-010-0140-x; Shrira A, 2014, J GERONTOL B-PSYCHOL, V69, P953, DOI 10.1093/geronb/gbu056; Shuey KM, 2008, RES AGING, V30, P200, DOI 10.1177/0164027507311151; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Spence NJ, 2011, J HEALTH SOC BEHAV, V52, P444, DOI 10.1177/0022146511410432; Van Deurzen I, RES AGING; Vanhoutte B, 2016, J POPUL AGEING, V9, P157, DOI 10.1007/s12062-015-9127-x; Warner DF, 2011, SOC SCI MED, V72, P1236, DOI 10.1016/j.socscimed.2011.02.034; Willson AE, 2007, AM J SOCIOL, V112, P1886, DOI 10.1086/512712; Wu YT, 2020, LANCET PUBLIC HEALTH, V5, pE386, DOI 10.1016/S2468-2667(20)30077-3; Xu X, 2015, J GERONTOL B-PSYCHOL, V70, P661, DOI 10.1093/geronb/gbu095; Yang Y, 2011, HDB AGING SOCIAL SCI, V7th; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16, DOI 10.1177/002214650704800102; Yang Y, 2010, J GERONTOL B-PSYCHOL, V65, P246, DOI 10.1093/geronb/gbp102; Yang Y, 2009, SOC FORCES, V87, P2093, DOI 10.1353/sof.0.0183; Zaninotto P, 2018, J EPIDEMIOL COMMUN H, V72, P685, DOI 10.1136/jech-2017-210116; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	88	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244371	10.1371/journal.pone.0244371	http://dx.doi.org/10.1371/journal.pone.0244371			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378335	gold, Green Published			2022-12-27	WOS:000605651300050
J	Njagi, P; Arsenijevic, J; Groot, W				Njagi, Purity; Arsenijevic, Jelena; Groot, Wim			Decomposition of changes in socioeconomic inequalities in catastrophic health expenditure in Kenya	PLOS ONE			English	Article							SECTOR	Background Catastrophic health expenditure (CHE) is frequently used as an indicator of financial protection. CHE exists when health expenditure exceeds a certain threshold of household consumption. Although CHE is reported to have declined in Kenya, it is still unacceptably high and disproportionately affects the poor. This study examines the socioeconomic factors that contribute to inequalities in CHE as well as the change in these inequalities over time in Kenya. Methods We used data from the Kenya household health expenditure and utilisation (KHHEUS) surveys in 2007 and 2013. The concertation index was used to measure the socioeconomic inequalities in CHE. Using the Wagstaff (2003) approach, we decomposed the concentration index of CHE to assess the relative contribution of its determinants. We applied Oaxaca-type decomposition to assess the change in CHE inequalities over time and the factors that explain it. Results The findings show that while there was a decline in the incidence of CHE, inequalities in CHE increased from -0.271 to -0.376 and was disproportionately concentrated amongst the less well-off. Higher wealth quintiles and employed household heads positively contributed to the inequalities in CHE, suggesting that they disadvantaged the poor. The rise in CHE inequalities overtime was explained mainly by the changes in the elasticities of the household wealth status. Conclusion Inequalities in CHE are persistent in Kenya and are largely driven by the socioeconomic status of the households. This implies that the existing financial risk protection mechanisms have not been sufficient in cushioning the most vulnerable from the financial burden of healthcare payments. Understanding the factors that sustain inequalities in CHE is, therefore, paramount in shaping pro-poor interventions that not only protect the poor from financial hardship but also reduce overall socioeconomic inequalities. This underscores the fundamental need for a multi-sectoral approach to broadly address existing socioeconomic inequalities.	[Njagi, Purity; Groot, Wim] Maastricht Univ, United Nations Univ, Maastricht Grad Sch Governance, MERIT, Maastricht, Netherlands; [Arsenijevic, Jelena] Univ Utrecht, Sch Governance, Fac Law Econ & Governance, Utrecht, Netherlands; [Groot, Wim] Maastricht Univ, Dept Hlth Serv Res, Fac Hlth Med & Life Sci, Maastricht, Netherlands	Maastricht University; Utrecht University; Maastricht University	Njagi, P (corresponding author), Maastricht Univ, United Nations Univ, Maastricht Grad Sch Governance, MERIT, Maastricht, Netherlands.	p.njagi@student.maastrichtuniversity.nl		Njagi, Purity/0000-0003-3157-4413				Acharya A, 2013, WORLD BANK RES OBSER, V28, P236, DOI 10.1093/wbro/lks009; Barasa EW, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0526-x; Boing AC, 2014, REV SAUDE PUBL, V48, P632, DOI 10.1590/S0034-8910.2014048005111; Buigut S, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0168-9; Carrin G, 2007, HLTH FINANCING REFOR, V97, P6; Chuma J, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1472-6963-12-413, 10.1186/1471-2458-12-20]; Chuma J, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-22; Culyer A.J., 2014, ENCY HLTH EC, V2, P240, DOI DOI 10.1016/B978-0-12-375678-7.00206-6; David NK, 2017, PUBLIC HLTH RES, V7, P55; Dyer SJ, 2013, HUM REPROD, V28, P2755, DOI 10.1093/humrep/det290; Erreygers G, 2009, J HEALTH ECON, V28, P521, DOI 10.1016/j.jhealeco.2008.12.001; Ezat Wan Puteh S, 2017, HLTH SYST POLICY RES, V04; Feinstein L, 2006, 4 WHAT ARE EFFECTS E, P184; Ghafoori S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0093-2; Haghparast-Bidgoli H, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0216-5; Heckley G, 2016, J HEALTH ECON, V48, P89, DOI 10.1016/j.jhealeco.2016.03.006; Ilinca S, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1106-z; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kazungu JS, 2017, TROP MED INT HEALTH, V22, P1175, DOI 10.1111/tmi.12912; Kimani D, 2016, EUR SCI J, V12; Kiringai J, 2016, 104289 WORLD BANK; Kjellsson G, 2013, J HEALTH ECON, V32, P659, DOI 10.1016/j.jhealeco.2012.10.012; KNBS, 2018, BAS REP WELL BEING K; Kunna R, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0578-y; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Luoma M., 2010, KENYA HLTH SYSTEM AS; Mazyavkina Nina, 2020, EUR J NEUROSCI, DOI [10.1016/j.medj.2022.03.004, DOI 10.1016/0735-1933(85)90003-X]; MOH, 2014, 2013 KEN HOUS HLTH E; Muiya BM, 2013, UNIVERSAL HLTH CARE; Munge K, 2014, HEALTH POLICY PLANN, V29, P912, DOI 10.1093/heapol/czt073; Mussa R, 2016, INT J HEALTH ECON MA, V16, P163, DOI 10.1007/s10754-015-9184-y; Njagi P, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05189-3; Njagi P, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-018-0799-1; O'Donnell O, 2007, ANAL HLTH EQUITY USI, DOI [10.1596/978-0-8213-6933-3, DOI 10.1596/978-0-8213-6933-3]; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; Saksena P, 2010, 21 WHO; Salari P, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001809; Sauerborn R, 1996, SOC SCI MED, V43, P281, DOI 10.1016/0277-9536(95)00374-6; SID, 2004, IN KEN PULL AP FACTS; Kien VD, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0460-3; Wagstaff A, 2003, J ECONOMETRICS, V112, P207, DOI 10.1016/S0304-4076(02)00161-6; Wagstaff A, 2014, CATA MEETS IMPOV UNI; Wagstaff A, 2018, LANCET GLOB HEALTH, V6, pE169, DOI [10.1016/S2214-109X(17)30486-2, 10.1016/s2214-109x(17)30486-2, 10.1016/S2214-109X(17)30429-1]; Wagstaff A, 2009, J HEALTH ECON, V28, P516, DOI 10.1016/j.jhealeco.2008.12.003; Wang Q, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1716-8; Wang ZH, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0134-6; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; WHO, 2005, 25 WHO; Woolf SH, 2015, URBAN I VA COMMONW U, V22; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2006, 32006 WHO; Xu K., 2005, DISTRIBUTION HLTH PA; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Zimmerman E, 2015, UNDERSTANDING RELATI	56	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244428	10.1371/journal.pone.0244428	http://dx.doi.org/10.1371/journal.pone.0244428			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373401	Green Published, gold			2022-12-27	WOS:000603612300058
J	Arakawa, H; Anme, T				Arakawa, Hiromi; Anme, Tokie			The effect of an experiential learning program on motivations and activity involvement among dementia supporters in Japan	PLOS ONE			English	Article							HEALTH; PEOPLE; CARE	Purpose The purpose of this study was to examine the effectiveness of an experiential learning program based on Kolb's theory in increasing dementia supporters' motivation and activity involvement within the community. Method In this interventional study, the sample was divided into two groups. The intervention group underwent dementia supporter training and participated in an experiential learning program, which was conducted two weeks after the initial training session. The control group underwent only the dementia supporter training. Results Kolb's experiential learning model consists of four stages: concrete experience, reflective observation, conceptualization, and active experimentation. A total of 37 and 44 individuals constituted the intervention and control groups, respectively. The Wilcoxon signed-rank test revealed that there was a significant increase in motivation among the intervention group participants, when compared to the control group participants. Moreover, the activity rate was higher among the intervention group participants. Discussion The experiential learning program was effective in increasing motivation levels and activity involvement among the dementia supporters. Conclusions The experiential learning program for dementia supporters can be used to improve other volunteer and professional programs. Moreover, Kolb's theory can be used to support individuals with dementia within the community.	[Arakawa, Hiromi] Int Univ Hlth & Welf, Dept Nursing, Ohtawara, Tochigi, Japan; [Anme, Tokie] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan	International University of Health & Welfare; University of Tsukuba	Arakawa, H (corresponding author), Int Univ Hlth & Welf, Dept Nursing, Ohtawara, Tochigi, Japan.	arakawahrn219@iuhw.ac.jp						[Anonymous], 2017, J ONCOL PRACT, V13, pe353; [Anonymous], 2010, ARCH IRAN MED, V13, P34; Antonovsky A, 2010, UNRAVELING MYSTERY H, P221; Arakawa H, 2017, TSUKUBA GLOBAL SCI W; Arakawa H., 2016, J JAPANESE SOC DEMEN, V15, P634; Arakawa H, 2012, JAPANESE SOC DEMENTI, V11, P665; Dewey J, 2004, EXPERIENCE ED 1938; Hoshina N, 2008, JAPANESE SOC STUDY S, V49, P111; Hoyrup S., 2004, J WORKPLACE LEARN, V16, P442, DOI [10.1108/13665620410566414, DOI 10.1108/13665620410566414]; Ito M, 2011, JAPANESE SOC DEMENTI, V10, P325; Khazanov EA, 1999, QUANTUM ELECTRON+, V29, P59, DOI 10.1070/QE1999v029n01ABEH001412; Kim K., 2011, J JAPANESE SOC DEMEN, V10, P88; Kimzey M, 2016, NURS EDUC TODAY, V46, P57, DOI 10.1016/j.nedt.2016.08.031; Kolb D. A, 2014, EXPERIENTIAL LEARNIN; Masago M, 2015, JAPANESE J PUBLIC HL, V71, P994; Matsushita Y, 2012, JAPAN ACAD HOME CARE, V15, P25; Ministry of health labor and welfare, 2018, NAT LIF SURV JAP; Mochizuki K, U SHIZUOKA DEP B PAP, V24, P155; Murao M, 2015, EXPERIENTIAL LEARNIN; Murayama Y, 2015, AGING MENT HEALTH, V19, P306, DOI 10.1080/13607863.2014.933309; Nakahara J, 2013, THEORETICAL LINEAGE, V639, P4; National social security Population research institute, 2017, EXP POP JAP; OECD/OCDE, OECD GUIDELINE TESTI, DOI [10.1787/9789264091016-en, DOI 10.1787/9789264091016-EN]; Risco E, 2016, AM J ALZHEIMERS DIS, V31, P223, DOI 10.1177/1533317515603818; Skog M, 2000, NURS EDUC TODAY, V20, P288, DOI 10.1054/nedt.1999.0388; Takeda E, 2017, J ECON EDUC, V36, P140; Tan KK, 2016, PATIENT EDUC COUNS, V99, P108, DOI 10.1016/j.pec.2015.08.003; Yamada S., 2010, Journal of the National Institute of Public Health, V59, P159; Yamakawa S, 2004, EXPERIENTIAL LEARNIN; Yamano F, 2016, OSAKA MED COLL J NUR, V6, P94; Yamazaki Y, 2003, PROCESS STRESS PROGR, P178	31	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244337	10.1371/journal.pone.0244337	http://dx.doi.org/10.1371/journal.pone.0244337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370370	Green Published, gold			2022-12-27	WOS:000603611900045
J	Braun, A; Evdokimov, D; Frank, J; Pauli, P; Uceyler, N; Sommer, C				Braun, Alexandra; Evdokimov, Dimitar; Frank, Johanna; Pauli, Paul; Ueceyler, Nurcan; Sommer, Claudia			Clustering fibromyalgia patients: A combination of psychosocial and somatic factors leads to resilient coping in a subgroup of fibromyalgia patients	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; QUALITY-OF-LIFE; GERMAN VERSION; VITAMIN-D; PAIN; PROFILES; FATIGUE; VALIDATION; STRATEGIES; CYTOKINES	Background Coping strategies and their efficacy vary greatly in patients suffering from fibromyalgia syndrome (FMS). Objective We aimed to identify somatic and psychosocial factors that might contribute to different coping strategies and resilience levels in FMS. Subjects and methods Standardized questionnaires were used to assess coping, pain, and psychological variables in a cohort of 156 FMS patients. Quantitative real-time polymerase chain reaction (qRT-PCR) determined gene expression of selected cytokines in white blood cells of 136 FMS patients and 25 healthy controls. Data of skin innervation, functional and structural sensory profiles of peripheral nociceptive nerve fibers of a previous study were included into the statistics. An exploratory factor analysis was used to define variance explaining factors, which were then included into cluster analysis. Results 54.9% of the variance was explained by four factors which we termed (1) affective load, (2) coping, (3) pain, and (4) pro-inflammatory cytokines (p < 0.05). Considering differences in the emerged factors, coping strategies, cytokine profiles, and disability levels, 118 FMS patients could be categorized into four clusters which we named "maladaptive", "adaptive", "vulnerable", and "resilient" (p < 0.05). The adaptive cluster had low scores in disability and in all symptom categories in contrast to the vulnerable cluster, which was characterized by high scores in catastrophizing and disability (p < 0.05). The resilient vs. the maladaptive cluster was characterized by better coping and a less pro-inflammatory cytokine pattern (p < 0.05). Conclusion Our data suggest that problem- and emotion-focused coping strategies and an anti-inflammatory cytokine pattern are associated with reduced disability and might promote resilience. Additional personal factors such as low anxiety scores, ability of acceptance, and persistence further favor a resilient phenotype. Individualized therapy should take these factors into account.	[Braun, Alexandra; Evdokimov, Dimitar; Frank, Johanna; Ueceyler, Nurcan; Sommer, Claudia] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Pauli, Paul] Univ Wurzburg, Dept Psychol Biol Psychol Clin Psychol & Psychoth, Wurzburg, Germany; [Pauli, Paul] Univ Wurzburg, Ctr Mental Hlth, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Braun, A (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.	Braun_A5@ukw.de			Evangelisches Studienwerk e.V.; Else Kroner-Fresenius-Stiftung; Department of Neurology of the University hospital Wurzburg;  [2014_A129]	Evangelisches Studienwerk e.V.; Else Kroner-Fresenius-Stiftung; Department of Neurology of the University hospital Wurzburg; 	A.B. was funded by Evangelisches Studienwerk e.V. (available from: https://www.evstudienwerk.de/english/doctoral.html) and the study is part of her doctoral thesis in the framework of the German graduate program DoloRes (available from: http://www.dolo-res.de/). The funding only included salary for A.B., a grant number is not available. The study was in part funded by Else Kroner-Fresenius-Stiftung (available from: https://www.ekfs.de/en). N.U. was the recipient of the grant with the grant number 2014_A129. Further funding came from internal research funds of the Department of Neurology of the University hospital Wurzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ablin JN, 2016, PEERJ, V4, DOI 10.7717/peerj.2421; Allen D., 2013, CLUSTER ANAL NEUROPS, DOI [10.1007/978-1-4614-6744-1, DOI 10.1007/978-1-4614-6744-1]; [Anonymous], 1995, SO AFRICAN J CHILD A, DOI DOI 10.1080/16826108.1995.9632442; Ayed N, 2019, PSYCHOL PSYCHOTHER-T, V92, P299, DOI 10.1111/papt.12185; Baastrup S, 2016, SCAND J PSYCHOL, V57, P516, DOI 10.1111/sjop.12325; Bartley EJ, 2018, J PAIN, V19, P372, DOI 10.1016/j.jpain.2017.11.014; Basu N, 2017, PSYCHOSOM MED, V79, P1051, DOI 10.1097/PSY.0000000000000498; Becker LA, EFFECT SIZE CALCULAT; Belcaro G, 2014, PHYTOTHER RES, V28, P444, DOI 10.1002/ptr.5014; Bender D, 1998, PROTEKTIVE FAKTOREN, P117; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Block JH, 1980, ROLE EGO CONTROL EGO, P64; Brown MM, 2010, PSYCHOL REP, V106, P383, DOI 10.2466/PR0.106.2.383-393; Bullinger M., 1995, J PUBLIC HEALTH-UK, V3, P21, DOI [DOI 10.1007/BF02959944, 10.1007/BF02959944]; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Casale R, 2019, CLIN EXP RHEUMATOL, V37, pS105; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CORNELIUS SW, 1987, PSYCHOL AGING, V2, P144, DOI 10.1037/0882-7974.2.2.144; da Silva MM, 2018, LASER MED SCI, V33, P343, DOI 10.1007/s10103-017-2388-2; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2018, BRAIN BEHAV IMMUN, V74, P28, DOI 10.1016/j.bbi.2018.08.010; Dorado K, 2018, HEALTH PSYCHOL OPEN, V5, DOI 10.1177/2055102918807406; Ellingson LD, 2018, PAIN MED, V19, P2408, DOI 10.1093/pm/pny008; Estevez-Lopez F, 2017, RHEUMATOLOGY, V56, P2015, DOI 10.1093/rheumatology/kex302; Evdokimov D, 2019, ANN NEUROL, V86, P504, DOI 10.1002/ana.25565; Feder A, 2019, BIOL PSYCHIAT, V86, P443, DOI 10.1016/j.biopsych.2019.07.012; Follick BT, 2016, J AM ASSOC NURSE PRA, V28, P19, DOI 10.1002/2327-6924.12270; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Hauser W, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.22; Hauser W, 2011, DTSCH ARZTEBL INT, V108, P287, DOI 10.3238/arztebl.2011.0287; HAITOVSKY Y, 1969, REV ECON STAT, V51, P486, DOI 10.2307/1926450; Hassett AL, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0567-7; Jacobs H, 2019, CLIN RHEUMATOL; Kline P, 1999, HDB PSYCHOL TESTING, P744; Klitsch A, 2020, J PERIPHER NERV SYST, V25, P9, DOI 10.1111/jns.12360; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kumpfer K.L., 2002, RESILIENCE DEV, P179, DOI DOI 10.1007/0-306-47167-1_9; Lami MJ, 2018, J CLIN PSYCHOL MED S, V25, P80, DOI 10.1007/s10880-018-9543-1; Laux L., 1981, STATE TRAIT ANGSTINV; Lee YC, 2014, ARTHRITIS RHEUMATOL, V66, P2006, DOI 10.1002/art.38682; Leppert K, 2005, PSYCHOTHER PSYCH MED, V55, P365, DOI 10.1055/s-2005-866873; Loevinger BL, 2012, CLIN RHEUMATOL, V31, P677, DOI 10.1007/s10067-011-1912-1; Luciano JV, 2016, CLIN J PAIN, V32, P829, DOI 10.1097/AJP.0000000000000336; Lukkahatai N, 2016, ARTHRIT CARE RES, V68, P99, DOI 10.1002/acr.22626; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Meyer TD, 2001, DIAGNOSTICA, V47, P208, DOI 10.1026//0012-1924.47.4.208; Moos RH, 2003, J CLIN PSYCHOL, V59, P1387, DOI 10.1002/jclp.10229; Moyal N, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01019; Musekamp G, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0903-4; Navrady Lauren B, 2018, Wellcome Open Res, V3, P12, DOI 10.12688/wellcomeopenres.13854.1; Offenbaecher M, 2000, J RHEUMATOL, V27, P1984; Park C.L., 1997, REV GEN PSYCHOL, V1, P115, DOI [10.1037/1089-2680.1.2.115, DOI 10.1037/1089-2680.1.2.115, 10.1037//1089-2680.1.2.115, DOI 10.1037//1089-2680.1.2.115]; Perez-Aranda A, 2018, PAIN; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Ramirez-Maestre C, 2008, EUR J PAIN, V12, P749, DOI 10.1016/j.ejpain.2007.11.004; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Rodman AM, 2019, BIOL PSYCHIAT, V86, P464, DOI 10.1016/j.biopsych.2019.04.033; Salaffi F, 2016, J PAIN RES, V9, P279, DOI 10.2147/JPR.S100829; Segura-Jimenez V, 2019, ARCH PHYS MED REHAB, V100, P1234, DOI 10.1016/j.apmr.2018.12.019; Seminowicz DA, 2007, CEREB CORTEX, V17, P1412, DOI 10.1093/cercor/bhl052; Signoret-Genest J, 2019, 3D MODEL ROTATING FM; Singh L, 2019, NEUROCHEM RES, V44, P1517, DOI 10.1007/s11064-019-02805-5; Sommer C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-104; Stainton A, 2019, EARLY INTERV PSYCHIA, V13, P725, DOI 10.1111/eip.12726; Sturgeon JA, 2014, PAIN, V155, P292, DOI 10.1016/j.pain.2013.10.007; Sturgeon JA, 2010, CURR PAIN HEADACHE R, V14, P105, DOI 10.1007/s11916-010-0095-9; Trinanes Y, 2014, RHEUMATOL INT, V34, P1571, DOI 10.1007/s00296-014-3007-1; Tuarp J., 2000, QUINTESSENZ, V51, P721; Turk DC, 1998, ARTHRIT CARE RES, V11, P397, DOI 10.1002/art.1790110511; Turk DC, 1996, J RHEUMATOL, V23, P1255; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Uceyler N, 2015, J NEUROL, V262, P203, DOI 10.1007/s00415-014-7556-8; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Uceyler N, 2006, ARTHRITIS RHEUM-US, V54, P2656, DOI 10.1002/art.22026; van Koulil S, 2010, ARTHRIT CARE RES, V62, P1377, DOI 10.1002/acr.20268; van Leeuwen N, 2015, RHEUMATOLOGY, V54, P776, DOI 10.1093/rheumatology/keu387; Verra ML, 2006, J PAIN, V7, P327, DOI 10.1016/j.jpain.2005.12.005; Vincent A, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0463-7; Wirtz MA, 2018, DIAGNOSTICA, V64, P215, DOI 10.1026/0012-1924/a000205; Wittbrodt MT, 2019, J AFFECT DISORDERS, V254, P49, DOI 10.1016/j.jad.2019.05.018; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Yim YR, 2017, EUR J PAIN, V21, P374, DOI 10.1002/ejp.935; Yong WC, 2017, CLIN RHEUMATOL, V36, P2825, DOI 10.1007/s10067-017-3754-y	85	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243806	10.1371/journal.pone.0243806	http://dx.doi.org/10.1371/journal.pone.0243806			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370324	gold, Green Published, Green Submitted			2022-12-27	WOS:000603611900066
J	Armstrong-Hough, M; Sharma, S; Kishore, SP; Akiteng, AR; Schwartz, JI				Armstrong-Hough, Mari; Sharma, Srish; Kishore, Sandeep P.; Akiteng, Ann R.; Schwartz, Jeremy I.			Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis	PLOS ONE			English	Article							ADHERENCE; ACCESS; CARE	Background Availability of essential medicines for non-communicable diseases (NCDs) is poor in low- and middle-income countries. Availability and cost are conventionally assessed using cross-sectional data. However, these characteristics may vary over time. Methods We carried out a prospective, descriptive analysis of the availability and cost of essential medicines in 23 Ugandan health facilities over a five-week period. We surveyed facility pharmacies in-person up to five times, recording availability and cost of 19 essential medicines for NCDs and four essential medicines for communicable diseases. Results Availability of medicines varied substantially over time, especially among public facilities. Among private-for-profit facilities, the cost of the same medicine varied from week to week. Private-not-for-profit facilities experienced less dramatic fluctuations in price. Conclusions We conclude that there is a need for standardized, continuous monitoring to better characterize the availability and cost of essential medicines, understand demand for these medicines, and reduce uncertainty for patients.	[Armstrong-Hough, Mari] NYU, Sch Global Publ Hlth, New York, NY 10012 USA; [Sharma, Srish] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Kishore, Sandeep P.] Icahn Sch Med Mt Sinai, Arnhold Inst Global Hlth, New York, NY 10029 USA; [Kishore, Sandeep P.] Young Profess Chron Dis Network, New York, NY USA; [Akiteng, Ann R.; Schwartz, Jeremy I.] Uganda Initiat Integrated Management Noncommun, Kampala, Uganda; [Schwartz, Jeremy I.] Yale Sch Med, Dept Internal Med, New Haven, CT USA	New York University; Wake Forest University; Icahn School of Medicine at Mount Sinai; Yale University	Armstrong-Hough, M (corresponding author), NYU, Sch Global Publ Hlth, New York, NY 10012 USA.	mah842@nyu.edu	Armstrong-Hough, Mari/AGF-1466-2022	Schwartz, Jeremy/0000-0003-0139-2600	MacMillan Center of Yale University; Yale Global Health Leadership Institute; Knoema	MacMillan Center of Yale University; Yale Global Health Leadership Institute; Knoema	The MacMillan Center of Yale University and the Yale Global Health Leadership Institute provided funding to support travel for JIS through the Hecht-Albert Pilot Innovation Award for Junior Faculty. Knoema provided funding for data collection and the development of the data collection and management tool. The funders played no further role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Muhammed, 2017, BMC Res Notes, V10, P676, DOI 10.1186/s13104-017-3025-7; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Ansah EK, 2016, INT HEALTH, V8, P427, DOI 10.1093/inthealth/ihw041; Armstrong-Hough M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192332; Bahendeka S, 2016, TROP MED INT HEALTH, V21, P405, DOI 10.1111/tmi.12663; Chiwanga FS, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31440; Fung V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191817; Gaziano T, 2015, HEALTH AFFAIR, V34, P1578, DOI 10.1377/hlthaff.2015.0351; Guwatudde D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138991; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Kishore SP, 2018, J AM COLL CARDIOL, V71, P564, DOI 10.1016/j.jacc.2017.11.056; Kishore SP, 2015, HEALTH AFFAIR, V34, P1569, DOI 10.1377/hlthaff.2015.0375; Ministry of Health ROU, 2012, ESS MED HLTH SUPPL L; National Medical Logistics, FY 2017 18 NAT MED S; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Rash JA, 2016, PREV MED, V90, P155, DOI 10.1016/j.ypmed.2016.07.006; Robertson J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0105-0; Schwartz JI, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0077-5; Siddharthan T, 2015, HEALTH AFFAIR, V34, P1506, DOI 10.1377/hlthaff.2015.0382; United Nations, 2018, SUST DEV GOALS REP 2; World Health Organization, 2014, NONC DIS GLOB MON FR; World Health Organization, 2015, UG WHO STAT PROF; Yadav P., 2010, ALWAYS COLA RARELY E	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0241555	10.1371/journal.pone.0241555	http://dx.doi.org/10.1371/journal.pone.0241555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362249	gold, Green Submitted, Green Published			2022-12-27	WOS:000603071600065
J	Fervers, P; Kottlors, J; Zopfs, D; Bremm, J; Maintz, D; Safarov, O; Tritt, S; Abdullayev, N; Persigehl, T				Fervers, Philipp; Kottlors, Jonathan; Zopfs, David; Bremm, Johannes; Maintz, David; Safarov, Orkhan; Tritt, Stephanie; Abdullayev, Nuran; Persigehl, Thorsten			Calcification of the thoracic aorta on low-dose chest CT predicts severe COVID-19	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RISK-FACTORS; ATHEROSCLEROSIS; DEFINITION; DISEASE	Background Cardiovascular comorbidity anticipates poor prognosis of SARS-CoV-2 disease (COVID-19) and correlates with the systemic atherosclerotic transformation of the arterial vessels. The amount of aortic wall calcification (AWC) can be estimated on low-dose chest CT. We suggest quantification of AWC on the low-dose chest CT, which is initially performed for the diagnosis of COVID-19, to screen for patients at risk of severe COVID-19. Methods Seventy consecutive patients (46 in center 1, 24 in center 2) with parallel low-dose chest CT and positive RT-PCR for SARS-CoV-2 were included in our multi-center, multi-vendor study. The outcome was rated moderate (no hospitalization, hospitalization) and severe (ICU, tracheal intubation, death), the latter implying a requirement for intensive care treatment. The amount of AWC was quantified with the CT vendor's software. Results Of 70 included patients, 38 developed a moderate, and 32 a severe COVID-19. The average volume of AWC was significantly higher throughout the subgroup with severe COVID-19, when compared to moderate cases (771.7 mm(3) (Q1 = 49.8 mm(3), Q3 = 3065.5 mm(3)) vs. 0 mm(3) (Q1 = 0 mm(3), Q3 = 57.3 mm(3))). Within multivariate regression analysis, including AWC, patient age and sex, as well as a cardiovascular comorbidity score, the volume of AWC was the only significant regressor for severe COVID-19 (p = 0.004). For AWC > 3000 mm(3), the logistic regression predicts risk for a severe progression of 0.78. If there are no visually detectable AWC risk for severe progression is 0.13, only. Conclusion AWC seems to be an independent biomarker for the prediction of severe progression and intensive care treatment of COVID-19 already at the time of patient admission to the hospital; verification in a larger multi-center, multi-vendor study is desired.	[Fervers, Philipp; Kottlors, Jonathan; Zopfs, David; Bremm, Johannes; Maintz, David; Abdullayev, Nuran; Persigehl, Thorsten] Univ Cologne, Fac Med, Dept Diagnost & Intervent Radiol, Cologne, Germany; [Fervers, Philipp; Kottlors, Jonathan; Zopfs, David; Bremm, Johannes; Maintz, David; Abdullayev, Nuran; Persigehl, Thorsten] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Safarov, Orkhan; Tritt, Stephanie] Helios Dr Horst Schmidt Kliniken Wiesbaden, Dept Radiol, Wiesbaden, Germany	University of Cologne; University of Cologne	Fervers, P (corresponding author), Univ Cologne, Fac Med, Dept Diagnost & Intervent Radiol, Cologne, Germany.; Fervers, P (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.	philipp.fervers@uk-koeln.de	Abdullayev, Nuran/P-5363-2019	Abdullayev, Nuran/0000-0003-4522-537X; Fervers, Philipp/0000-0003-3663-3486				Basta Giuseppina, 2020, Recenti Prog Med, V111, P238, DOI 10.1701/3347.33187; Berlin I, 2020, NICOTINE TOB RES, V22, P1650, DOI 10.1093/ntr/ntaa059; Berman DS, 2016, JACC-CARDIOVASC IMAG, V9, P1417, DOI 10.1016/j.jcmg.2016.05.020; Bluemke DA, FLEISCHNER STATEMENT; Borsa S, 2020, ACTA NEUROCHIR, V162, P1227, DOI 10.1007/s00701-020-04333-6; Breheny P, 2017, R J, V9, P56, DOI 10.32614/RJ-2017-046; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; Djekic D, 2018, EUR J PREV CARDIOL, V25, P1756, DOI 10.1177/2047487318792103; Du YZ, 2020, AM J RESP CRIT CARE, V201, P1372, DOI 10.1164/rccm.202003-0543OC; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Grani C, 2018, EUR HEART J-CARD IMG, V19, P1362, DOI 10.1093/ehjci/jey019; Grundy EJ, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/124788; Hariyanto TI, 2020, DIABETES METAB SYND, V14, P1463, DOI 10.1016/j.dsx.2020.07.054; Isgum I, 2010, MED PHYS, V37, P714, DOI 10.1118/1.3284211; Itani Y, 2004, CIRC J, V68, P538, DOI 10.1253/circj.68.538; JANOWITZ WR, 1991, AM J CARDIOL, V68, P1, DOI 10.1016/0002-9149(91)90700-U; John F., 2019, R COMPANION APPL REG, VThird; Kim Hyungjin, 2020, Radiology, V296, pE145, DOI 10.1148/radiol.2020201343; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Kwong JC, 2018, NEW ENGL J MED, V378, P345, DOI 10.1056/NEJMoa1702090; Lessmann N, 2018, IEEE T MED IMAGING, V37, P615, DOI 10.1109/TMI.2017.2769839; Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549; Mahdjoub E, 2020, INTENS CARE MED, V46, P1648, DOI 10.1007/s00134-020-06118-y; Midi H, 2010, J INTERDISCIP MATH, V13, P253, DOI 10.1080/09720502.2010.10700699; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nikolich-Zugich J, 2020, GEROSCIENCE, V42, P505, DOI 10.1007/s11357-020-00186-0; Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9; Olds JL, 2020, FEBS J, V287, P3651, DOI 10.1111/febs.15303; Ozma MA, INFEZ MED, V28, P153; Rubin GD, 2020, RADIOLOGY, V296, P172, DOI [10.1148/radiol.2020201365, 10.1016/j.chest.2020.04.003]; Rusnak J, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-017-0290-9; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Takasu J, 2008, AM HEART J, V155, P765, DOI 10.1016/j.ahj.2007.11.019; Thomas IC, 2018, ARTERIOSCL THROM VAS, V38, P1926, DOI 10.1161/ATVBAHA.118.310850; van Velzen SGM, 2020, RADIOLOGY, V295, P66, DOI 10.1148/radiol.2020191621; van Zyl-Smit RN, 2020, LANCET RESP MED, V8, P664, DOI 10.1016/S2213-2600(20)30239-3; WITTEMAN JCM, 1986, LANCET, V2, P1120; WITTEMAN JCM, 1990, AM J CARDIOL, V66, P1060, DOI 10.1016/0002-9149(90)90505-U; World Health Organization, 2020, SMOK COVID 19 SCI BR; Zhai Pan, 2020, Int J Antimicrob Agents, V55, P105955, DOI 10.1016/j.ijantimicag.2020.105955; Zhang HF, 2020, ANESTHESIOLOGY, V132, P1333, DOI 10.1097/ALN.0000000000003300; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou M, 2020, 2020 THE 3RD INTERNATIONAL CONFERENCE ON INTELLIGENT AUTONOMOUS SYSTEMS (ICOIAS'2020), P1, DOI 10.1109/ICoIAS49312.2020.9081851	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244267	10.1371/journal.pone.0244267	http://dx.doi.org/10.1371/journal.pone.0244267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362199	Green Published, gold			2022-12-27	WOS:000603071600071
J	Jiang, W; Zhang, K; Wang, N; Yu, M				Jiang, Wei; Zhang, Kai; Wang, Nan; Yu, Miao			MeshCut data augmentation for deep learning in computer vision	PLOS ONE			English	Article								To solve overfitting in machine learning, we propose a novel data augmentation method called MeshCut, which uses a mesh-like mask to segment the whole image to achieve more partial diversified information. In our experiments, this strategy outperformed the existing augmentation strategies and achieved state-of-the-art results in a variety of computer vision tasks. MeshCut is also an easy-to-implement strategy that can efficiently improve the performance of the existing convolutional neural network models by a good margin without careful hand-tuning. The performance of such a strategy can be further improved by incorporating it into other augmentation strategies, which can make MeshCut a promising baseline strategy for future data augmentation algorithms.	[Jiang, Wei; Zhang, Kai; Yu, Miao] Sichuan Univ, Sch Mech Engn, Chengdu, Peoples R China; [Wang, Nan] Southwest Jiaotong Univ, Sch Phys Sci & Technol, Chengdu, Peoples R China	Sichuan University; Southwest Jiaotong University	Yu, M (corresponding author), Sichuan Univ, Sch Mech Engn, Chengdu, Peoples R China.; Wang, N (corresponding author), Southwest Jiaotong Univ, Sch Phys Sci & Technol, Chengdu, Peoples R China.	705679317@qq.com; miaoyu@scu.edu.cn			Sichuan Province Science and Technology Support Program [2019YFG0373]; Major Special Projects of Sichuan Province [2020ZDZX0024]; Department of Science and Technology of Sichuan Province [2019YFG0397]	Sichuan Province Science and Technology Support Program; Major Special Projects of Sichuan Province; Department of Science and Technology of Sichuan Province	The project of Sichuan Province Science and Technology Support Program under Grant 2019YFG0373; The Major Special Projects of Sichuan Province under Grant 2020ZDZX0024; Department of Science and Technology of Sichuan Province, 2019YFG0397.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; DeVries Terrance, 2017, ARXIV170804552; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/TPAMI.2018.2844175, 10.1109/ICCV.2017.322]; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Li W., 2013, INT C MACH LEARN; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Poria S, 2016, IEEE DATA MINING, P439, DOI [10.1109/ICDM.2016.178, 10.1109/ICDM.2016.0055]; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Singh K. K., 2018, HIDE AND SEEK DATA A; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; SZEGEDY C, 2016, PROC CVPR IEEE, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Wang SJ, 2019, ENVIRON CHEM LETT, V17, P509, DOI 10.1007/s10311-018-0796-6; Yun Sangdoo, 2019, CUTMIX REGULARIZATIO; Zagoruyko S., 2017, ARXIV160507146; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660; Zhong Z, 2020, AAAI CONF ARTIF INTE, V34, P13001; ZHOU B, 2016, PROC CVPR IEEE, P2921, DOI DOI 10.1109/CVPR.2016.319; 2018, INT J COMMUN SYST, V31	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243613	10.1371/journal.pone.0243613	http://dx.doi.org/10.1371/journal.pone.0243613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362231	Green Published, gold			2022-12-27	WOS:000603071600060
J	Bassett, IV; Triant, VA; Bunda, BA; Selvaggi, CA; Shinnick, DJ; He, W; Lu, F; Porneala, BC; Cao, TY; Lubitz, SA; Meigs, JB; Hsu, J; Foulkes, AS				Bassett, Ingrid V.; Triant, Virginia A.; Bunda, Bridget A.; Selvaggi, Caitlin A.; Shinnick, Daniel J.; He, Wei; Lu, Frances; Porneala, Bianca C.; Cao, Tingyi; Lubitz, Steven A.; Meigs, James B.; Hsu, John; Foulkes, Andrea S.			Massachusetts general hospital Covid-19 registry reveals two distinct populations of hospitalized patients by race and ethnicity	PLOS ONE			English	Article							ADULT PATIENTS	Objective To evaluate differences by race/ethnicity in clinical characteristics and outcomes among hospitalized patients with Covid-19 at Massachusetts General Hospital (MGH). Methods The MGH Covid-19 Registry includes confirmed SARS-CoV-2-infected patients hospitalized at MGH and is based on manual chart reviews and data extraction from electronic health records (EHRs). We evaluated differences between White/Non-Hispanic and Hispanic patients in demographics, complications and 14-day outcomes among the N = 866 patients hospitalized with Covid-19 from March 11, 2020-May 4, 2020. Results Overall, 43% of patients hospitalized with Covid-19 were women, median age was 60.4 [IQR = (48.2, 75)], 11.3% were Black/non-Hispanic and 35.2% were Hispanic. Hispanic patients, representing 35.2% of patients, were younger than White/non-Hispanic patients [median age 51y; IQR = (40.6, 61.6) versus 72y; (58.0, 81.7) (p<0.001)]. Hispanic patients were symptomatic longer before presenting to care (median 5 vs 3d, p = 0.039) but were more likely to be sent home with self-quarantine than be admitted to hospital (29% vs 16%, p<0.001). Hispanic patients had fewer comorbidities yet comparable rates of ICU or death (34% vs 36%). Nonetheless, a greater proportion of Hispanic patients recovered by 14 days after presentation (62% vs 45%, p<0.001; OR = 1.99, p = 0.011 in multivariable adjusted model) and fewer died (2% versus 18%, p<0.001). Conclusions Hospitalized Hispanic patients were younger and had fewer comorbidities compared to White/non-Hispanic patients; despite comparable rates of ICU care or death, a greater proportion recovered. These results have implications for public health policy and the design and conduct of clinical trials.	[Bassett, Ingrid V.; Triant, Virginia A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bassett, Ingrid V.; Triant, Virginia A.; He, Wei; Porneala, Bianca C.; Meigs, James B.; Hsu, John] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Bassett, Ingrid V.; Bunda, Bridget A.; Hsu, John] Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Bassett, Ingrid V.; Triant, Virginia A.; Lubitz, Steven A.; Meigs, James B.; Hsu, John; Foulkes, Andrea S.] Harvard Med Sch, Boston, MA 02115 USA; [Selvaggi, Caitlin A.; Lu, Frances; Foulkes, Andrea S.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Shinnick, Daniel J.; Cao, Tingyi] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Lubitz, Steven A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Bassett, IV (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.; Bassett, IV (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.; Bassett, IV (corresponding author), Massachusetts Gen Hosp, Dept Med, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Bassett, IV (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ibassett@mgh.harvard.edu		Cao, Tingyi/0000-0002-4210-7127; Lu, Frances/0000-0003-2031-7884	Weissman Family MGH Research Scholar; MGH Division of Clinical Research; National Institutes of Health [R37AI058736-16S1, R01GM127862, R01HL132786, R01AG062393]	Weissman Family MGH Research Scholar; MGH Division of Clinical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Weissman Family MGH Research Scholar (IVB); MGH Division of Clinical Research (ASF, JBM); The National Institutes of Health: R37AI058736-16S1 (IVB); R01GM127862 (ASF); R01HL132786 (VAT); R01AG062393 (VAT) The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2020, MASS DEP PUBL HLTH C; [Anonymous], MASS DEP PUBL HLTH C; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; CDC, 2020, ED ELEMENTS; Chowkwanyun M, 2020, NEW ENGL J MED, V383, P201, DOI 10.1056/NEJMp2012910; Clark E, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008484; de l I, 2018, J CLIN GASTROENTEROL, V52, pe63; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Gottlieb M, 2020, ACAD EMERG MED, V27, P963, DOI 10.1111/acem.14104; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Hawkins Devan, 2020, J Prev Med Public Health, V53, P220, DOI 10.3961/jpmph.20.256; Haynes N, 2020, CIRCULATION, V142, P105, DOI 10.1161/CIRCULATIONAHA.120.048126; Hsu HE, 2020, MMWR-MORBID MORTAL W, V69, P864, DOI 10.15585/mmwr.mm6927a3; Lewis NM, 2020, MMWR-MORBID MORTAL W, V69, P1369, DOI 10.15585/mmwr.mm6938a4; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Richardson Safiya, 2020, JAMA, V323, P2052, DOI 10.1001/jama.2020.6775; Schnitzer K, 2020, ACAD EMERG MED, V27, P943, DOI 10.1111/acem.14092; U.S. Census Bureau, 2017, AM COMMUNITY SURVEY; Vahidy FS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039849; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Weber GM, 2017, J AM MED INFORM ASSN, V24, P1134, DOI 10.1093/jamia/ocx071	23	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244270	10.1371/journal.pone.0244270	http://dx.doi.org/10.1371/journal.pone.0244270			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351826	gold, Green Published, Green Submitted			2022-12-27	WOS:000603071400014
J	Galea, N; Rosato, E; Gigante, A; Borrazzo, C; Fiorelli, A; Barchetti, G; Trombetta, AC; Digiulio, MA; Francone, M; Catalano, C; Carbone, I				Galea, Nicola; Rosato, Edoardo; Gigante, Antonietta; Borrazzo, Cristian; Fiorelli, Andrea; Barchetti, Giovanni; Trombetta, Amelia Chiara; Digiulio, Maria Anna; Francone, Marco; Catalano, Carlo; Carbone, Iacopo			Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: A cardiovascular magnetic resonance study with cold pressor test	PLOS ONE			English	Article							FOLLOW-UP; QUANTIFICATION; DIAGNOSIS; FIBROSIS; EDEMA; CLASSIFICATION; ENHANCEMENT; INVOLVEMENT; SCLERODERMA; PERFUSION	Purpose Cardiac involvement in Systemic Sclerosis (SSc) is increasingly recognized as a mayor cause of morbidity and mortality. The aim of present study is to investigate the early stages of cardiac involvement in SSc by Cardiovascular magnetic resonance (CMR), combining the non-invasive detection of myocardial inflammation and fibrosis using T2 and T1 mapping techniques and the assessment of microcirculatory impairment through perfusion response to cold pressor test (CPT). Methods 40 SSc patients (30 females, mean age: 42.1 years) without cardiac symptoms and 10 controls underwent CMR at 1.5 T unit. CMR protocol included: native and contrast-enhanced T1 mapping, T2 mapping, T2-weighted, cineMR and late gadolinium enhancement (LGE) imaging. Microvascular function was evaluated by comparing myocardial blood flow (MBF) on perfusion imaging acquired at rest and after CPT. Native myocardial T1 and T2 relaxation times, extracellular volume fraction (ECV), T2 signal intensity ratio, biventricular volumes and LGE were assessed in each patient. Results SSc patients had significantly higher mean myocardial T1 (1029 +/- 32ms vs. 985 +/- 18ms, p<0.01), ECV (30.1 +/- 4.3% vs. 26.7 +/- 2.4%, p<0.05) and T2 (50.1 +/- 2.8ms vs. 47 +/- 1.5ms, p<0.01) values compared with controls. No significant differences were found between absolute MBF values at rest and after CPT; whereas lower MBF variation after CPT was observed in SSc patients (+33 +/- 14% vs. +44 +/- 12%, p<0.01). MBF variation had inverse correlation with native T1 values (r: -0.32, p<0.05), but not with ECV. Conclusions Myocardial involvement in SSc at preclinical stage increases native T1, T2 and ECV values, reflecting inflammation and fibrosis, and reduces vasodilatory response to CPT, as expression of microvascular dysfunction.	[Galea, Nicola; Fiorelli, Andrea; Barchetti, Giovanni; Francone, Marco; Catalano, Carlo; Carbone, Iacopo] Sapienza Univ Rome, Dept Expt Med, Rome, Italy; [Galea, Nicola] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy; [Rosato, Edoardo; Gigante, Antonietta; Trombetta, Amelia Chiara; Digiulio, Maria Anna] Sapienza Univ Rome, Scleroderma Ctr, Clin Immunol Unit, Dept Clin Med, Rome, Italy; [Borrazzo, Cristian] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Stat Unit, Rome, Italy; [Borrazzo, Cristian] Osped San Pietro Fatebenefratelli, Radiotherapy Unit, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Galea, N (corresponding author), Sapienza Univ Rome, Dept Expt Med, Rome, Italy.; Galea, N (corresponding author), Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy.	nicola.galea@uniroma1.it	Trombetta, Amelia Chiara/AAL-1841-2021; Borrazzo, Cristian/AAS-6644-2020; Galea, Nicola/AAQ-6612-2020	Borrazzo, Cristian/0000-0002-2346-898X; Galea, Nicola/0000-0003-4708-5120				Barison A, 2015, EUR HEART J-CARD IMG, V16, P74, DOI 10.1093/ehjci/jeu167; Cannarile F, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.12; Cianci R, 2020, KIDNEY BLOOD PRESS R, V45, P350, DOI 10.1159/000505659; Cutolo M, 2006, RHEUMATOLOGY, V45, P43, DOI 10.1093/rheumatology/kel310; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; Di Cesare E, 2013, EUR J RADIOL, V82, pE268, DOI 10.1016/j.ejrad.2013.02.014; Faccini A, 2016, EUR HEART J, V37, P1799, DOI 10.1093/eurheartj/ehw018; Faccini A, 2015, CIRC J, V79, P825, DOI 10.1253/circj.CJ-14-1114; Fairbairn TA, 2014, RADIOLOGY, V270, P82, DOI 10.1148/radiol.13122345; Ferreira VM, 2013, JACC-CARDIOVASC IMAG, V6, P1048, DOI 10.1016/j.jcmg.2013.03.008; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; FOLLANSBEE WP, 1984, NEW ENGL J MED, V310, P142, DOI 10.1056/NEJM198401193100302; FOLLANSBEE WP, 1990, J RHEUMATOL, V17, P656; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Galea N, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8437927; GUSTAFSSON R, 1989, LANCET, V2, P475; Gyllenhammar T, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0756-x; Hachulla AL, 2009, ANN RHEUM DIS, V68, P1878, DOI 10.1136/ard.2008.095836; Hromadka M, 2017, INT J CARDIOL, V249, P448, DOI 10.1016/j.ijcard.2017.08.072; Jerosch-Herold M, 1998, MED PHYS, V25, P73, DOI 10.1118/1.598163; Kahaleh B, 2008, RHEUMATOLOGY, V47, pV14, DOI 10.1093/rheumatology/ken279; Kellman P, 2007, MAGN RESON MED, V57, P891, DOI 10.1002/mrm.21215; Komocsi A, 2012, RHEUMATOLOGY, V51, P1027, DOI 10.1093/rheumatology/ker357; Krumm P, 2020, ROFO-FORTSCHR RONTG, V192, P669, DOI 10.1055/a-1088-3478; Krumm P, 2016, J CARDIOVASC MAGN R, V18, DOI 10.1186/s12968-016-0289-3; LEROY EC, 1988, J RHEUMATOL, V15, P202; Mavrogeni S, 2017, INT J CARDIOL, V228, P444, DOI 10.1016/j.ijcard.2016.11.242; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Miller CA, 2013, CIRC-CARDIOVASC IMAG, V6, P373, DOI 10.1161/CIRCIMAGING.112.000192; Mizuno R, 2010, EUR J HEART FAIL, V12, P268, DOI 10.1093/eurjhf/hfp198; Mueller KAL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126707; Ntusi NAB, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-21; Pingitore A, 2013, RHEUMATOLOGY, V52, P1920, DOI 10.1093/rheumatology/ket002; Poindron V, 2020, SEMIN ARTHRITIS RHEU, V50, P128, DOI 10.1016/j.semarthrit.2019.06.013; Quarta S, 2016, EXPERT REV CLIN IMMU, V12, P251, DOI 10.1586/1744666X.2016.1134320; Sano M, 2015, HEART VESSELS, V30, P779, DOI 10.1007/s00380-014-0539-y; Thuny F, 2014, RADIOLOGY, V271, P373, DOI 10.1148/radiol.13131280; Tzelepis GE, 2007, ARTHRITIS RHEUM-US, V56, P3827, DOI 10.1002/art.22971; Valentini G, 2001, ANN RHEUM DIS, V60, P592, DOI 10.1136/ard.60.6.592; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Wong TC, 2012, CIRCULATION, V126, P1206, DOI 10.1161/CIRCULATIONAHA.111.089409; Zhang Y, 2015, INT J CARDIOVAS IMAG, V31, P389, DOI 10.1007/s10554-014-0560-3	42	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244282	10.1371/journal.pone.0244282	http://dx.doi.org/10.1371/journal.pone.0244282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351821	Green Published, gold			2022-12-27	WOS:000603071400023
J	Hahnel, V; Peterhoff, D; Bauerlein, V; Brosig, AM; Pamler, I; Johnson, C; Bica, A; Totir, M; Ossner, T; Stemmer, B; Toelge, M; Schutz, A; Niller, HH; Schmidt, B; Wagner, R; Gessner, A; Burkhard, R; Offner, R				Hahnel, Viola; Peterhoff, David; Bauerlein, Veronika; Brosig, Andreas-Michael; Pamler, Irene; Johnson, Christian; Bica, Adelina; Totir, Monica; Ossner, Thomas; Stemmer, Barbara; Toelge, Martina; Schutz, Anja; Niller, Hans-Helmut; Schmidt, Barbara; Wagner, Ralf; Gessner, Andre; Burkhard, Ralph; Offner, Robert			Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality	PLOS ONE			English	Article							CORONAVIRUS; PNEUMONIA; THERAPY; COV	The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019. Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the manufacturing of a plasma-based product containing antibodies specific to SARS-CoV-2 obtained from recently recovered COVID-19 patients. Convalescent plasma donors were screened as follows: 1) previously confirmed SARS-CoV-2 infection (by real-time PCR (RT-PCR)); 2) a subsequent negative PCR test followed by a 2-week waiting period; 3) an additional negative PCR test prior to plasmapheresis; and 4) confirmation of the presence of SARS-CoV-2 specific antibodies. Convalescent plasma was stored fresh (2-6 degrees C) for up to 5 days or frozen (-30 degrees C) for long-term storage. Donor peripheral blood and final plasma product were assayed for binding antibodies targeting the SARS-CoV-2 S-protein receptor-binding domain (RBD) and their titers measured by an enzyme-linked immunosorbent assay (ELISA). We performed 72 plasmaphereses resulting in 248 final products. Convalescent plasma contained an RBD-specific antibody titer (IgG) ranging from 1:100 to 1:3200 (median 1:800). The titer was congruent to the titer of the blood (n = 34) before collection (1:100-1:6400, median 1:800). Levels of IL-8 and LBP of donors were slightly increased. Therapeutic products derived from a human origin must undergo rigorous testing to ensure uniform quality and patient safety. Whilst previous publications recommended RBD-specific binding antibody titers of >= 1:320, we selected a minimum titer of 1:800 in order to maximize antibody delivery. Production of highly standardized convalescent plasma was safe, feasible and was readily implemented in the treatment of severely ill COVID-19 patients.	[Hahnel, Viola; Bauerlein, Veronika; Brosig, Andreas-Michael; Pamler, Irene; Johnson, Christian; Bica, Adelina; Totir, Monica; Ossner, Thomas; Stemmer, Barbara; Burkhard, Ralph; Offner, Robert] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Transfus Med, Regensburg, Germany; [Peterhoff, David; Toelge, Martina; Schutz, Anja; Niller, Hans-Helmut; Schmidt, Barbara; Wagner, Ralf; Gessner, Andre] Univ Hosp Regensburg, Inst Med Microbiol & Hyg, Regensburg, Germany; [Niller, Hans-Helmut; Schmidt, Barbara; Wagner, Ralf; Gessner, Andre] Univ Hosp Regensburg, Inst Clin Microbiol & Hyg, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Hahnel, V (corresponding author), Univ Hosp Regensburg, Inst Clin Chem & Lab Med, Transfus Med, Regensburg, Germany.	viola.haehnel@ukr.de	Wagner, Ralf/D-1389-2010; Schmidt, Barbara/AEZ-2050-2022; Peterhoff, David/ABD-6746-2020	Wagner, Ralf/0000-0002-0220-2154; Johnson, Christian/0000-0001-9942-672X	Bavarian Ministry of Science and Art; project EHVA (H2020) [681032]	Bavarian Ministry of Science and Art; project EHVA (H2020)	The authors acknowledge financial support through the pandemic responsiveness of The Bavarian Ministry of Science and Art. DP, AS were funded by project EHVA (H2020, Grant 681032 to RW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, Cancer Discov, V10, pOF8, DOI 10.1158/2159-8290.CD-ND2020-008; [Anonymous], 2017, RICHTL GEW BLUT BLUT; [Anonymous], 2020, EU PROGRAMME COVID 1; Arabi YM, 2016, EMERG INFECT DIS, V22, P1554, DOI 10.3201/eid2209.151164; Bica AF, 2020, TRANFUS MED HEMOT S1, V47, P1; Brown BL, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102790; Bulow S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02768; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Garraud O, 2016, TRANSFUS CLIN BIOL, V23, P39, DOI 10.1016/j.tracli.2015.12.003; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gupta R, 2021, MOL CELL BIOCHEM, V476, P633, DOI 10.1007/s11010-020-03932-2; Gupta R, 2020, DIABETES METAB SYND, V14, P251, DOI 10.1016/j.dsx.2020.03.012; Henss L, 2021, J INFECT DIS, V223, P56, DOI 10.1093/infdis/jiaa680; Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020; Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P152, DOI 10.2450/2015.0131-15; Meftahi GH, 2020, INFLAMM RES, V69, P825, DOI 10.1007/s00011-020-01372-8; Ossner T SB, 2020, TRANFUS MED HEMOT S1, V47, P1; Pamler I, 2020, TRANSFUSION, V60, P1260, DOI 10.1111/trf.15801; Peterhoff D, 2021, INFECTION, V49, P75, DOI 10.1007/s15010-020-01503-7; Roback JD, 2020, JAMA-J AM MED ASSOC, V323, P1561, DOI 10.1001/jama.2020.4940; Rojas M, 2020, J TRANSL AUTOIMMUN, V3, DOI 10.1016/j.jtauto.2020.100069; Rojas M, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102554; Rychter AM, 2020, OBES REV, V21, DOI 10.1111/obr.13083; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Tamara A, 2020, DIABETES METAB SYND, V14, P655, DOI 10.1016/j.dsx.2020.05.020; Tarrant JM, 2010, TOXICOL SCI, V117, P4, DOI 10.1093/toxsci/kfq134; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Valk SJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013600; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Xie MX, 2020, INT J INFECT DIS, V94, P119, DOI 10.1016/j.ijid.2020.03.071; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346; Zeng QL, 2020, J INFECT DIS, V222, P38, DOI 10.1093/infdis/jiaa228; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu H, 2020, CURR CARDIOL REP, V22, DOI [10.1007/s11886-020-01292-3, 10.1007/s11886-020-01302-4]	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243967	10.1371/journal.pone.0243967	http://dx.doi.org/10.1371/journal.pone.0243967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351831	gold, Green Published			2022-12-27	WOS:000603071400034
J	Kang, H; Lee, SJ; Shin, HJ; Lee, AG				Kang, Hyunkyoo; Lee, Sang Jae; Shin, Hyun Jin; Lee, Andrew G.			Measuring ocular torsion and its variations using different nonmydriatic fundus photographic methods	PLOS ONE			English	Article							CYCLODEVIATION; SIGN	Purpose To compare the variations in ocular torsion measurements made using different fundus photographic methods. Methods We enrolled subjects with three conditions: (1) patients with intermittent exotropia (IXT) (n = 44), (2) patients with unilateral superior oblique palsy (SOP) (n = 10), and (3) normal subjects as controls (n = 85). Ocular torsion was measured by disc-center-fovea angle (DFA) using three different imaging modalities: (1) conventional fundus photography (CFP) with a 45 degrees field of view (FV), (2) wide-field fundus photography (WFP) with a 200 degrees FV, and (3) optical coherence tomography (OCT) with a 55 degrees FV. Results In the IXT group, the DFAs in the right and left eyes were 5.70 +/- 3.35 degrees and 6.37 +/- 3.36 degrees, respectively, for CFP, 8.39 +/- 5.24 degrees and 8.61 +/- 3.67 degrees for WFP, and 5.73 +/- 3.61 degrees for 6.16 +/- 3.50 degrees for OCT. In the SOP group, the DFAs in paretic and nonparetic eyes were 12.19 +/- 1.69 degrees and 6.71 +/- 1.09 degrees, respectively, for CFP, 14.29 +/- 2.36 degrees and 8.23 +/- 3.31 degrees for WFP, and 12.12 +/- 1.73 degrees and 6.91 +/- 1.12 degrees for OCT. In the control group, the DFAs in the right and left eyes were 5.39 +/- 2.65 degrees and 5.71 +/- 3.16 degrees, respectively, for CFP, 8.77 +/- 5.56 degrees and 8.90 +/- 6.24 degrees for WFP, and 5.27 +/- 2.67 degrees and 5.72 +/- 3.20 degrees for OCT. There was no difference between the results from CFP and OCT among the three groups. However, the torsional angle was larger when measured using WFP than the other two photographic methods (CFP and OCT) in all three groups (all p<0.05). Conclusion The ocular torsion measurement varies with the fundus photographic method used to measure it. Clinicians should be careful to avoid overestimating ocular extorsion when it is evaluated using WFP.	[Kang, Hyunkyoo] Konkuk Univ, Dept Mechatron & Elect Engn, Glocal Campus, Chungcheongbuk Do, South Korea; [Lee, Sang Jae] Konkuk Univ, Sch Med, Seoul, South Korea; [Shin, Hyun Jin] Konkuk Univ, Med Ctr, Res Inst Med Sci, Sch Med,Dept Ophthalmol, Seoul, South Korea; [Lee, Andrew G.] Houston Methodist Hosp, Blanton Eye Inst, Dept Ophthalmol, Houston, TX USA; [Lee, Andrew G.] Weill Cornell Med, Dept Ophthalmol, Neurol, Neurosurg, New York, NY USA; [Lee, Andrew G.] Univ Texas Med Branch, Dept Ophthalmol, Galveston, TX USA; [Lee, Andrew G.] UT MD Anderson Canc Ctr, Dept Ophthalmol, Houston, TX USA; [Lee, Andrew G.] Texas A & M Coll Med, Dept Ophthalmol, College Stn, TX USA; [Lee, Andrew G.] Univ Iowa Hosp & Clin, Dept Ophthalmol, Iowa City, IA USA; [Lee, Andrew G.] Baylor Coll Med, Ctr Space Med, Dept Ophthalmol, Houston, TX USA; [Lee, Andrew G.] Univ Buffalo, Dept Ophthalmol, Buffalo, NY USA	Konkuk University; Konkuk University; Konkuk University Medical Center; Konkuk University; Konkuk University Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Iowa; Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shin, HJ (corresponding author), Konkuk Univ, Med Ctr, Res Inst Med Sci, Sch Med,Dept Ophthalmol, Seoul, South Korea.	shineye@kuh.ac.kr	Shin, Hyunjin/ABF-6057-2021; Lee, Andrew/GVU-2817-2022	Shin, Hyun Jin/0000-0002-3563-8042; Kang, Hyunkyoo/0000-0001-9664-1563	National Research Foundation of Korea(NRF) by Ministry of Education;  [2020R1I1A3075301]	National Research Foundation of Korea(NRF) by Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); 	Initials of the authors who received each award: H Kang center dot Grant numbers awarded to each author: 2020R1I1A3075301 center dot The full name of each funder: Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education center dot URL of each funder website: www.nrf.re.kr www.moe.go.kr center dot Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET HIV, V2017, pPE475; BIXENMAN WW, 1982, OPHTHALMOLOGY, V89, P58; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRANDT T, 1993, ANN NEUROL, V33, P528, DOI 10.1002/ana.410330518; Brodsky MC, 2014, J AAPOS, V18, P306, DOI 10.1016/j.jaapos.2014.01.009; Ehrt O, 2001, GRAEF ARCH CLIN EXP, V239, P678, DOI 10.1007/s004170100347; GALETTA SL, 1994, AM J OPHTHALMOL, V118, P509; GUYTON DL, 1988, GRAEF ARCH CLIN EXP, V226, P241, DOI 10.1007/BF02181189; Hyung Lee Si, 2013, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V54, P1091; Jethani J, 2010, INDIAN J OPHTHALMOL, V58, P417, DOI 10.4103/0301-4738.67060; Kothari Mihir T., 2005, Indian Journal of Ophthalmology, V53, P43; Kushner BJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P712, DOI 10.1001/archophthalmol.2010.88; Le Jeune C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191007; LEE J, 1985, BRIT J OPHTHALMOL, V69, P508, DOI 10.1136/bjo.69.7.508; LEVINE MH, 1972, AM J OPHTHALMOL, V73, P262, DOI 10.1016/0002-9394(72)90142-0; Ong JKY, 2010, J NEUROSCI METH, V192, P261, DOI 10.1016/j.jneumeth.2010.08.004; Parsa CF, 2013, BRIT J OPHTHALMOL, V97, P126, DOI 10.1136/bjophthalmol-2011-300867; Philips PH, 1999, CLIN STRABISMUS MANA, P52; Piedrahita-Alonso E, 2014, BRIT J OPHTHALMOL, V98, P115, DOI 10.1136/bjophthalmol-2013-303680; Qiu KL, 2019, BRIT J OPHTHALMOL, V103, P821, DOI 10.1136/bjophthalmol-2018-312162; Rohrschneider K, 2004, INVEST OPHTH VIS SCI, V45, P3257, DOI 10.1167/iovs.03-1157; SIMONS K, 1994, OPHTHALMOLOGY, V101, P1897; Toslak D, 2020, BIOMED OPT EXPRESS, V11, P68, DOI 10.1364/BOE.11.000068	23	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244230	10.1371/journal.pone.0244230	http://dx.doi.org/10.1371/journal.pone.0244230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351818	Green Published, gold			2022-12-27	WOS:000603071400008
J	Shin, HK; Park, SH; Kim, KW				Shin, Hye-kyung; Park, Sang Hee; Kim, Kyoung-woo			Inter-floor noise classification using convolutional neural network	PLOS ONE			English	Article							IMPACT; DWELLINGS; COMFORT; SOUNDS	In apartment houses, noise between floors can disturb pleasant living environments and cause disputes between neighbors. As a means of resolving disputes caused by inter-floor noise, noises are recorded for 24 hours in a household to verify whether the inter-floor noise exceeded the legal standards. If the noise exceeds the legal standards, the recorded sound is listened to, and it is checked whether the noise comes from neighboring households. When done manually, this process requires time and is costly, and there is a problem of whether the listener's judgments of the sound source are consistent. This study aims to classify inter-floor noise according to noise sources by using a convolutional neural network model. A total of 1,515 sound sources of data recorded for 24 h from three households were annotated, and 40 4s audio clips of six noise sources, including "Footsteps," "Dragging furniture," "Hammering," "Instant impact (dropping a heavy item)," "Vacuum cleaner," and "Public announcement system" were identified. Moreover, datasets of 16 classes using ESC50's urban sound category audio were used to distinguish the inter-floor noise heard indoors from the external noise. Although DenseNet, ResNet, Inception, and EfficientNet are models that use images as their domains, they showed an accuracy of 91.43-95.27% when classifying the inter-floor noise dataset. Among the reviewed models, ResNet showed an accuracy of 95.27 +/- 2.30% as well as a highest performance level in the F1 score, precision, and recall metrics. Additionally, ResNet showed the shortest inference time. This paper concludes by suggesting that the present findings can be extended in future research for monitoring acoustic elements of indoor soundscape.	[Shin, Hye-kyung; Park, Sang Hee; Kim, Kyoung-woo] Korea Inst Civil Engn & Bldg Technol, Dept Living & Built Environm Res, Goyang Si, Kyeonggi Do, South Korea	Korea Institute of Civil Engineering & Building Technology (KICT)	Kim, KW (corresponding author), Korea Inst Civil Engn & Bldg Technol, Dept Living & Built Environm Res, Goyang Si, Kyeonggi Do, South Korea.	kwmj@kict.re.kr		Park, Sang Hee/0000-0002-1476-2378	Residential Environment Research Program - Ministry of Land, Infrastructure and Transport of the Korean government [20RERP-B082204-07]	Residential Environment Research Program - Ministry of Land, Infrastructure and Transport of the Korean government	This research was supported by a grant (20RERP-B082204-07) from Residential Environment Research Program funded by Ministry of Land, Infrastructure and Transport of the Korean government.	[Anonymous], 2015, NAT BUILD COD CAN; Barbas Carmen Sílvia Valente, 2014, Rev. bras. ter. intensiva, V26, P215, DOI 10.5935/0103-507X.20140034; Choi H, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183735; Frontczak M, 2011, BUILD ENVIRON, V46, P922, DOI 10.1016/j.buildenv.2010.10.021; Guzhov A., 2020, ESRESNET ENV SOUND C; Ha J.W., 2020, ARXIV200608217; He K., 2015, DEEP RESIDUAL LEARNI, DOI DOI 10.1109/CVPR.2016.90; Huang G, 2018, ARXIV160806993V5, DOI [10.3969/j.issn.1673-4254.2018.06.04, DOI 10.3969/J.ISSN.1673-4254.2018.06.04]; International Code Council, 2018, INT BUILD COD; ISO, 2003, 156662003E ISOTS; Jakovjevic B, 2009, ENVIRON INT, V35, P552, DOI 10.1016/j.envint.2008.10.001; Jeon JY, 2015, BUILD ENVIRON, V94, P821, DOI 10.1016/j.buildenv.2015.07.021; Kim K, 2015, ELEC DES ADV PACKAG, P12, DOI 10.1109/EDAPS.2015.7383663; Kim KW, 2009, BUILD ENVIRON, V44, P1589, DOI 10.1016/j.buildenv.2008.10.005; Korea Environment Corporation, 2019, INT NOIS NEIGHB CTR; Lee J., 2017, ARXIV PREPRINT ARXIV; Lee PJ, 2009, ACTA ACUST UNITED AC, V95, P707, DOI 10.3813/AAA.918199; Li XY, 2019, INTERSPEECH, P3604, DOI 10.21437/Interspeech.2019-3019; McFee B., 2019, LIBROSA LIBROSA 0 6; Ministry of Environment, 2014, AP NEIGHB NOIS RES S; Mukhopadhyay AK, 2020, ARXIV191210905; Sousa ANE, 2011, APPL ACOUST, V72, P177, DOI 10.1016/j.apacoust.2010.11.006; Nordtest ACOU, 2002, 111 HUM SOUND PERC G; Palanisamy K., 2020, RETHINKING CNN MODEL; Park SH, 2019, APPL ACOUST, V150, P268, DOI 10.1016/j.apacoust.2019.02.021; Piczak KJ, 2015, MM'15: PROCEEDINGS OF THE 2015 ACM MULTIMEDIA CONFERENCE, P1015, DOI 10.1145/2733373.2806390; Qawaqneh Z, 2017, KNOWL-BASED SYST, V115, P5, DOI 10.1016/j.knosys.2016.10.008; Rasmussen B., 2019, PROC ICA 2019, P5102; Salamon J, 2017, IEEE SIGNAL PROC LET, V24, P279, DOI 10.1109/LSP.2017.2657381; Schoenwald S, 2010, INFLUENCE RECEIVE RO; Szegedy C., 2015, P IEEE C COMPUTER VI, P1; Tan M, 2019, ARXIV190511946V5; Vacher M, 2014, P 4 C SPEECH TECHN H, P135, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CB09781107415324.004]; Vardaxis NG, 2018, BUILD ACOUST, V25, P151, DOI 10.1177/1351010X18762687; Wang H, 2020, ARXIV191206808V2, DOI [10.4057/jsr.65.145, DOI 10.4057/JSR.65.145]; Woo SH, 2018, LECT NOTES COMPUT SC, V11211, P3, DOI 10.1007/978-3-030-01234-2_1; Xue P, 2016, ENERG BUILDINGS, V116, P181, DOI 10.1016/j.enbuild.2016.01.006; Yeon JO, 2017, APPL ACOUST, V125, P20, DOI 10.1016/j.apacoust.2017.03.019; Yu L., 2005, J ACOUST SOC AM, V117, P2591, DOI DOI 10.1121/1.4777296	39	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243758	10.1371/journal.pone.0243758	http://dx.doi.org/10.1371/journal.pone.0243758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351829	Green Published, gold			2022-12-27	WOS:000603071400020
J	Wright, JD; Climenhage, LJ; Schmitt, MT; Branscombe, NR				Wright, Joshua D.; Climenhage, L. James; Schmitt, Michael T.; Branscombe, Nyla R.			Perceptual harmony in judgments of group prototypicality and intragroup respect	PLOS ONE			English	Article							SELF-CATEGORIZATION; SOCIAL IDENTITY; BALANCE; DISCRIMINATION; ATTRACTION; LEADERS	We test common sense psychology of intragroup relations whereby people assume that intragroup respect and ingroup prototypicality are positively related. In Study 1a, participants rated a group member as more prototypical if they learned that group member was highly respected rather than disrespected. In Study 1b, participants rated a group member as more respected by other group members if they learned that group member was prototypical rather than unprototypical. As a commonsense psychology of groups, we reasoned that the perceived relationship between prototypicality and intragroup respect would be stronger for cohesive groups compared to incohesive groups. The effect of intragroup respect on perceptions of prototypicality (Study 2a & 2c) and the effect of prototypicality on perceptions of intragroup respect (Study 2b) were generally stronger for participants considering cohesive groups relative to incohesive groups. However, the interaction effect of prototypicality and group cohesion on intragroup respect did fail to replicate in Study 2d. In Studies 3, 4a, and 4b we manipulated the relationship between prototypicality and intragroup respect and found that when these variables were in perceptual harmony participants perceived groups as more cohesive. The results of eight out of nine studies conducted are consistent with the prediction that people make inferences about intragroup respect, prototypicality, and group cohesion in a manner that maintains perceptual harmony.	[Wright, Joshua D.; Climenhage, L. James; Schmitt, Michael T.] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Branscombe, Nyla R.] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA	Simon Fraser University; University of Kansas	Wright, JD (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.	jwright6@sjcny.edu		Wright, Joshua D./0000-0001-9077-0700; Schmitt, Michael/0000-0002-7116-2280	Social Sciences and Humanities Research Council of Canada (SSHRC)	Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR)	This research was supported through a Social Sciences and Humanities Research Council of Canada (SSHRC) grant to the third author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Branscombe NR, 2002, PERS SOC PSYCHOL B, V28, P744, DOI 10.1177/0146167202289004; Brewer MB., 2010, ADV SOCIAL PSYCHOL S, P535; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Churchland P., 1989, PHILOS PERSPECT, V3, P225, DOI [10.2307/2214269, DOI 10.2307/2214269]; Crandall CS, 2007, REV GEN PSYCHOL, V11, P12, DOI 10.1037/1089-2680.11.1.12; De Cremer D., 2005, SOC JUSTICE RES, V18, P121, DOI DOI 10.1007/S11211-005-7366-3; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gelman SA, 2011, ANNU REV ANTHROPOL, V40, P379, DOI 10.1146/annurev-anthro-081309-145822; Heider, 1958, PSYCHOL INTERPERSONA; Hogg MA, 2000, ACAD MANAGE REV, V25, P121, DOI 10.1093/cdj/bsi087; Hogg MA, 2006, COMMUN THEOR, V16, P7, DOI 10.1111/j.1468-2885.2006.00003.x; HOGG MA, 1991, PERS SOC PSYCHOL B, V17, P175, DOI 10.1177/014616729101700209; HOGG MA, 1993, PERS SOC PSYCHOL B, V19, P452, DOI 10.1177/0146167293194010; Hogg MA, 2001, PERS SOC PSYCHOL REV, V5, P184, DOI 10.1207/S15327957PSPR0503_1; HORGAN T, 1985, PHILOS REV, V94, P197, DOI 10.2307/2185428; HUMMERT ML, 1990, J PERS SOC PSYCHOL, V58, P5, DOI 10.1037/0022-3514.58.1.5; Huo YJ, 2010, PERS SOC PSYCHOL B, V36, P200, DOI 10.1177/0146167209356787; Huo YJ, 2008, SOC PERSONAL PSYCHOL, V2, P1570, DOI 10.1111/j.1751-9004.2008.00129.x; Jackson LM, 2001, PERS SOC PSYCHOL B, V27, P48, DOI 10.1177/0146167201271005; Jetten J, 1997, EUR J SOC PSYCHOL, V27, P635, DOI 10.1002/(SICI)1099-0992(199711/12)27:6<635::AID-EJSP835>3.0.CO;2-#; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P875, DOI 10.1177/1948550617693058; Litman L, 2017, BEHAV RES METHODS, V49, P433, DOI 10.3758/s13428-016-0727-z; Mehl MR, 2006, J PERS SOC PSYCHOL, V90, P862, DOI 10.1037/0022-3514.90.5.862; Pew Research Center, 2018, DAT WOM LEAD; Rast DE, 2012, J EXP SOC PSYCHOL, V48, P646, DOI 10.1016/j.jesp.2011.12.013; Rydell RJ, 2005, PERS SOC PSYCHOL B, V31, P99, DOI 10.1177/0146167204271316; Schimmack U, 2012, PSYCHOL METHODS, V17, P551, DOI 10.1037/a0029487; Schmitt MT, 2001, J EXP SOC PSYCHOL, V37, P510, DOI 10.1006/jesp.2001.1476; Simonsohn U, 2015, J EXP PSYCHOL GEN, V144, P1146, DOI 10.1037/xge0000104; SMITH ER, 1990, SOC COGNITION, V8, P243, DOI 10.1521/soco.1990.8.3.243; Smith HJ, 1997, J EXP SOC PSYCHOL, V33, P146, DOI 10.1006/jesp.1996.1318; Spears R, 2005, EUR J SOC PSYCHOL, V35, P263, DOI 10.1002/ejsp.248; TAJFEL H, 1963, BRIT J PSYCHOL, V54, P101, DOI 10.1111/j.2044-8295.1963.tb00865.x; Turner J.C., 2010, KEY READINGS SOCIAL, P243; Turner J.C., 2012, THEORIES SOCIAL PSYC, P399, DOI [10.4135/9781446249222.n46, DOI 10.4135/9781446249222.N46]; Ullrich J, 2009, J APPL PSYCHOL, V94, P235, DOI 10.1037/a0012936	37	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243821	10.1371/journal.pone.0243821	http://dx.doi.org/10.1371/journal.pone.0243821			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351832	Green Published, Green Submitted, gold			2022-12-27	WOS:000603071400005
J	Bedard, A; Lamarche, PO; Gregoire, LM; Trudel-Guy, C; Provencher, V; Desroches, S; Lemieux, S				Bedard, Alexandra; Lamarche, Pierre-Olivier; Gregoire, Lucie-Maude; Trudel-Guy, Catherine; Provencher, Veronique; Desroches, Sophie; Lemieux, Simone			Can eating pleasure be a lever for healthy eating? A systematic scoping review of eating pleasure and its links with dietary behaviors and health	PLOS ONE			English	Review							FOOD-CHOICE-MOTIVES; HEDONIC CHARACTERISTICS; TASTE ATTITUDES; WEIGHT-LOSS; ENJOYMENT; INTERVENTION; DEFINITION; VEGETABLES; CONSUMERS; QUALITY	The aims of this review were to map and summarize data currently available about 1) key dimensions of eating pleasure; 2) associations of eating pleasure, and its key dimensions, with dietary and health outcomes and 3) the most promising intervention strategies using eating pleasure to promote healthy eating. Using the scoping review methodology, a comprehensive search of the peer-reviewed literature (Medline, PsycInfo, Embase, ERIC, Web of Science, CINAHL, ABI/Inform global and Sociology Abstract) and of the grey literature (ProQuest Dissertations & Theses and Google) was carried out by two independent reviewers. We included 119 of the 28,908 studies found. In total, 89 sub-dimensions of eating pleasure were grouped into 22 key dimensions. The most frequently found related to sensory experiences (in 50.9% of the documents), social experiences (42.7%), food characteristics besides sensory attributes (27.3%), food preparation process (19.1%), novelty (16.4%), variety (14.5%), mindful eating (13.6%), visceral eating (12.7%), place where food is consumed (11.8%) and memories associated with eating (10.9%). Forty-five studies, mostly cross-sectional (62.2%), have documented links between eating pleasure and dietary and/or health outcomes. Most studies (57.1%) reported favorable associations between eating pleasure and dietary outcomes. For health outcomes, results were less consistent. The links between eating pleasure and both dietary and health outcomes varied according to the dimensions of eating pleasure studied. Finally, results from 11 independent interventions suggested that strategies focusing on sensory experiences, cooking and/or sharing activities, mindful eating, and positive memories related to healthy food may be most promising. Thus, eating pleasure may be an ally in the promotion of healthy eating. However, systematically developed, evidence-based interventions are needed to better understand how eating pleasure may be a lever for healthy eating.	[Bedard, Alexandra; Gregoire, Lucie-Maude; Trudel-Guy, Catherine; Provencher, Veronique; Desroches, Sophie; Lemieux, Simone] Univ Laval, Inst Nutr & Funct Foods, Ctr Nutr Sante & Soc NUTRISS, Quebec City, PQ, Canada; [Lamarche, Pierre-Olivier] Univ Laval, Dept Sociol, Quebec City, PQ, Canada; [Gregoire, Lucie-Maude; Trudel-Guy, Catherine; Provencher, Veronique; Desroches, Sophie; Lemieux, Simone] Univ Laval, Sch Nutr, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Lemieux, S (corresponding author), Univ Laval, Inst Nutr & Funct Foods, Ctr Nutr Sante & Soc NUTRISS, Quebec City, PQ, Canada.; Lemieux, S (corresponding author), Univ Laval, Sch Nutr, Quebec City, PQ, Canada.	Simone.Lemieux@fsaa.ulaval.ca		Bedard, Alexandra/0000-0002-0526-6022; Gregoire, Lucie-Maude/0000-0002-9485-0481; Provencher, Veronique/0000-0002-0404-8883	Canadian Institutes of Health Research [FHG 129921]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (author who received this grant: Simone Lemieux; grant number FHG 129921; URL: https://cihr-irsc.gc.ca/).There was no additional external funding received for this study. The CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absolom S, 2011, J OCCUP SCI, V18, P339, DOI 10.1080/14427591.2011.586324; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adam M, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0305-2; Ainuki T, 2013, J NUTR EDUC BEHAV, V45, P274, DOI 10.1016/j.jneb.2012.11.001; Andersen BV, 2015, APPETITE, V95, P9, DOI 10.1016/j.appet.2015.06.011; [Anonymous], 2015, TRACK NUTR TRENDS; [Anonymous], 2017, ONCOGENESIS, V6, pe345; [Anonymous], 1948, CONST WHO PRINC; Appleton K M, 2006, Eat Behav, V7, P342, DOI 10.1016/j.eatbeh.2005.11.008; Arch JJ, 2016, BEHAV RES THER, V79, P23, DOI 10.1016/j.brat.2016.02.002; Arksey, 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Australian Government, 2017, DISCR FOOD DRINK CHO; Australian Government, 2019, UND FOOD LAB; Australian Government, 2015, CHOOS NUTR FOODS; Baek U, 2009, THESIS; Bailly N, 2015, ARCH GERONTOL GERIAT, V61, P330, DOI 10.1016/j.archger.2015.08.020; Barron P, 2011, HOW GOOGLE WORKS; Bedard A, 2020, SCOPING REV PROTOCOL; Bissell P, 2016, SOC SCI MED, V159, P14, DOI 10.1016/j.socscimed.2016.04.026; Block LG, 2011, J PUBLIC POLICY MARK, V30, P5, DOI 10.1509/jppm.30.1.5; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Cachelin FM, 1998, OBES RES, V6, P231, DOI 10.1002/j.1550-8528.1998.tb00342.x; Canadian Foundation for Dietetic Research, 2013, TRACK NUTR TRENDS 20; Centre de recherche et d'informations nutritionnelles (CERIN), 2018, BIEN MANG PLAIS EQ; Clifford D, 2015, J NUTR EDUC BEHAV, V47, P143, DOI 10.1016/j.jneb.2014.12.002; Colquhoun HL, 2014, J CLIN EPIDEMIOL, V67, P1291, DOI 10.1016/j.jclinepi.2014.03.013; Cornil Y, 2016, J MARKETING RES, V53, P847, DOI 10.1509/jmr.14.0299; Cornil Y, 2016, APPETITE, V104, P52, DOI 10.1016/j.appet.2015.08.045; Cornil Y, 2013, PSYCHOL SCI, V24, P1936, DOI 10.1177/0956797613481232; Coulthard H, 2018, APPETITE, V120, P609, DOI 10.1016/j.appet.2017.10.011; Coulthard H, 2015, J ACAD NUTR DIET, V115, P1134, DOI [10.1016/j.jand.2015.02.020, 1]; Crawford D, 2007, PUBLIC HEALTH NUTR, V10, P256, DOI 10.1017/S1368980007246798; Darcel N, 2016, APPETITE, V104, P1, DOI 10.1016/j.appet.2016.04.001; Demos KE, 2017, APPETITE, V114, P93, DOI 10.1016/j.appet.2017.03.013; Dodds A, 2017, APPETITE, V108, P42, DOI 10.1016/j.appet.2016.09.021; Ducrot P, 2017, BRIT J NUTR, V117, P851, DOI [10.1017/S0007114517000666, 10.1017/s0007114517000666]; Ducrot P, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070413; Dupuy A., 2008, ENFANCE PSYCHOL PEDA, V60, P261, DOI [https://doi.org/10.3917/enf.603.0261, DOI 10.3917/ENF.603.0261]; Ekmekcioglu C, 2012, TURK J MED SCI, V42, P1, DOI 10.3906/sag-1010-1270; Ensaff H, 2017, J PUBLIC HEALTH-UK, V39, P567, DOI 10.1093/pubmed/fdw086; Fries LR, 2019, NESTLE NUTR WORKS SE, V91, P31, DOI 10.1159/000493676; Gibson EL, 2012, OBES REV, V13, P85, DOI 10.1111/j.1467-789X.2011.00939.x; Goutons un monde meilleur, 2011, GOUTONS MONDE MEILLE; Gouvernement du Canada, 2010, AM COMP CUL SYNTH DO; Gouvernement du Canada, 2011, TEND MOND CONS EXP S; Gouvernement du Canada, 2007, BIEN MANG AV GUID AL; Gouvernement du Quebec, 2009, BIEN MANG MIEUX GRAN; Government of Brazil, 2014, DIET GUID BRAZ POP; Government of Canada, 2019, CAN FOOD GUID CULT F; Government of Canada, 2019, CAN FOOD GUID HLTH E; Government of Canada, 2019, CAN FOOD GUID EAT MA; Government of Canada, 2019, CAN FOOD GUID CAN DI; Government of Canada, 2019, CAN FOOD GUID TAK TI; Government of Canada, 2019, CAN FOOD GUID ENJ YO; Government of Canada, 2004, EAT WELL AG WELL; Government of South Australia, 2009, NUTR INF FACT SHEET; Gravel K, 2014, J ACAD NUTR DIET, V114, P99, DOI 10.1016/j.jand.2013.06.354; Gravel K, 2014, FOOD QUAL PREFER, V32, P271, DOI 10.1016/j.foodqual.2013.09.001; Guillemin I, 2016, APPETITE, V96, P333, DOI 10.1016/j.appet.2015.09.021; Hansen T., 2002, J INT CONSUMER MARKE, V15, P31, DOI [10.1300/J046v15n01_03, DOI 10.1300/J046V15N01_03]; Harvard School of Public Health Prevention Research Center (HPRC), 2011, FOOD FUN SCH CHANG I; Hege MA, 2018, APPETITE, V125, P492, DOI 10.1016/j.appet.2018.03.006; Helland SH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2952-x; Higgs S, 2008, PHYSIOL BEHAV, V94, P734, DOI 10.1016/j.physbeh.2008.04.012; Hong PY, 2014, MINDFULNESS, V5, P80, DOI 10.1007/s12671-012-0154-x; Huang YH, 2016, FOOD QUAL PREFER, V54, P75, DOI 10.1016/j.foodqual.2016.07.007; Hunot C, 2016, APPETITE, V105, P356, DOI 10.1016/j.appet.2016.05.024; Hur J, 2015, INT J HOSP MANAG, V48, P113, DOI 10.1016/j.ijhm.2015.04.015; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Institut national de la recherche agronomique (INRA), 2010, COMP AL QUELS SONT D; Iulio S. de, 2014, International Journal of Sociology of Agriculture and Food, V21, P327; Jackson B, 2003, J RES PERS, V37, P297, DOI 10.1016/S0092-6566(02)00574-3; Jacquier C, 2012, NUTR REV, V70, P118, DOI 10.1111/j.1753-4887.2011.00447.x; Jallinoja P, 2010, HEALTH-LONDON, V14, P115, DOI 10.1177/1363459309353292; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; Kauppinen-Raisanen H, 2013, BRIT FOOD J, V115, P666, DOI 10.1108/00070701311331571; Kiefer I., 2005, J MENS HLTH GENDER, V2, P194, DOI 10.1016/j.jmhg.2005.04.010; Landry M, 2018, APPETITE, V125, P537, DOI 10.1016/j.appet.2018.02.033; Larson JS, 2014, J CONSUM PSYCHOL, V24, P188, DOI 10.1016/j.jcps.2013.09.001; Le Bel JL, 2000, INVESTIGATION EXPERI; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Lieffere JRL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196333; Lindeman M, 1999, APPETITE, V33, P141, DOI 10.1006/appe.1999.0241; Lindeman M, 2000, APPETITE, V35, P263, DOI 10.1006/appe.2000.0357; Loewenstein G, 1996, ORGAN BEHAV HUM DEC, V65, P272, DOI 10.1006/obhd.1996.0028; Loh DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082885; Lovell-Smith D, 2010, MED HYPOTHESES, V75, P172, DOI 10.1016/j.mehy.2010.02.013; Lupton D, 2000, SOCIOL HEALTH ILL, V22, P94, DOI 10.1111/1467-9566.00193; Macht M., 2005, J HAPPINESS STUD, V6, P137, DOI DOI 10.1007/S10902-005-0287-X; Marquis M, 2005, CAN J DIET PRACT RES, V66, P77, DOI 10.3148/66.2.2005.77; Marty L, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0618-4; Marty L, 2018, APPETITE, V120, P265, DOI 10.1016/j.appet.2017.09.006; Mason TB, 2019, ASSESSMENT, V26, P907, DOI 10.1177/1073191117719508; Mayes CR, 2015, J BIOETHIC INQ, V12, P587, DOI 10.1007/s11673-015-9670-4; McClain AD, 2011, EAT BEHAV, V12, P277, DOI 10.1016/j.eatbeh.2011.07.010; Mela DJ, 2006, APPETITE, V47, P10, DOI 10.1016/j.appet.2006.02.006; Menneteau U., 2009, OBESITE, V4, P120; Monnery-Patris S, 2016, APPETITE, V96, P580, DOI 10.1016/j.appet.2015.10.026; Moore DJ, 2013, MARKET LETT, V24, P399, DOI 10.1007/s11002-013-9230-9; Muzaffar H, 2018, CURR DEV NUTR, V2, DOI 10.1093/cdn/nzy016; Newcombe MA, 2012, APPETITE, V59, P391, DOI 10.1016/j.appet.2012.05.031; Nicklaus S, 2016, APPETITE, V104, P3, DOI 10.1016/j.appet.2015.08.022; NIH: National Institute on Anging, 2019, HLTH EAT CHOOS HLTH; Niva M, 2007, APPETITE, V48, P384, DOI 10.1016/j.appet.2006.10.006; Olsen SO, 2017, FOOD RES INT, V99, P98, DOI 10.1016/j.foodres.2017.05.008; Onwezen MC, 2013, FOOD QUAL PREFER, V28, P226, DOI 10.1016/j.foodqual.2012.07.010; Otake K, 2017, J HAPPINESS STUD, V18, P691, DOI 10.1007/s10902-016-9747-8; Peters M.D.J., 2020, SCOPING REV JBI REVI; Peterson J, 2017, J AM ASSOC NURSE PRA, V29, P12, DOI 10.1002/2327-6924.12380; Petit O, 2016, PSYCHOL MARKET, V33, P608, DOI 10.1002/mar.20903; Petit O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156333; Pettigrew S, 2016, APPETITE, V104, P60, DOI 10.1016/j.appet.2015.10.004; Phan UTX, 2016, APPETITE, V105, P204, DOI 10.1016/j.appet.2016.05.031; Phan UTX, 2016, J SENS STUD, V31, P114, DOI 10.1111/joss.12197; Phull S, 2015, SOCIOL COMPASS, V9, P977, DOI 10.1111/soc4.12307; Potestio KG, 2012, THESIS; Prior AL, 2013, J CHILD HEALTH CARE, V17, P354, DOI 10.1177/1367493512462261; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; RAPPOPORT L, 1993, APPETITE, V20, P33, DOI 10.1006/appe.1993.1004; RAPPOPORT LH, 1992, ECOL FOOD NUTR, V28, P171, DOI 10.1080/03670244.1992.9991269; Ray Chaudhury S, 2010, PAINSTAKING PLEASURA; Regnier F, 2014, SOCIOL SOC, V46, P85; Remick AK, 2009, EAT BEHAV, V10, P42, DOI 10.1016/j.eatbeh.2008.11.001; Republique Francaise, 2019, REC AL ACT PHYS SED; Republique Francaise, 2013, OUT AID VAL SERV RES; Republique Francaise, 2012, EV AL FRANC; Republique Francaise, 2018, ED AL JEUN; Republique Francaise, 2010, AT CUIS AL DUR; Republique Francaise, 2010, QUAL GUST AL ENV REP; Republique Francaise, 2005, AL INS GUID ACC CAL; Republique Francaise, 2014, INT SOC AL; Republique Francaise, 2016, CONS STRAT; Republique Francaise, 2002, PROGR NAT NUTR SANT; Republique Francaise, 2016, FAIR SOI MEM; Republique Francaise, 2011, PROGR FORM ENS CLASS; Republique Francaise. Ministere de l'education nationale et de la jeunesse, 2019, MIN ED NAT JEUN ED A; Robinson E, 2012, BRIT J NUTR, V108, P1505, DOI 10.1017/S0007114511007021; Robinson E, 2011, J AM DIET ASSOC, V111, P1543, DOI 10.1016/j.jada.2011.07.012; Roininen K, 1999, APPETITE, V33, P71, DOI 10.1006/appe.1999.0232; Roininen K, 2001, APPETITE, V37, P33, DOI 10.1006/appe.2001.0414; Roininen K, 1999, FOOD QUAL PREFER, V10, P357, DOI 10.1016/S0950-3293(98)00057-3; Roininen K, 2000, ECOL FOOD NUTR, V39, P61, DOI [10.1080/03670244.2000.9991605, NO_DOI]; Rozin P, 1999, APPETITE, V33, P163, DOI 10.1006/appe.1999.0244; Rozin P, 2003, J PERS SOC PSYCHOL, V85, P132, DOI 10.1037/0022-3514.85.1.132; Salvat E, 2010, YOUNG CONSUM, V11, P148, DOI 10.1108/17473611011065836; Sasson L., 2007, Topics in Clinical Nutrition, V22, P357; Schuldt JP, 2013, APPETITE, V62, P76, DOI 10.1016/j.appet.2012.11.004; Smith T, 2006, AM J HEALTH EDUC, V37, P130, DOI 10.1080/19325037.2006.10598892; Somers J, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-60; Stroebe W, 2013, PSYCHOL REV, V120, P110, DOI 10.1037/a0030849; Thogersen-Ntoumani C, 2009, EAT BEHAV, V10, P107, DOI 10.1016/j.eatbeh.2009.03.001; Tribole E., 2020, INTUITIVE EATING REC, V4th; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; TUORILA H, 1994, APPETITE, V23, P247, DOI 10.1006/appe.1994.1057; UN Development Programme , 2016, HUMAN DEV REPORT 201; United States Department of Agriculture, 2016, ENJ YOUR FOOD BUT EA; United States Department of Agriculture, 2016, 10 TIPS CUT BACK YOU; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Victoria State Government, 2011, CHILDR DIET FRUIT VE; Victoria State Government, 2012, SEN CEL GOOD EAT FOO; Victoria State Government, 2011, FRUIT VEG; Vinai P, 2016, EAT WEIGHT DISORD-ST, V21, P453, DOI 10.1007/s40519-015-0243-7; Vogel E, 2014, SOCIOL HEALTH ILL, V36, P305, DOI 10.1111/1467-9566.12116; Wahl DR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17262-9; Wallace TC, 2020, CRIT REV FOOD SCI, V60, P2174, DOI 10.1080/10408398.2019.1632258; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Warren JM, 2017, NUTR RES REV, V30, P272, DOI 10.1017/S0954422417000154; Werle COC, 2013, FOOD QUAL PREFER, V28, P116, DOI 10.1016/j.foodqual.2012.07.007; Werle COC, 2012, MARKET LETT, V23, P883, DOI 10.1007/s11002-012-9195-0; West D, 2004, THESIS; WHO, 2002, DIET NUTR PREV CHRON; WHO, 2020, HLTH DIET; Wiggins S, 2017, FUTURE DIETS DEV WOR; Yang CL, 2014, J HOSP MARKET MANAG, V23, P579, DOI 10.1080/19368623.2013.813887; Yang ECL, 2015, ASIA PAC J TOUR RES, V20, P1545, DOI 10.1080/10941665.2014.998248; Zheng HY, 2007, CURR OPIN PHARMACOL, V7, P607, DOI 10.1016/j.coph.2007.10.011; Zurawicki L, 2015, FOOD RES INT, V76, P200, DOI 10.1016/j.foodres.2015.05.003	178	12	13	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244292	10.1371/journal.pone.0244292	http://dx.doi.org/10.1371/journal.pone.0244292			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347469	Green Published, gold			2022-12-27	WOS:000603071100042
J	McEvoy, M; Luker, J; Fryer, C; Lewis, LK				McEvoy, Maureen; Luker, Julie; Fryer, Caroline; Lewis, Lucy K.			Changes in physiotherapists' perceptions of evidence-based practice after a year in the workforce: A mixed-methods study	PLOS ONE			English	Article								Background Few studies have explored evidence-based practice (EBP) knowledge, attitudes and behaviours of health professional graduates transitioning into the workforce. This study evaluated changes in these EBP domains in physiotherapists after one year of working. Method A mixed methods design was used. Participants completed two psychometrically-tested EBP questionnaires at two timepoints. The Evidence-Based Practice Profile questionnaire collected self-report EBP data (Terminology, Relevance, Confidence, Practice, Sympathy) and the Knowledge of Research Evidence Competencies collected objective data (Actual Knowledge). Changes were calculated using descriptive statistics (paired t-tests, 95% CI, effect sizes). Qualitative interview data collected at one timepoint were analysed using a descriptive approach and thematic analysis, to examine the lived experience of participants in the context of their first employment. The aim of the mixed methods approach was a broader and deeper understanding of participants' first year of employment and using EBP. Results Data were analysed from 50 participants who completed both questionnaires at the two timepoints. After one year in the workforce, there was a significant decrease in participants' perceptions of Relevance (p<0.001) and Confidence with EBP (p<0.001) and non-significant decreases in the other domains. Effect sizes showed medium decreases for Relevance (0.69) and Confidence (0.57), small decreases in Terminology (0.28) and Practice (0.23), and very small decreases in Sympathy (0.08) and Actual Knowledge (0.11). Seven themes described participants experience of using EBP in their first working year. Conclusions After a year in the workplace, confidence and perceptions of relevance of EBP were significantly reduced. A subtle interplay of features related to workplace culture, competing demands to develop clinical skills, internal and external motivators to use EBP and patient expectations, together with availability of resources and time, may impact early graduates' perceptions of EBP. Workplace role models who immersed themselves in evidence discussion and experience were inspiring to early graduates.	[McEvoy, Maureen; Luker, Julie; Fryer, Caroline] Univ South Australia, Allied Hlth & Human Performance Unit, Adelaide, SA, Australia; [Lewis, Lucy K.] Flinders Univ S Australia, Caring Futures Inst, Coll Nursing & Hlth Sci, Adelaide, SA, Australia	University of South Australia; Flinders University South Australia	McEvoy, M (corresponding author), Univ South Australia, Allied Hlth & Human Performance Unit, Adelaide, SA, Australia.	maureen.mcevoy@unisa.edu.au	McEvoy, Maureen P/C-8172-2009; Fryer, Caroline/D-4592-2009	McEvoy, Maureen P/0000-0002-2668-4856; Lewis, Lucy/0000-0001-9579-9991; Fryer, Caroline/0000-0001-8281-2130	University of South Australia Learning and Teaching Grant	University of South Australia Learning and Teaching Grant	MM, LL, JL received a University of South Australia Learning and Teaching Grant 2013 ($9985.23) (no number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Beidas RS, 2010, CLIN PSYCHOL-SCI PR, V17, P1, DOI 10.1111/j.1468-2850.2009.01187.x; Bozzolan M, 2014, PHYSIOTHER THEOR PR, V30, P557, DOI 10.3109/09593985.2014.910285; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cook D J, 1992, J Intensive Care Med, V7, P275; Dawes Martin, 2005, BMC Med Educ, V5, P1; Delany CM, 2005, PHYSIOTHERAPY, V91, P197, DOI 10.1016/j.physio.2005.05.002; Denzin N., 2005, HDB QUALITATIVE RES, P1, DOI DOI 10.1163/9789087909086_002; Dreyfus HL, 2005, ORGAN STUD, V26, P779, DOI 10.1177/0170840605053102; Fetters MD, 2013, HEALTH SERV RES, V48, P2134, DOI 10.1111/1475-6773.12117; Glisczinski D, 2018, J TRANSFORM EDUC, V16, P175, DOI 10.1177/1541344618777367; Guyatt G., 1991, ACP J CLUB A, VA-16, P114; Hayward LM, 2013, PHYS THER, V93, P369, DOI 10.2522/ptj.20120214; Ilic D, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0321-6; Ilic D, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-169; Leffler JM, 2013, PROF PSYCHOL-RES PR, V44, P20, DOI 10.1037/a0029241; Lewis LK, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-77; Lizarondo L, 2011, J MULTIDISCIP HEALTH, V4, P261, DOI 10.2147/JMDH.S23144; McEvoy MP, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1212-4; McEvoy MP, 2016, TEACH LEARN MED, V28, P26, DOI 10.1080/10401334.2015.1107490; McEvoy MP, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-100; McEvoy MP, 2010, MED TEACH, V32, pE373, DOI 10.3109/0142159X.2010.494741; MEDINA MS, 2017, AM J PHARM EDUC, V81; Sanders Matthew R, 2005, Child Adolesc Ment Health, V10, P158, DOI 10.1111/j.1475-3588.2005.00367.x; Scurlock-Evans L, 2014, PHYSIOTHERAPY, V100, P208, DOI 10.1016/j.physio.2014.03.001; Stanley M., 2015, QUALITATIVE RES METH, P21; Thomas A, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-0895-2; Thorne S., 2004, INT J QUAL METH, V3, P1, DOI [DOI 10.1177/160940690400300101, 10.1177/160940690400300101]; Tilson JK, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0654-9; Tilson JK, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-125; Tilson JK, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-126	30	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244190	10.1371/journal.pone.0244190	http://dx.doi.org/10.1371/journal.pone.0244190			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347468	Green Accepted, gold, Green Published			2022-12-27	WOS:000603071100015
J	Shahidullah, M; Wilson, WS; Rafiq, K; Sikder, MH; Ferdous, J; Delamere, NA				Shahidullah, Mohammad; Wilson, William Stuart; Rafiq, Kazi; Sikder, Mahmudul Hasan; Ferdous, Jannatul; Delamere, Nicholas Anthony			Terbutaline, forskolin and cAMP reduce secretion of aqueous humour in the isolated bovine eye	PLOS ONE			English	Article							CAPACITATIVE CALCIUM-ENTRY; INTRACELLULAR-CALCIUM; CYCLIC-AMP; INOSITOL TRISPHOSPHATE; INTRAOCULAR-PRESSURE; CA2+ MOBILIZATION; EPITHELIAL-CELLS; CILIARY; TIMOLOL; TRANSPORT	In order to elucidate involvement of cyclic AMP and intracellular Ca2+,[Ca2+](i), in the modulation of aqueous humour formation (AHF), we studied the effects of terbutaline, forskolin and 8-Br-cAMP in the isolated bovine eye. We also studied the interaction of cAMP on calcium signaling in cultured ciliary epithelial (CE) cells. Drug effects on AHF were measured by fluorescein dilution. Drug effects on [Ca2+](i) were studied by the fura-2 fluorescence ratio technique. Terbutaline (100 nmol-100 M), forskolin (30 nM-100 M) or 8-Br-cAMP (100 nM- 10 mu M), administered in the arterial perfusate produced significant reductions in AHF. The AH reducing effect of terbutaline was blocked by a selective inhibitor of protein kinase A (KT-5720). ATP (100 M) caused a rapid, transient (peak) increase in [Ca2+](i) followed by a sustained plateau phase lasting more than 5 minutes. Preincubation of the cells (6 min) with terbutaline, forskolin or 8-Br-cAMP significantly reduced the peak calcium response to ATP. The sustained plateau phase of the response, on the other hand, was augmented by each of the agents. KT-5720 partially reversed the inhibitory effect of terbutaline on the peak and totally inhibited its effect on the plateau phase. These data indicate: (a) that AHF in the bovine eye can be manipulated through cyclic AMP, operating via protein kinase A, (b) that protein kinase A can affect [Ca2+](i) homeostasis, (c) that calcium release from the intracellular store, not the entry, affects AHF, and (d) that interaction of [Ca2+](i) with cAMP plays a role in modulating AH secretion.	[Shahidullah, Mohammad; Delamere, Nicholas Anthony] Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA; [Shahidullah, Mohammad; Delamere, Nicholas Anthony] Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA; [Wilson, William Stuart] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Rafiq, Kazi; Sikder, Mahmudul Hasan; Ferdous, Jannatul] Bangladesh Agr Univ, Dept Pharmacol, Mymensing, Bangladesh	University of Arizona; University of Arizona; University of Glasgow; Bangladesh Agricultural University (BAU)	Shahidullah, M (corresponding author), Univ Arizona, Dept Physiol, Tucson, AZ 85721 USA.; Shahidullah, M (corresponding author), Univ Arizona, Dept Ophthalmol & Vis Sci, Tucson, AZ 85721 USA.	shahidua@arizona.edu	Rafiq, Kazi/AEU-4834-2022; Shahidullah, Mohammad/AAA-1359-2022	Shahidullah, Mohammad/0000-0002-1142-4242	Fight for Sight, London, through National Lottery Charities Board, UK; USPHS Research Award, USA [R01EY029171]	Fight for Sight, London, through National Lottery Charities Board, UK; USPHS Research Award, USA	This research was generously supported by the charity, Fight for Sight, London, through a grant from the National Lottery Charities Board, UK and by a USPHS Research Award, R01EY029171, USA.	Abdollahi M, 2001, FUND CLIN PHARMACOL, V15, P307, DOI 10.1046/j.1472-8206.2001.00041.x; [Anonymous], 2004, AM J PHYSIOL-ENDOC M, V287, pE955; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BRUBAKER RF, 1984, INVEST OPHTH VIS SCI, V25, P357; BRUNE B, 1992, EUR J BIOCHEM, V207, P607, DOI 10.1111/j.1432-1033.1992.tb17087.x; Civan MM, 2003, J EXP ZOOL PART A, V300A, P5, DOI 10.1002/jez.a.10303; Civan MM, 2008, CURR TOP MEMBR, V62, P1, DOI 10.1016/S1063-5823(08)00401-8; COAKES RL, 1978, ARCH OPHTHALMOL-CHIC, V96, P2045, DOI 10.1001/archopht.1978.03910060433007; CROOK RB, 1991, CURR EYE RES, V10, P593, DOI 10.3109/02713689109013851; CROOK RB, 1992, EXP EYE RES, V55, P785, DOI 10.1016/0014-4835(92)90005-D; DAILEY RA, 1982, AM J OPHTHALMOL, V93, P232, DOI 10.1016/0002-9394(82)90419-6; Farahbakhsh NA, 1997, EXP EYE RES, V64, P173, DOI 10.1006/exer.1996.0194; Fleischhauer JC, 2001, AM J PHYSIOL-CELL PH, V281, pC1614, DOI 10.1152/ajpcell.2001.281.5.C1614; GAMBERUCCI A, 1994, J BIOL CHEM, V269, P23597; Giovanelli A, 1996, BIOCHEM BIOPH RES CO, V220, P472, DOI 10.1006/bbrc.1996.0423; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HALLAM TJ, 1988, BIOCHEM J, V251, P243, DOI 10.1042/bj2510243; Jackson TS, 1996, AM J PHYSIOL-HEART C, V271, pH924, DOI 10.1152/ajpheart.1996.271.3.H924; Kageyama Kyoko, 2004, J Anesth, V18, P107, DOI 10.1007/s00540-004-0228-6; Leipziger J, 1997, PFLUG ARCH EUR J PHY, V434, P77; LINCOLN TM, 1990, AM J PHYSIOL, V258, pC399, DOI 10.1152/ajpcell.1990.258.3.C399; MITTAG TW, 1993, AM J PHYSIOL, V264, pF1060, DOI 10.1152/ajprenal.1993.264.6.F1060; NATHANSON JA, 1980, P NATL ACAD SCI-BIOL, V77, P7420, DOI 10.1073/pnas.77.12.7420; NEUFELD AH, 1972, EXP EYE RES, V14, P242, DOI 10.1016/0014-4835(72)90009-7; Niisato N, 1997, CAN J PHYSIOL PHARM, V75, P1030, DOI 10.1139/cjpp-75-8-1030; PATERSON GD, 1972, BRIT J OPHTHALMOL, V56, P288, DOI 10.1136/bjo.56.3.288; POZZAN T, 1994, PHYSIOL REV, V74, P595, DOI 10.1152/physrev.1994.74.3.595; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; Schutte M, 1996, J PHYSIOL-LONDON, V496, P25, DOI 10.1113/jphysiol.1996.sp021662; Shaharuddin M.I., 2011, MED CHEM RES, P1; Shahidullah M, 2003, INVEST OPHTH VIS SCI, V44, P1185, DOI 10.1167/iovs.02-0397; SHAHIDULLAH M, 1995, CURR EYE RES, V14, P519, DOI 10.3109/02713689508998398; Shahidullah M, 1997, CURR EYE RES, V16, P1006, DOI 10.1076/ceyr.16.10.1006.9018; Shahidullah M, 1999, BRIT J PHARMACOL, V127, P1438, DOI 10.1038/sj.bjp.0702681; Song SK, 1998, BIOCHEM PHARMACOL, V56, P561, DOI 10.1016/S0006-2952(97)00660-6; STRAUSS O, 1992, J OCUL PHARMACOL, V8, P359, DOI 10.1089/jop.1992.8.359; SUPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747, DOI 10.1073/pnas.85.22.8747; Suzuki Y, 1997, CURR EYE RES, V16, P166, DOI 10.1076/ceyr.16.2.166.5095; TSUNODA Y, 1993, BIOCHIM BIOPHYS ACTA, V1154, P105, DOI 10.1016/0304-4157(93)90008-C; Wang Z, 2010, AM J PHYSIOL-CELL PH, V298, pC798, DOI 10.1152/ajpcell.00406.2009; WETTRELL K, 1977, EXP EYE RES, V24, P613, DOI 10.1016/0014-4835(77)90119-1; WETTRELL K, 1977, ACTA OPHTHALMOL, P7; WILSON WS, 1993, CURR EYE RES, V12, P609, DOI 10.3109/02713689309001840; YABLONSKI ME, 1978, EXP EYE RES, V27, P135, DOI 10.1016/0014-4835(78)90083-0; Yang CM, 1996, PFLUG ARCH EUR J PHY, V432, P708, DOI 10.1007/s004240050189; YOSHIMURA N, 1995, CURR EYE RES, V14, P629, DOI 10.3109/02713689508998489	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244253	10.1371/journal.pone.0244253	http://dx.doi.org/10.1371/journal.pone.0244253			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347508	Green Published, gold, Green Accepted			2022-12-27	WOS:000603071100033
J	Viana, MVC; Profeta, R; da Silva, AL; Hurtado, R; Cerqueira, JC; Ribeiro, BFS; Almeida, MO; Morais-Rodrigues, F; Soares, SD; Oliveira, M; Tavares, L; Figueiredo, H; Wattam, AR; Barh, D; Ghosh, P; Silva, A; Azevedo, V				Viana, Marcus Vinicius Canario; Profeta, Rodrigo; da Silva, Alessandra Lima; Hurtado, Raquel; Cerqueira, Janaina Canario; Ribeiro, Bruna Ferreira Sampaio; Almeida, Marcelle Oliveira; Morais-Rodrigues, Francielly; Soares, Siomar de Castro; Oliveira, Manuela; Tavares, Luis; Figueiredo, Henrique; Wattam, Alice Rebecca; Barh, Debmalya; Ghosh, Preetam; Silva, Artur; Azevedo, Vasco			Taxonomic classification of strain PO100/5 shows a broader geographic distribution and genetic markers of the recently described Corynebacterium silvaticum	PLOS ONE			English	Article							PATHOGEN; PROTEIN; DNA	The bacterial strain PO100/5 was isolated from a skin abscess taken from a pig (Sus scrofa domesticus) in the Alentejo region of southern Portugal. It was identified as Corynebacterium pseudotuberculosis using biochemical tests, multiplex PCR and Pulsed Field Gel Electrophoresis. After genome sequencing and rpoB phylogeny, the strain was classified as C. ulcerans. To better understand the taxonomy of this strain and improve identification methods, we compared strain PO100/5 to other publicly available genomes from C. diphtheriae group. Taxonomic analysis reclassified it and three others strains as the recently described C. silvaticum, which have been isolated from wild boar and roe deer in Germany and Austria. The results showed that PO100/5 is the first sequenced genome of a C. silvaticum strain from livestock and a different geographical region, has the unique sequence type ST709, and could be could produce the diphtheriae toxin, along with strain 05-13. Genomic analysis of PO100/5 showed four prophages, and eight conserved genomic islands in comparison to C. ulcerans. Pangenome analysis of 38 C. silvaticum and 76 C. ulcerans genomes suggested that C. silvaticum is a genetically homogeneous species, with 73.6% of its genes conserved and a pangenome near to be closed (alpha > 0.952). There are 172 genes that are unique to C. silvaticum in comparison to C. ulcerans. Most of these conserved genes are related to nutrient uptake and metabolism, prophages or immunity against them, and could be genetic markers for species identification. Strains PO100/5 (livestock) and KL0182(T) (wild boar) were predicted to be potential human pathogens. This information may be useful for identification and surveillance of this pathogen.	[Viana, Marcus Vinicius Canario; Profeta, Rodrigo; da Silva, Alessandra Lima; Hurtado, Raquel; Cerqueira, Janaina Canario; Ribeiro, Bruna Ferreira Sampaio; Almeida, Marcelle Oliveira; Morais-Rodrigues, Francielly; Azevedo, Vasco] Univ Fed Minas Gerais, Inst Biol Sci, Dept Genet Ecol & Evolut, Belo Horizonte, MG, Brazil; [Viana, Marcus Vinicius Canario; Silva, Artur] Fed Univ Para, Inst Biol Sci, Dept Genet, Belem, Para, Brazil; [Soares, Siomar de Castro] Univ Fed Triangulo Mineiro, Inst Biol Sci & Nat Sci, Dept Immunol Microbiol & Parasitol, Uberaba, MG, Brazil; [Oliveira, Manuela; Tavares, Luis] Univ Lisbon, Ctr Interdisciplinary Res Anim Hlth, Fac Vet Med, Lisbon, Portugal; [Figueiredo, Henrique] Univ Fed Minas Gerais, Natl Reference Lab Aquat Anim Dis, Belo Horizonte, MG, Brazil; [Wattam, Alice Rebecca] Univ Virginia, Biocomplex Inst, Charlottesville, VA USA; [Barh, Debmalya] Inst Integrat Omics & Appl Biotechnol, Purba Medinipur, W Bengal, India; [Ghosh, Preetam] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA USA	Universidade Federal de Minas Gerais; Universidade Federal do Para; Universidade Federal do Triangulo Mineiro; Universidade de Lisboa; Universidade Federal de Minas Gerais; University of Virginia; Virginia Commonwealth University	Azevedo, V (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Genet Ecol & Evolut, Belo Horizonte, MG, Brazil.	vasco@icb.ufmg.br	Barh, Debmalya/O-4246-2015; Azevedo, Vasco/B-1556-2019; de Castro Soares, Siomar/I-2705-2012; Lima da Silva, Alessandra/AGF-3709-2022	Barh, Debmalya/0000-0002-2557-7768; Azevedo, Vasco/0000-0002-4775-2280; de Castro Soares, Siomar/0000-0001-7299-3724; Lima da Silva, Alessandra/0000-0002-2698-6889; Tavares, Luis/0000-0001-8671-6285; Cerqueira, Janaina/0000-0003-3410-1419; Ghosh, Preetam/0000-0003-3880-5886; Ribeiro, Bruna/0000-0001-7068-7539; Oliveira, Manuela/0000-0002-3910-1525; Canario Viana, Marcus Vinicius/0000-0002-7017-6437	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Minas Gerais (UFMG); Pro-Reitoria de Pesquisa da UFMG (PRPQ-UFMG); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201400027C]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Universidade Federal de Minas Gerais (UFMG); Pro-Reitoria de Pesquisa da UFMG (PRPQ-UFMG); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade Federal de Minas Gerais (UFMG); and Pro-Reitoria de Pesquisa da UFMG (PRPQ-UFMG); A. R. Wattam was supported by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272201400027C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; [Anonymous], 2017, Future Oncol, V13, P1, DOI 10.2217/fon-2017-0071; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Badell E, 2020, RES MICROBIOL, V171, P122, DOI 10.1016/j.resmic.2020.02.003; Badell E, 2019, J MED MICROBIOL, V68, P1455, DOI 10.1099/jmm.0.001070; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Berger A, 2013, ZOONOSES PUBLIC HLTH, V60, P539, DOI 10.1111/zph.12031; Berger AA, 2014, WHAT OBJECTS MEAN: AN INTRODUCTION TO MATERIAL CULTURE, 2ND EDITION, P171; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chang CY, 2011, MOL MICROBIOL, V79, P1236, DOI 10.1111/j.1365-2958.2010.07515.x; Contzen M, 2011, ZOONOSES PUBLIC HLTH, V58, P479, DOI 10.1111/j.1863-2378.2011.01396.x; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; Dangel A, 2020, INT J SYST EVOL MICR, V70, P3614, DOI 10.1099/ijsem.0.004195; Dazas M, 2018, INT J SYST EVOL MICR, V68, P3826, DOI 10.1099/ijsem.0.003069; Eisenberg T, 2014, EMERG INFECT DIS, V20, P448, DOI 10.3201/eid2003.130423; Emms DM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0721-2; Fimereli Danai K., 2012, Artificial Intelligence: Theories and Applications. Proceedings 7th Hellenic Conference on AI, SETN 2012, P285, DOI 10.1007/978-3-642-30448-4_36; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Jain C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07641-9; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Konig C, 2014, J CLIN MICROBIOL, V52, P4318, DOI 10.1128/JCM.02291-14; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu HH, 2020, COGNITION, V194, DOI 10.1016/j.cognition.2019.104055; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P20, DOI 10.1093/nar/gkt847; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Meier-Kolthoff JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10210-3; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Meinel DM, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0113-3; Meng XJ, 2009, PHILOS T R SOC B, V364, P2697, DOI 10.1098/rstb.2009.0086; Moller JR, 2020, ANTON LEEUW INT J G, V113, P1225, DOI 10.1007/s10482-020-01430-5; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Oliveira M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0218-3; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Pacheco LGC, 2007, J MED MICROBIOL, V56, P480, DOI 10.1099/jmm.0.46997-0; Page AJ., 2016, J OPEN SOURCE SOFTW, V1, P118, DOI 10.21105/joss.00118; Ramirez NA, 2020, TRENDS MICROBIOL, V28, P999, DOI 10.1016/j.tim.2020.05.008; Rau J, 2019, VET MICROBIOL, V237, DOI 10.1016/j.vetmic.2019.108399; Schaeffer J, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.00946-20; Schuhegger Regina, 2009, Emerg Infect Dis, V15, P1314, DOI 10.3201/eid1508.081568; Seth-Smith HMB, 2019, FRONT PUBLIC HEALTH, P1, DOI [10.3389/fpubh.2019.00001, DOI 10.3389/FPUBH.2019.00001]; Soares SC, 2016, J BIOTECHNOL, V232, P2, DOI 10.1016/j.jbiotec.2015.09.008; Subedi R., 2018, New Microbes and New Infections, V25, P7, DOI 10.1016/j.nmni.2018.05.005; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tauch A, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv185; Tenor JL, 2004, CURR BIOL, V14, P1018, DOI 10.1016/j.cub.2004.05.050; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Trost E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-383; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017	58	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244210	10.1371/journal.pone.0244210	http://dx.doi.org/10.1371/journal.pone.0244210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347470	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071100035
J	Chen, CY; Liang, SH; Su, YY; Chiang, NJ; Wang, HC; Chiu, CF; Chen, LT; Bai, LY				Chen, Chia-Yu; Liang, Shih-Hsin; Su, Yung-Yeh; Chiang, Nai-Jung; Wang, Hui-Ching; Chiu, Chang-Fang; Chen, Li-Tzong; Bai, Li-Yuan			Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan	PLOS ONE			English	Article							RANDOMIZED PHASE-II; DOSE RATE INFUSION; 30-MINUTE INFUSION; PLUS LEUCOVORIN; CANCER; OXALIPLATIN; SURVIVAL; PLASMA; TRIAL	Background In pancreatic cancer, toxicities associated with current chemotherapeutic regimens remain concerning. A modified combination of gemcitabine, S-1, and leucovorin (GSL) was used as the first-line treatment for newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma patients. Methods GSL was administered every 2 weeks-intravenous gemcitabine 800 mg/m(2) at a fixed-dose rate of 10 mg/m(2)/min on day 1 and oral S-1 (80-120 mg/day) plus leucovorin 30 mg twice daily on days 1-7. We retrospectively analyzed the feasibility of GSL and patient outcomes in three medical centers in Taiwan. Results Overall, 49 patients received GSL with a median follow-up of 24.9 months from May 2015 to March 2019. The median patient age was 68 years (range, 47-83 years), with a marginally higher number of females (57.1%). Among the 44 patients who underwent image evaluation, 13 demonstrated a partial response (29.5%) and 17 presented with stable disease (38.6%). The partial response rate and stable disease rate was 26.5% and 34.7%, respectively, in the intent-to-treat analysis. The median time-to-treatment failure was 5.79 months (95% C.I., 2.63-8.94), progression-free survival was 6.94 months (95% C.I., 5.55-8.33), and overall survival time was 11.53 months (95% C.I., 9.94-13.13). For GSL treatment, the most common grade 3 or worse toxicities were anemia (18.3%), neutropenia (6.1%), nausea (4.1%), and mucositis (4.1%). Treatment discontinuation was mostly due to disease progression (65.3%). Conclusions The modified GSL therapy can be a promising and affordable treatment for patients with advanced and metastatic pancreatic cancer in Taiwan. A prospective trial of modified GSL for elderly patients is currently ongoing in Taiwan.	[Chen, Chia-Yu; Liang, Shih-Hsin; Chiu, Chang-Fang; Bai, Li-Yuan] China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung, Taiwan; [Liang, Shih-Hsin] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Chiayi, Taiwan; [Su, Yung-Yeh; Chiang, Nai-Jung; Chen, Li-Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Su, Yung-Yeh; Chiang, Nai-Jung; Chen, Li-Tzong] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Div Hematol & Oncol,Dept Internal Med, Tainan, Taiwan; [Wang, Hui-Ching; Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chiu, Chang-Fang; Bai, Li-Yuan] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Chiu, Chang-Fang] China Med Univ Hosp, Ctr Canc, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Bai, LY (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Taichung, Taiwan.; Chen, LT (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan.; Chen, LT (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Div Hematol & Oncol,Dept Internal Med, Tainan, Taiwan.; Chen, LT (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan.; Bai, LY (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.	leochen@nhri.edu.tw; lybai6@gmail.com		Su, Yung-Yeh/0000-0002-5133-5316	National Health Research Institutes, Taiwan [NHRI-109A1-CACO-13202002]; Ministry of Health and Welfare, Taiwan [MOHW109-TDU-B-212-134026, MOHW109-TDU-B-212-010001]; Ministry of Science and Technology, Taiwan [MOST109-2321-8-006-011-]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Health and Welfare, Taiwan; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	LYB: grants from the National Health Research Institutes, Taiwan (NHRI-109A1-CACO-13202002), the Ministry of Health and Welfare, Taiwan (MOHW109-TDU-B-212-134026), and Ministry of Science and Technology, Taiwan (MOST109-2321-8-006-011-) during the study. CFC: grants from the Ministry of Health and Welfare, Taiwan (MOHW109-TDU-B-212-010001).	ABBRUZZESE JL, 1991, J CLIN ONCOL, V9, P491, DOI 10.1200/JCO.1991.9.3.491; Attia S, 2009, CANCER CHEMOTH PHARM, V64, P45, DOI 10.1007/s00280-008-0844-1; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chen JS, 2015, ANN ONCOL, V26, P943, DOI 10.1093/annonc/mdv035; Chiang NJ, 2020, EUR J CANCER, V124, P123, DOI 10.1016/j.ejca.2019.10.023; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; GRUNEWALD R, 1992, J CLIN ONCOL, V10, P406, DOI 10.1200/JCO.1992.10.3.406; Health Promotion Administration, 2016, CANC REG ANN REP 201; Hironaka S, 2016, LANCET ONCOL, V17, P99, DOI 10.1016/S1470-2045(15)00410-6; Koizumi W, 2010, ANN ONCOL, V21, P766, DOI 10.1093/annonc/mdp371; Li J, 2017, CANCER SCI, V108, P2045, DOI 10.1111/cas.13335; Ozaka M, 2018, CANCER CHEMOTH PHARM, V81, P1017, DOI 10.1007/s00280-018-3577-9; Poplin E, 2009, J CLIN ONCOL, V27, P3778, DOI 10.1200/JCO.2008.20.9007; Saito K, 2019, INVEST NEW DRUG, V37, P338, DOI 10.1007/s10637-018-0691-9; Tempero M, 2003, J CLIN ONCOL, V21, P3402, DOI 10.1200/JCO.2003.09.140; Ueno H, 2013, J CLIN ONCOL, V31, P1640, DOI 10.1200/JCO.2012.43.3680; Ueno M, 2016, ANN ONCOL, V27, P502, DOI 10.1093/annonc/mdv603; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	18	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244487	10.1371/journal.pone.0244487	http://dx.doi.org/10.1371/journal.pone.0244487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373398	Green Published, gold			2022-12-27	WOS:000603612300025
J	Chen, YC; Huang, YT; Yang, CC; Lai, ECC; Liu, CH; Hsu, CK; Wong, TW; Chao, SC; Sheu, HM; Lee, CN				Chen, Yu-Chen; Huang, Yi-Ting; Yang, Chao-Chun; Lai, Edward Chia-Cheng; Liu, Cheng-Han; Hsu, Chao-Kai; Wong, Tak-Wah; Chao, Sheau-Chiou; Sheu, Hamm-Ming; Lee, Chaw-Ning			Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan	PLOS ONE			English	Article							CONTROLLED-TRIAL; SECUKINUMAB; SAFETY; PATHOGENESIS; USABILITY; LIFE	Background Real-world clinical data on psoriasis patients receiving different biological agents is needed, especially in Asian populations. Objectives Our aim is to compare and analyze the efficacy and safety profile of four biological agents (etanercept, adalimumab, ustekinumab and secukinumab) in a real-world setting in Taiwan. Methods We retrospectively analyzed the clinical data of all patients with moderate-to-severe plaque psoriasis (Psoriasis Area and Severity Index (PASI) >= 10) who received etanercept, adalimumab, ustekinumab or secukinumab between January 2011 and December 2018 in a tertiary hospital in Taiwan. Results A total of 119 treatment episodes in 75 patients were included in this study. Ustekinumab was used in 49 treatment episodes, followed by secukinumab in 46 treatment episodes, adalimumab in 14 treatment episodes and etanercept in 10 treatment episodes. The proportion of the biologic-naive was highest in etanercept (100%) and lowest in secukinumab (23.9%). The PASI-75, -90 and -100 were the highest in secukinumab (91.3%, 82.6%, 41.3%, respectively), followed by ustekinumab (79.6%, 44.9%, 16.3%), adalimumab (64.3%, 28.6%, 7.1%) and etanercept (50.0%, 30.0%, 0%). The rate of adverse events that required treatment was highest for secukinumab (15.2%), followed by adalimumab (14.3%), ustekinumab (8.2%), and etanercept (0%), including 4 cases of infections, 2 cases of cardiovascular diseases and 4 cases of cancers. Conclusions This real world data showed differential efficacy and safety of the four biological agents.	[Chen, Yu-Chen; Huang, Yi-Ting; Yang, Chao-Chun; Liu, Cheng-Han; Hsu, Chao-Kai; Wong, Tak-Wah; Chao, Sheau-Chiou; Sheu, Hamm-Ming; Lee, Chaw-Ning] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Dermatol, Coll Med, Tainan, Taiwan; [Yang, Chao-Chun; Hsu, Chao-Kai] Natl Cheng Kung Univ, Int Ctr Wound Repair & Regenerat, Tainan, Taiwan; [Lai, Edward Chia-Cheng; Lee, Chaw-Ning] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Coll Med, Tainan, Taiwan; [Wong, Tak-Wah] Natl Cheng Kung Univ, Dept Biochem & Mol Biol, Coll Med, Tainan, Taiwan; [Wong, Tak-Wah] Natl Cheng Kung Univ, Ctr Appl Nanomed, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Lee, CN (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Dermatol, Coll Med, Tainan, Taiwan.; Lee, CN (corresponding author), Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Coll Med, Tainan, Taiwan.	joyce060324@gmail.com	huang, yiting/HDM-3648-2022	Chen, Yu-Chen/0000-0002-9467-0325	Ministry of Science and Technology, Taiwan [MOST 109-2628-B-006 -035]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The work was funded by a grant (MOST 109-2628-B-006 -035) from the Ministry of Science and Technology, Taiwan to CCY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis Andrew F, 2014, J Clin Aesthet Dermatol, V7, P16; Amherd-Hoekstra A, 2010, J DTSCH DERMATOL GES, V8, P332, DOI 10.1111/j.1610-0387.2009.07334.x; Augustin M, 2018, J EUR ACAD DERMATOL, V32, P2191, DOI 10.1111/jdv.15047; Blauvelt A, 2015, BRIT J DERMATOL, V172, P484, DOI 10.1111/bjd.13348; Boehncke WH, 2009, J DTSCH DERMATOL GES, V7, P946, DOI 10.1111/j.1610-0387.2009.07083.x; Chiu HY, 2018, DERMATOL SIN, V36, P115, DOI 10.1016/j.dsi.2018.06.001; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Kishimoto M, 2020, J DERMATOL, V47, P33, DOI 10.1111/1346-8138.15146; Langley RG, 2015, BRIT J DERMATOL, V172, P1371, DOI 10.1111/bjd.13469; Langley RG, 2004, J AM ACAD DERMATOL, V51, P563, DOI 10.1016/j.jaad.2004.04.012; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Lin PT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34293-y; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Papp KA, 2018, BRIT J DERMATOL, V179, P320, DOI 10.1111/bjd.16464; Paul C, 2015, J EUR ACAD DERMATOL, V29, P1082, DOI 10.1111/jdv.12751; Puig L, 2017, J DERMATOL TREAT, V28, P623, DOI 10.1080/09546634.2017.1364687; Roche H, 2019, J DERMATOL TREAT, V30, P540, DOI 10.1080/09546634.2018.1480746; Ronholt K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112297; Schmitt-Egenolf M, 2006, DERMATOLOGY, V213, P327, DOI 10.1159/000096196; Thaci D, 2015, J AM ACAD DERMATOL, V73, P400, DOI 10.1016/j.jaad.2015.05.013; Tsai TF, 2017, DERMATOL SIN, V35, P66, DOI 10.1016/j.dsi.2017.01.002; Yiu ZZN, 2020, BRIT J DERMATOL, V183, P294, DOI 10.1111/bjd.18981	22	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244620	10.1371/journal.pone.0244620	http://dx.doi.org/10.1371/journal.pone.0244620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373425	gold, Green Published			2022-12-27	WOS:000603612300053
J	Otalora, Y; Taborda-Osorio, H				Otalora, Yenny; Taborda-Osorio, Hernando			Developmental differences in children's and adults' use of geometric information in map-reading tasks	PLOS ONE			English	Article							YOUNG-CHILDREN; CORE KNOWLEDGE; REPRESENTATION; ANGLES	Using maps effectively requires the ability to scale distances while preserving angle and orientation, the three properties of Euclidean geometry. The aim of the current study was twofold: first, to examine how the ability to represent and use these Euclidean properties changes with development when scaling maps in object-to-object relationships and, second, to explore the effects on the scaling performance of two variables of the array of objects, type of angular configuration and relative vector length. To this end, we tested seventy-five 4-, 6-, and 8-year-old children, as well as twenty-five adults, in a simple completion task with different linear and triangular configurations of objects. This study revealed important developmental changes between 4 and 6 years of age and between 8 years of age and adulthood for both distance and angle representation, while it also showed that the configuration variables affected younger and older children's performances in different ways when scaling distances and preserving angles and orientation. This study was instrumental in showing that, from an early age, children are able to exploit an intrinsic system of reference to scale geometrical configurations of objects.	[Otalora, Yenny] Univ Valle, Inst Psychol, Ctr Res Psychol Cognit & Culture, Cali, Colombia; [Taborda-Osorio, Hernando] Pontificia Univ Javeriana, Dept Psychol, Bogota, Colombia	Universidad del Valle; Pontificia Universidad Javeriana	Otalora, Y (corresponding author), Univ Valle, Inst Psychol, Ctr Res Psychol Cognit & Culture, Cali, Colombia.	yenny.otalora@correounivalle.edu.co		Taborda-Osorio, Hernando/0000-0001-6668-4415; Otalora, Yenny/0000-0001-5343-5882	Mineducacion, Minciencias and Dividendo por Colombia [1203-100372878]; Pontificia Universidad Javeriana, Bogota-Colombia [00007819]	Mineducacion, Minciencias and Dividendo por Colombia; Pontificia Universidad Javeriana, Bogota-Colombia	This is a Research Article product of the research projects "Innovation in educational intervention for the development of mathematical thinking in early childhood" code 1203-100372878, funded by Mineducacion, Minciencias and Dividendo por Colombia, awarded to YO and HT and "Prediction in young children and social behavior", code 00007819, funded by Pontificia Universidad Javeriana, Bogota-Colombia, awarded to HT.	[Anonymous], 2008, IPHOTOMEASURE COMP S; Clements D. H., 2014, LEARNING TEACHING EA; Dehaene S, 2006, SCIENCE, V311, P381, DOI 10.1126/science.1121739; DELOACHE JS, 1987, SCIENCE, V238, P1556, DOI 10.1126/science.2446392; DELOACHE JS, 1994, COGNITION, V52, P83, DOI 10.1016/0010-0277(94)90063-9; DELOACHE JS, 1991, CHILD DEV, V62, P736, DOI 10.2307/1131174; Dillon MR, 2018, DEV PSYCHOL, V54, P1304, DOI 10.1037/dev0000509; Dillon MR, 2013, P NATL ACAD SCI USA, V110, P14191, DOI 10.1073/pnas.1312640110; Duffy S, 2005, J COGN DEV, V6, P51, DOI 10.1207/s15327647jcd0601_4; Frick A, 2012, COGNITIVE DEV, V27, P270, DOI 10.1016/j.cogdev.2012.05.004; Gilligan KA, 2018, COGNITIVE DEV, V47, P133, DOI 10.1016/j.cogdev.2018.04.001; Gouteux S, 2001, COGNITION, V81, P119, DOI 10.1016/S0010-0277(01)00128-7; Gregory E, 2011, VIS COGN, V19, P1035, DOI 10.1080/13506285.2011.610764; Hohol M., 2020, FDN GEOMETRIC COGNIT; Huttenlocher J, 1999, PSYCHOL SCI, V10, P393, DOI 10.1111/1467-9280.00175; Izard V, 2014, CHILD DEV, V85, P237, DOI 10.1111/cdev.12114; Izard V, 2011, ATTENTION PERFORM, P319, DOI 10.1016/B978-0-12-385948-8.00019-0; Mohring W, 2016, J EXP PSYCHOL LEARN, V42, P1473, DOI 10.1037/xlm0000240; Mohring W, 2014, DEV PSYCHOL, V50, P1614, DOI 10.1037/a0035905; Nardini M, 2006, COGNITION, V101, P153, DOI 10.1016/j.cognition.2005.09.005; Negen J, 2015, PLOS ONE, V10, P1; Sandberg EH, 1996, CHILD DEV, V67, P721, DOI 10.2307/1131858; Shusterman A, 2008, DEVELOPMENTAL SCI, V11, pF1, DOI 10.1111/j.1467-7687.2007.00670.x; Spelke E, 2010, COGNITIVE SCI, V34, P863, DOI 10.1111/j.1551-6709.2010.01110.x; Spelke ES, 2011, DEVELOPMENTAL SCI, V14, P809, DOI 10.1111/j.1467-7687.2010.01029.x; Uttal D. H., 2000, COGNITIVE MAPPING PR, V4, P147; Uttal DH, 2014, J COGN EDUC PSYCHOL, V13, P188, DOI 10.1891/1945-8959.13.2.188; Uttal DH, 1996, CHILD DEV, V67, P2763, DOI 10.2307/1131751; Vasilyeva M, 2004, DEV PSYCHOL, V40, P682, DOI 10.1037/0012-1649.40.5.682; Vasilyeva M, 2006, J EXP CHILD PSYCHOL, V95, P255, DOI 10.1016/j.jecp.2006.05.001; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304; Winkler-Rhoades N, 2013, DEVELOPMENTAL SCI, V16, P365, DOI 10.1111/desc.12038	32	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0243845	10.1371/journal.pone.0243845	http://dx.doi.org/10.1371/journal.pone.0243845			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373365	gold, Green Published			2022-12-27	WOS:000603612300037
J	Ali, Z; Ullah, I; Nazir, N; Asif, M; Azeem, M				Ali, Zulfiqar; Ullah, Ikram; Nazir, Naila; Asif, Muhammad; Azeem, Muhammad			Social and financial efficiency: Institutional characteristics of the partner organizations of Pakistan Poverty Alleviation Fund	PLOS ONE			English	Article							MICROFINANCE INSTITUTIONS; SUSTAINABILITY; DETERMINANTS; OUTREACH; DEA	Efficiency analysis of the Partner Organizations can benefit all the microfinance sector's key stakeholders to benchmark the current scene and formulate optimal policy agenda. This study seeks to measure the partner organizations of the Pakistan Poverty Alleviation Fund's social and financial efficiency and to identify causes and sources of their inefficiencies. A non-parametric technique known as Data Envelopment Analysis is applied to investigate the Partner Organizations' efficiency throughout 2005-2015. The required data was obtained from the database of the Mix-Market and Pakistan Microfinance Network. The social and financial efficiency was estimated assuming Constant Return to Scale, Variable Return to Scale, and with respect to the Operational Scale of the Partner Organizations. Results revealed that the partner organizations are more scale efficient (median = 75%) than pure technically efficient (median = 55%). Further, graphical representations show a decreasing linear trend and negative serial correlation in the percentage of efficient partner organizations. The model fit results show that institutional characteristics that influence partner organizations' efficiencies significantly include their age, Operational Self-Sufficiency, personnel, loan officers, assets and debt. Finally, the diagnostic tests for endogeneity, heteroskedasticity, heterogeneity, and cross-sectional dependence were performed.	[Ali, Zulfiqar] Govt Coll Peshawar, Peshawar, Pakistan; [Ali, Zulfiqar; Nazir, Naila] Univ Peshawar, Dept Econ, Peshawar, Pakistan; [Ullah, Ikram] Univ Malakand, Dept Econ, Chakdara, Pakistan; [Asif, Muhammad; Azeem, Muhammad] Univ Malakand, Dept Stat, Chakdara, Pakistan	University of Peshawar; University of Malakand; University of Malakand	Asif, M (corresponding author), Univ Malakand, Dept Stat, Chakdara, Pakistan.	m.asif@uom.edu.pk	Asif, Muhammad/X-2226-2019; Azeem, Muhammad/AAK-6174-2021	Asif, Muhammad/0000-0002-6458-5154; Azeem, Muhammad/0000-0002-6409-550X; Ullah, Ikram/0000-0003-3675-0738; Azeem, Muhammad/0000-0002-6475-6072				Adusei M, 2019, INT REV ECON FINANC, V64, P393, DOI 10.1016/j.iref.2019.07.008; Ahmad R, 2017, EMPIRICAL INVESTIGAT, V3, P147; Annim SK, 2010, MICROFINANCE EFFICIE; [Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2018, MED LETT DRUGS THER, V60, P103; [Anonymous], 2016, CRIT CARE NURSE; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2019, REPROD MED S1, V39, pe1; [Anonymous], 2018, KOMMERSANT, V8, P17; [Anonymous], 2015, ARCT REV LAW POLITIC, V6, P52, DOI [10.17585/arctic.v6.59, DOI 10.17585/ARCTIC.V6.59]; Avkiran NK, 1999, INT J BANK MARKETING; Ayayi AG, 2018, QUAL QUANT, V52, P2331, DOI 10.1007/s11135-017-0668-3; Baltagi B. H., 2008, ECONOMETRIC ANAL PAN, DOI DOI 10.1108/IJSHE-06-2013-0065; Basharat A, 2012, PAKISTAN MICROFINANC; Bassem B., 2008, TRANSITION STUDY REV, V15, P343, DOI DOI 10.1007/S11300-008-0012-7; Bensalem S, 2019, INFOR, V57, P411, DOI 10.1080/03155986.2017.1412123; Berger AN, 1997, EUR J OPER RES, V98, P175, DOI 10.1016/S0377-2217(96)00342-6; Blanco-Oliver A, 2016, J BUS RES, V69, P4643, DOI 10.1016/j.jbusres.2016.03.054; Bogan V., 2007, ECONOMICS, V7, P2013; Bogan VL, 2012, REV ECON STAT, V94, P1045, DOI 10.1162/REST_a_00223; Brownlow D, 2007, INT BANKING SYSTEMS; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Charnes A., 1997, J OPER RES SOC, DOI [10.1057/palgrave.jors.2600342, DOI 10.1057/PALGRAVE.JORS.2600342]; Cooper WW, 2006, DEA SOLVER SOFTWARE; Cooper WW, 2011, SPRINGER SCI BUSINES; Efendic V, 2017, SOUTH EAST EUR J E B, V12, P85, DOI 10.1515/jeb-2017-0018; Fall F, 2018, WORLD DEV, V107, P176, DOI 10.1016/j.worlddev.2018.02.032; Farooq S, 2018, PROFITABILITY PERSPE, V5, P111; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Gonzalez A, 2007, RESILIENCE MICROFINA; Green WH, 2018, ECONOMETRIC ANAL, V8; Gutierrez-Nieto B, 2007, OMEGA-INT J MANAGE S, V35, P131, DOI 10.1016/j.omega.2005.04.001; Haider V., 2018, UCP MANAGEMENT REV U, P75; Haq M, 2010, ASIA-PAC FINANC MARK, V17, P63, DOI 10.1007/s10690-009-9103-7; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hina H, 2014, COMMERCIALISATION MI; Hoque M, 2011, MANAGERIAL FINANCE; Hossain M. S., 2016, DEV COUNTRY STUDIES, V6, P69; Hussein MalihaHamid., 2009, STATE MICROFINANCE P; Kaur P., 2016, VISION, V20, P54, DOI DOI 10.1177/0972262916628988; Khan Z.A., 2017, EUR ONLINE J NAT SOC, V6, P296; Khan Z, 2015, ROUTL CONT S ASIA SE, P38; Khan Z, 2015, ECON STUD INEQUAL SO, P31, DOI 10.1007/978-981-287-420-7_3; Kyereboah-Coleman A, 2007, J RISK FINANCE; Lebovics M, 2016, ANN PUBLIC COOP ECON, V87, P55, DOI 10.1111/apce.12085; Li LY, 2019, ECON MODEL, V81, P308, DOI 10.1016/j.econmod.2019.05.014; Littlefield E. L., 2009, GLOBAL FINANCIAL CRI, P1; Mamiza H., 2008, INT REV BUSINESS RES, V4, P421; Mia MA, 2019, EUR J DEV RES, V31, P809, DOI 10.1057/s41287-018-0188-6; Mia MA, 2016, ECON ANAL POLICY, V51, P32, DOI 10.1016/j.eap.2016.05.003; Moreno A. M., 2010, GRAMEEN MICROFINANCE; Pakistan, 2018, EC SURVEY PAKISTAN; Pandey P., 2018, J EC POLICY RES, V13, P57; Rauf SA, 2009, PAKISTAN EC SOCIAL R, P99; Riaz M., 2015, J EC BEHAV STUDIES, V7, P1, DOI DOI 10.22610/jebs.v7i1(J).558; Richardson M, 2018, ENVIRON HUMANITIES, V10, P1, DOI 10.1215/22011919-4385444; Sarker A. E., 2001, SECRETS SUCCESS GRAM; SBP M, 2011, STRATEGIC FRAMEWORK; Serrano-Cinca C., 2011, HDB MICROFINANCE, P397; Sexton T. R., 1986, NEW DIRECTIONS PROGR, V1986, P73; Siddique, 2018, PYREX J BUSINESS FIN, V4, P12; Silva TC, 2017, PHYSICA A, V469, P216, DOI 10.1016/j.physa.2016.11.041; Sinha R.P., 2019, INT J RURAL MANAGEME, V15, P49, DOI [10.1177/0973005219832494, DOI 10.1177/0973005219832494]; Soteriou A, 1999, MANAGE SCI, V45, P1221, DOI 10.1287/mnsc.45.9.1221; Thanassoulis E., 2001, INTRO THEORY APPL DA; Ullah I, 2019, ECON RES-EKON ISTRAZ, V32, P2122, DOI 10.1080/1331677X.2019.1642779; UNCTAD, 2020, COV 19 SHOCK DEV COU; Van Damme P., 2016, S ASIA EC J, V17, P236, DOI DOI 10.1177/1391561416650102; VASSILOGLOU M, 1990, J OPER RES SOC, V41, P591, DOI 10.2307/2583436; Wijesiri M, 2017, J MULTINATL FINANC M, V40, P63, DOI 10.1016/j.mulfin.2017.05.004	70	3	3	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244444	10.1371/journal.pone.0244444	http://dx.doi.org/10.1371/journal.pone.0244444			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370406	Green Published, gold			2022-12-27	WOS:000603611900078
J	Deng, ZH; Law, YW				Deng, Zihong; Law, Yik Wa			Rural-to-urban migration, discrimination experience, and health in China: Evidence from propensity score analysis	PLOS ONE			English	Article							MENTAL-HEALTH; PERCEIVED DISCRIMINATION; CARDIOVASCULAR-DISEASE; INTERNAL MIGRATION; MEDIATION ANALYSIS; MIGRANT WORKERS; HUKOU SYSTEM; RISK-FACTORS; OUTCOMES; DISPARITIES	This research examines how rural-to-urban migration influences health through discrimination experience in China after considering migration selection bias. We conducted propensity score matching (PSM) to obtain a matched group of rural residents and rural-to-urban migrants with a similar probability of migrating from rural to urban areas using data from the 2014 China Family Panel Studies (CFPS). Regression and mediation analyses were performed after PSM. The results of regression analysis after PSM indicated that rural-to-urban migrants reported more discrimination experience than rural residents, and those of mediation analysis revealed discrimination experience to exert negative indirect effects on the associations between rural-to-urban migration and three measures of health: self-reported health, psychological distress, and physical discomfort. Sensitivity analysis using different calipers yielded similar results. Relevant policies and practices are required to respond to the unfair treatment and discrimination experienced by this migrant population.	[Deng, Zihong; Law, Yik Wa] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China; [Deng, Zihong] Univ New South Wales, Social Policy Res Ctr, Sydney, NSW, Australia	University of Hong Kong; University of New South Wales Sydney	Law, YW (corresponding author), Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China.	flawhk@hku.hk		Law, Yik Wa/0000-0001-5165-8193; Deng, Zihong/0000-0001-6565-9090				[Anonymous], 2016, IEEE IC COMP COM NET; [Anonymous], 2016, P 12 IAPR WORKSH, DOI DOI 10.1109/DAS.2016.42; [Anonymous], **DATA OBJECT**; Araujo BY, 2006, HISPANIC J BEHAV SCI, V28, P245, DOI 10.1177/0739986305285825; Benatar SR, 1998, AM J PUBLIC HEALTH, V88, P295, DOI 10.2105/AJPH.88.2.295; Chan FY, 2012, INT J PUBLIC HEALTH, V57, P849, DOI 10.1007/s00038-012-0400-y; Chan KW, 2008, CHINA QUART, P582, DOI 10.1017/S0305741008000787; Chan KW, 2019, HANDB RES CONT CHINA, P59; Chan KW, 1999, CHINA QUART, P818, DOI 10.1017/S0305741000001351; Chen J., 2013, J SOCIOLOGY SOCIAL W, V40, P131; Cho Sun-Ran, 2018, Korean Journal of Applied Entomology, V57, P43, DOI 10.5656/KSAE.2018.02.0.009; Cinelli C, 2020, TECHNICAL REPORT; Coffman DL, 2011, STRUCT EQU MODELING, V18, P357, DOI 10.1080/10705511.2011.582001; De Maio FG, 2010, GLOB PUBLIC HEALTH, V5, P462, DOI 10.1080/17441690902942480; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Emsley R, 2013, STAT SOFTWARE COMPON; Emsley RA, 2014, STATA J; Gee GC, 2009, EPIDEMIOL REV, V31, P130, DOI 10.1093/epirev/mxp009; Guo S, 2014, PROPENSITY SCORE ANA, V2nd; Hahm HC, 2010, WOMEN HEALTH ISS, V20, P350, DOI 10.1016/j.whi.2010.05.002; Hartung FM, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00147; Hu B, 2018, SPRINGERBRIEFS EDUC, P1, DOI 10.1007/978-981-13-1147-5; In C.-W., 2014, J NONDESTRUCT EVAL, V34, P1; Institute of Social Science Survey (ISSS) of Peking University, 2015, SURV PROGR CFPS2014; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jin L, 2016, AM BEHAV SCI, V60, P750, DOI 10.1177/0002764216632826; Jo B, 2011, MULTIVAR BEHAV RES, V46, P425, DOI 10.1080/00273171.2011.576624; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Kreuter F, 2007, STATA J, V7, P1; LaMorte WW, 2016, CONFIDENCE INTERVALS; Lee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076494; Leuven E., 2018, STAT SOFTW COMPONENT; Li HZ, 2002, URBAN STUD, V39, P2219, DOI 10.1080/0042098022000033836; Li J, 2017, HEALTH PLACE, V48, P20, DOI 10.1016/j.healthplace.2017.08.009; Li L, 2007, SOC PSYCH PSYCH EPID, V42, P716, DOI 10.1007/s00127-007-0221-0; Li Xiaoming, 2009, World Health Popul, V11, P24; Lin DH, 2011, COMMUNITY MENT HLT J, V47, P171, DOI 10.1007/s10597-009-9278-4; Loeys T, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01549; Lu Y, 2014, SOC SCI MED, V102, P41, DOI 10.1016/j.socscimed.2013.11.040; Lu Y, 2010, SOC SCI MED, V70, P412, DOI 10.1016/j.socscimed.2009.10.028; Meng X, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234615; Migrant Population Service Center of China, 2017, STAT DAT SHEET PERM; Mou J, 2013, BRIT MED BULL, V106, P19, DOI 10.1093/bmb/ldt016; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; Peterson LM, 2016, HEALTH PSYCHOL, V35, P313, DOI 10.1037/hea0000288; Qiu PY, 2011, J AFFECT DISORDERS, V134, P198, DOI 10.1016/j.jad.2011.05.043; Razum O, 2005, J ETHN MIGR STUD, V31, P719, DOI 10.1080/13691830500109894; Richiardi L, 2013, INT J EPIDEMIOL, V42, P1511, DOI 10.1093/ije/dyt127; Rubin DB., 2001, HLTH SERV OUTCOME RE, V2, P169, DOI 10.1023/A:1020363010465; Sanchez JI, 1996, ACAD MANAGE J, V39, P704, DOI 10.2307/256660; Solinger DJ, 1999, CONTESTING CITIZENSH; Song Y, 2016, HEALTH ECON, V25, P1252, DOI 10.1002/hec.3212; StataCorp LLC, 2013, SVY EST EST COMM SUR; Tan X, 2016, INTERNAL MIGRATION M; The State Council of China, 2014, OP STAT COUNC FURTH; Tong YY, 2012, POPUL RES POLICY REV, V31, P497, DOI 10.1007/s11113-012-9240-y; Torun B, 2002, INT J EPIDEMIOL, V31, P218, DOI 10.1093/ije/31.1.218; Treiman DJ, 2012, RES SOC STRAT MOBIL, V30, P33, DOI 10.1016/j.rssm.2011.10.001; Vansteelandt S, 2012, BIOMETRICS, V68, P1019, DOI 10.1111/j.1541-0420.2012.01777.x; Viruell-Fuentes EA, 2007, SOC SCI MED, V65, P1524, DOI 10.1016/j.socscimed.2007.05.010; Virupaksha H G, 2014, J Nat Sci Biol Med, V5, P233, DOI 10.4103/0976-9668.136141; Wang JW, 2010, HEALTH PROMOT INT, V25, P394, DOI 10.1093/heapro/daq039; Wang J, 2017, SOC INDIC RES, V134, P1113, DOI 10.1007/s11205-016-1457-4; Wang LG, 2016, J POWER SOURCES, V319, P210, DOI 10.1016/j.jpowsour.2016.04.059; Weigensberg EC, 2009, CHILD YOUTH SERV REV, V31, P383, DOI 10.1016/j.childyouth.2008.09.001; Wong DFK, 2007, INT J SOC WELF, V16, P32, DOI 10.1111/j.1468-2397.2007.00475.x; Woodford MR, 2014, J GAY LESBIAN MENT H, V18, P142, DOI 10.1080/19359705.2013.833882; Wu L, 2013, POLICY SOC, V32, P33, DOI 10.1016/j.polsoc.2013.01.002; Zhang JT, 2009, QUAL LIFE RES, V18, P291, DOI 10.1007/s11136-009-9454-6; Zhang LW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2074-x; Zhou X, 2016, CHINA J EC, P79	71	8	8	7	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244441	10.1371/journal.pone.0244441	http://dx.doi.org/10.1371/journal.pone.0244441			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370369	gold, Green Published			2022-12-27	WOS:000603611900089
J	Parks, M; Kedy, C; Skalla, C				Parks, Matthew; Kedy, Cameron; Skalla, Casey			Consistent patterns in 16S and 18S microbial diversity from the shells of the common and widespread red-eared slider turtle (Trachemys scripta)	PLOS ONE			English	Article							GRAPTEMYS-GEOGRAPHICA; MAP TURTLES; HABITAT USE; BEHAVIOR; GENUS; COMMUNITIES; POPULATION; BASICLADIA; GROWTH; PICTA	Microbial communities associated with freshwater aquatic habitats and resident species are both critical to and indicative of ecosystem status and organismal health. External surfaces of turtle shells readily accumulate microbial growth and could carry representation of habitat-wide microbial diversity, since they are in regular contact with multiple elements of freshwater environments. Yet, microbial diversity residing on freshwater turtle shells is poorly understood. We applied 16S and 18S metabarcoding to characterize microbiota associated with external shell surfaces of 20 red-eared slider (Trachemys scripta) turtles collected from varied habitats in central and western Oklahoma, and ranging to southeast Iowa. Shell-associated microbial communities were highly diverse, with samples dominated by Bacteroidia and alpha-/gamma-proteobacteria, and ciliophoran alveolates. Alpha diversity was lower on turtle shells compared to shallow-water-associated environmental samples, likely resulting from basking-drying behavior and seasonal scute shedding, while alpha diversity was higher on carapace than plastron surfaces. Beta diversity of turtle shells was similarly differentiated from environmental samples, although sampling site was consistently a significant factor. Deinococcus-Thermus bacteria and ciliophoran alveolates were recovered with significantly higher abundance on turtle shells versus environmental samples, while bacterial taxa known to include human-pathogenic species were variably more abundant between shell and environmental samples. Microbial communities from a single, shared-site collection of the ecologically similar river cooter (P. concinna) largely overlapped with those of T. scripta. These data add to a foundation for further characterization of turtle shell microbial communities across species and habitats, with implications for freshwater habitat assessment, microbial ecology and wildlife conservation efforts.	[Parks, Matthew; Kedy, Cameron; Skalla, Casey] Univ Cent Oklahoma, Dept Biol, Edmond, OK 73034 USA	University of Central Oklahoma	Parks, M (corresponding author), Univ Cent Oklahoma, Dept Biol, Edmond, OK 73034 USA.	mparks10@uco.edu			UCO CURE-STEM program; UCO Office of Research and Sponsored Programs	UCO CURE-STEM program; UCO Office of Research and Sponsored Programs	Funding for this project was provided by the UCO CURE-STEM program and the UCO Office of Research and Sponsored Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker K, 1996, J EXP MAR BIOL ECOL, V203, P245, DOI 10.1016/0022-0981(96)02575-0; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bradley IM, 2016, APPL ENVIRON MICROB, V82, P5878, DOI 10.1128/AEM.01630-16; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carda-Dieguez M, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0376-1; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Cook David G., 2004, Transactions of the Western Section of the Wildlife Society, V40, P84; Dalla Valle L, 2009, J ANAT, V214, P284, DOI 10.1111/j.1469-7580.2008.01030.x; Elbrecht V, 2019, FRESHWATER BIOL, V64, P380, DOI 10.1111/fwb.13220; Frick MG, 2004, SOUTHEAST NAT, V3, P613, DOI 10.1656/1528-7092(2004)003[0613:NRAOOE]2.0.CO;2; FUSELIER L, 1994, J HERPETOL, V28, P154, DOI 10.2307/1564614; Gibbons J.W., 1990, P201; GIBBONS JW, 1968, AM MIDL NAT, V79, P517, DOI 10.2307/2423197; Harrel JB, 1996, AM MIDL NAT, V135, P60, DOI 10.2307/2426872; HERBERT CV, 1985, PHYSIOL ZOOL, V58, P670, DOI 10.1086/physzool.58.6.30156071; Hoffmann WE, 1930, BOT GAZ, V89, P374, DOI 10.1086/334069; HUBERT W A, 1975, Journal of Wildlife Diseases, V11, P241; HUDSON DA, 1994, AQUACULTURE, V120, P183, DOI 10.1016/0044-8486(94)90077-9; Jones S, 2018, HYDROBIOLOGIA, V815, P37, DOI 10.1007/s10750-018-3545-8; Krotman Y, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-0784-5; Lovich JE, 2018, BIOSCIENCE, V68, P771, DOI 10.1093/biosci/biy095; Lowe S., 2004, 100 WORLDS WORST INV; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; Majewska R, 2017, MICROB ECOL, V74, P969, DOI 10.1007/s00248-017-0987-x; Majewska R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130351; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MC P, 1887, BOT J LINNAEAN SOC, V24, P251; McKenzie VJ, 2012, ISME J, V6, P588, DOI 10.1038/ismej.2011.129; McKnight DT, 2020, MICROBIOL-SGM, V166, P440, DOI 10.1099/mic.0.000904; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moore MJC, 2006, BIOL CONSERV, V130, P386, DOI 10.1016/j.biocon.2006.01.001; Oksanen J., 2016, VEGAN COMMUNITY ECOL; Peterman WE, 2009, NORTHEAST NAT, V16, P629, DOI 10.1656/045.016.n412; PLUTO TG, 1986, J HERPETOL, V20, P22, DOI 10.2307/1564121; PROCTOR VW, 1958, ECOLOGY, V39, P634, DOI 10.2307/1931604; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rebollar EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095484; Reese DA, 1998, J WILDLIFE MANAGE, V62, P842, DOI 10.2307/3802535; Rhodin AGJ, 2018, CHELONIAN CONSERV BI, V17, P135, DOI 10.2744/CCB-1348.1; Rivera SF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195770; Robertson BR, 2001, INT J SYST EVOL MICR, V51, P861, DOI 10.1099/00207713-51-3-861; Robinson NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157011; Ross John R., 1967, THESIS; Rowe HM, 2014, DEV COMP IMMUNOL, V46, P96, DOI 10.1016/j.dci.2014.02.014; Sievert G, 2005, FIELD GUIDE OKLAHOMA; Sims A, 2013, WATER RES, V47, P1711, DOI 10.1016/j.watres.2013.01.023; SLADECEK V, 1981, HYDROBIOLOGIA, V79, P229, DOI 10.1007/BF00006317; Slugocki L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66730-2; Stone PA, 2005, SOUTHWEST NAT, V50, P166, DOI 10.1894/0038-4909(2005)050[0166:FTAICO]2.0.CO;2; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Tanabe AS, 2016, MOL ECOL RESOUR, V16, P402, DOI 10.1111/1755-0998.12459; TAYLOR WD, 1983, CAN J ZOOL, V61, P2023, DOI 10.1139/z83-267; Theodorakopoulos N, 2013, MICROBIOLOGYOPEN, V2, P862, DOI 10.1002/mbo3.119; Verni F, 2011, ITAL J ZOOL, V78, P134, DOI 10.1080/11250003.2011.560579; Wang JZ, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00713-17, 10.1128/aem.00713-17]; Wang X, 2013, MICROB ECOL, V65, P361, DOI 10.1007/s00248-012-0144-5; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson DS, 2003, HERPETOLOGICA, V59, P178, DOI 10.1655/0018-0831(2003)059[0178:EAOTFG]2.0.CO;2; Woodburn DB, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00628-18; Woodhams DC, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-019-1908-8; Zeglin LH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00454; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	65	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244489	10.1371/journal.pone.0244489	http://dx.doi.org/10.1371/journal.pone.0244489			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370423	Green Published, gold			2022-12-27	WOS:000603611900018
J	Schwartz, KL; Achonu, C; Buchan, SA; Brown, KA; Lee, B; Whelan, M; Wu, JHC; Garber, G				Schwartz, Kevin L.; Achonu, Camille; Buchan, Sarah A.; Brown, Kevin A.; Lee, Brenda; Whelan, Michael; Wu, Julie H. C.; Garber, Gary			Epidemiology, clinical characteristics, household transmission, and lethality of severe acute respiratory syndrome coronavirus-2 infection among healthcare workers in Ontario, Canada	PLOS ONE			English	Article								Introduction Protecting healthcare workers (HCWs) from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a priority to maintain a safe and functioning healthcare system. Our objective was to describe and compare the epidemiology, clinical characteristics, and lethality of SARS-CoV-2 infections among HCWs compared to non-HCWs. Methods Using reportable disease data at Public Health Ontario, we conducted a population-based cross-sectional study comparing demographic, exposure, and clinical variables between HCWs and non-HCWs with SARS-CoV-2 infections as of 30 September 2020. We calculated rates of infections over time and determined the frequency of within household transmissions using natural language processing based on residential address. We evaluated the risk of death using a multivariable logistic regression model adjusting for age, sex, comorbidities, symptoms, and long-term care home exposure. Results There were 7,050 (12.5%) HCW SARS-CoV-2 infections in Ontario, Canada, of whom 24.9% were nurses, 2.3% were physicians, and the remaining 72.8% other specialties, including personal support workers. Overall HCWs had an infection rate of 1,276 per 100,000 compared to non-HCWs of 346 per 100,000 (3.7 times higher). This difference decreased from a 7 times higher rate in April to no difference in September 2020. Twenty-six percent of HCWs had a household member with SARS-CoV-2 infection; 6.8% were probable acquisitions, 12.3% secondary transmissions, and 6.9% unknown direction of transmission. Death among HCWs was 0.2% compared to 6.1% of non-HCWs. The risk of death in HCWs remained significantly lower than non-HCWs after adjustment (adjusted odds ratio 0.09; 95%CI 0.05-0.17). Conclusion HCWs represent a disproportionate number of diagnosed SARS-CoV-2 infections in Ontario, however this discrepancy is at least partially explained by limitations in testing earlier in the pandemic for non-HCWs. We observed a low risk of death in HCWs which could not be completely explained by other factors.	[Schwartz, Kevin L.; Achonu, Camille; Buchan, Sarah A.; Brown, Kevin A.; Lee, Brenda; Whelan, Michael; Wu, Julie H. C.; Garber, Gary] Publ Hlth Ontario, Toronto, ON, Canada; [Schwartz, Kevin L.; Buchan, Sarah A.; Brown, Kevin A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Schwartz, Kevin L.] Unity Hlth Toronto, Toronto, ON, Canada; [Garber, Gary] Ottawa Hosp, Res Inst, Ottawa, ON, Canada	University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Schwartz, KL (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Schwartz, KL (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Schwartz, KL (corresponding author), Unity Hlth Toronto, Toronto, ON, Canada.	Kevin.schwartz@oahpp.ca		Brown, Kevin Antoine/0000-0002-1483-2188; Whelan, Michael/0000-0003-2858-5496				Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Alberta Health Services, COVID 19 SCI ADV GRO; Bates W, ITALY 3320 SEROLOGIC; Burrer SL, 2020, CHARACTERISTICS HLTH; Canadian Institute for Health Information, 2020, CAN HLTH CAR PROV 20; Chang Z, 2020, CLIN INFECT DIS, DOI 10.1093/cid/ciaa450; Cheng HY, 2020, JAMA INTERN MED, V180, P1156, DOI 10.1001/jamainternmed.2020.2020; Cheng VCC, 2020, INFECT CONT HOSP EP, V41, P1258, DOI 10.1017/ice.2020.282; Chou R, 2020, ANN INTERNAL MED; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guerrero-Torres L, 2021, CLIN INFECT DIS, V73, pE199, DOI 10.1093/cid/ciaa1465; Hunter E, 2020, LANCET, V395, pE77, DOI 10.1016/S0140-6736(20)30970-3; Iversen K, 2020, LANCET INFECT DIS, V20, P1401, DOI 10.1016/S1473-3099(20)30589-2; Jeremias A, 2020, JAMA INTERNAL MED; Kambhampati AK, 2020, MMWR-MORBID MORTAL W, V69, P1576, DOI 10.15585/mmwr.mm6943e3; Kluytmans-van Den Bergh MFQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9673; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lai XQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9666; Lentz RJ, 2021, INFECT CONT HOSP EP, V42, P381, DOI 10.1017/ice.2020.455; Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344; McMichael TM, 2020, MMWR-MORBID MORTAL W, V69, P339, DOI 10.15585/mmwr.mm6912e1; Ng K, 2020, ANN INTERN MED, V172, P766, DOI 10.7326/L20-0175; Office of the Premier, 2020, ONT OP COVID 19 TEST; Ontario Ministry of Health, COVID 19 PROV TEST G; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Statistics Canada, 2018, OCC NATL OCC CLASS N; Steensels D, 2020, JAMA-J AM MED ASSOC, V324, P195, DOI 10.1001/jama.2020.11160; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V41, P145, DOI DOI 10.1056/NEJMcp2009249; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585	29	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244477	10.1371/journal.pone.0244477	http://dx.doi.org/10.1371/journal.pone.0244477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370384	Green Published, gold			2022-12-27	WOS:000603611900001
J	Sujarwoto, S; Maharani, A				Sujarwoto, Sujarwoto; Maharani, Asri			Participation in community-based health care interventions (CBHIs) and its association with hypertension awareness, control and treatment in Indonesia	PLOS ONE			English	Article							INCOME COUNTRIES; BLOOD-PRESSURE; GLOBAL BURDEN; RISK-FACTORS; PREVALENCE; PREVENTION; MANAGEMENT; INSURANCE; SERVICES; PROGRAM	Background Little attention has been paid to whether CBHIs improve awareness, treatment and control of hypertension in the contexts of low- and middle- income countries (LMICs). This study therefore aims to examine participation in CBHIs for non-communicable diseases (NCDs) and its association with awareness, treatment, and control of hypertension among Indonesians. Methods This study used data from the 2014 Indonesia Family Life Survey (IFLS), drawn from 30,351 respondents aged 18 years and older. Participation in CBHIs was measured by respondents' participation in CBHIs for NCDs (Posbindu PTM and Posbindu Lansia) during the 12 months prior to the survey. Logistic regressions were used to identify the relationships between participation in CBHIs for NCDs and awareness, treatment, and control of blood pressure among respondents with hypertension. Results The age-adjusted prevalence of hypertension was 31.2% and 29.2% in urban and rural areas, respectively. The overall age-adjusted prevalence was 30.2%. Approximately 41.8% of respondents with hypertension were aware of their condition, and only 6.6% of respondents were receiving treatment. Participation in CBHIs for NCDs was associated with 50% higher odds of being aware and 118% higher odds of receiving treatment among adults with hypertension. There was no significant association between participation in CBHIs for NCDs and controlled hypertension. Conclusion Our data emphasise the importance of CBHIs for NCDs to improve the awareness and treatment of hypertension in the Indonesian population.	[Sujarwoto, Sujarwoto] Univ Brawijaya, Portsmouth Brawijaya Ctr Global Hlth Populat & Po, Malang, Indonesia; [Sujarwoto, Sujarwoto] Univ Brawijaya, Dept Publ Adm, Malang, Indonesia; [Maharani, Asri] Univ Manchester, Div Nursing Midwifery & Social Work, Manchester, Lancs, England; [Maharani, Asri] Univ Brawijaya, Fac Med, Malang, Indonesia	Brawijaya University; Brawijaya University; University of Manchester; Brawijaya University	Sujarwoto, S (corresponding author), Univ Brawijaya, Portsmouth Brawijaya Ctr Global Hlth Populat & Po, Malang, Indonesia.; Sujarwoto, S (corresponding author), Univ Brawijaya, Dept Publ Adm, Malang, Indonesia.	sujarwoto@ub.ac.id	sujarwoto, sujarwoto/G-8205-2019; Maharani, Asri/U-7663-2017	sujarwoto, sujarwoto/0000-0003-4197-4592; Maharani, Asri/0000-0002-5931-8692	Kementerian Riset, Teknologi dan Pendidikan Tinggi (The Directorate General of Higher Education, Ministry of Education and Culture, Republic of Indonesia) [292.58 UN 10. C10/PN/2020]	Kementerian Riset, Teknologi dan Pendidikan Tinggi (The Directorate General of Higher Education, Ministry of Education and Culture, Republic of Indonesia)	SS and AM received funding from Kementerian Riset, Teknologi dan Pendidikan Tinggi, 292.58 UN 10. C10/PN/2020 (The Directorate General of Higher Education, Ministry of Education and Culture, Republic of Indonesia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Majid NL, 2018, J HUM HYPERTENS, V32, P617, DOI 10.1038/s41371-018-0082-x; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; [Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bennett S, 2004, HEALTH POLICY PLANN, V19, P147, DOI 10.1093/heapol/czh018; Bjork C., 2013, ED INDONESIA, P53, DOI 10.1355/9789814459877-008; BOSSERT T, 1991, HEALTH POLICY PLANN, V6, P55, DOI 10.1093/heapol/6.1.55; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; Bromfield S, 2013, CURR HYPERTENS REP, V15, P134, DOI 10.1007/s11906-013-0340-9; Bunting BA, 2008, J AM PHARM ASSOC, V48, P23, DOI 10.1331/JAPhA.2008.07140; Chan D, 2009, STATISTICAL AND METHODOLOGICAL MYTHS AND URBAN LEGENDS: DOCTRINE, VERITY AND FABLE IN THE ORGANIZATIONAL AND SOCIAL SCIENCES, P309; CHERNICHOVSKY D, 1986, SOC SCI MED, V23, P611, DOI 10.1016/0277-9536(86)90155-3; Christiani Y, 2015, J HUM HYPERTENS, V29, P683, DOI 10.1038/jhh.2015.8; de-Graft Aikins A, 2014, BMC PUBLIC HLTH S, V14, pS3; Deaton A., 2002, GUIDELINES CONSTRUCT, V135; Devi P, 2013, J HUM HYPERTENS, V27, P281, DOI 10.1038/jhh.2012.33; Devkota S, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00026; Dhingra R, 2012, MED CLIN N AM, V96, P87, DOI 10.1016/j.mcna.2011.11.003; Ekman B, 2004, HEALTH POLICY PLANN, V19, P249, DOI 10.1093/heapol/czh031; FAUVEAU V, 1991, LANCET, V338, P1183, DOI 10.1016/0140-6736(91)92041-Y; Ferdinand KC, 2012, J CLIN HYPERTENS, V14, P336, DOI 10.1111/j.1751-7176.2012.00622.x; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Fulwood R, 2006, CURR HYPERTENS REP, V8, P512, DOI 10.1007/s11906-006-0031-x; Geldsetzer P, 2018, JAMA INTERN MED, V178, P363, DOI 10.1001/jamainternmed.2017.8094; Giles TD, 2009, J CLIN HYPERTENS, V11, P611, DOI 10.1111/j.1751-7176.2009.00179.x; Haldane V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216112; Hales CM., 2017, HYPERTENSION PREVALE; Hasan M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198028; Hearn J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219141; Herningtyas EH, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6711-7; Heywood P, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-3; Hussain MA, 2016, J EPIDEMIOL, V26, P515, DOI 10.2188/jea.JE20150178; Hussain MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160922; Iacovou M, 2013, PUBLIC HEALTH NUTR, V16, P535, DOI 10.1017/S1368980012002753; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Laksono AD., 2019, MALAYSIAN J PUBLIC H, V19, P158; Lee LL, 2007, PREV MED, V44, P160, DOI 10.1016/j.ypmed.2006.09.001; Lees NB, 2002, HLTH PROMOT PRACT, V3, P264, DOI DOI 10.1177/152483990200300221; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; Liu XY, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1735-5; Menard Scott, 2002, APPL LOGISTIC REGRES, V106; Miller RB, 1995, J MARRIAGE FAM, V57, P921, DOI 10.2307/353412; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Ministry of Health, 2019, PET LOK POSB PTM; Ministry of Health, 2012, PET TEKN POSB PTM; Mohan S, 2013, INDIAN J MED RES, V137, P627; Park JB, 2015, HYPERTENS RES, V38, P227, DOI 10.1038/hr.2014.169; Pearce N, 2015, J PUBLIC HEALTH POL, V36, P408, DOI 10.1057/jphp.2015.29; Peltzer K, 2018, INT J HYPERTENS, V2018, DOI 10.1155/2018/5610725; Pratono AH, 2018, J AGING HEALTH, V30, P1556, DOI 10.1177/0898264318794732; Premkumar Ramaswamy, 2016, Indian Heart J, V68, P270, DOI 10.1016/j.ihj.2015.08.013; Quaderi SA, 2018, GLOB HEALTH EPIDEM G, V3, DOI 10.1017/gheg.2018.1; Ramadhan AP, 2015, J PUBLIC HEALTH-HEID, V23, P165, DOI 10.1007/s10389-015-0667-6; Scott VK, 2015, STUD FAMILY PLANN, V46, P241, DOI 10.1111/j.1728-4465.2015.00028.x; Strauss J., 2016, WR11431NIANICHD RAND; Thabrany H., 2006, REGIONAL HLTH FORUM; Vargha A, 1998, J EDUC BEHAV STAT, V23, P170, DOI 10.3102/10769986023002170; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organisation, 2005, MON EV INT COMM BAS; World Health Organization, 2010, PACK ESS NONC PEN DI; Wu MP, 2012, NURS HEALTH SCI, V14, P173, DOI 10.1111/j.1442-2018.2011.00675.x; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027; Zhang DL, 2017, AM J PREV MED, V53, pS121, DOI 10.1016/j.amepre.2017.05.008; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5	65	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244333	10.1371/journal.pone.0244333	http://dx.doi.org/10.1371/journal.pone.0244333			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370385	Green Published, gold			2022-12-27	WOS:000603611900049
J	Tesfa, E; Nibret, E; Munshea, A				Tesfa, Endalamaw; Nibret, Endalkachew; Munshea, Abaineh			Maternal lipid profile and risk of pre-eclampsia in African pregnant women: A systematic review and meta-analysis	PLOS ONE			English	Review							LOW-DENSITY-LIPOPROTEIN; HYPERTENSION; CHOLESTEROL; METABOLISM	Introduction Some studies have reported the association between maternal serum lipid profile abnormalities and pre-eclampsia. However, many studies have reported controversial results. Hence, this systematic review and meta-analysis was planned to generate summarized evidence on the association between maternal serum lipid profiles and pre-eclampsia in African women. Methods Four electronic databases such as; PubMed, Hinari, Google Scholar, and African Journals Online were searched for studies published in English. Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument and Newcastle-Ottawa Scale were used for data extraction and quality assessment of the included studies. The meta- regression analysis was performed by Stata 14 software. The standardized mean difference (SMD) values of lipid profiles were computed to assess their association with pre-eclampsia at 95% CI. Results In this review a total of 15 observational studies were included. The mean values of triglyceride (TG), total cholesterol (TC), low density lipoprotein- cholesterol (LDL-c) and very low density lipoprotein- cholesterol (VLDL-c) were significantly higher in pre-eclamptic women as compared with normotensive pregnant women (TG = 229.61 +/- 88.27 and 147.00 +/- 40.47, TC = 221.46 +/- 45.90 and 189.67 +/- 39.18, LDL = 133.92 +/- 38.77 and 112.41 +/- 36.08, VLDL = 41.44 +/- 19.68 and 26.64 +/- 7.87), respectively. The serum high density lipoprotein cholesterol (HDL-c) level was lower, but it is not statistically significant (HDL-c = 51.02 +/- 16.01 and 61.80 +/- 25.63) in pre-eclamptic women as compared with controls. The pooled standardized mean difference (SMD) of TG, TC, LDL-C and VLDL-C were significantly increased in pre-eclamptic women as compared with normotensive pregnant women with the SMD of (TG = 1.65 (1.10, 2.21), TC = 0.84 (0.40, 1.29), LDL-C = 0.95 (0.46, 1.45) and VLDL-C = 1.27 (0.72, 1.81)) at 95% CI, respectively, but the pooled SMD of HDL-cholesterol was decreased in pre-eclamptic women as compared with normotensive pregnant women (SMD = -0.91 (95% CI: -1.43, -0.39). Conclusions In this review, the maternal serum levels of TG, TC, LDL-c and VLDL-c were significantly associated with the risk of preeclampsia. However, HDL- cholesterol was not significantly associated but it was lower in pre-eclamptic women. Further, large scale prospective studies should verify these outcomes and it is recommended that lipid profiles should be included as a routine diagnostic test for pre-eclamptic women.	[Tesfa, Endalamaw] Bahir Dar Univ, Dept Biochem, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Tesfa, Endalamaw; Nibret, Endalkachew; Munshea, Abaineh] Bahir Dar Univ, Biotechnol Res Inst, Bahir Dar, Ethiopia; [Nibret, Endalkachew; Munshea, Abaineh] Bahir Dar Univ, Dept Biol, Coll Sci, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University; Bahir Dar University	Tesfa, E (corresponding author), Bahir Dar Univ, Dept Biochem, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.; Tesfa, E (corresponding author), Bahir Dar Univ, Biotechnol Res Inst, Bahir Dar, Ethiopia.	endalamaw2009@gmail.com	Damtie, Endalamaw Tesfa/GPF-8119-2022	Damtie, Endalamaw Tesfa/0000-0002-1554-2190				Abubakar A, 2011, WEBMEDCENTRAL, P1; Adank MC, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.03.025; Agarwal V, 2014, J CLIN DIAGN RES, V8, pCC4, DOI 10.7860/JCDR/2014/7901.4533; Ahenkorah L., 2008, Journal of Medical Sciences (Pakistan), V8, P691, DOI 10.3923/jms.2008.691.698; Ahmed AA, 2018, EGYPT J HOSP MED, V71, P3434; Anand S, 2016, J LIPID RES, V57, P687, DOI 10.1194/jlr.P064451; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Avidime AR, 2018, BIOMED J SCI TECH RE, V3, P3003, DOI [10.1016/j.bj.2019.07.007, DOI 10.1016/J.BJ.2019.07.007]; Baker AM, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.037; Basaran A, 2009, REPROD SCI, V16, P431, DOI 10.1177/1933719108330569; Baumfeld Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139164; Busso D, 2018, ATHEROSCLEROSIS, V276, P163, DOI 10.1016/j.atherosclerosis.2018.06.884; Chaiworapongsa T, 2014, NAT REV NEPHROL, V10, P466, DOI 10.1038/nrneph.2014.102; Choudhury KN, 2014, VASC HEALTH RISK MAN, V10, P327, DOI 10.2147/VHRM.S61019; De J, 2006, INDIAN J CLIN BIOCHE, V21, P165, DOI 10.1007/BF02912935; El Khouly NI, 2016, HYPERTENS PREGNANCY, V35, P73, DOI 10.3109/10641955.2015.1115060; Enaruna Nosakhare O, 2014, Niger Med J, V55, P423, DOI 10.4103/0300-1652.140387; Enquobahrie DA, 2004, AM J HYPERTENS, V17, P574, DOI 10.1016/j.amjhyper.2004.03.666; Ephraim RKD, 2014, ANN MED HEALTH SCI R, V4, P746, DOI 10.4103/2141-9248.141542; Flaquer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126294; Gallos ID, 2013, BJOG-INT J OBSTET GY, V120, P1321, DOI 10.1111/1471-0528.12375; Gohil JT, 2011, J OBSTET GYN INDIA, V61, P399, DOI 10.1007/s13224-011-0057-0; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Granger JP, 2001, HYPERTENSION, V38, P718, DOI 10.1161/01.HYP.38.3.718; Gupta S, 2009, OBSTET GYNECOL SURV, V64, P750, DOI 10.1097/OGX.0b013e3181bea0ac; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P982, DOI 10.1016/j.jclinepi.2013.03.003; Herrera E, 2016, HORM MOL BIOL CLIN I, V26, P109, DOI 10.1515/hmbci-2015-0025; Herrera E, 2010, CLIN LIPIDOL, V5, P899, DOI 10.2217/CLP.10.64; Jin WY, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0852-9; Joanna Briggs Institute, 2014, J BRIGGS I REV MAN 2, DOI DOI 10.14194/IJMBR.3.2.10; Joanna Briggs Institute, 2014, JOANNA BRIGGS I REVI, V2014; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Landmesser U, 2018, EUR HEART J, V39, P2179, DOI 10.1093/eurheartj/ehy299; Mittal M, 2014, INT J REPROD CONTRAC, V3, P732; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Neves FF, 2014, AM J LIFE SCI, V2, P150; Olalere FDH, 2020, J MATERN-FETAL NEO M, V33, P794, DOI 10.1080/14767058.2018.1505851; Onuegbu AJ, 2015, MED PRIN PRACT, V24, P276, DOI 10.1159/000381778; Qiu C, 2006, PHYSIOL RES, V55, P491, DOI 10.33549/physiolres.930813; Raijmakers MTM, 2004, HYPERTENSION, V44, P374, DOI 10.1161/01.HYP.0000141085.98320.01; Sarbjit G, 2018, WILEY INTERDISCIPL R, V7, pe286, DOI 10.1002/WENE.286; Spracklen CN, 2014, AM J EPIDEMIOL, V180, P346, DOI 10.1093/aje/kwu145; Talayero Beatriz G, 2011, Curr Cardiol Rep, V13, P544, DOI 10.1007/s11886-011-0220-3; Timalsina S, 2016, INT J WOMENS HEALTH, V8, P627, DOI 10.2147/IJWH.S117850; Vanderjagt DJ, 2004, ACTA OBSTET GYN SCAN, V83, P536, DOI 10.1111/j.1600-0412.2004.00513.x; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Yeboah FA, 2017, INT J WOMENS HEALTH, V9, DOI 10.2147/IJWH.S134088	47	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243538	10.1371/journal.pone.0243538	http://dx.doi.org/10.1371/journal.pone.0243538			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362205	Green Published, gold			2022-12-27	WOS:000603071600063
J	Kempnich, MW; Sison-Mangus, MP				Kempnich, Michael W.; Sison-Mangus, Marilou P.			Presence and abundance of bacteria with the Type VI secretion system in a coastal environment and in the global oceans	PLOS ONE			English	Article							PREDATION; ANTIBACTERIAL; POPULATIONS; COMPETITION; DIVERSITY; SEQUENCES; SINKING; BIOMASS; DIATOM; SNOW	Marine bacteria employ various strategies to maintain their competitive advantage over others in a mixed community. The use of Type VI Secretion Systems (T6SS), a protein secretion apparatus used as a molecular weapon for interbacterial competition and eukaryotic interactions, is one of the competitive strategies that is least studied among heterotrophic bacteria living in the water column. To get an insight into the temporal and spatial distribution of bacteria with T6SS in this portion of the marine environment, we examine the presence and abundance of T6SS-bearing bacteria at both local and global scales through the use of metagenome data from water samples obtained from the coast of Monterey Bay and the TARA Oceans project. We also track the abundance of T6SS-harboring bacteria through a two-year time series of weekly water samples in the same coastal site to examine the environmental factors that may drive their presence and abundance. Among the twenty-one T6SS-bearing bacterial genera examined, we found several genera assume a particle-attached lifestyle, with only a few genera having a free-living lifestyle. The abundance of T6SS-harboring bacteria in both niches negatively correlates with the abundance of autotrophs. Globally, we found that T6SS genes are much more abundant in areas with low biological productivity. Our data suggest that T6SS-harboring bacteria tend to be abundant spatially and temporally when organic resources are limited. This ecological study agrees with the patterns observed from several in vitro studies; that T6SS could be an adaptive strategy employed by heterotrophic bacteria to obtain nutrients or reduce competition when resources are in limited quantity.	[Kempnich, Michael W.; Sison-Mangus, Marilou P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Kempnich, Michael W.; Sison-Mangus, Marilou P.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Sison-Mangus, MP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	msisonma@ucsc.edu		Sison-Mangus, Marilou/0000-0002-6569-9380; Kempnich, Michael/0000-0002-8884-2194	Myers Trust; TARA Oceans project	Myers Trust; TARA Oceans project	The authors thank Sanjin Mehic and Terrill Yazzie for their contributions to sample collection, and Jiunn Fong for his support throughout the experiments. We also acknowledge the support from Myers Trust to MWK and the TARA Oceans project for its open-source data policies that made worldwide metagenomics comparisons possible.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; ALLDREDGE AL, 1986, LIMNOL OCEANOGR, V31, P68, DOI 10.4319/lo.1986.31.1.0068; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Anderson MC, 2017, CELL HOST MICROBE, V21, P769, DOI 10.1016/j.chom.2017.05.004; Martin-Fernandez JA, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P43; Azam F, 2001, NATURE, V414, P495, DOI 10.1038/35107174; Basler M, 2012, SCIENCE, V337, P815, DOI 10.1126/science.1222901; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Bruland KW, 2001, LIMNOL OCEANOGR, V46, P1661, DOI 10.4319/lo.2001.46.7.1661; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen LH, 2015, MICROBIOL RES, V172, P19, DOI 10.1016/j.micres.2015.01.004; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385; Das S, 2006, CURR SCI INDIA, V90, P1325; De La Rocha CL, 2007, DEEP-SEA RES PT II, V54, P639, DOI 10.1016/j.dsr2.2007.01.004; Diniz JA, 2015, CELL MICROBIOL, V17, P1742, DOI 10.1111/cmi.12532; Dorr NCD, 2018, P NATL ACAD SCI USA, V115, P8855, DOI 10.1073/pnas.1812776115; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Guillemette R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227864; Heip C, 2009, MARINE BIODIVERSITY, P100, DOI [10.13140/RG.2.1.2569.4966, DOI 10.13140/RG.2.1.2569.4966]; Hunter-Cevera J, 2005, AM ACAD MICROBIOLOGY, DOI [10.1128/AAMCol.8Apr.2005, DOI 10.1128/AAMCOL.8APR.2005]; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Jiang F, 2014, CELL HOST MICROBE, V15, P600, DOI 10.1016/j.chom.2014.04.010; Jurgens K, 2002, ANTON LEEUW INT J G, V81, P413, DOI 10.1023/A:1020505204959; Kudela RM, 2020, HABS DATA; Long E., 1999, NAT RES COUNC US STE; Lovejoy C, 1998, APPL ENVIRON MICROB, V64, P2806; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Marsay CM, 2015, P NATL ACAD SCI USA, V112, P1089, DOI 10.1073/pnas.1415311112; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Oksanen J., 2019, R PACKAGE VERSION; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Perez J, 2016, ENVIRON MICROBIOL, V18, P766, DOI 10.1111/1462-2920.13171; Pokrzywinski KL, 2012, HARMFUL ALGAE, V19, P23, DOI 10.1016/j.hal.2012.05.002; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00384; Quinn TP, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz107; Ray A, 2017, EMBO REP, V18, P1978, DOI 10.15252/embr.201744226; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Sherr EB, 2002, ANTON LEEUW INT J G, V81, P293, DOI 10.1023/A:1020591307260; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Sison-Mangus MP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01433; Sison-Mangus MP, 2014, ISME J, V8, P63, DOI 10.1038/ismej.2013.138; Speare L, 2018, P NATL ACAD SCI USA, V115, pE8528, DOI 10.1073/pnas.1808302115; Su JQ, 2011, BIOL CONTROL, V56, P132, DOI 10.1016/j.biocontrol.2010.10.004; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Tian YL, 2017, PHYTOPATHOLOGY, V107, P654, DOI [10.1094/PHYTO-11-16-0393-R, 10.1094/phyto-11-16-0393-r]; Townsley L, 2016, APPL ENVIRON MICROB, V82, P4441, DOI 10.1128/AEM.00807-16; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WATSON SW, 1977, APPL ENVIRON MICROB, V33, P940, DOI 10.1128/AEM.33.4.940-946.1977; Wexler AG, 2016, P NATL ACAD SCI USA, V113, P3639, DOI 10.1073/pnas.1525637113; Zhao WJ, 2018, SCIENCE, V359, P210, DOI 10.1126/science.aap8775; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	60	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244217	10.1371/journal.pone.0244217	http://dx.doi.org/10.1371/journal.pone.0244217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351849	Green Published, gold			2022-12-27	WOS:000603071400032
J	Tong, WT; Lee, YK; Ng, CJ; Lee, PY				Tong, Wen Ting; Lee, Yew Kong; Ng, Chirk Jenn; Lee, Ping Yein			Factors influencing implementation of an insulin patient decision aid at public health clinics in Malaysia: A qualitative study	PLOS ONE			English	Article							PRIMARY-CARE	Background Many patient decision aids (PDAs) are developed in academic settings by academic researchers. Academic settings are different from public health clinics where the focus is on clinical work. Thus, research on implementation in public health settings will provide insights to effective implementation of PDA in real-world settings. This study explores perceived factors influencing implementation of an insulin PDA in five public health clinics. Methods This study adopted a comparative case study design with a qualitative focus to identify similarities and differences of the potential barriers and facilitators to implementing the insulin PDA across different sites. Focus groups and individual interviews were conducted with 28 healthcare providers and 15 patients from five public health clinics under the Ministry of Health in Malaysia. The interviews were transcribed verbatim and analysed using the thematic approach. Results Five themes emerged which were: 1) time constraint; 2) PDA costs; 3) tailoring PDA use to patient profile; 4) patient decisional role; and 5) leadership and staff motivation. Based on the interviews and drawing on observations and interview reflection notes, time constraint emerged as the common prominent factor that cut across all the clinics, however, tailoring PDA use to patient profile; patient decisional role; leadership and staff motivation varied due to the distinct challenges faced by specific clinics. Among clinics from semi-urban areas with more patients from limited education and lower socio-economic status, patients' ability to comprehend the insulin PDA and their tendency to rely on their doctors and family to make health decisions were felt to be a prominent barrier to the insulin PDA implementation. Staff motivation appeared to be stronger in most of the clinics where specific time was allocated to diabetes team to attend to diabetes patients and this was felt could be a potential facilitator, however, a lack of leadership might affect the insulin PDA implementation even though a diabetes team is present. Conclusions This study found time constraint as a major potential barrier for PDA implementation and effective implementation of the insulin PDA across different public health clinics would depend on leadership and staff motivation and, the need to tailor PDA use to patient profile. To ensure successful implementation, implementers should avoid a 'one size fits all' approach when implementing health innovations.	[Tong, Wen Ting; Lee, Yew Kong; Ng, Chirk Jenn] Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia; [Lee, Ping Yein] Univ Putra Malaysia, Dept Family Med, Fac Med & Hlth Sci, Serdang, Malaysia	Universiti Malaya; Universiti Putra Malaysia	Lee, YK (corresponding author), Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia.	leeyk@um.edu.my	Lee, Ping Yein/C-1923-2012; Lee, Yew Kong/K-4339-2013; Tong, Wen Ting/G-8106-2012	Lee, Ping Yein/0000-0002-0912-6043; Lee, Yew Kong/0000-0002-3034-8601; Tong, Wen Ting/0000-0002-9081-191X	University of Malaya Research Grant (UMRG) [RP041C-15HTM]; University of Malaya Postgraduate Research Grant (PPP) [PG264-2016A]	University of Malaya Research Grant (UMRG); University of Malaya Postgraduate Research Grant (PPP)	This study was supported by the University of Malaya Research Grant (UMRG) (RP041C-15HTM) (YKL, WTT; CJN, PYL); and the University of Malaya Postgraduate Research Grant (PPP) (PG264-2016A) (YKL, WTT, CJN, PYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoakoh-Coleman M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157542; Azmi, 2013, MINIST HLTH MALAYS, V1, P2009; Azmiah ZN, 2011, INT MED J MALAYS, V10, P7; Belkora JK, 2011, PATIENT EDUC COUNS, V83, P234, DOI 10.1016/j.pec.2010.07.003; Berkman ND, 2011, ANN INTERN MED, V155, P97, DOI 10.7326/0003-4819-155-2-201107190-00005; Bhavnani V, 2010, HEALTH EXPECT, V13, P45, DOI 10.1111/j.1369-7625.2009.00556.x; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Crothers K, 2016, ANN AM THORAC SOC, V13, P1992, DOI 10.1513/AnnalsATS.201604-289OC; Department of Statistics Malaysia, 2019, STAT CAUS DEATHS MAL; Department of Statistics Malaysia, 2010, POP HOUS CENS MAL PO; Dyson J, 2010, J INFECT PREVENTION; Elwyn G, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S14; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Glaser B. G., 1978, THEORETICAL SENSITIV; Goodrick D, 2014, COMP CASE STUDIES ME, V9; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Hahlweg P, 2019, ARCH GYNECOL OBSTET, V299, P1141, DOI 10.1007/s00404-018-5035-7; Holmes-Rovner M, 2011, PATIENT EDUC COUNS, V85, P219, DOI 10.1016/j.pec.2010.12.028; Holmes-Rovner Margaret, 2000, Health Expect, V3, P182, DOI 10.1046/j.1369-6513.2000.00093.x; Hsu C, 2013, MED DECIS MAKING, V33, P85, DOI 10.1177/0272989X12468615; Institutue for Public Health. Malaysia National Health and Morbidity Survey, 2019, MAL NAT HLTH MORB SU, P2019; Joseph-Williams N, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1744; Lee PY, 2016, HEALTH EXPECT, V19, P427, DOI 10.1111/hex.12366; Lee YK, 2017, Z EVIDENZ FORTBILD Q, V123-124, P66, DOI 10.1016/j.zefq.2017.05.019; Lee YK, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-28; Lee YK, 2012, DECISION AID SUMMARY; Legare F, 2012, PATIENT, V5, P1, DOI 10.2165/11592180-000000000-00000; Lin GA, 2013, HEALTH AFFAIR, V32, P311, DOI 10.1377/hlthaff.2012.1070; Low LL, 2009, PATIENTS UNVOICED NE; Malaysian Medical Council, 2020, GOOD MED PRACT 2001; McCaffery KJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S10; Miller KM, 2012, PATIENT EDUC COUNS, V86, P189, DOI 10.1016/j.pec.2011.04.033; Mills AJ, 2010, ENCY CASE STUDY RES; Ministry of Health Malaysia, 1997, TEL FLAGSH APPL MAL; Ministry of Health Malaysia, 2009, CLIN PRACT GUID CPG, V4th; Ministry of Health Malaysia, 2013, GOV COMM CLIN KLINK; Moulton BW, 2016, SHARED DECISION MAKI, P3; Newsome A, 2012, FAM MED, V44, P26; Ng CJ, 2015, INT J CLIN PRACT, V69, P1050, DOI 10.1111/ijcp.12691; Ng CJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-408; Sepucha KR, 2016, HEALTH AFFAIR, V35, P630, DOI 10.1377/hlthaff.2015.1376; Shultz CG, 2015, FAM MED, V47, P679; Stacey D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001431.pub5; Tan WL, 2015, SINGAP MED J, V56, P224, DOI 10.11622/smedj.2014170; Trenaman L, 2017, OSTEOARTHR CARTILAGE, V25, P1615, DOI 10.1016/j.joca.2017.05.022; Volandes AE, 2010, MED DECIS MAKING, V30, P29, DOI 10.1177/0272989X09341587	46	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244645	10.1371/journal.pone.0244645	http://dx.doi.org/10.1371/journal.pone.0244645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378349	Green Published, gold, Green Accepted			2022-12-27	WOS:000605651300029
J	Turgeon, J; Berube, A; Blais, C; Lemieux, A; Fournier, A				Turgeon, Jessica; Berube, Annie; Blais, Caroline; Lemieux, Annie; Fournier, Amelie			Recognition of children's emotional facial expressions among mothers reporting a history of childhood maltreatment	PLOS ONE			English	Article							INTERGENERATIONAL TRANSMISSION; EXPERIENCED MALTREATMENT; ABUSE; YOUNG; ATTACHMENT; AGE; DISPLAYS; NEGLECT; BIASES; FACES	Several studies have shown that child maltreatment is associated with both positive and negative effects on the recognition of facial emotions. Research has provided little evidence of a relation between maltreatment during childhood and young adults' ability to recognize facial displays of emotion in children, an essential skill for a sensitive parental response. In this study, we examined the consequences of different forms of maltreatment experienced in childhood on emotion recognition during parenthood. Participants included sixty-three mothers of children aged 2 to 5 years. Retrospective self-reports of childhood maltreatment were assessed using the short form of the Childhood Trauma Questionnaire (CTQ). Emotion recognition was measured using a morphed facial emotion identification task of all six basic emotions (anger, disgust, fear, happiness, sadness, and surprise). A Path Analysis via Structural Equation Model revealed that a history of physical abuse is related to a decreased ability to recognize both fear and sadness in children, whereas emotional abuse and sexual abuse are related to a decreased ability to recognize anger in children. In addition, emotional neglect is associated with an increased ability to recognize anger, whereas physical neglect is associated with less accuracy in recognizing happiness in children's facial emotional expressions. These findings have important clinical implications and expand current understanding of the consequences of childhood maltreatment on parents' ability to detect children's needs.	[Turgeon, Jessica; Fournier, Amelie] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ, Canada; [Berube, Annie; Blais, Caroline; Lemieux, Annie] Univ Quebec Outaouais, Dept Psychoeduc & Psychol, Gatineau, PQ, Canada	University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University Quebec Outaouais	Turgeon, J (corresponding author), Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ, Canada.	jessica.turgeon@uqo.ca		Fournier, Amelie/0000-0002-3434-9185	Centre de recherche universitaire sur les jeunes et les familles (CRUJeF); Social Sciences and Humanities Research Council (SSHRC) [4302016-00521]	Centre de recherche universitaire sur les jeunes et les familles (CRUJeF); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC))	The study was funded by the Centre de recherche universitaire sur les jeunes et les familles (CRUJeF) https://www.crujef.ca/, (JT) and the Social Sciences and Humanities Research Council (SSHRC) https://www.sshrc-crsh.gc.ca/, 4302016-00521, (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, INFANT MOTHER ATTACH; Arteche A, 2011, J AFFECT DISORDERS, V133, P197, DOI 10.1016/j.jad.2011.04.015; Bartlett JD, 2017, CHILD ABUSE NEGLECT, V63, P84, DOI 10.1016/j.chiabu.2016.11.021; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Berube A, 2020, CHILD ABUSE NEGLECT, V102, DOI 10.1016/j.chiabu.2020.104432; Bland VJ, 2018, CLIN PSYCHOL REV, V60, P126, DOI 10.1016/j.cpr.2018.02.001; Buisman RSM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225839; CLIPP Centre de Liaison sur l'Intervention et la Prevention Psychosociales, 2008, NEGL ENV ENF BIL CON; Curtis WJ, 2013, CHILD MALTREATMENT, V18, P140, DOI 10.1177/1077559513487944; Curtis WJ, 2011, DEV PSYCHOPATHOL, V23, P373, DOI 10.1017/S0954579411000125; Dayton CJ, 2016, EMOTION, V16, P436, DOI 10.1037/emo0000114; Dixon L, 2005, J CHILD PSYCHOL PSYC, V46, P58, DOI 10.1111/j.1469-7610.2004.00340.x; Ebner NC, 2009, EMOTION, V9, P329, DOI 10.1037/a0015179; Elklit A, 2018, SCAND J EDUC RES, V62, P150, DOI 10.1080/00313831.2016.1253608; English LH, 2018, CHILD ABUSE NEGLECT, V80, P146, DOI 10.1016/j.chiabu.2018.02.006; Evans C.B., 2013, J CHILD ADOLES TRAUM, V6, P231, DOI [DOI 10.1080/19361521.2013.837567, 10.1080/19361521.2013.837567]; Germine L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129612; Gibb BE, 2009, CHILD MALTREATMENT, V14, P148, DOI 10.1177/1077559508326358; Grady MD, 2017, TRAUMA VIOLENCE ABUS, V18, P433, DOI 10.1177/1524838015627147; Grossmann K., 2005, ATTACHMENT INFANCY A, P98; Hagborg JM, 2020, ADDICT BEHAV, V106, DOI 10.1016/j.addbeh.2020.106365; Hartling C, 2019, PSYCHONEUROENDOCRINO, V99, P28, DOI 10.1016/j.psyneuen.2018.08.030; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Izard C. E., 1994, INNATE UNIVERSAL FAC, DOI [10.1037/0033-2909.115.2.288, DOI 10.1037/0033-2909.115.2.288]; Jenny C, 2008, PEDIATRICS, V122, P667, DOI 10.1542/peds.2008-1885; Johnson AL, 2010, COGNITIVE THER RES, V34, P380, DOI 10.1007/s10608-009-9269-3; Kerig P.K., 2015, DEV CRIMINAL ANTISOC, P181, DOI [10.1007/978-3-319-08720-7_12, DOI 10.1007/978-3-319-08720-7_12]; Kim H, 2017, AM J PUBLIC HEALTH, V107, P274, DOI [10.2105/AJPH.2016.303545, 10.2105/ajph.2016.303545]; Kline R.B., 2011, PRINCIPLES PRACTICE; Kolijn L, 2020, SOC NEUROSCI-UK, V15, P108, DOI 10.1080/17470919.2019.1660709; Kuefner D, 2008, J EXP PSYCHOL HUMAN, V34, P811, DOI 10.1037/0096-1523.34.4.811; Leerkes EM, 2009, CHILD DEV, V80, P762, DOI 10.1111/j.1467-8624.2009.01296.x; Leist Tatyana, 2009, Clin Child Psychol Psychiatry, V14, P237, DOI 10.1177/1359104508100887; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; Lipp OV, 2015, SOC PSYCHOL PERS SCI, V6, P109, DOI 10.1177/1948550614546047; Lo CC, 2007, AM J DRUG ALCOHOL AB, V33, P139, DOI 10.1080/00952990601091119; Lobue V, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01532; Madigan S, 2019, DEV PSYCHOPATHOL, V31, P23, DOI 10.1017/S0954579418001700; Manly JT, 2005, CHILD ABUSE NEGLECT, V29, P425, DOI 10.1016/j.chiabu.2005.04.001; Masten CL, 2008, CHILD ABUSE NEGLECT, V32, P139, DOI 10.1016/j.chiabu.2007.09.006; McCrory E, 2010, J CHILD PSYCHOL PSYC, V51, P1079, DOI 10.1111/j.1469-7610.2010.02271.x; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Moss E, 2001, DEV PSYCHOL, V37, P863, DOI 10.1037//0012-1649.37.6.863; NELSON CA, 1987, CHILD DEV, V58, P889, DOI 10.2307/1130530; Olsavsky AK, 2019, SOC COGN AFFECT NEUR, V14, P997, DOI 10.1093/scan/nsz069; Paquette Daniel, 2004, Sante Ment Que, V29, P201; Pears KC, 2005, DEV PSYCHOPATHOL, V17, P47, DOI 10.1017/S0954579405050030; Peterson C, 2018, CHILD ABUSE NEGLECT, V86, P178, DOI 10.1016/j.chiabu.2018.09.018; Pollak SD, 2005, CHILD DEV, V76, P968, DOI 10.1111/j.1467-8624.2005.00890.x; Pollak SD, 2003, J ABNORM PSYCHOL, V112, P323, DOI 10.1037/0021-843X.112.3.323; Pollak SD, 2002, DEV PSYCHOL, V38, P784, DOI 10.1037/0012-1649.38.5.784; Pollak SD, 2001, PSYCHOPHYSIOLOGY, V38, P267, DOI 10.1111/1469-8986.3820267; Pollak SD, 2000, DEV PSYCHOL, V36, P679, DOI 10.1037//0012-1649.36.5.679; Pollak SD, 2009, COGNITION, V110, P242, DOI 10.1016/j.cognition.2008.10.010; Raikes HA, 2006, BRIT J DEV PSYCHOL, V24, P89, DOI 10.1348/026151005X70427; Richoz AR, 2018, J VISION, V18, DOI 10.1167/18.9.5; Romano E, 2015, TRAUMA VIOLENCE ABUS, V16, P418, DOI 10.1177/1524838014537908; Savage LE, 2019, DEV PSYCHOPATHOL, V31, P9, DOI 10.1017/S0954579418001542; Shipman K, 2005, CHILD ABUSE NEGLECT, V29, P1015, DOI 10.1016/j.chiabu.2005.01.006; Shipman K, 2000, DEV PSYCHOPATHOL, V12, P47, DOI 10.1017/S0954579400001036; Stoltenborgh M, 2015, CHILD ABUSE REV, V24, P37, DOI 10.1002/car.2353; Suzuki A, 2015, CHILD MALTREATMENT, V20, P240, DOI 10.1177/1077559515600781; Swain JE, 2014, BRAIN RES, V1580, P78, DOI 10.1016/j.brainres.2014.03.007; Thornberry TP, 2012, TRAUMA VIOLENCE ABUS, V13, P135, DOI 10.1177/1524838012447697; Toth SL, 2019, CHILD DEV PERSPECT, V13, P59, DOI 10.1111/cdep.12317; Trocme N. M., 2005, ETUDE CANADIENNE LIN; Twardosz S, 2010, AGGRESS VIOLENT BEH, V15, P59, DOI 10.1016/j.avb.2009.08.003; Veague HB, 2014, PSYCHIAT RES, V215, P687, DOI 10.1016/j.psychres.2013.12.045; Wade TJ, 2018, J CHILD ADOLES TRAUM, V11, P159, DOI 10.1007/s40653-017-0186-4; WAGNER HL, 1993, J NONVERBAL BEHAV, V17, P3, DOI 10.1007/BF00987006; Young AW, 1997, COGNITION, V63, P271, DOI 10.1016/S0010-0277(97)00003-6	74	3	3	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0243083	10.1371/journal.pone.0243083	http://dx.doi.org/10.1371/journal.pone.0243083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373377	gold, Green Published			2022-12-27	WOS:000603612300040
J	Yano, H; Nishimiya, D; Kawaguchi, Y; Tamura, M; Hashimoto, R				Yano, Hidenori; Nishimiya, Daisuke; Kawaguchi, Yoshirou; Tamura, Masakazu; Hashimoto, Ryuji			Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE-9 MMP-9; MATRIX METALLOPROTEINASES; IV COLLAGENASE; HIGH-AFFINITY; GELATINASE; DOMAIN; SUBSTRATE; PRECURSOR; BINDING; COMPLICATIONS	Matrix metalloproteinases (MMPs) contribute to many physiological and pathological phenomena via the proteolysis of extracellular matrix components. Specific blocking of the active site of each MMP sheds light on its particular role. However, it remains difficult to acquire an active-site inhibitor with high specificity for only the target MMP due to the highly conserved structure around the active site of MMPs. Recently, we reported that potent and specific inhibitors of serine proteases were obtained from our proprietary engineered serine protease inhibitor Kazal type 2 (SPINK2) library. In this research, using this library, we succeeded in obtaining potent and specific MMP-9 inhibitors. The obtained inhibitors bound to the active site of MMP-9 and inhibited MMP-9 with low nanomolar K-i values. The inhibitors did not cross-react with other MMPs that we tested. Further analysis using MMP-9 mutants demonstrated that the inhibitors recognize not only the residues around the conserved active site of MMP-9 but also different and unique residues in exosites that are distant from each other. This unique recognition manner, which can be achieved by the large interface provided by engineered SPINK2, may contribute to the generation of specific active-site inhibitors of MMPs.	[Yano, Hidenori; Nishimiya, Daisuke; Kawaguchi, Yoshirou; Tamura, Masakazu; Hashimoto, Ryuji] Daiichi Sankyo Co Ltd, Div Biol, Modal Res Labs, Tokyo, Japan; [Yano, Hidenori] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan	Daiichi Sankyo Company Limited; University of Tsukuba	Yano, H (corresponding author), Daiichi Sankyo Co Ltd, Div Biol, Modal Res Labs, Tokyo, Japan.; Yano, H (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan.	yano.hidenori.kb@daiichisankyo.co.jp		Yano, Hidenori/0000-0002-1686-4319	Daiichi Sankyo Co., Ltd	Daiichi Sankyo Co., Ltd(Daiichi Sankyo Company Limited)	This work was fully supported by Daiichi Sankyo Co., Ltd. All authors are employees of Daiichi Sankyo Co., Ltd. The funder provided support in the form of salaries for authors: H.Y., D. N., Y.K., M.T., and R.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alford VM, 2017, ACS CHEM BIOL, V12, P2788, DOI 10.1021/acschembio.7b00758; Appleby TC, 2017, J BIOL CHEM, V292, P6810, DOI 10.1074/jbc.M116.760579; Arkadash V, 2017, J BIOL CHEM, V292, P3481, DOI 10.1074/jbc.M116.756718; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Cheng MY, 2000, J MED CHEM, V43, P369, DOI 10.1021/jm990366q; Ciferri C, 2015, BIOCHEM J, V472, P169, DOI 10.1042/BJ20150601; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; Nam DH, 2016, P NATL ACAD SCI USA, V113, P14970, DOI 10.1073/pnas.1609375114; Dufour A, 2011, CANCER RES, V71, P4977, DOI 10.1158/0008-5472.CAN-10-4552; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Goffin L, 2016, INFLAMM BOWEL DIS, V22, P2041, DOI 10.1097/MIB.0000000000000863; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Hariono M, 2020, J CHEM INF MODEL, V60, P349, DOI 10.1021/acs.jcim.9b00630; Hashimoto H, 2011, J BIOL CHEM, V286, P33236, DOI 10.1074/jbc.M111.264176; Higashi S, 2008, J BIOL CHEM, V283, P10068, DOI 10.1074/jbc.M709509200; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Ishida Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19763-0; Itoh T, 1999, CLIN EXP METASTAS, V17, P177, DOI 10.1023/A:1006603723759; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Kaplan A, 2014, NEURON, V81, P333, DOI 10.1016/j.neuron.2013.12.009; Kridel SJ, 2001, J BIOL CHEM, V276, P20572, DOI 10.1074/jbc.M100900200; Lin C, 2021, CELL MOL NEUROBIOL, V41, P1651, DOI 10.1007/s10571-020-00933-z; Marshall DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127063; Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019; Mishiro K, 2012, NEUROSCIENCE, V205, P39, DOI 10.1016/j.neuroscience.2011.12.042; Mondal S, 2020, EUR J MED CHEM, V194, DOI 10.1016/j.ejmech.2020.112260; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; MURPHY G, 1989, BIOCHEM J, V258, P463, DOI 10.1042/bj2580463; Nishimiya D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47615-5; O'Farrell TJ, 1998, ARCH BIOCHEM BIOPHYS, V354, P24, DOI 10.1006/abbi.1998.0662; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Roeb E, 2000, FASEB J, V14, P1671; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Scannevin RH, 2017, J BIOL CHEM, V292, P17963, DOI 10.1074/jbc.M117.806075; Sela-Passwell NA, 2012, NAT MED, V18, P143, DOI 10.1038/nm.2582; Sharabi O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093712; Shirian J, 2018, FEBS LETT, V592, P1122, DOI 10.1002/1873-3468.13016; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Tranchant I, 2014, CHEM BIOL, V21, P408, DOI 10.1016/j.chembiol.2014.01.008; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Xu XP, 2005, BIOCHEM J, V392, P127, DOI 10.1042/BJ20050650; Zitka O, 2010, CURR MED CHEM, V17, P3751, DOI 10.2174/092986710793213724	50	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244656	10.1371/journal.pone.0244656	http://dx.doi.org/10.1371/journal.pone.0244656			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373399	gold, Green Published			2022-12-27	WOS:000603612300034
J	Bandara, AY; Weerasooriya, DK; Conley, SP; Allen, TW; Esker, PD				Bandara, Ananda Y.; Weerasooriya, Dilooshi K.; Conley, Shawn P.; Allen, Tom W.; Esker, Paul D.			Modeling the relationship between estimated fungicide use and disease-associated yield losses of soybean in the United States II: Seed-applied fungicides vs seedling diseases	PLOS ONE			English	Article							CULTIVAR RESPONSE; ROOT-ROT; PROFITABILITY; CORN	Use of seed-applied fungicides has become commonplace in the United States soybean production systems. Although fungicides have the potential to protect seed/seedlings from critical early stage diseases such as damping-off and root/stem rots, results from previous studies are not consistent in terms of seed-applied fungicide's ability to mitigate yield losses. In the current study, the relationship between estimated soybean production losses due to seedling diseases and estimated seed-applied fungicide use was investigated using annual data from 28 soybean growing states in the U.S. over the period of 2006 to 2014. National, regional (northern and southern U.S.), state, and temporal scale trends were explored using mixed effects version of the regression analysis. Mixed modeling allowed computing generalized R-2 values for conditional (R-GLMM(c)(2); contains fixed and random effects) and marginal (R-GLMM(m)(2); contains only fixed effects) models. Similar analyses were conducted to investigate how soybean production was related to fungicide use. National and regional scale modeling revealed that R-GLMM(c)(2) values were significantly larger compared to R-GLMM(m)(2) values, meaning fungicide use had limited utility in explaining the national/regional scale variation of yield loss and production. The state scale analysis revealed the usefulness of seed-applied fungicides to mitigate seedling diseases-associated soybean yield losses in Illinois, Indiana, North Carolina, and Ohio. Further, fungicide use positively influenced the soybean production and yield in Illinois and South Dakota. Taken together, use of seed-applied fungicide did not appear to be beneficial to many of the states. Our findings corroborate the observations made by a number of scientists through field scale seed-applied fungicide trials across the U.S and reiterate the importance of need base-use of seed-applied fungicides rather than being a routine practice in soybean production systems.	[Bandara, Ananda Y.; Weerasooriya, Dilooshi K.; Esker, Paul D.] Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA; [Conley, Shawn P.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Allen, Tom W.] Mississippi State Univ, Delta Res & Extens Ctr, Stoneville, MS USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Wisconsin System; University of Wisconsin Madison; Mississippi State University	Bandara, AY; Esker, PD (corresponding author), Penn State Univ, Dept Plant Pathol & Environm Microbiol, University Pk, PA 16802 USA.	axb1739@psu.edu; pde6@psu.edu		Y. Bandara, Ananda/0000-0003-0725-8226; Conley, Shawn/0000-0002-8413-1088	United Soybean Board [2215, 1520-532-5637, 1620-532-5637]; USDA National Institute of Food and Federal Appropriations [PEN04660, 1016474]	United Soybean Board; USDA National Institute of Food and Federal Appropriations	Funding for this research was received from the United Soybean Board, including award 2215 (PDE), 1520-532-5637 (TWA and PDE), and 1620-532-5637 (TWA). Additional support was also from the USDA National Institute of Food and Federal Appropriations under Project PEN04660 and Accession number 1016474 (PDE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 2017, PLANT HLTH PROG, V18, P19, DOI 10.1094/PHP-RS-16-0066; Babadoost M, 2003, PLANT DIS, V87, P63, DOI 10.1094/PDIS.2003.87.1.63; Bandara AY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234390; Bandara AY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231141; BARTO K, 2009, MUMIN MULTIMODEL INF; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bowers G.R., 1999, SOYBEAN PRODUCTION M, V1st ed., P231; Bradley CA, 2008, PLANT DIS, V92, P120, DOI 10.1094/PDIS-92-1-0120; Bradley CA, 2001, CROP PROT, V20, P615, DOI 10.1016/S0261-2194(01)00057-6; Broders KD, 2007, PLANT DIS, V91, P727, DOI 10.1094/PDIS-91-6-0727; Broders KD, 2009, PHYTOPATHOLOGY, V99, P957, DOI 10.1094/PHYTO-99-8-0957; Cox WJ, 2008, AGRON J, V100, P1662, DOI 10.2134/agronj2008.0015; Dorrance AE, 2016, PLANT DIS, V100, P1429, DOI 10.1094/PDIS-08-15-0879-RE; Dorrance AE, 2003, PLANT DIS, V87, P533, DOI 10.1094/PDIS.2003.87.5.533; Dorrance AE, 2001, PLANT DIS, V85, P1063, DOI 10.1094/PDIS.2001.85.10.1063; Esker PD, 2012, CROP SCI, V52, P351, DOI 10.2135/cropsci2011.06.0311; Gaspar AP, 2017, CROP SCI, V57, P2251, DOI 10.2135/cropsci2016.11.0967; Gaspar AP, 2015, CROP SCI, V55, P924, DOI 10.2135/cropsci2014.02.0114; Gelman A., 2018, PACKAGE ARM R PACKAG; GUY SO, 1989, J PROD AGRIC, V2, P179, DOI 10.2134/jpa1989.0179; GUY SO, 1989, AGRON J, V81, P529, DOI 10.2134/agronj1989.00021962008100030027x; Hartman G. L., 2015, COMPENDIUM SOYBEAN D, V5th; Heitholt JJ, 2005, CROP MANAGE, DOI [DOI 10.1094/CM-2005-0329-01-RS, 10.1094/CM-2005-0329-01-RS.]; Hitaj C, 2020, BIOSCIENCE, V70, P390, DOI 10.1093/biosci/biaa019; Koenning S.R., 2010, PLANT HLTH PROGR, V11, DOI DOI 10.1094/PHP-2010-1122-1001-RS; Koenning SR, 2009, P SO SOYB DIS WORK M, P10; Lal R, 2009, FOOD SECUR, V1, P45, DOI 10.1007/s12571-009-0009-z; LUESCHEN WE, 1991, J PROD AGRIC, V4, P580, DOI 10.2134/jpa1991.0580; Melillo J.M., 2014, 3 NATL COMMUNICATION; Munkvold GP, 2009, ANNU REV PHYTOPATHOL, V47, P285, DOI 10.1146/annurev-phyto-080508-081916; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navi SS, 2019, PHYTOPATHOL RES, V1, DOI 10.1186/s42483-019-0015-9; Orlowski JM, 2016, CROP SCI, V56, P1988, DOI 10.2135/cropsci2015.10.0620; Poag PS, 2005, AGRON J, V97, P1647, DOI 10.2134/agronj2005.0095; Rizvi SSA, 1996, PLANT DIS, V80, P57, DOI 10.1094/PD-80-0057; Rossman DR, 2018, CROP PROT, V114, P44, DOI 10.1016/j.cropro.2018.08.003; Rothrock CS., 2015, COMPENDIUM SOYBEAN D, P76; Schulz TJ, 2008, CROP SCI, V48, P1975, DOI 10.2135/cropsci2008.02.0108; Singmann H., 2015, AFEX ANAL FACTORIAL; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Thelin W, 2013, INVEST OPHTH VIS SCI, V54; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Urrea K, 2013, PLANT DIS, V97, P807, DOI 10.1094/PDIS-08-12-0772-RE; USDA-Economic Research Service, 2016, REC US SOYB PROD COS; WALL MT, 1983, AGRON J, V75, P969, DOI 10.2134/agronj1983.00021962007500060025x; Wrather JA, 2006, J NEMATOL, V38, P173; Yang Chia-Anne, 2010, Int J Alzheimers Dis, V2011, P607861, DOI 10.4061/2011/607861; Yang X.B., 1999, COMPENDIUM SOYBEAN D, P42; Yang XB., 1999, COMPENDIUM SOYBEAN D, V4, P45	49	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244424	10.1371/journal.pone.0244424	http://dx.doi.org/10.1371/journal.pone.0244424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370391	Green Published, gold			2022-12-27	WOS:000603611900112
J	Kenny, LC; Thomas, G; Poston, L; Myers, JE; Simpson, NAB; McCarthy, FP; Brown, LW; Bond, AE; Tuytten, R; Baker, PN				Kenny, Louise C.; Thomas, Gregoire; Poston, Lucilla; Myers, Jenny E.; Simpson, Nigel A. B.; McCarthy, Fergus P.; Brown, Leslie W.; Bond, Alison E.; Tuytten, Robin; Baker, Philip N.		Screening Pregnancy Endpoints Cons	Prediction of preeclampsia risk in first time pregnant women: Metabolite biomarkers for a clinical test	PLOS ONE			English	Article							PLACENTAL GROWTH-FACTOR; PERFORMANCE; MODELS	Preeclampsia remains a leading cause of maternal and perinatal morbidity and mortality. Accurate prediction of preeclampsia risk would enable more effective, risk-based prenatal care pathways. Current risk assessment algorithms depend on clinical risk factors largely unavailable for first-time pregnant women. Delivering accurate preeclampsia risk assessment to this cohort of women, therefore requires for novel biomarkers. Here, we evaluated the relevance of metabolite biomarker candidates for their selection into a prototype rapid, quantitative Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) based clinical screening assay. First, a library of targeted LC-MS/MS assays for metabolite biomarker candidates was developed, using a medium-throughput translational metabolomics workflow, to verify biomarker potential in the Screening-for-Pregnancy-Endpoints (SCOPE, European branch) study. A variable pre-selection step was followed by the development of multivariable prediction models for pre-defined clinical use cases, i.e., prediction of preterm preeclampsia risk and of any preeclampsia risk. Within a large set of metabolite biomarker candidates, we confirmed the potential of dilinoleoyl-glycerol and heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine to effectively complement Placental Growth Factor, an established preeclampsia biomarker, for the prediction of preeclampsia risk in first-time pregnancies without overt risk factors. These metabolites will be considered for integration in a prototype rapid, quantitative LC-MS/MS assay, and subsequent validation in an independent cohort.	[Kenny, Louise C.] Univ Liverpool, Fac Hlth & Life Sci, Liverpool, Merseyside, England; [Thomas, Gregoire] SQU4RE, Lokeren, Belgium; [Thomas, Gregoire; Brown, Leslie W.; Bond, Alison E.; Tuytten, Robin] Metabol Diagnost, Cork, Ireland; [Poston, Lucilla] Kings Coll London, Dept Women & Childrens Hlth, London, England; [Myers, Jenny E.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Simpson, Nigel A. B.] Univ Leeds, Dept Womens & Childrens Hlth, Leeds, W Yorkshire, England; [McCarthy, Fergus P.] Univ Coll Cork, Irish Ctr Fetal & Neonatal Translat Res, Cork, Ireland; [Baker, Philip N.] Univ Leicester, Coll Life Sci, Leicester, Leics, England; [Bond, Alison E.] BBI Solut, Cardiff, Wales	University of Liverpool; University of London; King's College London; University of Manchester; University of Leeds; University College Cork; University of Leicester	Kenny, LC (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Liverpool, Merseyside, England.; Tuytten, R (corresponding author), Metabol Diagnost, Cork, Ireland.	Louise.Kenny@liverpool.ac.uk; robin.tuytten@metabolomicdiagnostics.com	Tuytten, Robin/AAT-3447-2021; Kenny, Louise/G-1112-2011	Tuytten, Robin/0000-0002-8734-7335; Poston, Lucilla/0000-0003-1100-2821; , Gregoire/0000-0002-6247-9438; Myers, Jenny/0000-0003-0913-2096; Kenny, Louise/0000-0002-9011-759X	EU-HEALTH Project IMPROvED of the Seventh Framework Programme [305169]; New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund, Auckland District Health Board Charitable Trust (New Zealand); Premier's Science and Research Fund, South Australian Government (Australia); Health Research Board (Ireland)	EU-HEALTH Project IMPROvED of the Seventh Framework Programme; New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; Evelyn Bond Fund, Auckland District Health Board Charitable Trust (New Zealand); Premier's Science and Research Fund, South Australian Government (Australia); Health Research Board (Ireland)	This study received funding from the EU-HEALTH Project IMPROvED (305169) of the Seventh Framework Programme, the goal of IMPROvED is to develop a clinically robust predictive blood test for pre-eclampsia. SCOPE was funded by the New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council; and Evelyn Bond Fund, Auckland District Health Board Charitable Trust (New Zealand); Premier's Science and Research Fund, South Australian Government (Australia); and Health Research Board (Ireland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LWB and RT are employees of Metabolomic Diagnostics. AEB was an employee of Metabolomic Diagnostics at the time this work was conducted. GT is the owner of SQU4RE, an independent Statistics and Data mining provider. The respective funders Metabolomic Diagnostics and SQU4RE provided support in the form of salaries for authors (LWB, RT, AEB, GT) insofar these were not covered by the EU-HEALTH Project IMPROvED (305169) of the Seventh Framework Programme, but did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contribution' section. Mass spectrometry data acquisition was funded Metabolomic Diagnostics, insofar this was not covered by the EUHEALTH Project IMPROvED (305169) of the Seventh Framework Programme.	ACOG Committee, 2018, OBSTET GYNECOL, V132, P254; Agrawal S, 2019, HYPERTENSION, V74, P1124, DOI 10.1161/HYPERTENSIONAHA.119.13360; Akolekar R, 2013, FETAL DIAGN THER, V33, P8, DOI 10.1159/000341264; [Anonymous], 2019, Obstet Gynecol, V133, P1, DOI 10.1097/AOG.0000000000003018; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; [Anonymous], 2013, E39912E2 ASTM, V99, P1; Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753; Benton SJ, 2016, PLACENTA, V42, P1, DOI 10.1016/j.placenta.2016.03.010; Brereton RG, 2014, J CHEMOMETR, V28, P213, DOI 10.1002/cem.2609; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; Brunelli VB, 2015, BJOG-INT J OBSTET GY, V122, P904, DOI 10.1111/1471-0528.13334; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Chau K, 2017, J HUM HYPERTENS, V31, P782, DOI 10.1038/jhh.2017.61; Considine EC, 2019, METABOLITES, V9, DOI 10.3390/metabo9070126; Devroye Luc P., 1996, PROBABILISTIC THEORY, V31; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Freeman DJ, 2004, HYPERTENSION, V44, P708, DOI 10.1161/01.HYP.0000143849.67254.ca; Fujii T, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13176; Gayat E, 2015, INT J CARDIOL, V199, P241, DOI 10.1016/j.ijcard.2015.07.039; Hauth JC, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.024; Hernandez-Diaz S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2255; Kenny LC, 2014, HYPERTENSION, V64, P644, DOI 10.1161/HYPERTENSIONAHA.114.03578; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kyozuka H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70974-3; Lamain-de Ruiter M, 2019, HYPERTENS PREGNANCY, V38, P78, DOI 10.1080/10641955.2019.1584210; LaMarca B, 2013, PHYSIOLOGY, V28, P225, DOI 10.1152/physiol.00006.2013; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; McCowan LME, 2010, BJOG-INT J OBSTET GY, V117, P1599, DOI 10.1111/j.1471-0528.2010.02737.x; Meertens LJE, 2019, FETAL DIAGN THER, V45, P381, DOI 10.1159/000490385; Moher D., 2009, ANN INTERN MED, V6, DOI [DOI 10.18632/aging.103000, 10.1371/journal.pmed.100009]; Myatt L, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0595-4; Myers J, 2019, PREGNANCY HYPERTENS, V17, pS21; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; National Institute for Health and Care Excellence, 2008, ANT CAR UNC PREGN; National Institute for Health and Care Excellence, 2019, HYPERTENSION PREGNAN; Navaratnam K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-226; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; North EJ, 2009, BIOORGAN MED CHEM, V17, P3433, DOI 10.1016/j.bmc.2009.03.030; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; O'Gorman N, 2017, ULTRASOUND OBST GYN, V49, P756, DOI 10.1002/uog.17455; Polewski MA, 2015, J LIPID RES, V56, P1461, DOI [10.1194/jlr.M057562, 10.1194/jlr.M]; Poon LC, 2019, INT J GYNECOL OBSTET, V145, P1, DOI 10.1002/ijgo.12802; Powers RW, 2012, HYPERTENSION, V60, P239, DOI 10.1161/HYPERTENSIONAHA.112.191213; Prins JR, 2009, HYPERTENS PREGNANCY, V28, P300, DOI 10.1080/10641950802601237; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Ribatti D, 2008, ANGIOGENESIS, V11, P215, DOI 10.1007/s10456-008-9114-4; Roberts DJ, 2008, J CLIN PATHOL, V61, P1254, DOI 10.1136/jcp.2008.055236; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Rolnik DL, 2017, ULTRASOUND OBST GYN, V50, P492, DOI 10.1002/uog.18816; Rolnik DL, 2017, NEW ENGL J MED, V377, P613, DOI 10.1056/NEJMoa1704559; Ross KM, 2019, J PERINATOL, V39, P314, DOI 10.1038/s41372-018-0275-8; Scioscia M, 2015, J REPROD IMMUNOL, V108, P42, DOI 10.1016/j.jri.2015.01.009; Sovio U, 2019, BJOG-INT J OBSTET GY, V126, P963, DOI 10.1111/1471-0528.15664; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Team RC., 2013, R LANG ENV STAT COMP; Thomas Gregoire, 2017, Diagn Progn Res, V1, P17, DOI 10.1186/s41512-017-0017-y; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Wright D, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.018; Wright D, 2012, FETAL DIAGN THER, V32, P171, DOI 10.1159/000338470; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; ZWEIG MH, 1993, CLIN CHEM, V39, P561	65	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244369	10.1371/journal.pone.0244369	http://dx.doi.org/10.1371/journal.pone.0244369			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370367	Green Published, gold			2022-12-27	WOS:000603611900019
J	Neelakantan, A; DeFries, R; Fanzo, J				Neelakantan, Amrita; DeFries, Ruth; Fanzo, Jessica			Food security and livelihoods of post-resettlement households around Kanha National Park	PLOS ONE			English	Article							CONSERVATION-INDUCED DISPLACEMENT; PROTECTED AREAS; DEVELOPING-COUNTRIES; HUMAN-POPULATION; BIODIVERSITY; VILLAGE; POVERTY; IMPACT; CONSEQUENCES; MANAGEMENT	Globally, conservation efforts have moved millions of people out of protected areas since the 1970s, yet quantitative studies on post-resettlement well-being remain a challenge due to poor documentation. Since 2008, the Indian forest department records demographic and financial details at the household level under standardized guidelines for resettlement. Here, we examine the food security of approximately 600 households' post-resettlement from Kanha National Park (KNP) in central India between 2009 and 2014. We compare food security of resettled households with host community households with a total of 3519 household surveys, conducted over three seasons within one year. We measure food security using food consumption scores (FCSs), coping strategies index (CSI) and household hunger scale (HHS). Food insecurity is widespread in the landscape, with over 80% of households reporting poor or borderline FCSs year-round. Additionally, we recorded food insecurity increases in monsoon for all households regardless of resettlement status. Results indicate that resettled households are comparable to their host community neighbors in FCS and all households use mild coping strategies to combat food insecurity. While widespread, food insecurity in the KNP landscape is not acute with very few (<10) reports of severe hunger (as measured by the HHS). Almost all foods are market bought (>90%) and sometimes supplemented by gathering locally prevalent greens or from kitchen gardens (forest dependency for food was negligible). Accruing assets and diversifying incomes from non-labor avenues would alleviate food insecurity for all households. The patterns of market dependence and food security associated with diversified stable incomes around protected areas is in contrast with many studies but is likely to occur in similar human-dominated landscapes.	[Neelakantan, Amrita; DeFries, Ruth] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Fanzo, Jessica] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Neelakantan, A (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	amrita.neelakantan@columbia.edu	Fanzo, Jessica/HCH-3533-2022	Neelakantan, Amrita/0000-0001-6306-7243				Agarwala M, 2016, REG ENVIRON CHANGE, V16, P5, DOI 10.1007/s10113-015-0903-1; Agrawal A., 2009, CONSERV SOC, V7, P1, DOI 10.4103/0972-4923.54790; Alders RG, 2009, WORLD POULTRY SCI J, V65, P181, DOI 10.1017/S0043933909000117; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; [Anonymous], 2019, NAT ENERGY, V4, P1, DOI 10.1038/s41560-018-0323-9; [Anonymous], 2002, AM DEMOGRAPHICS, V24, pS4; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; [Anonymous], 2008, FORM PREP VILL REL P; Ballard Terri, 2011, HOUSEHOLD HUNGER SCA; Barrett C. B., 2005, MEAS FOOD INSECURITY, P1; Bawa KS, 2007, AGR ECOSYST ENVIRON, V121, P287, DOI 10.1016/j.agee.2006.12.023; Bharucha Z, 2010, PHILOS T R SOC B, V365, P2913, DOI 10.1098/rstb.2010.0123; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Castor Mei L, 2008, Infect Dis Obstet Gynecol, V2008, P727505, DOI 10.1155/2008/727505; Census of India, 2011, CENS IND POP FIND; Cernea MM, 2006, WORLD DEV, V34, P1808, DOI 10.1016/j.worlddev.2006.02.008; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Colding J, 2019, ECOL SOC, V24, DOI 10.5751/ES-10598-240102; de Hoop J., 2019, WORLD BANK ECON REV, V0, P1; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; European Space Agency, 2012, GLOBC V2 3; Fanzo J, 2020, PHYSIOL BEHAV, V222, DOI 10.1016/j.physbeh.2020.112929; Gasper D, 2007, STUD DEV ECON POLICY, P23; Gavin M.C., 2018, SUSTAINABILITY, V10, P1; Golden Christopher D., 2014, Madagascar Conservation & Development, V9, P83; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; GROSSMAN LS, 1991, ECOL FOOD NUTR, V26, P235, DOI 10.1080/03670244.1991.9991205; Hanazaki N, 2013, HUM ECOL, V41, P153, DOI 10.1007/s10745-012-9553-9; Harihar A, 2015, GLOBAL ENVIRON CHANG, V33, P122, DOI 10.1016/j.gloenvcha.2015.05.004; Harihar A, 2014, BIOL CONSERV, V169, P167, DOI 10.1016/j.biocon.2013.11.012; Hesselberg J, 2006, GEOJOURNAL, V67, P41, DOI 10.1007/s10708-006-9007-2; ISCGM, 2007, INT STEER COMM GLOB; Johnson KB, 2013, GLOB HEALTH-SCI PRAC, V1, P237, DOI 10.9745/GHSP-D-13-00055; Jones AD, 2013, ADV NUTR, V4, P481, DOI 10.3945/an.113.004119; Kabra A., 2009, CONSERV SOC, V7, P249, DOI DOI 10.4103/0972-4923.65172; Kabra A, 2014, LAND USE POLICY, V41, P217, DOI 10.1016/j.landusepol.2014.05.010; Karanth KK, 2007, BIOL CONSERV, V139, P315, DOI 10.1016/j.biocon.2007.07.004; Kashwan P, 2013, LAND USE POLICY, V31, P613, DOI 10.1016/j.landusepol.2012.09.009; Lasgorceix A., 2009, Economic and Political Weekly, V44, P37; Leroy JL, 2015, FOOD NUTR BULL, V36, P167, DOI 10.1177/0379572115587274; Macura B, 2016, REG ENVIRON CHANGE, V16, P125, DOI 10.1007/s10113-016-0978-3; Maxwell D, 2013, DIFFERENT INDICATORS; Maxwell D., 2008, COPING STRATEGIES IN; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Milgroom J, 2014, HUM ECOL, V42, P199, DOI 10.1007/s10745-013-9635-3; Milner-Gulland EJ, 2014, CONSERV BIOL, V28, P1160, DOI 10.1111/cobi.12277; Mukherji A, 2013, J DEV STUD, V49, P1548, DOI 10.1080/00220388.2013.800859; Munang RT, 2011, SUSTAINABILITY-BASEL, V3, P937, DOI 10.3390/su3070937; Nakamura EM, 2017, HUM ECOL REV, V23, P101, DOI 10.22459/HER.23.01.2017.06; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Neelakantan A, 2020, REG ENVIRON CHANGE, V20, DOI 10.1007/s10113-020-01589-7; Neelakantan A, 2019, BIOL CONSERV, V232, P142, DOI 10.1016/j.biocon.2019.01.033; Neves K, 2012, TIJDSCHR ECON SOC GE, V103, P164, DOI 10.1111/j.1467-9663.2012.00710.x; Nsimba SE, 1999, DRUG INF J, V33, P1025, DOI 10.1177/009286159903300407; OECD, 2011, COM OECD WELL BEING; Offer A., 2000, NUFF OX AC UK, V34, P2000; PRIA, 1993, NAT WORKSH DECL ACC; Rathore CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039996; REARDON T, 1995, WORLD DEV, V23, P1495, DOI 10.1016/0305-750X(95)00061-G; Reed J, 2017, FOREST POLICY ECON, V84, P62, DOI 10.1016/j.forpol.2017.01.012; Revankar R.G., 1971, INDIAN CONSTITUTION; Ribot JC, 2003, RURAL SOCIOL, V68, P153, DOI 10.1111/j.1549-0831.2003.tb00133.x; Salafsky N, 2000, WORLD DEV, V28, P1421, DOI 10.1016/S0305-750X(00)00031-0; Schmidt PM, 2009, CONSERV BIOL, V23, P1458, DOI 10.1111/j.1523-1739.2009.01262.x; Schmidt-Soltau K, 2007, WORLD DEV, V35, P2182, DOI 10.1016/j.worlddev.2007.02.008; Sekar N, 2016, REG ENVIRON CHANGE, V16, P111, DOI 10.1007/s10113-015-0913-z; Shahabuddin G, 2014, ENVIRON JUSTICE, V7, P122, DOI 10.1089/env.2014.0012; Shahabuddin G, 2010, BIOL CONSERV, V143, P2926, DOI 10.1016/j.biocon.2010.04.040; Snodgrass J. G., 2016, World Development Perspectives, V2, P25, DOI 10.1016/j.wdp.2016.09.001; Spangenberg Joachim H., 2014, International Journal of Biodiversity Science Ecosystem Services & Management, V10, P40, DOI 10.1080/21513732.2014.884166; Sterling EJ, 2020, SUSTAIN SCI, V15, P1129, DOI 10.1007/s11625-020-00822-w; Sunderland TCH., 2013, FOOD SECURITY NUTR R, DOI [10.1016/S0306-9192(00)00026-9, DOI 10.1016/S0306-9192(00)00026-9]; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Tallis H., 2014, NATURE, V2, P37; Vaccaro I, 2013, J POLIT ECOL, V20, P255, DOI 10.2458/v20i1.21748; Valencia V, 2018, LAND USE POLICY, V79, P463, DOI 10.1016/j.landusepol.2018.08.020; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308; West P, 2006, CONSERV BIOL, V20, P609, DOI 10.1111/j.1523-1739.2006.00432.x; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Xi J, 2011, SOC INDIC RES, V104, P507, DOI 10.1007/s11205-010-9758-5	80	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243825	10.1371/journal.pone.0243825	http://dx.doi.org/10.1371/journal.pone.0243825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370335	gold, Green Published			2022-12-27	WOS:000603611900036
J	Zoppini, G; Bergamini, C; Trombetta, M; Mantovani, A; Targher, G; Toffalini, A; Bittante, C; Bonora, E				Zoppini, Giacomo; Bergamini, Corinna; Trombetta, Maddalena; Mantovani, Alessandro; Targher, Giovanni; Toffalini, Anna; Bittante, Cristina; Bonora, Enzo			Echocardiographic parameters according to insulin dose in young patients affected by type 1 diabetes	PLOS ONE			English	Article							DIASTOLIC FUNCTION; BLOOD-PRESSURE; HYPERINSULINEMIA; DYSFUNCTION; HYPERTROPHY; CONTRIBUTES; EXPRESSION; MELLITUS; OBESITY; IMPACT	Insulin dose has been found to associate to several cardiometabolic risk factors in type 1 diabetes. Changes over time in body weight and composition may partly explain this association. However, no data are available on the relationship between insulin dose and echocardiographic parameters of both systolic and diastolic function in type 1 diabetes. Therefore, the aim of the present study was to examine systolic and diastolic echocardiographic parameters in relation to insulin dose in young patients with type 1 diabetes. The study was carried out on 93 consecutive outpatients with type 1 diabetes with a mean age of 32.8 +/- 9.8 years. All patients were examined with a transthoracic echocardiography. Clinical and laboratory data were collected. The median value of daily insulin dose was used to categorized patients in two groups: high and low insulin dose group. Patients belonging to the high insulin dose group showed higher levels of cardiometabolic risk factors such as BMI, triglycerides and TG/HDL cholesterol ratio. Indexes of both systolic and diastolic function were similar in both groups except isovolumetric relaxation time (IVRT), that was significantly prolonged in patients of the high insulin group (94.4 +/- 15.0 vs 86.7 +/- 13.1 ms, p = 0.008). In the multivariate regression analysis, insulin dose was positively and significantly associated with IVRT. In this study we report an association between insulin dose and impaired active diastolic myocardial relaxation. Future studies are needed to further explore this observation.	[Zoppini, Giacomo; Trombetta, Maddalena; Mantovani, Alessandro; Targher, Giovanni; Toffalini, Anna; Bittante, Cristina; Bonora, Enzo] Azienda Osped Univ Integrata, Sect Endocrinol Diabet & Metab, Dept Med, Verona, Italy; [Bergamini, Corinna] Azienda Osped Univ Integrata, Sect Cardiol, Dept Med, Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Zoppini, G (corresponding author), Azienda Osped Univ Integrata, Sect Endocrinol Diabet & Metab, Dept Med, Verona, Italy.	giacomo.zoppini@univr.it	Trombetta, Maddalena/AAA-9257-2022; zoppini, giacomo/AAA-9000-2022; Bonora, Enzo/AAA-5300-2022; Mantovani, Alessandro/AAB-9015-2019	Trombetta, Maddalena/0000-0002-0825-1117; zoppini, giacomo/0000-0003-1085-554X; Mantovani, Alessandro/0000-0002-7271-6329; Targher, Giovanni/0000-0002-4325-3900				Braffett BH, 2019, DIABETES CARE, V42, P657, DOI 10.2337/dc18-1574; Brzyzkiewicz H, 2016, POL ARCH MED WEWN, V126, P12; Buzzetti R, 2020, DIABETES OBES METAB, V22, P1009, DOI 10.1111/dom.14022; Byrne D, 2020, IRISH J MED SCI, V189, P109, DOI 10.1007/s11845-019-02032-5; Despres JP, 1996, NEW ENGL J MED, V334, P952, DOI 10.1056/NEJM199604113341504; Di Rocco M, 2007, Acta Myol, V26, P42; Eguchi K, 2008, AM J CARDIOL, V101, P1787, DOI 10.1016/j.amjcard.2008.02.082; Elgeti T, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-60; Gordon J, 2020, DIABETES THER, V11, P1135, DOI 10.1007/s13300-020-00807-z; Grassi G, 2020, J HYPERTENS, V38, P1436, DOI 10.1097/HJH.0000000000002431; Gregory JM, 2020, DIABETES, V69, P837, DOI 10.2337/dbi19-0026; Guo CA, 2017, J ENDOCRINOL, V233, pR131, DOI 10.1530/JOE-16-0679; Hammoudi N, 2017, CARDIOVASC DRUG THER, V31, P233, DOI 10.1007/s10557-017-6734-1; Iso T, 2019, CIRC J, V83, P1330, DOI 10.1253/circj.CJ-18-1245; Jia GH, 2016, NAT REV ENDOCRINOL, V12, P144, DOI 10.1038/nrendo.2015.216; Karason K, 2003, EUR HEART J, V24, P1500, DOI 10.1016/S0195-668X(03)00312-9; LAUGHLIN MR, 1990, AM J PHYSIOL, V258, pE184, DOI 10.1152/ajpendo.1990.258.1.E184; Lima-Leopoldo AP, 2014, J APPL PHYSIOL, V117, P669, DOI 10.1152/japplphysiol.00088.2014; Little WC, 1998, CLIN CARDIOL, V21, P5, DOI 10.1002/clc.4960210102; Magkos F, 2010, NUTRITION, V26, P686, DOI 10.1016/j.nut.2009.10.013; Mellor KM, 2014, AM J PHYSIOL-HEART C, V306, pH1240, DOI 10.1152/ajpheart.00059.2014; Nakao Masahide, 1993, Heart and Vessels, V8, P171, DOI 10.1007/BF01744738; Pires KM, 2017, J MOL CELL CARDIOL, V113, P39, DOI 10.1016/j.yjmcc.2017.10.001; Purnell JQ, 1998, JAMA-J AM MED ASSOC, V280, P140, DOI 10.1001/jama.280.2.140; Rawshani A, 2017, NEW ENGL J MED, V376, P1407, DOI 10.1056/NEJMoa1608664; Riehle C, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.134920; Samuelsson AM, 2006, AM J PHYSIOL-HEART C, V291, pH787, DOI 10.1152/ajpheart.00974.2005; Schirmer SH, 2014, J AM COLL CARDIOL, V63, P1916, DOI 10.1016/j.jacc.2013.10.073; Shimizu I, 2010, J CLIN INVEST, V120, P1506, DOI 10.1172/JCI40096; Thapa K, 2018, CELL BIOSCI, V8, DOI 10.1186/s13578-018-0244-0; THOMAS JD, 1992, AM HEART J, V124, P1305, DOI 10.1016/0002-8703(92)90416-S; Varma U, 2018, BBA-MOL BASIS DIS, V1864, P1949, DOI 10.1016/j.bbadis.2017.10.035; Vasanji Z, 2004, MOL CELL BIOCHEM, V261, P245, DOI 10.1023/B:MCBI.0000028762.97754.26; Verges B, 2020, TRENDS ENDOCRIN MET, V31, P422, DOI 10.1016/j.tem.2020.01.015; Warren S, 1930, AM J MED SCI, V179, P482; Wold LE, 2005, J MOL CELL CARDIOL, V39, P297, DOI 10.1016/j.yjmcc.2005.03.014; Zarain-Herzberg A, 2014, CELL CALCIUM, V56, P302, DOI 10.1016/j.ceca.2014.09.005; Zoppini G, 2019, J ENDOCRINOL INVEST, V42, P1109, DOI 10.1007/s40618-019-01032-7	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244483	10.1371/journal.pone.0244483	http://dx.doi.org/10.1371/journal.pone.0244483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370380	Green Published, gold			2022-12-27	WOS:000603611900027
J	Bonert, M; Schneider, M; Solyanik, O; Hellbach, K; Bondesson, D; Gaass, T; Thaens, N; Ricke, J; Benkert, T; Dinkel, J				Bonert, Madeleine; Schneider, Moritz; Solyanik, Olga; Hellbach, Katharina; Bondesson, David; Gaass, Thomas; Thaens, Natalie; Ricke, Jens; Benkert, Thomas; Dinkel, Julien			Diagnostic accuracy of magnetic resonance imaging for the detection of pulmonary nodules simulated in a dedicated porcine chest phantom	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; LUNG; MR; STATISTICS; CT	Objective CT serves as gold standard for the evaluation of pulmonary nodules. However, CT exposes patients to ionizing radiation, a concern especially in screening scenarios with repeated examinations. Due to recent technological advances, MRI emerges as a potential alternative for lung imaging using 3D steady state free precession and ultra-short echo-time sequences. Therefore, in this study we assessed the performance of three state-of-the-art MRI sequences for the evaluation of pulmonary nodules. Methods Lesions of variable sizes were simulated in porcine lungs placed in a dedicated chest phantom mimicking a human thorax, followed by CT and MRI examinations. Two blinded readers evaluated the acquired MR-images locating and measuring every suspect lesion. Using the CT-images as reference, logistic regression was performed to investigate the sensitivity of the tested MRI-sequences for the detection of pulmonary nodules. Results For nodules with a diameter of 6 mm, all three sequences achieved high sensitivity values above 0.91. However, the sensitivity dropped for smaller nodules, yielding an average of 0.83 for lesions with 4 mm in diameter and less than 0.69 for lesions with 2 mm in diameter. The positive predictive values ranged between 0.91 and 0.96, indicating a low amount of false positive findings. Furthermore, the size measurements done on the MR-images were subject to a bias ranging from 0.83 mm to -1.77 mm with standard deviations ranging from 1.40 mm to 2.11 mm. There was no statistically significant difference between the three tested sequences. Conclusion While showing promising sensitivity values for lesions larger than 4 mm, MRI appears to be not yet suited for lung cancer screening. Nonetheless, the three tested MRI sequences yielded high positive predictive values and accurate size measurements; therefore, MRI could potentially figure as imaging method of the chest in selected follow-up scenarios, e.g. of incidental findings subject to the Fleischner Criteria.	[Bonert, Madeleine; Schneider, Moritz; Solyanik, Olga; Hellbach, Katharina; Bondesson, David; Gaass, Thomas; Thaens, Natalie; Ricke, Jens; Dinkel, Julien] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany; [Schneider, Moritz; Bondesson, David; Thaens, Natalie; Dinkel, Julien] German Ctr Lung Res, Comprehens Pneumol Ctr, Munich, Germany; [Benkert, Thomas] Siemens Healthcare GmbH, MR Applicat Predev, Erlangen, Germany	University of Munich; Siemens AG	Dinkel, J (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany.; Dinkel, J (corresponding author), German Ctr Lung Res, Comprehens Pneumol Ctr, Munich, Germany.	julien.dinkel@med.uni-muenchen.de		Bonert, Madeleine/0000-0002-8478-6770				Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Adrian H, 2016, EUR RADIOL, V26, P3643, DOI 10.1007/s00330-015-4192-3; Al Mohammad B, 2017, CLIN RADIOL, V72, P433, DOI 10.1016/j.crad.2017.01.002; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Biederer J, 2012, INSIGHTS IMAGING, V3, P355, DOI 10.1007/s13244-011-0146-8; Biederer J, 2003, RADIOLOGY, V227, P475, DOI 10.1148/radiol.2272020635; Biederer J, 2003, RADIOLOGY, V226, P250, DOI 10.1148/radiol.2261011275; Bieri O, 2013, MAGN RESON MED, V70, P657, DOI 10.1002/mrm.24858; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chudgar NP, 2015, THORAC SURG CLIN, V25, P145, DOI 10.1016/j.thorsurg.2014.11.002; Cieszanowski A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156272; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Heye T, 2012, ACTA RADIOL, V53, P153, DOI 10.1258/ar.2011.110445; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Meier-Schroers M, 2019, EUR RADIOL, V29, P898, DOI 10.1007/s00330-018-5607-8; Mugler III JP, 2015, P 23 ANN M ISMRM TOR, V23, P1476; Mugler III JP, 2017, P 25 ANN M ISMRM HON, V25, P4904; Regier M, 2007, EUR RADIOL, V17, P1341, DOI 10.1007/s00330-006-0422-z; Renz DM, 2015, INVEST RADIOL, V50, P733, DOI 10.1097/RLI.0000000000000178; Riordan RD, 2004, BRIT J RADIOL, V77, P991, DOI 10.1259/bjr/36674326; Schroeder T, 2005, AM J ROENTGENOL, V185, P979, DOI 10.2214/AJR.04.0814; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Staff News Brief, 2017, APPL RADIOLOGY; Stewart B. W., 2003, World Cancer Report; World Health Organization, 2018, TOP 10 CAUS DEATH; Yip R, 2014, RADIOLOGY, V273, P591, DOI 10.1148/radiol.14132950	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244382	10.1371/journal.pone.0244382	http://dx.doi.org/10.1371/journal.pone.0244382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362273	Green Published, gold			2022-12-27	WOS:000603071600064
J	Eickhoff, MK; Winther, SA; Hansen, TW; Diaz, LJ; Persson, F; Rossing, P; Frimodt-Moller, M				Eickhoff, Mie Klessen; Winther, Signe Abitz; Hansen, Tine Willum; Diaz, Lars Jorge; Persson, Frederik; Rossing, Peter; Frimodt-Moller, Marie			Assessment of the sublingual microcirculation with the GlycoCheck system: Reproducibility and examination conditions	PLOS ONE			English	Article							ENDOTHELIAL-CELL GLYCOCALYX; MICROVASCULAR GLYCOCALYX; DYSFUNCTION; DAMAGE; PERMEABILITY; HYALURONAN; COINCIDES; STRESS; COFFEE	Background The glycocalyx is an extracellular layer lining the lumen of the vascular endothelium, protecting the endothelium from shear stress and atherosclerosis and contributes to coagulation, immune response and microvascular perfusion. The GlycoCheck system estimates glycocalyx' thickness in vessels under the tongue from perfused boundary region (PBR) and microvascular perfusion (red blood cell (RBC) filling) via a camera and dedicated software. Objectives Evaluating reproducibility and influence of examination conditions on measurements with the GlycoCheck system. Methods Open, randomised, controlled study including 42 healthy smokers investigating day-to-day, side-of-tongue, inter-investigator variance, intraclass-correlation (ICC) and influence of examination conditions at intervals from 0-180 minutes on PBR and RBC filling. Results Mean (SD) age was 24.9 (6.1) years, 52% were male. There was no significant intra- or inter-investigator variation for PBR or RBC filling nor for PBR for side-of-tongue. A small day-to-day variance was found for PBR (0.012 mu m, p = 0.007) and RBC filling (0.003%, p = 0.005) and side-of-tongue, RBC filling (0.025%, p = 0.009). ICC was modest but highly improved by increasing measurements. Small significant influence of cigarette smoking (from 40-180 minutes), high calorie meal intake and coffee consumption was found. The latter two peaking immediately and tapering off but remained significant up to 180 minutes, highest PBR changes for the three being 0.042 mu m (p<0.05), 0.183 mu m (p<0.001) and 0.160 mu m (p<0.05) respectively. Conclusions Measurements with the GlycoCheck system have a moderate reproducibility, but highly increases with multiple measurements and a small day-to-day variability. Smoking, meal and coffee intake had effects up to 180 minutes, abstinence is recommended at least 180 minutes before GlycoCheck measurements. Future studies should standardise conditions during measurements.	[Eickhoff, Mie Klessen; Winther, Signe Abitz; Hansen, Tine Willum; Diaz, Lars Jorge; Persson, Frederik; Rossing, Peter; Frimodt-Moller, Marie] Steno Diabet Ctr Copenhagen, Gentofte, Denmark; [Rossing, Peter] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	Steno Diabetes Center; University of Copenhagen	Frimodt-Moller, M (corresponding author), Steno Diabet Ctr Copenhagen, Gentofte, Denmark.	Marie.frimodt-moeller@regionh.dk	rossing, peter/AAZ-3415-2021; rossing, peter/AAH-7879-2021; Frimodt-Moller, Marie/AAS-6945-2021; Persson, Frederik/AAE-6572-2020; Hansen, Thomas/GWZ-2858-2022	rossing, peter/0000-0002-1531-4294; Frimodt-Moller, Marie/0000-0002-8486-1515; Persson, Frederik/0000-0001-6242-6638; Diaz, Lars/0000-0002-5853-721X; Hansen, Tine/0000-0003-2274-0352	Novo Nordisk Foundation; NNF [14OC0013659]	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); NNF	This work was funded by a grant received by PR from the Novo Nordisk Foundation, grant no. NNF 14OC0013659. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amraoui F, 2014, MICROCIRCULATION, V21, P499, DOI 10.1111/micc.12125; [Anonymous], 2016, J CHIROPR MED, V15, P155, DOI DOI 10.1016/J.JCM.2016.02.012; Armitage P., 2002, STAT METHODS MED RES; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bol ME, 2020, SHOCK, V54, P9, DOI 10.1097/SHK.0000000000001470; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Broekhuizen LN, 2009, CURR OPIN LIPIDOL, V20, P57, DOI 10.1097/MOL.0b013e328321b587; Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Donati A, 2013, MICROVASC RES, V90, P86, DOI 10.1016/j.mvr.2013.08.007; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Gouverneur M, 2006, AM J PHYSIOL-HEART C, V290, pH458, DOI 10.1152/ajpheart.00592.2005; Gu YM, 2015, HYPERTENSION, V65, P993, DOI 10.1161/HYPERTENSIONAHA.114.05119; Ikonomidis I, 2018, J CLIN HYPERTENS, V20, P672, DOI 10.1111/jch.13236; Jeansson M, 2006, AM J PHYSIOL-RENAL, V290, pF111, DOI 10.1152/ajprenal.00173.2005; Kackov S, 2013, PHYSIOL RES, V62, P643, DOI 10.33549/physiolres.932493; Matsuzawa Y, 2015, INT J CARDIOL, V190, P90, DOI 10.1016/j.ijcard.2015.04.124; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Mulders TA, 2013, INT J CARDIOL, V168, P5026, DOI 10.1016/j.ijcard.2013.07.166; Nieuwdorp M, 2007, DIABETOLOGIA, V50, P1288, DOI 10.1007/s00125-007-0666-4; Nieuwdorp M, 2006, DIABETES, V55, P1127, DOI 10.2337/diabetes.55.04.06.db05-1619; Nieuwdorp M, 2006, DIABETES, V55, P480, DOI 10.2337/diabetes.55.02.06.db05-1103; Nieuwdorp M, 2008, J APPL PHYSIOL, V104, P845, DOI 10.1152/japplphysiol.00440.2007; Noble MIM, 2008, QJM-INT J MED, V101, P513, DOI 10.1093/qjmed/hcn024; Padberg JS, 2014, ATHEROSCLEROSIS, V234, P335, DOI 10.1016/j.atherosclerosis.2014.03.016; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rovas A, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0483-4; Valerio L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213097; Valerio L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213175; van den Berg Bernard M, 2006, Pharmacol Rep, V58 Suppl, P75; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; van Haaren PMA, 2003, AM J PHYSIOL-HEART C, V285, pH2848, DOI 10.1152/ajpheart.00117.2003; Weissgerber TL, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010647; Wiesinger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080905; 2014, REG ANESTH PAIN MED, V9	36	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243737	10.1371/journal.pone.0243737	http://dx.doi.org/10.1371/journal.pone.0243737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362252	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071600020
J	Flynn, DE; Mao, D; Yerkovich, ST; Franz, R; Iswariah, H; Hughes, A; Shaw, IM; Tam, DPL; Chandrasegaram, MD				Flynn, David E.; Mao, Derek; Yerkovich, Stephanie T.; Franz, Robert; Iswariah, Harish; Hughes, Andrew; Shaw, Ian M.; Tam, Diana P. L.; Chandrasegaram, Manju D.			The impact of comorbidities on post-operative complications following colorectal cancer surgery	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; CLASSIFICATION; INDEX; AGE	Background Colorectal cancer surgery is complex and can result in severe post-operative complications. Optimisation of surgical outcomes requires a thorough understanding of the background complexity and comorbid status of patients. Aim The aim of this study is to determine whether certain pre-existing comorbidities are associated with high grade post-operative complications following colorectal cancer surgery. The study also aims to define the prevalence of demographic, comorbid and surgical features in a population undergoing colorectal cancer resection. Method A colorectal cancer database at The Prince Charles Hospital was established to capture detailed information on patient background, comorbidities and clinicopathological features. A single-centre retrospective study was undertaken to assess the effect of comorbidities on post-operative outcomes following colorectal cancer resection. Five hundred and thirty-three patients were reviewed between 2010-2018 to assess if specific comorbidities were associated with higher grade post-operative complications. A Clavien-Dindo grade of three or higher was defined as a high grade complication. Results Fifty-eight percent of all patients had an ASA grade of ASA III or above. The average BMI of patients undergoing resection was 28 +/- 6.0. Sixteen percent of all patients experienced a high grade complications. Patients with high grade complications had a higher mean average age compared to patients with low grade or no post-operative complications (74 years vs 70 years, p = 0.01). Univariate analysis revealed patients with atrial fibrillation, COPD, ischaemic heart disease and heart failure had an increased risk of high grade complications. Multivariate analysis revealed pre-existing atrial fibrillation (OR 2.70, 95% CI 1.53-4.89, p <0.01) and COPD (OR 2.02 1.07-3.80, p = 0.029) were independently associated with an increased risk of high grade complications. Conclusion Pre-existing atrial fibrillation and COPD are independent risk factors for high grade complications. Targeted perioperative management is necessary to optimise outcomes.	[Flynn, David E.; Mao, Derek; Franz, Robert; Iswariah, Harish; Hughes, Andrew; Shaw, Ian M.; Tam, Diana P. L.; Chandrasegaram, Manju D.] Prince Charles Hosp, Dept Gen Surg, Brisbane, Qld, Australia; [Yerkovich, Stephanie T.] Prince Charles Hosp, Common Good Fdn, Brisbane, Qld, Australia	Prince Charles Hospital; Prince Charles Hospital	Flynn, DE (corresponding author), Prince Charles Hosp, Dept Gen Surg, Brisbane, Qld, Australia.	deflynn75@gmail.com	Iswariah, Harish/G-3503-2011	Iswariah, Harish/0000-0001-6272-3755; Mao, Derek/0000-0002-3979-734X				American Diabetes Association, 2005, DIABETES CARE S1, V28, pS37; An Qi, 2016, Zhonghua Wei Chang Wai Ke Za Zhi, V19, P1035; Andre C, 2015, ARQ NEURO-PSIQUIAT, V73, P704, DOI 10.1590/0004-282X20150085; [Anonymous], 2014, DIABETES CARE, V1, pS14; Aquina CT, 2017, BRIT J CANCER, V116, P389, DOI 10.1038/bjc.2016.421; Austin SR, 2015, MED CARE, V53, pE65, DOI 10.1097/MLR.0b013e318297429c; Australian Institute of Health and Welfare, 2018, CANC DAT AUSTR AUSTR; Australian Institute of Health and Welfare, 2019, AUSTR BURD DIS STUD; Ball J, 2015, MED J AUSTRALIA, V202, P32, DOI 10.5694/mja14.00238; Bokey L, 2015, ANZ J SURG, V85, P128, DOI 10.1111/ans.12685; Capucci A, 1997, PACE, V20, P2684, DOI 10.1111/j.1540-8159.1997.tb06117.x; Cuthbert CA, 2018, J CANCER SURVIV, V12, P733, DOI 10.1007/s11764-018-0710-z; Dasgupta P, 2013, CANCER CAUSE CONTROL, V24, P897, DOI 10.1007/s10552-013-0166-4; Duraes LC, 2018, ANN SURG ONCOL, V25, P188, DOI 10.1245/s10434-017-6142-6; Fitz-Henry J, 2011, ANN ROY COLL SURG, V93, P185, DOI 10.1308/rcsann.2011.93.3.185a; Grosso G, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-S1-S20; Heriot A, 2018, BINATIONAL COLORECTA; Lemmens VEPP, 2007, WORLD J SURG, V31, P192, DOI 10.1007/s00268-005-0711-8; Mann CJ, 2007, HEART, V93, P45, DOI 10.1136/hrt.2006.099929; Pedrazzani C, 2009, WORLD J GASTROENTERO, V15, P5706, DOI 10.3748/wjg.15.5706; Pule ML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44969-8; Sutton C D, 2004, Colorectal Dis, V6, P21, DOI 10.1111/j.1463-1318.2004.00574.x; Tominaga T, 2018, INDIAN J SURG, V80, P54, DOI 10.1007/s12262-016-1544-4; Walsh Stewart R, 2004, World J Surg Oncol, V2, P40; Xu L, 2018, Zhonghua Wai Ke Za Zhi, V56, P900, DOI 10.3760/cma.j.issn.0529-5815.2018.12.005; Yap R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167271	26	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243995	10.1371/journal.pone.0243995	http://dx.doi.org/10.1371/journal.pone.0243995			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362234	Green Published, gold			2022-12-27	WOS:000603071600025
J	Hajduk, S				Hajduk, Slawomira			Using multivariate statistical methods to assess the urban smartness on the example of selected European cities	PLOS ONE			English	Article							CITY	The growing importance of maturity smart cities is currently observed worldwide. The vast majority of smart city models focus on hard domains such as communication and technology infrastructure. Scientists emphasize the need to take into account social capital and the knowledge of residents. The smart cities invest in enhanced openness and transparency data. Mature smart cities use real-time evidences and information to citizens, businesses and visitors. The smart cities are characterized by bottom-down management and civil government. The paper aims to assess the urban smartness of selected European cities based on the ISO 37120 standard. Several research methods including the Multidimensional Statistical Analysis (MSA) were applied. Using the statistical analysis of European smart cities with the implemented ISO 37120 standard, the author tried to fill gaps in the knowledge and to evaluate maturity smart cities. The results of the research have shown that the smart city concept is a viable strategy which contributes to the urban sustainability. The author also found out that urban sustainability frameworks contain a large number of indicators measuring environmental sustainability, the smart city frameworks lack environmental indicators while highlighting social and economic aspects.	[Hajduk, Slawomira] Bialystok Tech Univ, Fac Engn Management, Bialystok, Poland	Bialystok University of Technology	Hajduk, S (corresponding author), Bialystok Tech Univ, Fac Engn Management, Bialystok, Poland.	s.hajduk@pb.edu.pl	Hajduk, Sławomira/N-2088-2019; Hajduk, Sławomira/F-2451-2016	Hajduk, Sławomira/0000-0003-0314-1661	Polish Ministry of Science and Higher Education [WZ/WIZ-INZ/2/2019]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was realized during scientific project WZ/WIZ-INZ/2/2019 supported by Polish Ministry of Science and Higher Education.	Akande A, 2019, SUSTAIN CITIES SOC, V44, P475, DOI 10.1016/j.scs.2018.10.009; [Anonymous], 1999, AFRICAN J INT COMP L, V11, P803; Arroyo-Canada FJ, 2017, INNOV TECH KNOWL MAN, P49, DOI 10.1007/978-3-319-40895-8_4; Bakici T, 2013, J KNOWL ECON, V4, P135, DOI 10.1007/s13132-012-0084-9; Aleta NB, 2017, TRANSP RES PROC, V24, P163, DOI 10.1016/j.trpro.2017.05.084; Caragliu A, 2011, J URBAN TECHNOL, V18, P65, DOI 10.1080/10630732.2011.601117; Clarke R.Y, 2017, MANAGING SOCIAL IMPA, P239, DOI [10.1007/978-3-319-46021-5_14, DOI 10.1007/978-3-319-46021-5_14]; Cocchia A, 2014, PROGR IS, P13, DOI 10.1007/978-3-319-06160-3_2; Dameri R. P., 2013, INT J COMP TECH, V11, P2544, DOI [DOI 10.24297/IJCT.V11I5.1142, 10.24297/ijct.v11i5.1142]; Dameri RP, 2017, PROGR IS, P67, DOI 10.1007/978-3-319-45766-6_4; European Union, 2014, MAPP SMART CIT EU 20; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Fernandez-Anez V, 2016, LECT NOTES COMPUT SC, V9704, P157, DOI 10.1007/978-3-319-39595-1_16; Ferrara R, 2015, ENERGIES, V8, P4724, DOI 10.3390/en8064724; Fox M. S., 2015, 2015 IEEE 1 INT SMAR, P1, DOI [10.1109/ISC2.2015.7366147, DOI 10.1109/ISC2.2015.7366147]; Fox MS, 2015, COMPUT ENVIRON URBAN, V54, P266, DOI 10.1016/j.compenvurbsys.2015.09.009; Giffinger R., 2007, SMART CITIES RANKING; Gonzalez-Garcia S, 2018, J CLEAN PROD, V178, P599, DOI 10.1016/j.jclepro.2018.01.056; Hajduk S, 2018, ROCZ OCHR SR, V20, P1219; Hajduk S, 2016, BUS MANAG, DOI 10.3846/bm.2016.57; Harrison C, 2010, IBM J RES DEV, V54, DOI 10.1147/JRD.2010.2048257; Hollands Robert, 2008, CITY, V12, P303, DOI [10.1080/1360481080247926, 10.1080/13604810802479126, DOI 10.1080/13604810802479126]; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Lazaroiu GC, 2012, ENERGY, V47, P326, DOI 10.1016/j.energy.2012.09.028; Lombardi P, 2012, INNOVATION-ABINGDON, V25, P137, DOI 10.1080/13511610.2012.660325; Maltese I, 2016, GREEN ENERGY TECHNOL, P25, DOI 10.1007/978-3-319-31157-9_2; Marsal-Llacuna ML, 2015, LECT NOTES COMPUT SC, V9156, P593, DOI 10.1007/978-3-319-21407-8_42; McCarney Patricia, 2015, Statistical Journal of the IAOS, V31, P103, DOI 10.3233/SJI-150874; Nam T., 2011, P 12 ANN INT DIG GOV, P282, DOI [DOI 10.1145/2037556.2037602, 10.1145/2037556.2037602]; Nations U, 2016, HOUSING IS CTR SUSTA; Papa R, 2017, 2017 5TH IEEE INTERNATIONAL CONFERENCE ON MODELS AND TECHNOLOGIES FOR INTELLIGENT TRANSPORTATION SYSTEMS (MT-ITS), P409, DOI 10.1109/MTITS.2017.8005707; Ramaprasad A, 2017, LECT NOTES COMPUT SC, V10428, P13, DOI 10.1007/978-3-319-64677-0_2; Salvati L, 2018, SCI TOTAL ENVIRON, V625, P722, DOI 10.1016/j.scitotenv.2017.12.341; Singh KCD, 2012, M&SOM-MANUF SERV OP, V14, P50, DOI 10.1287/msom.1110.0341; Thuzar M., 2011, REGIONAL OUTLOOK, P96, DOI DOI 10.1355/9789814311694-022; Trindade E.P., 2017, J OPEN INNOV TECHNOL, V3, P11, DOI [DOI 10.1186/S40852-017-0063-2, 10.1186/s40852-017-0063-2]; United Nations, WORLDS CIT 2016; Van der Meer A, 2003, REG STUD, V37, P407, DOI 10.1080/0034340032000074433; Wiseman J., 2014, RESILIENT SUSTAINABL, P31; Yan Y, 2018, J CLEAN PROD, V178, P67, DOI 10.1016/j.jclepro.2018.01.013; Zygiaris S, 2013, J KNOWL ECON, V4, P217, DOI 10.1007/s13132-012-0089-4	41	5	5	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0240260	10.1371/journal.pone.0240260	http://dx.doi.org/10.1371/journal.pone.0240260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362224	gold, Green Published			2022-12-27	WOS:000603071600058
J	Syuhada, K; Hakim, A				Syuhada, Khreshna; Hakim, Arief			Modeling risk dependence and portfolio VaR forecast through vine copula for cryptocurrencies	PLOS ONE			English	Article							VARIANCE; BITCOIN; ENERGY; OIL	Risk in finance may come from (negative) asset returns whilst payment loss is a typical risk in insurance. It is often that we encounter several risks, in practice, instead of single risk. In this paper, we construct a dependence modeling for financial risks and form a portfolio risk of cryptocurrencies. The marginal risk model is assumed to follow a heteroscedastic process of GARCH(1,1) model. The dependence structure is presented through vine copula. We carry out numerical analysis of cryptocurrencies returns and compute Value-at-Risk (VaR) forecast along with its accuracy assessed through different backtesting methods. It is found that the VaR forecast of returns, by considering vine copula-based dependence among different returns, has higher forecast accuracy than that of returns under prefect dependence assumption as benchmark. In addition, through vine copula, the aggregate VaR forecast has not only lower value but also higher accuracy than the simple sum of individual VaR forecasts. This shows that vine copula-based forecasting procedure not only performs better but also provides a well-diversified portfolio.	[Syuhada, Khreshna; Hakim, Arief] Inst Teknol Bandung, Stat Res Div, Bandung, Indonesia	Institute Technology of Bandung	Syuhada, K (corresponding author), Inst Teknol Bandung, Stat Res Div, Bandung, Indonesia.	khreshna@math.itb.ac.id	Hakim, Arief/AAT-4696-2021	Hakim, Arief/0000-0001-6675-1040	Institut Teknologi Bandung (ITB)	Institut Teknologi Bandung (ITB)	The research if funded by Institut Teknologi Bandung (ITB).	Aas K, 2009, INSUR MATH ECON, V44, P182, DOI 10.1016/j.insmatheco.2007.02.001; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2017, Hepatol Int, V11, P1, DOI 10.1007/s12072-016-9783-9; [Anonymous], 2009, NAT REV DRUG DISCOV, V8, P87, DOI [DOI 10.1038/NRD2791, 10.1038/nrd2791]; Bedford T, 2002, ANN STAT, V30, P1031; Bedford T, 2001, ANN MATH ARTIF INTEL, V32, P245, DOI 10.1023/A:1016725902970; Boako G., 2019, INT EC, V158, P77; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; Bouri E, 2020, FINANC RES LETT, V33, DOI 10.1016/j.frl.2019.05.006; Bouri E, 2018, Q REV ECON FINANC, V69, P297, DOI 10.1016/j.qref.2018.04.003; Cekin SE, 2020, Q REV ECON FINANC, V76, P207, DOI 10.1016/j.qref.2019.07.004; Christoffersen PF, 1998, INT ECON REV, V39, P841, DOI 10.2307/2527341; Corbet S, 2018, FINANC RES LETT, V26, P81, DOI 10.1016/j.frl.2017.12.006; Czado C, 2012, STAT MODEL, V12, P229, DOI 10.1177/1471082X1101200302; Diestel R., 2017, GRAPH THEORY; Dissmann J, 2013, COMPUT STAT DATA AN, V59, P52, DOI 10.1016/j.csda.2012.08.010; Embrechts P, 2013, J BANK FINANC, V37, P2750, DOI 10.1016/j.jbankfin.2013.03.014; Embrechts P, 2009, INSUR MATH ECON, V44, P164, DOI 10.1016/j.insmatheco.2008.08.001; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; GENEST C, 1993, J AM STAT ASSOC, V88, P1034, DOI 10.2307/2290796; Genest C, 2006, SCAND J STAT, V33, P337, DOI 10.1111/j.1467-9469.2006.00470.x; Graler B, 2013, HYDROL EARTH SYST SC, V17, P1281, DOI 10.5194/hess-17-1281-2013; Guidelines for oxytocin administration after birth, 2015, J OBSTET GYNECOL NEO, V44, P161; Han JL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215032; Hernandez JA, 2019, APPL ECON, V51, P4856, DOI 10.1080/00036846.2019.1602716; Ji Q, 2019, ENERG ECON, V81, P1042, DOI 10.1016/j.eneco.2019.06.005; Jimenez I, 2020, OPER RES LETT, V48, P534, DOI 10.1016/j.orl.2020.06.004; Joe H., 1996, LECT NOTES MONOGRAPH, V28, P120, DOI DOI 10.1214/LNMS/1215452614; Joe H., 2015, DEPENDENCE MODELING; Kabaila P, 2008, J TIME SER ANAL, V29, P213, DOI 10.1111/j.1467-9892.2007.00553.x; Kabaila P, 2010, STAT PROBABIL LETT, V80, P1348, DOI 10.1016/j.spl.2010.04.016; Kim JHT, 2019, INSUR MATH ECON, V86, P145, DOI 10.1016/j.insmatheco.2019.02.010; Klein T, 2018, INT REV FINANC ANAL, V59, P105, DOI 10.1016/j.irfa.2018.07.010; Kumar S, 2020, APPL ECON, V52, P3055, DOI 10.1080/00036846.2019.1705240; Kurowicka D., 2006, WILEY SERIES PROBABI; Kwon JH, 2020, J INT FINANC MARK I, V67, DOI 10.1016/j.intfin.2020.101202; McNeil AJ, 2005, PRINC SER FINANC, P1; Mejdoub H, 2018, ECON POLIT STUD-EPS, V6, P176, DOI 10.1080/20954816.2018.1463600; Naifar N, 2016, BORSA ISTANB REV, V16, P157, DOI 10.1016/j.bir.2016.01.005; Nakamoto S., 2008, DECENTRALIZED BUS RE, V4, P21260; Nelsen R. B, 2006, INTRO COPULAS; Nieto MR, 2016, INT J FORECASTING, V32, P475, DOI 10.1016/j.ijforecast.2015.08.003; Patton AJ, 2006, INT ECON REV, V47, P527, DOI 10.1111/j.1468-2354.2006.00387.x; Qureshi S, 2020, PHYSICA A, V559, DOI 10.1016/j.physa.2020.125077; SCHWEIZER B, 1981, ANN STAT, V9, P879, DOI 10.1214/aos/1176345528; Syuhada Khreshna, 2020, Journal of Applied Mathematics, V2020, DOI 10.1155/2020/8276019; Syuhada K, 2020, J PROBAB STAT, V2020, DOI 10.1155/2020/7638517; Huynh TLD, 2020, J MULTINATL FINANC M, V56, DOI 10.1016/j.mulfin.2020.100628; Trabelsi N, 2017, BORSA ISTANB REV, V17, P228, DOI 10.1016/j.bir.2017.07.001; Trucios C, 2020, APPL ECON, V52, P2580, DOI 10.1080/00036846.2019.1693023; Usman M, 2019, BORSA ISTANB REV, V19, pS56, DOI 10.1016/j.bir.2018.09.001; Wajdi M, 2020, COMPUT SECUR, V96, DOI 10.1016/j.cose.2020.101860; White R, 2020, TECHNOL FORECAST SOC, V151, DOI 10.1016/j.techfore.2019.119877; Zhang BZ, 2014, PHYSICA A, V416, P112, DOI 10.1016/j.physa.2014.08.043	54	4	4	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242102	10.1371/journal.pone.0242102	http://dx.doi.org/10.1371/journal.pone.0242102			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362227	Green Published, gold			2022-12-27	WOS:000603071600030
J	Okita, M; Nio, K; Murabata, M; Murata, H; Iwamoto, S				Okita, Mayumi; Nio, Kaori; Murabata, Mayumi; Murata, Hiroaki; Iwamoto, Shotaro			Reliability and validity of the Japanese version of the Paediatric Pain Profile for children with severe motor and intellectual disabilities	PLOS ONE			English	Article							CEREBRAL-PALSY; VALIDATION; SYSTEM; TOOL	Children with severe motor and intellectual disabilities experience chronic pain but cannot communicate verbally. However, no Japanese tool currently exists for assessing pain in this population. This study aimed to develop and evaluate the reliability and validity of a Japanese version of the Paediatric Pain Profile, which is a behavioral rating scale to assess pain in children with severe neurological disabilities. The sample comprised 30 children with severe motor and intellectual disabilities at three hospitals in Japan. Three specialist nurses rated low and high pain video scenes of the children (twice at 1-week intervals) using the Face, Legs, Activity, Cry, Consolability behavioral scale and a translated Japanese version of the Paediatric Pain Profile. On the basis of their ratings, we calculated the internal consistency, test-retest reliability, and intra- and inter-observer reliabilities of the Paediatric Pain Profile. Additionally, we assessed concurrent validity using the Face, Legs, Activity, Cry, Consolability behavioral scale and construct validity using low versus high pain scenes. Both internal consistency (low pain: alpha = 0.735; high pain: alpha = 0.928) and test-retest reliability (r = 0.846) of the Japanese version of the Paediatric Pain Profile were good. Intra-observer reliability was substantial (r = 0.748), whereas inter-observer reliability was only moderate (r = 0.529). However, the concurrent validity with Face, Legs, Activity, Cry, Consolability scores was good (r = 0.629) and construct validity was confirmed (p < 0.001). We confirmed the validity of the Japanese version of the Paediatric Pain Profile, but reliable pain assessment may require repeated ratings by the same person. To accurately assess pain in children with severe motor and intellectual disabilities, healthcare staff must be properly trained and become more skilled in using the Japanese version of the Paediatric Pain Profile.	[Okita, Mayumi; Nio, Kaori; Murabata, Mayumi] Mie Univ, Grad Sch Med, Course Nursing Sci, Child Hlth Nursing, Tsu, Mie, Japan; [Murata, Hiroaki] Natl Hosp Org Mie Hosp, Dept Pediat, Tsu, Mie, Japan; [Iwamoto, Shotaro] Mie Univ, Grad Sch Med, Total Care Ctr Children, Tsu, Mie, Japan	Mie University; Mie University	Okita, M (corresponding author), Mie Univ, Grad Sch Med, Course Nursing Sci, Child Hlth Nursing, Tsu, Mie, Japan.	mokita@med.mie-u.ac.jp		Okita, Mayumi/0000-0002-5849-3691	JSPS KAKENHI [JP19K11031]; Mie Medical Research foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mie Medical Research foundation	This study was supported by JSPS KAKENHI Grant Number JP19K11031 and Mie Medical Research foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottos S, 2006, PAIN CHILDREN ADULTS, P67; Breau LM, 2003, ARCH PEDIAT ADOL MED, V157, P1219, DOI 10.1001/archpedi.157.12.1219; Craig KD, 2010, J PAIN, V11, P101, DOI 10.1016/j.jpain.2009.08.008; Friedrichsdorf SJ, 2017, J PAIN RES, V10, P1841, DOI 10.2147/JPR.S138153; Hanaoka T, 2010, J EPIDEMIOL, V20, P77, DOI 10.2188/jea.JE20090024; Hunt A, 2004, DEV MED CHILD NEUROL, V46, P9, DOI 10.1017/S0012162204000039; Hunt A, 2003, INT J NURS STUD, V40, P171, DOI 10.1016/S0020-7489(02)00058-5; Hunt A, 2007, J PAIN SYMPTOM MANAG, V33, P276, DOI 10.1016/j.jpainsymman.2006.08.011; Kabes AM, 2009, CRIT CARE NURSE, V29, P59, DOI 10.4037/ccn2009992; Kane M. T., 2006, ED MEASUREMENT, V4th, P17, DOI DOI 10.1037/0033-2909.114.3.533; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Malviya S, 2006, PEDIATR ANESTH, V16, P258, DOI 10.1111/j.1460-9592.2005.01773.x; Matsuishi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194094; Mensch SM, 2019, J INTELL DISABIL RES, V63, P100, DOI 10.1111/jir.12546; Merkel S I, 1997, Pediatr Nurs, V23, P293; Oshima K., 1971, NIPPON KOSHU EISEI, V35, P648; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Parkinson KN, 2013, ARCH DIS CHILD, V98, P434, DOI 10.1136/archdischild-2012-303482; POOLE GD, 1992, J PERS SOC PSYCHOL, V63, P797, DOI 10.1037/0022-3514.63.5.797; Riquelme I, 2011, PAIN MED, V12, P535, DOI 10.1111/j.1526-4637.2011.01094.x; Siden H, 2015, PAED CHILD HEALT-CAN, V20, P139, DOI 10.1093/pch/20.3.139; Steele R, 2014, ARCH DIS CHILD, V99, P754, DOI 10.1136/archdischild-2013-305246; Stinson JN, 2006, PAIN, V125, P143, DOI 10.1016/j.pain.2006.05.006; Streiner DL, 2015, PRACTICAL GUIDE THEI; The Lancet Public H, 2018, LANCET PUBLIC HEALTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Warlow TA, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5010013	26	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243566	10.1371/journal.pone.0243566	http://dx.doi.org/10.1371/journal.pone.0243566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351799	gold, Green Published			2022-12-27	WOS:000603071400031
J	Kim, EJ; Kim, DK; Kho, SY; Chung, K				Kim, Eui-Jin; Kim, Dong-Kyu; Kho, Seung-Young; Chung, Koohong			Spatiotemporal filtering method for detecting kinematic waves in a connected environment	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; SIMULATION; COMMUNICATION; PARAMETERS; FEATURES	Backward-moving kinematic waves (KWs) (e.g., stop-and-go traffic conditions and a shock wave) cause unsafe driving conditions, decreases in the capacities of freeways, and increased travel time. In this paper, a sequential filtering method is proposed to detect KWs using data collected in a connected environment, which can aid in developing a traffic control strategy for connected vehicles to stop or dampen the propagation of these KWs. The proposed method filters out random fluctuation in the data using ensemble empirical mode decomposition that considers the spectral features of KWs. Then, the spatial movements of KWs are considered using cross-correlation to identify potential candidate KWs. Asynchronous changes in the denoised flow and speed are used to evaluate candidate KWs using logistic regression to identify the KWs from localized reductions in speed that are not propagated upstream. The findings from an empirical evaluation of the proposed method showed strong promise for detecting KWs using data in a connected environment, even at 30% of the market penetration rates. This paper also addresses how data resolution of the connected environment affects the performance in detecting KWs.	[Kim, Eui-Jin] Seoul Natl Univ, Dept Civil & Environm Engn, Seoul, South Korea; [Kim, Dong-Kyu; Kho, Seung-Young] Seoul Natl Univ, Dept Civil & Environm Engn, Seoul, Seoul, South Korea; [Kim, Dong-Kyu; Kho, Seung-Young] Seoul Natl Univ, Inst Construct & Environm Engn, Seoul, Seoul, South Korea; [Chung, Koohong] Korea Univ, Sch Civil Environm & Architectural Engn, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University	Chung, K (corresponding author), Korea Univ, Sch Civil Environm & Architectural Engn, Seoul, South Korea.	koohong@korea.ac.kr	Kim, Eui-Jin/GYV-0961-2022	Kim, Eui-Jin/0000-0003-1057-2806; KHO, Seung-Young/0000-0001-5243-0406; Kim, Dong-Kyu/0000-0003-0746-3043	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [2020R1F1A1074395]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT	Dong-Kyu Kim was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT No. 2020R1F1A1074395.(https://www.nrf.re.kr/eng/ index) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahn S., 2007, 17 INT S TRANSP TRAF, P1; Alexiadis V, 2004, ITE J, V74, P22; [Anonymous], J AM GERIATR SOC; Bates D., 2007, TECHNICAL REPORT; Caltrans, 2020, PERF MEAS SYST PEMS; Cassidy MJ, 1999, TRANSPORT RES B-METH, V33, P25, DOI 10.1016/S0191-2615(98)00023-X; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chung K, 2007, TRANSPORT RES B-METH, V41, P82, DOI 10.1016/j.trb.2006.02.011; Dong BW, 2018, J ADV TRANSPORT, DOI 10.1155/2018/2702360; Duret A, 2012, TRANSPORT RES C-EMER, V24, P157, DOI 10.1016/j.trc.2012.02.009; Edie L. C., 1965, P 2 INT S THEOR TRAF, P139; Elfar A, 2018, TRANSPORT RES REC, V2672, P203, DOI 10.1177/0361198118794717; Flandrin P, 2004, EUR SIGN PROC C; Khan SM, 2017, IEEE T INTELL TRANSP, V18, P1687, DOI 10.1109/TITS.2017.2658664; Khondaker B, 2015, TRANSPORT RES C-EMER, V58, P146, DOI 10.1016/j.trc.2015.07.014; Kim EJ, 2019, J ADV TRANSPORT, V2019, DOI 10.1155/2019/3958127; Kim K, 2012, TRANSPORT RES B-METH, V46, P1260, DOI 10.1016/j.trb.2012.06.002; Kim NS, 2014, ACCIDENT ANAL PREV, V71, P29, DOI 10.1016/j.aap.2014.05.007; Kopsinis Y, 2009, IEEE T SIGNAL PROCES, V57, P1351, DOI 10.1109/TSP.2009.2013885; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Laval JA, 2014, TRANSPORT RES B-METH, V70, P228, DOI 10.1016/j.trb.2014.09.004; Li XP, 2010, TRANSPORT RES B-METH, V44, P1, DOI 10.1016/j.trb.2009.05.003; Li ZB, 2014, ACCIDENT ANAL PREV, V64, P52, DOI 10.1016/j.aap.2013.11.003; Ma JQ, 2016, IEEE T INTELL VEHICL, V1, P78, DOI 10.1109/TIV.2016.2551540; Mauch M, 2002, TRANSPORTATION AND TRAFFIC THEORY IN THE 21ST CENTURY, P653, DOI 10.1016/B978-008043926-6/50034-8; NGSIM, 2006, NEXT GEN SIM; Sahin I, 2009, TRANSPORT RES REC, P186, DOI 10.3141/2124-18; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Stern RE, 2018, TRANSPORT RES C-EMER, V89, P205, DOI 10.1016/j.trc.2018.02.005; Talebpour A, 2016, TRANSPORT RES REC, P75, DOI 10.3141/2560-09; Talebpour A, 2013, TRANSPORT RES REC, P69, DOI 10.3141/2391-07; Tian JF, 2016, TRANSPORT RES B-METH, V93, P338, DOI 10.1016/j.trb.2016.08.001; Treiber M, 2012, TRANSPORT RES C-EMER, V21, P31, DOI 10.1016/j.trc.2011.09.002; USDOT, 2015, CONN VEH REF IMPL AR; Wang M, 2016, J INTELL TRANSPORT S, V20, P559, DOI 10.1080/15472450.2016.1157022; Wu G, 2019, INT J PAVEMENT ENG, V20, P734, DOI 10.1080/10298436.2017.1334460; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yeo H, 2009, TRANSPORTATION AND TRAFFIC THEORY 2009: GOLDEN JUBILEE, P99, DOI 10.1007/978-1-4419-0820-9_6; Zeng Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082768; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zhao TT, 2014, TRANSPORT RES B-METH, V61, P1, DOI 10.1016/j.trb.2013.12.007; Zheng ZD, 2012, TRANSPORT RES C-EMER, V25, P18, DOI 10.1016/j.trc.2012.03.006; Zheng Z, 2011, TRANSPORT RES B-METH, V45, P372, DOI 10.1016/j.trb.2010.08.002; Zheng ZD, 2010, ACCIDENT ANAL PREV, V42, P626, DOI 10.1016/j.aap.2009.10.009	45	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244329	10.1371/journal.pone.0244329	http://dx.doi.org/10.1371/journal.pone.0244329			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347491	gold, Green Published			2022-12-27	WOS:000603071100021
J	Lin, WY; Liang, WC; Nguy, T; Maia, M; Tyagi, T; Chiu, C; Hoi, KH; Chen, YM; Wu, Y				Lin, WeiYu; Liang, Wei-Ching; Nguy, Trung; Maia, Mauricio; Tyagi, Tulika; Chiu, Cecilia; Hoi, Kam Hon; Chen, Yongmei; Wu, Yan			Rapid identification of anti-idiotypic mAbs with high affinity and diverse epitopes by rabbit single B-cell sorting-culture and cloning technology	PLOS ONE			English	Article							GENERATION; ANTIBODIES	The proactive generation of anti-idiotypic antibodies (anti-IDs) against therapeutic antibodies with desirable properties is an important step in pre-clinical and clinical assay development supporting their bioanalytical programs. Here, we describe a robust platform to generate anti-IDs using rabbit single B cell sorting-culture and cloning technology by immunizing rabbits with therapeutic drug Fab fragment and sorting complementarity determining regions (CDRs) specific B cells using designed framework control as a negative gate to exclude non-CDRs-specific B cells. The supernatants of cultured B cells were subsequently screened for binding to drug-molecule by enzyme-linked immunosorbent assay and the positive hits of B cell lysates were selected for cloning of their immunoglobulin G (IgG) variable regions. The recombinant monoclonal anti-IDs generated with this method have high affinity and specificity with broad epitope coverage and different types. The recombinant anti-IDs were available for assay development to support pharmacokinetic (PK) and immunogenicity studies within 12 weeks from the start of rabbit immunization. Using this novel rapid and efficient in-house approach we have generated a large panel of anti-IDs against a series of 11 therapeutic antibody drugs and successfully applied them to the clinical assay development.	[Lin, WeiYu; Liang, Wei-Ching; Tyagi, Tulika; Chiu, Cecilia; Hoi, Kam Hon; Chen, Yongmei; Wu, Yan] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Nguy, Trung; Maia, Mauricio] Genentech Inc, DevSci BioAnalyt Sci, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Wu, Y (corresponding author), Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA.	yw@gene.com						[Anonymous], 2007, AAPS J, V9, pE336; [Anonymous], 2015, STRED CTR J INTERDIS, V7, P9; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Bos AB, 2015, BIOTECHNOL BIOENG, V112, P1832, DOI 10.1002/bit.25601; Carter PJ, 2018, NAT REV DRUG DISCOV, V17, P197, DOI 10.1038/nrd.2017.227; DeSilva B, 2003, PHARM RES-DORDR, V20, P1885, DOI 10.1023/B:PHAM.0000003390.51761.3d; Iezzi ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00273; Gomes CPC, 2017, MOL THER-NUCL ACIDS, V8, P494, DOI 10.1016/j.omtn.2017.07.014; Harth S, 2019, MABS-AUSTIN, V11, P178, DOI 10.1080/19420862.2018.1538723; Huehls AM, 2015, IMMUNOL CELL BIOL, V93, P290, DOI 10.1038/icb.2014.93; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Liu ZQ, 2003, HYBRIDOMA HYBRIDOM, V22, P219, DOI 10.1089/153685903322328947; Seeber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086184; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Starkie DO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152282; Tiller T, 2011, NEW BIOTECHNOL, V28, P453, DOI 10.1016/j.nbt.2011.03.014; Wranik BJ, 2012, J BIOL CHEM, V287, P43331, DOI 10.1074/jbc.M112.397869; Zhao Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096697	20	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244158	10.1371/journal.pone.0244158	http://dx.doi.org/10.1371/journal.pone.0244158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347473	Green Published, gold			2022-12-27	WOS:000603071100001
J	Oshio, T; Kimura, H; Nishizaki, T; Omori, T				Oshio, Takashi; Kimura, Hiromi; Nishizaki, Toshimi; Omori, Takashi			Association between the use of social networking sites, perceived social support, and life satisfaction: Evidence from a population-based survey in Japan	PLOS ONE			English	Article							FACE-TO-FACE; FRIENDS; DEPRESSION; BENEFITS; ENHANCE; STRESS	This study examined the association between the use of social networking sites (SNS), perceived social support (PSS), and life satisfaction (LS), focusing on the mediating effect of PSS on the association between SNS use and LS. To this end, we used data (N = 15,574) obtained from a population-based, nationwide internet survey conducted in Japan. First, we confirmed that the number of SNS friends was positively associated with life satisfaction for all age groups: young (15-29 years), middle-aged (30-59 years), and old (60-86 years). However, the association was mixed if there were 100 or more SNS friends. Second, our structural equation modeling analysis underscored the mediating effect of PSS on the association between the number of SNS friends and LS for all age groups. Specifically, PSS mediated 36.5% (standard error [SE]: 8.6%), 39.8% (SE: 6.3%), and 40.3% (SE: 11.4%) of the association for the young, middle-aged, and old groups, respectively, if we defined SNS use as having 10 or more SNS friends. The mediating effect of PSS consistently contributed to the positive association between SNS use and LS regardless of the number of SNS friends, suggesting that SNS use has the potential to enhance subjective well-being via its positive impact on PSS.	[Oshio, Takashi] Hitotsubashi Univ, Inst Econ Res, Kunitachi, Tokyo, Japan; [Kimura, Hiromi] Survey Res Ctr, Chuo Ku, Tokyo, Japan; [Nishizaki, Toshimi] Japan Cabinet Off, Chiyoda Ku, Tokyo, Japan; [Omori, Takashi] Osaka Univ, Suita, Osaka, Japan	Hitotsubashi University; Osaka University	Oshio, T (corresponding author), Hitotsubashi Univ, Inst Econ Res, Kunitachi, Tokyo, Japan.	oshio@ier.hit-u.ac.jp			Japan Society for the Promotion of Science [20K01722]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	TOs was supported by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) [grant number 20K01722]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amichai-Hamburger Y., 2013, SOCIAL NET UNDERSTAN, DOI [10.1093/acprof:oso/9780199639540.001.0001, DOI 10.1093/ACPROF:OSO/9780199639540.001.0001]; Amichai-Hamburger Y, 2010, COMPUT HUM BEHAV, V26, P1289, DOI 10.1016/j.chb.2010.03.018; Baker DA, 2016, CYBERPSYCH BEH SOC N, V19, P638, DOI 10.1089/cyber.2016.0206; Bolger N, 2007, J PERS SOC PSYCHOL, V92, P458, DOI 10.1037/0022-3514.92.3.458; Chopik WJ, 2016, CYBERPSYCH BEH SOC N, V19, P551, DOI 10.1089/cyber.2016.0151; Ellison N.B., 2017, J COMPUT-MEDIAT COMM, V12, P1143; Eysenbach G, 2014, J MED INTERNET RES, V16, P4, DOI [10.2196/jmir.3358, 10.2196/jmir.3304]; Gallagher EN, 2008, PERS INDIV DIFFER, V44, P1551, DOI 10.1016/j.paid.2008.01.011; Grieve R, 2013, COMPUT HUM BEHAV, V29, P604, DOI 10.1016/j.chb.2012.11.017; Haber MG, 2007, AM J COMMUN PSYCHOL, V39, P133, DOI 10.1007/s10464-007-9100-9; Hayes M, 2015, COMPUT HUM BEHAV, V49, P507, DOI 10.1016/j.chb.2015.03.040; Huang CJ, 2017, CYBERPSYCH BEH SOC N, V20, P346, DOI 10.1089/cyber.2016.0758; ICT Research & Consulting, SURV SNS US 2020; Indian M, 2014, PERS INDIV DIFFER, V59, P102, DOI 10.1016/j.paid.2013.11.016; Kalpidou M, 2011, CYBERPSYCH BEH SOC N, V14, P183, DOI 10.1089/cyber.2010.0061; Kim J, 2011, CYBERPSYCH BEH SOC N, V14, P359, DOI 10.1089/cyber.2010.0374; Manago AM, 2012, DEV PSYCHOL, V48, P369, DOI 10.1037/a0026338; McCloskey W, 2015, CYBERPSYCH BEH SOC N, V18, P499, DOI 10.1089/cyber.2014.0538; McDougall MA, 2016, PSYCHIAT RES, V246, P223, DOI 10.1016/j.psychres.2016.09.018; Nabi RL, 2013, CYBERPSYCH BEH SOC N, V16, P721, DOI 10.1089/cyber.2012.0521; Nadkarni A, 2012, PERS INDIV DIFFER, V52, P243, DOI 10.1016/j.paid.2011.11.007; Nef T, 2013, INT PSYCHOGERIATR, V25, P1041, DOI 10.1017/S1041610213000355; Oh HJ, 2014, COMPUT HUM BEHAV, V30, P69, DOI 10.1016/j.chb.2013.07.053; Pantic I, 2014, CYBERPSYCH BEH SOC N, V17, P652, DOI 10.1089/cyber.2014.0070; Park N, 2009, CYBERPSYCHOL BEHAV, V12, P729, DOI 10.1089/cpb.2009.0003; Quinn D, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5377; Statacorp, 2017, STATA STAT SOFTWARE, DOI DOI 10.2307/2234838; Valenzuela S, 2009, J COMPUT-MEDIAT COMM, V14, P875, DOI 10.1111/j.1083-6101.2009.01474.x; Vangelisti AL, 2009, J SOC PERS RELAT, V26, P39, DOI 10.1177/0265407509105520; Verduyn P, 2017, SOC ISS POLICY REV, V11, P274, DOI 10.1111/sipr.12033	31	4	4	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244199	10.1371/journal.pone.0244199	http://dx.doi.org/10.1371/journal.pone.0244199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338072	gold, Green Published			2022-12-27	WOS:000601313500004
J	Kulikov, AM; Sorokina, SY; Melnikov, AI; Gornostaev, NG; Seleznev, DG; Lazebny, OE				Kulikov, Alex M.; Sorokina, Svetlana Yu.; Melnikov, Anton I.; Gornostaev, Nick G.; Seleznev, Dmitriy G.; Lazebny, Oleg E.			The effects of the sex chromosomes on the inheritance of species-specific traits of the copulatory organ shape in Drosophila virilis and Drosophila lummei	PLOS ONE			English	Article							MALE COURTSHIP SONG; GENE-EXPRESSION; X-CHROMOSOME; Y-CHROMOSOME; REPRODUCTIVE ISOLATION; ARTIFICIAL SELECTION; HYBRID STERILITY; CANDIDATE GENES; MALE GENITALIA; LINKED GENES	The shape of the male genitalia in many taxa is the most rapidly evolving morphological structure, often driving reproductive isolation, and is therefore widely used in systematics as a key character to distinguish between sibling species. However, only a few studies have used the genital arch of the male copulatory organ as a model to study the genetic basis of species-specific differences in the Drosophila copulatory system. Moreover, almost nothing is known about the effects of the sex chromosomes on the shape of the male mating organ. In our study, we used a set of crosses between D. virilis and D. lummei and applied the methods of quantitative genetics to assess the variability of the shape of the male copulatory organ and the effects of the sex chromosomes and autosomes on its variance. Our results showed that the male genital shape depends on the species composition of the sex chromosomes and autosomes. Epistatic interactions of the sex chromosomes with autosomes and the species origin of the Y-chromosome in a male in interspecific crosses also influenced the expression of species-specific traits in the shape of the male copulatory system. Overall, the effects of sex chromosomes were comparable to the effects of autosomes despite the great differences in gene numbers between them. It may be reasonably considered that sexual selection for specific genes associated with the shape of the male mating organ prevents the demasculinization of the X chromosome.	[Kulikov, Alex M.; Sorokina, Svetlana Yu.; Melnikov, Anton I.; Gornostaev, Nick G.; Lazebny, Oleg E.] Russian Acad Sci, Koltzov Inst Dev Biol, Dept Evolutionary Genet Dev, Moscow, Russia; [Seleznev, Dmitriy G.] Russian Acad Sci, Papanin Inst Biol Inland Waters, Dept Ecol Aquat Invertebrates, Borok Village, Yaroslavl Regio, Russia	Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences	Lazebny, OE (corresponding author), Russian Acad Sci, Koltzov Inst Dev Biol, Dept Evolutionary Genet Dev, Moscow, Russia.	oelazebny@gmail.com	Lazebny, Oleg/R-9208-2016; Seleznev, Dmitriy G/A-9676-2017; Gornostaev, Nikolay/E-6135-2014; Kulikov, Alex/E-5495-2014	Lazebny, Oleg/0000-0003-3136-0415; Seleznev, Dmitriy G/0000-0003-2782-1696; Kulikov, Alex/0000-0001-6179-6848; Gornostaev, Nikolay/0000-0002-5331-6709	Institute of Developmental Biology Russian Academy of Sciences Government [0108-2019-0007]	Institute of Developmental Biology Russian Academy of Sciences Government	This work was conducted under the Institute of Developmental Biology Russian Academy of Sciences Government basic research program, No. 0108-2019-0007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Arbuthnott D, 2009, HEREDITY, V103, P15, DOI 10.1038/hdy.2009.22; Argyridou E, 2018, GENES-BASEL, V9, DOI 10.3390/genes9050242; Arnold SJ, 1996, EVOLUTION, V50, P1024, DOI 10.1111/j.1558-5646.1996.tb02343.x; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Bailey RI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017358; Bateson W., 1909, DOI 10.1017/CBO9780511693953.007; Bay RA, 2017, CURR BIOL, V27, P3344, DOI 10.1016/j.cub.2017.09.037; Bayes JJ, 2009, SCIENCE, V326, P1538, DOI 10.1126/science.1181756; Branco AT, 2013, HEREDITY, V111, P8, DOI 10.1038/hdy.2013.5; CARSON HL, 1984, P NATL ACAD SCI-BIOL, V81, P6904, DOI 10.1073/pnas.81.21.6904; Carvalho AB, 2001, P NATL ACAD SCI USA, V98, P13225, DOI 10.1073/pnas.231484998; Cattani MV, 2012, GENETICS, V191, P549, DOI 10.1534/genetics.112.139683; Chen PS, 1996, EXPERIENTIA, V52, P503, DOI 10.1007/BF01969718; CHEN PS, 1985, INSECT BIOCHEM, V15, P385, DOI 10.1016/0020-1790(85)90030-7; Conith MR, 2018, P NATL ACAD SCI USA, V115, P7063, DOI 10.1073/pnas.1719798115; Coyne J.A., 1989, P180; Coyne J.A., 2004, SPECIATION; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Deng XX, 2011, NAT GENET, V43, P1179, DOI 10.1038/ng.948; Deng XX, 2009, GENETICS, V182, P481, DOI 10.1534/genetics.109.102087; Dobzhansky T, 1937, AM NAT, V71, P404, DOI 10.1086/280726; Dobzhansky T, 1936, GENETICS, V21, P113; Dobzhansky T., 1937; Dworkin I, 2003, CURR BIOL, V13, P1888, DOI 10.1016/j.cub.2003.10.001; Eberhard W.G., 1985, SEXUAL SELECTION ANI; EHRMAN L, 1987, EVOL BIOL, V21, P1; Estill MS, 2019, NUCLEIC ACIDS RES, V47, P2263, DOI 10.1093/nar/gky1223; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fisher R.A., 1930, GENETICAL THEORY NAT; Francisco Flavio O, 2014, J Genomics, V2, P94, DOI 10.7150/jgen.8043; Friberg U, 2012, BIOL LETTERS, V8, P71, DOI 10.1098/rsbl.2011.0608; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; Gillespie JH, 1989, OXFORD SURV EVOL BIO, V4, P10; Gleason JM, 2004, GENETICS, V166, P1303, DOI 10.1534/genetics.166.3.1303; Haerty W, 2007, GENETICS, V177, P1321, DOI 10.1534/genetics.107.078865; Haldane J. B. S., 1924, Trans Phil Soc Cambridge U K, V23, P19; Hill WG, 2014, GENETICS, V196, P1, DOI 10.1534/genetics.112.147850; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hoikkala A, 2005, CURR TOP DEV BIOL, V67, P225, DOI 10.1016/S0070-2153(05)67007-X; HOIKKALA A, 1987, EVOLUTION, V41, P827, DOI 10.1111/j.1558-5646.1987.tb05856.x; Hoikkala A, 2000, GENET RES, V75, P37, DOI 10.1017/S0016672399004097; Huang W, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006421; Huttunen S, 2003, BEHAV GENET, V33, P17, DOI 10.1023/A:1021095331850; Huxley J, 1940, NEW SYSTEMATICS, P185; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; Johnson NA, 2012, ANN NY ACAD SCI, V1256, pE1, DOI 10.1111/j.1749-6632.2012.06748.x; Johnson T, 2005, PHILOS T R SOC B, V360, P1411, DOI 10.1098/rstb.2005.1667; Johnstone RA, 2000, AM NAT, V156, P368, DOI 10.1086/303392; Khodursky S, 2020, GENOME RES, V30, P874, DOI 10.1101/gr.259069.119; Kirkpatrick M, 2001, P ROY SOC B-BIOL SCI, V268, P1259, DOI 10.1098/rspb.2000.1427; Kotelnikov RN, 2009, NUCLEIC ACIDS RES, V37, P3254, DOI 10.1093/nar/gkp167; Kulikov AM, 2013, RUSS J GENET+, V49, P588, DOI 10.1134/S1022795413060069; Kulikov AM, 2013, RUSS J GENET+, V49, P158, DOI 10.1134/S1022795413020075; Kulikov AM, 2004, J ZOOL SYST EVOL RES, V42, P135, DOI 10.1111/j.1439-0469.2004.00246.x; Landeen EL, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002499; Laurie CC, 1997, GENETICS, V145, P339; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lendenmann MH, 2016, HEREDITY, V116, P384, DOI 10.1038/hdy.2015.111; Lin G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166723; Liu J, 1996, GENETICS, V142, P1129; Liu J, 1995, ABS DROS RES C, p305A; Lu XM, 2010, GENOME RES, V20, P1097, DOI 10.1101/gr.076620.108; Mackay TFC, 2015, METHODS MOL BIOL, V1253, P47, DOI 10.1007/978-1-4939-2155-3_4; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; MARKOW TA, 1981, SCIENCE, V213, P1405, DOI 10.1126/science.213.4514.1405; MAYNARDSMITH J, 1976, AM NAT, V110, P331, DOI 10.1086/283071; Mazzi D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-132; McGraw LA, 2008, GENETICS, V179, P1395, DOI 10.1534/genetics.108.086934; Meiklejohn CD, 2010, TRENDS ECOL EVOL, V25, P215, DOI 10.1016/j.tree.2009.10.005; Menon DU, 2009, GENETICS, V183, P811, DOI 10.1534/genetics.109.107219; Muller HJ, 1942, BIOL S, V6, P71; Nickel D, 2009, GENOME, V52, P49, DOI 10.1139/G08-102; Nurminsky D, 2005, LANDES BIOSCIENCE EU; Olenkina OM, 2012, GENE, V499, P143, DOI 10.1016/j.gene.2012.03.023; ORR HA, 1993, NATURE, V361, P532, DOI 10.1038/361532a0; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Paallysaho S, 2003, BEHAV GENET, V33, P25, DOI 10.1023/A:1021047415921; Piergentili R, 2008, J CELL SCI, V121, P1605, DOI 10.1242/jcs.025320; Schuler HG., 2016, REV CELL BIOL MOL ME, V2, P60, DOI 10.1002/3527600906.mcb.201600015; Sharma MD, 2012, J HERED, V103, P230, DOI 10.1093/jhered/esr132; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Somer RA, 2014, CURR OPIN GENET DEV, V27, P43, DOI 10.1016/j.gde.2014.03.008; Sturgill D, 2007, NATURE, V450, P238, DOI 10.1038/nature06330; SUVANTO L, 1994, BEHAV GENET, V24, P85, DOI 10.1007/BF01067932; Sweigart AL, 2010, GENETICS, V184, P401, DOI 10.1534/genetics.109.111245; Tao Y, 2003, EVOLUTION, V57, P2580; Tao Y, 2007, PLOS BIOL, V5, P2560, DOI 10.1371/journal.pbio.0050292; Tao Y, 2007, PLOS BIOL, V5, P2576, DOI 10.1371/journal.pbio.0050293; Terekhanova NV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004696; Throckmorton L.H., 1982, Genetics and Biology of Drosophila, V3b, P227; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TURELLI M, 1995, GENETICS, V140, P389; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Vibranovski MD, 2008, GENETICS, V179, P2325, DOI 10.1534/genetics.108.086819; Vibranovski Maria D, 2014, J Genomics, V2, P104, DOI 10.7150/jgen.8178; Wang HY, 2008, P NATL ACAD SCI USA, V105, P6362, DOI 10.1073/pnas.0711774105; Wayne ML, 2004, GENETICS, V168, P1413, DOI 10.1534/genetics.104.030973; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Zan YJ, 2017, MOL BIOL EVOL, V34, P2678, DOI 10.1093/molbev/msx194; Zeng ZB, 2000, GENETICS, V154, P299; Zhang XS, 2005, GENETICS, V169, P411, DOI 10.1534/genetics.104.032573	105	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244339	10.1371/journal.pone.0244339	http://dx.doi.org/10.1371/journal.pone.0244339			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373382	Green Published, gold			2022-12-27	WOS:000603612300036
J	Qin, XX; Li, PP; Lu, SW; Sun, YC; Meng, LF; Hao, JH; Fan, SX				Qin, Xiaoxiao; Li, Panpan; Lu, Shaowei; Sun, Yanchuan; Meng, Lifeng; Hao, Jinghong; Fan, Shuangxi			Phosphoproteomic analysis of lettuce (Lactuca sativa L.) reveals starch and sucrose metabolism functions during bolting induced by high temperature	PLOS ONE			English	Article							SUGAR; HEAT; EVOLUTION; GROWTH; LEAVES	High temperatures induce early bolting in lettuce (Lactuca sativa L.), which decreases both quality and production. However, knowledge of the molecular mechanism underlying high temperature promotes premature bolting is lacking. In this study, we compared lettuce during the bolting period induced by high temperatures (33/25 degrees C, day/night) to which raised under controlled temperatures (20/13 degrees C, day/night) using iTRAQ-based phosphoproteomic analysis. A total of 3,814 phosphorylation sites located on 1,766 phosphopeptides from 987 phosphoproteins were identified after high-temperature treatment,among which 217 phosphoproteins significantly changed their expression abundance (116 upregulated and 101 downregulated). Most phosphoproteins for which the abundance was altered were associated with the metabolic process, with the main molecular functions were catalytic activity and transporter activity. Regarding the functional pathway, starch and sucrose metabolism was the mainly enriched signaling pathways. Hence, high temperature influenced phosphoprotein activity, especially that associated with starch and sucrose metabolism. We suspected that the lettuce shorten its growth cycle and reduce vegetative growth owing to changes in the contents of starch and soluble sugar after high temperature stress, which then led to early bolting/flowering. These findings improve our understanding of the regulatory molecular mechanisms involved in lettuce bolting.	[Qin, Xiaoxiao; Li, Panpan; Sun, Yanchuan; Hao, Jinghong; Fan, Shuangxi] Beijing Agr Univ, Beijing Key Lab New Technol Agr Applicat, Natl Demonstrat Ctr Expt Plant Prod Educ, Plant Sci & Technol Coll, Beijing, Peoples R China; [Lu, Shaowei] Minist Agr, Planning & Design Res Acad, Facil Hort Inst, Beijing, Peoples R China; [Meng, Lifeng] Chinese Acad Agr Sci, Inst Apicultural Res, Key Lab Pollinating Insect Biol, Minist Agr, Beijing, Peoples R China	Beijing University of Agriculture; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs	Hao, JH; Fan, SX (corresponding author), Beijing Agr Univ, Beijing Key Lab New Technol Agr Applicat, Natl Demonstrat Ctr Expt Plant Prod Educ, Plant Sci & Technol Coll, Beijing, Peoples R China.	haojinghong2013@126.com; fsx20@bua.edu.cn			National Natural Science Foundation of China [32072560]; 2018 Joint Funding Project of Beijing Natural Science Foundation-the Municipal Education Commission [KZ201810020027]; Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System [BAIC07-2021]; Construction of Beijing Science and Technology Innovation and Service Capacity in Top Subjects [CEFF-PXM2019_014207_000032]; Beijing University of Agriculture-Three Funds-Youth Humanities Foundation [5077516001/003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2018 Joint Funding Project of Beijing Natural Science Foundation-the Municipal Education Commission; Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System; Construction of Beijing Science and Technology Innovation and Service Capacity in Top Subjects; Beijing University of Agriculture-Three Funds-Youth Humanities Foundation	This study was supported by the National Natural Science Foundation of China (Grant No. 32072560); the 2018 Joint Funding Project of Beijing Natural Science Foundation-the Municipal Education Commission (KZ201810020027); Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System (BAIC07-2021); The Construction of Beijing Science and Technology Innovation and Service Capacity in Top Subjects (CEFF-PXM2019_014207_000032). Beijing University of Agriculture-Three Funds-Youth Humanities Foundation (No.5077516001/003).	Abele D, 2002, J EXP BIOL, V205, P1831; Amasino RM, 2010, PLANT PHYSIOL, V154, P516, DOI 10.1104/pp.110.161653; Armengot L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157168; Carvalho RF, 2016, PLANT CELL, V28, P1910, DOI 10.1105/tpc.16.00301; Ciereszko I, 2018, ACTA SOC BOT POL, V87, DOI 10.5586/asbp.3583; de Zelicourt A, 2016, TRENDS PLANT SCI, V21, P677, DOI 10.1016/j.tplants.2016.04.004; Fukuda M, 2009, J PLANT PHYSIOL, V166, P2077, DOI 10.1016/j.jplph.2009.06.003; Geigenberger P, 1998, PLANT PHYSIOL, V117, P1307, DOI 10.1104/pp.117.4.1307; Hao JH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102967; Hao JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160909; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Hu XL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00298; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Jenni S, 2009, PLANT BREEDING, V128, P374, DOI 10.1111/j.1439-0523.2009.01657.x; Johnson LN, 2009, BIOCHEM SOC T, V37, P627, DOI 10.1042/BST0370627; Kaushal N, 2013, FUNCT PLANT BIOL, V40, P1334, DOI 10.1071/FP13082; Kelly G, 2017, PLANT J, V91, P325, DOI 10.1111/tpj.13568; Knippschild U, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00096; Lastdrager J, 2014, J EXP BOT, V65, P799, DOI 10.1093/jxb/ert474; Lee K, 2017, J INTEGR PLANT BIOL, V59, P742, DOI 10.1111/jipb.12560; Moreno-Romero J, 2008, PLANT J, V55, P118, DOI 10.1111/j.1365-313X.2008.03494.x; Moustafa K, 2014, PLANT CELL REP, V33, P1217, DOI 10.1007/s00299-014-1629-0; Mulekar JJ, 2015, PLANT SCI, V236, P295, DOI 10.1016/j.plantsci.2015.04.013; Nagy SK, 2015, BIOCHEM J, V467, P167, DOI 10.1042/BJ20141176; Narushima Y, 2016, BIOINFORMATICS, V32, P2083, DOI 10.1093/bioinformatics/btw164; Pastenes C, 1996, PLANT PHYSIOL, V112, P1245, DOI 10.1104/pp.112.3.1245; RASKIN I, 1984, PLANTA, V162, P556, DOI 10.1007/BF00399922; Sangwan V, 2002, FEBS LETT, V531, P561, DOI 10.1016/S0014-5793(02)03626-8; Schluepmann H, 2012, J EXP BOT, V63, P3379, DOI 10.1093/jxb/err311; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Tan ST, 2014, CELL REP, V9, P1692, DOI 10.1016/j.celrep.2014.10.047; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; Wan HJ, 2018, TRENDS PLANT SCI, V23, P163, DOI 10.1016/j.tplants.2017.11.001; Wingler A, 2018, PLANT PHYSIOL, V176, P1075, DOI 10.1104/pp.17.01229; Zhang YF, 2018, CROP J, V6, P600, DOI 10.1016/j.cj.2018.04.003; Zhu L, 2013, PLANT PHYSIOL, V161, P904, DOI 10.1104/pp.112.204487	37	6	6	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244198	10.1371/journal.pone.0244198	http://dx.doi.org/10.1371/journal.pone.0244198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373388	Green Published, gold			2022-12-27	WOS:000603612300011
J	Kato, T; Yaku, H; Morimoto, T; Inuzuka, Y; Tamaki, Y; Ozasa, N; Yamamoto, E; Yoshikawa, Y; Kitai, T; Taniguchi, R; Iguchi, M; Kato, M; Takahashi, M; Jinnai, T; Ikeda, T; Nagao, K; Kawai, T; Komasa, A; Nishikawa, R; Kawase, Y; Morinaga, T; Kawato, M; Seko, Y; Shiba, M; Toyofuku, M; Furukawa, Y; Ando, K; Kadota, K; Sato, Y; Kuwahara, K; Kimura, T				Kato, Takao; Yaku, Hidenori; Morimoto, Takeshi; Inuzuka, Yasutaka; Tamaki, Yodo; Ozasa, Neiko; Yamamoto, Erika; Yoshikawa, Yusuke; Kitai, Takeshi; Taniguchi, Ryoji; Iguchi, Moritake; Kato, Masashi; Takahashi, Mamoru; Jinnai, Toshikazu; Ikeda, Tomoyuki; Nagao, Kazuya; Kawai, Takafumi; Komasa, Akihiro; Nishikawa, Ryusuke; Kawase, Yuichi; Morinaga, Takashi; Kawato, Mitsunori; Seko, Yuta; Shiba, Masayuki; Toyofuku, Mamoru; Furukawa, Yutaka; Ando, Kenji; Kadota, Kazushige; Sato, Yukihito; Kuwahara, Koichiro; Kimura, Takeshi			Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HYPOALBUMINEMIA	Background Despite the prognostic importance of hypoalbuminemia, the prognostic implication of a change in albumin levels has not been fully investigated during hospitalization in patients with acute decompensated heart failure (ADHF). Methods Using the data from the Kyoto Congestive Heart Failure registry on 3160 patients who were discharged alive for acute heart failure hospitalization and in whom the change in albumin levels was calculated at discharge, we evaluated the association with an increase in serum albumin levels from admission to discharge and clinical outcomes by a multivariable Cox hazard model. The primary outcome measure was a composite of all-cause death or hospitalization for heart failure. Findings Patients with increased albumin levels (N = 1083, 34.3%) were younger and less often had smaller body mass index and renal dysfunction than those with no increase in albumin levels (N = 2077, 65.7%). Median follow-up was 475 days with a 96% 1-year follow-up rate. Relative to the group with no increase in albumin levels, the lower risk of the increased albumin group remained significant for the primary outcome measure (hazard ratio: 0.78, 95% confidence interval: 0.69-0.90: P = 0.0004) after adjusting for confounders including baseline albumin levels. When stratified by the quartiles of baseline albumin levels, the favorable effect of increased albumin was more pronounced in the lower quartiles of albumin levels, but without a significant interaction effect (interaction P = 0.49). Conclusions Independent of baseline albumin levels, an increase in albumin during index hospitalization was associated with a lower 1-year risk for a composite of all-cause death and hospitalization in patients with acute heart failure.	[Kato, Takao; Yaku, Hidenori; Ozasa, Neiko; Yamamoto, Erika; Yoshikawa, Yusuke; Shiba, Masayuki; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan; [Inuzuka, Yasutaka] Shiga Gen Hosp, Dept Cardiovasc Med, Shiga, Japan; [Tamaki, Yodo] Tenri Hosp, Div Cardiol, Nara, Japan; [Kitai, Takeshi; Furukawa, Yutaka] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Taniguchi, Ryoji; Sato, Yukihito] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Cardiol, Amagasaki, Hyogo, Japan; [Iguchi, Moritake] Natl Hosp Org Kyoto Med Ctr, Dept Cardiol, Kyoto, Japan; [Kato, Masashi] Mitsubishi Kyoto Hosp, Dept Cardiol, Kyoto, Japan; [Takahashi, Mamoru] Shimabara Hosp, Dept Cardiol, Kyoto, Japan; [Jinnai, Toshikazu] Japanese Red Cross Otsu Hosp, Dept Cardiol, Shiga, Japan; [Ikeda, Tomoyuki] Hikone Municipal Hosp, Dept Cardiol, Shiga, Japan; [Nagao, Kazuya] Osaka Red Cross Hosp, Dept Cardiol, Osaka, Japan; [Kawai, Takafumi] Kishiwada City Hosp, Dept Cardiol, Osaka, Japan; [Komasa, Akihiro] Kansai Elect Power Hosp, Dept Cardiol, Osaka, Japan; [Nishikawa, Ryusuke] Shizuoka Prefectural Gen Hosp, Dept Cardiol, Shizuoka, Japan; [Kawase, Yuichi; Kadota, Kazushige] Kurashiki Cent Hosp, Dept Cardiol, Okayama, Japan; [Morinaga, Takashi; Ando, Kenji] Kokura Mem Hosp, Dept Cardiol, Fukuoka, Japan; [Kawato, Mitsunori] Kobe City Nishi Kobe Med Ctr, Dept Cardiol, Kobe, Hyogo, Japan; [Seko, Yuta] Kitano Hosp, Osaka, Japan; [Toyofuku, Mamoru] Japanese Red Cross Wakayama Med Ctr, Dept Cardiol, Wakayama, Japan; [Kuwahara, Koichiro] Shinshu Univ, Grad Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano, Japan	Kyoto University; Hyogo College of Medicine; Tenri Hospital; Kobe City Medical Center General Hospital; Osaka Red Cross Hospital; Shizuoka General Hospital; Kurashiki Central Hospital; Kokura Memorial Hospital; Kobe City Medical Center General Hospital; Kitano Hospital; Shinshu University	Kato, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan.	tkato75@kuhp.kyoto-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022; Yoshikawa, Yusuke/AAV-6436-2021	Kuwahara, Koichiro/0000-0003-2670-7170; Yoshikawa, Yusuke/0000-0001-8082-2036; Kato, Takao/0000-0001-8213-7999; Yaku, Hidenori/0000-0002-1011-1033	Japan Agency for Medical Research and Development [18059186]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Agency for Medical Research and Development [18059186] (Drs T. Kato, T. Kuwahara, and N. Ozasa). The founder had no role in the study design, collection, analysis or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.	Allen LA, 2009, EUR J HEART FAIL, V11, P170, DOI 10.1093/eurjhf/hfn031; [Anonymous], 2008, JAPANS ETHICAL GUIDE; Arques S, 2008, INT J CARDIOL, V125, P265, DOI 10.1016/j.ijcard.2007.07.094; Arques S, 2011, J CARD FAIL, V17, P451, DOI 10.1016/j.cardfail.2011.02.010; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato T, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60404-9; Kawamoto A, 2015, INT J CARDIOL, V187, P27, DOI 10.1016/j.ijcard.2015.03.354; Kitai T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4296; Koyama S, 2013, CIRC-HEART FAIL, V6, P227, DOI 10.1161/CIRCHEARTFAILURE.112.000152; Bonilla-Palomas JL, 2014, J CARD FAIL, V20, P350, DOI 10.1016/j.cardfail.2014.01.016; Nakayama H, 2016, AM J CARDIOL, V117, P1305, DOI 10.1016/j.amjcard.2016.01.030; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Regalbuto R, 2014, J CARD FAIL, V20, P641, DOI 10.1016/j.cardfail.2014.06.358; Su Kanae, 2019, Circ Rep, V1, P517, DOI 10.1253/circrep.CR-19-0054; Tanada Y, 2015, LIFE SCI, V137, P20, DOI 10.1016/j.lfs.2015.06.021; Uchino Y, 2018, AM J CARDIOVASC DRUG, V18, P327, DOI 10.1007/s40256-018-0269-0; Yaku H, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5892; Yaku H, 2018, CIRC J, V82, P2811, DOI 10.1253/circj.CJ-17-1386; Yamamoto E, 2017, ESC HEART FAIL, V4, P216, DOI 10.1002/ehf2.12138; Ziaeian B, 2016, NAT REV CARDIOL, V13, P368, DOI 10.1038/nrcardio.2016.25	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243818	10.1371/journal.pone.0243818	http://dx.doi.org/10.1371/journal.pone.0243818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370299	gold, Green Published			2022-12-27	WOS:000603611900013
J	Kisten, L; Tolmay, VL; Mathew, I; Sydenham, SL; Venter, E				Kisten, Lavinia; Tolmay, Vicki L.; Mathew, Isack; Sydenham, Scott L.; Venter, Eduard			Genome-wide association analysis of Russian wheat aphid (Diuraphis noxia) resistance in Dn4 derived wheat lines evaluated in South Africa	PLOS ONE			English	Article							GENE CONFERRING RESISTANCE; MONOSOMIC ANALYSIS; INHERITANCE; DIVERSITY; BIOTYPE; HEMIPTERA; DEFENSE; IDENTIFICATION; REGISTRATION; HOMOPTERA	Russian wheat aphid (RWA; Diuraphis noxia Kurdjumov) resistance on the 1D chromosome of wheat has been the subject of intensive research. Conversely, the deployment of the Dn4 derived RWA resistant varieties diminished in recent years due to the overcoming of the resistance it imparts in the United States of America. However, this resistance has not been deployed in South Africa despite reports that Dn4 containing genotypes exhibited varying levels of resistance against the South African RWA biotypes. It is possible that there may be certain genetic differences within breeding lines or cultivars that influence the expression of resistance. The aim of this study was to identify single nucleotide polymorphism (SNP) markers associated with resistance to South African RWA biotypes. A panel of thirty-two wheat lines were phenotyped for RWA resistance using four South African RWA biotypes and a total of 181 samples were genotyped using the Illumina 9K SNP wheat chip. A genome wide association study using 7598 polymorphic SNPs showed that the population was clustered into two distinct subpopulations. Twenty-seven marker trait associations (MTA) were identified with an average linkage disequilibrium of 0.38 at 10 Mbp. Four of these markers were highly significant and three correlated with previously reported quantitative trait loci linked to RWA resistance in wheat. Twenty putative genes were annotated using the IWGSC RefSeq, three of which are linked to plant defence responses. This study identified novel chromosomal regions that contribute to RWA resistance and contributes to unravelling the complex genetics that control RWA resistance in wheat.	[Kisten, Lavinia; Tolmay, Vicki L.] ARC Small Grain, Germplasm Dev, Bethlehem, Free State, South Africa; [Kisten, Lavinia; Venter, Eduard] Univ Johannesburg, Dept Bot & Plant Biotechnol, Johannesburg, Gauteng, South Africa; [Mathew, Isack] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, Pietermaritzburg, KwaZulu Natal, South Africa; [Sydenham, Scott L.] LongReach Plant Breeders Management Pty Ltd, York, WA, Australia	University of Johannesburg; University of Kwazulu Natal	Kisten, L; Tolmay, VL (corresponding author), ARC Small Grain, Germplasm Dev, Bethlehem, Free State, South Africa.; Kisten, L (corresponding author), Univ Johannesburg, Dept Bot & Plant Biotechnol, Johannesburg, Gauteng, South Africa.	kistenl@arc.agric.za; tolmayv@arc.agric.za	Tolmay, Vicki/I-9734-2015; Venter, Eduard/B-9988-2008	Tolmay, Vicki/0000-0002-7374-5295; Kisten, Lavinia/0000-0003-2481-399X; Venter, Eduard/0000-0002-1838-6453	South African Winter Cereal Trust [WCT/W/2018/06]; National Research Foundation [RTF1505 2911 8466, PDP160318160924]; LongReach Plant Breeders Management Pty Ltd	South African Winter Cereal Trust; National Research Foundation; LongReach Plant Breeders Management Pty Ltd	Funding for the research undertaken in this manuscript were sourced from the following funders: 1. South African Winter Cereal Trust https://www.wintercerealtrust.co.za Grant WCT/W/2018/06 - Awarded to VT PhD bursary - Awarded to LK 2. National Research Foundation - Research and Technology Fund https://www.nrf.ac.za Grant RTF1505 2911 8466 - Awarded to VT 3. National Research Foundation - Professional Development Programme https://www.nrf.ac.za Block Grant PDP160318160924 - Awarded to VT via Jasper Rees PhD bursary - Awarded to LK 4. LongReach Plant Breeders Management Pty Ltd https://www.longreachpb.com.au Salary of SLS The funders [1-3] mentioned above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder (LongReach Plant Breeders Management Pty Ltd) provided support in the form of salaries for author SLS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson GR, 2003, THEOR APPL GENET, V107, P1297, DOI 10.1007/s00122-003-1358-1; [Anonymous], 2017, R LANG ENV STAT COMP; [Anonymous], 2018, BMJ, V361, pk2475; Arzani A, 2004, EUPHYTICA, V139, P167, DOI 10.1007/s10681-004-2898-4; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Blake VC, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz065; Botha AM, 2005, J PLANT INTERACT, V1, P211, DOI 10.1080/17429140601073035; Bryant RRM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-10; Castro A.M., 2008, P 11 INT WHEAT GENET, V3, P721; Castro AM, 2005, PLANT BREEDING, V124, P229, DOI 10.1111/j.1439-0523.2005.01082.x; Castro AM, 2001, EUPHYTICA, V118, P321, DOI 10.1023/A:1017503828952; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chen MS, 2014, J ECON ENTOMOL, V107, P1266, DOI 10.1603/EC13357; Dahleen LS, 2015, CROP SCI, V55, P1925, DOI 10.2135/cropsci2014.09.0634; Dahleen LS, 2014, CROP SCI, V54, P1505, DOI 10.2135/cropsci2013.09.0616; Dahleen LS, 2012, CROP SCI, V52, P1651, DOI 10.2135/cropsci2011.09.0525; DONG HS, 1995, EUPHYTICA, V81, P299, DOI 10.1007/BF00025621; DUTOIT F, 1985, CEREAL RES COMMUN, V13, P371; DUTOIT F, 1989, J ECON ENTOMOL, V82, P1779, DOI 10.1093/jee/82.6.1779; DUTOIT F, 1995, CEREAL RES COMMUN, V23, P15; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fazel-Najafabadi M, 2015, EUPHYTICA, V203, P607, DOI 10.1007/s10681-014-1284-0; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Haley SD, 2009, J PLANT REGIST, V3, P181, DOI 10.3198/jpr2008.12.0727crc; Haley SD, 2005, CROP SCI, V45, P2654, DOI 10.2135/cropsci2005.0030; HARVEY TL, 1990, CEREAL RES COMMUN, V18, P127; Heng-Moss TM, 2003, J ECON ENTOMOL, V96, P475, DOI 10.1603/0022-0493-96.2.475; Heyns I, 2006, CROP SCI, V46, P630, DOI 10.2135/cropsci2005.0174; Hillwig MS, 2016, MOL PLANT PATHOL, V17, P225, DOI 10.1111/mpp.12274; HOLMES ND, 1984, CAN ENTOMOL, V116, P677, DOI 10.4039/Ent116677-5; Huang JC, 2000, BIOTECHNIQUES, V28, P432, DOI 10.2144/00283bm08; Jankielsohn, 2019, SA GRAIN MAGAZINE, P70; Joukhadar R, 2013, MOL BREEDING, V32, P943, DOI 10.1007/s11032-013-9924-y; Jung C, 2015, PLANT CELL, V27, P2016, DOI 10.1105/tpc.15.00385; Keller Y, 1998, EUR J BIOCHEM, V251, P413, DOI 10.1046/j.1432-1327.1998.2510413.x; Khan SA, 2009, J ECON ENTOMOL, V102, P1654, DOI 10.1603/029.102.0433; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; LANNING SP, 1993, CROP SCI, V33, P1420, DOI 10.2135/cropsci1993.0011183X003300060083x; Li GQ, 2018, CROP SCI, V58, P1219, DOI 10.2135/cropsci2017.10.0649; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Liu XM, 2001, THEOR APPL GENET, V102, P504, DOI 10.1007/s001220051674; Liu XM, 2005, CROP SCI, V45, P2273, DOI 10.2135/cropsci2004.0704; Liu XM, 2002, THEOR APPL GENET, V104, P1042, DOI 10.1007/s00122-001-0831-y; Ma ZQ, 1998, GENOME, V41, P303, DOI 10.1139/gen-41-2-303; MARAIS GF, 1993, PLANT BREEDING, V111, P246, DOI 10.1111/j.1439-0523.1993.tb00636.x; MARAIS GF, 1994, PLANT BREEDING, V113, P265, DOI 10.1111/j.1439-0523.1994.tb00735.x; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; Miller CA, 2001, CROP SCI, V41, P1584, DOI 10.2135/cropsci2001.4151584x; Munne-Bosch S, 2007, PLANTA, V225, P681, DOI 10.1007/s00425-006-0375-0; Navabi Z, 2004, CEREAL RES COMMUN, V32, P451; Negeri A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-106; NKONGOLO KK, 1991, CAN J PLANT SCI, V71, P703, DOI 10.4141/cjps91-103; NKONGOLO KK, 1991, CROP SCI, V31, P905, DOI 10.2135/cropsci1991.0011183X003100040012x; Payne RW., 2017, GENSTAT WINDOWS, V19th; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, PLINK 1 07; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Puterka GJ, 2015, J ECON ENTOMOL, V108, P798, DOI 10.1093/jee/tov008; Puterka GJ, 2007, J ECON ENTOMOL, V100, P1679, DOI 10.1603/0022-0493(2007)100[1679:DADORW]2.0.CO;2; Reidt W, 2006, EMBO J, V25, P4326, DOI 10.1038/sj.emboj.7601313; Ricciardi M, 2010, CROP PASTURE SCI, V61, P970, DOI 10.1071/CP10188; Roder MS, 1998, GENETICS, V149, P2007; Saidi A, 1994, 6 RUSS WHEAT APH C; Sarnowski TJ, 2005, PLANT CELL, V17, P2454, DOI 10.1105/tpc.105.031203; SAS, 2012, STAT PROC MAN; SCHROEDERTEETER S, 1994, EUPHYTICA, V74, P117, DOI 10.1007/BF00033775; SCHROEDERTEETER S, 1990, AGR ABSTR ANN M ASA, P108; Selladurai S, 2016, GENETIC MAPPING MOL; Shin J.-H., 2006, J STAT SOFTWARE, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Smith CM, 2004, J ECON ENTOMOL, V97, P1112, DOI 10.1603/0022-0493(2004)097[1112:IORWAH]2.0.CO;2; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Toit F. du, 1984, Technical Communication, Department of Agriculture, South Africa, P58; Tolmay V. L., 2017, South African Journal of Plant and Soil, V34, P65, DOI 10.1080/02571862.2016.1180716; Tolmay VL, 2013, J APPL ENTOMOL, V137, P476, DOI 10.1111/jen.12008; Tolmay VL, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218271; Tonk FA, 2016, PLANT BREEDING, V135, P21, DOI 10.1111/pbr.12339; Trapp O, 2011, FRONT PLANT SCI, P2, DOI [10.3389/fpls.2011.00002, DOI 10.3389/FPLS.2011.00002]; UPOV, 2002, GEN INTR EX DIST UN; Valdez VA, 2012, CROP SCI, V52, P676, DOI 10.2135/cropsci2011.06.0331; Voothuluru P, 2006, J ECON ENTOMOL, V99, P1854, DOI 10.1603/0022-0493-99.5.1854; Walters MC, 1984, M RUSS APH TASK TEAM; Wang D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005844; Wang S, 2010, P NATL ACAD SCI USA, V107, P22716, DOI 10.1073/pnas.1005978107; Yan SP, 2013, MOL CELL, V52, P602, DOI 10.1016/j.molcel.2013.09.019; Yu QQ, 2016, PLANT CELL REP, V35, P1297, DOI 10.1007/s00299-016-1961-7; Zhao HW, 2009, PLANT PHYSIOL, V151, P1546, DOI 10.1104/pp.109.142729; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zou C, 2016, PLANT BIOTECHNOL J, V14, P1941, DOI 10.1111/pbi.12559; Zust T, 2017, ANNU REV PLANT BIOL, V68, P513, DOI 10.1146/annurev-arplant-042916-040856	93	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244455	10.1371/journal.pone.0244455	http://dx.doi.org/10.1371/journal.pone.0244455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370360	Green Published, gold			2022-12-27	WOS:000603611900040
J	Mejia, F; Medina, C; Cornejo, E; Morello, E; Vasquez, S; Alave, J; Schwalb, A; Malaga, G				Mejia, Fernando; Medina, Carlos; Cornejo, Enrique; Morello, Enrique; Vasquez, Sergio; Alave, Jorge; Schwalb, Alvaro; Malaga, German			Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru	PLOS ONE			English	Article							NEW-YORK-CITY; HYPOXEMIA; OUTCOMES; CARE	Introduction Peru is among the top ten countries with the highest number of coronavirus disease 2019 (COVID-19) cases worldwide. The aim of the study was to describe the clinical features of hospitalized adult patients with COVID-19 and to determine the prognostic factors associated with in-hospital mortality. Methods We conducted a retrospective cohort study among adult patients with COVID-19 admitted to Hospital Cayetano Heredia; a tertiary care hospital in Lima, Peru. The primary outcome was in-hospital mortality. Multivariate Cox proportional hazards regression was used to identify factors independently associated with in-hospital mortality. Results A total of 369 patients (median age 59 years [IQR:49-68]; 241 (65.31%) male) were included. Most patients (68.56%) reported at least one comorbidity; more frequently: obesity (42.55%), diabetes mellitus (21.95%), and hypertension (21.68%). The median duration of symptoms prior to hospital admission was 7 days (IQR: 5-10). Reported in-hospital mortality was 49.59%. By multiple Cox regression, oxygen saturation (SaO(2)) values of less than 90% on admission correlated with mortality, presenting 1.86 (95%CI: 1.02-3.39), 4.44 (95%CI: 2.46-8.02) and 7.74 (95%CI: 4.54-13.19) times greater risk of death for SaO(2) of 89-85%, 84-80% and <80%, respectively, when compared to patients with SaO(2) >90%. Additionally, age >60 years was associated with 1.88 times greater mortality. Conclusions Oxygen saturation below 90% on admission is a strong predictor of in-hospital mortality in patients with COVID-19. In settings with limited resources, efforts to reduce mortality in COVID-19 should focus on early identification of hypoxemia and timely access to hospital care.	[Mejia, Fernando; Medina, Carlos; Cornejo, Enrique; Schwalb, Alvaro] Univ Peruana Cayetano Heredia, Inst Medicina Trop Alexander von Humboldt, Lima, Peru; [Mejia, Fernando; Medina, Carlos; Cornejo, Enrique; Morello, Enrique; Vasquez, Sergio; Alave, Jorge; Malaga, German] Hosp Cayetano Heredia, Lima, Peru; [Alave, Jorge] Univ Peruana Union, Sch Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Union	Mejia, F (corresponding author), Univ Peruana Cayetano Heredia, Inst Medicina Trop Alexander von Humboldt, Lima, Peru.; Mejia, F (corresponding author), Hosp Cayetano Heredia, Lima, Peru.	fernando.mejia.c@upch.pe	Alave, Jorge/GSN-3726-2022; Cisneros, Enrique Cornejo/AAF-2247-2021; Schwalb, Alvaro/AAW-5757-2020	Alave, Jorge/0000-0002-1178-2445; Cisneros, Enrique Cornejo/0000-0003-1987-1212; Schwalb, Alvaro/0000-0002-6518-9719; mejia, fernando/0000-0001-8429-8833				Celis-Rodriguez E, 2006, CRIT CARE CLIN, V22, P439, DOI 10.1016/j.ccc.2006.03.014; Cuba-Fuentes María Sofia, 2018, An. Fac. med., V79, P346, DOI 10.15381/anales.v79i4.15642; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Dhont S, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01462-5; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Kammar-Garcia A, 2020, REV INVEST CLIN, V72, P151, DOI [10.24875/ric.20000207, 10.24875/RIC.20000207]; Lazzerini M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136166; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Neelsen S, 2017, HEALTH ECON, V26, pE179, DOI 10.1002/hec.3492; Pan F, 2020, INT J MED SCI, V17, P1281, DOI 10.7150/ijms.46614; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Pipeling MR, 2010, JAMA-J AM MED ASSOC, V304, P2521, DOI 10.1001/jama.2010.1752; Ponce-Varillas Tomás Ignacio, 2017, An. Fac. med., V78, P218, DOI 10.15381/anales.v78i2.13221; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Sanchez-Moreno Francisco, 2013, Rev Peru Med Exp Salud Publica, V30, P676; Shah S, 2020, ACAD EMERG MED, V27, P681, DOI 10.1111/acem.14053; Sousa GJB, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001405; Tamara A, 2020, DIABETES METAB SYND, V14, P655, DOI 10.1016/j.dsx.2020.05.020; Vidal-Anzardo Margot, 2020, Rev. perú. med. exp. salud publica, V37, P203, DOI 10.17843/rpmesp.2020.372.5534; Wang K, 2020, CLIN INFECT DIS, V71, P2079, DOI 10.1093/cid/ciaa538; World Health Organization, 2020, 158 WHO; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie J, 2020, MAYO CLIN PROC, V95, P1138, DOI 10.1016/j.mayocp.2020.04.006; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zuniga-Moya JC, 2021, CLIN INFECT DIS, V72, pE476, DOI 10.1093/cid/ciaa1188	32	54	58	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244171	10.1371/journal.pone.0244171	http://dx.doi.org/10.1371/journal.pone.0244171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370364	Green Accepted, Green Published, gold			2022-12-27	WOS:000603611900050
J	Menneson, S; Serrand, Y; Janvier, R; Noirot, V; Etienne, P; Coquery, N; Val-Laillet, D				Menneson, Sophie; Serrand, Yann; Janvier, Regis; Noirot, Virginie; Etienne, Pierre; Coquery, Nicolas; Val-Laillet, David			Regular exposure to a Citrus-based sensory functional food ingredient alleviates the BOLD brain responses to acute pharmacological stress in a pig model of psychosocial chronic stress	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; SWEET ORANGE AROMA; FMRI; PREFERENCES; DEPRESSION; ANHEDONIA; SURVIVAL; NEURONS; ANXIETY; IMPACT	Psychosocial chronic stress is a critical risk factor for the development of mood disorders. However, little is known about the consequences of acute stress in the context of chronic stress, and about the related brain responses. In the present study we examined the physio-behavioural effects of a supplementation with a sensory functional food ingredient (FI) containing Citrus sinensis extract (D11399, Phode, France) in a pig psychosocial chronic stress model. Female pigs underwent a 5- to 6-week stress protocol while receiving daily the FI (FI, n = 10) or a placebo (Sham, n = 10). We performed pharmacological magnetic resonance imaging (phMRI) to study the brain responses to an acute stress (injection of Synacthen(R), a synthetic ACTH-related agonist) and to the FI odour with or without previous chronic supplementation. The olfactory stimulation with the ingredient elicited higher brain responses in FI animals, demonstrating memory retrieval and habituation to the odour. Pharmacological stress with Synacthen injection resulted in an increased activity in several brain regions associated with arousal, associative learning (hippocampus) and cognition (cingulate cortex) in chronically stressed animals. This highlighted the specific impact of acute stress on the brain. These responses were alleviated in animals previously supplemented by the FI during the entire chronic stress exposure. As chronic stress establishes upon the accumulation of acute stress events, any attenuation of the brain responses to acute stress can be interpreted as a beneficial effect, suggesting that FI could be a viable treatment to help individuals coping with repeated stressful events and eventually to reduce chronic stress. This study provides additional evidence on the potential benefits of this FI, of which the long-term consequences in terms of behaviour and physiology need to be further investigated.	[Menneson, Sophie; Serrand, Yann; Janvier, Regis; Coquery, Nicolas; Val-Laillet, David] Univ Rennes, INSERM, Nutr Metabolisms & Canc, INRAE,NuMeCan, Rennes, France; [Menneson, Sophie; Noirot, Virginie; Etienne, Pierre] Phode, Terssac, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Coquery, N (corresponding author), Univ Rennes, INSERM, Nutr Metabolisms & Canc, INRAE,NuMeCan, Rennes, France.	nicolas.coquery@inrae.fr	coquery, nicolas/GQP-5662-2022; coquery, nicolas/N-9206-2019; VAL-LAILLET, David/AAH-6454-2021	coquery, nicolas/0000-0002-4687-5924; coquery, nicolas/0000-0002-4687-5924; Noirot, Virginie/0000-0002-7489-3783	Phode (Terssac, France); Association Nationale de la Recherche et de la Technologie (ANRT); french Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE) [2016/0891]	Phode (Terssac, France); Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); french Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE)	The funder (Phode (Terssac, France; https://www.phode.com/en/) provided the functional ingredient tested and support in the form of salaries for authors SM, VN, and PE but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors affiliated to our private partner are articulated in the 'author contributions' section. Notably, authors PE and VN read and validated the final manuscript but did not decide which results to publish and how to interpret these results. The Association Nationale de la Recherche et de la Technologie (ANRT; http://www.anrt.asso.fr/fr), and the french Institut national de recherche pour l'agriculture, l'alimentation et l'environnement (INRAE; https://www.inrae.fr/) (PhD grant CIFRE of SM, No 2016/0891) also provided funding for this study.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Arnsten AFT, 2015, NEUROBIOL STRESS, V1, P89, DOI 10.1016/j.ynstr.2014.10.002; Arts JWM, 2009, BEHAV BRAIN RES, V205, P303, DOI 10.1016/j.bbr.2009.06.014; Bali A, 2015, REV NEUROSCIENCE, V26, P555, DOI 10.1515/revneuro-2015-0004; Brooks SJ, 2012, NEUROIMAGE, V59, P2962, DOI 10.1016/j.neuroimage.2011.09.077; Campolongo P, 2011, HDB STRESS NEUROPSYC, P179, DOI [10.1002/9781118083222.ch9, DOI 10.1002/9781118083222.CH9]; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chen HJ, 2019, AUST NZ J PSYCHIAT, V53, P68, DOI 10.1177/0004867418812674; Cho S, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1431; Clouard C, 2014, J ANIM SCI, V92, P2133, DOI 10.2527/jas.2013-6809; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Coquery N, 2019, J FOOD SCI, V84, P2666, DOI 10.1111/1750-3841.14772; Coquery N, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00151; Costa CARA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-42; Coutens B, 2020, NEUROSCIENCE, V451, P149, DOI 10.1016/j.neuroscience.2020.09.040; Dedovic K, 2005, J PSYCHIATR NEUROSCI, V30, P319; Dedovic K, 2009, BRAIN RES, V1293, P49, DOI 10.1016/j.brainres.2009.06.044; Duong TQ, 2007, BRAIN RES, V1135, P186, DOI 10.1016/j.brainres.2006.11.097; Faturi CB, 2010, PROG NEURO-PSYCHOPH, V34, P605, DOI 10.1016/j.pnpbp.2010.02.020; Ferrari L, 2012, J NEUROSCI METH, V204, P9, DOI 10.1016/j.jneumeth.2011.10.020; Finsterwald C, 2014, NEUROBIOL LEARN MEM, V112, P17, DOI 10.1016/j.nlm.2013.09.017; Gautier Y, 2018, FASEB J, V32, P6478, DOI 10.1096/fj.201701541; Gieling ET, 2011, ANIM COGN, V14, P151, DOI 10.1007/s10071-010-0364-3; Goes TC, 2012, J ALTERN COMPLEM MED, V18, P798, DOI 10.1089/acm.2011.0551; Gompf HS, 2010, J NEUROSCI, V30, P14543, DOI 10.1523/JNEUROSCI.3037-10.2010; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Heilbronner SR, 2016, ANNU REV NEUROSCI, V39, P149, DOI 10.1146/annurev-neuro-070815-013952; In MH, 2017, NEUROIMAGE, V158, P26, DOI 10.1016/j.neuroimage.2017.06.069; Ironside M, 2018, CURR OPIN BEHAV SCI, V22, P106, DOI 10.1016/j.cobeha.2018.01.016; Jafarzadeh Mehdi, 2013, Adv Biomed Res, V2, P10, DOI 10.4103/2277-9175.107968; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Lewis AH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00179; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mannucci C, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/3624094; Menneson S, 2020, J FUNCT FOODS, V64, DOI 10.1016/j.jff.2019.103599; Menneson S, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00161; Murphy E, 2014, APPL ANIM BEHAV SCI, V159, P9, DOI 10.1016/j.applanim.2014.08.002; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Okuyama S, 2018, BIOSCI BIOTECH BIOCH, V82, P869, DOI 10.1080/09168451.2018.1433993; OP026, 2016, J CROHNS COLITIS, V10, pS21; Page GG, 2016, NEUROBIOL STRESS, V3, P105, DOI 10.1016/j.ynstr.2016.03.002; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rochefort C, 2005, EUR J NEUROSCI, V22, P2863, DOI 10.1111/j.1460-9568.2005.04486.x; Rolls ET, 2019, BRAIN STRUCT FUNCT, V224, P3001, DOI 10.1007/s00429-019-01945-2; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Rygula R, 2005, BEHAV BRAIN RES, V162, P127, DOI 10.1016/j.bbr.2005.03.009; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Sawamoto A, 2016, MOLECULES, V21, DOI 10.3390/molecules21040541; Shenhav A, 2016, NAT NEUROSCI, V19, P1286, DOI 10.1038/nn.4384; Tang CY, 2016, INT ANESTHESIOL CLIN, V54, P129, DOI 10.1097/AIA.0000000000000081; Val-Laillet D, 2019, ANIMAL, V13, P2699, DOI 10.1017/S1751731119001745; Val-Laillet D, 2017, FASEB J, V31, P2037, DOI 10.1096/fj.201601015R; Val-Laillet D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162660; Valle-Leija P, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/975367; Valle-Leija P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035358; Van Bokhoven P, 2011, EUR J NEUROSCI, V33, P1833, DOI 10.1111/j.1460-9568.2011.07668.x; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015; Willner P, 2017, NEUROBIOL STRESS, V6, P78, DOI 10.1016/j.ynstr.2016.08.002; Wolffenbuttel AN, 2018, PHYTOTHER RES, V32, P160, DOI 10.1002/ptr.5964; Zhang LL, 2019, J AGR FOOD CHEM, V67, P13817, DOI 10.1021/acs.jafc.9b00650; 2019, J CROHNS COLITIS S1, V13	63	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243893	10.1371/journal.pone.0243893	http://dx.doi.org/10.1371/journal.pone.0243893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370353	gold, Green Published			2022-12-27	WOS:000603611900064
J	Okello, N; Oloro, J; Kyakwera, C; Kumbakumba, E; Obua, C				Okello, Nelson; Oloro, Joseph; Kyakwera, Catherine; Kumbakumba, Elias; Obua, Celestino			Antibiotic prescription practices among prescribers for children under five at public health centers III and IV in Mbarara district	PLOS ONE			English	Article							MANAGEMENT	Introduction Rational use of medicines requires that patients receive medications appropriate to their clinical needs. Irrational prescription of antibiotics has been reported in many health systems across the world. In Uganda, mainly nurses and assistant medical officers (Clinical officers) prescribe for children at level III and IV primary care facilities (health center II and IV). Nurses are not primarily trained prescribers; their antibiotic prescription maybe associated with errors. There is a need to understand the practices of antibiotic prescription among prescribers in the public primary care facilities. We therefore determined antibiotic prescription practices of prescribers for children under five years at health center III and IV in Mbarara district, South Western Uganda. Methods This was a retrospective descriptive cross-sectional study. We reviewed outpatient records of children <5 years of age retrospectively. Information obtained from the outpatient registers were captured in predesigned data abstraction form. Health care providers working at health centers III and IV were interviewed using a structured questionnaire. They provided information on socio-demographic, health facility, antibiotic prescription practices and availability of reference tools. Data was analyzed using STATA software version 13 center dot 0. Results There were 1218 outpatients records of children under five years reviewed and 35 health care providers interviewed. The most common childhood illness diagnosed was upper respiratory tract infection. It received the most antibiotic prescription (53%). The most commonly prescribed oral antibiotics were cotrimoxazole and amoxicillin, and ceftriaxone and benzyl penicillin were the commonest prescribed injectable antibiotics. Up to 68.4% of the antibiotic prescription was irrational. No prescriber or facility factors were associated with irrational antibiotic prescription practices. Conclusion Upper respiratory tract infection is the most diagnosed condition in children under five years with Cotrimoxazole and Amoxicillin being the most commonly prescribed antibiotics. Antibiotics are being prescribed irrationally at health centers III and IV in Mbarara District. Training and support supervision of prescribers at health centers III and IV in Mbarara district need to be prioritized by the district health team.	[Okello, Nelson; Kyakwera, Catherine; Kumbakumba, Elias] Mbarara Univ Sci & Technol, Dept Paediat & Child Hlth, Fac Med, Mbarara, Uganda; [Okello, Nelson] Lira Univ, Dept Paediat & Child Hlth, Fac Hlth Sci, Lira, Uganda; [Oloro, Joseph; Obua, Celestino] Mbarara Univ Sci & Technol, Dept Pharmacol & Therapeut, Fac Med, Mbarara, Uganda	Mbarara University of Science & Technology; Mbarara University of Science & Technology	Okello, N (corresponding author), Mbarara Univ Sci & Technol, Dept Paediat & Child Hlth, Fac Med, Mbarara, Uganda.; Okello, N (corresponding author), Lira Univ, Dept Paediat & Child Hlth, Fac Hlth Sci, Lira, Uganda.	docnelsons@gmail.com		Neli, Nelson/0000-0002-7791-4068	Makerere University - Swedish International development Agency (SIDA)	Makerere University - Swedish International development Agency (SIDA)	This study was funded by Makerere University - Swedish International development Agency (SIDA) research scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bozic B, 2015, ARCH DIS CHILD, V100, P966, DOI 10.1136/archdischild-2015-308274; Cochran W, 1963, G 1963 SAMPLING TECH; Dekker ARJ, 2017, FAM PRACT, V34, P169, DOI 10.1093/fampra/cmw125; DEMERS P, 1968, CAN MED ASSOC J, V99, P849; Desalegn AA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-170; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; health UMo, 2016, UG CLIN GUID, P335; HOGERZEIL HV, 1995, BRIT J CLIN PHARMACO, V39, P1; Kotwani A, 2012, J CLIN PHARM THER, V37, P308, DOI 10.1111/j.1365-2710.2011.01293.x; Maheshwari A, 2012, INDIAN J PEDIATR, V79, P75, DOI 10.1007/s12098-011-0540-8; Mihani J, 2018, OPEN ACCESS MACED J, DOI [10.3889/oamjms.2018.150, DOI 10.3889/0AMJMS.2018.150]; MoH, 2016, UG CLIN GUID; Nash DR, 2002, ARCH PEDIAT ADOL MED, V156, P1114, DOI 10.1001/archpedi.156.11.1114; Prah J, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.214.13940; Statistics UBo, 2016, NAT POP HOUS CENS 20; van Driel ML, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0470-7; World Health Organization, 2007, INT CLASS DIS REL HL	17	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243868	10.1371/journal.pone.0243868	http://dx.doi.org/10.1371/journal.pone.0243868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370280	Green Published, gold			2022-12-27	WOS:000603611900072
J	Sabatino, J; De Rosa, S; Leo, I; Spaccarotella, C; Mongiardo, A; Polimeni, A; Sorrentino, S; Di Salvo, G; Indolfi, C				Sabatino, Jolanda; De Rosa, Salvatore; Leo, Isabella; Spaccarotella, Carmen; Mongiardo, Annalisa; Polimeni, Alberto; Sorrentino, Sabato; Di Salvo, Giovanni; Indolfi, Ciro			Non-invasive myocardial work is reduced during transient acute coronary occlusion	PLOS ONE			English	Article							LONGITUDINAL 2D STRAIN; ARTERY OCCLUSION; LOOP AREA; MOTION; INDEX; ECHOCARDIOGRAPHY; STRESS; QUANTIFICATION; INFARCTION; PRESSURE	Background During ischemia a close relationship exists between sub-endocardial blood flow and myocardial function. Strain parameters can capture an impairment of regional longitudinal function but are load dependent. Recently, a novel non-invasive method to calculate Myocardial Work (MW) showed a strong correlation with invasive work measurements. Our aim was to investigate the ability of non-invasive MW indices to identify the ischaemic risk area during transient acute coronary occlusion (TACO). Methods and results The study population comprises 50 individuals with critical coronary stenosis (CCS). Echocardiography recordings were obtained before coronary angiography, during TACO and after revascularization to measure global longitudinal strain (GLS), Myocardial Work Index (MWI), Myocardial Constructive Work (MCW), Myocardial Wasted work (MWW), Myocardial work efficiency (MWE). Compared to baseline, we found a significant reduction of GLS (p = 0.005), MWI, MCW and MWE (p<0.001) during TACO. Conclusions The non-invasive measurement of MW parameters is a sensitive and early marker of myocardial ischemia during TACO.	[Sabatino, Jolanda; De Rosa, Salvatore; Leo, Isabella; Spaccarotella, Carmen; Mongiardo, Annalisa; Polimeni, Alberto; Sorrentino, Sabato; Indolfi, Ciro] Magna Graecia Univ Catanzaro, Div Cardiol, Dept Med & Surg Sci, Catanzaro, CZ, Italy; [Sabatino, Jolanda; De Rosa, Salvatore; Spaccarotella, Carmen; Polimeni, Alberto; Sorrentino, Sabato; Indolfi, Ciro] Magna Graecia Univ Catanzaro, Cardiovasc Res Ctr, Catanzaro, CZ, Italy; [Sabatino, Jolanda; Di Salvo, Giovanni] Royal Brompton Hosp, Dept Paediat Cardiol, London, England; [Di Salvo, Giovanni] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Indolfi, Ciro] Mediterranea Cardioctr, Naples, NA, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; Royal Brompton Hospital; University of Padua	De Rosa, S; Indolfi, C (corresponding author), Magna Graecia Univ Catanzaro, Div Cardiol, Dept Med & Surg Sci, Catanzaro, CZ, Italy.; De Rosa, S; Indolfi, C (corresponding author), Magna Graecia Univ Catanzaro, Cardiovasc Res Ctr, Catanzaro, CZ, Italy.; Indolfi, C (corresponding author), Mediterranea Cardioctr, Naples, NA, Italy.	saderosa@unicz.it; indolfi@unicz.it	Polimeni, Alberto AP/K-4731-2018; De Rosa, Salvatore/J-6350-2012; Sabatino, Jolanda/M-2506-2017	Polimeni, Alberto AP/0000-0002-9166-3031; De Rosa, Salvatore/0000-0001-5388-942X; Leo, Isabella/0000-0002-4774-0888; Sabatino, Jolanda/0000-0002-1661-5419; Spaccarotella, CARMEN ANNA MARIA/0000-0003-1825-0510	ESC	ESC	This study was partly supported through an ESC Training Grant 2019, awarded to JS. There was no additional external funding received for this study.	Bijnens B, 2007, CIRCULATION, V116, P2453, DOI 10.1161/CIRCULATIONAHA.106.684357; Boe E, 2015, EUR HEART J-CARD IMG, V16, P1247, DOI 10.1093/ehjci/jev078; Borrelli N, 2020, INT J CARDIOL, V317, P56, DOI 10.1016/j.ijcard.2020.03.085; Chan J, 2019, EUR HEART J-CARD IMG, V20, P31, DOI 10.1093/ehjci/jey131; Choi JO, 2009, EUR J ECHOCARDIOGR, V10, P695, DOI 10.1093/ejechocard/jep041; Cutruzzola A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68908-0; Dahlslett T, 2014, J AM SOC ECHOCARDIOG, V27, P512, DOI 10.1016/j.echo.2014.01.019; De Rosa S, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0664-5; De Rosa S, 2013, CIRC-CARDIOVASC INTE, V6, P44, DOI 10.1161/CIRCINTERVENTIONS.112.971705; DELHAAS T, 1994, J PHYSIOL-LONDON, V477, P481, DOI 10.1113/jphysiol.1994.sp020209; Edvardsen T, 2001, J AM COLL CARDIOL, V37, P726, DOI 10.1016/S0735-1097(00)01160-8; Edwards NFA, 2019, J AM SOC ECHOCARDIOG, V32, P947, DOI 10.1016/j.echo.2019.02.014; Fredholm M, 2017, ACTA ANAESTH SCAND, V61, P1155, DOI 10.1111/aas.12954; HAUSER AM, 1985, J AM COLL CARDIOL, V5, P193, DOI 10.1016/S0735-1097(85)80036-X; HISANO R, 1987, CIRC RES, V61, P318, DOI 10.1161/01.RES.61.3.318; INDOLFI C, 1989, CIRCULATION, V80, P983, DOI 10.1161/01.CIR.80.4.983; Irace C, 2018, J INVEST MED, V66, P905, DOI 10.1136/jim-2017-000644; JONES CJH, 1990, BRIT HEART J, V63, P215; Kukulski T, 2003, J AM COLL CARDIOL, V41, P810, DOI 10.1016/S0735-1097(02)02934-0; Kvitting JPE, 1999, J AM SOC ECHOCARDIOG, V12, P698, DOI 10.1016/S0894-7317(99)70019-2; LAZAR HL, 1987, ANN THORAC SURG, V44, P350, DOI 10.1016/S0003-4975(10)63789-7; Liel-Cohen N, 2010, CIRC-CARDIOVASC IMAG, V3, P47, DOI 10.1161/CIRCIMAGING.108.841874; Manganaro R, 2019, EUR HEART J-CARD IMG, V20, P582, DOI 10.1093/ehjci/jey188; Mazzitelli M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3426-9; MIYAZAKI S, 1993, AM J PHYSIOL, V264, pH110, DOI 10.1152/ajpheart.1993.264.1.H110; Murai D, 2017, HEART VESSELS, V32, P574, DOI 10.1007/s00380-016-0900-4; Niccoli G, 2019, CIRC RES, V125, P245, DOI 10.1161/CIRCRESAHA.119.315344; Pavasini R, 2020, EUR HEART J, V41, P4103, DOI 10.1093/eurheartj/ehz896; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; Russell K, 2013, AM J PHYSIOL-HEART C, V305, pH996, DOI 10.1152/ajpheart.00191.2013; Russell K, 2012, EUR HEART J, V33, P724, DOI 10.1093/eurheartj/ehs016; Sabatino J, 2019, CIRC-CARDIOVASC IMAG, V12, DOI 10.1161/CIRCIMAGING.118.007805; SAFWAT A, 1991, J AM COLL CARDIOL, V17, P790, DOI 10.1016/S0735-1097(10)80199-8; SAGAWA K, 1977, AM J CARDIOL, V40, P748, DOI 10.1016/0002-9149(77)90192-8; Schwietz T, 2013, J INTERV CARDIOL, V26, P29, DOI 10.1111/j.1540-8183.2013.12014.x; Sorrentino S, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0163-5; SUGA H, 1979, AM J PHYSIOL, V236, pH498, DOI 10.1152/ajpheart.1979.236.3.H498; Sutherland GR, 2004, J AM SOC ECHOCARDIOG, V17, P788, DOI 10.1016/j.echo.2004.03.027; TAKAYAMA M, 1988, CIRCULATION, V78, P994, DOI 10.1161/01.CIR.78.4.994; THEROUX P, 1974, CIRC RES, V35, P896, DOI 10.1161/01.RES.35.6.896; Thygesen K., 2018, CIRCULATION, V138, pe618, DOI [10.1161/CIR.0000000000000617, DOI 10.1161/CIR.0000000000000617, DOI 10.1016/J.JACC.2018.08.1038, 10.1161/cir.0000000000000617]; Urheim S, 2005, AM J PHYSIOL-HEART C, V288, pH2375, DOI 10.1152/ajpheart.00946.2004; Wang CL, 2010, INT J COMPUT ASS RAD, V5, P275, DOI 10.1007/s11548-009-0393-z; Whitaker D, 1999, VISION RES, V39, P2999, DOI 10.1016/S0042-6989(99)00010-3	44	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244397	10.1371/journal.pone.0244397	http://dx.doi.org/10.1371/journal.pone.0244397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370359	gold, Green Published			2022-12-27	WOS:000603611900074
J	Schelleman-Offermans, K; Massar, K				Schelleman-Offermans, Karen; Massar, Karlijn			Explaining socioeconomic inequalities in self-reported health outcomes: The mediating role of perceived life stress, financial self-reliance, psychological capital, and time perspective orientations	PLOS ONE			English	Article							FUTURE CONSEQUENCES; SMOKING; INTERVENTION; ASSOCIATION; RESOURCES; MORTALITY; BELIEFS; WOMEN	Objective The main aim of the current study was to investigate what role perceived life stress, psychological capital (PsyCap), financial self-reliance and time perspective orientations play in explaining socioeconomic health inequalities, specifically self-perceived health and self-reported physical health conditions. Methods Individuals (total n = 600) aged 16+ years from a general Dutch population sample (LISS panel) completed an online questionnaire measuring three different SEP indicators (highest achieved educational level, personal monthly disposable income and being in paid employment), perceived life stress, PsyCap, financial self-reliance, time perspective, self-perceived health, and self-reported physical health conditions. Structural equation modelling using a cross-sectional design was used to test the mediation paths from SEP indicators to self-perceived health and self-reported physical health conditions through perceived life stress, PsyCap, financial self-reliance and time perspective orientations. Results Highest achieved educational level and being in paid employment showed to play a role in the social stratification within self-reported and self-perceived health outcomes, whereas this was not found for personal monthly disposable income. The association between a lower highest achieved educational level and lower self-perceived health was mediated by lower PsyCap and higher perceived life stress levels. The association between a lower highest achieved educational level and higher levels of self-reported physical health conditions was mediated by less financial self-reliance and higher perceived life stress levels. Although no mediating role was found for time perspective orientations in the association between the measured SEP indicators and health outcomes, negative time perspective orientations were associated with either self-perceived health or self-reported physical health conditions. Conclusions reserves (PsyCap and financial self-reliance) and perceived life stress seem to play a larger role in explaining the health gradient in achieved educational level than time perspective orientations. Prevention efforts trying to reduce the SEP-health gradient should focus on a) increasing reserves and lowering perceived life stress levels for individuals with a low achieved educational level, and b) reducing unemployment and narrowing opportunity gaps in education for people with a low SEP.	[Schelleman-Offermans, Karen; Massar, Karlijn] Maastricht Univ, Dept Work & Social Psychol, Maastricht, Limburg, Netherlands	Maastricht University	Schelleman-Offermans, K (corresponding author), Maastricht Univ, Dept Work & Social Psychol, Maastricht, Limburg, Netherlands.	Karen.Offermans@maastrichtuniversity.nl			Netherlands Organisation for Health Research and Development [531001410]; Netherlands Organization for Scientific Research	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was funded by the Netherlands Organisation for Health Research and Development (https://www.zonmw.nl/en/), grant number 531001410, awarded to KM. The LISS panel data were collected by CentERdata (Tilburg University, The Netherlands) through its MESS (Measurement and Experimentation in the Social Sciences) project funded by the Netherlands Organization for Scientific Research (https://www.nwo.nl/en). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2009, HEALTH PSYCHOL, V28, P83, DOI 10.1037/0278-6133.28.1.83; Arcaya MC, 2016, SOC SCI MED, V168, P16, DOI 10.1016/j.socscimed.2016.08.047; Baltussen M, 2019, STAAT ONDERWIJS 2019; Bennett KK, 2015, J BEHAV MED, V38, P110, DOI 10.1007/s10865-014-9583-4; Bosma H, 1999, BRIT MED J, V319, P1469, DOI 10.1136/bmj.319.7223.1469; Bosma H, 1999, BRIT MED J, V318, P18; [Centraal Bureau voor Statistiek Statline], 2017, STATL; Coburn SS, 2016, ARCH WOMEN MENT HLTH, V19, P1009, DOI 10.1007/s00737-016-0649-x; Dello Russo S, 2015, HUM RESOUR DEV Q, V26, P329, DOI 10.1002/hrdq.21212; Gallo LC, 2005, J PERS SOC PSYCHOL, V88, P386, DOI 10.1037/0022-3514.88.2.386; Gallo LC, 2003, PSYCHOL BULL, V129, P10, DOI 10.1037//0033-2909.129.1.10; Gallo LC, 2009, CURR DIR PSYCHOL SCI, V18, P269, DOI 10.1111/j.1467-8721.2009.01650.x; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Haring R, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-103; Hoge EA, 2013, J CLIN PSYCHIAT, V74, P786, DOI 10.4088/JCP.12m08083; Hu YN, 2016, J EPIDEMIOL COMMUN H, V70, P644, DOI 10.1136/jech-2015-206780; IBM Corp, 2016, IBM SPSS STAT WINDOW; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Keough KA, 1999, BASIC APPL SOC PSYCH, V21, P149, DOI 10.1207/S15324834BA210207; Kooij DTAM, 2018, J APPL PSYCHOL, V103, P867, DOI 10.1037/apl0000306; Krasikova DV, 2015, J LEADERSH ORG STUD, V22, P280, DOI 10.1177/1548051815585853; Laureiro-Martinez D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00101; Lee EH, 2012, ASIAN NURS RES, V6, P121, DOI 10.1016/j.anr.2012.08.004; Lorenz T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152892; Luthans BC, 2014, J LEADERSH ORG STUD, V21, P191, DOI 10.1177/1548051813517003; Luthans F, 2006, J ORGAN BEHAV, V27, P387, DOI 10.1002/job.373; Luthans F, 2007, PERS PSYCHOL, V60, P541, DOI 10.1111/j.1744-6570.2007.00083.x; Luthans F, 2013, J LEADERSH ORG STUD, V20, P118, DOI 10.1177/1548051812465893; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot MG, 2003, PERSPECT BIOL MED, V46, pS9, DOI 10.1353/pbm.2003.0056; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Marmot M, 2017, EUR J EPIDEMIOL, V32, P537, DOI 10.1007/s10654-017-0286-3; Matthews KA, 2008, HEALTH PSYCHOL, V27, P576, DOI 10.1037/0278-6133.27.5.576; Mulder BC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-798; Muthen LK., 2017, MPLUS, VEight; Niederdeppe J, 2007, CANCER EPIDEM BIOMAR, V16, P998, DOI 10.1158/1055-9965.EPI-06-0608; Organization for Economic Co-operation and Development, OECD DAT INC IN; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Petry NM, 1998, ADDICTION, V93, P729, DOI 10.1046/j.1360-0443.1998.9357298.x; Rasmussen HN, 2009, ANN BEHAV MED, V37, P239, DOI 10.1007/s12160-009-9111-x; Rew L, 2017, WESTERN J NURS RES, V39, P356, DOI 10.1177/0193945916658861; Riolli L., 2012, PSYCHOLOGY, V3, P1202, DOI DOI 10.4236/PSYCH.2012.312A178; Scherpenzeel A., 2009, CENTERDATA; Scioli A, 1997, PSYCHOL REP, V81, P723, DOI 10.2466/pr0.1997.81.3.723; SIEGRIST J, 2006, SOCIAL INEQUALITIES; Stolarski M, 2014, J HAPPINESS STUD, V15, P809, DOI 10.1007/s10902-013-9450-y; STRATHMAN A, 1994, J PERS SOC PSYCHOL, V66, P742, DOI 10.1037/0022-3514.66.4.742; Taylor SE, 1999, ANN NY ACAD SCI, V896, P210, DOI 10.1111/j.1749-6632.1999.tb08117.x; Thoits PA, 2010, J HEALTH SOC BEHAV, V51, pS41, DOI 10.1177/0022146510383499; van der Heide I, 2013, J HEALTH COMMUN, V18, P172, DOI 10.1080/10810730.2013.825668; Vangeli E, 2008, TOB CONTROL, V17, P410, DOI 10.1136/tc.2008.025650; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; Zhang JW, 2013, TIME SOC, V22, P391, DOI 10.1177/0961463X12441174; Zimbardo PG, 1999, J PERS SOC PSYCHOL, V77, P1271, DOI 10.1037/0022-3514.77.6.1271	56	7	7	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243730	10.1371/journal.pone.0243730	http://dx.doi.org/10.1371/journal.pone.0243730			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370306	gold, Green Published			2022-12-27	WOS:000603611900111
J	Alemu, MH; Grebitus, C				Alemu, Mohammed Hussen; Grebitus, Carola			Towards sustainable urban food systems: Analyzing contextual and intrapsychic drivers of growing food in small-scale urban agriculture	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; COMMUNITY GARDENS; ENVIRONMENTAL SUSTAINABILITY; KNOWLEDGE; BEHAVIOR; DETROIT; DESERT; URBANIZATION; VEGETABLES; ATTITUDES	Small-scale urban agriculture is associated with positive health and environmental outcomes. Previous studies examined factors that drive people to grow foods in urban areas mainly drawing on qualitative data. This research investigates quantitatively what determines consumer preferences for growing foods in community gardens, informing efforts to upscale urban agriculture. We conducted choice experiments in North America and performed latent class analysis of contextual and intrapsychic factors affecting consumers' preferences for growing foods in cities. Results show that providing tools and guidance are the most important contextual factors affecting community garden participation. The preferences of proponents of growing foods are explained by their high subjective knowledge about growing foods and reasons tied to the benefits of participating in community gardening. Opponents of growing foods at community gardens are characterized by low knowledge. The findings can be used to design policies that promote sustainable food systems in urban areas.	[Alemu, Mohammed Hussen] Univ Copenhagen, Dept Food & Resource Econ, Frederiksberg C, Denmark; [Grebitus, Carola] Arizona State Univ, WP Carey Sch Business, Morrison Sch Agribusiness, Mesa, AZ USA	University of Copenhagen; Arizona State University	Alemu, MH (corresponding author), Univ Copenhagen, Dept Food & Resource Econ, Frederiksberg C, Denmark.	mha@ifro.ku.dk	Alemu, Mohammed Hussen/O-6772-2017	Alemu, Mohammed Hussen/0000-0002-0404-0232	EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA [201567003-23508]; NSF-MPS-DMS [1419593]	EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA; NSF-MPS-DMS	This work was supported by EASM-3: Collaborative Research: "Physics-Based Predictive Modeling for Integrated Agricultural and Urban Applications", USDA-NIFA (Grant Number: 201567003-23508) and NSF-MPS-DMS (Award Number: 1419593). Dr. Carola Grebitus was the grand holder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; AJZEN I, 1977, PSYCHOL BULL, V84, P888, DOI 10.1037/0033-2909.84.5.888; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Andrews RL, 2003, J MARKETING RES, V40, P235, DOI 10.1509/jmkr.40.2.235.19225; Artmann M, 2020, J CLEAN PROD, V255, DOI 10.1016/j.jclepro.2020.120220; Artmann M, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10061937; Benis K, 2017, J CLEAN PROD, V140, P784, DOI 10.1016/j.jclepro.2016.05.176; Bethlehem J, 2010, INT STAT REV, V78, P161, DOI 10.1111/j.1751-5823.2010.00112.x; BLACK JS, 1985, J APPL PSYCHOL, V70, P3, DOI 10.1037/0021-9010.70.1.3; Boxall PC, 2002, ENVIRON RESOUR ECON, V23, P421, DOI 10.1023/A:1021351721619; Budzynska K, 2013, PUBLIC HEALTH NUTR, V16, P2114, DOI 10.1017/S1368980013000967; Carley S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204917; Carlson JP, 2009, J CONSUM RES, V35, P864, DOI 10.1086/593688; Carmody D, 2018, GROWING CITY DETROIT; ChoiceMetrics, 2012, NGENE 111 USER MANUA; Cohen N, 2015, RENEW AGR FOOD SYST, V30, P103, DOI 10.1017/S1742170514000210; Colasanti KJA, 2012, URBAN GEOGR, V33, P348, DOI 10.2747/0272-3638.33.3.348; Dancey C., 2004, STAT MATHS PSYCHOL U; de-Magistris T, 2016, J CLEAN PROD, V118, P97, DOI 10.1016/j.jclepro.2016.01.050; Diaz JM, 2018, URBAN FOR URBAN GREE, V31, P197, DOI 10.1016/j.ufug.2018.02.014; Dietrich F, 2013, NOUS, V47, P104, DOI 10.1111/j.1468-0068.2011.00840.x; Drake L, 2015, AGR HUM VALUES, V32, P241, DOI 10.1007/s10460-014-9558-7; DUG. Denver Urban Gardens, 2012, GROW COMM GARD DENV; Ericksen PJ, 2008, GLOBAL ENVIRON CHANG, V18, P234, DOI 10.1016/j.gloenvcha.2007.09.002; Fila SA, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-11; Garnett T, 2016, SCIENCE, V353, P1202, DOI 10.1126/science.aah4765; Gerster-Bentaya M, 2013, FOOD SECUR, V5, P723, DOI 10.1007/s12571-013-0295-3; Global Panel on Agriculture and Food Systems for Nutrition, 2016, FOOD SYSTEMS DIETS F; GLOPAN, 2017, URB DIETS NUTR TREND; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Grebitus C, 2017, ECOL ECON, V136, P189, DOI 10.1016/j.ecolecon.2017.02.010; Guitart D, 2012, URBAN FOR URBAN GREE, V11, P364, DOI 10.1016/j.ufug.2012.06.007; Holland L., 2004, Local Environment, V9, P285, DOI 10.1080/1354983042000219388; Joiner C, 1998, ADV CONSUM RES, V25, P311; Keep Growing Detroit, 2019, SOW SEEDS REL 2019 A; Kline P., 1994, EASY GUIDE FACTOR AN, DOI DOI 10.4324/9781315788135; Kulak M, 2013, LANDSCAPE URBAN PLAN, V111, P68, DOI 10.1016/j.landurbplan.2012.11.007; Leiserowitz AA, 2006, ANNU REV ENV RESOUR, V31, P413, DOI 10.1146/annurev.energy.31.102505.133552; Loomis JB, 2014, J AGR RESOUR ECON, V39, P34; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Lusk JL, 2003, AM J AGR ECON, V85, P840, DOI 10.1111/1467-8276.00492; Maller C, 2006, HEALTH PROMOT INT, V21, P45, DOI 10.1093/heapro/dai032; McDougall R, 2019, P NATL ACAD SCI USA, V116, P129, DOI 10.1073/pnas.1809707115; McFadden D., 1986, MARKET SCI, V5, p275?297, DOI [10.1287/mksc.5.4.275, DOI 10.1287/MKSC.5.4.275]; McVey D, 2018, REG STUD REG SCI, V5, P40, DOI 10.1080/21681376.2017.1409650; Milburn L.A.S., 2010, LANDSC J, V29, P71, DOI [10.3368/lj.29.1.71, DOI 10.3368/LJ.29.1.71]; National Research Center I, 2006, COMM FOOD PROJ EV TO; Ochoa J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11143978; Parfit Derek., 1984, REASONS PERSONS; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; Peschel AO, 2016, APPETITE, V106, P78, DOI 10.1016/j.appet.2016.02.162; Raju P.S., 1995, J CONSUM PSYCHOL, V4, P153, DOI DOI 10.1207/S15327663JCP0402_04; Raz J., 1999, PRACTICAL REASON NOR; Savoie-Roskos MR, 2017, J ACAD NUTR DIET, V117, P240, DOI 10.1016/j.jand.2016.10.014; Schram-Bijkerk D, 2018, SCI TOTAL ENVIRON, V621, P863, DOI 10.1016/j.scitotenv.2017.11.160; Seto KC, 2016, SCIENCE, V352, P943, DOI 10.1126/science.aaf7439; Shrestha MK, 2012, APPL GEOGR, V32, P522, DOI 10.1016/j.apgeog.2011.04.004; Soga Masashi, 2017, Prev Med Rep, V5, P92; Solino M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089603; Somerset S, 2009, PUBLIC HEALTH NUTR, V12, P214, DOI 10.1017/S1368980008003327; Sorqvist P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080719; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Swait J., 1994, J RETAIL CONSUM SERV, V1, P77, DOI [10.1016/0969-6989(94)90002-7, DOI 10.1016/0969-6989(94)90002-7]; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Taylor DE, 2015, ENVIRON PRAC, V17, P102, DOI 10.1017/S1466046614000544; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Twiss J, 2003, AM J PUBLIC HEALTH, V93, P1435, DOI 10.2105/AJPH.93.9.1435; United Nations, 2015, TRANSF OUR WORLD 203; Vallin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152160; Vavra J, 2018, J CLEAN PROD, V185, P1015, DOI 10.1016/j.jclepro.2018.02.261; Vermeulen SJ, 2012, ANNU REV ENV RESOUR, V37, P195, DOI 10.1146/annurev-environ-020411-130608; Wallace RJ, 2004, REASON VALUE THEMES; Wang HL, 2014, APPL GEOGR, V55, P127, DOI 10.1016/j.apgeog.2014.09.010; Warren E, 2015, FOOD POLICY, V53, P54, DOI 10.1016/j.foodpol.2015.03.004; Watson DLB, 2011, PERSPECT PUBLIC HEAL, V131, P163, DOI 10.1177/1757913911412475; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; Weidner T, 2019, J CLEAN PROD, V209, P1637, DOI 10.1016/j.jclepro.2018.11.004; Weinberger K, 2013, FOOD SECUR, V5, P847, DOI 10.1007/s12571-013-0299-z; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Wils WPJ, 2019, WORLD COMPET, V42, P21; Wooldridge J.M., 2008, INTRO ECONOMETRICS M, VFourth; Zick CD, 2013, AM J PUBLIC HEALTH, V103, P1110, DOI 10.2105/AJPH.2012.301009	84	4	4	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243949	10.1371/journal.pone.0243949	http://dx.doi.org/10.1371/journal.pone.0243949			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362258	Green Published, gold			2022-12-27	WOS:000603071600031
J	Camougrand, N; Vigie, P; Gonzalez, C; Manon, S; Bhatia-Kissova, I				Camougrand, Nadine; Vigie, Pierre; Gonzalez, Cecile; Manon, Stephen; Bhatia-Kissova, Ingrid			The yeast mitophagy receptor Atg32 is ubiquitinated and degraded by the proteasome	PLOS ONE			English	Article							N-TERMINAL ACETYLATION; MITOCHONDRIAL AUTOPHAGY; ATP SYNTHASE; PROTEIN; DEGRADATION; LIGASE; FUNDC1; SYSTEM; ULK1	Mitophagy, the process that degrades mitochondria selectively through autophagy, is involved in the quality control of mitochondria in cells grown under respiratory conditions. In yeast, the presence of the Atg32 protein on the outer mitochondrial membrane allows for the recognition and targeting of superfluous or damaged mitochondria for degradation. Post-translational modifications such as phosphorylation are crucial for the execution of mitophagy. In our study we monitor the stability of Atg32 protein in the yeast S. cerevisiae and show that Atg32 is degraded under normal growth conditions, upon starvation or rapamycin treatment. The Atg32 turnover can be prevented by inhibition of the proteasome activity, suggesting that Atg32 is also ubiquitinated. Mass spectrometry analysis of purified Atg32 protein revealed that at least lysine residue in position 282 is ubiquitinated. Interestingly, the replacement of lysine 282 with alanine impaired Atg32 degradation only partially in the course of cell growth, suggesting that additional lysine residues on Atg32 might also be ubiquitinated. Our results provide the foundation to further elucidate the physiological significance of Atg32 turnover and the interplay between mitophagy and the proteasome.	[Camougrand, Nadine; Vigie, Pierre; Gonzalez, Cecile; Manon, Stephen] CNRS, Bordeaux, France; [Camougrand, Nadine; Vigie, Pierre; Gonzalez, Cecile; Manon, Stephen] Univ Bordeaux, IBGC, UMR5095, Bordeaux, France; [Bhatia-Kissova, Ingrid] Comenius Univ, Fac Nat Sci, Dept Biochem, Bratislava, Slovakia; [Gonzalez, Cecile] Univ Lyon, IBCP, UMR5086, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Comenius University Bratislava; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Camougrand, N (corresponding author), CNRS, Bordeaux, France.; Camougrand, N (corresponding author), Univ Bordeaux, IBGC, UMR5095, Bordeaux, France.	n.camougrand@ibgc.cnrs.fr			Slovak APVV agency [SK-FR-20150005]; CNRS; University of Bordeaux; Agence Nationale pour la Recherche [ANR-10-IDEX-03-02]; Campus France (Stefanik) [35809VC]	Slovak APVV agency(Slovak Research and Development Agency); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Campus France (Stefanik)	IBK: Slovak APVV agency (SK-FR-20150005) NC and PV: CNRS, the University of Bordeaux and the Doctoral International Program from IDEX of Bordeaux supported by Agence Nationale pour la Recherche (ANR-10-IDEX-03-02) NC and IBK: France/Slovakia collaboration was supported by Campus France (Stefanik no 35809VC) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Arselin G, 1996, J BIOL CHEM, V271, P20284, DOI 10.1074/jbc.271.34.20284; Becuwe M, 2012, J CELL BIOL, V196, P247, DOI 10.1083/jcb.201109113; Belgareh-Touze N, 2017, AUTOPHAGY, V13, P114, DOI 10.1080/15548627.2016.1252889; Braun RJ, 2017, TRENDS CELL BIOL, V27, P441, DOI 10.1016/j.tcb.2017.02.007; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen G, 2014, MOL CELL, V54, P362, DOI 10.1016/j.molcel.2014.02.034; Chen ZH, 2017, EMBO REP, V18, P495, DOI 10.15252/embr.201643309; Cohen MMJ, 2008, MOL BIOL CELL, V19, P2457, DOI 10.1091/mbc.E08-02-0227; Deffieu M, 2009, J BIOL CHEM, V284, P14828, DOI 10.1074/jbc.M109.005181; Eiyama A, 2015, J BIOL CHEM, V290, P25034, DOI 10.1074/jbc.M115.677468; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Hu GH, 2020, BIOCHEM BIOPH RES CO, V522, P254, DOI 10.1016/j.bbrc.2019.11.089; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kondo-Okamoto N, 2012, J BIOL CHEM, V287, P10631, DOI 10.1074/jbc.M111.299917; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lemasters JJ, 2014, REDOX BIOL, V2, P749, DOI 10.1016/j.redox.2014.06.004; Levchenko M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168518; Liu CC, 2016, MOL CELL, V61, P84, DOI 10.1016/j.molcel.2015.11.001; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Sakakibara K, 2015, EMBO J, V34, P2703, DOI 10.15252/embj.201591440; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Velours J, 2000, BBA-BIOENERGETICS, V1458, P443, DOI 10.1016/S0005-2728(00)00093-1; Vigie P, 2019, J CELL SCI, V132, DOI 10.1242/jcs.221655; Wang K, 2013, AUTOPHAGY, V9, P1828, DOI 10.4161/auto.26281; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Yonashiro R, 2006, EMBO J, V25, P3618, DOI 10.1038/sj.emboj.7601249; Zhang BC, 2008, CELL RES, V18, P900, DOI 10.1038/cr.2008.75	38	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0241576	10.1371/journal.pone.0241576	http://dx.doi.org/10.1371/journal.pone.0241576			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362225	Green Published, gold			2022-12-27	WOS:000603071600028
J	Kim, HS; Lee, JH; Yoo, SH				Kim, Hyoung-Sukh; Lee, Jin-Hwa; Yoo, So-Hyeon			Is consumer neural response to visual merchandising types different depending on their fashion involvement?	PLOS ONE			English	Article							PREFRONTAL CORTEX; PROCESSING FLUENCY; WORKING-MEMORY; SPECTROSCOPY; BEHAVIOR	This study investigated consumers' responses to fashion visual merchandising (VM) from a neuroscientific perspective. The brain activations of 20 subjects differently involved in fashion were recorded using functional near-infrared spectroscopy in response to three different fashion VM types. According to the types of fashion VM, significant differences were observed, which were significantly higher for the creative VM. Moreover, highly fashion-involved subjects showed activation of the orbital frontal cortex region in response to the creative VM. Based on these results, it is suggested that marketing strategies should be devised explicitly for the brand's targeted audience and goals.	[Kim, Hyoung-Sukh] Dongseo Univ, Coll Design, Busan, South Korea; [Lee, Jin-Hwa] Pusan Natl Univ, Coll Human Ecol, Dept Clothing & Text, Busan, South Korea; [Yoo, So-Hyeon] Pusan Natl Univ, Sch Mech Engn, Busan, South Korea	Dongseo University; Pusan National University; Pusan National University	Lee, JH (corresponding author), Pusan Natl Univ, Coll Human Ecol, Dept Clothing & Text, Busan, South Korea.	onleejh@pusan.ac.kr						ANDREWS JC, 1990, J ADVERTISING, V19, P27, DOI 10.1080/00913367.1990.10673198; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2015, COMPARAISON, V1, P61; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bell J., 2006, SILENT SELLING BEST; Cant M. C., 2012, J APPL BUSINESS RES, V28, P1489; CELSI RL, 1988, J CONSUM RES, V15, P210, DOI 10.1086/209158; Chebat JC, 2003, J BUS RES, V56, P529, DOI 10.1016/S0148-2963(01)00247-8; Cho Kakhyun, 2012, [Journal of Communication Design, 커뮤니케이션디자인학연구], V39, P43; Choo HJ, 2014, INT J CONSUM STUD, V38, P175, DOI 10.1111/ijcs.12078; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Cornelius B, 2010, J RETAIL CONSUM SERV, V17, P143, DOI 10.1016/j.jretconser.2009.11.004; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Curtis E, 2004, FASHION RETAIL INTER, VFirst; D'Esposito M, 1999, BRAIN COGNITION, V41, P66, DOI 10.1006/brcg.1999.1096; Dijksterhuis A, 2001, ADV EXP SOC PSYCHOL, V33, P1, DOI 10.1016/S0065-2601(01)80003-4; Dijksterhuis A, 2007, SOCIAL PSYCHOL UNCON; DONOVAN RJ, 1982, J RETAILING, V58, P34; Ebster C, 2011, STORE DESIGN VISUAL, DOI 10.41289781606490952; Ferguson MJ, 2004, J PERS SOC PSYCHOL, V87, P557, DOI 10.1037/0022-3514.87.5.557; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Gabrieli JDE, 2015, NEURON, V85, P11, DOI 10.1016/j.neuron.2014.10.047; Gardner R.C., 1985, SOCIAL PSYCHOL 2 LAN; Go GS, 2017, HCI SOC KOR C; Goldsmith R. E., 1993, PSYCHOL MARKETING, V10, P399, DOI [10.1002/mar.4220100504, DOI 10.1002/MAR.4220100504]; Goldsmith R. E., 1999, J FASHION MARKETING, V3, P337; Gordon ME, 1998, PSYCHOL MARKET, V15, P443, DOI 10.1002/(SICI)1520-6793(199808)15:5<443::AID-MAR3>3.0.CO;2-7; Gramann K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00444; Nguyen HD, 2018, BIOMED ENG ONLINE, V17, DOI 10.1186/s12938-018-0613-2; Hong KS, 2018, FRONT NEUROROBOTICS, V12, DOI 10.3389/fnbot.2018.00069; Hong KS, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00246; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Oh H, 2012, J RETAIL CONSUM SERV, V19, P27, DOI 10.1016/j.jretconser.2011.08.003; 박현희, 2007, [Journal of Marketing Management Research, 마케팅관리연구], V12, P55; jung Lee ho, 2014, [Fashion & Textile Research Journal, 한국의류산업학회지], V16, P580; Karmarkar UR, 2016, CURR OPIN PSYCHOL, V10, P160, DOI 10.1016/j.copsyc.2016.01.010; Karmarkar UR, 2015, HARVARD BUSINESS REV; Khan MJ, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00479; Kida T, 2013, NEUROSCI RES, V76, P76, DOI 10.1016/j.neures.2013.03.006; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Kwon HS, 2006, J FASHION BUSINESS, V10, P93; Lee EY, 1997, FASHION MARKETING; Lee S., 2015, THESIS; Lim GC, 2016, YONHAP NEWS; Lim HN., 2014, THESIS; Martin N, 2011, J BRAND MANAG, V18, P483, DOI 10.1057/bm.2011.10; Mehta N., 2013, UNIVERSAL J MANAGEME, V1, P76; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Naderi I, 2013, INT J CONSUM STUD, V37, P84, DOI 10.1111/j.1470-6431.2011.01041.x; Naseer N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00172; O'Cass A., 2004, EUR J MARKETING, V38, P869, DOI DOI 10.1108/03090560410539294; Oh S, 2009, THESIS; Orth UR, 2014, J SERV RES-US, V17, P296, DOI 10.1177/1094670514529606; PARK Hyun Hee, 2011, AP ASIA PACIFIC ADV, V9, P134; Petrides M, 1998, PREFRONTAL CORTEX EX, P103; Pinti P, 2015, JOVE-J VIS EXP, DOI 10.3791/53336; Plassmann H, 2015, CAMBRIDGE HDB CONSUM; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Richins ML, 1997, J CONSUM RES, V24, P127, DOI 10.1086/209499; Sato H, 2013, NEUROIMAGE, V83, P158, DOI 10.1016/j.neuroimage.2013.06.043; Shallice T, 1993, ATTENTION SELECTION, P171; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Singh M., 2015, INT J SCI TECHNOLOGY, V4, P150; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Suk Kim Hyoung, 2017, [Journal of the Korean Society of Clothing and Textiles, 한국의류학회지], V41, P254; Suk Kim Hyoung, 2017, [Journal of Fashion Design, 한국패션디자인학회지], V17, P49, DOI 10.18652/2017.17.4.4; Sul JH., 2011, THESIS; SWINYARD WR, 1993, J CONSUM RES, V20, P271, DOI 10.1086/209348; Touchette B, 2017, CLOTH TEXT RES J, V35, P3, DOI 10.1177/0887302X16673157; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; VITZ PC, 1966, BEHAV SCI, V11, P105, DOI 10.1002/bs.3830110204; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wegner D. M., 1998, HDB SOCIAL PSYCHOL, P446; Wheeler SC, 2001, PSYCHOL BULL, V127, P797, DOI 10.1037//0033-2909.127.6.797; Wright LT, 2006, EUR J MARKETING, V40, P925, DOI 10.1108/03090560610680934; Zafar A, 2018, INT J NEURAL SYST, V28, DOI 10.1142/S0129065718500314; 박지영, 2010, [Journal of the Korean Society of Clothing and Textiles, 한국의류학회지], V34, P40	77	3	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0241578	10.1371/journal.pone.0241578	http://dx.doi.org/10.1371/journal.pone.0241578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362255	Green Published, gold			2022-12-27	WOS:000603071600026
J	Peixoto, MA; Alves, RS; Coelho, IF; Evangelista, JSPC; de Resende, MDV; Rocha, JRDSD; Silva, FFE; Laviola, BG; Bhering, LL				Peixoto, Marco Antonio; Alves, Rodrigo Silva; Coelho, Igor Ferreira; Evangelista, Jeniffer Santana Pinto Coelho; de Resende, Marcos Deon Vilela; Rocha, Joao Romero do Amaral Santos de Carvalho; Silva, Fabyano Fonseca; Laviola, Bruno Galveas; Bhering, Leonardo Lopes			Random regression for modeling yield genetic trajectories in Jatropha curcas breeding	PLOS ONE			English	Article							SELECTION; STABILITY; INCREASE; BIOFUEL; OIL; L.	Random regression models (RRM) are a powerful tool to evaluate genotypic plasticity over time. However, to date, RRM remains unexplored for the analysis of repeated measures in Jatropha curcas breeding. Thus, the present work aimed to apply the random regression technique and study its possibilities for the analysis of repeated measures in Jatropha curcas breeding. To this end, the grain yield (GY) trait of 730 individuals of 73 half-sib families was evaluated over six years. Variance components were estimated by restricted maximum likelihood, genetic values were predicted by best linear unbiased prediction and RRM were fitted through Legendre polynomials. The best RRM was selected by Bayesian information criterion. According to the likelihood ratio test, there was genetic variability among the Jatropha curcas progenies; also, the plot and permanent environmental effects were statistically significant. The variance components and heritability estimates increased over time. Non-uniform trajectories were estimated for each progeny throughout the measures, and the area under the trajectories distinguished the progenies with higher performance. High accuracies were found for GY in all harvests, which indicates the high reliability of the results. Moderate to strong genetic correlation was observed across pairs of harvests. The genetic trajectories indicated the existence of genotype x measurement interaction, once the trajectories crossed, which implies a different ranking in each year. Our results suggest that RRM can be efficiently applied for genetic selection in Jatropha curcas breeding programs.	[Peixoto, Marco Antonio; Coelho, Igor Ferreira; Evangelista, Jeniffer Santana Pinto Coelho; Rocha, Joao Romero do Amaral Santos de Carvalho; Silva, Fabyano Fonseca; Bhering, Leonardo Lopes] Univ Fed Vicosa, Vicosa, MG, Brazil; [Alves, Rodrigo Silva] Univ Fed Vicosa, INCT Cafe, Vicosa, MG, Brazil; [de Resende, Marcos Deon Vilela] Univ Fed Vicosa, Embrapa Cafe, Vicosa, MG, Brazil; [Laviola, Bruno Galveas] Embrapa Agroenergia, Brasilia, DF, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Bhering, LL (corresponding author), Univ Fed Vicosa, Vicosa, MG, Brazil.	leonardo.bhering@ufv.br		Bhering, Leonardo/0000-0002-6072-0996; Peixoto, Marco Antonio/0000-0003-0564-7068				Alves RS, 2020, BRAGANTIA, V79, P360, DOI [10.1590/1678-4499.20200125, 10.1590/1678-4499.20200125.]; Alves RS, 2020, TREE GENET GENOMES, V16, DOI 10.1007/s11295-020-01431-5; Alves RS, 2019, IND CROP PROD, V130, P558, DOI 10.1016/j.indcrop.2018.12.019; Alves RS, 2018, IND CROP PROD, V119, P290, DOI 10.1016/j.indcrop.2018.04.029; [Anonymous], 2007, PESQUI AGROPECUARIA, DOI DOI 10.5216/PAT.V37I3.1867; Berchmans HJ, 2008, BIORESOURCE TECHNOL, V99, P1716, DOI 10.1016/j.biortech.2007.03.051; Bhering LL, 2013, IND CROP PROD, V41, P260, DOI 10.1016/j.indcrop.2012.04.026; Carels N., 2013, JATROPHA CHALLENGES, P263, DOI [10.1007/978-1-4614-4915-7_14, DOI 10.1007/978-1-4614-4915-7_14]; Gilmour A. R., 2015, ASREML USER GUIDE RE; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Iglesias Domingo J., 2007, Braz. J. Plant Physiol., V19, P333, DOI 10.1590/S1677-04202007000400006; Junqueira VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157038; KIRKPATRICK M, 1990, GENETICS, V124, P979; Laviola BG, 2019, EMBRAPA AGROENERGIA, V1, P420; Laviola BG, 2018, IND CROP PROD, V117, P216, DOI 10.1016/j.indcrop.2018.03.003; Laviola BG, 2013, IND CROP PROD, V51, P70, DOI 10.1016/j.indcrop.2013.08.016; Marchal A., 2019, PLANT GENOME-US, V13, P281, DOI [10.1017/S0021859605005587, DOI 10.1017/S0021859605005587]; Marchal A, 2019, G3-GENES GENOM GENET, V9, P21, DOI 10.1534/g3.118.200697; Meyer K, 2004, LIVEST PROD SCI, V86, P69, DOI 10.1016/S0301-6226(03)00142-8; Morrissey MB, 2016, EVOLUTION, V70, P1944, DOI 10.1111/evo.13003; Mota RR, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-015-0178-5; Nithiyanantham S, 2012, J AM OIL CHEM SOC, V89, P961, DOI 10.1007/s11746-012-2012-3; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Peixoto LD, 2016, IND CROP PROD, V80, P70, DOI 10.1016/j.indcrop.2015.10.034; Peixoto MA, 2020, AGRON J, DOI [10.1002/agj2.20344, DOI 10.1002/AGJ2.20344]; Pu Y, 2011, BIORESOURCES, V6, P4856; R Development Core Team, 2020, R LANGUAGE ENV STAT; RESENDE M. D. V., 2014, ESTATISTICA MATEMATI; Resende M.D.V, 2015, GENETICA QUANTITATIV, P463; RESENDE M.D.V. de, 2002, GENETICA BIOMETRICA; Resende MDV, 2001, ESTIMATIVAS PARAMETR; Riday H, 2006, CROP SCI, V46, P1058, DOI 10.2135/cropsci2005.0272; Rosado TB, 2010, CROP SCI, V50, P2372, DOI 10.2135/cropsci2010.02.0112; Rocha JRDSD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203818; Schaeffer LR, 2016, RANDOM REGRESSION MO, P171, DOI DOI 10.1016/J.FORSCIINT.2016.12.027; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Wilkins PW, 2003, J AGR SCI-CAMBRIDGE, V140, P129, DOI 10.1017/S0021859603003058; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244021	10.1371/journal.pone.0244021	http://dx.doi.org/10.1371/journal.pone.0244021			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362265	Green Published, gold			2022-12-27	WOS:000603071600067
J	Stessel, B; Nijs, K; Pelckmans, C; Vandenbrande, J; Ory, JP; Yilmaz, A; Starinieri, P; Van Tornout, M; De Klippel, N; Dendale, P				Stessel, Bjorn; Nijs, Kristof; Pelckmans, Caroline; Vandenbrande, Jeroen; Ory, Jean-Paul; Yilmaz, Alaaddin; Starinieri, Pascal; Van Tornout, Michiel; De Klippel, Nina; Dendale, Paul			Neurological outcome after minimally invasive coronary artery bypass surgery (NOMICS): An observational prospective cohort study	PLOS ONE			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; QUALITY-OF-LIFE; CARDIAC-SURGERY; ON-PUMP; STROKE; IMPACT	Background/Objectives Endoscopic coronary artery bypass grafting (Endo-CABG) is a minimally invasive CABG procedure with retrograde arterial perfusion. The main objective of this study is to assess neurocognitive outcome after Endo-CABG. Methods/Design In this prospective observational cohort study, patients were categorised into: Endo-CABG (n = 60), a comparative Percutaneous Coronary Intervention (PCI) group (n = 60) and a healthy volunteer group (n = 60). A clinical neurological examination was performed both pre- and postoperatively, delirium was assessed postoperatively. A battery of 6 neurocognitive tests, Quality of life (QoL) and the level of depressive feelings were measured at baseline and after 3 months. Patient Satisfaction after Endo-CABG was assessed at 3-month follow-up. Primary endpoints were incidence of postoperative cognitive dysfunction (POCD), stroke and delirium after Endo-CABG. Secondary endpoints were QOL, patient satisfaction and the incidence of depressive feelings after Endo-CABG. Results In total, 1 patient after Endo-CABG (1.72%) and 1 patient after PCI (1.67%) suffered from stroke during the 3-month follow-up. POCD in a patient is defined as a Reliable Change Index <=-1.645 or Z-score <=-1.645 in at least two tests, and was found in respectively 5 and 6 patients 3 months after Endo-CABG and PCI. Total incidence of POCD/stroke was not different (PCI: n= 7 [15.9%]; Endo-CABG: n= 6 [13.0%], p = 0.732). ICU delirium after Endo-CABG was found in 5 (8.6%) patients. QoL increased significantly three months after Endo-CABG and was comparable with QoL level after PCI and in the control group. Patient satisfaction after Endo-CABG and PCI was comparable. At follow-up, the level of depressive feelings was decreased in all groups. Conclusions The incidence of poor neurocognitive outcome, including stroke, POCD and postoperative ICU delirium until three months after Endo-CABG is low and comparable with PCI.	[Stessel, Bjorn; Nijs, Kristof; Pelckmans, Caroline; Vandenbrande, Jeroen; Ory, Jean-Paul; Van Tornout, Michiel] Jessa Hosp, Dept Anesthesiol & Pain Med, Hasselt, Belgium; [Stessel, Bjorn; Dendale, Paul] Hasselt Univ, LCRC, Fac Med & Life Sci, Diepenbeek, Belgium; [Nijs, Kristof] Univ Hosp, Dept Anaesthesiol & Pain Med, Leuven, Belgium; [Yilmaz, Alaaddin; Starinieri, Pascal] Jessa Hosp, Dept Cardiothorac Surg, Hasselt, Belgium; [De Klippel, Nina] Jessa Hosp, Dept Neurol, Hasselt, Belgium; [Dendale, Paul] Jessa Hosp, Dept Cardiol, Hasselt, Belgium	Hasselt University	Stessel, B (corresponding author), Jessa Hosp, Dept Anesthesiol & Pain Med, Hasselt, Belgium.; Stessel, B (corresponding author), Hasselt Univ, LCRC, Fac Med & Life Sci, Diepenbeek, Belgium.	bjornstessel@hotmail.com		Stessel, Bjorn/0000-0002-1422-2777				Baker RA, 2005, ANN THORAC SURG, V80, P1746, DOI 10.1016/j.athoracsur.2005.04.059; Bonaros N, 2009, CARDIOLOGY, V114, P59, DOI 10.1159/000212115; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Deiner S, 2009, Br J Anaesth, V103 Suppl 1, pi41, DOI 10.1093/bja/aep291; Eefting F, 2003, CIRCULATION, V108, P2870, DOI 10.1161/01.CIR.0000100723.50363.2C; Floyd TF, 2006, ANN THORAC SURG, V81, P2160, DOI 10.1016/j.athoracsur.2006.01.080; Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407; Hernandez F, 2007, ANN THORAC SURG, V84, P1897, DOI 10.1016/j.athoracsur.2007.07.036; Kalkman DN, 2018, EUR HEART J, V39, P4101, DOI 10.1093/eurheartj/ehy633; Kok WF, 2017, ANAESTHESIA, V72, P359, DOI 10.1111/anae.13712; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; Liu Y, 2019, CURR OPIN ANESTHESIO, V32, P563, DOI 10.1097/ACO.0000000000000755; Modi P, 2013, ANN CARDIOTHORAC SUR, V2, DOI 10.3978/j.issn.2225-319X.2013.11.13; Mulhern B, 2018, PHARMACOECONOMICS, V36, P699, DOI 10.1007/s40273-018-0628-3; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Murkin JM, 2010, SEMIN CARDIOTHORAC V, V14, P190, DOI 10.1177/1089253210378177; Newman MF, 2001, STROKE, V32, P2874, DOI 10.1161/hs1201.099803; Nijs K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017823; Peric V, 2015, ANN THORAC CARDIOVAS, V21, P474, DOI 10.5761/atcs.oa.15-00041; Rudolph JL, 2010, ACTA ANAESTH SCAND, V54, P663, DOI 10.1111/j.1399-6576.2010.02236.x; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Stamou SC, 2006, STROKE, V37, P284, DOI 10.1161/01.STR.0000199048.87363.aa; Sun LY, 2018, ANESTHESIOLOGY, V129, P440, DOI 10.1097/ALN.0000000000002298; Sweet JJ, 2008, ANN THORAC SURG, V85, P1571, DOI 10.1016/j.athoracsur.2008.01.090; Theunissen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100225; Toeg HD, 2013, J THORAC CARDIOV SUR, V145, P1545, DOI 10.1016/j.jtcvs.2013.02.061; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x; Vedel AG, 2018, CIRCULATION, V137, P1770, DOI 10.1161/CIRCULATIONAHA.117.030308; Versteegh MM, 2016, VALUE HEALTH, V19, P343, DOI 10.1016/j.jval.2016.01.003; Yilmaz A, 2020, J CARDIOL, V75, P614, DOI 10.1016/j.jjcc.2019.11.007	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242519	10.1371/journal.pone.0242519	http://dx.doi.org/10.1371/journal.pone.0242519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362277	Green Published, gold			2022-12-27	WOS:000603071600072
J	Linassi, F; Kreuzer, M; Maran, E; Farnia, A; Zanatta, P; Navalesi, P; Carron, M				Linassi, Federico; Kreuzer, Matthias; Maran, Eleonora; Farnia, Antonio; Zanatta, Paolo; Navalesi, Paolo; Carron, Michele			Age influences on Propofol estimated brain concentration and entropy during maintenance and at return of consciousness during total intravenous anesthesia with target-controlled infusion in unparalyzed patients: An observational prospective trial	PLOS ONE			English	Article							FACTORS AFFECTING RECOVERY; POSTOPERATIVE DELIRIUM; BURST-SUPPRESSION; REMIFENTANIL; ELECTROENCEPHALOGRAM; PHARMACOKINETICS; INDEX; PHARMACODYNAMICS; AWARENESS; STIMULI	Purpose Aging affects pharmacodynamics/pharmacokinetics of anesthetics, but age effects on Entropy-guided total intravenous anesthesia with target-controlled infusions (TIVA-TCI) are not fully characterized. We compared aging effects on effective estimated brain concentration of Propofol (CeP) during TIVA-TCI Entropy-guided anesthesia, without neuromuscular blockade (NMB). Methods We performed an observational, prospective, single-center study enrolling 75 adult women undergoing Entropy-guided Propofol-Remifentanil TIVA-TCI for breast surgery. Primary endpoint was the relationship between age and CeP at maintenance of anesthesia (MA) during Entropy-guided anesthesia. Secondary endpoints were relationships between age and CeP at arousal reaction (AR), return of consciousness (ROC) and explicit recall evenience. We calculated a linear model to evaluate the age's impact on observational variable and performed pairwise tests to compare old (>= 65 years, n = 50) and young (<65 years, n = 25) patients or patients with and without an AR. Results We did not observe age-related differences in CeP during MA, but CeP significantly (p = 0,01) decreased with age at ROC. Entropy values during MA increased with age and were significantly higher in the elderly (RE: median 56[IQR49.3-61] vs 47.5[42-52.5],p = 0.001; SE: 51.6[45-55.5] vs 44[IQR40-50],p = 0.005). 18 patients had an AR, having higher maximum RE (92.5[78-96.3] vs 65[56.5-80.5],p<0.001), SE (79[64.8-84] vs 61[52.5-69],p = 0.03, RE-SE (12.5[9.5-16.5] vs 6 [3-9],pConclusion Older age was associated with lower CeP at ROC, but not during MA in unparalysed patients undergoing breast surgery. Although RE and SE during MA, at comparable CeP, were higher in the elderly, Entropy, and in particular an increasing RE-SE, is a reliable index to detect an AR.	[Linassi, Federico; Maran, Eleonora; Navalesi, Paolo; Carron, Michele] Univ Padua, Sect Anesthesiol & Intens Care, Dept Med DIMED, Padua, Italy; [Linassi, Federico; Kreuzer, Matthias] Tech Univ Munich, Klinikum Rechts Isar, Sch Med, Dept Anesthesiol & Intens Care, Munich, Germany; [Farnia, Antonio] Piazzale Osped, Treviso Reg Hosp, Dept Anesthesia & Intens Care, Treviso, Italy; [Zanatta, Paolo] Integrated Univ Hosp Verona, Dept Anesthesia & Intens Care, Piazzale Aristide Stefani, Verona, Italy	University of Padua; Technical University of Munich; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Linassi, F (corresponding author), Univ Padua, Sect Anesthesiol & Intens Care, Dept Med DIMED, Padua, Italy.; Linassi, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Sch Med, Dept Anesthesiol & Intens Care, Munich, Germany.	federico.linassi@gmail.com	Kreuzer, Matthias/AAX-6501-2021; Navalesi, Paolo/F-9559-2010	Navalesi, Paolo/0000-0002-3733-3453; Linassi, Federico/0000-0003-0751-1164				Absalom AR, 2014, BRIT J ANAESTH, V113, P527, DOI 10.1093/bja/aeu349; Aho AJ, 2009, BRIT J ANAESTH, V102, P227, DOI 10.1093/bja/aen356; Al-Rifai Z, 2016, BJA EDUC, V16, P276, DOI 10.1093/bjaed/mkv074; Bergmann I, 2013, BRIT J ANAESTH, V110, P622, DOI 10.1093/bja/aes426; Brandon R, 2015, SCAND J MED SCI SPOR, V25, P630, DOI 10.1111/sms.12289; Chan MTV, 2013, J NEUROSURG ANESTH, V25, P33, DOI 10.1097/ANA.0b013e3182712fba; Fritz BA, 2016, ANESTH ANALG, V122, P234, DOI 10.1213/ANE.0000000000000989; Hart SM, 2009, ANAESTH INTENS CARE, V37, P1002, DOI 10.1177/0310057X0903700619; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Koo BN, 2012, ACTA PHARMACOL SIN, V33, P1080, DOI 10.1038/aps.2012.85; Kreuzer M, 2020, ANESTHESIOLOGY, V132, P1003, DOI 10.1097/ALN.0000000000003182; LANIER WL, 1994, ANESTHESIOLOGY, V80, P392, DOI 10.1097/00000542-199402000-00019; Ledowski T, 2016, BRIT J ANAESTH, V117, P371, DOI 10.1093/bja/aew226; Linassi F, 2018, BRIT J ANAESTH, V121, P198, DOI 10.1016/j.bja.2018.02.019; Liu SH, 2017, J INT MED RES, V45, P1007, DOI 10.1177/0300060517705539; Minto CF, 1997, ANESTHESIOLOGY, V86, P10, DOI 10.1097/00000542-199701000-00004; Minto CF, 1997, ANESTHESIOLOGY, V86, P24, DOI 10.1097/00000542-199701000-00005; Muhlhofer WG, 2017, BRIT J ANAESTH, V118, P755, DOI 10.1093/bja/aex054; Ni K, 2019, BRIT J ANAESTH, V123, P288, DOI 10.1016/j.bja.2019.05.040; Ouattara A, 2003, BRIT J ANAESTH, V90, P617, DOI 10.1093/bja/aeg124; Pollard RJ, 2007, ANESTHESIOLOGY, V106, P269, DOI 10.1097/00000542-200702000-00014; Purdon PL, 2015, BRIT J ANAESTH, V115, P46, DOI 10.1093/bja/aev213; Sanders RD, 2018, BRIT J ANAESTH, V121, P191, DOI 10.1016/j.bja.2018.03.019; Sanders RD, 2012, ANESTHESIOLOGY, V116, P946, DOI 10.1097/ALN.0b013e318249d0a7; Schnider TW, 1998, ANESTHESIOLOGY, V88, P1170, DOI 10.1097/00000542-199805000-00006; Schnider TW, 1999, ANESTHESIOLOGY, V90, P1502, DOI 10.1097/00000542-199906000-00003; Schults A, 2004, ACETA ANESTHESIOL SC, V58, P27; Shortal BP, 2019, BRIT J ANAESTH, V123, P206, DOI 10.1016/j.bja.2019.03.046; Soehle M, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0051-7; Struys MMRF, 2007, BRIT J ANAESTH, V99, P359, DOI 10.1093/bja/aem173; Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x; Wang M, 2012, ANAESTHESIA, V67, P1197, DOI 10.1111/anae.12041; Wildes TS, 2019, JAMA-J AM MED ASSOC, V321, P2471, DOI 10.1001/jama.2019.5161	33	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244145	10.1371/journal.pone.0244145	http://dx.doi.org/10.1371/journal.pone.0244145			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351856	Green Published, gold			2022-12-27	WOS:000603071400052
J	Adhyapok, P; Fu, X; Sluka, JP; Clendenon, SG; Sluka, VD; Wang, ZM; Dunn, K; Klaunig, JE; Glazier, JA				Adhyapok, Priyom; Fu, Xiao; Sluka, James P.; Clendenon, Sherry G.; Sluka, Victoria D.; Wang, Zemin; Dunn, Kenneth; Klaunig, James E.; Glazier, James A.			A computational model of liver tissue damage and repair	PLOS ONE			English	Article							INDUCED HEPATIC-NECROSIS; CELLULAR-AUTOMATON MODEL; IMMUNOHISTOCHEMICAL LOCALIZATION; CONTACT INHIBITION; ACETAMINOPHEN; PROTEIN; FAILURE; INJURY; QUANTIFICATION; HEPATOTOXICITY	Drug induced liver injury (DILI) and cell death can result from oxidative stress in hepatocytes. An initial pattern of centrilobular damage in the APAP model of DILI is amplified by communication from stressed cells and immune system activation. While hepatocyte proliferation counters cell loss, high doses are still lethal to the tissue. To understand the progression of disease from the initial damage to tissue recovery or death, we computationally model the competing biological processes of hepatocyte proliferation, necrosis and injury propagation. We parametrize timescales of proliferation (alpha), conversion of healthy to stressed cells (beta) and further sensitization of stressed cells towards necrotic pathways (gamma) and model them on a Cellular Automaton (CA) based grid of lattice sites. 1D simulations show that a small alpha/beta (fast proliferation), combined with a large gamma/beta (slow death) have the lowest probabilities of tissue survival. At large alpha/beta, tissue fate can be described by a critical gamma/beta* ratio alone; this value is dependent on the initial amount of damage and proportional to the tissue size N. Additionally, the 1D model predicts a minimum healthy population size below which damage is irreversible. Finally, we compare 1D and 2D phase spaces and discuss outcomes of bistability where either survival or death is possible, and of coexistence where simulated tissue never completely recovers or dies but persists as a mixture of healthy, stressed and necrotic cells. In conclusion, our model sheds light on the evolution of tissue damage or recovery and predicts potential for divergent fates given different rates of proliferation, necrosis, and injury propagation.	[Adhyapok, Priyom; Sluka, James P.; Clendenon, Sherry G.; Sluka, Victoria D.; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA; [Adhyapok, Priyom] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Fu, Xiao] Francis Crick Inst, London, England; [Sluka, James P.; Clendenon, Sherry G.; Glazier, James A.] Indiana Univ, Dept Intelligent Syst Engn, Bloomington, IN USA; [Wang, Zemin; Klaunig, James E.] Indiana Univ, Sch Publ Hlth, Bloomington, IN USA; [Dunn, Kenneth] Indiana Univ, Sch Med, Indianapolis, IN USA; [Sluka, Victoria D.] UCL, Inst Archaeol, London, England; [Wang, Zemin] US FDA, Washington, DC 20204 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Francis Crick Institute; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; University of London; University College London; US Food & Drug Administration (FDA)	Adhyapok, P (corresponding author), Indiana Univ, Biocomplex Inst, Bloomington, IN 47405 USA.; Adhyapok, P (corresponding author), Indiana Univ, Dept Phys, Bloomington, IN 47405 USA.	priyom.adhyapok@gmail.com	Sluka, James P/AAL-9294-2021	Sluka, James P/0000-0002-5901-1404; Klaunig, James/0000-0002-4736-2223; Glazier, James Alexander/0000-0003-3634-190X; Wang, Zemin/0000-0003-4189-578X; Fu, Xiao/0000-0002-8611-891X; Adhyapok, Priyom/0000-0003-3067-7058	National Institute of Health; NIH [U01 GM111243, R01 GM122424, U24 EB028887]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health (www.nih.gov) grants; NIH U01 GM111243 Development of a Multiscale Mechanistic Simulation of Acetaminophen Induced Liver Damage funded JPS, SGC, VDS, ZW, KD, JEK, JAG; NIH R01 GM122424 Competitive Renewal of Development, Improvement and Extension of the Tissue Simulation Environment -CompuCell3D funded JPS, JAG; and NIH U24 EB028887 Dissemination of libRoadRunner and CompuCell3D funded JPS, JAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERMAN P, 1992, AM J PHYSIOL, V263, pG579, DOI 10.1152/ajpgi.1992.263.4.G579; Antoine DJ, 2009, TOXICOL SCI, V112, P521, DOI 10.1093/toxsci/kfp235; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Baratta JL, 2009, HISTOCHEM CELL BIOL, V131, P713, DOI 10.1007/s00418-009-0577-1; BARTOLONE JB, 1989, FUND APPL TOXICOL, V13, P859, DOI 10.1016/0272-0590(89)90339-4; Bartolozzi M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046112; Blackmore L, 2015, CLIN MED, V15, P468, DOI 10.7861/clinmedicine.15-5-468; BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125; Clendenon SG, 2011, MICROSC MICROANAL, V17, P614, DOI 10.1017/S1431927611000535; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Dunn KW, 2020, TOXICOLOGY, V439, DOI 10.1016/j.tox.2020.152464; El-Benna J, 2005, ARCH IMMUNOL THER EX, V53, P199; Encinas LH, 2007, APPL MATH MODEL, V31, P1213, DOI 10.1016/j.apm.2006.04.001; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; Fu GB, 2019, CELL RES, V29, P8, DOI 10.1038/s41422-018-0103-x; Fu X, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198060; Gekle S, 2005, EUR PHYS J B, V45, P569, DOI 10.1140/epjb/e2005-00215-3; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Jaeschke H, 2006, HEPATOLOGY, V43, P1191, DOI 10.1002/hep.21246; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jaeschke H, 2015, DIGEST DIS, V33, P464, DOI 10.1159/000374090; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Kamp C, 2002, P ROY SOC B-BIOL SCI, V269, P2035, DOI 10.1098/rspb.2002.2095; Karafyllidis I, 1997, ECOL MODEL, V99, P87, DOI 10.1016/S0304-3800(96)01942-4; Kennedy RC, 2019, TOXICOL SCI, V169, P151, DOI 10.1093/toxsci/kfz029; Kerner BS, 2002, J PHYS A-MATH GEN, V35, P9971, DOI 10.1088/0305-4470/35/47/303; Klotz U, 2012, ARZNEIMITTELFORSCH, V62, P355, DOI 10.1055/s-0032-1321785; Krapivsky PL, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238701; Lawson JA, 2000, TOXICOL SCI, V54, P509, DOI 10.1093/toxsci/54.2.509; LEE Y, 1995, BIOPHYS J, V69, P1284, DOI 10.1016/S0006-3495(95)79996-9; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Machide M, 2006, J BIOL CHEM, V281, P8765, DOI 10.1074/jbc.M512298200; MEYERS LL, 1988, TOXICOL APPL PHARM, V93, P378, DOI 10.1016/0041-008X(88)90040-3; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8; Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618; Moore RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010794.pub2; Nourjah P, 2006, PHARMACOEPIDEM DR S, V15, P398, DOI 10.1002/pds.1191; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Patel SJ, 2012, NAT BIOTECHNOL, V30, P179, DOI 10.1038/nbt.2089; QI AS, 1993, J THEOR BIOL, V161, P1, DOI 10.1006/jtbi.1993.1035; Qiu YC, 2001, ADV EXP MED BIOL, V500, P663; ROBERTS DW, 1991, AM J PATHOL, V138, P359; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Saito C, 2014, SCI REP-UK, V4, DOI 10.1038/srep05169; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Shoda LKM, 2017, GENE REGUL SYST BIO, V11, DOI 10.1177/1177625017696074; Simpson MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021918; Sipahi R, 2018, J THEOR BIOL, V445, P151, DOI 10.1016/j.jtbi.2018.02.025; Streichan SJ, 2014, P NATL ACAD SCI USA, V111, P5586, DOI 10.1073/pnas.1323016111; TIRMENSTEIN MA, 1989, J BIOL CHEM, V264, P9814; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; van Ballegooijen WM, 2004, P NATL ACAD SCI USA, V101, P18246, DOI 10.1073/pnas.0405682101; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756	60	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243451	10.1371/journal.pone.0243451	http://dx.doi.org/10.1371/journal.pone.0243451			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347443	Green Published, gold			2022-12-27	WOS:000603071100053
J	Mineur, L; Francois, E; Plassot, C; Phelip, JM; Miglianico, L; Dourthe, LM; Bonichon, N; Moreau, L; Guimbaud, R; Smith, D; Achille, E; Herve, R; Bons, JM; Remy, S; Faroux, R; Villing, AL; Mahamat, A; Rabbia, I; Soulie, P; Baumgaertner, I; Mathe, N; Vazquez, L; Boustany, R				Mineur, L.; Francois, E.; Plassot, C.; Phelip, J. M.; Miglianico, L.; Dourthe, L. M.; Bonichon, N.; Moreau, L.; Guimbaud, R.; Smith, D.; Achille, E.; Herve, R.; Bons, J. M.; Remy, S.; Faroux, R.; Villing, A. L.; Mahamat, A.; Rabbia, I.; Soulie, P.; Baumgaertner, I.; Mathe, N.; Vazquez, L.; Boustany, R.			PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer	PLOS ONE			English	Article							PROGRESSION-FREE SURVIVAL; PRIMARY TUMOR; PLUS CETUXIMAB; END-POINT; FLUOROURACIL; LEUCOVORIN; CHEMOTHERAPY; PANITUMUMAB; OXALIPLATIN; TRIALS	Background Cetuximab improves progression-free survival (PFS) and overall survival (OS) in patients with KRAS wild type (wt) metastatic colorectal cancer (mCRC). Few data are available on factors impacting both efficacy and compliance to cetuximab treatment, which is, in combination with chemotherapy, a standard-of-care first-line treatment regimen for patients with KRAS wt mCRC. Patients and methods PREMIUM is a prospective, French multicenter, observational study that recruited patients with KRAS wt mCRC scheduled to receive cetuximab, with or without first-line chemotherapy, as part of routine clinical practice, between October 28, 2009 and April 5, 2012 (ClinicalTrials.gov Identifier: NCT01756625). The main endpoints were the factors impacting on efficacy and compliance to cetuximab treatment. Predefined efficacy endpoints were PFS and safety. Results A total of 493 patients were recruited by 94 physicians. Median follow-up was 12.9 months. Median progression-free survival was 11 months [9.6-12]. In univariate analyses, ECOG performance status (PS), smoking status, primary tumor location, number of metastatic organs, metastasis resectability, surgery, folliculitis, xerosis and paronychia maximum grade, and acne preventive treatment were statistically significant. In multivariate analysis (Hazard Ratios of multivariate stepwise Cox models), ECOG PS, surgery, xerosis and folliculitis were positive prognostics factors for longer PFS. Among all patients, 69 (14%) were non-compliant. In multivariate analysis, no variables were statistically significant. The safety profile of cetuximab was consistent with previous studies. Conclusions ECOG PS <2, surgical treatment performed, and maximum grade xerosis or folliculitis developed were predictive factors of cetuximab efficacy on KRAS wt mCRC patients. Unfortunately, we failed in identifying predictive factors for compliance in these patients.	[Mineur, L.; Vazquez, L.; Boustany, R.] Inst Sainte Catherine, Avignon, France; [Francois, E.] Lacassagne Anticanc Ctr, Nice, France; [Plassot, C.] Inst Univ Rech Clin, Montpellier, France; [Phelip, J. M.] CHU Nord St Etienne, Hop Univ, St Etienne, France; [Miglianico, L.] St Gregoire Hosp, St Gregoire, France; [Dourthe, L. M.] Strasbourg Oncol Liberale, Strasbourg, France; [Bonichon, N.] Clin TIVOLI, Bordeaux, France; [Moreau, L.] Clin Domes, Clermont Ferrand, France; [Guimbaud, R.] CHU Rangueil, Toulouse, France; [Smith, D.] Hop St Andre, Bordeaux, France; [Achille, E.] Clin Orangerie, Strasbourg, France; [Herve, R.] CH Prive Clairval, Marseille, France; [Bons, J. M.] Polyclin St Francois, Francois, France; [Remy, S.] Ctr Oncol Cote Basque, Bayonne, France; [Faroux, R.] CHD, La Roche Sur Yon, France; [Villing, A. L.] CH Auxerre, Auxerre, France; [Mahamat, A.] CHU Archet II, Nice, France; [Rabbia, I.] Cabinet Med, Paris, France; [Soulie, P.] CLCC Paul Papin, Angers, France; [Baumgaertner, I.] CH Henri Mondor, Creteil, France; [Mathe, N.] Ctr Clin Soyaux, Soyaux, France	Universite de Montpellier; CHU de St Etienne; CHU de Toulouse; CHU Bordeaux; CHD Vendee; CHU Nice; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Vazquez, L (corresponding author), Inst Sainte Catherine, Avignon, France.	lea.vazquez@hotmail.fr		HERVE, Bob/0000-0002-0346-077X	Merck Serono, France., an affiliate of Merck KGaA Darmstadt, Germany	Merck Serono, France., an affiliate of Merck KGaA Darmstadt, Germany	The PREMIUM study was funded by Merck Serono, France., an affiliate of Merck KGaA Darmstadt, Germany. Funding entities had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2016, J CANCER, V7, P837, DOI 10.7150/jca.14717; Arnold D, 2017, ANN ONCOL, V28, P1713, DOI 10.1093/annonc/mdx175; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cardoso H.F., 2017, REV PSICOL, V17, P121, DOI [10.17652/rpot/2017.2.12796, DOI 10.17652/RPOT/2017.2.12796]; Cicero G, 2018, ONCOTARGETS THER, V11, P3059, DOI 10.2147/OTT.S151276; Clancy C, 2014, ANN SURG ONCOL, V21, P3900, DOI 10.1245/s10434-014-3805-4; Cook AD, 2005, ANN SURG ONCOL, V12, P637, DOI 10.1245/ASO.2005.06.012; Cremolini C, 2017, CANCER RES TREAT, V49, P834, DOI 10.4143/crt.2016.249; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Jaka A, 2015, ACTAS DERMO-SIFILOGR, V106, P483, DOI 10.1016/j.ad.2015.01.006; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Kim K, 2018, J BUON, V23, pS11; Lee MS, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3506; Loupakis F, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju427; Maughan TS, 2011, LANCET, V377, P2103, DOI 10.1016/S0140-6736(11)60613-2; Modest DP, 2014, ANTI-CANCER DRUG, V25, P212, DOI 10.1097/CAD.0000000000000041; Petrelli F, 2013, TARGET ONCOL, V8, P173, DOI 10.1007/s11523-013-0257-x; Qin SK, 2018, J CLIN ONCOL, V36, P3031, DOI 10.1200/JCO.2018.78.3183; Ruers T, 2012, ANN ONCOL, V23, P2619, DOI 10.1093/annonc/mds053; Sanz-Garcia E, 2017, ANN ONCOL, V28, P2648, DOI 10.1093/annonc/mdx401; Sargent DJ, 2009, J CLIN ONCOL, V27, P1948, DOI 10.1200/JCO.2008.20.2879; Shi Q, 2015, J CLIN ONCOL, V33, P22, DOI 10.1200/JCO.2014.56.5887; Tejpar S, 2017, JAMA ONCOL, V3, P194, DOI 10.1001/jamaoncol.2016.3797; Thaler J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-438; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; Trojan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140717; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Van Cutsem E, 2015, J CLIN ONCOL, V33, P692, DOI 10.1200/JCO.2014.59.4812; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Venook AP, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3504; Wang F, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0022-x; Zhang Y, 2015, INT J COLORECTAL DIS, V30, P1173, DOI 10.1007/s00384-015-2273-z	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243997	10.1371/journal.pone.0243997	http://dx.doi.org/10.1371/journal.pone.0243997			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347495	gold, Green Published			2022-12-27	WOS:000603071100019
J	Wang, SY; Rajananda, S; Lau, H; Knotts, JD				Wang, Shiyun; Rajananda, Sivananda; Lau, Hakwan; Knotts, J. D.			New measures of agency from an adaptive sensorimotor task	PLOS ONE			English	Article							CONSCIOUS INTENTION; MOVEMENT-DISORDERS; DIAGNOSIS; SENSE; DISEASE; TIME; WILL	Self-agency, the sense that one is the author or owner of one's behaviors, is impaired in multiple psychological and neurological disorders, including functional movement disorders, Parkinson's Disease, alien hand syndrome, schizophrenia, and dystonia. Existing assessments of self-agency, many of which focus on agency of movement, can be prohibitively time-consuming and often yield ambiguous results. Here, we introduce a short online motion tracking task that quantifies movement agency through both first-order perceptual and second-order metacognitive judgments. The task assesses the degree to which a participant can distinguish between a motion stimulus whose trajectory is influenced by the participant's cursor movements and a motion stimulus whose trajectory is random. We demonstrate the task's reliability in healthy participants and discuss how its efficiency, reliability, and ease of online implementation make it a promising new tool for both diagnosing and understanding disorders of agency.	[Wang, Shiyun; Rajananda, Sivananda; Lau, Hakwan; Knotts, J. D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Lau, Hakwan] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Lau, Hakwan] Univ Hong Kong, Dept Psychol, Pok Fu Lam, Hong Kong, Peoples R China; [Lau, Hakwan] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pok Fu Lam, Hong Kong, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Hong Kong; University of Hong Kong	Knotts, JD (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	jeffreydknotts@gmail.com		WANG, SHIYUN/0000-0002-1494-5908				Armstrong MJ, 2020, JAMA-J AM MED ASSOC, V323, P548, DOI 10.1001/jama.2019.22360; Biran I, 2004, ARCH NEUROL-CHICAGO, V61, P292, DOI 10.1001/archneur.61.2.292; Brown P, 2001, MOVEMENT DISORD, V16, P595, DOI 10.1002/mds.1145; Chambon V., 2014, COGNITIVE NEUROSCIEN, DOI [10.1007/978-3-642-45190-4_14, DOI 10.1007/978-3-642-45190-4_14]; Chmielewski M, 2020, SOC PSYCHOL PERS SCI, V11, P464, DOI 10.1177/1948550619875149; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Delorme C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162191; DENNETT DC, 1992, BEHAV BRAIN SCI, V15, P183, DOI 10.1017/S0140525X00068229; Edwards MJ, 2011, NEUROPSYCHOLOGIA, V49, P2791, DOI 10.1016/j.neuropsychologia.2011.05.021; Eisenberg IW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10301-1; Enkavi AZ, 2019, P NATL ACAD SCI USA, V116, P5472, DOI 10.1073/pnas.1818430116; FACTOR SA, 1995, J NEUROL NEUROSUR PS, V59, P406, DOI 10.1136/jnnp.59.4.406; Fahn S, 1988, Adv Neurol, V50, P431; Farrer C, 2008, CEREB CORTEX, V18, P254, DOI 10.1093/cercor/bhm050; Fleming SM, 2017, PSYCHOL REV, V124, P91, DOI 10.1037/rev0000045; Fried I, 2017, J NEUROSCI, V37, P10842, DOI 10.1523/JNEUROSCI.2584-17.2017; Furr M., 2012, ENCY RES DESIGN, P1411; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Garbarini F, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00043; Gomes G, 2002, CONSCIOUS COGN, V11, P221, DOI 10.1006/ccog.2002.0556; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Haggard P, 2003, CONSCIOUS COGN, V12, P695, DOI 10.1016/S1053-8100(03)00052-7; Hauser DJ, 2016, BEHAV RES METHODS, V48, P400, DOI 10.3758/s13428-015-0578-z; Hauser M, 2011, SCHIZOPHR RES, V126, P20, DOI 10.1016/j.schres.2010.10.031; Jinnah HA, 2015, NEUROL CLIN, V33, P77, DOI 10.1016/j.ncl.2014.09.002; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Kranick SM, 2013, EXP BRAIN RES, V229, P313, DOI 10.1007/s00221-013-3399-2; Kranick SM, 2013, MOVEMENT DISORD, V28, P1110, DOI 10.1002/mds.25408; Lau H. C., 2008, FRONT PSYCHOL; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Maniscalco B, 2014, COGNITIVE NEUROSCIEN, P25, DOI [DOI 10.1007/978-3-642-45190-4, 10.1007/978-3-642-45190-4, 10.1007/978-3-642-45190-4_3, DOI 10.1007/978-3-642-45190-4_3]; Maniscalco B, 2012, CONSCIOUS COGN, V21, P422, DOI 10.1016/j.concog.2011.09.021; Matsuhashi M, 2008, EUR J NEUROSCI, V28, P2344, DOI 10.1111/j.1460-9568.2008.06525.x; Matthews J, 2020, CORTEX, V125, P161, DOI 10.1016/j.cortex.2019.12.009; Maurer CW, 2016, NEUROLOGY, V87, P564, DOI 10.1212/WNL.0000000000002940; McAuley J, 2004, MOVEMENT DISORD, V19, P253, DOI 10.1002/mds.10707; Patel Krishna R, 2014, P T, V39, P638; Pierre JM, 2014, PSYCHOL MED, V44, P2465, DOI 10.1017/S0033291713002985; Ricciardi L, 2017, PARKINSONISM RELAT D, V40, P51, DOI 10.1016/j.parkreldis.2017.04.011; Schimansky J, 2010, PSYCHIAT RES, V178, P39, DOI 10.1016/j.psychres.2010.04.002; Tsakiris M, 2007, CONSCIOUS COGN, V16, P645, DOI 10.1016/j.concog.2007.05.012; Voon V, 2010, NEUROLOGY, V74, P223, DOI 10.1212/WNL.0b013e3181ca00e9; Wen W, 2020, COGNITION, V195, DOI 10.1016/j.cognition.2019.104074; Wen W, 2018, J COGNITIVE NEUROSCI, V30, P603, DOI 10.1162/jocn_a_01226; Williams D T, 1995, Adv Neurol, V65, P231	49	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244113	10.1371/journal.pone.0244113	http://dx.doi.org/10.1371/journal.pone.0244113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347502	Green Submitted, Green Published, gold			2022-12-27	WOS:000603071100014
J	Nkhata, W; Shimelis, H; Melis, R; Chirwa, R; Mzengeza, T; Mathew, I; Shayanowako, A				Nkhata, Wilson; Shimelis, Hussein; Melis, Rob; Chirwa, Rowland; Mzengeza, Tenyson; Mathew, Isack; Shayanowako, Admire			Population structure and genetic diversity analyses of common bean germplasm collections of East and Southern Africa using morphological traits and high-density SNP markers	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; GENOTYPES; POLYMORPHISM; IDENTIFICATION; QUALITY; ORIGIN	Knowledge of genetic diversity in plant germplasm and the relationship between genetic factors and phenotypic expression is vital for crop improvement. This study's objectives were to understand the extent of genetic diversity and population structure in 60 common bean genotypes from East and Southern Africa. The common bean genotypes exhibited significant (p<0.05) levels of variability for traits such as days to flowering (DTF), days to maturity (DTM), number of pods per plant (NPP), number of seeds per pod (NSP), and grain yield per hectare in kilograms (GYD). About 47.82 per cent of the variation among the genotypes was explained by seven principal components (PC) associated with the following agronomic traits: NPP, NFF (nodes to first flower), DTF, GH (growth habit) and GYD. The SNP markers revealed mean gene diversity and polymorphic information content values of 0.38 and 0.25, respectively, which suggested the presence of considerable genetic variation among the assessed genotypes. Analysis of molecular variance showed that 51% of the genetic variation were between the gene pools, while 49% of the variation were within the gene pools. The genotypes were delineated into two distinct groups through the population structure, cluster and phylogenetic analyses. Genetically divergent genotypes such as DRK57, MW3915, NUA59, and VTTT924/4-4 with high yield and agronomic potential were identified, which may be useful for common bean improvement.	[Nkhata, Wilson; Shimelis, Hussein; Melis, Rob; Mathew, Isack; Shayanowako, Admire] Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, African Ctr Crop Improvement, Pietermaritzburg, South Africa; [Chirwa, Rowland] Int Ctr Trop Agr, Chitedze Agr Res Stn, Lilongwe, Malawi; [Mzengeza, Tenyson] Chitedze Agr Res Stn, Dept Agr Res Serv, Lilongwe, Malawi	University of Kwazulu Natal; Alliance; International Center for Tropical Agriculture - CIAT	Nkhata, W (corresponding author), Univ KwaZulu Natal, Sch Agr Earth & Environm Sci, African Ctr Crop Improvement, Pietermaritzburg, South Africa.	wilsonkhata@gmail.com	Shimelis, Hussein/N-5073-2013	Shimelis, Hussein/0000-0003-2793-8392; Nkhata, Wilson/0000-0003-2698-8398	Alliance for A Green in Africa (AGRA)	Alliance for A Green in Africa (AGRA)	WN received from Alliance for A Green in Africa (AGRA). Grant/Award number. AGRAPASS30.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu H., 2017, INT J ADV RES PUBLIC, V1, P39; [Anonymous], 2014, SCI SIGNAL, V7, pra13; Asfaw A, 2009, THEOR APPL GENET, V120, P1, DOI 10.1007/s00122-009-1154-7; Bhutta WM, 2006, S AFR J BOT, V72, P280, DOI 10.1016/j.sajb.2005.09.005; Bitocchi E, 2012, P NATL ACAD SCI USA, V109, pE788, DOI 10.1073/pnas.1108973109; Blair MW, 2013, THEOR APPL GENET, V126, P535, DOI 10.1007/s00122-012-1999-z; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; Blair MW, 2009, THEOR APPL GENET, V119, P955, DOI 10.1007/s00122-009-1064-8; Blair MW, 2006, THEOR APPL GENET, V112, P1149, DOI 10.1007/s00122-006-0217-2; Blair MW, 2006, THEOR APPL GENET, V112, P913, DOI 10.1007/s00122-005-0195-9; Cabral PDS, 2011, GENET MOL RES, V10, P140, DOI 10.4238/vol10-1gmr993; Chacon S MI, 2007, PLANT SYST EVOL, V266, P175, DOI 10.1007/s00606-007-0536-z; Chiorato AF, 2006, GENET MOL BIOL, V29, P105, DOI 10.1590/S1415-47572006000100020; Cichy KA, 2015, CROP SCI, V55, P2149, DOI 10.2135/cropsci2014.09.0653; Cichy KA, 2015, THEOR APPL GENET, V128, P1555, DOI 10.1007/s00122-015-2531-z; Coates BS, 2009, J HERED, V100, P556, DOI 10.1093/jhered/esp028; Cooper H, 2001, BROADENING GENETIC B, P1, DOI DOI 10.1079/9780851994116.0001; Cortes AJ, 2011, THEOR APPL GENET, V123, P827, DOI 10.1007/s00122-011-1630-8; Eltaher S, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00076; Fisseha Z., 2016, African Journal of Biotechnology, V15, P2824; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gayacharan, 2020, ANN APPL BIOL, V177, P346, DOI 10.1111/aab.12624; GENTRY HS, 1969, ECON BOT, V23, P55, DOI 10.1007/BF02862972; Goncalves-Vidigal MC, 2008, EUPHYTICA, V164, P551, DOI 10.1007/s10681-008-9758-6; Guidoti DT, 2018, ACTA SCI-AGRON, V40, DOI 10.4025/actasciagron.v40i1.33032; Hallauer A.R., 1988, QUANTITATIVE GENETIC; Hegay S., 2012, Scientific Journal of Crop Science, V1, P63; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; IBPGR, 1982, DESCR PHAS VUL L; Katungi E., 2009, INT CTR TROPIC AGR, V61, P1; Katungi E., 2009, COMMON BEAN E SO AFR; Kimani P., 2001, PAN AFR BEAN RES NET, P13; Kumar V, 2008, SCI HORTIC-AMSTERDAM, V116, P138, DOI 10.1016/j.scienta.2007.12.001; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Liu K, 2005, POWERMAKER INTEGRATE; Luo ZN, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00184; McClean PE, 2012, GENET RESOUR CROP EV, V59, P499, DOI 10.1007/s10722-011-9699-0; Mercati F, 2013, GENET RESOUR CROP EV, V60, P839, DOI 10.1007/s10722-012-9879-6; Metais I, 2000, THEOR APPL GENET, V101, P1207, DOI 10.1007/s001220051599; Muturi PW, 2014, INT J TROP INSECT SC, V34, P260, DOI 10.1017/S1742758414000459; Mwadzingeni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171692; Nadeem MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205363; Ojwang PPO, 2011, FIELD CROP RES, V120, P223, DOI 10.1016/j.fcr.2010.10.010; Okii D., 2014, African Crop Science Journal, V22, P59; Payne RW., 2017, GENSTAT WINDOWS, V19th; Silva VMPE, 2013, SCI AGR, V70, P167, DOI 10.1590/S0103-90162013000300005; Petry N, 2015, NUTRIENTS, V7, P1144, DOI 10.3390/nu7021144; Polania J, PLANT PHYSL, V40, P503; Pritchard JK, 2000, GENETICS, V155, P945; Raatz B, 2019, GENET RESOUR CROP EV, V66, P707, DOI 10.1007/s10722-019-00746-0; Radosavljevic I, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv106; Salem KFM, 2016, CR BIOL, V339, P1, DOI 10.1016/j.crvi.2015.11.003; Sartie A, 2012, GENET RESOUR CROP EV, V59, P1753, DOI 10.1007/s10722-012-9797-7; Sharma PN, 2013, PLANT GENET RESOUR-C, V11, P121, DOI 10.1017/S1479262112000469; Sicard D, 2005, PLANT BREEDING, V124, P464, DOI 10.1111/j.1439-0523.2005.01137.x; SINGH SP, 1991, CROP SCI, V31, P19, DOI 10.2135/cropsci1991.0011183X003100010004x; Somta P, 2009, BREEDING SCI, V59, P149, DOI 10.1270/jsbbs.59.149; Sperling L, 2001, BIODIVERS CONSERV, V10, P989, DOI 10.1023/A:1016628310917; Sundaram P, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2464-8; Talukder ZI, 2010, CAN J PLANT SCI, V90, P49, DOI 10.4141/CJPS09096; Tiranti B, 2007, MOL ECOL, V16, P4942, DOI 10.1111/j.1365-294X.2007.03566.x; Vahdati K, 2015, PLANT SYST EVOL, V301, P691, DOI 10.1007/s00606-014-1107-8; Valdisser PAMR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3805-4; Vinu V, 2013, REV BIOL TROP, V61, P1919; Vitorino CA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00159	66	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243238	10.1371/journal.pone.0243238	http://dx.doi.org/10.1371/journal.pone.0243238			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338076	Green Published, gold			2022-12-27	WOS:000601313500035
J	Shongwe, NA; Byaruhanga, C; Dorny, P; Dermauw, V; Qekwana, DN				Shongwe, Nothando Altrecia; Byaruhanga, Charles; Dorny, Pierre; Dermauw, Veronique; Qekwana, Daniel Nenene			Knowledge, practices and seroprevalence of Taenia species in smallholder farms in Gauteng, South Africa	PLOS ONE			English	Article							SOLIUM PORCINE CYSTICERCOSIS; EASTERN CAPE PROVINCE; RISK-FACTORS; HEALTH-EDUCATION; MBULU DISTRICT; PREVALENCE; PIGS; NEUROCYSTICERCOSIS; HYDATIGENA; COMMUNITY	Porcine cysticercosis and associated human infections are endemic in Sub-Saharan Africa, Latin America, and Asia. Poor agricultural practices, sanitary practices, and lack of knowledge increase the burden of the diseases in susceptible populations. This study investigates the seroprevalence of Taenia spp. in township pigs in Gauteng, South Africa and describes knowledge and farming practices of pig farmers regarding T. solium infections. Blood samples were collected from 126 pigs in three Gauteng township areas, and analyzed for active Taenia spp. infection using the B158/B60 Ag-ELISA. Farmer questionnaire surveys were conducted in four township areas to investigate the level of knowledge and practices associated with porcine cysticercosis and neurocysticercosis. Logistic regression models were used to assess the relationship between predictor variables and the outcome variable, knowledge of porcine cysticercosis or knowledge of neurocysticercosis. Overall, 7% of the pigs were seropositive for active Taenia spp. infection. 46% of farmers practiced a free-ranging system, while 25% practiced a semi-intensive system. Latrines were absent on all farms; however, 95% of farmers indicated that they have access to latrines at home. Most farmers had no knowledge of porcine cysticercosis (55%) or neurocysticercosis (79%), and this was not associated with any of the factors investigated. The prevalence of active Taenia spp. infection was reasonably low in this study, yet the knowledge level was also low, thus calling for further educational and training programmes to prevent Taenia spp. transmission in these communities.	[Shongwe, Nothando Altrecia; Byaruhanga, Charles; Qekwana, Daniel Nenene] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Pretoria, South Africa; [Dorny, Pierre; Dermauw, Veronique] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Dorny, Pierre] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Qekwana, Daniel Nenene] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Sect Vet Publ Hlth, Pretoria, South Africa	University of Pretoria; Institute of Tropical Medicine (ITM); Ghent University; University of Pretoria	Qekwana, DN (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Sect Vet Publ Hlth, Pretoria, South Africa.	Nenene.Qekwana@up.ac.za	Dermauw, Veronique/AFO-8354-2022	Dermauw, Veronique/0000-0001-8745-5304; Byaruhanga, Charles/0000-0002-5368-6400	Belgian Directorate-General for Development Co-operation Framework Agreement (FA4 DGDITM 2017-2021)	Belgian Directorate-General for Development Co-operation Framework Agreement (FA4 DGDITM 2017-2021)	NA Shongwe received funding from the Belgian Directorate-General for Development Co-operation Framework Agreement (FA4 DGDITM 2017-2021). URL:https://diplomatie.belgium.be/en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AM, 2012, INT HEALTH, V4, P164, DOI 10.1016/j.inhe.2012.04.003; [Anonymous], 2010, ADV MAT, V22, pE170; Apdia bvba, 2004, AP IN VITR DIAGN KIT, P5; Audige L, 2005, PREV VET MED, DOI [10.1016/j.prevetmed.2004.11.001, DOI 10.1016/J.PREVETMED.2004.11.001]; Braae Uffe Christian, 2016, Parasite Epidemiol Control, V1, P245; Braae UC, 2015, TROP ANIM HEALTH PRO, V47, P1523, DOI 10.1007/s11250-015-0892-6; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Bulaya C, 2015, VET PARASITOL, V207, P241, DOI 10.1016/j.vetpar.2014.12.030; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; CHEMBENSOFU M, 2017, PARASITE VECTOR, V10, P1; Dahourou L. D., 2018, Health, V10, P95, DOI 10.4236/health.2018.101008; Del Brutto OH, 2012, SCI WORLD J, DOI 10.1100/2012/159821; Dermauw V, 2016, VET PARASITOL, V230, P9, DOI 10.1016/j.vetpar.2016.10.022; Dinno A, 2009, STATA J, V9, P291, DOI 10.1177/1536867X0900900207; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Dorny P, 2003, ACTA TROP, V87, P79, DOI 10.1016/S0001-706X(03)00058-5; Dyson LL, 2009, WATER SA, V35, P627; Flisser A, 2007, PARASITE IMMUNOL, V29, P637, DOI 10.1111/j.1365-3024.2007.00981.x; Foyaca-Sibat H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000562; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gonzalez AE, 2006, PARASITOL INT, V55, pS131, DOI 10.1016/j.parint.2005.11.021; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Kabululu ML, 2020, PERFORMANCE AG ELISA, P1; Komba EVG, 2013, VET PARASITOL, V198, P284, DOI 10.1016/j.vetpar.2013.09.020; Krecek RC, 2008, VET PARASITOL, V154, P38, DOI 10.1016/j.vetpar.2008.03.005; Krecek RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037718; Kungu JM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2122-x; Lightowlers MW, 2010, INT J PARASITOL, V40, P1183, DOI 10.1016/j.ijpara.2010.05.001; Mafojane NA, 2003, ACTA TROP, V87, P25, DOI 10.1016/S0001-706X(03)00052-4; Nguyen MTT, 2016, VET PARASITOL, V226, P97, DOI 10.1016/j.vetpar.2016.06.034; Maridadi A. F., 2011, International Journal of Animal and Veterinary Advances, V3, P196; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Myeni L, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113003; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2004, TROP ANIM HEALTH PRO, V36, P335, DOI 10.1023/B:TROP.0000026663.07862.2a; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Pal DK, 2000, J NEUROL NEUROSUR PS, V68, P137, DOI 10.1136/jnnp.68.2.137; Phiri IK, 2003, ACTA TROP, V87, P13, DOI 10.1016/S0001-706X(03)00051-2; Pondja A, 2015, PREV VET MED, V118, P493, DOI 10.1016/j.prevetmed.2015.01.001; Porphyre V, 2016, VET PARASITOL, V219, P77, DOI 10.1016/j.vetpar.2015.08.027; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004; Shey-Njila O, 2004, J HELMINTHOL, DOI [10.1079/joh2003179, DOI 10.1079/J0H200317914649245]; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; Statistics South Africa, 2016, COMM SURV 2016 AGR H; Statistics South Africa, 2011, 030005 STAT S AFR; StatsSA, 2019, STAT REL P0302 2000; Thomas LF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005371; Thys S, 2016, VET PARASITOL, V225, P33, DOI 10.1016/j.vetpar.2016.05.029; Thys S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003570; Trevisan C, 2017, ACTA TROP, V165, P141, DOI 10.1016/j.actatropica.2015.12.021; Tsotetsi-Khambule AM, 2018, TROP ANIM HEALTH PRO, V50, P1951, DOI 10.1007/s11250-018-1627-2; Tsotetsi-Khambule AM, 2017, ACTA TROP, V172, P91, DOI 10.1016/j.actatropica.2017.04.019; WHO/FAO/OIE, 2005, GUID SURV PREV CONTR; Winkler AS, 2012, PATHOG GLOB HEALTH, V106, P261, DOI 10.1179/2047773212Y.0000000047; Zammarchi L, 2018, EUROSURVEILLANCE, V23, P23, DOI 10.2807/1560-7917.ES.2018.23.40.1700709; Zirintunda G, 2007, OCCURRENCE PORCINE C, P1, DOI [10.4102/ojvr.v82i1.888, DOI 10.4102/0JVR.V82I1.88826244682]	58	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244055	10.1371/journal.pone.0244055	http://dx.doi.org/10.1371/journal.pone.0244055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338060	Green Published, gold			2022-12-27	WOS:000601313500013
J	Akter, S; Rich, JL; Davies, K; Inder, KJ				Akter, Shahinoor; Rich, Jane Louise; Davies, Kate; Inder, Kerry Jill			Prevalence and factors associated with antenatal care service access among Indigenous women in the Chittagong Hill Tracts, Bangladesh: A cross-sectional study	PLOS ONE			English	Article							MATERNAL HEALTH-SERVICES; TRIBAL WOMEN; MORTALITY; DYNAMICS; BARRIERS; PEOPLES	Background Prevalence of accessing antenatal care (ANC) services among Indigenous women in the Chittagong Hill Tracts (CHT) is unknown. This study aims to estimate the prevalence of accessing ANC services by Indigenous women in the CHT and identify factors associated with knowledge of, and attendance at, ANC services. Methods Using a cross-sectional design three Indigenous groups in Khagrachari district, CHT, Bangladesh were surveyed between September 2017 and February 2018. Indigenous women within 36 months of delivery were asked about attending ANC services and the number who attended was used to estimate prevalence. Socio-demographic and obstetric characteristics were used to determine factors associated with knowledge and attendance using multivariable logistic regression techniques adjusted for clustering by village; results are presented as odds ratios (OR), adjusted OR, and 95% confidence intervals (CI). Results Of 494 indigenous women who met the inclusion criteria in two upazilas, 438 participated (89% response rate) in the study, 75% were aged 16-29 years. Sixty-nine percent were aware of ANC services and the prevalence of attending ANC services was 53% (n = 232, 95%CI 0.48-0.58). Half (52%; n = 121) attended private facilities. Independent factors associated with knowledge about ANC were age >= 30 years (OR 2.2, 95%CI 1.1-4.6), monthly household income greater than 20,000 Bangladeshi Taka (OR 3.4, 95%CI 1.4-8.6); knowledge of pregnancy-related complications (OR 3.6, 95%CI 1.6-8.1), knowledge about nearest health facilities (OR 4.3, 95%CI 2.1-8.8); and attending secondary school or above (OR 4.8, 95%CI 2.1-11). Independent factors associated with attending ANC services were having prior knowledge of ANC benefits (OR 7.7, 95%CI 3.6-16), Indigenous women residing in Khagrachhari Sadar subdistrict (OR 6.5, 95%CI 1.7-25); and monthly household income of 20,000 Bangladeshi Taka or above (OR 2.8, 95%CI 1.1-7.4). Conclusion Approximately half of Indigenous women from Chittagong Hill Tracts Bangladesh attended ANC services at least once. Better awareness and education may improve ANC attendance for Indigenous women. Cultural factors influencing attendance need to be explored.	[Akter, Shahinoor; Rich, Jane Louise] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Akter, Shahinoor; Inder, Kerry Jill] Univ Newcastle, Prior Res Ctr Generat Hlth & Ageing, Callaghan, NSW, Australia; [Akter, Shahinoor; Inder, Kerry Jill] Hunter Med Res Inst, New Lambton, NSW, Australia; [Akter, Shahinoor] Jagannath Univ, Dept Anthropol, Dhaka, Bangladesh; [Rich, Jane Louise] Ctr Brain & Mental Hlth Res, Callaghan, NSW, Australia; [Davies, Kate] Univ Newcastle, Fac Educ & Arts, Sch Humanities & Social Sci, Callaghan, NSW, Australia; [Inder, Kerry Jill] Univ Newcastle, Fac Hlth & Med, Sch Nursing & Midwifery, Callaghan, NSW, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle	Akter, S (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Callaghan, NSW, Australia.; Akter, S (corresponding author), Univ Newcastle, Prior Res Ctr Generat Hlth & Ageing, Callaghan, NSW, Australia.; Akter, S (corresponding author), Hunter Med Res Inst, New Lambton, NSW, Australia.; Akter, S (corresponding author), Jagannath Univ, Dept Anthropol, Dhaka, Bangladesh.	Shahinoor.Akter@uon.edu.au		Davies, Kate/0000-0003-2638-0980; Inder, Kerry/0000-0003-4412-0322; AKTER, SHAHINOOR/0000-0002-5236-3597				Adhikari T, 2016, INDIAN J MED RES, V143, P58, DOI 10.4103/0971-5916.193284; Akter S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033224; Akter S, 2019, INT J PUBLIC HEALTH, V64, P343, DOI 10.1007/s00038-018-1177-4; Ali N, 2018, HEALTH SERV RES MANA, V5, DOI 10.1177/2333392818781729; Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amano Tatsuya, 2016, PLoS Biol, V14, pe2000933, DOI 10.1371/journal.pbio.2000933; Badiuzzaman M, 2020, J DEV STUD, V56, P384, DOI 10.1080/00220388.2018.1554211; Bangladesh Bureau of Statistics, 2013, DISTR STAT 2011 KHAG; Barkat A., 2009, SOCIOECONOMIC BASELI; BHUTTA ZA, 2018, BMJ-BRIT MED J, V363, DOI DOI 10.1136/BMJ.K4884; Bursac Z, PURPOSEFUL SELECTION; Dahlui M, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.28822; Dansereau E., 2018, Maternal death and pregnancy-related morbidity among indigenous women of Mexico and Central America. An anthropological, epidemiological, and biomedical approach, P133; Davy C, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0450-5; DESAI S, 1994, POPUL DEV REV, V20, P115, DOI 10.2307/2137632; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ha BTT, 2015, INT J WOMENS HEALTH, V7, P699, DOI 10.2147/IJWH.S87276; Harris A, 2010, HEALTH POLICY PLANN, V25, P311, DOI 10.1093/heapol/czp062; Human Development Research Centre, 2014, STAT DEV CHITT HILL; Ibanez-Cuevas M, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0289-1; Islam MR, 2011, RURAL REMOTE HEALTH, V11; Islam RM, 2017, WOMEN HEALTH, V57, P108, DOI 10.1080/03630242.2016.1153020; IWGIA, STAT IND WOM GIRLS B; Ruiz MJ, 2013, CULT HEALTH SEX, V15, P205, DOI 10.1080/13691058.2012.751128; Kamal N, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0311-2; Kamal SMM, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1467, DOI 10.1177/1010539513485786; Kamal S M Mostafa, 2013, J Family Reprod Health, V7, P73; Lehmann U, 2007, STATE EVIDENCE PROGR, P1; Lennox C., 2013, ADDRESSING HLTH INEQ; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Miltenburg AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188279; MOHFW (Ministry of Health and Family Welfare), 2012, BANGL POP POL 2012; NIPORT ACPR ICF, 2018, BANGL HLTH FAC SURV; NIPORT icddrb Evaluation M, 2017, BANGLADESH MATERNAL; NIPORT Mitra and Associates & ICF International, 2014, BANGL DEM HLTH SURV; Pulok MH, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0970-4; Rahman A, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-016-0078-5; Razak BA, 2013, HLTH POLICY PLANNING, V29, P580, DOI 10.1093/heapol/czt044; Roy P., 2014, QUEST SECURITY EQUAL; SEDGWICK P, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G2979; SEDGWICK P, 2015, BMJ-BRIT MED J, V350, DOI DOI 10.1136/BMJ.H1286; Shah R, 2011, CAN STUD POPUL, V38, P83, DOI 10.25336/P6Z89V; Shahjahan M, 2017, MIDWIFERY, V52, P42, DOI 10.1016/j.midw.2017.05.011; Siddique AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205149; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Stephens C, 2005, LANCET, V366, P10, DOI 10.1016/S0140-6736(05)66801-8; Tuhin M, 2015, HLTH DISCOURSE CHITT; Uddin A, 2016, ETHNOPOLITICS, V15, P319, DOI 10.1080/17449057.2015.1037060; UNICEF, 2015, CHITTAGONG HILL TRAC; Van Schendel W, 2000, CHITTAGONG HILL TRAC, DOI [10.1103/PhysRevLett.84.2642, DOI 10.1103/PHYSREVLETT.84.2642]; Varma GR, 2011, J EGYPT PUBLIC HEAL, V86, P11, DOI 10.1097/01.EPX.0000395395.17777.be; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; White J, 2012, GLOB PUBLIC HEALTH, V7, P869, DOI 10.1080/17441692.2012.679743; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization, 2015, 9241509090 WHO; World Health Organization, 2018, MAN COMPL PREGN CHIL	57	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244640	10.1371/journal.pone.0244640	http://dx.doi.org/10.1371/journal.pone.0244640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373416	Green Published, gold			2022-12-27	WOS:000603612300023
J	Mu, HW; Chen, CH; Yang, KW; Pan, CS; Lin, CL; Hung, DZ				Mu, Han-Wei; Chen, Chun-Hung; Yang, Kai-Wei; Pan, Chi-Syuan; Lin, Cheng-Li; Hung, Dong-Zong			The prevalence of esophageal cancer after caustic and pesticide ingestion: A nationwide cohort study	PLOS ONE			English	Article							UPPER GASTROINTESTINAL-TRACT; CARCINOMA; INJURY; BURNS	Habits such as smoking and alcohol drinking and existing esophageal malfunction are considered the main risk factors for esophageal carcinogenesis. Caustic ingestion of acidic or alkaline agents or strong irritants can induce severe esophageal corrosive injury and increase esophageal cancer risk. We studied the relationship between esophageal carcinoma and acute detergent or pesticide poisoning by using nationwide health insurance data. Methodology/Principle findings: We compared a pesticide/detergent intoxication cohort (N = 21,840) and an age- and gender-matched control cohort (N = 21,840) identified from the National Health Insurance Research Database between 2000 and 2011. We used the multivariable Cox proportional model to determine esophageal carcinoma risk. The overall incidence density of esophageal cancer was 1.66 per 10,000 person-years in the comparison cohort and 4.36 per 10,000 person-years in the pesticide/detergent intoxication cohort. The corresponding adjusted hazard ratio (HR) for esophageal cancer was 2.33 (95% confidence interval [CI] = 1.41-3.86) in the pesticide/detergent intoxication cohort compared with the control cohort. Patients with corrosive and detergent intoxication did not have a higher risk of esophageal cancer (adjusted HR = 0.98, 95% CI = 0.29-3.33) than those without pesticide/detergent intoxication. However, patients with pesticide intoxication had a significantly higher risk of esophageal cancer (adjusted HR = 2.52, 95% CI = 1.52-4.18) than those without pesticide/detergent intoxication. Conclusion: In the present study, after adjusting for conventional risk factors, we observed that pesticide intoxication could exert substantial effects through increased esophageal cancer risk. However, patients with detergent intoxication may not have an increased risk of esophageal cancer.	[Mu, Han-Wei; Chen, Chun-Hung; Yang, Kai-Wei; Pan, Chi-Syuan; Hung, Dong-Zong] China Med Univ Hosp, Div Toxicol, Taichung, Taiwan; [Mu, Han-Wei; Chen, Chun-Hung; Yang, Kai-Wei; Pan, Chi-Syuan] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Hung, DZ (corresponding author), China Med Univ Hosp, Div Toxicol, Taichung, Taiwan.	dzhung0224@gmail.com		Hung, dong-zong/0000-0002-5131-8786	Ministry of Health and Welfare, Taiwan [MOHW108-TDU-B-212-133004]; China Medical University Hospital [DMR-107-192, CMU107-ASIA-19]; Academia Sinica Stroke Biosignature Project [BM10701010021]; MOST Clinical Trial Consortium for Stroke [MOST 107-2321-B-039 -004-]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Ministry of Health and Welfare, Taiwan; China Medical University Hospital; Academia Sinica Stroke Biosignature Project; MOST Clinical Trial Consortium for Stroke; Tseng-Lien Lin Foundation, Taichung, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This work was supported by grants from the Ministry of Health and Welfare, Taiwan (MOHW108-TDU-B-212-133004), China Medical University Hospital (DMR-107-192, CMU107-ASIA-19), Academia Sinica Stroke Biosignature Project (BM10701010021), MOST Clinical Trial Consortium for Stroke (MOST 107-2321-B-039 -004-), Tseng-Lien Lin Foundation, Taichung, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	APPELQVIST P, 1980, CANCER, V45, P2655, DOI 10.1002/1097-0142(19800515)45:10<2655::AID-CNCR2820451028>3.0.CO;2-P; Arnold M, 2016, CANCER EPIDEM BIOMAR, V25, P90, DOI 10.1158/1055-9965.EPI-15-0753; CARVER GM, 1956, JAMA-J AM MED ASSOC, V160, P1447, DOI 10.1001/jama.1956.02960520009003; Chang CY, 1999, HUM EXP TOXICOL, V18, P475, DOI 10.1191/096032799678847078; Contini S, 2013, WORLD J GASTROENTERO, V19, P3918, DOI 10.3748/wjg.v19.i25.3918; CSIKOS M, 1985, LANGENBECK ARCH CHIR, V365, P231, DOI 10.1007/BF01459611; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; HOPKINS RA, 1981, ANN SURG, V194, P146, DOI 10.1097/00000658-198108000-00005; Howard J, 2012, MINIMUM LATENCY TYPE; Huang FL, 2018, ASIAN J SURG, V41, P210, DOI 10.1016/j.asjsur.2016.10.005; Hung DZ, 1997, HUM EXP TOXICOL, V16, P596, DOI 10.1177/096032719701601007; IMRE J, 1972, THORAX, V27, P594, DOI 10.1136/thx.27.5.594; Jansson C, 2006, OCCUP ENVIRON MED, V63, P107, DOI 10.1136/oem.2005.022467; Kim YT, 2001, EUR J CARDIO-THORAC, V20, P1, DOI 10.1016/S1010-7940(01)00747-3; KIVIRANTA U K, 1952, Acta Otolaryngol, V42, P89, DOI 10.3109/00016485209120330; Matic MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099448; MEIJSSEN MAC, 1992, GUT, V33, P155, DOI 10.1136/gut.33.2.155; Meyer A, 2011, INT J HYG ENVIR HEAL, V214, P151, DOI 10.1016/j.ijheh.2010.11.002; Ruol A, 2010, EUR J CARDIO-THORAC, V38, P659, DOI 10.1016/j.ejcts.2010.03.057; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; TI TK, 1983, BRIT J SURG, V70, P223, DOI 10.1002/bjs.1800700413; Uhlenhopp DJ, 2020, CLIN J GASTROENTEROL, V13, P1010, DOI 10.1007/s12328-020-01237-x	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0243922	10.1371/journal.pone.0243922	http://dx.doi.org/10.1371/journal.pone.0243922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373373	Green Published, gold			2022-12-27	WOS:000603612300038
J	Sato, Y; Yoshihisa, A; Watanabe, K; Hotsuki, Y; Kimishima, Y; Yokokawa, T; Misaka, T; Sato, T; Kaneshiro, T; Oikawa, M; Kobayashi, A; Takeishi, Y				Sato, Yu; Yoshihisa, Akiomi; Watanabe, Koichiro; Hotsuki, Yu; Kimishima, Yusuke; Yokokawa, Tetsuro; Misaka, Tomofumi; Sato, Takamasa; Kaneshiro, Takashi; Oikawa, Masayoshi; Kobayashi, Atsushi; Takeishi, Yasuchika			Association between platelet distribution width and prognosis in patients with heart failure	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; TYPE-2 DIABETES-MELLITUS; CELL DISTRIBUTION WIDTH; TUMOR-NECROSIS-FACTOR; VOLUME; ACTIVATION; SEVERITY; INDEXES; ANEMIA; MARKER	Background The prognostic impact of platelet distribution width (PDW), which is a specific marker of platelet activation, has been unclear in patients with heart failure (HF). Methods and results We conducted a prospective observational study enrolling 1,746 hospitalized patients with HF. Patients were divided into tertiles based on levels of PDW: 1(st) (PDW < 15.9 fL, n = 586), 2(nd) (PDW 15.9-16.8 fL, n = 617), and 3(rd) (PDW >= 16.9, n = 543) tertiles. We compared baseline patients' characteristics and post-discharge prognosis: all-cause death; cardiac death; and cardiac events. The 3(rd) tertile showed the highest age and levels of B-type natriuretic peptide compared to other tertiles (1(st), 2(nd), and 3(rd) tertiles; age, 69.0, 68.0, and 70.0 years old, P = 0.038; B-type natriuretic peptide, 235.2, 171.9, and 241.0 pg/mL, P < 0.001). Left ventricular ejection fraction was equivalent among the tertiles. In the Kaplan-Meier analysis, rates of all endpoints were the highest in the 3(rd) tertile (log-rank P < 0.001, respectively). The Cox proportional hazard analysis revealed that the 3(rd) tertile was associated with adverse prognosis (all-cause death, hazard ratio [HR] 1.716, P < 0.001; cardiac death, HR 1.919, P < 0.001; cardiac event, HR 1.401, P = 0.002). Conclusions High PDW is a novel predictor of adverse prognosis in patients with HF.	[Sato, Yu; Yoshihisa, Akiomi; Watanabe, Koichiro; Hotsuki, Yu; Kimishima, Yusuke; Yokokawa, Tetsuro; Misaka, Tomofumi; Sato, Takamasa; Kaneshiro, Takashi; Oikawa, Masayoshi; Kobayashi, Atsushi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan; [Yoshihisa, Akiomi; Misaka, Tomofumi] Fukushima Med Univ, Dept Adv Cardiac Therapeut, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Yoshihisa, A (corresponding author), Fukushima Med Univ, Dept Cardiovasc Med, Fukushima, Japan.; Yoshihisa, A (corresponding author), Fukushima Med Univ, Dept Adv Cardiac Therapeut, Fukushima, Japan.	yoshihis@fmu.ac.jp		Sato, Yu/0000-0003-1084-6475	Japan Society for the Promotion of Science [20K07828]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant-in-aid for Scientific Research (No. 20K07828) from the Japan Society for the Promotion of Science. There was no additional external funding received for this study.	Akin F, 2016, PERFUSION-UK, V31, P216, DOI 10.1177/0267659115594231; Al-Ahmad A, 2001, J AM COLL CARDIOL, V38, P955, DOI 10.1016/S0735-1097(01)01470-X; Bekler A, 2015, ANGIOLOGY, V66, P638, DOI 10.1177/0003319714545779; Beutler E, 2006, BLOOD, V107, P1747, DOI 10.1182/blood-2005-07-3046; Chandrashekar L, 2015, CLIN CHIM ACTA, V446, P181, DOI 10.1016/j.cca.2015.04.023; De Luca G, 2010, PLATELETS, V21, P508, DOI 10.3109/09537104.2010.494743; Demirtas L, 2015, INT J CLIN EXP MED, V8, P11420; El Haouari M, 2008, BLOOD CELL MOL DIS, V41, P119, DOI 10.1016/j.bcmd.2008.02.010; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; FERRARI R, 1995, CIRCULATION, V92, P1479, DOI 10.1161/01.CIR.92.6.1479; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; He SQ, 2019, AM J CARDIOL, V123, P239, DOI 10.1016/j.amjcard.2018.10.016; Hu CP, 2018, CHINESE MED J-PEKING, V131, P757, DOI 10.4103/0366-6999.228247; Ibrahim NE, 2017, CLIN CHEM, V63, P211, DOI 10.1373/clinchem.2016.259564; Isik T, 2012, CARDIOL J, V19, P355, DOI 10.5603/CJ.2012.0065; Iwanaga Y, 2006, J AM COLL CARDIOL, V47, P742, DOI 10.1016/j.jacc.2005.11.030; Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192; Jeon K, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019096; Jindal S, 2011, HEMATOLOGY, V16, P86, DOI 10.1179/102453311X12902908412110; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kayacan O, 2006, AM J CLIN ONCOL-CANC, V29, P328, DOI 10.1097/01.coc.0000221300.72657.e0; Larsen SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085566; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li B, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019400; Liu JX, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180172; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; O'Meara E, 2014, CIRC-HEART FAIL, V7, P773, DOI 10.1161/CIRCHEARTFAILURE.114.001100; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rechcinski T, 2013, CARDIOL J, V20, P491, DOI 10.5603/CJ.2013.0134; Ren XJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004573; RICKHAM PP, 1964, BRIT MED J, V2, P173; Sincer I, 2020, NORTH CLIN ISTANB, V7, P112, DOI 10.14744/nci.2019.47374; Soydinc S, 2014, INFLAMMATION, V37, P100, DOI 10.1007/s10753-013-9716-x; THOMPSON CB, 1982, BRIT J HAEMATOL, V50, P509, DOI 10.1111/j.1365-2141.1982.tb01947.x; Tokola H, 2001, CAN J PHYSIOL PHARM, V79, P646, DOI 10.1139/cjpp-79-8-646; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Tsutsui H, 2019, CIRC J, V83, P2084, DOI 10.1253/circj.CJ-19-0342; Ulucan S, 2016, HEART LUNG CIRC, V25, P29, DOI 10.1016/j.hlc.2015.05.017; Vagdatli E, 2010, HIPPOKRATIA, V14, P28; Vatankulu MA, 2014, ANGIOLOGY, V65, P60, DOI 10.1177/0003319713486339; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yoshihisa A, 2020, OPEN HEART, V7, DOI 10.1136/openhrt-2019-001112; Yoshihisa A, 2019, CIRC J, V83, P1709, DOI 10.1253/circj.CJ-19-0279	46	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244608	10.1371/journal.pone.0244608	http://dx.doi.org/10.1371/journal.pone.0244608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373413	Green Published, gold			2022-12-27	WOS:000603612300052
J	Tupetz, A; Friedman, K; Zhao, D; Liao, HP; Von Isenburg, M; Keating, EM; Vissoci, JRN; Staton, CA				Tupetz, Anna; Friedman, Kaitlyn; Zhao, Duan; Liao, Huipeng; Von Isenburg, Megan; Keating, Elizabeth M.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.			Prevention of childhood unintentional injuries in low- and middle-income countries: A systematic review	PLOS ONE			English	Review							PENSE BEM-CAXIAS; DROWNING PREVENTION; ROAD SAFETY; EDUCATIONAL INTERVENTION; GLOBAL BURDEN; WATER SAFETY; CHILDREN; PROGRAM; BURNS; IMPACT	Injuries are a leading cause of death and disability among children. Numerous injury prevention strategies have been successful in high-income countries, but the majority of unintentional injuries happen to children living in low- and middle-income countries (LMICs). This project aims to delineate the childhood injury prevention initiatives in LMICs. For inclusion, peer-reviewed articles needed to address unintentional injury, include children <18, assess a prevention-related intervention, contain a control group, and be published after 1988. Two pairs of reviewers evaluated articles independently to determine study eligibility. 74 articles were included. 30 studies addressed road traffic injuries, 11 drowning, 8 burns, 3 falls, 8 poisonings, and 21 an unspecified injury type. The findings show positive effects on injury outcome measures following educational interventions, the need for longer follow-up periods after the intervention, the need for effectiveness trials for behavior change, and the need for an increase in injury prevention services in LMICs. This is the first systematic review to summarize the prevention initiatives for all types of childhood unintentional injuries in LMICs. Increased attention and funding are required to go beyond educational initiatives with self-reported measures and little follow-up time to robust interventions that will reduce the global burden of unintentional injuries among children.	[Tupetz, Anna; Friedman, Kaitlyn; Liao, Huipeng; Von Isenburg, Megan; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Global Hlth Inst, Durham, NC 27710 USA; [Tupetz, Anna; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Emergency Med, Durham, NC 27708 USA; [Zhao, Duan] Duke Kunshan Univ, Suzhou, Jiangsu, Peoples R China; [Keating, Elizabeth M.] Univ Utah, Div Pediat Emergency Med, Div Publ Hlth, Salt Lake City, UT USA	Duke University; Duke University; Duke Kunshan University; Utah System of Higher Education; University of Utah	Staton, CA (corresponding author), Duke Global Hlth Inst, Durham, NC 27710 USA.; Staton, CA (corresponding author), Duke Univ, Med Ctr, Dept Emergency Med, Durham, NC 27708 USA.	Catherine.staton@duke.edu	liao, hui/GSE-5758-2022	Staton, Catherine/0000-0002-6468-2894; Zhao, Duan/0000-0003-0226-7940; von Isenburg, Megan/0000-0001-6084-5775	Fogarty International Center of the National Institute of Health [K01TW010000]	Fogarty International Center of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Dr. Catherine Staton acknowledges salary support from the Fogarty International Center of the National Institute of Health Award Number K01TW010000 (PI, Staton). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo WL, 2008, WORLD J SURG, V32, P2631, DOI 10.1007/s00268-008-9773-8; Ahmad H, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-0982-5; Alonge O, 2014, ARCH DIS CHILD, V99, P62, DOI 10.1136/archdischild-2013-304177; Freitas CKAC, 2019, REV PAUL PEDIATR, V37, P458, DOI 10.1590/1984-0462/;2019;37;4;00012; [Anonymous], 2015, JMIR MED INFORM, V3, pe22; [Anonymous], 2014, DABIQ; [Anonymous], 2017, JEFFREY S MOORAD SPO, V24, P143; Bartlett SN, 2002, HEALTH POLICY PLANN, V17, P1, DOI 10.1093/heapol/17.1.1; Bhalla K, 2010, B WORLD HEALTH ORGAN, V88, P831, DOI 10.2471/BLT.09.068809; Silva FBE, 2018, ACTA PAUL ENFERM, V31, P32, DOI 10.1590/1982-0194201800006; Callaghan JA, 2010, J EPIDEMIOL COMMUN H, V64, P645, DOI 10.1136/jech.2008.080903; Cao BL, 2015, INT J ENV RES PUB HE, V12, P3903, DOI 10.3390/ijerph120403903; Castillo Rivera R, 2014, HUMANIDADES MED, V14, P423; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2012, NAT ACT PLAN CHILD I; Chen XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105100; Charry JD, 2017, CHIN J TRAUMATOL, V20, P275, DOI 10.1016/j.cjtee.2017.04.006; Davoudi-Kiakalayeh A, 2013, E MEDITERR HEALTH J, V19, P629; Abreu DRDM, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311x00122117, 10.1590/0102-311X00122117]; Dorigatti Alcir Escocia, 2014, Rev. Col. Bras. Cir., V41, P245, DOI 10.1590/0100-69912014004004; Ederer DJ, 2016, INJURY PREV, V22, P52, DOI 10.1136/injuryprev-2014-041434; Erkoboni D, 2010, INJURY PREV, V16, P296, DOI 10.1136/ip.2009.023341; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Falavigna A, 2014, J NEUROSURG-PEDIATR, V14, P94, DOI 10.3171/2014.3.PEDS13295; Falavigna A, 2012, J NEUROSURG-PEDIATR, V9, P562, DOI 10.3171/2011.12.PEDS11169; Farro-Pena G, 2012, REV ENFERM HEREDIANA, V5, P42; Forjuoh SN, 2006, BURNS, V32, P529, DOI 10.1016/j.burns.2006.04.002; Foroutan Ali, 2019, Bull Emerg Trauma, V7, P404, DOI 10.29252/beat-070410; Forward KE, 2018, CURR PEDIATR REV, V14, P48, DOI 10.2174/1573396313666171010111722; Free-space Optical, 2017, COMMUN J, V5, P10; Gimeniz-Paschoal Sandra Regina, 2007, Rev. paul. pediatr., V25, P331; Gimeniz-Paschoal SR, 2009, REV LAT-AM ENFERM, V17, P341, DOI 10.1590/S0104-11692009000300010; Gosselin RA, 2009, B WORLD HEALTH ORGAN, V87, P246, DOI 10.2471/BLT.08.052290; Griffith AK, 2010, COMMITTEE PREVENTION; Guo, 2010, EFFECT EVALUATION WA; Guo Qiao-zhi, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P22; Heard JP, 2013, J BURN CARE RES, V34, P598, DOI 10.1097/BCR.0b013e3182a2aa27; Hemmo-Lotem M, 2005, THESCIENTIFICWORLDJO, V5, P253, DOI 10.1100/tsw.2005.32; Hidalgo-Solorzano E, 2008, SALUD PUBLICA MEXICO, V50, pS60, DOI 10.1590/S0036-36342008000700010; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hijar M, 2013, INJURY, V44, pS4, DOI 10.1016/S0020-1383(13)70206-7; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Huang, 2011, CHIN J SCH HLTH, V32, P1330; Hyder AA, 2009, B WORLD HEALTH ORGAN, V87, P345, DOI 10.2471/BLT.08.055798; Jetten P, 2011, BURNS, V37, P139, DOI 10.1016/j.burns.2010.05.002; Jin Hui-Qing, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P797; Kahriman I, 2018, J TRAUMA NURS, V25, P327, DOI 10.1097/JTN.0000000000000384; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Khatlani K, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050515; Kohrt BA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-127; Konradsen F, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-13; KRUG A, 1994, S AFR MED J, V84, P730; Lama BB, 2015, BURNS, V41, P1306, DOI 10.1016/j.burns.2015.01.006; Lao ZQ, 2012, INT J PREVENTIVE MED, V3, P303; Linnan, 2009, EVALUATION PRECISE C; Linnan L, 2007, AM J HEALTH PROMOT, V21, P521, DOI 10.4278/0890-1171-21.6.521; Liu XX, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080777; Makhubalo O, 2018, BURNS, V44, P1361, DOI 10.1016/j.burns.2018.04.013; Meng FX, 2015, TRAFFIC INJ PREV, V16, P474, DOI 10.1080/15389588.2014.973945; Mock C, 2003, B WORLD HEALTH ORGAN, V81, P591; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Muguku J, 2010, E AFR MED J, V87; Muniz C, 2019, REVENF 0130; Mutto Milton, 2002, Afr Health Sci, V2, P89; Nazif-Munoz JI, 2019, J PUBLIC HEALTH-UK, V41, P287, DOI 10.1093/pubmed/fdy105; Nazif-Munoz JI, 2018, TRAFFIC INJ PREV, V19, pS7, DOI 10.1080/15389588.2017.1387254; Ning PS, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/13519; Nthumba PM, 2016, BURNS, V42, P258, DOI 10.1016/j.burns.2015.04.006; Odendaal W, 2009, ACCIDENT ANAL PREV, V41, P183, DOI 10.1016/j.aap.2008.10.009; PEARN JH, 1979, PEDIATRICS, V64, P187; Peden M., 2008, World report on child injury prevention; Poswayo A, 2019, INJURY PREV, V25, P414, DOI 10.1136/injuryprev-2018-042786; Rahman F, 2012, PEDIATRICS, V130, pE1621, DOI 10.1542/peds.2012-0757; Ravelo Elvirez M, 2017, REV CUB HIG EPIDEMIO, V55, P24; Rehmani R, 2010, INT J EMERG MED, V3, P333, DOI 10.1007/s12245-010-0238-0; Reuben DB, 2017, J AM GERIATR SOC, V65, P2733, DOI 10.1111/jgs.15121; Rimal RN, 2019, ACCIDENT ANAL PREV, V122, P172, DOI 10.1016/j.aap.2018.09.034; Rothman L, 2019, PREV MED REP, V15, DOI 10.1016/j.pmedr.2019.100918; Salvarani CP, 2009, SURG NEUROL, V72, P6, DOI 10.1016/j.surneu.2007.10.008; Schwebel DC, 2009, HEALTH PSYCHOL, V28, P493, DOI 10.1037/a0014531; Setyowati DL, 2019, IND J PUBL HLTH RES, V10, P1709; Shen JB, 2016, J PEDIATR PSYCHOL, V41, P555, DOI 10.1093/jpepsy/jsv104; Sinha I, 2011, J BURN CARE RES, V32, pE112, DOI 10.1097/BCR.0b013e3182223c6f; Solomon R, 2013, INT J INJ CONTROL SA, V20, P266, DOI 10.1080/17457300.2012.717083; Swart L, 2008, INJURY PREV, V14, P164, DOI 10.1136/ip.2007.016832; Trevino-Siller S, 2017, TRAFFIC INJ PREV, V18, P164, DOI 10.1080/15389588.2016.1224344; Turgut T, 2016, SOC INDIC RES, V129, P787, DOI 10.1007/s11205-015-1109-0; Vecino-Ortiz AI, 2018, LANCET GLOB HEALTH, V6, pE523, DOI 10.1016/S2214-109X(18)30107-4; Verma SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150939; Waisman Ingrid, 2005, Arch. argent. pediatr., V103, P23; Wang H, 2015, PEDIATR EMERG CARE, V31, P708, DOI 10.1097/PEC.0000000000000563; Wang Xin, 2009, Wei Sheng Yan Jiu, V38, P449; World Bank, 2017, WORLD BANK COUNTR LE; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2014, INJ VIOL FACTS 2014; World Health Organization (WHO), 2018, BURNS; Xiao, 2013, CHIN MED, V11, P795; Yousef AA, 2017, REV NONFATAL DROWNIN; Zare H, 2019, TRANSPORT RES F-TRAF, V60, P734, DOI 10.1016/j.trf.2018.10.021; Zhang, 2012, MAT CHILD HLTH CARE, V27, P5049; Zhang Pei-bin, 2003, Zhonghua Er Ke Za Zhi, V41, P497; Zhao Chong-Hua, 2006, Zhongguo Dang Dai Er Ke Za Zhi, V8, P331; Zhou HH, 2013, INT J PEDIATR OTORHI, V77, P494, DOI 10.1016/j.ijporl.2012.12.017; Zhou X, 2013, J ZHEJIANG U TRADITI, V5, P543; Zhu, 2016, PREV MED, V28, P1098; Zhu YC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4462-x; Zimmerman K, 2015, TRAFFIC INJ PREV, V16, P456, DOI 10.1080/15389588.2014.973491; Zwi AB, 1996, T ROY SOC TROP MED H, V90, P593, DOI 10.1016/S0035-9203(96)90399-5	107	12	12	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0243464	10.1371/journal.pone.0243464	http://dx.doi.org/10.1371/journal.pone.0243464			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PS4IU	33373371	Green Published, gold			2022-12-27	WOS:000607887800001
J	Vacaru, SV; van Schaik, JE; de Water, E; Hunnius, S				Vacaru, Stefania V.; van Schaik, Johanna E.; de Water, Erik; Hunnius, Sabine			Five-year-olds' facial mimicry following social ostracism is modulated by attachment security	PLOS ONE			English	Article							EMOTIONAL MIMICRY; NEURAL RESPONSES; EXPRESSIONS; EXCLUSION; BEHAVIOR; CHILDREN; CONSEQUENCES; ASSOCIATIONS; CYBERBALL; IMITATION	Social ostracism triggers an increase in affiliative behaviours. One such behaviour is the rapid copying of others' facial expressions, called facial mimicry. Insofar, it remains unknown how individual differences in intrinsic affiliation motivation regulate responses to social ostracism during early development. We examined children's facial mimicry following ostracism as modulated by individual differences in the affiliation motivation, expressed in their attachment tendencies. Resistant and avoidant tendencies are characterized by high and low affiliation motivation, and were hypothesized to lead to facial mimicry enhancement or suppression towards an ostracizing partner, respectively. Following an ostracism manipulation in which children played a virtual game (Cyberball) with an includer and an excluder peer, mimicry of the two peers' happy and sad facial expressions was recorded with electromyography (EMG). Attachment was assessed via parent-report questionnaire. We found that 5-year-olds smiled to sad facial expressions of the excluder peer, while they showed no facial reactions for the includer peer. Neither resistant nor avoidant tendencies predicted facial mimicry to the excluder peer. Yet, securely attached children smiled towards the excluder peer, when sad facial expressions were displayed. In conclusion, these findings suggest a modulation of facial reactions following ostracism by early attachment.	[Vacaru, Stefania V.; Hunnius, Sabine] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [van Schaik, Johanna E.] Vrije Univ, Amsterdam, Netherlands; [de Water, Erik] Univ Minnesota, Minneapolis, MN USA	Radboud University Nijmegen; Vrije Universiteit Amsterdam; University of Minnesota System; University of Minnesota Twin Cities	Vacaru, SV (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	v.vacaru@donders.ru.nl			Aspasia Prize of the Netherlands Organisation for Scientific Research (NWO)	Aspasia Prize of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by an Aspasia Prize of the Netherlands Organisation for Scientific Research (NWO) awarded to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addabbo M, 2020, DEVELOPMENTAL SCI, V23, DOI 10.1111/desc.12873; AINSWORTH MDS, 1979, AM PSYCHOL, V34, P932, DOI 10.1037/0003-066X.34.10.932; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2011, HDB THEORIES SOCIALP, V2, P121, DOI [10.4135/9781446249222.n32, DOI 10.4135/9781446249222.N32]; BAYES MA, 1972, J CONSULT CLIN PSYCH, V39, P333, DOI 10.1037/h0033367; Bos PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167991; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Bowlby J, 1988, SECURE BASE PARENT C; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Chow RM, 2008, J EXP SOC PSYCHOL, V44, P896, DOI 10.1016/j.jesp.2007.09.004; Colonnesi C, 2013, RES SOCIAL WORK PRAC, V23, P179, DOI 10.1177/1049731512469301; Crisp RJ, 2009, J EXP SOC PSYCHOL, V45, P115, DOI 10.1016/j.jesp.2008.09.006; Datyner A, 2017, DEV PSYCHOBIOL, V59, P1046, DOI 10.1002/dev.21575; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; De Luca G., 2003, FUNDAMENTAL CONCEPTS; de Wied M, 2006, J PSYCHIAT RES, V40, P112, DOI 10.1016/j.jpsychires.2005.08.003; DeWall CN, 2012, SOC COGN AFFECT NEUR, V7, P184, DOI 10.1093/scan/nsq107; DIMBERG U, 1982, PSYCHOPHYSIOLOGY, V19, P643, DOI 10.1111/j.1469-8986.1982.tb02516.x; Dufner M, 2015, J PERS SOC PSYCHOL, V109, P662, DOI 10.1037/pspp0000025; Fodor EM, 2006, J RES PERS, V40, P598, DOI 10.1016/j.jrp.2005.06.001; Fraley R, 1998, DISMISSING AVOIDANCE; Fraley R.C., 2000, REV GEN PSYCHOL, V4, P132, DOI [DOI 10.1037/1089-2680.4.2.132, 10.1037/1089-2680.4.2.132, DOI 10.1037/0022-3514.52.3.511, https://doi.org/10.1037/1089-2680.4.2.132]; Furl N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033461; Geangu E, 2016, J EXP CHILD PSYCHOL, V144, P1, DOI 10.1016/j.jecp.2015.11.001; GmbH. BP, 2009, BRAINVISION AN 2 0 1; Groh AM, 2017, CHILD DEV PERSPECT, V11, P70, DOI 10.1111/cdep.12213; Hall NR, 2012, J NONVERBAL BEHAV, V36, P235, DOI 10.1007/s10919-012-0136-7; Hartgerink CHJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127002; Hess U, 2017, ROLE EMOTIONAL MIMIC, DOI [10.1093/ACREFORE/9780190228613.013.433, DOI 10.1093/ACREFORE/9780190228613.013.433]; Hess U., 2016, EMOTIONAL MIMICRY SO, P90, DOI [10.1017/CBO9781107587595.006, DOI 10.1017/CBO9781107587595.006, 10.1017/CBO9781107587595]; Hess U, 2014, SOC PERSONAL PSYCHOL, V8, P45, DOI 10.1111/spc3.12083; Huhnel I, 2018, COGNITION EMOTION, V32, P92, DOI 10.1080/02699931.2017.1284046; ISABELLA RA, 1993, CHILD DEV, V64, P605, DOI 10.2307/1131272; Kaiser J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17556-y; Kampf MS, 2018, PSYCHOL SCI, V29, P131, DOI 10.1177/0956797617727121; Karremans JC, 2011, INT J PSYCHOPHYSIOL, V81, P44, DOI 10.1016/j.ijpsycho.2011.04.003; Kobak R, 2019, CURR OPIN PSYCHOL, V25, P76, DOI 10.1016/j.copsyc.2018.02.018; KOCHANSKA G, 1993, CHILD DEV, V64, P325, DOI 10.2307/1131254; Kraaijenvanger EJ, 2017, NEUROSCI BIOBEHAV R, V77, P98, DOI 10.1016/j.neubiorev.2017.03.006; Laible DJ, 2000, CHILD DEV, V71, P1424, DOI 10.1111/1467-8624.00237; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lapatki BG, 2010, PSYCHOPHYSIOLOGY, V47, P299, DOI 10.1111/j.1469-8986.2009.00935.x; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Moor BG, 2012, NEUROIMAGE, V59, P708, DOI 10.1016/j.neuroimage.2011.07.028; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Niermann Hannah C M, 2015, Front Behav Neurosci, V9, P263, DOI 10.3389/fnbeh.2015.00263; Oberman LM, 2009, DEVELOPMENTAL SCI, V12, P510, DOI 10.1111/j.1467-7687.2008.00796.x; Over H, 2009, PSYCHOL SCI, V20, P1189, DOI 10.1111/j.1467-9280.2009.02419.x; Over H, 2009, DEVELOPMENTAL SCI, V12, pF1, DOI 10.1111/j.1467-7687.2008.00820.x; Powell B., 2009, HDB INFANT MENTAL HL, P450; Puetz VB, 2014, J AM ACAD CHILD PSY, V53, P1328, DOI 10.1016/j.jaac.2014.09.004; Raikes HA, 2008, ATTACH HUM DEV, V10, P319, DOI 10.1080/14616730802113620; Roisman GI, 2005, ATTACH HUM DEV, V7, P105, DOI 10.1080/14616730500134928; Scheithauer H., 2013, INT J DEV SCI, V7, P1, DOI [10.3233/DEV-1300071, DOI 10.3233/DEV-1300071]; Song HJ, 2012, J EXP SOC PSYCHOL, V48, P450, DOI 10.1016/j.jesp.2011.10.003; Song RT, 2015, DEV PSYCHOL, V51, P831, DOI 10.1037/a0039176; Sonnby-Borgstrom M, 2004, SCAND J PSYCHOL, V45, P103, DOI 10.1111/j.1467-9450.2004.00385.x; Sroufe L. A., 2005, ATTACHMENT INFANCY A; TASSINARY LG, 1989, PSYCHOPHYSIOLOGY, V26, P1, DOI 10.1111/j.1469-8986.1989.tb03125.x; Thompson R.A., 2008, HDB ATTACHMENT THEOR, V2nd ed., P348; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Twenge JM, 2001, J PERS SOC PSYCHOL, V81, P1058, DOI 10.1037//0022-3514.81.6.1058; Vacaru SV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218676; van Boxtel A., 2010, P MEAS BEH 2010 EIND, P104, DOI DOI 10.1145/1931344.1931382; van Ijzendoorn MH, 1999, DEV PSYCHOPATHOL, V11, P225, DOI 10.1017/S0954579499002035; van Schaik JE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194102; van Schaik JE, 2016, J EXP CHILD PSYCHOL, V147, P71, DOI 10.1016/j.jecp.2016.03.003; Watson R., 2013, RITUALISTIC CHILD IM; Watson-Jones RE, 2016, PSYCHOL SCI, V27, P34, DOI 10.1177/0956797615607205; Watson-Jones RE, 2014, EVOL HUM BEHAV, V35, P204, DOI 10.1016/j.evolhumbehav.2014.01.004; White LO, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01926; Will GJ, 2016, DEV COGN NEUROS-NETH, V19, P288, DOI 10.1016/j.dcn.2016.05.004; Williams K. D., 2005, SOCIAL PSYCHOL INCLU, P47; Williams KD, 2007, ANNU REV PSYCHOL, V58, P425, DOI 10.1146/annurev.psych.58.110405.085641; Williams KD, 2006, BEHAV RES METHODS, V38, P174, DOI 10.3758/BF03192765; Williams KD, 2011, CURR DIR PSYCHOL SCI, V20, P71, DOI 10.1177/0963721411402480; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Wissink IB, 2016, CHILD INDIC RES, V9, P533, DOI 10.1007/s12187-015-9322-6	81	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0240680	10.1371/journal.pone.0240680	http://dx.doi.org/10.1371/journal.pone.0240680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373379	Green Published, gold			2022-12-27	WOS:000603612300015
J	Cerda, P; Ribas, J; Iriarte, A; Mora-Lujan, JM; Torres, R; del Rio, B; Jofre, HI; Ruiz, Y; Huguet, M; Fuset, MP; Martinez-Yelamos, S; Santos, S; Llecha, N; Corbella, X; Riera-Mestre, A				Cerda, Pau; Ribas, Jesus; Iriarte, Adriana; Mora-Lujan, Jose Maria; Torres, Raquel; del Rio, Belen; Jofre, Hector Ignacio; Ruiz, Yolanda; Huguet, Marta; Fuset, Mari Paz; Martinez-Yelamos, Sergio; Santos, Salud; Llecha, Nuria; Corbella, Xavier; Riera-Mestre, Antoni			Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosis	PLOS ONE			English	Article							MANAGEMENT; COAGULOPATHY	Background A higher incidence of thrombotic events, mainly pulmonary embolism (PE), has been reported in hospitalized patients with COVID-19. The main objective was to assess clinical and laboratory differences in hospitalized COVID-19 patients according to occurrence of PE. Methods This retrospective study included all consecutive patients hospitalized with COVID-19 who underwent a computed tomography (CT) angiography for PE clinical suspicion. Clinical data and median blood test results distributed into weekly periods from COVID-19 symptoms onset, were compared between PE and non-PE patients. Results Ninety-two patients were included, 29 (32%) had PE. PE patients were younger (63.9 (SD 13.7) vs 69.9 (SD 12.5) years). Clinical symptoms and COVID-19 CT features were similar in both groups. PE was diagnosed after a mean of 20.0 (SD 8.6) days from the onset of COVID-19 symptoms. Corticosteroid boluses were more frequently used in PE patients (62% vs. 43%). No patients met ISTH DIC criteria. Any parameter was statistically significant or clinically relevant except for D-Dimer when comparing both groups. Median values [IQR] of D-dimer in PE vs non-PE patients were: week 2 (2010.7 [770.1-11208.9] vs 626.0 [374.0-2382.2]; p = 0.004); week 3 (3893.1 [1388.2-6694.0] vs 1184.4 [461.8-2447.8]; p = 0.003); and week 4 (2736.3 [1202.1-8514.1] vs 1129.1 [542.5-2834.6]; p = 0.01). Median fold-increase of D-dimer between week 1 and 2 differed between groups (6.64 [3.02-23.05] vs 1.57 [0.64-2.71], p = 0.003); ROC curve AUC was 0.879 (p = 0.003) with a sensitivity and specificity for PE of 86% and 80%, respectively. Conclusions Among hospitalized COVID-19 patients, D-dimer levels are higher at weeks 2, 3 and 4 after COVID-19 symptom onset in patients who develop PE. This difference is more pronounced when the fold increase between weeks 1 and 2 is compared.	[Cerda, Pau; Iriarte, Adriana; Mora-Lujan, Jose Maria; Torres, Raquel; Corbella, Xavier; Riera-Mestre, Antoni] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Internal Med, Barcelona, Spain; [Ribas, Jesus; Ruiz, Yolanda; Santos, Salud] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Pneumol, Barcelona, Spain; [del Rio, Belen; Jofre, Hector Ignacio] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Imaging Diagnost, Barcelona, Spain; [Huguet, Marta; Fuset, Mari Paz] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Intens Med, Barcelona, Spain; [Martinez-Yelamos, Sergio] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Neurol, Barcelona, Spain; [Llecha, Nuria] Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Clin Lab, Barcelona, Spain; [Corbella, Xavier] Univ Int Catalunya, Sch Med, Barcelona, Spain; [Riera-Mestre, Antoni] Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universitat Internacional de Catalunya (UIC); University of Barcelona	Riera-Mestre, A (corresponding author), Hosp Univ Bellvitge, Bellvitge Biomed Res Inst IDIBELL, Dept Internal Med, Barcelona, Spain.; Riera-Mestre, A (corresponding author), Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain.	ariera@bellvitgehospital.cat		Santos, Salud/0000-0002-5835-1028; Cerda, Pau/0000-0003-4368-6260; Ribas Sola, Jesus/0000-0001-7356-4307	Research Committee of the University Hospital of Bellvitge (HUB; Barcelona, Spain)	Research Committee of the University Hospital of Bellvitge (HUB; Barcelona, Spain)	PC receives a salary by an Intensification/Post-Residency Grant from Research Committee of the University Hospital of Bellvitge (HUB; Barcelona, Spain) 2019-2021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Avruscio G, 2020, CTS-CLIN TRANSL SCI, V13, P1108, DOI 10.1111/cts.12907; Barco S, 2020, LANCET RESP MED, V8, P277, DOI 10.1016/S2213-2600(19)30354-6; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Bompard F, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01365-2020; Cattaneo M, 2020, THROMB HAEMOSTASIS, V120, P1230, DOI 10.1055/s-0040-1712097; Cui SP, 2020, J THROMB HAEMOST, V18, P1421, DOI 10.1111/jth.14830; Di Nisio M, 2021, EUR J INTERN MED, V83, P34, DOI 10.1016/j.ejim.2020.10.020; Esmon CT, 2005, BIOCHEM SOC T, V33, P401, DOI 10.1042/BST0330401; Fu JH, 2020, THROMB RES, V192, P3, DOI 10.1016/j.thromres.2020.05.006; Grillet F, 2020, RADIOLOGY, V296, pE186, DOI 10.1148/radiol.2020201544; Grimes DA, 2002, LANCET, V359, P145, DOI 10.1016/S0140-6736(02)07373-7; Gustafson D, 2020, ARTERIOSCL THROM VAS, V40, P1818, DOI 10.1161/ATVBAHA.120.314558; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Iba T, 2018, J THROMB HAEMOST, V16, P231, DOI 10.1111/jth.13911; Iba T, 2019, J THROMB HAEMOST, V17, P1989, DOI 10.1111/jth.14578; Jackson SP, 2019, BLOOD, V133, P906, DOI 10.1182/blood-2018-11-882993; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Konstantinides Stavros V, 2020, Eur Heart J, V41, P543, DOI 10.1093/eurheartj/ehz405; Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561; Lippi G, 2020, THROMB HAEMOSTASIS, V120, P876, DOI 10.1055/s-0040-1709650; Marietta M, 2020, BLOOD TRANSFUS-ITALY, V18, P167, DOI 10.2450/2020.0083-20; Marongiu F, 2020, J THROMB HAEMOST, V18, P1511, DOI 10.1111/jth.14818; Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888; Panigada M, 2020, J THROMB HAEMOST, V18, P1738, DOI 10.1111/jth.14850; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Prokop M, 2020, RADIOLOGY, V296, pE97, DOI 10.1148/radiol.2020201473; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Spiezia L, 2020, THROMB HAEMOSTASIS, V120, P998, DOI 10.1055/s-0040-1710018; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Thachil J, 2020, J THROMB HAEMOST, V18, P1795, DOI 10.1111/jth.14841; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; WHO, 2020, COR DIS COVID 19 OUT; Whyte MB, 2020, THROMB RES, V195, P95, DOI 10.1016/j.thromres.2020.07.025; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Yin JJ, 2014, STAT MED, V33, P985, DOI 10.1002/sim.5992; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu JY, 2020, J MED VIROL, V92, P1902, DOI [10.1002/jmv.25884, 10.1002/jmv.26085]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	44	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243533	10.1371/journal.pone.0243533	http://dx.doi.org/10.1371/journal.pone.0243533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370304	Green Published, gold			2022-12-27	WOS:000603611900055
J	Heikkinen, T; Bragge, T; Bhattarai, N; Parkkari, T; Puolivali, J; Kontkanen, O; Sweeney, P; Park, LC; Munoz-Sanjuan, I				Heikkinen, Taneli; Bragge, Timo; Bhattarai, Niina; Parkkari, Teija; Puolivali, Jukka; Kontkanen, Outi; Sweeney, Patrick; Park, Larry C.; Munoz-Sanjuan, Ignacio			Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease	PLOS ONE			English	Article							INTERLIMB COORDINATION; GAIT ANALYSIS; MOTOR ABNORMALITIES; TIME-COURSE; SYMPTOMS; DISTURBANCES; IMPAIRMENT; RECOVERY; ROTATION; REPEAT	Huntington's disease (HD) is an inherited neurodegenerative disorder characterized by severe disruption of cognitive and motor functions, including changes in posture and gait. A number of HD mouse models have been engineered that display behavioral and neuropathological features of the disease, but gait alterations in these models are poorly characterized. Sensitive high-throughput tests of fine motor function and gait in mice might be informative in evaluating disease-modifying interventions. Here, we describe a hypothesis-free workflow that determines progressively changing locomotor patterns across 79 parameters in the R6/2 and Q175 mouse models of HD. R6/2 mice (120 CAG repeats) showed motor disturbances as early as at 4 weeks of age. Similar disturbances were observed in homozygous and heterozygous Q175 KI mice at 3 and 6 months of age, respectively. Interestingly, only the R6/2 mice developed forelimb ataxia. The principal components of the behavioral phenotypes produced two phenotypic scores of progressive postural instability based on kinematic parameters and trajectory waveform data, which were shared by both HD models. This approach adds to the available HD mouse model research toolbox and has a potential to facilitate the development of therapeutics for HD and other debilitating movement disorders with high unmet medical need.	[Heikkinen, Taneli; Bragge, Timo; Parkkari, Teija; Puolivali, Jukka; Kontkanen, Outi] Charles River Discovery Serv, Kuopio, Finland; [Bhattarai, Niina] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland; [Sweeney, Patrick; Park, Larry C.] Naason Sci Inc, Chungcheongbuk Do, South Korea; [Park, Larry C.; Munoz-Sanjuan, Ignacio] CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA	University of Eastern Finland	Munoz-Sanjuan, I (corresponding author), CHDI Fdn, CHDI Management, Los Angeles, CA 90045 USA.	ignacio.munoz@chdifoundation.org	Harju, Niina/ABA-7085-2020	Harju, Niina/0000-0001-9031-5353; Heikkinen, Taneli/0000-0002-8844-6618; Bragge, Timo/0000-0002-8634-0297	CHDI Foundation	CHDI Foundation	CHDI Foundation is a not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. The research described was conducted by Charles River under a fee-for-service agreement for CHDI Foundation in collaboration with and funded by CHDI Foundation. The funder, through CHDI Management, fully participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Abada YSK, 2016, BEHAV PHARMACOL, V27, P403, DOI 10.1097/FBP.0000000000000217; Abd-Elrahman KS, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan6387; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Alexandrov V, 2016, NAT BIOTECHNOL, V34, P838, DOI 10.1038/nbt.3587; Alpaugh M, 2017, EMBO MOL MED, V9, P1537, DOI 10.15252/emmm.201707763; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; BARCLAY OR, 1953, J EXP BIOL, V30, P116; Bellardita C, 2015, CURR BIOL, V25, P1426, DOI 10.1016/j.cub.2015.04.005; Biglan KM, 2009, MOVEMENT DISORD, V24, P1763, DOI 10.1002/mds.22601; Broom L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03336-1; Carlozzi NE, 2014, J HUNTINGTONS DIS, V3, P233, DOI 10.3233/JHD-140115; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen X, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-81; Croft JL, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00716; Dai Y, 2009, J NEUROSCI, V29, P11550, DOI 10.1523/JNEUROSCI.3307-09.2009; Datson NA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171127; Defazio Giovanni, 2013, Tremor Other Hyperkinet Mov (N Y), V3, DOI 10.7916/D8QN65GQ; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Delval A, 2006, J NEUROL, V253, P73, DOI 10.1007/s00415-005-0929-2; Delval A, 2008, MOVEMENT DISORD, V23, P684, DOI 10.1002/mds.21896; Deng YP, 2021, J COMP NEUROL, V529, P1327, DOI 10.1002/cne.25023; Dong Y, 2013, CLIN GENET, V83, P380, DOI 10.1111/j.1399-0004.2012.01927.x; Federolf PA, 2013, J BIOMECH, V46, P2173, DOI 10.1016/j.jbiomech.2013.06.032; Ferrara JM, 2012, NEUROL THER, V1, DOI 10.1007/s40120-012-0005-7; Fiander MDJ, 2017, JOVE-J VIS EXP, DOI 10.3791/56032; Garry MI, 2005, HUM MOVEMENT SCI, V24, P849, DOI 10.1016/j.humov.2005.10.005; Gassner H, 2020, J NEUROL, V267, P1594, DOI 10.1007/s00415-020-09725-3; Gloersen O, 2018, J SPORT SCI, V36, P229, DOI 10.1080/02640414.2017.1298826; Grande G, 2019, EXP GERONTOL, V124, DOI 10.1016/j.exger.2019.05.014; Grimbergen YAM, 2008, MOVEMENT DISORD, V23, P970, DOI 10.1002/mds.22003; Gulinello M, 2019, NEUROBIOL LEARN MEM, V165, DOI 10.1016/j.nlm.2018.01.001; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Heikkinen T, 2016, 31127M10 SOC NEUR; Heikkinen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050717; Hetze S, 2012, J NEUROSCI METH, V206, P7, DOI 10.1016/j.jneumeth.2012.02.001; Hsieh TH, 2011, BEHAV BRAIN RES, V222, P1, DOI 10.1016/j.bbr.2011.03.031; Jolliffe I, 2011, PRINCIPAL COMPONENT; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kale A, 2008, HYPERKINETIC RIGID G; Kegelmeyer DA, 2014, J NEUROL SCI, V347, P219, DOI 10.1016/j.jns.2014.09.053; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; LAZARUS JAC, 1992, MOVEMENT DISORD, V7, P159, DOI 10.1002/mds.870070211; Leblond H, 2003, J NEUROSCI, V23, P11411; Lee HY, 2012, MED BIOL ENG COMPUT, V50, P937, DOI 10.1007/s11517-012-0933-5; Li KZH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00913; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mancuso R, 2011, BRAIN RES, V1406, P65, DOI 10.1016/j.brainres.2011.06.033; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; McColgan P, 2018, EUR J NEUROL, V25, P24, DOI 10.1111/ene.13413; Menalled LB, 2003, J COMP NEUROL, V465, P11, DOI 10.1002/cne.10776; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Menalled LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049838; Mestre TA, 2018, MOV DISORD CLIN PRAC, V5, P111, DOI 10.1002/mdc3.12571; Mirelman A, 2019, LANCET NEUROL, V18, P697, DOI 10.1016/S1474-4422(19)30044-4; Muybridge E., 1881, ATTITUDES ANIMALS MO; Nanhoe-Mahabier W, 2011, NEUROSCIENCE, V182, P217, DOI 10.1016/j.neuroscience.2011.02.061; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Paldino E, 2020, MOL NEUROBIOL, V57, P1889, DOI 10.1007/s12035-019-01847-8; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Pyo SJ, 2017, J MOV DISORD, V10, P140, DOI 10.14802/jmd.17041; Ramaswamy S, 2007, ILAR J, V48, P356, DOI 10.1093/ilar.48.4.356; Reiner A, 2012, NEUROBIOL DIS, V47, P75, DOI 10.1016/j.nbd.2012.03.025; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Rodriguez-Quiroga Sergio Alejandro, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2012-008380; Rostosky CM, 2018, JOVE-J VIS EXP, DOI 10.3791/57752; Schutte LM, 2000, GAIT POSTURE, V11, P25, DOI 10.1016/S0966-6362(99)00047-8; Schwartz MH, 2008, GAIT POSTURE, V28, P351, DOI 10.1016/j.gaitpost.2008.05.001; Shuvaev AN, 2017, J PHYSIOL-LONDON, V595, P141, DOI 10.1113/JP272950; SPARROW WA, 1983, J MOTOR BEHAV, V15, P237; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Takakusaki K, 2017, J MOV DISORD, V10, P1, DOI 10.14802/jmd.16062; Takeuchi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047553; Tanahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084423; Thibaudier Y, 2017, J NEUROTRAUM, V34, P1751, DOI 10.1089/neu.2016.4421; Vandeputte C, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-92; Vuong K, 2018, HAND CLINIC, V159, P251, DOI 10.1016/B978-0-444-63916-5.00016-1; Wang XH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-142; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; William Yang X, 2011, NEUROBIOLOGY HUNTING; Zimmermann T, 2016, STEM CELL REP, V7, P693, DOI 10.1016/j.stemcr.2016.08.018; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	84	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243052	10.1371/journal.pone.0243052	http://dx.doi.org/10.1371/journal.pone.0243052			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370315	gold, Green Published			2022-12-27	WOS:000603611900122
J	Pan, X; Wang, ZY; Gao, Y; Zhang, ZC; Meng, ZJ; Dang, XH; Lu, LQ; Chen, JH				Pan, Xia; Wang, Zhenyi; Gao, Yong; Zhang, Zhengcai; Meng, Zhongjv; Dang, Xiaohong; Lu, Liqiang; Chen, Jiahuan			Windbreak and airflow performance of different synthetic shrub designs based on wind tunnel experiments	PLOS ONE			English	Article							WATER-USE EFFICIENCY; SHELTERBELT STRUCTURE; SEDIMENT TRANSPORT; ECOSYSTEM SERVICES; EROSION; SPEED; DESERTIFICATION; BIODIVERSITY; RESPONSES; RECOVERY	Wind erosion has gained increasing attention as one of the most serious global ecological and environmental threats. Windbreaks are effective at decreasing wind erosion by reducing wind speed to protect crops, livestock, and farmsteads, while providing wildlife habitats. Synthetic shrubs can act as novel windbreaks; however, there is limited knowledge on how their design affects wind speed. This study determined the protective effects (airflow field and sheltering efficiency) based on the design of synthetic shrubs in a wind tunnel. Broom-shaped synthetic shrubs weakened the wind speeds mainly at the middle and upper parts of the shrubs (5-14 cm), while for hemisphere-shaped shrubs this effect was greatest near their bases (below 4 cm) and least in the middle and upper parts (7-14 cm). Spindle-shaped synthetic shrubs provided the best reduction effect in wind range and strength. Moreover, the wind speed reduction ratio decreased with improved wind speeds and ranged from 26.25 cm (between the second and third rows) to 52.5 cm (after the third row). These results provide strong evidence that synthetic shrubs should be considered to decrease wind speed and prevent wind erosion.	[Pan, Xia; Wang, Zhenyi; Gao, Yong; Meng, Zhongjv; Dang, Xiaohong; Lu, Liqiang; Chen, Jiahuan] Inner Mongolia Agr Univ, Coll Desert Control Sci & Engn, Hohhot, Inner Mongolia, Peoples R China; [Gao, Yong; Meng, Zhongjv] Wind Eros Key Lab Cent & Govt, Hohhot, Inner Mongolia, Peoples R China; [Zhang, Zhengcai] Chinese Acad Sci, Key Lab Desert & Desertificat, Northwest Inst Ecoenvironm & Resources, Lanzhou, Peoples R China; [Dang, Xiaohong] Natl Positioning Observat Res Stn Hangjin Desert, Ordos, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Chinese Academy of Sciences	Gao, Y (corresponding author), Inner Mongolia Agr Univ, Coll Desert Control Sci & Engn, Hohhot, Inner Mongolia, Peoples R China.; Gao, Y (corresponding author), Wind Eros Key Lab Cent & Govt, Hohhot, Inner Mongolia, Peoples R China.	13948815709@163.com		xia, Pan/0000-0001-6618-4162	National Natural Science Foundation of China [41967009]; 10th "Prairie Talents" of Inner Mongolia Autonomous Region [PC201907220608]; China Scholarship Council [201908150155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 10th "Prairie Talents" of Inner Mongolia Autonomous Region; China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China: Action Mechanism Research on Ecology Spatial Configuration of Desert Shrub to the Formation and Development of Fertile Island (41967009), the 10th "Prairie Talents" of Inner Mongolia Autonomous Region (PC201907220608), and the China Scholarship Council (201908150155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANZHAF J, 1992, AGRON J, V84, P1056, DOI 10.2134/agronj1992.00021962008400060028x; Boutraa T, 2010, J TAIBAH UNIV SCI, V3, P39, DOI 10.1016/S1658-3655(12)60019-3; Brandle JR, 2004, AGROFOREST SYST, V61-2, P65, DOI 10.1023/B:AGFO.0000028990.31801.62; Cao JX, 2012, URBAN FOR URBAN GREE, V11, P465, DOI 10.1016/j.ufug.2012.05.003; Chen BY, 2019, AEOLIAN RES, V38, P1, DOI 10.1016/j.aeolia.2019.03.001; Chen XH, 2016, LAND DEGRAD DEV, V27, P561, DOI 10.1002/ldr.2400; Chen YF, 2003, ENVIRON MANAGE, V32, P413, DOI 10.1007/s00267-003-0042-1; Cheng H, 2019, AGR FOREST METEOROL, V266, P29, DOI 10.1016/j.agrformet.2018.11.039; Cheng H, 2018, AGR FOREST METEOROL, V263, P362, DOI 10.1016/j.agrformet.2018.08.025; Cornelis Wim M., 2000, Secheresse (Montrouge), V11, P52; Cornelis WM, 2005, J ARID ENVIRON, V61, P315, DOI 10.1016/j.jaridenv.2004.10.005; Van Thuyet D, 2014, AGROFOREST SYST, V88, P237, DOI 10.1007/s10457-013-9671-4; Dong ZB, 2007, AGR FOREST METEOROL, V146, P82, DOI 10.1016/j.agrformet.2007.05.009; Dupont S, 2014, J GEOPHYS RES-EARTH, V119, P168, DOI 10.1002/2013JF002875; Dupont S, 2009, J FLUID MECH, V630, P93, DOI 10.1017/S0022112009006739; Dupont S, 2011, AGR FOREST METEOROL, V151, P328, DOI 10.1016/j.agrformet.2010.11.007; Finnigan J, 2000, ANNU REV FLUID MECH, V32, P519, DOI 10.1146/annurev.fluid.32.1.519; Fu LT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48574-7; GANDEMER J, 1979, J IND AERODYNAM, V4, P371, DOI 10.1016/0167-6105(79)90013-8; Gillies JA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001259; Gillies JA, 2014, AEOLIAN RES, V12, P135, DOI 10.1016/j.aeolia.2013.12.005; Hesp PA, 2019, GEOMORPHOLOGY, V337, P165, DOI 10.1016/j.geomorph.2019.03.020; Hong Y, 2016, J EARTH SYST SCI, V125, P499, DOI 10.1007/s12040-016-0684-z; Hua FY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12717; Leenders JK, 2007, EARTH SURF PROC LAND, V32, P1454, DOI 10.1002/esp.1452; Leenders JK, 2011, EARTH SURF PROC LAND, V36, P1218, DOI 10.1002/esp.2147; Li GS, 2013, ECOL ENG, V57, P293, DOI 10.1016/j.ecoleng.2013.04.042; Li WH, 2004, FOREST ECOL MANAG, V201, P33, DOI 10.1016/j.foreco.2004.06.010; [李雪琳 Li Xuelin], 2018, [中国沙漠, Journal of Desert Research], V38, P936; Liu BL, 2019, CATENA, V172, P266, DOI 10.1016/j.catena.2018.08.037; Liu CC, 2011, TREES-STRUCT FUNCT, V25, P537, DOI 10.1007/s00468-010-0533-7; Liu YA, 2010, AFR J AGR RES, V5, P1598; Ma R, 2010, J WIND ENG IND AEROD, V98, P767, DOI 10.1016/j.jweia.2010.07.001; Miri A, 2019, CATENA, V172, P421, DOI 10.1016/j.catena.2018.09.006; Moore JC, 2016, EARTHS FUTURE, V4, P588, DOI 10.1002/2016EF000402; Munson SM, 2011, P NATL ACAD SCI USA, V108, P3854, DOI 10.1073/pnas.1014947108; Neumeier U, 2005, ESTUAR COAST SHELF S, V63, P489, DOI 10.1016/j.ecss.2004.12.009; Okin GS, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000758; Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295; PERERA MDAES, 1981, J WIND ENG IND AEROD, V8, P93, DOI 10.1016/0167-6105(81)90010-6; RAUPACH MR, 1992, BOUND-LAY METEOROL, V60, P375, DOI 10.1007/BF00155203; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Rosenberg N.J., 1974, MICROCLIMATE BIOL EN; Safriel U, 2017, SILVA FENN, V51, DOI 10.14214/sf.1650; Schlesinger WH, 1996, ECOLOGY, V77, P364, DOI 10.2307/2265615; SEGUIN B, 1973, AGR METEOROL, V11, P79, DOI 10.1016/0002-1571(73)90052-6; Shen W, 2012, GLOBAL PLANET CHANGE, V86-87, P37, DOI 10.1016/j.gloplacha.2012.01.012; Skidmore E. L., 1988, Soil erosion research methods., P203; Torita H, 2007, AGR FOREST METEOROL, V145, P186, DOI 10.1016/j.agrformet.2007.04.018; Torres L, 2015, LAND DEGRAD DEV, V26, P433, DOI 10.1002/ldr.2392; Wang GuoQian, 2012, Journal of Resources and Ecology, V3, P97; Wu XX, 2015, AEOLIAN RES, V16, P11, DOI 10.1016/j.aeolia.2014.10.004; Xu WH, 2017, P NATL ACAD SCI USA, V114, P1601, DOI 10.1073/pnas.1620503114; Yang YY, 2019, J GEOPHYS RES-EARTH, V124, P1835, DOI 10.1029/2018JF004695; Zang YunXiao, 2015, Environmental Technology Reviews, V4, P119, DOI 10.1080/21622515.2015.1105307; Zhang Hua, 2003, Yingyong Shengtai Xuebao, V14, P1591; [张莹花 Zhang Yinghua], 2017, [中国沙漠, Journal of Desert Research], V37, P859; Zhang ZC, 2017, BOUND-LAY METEOROL, V163, P523, DOI 10.1007/s10546-017-0235-4; Zhang ZC, 2015, AEOLIAN RES, V17, P1, DOI 10.1016/j.aeolia.2015.01.004; Zhou XH, 2002, AGR FOREST METEOROL, V111, P93, DOI 10.1016/S0168-1923(02)00017-5; 2004, COMMUN PURE APPL MAT, V57, P1	61	4	4	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244213	10.1371/journal.pone.0244213	http://dx.doi.org/10.1371/journal.pone.0244213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370328	gold, Green Published			2022-12-27	WOS:000603611900041
J	Raghunathan, N; Francois, L; Cazetta, E; Pitance, JL; De Vleeschouwer, K; Hambuckers, A				Raghunathan, Nima; Francois, Louis; Cazetta, Eliana; Pitance, Jean-Luc; De Vleeschouwer, Kristel; Hambuckers, Alain			Deterministic modelling of seed dispersal based on observed behaviours of an endemic primate in Brazil	PLOS ONE			English	Article							TAMARINS LEONTOPITHECUS-CHRYSOMELAS; LION TAMARINS; MOVEMENT BEHAVIOR; FORAGING STRATEGY; ATLANTIC FOREST; HOME-RANGE; ENVIRONMENTS; SELECTION; DYNAMICS; PATTERNS	Plant species models are among the available tools to predict the future of ecosystems threatened by climate change, habitat loss, and degradation. However, they suffer from low to no inclusion of plant dispersal, which is necessary to predict ecosystem evolution. A variety of seed dispersal models have been conceived for anemochorous and zoochorous plant species, but the coupling between vegetation models and seed dispersal processes remains rare. The main challenge in modelling zoochoric dispersal is simulating animal movements in their complex habitat. Recent developments allow straightforward applications of hidden Markov modelling (HMM) to animal movements, which could ease generalizations when modelling zoochoric seed dispersal. We tested the use of HMM to model seed dispersal by an endangered primate in the Brazilian Atlantic forest, to demonstrate its potential simplicity to simulate seed dispersal processes. We also discuss how to adapt it to other species. We collected information on movement, fruit consumption, deposition, and habitat use of Leontopithecus chrysomelas. We analysed daily trajectories using HMM and built a deterministic Model Of Seed Transfer (MOST), which replicated, with good approximation, the primate's movement and seed deposition patterns as observed in the field. Our results suggest that the dispersal behaviour and short daily-trajectories of L. chrysomelas restrict the species' role in large-scale forest regeneration, but contribute to the prevalence of resource tree species locally, and potentially maintaining tree diversity by preventing local extinction. However, it may be possible to accurately simulate dispersal in an area, without necessarily quantifying variables that influence movement, if the movement can be broken down to step-length and turning angles, and parametrised along with the distribution of gut-transit times. For future objectives, coupling MOST with a DVM could be used to test hypotheses on tree species survival in various scenarios, simulating regeneration and growth at regional scales by including data on main dispersal agents over the area of interest, distribution of tree species, and land use data. The principal advantage of the MOST model is its functionality with data available from the literature as the variables are easy to parametrise. We suggest using the coupled model to perform experiments using only available information, but varying the numbers and species of seed dispersers, or modifying land cover or configuration to test for possible thresholds preventing the extinction of selected tree species.	[Raghunathan, Nima; Francois, Louis; Pitance, Jean-Luc; Hambuckers, Alain] Univ Liege, UR SPHERES, Liege, Belgium; [Raghunathan, Nima; Cazetta, Eliana] Univ Estadual Santa Cruz, Appl Ecol & Conservat Lab, Grad Program Ecol & Biodivers Conservat, Ilheus, BA, Brazil; [De Vleeschouwer, Kristel] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [De Vleeschouwer, Kristel] Bicho do Mato Res Inst, Belo Horizonte, MG, Brazil	University of Liege; Universidade Estadual de Santa Cruz	Raghunathan, N (corresponding author), Univ Liege, UR SPHERES, Liege, Belgium.; Raghunathan, N (corresponding author), Univ Estadual Santa Cruz, Appl Ecol & Conservat Lab, Grad Program Ecol & Biodivers Conservat, Ilheus, BA, Brazil.	nima_toad@hotmail.com	; De Vleeschouwer, Kristel/L-1547-2018	Pitance, Jean-Luc/0000-0003-4379-1554; De Vleeschouwer, Kristel/0000-0002-6358-5603	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.S.-FRIA), Belgium; Wallonie-Bruxelles International (WBI), Belgium; Direction Administration de Recherche et Developpement (DIR-ARD); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.S.-FRIA), Belgium; Wallonie-Bruxelles International (WBI), Belgium; Direction Administration de Recherche et Developpement (DIR-ARD); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	NR: Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.S.-FRIA), Belgium, Wallonie-Bruxelles International (WBI), Belgium, Direction Administration de Recherche et Developpement (DIR-ARD) NR & EC: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 https://www.frs-fnrs.be/fr/http://www.wbi.be/https://www.capes.gov.br/. The funders had no role in study design, data collection & analysis, decision to publich, or preparation of the manuscript.	Albert A, 2013, INT J PRIMATOL, V34, P696, DOI 10.1007/s10764-013-9690-z; Albert A, 2013, RAFFLES B ZOOL, V61, P423; Babweteera F, 2009, BIODIVERS CONSERV, V18, P1611, DOI 10.1007/s10531-008-9546-6; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bateman AW, 2015, J ANIM ECOL, V84, P260, DOI 10.1111/1365-2656.12267; Bequet R, 2012, EUR J FOREST RES, V131, P283, DOI 10.1007/s10342-011-0500-x; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Bialozyt R, 2014, ECOL MODEL, V278, P74, DOI 10.1016/j.ecolmodel.2014.02.004; Bologna S, 2018, MAMM BIOL, V91, P7, DOI 10.1016/j.mambio.2018.03.001; Boyer D, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434014; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Brotcorne F, 2014, AM J PRIMATOL, V76, P1140, DOI 10.1002/ajp.22299; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; Cardoso NA, 2011, MAMMALIA, V75, P327, DOI 10.1515/MAMM.2011.042; Catenacci LS, 2009, BIOTROPICA, V41, P744, DOI 10.1111/j.1744-7429.2009.00530.x; Cattarino L, 2016, J ANIM ECOL, V85, P168, DOI 10.1111/1365-2656.12427; Cheddadi R, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00114; Cruzan MB, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600041; de Paula MD, 2018, OIKOS, V127, P1526, DOI 10.1111/oik.05084; De Vleeschouwer Kristel M, 2017, Primate Biol, V4, P61, DOI 10.5194/pb-4-61-2017; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Fischer M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199617; Fontaine CM, 2014, J LAND USE SCI, V9, P278, DOI 10.1080/1747423X.2013.786150; FOURNIER LA, 1974, TURRIALBA, V24, P422; Gazagne E, 2020, RAFFLES B ZOOL, V68, P735, DOI 10.26107/RBZ-2020-0085; Gazagne E, 2020, FORESTS, V11, DOI 10.3390/f11111184; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; Gonsalves L, 2018, AUST MAMMAL, V40, P220, DOI 10.1071/AM17031; Granier N, 2014, AM J PRIMATOL, V76, P999, DOI 10.1002/ajp.22278; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Holbrook KM, 2011, BIOTROPICA, V43, P357, DOI 10.1111/j.1744-7429.2010.00710.x; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Lapenta MJ, 2008, TROP CONSERV SCI, V1, P122, DOI 10.1177/194008290800100205; Lehrke RM, 2017, WILDLIFE RES, V44, P558, DOI 10.1071/WR17064; Levey DJ, 2008, J ECOL, V96, P599, DOI 10.1111/j.1365-2745.2008.01401.x; Michelot T, 2016, METHODS ECOL EVOL, V7, P1308, DOI 10.1111/2041-210X.12578; Nabe-Nielsen J, 2013, OIKOS, V122, P1307, DOI 10.1111/j.1600-0706.2013.00069.x; Nather W, 2003, BIOMETRICAL J, V45, P1006, DOI 10.1002/bimj.200390058; Neumann W, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0036-7; Nield AP, 2020, J ECOL, V108, P687, DOI 10.1111/1365-2745.13287; Nuttle T, 2005, AM NAT, V165, P336, DOI 10.1086/428298; Oleksy R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184023; Pakeman RJ, 2001, J BIOGEOGR, V28, P795, DOI 10.1046/j.1365-2699.2001.00581.x; Palminteri S, 2012, OIKOS, V121, P1896, DOI 10.1111/j.1600-0706.2012.20456.x; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Pessoa MS, 2017, PERSPECT PLANT ECOL, V28, P78, DOI 10.1016/j.ppees.2017.09.001; Pessoa MS, 2017, BIOTROPICA, V49, P45, DOI 10.1111/btp.12359; Plante S, 2014, J ANIM ECOL, V83, P116, DOI 10.1111/1365-2656.12119; Pyke GH, 2015, METHODS ECOL EVOL, V6, P1, DOI 10.1111/2041-210X.12298; Raghunathan N, 2019, REG ENVIRON CHANGE, V19, P219, DOI 10.1007/s10113-018-1405-8; Raghunathan N, 2015, REG ENVIRON CHANGE, V15, P683, DOI 10.1007/s10113-014-0625-9; Redwine C, 1995, UPGRADING FORTRAN 90, DOI [10.1007/978-1-4612-2562-1, DOI 10.1007/978-1-4612-2562-1]; Reid, 2016, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2016-1.RLTS.T41635A45211301.en; Reid JL, 2015, ECOL APPL, V25, P1072, DOI 10.1890/14-1399.1; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; Schleppi P, 2007, AGR FOREST METEOROL, V144, P236, DOI 10.1016/j.agrformet.2007.02.004; Steinbauer MJ, 2018, NATURE, V556, P231, DOI 10.1038/s41586-018-0005-6; Stevenson PR, 2007, PLANT ECOL, V190, P245, DOI 10.1007/s11258-006-9205-5; TAYLOR PD, 2017, AVIAN CONSERV ECOL, V12, DOI DOI 10.5751/ACE-00953-120108; Thimonier A, 2010, EUR J FOREST RES, V129, P543, DOI 10.1007/s10342-009-0353-8; Trolliet F, 2017, ACTA OECOL, V85, P69, DOI 10.1016/j.actao.2017.09.010; Trolliet F, 2014, BIOTECHNOL AGRON SOC, V18, P446; van Putten B, 2012, METHODS ECOL EVOL, V3, P642, DOI 10.1111/j.2041-210X.2012.00208.x	64	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244220	10.1371/journal.pone.0244220	http://dx.doi.org/10.1371/journal.pone.0244220			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370339	gold, Green Published			2022-12-27	WOS:000603611900061
J	Yap, L; Jones, J; Donovan, B; Nathan, S; Sullivan, E; Davison, S; Heffernan, E; Richards, A; Meurk, C; Steele, M; Fisher, C; Ton, B; Butler, T				Yap, Lorraine; Jones, Jocelyn; Donovan, Basil; Nathan, Sally; Sullivan, Elizabeth; Davison, Sophie; Heffernan, Ed; Richards, Alun; Meurk, Carla; Steele, Megan; Fisher, Christopher; Ton, Bianca; Butler, Tony			The sexual behaviours of adolescents aged between 14 and 17 years involved with the juvenile justice system in Australia: A community-based survey	PLOS ONE			English	Article							AIDS RISK BEHAVIORS; HEALTH; DISORDERS; SAMPLE; YOUTH; HIV	Objectives To overcome key knowledge gaps in relation to justice involved and vulnerable young people and their sexual health and to compare this group with their peers from other youth health surveys in Australia to determine the extent of the issues. Methods Young people, aged between 14 and 17 years, who had ever been or were currently involved with the criminal justice system were purposively sampled. The survey was anonymous and delivered using Computer Assisted Telephone Interview (CATI). Results A total of 465 justice involved MeH-JOSH young people, aged between 14 and 17 years, participated in the study: 44% Aboriginal and/or Torres Strait Islander (Indigenous) and 37% not attending school. Of the total valid responses, 76% (n = 348) reported having ever had sex, with sexual initiation at a median age of 14 years. We compared these data with their peers in other Australian surveys and found that young people in our study had a higher engagement in sex and start having sex at a younger age, reporting more sexual partners at all ages. Conclusions The sexual behaviours of young people involved in the justice system in this study suggest they may be at a greater risk for sexually transmissible infections than their age-matched peers in the general population. Policymakers should elevate them to a priority population for targeting sexual health services and health promotion.	[Yap, Lorraine; Donovan, Basil] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia; [Jones, Jocelyn; Davison, Sophie] Natl Drug Res Inst, Perth, WA, Australia; [Nathan, Sally; Ton, Bianca; Butler, Tony] Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia; [Sullivan, Elizabeth] Univ Newcastle, Callaghan, NSW, Australia; [Davison, Sophie] North Metropolitan Hlth Serv, State Forens Mental Hlth Serv, Nedlands, WA, Australia; [Davison, Sophie] Off Chief Psychiatrist, Nedlands, WA, Australia; [Heffernan, Ed; Meurk, Carla] Queensland Forens Mental Hlth Serv, Brisbane, Qld, Australia; [Heffernan, Ed; Meurk, Carla; Steele, Megan] Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Heffernan, Ed] Univ Queensland, Brisbane, Qld, Australia; [Richards, Alun] Communicable Dis Branch Queensland Hlth, Immunisat Program, Brisbane, Qld, Australia; [Richards, Alun] Communicable Dis Branch Queensland Hlth, BBV STI Unit, Brisbane, Qld, Australia; [Fisher, Christopher] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Newcastle; Queensland Centre for Mental Health Research; University of Queensland; La Trobe University	Butler, T (corresponding author), Univ New South Wales, Sch Populat Hlth, Sydney, NSW, Australia.	tbutler@unsw.edu.au	Fisher, Christopher Micheal/M-1800-2017	Fisher, Christopher Micheal/0000-0001-8757-0847; Jones, Jocelyn/0000-0001-6260-0472	Australian National Health and Medical Research Council [1043693]; NHMRC	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The authors disclosed that they received the following support for their research and/or authorship of this article: MeH-JOSH study was funded by the Australian National Health and Medical Research Council Project Grant No. 1043693 (awarded to TB, LY, BD, ES, SN). Tony Butler is supported by an NHMRC Fellowship and Basil Donovan is supported by a NHMRC Practitioner Fellowship: https://www.nhmrc.gov.au. Any material published or made publicly available by the researchers cannot be considered as either endorsed or an expression of the policies or view by the Western Australia Department of Justice and Western Australia Department of Health. Any errors of omission or commission are the responsibility of the researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, YOUNG PEOPL CUST HLT; Australian Institute of Health and Welfare, 2018, NAT DATA HLTH JUST I; Australian Institute of Health and Welfare, 2015, AUSTR WELF SER, V12; Australian Institute of Health and Welfare, 2017, YOUTH JUST FACT SHEE; Australian Institute of Health and Welfare, 2019, YOUTH JUST AUSTR 201; Australian Institute of Health and Welfare (AIHW), YOUTH JUST AUSTR 201; Australian Institute of Health and Welfare Youth Justice, TABL S31 AUSTR POP A; Bird S, 2011, AUST FAM PHYSICIAN, V40, P159; Brotherton JML, 2017, MED J AUSTRALIA, V206, P262, DOI 10.5694/mja16.00958; Bryan AD, 2012, DEV PSYCHOL, V48, P1429, DOI 10.1037/a0027547; DICLEMENTE RJ, 1991, AM J PUBLIC HEALTH, V81, P628, DOI 10.2105/AJPH.81.5.628; Elkington KS, 2008, J AM ACAD CHILD PSY, V47, P901, DOI 10.1097/CHI.0b013e318179962b; Fisher C.M., 2019, ARCSHS MONOGRAPH SER, V113; Kenny DT, 2008, YOUNG OFFENDERS ON COMMUNITY ORDERS: HEALTH, WELFARE AND CRIMINOGENIC NEEDS, P1; Kinner SA, 2014, J ADOLESCENT HEALTH, V54, P521, DOI 10.1016/j.jadohealth.2013.10.003; Kirby Institute, 2020, NAT UPD HIV VIR HEP; Lawrence D., 2015, MENTAL HLTH CHILDREN; Rissel C, 2014, SEX HEALTH, V11, P406, DOI 10.1071/SH14113; Robbins RN, 2004, J ADOLESCENT RES, V19, P428, DOI 10.1177/0743558403258860; Teplin LA, 2005, PSYCHIAT SERV, V56, P823, DOI 10.1176/appi.ps.56.7.823; Teplin LA, 2003, AM J PUBLIC HEALTH, V93, P906, DOI 10.2105/AJPH.93.6.906; Ward J., 2014, RESULTS 1 NATL STUDY	22	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243633	10.1371/journal.pone.0243633	http://dx.doi.org/10.1371/journal.pone.0243633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370362	Green Published, gold			2022-12-27	WOS:000603611900085
J	Schirrmacher, J; Andersen, N; Schneider, RR; Weinelt, M				Schirrmacher, Julien; Andersen, Nils; Schneider, Ralph R.; Weinelt, Mara			Fossil leaf wax hydrogen isotopes reveal variability of Atlantic and Mediterranean climate forcing on the southeast Iberian Peninsula between 6000 to 3000 cal. BP	PLOS ONE			English	Article							DELTA-D VALUES; 4.2 KA EVENT; N-ALKANES; AFRICAN HYDROLOGY; TERRESTRIAL VEGETATION; STABLE-ISOTOPES; POLLEN RECORDS; PLANT; OSCILLATION; HOLOCENE	Many recently published papers have investigated the spatial and temporal manifestation of the 4.2 ka BP climate event at regional and global scales. However, questions with regard to the potential drivers of the associated climate change remain open. Here, we investigate the interaction between Atlantic and Mediterranean climate forcing on the south-eastern Iberian Peninsula during the mid- to late Holocene using compound-specific hydrogen isotopes from fossil leaf waxes preserved in marine sediments. Variability of hydrogen isotope values in the study area is primarily related to changes in the precipitation source and indicates three phases of increased Mediterranean sourced precipitation from 5450 to 5350 cal. BP, from 5150 to 4300 cal. BP including a short-term interruption around 4800 cal. BP, and from 3400 to 3000 cal. BP interrupted around 3200 cal. BP. These phases are in good agreement with times of prevailing positive modes of the North Atlantic Oscillation (NAO) and reduced storm activity in the Western Mediterranean suggesting that the NAO was the dominant modulator of relative variability in precipitation sources. However, as previously suggested other modes such as the Western Mediterranean Oscillation (WeMO) may have altered this overall relationship. In this regard, a decrease in Mediterranean moisture source coincident with a rapid reduction in warm season precipitation during the 4.2 ka BP event at the south-eastern Iberian Peninsula might have been related to negative WeMO conditions.	[Schirrmacher, Julien; Schneider, Ralph R.; Weinelt, Mara] Univ Kiel, CRC1266, Kiel, Germany; [Schirrmacher, Julien; Andersen, Nils; Schneider, Ralph R.] Univ Kiel, Leibniz Lab Radiometr Dating & Stable Isotope Res, Kiel, Germany; [Schneider, Ralph R.] Univ Kiel, Inst Geosci, Kiel, Germany	University of Kiel; University of Kiel; University of Kiel	Schirrmacher, J (corresponding author), Univ Kiel, CRC1266, Kiel, Germany.; Schirrmacher, J (corresponding author), Univ Kiel, Leibniz Lab Radiometr Dating & Stable Isotope Res, Kiel, Germany.	jschirrmacher@leibniz.uni-kiel.de	Weinelt, Mara/AAD-5295-2020	Schirrmacher, Julien/0000-0003-3667-3242	DFG (German Research Foundation) [CRC 1266, 2901391021]	DFG (German Research Foundation)(German Research Foundation (DFG))	This research was performed in the framework of the CRC 1266 "Scales of transformation" (project number: 2901391021) funded by the DFG (German Research Foundation).	[Anonymous], 2009, CLIM PAST DISC; [Anonymous], 2017, CATHOLIC HIST REV, V103, P1, DOI 10.1353/cat.2017.0000; [Anonymous], 2012, TRU, V77, P1; [Anonymous], 2002, FLORENSIA, V16-17, P89; [Anonymous], 2002, EVANGEL, V20, P9; Araguas-Araguasa LJ, 2005, ISOTOPIC COMPOSITION, P173; Baldini LM, 2019, QUATERNARY SCI REV, V226, DOI 10.1016/j.quascirev.2019.105998; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Bini M, 2019, CLIM PAST, V15, P555, DOI 10.5194/cp-15-555-2019; BIRD MI, 1995, GEOCHIM COSMOCHIM AC, V59, P2853, DOI 10.1016/0016-7037(95)00160-2; Booth RK, 2005, HOLOCENE, V15, P321, DOI 10.1191/0959683605hl825ft; Bradley RS, 2019, CLIM PAST, V15, P1665, DOI 10.5194/cp-15-1665-2019; BRAY EE, 1961, GEOCHIM COSMOCHIM AC, V22, P2, DOI 10.1016/0016-7037(61)90069-2; Burjachs F., 1997, PAISAJE MEDITERRANEO, P379; Burjachs F, 2015, CATENA, V135, P340, DOI 10.1016/j.catena.2014.10.006; Bush RT, 2013, GEOCHIM COSMOCHIM AC, V117, P161, DOI 10.1016/j.gca.2013.04.016; Carinanos P, 2004, ENVIRON EXP BOT, V52, P11, DOI 10.1016/j.envexpbot.2003.11.008; Carrion JS, 2003, HOLOCENE, V13, P839, DOI 10.1191/0959683603hl662rp; Clark-Carter D, 2014, WILEY STATSREF STAT, P44; Collins JA, 2013, QUATERNARY SCI REV, V65, P88, DOI 10.1016/j.quascirev.2013.01.007; Comas MC, 1996, P OC DRILL PROGR 161; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; DANSGAARD W, 1964, TELLUS, V16, P436; Dezileau L, 2016, CLIM PAST, V12, P1389, DOI 10.5194/cp-12-1389-2016; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Jones SE, 2018, QUATERNARY SCI REV, V184, P201, DOI 10.1016/j.quascirev.2017.12.015; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fletcher WJ, 2010, CLIM PAST, V6, P245, DOI 10.5194/cp-6-245-2010; Fletcher WJ, 2008, QUATERNARY RES, V70, P451, DOI 10.1016/j.yqres.2008.07.002; Fundacio Institut Catala de Farmacologia, 2018, BUTLLETI GROC, V31, P1; Gamarra B, 2016, PLANT CELL ENVIRON, V39, P2390, DOI 10.1111/pce.12789; Garcia-Alix A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07854-w; Garcin Y, 2012, GEOCHIM COSMOCHIM AC, V79, P106, DOI 10.1016/j.gca.2011.11.039; Geirsdottir A, 2019, CLIM PAST, V15, P25, DOI 10.5194/cp-15-25-2019; Giesche A, 2019, CLIM PAST, V15, P73, DOI 10.5194/cp-15-73-2019; Gimeno L, 2010, J HYDROMETEOROL, V11, P421, DOI 10.1175/2009JHM1182.1; Gouveia C, 2008, INT J CLIMATOL, V28, P1835, DOI 10.1002/joc.1682; Hernandez A, 2015, CLIM DYNAM, V45, P3403, DOI 10.1007/s00382-015-2547-8; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Ilvonen L, 2019, CLIM PAST, P1, DOI DOI 10.5194/CP-2019-33; International Atomic Energy Agency, 2005, IAEATECDOC1453, P125, DOI 10.1079/bjn20051445; Jalali B, 2019, CLIM PAST, V15, P701, DOI 10.5194/cp-15-701-2019; Kaniewski D, 2018, CLIM PAST, V14, P1529, DOI 10.5194/cp-14-1529-2018; Kathayat G, 2018, CLIM PAST, V14, P1869, DOI 10.5194/cp-14-1869-2018; Kuechler RR, 2013, QUATERNARY SCI REV, V82, P56, DOI 10.1016/j.quascirev.2013.10.013; Leider A, 2013, GEOCHIM COSMOCHIM AC, V117, P16, DOI 10.1016/j.gca.2013.04.018; Li HL, 2019, CAN J PHYSIOL PHARM, V97, P341, DOI 10.1139/cjpp-2018-0404; Lionello P, 2012, ELSEV INSIGHT, P1; Liu FG, 2012, HOLOCENE, V22, P1181, DOI 10.1177/0959683612441839; Loidi J., 2017, VEGETATION IBERIAN P; Lopez-Bustins JA, 2020, ATMOS RES, V236, DOI 10.1016/j.atmosres.2019.104819; Martin-Vide J, 2006, INT J CLIMATOL, V26, P1455, DOI 10.1002/joc.1388; Mendes D, 2019, STEM CELL REV REP, V15, P463, DOI 10.1007/s12015-019-09897-0; Nelson DM, 2013, ORG GEOCHEM, V56, P106, DOI 10.1016/j.orggeochem.2012.12.010; Niedermeyer EM, 2016, GEOCHIM COSMOCHIM AC, V184, P55, DOI 10.1016/j.gca.2016.03.034; Niedermeyer EM, 2010, QUATERNARY SCI REV, V29, P2996, DOI 10.1016/j.quascirev.2010.06.039; Norstrom E, 2017, GEOCHIM COSMOCHIM AC, V219, P96, DOI 10.1016/j.gca.2017.09.029; Olsen J, 2012, NAT GEOSCI, V5, P808, DOI [10.1038/NGEO1589, 10.1038/ngeo1589]; Pantaleon-Cano J, 2003, HOLOCENE, V13, P109, DOI 10.1191/0959683603hl598rp; Peyron O, 2017, CLIM PAST, V13, P249, DOI 10.5194/cp-13-249-2017; Railsback LB, 2018, QUATERNARY SCI REV, V186, P78, DOI 10.1016/j.quascirev.2018.02.015; Ramos-Roman MJ, 2018, CLIM PAST, V14, P117, DOI 10.5194/cp-14-117-2018; Risch R, 2015, 2200 BC KLIMASTURZ A, P35; Sachse D, 2006, ORG GEOCHEM, V37, P469, DOI 10.1016/j.orggeochem.2005.12.003; Sachse D, 2012, ANNU REV EARTH PL SC, V40, P221, DOI 10.1146/annurev-earth-042711-105535; Schafer IK, 2018, PALAEOGEOGR PALAEOCL, V507, P52, DOI 10.1016/j.palaeo.2018.06.039; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Schemmel F, 2016, QUATERNARY SCI REV, V133, P96, DOI 10.1016/j.quascirev.2015.12.019; Schimmelmann A, 2006, ANNU REV EARTH PL SC, V34, P501, DOI 10.1146/annurev.earth.34.031405.125011; Schirrmacher J, 2020, QUATERNARY SCI REV, V233, DOI 10.1016/j.quascirev.2020.106220; Schirrmacher J, 2019, CLIM PAST, V15, P617, DOI 10.5194/cp-15-617-2019; Schreuder LT, 2018, ORG GEOCHEM, V115, P113, DOI 10.1016/j.orggeochem.2017.10.010; Schwab VF, 2015, ORG GEOCHEM, V78, P99, DOI 10.1016/j.orggeochem.2014.09.007; Staubwasser M, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016822; Struck J, 2020, BIOGEOSCIENCES, V17, P567, DOI 10.5194/bg-17-567-2020; Taylor AK, 2018, J QUATERNARY SCI, V33, P79, DOI 10.1002/jqs.3000; Toney JL, 2020, QUATERNARY SCI REV, V240, DOI 10.1016/j.quascirev.2020.106395; Trigo RM, 2004, INT J CLIMATOL, V24, P925, DOI 10.1002/joc.1048; Valera I, 2015, IEEE DATA MINING, P409, DOI 10.1109/ICDM.2015.40; Walczak IW, 2015, QUATERNARY SCI REV, V127, P117, DOI 10.1016/j.quascirev.2015.06.013; Wang CR, 2017, ORG GEOCHEM, V112, P47, DOI 10.1016/j.orggeochem.2017.07.006; Wang YMV, 2013, GEOCHIM COSMOCHIM AC, V111, P128, DOI 10.1016/j.gca.2012.10.016; WEISS H, 1993, SCIENCE, V261, P995, DOI 10.1126/science.261.5124.995; Weiss Harvey, 2016, J SALT LAKE RES, V24, P62; Welc F, 2014, QUATERN INT, V324, P124, DOI 10.1016/j.quaint.2013.07.035; Wirth SB, 2016, QUATERNARY SCI REV, V148, P176, DOI 10.1016/j.quascirev.2016.07.020; Yan M, 2019, CLIM PAST, V15, P265, DOI 10.5194/cp-15-265-2019; Zhang HW, 2018, CLIM PAST, V14, P1805, DOI 10.5194/cp-14-1805-2018; Zielhofer C, 2017, QUATERNARY SCI REV, V157, P29, DOI 10.1016/j.quascirev.2016.11.037	90	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243662	10.1371/journal.pone.0243662	http://dx.doi.org/10.1371/journal.pone.0243662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362206	Green Published, gold			2022-12-27	WOS:000603071600016
J	Wang, Y; Liang, HY; Zhang, L; Zhang, Z; Wu, L; Ni, L; Gao, GJ; Yang, D; Zhao, HX; Xiao, J				Wang, Yu; Liang, Hongyuan; Zhang, Ling; Zhang, Zhe; Wu, Liang; Ni, Liang; Gao, Guiju; Yang, Di; Zhao, Hongxin; Xiao, Jiang			The burden of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China: An observational cohort study	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; ADULTS; RISK; SUPPRESSION; ETIOLOGY	The objective of this study was to elucidate the burden, risk factors, and prognosis of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China. The evaluation of the burden, risk factors and prognosis of serious NADEs was carried out among 1309 cART-naive AIDS patients (median age: 38.2 years, range: 18-78 years) admitted in Beijing Ditan Hospital between January 2009 and December 2018. Among 1309 patients, 143 patients (10.9%) had at least one serious NADEs, including 49 (3.8%) with cerebrovascular diseases, 37 (2.8%) with non-AIDS-defining cancers, 28 (2.1%) with chronic kidney diseases, 26 (2.0%) with cardiovascular diseases, and 18 (1.4%) with liver cirrhosis. Serious NADEs distributed in different age and CD4 levels, especially with age >= 50 years and CD4 <= 350 cells/ul. Other traditional risk factors, including cigarette smoking (OR = 1.9, 95%CI = 1.3-2.8, p = 0.002), hypertension (OR = 2.5, 95%CI = 1.7-3.7, p<0.001), chronic HCV infection (OR = 2.8, 95%CI = 1.4-5.6, p = 0.004), and hypercholesterolemia (OR = 4.1, 95% CI = 1.2-14.1, p = 0.026), were also associated with serious NADEs. Seventeen cases (1.3%) with serious NADEs died among hospitalized cART-naive AIDS patients, and severe pneumonia (HR = 5.5, 95%CI = 1.9-15.9, p<0.001) and AIDS-defining cancers (HR = 3.8, 95%CI = 1.1-13.2, p = 0.038) were identified as risk factors associated with an increased hazard of mortality among these patients with serious NADEs. Serious NADEs also occurred in cART-naive AIDS patients in China with low prevalence. Our results reminded physicians that early screening of serious NADEs, timely intervention of their risk factors, management of severe AIDS-defining events, multi-disciplinary cooperation, and early initiation of cART were essential to reduce the burden of serious NADEs.	[Wang, Yu; Liang, Hongyuan; Zhang, Ling; Zhang, Zhe; Wu, Liang; Ni, Liang; Gao, Guiju; Yang, Di; Zhao, Hongxin; Xiao, Jiang] Capital Med Univ, Beijing Ditan Hosp, Clin & Res Ctr Infect Dis, Beijing, Peoples R China	Capital Medical University	Zhao, HX; Xiao, J (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Clin & Res Ctr Infect Dis, Beijing, Peoples R China.	13911022130@163.com; shawjiang@163.com			National Key Project Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis: Popularization and application of diagnosis and treatment of Belt and Road HIV/ AIDS with Traditional Chinese Medicine [2018ZX10101001-005-001]; National Key Project-the Development of New Pharmaceuticals: the Construction of Platform for Clinical Evaluation of New Antiretroviral Therapy-Clinical trial phase IIV [2017ZX09304027-001-010]; Thirteen-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing [2018ZX10715-005]; National natural Science Fund the Study for Delay and Persistent Poor Immune Reconstitution in HIV/AIDS patients [81672000]; Beijing Municipal Committee of Science & Technology The study of HIV/HBV co-infection [D161100000416004]; Project for Capital Characteristics The study for blood concentration of efavirenz influenced by rifampin in HIV/TB coinfected patient [Z171100001017053]; Program for the 13th Five-year Plan of China The study of non-AIDS-defining events among HIVinfected population long-term receiving ART [2017ZX10202101004]; Key project from Beijing Hospital Authority [DFL20191802]	National Key Project Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis: Popularization and application of diagnosis and treatment of Belt and Road HIV/ AIDS with Traditional Chinese Medicine; National Key Project-the Development of New Pharmaceuticals: the Construction of Platform for Clinical Evaluation of New Antiretroviral Therapy-Clinical trial phase IIV; Thirteen-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing; National natural Science Fund the Study for Delay and Persistent Poor Immune Reconstitution in HIV/AIDS patients; Beijing Municipal Committee of Science & Technology The study of HIV/HBV co-infection; Project for Capital Characteristics The study for blood concentration of efavirenz influenced by rifampin in HIV/TB coinfected patient; Program for the 13th Five-year Plan of China The study of non-AIDS-defining events among HIVinfected population long-term receiving ART; Key project from Beijing Hospital Authority	We acknowledge the work of HIV health care providers for their diagnosis, nursing and treatment of HIV/AIDS patients in Ditan Hospital. Support for this work was provided by: (1) The National Key Project Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis: Popularization and application of diagnosis and treatment of Belt and Road HIV/ AIDS with Traditional Chinese Medicine (grant 2018ZX10101001-005-001); (2) The National Key Project-the Development of New Pharmaceuticals: the Construction of Platform for Clinical Evaluation of New Antiretroviral Therapy-Clinical trial phase IIV. (grant 2017ZX09304027-001-010); (3) The Thirteen-fifth Key Project The Study of Construction of Representative areas for Prevention and Therapy of Fatal Infectious Diseases such AIDS & Viral Hepatitis in Chaoyang District, Beijing (grant 2018ZX10715-005); (4) the National natural Science Fund the Study for Delay and Persistent Poor Immune Reconstitution in HIV/AIDS patients (grant 81672000); (5) Project from Beijing Municipal Committee of Science & Technology The study of HIV/HBV co-infection (grant D161100000416004). (6) Project for Capital Characteristics The study for blood concentration of efavirenz influenced by rifampin in HIV/TB coinfected patient (grant Z171100001017053). (7) the Program for the 13th Five-year Plan of China The study of non-AIDS-defining events among HIVinfected population long-term receiving ART (2017ZX10202101004); (8) The Key project from Beijing Hospital Authority (DFL20191802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adal M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195942; Althoff KN, 2019, LANCET HIV, V6, pE93, DOI 10.1016/S2352-3018(18)30295-9; [Anonymous], 2007, ZHONGHUA XINXUEGUANB; Appay V, 2016, CURR OPIN HIV AIDS, V11, P242, DOI 10.1097/COH.0000000000000240; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; Borges AH, 2015, J INFECT DIS, V212, P585, DOI 10.1093/infdis/jiv123; Castellares C, 2008, J VIRAL HEPATITIS, V15, P165, DOI 10.1111/j.1365-2893.2007.00903.x; Cooper CL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4315-6; Daniyam CA, 2013, ANN MED HEALTH SCI R, V3, P26, DOI 10.4103/2141-9248.109468; Esan H, 2019, ADDICT BEHAV, V90, P301, DOI 10.1016/j.addbeh.2018.10.051; Escota GV, 2018, INT J INFECT DIS, V66, P56, DOI 10.1016/j.ijid.2017.11.010; Fontela C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65841-0; Hoffmann Christian, 2010, HIVBOOK2010; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hurtubise J, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0632-z; Kaspar MB, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000166; Kim HN, 2016, JAIDS-J ACQ IMM DEF, V72, P437, DOI 10.1097/QAI.0000000000000992; Lewden C, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18797; Li YM, 2019, J DIGEST DIS, V20, P174, DOI 10.1111/1751-2980.12687; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Mitsuyasu Ronald T, 2014, Top Antivir Med, V22, P660; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Naicker S, 2015, CLIN NEPHROL, V83, pS32, DOI 10.5414/CNP83S032; Nordell AD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000844; Oursler KA, 2016, INT J INFECT DIS, V53, P59, DOI 10.1016/j.ijid.2016.11.414; Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, PANEL OPPORTUNISTIC; Panigrahi S, 2016, J INFECT DIS, V213, P1419, DOI 10.1093/infdis/jiv749; Pettit AC, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25031; Ruzicka DJ, 2019, J INFECT CHEMOTHER, V25, P89, DOI 10.1016/j.jiac.2018.10.006; Ruzicka DJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019985; Salter ML, 2011, CLIN INFECT DIS, V53, P1256, DOI 10.1093/cid/cir673; van Zoest RA, 2017, CURR OPIN HIV AIDS, V12, P513, DOI 10.1097/COH.0000000000000406; Wester CW, 2011, AIDS, V25, P1471, DOI 10.1097/QAD.0b013e328347f9d4; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Wing EJ, 2016, INT J INFECT DIS, V53, P61, DOI 10.1016/j.ijid.2016.10.004; Xiao J, 2016, AIDS RES HUM RETROV, V32, P782, DOI [10.1089/aid.2015.0271, 10.1089/AID.2015.0271]; Xiao J, 2015, J MED VIROL, V87, P366, DOI 10.1002/jmv.24063; Xiao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075915; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang S, 2015, HIV MED, V16, P265, DOI 10.1111/hiv.12202	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243773	10.1371/journal.pone.0243773	http://dx.doi.org/10.1371/journal.pone.0243773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351812	gold, Green Published			2022-12-27	WOS:000603071400041
J	Marco-Gardoqui, M; Eizaguirre, A; Garcia-Feijoo, M				Marco-Gardoqui, Marta; Eizaguirre, Almudena; Garcia-Feijoo, Maria			The impact of service-learning methodology on business schools' students worldwide: A systematic literature review	PLOS ONE			English	Review							EDUCATION; ETHICS; IMPLEMENTATION; EXPERIENCES; COMMUNITY; WORKING; SKILLS	The purpose of this research is to perform a systematic review of the literature published on the benefits of applying the service-learning methodology with business students. Several works and studies identify significant contributions that are important to the student's profile; however, a systematic review of the benefits derived from the methodology application in the profile previously described has not yet been conducted. The main objective of this study is to gather, identify, and classify evidence from 32 studies conducted across global business schools regarding the benefits of service-learning in university students. The applied methodology follows the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" statement for systematic reviews. The studies were extracted from the World of Science, Scopus, and Educational Resource Information Center databases and were analyzed according to the suggested objectives. The suggested systematic review provides a rigorous analysis of academic literature on the benefits of service learning in the student's personal, social, academic, and civic environment. A theoretical framework that combines all gathered benefits from the 32 studies has been suggested in these pages, by means of grouping these benefits into four categories considering prior research on the academic, personal, social, and citizenship outcomes. Several quantitative, qualitative, and mixed studies support the benefits of this methodology, focusing on the student's profile development. We found that students enjoy plenty of outcomes after participating in the service-learning experience, thus, the most frequent outcome is greater social engagement. With more than 4,000 students involved in the total analyzed studies, we present a list of ranked outcomes that reflects and supports the strength of the methodology. Through this study, institutions as well as teachers may be aware of the potential present in this methodology. Our study also suggested a framework for university coordinators to act.	[Marco-Gardoqui, Marta; Eizaguirre, Almudena; Garcia-Feijoo, Maria] Univ Deusto, Deusto Business Sch, Management Dept, Bilbao, Spain	University of Deusto	Marco-Gardoqui, M (corresponding author), Univ Deusto, Deusto Business Sch, Management Dept, Bilbao, Spain.	marta.marcogardoqui@deusto.es		Garcia-Feijoo, Maria/0000-0002-5930-2260; Marco-Gardoqui, Marta/0000-0001-8407-1196				Abdoolcarim Z., 1995, ASIAN BUSINESS, V31, P32; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P301; [Anonymous], 2010, ICC INT CT ARB B, V21, P5; Blewitt JM, 2018, J EDUC BUS, V93, P412, DOI 10.1080/08832323.2018.1498315; Borrego M, 2014, J ENG EDUC, V103, P45, DOI 10.1002/jee.20038; Braunsberger K, 2013, VOLUNTAS, V24, P1, DOI 10.1007/s11266-012-9289-6; Buchanan B, 2014, J INT EDUC BUS, V7, P108, DOI 10.1108/JIEB-10-2013-0041; Cadwallader S., 2013, MARKETING ED REV, V23, P137; Carmichael T, 2008, PROBLEMS PERSPECTIVE, V6, P82; Cebrian G, 2015, SUSTAINABILITY-BASEL, V7, P2768, DOI 10.3390/su7032768; Chen TT, 2018, ACAD MANAG LEARN EDU, V17, P474, DOI 10.5465/amle.2016.0309; Coffey BS, 2006, J EDUC BUS, V82, P119, DOI 10.3200/JOEB.82.2.119-124; Conway JM, 2009, TEACH PSYCHOL, V36, P233, DOI 10.1080/00986280903172969; Crutchfield TN, 2017, J EDUC BUS, V92, P371, DOI 10.1080/08832323.2017.1396957; Dean KL, 2006, J MANAG EDUC, V30, P15, DOI 10.1177/1052562905280839; Easterling D., 1997, J ED BUSINESS, V73, P58, DOI DOI 10.1080/08832329709601617; Eizaguirre A., 2020, VIRTUOUS CYCLES HUMA, P3; Eyler J, 2002, J SOC ISSUES, V58, P517, DOI 10.1111/1540-4560.00274; Eyler J., 2001, GLANCE WHAT WE KNOW; Gonzalez IF, 2011, REV ESP CARDIOL, V64, P688, DOI [10.1016/j.recesp.2011.03.029, 10.1016/j.rec.2011.03.027]; Flannery BL, 2008, J BUS ETHICS, V80, P465, DOI 10.1007/s10551-007-9431-3; Furco A., 1996, SERVICE LEARNING BAL; Gallagher MJ, 2015, INT ADV ECON RES, V21, P467, DOI 10.1007/s11294-015-9550-z; Garcia-Feijoo M., 2019, ALFABETIZACION DIGIT, P183; Gerholz KH, 2018, ACT LEARN HIGH EDUC, V19, P47, DOI 10.1177/1469787417721420; Geringer S. D., 2009, J ADV MARKETING ED, V14, P1; Ghoshal S, 2005, ACAD MANAG LEARN EDU, V4, P75, DOI 10.5465/AMLE.2005.16132558; Giacalone R., 2009, J BUSINESS ETHICS ED, V6, P1, DOI [10.5840/jbee200969, DOI 10.1108/SBR-11-2015-0066]; Gough D., 2017, INTRO SYSTEMATIC REV, V2nd; Ingols C, 2014, J MANAG EDUC, V38, P412, DOI 10.1177/1052562913489029; Jacoby B., 2014, SERVICE LEARNING ESS; Jerusalem M., 1999, SKALEN ERFASSUNG LEH; Jordan MH, 2011, INT J, V25, P21, DOI [10.1108/14777281111159401, DOI 10.1108/14777281111159401]; Killian S, 2019, INT J MANAG EDUC-OXF, V17, DOI 10.1016/j.ijme.2019.100307; Klink R. R., 2004, J MARKET EDUC, V26, P145; Landa-Ramirez E., 2014, PSICOONCOLOG A, V11, P259, DOI [10.5209/rev_PSIC.2014.v11.n2-3.47387, DOI 10.5209/REV_PSIC.2014.V11.N2-3.47387]; Larsen MA, 2017, J EXP EDUC, V40, P279, DOI 10.1177/1053825917706379; Levitt C, 2010, J INSTRUCTIONAL PEDA, P3; Lockwood C, 2015, INT J EVID-BASED HEA, V13, P179, DOI 10.1097/XEB.0000000000000062; Lozano R, 2015, J CLEAN PROD, V108, P1, DOI 10.1016/j.jclepro.2014.09.048; Mabry J. B., 1998, MICHIGAN J COMMUNITY, V5, P32; Madsen S. R., 2004, J ED BUSINESS, V19, P328; Madsen SR, 2006, J MANAG EDUC, V30, P724, DOI 10.1177/1052562905283710; Mason M., 2010, FORUM QUAL SOC RES, V11; McDonald R.A., 2000, INTERCHANGE, V31, P385, DOI [10.1023/A:1011007310120, DOI 10.1023/A:1011007310120]; McHugh M., 2006, INT J TEACHING LEARN, V18, P131; Mcintyre F.S., 2005, MARKETING ED REV, V15, DOI [10.1080/10528008.2005.11488889, DOI 10.1080/10528008.2005.11488889]; McWhorter RR, 2016, J INTERACT ONLINE LE, V14, P80; Metcalf LE, 2010, J MARKET EDUC, V32, P155, DOI 10.1177/0273475309360157; Methley AM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0579-0; Moorer C., 2009, AM J BUSINESS ED, V2, P63, DOI DOI 10.19030/AJBE.V2I3.4050; Mosakowski E, 2013, ACAD MANAG LEARN EDU, V12, P198, DOI 10.5465/amle.2013.0149; Murphy, 2008, J ADV MARKETING ED, V13, P28; Ngui KS, 2017, EDUC TRAIN, V59, P579, DOI 10.1108/ET-04-2016-0078; O'Brien K, 2017, J MANAG EDUC, V41, P599, DOI 10.1177/1052562917702495; Petkus E., 2000, J MARKET EDUC, V22, P64; Petrovskaya I, 2019, HORIZON, V27, P5, DOI 10.1108/OTH-06-2017-0031; Poon P, 2011, J TEACH INT BUS, V22, P185, DOI 10.1080/08975930.2011.653746; Reinders Heinz., 2009, RAUS ELFENBEINTURM, P128; Ritchie J., 2013, QUALITATIVE RES PRAC, P77; Sabbaghi O, 2013, J BUS ETHICS, V118, P127, DOI 10.1007/s10551-012-1545-6; Schneider AB, 2018, BUS HORIZONS, V61, P913, DOI 10.1016/j.bushor.2018.08.001; SCHWARTZ S.H., 2012, ONLINE READINGS PSYC, V2, DOI [10.9707/2307-0919.1116, DOI 10.9707/2307-0919.1116]; Steinke Pamela, 2002, MICHIGAN J COMMUNITY, V8, P5; Toncar MF, 2006, J MARKET THEORY PRAC, V14, P223, DOI 10.2753/MTP1069-6679140304; Vega G, 2007, J MANAG EDUC, V31, P647, DOI 10.1177/1052562906296573; Waldner L.S., 2012, J HIGHER ED OUTREACH, V16, P123; Wang L, 2018, J EDUC BUS, V93, P204, DOI 10.1080/08832323.2018.1444574; Weber J., 2000, TEACH BUS ETHICS, V4, P341, DOI [10.1023/A:1009862806641, DOI 10.1023/A:1009862806641]; Weber PS, 2004, J BUS ETHICS, V49, P359, DOI 10.1023/B:BUSI.0000020881.58352.ab; Wickam M.J., 2018, J HIGHER ED OUTREACH, V22, P163; Wittmer DP, 2004, J BUS ETHICS, V51, P359, DOI 10.1023/B:BUSI.0000032514.05498.2b; Young S, 2015, EDUC TRAIN, V57, P774, DOI 10.1108/ET-04-2014-0041; Yu D. D., 2011, NEW HORIZONS ED, V59, P95	74	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244389	10.1371/journal.pone.0244389	http://dx.doi.org/10.1371/journal.pone.0244389			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347503	Green Published, gold			2022-12-27	WOS:000603071100044
J	Rajput, SA; Mirza, MR; Choudhary, MI				Rajput, Sajid Ali; Mirza, Munazza Raza; Choudhary, M. Iqbal			Bergenin protects pancreatic beta cells against cytokine-induced apoptosis in INS-1E cells	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; KAPPA-B; DERIVATIVES; MECHANISMS; TOXICITY; BARK; MASS	Beta cell apoptosis induced by proinflammatory cytokines is one of the hallmarks of diabetes. Small molecules which can inhibit the cytokine-induced apoptosis could lead to new drug candidates that can be used in combination with existing therapeutic interventions against diabetes. The current study evaluated several effects of bergenin, an isocoumarin derivative, in beta cells in the presence of cytokines. These included (i) increase in beta cell viability (by measuring cellular ATP levels) (ii) suppression of beta cell apoptosis (by measuring caspase activity), (iii) improvement in beta cell function (by measuring glucose-stimulated insulin secretion), and (iv) improvement of beta cells mitochondrial physiological functions. The experiments were carried out using rat beta INS-1E cell line in the presence or absence of bergenin and a cocktail of proinflammatory cytokines (interleukin-1beta, tumor necrosis factor-alpha, and interferon- gamma) for 48 hr. Bergenin significantly inhibited beta cell apoptosis, as inferred from the reduction in the caspase-3 activity (IC50 = 7.29 +/- 2.45 mu M), and concurrently increased cellular ATP Levels (EC50 = 1.97 +/- 0.47 mu M). Bergenin also significantly enhanced insulin secretion (EC50 = 6.73 +/- 2.15 mu M) in INS-1E cells, presumably because of the decreased nitric oxide production (IC50 = 6.82 +/- 2.83 mu M). Bergenin restored mitochondrial membrane potential (EC50 = 2.27 +/- 0.83 mu M), decreased ROS production (IC50 = 14.63 +/- 3.18 mu M), and improved mitochondrial dehydrogenase activity (EC50 = 1.39 +/- 0.62 mu M). This study shows for the first time that bergenin protected beta cells from cytokine-induced apoptosis and restored insulin secretory function by virtue of its anti-inflammatory, antioxidant and anti-apoptotic properties. To sum up, the above mentioned data highlight bergenin as a promising anti-apoptotic agent in the context of diabetes.	[Rajput, Sajid Ali; Mirza, Munazza Raza; Choudhary, M. Iqbal] Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Sindh, Pakistan; [Choudhary, M. Iqbal] Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Sindh, Pakistan; [Choudhary, M. Iqbal] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia; [Rajput, Sajid Ali] Univ Sindh, Inst Biotechnol & Genet Engn, Jamshoro, Sindh, Pakistan	University of Karachi; University of Karachi; King Abdulaziz University; University of Sindh	Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, Dr Panjwani Ctr Mol Med & Drug Res, Karachi, Sindh, Pakistan.; Choudhary, MI (corresponding author), Univ Karachi, Int Ctr Chem & Biol Sci, HEJ Res Inst Chem, Karachi, Sindh, Pakistan.; Choudhary, MI (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia.	iqbal.choudhary@iccs.edu	Choudhary, M. Iqbal/C-8633-2012	Choudhary, M. Iqbal/0000-0001-5356-3585	Institute, Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi; Searle Pharmaceuticals Pakistan Ltd.	Institute, Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi; Searle Pharmaceuticals Pakistan Ltd.	This work was supported by our Institute, Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi. We thank the Institute for supporting this work by providing recurrent grant for chemicals and consumables and for allowing work in the cell culture facility at PCMD. The authors also received funds from Searle Pharmaceuticals Pakistan Ltd. for publishing this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 2005, GUT, V54, pv1; [Anonymous], 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/glan290; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chou DHC, 2010, ACS CHEM BIOL, V5, P729, DOI 10.1021/cb100129d; Silva Saulo L. da, 2009, Acta Amaz., V39, P187, DOI 10.1590/S0044-59672009000100019; Darville MI, 1998, DIABETOLOGIA, V41, P1101, DOI 10.1007/s001250051036; De Abreu HA, 2008, ORG BIOMOL CHEM, V6, P2713, DOI 10.1039/b804385j; de Oliveira CM, 2011, J NAT PROD, V74, P2062, DOI 10.1021/np200232s; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; ECB, 2003, MONTHLY B, V46, P3; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Ejaz Ahmed, 2004, Asian Journal of Plant Sciences, V3, P410; Fourth International Ankle Symposium, 2009, J ORTHOPAEDIC SPORTS, V39, pA1; Gao XJ, 2015, INFLAMMATION, V38, P1142, DOI 10.1007/s10753-014-0079-8; Gavin JR, 1997, DIABETES CARE, V20, P1183; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Li HB, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2910643; Matsuda T, 2005, ENDOCRINOLOGY, V146, P175, DOI 10.1210/en.2004-0850; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Nazir N, 2007, J ETHNOPHARMACOL, V112, P401, DOI 10.1016/j.jep.2007.02.023; Nazir N, 2011, EUR J MED CHEM, V46, P2415, DOI 10.1016/j.ejmech.2011.03.025; Nunomura RCS, 2009, J BRAZIL CHEM SOC, V20, P1060, DOI 10.1590/S0103-50532009000600009; Popov SV, 2005, PHYTOTHER RES, V19, P1052, DOI 10.1002/ptr.1789; Posner RA, 2009, DUKE LAW J, V58, P1807; Remedi MS, 2016, DIABETES OBES METAB, V18, P110, DOI 10.1111/dom.12727; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Seth SDS, 1974, J RES INDIAN MED, V9, P1; Shah MR, 2012, BIOORG MED CHEM LETT, V22, P2744, DOI 10.1016/j.bmcl.2012.02.096; Sinha S, 2001, FITOTERAPIA, V72, P550, DOI 10.1016/S0367-326X(00)00322-1; Sinha S, 2001, J PHARM PHARMACOL, V53, P193, DOI 10.1211/0022357011775398; Srinivasan R, 2007, J ETHNOPHARMACOL, V113, P284, DOI 10.1016/j.jep.2007.06.006; Sumino M, 2002, CHEM PHARM BULL, V50, P1484, DOI 10.1248/cpb.50.1484; Takahashi H, 2003, BIOORGAN MED CHEM, V11, P1781, DOI 10.1016/S0968-0896(02)00666-1; Uddin G, 2014, TROP BIOMED, V31, P143; Uniyal SK, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-14; VANWYK CW, 1993, S AFR MED J, V83, P425; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Villarreal CF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144850; Xiang SH, 2020, DRUG DES DEV THER, V14, P129, DOI 10.2147/DDDT.S229063; Zamarrud, 2011, FITOTERAPIA, V82, P722, DOI 10.1016/j.fitote.2011.03.002; Zawawi NKNA, 2015, BIOORG MED CHEM LETT, V25, P4672, DOI 10.1016/j.bmcl.2015.08.022	48	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0241349	10.1371/journal.pone.0241349	http://dx.doi.org/10.1371/journal.pone.0241349			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347462	Green Published, gold			2022-12-27	WOS:000603071100031
J	Rosa, F; Osorio, JS				Rosa, Fernanda; Osorio, Johan S.			Quantitative determination of histone methylation via fluorescence resonance energy transfer (FRET) technology in immortalized bovine mammary alveolar epithelial cells supplemented with methionine	PLOS ONE			English	Article							DAIRY-COWS; S-ADENOSYLMETHIONINE; SMARTAMINE M; PROTEIN; DNA; METHYLTRANSFERASE; TRANSCRIPTION; PERFORMANCE; NUTRITION; PROMOTER	Methionine (Met) is an essential precursor of S-adenosylmethionine (SAM), which is the primary methyl donor required for biological processes such as DNA and histone methylation, which alter gene expression. In dairy cows, dietary Met has been observed to exert transcriptional alterations with beneficial effects on milk biosynthesis; however, the extent of these effects via SAM remains unknown. Therefore, we evaluated the effect of Met supply on histone methylation in lysine residues K9 and K27 in the histone tail H3 via a fluorescence resonance energy transfer (FRET) system in immortalized bovine mammary alveolar epithelial cells (MACT) incubated varying concentration of Met. The histone methylation data was complemented with global DNA methylation, cellular protein synthesis, and RT-qPCR analysis of genes related to Met cycle, DNA and histone methylation, AA transporters, and protein synthesis. The histone methylation data was performed on MACT cells seeded at 30,000 cells/well in 96-well plates 24 h prior to transfection. The transfections of FRET gene reporter plasmids H3K9 and H3K27 was performed with 0.3 mu L/well of Lipofectamine (R) 3000 and 50 ng of plasmid DNA per well. At 24 h post-transfection, cells were treated with 0, 125, 250, and 500 mu M of Met, and quantification of histone methylation was performed at 0, 12, and 24 h post-treatment as well as cell viability at 24 h using CellProfiler software. An inverted microscope for live imagining (EVOS(R) FL Auto) equipped with a motorized scanning stage, and an environment-controlled chamber at 37C and 5.0% of CO2 was used to take 4 pictures/well at 4x magnification. A more defined response on histone methylation was observed in H3K9 than H3K27 to Met supply, where maximal histone methylation in H3K9 was observed with 125 mu M of Met. This greater histone methylation in H3K9 at 125 mu M was accompanied by greater cellular protein concentration. The linear increase in Met supply causes a linear decrease in global DNA methylation, while linearly upregulating genes related to the Met cycle (i.e., MAT1A, PEMT, SAHH, and MTR). The histone methylation data suggest that, to some extent, methyl-donors such as Met may affect the methylation sites, H3K9 and H3K27, and consequently causing a different epigenetic alteration. In the context of the dairy cow, further refinement to this FRET assay to study histone methylation could lead to establishing novel potential mechanisms of how dietary methyl donors may control the structural conformation of the bovine genome and, by extension, gene expression.	[Rosa, Fernanda; Osorio, Johan S.] South Dakota State Univ, Dept Dairy & Food Sci, Brookings, SD 57007 USA	South Dakota State University	Osorio, JS (corresponding author), South Dakota State Univ, Dept Dairy & Food Sci, Brookings, SD 57007 USA.	Johan.Osorio@sdstate.edu	Rosa, Fernanda/AAA-6140-2022		South Dakota Agricultural Experiment State [SD00H612-16]	South Dakota Agricultural Experiment State	This work was supported by the South Dakota Agricultural Experiment State under project No. SD00H612-16 to JSO. https://www.sdstate.edu/south-dakota-agricultural-experiment-stationsdsu.The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2004, DIGEST DIS SCI, V49, P1889, DOI 10.1007/s10620-004-9589-9; Algar WR, 2019, NAT METHODS, V16, P815, DOI 10.1038/s41592-019-0530-8; [Anonymous], 2012, J MED ASS THAI S12, V95, pS32; [Anonymous], 2012, REGEN MED S3, V7, pS14; Bajar BT, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091488; Batistel F, 2017, J DAIRY SCI, V100, P7455, DOI 10.3168/jds.2017-12689; Bionaz M, 2015, J ANIM SCI, V93, P5531, DOI 10.2527/jas.2015-9192; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; Breton A, 2010, J REPROD DEVELOP, V56, P379, DOI 10.1262/jrd.09-182A; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Dobosy JR, 2008, PROSTATE, V68, P1187, DOI 10.1002/pros.20782; Dong X, 2018, J DAIRY SCI, V101, P1708, DOI 10.3168/jds.2017-13351; Esfandiari F, 2010, HEPATOLOGY, V51, P932, DOI 10.1002/hep.23382; Fu K, 2020, EPIGENETICS-US, V15, P272, DOI 10.1080/15592294.2019.1666649; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Halsted CH, 2004, SEMIN LIVER DIS, V24, P289, DOI 10.1055/s-2004-832941; He YH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2947-0; Hernandez-Ortega K, 2016, BRAIN PATHOL, V26, P593, DOI 10.1111/bpa.12335; Hu LY, 2020, FOOD FUNCT, V11, P883, DOI [10.1039/c9fo02379h, 10.1039/C9FO02379H]; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Kera Y, 2013, J BIOL CHEM, V288, P13592, DOI 10.1074/jbc.M112.429738; Lapierre H, 2006, J DAIRY SCI, V89, pE1, DOI 10.3168/jds.S0022-0302(06)72359-1; Lin CW, 2004, J AM CHEM SOC, V126, P5982, DOI 10.1021/ja038854h; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Ma YF, 2019, J DAIRY SCI, V102, P4264, DOI 10.3168/jds.2018-15451; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Michalak EM, 2019, NAT REV MOL CELL BIO, V20, P573, DOI 10.1038/s41580-019-0143-1; Momparler RL, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-19; Nan XM, 2014, PHYSIOL GENOMICS, V46, P268, DOI 10.1152/physiolgenomics.00119.2013; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Ordway RS, 2009, J DAIRY SCI, V92, P5154, DOI 10.3168/jds.2009-2259; Osorio JS, 2016, J DAIRY SCI, V99, P234, DOI 10.3168/jds.2015-10157; Osorio JS, 2014, J DAIRY SCI, V97, P7451, DOI 10.3168/jds.2014-8680; Osorio JS, 2013, J DAIRY SCI, V96, P6248, DOI 10.3168/jds.2012-5790; Osorio JS, 2012, J DAIRY SCI, V95, P5831, DOI 10.3168/jds.2011-5042; Osorio J.S., 2018, FLORIDA RUMINANT NUT, VFlorida, P19; Osorio JS, 2017, GENE, V626, P200, DOI 10.1016/j.gene.2017.05.025; Osorio JS, 2016, PHYSIOL GENOMICS, V48, P231, DOI 10.1152/physiolgenomics.00016.2015; Rijnkels M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053270; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Shima H, 2017, CELL REP, V21, P3354, DOI 10.1016/j.celrep.2017.11.092; Shinkai Y, 2011, GENE DEV, V25, P781, DOI 10.1101/gad.2027411; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teperino R, 2010, CELL METAB, V12, P321, DOI 10.1016/j.cmet.2010.09.004; Torrano J, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0644-y; Vanselow J, 2006, J MOL ENDOCRINOL, V37, P463, DOI 10.1677/jme.1.02131; Wang LJ, 2014, J NUTR BIOCHEM, V25, P329, DOI 10.1016/j.jnutbio.2013.11.007; Wang LJ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-34; Wu X, 2011, ZYGOTE, V19, P31, DOI 10.1017/S0967199410000328; ZAVIZION B, 1995, J DAIRY SCI, V78, P515, DOI 10.3168/jds.S0022-0302(95)76662-0; Zhao Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12464; Zhou Z, 2016, J DAIRY SCI, V99, P8716, DOI 10.3168/jds.2015-10525; Zhou Z, 2017, J NUTR, V147, P11, DOI 10.3945/jn.116.240234; Zinner R, 2006, HISTOCHEM CELL BIOL, V125, P3, DOI 10.1007/s00418-005-0049-1	56	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244135	10.1371/journal.pone.0244135	http://dx.doi.org/10.1371/journal.pone.0244135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347518	gold, Green Published			2022-12-27	WOS:000603071100038
J	Tangerina, MMP; Furtado, LC; Leite, VMB; Bauermeister, A; Velasco-Alzate, K; Jimenez, PC; Garrido, LM; Padilla, G; Lopes, NP; Costa-Lotufo, LV; Ferreira, MPJ				Tangerina, Marcelo M. P.; Furtado, Luciana Costa; Leite, Vida M. B.; Bauermeister, Anelize; Velasco-Alzate, Karen; Jimenez, Paula C.; Garrido, Leandro M.; Padilla, Gabriel; Lopes, Norberto P.; Costa-Lotufo, Leticia V.; Pena Ferreira, Marcelo J.			Metabolomic study of marine Streptomyces sp.: Secondary metabolites and the production of potential anticancer compounds	PLOS ONE			English	Article							NATURAL-PRODUCTS; DIKETOPIPERAZINE DERIVATIVES; MOLECULAR NETWORKING; CYCLIC OCTAPEPTIDE; DRUG DISCOVERY; DIVERSITY; GENOME; GROWTH; DEREPLICATION; COMPLETENESS	Resorting to a One Strain Many Compounds (OSMAC) approach, the marine Streptomyces sp. BRB081 strain was grown in six different media settings over 1, 2, 3 or 7 days. Extractions of mycelium and broth were conducted separately for each media and cultivation period by sonication using methanol/acetone 1:1 and agitation with ethyl acetate, respectively. All methanol/acetone and ethyl acetate crude extracts were analysed by HPLC-MS/MS and data treatment was performed through GNPS platform using MZmine 2 software. In parallel, the genome was sequenced, assembled and mined to search for biosynthetic gene clusters (BGC) of secondary metabolites using the AntiSMASH 5.0 software. Spectral library search tool allowed the annotation of desferrioxamines, fatty acid amides, diketopiperazines, xanthurenic acid and, remarkably, the cyclic octapeptides surugamides. Molecular network analysis allowed the observation of the surugamides cluster, where surugamide A and the protonated molecule corresponding to the B-E isomers, as well as two potentially new analogues, were detected. Data treatment through MZmine 2 software allowed to distinguish that the largest amount of surugamides was obtained by cultivating BRB081 in SCB medium during 7 days and extraction of culture broth. Using the same data treatment, a chemical barcode was created for easy visualization and comparison of the metabolites produced overtime in all media. By genome mining of BRB081 four regions of biosynthetic gene clusters of secondary metabolites were detected supporting the metabolic data. Cytotoxic evaluation of all crude extracts using MTT assay revealed the highest bioactivity was also observed for extracts obtained in the optimal conditions as those for surugamides production, suggesting these to be the main active compounds herein. This method allowed the identification of compounds in the crude extracts and guided the selection of best conditions for production of bioactive compounds.	[Tangerina, Marcelo M. P.; Pena Ferreira, Marcelo J.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Furtado, Luciana Costa; Bauermeister, Anelize; Velasco-Alzate, Karen; Costa-Lotufo, Leticia V.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Farmacol, Sao Paulo, SP, Brazil; [Leite, Vida M. B.; Garrido, Leandro M.; Padilla, Gabriel] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, SP, Brazil; [Bauermeister, Anelize; Lopes, Norberto P.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Biomol, NPPNS, Ribeirao Preto, SP, Brazil; [Jimenez, Paula C.] Univ Fed Sao Paulo, Inst Mar, Dept Ciencias Mar, Santos, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Tangerina, MMP; Ferreira, MPJ (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	marcelotangerina@usp.br; marcelopena@ib.usp.br	Lopes, Norberto P/C-7148-2012; Garrido, Leandro M/G-8793-2012; Tangerina, Marcelo/AEF-1225-2022; Bauermeister, Anelize/N-1255-2015; Tangerina, Marcelo M P Marucci Pereira/L-3580-2016; Costa-Lotufo, Leticia/ABC-5742-2021; Jimenez, Paula C/J-6128-2015; Costa-Lotufo, Leticia/D-4998-2014; Costa Furtado, Luciana/O-1426-2017; Padilla, Gabriel/M-2183-2016	Lopes, Norberto P/0000-0002-8159-3658; Bauermeister, Anelize/0000-0001-9731-6172; Tangerina, Marcelo M P Marucci Pereira/0000-0002-4236-094X; Costa-Lotufo, Leticia/0000-0003-1861-5153; Jimenez, Paula C/0000-0002-5244-9761; Costa-Lotufo, Leticia/0000-0003-1861-5153; Costa Furtado, Luciana/0000-0002-2306-7959; Padilla, Gabriel/0000-0001-8086-3065	Sao Paulo Research Foundation (FAPESP) [2017/16606-6, 2017/18235-5, 2017/17648-4, 2015/17177-6]; Coordination for the Improvement of Higher Education Personnel -CAPES [Brazil] [001]; Brazilian National Council for Scientific and Technological Development -CNPq; Sistema Nacional de Gestao do Patrimonio Genetico e do Conhecimento Tradicional Associado [SisGen] within the Brazilian Environmental Ministry [A0031D5]; Instituto Florestal, within the Sao Paulo State Environmental Secretary [260108 -004.258/2018]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel -CAPES [Brazil](Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian National Council for Scientific and Technological Development -CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Sistema Nacional de Gestao do Patrimonio Genetico e do Conhecimento Tradicional Associado [SisGen] within the Brazilian Environmental Ministry; Instituto Florestal, within the Sao Paulo State Environmental Secretary	This research was supported by Sao Paulo Research Foundation (FAPESP) [grants 2017/16606-6 (M.M.P.T.), 2017/18235-5 (L.C.F.), 2017/17648-4 (A.B.) and 2015/17177-6 (L.V.C.L.)] and the Coordination for the Improvement of Higher Education Personnel -CAPES [Finance Code 001, Brazil]. L.V.C.L., M.J.P.F and N.P.L. were funded by a fellowship from the Brazilian National Council for Scientific and Technological Development -CNPq. This study is registered with the Sistema Nacional de Gestao do Patrimonio Genetico e do Conhecimento Tradicional Associado [SisGen #A0031D5] within the Brazilian Environmental Ministry, and has been authorized by Instituto Florestal, within the Sao Paulo State Environmental Secretary [process #260108 -004.258/2018]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SJ, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/2189814; Almeida EL, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7100394; [Anonymous], 2018, FRONT MICROBIOL, V9, P1; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 2018, 7 SER FPGAS DAT SHEE, V2, P1; Bauermeister A, 2019, ENVIRON MICROBIOL, V21, P1099, DOI 10.1111/1462-2920.14529; Bertrand S, 2014, BIOTECHNOL ADV, V32, P1180, DOI 10.1016/j.biotechadv.2014.03.001; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9; Bose U, 2015, MAR DRUGS, V13, P249, DOI 10.3390/md13010249; Bosi E, 2015, BIOINFORMATICS, V31, P2443, DOI 10.1093/bioinformatics/btv171; Bramhachari PV, 2019, ADV ENDOPHYTIC FUNGA, P339, DOI [10.1016/j.semcancer.2018.09.011, DOI 10.1016/J.SEMCANCER.2018.09.011, 10.1007/978-3-030-03589-1_15, DOI 10.1007/978-3-030-03589-1_15]; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Cho JY, 2012, BIOSCI BIOTECH BIOCH, V76, P1116, DOI 10.1271/bbb.110943; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Christian OE, 2005, J NAT PROD, V68, P1592, DOI 10.1021/np050293f; Conde-Martinez N, 2019, MAR DRUGS, V17, DOI 10.3390/md17040196; Crusemann M, 2017, J NAT PROD, V80, P588, DOI [10.1021/acsjnatprod.6b00722, 10.1021/acs.jnatprod.6b00722]; Dalisay DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077078; Das S, 2006, CURR SCI INDIA, V90, P1325; Procopio RED, 2012, BRAZ J INFECT DIS, V16, P466, DOI 10.1016/j.bjid.2012.08.014; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; Forner D, 2013, ANAL CHIM ACTA, V805, P70, DOI 10.1016/j.aca.2013.10.029; Gill KA, 2015, J NAT PROD, V78, P822, DOI 10.1021/np501060k; Gu BB, 2013, APPL MICROBIOL BIOT, V97, P8439, DOI 10.1007/s00253-013-5175-4; Han Q, 2001, BIOCHEM J, V360, P617, DOI 10.1042/0264-6021:3600617; Harvey AL, 2015, NAT REV DRUG DISCOV, V14, P111, DOI 10.1038/nrd4510; Hou Y, 2012, ANAL CHEM, V84, P4277, DOI 10.1021/ac202623g; Huang RM, 2010, CHEM BIODIVERS, V7, P2809, DOI 10.1002/cbdv.200900211; Ioca LP, 2014, NAT PROD REP, V31, P646, DOI 10.1039/c3np70112c; Jamie H, 2002, J PHARM PHARMACOL, V54, P1659, DOI 10.1211/002235702252; Konig GM, 2006, CHEMBIOCHEM, V7, P229, DOI 10.1002/cbic.200500087; Lan YX, 2016, SCI CHINA CHEM, V59, P1224, DOI 10.1007/s11426-016-0026-7; Lee HS, 2005, J NAT PROD, V68, P623, DOI 10.1021/np040220g; LOWN JW, 1993, PHARMACOL THERAPEUT, V60, P185; Ma YM, 2016, J AGR FOOD CHEM, V64, P6659, DOI 10.1021/acs.jafc.6b01772; Malina Halina Z., 2001, BMC Physiology, V1, P1; Mangamuri U.K., 2016, EGYPT J AQUATIC RES, V42, P169, DOI [DOI 10.1016/j.ejar.2016.03.001, 10.1016/j.ejar.2016.03.001]; Manivasagan P, 2013, MICROBIOL RES, V168, P311, DOI 10.1016/j.micres.2013.02.002; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Naman CB, 2017, J NAT PROD, V80, P625, DOI 10.1021/acs.jnatprod.6b00907; Nett M, 2009, NAT PROD REP, V26, P1362, DOI 10.1039/b817069j; Ninomiya A, 2017, CHEMBIOCHEM, V18, P1770, DOI 10.1002/cbic.201700401; Nishimura O, 2017, BIOINFORMATICS, V33, P3635, DOI 10.1093/bioinformatics/btx445; Pandey A, 2019, PHARM MICROBES ENV C, V28, DOI [10.1007/978-3-030-04675-0_1, DOI 10.1007/978-3-030-04675-0_1]; Pesic A, 2013, MAR DRUGS, V11, P4834, DOI 10.3390/md11124834; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Preciado S, 2013, MEDCHEMCOMM, V4, P1171, DOI 10.1039/c3md20353k; Rateb ME, 2011, J NAT PROD, V74, P1965, DOI 10.1021/np200470u; Romano S, 2018, MAR DRUGS, V16, DOI 10.3390/md16070244; Santa Maria KC, 2019, CHEMBIOCHEM, V20, P1387, DOI 10.1002/cbic.201900025; Scheepers T, 2010, AFR J BIOTECHNOL, V9, P8824; Seipke RF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116457; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Sood S, 2016, J CLIN DIAGN RES, V10, pDC01, DOI 10.7860/JCDR/2016/14989.7167; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Takada K, 2013, J ORG CHEM, V78, P6746, DOI 10.1021/jo400708u; Uyeda M, 2001, BIOSCI BIOTECH BIOCH, V65, P1252, DOI 10.1271/bbb.65.1252; UZMA F, 2018, FRONT PHARMACOL, V9, P1; Velasco-Alzate KY, 2019, MAR DRUGS, V17, DOI 10.3390/md17120671; Vior NM, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02828-17; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Wang P, 2013, MAR DRUGS, V11, P1035, DOI 10.3390/md11041035; Yamanaka K, 2005, MICROBIOL-SGM, V151, P2899, DOI 10.1099/mic.0.28139-0; Yang JY, 2013, J NAT PROD, V76, P1686, DOI 10.1021/np400413s	66	15	15	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244385	10.1371/journal.pone.0244385	http://dx.doi.org/10.1371/journal.pone.0244385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347500	Green Published, gold			2022-12-27	WOS:000603071100051
J	Coomans, I; De Kinder, S; Van Belleghem, H; De Groote, K; Panzer, J; De Wilde, H; Mosquera, LM; Francois, K; Bove, T; Martens, T; De Wolf, D; Boone, J; Vandekerckhove, K				Coomans, Ilse; De Kinder, Sara; Van Belleghem, Hannah; De Groote, Katya; Panzer, Joseph; De Wilde, Hans; Mosquera, Laura Muino; Francois, Katrien; Bove, Thierry; Martens, Thomas; De Wolf, Daniel; Boone, Jan; Vandekerckhove, Kristof			Analysis of the recovery phase after maximal exercise in children with repaired tetralogy of Fallot and the relationship with ventricular function	PLOS ONE			English	Article							HEART-RATE RECOVERY; OXYGEN-UPTAKE; QRS-DURATION; DETERMINANTS; CONSUMPTION; DYSFUNCTION; INTENSITY; CAPACITY; DYNAMICS; IMPACT	Background Few studies demonstrate delayed recovery after exercise in children and adults with heart disease. We assess the recovery patterns of gas exchange parameters and heart rate (HR) in children with repaired Tetralogy of Fallot (rToF) compared to healthy peers and investigate the correlation with ventricular function and QRS duration. Methods 45 children after rToF and 45 controls performed a maximal incremental cardiopulmonary exercise test. In the subsequent recovery period, patterns of VO2, VCO2 and HR were analysed. Half-life time (T-1/2) of the exponential decay and drop per minute (Rec(min)) were compared between groups. In the rToF group, correlations were examined between the recovery parameters and QRS-duration and ventricular function, described by fractional shortening (FS) and tricuspid annular plane systolic excursion (TAPSE) measured at baseline prior to exercise. Results Recovery of VO2 and VCO2 was delayed in rToF patients, half-life time values were higher compared to controls (T1/2VO2 52.51 11.29 s vs. 44.31 +/- 10.47 s; p = 0.001 and T1/2VCO2 68.28 +/- 13.84 s vs. 59.41 +/- 12.06 s; p = 0.002) and percentage drop from maximal value was slower at each minute of recovery (p<0.05). Correlations were found with FS (T1/2VO2: r = -0.517; p<0.001; Rec(1min)VO(2): r = -0.636, p<0.001; Rec(1min)VCO(2): r = -0.373, p = 0.012) and TAPSE (T1/2VO2: r = -0.505; p<0.001; Rec(1min)VO(2): r = -0.566, p<0.001; T1/2VCO2: r = -0.466; p = 0.001; Rec(1min)VCO(2): r = -0.507, p<0.001), not with QRS-duration. No difference was found in HR recovery between patients and controls. Conclusions Children after rToF show a delayed gas exchange recovery after exercise. This delay correlates to ventricular function, demonstrating its importance in recovery after physical activity.	[Coomans, Ilse; De Groote, Katya; Panzer, Joseph; De Wilde, Hans; Mosquera, Laura Muino; De Wolf, Daniel; Vandekerckhove, Kristof] Ghent Univ Hosp, Dept Pediat Cardiol, Ghent, Belgium; [De Kinder, Sara; Van Belleghem, Hannah] Univ Ghent, Fac Med, Ghent, Belgium; [Francois, Katrien; Bove, Thierry; Martens, Thomas] Ghent Univ Hosp, Dept Cardiac Surg, Ghent, Belgium; [Boone, Jan] Univ Ghent, Dept Movement & Sports Sci, Ghent, Belgium	Ghent University; Ghent University Hospital; Ghent University; Ghent University; Ghent University Hospital; Ghent University	Coomans, I (corresponding author), Ghent Univ Hosp, Dept Pediat Cardiol, Ghent, Belgium.	ilse.coomans@uzgent.be	Panzer, Joseph/HHM-2095-2022; de wolf, daniel/F-7481-2013; Muino Mosquera, Laura/ABD-5010-2020	Panzer, Joseph/0000-0002-8667-8001; de wolf, daniel/0000-0002-0846-8914; Muino Mosquera, Laura/0000-0002-3094-7807; Bove, Thierry/0000-0003-3786-0699; Boone, Jan/0000-0002-8485-6169; Vandekerckhove, Kristof/0000-0002-1481-0878; Coomans, Ilse/0000-0001-8321-0537; Van Belleghem, Hannah/0000-0001-7724-1732				Apitz C, 2009, LANCET, V374, P1462, DOI 10.1016/S0140-6736(09)60657-7; Armstrong N, 1994, Exerc Sport Sci Rev, V22, P435; Bailey CS, 2018, JACC-HEART FAIL, V6, P329, DOI 10.1016/j.jchf.2018.01.007; Bailliard F, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-2; Budts W, 2005, INT J CARDIOL, V104, P46, DOI 10.1016/j.ijcard.2004.09.017; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Falk B, 2006, EXERC SPORT SCI REV, V34, P107, DOI 10.1249/00003677-200607000-00004; GAESSER GA, 1984, MED SCI SPORT EXER, V16, P29; Giardini A, 2006, EUR J HEART FAIL, V8, P736, DOI 10.1016/j.ejheart.2006.01.012; Greutmann M, 2014, INT J CARDIOL, V176, P333, DOI 10.1016/j.ijcard.2014.06.033; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Kipps AK, 2011, AM J CARDIOL, V108, P99, DOI 10.1016/j.amjcard.2011.02.349; Koestenberger M, 2009, J AM SOC ECHOCARDIOG, V22, P715, DOI 10.1016/j.echo.2009.03.026; Lurz P, 2014, INT J CARDIOL, V177, P276, DOI 10.1016/j.ijcard.2014.09.014; Mann TN, 2014, EUR J APPL PHYSIOL, V114, P1809, DOI 10.1007/s00421-014-2907-9; Marcuccio E, 2012, PEDIATR CARDIOL, V33, P1165, DOI 10.1007/s00246-012-0276-x; Mercer-Rosa L, 2013, J AM SOC ECHOCARDIOG, V26, P1322, DOI 10.1016/j.echo.2013.06.022; Muller J, 2015, INT J CARDIOL, V196, P158, DOI 10.1016/j.ijcard.2015.05.174; Ohuchi H, 2002, CIRCULATION, V106, P2819, DOI 10.1161/01.CIR.0000038891.06306.BA; Ohuchi H, 2007, AM HEART J, V154, P165, DOI 10.1016/j.ahj.2007.03.031; Paul MH, 1999, PEDIATR CARDIOL, V20, P49, DOI 10.1007/s002469900395; Pecanha T, 2014, CLIN PHYSIOL FUNCT I, V34, P327, DOI 10.1111/cpf.12102; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Singh TP, 2008, MED SCI SPORT EXER, V40, P601, DOI 10.1249/MSS.0b013e3181621ec4; Singh TP, 2011, MED SCI SPORT EXER, V43, P555, DOI 10.1249/MSS.0b013e3181f683b8; Wasserman K., 1987, J CARDIOPULM REHABIL, V7, P189, DOI [DOI 10.1097/00008483-198704000-00014, 10.1097/00008483-198704000-00014]; Wessel HU, 1999, PEDIATR CARDIOL, V20, P39, DOI 10.1007/s002469900393; ZANCONATO S, 1991, J APPL PHYSIOL, V71, P993, DOI 10.1152/jappl.1991.71.3.993	28	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244312	10.1371/journal.pone.0244312	http://dx.doi.org/10.1371/journal.pone.0244312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338081	Green Published, gold			2022-12-27	WOS:000601313500026
J	Gedefaw, G; Goedert, MH; Abebe, E; Demis, A				Gedefaw, Getnet; Goedert, Martha H.; Abebe, Eskeziaw; Demis, Asmamaw			Effect of cesarean section on initiation of breast feeding: Findings from 2016 Ethiopian Demographic and Health Survey	PLOS ONE			English	Article							DELIVERY; PREGNANCY	Background Early initiation of breast feeding has great importance for both mothers and newborns. Despite, recommendations for exclusive and early initiation of breast feeding within one hour of birth, Ethiopia reports that 58% of infants under six months of age are exclusively breastfed. Cesarean deliveries may affect timing of breastfeeding initiation, establishment of milk supply and infant breastfeeding interest compared to vaginal deliveries. The aim of this study was to assess the impact of cesarean delivery on breastfeeding initiation. Methods A cross-sectional study was conducted with a total of 7115 study participants from the 2016 Ethiopian Demographic Health Survey (EDHS). Both descriptive and analytical statistical analysis was employed. Univariable and multivariable logistic regression analyses were used to identify anyassociations between variables. Odds ratios with its corresponding 95% confidence intervals (CI) were reported. During multivariable analysis, variables with p-value <0.05 were considered as statistically significant. Results The prevalence of late initiation of breast feeding among women with their last live birth was 25.03% (95%CI; 20.5-32.2). Significant factors associated with late initiation of breastfeeding were cesarean delivery [AOR = 4.06 (95%CI, 2.66-6.2)], primipara mother [AOR = 1.45(95%CI, 1.13-1.7)], and having an unplanned pregnancy [AOR = 1.35(95%CI, 1.1-1.65)]. Positively associated with early initiation of breastfeeding was the mother's age, for women between 20-34 years-old. This association, reported as a negative association of late initiation of breast feeding was [AOR = 0.77(95%CI, 0.61-0.98)]. Conclusion Cesarean delivery adversely affects the initiation of breast feeding. Cesarean delivery, unplanned pregnancy, and being primiparous, were associated with late initiation of breastfeeding. Women between the ages of 20-34 years of age had a reduced chance of late initiation of breastfeeding. Providing counseling regarding the strategy and importance of early initiation of breast feeding, could have crucial importance for the mother and her newborn.	[Gedefaw, Getnet; Abebe, Eskeziaw] Woldia Univ, Dept Midwifery, Coll Hlth Sci, Woldia, Ethiopia; [Goedert, Martha H.] Univ Nebraska Med Ctr, Dept Hlth Promot, Coll Publ Hlth, Omaha, NE USA; [Demis, Asmamaw] Woldia Univ, Dept Nursing, Coll Hlth Sci, Woldia, Ethiopia	University of Nebraska System; University of Nebraska Medical Center	Gedefaw, G (corresponding author), Woldia Univ, Dept Midwifery, Coll Hlth Sci, Woldia, Ethiopia.	gedefawget@gmail.com	Bizuneh, Asmamaw Demis/ABA-1868-2021; Kassahun, Eskeziaw Abebe/CAH-7384-2022	Kassahun, Eskeziaw Abebe/0000-0003-0580-5708				Abebe FE, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-015-0114-8; Ahmed KY, 2019, INT BREASTFEED J, V14, DOI 10.1186/s13006-019-0234-9; Amin T, 2010, INT NURS REV, V6, P59; Anbaran ZK, 2016, INT J PEDIATR-MASSHA, V4, P4043, DOI 10.22038/ijp.2016.7151; [Anonymous], 2018, GLOB STRAT INF YOUNG; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Berde AS, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0818-y; Berhe H, 2011, DETERMINANTS BREASTF; Central Statistical Agency (CSA) [Ethiopia] ICF, 2016, ETHIOPIA DEMOGRAPHIC; Cheng D, 2009, CONTRACEPTION, V79, P194, DOI 10.1016/j.contraception.2008.09.009; Ekubay M, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0146-0; Erbaydar NP, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2732-6; Gavhane S, 2018, INT J RES MED SCI, V6, P481, DOI [10.18203/2320, DOI 10.18203/2320, 10.18203/2320-6012.ijrms20180285, DOI 10.18203/2320-6012.IJRMS20180285]; Gebremedhin S, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-14; Karlstrom A, 2013, BJOG-INT J OBSTET GY, V120, P479, DOI 10.1111/1471-0528.12129; Kitano Naomi, 2016, Prev Med Rep, V3, P121, DOI 10.1016/j.pmedr.2015.12.010; Kost K, 1998, FAM PLANN PERSPECT, V30, P223, DOI 10.2307/2991608; Ksenia B, 2007, RANDOMIZED TRIAL ST, V2, P9, DOI [10.1186/1746-4358-2-9, DOI 10.1186/1746-4358-2-917488524]; Lauer J. A., 2010, DETERMINANTS CAESARE; Lin HC, 2004, ACTA OBSTET GYN SCAN, V83, P1178; McLachlan HL, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-7; Mukunya D, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1410975; Oakley L, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12535; Patel A, 2013, J HUM LACT, V29, P572, DOI 10.1177/0890334412474718; Patel RR, 2003, BIRTH-ISS PERINAT C, V30, P255, DOI 10.1046/j.1523-536X.2003.00255.x; Patil CL, 2015, J HEALTH POPUL NUTR, V34, DOI 10.1186/s41043-015-0004-2; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; Regan J, 2013, BREASTFEED MED, V8, P181, DOI 10.1089/bfm.2012.0049; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Seid AM, 2014, ISRN EPIDEMIOLOGY, V2014, P3; Setegn T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-217; Tamiru D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-363; The Demographic and Health Services Program-ICF, 2020, LIB DEM HLTH SURV 20; Tongun JB, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0170-0; Vieira TO, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-760; Wax JR, 2006, SEMIN PERINATOL, V30, P247, DOI 10.1053/j.semperi.2006.07.003; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; Zhao J, 2017, MATERN CHILD HLTH J, V21, P2008, DOI 10.1007/s10995-017-2369-x; Zhou YB, 2014, PLACENTA, V35, P1, DOI 10.1016/j.placenta.2013.10.011	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244229	10.1371/journal.pone.0244229	http://dx.doi.org/10.1371/journal.pone.0244229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338080	Green Published, gold			2022-12-27	WOS:000601313500019
J	Staniszewski, P; Bilek, M; Szwerc, W; Tomusiak, R; Osiak, P; Kocjan, R; Moskalik, T				Staniszewski, Pawel; Bilek, Maciej; Szwerc, Wojciech; Tomusiak, Robert; Osiak, Pawel; Kocjan, Ryszard; Moskalik, Tadeusz			The effect of tree age, daily sap volume and date of sap collection on the content of minerals and heavy metals in silver birch (Betula pendula Roth) tree sap	PLOS ONE			English	Article							IMPLEMENTING CERTIFICATION SYSTEM; CHEMICAL-COMPOSITION; VARIABILITY	The aim of this study was to determine the effect of the age of trees, daily sap volume as well as the term of tapping birch sap collected in the forest environment on the content of selected minerals (zinc, copper and manganese) and heavy metals (lead, nickel, chromium and cadmium). The study was performed on material taken from two stands (aged 34 and 84 years) in a moist broadleaved forest habitat with a dominant share of silver birch (Betula pendula Roth). The research results confirmed the presence of both nutritional essential minerals and hazardous heavy metals in the birch sap. At the same time, the content of minerals and heavy metals was found to be very variable and the differences between their concentrations, recorded on the same day of collecting in several trees of the same age group, can be even several dozen times higher. Depending on the examined elements, the factors influencing their content vary. The age of the trees determines only the manganese content; daily sap volume significantly affects the content of manganese and copper, and date of collection differentiates the content of zinc, lead, nickel and cadmium. The results may be interesting in the context of developing procedures for collecting birch sap for the purpose of obtaining raw material with beneficial nutritional values and a high level of health safety. For this reason, our recommendation for guaranteeing the health safety and high nutritional value of birch sap is to combine batches of raw material taken from as many trees as possible, and at the same time to publicize the fact that collecting birch sap from just one single tree may result in a raw material that is both dangerous and has no nutritional benefits.	[Staniszewski, Pawel; Moskalik, Tadeusz] Warsaw Univ Life Sci SGGW, Inst Forest Sci, Dept Forest Utilizat, Warsaw, Poland; [Bilek, Maciej] Univ Rzeszow, Inst Agr Sci Land Management & Environm Protect, Dept Agroecol, Rzeszow, Poland; [Szwerc, Wojciech; Kocjan, Ryszard] Med Univ Lublin, Chem Dept Analyt Chem, Lublin, Poland; [Tomusiak, Robert] Warsaw Univ Life Sci SGGW, Inst Forest Sci, Dept Forest Management Planning Dendrometry & For, Warsaw, Poland; [Osiak, Pawel] Warsaw Univ Life Sci SGGW, Forestry Students Sci Assoc, Warsaw, Poland	Warsaw University of Life Sciences; University of Rzeszow; Medical University of Lublin; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Moskalik, T (corresponding author), Warsaw Univ Life Sci SGGW, Inst Forest Sci, Dept Forest Utilizat, Warsaw, Poland.	tadeusz.moskalik@wl.sggw.pl		Bilek, Maciej/0000-0003-2232-5511; Moskalik, Tadeusz/0000-0003-1215-5272	Polish Ministry of Science and Higher Education within funds of the Institute of Forest Sciences, Warsaw University of Life Sciences (WULS)	Polish Ministry of Science and Higher Education within funds of the Institute of Forest Sciences, Warsaw University of Life Sciences (WULS)	The article was financed by the Polish Ministry of Science and Higher Education within funds of the Institute of Forest Sciences, Warsaw University of Life Sciences (WULS), for scientific research.	Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Agostoni C, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3844; Ahenkan Albert, 2011, Environment Development and Sustainability, V13, P863, DOI 10.1007/s10668-011-9295-7; [Anonymous], 2020, EUROPEAN CLIMATE ASS; [Anonymous], 2019, PRINC FOR UT ANN NO, P1; [Anonymous], 2014, BRIT EC DEV S E ASIA, V2, P50; Barszcz A., 2009, Folia Forestalia Polonica. Seria A, Lesnictwo, V51, P77; Barszcz A., 2006, Electronic Journal of Polish Agricultural Universities, V9, P08; Bilek M., 2017, Medycyna Srodowiskowa - Environmental Medicine, V20, P17; Bilek M., 2016, Medycyna Srodowiskowa - Environmental Medicine, V19, P31; Bilek M., 2015, ZYWNOSC NAUKA TECHNO, V100, P138; Bilek M., 2017, POSTEPY FITOTERAPII, V3, P183; Bilek M, 2015, ZYWN-NAUK TECHNOL JA, V101, P151; Bilek Maciej, 2018, Bromatologia i Chemia Toksykologiczna, V51, P284; Bilek M, 2019, SYLWAN, V163, P443, DOI 10.26202/sylwan.2018165; Bilek M, 2017, J ELEMENTOL, V22, P957, DOI 10.5601/jelem.2016.21.4.1224; Bilek M, 2017, J ELEMENTOL, V22, P497, DOI 10.5601/jelem.2016.21.3.1245; Bilek M, 2016, J ELEMENTOL, V21, P1277, DOI 10.5601/jelem.2015.20.4.1048; Bilek M, 2016, J ELEMENTOL, V21, P669, DOI 10.5601/jelem.2015.20.4.932; Boroduskis M., 2017, Environmental and Experimental Biology, V15, P29; Bresson JL, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4253; Enescu CM, 2017, SCI PAP-SER MANAG EC, V17, P191; European Food Safety Authority European Centre for Disease Prevention and Control, 2013, EFSA J, V11, P1, DOI DOI 10.2903/J.EFSA.2013.3158; Forest Data Bank, 2020, FOREST DATA BANK; Grabek-Lejko D, 2017, BALT FOR, V23, P394; Graves H. S., 1906, FOREST MENSURATION; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; HARJU L, 1990, J GEOCHEM EXPLOR, V37, P351, DOI 10.1016/0375-6742(90)90108-M; Hyde WF, 2005, SUSTAIN ECON NAT RES, V2, P193; Isakov I.Y., 2017, APPL INF ASP MED, V20, P212; Kostro L, 1974, SYLWAN, P44; Kuka Mara, 2013, Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences, V67, P437, DOI 10.2478/prolas-2013-0069; Lachowicz H, 2019, WOOD SCI TECHNOL, V53, P1135, DOI 10.1007/s00226-019-01121-z; Lachowicz H, 2016, SYLWAN, V160, P971; Maruca G, 2019, GENET RESOUR CROP EV, V66, P1027, DOI 10.1007/s10722-019-00768-8; Matsneva M, 2017, IZV SANKT PETERBURGS, P132; Mingaila J, 2020, FORESTS, V11, DOI 10.3390/f11040365; Niskanen A, 2005, ACTA SIL LING, P7; Ozolincius R, 2016, BALT FOR, V22, P222; Papp N, 2014, ACTA SOC BOT POL, V83, P113, DOI 10.5586/asbp.2014.011; Pettenella D, 2019, WHAT SCI CAN TELL, V10, P31; Purwestri RC, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12020566; Schoetz S, 2016, 2016 IEEE INTERNATIONAL SYMPOSIUM ON ASSEMBLY AND MANUFACTURING (ISAM), P70, DOI 10.1109/ISAM.2016.7750720; Seeland K., 2007, Small-scale Forestry, V6, P411, DOI 10.1007/s11842-007-9029-8; Soukand R, 2015, J ETHNOPHARMACOL, V170, P284, DOI 10.1016/j.jep.2015.05.018; Staniszewski P, 2020, SYLWAN, V164, P432, DOI 10.26202/sylwan.2020022; Staniszewski P, 2020, SYLWAN, V164, P424, DOI 10.26202/sylwan.2020021; Staniszewski P, 2011, SYLWAN, V155, P313; Staniszewski P, 2011, SYLWAN, V155, P253; Stasiuk E, 2019, ZESZ PROBL POSTPOW N, P113; Svanberg I, 2012, ACTA SOC BOT POL, V81, P343, DOI 10.5586/asbp.2012.036; VASQUEZ R, 1989, CONSERV BIOL, V3, P350, DOI 10.1111/j.1523-1739.1989.tb00241.x; Viskelis P., 2011, Sodininkyste ir Darzininkyste, V30, P75; Vladimirov M., 2019, ADV TECHNOL, V8, P65, DOI [DOI 10.5937/SAVTEH1901065V, 10.5937/SavTeh1901065V]; Wawer J., 2017, Postepy Nauki i Technologii Przemyslu Rolno-Spozywczego, V72, P51; Zajaczkowska U, 2019, SILVA FENN, V53, DOI 10.14214/sf.10048; Zyryanova O. A., 2010, Eurasian Journal of Forest Research, V13-1, P25	57	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244435	10.1371/journal.pone.0244435	http://dx.doi.org/10.1371/journal.pone.0244435			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373389	gold, Green Published			2022-12-27	WOS:000603612300004
J	Wang, JL; Barth, RF; Cavaliere, R; Puduvalli, VK; Giglio, P; Lonser, RR; Elder, JB				Wang, Joshua L.; Barth, Rolf F.; Cavaliere, Robert; Puduvalli, Vinay K.; Giglio, Pierre; Lonser, Russell R.; Elder, J. Bradley			Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas	PLOS ONE			English	Article							INTRAVENOUS CARBOPLATIN; LOCAL CHEMOTHERAPY; MALIGNANT GLIOMA; BRAIN; GLIOBLASTOMA; SURVIVAL; POLYMERS; SYSTEM; TUMOR	Background Carboplatin is a potent cytoreductive agent for a variety of solid tumors. However, when delivered systemically, clinical efficacy for the treatment of high grade gliomas is poor due to limited penetration across the blood-brain barrier (BBB). Direct intracerebral (IC) convection-enhanced delivery (CED) of carboplatin has been used to bypass the BBB and successfully treat the F98 rat glioma. Based on these studies, we initiated a Phase I clinical trial. Objective This Phase I clinical trial was conducted to establish the maximum tolerated dose and define the toxicity profile of carboplatin delivered intracerebrally via convection enhanced delivery (CED) for patients with high grade glial neoplasms. Methods Cohorts of 3 patients with recurrent WHO grade III or IV gliomas were treated with escalating doses of CED carboplatin (1-4 mu g in 54mL over 72 hours) delivered via catheters placed at the time of recurrent tumor resection. The primary outcome measure was determination of the maximum tolerated dose (MTD). Secondary outcome measures included overall survival (OS), progression-free survival (PFS), and radiographic correlation. Results A total of 10 patients have completed treatment with infusion doses of carboplatin of 1 mu g, 2 mu g, and 4 mu g. The total planned volume of infusion was 54mL for each patient. All patients had previously received surgery and chemoradiation. Histology at treatment include GBM (n = 9) and anaplastic oligodendroglioma (n = 1). Median KPS was 90 (range, 70 to 100) at time of treatment. Median PFS and OS were 2.1 and 9.6 months after completion of CED, respectively. A single adverse event possibly related to treatment was noted (generalized seizure). Conclusions IC CED of carboplatin as a potential therapy for recurrent malignant glioma is feasible and safe at doses up to 4 mu g in 54mL over 72 hours. Further studies are needed to determine the maximum tolerated dose and potential efficacy.	[Wang, Joshua L.; Lonser, Russell R.; Elder, J. Bradley] Ohio State Univ, Coll Med, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Barth, Rolf F.] Ohio State Univ, Coll Med, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA; [Cavaliere, Robert; Puduvalli, Vinay K.; Giglio, Pierre] Ohio State Univ, Coll Med, Dept Neurol, Wexner Med Ctr,Div Neurooncol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wang, JL (corresponding author), Ohio State Univ, Coll Med, Dept Neurol Surg, Wexner Med Ctr, Columbus, OH 43210 USA.	joshua.wang@osumc.edu		Puduvalli, Vinay/0000-0001-8396-9500; Wang, Joshua/0000-0002-3490-6957	Voices Against Brain Cancer	Voices Against Brain Cancer	This trial received funding from Voices Against Brain Cancer.	Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Barua NU, 2016, DRUG DELIV, V23, P167, DOI 10.3109/10717544.2014.908248; Bidros DS, 2010, FUTURE ONCOL, V6, P117, DOI 10.2217/FON.09.135; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; BOUVIER G, 1987, NEUROSURGERY, V20, P286, DOI 10.1227/00006123-198702000-00015; BREM H, 1990, BIOMATERIALS, V11, P699, DOI 10.1016/0142-9612(90)90030-T; Degen JW, 2003, J NEUROSURG, V99, P893, DOI 10.3171/jns.2003.99.5.0893; Elleaume H, 2020, J NEURO-ONCOL, V149, P193, DOI 10.1007/s11060-020-03600-x; Emerich DF, 2000, PHARMACEUT RES, V17, P776, DOI 10.1023/A:1007591721877; Emerich DF, 2002, CELL TRANSPLANT, V11, P495, DOI 10.3727/096020198389771; Groothuis DR, 2000, NEURO-ONCOLOGY, V2, P45, DOI 10.1093/neuonc/2.1.45; HILDEBRAND J, 1991, EUR J CANCER, V27, P568; Jahangiri A, 2017, J NEUROSURG, V126, P191, DOI 10.3171/2016.1.JNS151591; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Lonser RR, 2015, J NEUROSURG, V122, P697, DOI 10.3171/2014.10.JNS14229; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Olivi A, 1996, CANCER CHEMOTH PHARM, V39, P90; POISSON M, 1991, J NEURO-ONCOL, V10, P139, DOI 10.1007/BF00146875; Prados MD, 1996, AM J CLIN ONCOL-CANC, V19, P609, DOI 10.1097/00000421-199612000-00016; Rousseau J, 2007, CLIN CANCER RES, V13, P5195, DOI 10.1158/1078-0432.CCR-07-1002; Sheleg SV, 2002, J NEURO-ONCOL, V60, P53, DOI 10.1023/A:1020288015457; Shi MH, 2019, J ONCOL, V2019, DOI 10.1155/2019/9342796; Strege RJ, 2004, J NEURO-ONCOL, V67, P327, DOI 10.1023/B:NEON.0000024243.31886.ab; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vavra M, 2004, NEURO-ONCOLOGY, V6, P104, DOI 10.1215/S1152851703000449; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Yang WL, 2011, J NEURO-ONCOL, V101, P379, DOI 10.1007/s11060-010-0272-z; YUNG WKA, 1991, J CLIN ONCOL, V9, P860, DOI 10.1200/JCO.1991.9.5.860	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244383	10.1371/journal.pone.0244383	http://dx.doi.org/10.1371/journal.pone.0244383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373402	gold, Green Published			2022-12-27	WOS:000603612300060
J	Van Hedger, SC; Veillette, J; Heald, SLM; Nusbaum, HC				Van Hedger, Stephen C.; Veillette, John; Heald, Shannon L. M.; Nusbaum, Howard C.			Revisiting discrete versus continuous models of human behavior: The case of absolute pitch	PLOS ONE			English	Article							WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; TONE LANGUAGE; MUSICAL PITCH; IDENTIFICATION; STUDENTS; ACQUISITION; JUDGMENTS; AMERICAN; ABILITY	Many human behaviors are discussed in terms of discrete categories. Quantizing behavior in this fashion may provide important traction for understanding the complexities of human experience, but it also may bias understanding of phenomena and associated mechanisms. One example of this is absolute pitch (AP), which is often treated as a discrete trait that is either present or absent (i.e., with easily identifiable near-perfect "genuine" AP possessors and at-chance non-AP possessors) despite emerging evidence that pitch-labeling ability is not all-or-nothing. We used a large-scale online assessment to test the discrete model of AP, specifically by measuring how intermediate performers related to the typically defined "non-AP" and "genuine AP" populations. Consistent with prior research, individuals who performed at-chance (non-AP) reported beginning musical instruction much later than the near-perfect AP participants, and the highest performers were more likely to speak a tonal language than were the lowest performers (though this effect was not as statistically robust as one would expect from prior research). Critically, however, these developmental factors did not differentiate the near-perfect AP performers from the intermediate AP performers. Gaussian mixture modeling supported the existence of two performance distributions-the first distribution encompassed both the intermediate and near-perfect AP possessors, whereas the second distribution encompassed only the at-chance participants. Overall, these results provide support for conceptualizing intermediate levels of pitch-labeling ability along the same continuum as genuine AP-level pitch labeling ability-in other words, a continuous distribution of AP skill among all above-chance performers rather than discrete categories of ability. Expanding the inclusion criteria for AP makes it possible to test hypotheses about the mechanisms that underlie this ability and relate this ability to more general cognitive mechanisms involved in other abilities.	[Van Hedger, Stephen C.; Veillette, John; Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Ctr Pract Wisdom, Chicago, IL 60637 USA; [Van Hedger, Stephen C.; Veillette, John; Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Van Hedger, Stephen C.] Western Univ, Brain & Mind Inst, London, ON, Canada; [Van Hedger, Stephen C.] Huron Univ Coll, Dept Psychol, London, ON, Canada	University of Chicago; University of Chicago; Western University (University of Western Ontario); Western University (University of Western Ontario)	Van Hedger, SC; Veillette, J (corresponding author), Univ Chicago, Ctr Pract Wisdom, Chicago, IL 60637 USA.; Van Hedger, SC; Veillette, J (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.; Van Hedger, SC (corresponding author), Western Univ, Brain & Mind Inst, London, ON, Canada.; Van Hedger, SC (corresponding author), Huron Univ Coll, Dept Psychol, London, ON, Canada.	svanhedg@uwo.ca; johnv@uchicago.edu	Van Hedger, Stephen Charles/V-3248-2019	Van Hedger, Stephen Charles/0000-0002-2448-9088; Veillette, John/0000-0002-0332-4372	John Templeton Foundation [58345]	John Templeton Foundation	This research was supported in part from a grant from the John Templeton Foundation (58345) to HCN (https://www.templeton.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; BACHEM A, 1955, J ACOUST SOC AM, V27, P1180, DOI 10.1121/1.1908155; Bachem A, 1937, J ACOUST SOC AM, V9, P146, DOI 10.1121/1.1915919; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Bartlette C., 2015, PSYCHOMUSICOLOGY, V24, P279; Ben-Haim MS, 2014, J EXP PSYCHOL HUMAN, V40, P24, DOI 10.1037/a0033583; Benaglia T, 2009, J STAT SOFTW, V32, P1; Bermudez P, 2009, MUSIC PERCEPT, V27, P89, DOI 10.1525/MP.2009.27.2.89; Blagrove M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01351; BRADY PT, 1970, J ACOUST SOC AM, V48, P883, DOI 10.1121/1.1912227; Brauchli C, 2019, NEUROIMAGE, V189, P241, DOI 10.1016/j.neuroimage.2019.01.021; CUDDY LL, 1968, J ACOUST SOC AM, V43, P1069, DOI 10.1121/1.1910941; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Deutsch D, 2004, MUSIC PERCEPT, V21, P339, DOI 10.1525/mp.2004.21.3.339; Deutsch D., 2013, ABSOLUTE PITCH; Deutsch D, 2013, J ACOUST SOC AM, V134, P3853, DOI 10.1121/1.4824450; Deutsch D, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P141, DOI 10.1016/B978-0-12-381460-9.00005-5; Deutsch D, 2013, J ACOUST SOC AM, V133, P1859, DOI 10.1121/1.4792217; Deutsch D, 2009, J ACOUST SOC AM, V125, P2398, DOI 10.1121/1.3081389; Dohn A, 2014, MUSIC PERCEPT, V31, P359, DOI 10.1525/MP.2014.31.4.359; Dooley K. D., 2011, THESIS, P139; Eitan Z, 2017, MUSIC PERCEPT, V34, P569, DOI 10.1525/MP.2017.34.5.569; Frieler K, 2013, MUSIC SCI, V17, P334, DOI 10.1177/1029864913493802; Heald S. L. M., 2017, UNDERSTANDING SOUND, V232; Jakubowski K, 2017, Q J EXP PSYCHOL, V70, P434, DOI 10.1080/17470218.2015.1131726; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Leipold S, 2019, NEUROIMAGE, V200, P132, DOI 10.1016/j.neuroimage.2019.06.030; Levitin DJ, 2005, TRENDS COGN SCI, V9, P26, DOI 10.1016/j.tics.2004.11.007; Levitin DJ, 2003, MUSIC PERCEPT, V21, P105, DOI 10.1525/mp.2003.21.1.105; LEVITIN DJ, 1994, PERCEPT PSYCHOPHYS, V56, P414, DOI 10.3758/BF03206733; LOCKHEAD GR, 1981, J ACOUST SOC AM, V70, P387, DOI 10.1121/1.386773; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; Mankel K, 2018, P NATL ACAD SCI USA, V115, P13129, DOI 10.1073/pnas.1811793115; Marsman M, 2017, EUR J DEV PSYCHOL, V14, P545, DOI 10.1080/17405629.2016.1259614; Mitchell H., 2017, WALL STREET J; MIYAZAKI K, 1990, MUSIC PERCEPT, V8, P177; MIYAZAKI K, 1989, MUSIC PERCEPT, V7, P1; Miyazaki K, 2006, MUSIC PERCEPT, V24, P63, DOI 10.1525/mp.2006.24.1.63; Mull HK, 1925, AM J PSYCHOL, V36, P469, DOI 10.2307/1413906; Rachem A, 1940, J ACOUST SOC AM, V11, P434; Schellenberg EG, 2008, MUSIC PERCEPT, V25, P241, DOI 10.1525/MP.2008.25.3.241; Schellenberg EG, 2003, PSYCHOL SCI, V14, P262, DOI 10.1111/1467-9280.03432; SERGEANT D, 1969, J RES MUSIC EDUC, V17, P135, DOI 10.2307/3344200; Smith NA, 2008, J ACOUST SOC AM, V123, pEL77, DOI 10.1121/1.2896106; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; TAKEUCHI AH, 1991, MUSIC PERCEPT, V9, P27; TERHARDT E, 1983, MUSIC PERCEPT, V1, P63; Theusch E, 2009, AM J HUM GENET, V85, P112, DOI 10.1016/j.ajhg.2009.06.010; Van Hedger SC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223047; Van Hedger SC, 2018, ACTA PSYCHOL, V191, P251, DOI 10.1016/j.actpsy.2018.10.007; Van Hedger SC, 2018, Q J EXP PSYCHOL, V71, P879, DOI 10.1080/17470218.2017.1307427; Van Hedger SC, 2017, PSYCHON B REV, V24, P481, DOI 10.3758/s13423-016-1099-1; Van Hedger SC, 2016, COGNITION, V154, P139, DOI 10.1016/j.cognition.2016.06.001; Van Hedger SC, 2015, COGNITION, V140, P95, DOI 10.1016/j.cognition.2015.03.012; VANKREVELEN A, 1951, J EXP PSYCHOL, V42, P207, DOI 10.1037/h0062795; Vitouch O, 2003, MUSIC PERCEPT, V21, P111, DOI 10.1525/mp.2003.21.1.111; Wagner SL, 2016, CHILD NEUROPSYCHOL, V22, P853, DOI 10.1080/09297049.2015.1080232; Ward W.D., 1982, PSYCHOL MUSIC, V2nd ed., P431; Wengenroth M, 2014, CEREB CORTEX, V24, P1127, DOI 10.1093/cercor/bhs391; Wilson SJ, 2012, MUSIC PERCEPT, V29, P285, DOI 10.1525/MP.2012.29.3.285; Zatorre RJ, 2003, NAT NEUROSCI, V6, P692, DOI 10.1038/nn1085; ZATORRE RJ, 1989, MEM COGNITION, V17, P582, DOI 10.3758/BF03197081	63	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244308	10.1371/journal.pone.0244308	http://dx.doi.org/10.1371/journal.pone.0244308			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370349	Green Submitted, Green Published, gold			2022-12-27	WOS:000603611900121
J	Zhang, C; Kuncel, NR; Sackett, PR				Zhang, Charlene; Kuncel, Nathan R.; Sackett, Paul R.			The process of attrition in pre-medical studies: A large-scale analysis across 102 schools	PLOS ONE			English	Article							PIPELINE; PERSISTENCE; STUDENTS; ADMISSIONS; SUCCESS; WOMEN; MEN	The important but difficult choice of vocational trajectory often takes place in college, beginning with majoring in a subject and taking relevant coursework. Of all possible disciplines, pre-medical studies are often not a formally defined major but pursued by a substantial proportion of the college population. Understanding students' experiences with pre-med coursework is valuable and understudied, as most research on medical education focuses on the later medical school and residency. We examined the pattern and predictors of attrition at various milestones along the pre-med coursework track during college. Using a College Board dataset, we analyzed a sample of 15,442 students spanning 102 institutions who began their post-secondary education in years between 2006 and 2009. We examined whether students fulfilled the required coursework to remain eligible for medical schools at several milestones: 1) one semester of general chemistry, biology, physics, 2) two semesters of general chemistry, biology, physics, 3) one semester of organic chemistry, and 4) either the second semester of organic chemistry or one semester of biochemistry, and predictors of persistence at each milestone. Only 16.5% of students who intended to major in pre-med graduate college with the required coursework for medical schools. Attrition rates are highest initially but drop as students take more advanced courses. Predictors of persistence include academic preparedness before college (e.g., SAT scores, high school GPA) and college performance (e.g., grades in pre-med courses). Students who perform better academically both in high school and in college courses are more likely to remain eligible for medical school.	[Zhang, Charlene; Kuncel, Nathan R.; Sackett, Paul R.] Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Zhang, C (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	zhan5449@umn.edu		Zhang, Charlene/0000-0001-6975-5653	College Board	College Board	This research was supported by a grant from the College Board to Paul R. Sackett and Nathan R. Kuncel. Paul R. Sackett served as a consultant to the College Board. This relationship has been reviewed and managed by the University of Minnesota in accordance with its conflict of interest policies. This research is derived from data provided by the College Board. Copyright 2006-2011 The College Board. www.collegeboard.com The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMC, 1995, CHOOS BEST PREM MAJ; AAMC, 2013, ROADM EXC KEY CONC E; AAMC, 2018, APPL MATR DAT; AAMC, 2020, HOL REV; AAMC, 2020, POSTB PROGR; AAMC, 2019, MATR STUD QUEST 2019, P26; Alexander C, 2009, ACAD MED, V84, P797, DOI 10.1097/ACM.0b013e3181a3d948; Andriole DA, 2008, ARCH SURG-CHICAGO, V143, P1172, DOI 10.1001/archsurg.143.12.1172; [Anonymous], 2012, GLOBAL DIALOGUE, V14, P14, DOI DOI 10.1136/bcr-2012-007246; [Anonymous], 2016, TOP AGRAR, V10, P18; Arulampalam W, 2007, MED EDUC, V41, P385, DOI 10.1111/j.1365-2929.2007.02710.x; Association of American Medical Colleges, 2019, ADM REQ; Association of American Medical Colleges, 2019, FIN AID; Barr DA, 2010, ADV HEALTH SCI EDUC, V15, P45, DOI 10.1007/s10459-009-9165-3; Barr Donald A, 2008, Acad Med, V83, P503, DOI 10.1097/ACM.0b013e31816bda16; Bastedo MN, 2018, J HIGH EDUC, V89, P782, DOI 10.1080/00221546.2018.1442633; Bastrikin A, 2019, NUMBER COLL GRADUATE; Boston University School of Medicine, 2020, SEL FACT; Carter FE, 2010, THESIS; Chang MJ, 2010, WHAT MATTERS COLL RE, P43; Cole D, 2008, J COLL STUDENT DEV, V49, P285, DOI 10.1353/csd.0.0018; College Board, 2019, AP CRED POL SEARCH; Dyrbye LN, 2010, ACAD MED, V85, P94, DOI 10.1097/ACM.0b013e3181c46aad; FIORENTINE R, 1992, SOCIOL FORUM, V7, P469, DOI 10.1007/BF01117557; FIORENTINE R, 1987, AM J SOCIOL, V92, P1118, DOI 10.1086/228629; Gonzalez M, 2010, HISPANIC J BEHAV SCI, V32, P571, DOI 10.1177/0739986310378129; Grace MK, 2019, SOC SCI MED, V230, P222, DOI 10.1016/j.socscimed.2019.04.030; Harris RB, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz5687; Jacob JA, 2015, JAMA-J AM MED ASSOC, V314, P2222, DOI 10.1001/jama.2015.12005; LIBOFF AR, 1979, AM J PHYS, V47, P331, DOI 10.1119/1.11839; Lovecchio K, 2002, ACAD MED, V77, P719, DOI 10.1097/00001888-200207000-00016; Malgwi CA, 2005, J EDUC BUS, V80, P275, DOI 10.3200/JOEB.80.5.275-282; Perelman School of Medicine, 2020, ADM COMP; Roese NJ, 2005, PERS SOC PSYCHOL B, V31, P1273, DOI 10.1177/0146167205274693; Russell ML, 2005, J RES SCI TEACH, V42, P691, DOI 10.1002/tea.20068; Sackett PR, 2009, PSYCHOL BULL, V135, P1, DOI 10.1037/a0013978; Stanford University School of Medicine, 2020, EL REC; Thurmond VB, 1999, ACAD MED, V74, P448, DOI 10.1097/00001888-199904000-00044; Witzburg RA, 2013, NEW ENGL J MED, V368, P1565, DOI 10.1056/NEJMp1300411	39	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243546	10.1371/journal.pone.0243546	http://dx.doi.org/10.1371/journal.pone.0243546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370336	gold, Green Published			2022-12-27	WOS:000603611900004
J	Favaris, AP; Tuler, AC; Silva, WD; Rodrigues, SR; Leal, WS; Bento, JMS				Favaris, Arodi P.; Tuler, Amanda C.; Silva, Weliton D.; Rodrigues, Sergio R.; Leal, Walter S.; Bento, Jose M. S.			(3S,6E)-nerolidol-mediated rendezvous of Cyclocephala paraguayensis beetles in bottle gourd flowers	PLOS ONE			English	Article							FLORAL SCENT; SCARAB; POLLINATION; ATTRACTION; EVOLUTION; ANNONACEAE	Cyclocephalini beetles of the genus Cyclocephala (Coleoptera: Melolonthidae: Dynastinae) use flowers of some plants as food, shelter, and mating sites. However, little is known about floral scent chemistry involved in this interaction. Here we show that a sesquiterpene alcohol mediates attraction of Cyclocephala paraguayensis Arrow, on bottle gourd flowers, Lagenaria siceraria (Cucurbitaceae). Both males and females started to aggregate on the flowers at twilight; after that, mating began and remained for the entire night. GC-FID/EAD analysis of the L. siceraria floral scent collected in the field revealed that only the major constituent of the airborne volatiles elicited electroantennographic responses on male and female antennae of C. paraguayensis. This compound was identified as (3S,6E)-nerolidol, which was tested in two field trapping trials in Brazil. In the first bioassay, traps baited with nerolidol (mix of isomers) captured significantly more adult C. paraguayensis than control traps. In the second field trial, catches in traps baited with a mixture of isomers or enantiopure nerolidol were significantly higher than captures in control traps, but the treatments did not differ significantly. Analysis from the gut content of adult C. paraguayensis showed the presence of pollen, suggesting that they also use bottle gourd flowers for their nourishment. Taken together, these results suggest that (3S,6E)-nerolidol plays an essential role in the reproductive behavior of C. paraguayensis by eliciting aggregation, mating, and feeding.	[Favaris, Arodi P.; Tuler, Amanda C.; Silva, Weliton D.; Bento, Jose M. S.] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Rodrigues, Sergio R.] Univ Estadual Mato Grosso do Sul, Cassilandia, MS, Brazil; [Leal, Walter S.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Universidade de Sao Paulo; Universidade Estadual de Mato Grosso do Sul; University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Favaris, Arodí Prado/U-2653-2019; Leal, Walter/ABC-6940-2021; Bento, José Maurício Simões/A-9759-2008; Silva, Weliton D./N-9410-2019; Silva, Weliton D/J-5080-2015	Favaris, Arodí Prado/0000-0001-5537-2176; Bento, José Maurício Simões/0000-0001-8655-5178; Silva, Weliton D./0000-0001-9035-204X; Silva, Weliton D/0000-0001-9035-204X; Leal Filho, Walter/0000-0002-1241-5225; C. Tuler, Amanda/0000-0002-5563-4663	INCT-Semioquimicos na Agricultura [FAPESP 2014/50871-0, CNPq 465511/2014-7]	INCT-Semioquimicos na Agricultura	This research was supported by INCT-Semioquimicos na Agricultura (FAPESP 2014/50871-0 and CNPq 465511/2014-7).	Bomfim IGA, 2016, HDB CUCURBITS GROWTH, V1st, P594; Carde RT, 2014, J CHEM ECOL, V40, P519, DOI 10.1007/s10886-014-0465-6; Maia ACD, 2018, PEST MANAG SCI, V74, P2053, DOI 10.1002/ps.4895; Maia ACD, 2013, PHYTOCHEMISTRY, V93, P71, DOI 10.1016/j.phytochem.2013.03.005; Maia ACD, 2012, J CHEM ECOL, V38, P1072, DOI 10.1007/s10886-012-0173-z; Dotterl S, 2012, J CHEM ECOL, V38, P1539, DOI 10.1007/s10886-012-0210-y; Goncalves JA, 2020, J INSECT CONSERV, V24, P547, DOI 10.1007/s10841-020-00230-6; GOTTSBERGER G, 1990, BOT ACTA, V103, P360, DOI 10.1111/j.1438-8677.1990.tb00175.x; GOTTSBERGER G, 1986, PLANT SYST EVOL, V152, P29, DOI 10.1007/BF00985349; Gottsberger G, 2018, ACTA BOT BRAS, V32, P279, DOI 10.1590/0102-33062017abb0356; Gottsberger G, 2012, FLORA, V207, P107, DOI 10.1016/j.flora.2011.11.003; Havlickova J, 2019, Z NATURFORSCH C, V74, P251, DOI 10.1515/znc-2018-0197; Institute SAS, 2011, SAS STAT 9 3 USERS G; Kaiser R, 1991, PERFUMES ART SCI TCH, V1st, P213; Kistler L, 2014, P NATL ACAD SCI USA, V111, P2937, DOI 10.1073/pnas.1318678111; KNUDSEN JT, 1993, BOT J LINN SOC, V113, P263, DOI 10.1111/j.1095-8339.1993.tb00340.x; Maia ACD, 2019, J CHEM ECOL, V45, P204, DOI 10.1007/s10886-018-1018-1; McDonald J.H., 2014, HDB BIOL STAT; Moore MR, 2012, COLEOPTS BULL, V66, P200, DOI 10.1649/072.066.0303; Moore MR, 2018, ZOOKEYS, P1, DOI 10.3897/zookeys.745.23683; Moore MR, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.10001; Morimoto Yasuyuki, 2004, International Journal of Tropical Insect Science, V24, P79, DOI 10.1079/IJT20046; Munin Roberto Lobo, 2008, Braz. J. Bot., V31, P15, DOI 10.1590/S0100-84042008000100003; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Ortiz-Dominguez M, 2006, ENTOMOL EXP APPL, V119, P23, DOI 10.1111/j.1570-7458.2006.00388.x; PELLMYR O, 1986, TAXON, V35, P76, DOI 10.2307/1221036; Pereira J, 2014, BIOL J LINN SOC, V111, P679, DOI 10.1111/bij.12232; Schatz GE, 1990, REPROD ECOLOGY TROPI, P69; Schiestl FP, 2012, EVOLUTION, V66, P2042, DOI 10.1111/j.1558-5646.2012.01593.x; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Singh SP, 1996, CURR SCI INDIA, V70, P458; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575	33	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0235028	10.1371/journal.pone.0235028	http://dx.doi.org/10.1371/journal.pone.0235028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362256	Green Submitted, Green Published, gold			2022-12-27	WOS:000603071600054
J	Ko, RE; Huh, K; Kim, DH; Na, SJ; Chung, CR; Cho, YH; Jeon, K; Suh, GY; Yang, JH				Ko, Ryoung-Eun; Huh, Kyungmin; Kim, Dong-Hoon; Na, Soo Jin; Chung, Chi Ryang; Cho, Yang Hyun; Jeon, Kyeongman; Suh, Gee Young; Yang, Jeong Hoon			Nosocomial infections in in-hospital cardiac arrest patients who undergo extracorporeal cardiopulmonary resuscitation	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; BODY-MASS INDEX; MEMBRANE-OXYGENATION; DISEASES SOCIETY; RISK-FACTORS; DIAGNOSIS; CARE; PREVALENCE; PREVENTION; RESISTANT	Background Little is known of nosocomial infections (NI) in patients who suffer from in-hospital cardiac arrest who undergoing extracorporeal cardiopulmonary resuscitation. This study aimed to investigate clinical pictures of NI, and the association of NIs with clinical outcomes in in-hospital cardiac arrest patients who undergoing extracorporeal cardiopulmonary resuscitation. Methods To evaluate the incidence and clinical characteristics of NI in patients who undergoing extracorporeal cardiopulmonary resuscitation, a retrospective cohort study was conducted in a single tertiary referral center between January 2010 and December 2018. We included adult patients who undergoing extracorporeal cardiopulmonary resuscitation for in-hospital cardiac arrest and excluded patients who were out-of-hospital cardiac arrest or failed ECMO implantation. Clinical characteristics and outcomes were compared between NI and Non-NI patients, or multidrug-resistant (MDR) and non-MDR. The independent risk factors associated with NIs were also analyzed using multivariable logistic regression model. Results Thirty-five (23.3%) patients developed a NI. These cases included 21 patients with a gram negative (G-) infection, 12 patients with a gram positive (G+) bacterial infection, and two patients with fungal infection. Pneumonia was the most common type of NIs, followed by catheter-related infection. The in-hospital mortality and neurologic outcomes at discharge were not different between the NI and non-NI groups. Multidrug-resistant (MDR) pathogens were detected in 10 cases (28.6%). The MDR NI patients had a higher ICU mortality than did those with non-MDR NI (80% vs. 32%, p = 0.028). Following multivariable adjustment, body mass index (adjusted OR 0.87, 95% CI, 0.77-0.97, p = 0.016) and cardiopulmonary resuscitation to pump on time (adjusted OR 1.04, 95% CI, 1.01-1.06, p = 0.001) were independent predictors of NI development. Conclusions In patients who received extracorporeal cardiopulmonary resuscitation, NIs were not associated with an increase in in-hospital mortality. However, NIs with MDR organisms do increase the risk of in-hospital mortality. Lower body mass index and longer low flow time were significant predictors of NI development.	[Ko, Ryoung-Eun; Kim, Dong-Hoon; Na, Soo Jin; Chung, Chi Ryang; Jeon, Kyeongman; Suh, Gee Young; Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea; [Huh, Kyungmin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis,Dept Med, Seoul, South Korea; [Cho, Yang Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Jeon, Kyeongman; Suh, Gee Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Yang, Jeong Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Yang, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea.; Yang, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul, South Korea.	jhysmc@gmail.com	Jeon, Kyeongman/F-5963-2019; Huh, Kyungmin/U-8169-2019; Huh, Kyungmin/N-3405-2018	Jeon, Kyeongman/0000-0002-4822-1772; Huh, Kyungmin/0000-0002-5140-3964; Yang, Jeong Hoon/0000-0001-8138-1367				[Anonymous], 2015, CHIN ARCHAEOL, V15, P26, DOI 10.1515/char-2015-0003; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Austin Danielle E, 2017, Crit Care Resusc, V19, P68; Biffi S, 2017, INT J ANTIMICROB AG, V50, P9, DOI 10.1016/j.ijantimicag.2017.02.025; Bizzarro MJ, 2011, PEDIATR CRIT CARE ME, V12, P277, DOI 10.1097/PCC.0b013e3181e28894; Burket JS, 1999, CLIN INFECT DIS, V28, P828, DOI 10.1086/515200; Dobner J, 2018, CLIN MICROBIOL INFEC, V24, P24, DOI 10.1016/j.cmi.2017.02.013; Grasselli G, 2017, CRIT CARE MED, V45, P1726, DOI 10.1097/CCM.0000000000002652; Harpsoe MC, 2016, AM J EPIDEMIOL, V183, P1008, DOI 10.1093/aje/kwv300; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Huh K, 2016, AM J INFECT CONTROL, V44, pE145, DOI 10.1016/j.ajic.2016.01.025; Karanika S, 2016, ANTIMICROB AGENTS CH, V60, P4840, DOI 10.1128/AAC.00825-16; Ko RE, 2020, RESUSCITATION, V148, P121, DOI 10.1016/j.resuscitation.2020.01.015; Kutlesa M, 2017, MINERVA ANESTESIOL, V83, P493, DOI 10.23736/S0375-9393.17.11659-7; Lee DS, 2016, ANN THORAC SURG, V101, P133, DOI 10.1016/j.athoracsur.2015.06.077; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Na SJ, 2018, INFECT CONT HOSP EP, V39, P871, DOI 10.1017/ice.2018.90; Na SJ, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0375-9; Neidell MJ, 2012, CLIN INFECT DIS, V55, P807, DOI 10.1093/cid/cis552; Neumar RW, 2015, CIRCULATION, V132, pS315, DOI 10.1161/CIR.0000000000000252; Parker CM, 2008, J CRIT CARE, V23, P18, DOI 10.1016/j.jcrc.2008.02.001; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Rosenthal VD, 2014, AM J INFECT CONTROL, V42, P942, DOI 10.1016/j.ajic.2014.05.029; Ryu JA, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1604-6; Schmidt M, 2012, CLIN INFECT DIS, V55, P1633, DOI 10.1093/cid/cis783; Thomas G, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0335-9; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Vogel AM, 2011, J PEDIATR SURG, V46, P2260, DOI 10.1016/j.jpedsurg.2011.09.013; Yokoe DS, 2014, INFECT CONT HOSP EP, V35, P967, DOI 10.1086/677216	30	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243838	10.1371/journal.pone.0243838	http://dx.doi.org/10.1371/journal.pone.0243838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362276	Green Published, gold			2022-12-27	WOS:000603071600055
J	Menikou, S; McArdle, AJ; Li, MS; Kaforou, M; Langford, PR; Levin, M				Menikou, Stephanie; McArdle, Andrew J.; Li, Ming-Shi; Kaforou, Myrsini; Langford, Paul R.; Levin, Michael			A proteomics-based method for identifying antigens within immune complexes	PLOS ONE			English	Article							SERUM; PRECIPITATION; ASSAY; IGG; PATHOGENESIS; QUANTITATION; RESPONSES; SUBCLASS; CONTAIN; DISEASE	A novel approach to recover and identify immune complexes (ICs) was developed using size exclusion chromatography (SEC) and affinity chromatography on immunoglobulin binding columns (HiTrap Protein G). The purification process was monitored by 1D SDS-PAGE, protein staining, Western blotting and, finally, liquid chromatography tandem mass spectrometry (LC MS/MS) was used to identify the recovered antigens. This approach was applied to serum with artificially created immune complexes (ICs) comprising vaccine antigen (influenza) and antibody, which led to recovery and identification of influenza peptides within the recovered ICs. This approach was compared with the established method for IC detection and recovery, polyethylene glycol (PEG) precipitation, followed by LC MS/MS. Both approaches successfully enabled capture, recovery and characterization of immunoglobulins and influenza antigen(s) in complex with the immunoglobulins. However, PEG precipitation has the advantage of simplicity and is more suited for large scale studies.	[Menikou, Stephanie; McArdle, Andrew J.; Li, Ming-Shi; Kaforou, Myrsini; Langford, Paul R.; Levin, Michael] Imperial Coll London, Sect Paediat Infect Dis, Dept Infect Dis, London, England	Imperial College London	Menikou, S (corresponding author), Imperial Coll London, Sect Paediat Infect Dis, Dept Infect Dis, London, England.	s.menikou@imperial.ac.uk		Levin, Michael/0000-0003-2767-6919; Menikou, Stephanie/0000-0002-3476-5808; McArdle, Andrew/0000-0001-7448-0869	UK National Institute for Health Research (NIHR) Imperial Biomedical Research Centre at Imperial College; Javon Charitable Trust; Children of St Mary's Intensive Care Kawasaki Disease Research Fund; Wellcome Trust/Imperial College London 4i PhD Fellowship	UK National Institute for Health Research (NIHR) Imperial Biomedical Research Centre at Imperial College; Javon Charitable Trust; Children of St Mary's Intensive Care Kawasaki Disease Research Fund; Wellcome Trust/Imperial College London 4i PhD Fellowship	This work supported in part by the UK National Institute for Health Research (NIHR) Imperial Biomedical Research Centre at Imperial College (WMNP_P69099, the Javon Charitable Trust, the Children of St Mary's Intensive Care Kawasaki Disease Research Fund.) AJM is funded through a Wellcome Trust/Imperial College London 4i PhD Fellowship.	Aibara N, 2018, CLIN CHIM ACTA, V484, P26, DOI 10.1016/j.cca.2018.05.026; [Anonymous], 2008, J CHANGCHUN U, V8, P34; [Anonymous], 2003, VVDSTRL, V62, P37; BIBERFELD G, 1974, J IMMUNOL, V112, P413; Calvopina K, 2017, MOL MICROBIOL, V106, P492, DOI 10.1111/mmi.13831; Chen YJ, 2016, J CLIN LAB ANAL, V30, P1169, DOI 10.1002/jcla.21999; CHIA D, 1979, CLIN EXP IMMUNOL, V37, P399; COPPOCK JS, 1986, RHEUMATOL INT, V6, P79, DOI 10.1007/BF00541509; COYLE PK, 1987, J NEUROIMMUNOL, V15, P97, DOI 10.1016/0165-5728(87)90009-9; CREIGHTON WD, 1973, J IMMUNOL, V111, P1219; CrowleyNowick PA, 1996, IMMUNOL INVEST, V25, P91, DOI 10.3109/08820139609059293; DIGEON M, 1977, J IMMUNOL METHODS, V16, P165, DOI 10.1016/0022-1759(77)90051-5; El-Madhun AS, 1999, J INFECT DIS, V180, P1356, DOI 10.1086/315003; Elshafie AI, 2007, J IMMUNOL, V178, P5383, DOI 10.4049/jimmunol.178.8.5383; HARKISS GD, 1979, CLIN EXP IMMUNOL, V36, P117; HAY FC, 1976, CLIN EXP IMMUNOL, V24, P396; JEWELL DP, 1973, CLIN EXP IMMUNOL, V14, P219; Jiang K, 2003, CLIN EXP IMMUNOL, V131, P61, DOI 10.1046/j.1365-2249.2003.02046.x; LEVIN M, 1985, BRIT MED J, V290, P1456, DOI 10.1136/bmj.290.6480.1456; LEVINSKY RJ, 1981, J CLIN PATHOL, V34, P1214, DOI 10.1136/jcp.34.11.1214; Manenti A, 2017, VACCINE, V35, P191, DOI 10.1016/j.vaccine.2016.10.024; MANNIK M, 1988, SPRINGER SEMIN IMMUN, V10, P215, DOI 10.1007/BF01857226; Mathsson L, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1926; Menikou S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01156; MORROW WJW, 1986, CLIN IMMUNOL IMMUNOP, V40, P515, DOI 10.1016/0090-1229(86)90196-0; MYLLYLA G, 1971, CLIN EXP IMMUNOL, V8, P399; NYDEGGER UE, 1974, J CLIN INVEST, V54, P297, DOI 10.1172/JCI107765; Ohyama K, 2016, PARASITE IMMUNOL, V38, P609, DOI 10.1111/pim.12341; Ohyama K, 2017, INT J CANCER, V140, P370, DOI 10.1002/ijc.30455; Ohyama K, 2015, CLIN BIOCHEM, V48, P181, DOI 10.1016/j.clinbiochem.2014.11.008; ONYEWOTU II, 1974, NATURE, V248, P156, DOI 10.1038/248156a0; Pedersen GK, 2014, VACCINE, V32, P4550, DOI 10.1016/j.vaccine.2014.06.009; Przybylski G, 2014, MED SCI MONITOR, V20, P6, DOI 10.12659/MSM.889862; R Development Core Team, 2019, R FDN STAT COMP; ROBINSON MW, 1989, ANN RHEUM DIS, V48, P496, DOI 10.1136/ard.48.6.496; Sharma VK, 2004, AAPS PHARMSCI, V6, DOI 10.1208/ps060104; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; The Gene Ontology Consortium, 2019, NUCL ACIDS RES, V47, pD330; THEOFILOPOULOS AN, 1976, J CLIN INVEST, V57, P169, DOI 10.1172/JCI108257; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136	40	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244157	10.1371/journal.pone.0244157	http://dx.doi.org/10.1371/journal.pone.0244157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362259	Green Published, gold			2022-12-27	WOS:000603071600017
J	Rivera-Hechem, MI; Rodriguez-Sickert, C; Guzman, RA; Ramirez-Parada, T; Benavides, F; Landaeta-Torres, V; Aspe-Sanchez, M; Repetto, GM				Rivera-Hechem, Maria I.; Rodriguez-Sickert, Carlos; Guzman, Ricardo A.; Ramirez-Parada, Tadeo; Benavides, Felipe; Landaeta-Torres, Victor; Aspe-Sanchez, Mauricio; Repetto, Gabriela M.			No association between genetic variants in MAOA, OXTR, and AVPR1a and cooperative strategies	PLOS ONE			English	Article							OXYTOCIN RECEPTOR GENE; BY-ENVIRONMENT INTERACTION; MONOAMINE-OXIDASE; CANDIDATE GENE; INDIVIDUAL-DIFFERENCES; BEHAVIOR; POLYMORPHISM; TRUST; VASOPRESSIN; BIOLOGY	The effort to understand the genetic basis of human sociality has been encouraged by the diversity and heritability of social traits like cooperation. This task has remained elusive largely because most studies of sociality and genetics use sample sizes that are often unable to detect the small effects that single genes may have on complex social behaviors. The lack of robust findings could also be a consequence of a poor characterization of social phenotypes. Here, we explore the latter possibility by testing whether refining measures of cooperative phenotypes can increase the replication of previously reported associations between genetic variants and cooperation in small samples. Unlike most previous studies of sociality and genetics, we characterize cooperative phenotypes based on strategies rather than actions. Measuring strategies help differentiate between similar actions with different underlaying social motivations while controlling for expectations and learning. In an admixed Latino sample (n = 188), we tested whether cooperative strategies were associated with three genetic variants thought to influence sociality in humans-MAOA-uVNTR, OXTR rs53576, and AVPR1 RS3. We found no association between cooperative strategies and any of the candidate genetic variants. Since we were unable to replicate previous observations our results suggest that refining measurements of cooperative phenotypes as strategies is not enough to overcome the inherent statistical power problem of candidate gene studies.	[Rivera-Hechem, Maria I.; Rodriguez-Sickert, Carlos; Guzman, Ricardo A.; Ramirez-Parada, Tadeo; Landaeta-Torres, Victor; Aspe-Sanchez, Mauricio] Univ Desarrollo, Fac Gobierno, Ctr Invest Complejidad Social CICS, Santiago, Chile; [Benavides, Felipe; Repetto, Gabriela M.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Genet & Genom, Santiago, Chile	Universidad del Desarrollo; Universidad del Desarrollo	Guzman, RA (corresponding author), Univ Desarrollo, Fac Gobierno, Ctr Invest Complejidad Social CICS, Santiago, Chile.	ricardo.andres.guzman@gmail.com	Rodriguez-Sickert, Carlos/AAM-8128-2021; Ramirez Parada, Tadeo/AGD-7658-2022	Rodriguez-Sickert, Carlos/0000-0001-5102-7914; Ramirez Parada, Tadeo/0000-0002-9900-8373; Landaeta-Torres, Victor/0000-0001-8620-9259; Guzman, Ricardo/0000-0003-4742-6458	internal university fund that promotes collaborative research between departments (Proyecto Interfacultades UDD) [23400502]	internal university fund that promotes collaborative research between departments (Proyecto Interfacultades UDD)	This research was funded by an internal university fund that promotes collaborative research between departments (Proyecto Interfacultades UDD #23400502). The funds were granted to GR and CR. The funders did not participate in the research in any capacity.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Andreozzi L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70681-z; Apicella CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011153; Aspe-Sanchez M, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00510; Avinun R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025274; Bachner-Melman R, 2014, HAND CLINIC, V124, P53, DOI 10.1016/B978-0-444-59602-4.00004-6; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Baumgartner T, 2019, HUM BRAIN MAPP, V40, P4508, DOI 10.1002/hbm.24717; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; Brunnlieb C, 2016, P NATL ACAD SCI USA, V113, P2051, DOI 10.1073/pnas.1518825113; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Cesarini D, 2009, Q J ECON, V124, P809, DOI 10.1162/qjec.2009.124.2.809; Chabris CF, 2015, CURR DIR PSYCHOL SCI, V24, P304, DOI 10.1177/0963721415580430; Chabris CF, 2013, AM J PUBLIC HEALTH, V103, P152, DOI 10.2105/AJPH.2013.301327; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Chew SH, 2013, J ECON BEHAV ORGAN, V90, P28, DOI 10.1016/j.jebo.2013.03.008; Christ CC, 2016, J PERS, V84, P204, DOI 10.1111/jopy.12152; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P162; Das M, 2006, AM J MED GENET B, V141B, P637, DOI 10.1002/ajmg.b.30385; de Moor MHM, 2012, MOL PSYCHIATR, V17, P337, DOI 10.1038/mp.2010.128; Declerck CH, 2018, NAT HUM BEHAV, V2, P438, DOI 10.1038/s41562-018-0387-3; Duncan LE, 2019, NEUROPSYCHOPHARMACOL, V44, P1518, DOI 10.1038/s41386-019-0389-5; Duncan LE, 2011, AM J PSYCHIAT, V168, P1041, DOI 10.1176/appi.ajp.2011.11020191; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Elfenbein HA, 2007, J NONVERBAL BEHAV, V31, P205, DOI 10.1007/s10919-007-0033-7; Fehr E, 2018, NAT HUM BEHAV, V2, P458, DOI 10.1038/s41562-018-0385-5; Feng C, 2015, GENES BRAIN BEHAV, V14, P516, DOI 10.1111/gbb.12234; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gachter S, 2005, J EUR ECON ASSOC, V3, P303, DOI 10.1162/jeea.2005.3.2-3.303; Gachter S, 2017, NAT HUM BEHAV, V1, P650, DOI 10.1038/s41562-017-0191-5; Gong PY, 2017, PSYCHONEUROENDOCRINO, V80, P131, DOI 10.1016/j.psyneuen.2017.03.005; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Haas BW, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00801; Henrich J, 2015, CURR OPIN BEHAV SCI, V3, P84, DOI 10.1016/j.cobeha.2015.02.001; Hewitt JK, 2012, BEHAV GENET, V42, P1, DOI 10.1007/s10519-011-9504-z; Hiraishi K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00373; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Kasper C, 2017, MOL ECOL, V26, P4364, DOI 10.1111/mec.14208; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Krueger F, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00004; Krumhuber E, 2007, EMOTION, V7, P730, DOI 10.1037/1528-3542.7.4.730; Kurzban R, 2001, EUR J PERSONALITY, V15, pS37, DOI 10.1002/per.420; Leng G, 2016, BIOL PSYCHIAT, V79, P243, DOI 10.1016/j.biopsych.2015.05.003; Linner RK, 2019, NAT GENET, V51, P245, DOI 10.1038/s41588-018-0309-3; Luo SY, 2015, NEUROIMAGE, V110, P22, DOI 10.1016/j.neuroimage.2015.01.042; Lyon MF, 1999, CURR BIOL, V9, pR235, DOI 10.1016/S0960-9822(99)80151-1; McCullough ME, 2013, NEUROSCI BIOBEHAV R, V37, P1485, DOI 10.1016/j.neubiorev.2013.04.018; Mertins V, 2013, J NEUROSCI PSYCHOL E, V6, P97, DOI 10.1037/a0032877; Mertins V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020959; Mierop A, 2020, PERSPECT PSYCHOL SCI, V15, P1228, DOI 10.1177/1745691620921525; Miller JH, 2002, J ECON BEHAV ORGAN, V47, P179, DOI 10.1016/S0167-2681(01)00159-7; Nave G, 2015, PERSPECT PSYCHOL SCI, V10, P772, DOI 10.1177/1745691615600138; Nishina K, 2019, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00230; Nishina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137089; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2015, EMOTION, V15, P531, DOI 10.1037/emo0000076; Plomin R., 2008, BEHAV GENET; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Reuter M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00242; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; Schroeder KB, 2013, P NATL ACAD SCI USA, V110, P3955, DOI 10.1073/pnas.1216841110; Selten R., 1967, BEITRAGE EXPT WIRTSC, P136; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Sutter M, 2020, J ECON BEHAV ORGAN, V171, P286, DOI 10.1016/j.jebo.2020.01.010; Thoni C, 2018, ECON LETT, V171, P37, DOI 10.1016/j.econlet.2018.06.022; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Tsuchimine S, 2008, PROG NEURO-PSYCHOPH, V32, P1932, DOI 10.1016/j.pnpbp.2008.09.012; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Walum H, 2016, BIOL PSYCHIAT, V79, P251, DOI 10.1016/j.biopsych.2015.06.016; Wang JP, 2016, HUM BRAIN MAPP, V37, P2700, DOI 10.1002/hbm.23203; Way BM, 2010, SOC COGN AFFECT NEUR, V5, P203, DOI 10.1093/scan/nsq059; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zhong SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013765	79	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244189	10.1371/journal.pone.0244189	http://dx.doi.org/10.1371/journal.pone.0244189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362272	gold, Green Published			2022-12-27	WOS:000603071600070
J	Yanagisawa, K; Wichukchinda, N; Tsuchiya, N; Yasunami, M; Rojanawiwat, A; Tanaka, H; Saji, H; Ogawa, Y; Handa, H; Pathipvanich, P; Ariyoshi, K; Sawanpanyalert, P				Yanagisawa, Kunio; Wichukchinda, Nuanjun; Tsuchiya, Naho; Yasunami, Michio; Rojanawiwat, Archawin; Tanaka, Hidenori; Saji, Hiroh; Ogawa, Yoshiyuki; Handa, Hiroshi; Pathipvanich, Panita; Ariyoshi, Koya; Sawanpanyalert, Pathom			Deficiency of mannose-binding lectin is a risk of Pneumocystis jirovecii pneumonia in a natural history cohort of people living with HIV/AIDS in Northern Thailand	PLOS ONE			English	Article							OPPORTUNISTIC INFECTIONS; IMPACT; SUSCEPTIBILITY; DIVERSITY	Background Mannose-binding lectin (MBL) plays a pivotal role in innate immunity; however, its impact on susceptibility to opportunistic infections (OIs) has not yet been examined in a natural history cohort of people living with HIV/AIDS. Methods We used archived samples to analyze the association between MBL expression types and risk of major OIs including Pneumocystis jirovecii pneumonia (PCP), cryptococcosis, talaromycosis, toxoplasmosis, and tuberculosis in a prospective cohort in Northern Thailand conducted from 1 July 2000 to 15 October 2002 before the national antiretroviral treatment programme was launched. Results Of 632 patients, PCP was diagnosed in 96 (15.2%) patients, including 45 patients with new episodes during the follow-up period (1006.5 person-years). The total history of PCP was significantly associated with low MBL expression type: high/intermediate (81/587, 13.8%), low (10/33, 30.3%) and deficient (5/12, 41.7%) (p = 0.001), whereas the history of other OIs showed no relation with any MBL expression type. Kaplan-Meier analysis (n = 569; log-rank p = 0.011) and Cox's proportional hazards model revealed that deficient genotype dramatically increased the risk of PCP, which is independent upon sex, age, CD4 count, HIV-1 viral load and hepatitis B and C status (adjusted hazard ratio 7.93, 95% confidence interval 2.19-28.67, p = 0.002). Conclusions Deficiency of MBL expression is a strong risk factor determining the incidence of PCP but not other major OIs.	[Yanagisawa, Kunio; Ogawa, Yoshiyuki; Handa, Hiroshi] Gunma Univ Hosp, Dept Hematol, Maebashi, Gumma, Japan; [Yanagisawa, Kunio] Gunma Univ Hosp, Infect Control & Prevent Ctr, Maebashi, Gumma, Japan; [Wichukchinda, Nuanjun; Rojanawiwat, Archawin; Sawanpanyalert, Pathom] Minist Publ Hlth, Dept Med Sci, Nonthaburi, Thailand; [Tsuchiya, Naho] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi, Japan; [Yasunami, Michio] Saga Ken Med Ctr Koseikan, Dept Lab Med, Saga, Japan; [Tanaka, Hidenori; Saji, Hiroh] HLA Fdn Lab, Kyoto, Japan; [Pathipvanich, Panita] Lampang Hosp, Day Care Ctr, Lampang, Thailand; [Ariyoshi, Koya] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan; [Sawanpanyalert, Pathom] Minist Sci & Technol Higher Educ Sci Res & Innova, Bangkok, Thailand	Gunma University; Gunma University; Ministry of Public Health - Thailand; Tohoku University; Nagasaki University	Ariyoshi, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan.	kari@nagasaki-u.ac.jp			Joint Usage/Research Center on Tropical Diseases; Nagasaki University Institute of Tropical Medicine; Japan International Co-operation Agency (JICA); Thai Ministry of Public Health	Joint Usage/Research Center on Tropical Diseases; Nagasaki University Institute of Tropical Medicine; Japan International Co-operation Agency (JICA); Thai Ministry of Public Health	KY was financially supported by the grant of Joint Usage/Research Center on Tropical Diseases, Nagasaki University Institute of Tropical Medicine, Japan International Co-operation Agency (JICA) and Thai Ministry of Public Health for this work (2016-Ippan-4).http://www.tm.nagasaki-u.ac.jp/nekken/joint/files/h28reportbook.pdf.	Alanio A, 2017, EBIOMEDICINE, V22, P155, DOI 10.1016/j.ebiom.2017.06.027; Chalmers JD, 2013, LANCET RESP MED, V1, P224, DOI 10.1016/S2213-2600(13)70001-8; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; Ezekowitz RA, 2003, J INFECT DIS, V187, pS335, DOI 10.1086/374746; Gangcuangco LMA, 2017, AM J TROP MED HYG, V97, P49, DOI 10.4269/ajtmh.16-0783; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Goyal S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01261; Ivanova M, 2008, HUM IMMUNOL, V69, P877, DOI 10.1016/j.humimm.2008.09.007; Jiang XY, 2010, CRIT CARE, V14, pR66; Katano H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-229; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Koziel H, 2000, AM J RESP CELL MOL, V23, P452, DOI 10.1165/ajrcmb.23.4.4084; MASUR H, 1989, ANN INTERN MED, V111, P223, DOI 10.7326/0003-4819-111-3-223; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; Moongtui W, 2000, AM J INFECT CONTROL, V28, P365, DOI 10.1067/mic.2000.107885; Mori M, 2018, JAIDS-J ACQ IMM DEF, V78, P356, DOI 10.1097/QAI.0000000000001676; Mori M, 2015, AIDS, V29, P1607, DOI 10.1097/QAD.0000000000000747; Ou XT, 2011, J INFECT DIS, V203, P1686, DOI 10.1093/infdis/jir152; Pathipvanich P, 2003, JAIDS-J ACQ IMM DEF, V32, P157, DOI 10.1097/00126334-200302010-00007; Pathipvanich Panita, 2004, Journal of the Medical Association of Thailand, V87, P951; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Rojanawiwat A, 2011, INT HEALTH, V3, P101, DOI 10.1016/j.inhe.2010.12.004; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Saeng-aroon S, 2010, ANTIVIR RES, V87, P22, DOI 10.1016/j.antiviral.2010.04.001; Schoffelen AF, 2013, AIDS, V27, P1179, DOI 10.1097/QAD.0b013e32835e2c90; Sorensen CM, 2006, CLIN EXP IMMUNOL, V145, P173, DOI 10.1111/j.1365-2249.2006.03101.x; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; Tian C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00257-5; Tsuchiya N, 2013, EPIDEMIOL INFECT, V141, P1840, DOI 10.1017/S0950268812002397; Tsuchiya N, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0565-5; Wojtowicz A, 2019, AIDS, V33, P1719, DOI 10.1097/QAD.0000000000002283; Yanagisawa K, 2015, J INFECT CHEMOTHER, V21, P769, DOI 10.1016/j.jiac.2015.07.006; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242438	10.1371/journal.pone.0242438	http://dx.doi.org/10.1371/journal.pone.0242438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362211	Green Published, gold			2022-12-27	WOS:000603071600041
J	Elhakim, M; Tourab, SB; Zouiten, A				Elhakim, Mohamed; Tourab, Saleh Banoita; Zouiten, Ahmed			COVID-19 pandemic in Djibouti: Epidemiology and the response strategy followed to contain the virus during the first two months, 17 March to 16 May 2020	PLOS ONE			English	Article								First cases of COVID-19 were reported from Wuhan, China, in December 2019, and it progressed rapidly. On 30 January, WHO declared the new disease as a PHEIC, then as a Pandemic on 11 March. By mid-March, the virus spread widely; Djibouti was not spared and was hit by the pandemic with the first case detected on 17 March. Djibouti worked with WHO and other partners to develop a preparedness and response plan, and implemented a series of intervention measures. MoH together with its civilian and military partners, closely followed WHO recommended strategy based on four pillars: testing, isolating, early case management, and contact tracing. From 17 March to 16 May, Djibouti performed the highest per capita tests in Africa and isolated, treated and traced the contacts of each positive case, which allowed for a rapid control of the epidemic. COVID-19 data included in this study was collected through MoH Djibouti during the period from 17 March to 16 May 2020. A total of 1,401 confirmed cases of COVID-19 were included in the study with 4 related deaths (CFR: 0.3%) and an attack rate of 0.15%. Males represented (68.4%) of the cases, with the age group 31-45 years old (34.2%) as the most affected. Djibouti conducted 17,532 tests, and was considered as a champion for COVID-19 testing in Africa with 18.2 tests per 1000 habitant. All positive cases were isolated, treated and had their contacts traced, which led to early and proactive diagnosis of cases and in turn yielded up to 95-98% asymptomatic cases. Recoveries reached 69% of the infected cases with R0 (0.91). The virus was detected in 4 regions in the country, with the highest percentage in the capital (83%). Djibouti responded to COVID-19 pandemic following an efficient and effective strategy, using a strong collaboration between civilian and military health assets that increased the response capacities of the country. Partnership, coordination, solidarity, proactivity and commitment were the pillars to confront COVID-19 pandemic.	[Elhakim, Mohamed; Zouiten, Ahmed] WHO, Djibouti WHO Representat Off, Djibouti Ville, Djibouti; [Tourab, Saleh Banoita] Minist Hlth Djibouti, Djibouti Ville, Djibouti	World Health Organization	Elhakim, M (corresponding author), WHO, Djibouti WHO Representat Off, Djibouti Ville, Djibouti.	elhakimm@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Africa CDC, 2020, COR DIS 2019 COVID 1; [Anonymous], 2020, BBC NEWS; Bereketeab R., 2016, J AFRICAN FOREIGN AF, V3, P5; Central Mass, 2020, EPI WEEK CALENDARS; Estonian Government, 2020, **NON-TRADITIONAL**; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Hassany M, 2020, LANCET INFECT DIS; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Lone SA, 2020, EMERG MICROBES INFEC, V9, P1300, DOI 10.1080/22221751.2020.1775132; Ministry of Health of Djibouti, 2020, STATISTICS; Ministry of Health of Djibouti, 2020, NAT ACT PLAN PREP RE; NCDC, 2020, 1 CAS COR DIS CONF N; Reliefweb, 2020, 4 REL; Reliefweb, 2020, 4 REL; Reliefweb, 2020, 1 REL; The National Institute of Statistics of Djibouti (INSD), 2019, STAT YB STAT YB 2019; WHO, 2020, COVID 19 PUBL HLTH E; WHO-Statement, 2020, WHO TIMELINE COVID 1; World Health Organization, 2020, PUBLICATIONS; World Health Organization, 2020, 118 WHO; World Health Organization, 2020, WEEKLY EPI MONI 0216	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243698	10.1371/journal.pone.0243698	http://dx.doi.org/10.1371/journal.pone.0243698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351802	Green Submitted, Green Published, gold			2022-12-27	WOS:000603071400046
J	Bergh, C; Wennergren, D; Moller, M; Brisby, H				Bergh, Camilla; Wennergren, David; Moller, Michael; Brisby, Helena			Fracture incidence in adults in relation to age and gender: A study of 27,169 fractures in the Swedish Fracture Register in a well-defined catchment area	PLOS ONE			English	Article							FALL-RELATED FRACTURES; CHANGING EPIDEMIOLOGY; CLASSIFICATION; ACCESSIBILITY; RELIABILITY; MOBILITY; RISK	Studies on fracture incidence have mostly been based on retrospectively registered data from local hospital databases. The Swedish Fracture Register (SFR) is a national quality register collecting data prospectively on fractures, at the time of care-seeking. In the present study the incidence of all different fractures, regardless of location, in adults' >= 16 years treated at the only care provider for patients with fractures within a catchment area of approximately 550,000 inhabitants, during 2015-2018 are described. Age, gender, and fracture location (according to AO/OTA classification) was used for the analyses and presentation of fracture incidences. During the 4-year study period, 23,917 individuals sustained 27,169 fractures. The mean age at fracture was 57.9 years (range 16-105 years) and 64.5% of the fractures occurred in women. The five most common fractures accounted for more than 50% of all fractures: distal radius, proximal femur, ankle, proximal humerus, and metacarpal fractures. Seven fracture incidence distribution groups were created based on age- and gender-specific incidence curves, providing visual and easily accessible information on fracture distribution. This paper reports on incidence of all fracture locations based on prospectively collected data in a quality register. The knowledge on fracture incidence related to age and gender may be of importance for the planning of orthopaedic care, involving both in- and out-patients as well as allocating surgical resources. Further, this might be useful for organizing preventive measures, especially in countries with similar socioeconomic structure and fracture burden.	[Bergh, Camilla; Wennergren, David; Moller, Michael; Brisby, Helena] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Bergh, Camilla; Wennergren, David; Moller, Michael; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Bergh, C (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden.; Bergh, C (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, Gothenburg, Sweden.	camilla.m.bergh@vgregion.se		Bergh, Camilla/0000-0003-0116-4114; Wennergren, David/0000-0001-9882-6414	Swedish Research Council, Sweden; Government Funding of Clinical Research within the National Health Service (ALF) from Vastra Gotaland, Sweden [ALFGBG722931]; Felix Neubergh Foundation, Sweden; Gothenburg Medical Association, Sweden	Swedish Research Council, Sweden(Swedish Research Council); Government Funding of Clinical Research within the National Health Service (ALF) from Vastra Gotaland, Sweden; Felix Neubergh Foundation, Sweden; Gothenburg Medical Association, Sweden	This research was supported by grants from the Swedish Research Council (M.M), Government Funding of Clinical Research within the National Health Service (ALF) from Vastra Gotaland ALFGBG722931 (H.B), the Felix Neubergh Foundation (C.B.) and the Gothenburg Medical Association (C.B.), all in Sweden.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen B, 2010, OSTEOPOROSIS INT, V21, P373, DOI 10.1007/s00198-009-0957-3; Abtahi S, 2019, OSTEOPOROSIS INT, V30, P2217, DOI 10.1007/s00198-019-05109-0; ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; Alsnih R, 2003, TRANSPORT RES A-POL, V37, P903, DOI 10.1016/S0965-8564(03)00073-9; Amin S, 2014, J BONE MINER RES, V29, P581, DOI 10.1002/jbmr.2072; Axelsson KF, 2020, J BONE MINER RES, V35, P1216, DOI 10.1002/jbmr.3990; Beerekamp MSH, 2017, INJURY, V48, P1355, DOI 10.1016/j.injury.2017.04.047; Bergdahl C, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1009-8; Bolton JM, 2017, JAMA PSYCHIAT, V74, P641, DOI 10.1001/jamapsychiatry.2017.0449; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; Court-Brown CM, 2017, INJURY, V48, P819, DOI 10.1016/j.injury.2017.02.021; Court-Brown CM, 2011, OSTEOPOROSIS INT, V22, P1211, DOI 10.1007/s00198-010-1315-1; Court-Brown CM, 2006, INJURY, V37, P691, DOI 10.1016/j.injury.2006.04.130; Court-Brown CM, 2018, INJURY, V49, P2161, DOI 10.1016/j.injury.2018.11.009; Court-Brown CM, 2014, SCOT MED J, V59, P30, DOI 10.1177/0036933013518148; Cummings SR, 2020, OSTEOPOROSIS INT, V31, P1023, DOI 10.1007/s00198-020-05325-z; Curtis EM, 2017, BONE, V104, P29, DOI 10.1016/j.bone.2017.01.024; Dimai HP, 2014, OSTEOPOROSIS INT, V25, P2297, DOI 10.1007/s00198-014-2766-6; Driessen JHM, 2016, OSTEOPOROSIS INT, V27, P2017, DOI 10.1007/s00198-016-3488-8; HERNLUND E, 2013, ARCH OSTEOPOROS, V8, DOI DOI 10.1007/S11657-013-0136-1; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Juto H, 2016, INJURY, V47, P2579, DOI 10.1016/j.injury.2016.05.028; Kamin ST, 2016, Z GERONTOL GERIATR, V49, P372, DOI 10.1007/s00391-015-0946-4; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P669, DOI 10.1007/s001980070064; Kanis JA, 2001, OSTEOPOROSIS INT, V12, P417, DOI 10.1007/s001980170112; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Kihlstrom C, 2017, BMC MUSCULOSKEL DIS, V18, P1, DOI 10.1186/s12891-017-1444-1; Knutsson SB, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2579-z; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; Morgonskold D, 2019, WORLD J ORTHOP, V10, P14, DOI 10.5312/wjo.v10.i1.14; Muller MENS., 1990, COMPREHENSIVE CLASSI, V1st ed; Portegijs E, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14030333; Scott D, 2019, J GERONTOLOGY A; Shibuya N, 2014, J FOOT ANKLE SURG, V53, P606, DOI 10.1053/j.jfas.2014.03.011; Svedbom A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0137-0; Svenska frakturregistret registercentrum, 2017, TACKN 2017; Wennergren D, 2018, INJURY, V49, P2068, DOI 10.1016/j.injury.2018.09.008; Wennergren D, 2018, UNFALLCHIRURG, V121, P949, DOI 10.1007/s00113-018-0538-z; Wennergren D, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1612-3; Wennergren D, 2016, INJURY, V47, P478, DOI 10.1016/j.injury.2015.11.002; Wennergren D, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0795-8	42	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244291	10.1371/journal.pone.0244291	http://dx.doi.org/10.1371/journal.pone.0244291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347485	Green Published, gold			2022-12-27	WOS:000603071100041
J	Brady, L; Hayes, B; Sheill, G; Baird, AM; Guinan, E; Stanfill, B; Vlajnic, T; Casey, O; Murphy, V; Greene, J; Allott, EH; Hussey, J; Cahill, F; Van Hemelrijck, M; Peat, N; Mucci, L; Cunningham, M; Grogan, L; Lynch, T; Manecksha, RP; McCaffrey, J; O'Donnell, D; Sheils, O; O'Leary, J; Rudman, S; McDermott, R; Finn, S				Brady, Lauren; Hayes, Brian; Sheill, Grainne; Baird, Anne-Marie; Guinan, Emer; Stanfill, Bryan; Vlajnic, Tatjana; Casey, Orla; Murphy, Verena; Greene, John; Allott, Emma H.; Hussey, Juliette; Cahill, Fidelma; Van Hemelrijck, Mieke; Peat, Nicola; Mucci, Lorelei; Cunningham, Moya; Grogan, Liam; Lynch, Thomas; Manecksha, Rustom P.; McCaffrey, John; O'Donnell, Dearbhaile; Sheils, Orla; O'Leary, John; Rudman, Sarah; McDermott, Ray; Finn, Stephen			Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial	PLOS ONE			English	Article							RESISTANCE EXERCISE; METABOLIC SYNDROME; BLOOD; DEVICE; COUNTS; RISK	Background Circulating tumour cells (CTCs) represent a morphologically distinct subset of cancer cells, which aid the metastatic spread. The ExPeCT trial aimed to examine the effectiveness of a structured exercise programme in modulating levels of CTCs and platelet cloaking in patients with metastatic prostate cancer. Methods Participants (n = 61) were randomised into either standard care (control) or exercise arms. Whole blood was collected for all participants at baseline (T0), three months (T3) and six months (T6), and analysed for the presence of CTCs, CTC clusters and platelet cloaking. CTC data was correlated with clinico-pathological information. Results Changes in CTC number were observed within group over time, however no significant difference in CTC number was observed between groups over time. Platelet cloaking was identified in 29.5% of participants. A positive correlation between CTC number and white cell count (WCC) was observed (p = 0.0001), in addition to a positive relationship between CTC clusters and PSA levels (p = 0.0393). Conclusion The presence of platelet cloaking has been observed in this patient population for the first time, in addition to a significant correlation between CTC number and WCC. Trial registration ClincalTrials.gov identifier NCT02453139.	[Brady, Lauren; Baird, Anne-Marie; Greene, John; Allott, Emma H.; Sheils, Orla; Finn, Stephen] Trinity Coll Dublin, Trinity Translat Med Inst, Dept Histopathol & Morbid Anat, Dublin, Ireland; [Hayes, Brian] Cork Univ Hosp, Dept Histopathol, Cork, Ireland; [Hayes, Brian] Univ Coll Cork, Dept Pathol, Cork, Ireland; [Sheill, Grainne; Hussey, Juliette] Trinity Coll Dublin, Sch Med, Discipline Physiotherapy, Dublin, Ireland; [Guinan, Emer] Trinity Coll Dublin, Sch Med, Dublin, Ireland; [Stanfill, Bryan] Pacific Northwest Natl Lab, Richland, WA 99352 USA; [Vlajnic, Tatjana] Univ Hosp Basel, Inst Pathol, Basel, Switzerland; [Casey, Orla; Murphy, Verena; Finn, Stephen] Canc Trials Ireland, Dublin, Ireland; [Allott, Emma H.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Cahill, Fidelma; Van Hemelrijck, Mieke] Kings Coll London, Sch Canc & Pharmaceut Sci, Translat Oncol & Urol TOUR, London, England; [Peat, Nicola; Rudman, Sarah] Guys & St Thomas NHS Fdn Trust, London, England; [Mucci, Lorelei] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Cunningham, Moya] St Lukes Hosp, Dept Radiat Oncol, Dublin, Ireland; [Grogan, Liam] Beaumont Hosp, Dept Oncol, Dublin, Ireland; [Lynch, Thomas; Manecksha, Rustom P.] St James Hosp, Dept Urol, Dublin, Ireland; [Manecksha, Rustom P.] Trinity Coll Dublin, Dept Surg, Dublin, Ireland; [McCaffrey, John] Mater Misericordiae Univ Hosp, Dept Oncol, Dublin, Ireland; [O'Donnell, Dearbhaile] St James Hosp, HOPE Directorate, Dublin, Ireland; [O'Leary, John; Finn, Stephen] St James Hosp, Dept Histopathol, Dublin, Ireland; [McDermott, Ray] Tallaght Univ Hosp, Dept Oncol, Dublin, Ireland	Trinity College Dublin; University College Cork; University College Cork; Trinity College Dublin; Trinity College Dublin; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Basel; Queens University Belfast; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Harvard University; Harvard T.H. Chan School of Public Health; Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Mater Misericordiae University Hospital; University College Dublin; Trinity College Dublin; Trinity College Dublin	Finn, S (corresponding author), Trinity Coll Dublin, Trinity Translat Med Inst, Dept Histopathol & Morbid Anat, Dublin, Ireland.; Finn, S (corresponding author), Canc Trials Ireland, Dublin, Ireland.; Finn, S (corresponding author), St James Hosp, Dept Histopathol, Dublin, Ireland.	stephen.finn@tcd.ie	Sheils, Orla/B-8461-2015	Sheils, Orla/0000-0002-4493-9496; Brady, Lauren/0000-0002-7876-5164; McDermott, Ray/0000-0002-8952-4315; O'Leary, John/0000-0001-7311-9326; Greene, John/0000-0002-3341-6841; Hayes, Brian/0000-0002-5644-7253; Van Hemelrijck, Mieke/0000-0002-7317-0858; Sheill, Grainne/0000-0003-2955-4464; Baird, Anne-Marie/0000-0001-7501-1159; Manecksha, Rustom/0000-0003-3437-744X	Cancer Trials Ireland; World Cancer Research Fund [2012/1003]	Cancer Trials Ireland; World Cancer Research Fund(World Cancer Research Fund International (WCRF))	This research was sponsored by Cancer Trials Ireland. Author SF received funding from the World Cancer Research Fund (https://www.wcrf.org/; grant number 2012/1003). The funders had no role in the collection of specimens or analysis of data throughout the study duration, and had no role in preparation or review of this manuscript for publication.	Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Brintnall-Karabelas J, 2011, J EMPIR RES HUM RES, V6, P69, DOI 10.1525/jer.2011.6.1.69; Cooke NM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1634-x; Cormie P, 2013, PROSTATE CANCER P D, V16, P328, DOI 10.1038/pcan.2013.22; Cormie P, 2014, SUPPORT CARE CANCER, V22, P1537, DOI 10.1007/s00520-013-2103-1; Crawford ED, 2015, ONCOLOGY-NY, V29, P55; Denis JA, 2016, MOL ONCOL, V10, P1221, DOI 10.1016/j.molonc.2016.05.009; Desitter I, 2011, ANTICANCER RES, V31, P427; Efstathiou JA, 2007, CANCER-AM CANCER SOC, V110, P2691, DOI 10.1002/cncr.23093; Egan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026125; Fayanju OM, 2017, AM J SURG, V214, P666, DOI 10.1016/j.amjsurg.2017.06.005; Goldkorn A, 2014, J CLIN ONCOL, V32, P1136, DOI 10.1200/JCO.2013.51.7417; Hayes BD, 2016, CANCER EPIDEM BIOMAR, V25, P1281, DOI 10.1158/1055-9965.EPI-16-0223; Hofman V, 2012, CYTOPATHOLOGY, V23, P30, DOI 10.1111/j.1365-2303.2010.00835.x; Hou JM, 2011, AM J PATHOL, V178, P989, DOI 10.1016/j.ajpath.2010.12.003; Jung CH, 2013, YONSEI MED J, V54, P615, DOI 10.3349/ymj.2013.54.3.615; Kenfield SA, 2011, J CLIN ONCOL, V29, P726, DOI 10.1200/JCO.2010.31.5226; Kuvendjiska J, 2019, CANCERS, V11, DOI 10.3390/cancers11030397; Larsen SB, 2013, EUR J CANCER, V49, P3041, DOI 10.1016/j.ejca.2013.04.015; Lorente D, 2016, EUR UROL, V70, P985, DOI 10.1016/j.eururo.2016.05.023; Maheswaran S, 2010, CURR OPIN GENET DEV, V20, P96, DOI 10.1016/j.gde.2009.12.002; Mascalchi M, 2016, J CANCER RES CLIN, V142, P195, DOI 10.1007/s00432-015-2021-3; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Mu ZM, 2015, BREAST CANCER RES TR, V154, P563, DOI 10.1007/s10549-015-3636-4; Newton RU, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022899; Nieswandt B, 1999, CANCER RES, V59, P1295; Park JT, 2009, METABOLISM, V58, P1379, DOI 10.1016/j.metabol.2009.05.002; Pei C, 2015, EUR J INTERN MED, V26, P324, DOI 10.1016/j.ejim.2015.04.009; Rosenbaum MW, 2017, CANCER CYTOPATHOL, V125, P332, DOI 10.1002/cncy.21841; Santise G, 2019, AM J TRANSL RES, V11, P1771; Sarioglu AF, 2015, NAT METHODS, V12, P685, DOI [10.1038/nmeth.3404, 10.1038/NMETH.3404]; Sawabata N, 2020, GEN THORAC CARDIOVAS, V68, P975, DOI 10.1007/s11748-020-01308-3; Sheill G, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2201-3; Tao LY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004932	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243928	10.1371/journal.pone.0243928	http://dx.doi.org/10.1371/journal.pone.0243928			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338056	gold, Green Submitted, Green Published			2022-12-27	WOS:000601313500025
J	Cuadros, Z; Hurtado, E; Cornejo, C				Cuadros, Zamara; Hurtado, Esteban; Cornejo, Carlos			Infant-adult synchrony in spontaneous and nonspontaneous interactions	PLOS ONE			English	Article							MOTHER-INFANT; INTERPERSONAL COORDINATION; MOVEMENT SYNCHRONY; EMOTIONAL COORDINATION; SOCIAL-INTERACTION; DYADIC SYNCHRONY; BODY MOVEMENT; FATHER-INFANT; HEART-RATE; DYNAMICS	Infant-adult synchrony has been reported through observational and experimental studies. Nevertheless, synchrony is addressed differently in both cases. While observational studies measure synchrony in spontaneous infant-adult interactions, experimental studies manipulate it, inducing nonspontaneous synchronous and asynchronous interactions. A still unsolved question is to what extent differ spontaneous synchrony from the nonspontaneous one, experimentally elicited. To address this question, we conducted a study to compare synchrony in both interactional contexts. Forty-three 14-month-old infants were randomly assigned to one of two independent groups: (1) the spontaneous interaction context, consisting of a storytime session; and (2) the nonspontaneous interaction context, where an assistant bounced the infant in synchrony with a stranger. We employed an optical motion capture system to accurately track the time and form of synchrony in both contexts. Our findings indicate that synchrony arising in spontaneous exchanges has different traits than synchrony produced in a nonspontaneous interplay. The evidence presented here offers new insights for rethinking the study of infant-adult synchrony and its consequences on child development.	[Cuadros, Zamara; Hurtado, Esteban; Cornejo, Carlos] Pontificia Univ Catolica Chile, Escuela Psicol, Lab Lenguaje Interacc & Fenomenol, Santiago, Chile	Pontificia Universidad Catolica de Chile	Cornejo, C (corresponding author), Pontificia Univ Catolica Chile, Escuela Psicol, Lab Lenguaje Interacc & Fenomenol, Santiago, Chile.	cca@uc.cl		Cornejo, Carlos/0000-0001-5426-0025; Cuadros, Zamara/0000-0003-4729-1880	Scientific and Technological Equipment Program, FONDEQUIP [EQM120026]; Chilean National Commission for Scientific and Technological Research (CONICYT-PCHA/Doctorado Nacional/2016-folio) [21160537]; Chilean National Fund for Scientific and Technological Development (FONDECYT) [1181271]	Scientific and Technological Equipment Program, FONDEQUIP; Chilean National Commission for Scientific and Technological Research (CONICYT-PCHA/Doctorado Nacional/2016-folio); Chilean National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This research was supported by the Scientific and Technological Equipment Program, FONDEQUIP (Grant number EQM120026), the Chilean National Commission for Scientific and Technological Research (CONICYT-PCHA/Doctorado Nacional/2016-folio: 21160537), and The Chilean National Fund for Scientific and Technological Development (FONDECYT Grant No. 1181271).	Abney DH, 2017, INFANCY, V22, P514, DOI 10.1111/infa.12165; AMAZEEN PG, 1995, BIOL CYBERN, V72, P511, DOI 10.1007/BF00199893; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; [Anonymous], 1997, NSCA B, V18, P4; Araujo D, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01449; Astolfi L, 2010, BRAIN TOPOGR, V23, P243, DOI 10.1007/s10548-010-0147-9; Athreya DN, 2014, EXP BRAIN RES, V232, P2741, DOI 10.1007/s00221-014-3957-2; Atzil S, 2014, SOC COGN AFFECT NEUR, V9, P1193, DOI 10.1093/scan/nst105; Avikainen S, 2003, CURR BIOL, V13, P339, DOI 10.1016/S0960-9822(03)00087-3; Beebe B., 1982, INTERACTION RHYTHMS, P77; Bernieri F.J., 1991, FUNDAMENTALS NONVERB, P401, DOI DOI 10.1017/CBO9781107415324.004; BERNIERI FJ, 1988, J PERS SOC PSYCHOL, V54, P243, DOI 10.1037/0022-3514.54.2.243; BILOUS FR, 1988, LANG COMMUN, V8, P183, DOI 10.1016/0271-5309(88)90016-X; Boker SM, 2002, PSYCHOL METHODS, V7, P338, DOI 10.1037//1082-989X.7.3.338; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Brazelton TB, 1984, GROWING CHILD FAMILY, P19; Burger B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00903; Busuito A, 2019, DEV PSYCHOL, V55, P1034, DOI 10.1037/dev0000689; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chatel-Goldman J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00095; Cheng M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227880; Chiavarino, 2012, GIORNALE ITALIANO PS, V39, P73, DOI [10.1421/37063, DOI 10.1421/37063]; Cirelli LK, 2018, CURR OPIN PSYCHOL, V20, P35, DOI 10.1016/j.copsyc.2017.08.009; Cirelli LK, 2017, MUSIC PERCEPT, V34, P319, DOI 10.1525/MP.2017.34.3.319; Cirelli LK, 2016, INFANCY, V21, P807, DOI 10.1111/infa.12140; Cirelli LK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0400; Cirelli LK, 2014, DEVELOPMENTAL SCI, V17, P1003, DOI 10.1111/desc.12193; Clayton M, 2019, MUSIC SCI, V23, P304, DOI 10.1177/1029864919844809; Coey C, 2011, EXP BRAIN RES, V211, P483, DOI 10.1007/s00221-011-2689-9; Collis GM, 1979, SPEECH BEGINNING INT, P89; CONDON WS, 1974, CHILD DEV, V45, P456; CONDON WS, 1966, J NERV MENT DIS, V143, P338, DOI 10.1097/00005053-196610000-00005; Cornejo C., 2017, NEUROSCIENCE SOCIAL, P69, DOI [10.1007/978-3-319-68421-5, DOI 10.1007/978-3-319-68421-5]; Cornejo C, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01546; Cornejo C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01685; Costantini C, 2018, INFANCY, V23, P288, DOI 10.1111/infa.12220; Cross I, 2014, PSYCHOL MUSIC, V42, P809, DOI 10.1177/0305735614543968; Cuadros Z, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02839; Del-Monte J, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00137; Demos AP, 2012, J EXP PSYCHOL GEN, V141, P49, DOI 10.1037/a0023843; Dissanayake E., 2006, MUSIC MANIPULATION S, P31; Dittmann AT, 1987, NONVERBAL BEHAV COMM, P37; Doi H, 2011, J PHYSIOL SCI, V61, P211, DOI 10.1007/s12576-011-0138-y; Drees Bastian, 2016, PERSPEKTIVE BIBLIOTH, V5, P25; Dunphy-Lelii S, 2014, CAN J EXP PSYCHOL, V68, P38, DOI 10.1037/cep0000003; Duran ND, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178140; Ebisch SJ, 2012, BIOL PSYCHOL, V89, P123, DOI 10.1016/j.biopsycho.2011.09.018; Ellamil M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164783; Endedijk HM, 2015, DEV PSYCHOL, V51, P714, DOI 10.1037/a0038980; Farran D. C., 1990, J APPL DEV PSYCHOL, V11, P419, DOI [10.1016/0193-3973(90)90018-F, DOI 10.1016/0193-3973(90)90018-F]; Fawcett C, 2017, J EXP CHILD PSYCHOL, V160, P127, DOI 10.1016/j.jecp.2017.03.014; Fawcett C, 2012, INFANT CHILD DEV, V21, P239, DOI 10.1002/icd.739; Feldman R, 1999, DEV PSYCHOL, V35, P223, DOI 10.1037/0012-1649.35.1.223; Feldman R, 2006, DEV PSYCHOL, V42, P175, DOI 10.1037/0012-1649.42.1.175; Feldman R, 2003, INFANT MENT HEALTH J, V24, P1, DOI 10.1002/imhj.10041; Feldman R, 2007, AM J ORTHOPSYCHIAT, V77, P582, DOI 10.1037/0002-9432.77.4.582; Feldman R, 2007, CURR DIR PSYCHOL SCI, V16, P340, DOI 10.1111/j.1467-8721.2007.00532.x; Feldman R, 2011, INFANT BEHAV DEV, V34, P569, DOI 10.1016/j.infbeh.2011.06.008; Feldman R, 2011, DEVELOPMENTAL SCI, V14, P752, DOI 10.1111/j.1467-7687.2010.01021.x; FIELD T, 1989, INFANT BEHAV DEV, V12, P357, DOI 10.1016/0163-6383(89)90044-1; FIELD T, 1990, DEV PSYCHOL, V26, P7, DOI 10.1037/0012-1649.26.1.7; Gleissner B, 2000, DEVELOPMENTAL SCI, V3, P405, DOI 10.1111/1467-7687.00135; Gordon I, 2010, BIOL PSYCHIAT, V68, P377, DOI 10.1016/j.biopsych.2010.02.005; GOTTMAN JM, 1985, J CONSULT CLIN PSYCH, V53, P151, DOI 10.1037/0022-006X.53.2.151; Granat A, 2017, EMOTION, V17, P11, DOI 10.1037/emo0000204; Hammal Z, 2014, IEEE T AFFECT COMPUT, V5, P155, DOI 10.1109/TAFFC.2014.2326408; Harder S, 2015, DEV PSYCHOL, V51, P1778, DOI 10.1037/a0039834; Harel H, 2011, INFANCY, V16, P69, DOI 10.1111/j.1532-7078.2010.00037.x; Harrist AW, 2002, DEV REV, V22, P555, DOI 10.1016/S0273-2297(02)00500-2; Hoch J, 2020, PSYARXIV, P1, DOI [10.31234/osf.io/swr2y, DOI 10.31234/OSF.IO/SWR2Y]; Holler J, 2011, J NONVERBAL BEHAV, V35, P133, DOI 10.1007/s10919-011-0105-6; Hove MJ, 2009, SOC COGNITION, V27, P949, DOI 10.1521/soco.2009.27.6.949; Ilari B, 2015, J RES MUSIC EDUC, V62, P332, DOI 10.1177/0022429414555984; ISABELLA RA, 1989, DEV PSYCHOL, V25, P12, DOI 10.1037/0012-1649.25.1.12; ISABELLA RA, 1991, CHILD DEV, V62, P373, DOI 10.2307/1131010; Jakubowski K., 2017, FRONTIERS DIGITAL HU, V4, P9, DOI 10.3389/fdigh.2017.00009; KARGER RH, 1979, CHILD DEV, V50, P882, DOI 10.2307/1128959; KENDON A, 1970, ACTA PSYCHOL, V32, P100; Kirschner S, 2014, J CROSS CULT PSYCHOL, V45, P137, DOI 10.1177/0022022113493139; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Kokkinaki T, 2019, EUR J DEV PSYCHOL, V16, P268, DOI 10.1080/17405629.2017.1375909; Kokkinaki T, 2015, EUR J DEV PSYCHOL, V12, P69, DOI 10.1080/17405629.2014.950220; Kokkinaki TS, 2017, INFANT CHILD DEV, V26, DOI 10.1002/icd.1973; Konvalinka I, 2014, NEUROIMAGE, V94, P79, DOI 10.1016/j.neuroimage.2014.03.003; Konvalinka I, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00215; Krueger J., 2013, EMOTIONAL POWER MUSI, P177, DOI DOI 10.1093/ACPROF:OSO/9780199654888.003.0014; Kupper Z, 2010, SCHIZOPHR RES, V121, P90, DOI 10.1016/j.schres.2010.03.032; LAFRANCE M, 1977, J COMMUN, V27, P213; Latif N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105036; Launay J, 2014, COGN PROCESS, V15, P491, DOI 10.1007/s10339-014-0618-0; Leclere C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113571; Liszkowski U, 2008, COGNITION, V108, P732, DOI 10.1016/j.cognition.2008.06.013; Llobera J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147008; Lotzin A, 2016, DEV PSYCHOPATHOL, V28, P327, DOI 10.1017/S0954579415000516; Lotzin A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144417; Lundy BL, 2003, INFANT BEHAV DEV, V26, P200, DOI 10.1016/S0163-6383(03)00017-1; Marmelat V, 2012, EXP BRAIN RES, V222, P137, DOI 10.1007/s00221-012-3202-9; Marzoli D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014595; McFarland DH, 2020, DEV PSYCHOBIOL, V62, P50, DOI 10.1002/dev.21913; McFarland DH, 2001, J SPEECH LANG HEAR R, V44, P128, DOI 10.1044/1092-4388(2001/012); Miles LK, 2010, EUR J SOC PSYCHOL, V40, P52, DOI 10.1002/ejsp.721; Mitkidis P, 2015, PHYSIOL BEHAV, V149, P101, DOI 10.1016/j.physbeh.2015.05.033; Nessler JA, 2009, HUM MOVEMENT SCI, V28, P772, DOI 10.1016/j.humov.2009.04.007; Noel JP, 2018, IEEE T COGN DEV SYST, V10, P973, DOI 10.1109/TCDS.2017.2778141; Oullier O, 2008, SOC NEUROSCI, V3, P178, DOI 10.1080/17470910701563392; Ouwehand PW, 2015, NEUROSCI LETT, V606, P177, DOI 10.1016/j.neulet.2015.08.052; Papousek M., 1981, ADV INFANCY RES, V1, P163; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Paxton A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01135; Paxton A, 2013, Q J EXP PSYCHOL, V66, P2092, DOI 10.1080/17470218.2013.853089; Pierpaoli C, 2014, ARCH ITAL BIOL, V152, P20; Pratt M, 2015, DEV PSYCHOPATHOL, V27, P1191, DOI 10.1017/S0954579415000760; Preissmann D, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01673; Rabinowitch TC, 2017, J EXP CHILD PSYCHOL, V160, P21, DOI 10.1016/j.jecp.2017.03.001; Rabinowitch TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120878; Ragert M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00368; Ramseyer F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00979; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Reyna BA, 2012, INFANT BEHAV DEV, V35, P669, DOI 10.1016/j.infbeh.2012.06.003; Reyna BA, 2009, JOGNN-J OBST GYN NEO, V38, P470, DOI 10.1111/j.1552-6909.2009.01044.x; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Rodrigues M., 2013, ADV PHYS ED, V3, P209, DOI [10.4236/ape.2013.34034, DOI 10.4236/APE.2013.34034]; Ruvolo P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136492; Sanmartin R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00392; Schmidt RC, 1998, J EXP PSYCHOL HUMAN, V24, P884, DOI 10.1037/0096-1523.24.3.884; Seifert L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00075; Skuban EM, 2006, INFANT BEHAV DEV, V29, P423, DOI 10.1016/j.infbeh.2006.02.004; STREET RL, 1984, HUM COMMUN RES, V11, P139, DOI 10.1111/j.1468-2958.1984.tb00043.x; Tarr B, 2016, EVOL HUM BEHAV, V37, P343, DOI 10.1016/j.evolhumbehav.2016.02.004; Tarullo AR, 2017, INFANT BEHAV DEV, V47, P92, DOI 10.1016/j.infbeh.2017.03.007; Thomas KA, 2014, EARLY HUM DEV, V90, P885, DOI 10.1016/j.earlhumdev.2014.09.005; Toiviainen P, 2010, MUSIC PERCEPT, V28, P59, DOI 10.1525/MP.2010.28.1.59; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Trainor LJ, 2015, ANN NY ACAD SCI, V1337, P45, DOI 10.1111/nyas.12649; TREVARTHEN C., 1979, SPEECH BEGINNINGS HU, P321; TRONICK EZ, 1989, CHILD DEV, V60, P85, DOI 10.2307/1131074; TRONICK EZ, 1989, AM PSYCHOL, V44, P112, DOI 10.1037/0003-066X.44.2.112; Trost W., 2013, EMOTIONAL POWER MUSI, P213, DOI [https://doi.org/10.1093/acprof, DOI 10.1093/ACPROF:OSO/9780199654888.003.0016, 10.1093/acprof:oso/9780199654888.003.0016]; Tsai SY, 2011, BIOL RES NURS, V13, P80, DOI 10.1177/1099800410378889; Tschacher W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01323; Tsuchiya A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00817; Tuncgenc B, 2015, CHILD DEV, V86, P976, DOI 10.1111/cdev.12354; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; Valdesolo P, 2011, EMOTION, V11, P262, DOI 10.1037/a0021302; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Van Puyvelde M, 2010, INFANT BEHAV DEV, V33, P387, DOI 10.1016/j.infbeh.2010.04.003; Van Puyvelde M, 2013, INFANCY, V18, P849, DOI 10.1111/infa.12007; van Ulzen NR, 2008, NEUROSCI LETT, V432, P88, DOI 10.1016/j.neulet.2007.11.070; Varlet M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00029; Vesper C, 2013, J EXP PSYCHOL HUMAN, V39, P48, DOI 10.1037/a0028066; WAPNER S, 1968, CHILD DEV, V39, P887, DOI 10.1111/j.1467-8624.1968.tb04469.x; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Waters SF, 2016, ADAPT HUM BEHAV PHYS, V2, P298, DOI 10.1007/s40750-016-0045-9; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Yamamoto T, 2016, COMPUTER SIMULATION OF POLYMERIC MATERIALS: APPLICATIONS OF THE OCTA SYSTEM, P179, DOI 10.1007/978-981-10-0815-3_10; Zhao Z, 2015, HUM MOVEMENT SCI, V41, P240, DOI 10.1016/j.humov.2015.03.012; Zivotofsky AZ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-28	161	1	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244138	10.1371/journal.pone.0244138	http://dx.doi.org/10.1371/journal.pone.0244138			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338070	Green Published, gold			2022-12-27	WOS:000601313500039
J	Hansen, AV; Mortensen, LH; Trompet, S; Westendorp, R				Hansen, Anne Vinkel; Mortensen, Laust Hvas; Trompet, Stella; Westendorp, Rudi			Health care expenditure in the last five years of life is driven by morbidity, not age: A national study of spending trajectories in Danish decedents over age 65	PLOS ONE			English	Article							END; POPULATION	Background The high level of medical spending at the end of life is well-documented, but whether there is any real potential for cost reductions there is still in question, and studies have tended to overlook the costs of care. Aim To identify the most common health care spending trajectories over the last five years of life among older Danes, as well as the determinants of following a given trajectory. Methods We linked Danish health registries to obtain data on all health care expenditure (including hospital treatment, prescription drugs, primary care and costs of communal care) over the last five years of life for all Danish decedents above age 65 in the period 2013 through 2017. A latent class analysis identified the most common cost trajectories, which were then related to socio-economical characteristics and health status at five years before death. Results Total health care expenditures in the last five years of life were largely independent of age and cause of death. Costs of home care and residential care increased steeply with age at death whereas hospital costs decreased correspondingly. We found four main spending trajectories among decedents: 3 percent followed a late-rise trajectory, 11 percent had accelerating costs, and two groups of 43 percent each followed moderately or consistently high trajectories. The main predictor of total expenditure was the number of chronic diseases. Interpretation Spending at the end of life is largely determined by chronic disease, and age and cause of death only determine the distribution of expenses into care and cure.	[Hansen, Anne Vinkel; Mortensen, Laust Hvas; Westendorp, Rudi] Stat Denmark, Data Sci Lab, Copenhagen, Denmark; [Hansen, Anne Vinkel; Mortensen, Laust Hvas; Westendorp, Rudi] Univ Copenhagen, Sect Epidemiol, Dept Publ Hlth, Copenhagen, Denmark; [Trompet, Stella] Leiden Univ, Sect Gerontol & Geriatr, Dept Internal Med, Med Ctr, Leiden, Netherlands	University of Copenhagen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hansen, AV (corresponding author), Stat Denmark, Data Sci Lab, Copenhagen, Denmark.; Hansen, AV (corresponding author), Univ Copenhagen, Sect Epidemiol, Dept Publ Hlth, Copenhagen, Denmark.	aih@dst.dk		Hansen, Anne Vinkel/0000-0003-4523-3521	Novo Nordisk Fonden [NNF17OC0027812]	Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by an unconditional research grant from Novo Nordisk Fonden (NNF17OC0027812). AIH and LHM are employed at Statistics Denmark, the national Danish Statistics office, which organization holds the rights to the registry data used in the study. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Bjorner TB, 2012, INT J HEALTH CARE FI, V12, P129, DOI 10.1007/s10754-012-9106-1; Brockmann H, 2002, SOC SCI MED, V55, P593, DOI 10.1016/S0277-9536(01)00190-3; Cairns AJG, 2019, MODELLING SOCIOECONO, DOI [10.2139/ssrn.3376527, DOI 10.2139/SSRN.3376527]; Christensen BJ, 2016, FISC STUD, V37, P461, DOI 10.1111/j.1475-5890.2016.12119; Davis MA, 2016, HEALTH AFFAIR, V35, P1316, DOI 10.1377/hlthaff.2015.1419; Fassbender K, 2009, J PAIN SYMPTOM MANAG, V38, P75, DOI 10.1016/j.jpainsymman.2009.04.007; French EB, 2017, HEALTH AFFAIR, V36, P1211, DOI 10.1377/hlthaff.2017.0174; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kjellberg J, 2020, FREMTIDENS SUNDHEDSU; Lunney JR, 2002, J AM GERIATR SOC, V50, P1108, DOI 10.1046/j.1532-5415.2002.50268.x; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Nagin D., 2009, GROUP BASED MODELING; Nagin DS, 2005, CRIMINOLOGY, V43, P873, DOI 10.1111/j.1745-9125.2005.00026.x; Proust-Lima C, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.i02; Sato E, 2009, HEALTH ECON, V18, P843, DOI 10.1002/hec.1410; Shugarman LR, 2009, J PAIN SYMPTOM MANAG, V38, P15, DOI 10.1016/j.jpainsymman.2009.04.004; van de Schoot R, 2017, STRUCT EQU MODELING, V24, P451, DOI 10.1080/10705511.2016.1247646; von Wyl V, 2018, BMJ SUPPORT PALLIAT, V8, P325, DOI 10.1136/bmjspcare-2014-000784; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	22	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244061	10.1371/journal.pone.0244061	http://dx.doi.org/10.1371/journal.pone.0244061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338069	Green Published, gold			2022-12-27	WOS:000601313500023
J	Yang, C; Xie, ZY; Yang, QF; Su, M; Yan, R; Cai, XQ; Fu, XX; Gao, H; Du, L; Zhong, W; Xie, CG				Yang, Chan; Xie, Ziyan; Yang, Qiangfei; Su, Min; Yan, Ran; Cai, Xueqin; Fu, Xiaoxu; Gao, Hong; Du, Lian; Zhong, Wen; Xie, Chunguang			Characterization of lncRNA and mRNA profiles in rats with diabetic macroangiopathy	PLOS ONE			English	Article							MECHANISM; GENE	Diabetic macroangiopathy is part of the most common serious complications of diabetes. Previous studies indicate that lncRNAs involved in the process of diabetes and another vascular disease. However, their detailed mechanism of the lncRNAs involved in diabetic macroangiopathy has not been well characterized. In the present study, we generated rat models of diabetic macroangiopathy induced by High fat of 16weeks. A total of 15 GK rats were constructed as a test group, along with 15 Wistar rats set as control group, and thoracic aorta tissue from each group was collected. Whole genomic RNA sequencing was performed on thoracic aorta tissue; 3223 novel lncRNAs and 20367 annotated lncRNAs were indemnified in thoracic aorta samples, and 864 lncRNAs were expressed differently in the test and control groups. Gene ontology term enrichment showed the apparent enrichment of inflammatory response and cell apoptosis, which consistent with the results of H&E Staining, TUNEL Assay, and ELISA; Extensive literature reveals inflammatory response and cell apoptosis play an important role in the process of diabetic macroangiopathy. The results of the present study indicated that lncRNAs, especially Nrep. bSep08, Col5a1, aSep0, soygee.aSep08-unspliced, NONRATT013247.2, votar.aSep08-unspliced, etc, both participate in and mediate the process of inflammatory response, cell apoptosis. What's more. Our research provides further insights into understanding of the basic molecular mechanisms underlying diabetic macroangiopathy.	[Yang, Chan; Gao, Hong; Zhong, Wen; Xie, Chunguang] Univ Tradit Chinese Med, Hosp Chengdu, Chengdu, Peoples R China; [Xie, Ziyan; Su, Min; Yan, Ran; Cai, Xueqin; Fu, Xiaoxu] Chengdu Univ Tradit Chinese Med, Clin Med Coll, Chengdu, Peoples R China; [Yang, Qiangfei] Peoples Hosp Jianyang City, Dept Orthopaed, Chengdu, Peoples R China; [Du, Lian] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China	Chengdu University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine	Xie, CG (corresponding author), Univ Tradit Chinese Med, Hosp Chengdu, Chengdu, Peoples R China.	xcg718@aliyun.com			National Natural Science Foundation of China [81774302, 81804157, 81973585]; National Chinese Medicine Administration [JDZX2015212]; Department of Science and Technology of Sichuan Province [2016Z003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Chinese Medicine Administration; Department of Science and Technology of Sichuan Province	This work is funded by the National Natural Science Foundation of China (No. 81774302, 81804157, 81973585) and National Chinese Medicine Administration (JDZX2015212), Department of Science and Technology of Sichuan Province (2016Z003).	[Anonymous], 2008, NEUROONCOLOGY, V10, P759; Boon RA, 2016, J AM COLL CARDIOL, V67, P1214, DOI 10.1016/j.jacc.2015.12.051; Choi MJ, 2017, BIOCHEM PHARMACOL, V144, P120, DOI 10.1016/j.bcp.2017.07.021; Gan RT, 2012, MOL BIOL REP, V39, P4759, DOI 10.1007/s11033-011-1268-2; GETZ GS, 1993, ARTERIOSCLER THROMB, V13, P459, DOI 10.1161/01.ATV.13.3.459; Griffith M, 2010, NAT METHODS, V7, P843, DOI [10.1038/NMETH.1503, 10.1038/nmeth.1503]; Group UPDS, 1993, DIABETOLOGIA, V36, P1021; Hu Yong-He, 2014, Zhongguo Zhong Xi Yi Jie He Za Zhi, V34, P1078; Katakami N, 2018, J ATHEROSCLER THROMB, V25, P27, DOI 10.5551/jat.RV17014; Li Lian-xi, 2009, Zhonghua Yi Xue Za Zhi, V89, P2574; [刘俊田 Liu Juntian], 2015, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V36, P141; Liu Ya, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P640; MADONNA R, 2018, VASC PHARMACOL, V107, P27, DOI DOI 10.1016/J.VPH.2018.01.009; Parenti A, 2017, CURR PHARM DESIGN, V23, P1435, DOI 10.2174/1381612823666170124125826; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Watarai A, 2006, DIABETIC MED, V23, P894, DOI 10.1111/j.1464-5491.2006.01946.x; Yang JD, 2015, INFORMATION TECHNOLOGY, P371	17	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0243987	10.1371/journal.pone.0243987	http://dx.doi.org/10.1371/journal.pone.0243987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378343	Green Published, gold			2022-12-27	WOS:000605651300010
J	Chen, ZW; Dornelles, A; Fang, D; Wilson, JR				Chen, Ziwei; Dornelles, Adriana; Fang, Di; Wilson, Jeffrey R.			Impacts on knowledge and testing on HIV in waves of Mozambique surveys with Bayes estimates	PLOS ONE			English	Article								Background It is well known that it is more reliable to investigate the effects of several covariates simultaneously rather than one at time. Similarly, it is more informative to model responses simultaneously, as more often than not, the multiple responses from the same subject are correlated. This is particularly true in the analysis of Mozambique survey data from 2009 and 2018. Method A multiple response predictive model for testing positive for HIV and having sufficient HIV knowledge is modeled to 2009 and 2018 survey data with the use of Bayes estimates. These data are obtained through a hierarchical data structure. The model allows one to address the change in the response to HIV, as it relates to morbidity and to HIV knowledge in Mozambique in the fight against the disease in the last decade. Results A more affluent resident is more likely to test positive, more likely to be more knowledgeable about the disease. Whereas, individuals practicing the Islam faith are less likely to test positive but also less likely to be knowledgeable about the disease. Education, while still a factor, has declined in its impact on testing positive for HIV or being knowledgeable about HIV. Females are more likely to test positive but more likely to be knowledgeable about the disease than men. The rate of impact of affluence on knowledge has increased in the past decade. Marital status (cohabitating or married) showed no impact on the knowledge of the disease. Age had no impact on knowledge suggesting that the message is getting to resident. Conclusions A joint Bayes modeling of correlated binary (testing positive and knowledge about the disease) responses, while accounting for the hierarchy of the data collection, presents an opportunity to extract the extra variation before allocating the variation on the responses as the due of the covariates. The fight against HIV in Mozambique seems to be succeeding. Some knowledge is common among all ages, and Islam religion has a positive effect. While education still shows an influence on the binary responses, it has declined over the last decade.	[Chen, Ziwei] Arizona State Univ, Sch Math & Stat, Tempe, AZ USA; [Dornelles, Adriana] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA; [Fang, Di] Univ Arkansas, Agribusiness Dept, Fayetteville, AR 72701 USA; [Wilson, Jeffrey R.] Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Arkansas System; University of Arkansas Fayetteville; Arizona State University; Arizona State University-Tempe	Wilson, JR (corresponding author), Arizona State Univ, Dept Econ, Tempe, AZ 85287 USA.	jeffrey.wilson@asu.edu		Fang, Di/0000-0002-0717-7576				Beyrer C, 2007, CLIN INFECT DIS, V44, P981, DOI 10.1086/512371; Collett D., 1991, MODELLING BINARY DAT; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Ene M, 2015, SAS GLOB FOR 2015 P; Fang D, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00453-8; Fang D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190917; Gueorguieva RV, 2001, J AM STAT ASSOC, V96, P1102, DOI 10.1198/016214501753208762; Irimata KM, 2017, J APPL STAT, V16, P1; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Mbachu C, 2018, HEALTH EXPECT, V21, P270, DOI 10.1111/hex.12612; Pradhan NS, ANAL EFFECTIVENESS P; Ryan S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09170-x; Scott-Sheldon LAJ, 2013, AJAR-AFR J AIDS RES, V12, P195, DOI 10.2989/16085906.2013.863219; Vazquez-Arreola E, 2020, BIOSTATISTICS EPIDEM, V4, P238, DOI [10.1080/24709360.2020.1790085, DOI 10.1080/24709360.2020.1790085]; Wilson J.R., 2015, GEN METHOD MOMENTS L, V9, P131	15	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244563	10.1371/journal.pone.0244563	http://dx.doi.org/10.1371/journal.pone.0244563			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373426	Green Published, gold			2022-12-27	WOS:000603612300021
J	Zhou, GF; Yu, L; Wang, XM; Zhong, DB; Lee, MC; Kibret, S; Yan, GY				Zhou, Guofa; Yu, Leonard; Wang, Xiaoming; Zhong, Daibin; Lee, Ming-chieh; Kibret, Solomon; Yan, Guiyun			Behavioral response of insecticide-resistant mosquitoes against spatial repellent: A modified self-propelled particle model simulation	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; PERSONAL PROTECTION; TOPICAL REPELLENTS; CONTACT IRRITANT; AEDES-AEGYPTI; MALARIA; EFFICACY; NETS; KNOCKDOWN; METOFLUTHRIN	Rapidly increasing pyrethroid insecticide resistance and changes in vector biting and resting behavior pose serious challenges in malaria control. Mosquito repellents, especially spatial repellents, have received much attention from industry. We attempted to simulate interactions between mosquitoes and repellents using a machine learning method, the Self-Propelled Particle (SPP) model, which we modified to include attractiveness/repellency effects. We simulated a random walk scenario and scenarios with insecticide susceptible/resistant mosquitoes against repellent alone and against repellent plus attractant (to mimic a human host). Simulation results indicated that without attractant/repellent, mosquitoes would fly anywhere in the cage at random. With attractant, all mosquitoes were attracted to the source of the odor by the end. With repellent, all insecticide-susceptible mosquitoes eventually moved to the corner of the cage farthest from the repellent release point, whereas, a high proportion of highly resistant mosquitoes might reach the attractant release point (the human) earlier in the simulation. At fixed concentration, a high proportion of mosquitoes could be able to reach the host when the relative repellency efficacy (compare to attractant efficacy) was <1, whereas, no mosquitoes reached the host when the relative repellency efficacy was > 1. This result implies that repellent may not be sufficient against highly physiologically insecticide resistant mosquitoes, since very high concentrations of repellent are neither practically feasible nor cost-effective.	[Zhou, Guofa; Yu, Leonard; Wang, Xiaoming; Zhong, Daibin; Lee, Ming-chieh; Kibret, Solomon; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA	University of California System; University of California Irvine	Yan, GY (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA.	guiyuny@uci.edu	Zhong, Daibin/GRF-0564-2022; Kibret, Solomon/I-7770-2019; Lee, Ming-Chieh/ABE-8421-2021	Kibret, Solomon/0000-0003-1793-6908; Lee, Ming-Chieh/0000-0002-2462-6089; Wang, Xiaoming/0000-0003-1232-3125	National Institutes of Health [R01 A1050243, D43 TW01505, U19 AI129326]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	GZ, XW, DZ, MCL, SK, and GY were funded by the National Institutes of Health (R01 A1050243, D43 TW01505, and U19 AI129326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; Achee NL, 2009, J AM MOSQUITO CONTR, V25, P156, DOI 10.2987/08-5831.1; Agossa FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145207; Agramonte NM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005954; Ahmed I, 2017, MATER TODAY-PROC, V4, P65, DOI 10.1016/j.matpr.2017.01.194; Alexander-Katz A, 2018, ARXIV180104741V1; Amelia-Yap ZH, 2018, J ECON ENTOMOL, V111, P2854, DOI 10.1093/jee/toy296; [Anonymous], 2013, ARTIFICIAL INTELLIGE; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Bibbs CS, 2015, J MED ENTOMOL, V52, P739, DOI 10.1093/jme/tjv065; BIRKHOFF G, 1990, COMPUT MATH APPL, V19, P147, DOI 10.1016/0898-1221(90)90158-G; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; Buhagiar TS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2219-0; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Cagnetta F, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.158002; Chareonviriyaphap T, 2001, J AM MOSQUITO CONTR, V17, P13; Charlwood JD, 2016, MED VET ENTOMOL, V30, P229, DOI 10.1111/mve.12168; Chate H, 2008, EUR PHYS J B, V64, P451, DOI 10.1140/epjb/e2008-00275-9; Churcher T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002450; Clark JT, 2016, J CHEM ECOL, V42, P919, DOI 10.1007/s10886-016-0770-3; Coetzee M., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P400; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Corberi F, 2019, J STAT MECH-THEORY E, V2019, DOI 10.1088/1742-5468/ab3bc7; Deletre E, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3343-9; Deparis X, 2004, J MED ENTOMOL, V41, P914, DOI 10.1603/0022-2585-41.5.914; DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134; Dogan EB, 1999, J MED ENTOMOL, V36, P788, DOI 10.1093/jmedent/36.6.788; He ZB, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2765-3; Hiraoka T, 2017, J PHYS CONF SER, V921, DOI 10.1088/1742-6596/921/1/012006; Hogarh JN, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1126-8; Huepe C, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.168701; Iwashita H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-52; Jun M, 2012, PROCEDIA ENGINEER, V43, P547, DOI 10.1016/j.proeng.2012.08.095; Kanza JPB, 2013, T ROY SOC TROP MED H, V107, P8, DOI 10.1093/trstmh/trs002; Kawada H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-208; KENNEDY JS, 1947, B ENTOMOL RES, V37, P593, DOI 10.1017/S0007485300030091; Killeen GF, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000212; Killeen GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1280-z; Kitau J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-446; Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76; Lucas JR, 2007, J AM MOSQUITO CONTR, V23, P47, DOI 10.2987/8756-971X(2007)23[47:ULAFTO]2.0.CO;2; Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875; Meng XB, 2016, J EXP THEOR ARTIF IN, V28, P673, DOI 10.1080/0952813X.2015.1042530; Miller P., 2010, SMART SWARM UNDERSTA; Miot Helio Amante, 2008, Dermatol Online J, V14, P1; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Muenworn V, 2006, J AM MOSQUITO CONTR, V22, P689, DOI 10.2987/8756-971X(2006)22[689:IBRITP]2.0.CO;2; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mulamba C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110058; Mzilahowa T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1610-1; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Nguyen NM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004667; Norris EJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020124; Obermayr U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129878; Ogoma SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110433; Pan Q, 2017, SCI CHINA CHEM, V60, P1293, DOI 10.1007/s11426-017-9115-8; Parker JEA, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1909-6; Parker JEA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13392; Pennetier C, 2005, AM J TROP MED HYG, V72, P739, DOI 10.4269/ajtmh.2005.72.739; Pototsky A, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.042124; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Revay EE, 2013, ACTA TROP, V127, P63, DOI 10.1016/j.actatropica.2013.03.011; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Saffre F, 2018, SWARM INTELL-US, V12, P101, DOI 10.1007/s11721-017-0143-8; Said SH, 2009, J AM MOSQUITO CONTR, V25, P436, DOI 10.2987/09-5895.1; Sangoro O, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-324; Sangoro O, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-347; Sangoro O, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-159; SCHIMANSKYGEIER L, 1995, PHYS LETT A, V207, P140, DOI 10.1016/0375-9601(95)00700-D; SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P77; Sfara V, 2016, PEERJ, V4, DOI 10.7717/peerj.2150; Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7; Spitzen J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1293-7; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; Sukumaran D, 2014, PARASITOL RES, V113, P1739, DOI 10.1007/s00436-014-3819-7; Syafruddin D, 2014, AM J TROP MED HYG, V91, P1079, DOI 10.4269/ajtmh.13-0735; Tambwe MM, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0550-2; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; Tuetun B, 2008, PARASITOL RES, V104, P107, DOI 10.1007/s00436-008-1167-1; Uzzan B, 2009, FUND CLIN PHARMACOL, V23, P589, DOI 10.1111/j.1472-8206.2009.00731.x; Wagman JM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003726; Wanjala CL, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1194-6; WHO, 2019, WORLD MALARIA REPORT; WHO (World Health Organization), 2015, WHO REC LONG LAST IN; Williams YA, 2018, ADV PARASIT, V99, P345, DOI 10.1016/bs.apar.2018.01.003; Wilson AL, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-446; World Health Organization, 2004, WHOCDSCPEPVC20041020; Yates CA, 2011, CANADIAN APPL MATH Q, V18, P299; Zion Market Research, GLOB MARK SHAR MOSQ	91	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244447	10.1371/journal.pone.0244447	http://dx.doi.org/10.1371/journal.pone.0244447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373422	Green Submitted, Green Published, gold			2022-12-27	WOS:000603612300016
J	Brummitt, SI; Kjemtrup, AM; Harvey, DJ; Petersen, JM; Sexton, C; Replogle, A; Packham, AE; Bloch, EM; Barbour, AG; Krause, PJ; Green, V; Smith, WA				Brummitt, Sharon I.; Kjemtrup, Anne M.; Harvey, Danielle J.; Petersen, Jeannine M.; Sexton, Christopher; Replogle, Adam; Packham, Andrea E.; Bloch, Evan M.; Barbour, Alan G.; Krause, Peter J.; Green, Valerie; Smith, Woutrina A.			Borrelia burgdorferi and Borrelia miyamotoi seroprevalence in California blood donors	PLOS ONE			English	Article							FEVER GROUP SPIROCHETE; RELAPSING-FEVER; LYME-DISEASE; IXODES-PACIFICUS; UNITED-STATES; INFECTION; RISK; DIAGNOSIS; PATHOGEN; EXPOSURE	The western blacklegged tick, Ixodes pacificus, an important vector in the western United States of two zoonotic spirochetes: Borrelia burgdorferi (also called Borreliella burgdorferi), causing Lyme disease, and Borrelia miyamotoi, causing a relapsing fever-type illness. Human cases of Lyme disease are well-documented in California, with increased risk in the north coastal areas and western slopes of the Sierra Nevada range. Despite the established presence of B. miyamotoi in the human-biting I. pacificus tick in California, clinical cases with this spirochete have not been well studied. To assess exposure to B. burgdorferi and B. miyamotoi in California, and to address the hypothesis that B. miyamotoi exposure in humans is similar in geographic range to B. burgdorferi, 1,700 blood donor sera from California were tested for antibodies to both pathogens. Sampling was from high endemic and low endemic counties for Lyme disease in California. All sera were screened using the C6 ELISA. All C6 positive and equivocal samples and nine randomly chosen C6 negative samples were further analyzed for B. burgdorferi antibody using IgG western blot and a modified two ELISA test system and for B. miyamotoi antibody using the GlpQ ELISA and B. miyamotoi whole cell sonicate western blot. Of the 1,700 samples tested in series, eight tested positive for antibodies to B. burgdorferi (0.47%, Exact 95% CI: 0.20, 0.93) and two tested positive for antibodies to B. miyamotoi (0.12%, Exact 95% CI: 0.01, 0.42). There was no statistically significant difference in seroprevalence for either pathogen between high and low Lyme disease endemic counties. Our results confirm a low frequency of Lyme disease and an even lower frequency of B. miyamotoi exposure among adult blood donors in California; however, our findings reinforce public health messaging that there is risk of infection by these emerging diseases in the state.	[Brummitt, Sharon I.; Smith, Woutrina A.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Kjemtrup, Anne M.] Calif Dept Publ Hlth, Sacramento, CA USA; [Harvey, Danielle J.] Univ Calif Davis, Sch Med, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Petersen, Jeannine M.; Sexton, Christopher; Replogle, Adam] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Packham, Andrea E.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA; [Bloch, Evan M.] Johns Hopkins Univ, Dept Pathol & Transfus Med, Baltimore, MD USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Krause, Peter J.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Krause, Peter J.] Yale Sch Med, New Haven, CT USA; [Green, Valerie] Creat Testing Solut, Tempe, AZ USA	University of California System; University of California Davis; California Department of Public Health; University of California System; University of California Davis; Centers for Disease Control & Prevention - USA; University of California System; University of California Davis; Johns Hopkins University; University of California System; University of California Irvine; University of California System; University of California Irvine; Yale University; Yale University	Brummitt, SI (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	Sibrummitt@ucdavis.edu		Sexton, Christopher/0000-0003-0928-214X	National Institutes of Health [AI-100236]; National Heart, Lung, and Blood Institute of the National Institutes of Health [K23HL151826]; Gordon and Llura Gund Foundation; California Lyme Disease Association	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Gordon and Llura Gund Foundation; California Lyme Disease Association	This research was supported in part by a crowdfunding platform through experiment.com set up by S.I.B.: https://experiment.com/projects/ticks-carry-more-than-lyme-disease-in-californiaare-californians-at-risk.We would like to acknowledge the California Lyme Disease Association for providing matching funds to the experiment.com crowdfunding platform. This research was also supported in part by National Institutes of Health grant AI-100236 to A.G.B, The National Heart, Lung, and Blood Institute of the National Institutes of Health under award number K23HL151826 to E.M.B, and the Gordon and Llura Gund Foundation to P.J.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2015, VBDS ANN REP; [Anonymous], 2016, VBDS ANN REP; [Anonymous], 2017, VBDS ANN REP; [Anonymous], 2019, VBDS ANN REP; [Anonymous], 2018, VBDS ANN REP; Arnaboldi PM, 2013, CLIN VACCINE IMMUNOL, V20, P474, DOI 10.1128/CVI.00608-12; Atsma F, 2011, TRANSFUSION, V51, P1820, DOI 10.1111/j.1537-2995.2010.03055.x; Bacon RM, 2004, J CLIN MICROBIOL, V42, P2326, DOI 10.1128/JCM.42.5.2326-2328.2004; Branda JA, 2018, CLIN INFECT DIS, V66, P1133, DOI 10.1093/cid/cix943; Branda JA, 2011, CLIN INFECT DIS, V53, P541, DOI 10.1093/cid/cir464; California Department of Public health, 2018, TICK BORN REL FEV; Center for Disease Control and Prevention, 2019, TICK BORN REL FEV BO; Center for Disease Control and Prevention, 1995, NOT READ REC TEST PE; Center for Disease Control and Prevention, 2015, REL FEV; Center for Disease Control and Prevention, 2019, LYM DIS REC SURV DAT; Eisen L, 2004, MED VET ENTOMOL, V18, P38, DOI 10.1111/j.1365-2915.2004.0476.x; Eisen RJ, 2006, AM J TROP MED HYG, V75, P669, DOI 10.4269/ajtmh.2006.75.669; Eisen RJ, 2017, ILAR J, V58, P319, DOI 10.1093/ilar/ilx005; Eisen RJ, 2018, TRENDS PARASITOL, V34, P295, DOI 10.1016/j.pt.2017.12.006; Eisen RJ, 2006, AM J TROP MED HYG, V74, P632, DOI 10.4269/ajtmh.2006.74.632; Fritz CL, 1997, J INFECT DIS, V175, P1432, DOI 10.1086/516476; Fritz CL, 2013, VECTOR-BORNE ZOONOT, V13, P376, DOI 10.1089/vbz.2012.1137; Hamase A, 1996, FEMS MICROBIOL LETT, V140, P131, DOI 10.1111/j.1574-6968.1996.tb08326.x; Jahfari S, 2014, New Microbes New Infect, V2, P144, DOI 10.1002/nmi2.59; Jahfari S, 2017, J MICROBIOL METH, V136, P11, DOI 10.1016/j.mimet.2017.02.013; Koetsveld J, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2019.07.026; Krause PJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191725; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Lane RS, 2004, J MED ENTOMOL, V41, P239, DOI 10.1603/0022-2585-41.2.239; Liang FT, 2000, J INFECT DIS, V182, P1455, DOI 10.1086/315862; Molins CR, 2016, J CLIN MICROBIOL, V54, P2726, DOI 10.1128/JCM.00874-16; Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333; Molloy PJ, 2018, CLIN INFECT DIS, V66, P1407, DOI 10.1093/cid/cix1023; Moore A, 2016, EMERG INFECT DIS, V22, P1169, DOI 10.3201/eid2207.151694; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Nieto NC, 2014, J MED ENTOMOL, V51, P1029, DOI 10.1603/ME14021; Ogden N H, 2019, Can Commun Dis Rep, V45, P76, DOI 10.14745/ccdr.v45i04a01; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Pascoe EL, 2019, VECTOR-BORNE ZOONOT, V19, P871, DOI 10.1089/vbz.2019.2489; Philipp MT, 2005, CLIN DIAGN LAB IMMUN, V12, P1069, DOI 10.1128/CDLI.12.9.1069-1074.2005; Porwancher RB, 2011, CLIN VACCINE IMMUNOL, V18, P851, DOI 10.1128/CVI.00409-10; Prevention CfDCa, 2015, TICKB REL FEV US 199; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Scientific Z, 2020, BORRELIA VLSE1 PEPC1; Scientific Z . B, 2020, B BURGDORFERI IGG TE; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Steere AC, 2008, CLIN INFECT DIS, V47, P188, DOI 10.1086/589242; Steere AC, 2006, WIEN KLIN WOCHENSCHR, V118, P625, DOI 10.1007/s00508-006-0687-x; Sudhindra P, 2016, DIAGN MICR INFEC DIS, V86, P93, DOI 10.1016/j.diagmicrobio.2016.06.015; Swei A, 2012, VECTOR-BORNE ZOONOT, V12, P623, DOI 10.1089/vbz.2011.0783; US Food and Drug Administration, 2019, FDA CLEARS NEW IND E; van den Hurk K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186662; Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003; Xu G, 2019, VECTOR-BORNE ZOONOT, V19, P106, DOI 10.1089/vbz.2018.2323	55	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243950	10.1371/journal.pone.0243950	http://dx.doi.org/10.1371/journal.pone.0243950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370341	Green Published, gold			2022-12-27	WOS:000603611900015
J	Wang, C; Zhang, XF; Zhao, GH				Chen, Wang; Xiufeng, Zhang; Guohua, Zhao			Research on hot rolling scheduling problem based on Two-phase Pareto algorithm	PLOS ONE			English	Article							OPTIMIZATION ALGORITHM; SEARCH ALGORITHM	Under the background of excess capacity and energy saving in iron and steel enterprises, the hot rolling batch scheduling problem based on energy saving is a multi-objective and multi constraint optimization problem. In this paper, a hybrid multi-objective prize-collecting vehicle routing problem (Hybrid Price Collect Vehicle Routing Problem, HPCVRP) model is established to ensure minimum energy consumption, meet process rules, and maximize resource utilization. A two-phase Pareto search algorithm (2PPLS) is designed to solve this model. The improved MOEA/D with a penalty based boundary intersection distance (PBI) algorithm (MOEA/D-PBI) is introduced to decompose the HPCVRP in the first phase. In the second phase, the multi-objective ant colony system (MOACS) and Pareto local search (PLS) algorithm is used to generate approximate Pareto-optimal solutions. The final solution is then selected according to the actual demand and preference. In the simulation experiment, the 2PPLS is compared with five other algorithms, which shows the superiority of 2PPLS. Finally, the experiment was carried out on actual slab data from a steel plant in Shanghai. The results show that the model and algorithm can effectively reduce the energy consumption in the process of hot rolling batch scheduling.	[Chen, Wang; Xiufeng, Zhang; Guohua, Zhao] Hubei Univ Automot Technol, Dept Mech Engn, Shiyan, Peoples R China	Hubei University of Automotive Technology	Zhao, GH (corresponding author), Hubei Univ Automot Technol, Dept Mech Engn, Shiyan, Peoples R China.	893468804@qq.com			Shiyan Enterprises	Shiyan Enterprises	The project is funded by Shiyan Enterprises. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Attila Yilmaz, 2020, COMPUTERS IND ENG; Budinich M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171744; de Souza MZ, 2014, 2014 BRAZILIAN CONFERENCE ON INTELLIGENT SYSTEMS (BRACIS), P324, DOI 10.1109/BRACIS.2014.65; Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; Idris H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177567; Jia SJ, 2013, INT J PROD RES, V51, P667, DOI 10.1080/00207543.2011.654138; Lilan Liu, 2015, Applied Mechanics and Materials, V741, P869, DOI 10.4028/www.scientific.net/AMM.741.869; Ling T., 2018, MATH PROBLEMS ENG; Long JY, 2019, INFORM SCIENCES, V478, P40, DOI 10.1016/j.ins.2018.11.006; Lopez L, 1998, EUR J OPER RES, V106, P317, DOI 10.1016/S0377-2217(97)00277-4; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mezura-Montes E, 2011, SWARM EVOL COMPUT, V1, P173, DOI 10.1016/j.swevo.2011.10.001; Pan QK, 2019, APPL MATH MODEL, V73, P327, DOI 10.1016/j.apm.2019.04.006; Pei Jun, 2019, INFORMS J COMPUT, V31, P235; Pericleous S., 2017, 2017 8 INT C INF INT, P1, DOI 10.1109/IISA.2017.8316412; Sarika PR, 2016, INT J BIOL MACROMOL, V86, P1, DOI 10.1016/j.ijbiomac.2016.01.037; Spengler T. S., 2016, J BUSINESS EC, V86, P537, DOI 10.1007/s11573-015-0783-3; Tan YY, 2019, INT J NEUROSCI, V129, P1223, DOI 10.1080/00207454.2019.1655013; Wang YR, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/12/125101; Zangari M, 2017, NEUROCOMPUTING, V246, P58, DOI 10.1016/j.neucom.2016.09.122; Zhang B, 2018, COMPUT IND ENG, V116, P22, DOI 10.1016/j.cie.2017.12.013; Zhang R, 2020, IEEE T IND INFORM, V16, P2809, DOI 10.1109/TII.2019.2944247	23	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0241077	10.1371/journal.pone.0241077	http://dx.doi.org/10.1371/journal.pone.0241077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370776	gold, Green Published			2022-12-27	WOS:000603611900054
J	Wong, YS; Tsai, CF; Hsu, YH; Ong, CT				Wong, Yi-Sin; Tsai, Ching-Fang; Hsu, Yueh-Han; Ong, Cheung-Ter			Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: A population-based case-cohort study in Taiwan	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; HEALTH-CARE PROFESSIONALS; MINOR STROKE; HIGH-RISK; ANTIPLATELET THERAPY; DOUBLE-BLIND; DEFINITION; SAFETY; TRIAL; MATCH	Background In real-world practice settings, there is insufficient evidence on the efficacy of antiplatelet drugs, including clopidogrel, aspirin, and ticlopidine, in stroke prevention. Purpose To compare the efficacies between aspirin and clopidogrel and aspirin and ticlopidine in stroke prevention. Methods This population-based case-cohort study utilized the data obtained from a randomized sample of one million subjects in the Taiwan National Health Insurance Research Database. Patients who were hospitalized owing to the primary diagnosis of ischemic stroke from January 1, 2000 to December 31, 2010 and treated with aspirin, ticlopidine, or clopidogrel were included in the study. Propensity score matching with a 1:4 ratio was performed to compare aspirin with ticlopidine and clopidogrel. The criteria for inclusion were the use of one of the three antiplatelet drugs for more than 14 days within the first month after the stroke and then continued use of the antiplatelet drugs until the study endpoint of recurrent stroke. Results During the 3-year follow-up period, the recurrent stroke rates were 1.62% (42/2585), 1.48% (3/203), and 2.55% (8/314) in the aspirin, ticlopidine, and clopidogrel groups, respectively. Compared with the patients treated with aspirin, those treated with clopidogrel and ticlopidine showed competing risk-adjusted hazard ratios of recurrent stroke of 2.27 (1.02-5.07) and 0.62 (0.08-4.86), respectively. Conclusion Compared with the patients treated with aspirin, those treated with clopidogrel were at a higher risk of recurrent stroke. For stroke prevention, aspirin was superior to clopidogrel whereas ticlopidine was not inferior to aspirin.	[Wong, Yi-Sin] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Family Med, Chiayi, Taiwan; [Tsai, Ching-Fang; Hsu, Yueh-Han] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Med Res, Chiayi, Taiwan; [Ong, Cheung-Ter] Ditmanson Med Fdn Chiayi Christian Hosp, Dept Neurol, Chiayi, Taiwan	Chia-Yi Christian Hospital; Chia-Yi Christian Hospital; Chia-Yi Christian Hospital	Ong, CT (corresponding author), Ditmanson Med Fdn Chiayi Christian Hosp, Dept Neurol, Chiayi, Taiwan.	ctong98@yahoo.com.tw		Ong, Cheung-Ter/0000-0003-1814-4371				Bath PMW, 2010, STROKE, V41, P732, DOI 10.1161/STROKEAHA.109.564906; Berkowitz AL, 2014, NEUROLOGY, V83, P1004, DOI 10.1212/WNL.0000000000000779; Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624; COUCH JR, 1993, CLIN CARDIOL, V16, P703, DOI 10.1002/clc.4960161004; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; GENT M, 1989, LANCET, V1, P1215, DOI 10.1016/S0140-6736(89)92327-1; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gorelick PB, 2003, JAMA-J AM MED ASSOC, V289, P2947, DOI 10.1001/jama.289.22.2947; Hall P, 1996, CIRCULATION, V93, P215, DOI 10.1161/01.CIR.93.2.215; Hankey GJ, 2005, NEUROLOGY, V64, P1117, DOI 10.1212/01.WNL.0000156357.50448.8A; HASS WK, 1989, NEW ENGL J MED, V321, P501, DOI 10.1056/NEJM198908243210804; Hulot JS, 2020, JACC-CARDIOVASC INTE, V13, P621, DOI 10.1016/j.jcin.2020.01.219; Ito E, 2003, INTERNAL MED, V42, P793, DOI 10.2169/internalmedicine.42.793; Jeong HG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217723; Johnston SC, 2018, NEW ENGL J MED, V379, P215, DOI 10.1056/NEJMoa1800410; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Krupczynski P., 1993, ACTA U LODZIENSIS FO, V48, P27; Lablanche JM, 1996, EUR HEART J, V17, P1373; Lee M, 2016, J STROKE, V18, P60, DOI 10.5853/jos.2015.01326; Liu LP, 2018, STROKE, V49, P2278, DOI 10.1161/STROKEAHA.118.022696; Patrono C, 2003, J THROMB HAEMOST, V1, P1710, DOI 10.1046/j.1538-7836.2003.00284.x; Quinn MJ, 1999, CIRCULATION, V100, P1667, DOI 10.1161/01.CIR.100.15.1667; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; ten Berg JM, 2020, JACC-CARDIOVASC INTE, V13, P631, DOI 10.1016/j.jcin.2020.01.221; Uchiyama S, 2009, J NEUROL, V256, P888, DOI 10.1007/s00415-009-5035-4; Wang XW, 2015, NEUROLOGY, V85, P573, DOI 10.1212/WNL.0000000000001844; Wang YL, 2016, JAMA-J AM MED ASSOC, V316, P70, DOI 10.1001/jama.2016.8662; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242466	10.1371/journal.pone.0242466	http://dx.doi.org/10.1371/journal.pone.0242466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370282	Green Published, gold			2022-12-27	WOS:000603611900030
J	Bortolami, M; Comparato, A; Benna, C; Errico, A; Maretto, I; Pucciarelli, S; Cillo, U; Farinati, F				Bortolami, Marina; Comparato, Alessandra; Benna, Clara; Errico, Andrea; Maretto, Isacco; Pucciarelli, Salvatore; Cillo, Umberto; Farinati, Fabio			Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; MAMMALIAN TARGET; AUTOPHAGY; CANCER; PHOSPHORYLATION; INFLAMMATION; RESISTANCE; MICRORNAS; PATHWAY; MICE	The physiological role of autophagy in the progression of liver diseases is still debated. To understand the clinical relevance of autophagy in primary e secondary hepatic tumors, we analyzed the expression of mTOR (mammalian target of rapamycin), a key regulator of autophagy; Raptor (regulatory-associated protein of mTOR); ULK1 (Unc-51 like kinase 1) determinant in the autophagy initiation; LC3 (microtubule-associated protein 1A/1B-light chain 3), a specific marker of autophagosomes; and p62, a selective autophagy receptor. Samples from subjects with chronic hepatitis (n.58), cirrhosis (n.12), hepatocellular carcinoma (HCC, n.56), metastases (n.48) from colorectal cancer and hyperplasia or gallbladder stones (n.7), the latter considered as controls, were examined. Gene expression analysis was carried out in n.213 tissues by absolute q-PCR, while protein expression by Western Blot in n.191 lysates, including tumoral, surrounding tumoral and normal tissues. Nonparametric statistical tests were used for comparing expression levels in the above-mentioned groups. Subgroup analysis was performed considering viral infection and chemotherapy treatment. The mTOR transcriptional level was significantly lower in metastases compared to HCC (P = 0.0001). p-mTOR(Ser2448) and LC3II/LC3I protein levels were significantly higher in metastases compared to HCC (P = 0.008 and P<0.0001, respectively). ULK(Ser757) levels were significantly higher in HCC compared to metastases (P = 0.0002) while the HCV- and HBV- related HCC showed the highest p62 levels. Chemotherapy induced a down-regulation of the p-mTOR(Ser2448) in metastases and in non-tumor surrounding tissues in treated patients compared to untreated (P = 0.001 and P = 0.005, respectively). Conclusions: the different expression of proteins considered, owning their interaction and diverse tissue microenvironment, indicate an impairment of the autophagy flux in primary liver tumors that is critical for the promotion of tumorigenesis process and a coexistence of autophagy inhibition and activation mechanisms in secondary liver tumors. Differences in mTOR and LC3 transcripts emerged in tumor-free tissues, therefore particular attention should be considered in selecting the control group.	[Bortolami, Marina; Comparato, Alessandra; Errico, Andrea; Farinati, Fabio] Univ Padua, Dept Surg Oncol & Gastroenterol, DISCOG, Sch Med,Gastroenterol Unit, Padua, Italy; [Benna, Clara; Maretto, Isacco; Pucciarelli, Salvatore; Cillo, Umberto] Univ Padua, Dept Surg Oncol & Gastroenterol, DISCOG, Sch Med,Surg Unit, Padua, Italy	University of Padua; University of Padua	Bortolami, M (corresponding author), Univ Padua, Dept Surg Oncol & Gastroenterol, DISCOG, Sch Med,Gastroenterol Unit, Padua, Italy.	marina.bortolami@unipd.it	benna, clara/K-1083-2018; PUCCIARELLI, SALVATORE/J-5050-2018	PUCCIARELLI, SALVATORE/0000-0001-5289-9925; Maretto, Isacco/0000-0003-4878-9154; FARINATI, FABIO/0000-0002-2944-1374	University of Padova [BIRD175781]	University of Padova	MB: 2017-prot. BIRD175781 University of Padova The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; [Anonymous], 2016, TIMBERMART S, V21, P1; Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Bracho-Valdes I, 2011, IUBMB LIFE, V63, P896, DOI 10.1002/iub.558; Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200; Chude CI, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061279; Clark T, 2015, CURR PROBL DIAGN RAD, V44, P479, DOI 10.1067/j.cpradiol.2015.04.004; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; Czaja MJ, 2013, AUTOPHAGY, V9, P1131, DOI 10.4161/auto.25063; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Deretic Vojo, 2008, V445, P1, DOI 10.1007/978-1-59745-157-4_1; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Dogan F, 2018, GENE, V641, P235, DOI 10.1016/j.gene.2017.09.072; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Duffy A, 2015, CANCER CHEMOTH PHARM, V75, P439, DOI 10.1007/s00280-014-2637-z; Fahmy AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205189; Fletcher R, 2018, BBA-REV CANCER, V1869, P138, DOI 10.1016/j.bbcan.2017.12.002; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; He CJ, 2015, ONCOTARGET, V6, P28867, DOI 10.18632/oncotarget.4814; Hsu CC, 2019, CANCER MED-US, V8, P3453, DOI 10.1002/cam4.2229; Hung TM, 2015, AM J PATHOL, V185, P2454, DOI 10.1016/j.ajpath.2015.05.010; Jhanwar-Uniyal Meena, 2019, Advances in Biological Regulation, V72, P51, DOI 10.1016/j.jbior.2019.03.003; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Karim MR, 2007, AUTOPHAGY, V3, P553, DOI 10.4161/auto.4615; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim YC, 2015, J CLIN INVEST, V125, P25, DOI 10.1172/JCI73939; Kotsafti A, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-118; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lin CW, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0033-4; Marsh R, 2016, J IMMUNOL, V77, P616; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Oki E, 2018, ANN GASTROENT SURG, V2, P167, DOI 10.1002/ags3.12071; Pang L., 2018, LIVER RES, V2, P157; Paschos KA, 2014, WORLD J GASTROENTERO, V20, P3719, DOI 10.3748/wjg.v20.i14.3719; Peng YF, 2013, AUTOPHAGY, V9, P2056, DOI 10.4161/auto.26398; Peng YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074407; Rawat S, 2015, J VIROL, V89, P999, DOI 10.1128/JVI.02440-14; Santana-Codina N, 2017, ANNU REV CANC BIOL, V1, P19, DOI 10.1146/annurev-cancerbio-041816-122338; Sharma K, 2014, INT J MOL SCI, V15, P10034, DOI 10.3390/ijms150610034; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Tian T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030755; Tornesello ML, 2016, ONCOTARGET, V7, P25087, DOI 10.18632/oncotarget.7837; Torrecilla S, 2017, J HEPATOL, V67, P1222, DOI 10.1016/j.jhep.2017.08.013; Ueno T, 2017, NAT REV GASTRO HEPAT, V14, P170, DOI 10.1038/nrgastro.2016.185; Venkat SR, 2018, AM J ROENTGENOL, V210, P883, DOI 10.2214/AJR.17.18574; Wang CY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05449-1; Wang L, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007541; Wang P, 2018, J CANCER, V9, P667, DOI 10.7150/jca.22119; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wang YN, 2017, ONCOL LETT, V14, P3566, DOI 10.3892/ol.2017.6573; Wang Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/735672; World Health Organization, 2017, DEPR OTH COMM MENT D, DOI DOI 10.1109/IEEESTD.2017.7920364; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xu HT, 2013, INT J CLIN EXP PATHO, V6, P711; Xu X, 2018, J CANCER, V9, P3557, DOI 10.7150/jca.26350; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; 2019, MICROBIOME, V7, P1	64	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244356	10.1371/journal.pone.0244356	http://dx.doi.org/10.1371/journal.pone.0244356			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362215	gold, Green Published			2022-12-27	WOS:000603071600001
J	Klanten, OS; Gaither, MR; Greaves, S; Mills, K; O'Keeffe, K; Turnbull, J; McKinnon, R; Booth, DJ				Klanten, O. Selma; Gaither, Michelle R.; Greaves, Samuel; Mills, Kade; O'Keeffe, Kristine; Turnbull, John; McKinnon, Rob; Booth, David J.			Genomic and morphological evidence of distinct populations in the endemic common (weedy) seadragon Phyllopteryx taeniolatus (Syngnathidae) along the east coast of Australia	PLOS ONE			English	Article							EXTINCTION RISK; PHYLOGEOGRAPHY; TELEOSTEI; GENETICS; FISH; SEA; GLACIATION; SOFTWARE; PIPEFISH; STACKS	The common or weedy seadragon, Phyllopteryx taeniolatus, is an iconic and endemic fish found across temperate reefs of southern Australia. Despite its charismatic nature, few studies have been published, and the extent of population sub-structuring remains poorly resolved. Here we used 7462 single nucleotide polymorphisms (SNPs) to identify the extent of population structure in the weedy seadragon along the temperate southeast coast of Australia. We identified four populations, with strong genetic structure (F-ST = 0.562) between them. Both Discriminant Analysis of Principle Components (DAPC) and Bayesian clustering analyses support four distinct genetic clusters (north to south: central New South Wales, southern NSW, Victoria and Tasmania). In addition to these genetic differences, geographical variation in external morphology was recorded, with individuals from New South Wales shaped differently for a few measurements to those from the Mornington Peninsula (Victoria). We posit that these genetic and morphological differences suggest that the Victorian population of P. taeniolatus was historically isolated by the Bassian Isthmus during the last glacial maximum and should now be considered at least a distinct population. We also recorded high levels of genetic structure among the other locations. Based on the genomic and to a degree morphological evidence presented in this study, we recommend that the Victorian population be managed separately from the eastern populations (New South Wales and Tasmania).	[Klanten, O. Selma; Booth, David J.] Univ Technol Sydney, Sch Life Sci, Fish Ecol Lab, Sydney, NSW, Australia; [Gaither, Michelle R.; Greaves, Samuel] Univ Cent Florida, Dept Biol, Genom & Bioinformat Cluster, Orlando, FL USA; [Mills, Kade] Victorian Natl Parks Assoc, Melbourne, Vic, Australia; [O'Keeffe, Kristine; Turnbull, John] Underwater Res Grp URG, Sydney, NSW, Australia; [Turnbull, John] Univ New South Wales, Sch Biol Earth & Environm Sci, Ctr Marine Biodivers & Innovat, Sydney, NSW, Australia; [McKinnon, Rob] New South Wales Natl Parks & Wildlife Serv, Merimbula, NSW, Australia	University of Technology Sydney; State University System of Florida; University of Central Florida; University of New South Wales Sydney	Klanten, OS (corresponding author), Univ Technol Sydney, Sch Life Sci, Fish Ecol Lab, Sydney, NSW, Australia.	osklanten@me.com	Turnbull, John W/AAE-3371-2021; Klanten, Oya S./C-5628-2011	Klanten, Oya S./0000-0001-6296-4225; Greaves, Samuel/0000-0001-7299-2991; Booth, David/0000-0002-8256-1412	Sea World Research and Rescue Foundation Inc. [SWR/4/2016]	Sea World Research and Rescue Foundation Inc.	Funded study, single grant to OSK and DJB SWR/4/2016 by the Sea World Research and Rescue Foundation Inc. https://seaworld.com.au/conservation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, UNDP FOCUS, V1, P31; Baumsteiger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189417; Beheregaray LB, 2017, MOL PHYLOGENET EVOL, V111, P65, DOI 10.1016/j.ympev.2017.03.021; Benjamini Y, 2001, ANN STAT, V29, P1165; Bennett S, 2016, MAR FRESHWATER RES, V67, P47, DOI 10.1071/MF15232; Boehm JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116219; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bowen BW, 2001, EVOLUTION, V55, P1029, DOI 10.1554/0014-3820(2001)055[1029:POTTAR]2.0.CO;2; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Crane NL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198901; Deck J, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002925; Delrieu-Trottin E, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1068; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eble JA, 2009, MAR BIOL, V156, P689, DOI 10.1007/s00227-008-1119-4; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forsgren KL, 2006, MAR FRESHWATER RES, V57, P313, DOI 10.1071/MF05094; Fraser CI, 2009, MOL ECOL, V18, P2287, DOI 10.1111/j.1365-294X.2009.04201.x; Fricke R, 2022, ESCHMEYERS CATALOG F; Gaither MR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-189; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hobbs JPA, 2011, CONSERV BIOL, V25, P1053, DOI 10.1111/j.1523-1739.2011.01698.x; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kendrick AJ, 2005, ENVIRON BIOL FISH, V72, P415, DOI 10.1007/s10641-004-2597-y; Klanten OS, 2007, MAR BIOL, V150, P659, DOI 10.1007/s00227-006-0372-7; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kuiter R. H., 2009, SEAHORSES THEIR RELA; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Lewis SE, 2013, QUATERNARY SCI REV, V74, P115, DOI 10.1016/j.quascirev.2012.09.006; Lopez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117538; Lopez A, 2010, CONSERV GENET, V11, P2431, DOI 10.1007/s10592-010-0116-6; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; McDowall RM, 2002, J BIOGEOGR, V29, P207, DOI 10.1046/j.1365-2699.2002.00670.x; Mobley KB, 2010, J BIOGEOGR, V37, P1363, DOI 10.1111/j.1365-2699.2010.02288.x; Nickel J, 2012, NEW ZEAL J MAR FRESH, V46, P207, DOI 10.1080/00288330.2011.632014; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Partridge C, 2012, J HERED, V103, P821, DOI 10.1093/jhered/ess062; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Prates R. F., 2013, International Journal of Computer Science & Information Technology, V5, P39, DOI 10.5121/ijcsit.2013.5603; Pritchard JK, 2000, GENETICS, V155, P945; Puebla O, 2014, MOL ECOL, V23, P5291, DOI 10.1111/mec.12926; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rochette NC, 2019, MOL ECOL, V28, P4737, DOI 10.1111/mec.15253; Rouse Greg W., 2017, Marine Biodiversity Records, V10, P2, DOI 10.1186/s41200-016-0102-x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Roux C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.2000234; Saenz-Agudelo P, 2015, MOL ECOL, V24, P6241, DOI 10.1111/mec.13471; Sanchez-Camara J, 2005, J FISH BIOL, V67, P133, DOI 10.1111/j.0022-1112.2005.00720.x; Sanchez-Camara J, 2006, MAR FRESHWATER RES, V57, P737, DOI 10.1071/MF05220; Sanchez-Camara J, 2011, MAR ECOL PROG SER, V422, P253, DOI 10.3354/meps08920; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singh KV, 2012, MAR BIODIVERS, V42, P481, DOI 10.1007/s12526-012-0122-7; Stiller J, 2017, J HERED, V108, P152, DOI 10.1093/jhered/esw075; Stiller J, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140458; Syaifudin M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48339-2; Tenggardjaja KA, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3395-y; UN CBD, 2010, UN CONV BIOL DIV C P, V2011, P1; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Verges A, 2016, P NATL ACAD SCI USA, V113, P13791, DOI 10.1073/pnas.1610725113; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]; Wilson AB, 2006, MOL ECOL, V15, P1857, DOI 10.1111/j.1365-294X.2006.02911.x; Wilson AB, 2010, MOL ECOL, V19, P4535, DOI 10.1111/j.1365-294X.2010.04811.x; Wilson NG, 2017, CONSERV GENET, V18, P53, DOI 10.1007/s10592-016-0881-y; Wilson NG, 2010, ZOOL SCR, V39, P551, DOI 10.1111/j.1463-6409.2010.00449.x	69	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243446	10.1371/journal.pone.0243446	http://dx.doi.org/10.1371/journal.pone.0243446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362197	Green Published, gold			2022-12-27	WOS:000603071600037
J	Zingore, KM; Sithole, G; Abdel-Rahman, EM; Mohamed, SA; Ekesi, S; Tanga, CM; Mahmoud, MEE				Zingore, Kumbirai M.; Sithole, George; Abdel-Rahman, Elfatih M.; Mohamed, Samira A.; Ekesi, Sunday; Tanga, Chrysantus M.; Mahmoud, Mohammed E. E.			Global risk of invasion by Bactrocera zonata: Implications on horticultural crop production under changing climatic conditions	PLOS ONE			English	Article							FRUIT-FLIES DIPTERA; SPECIES DISTRIBUTIONS; SAMPLING BIAS; PREDICTION; MODELS; TEPHRITIDAE; MAXENT; FLY; PERFORMANCE; DISPERSAL	The peach fruit fly Bactrocera zonata (Saunders) (Diptera: Tephritidae) is an important invasive species causing substantial losses to the horticulture industry worldwide. Despite the severe economic impact caused by this pest in its native and invaded range, information on its potential range expansion under changing climate remains largely unknown. In this study, we employed maximum entropy (MaxEnt) modeling approach to predict the global potential climatic suitability of B. zonata under current climate and four Representative Concentration Pathways (RCPs) for the year 2050. Outputs from MaxEnt were merged with Spatial Production Allocation Model. A natural dispersal model using Gaussian dispersal kernel was developed. The Areas Under Curves generated by MaxEnt were greater than 0.92 for both current and future climate change scenarios, indicating satisfactory performances of the models. Mean temperature of the coldest quarter, precipitation of driest month and temperature seasonality significantly influenced the potential establishment of B. zonata. The models indicated high climatic suitability in tropical and subtropical areas in Asia and Africa, where the species has already been recorded. Suitable areas were predicted in West, East and Central Africa and to a lesser extent in Central and South America. Future climatic scenarios models, RCP 4.5 and 8.5 show significant potential range expansion of B. zonata in Western Sahara, while RCP 4.5 highlighted expansion in Southern Africa. Contrarily, RCP 2.6 showed considerable decrease in B. zonata range expansion in Central, East and West Africa. There was increased climatic suitability of B. zonata in Egypt and Middle East under RCP 6.0. The dispersal model revealed that B. zonata could spread widely within its vicinity with decreasing infestation rates away from the source points. Our findings can help to guide biosecurity agencies in decision-making and serve as an early warning tool to safeguard against the pest invasion into unaffected areas.	[Zingore, Kumbirai M.; Abdel-Rahman, Elfatih M.; Mohamed, Samira A.; Ekesi, Sunday; Tanga, Chrysantus M.; Mahmoud, Mohammed E. E.] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [Zingore, Kumbirai M.; Sithole, George] Univ Cape Town, Sch Architecture Planning & Geomat, Geomat Div, Rondebosch, South Africa; [Abdel-Rahman, Elfatih M.] Univ Khartoum, Fac Agr, Dept Agron, Khartoum, Sudan; [Mahmoud, Mohammed E. E.] Agr Res Corp, Wad Medan, Sudan	International Centre of Insect Physiology & Ecology (ICIPE); University of Cape Town; University of Khartoum	Tanga, CM (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya.	ctanga@icipe.org	Ekesi, Sunday/P-8944-2019		Dissertation Research Internship Programme (DRIP), In-Region Postgraduate Scholarship at the International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya; Norwegian Agency for Development Cooperation; Section for research, innovation, and higher education grant [RAF-3058 KEN-18/0005]; European Union [DCI-FOOD/2014/346-739]; Biovision Foundation Switzerland [BV PH-07/2016-2018, DPP_005 (01/2019-12/2021)]; International Atomic Energy Agency (IAEA), through the CRP on "Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constraints to SIT Application and International Trade through icipe; icipe core - United Kingdom's Foreign, Commonwealth and Development Office (FCDO); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Democratic Republic of Ethiopia; Government of the Republic of Kenya	Dissertation Research Internship Programme (DRIP), In-Region Postgraduate Scholarship at the International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya; Norwegian Agency for Development Cooperation; Section for research, innovation, and higher education grant; European Union(European Commission); Biovision Foundation Switzerland; International Atomic Energy Agency (IAEA), through the CRP on "Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constraints to SIT Application and International Trade through icipe; icipe core - United Kingdom's Foreign, Commonwealth and Development Office (FCDO); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Democratic Republic of Ethiopia; Government of the Republic of Kenya	The senior author K. M. Z was supported through the Dissertation Research Internship Programme (DRIP), In-Region Postgraduate Scholarship at the International Centre of Insect Physiology and Ecology (icipe), Nairobi, Kenya. We gratefully acknowledge the financial support for this research by the following organizations and agencies; Norwegian Agency for Development Cooperation, the Section for research, innovation, and higher education grant number RAF-3058 KEN-18/0005; European Union Funded Integrated Biological Control Applied Research Program (IBCARP)-Fruit Fly Component (Grant Contract No. DCI-FOOD/2014/346-739) and Biovision Foundation Switzerland [BV PH-07/2016-2018 and DPP_005 (01/2019-12/2021) and International Atomic Energy Agency (IAEA), through the CRP on "Resolution of Cryptic Species Complexes of Tephritid Pests to Overcome Constraints to SIT Application and International Trade through icipe. We also gratefully acknowledge the support of icipe core funding provided by United Kingdom's Foreign, Commonwealth and Development Office (FCDO); the Swedish International Development Cooperation Agency (Sida); the Swiss Agency for Development and Cooperation (SDC); the Federal Democratic Republic of Ethiopia; and the Government of the Republic of Kenya. The Agricultural Research Corporation also provided support in the form of salaries to one of the coauthors [MEEM]. However, all the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Therefore, the views expressed herein do not necessarily reflect the official opinion of the donors. The specific roles of these authors are articulated in the `author contributions' section.	Abdelaal M, 2019, ECOL INFORM, V50, P68, DOI 10.1016/j.ecoinf.2019.01.003; Adeva JJG, 2012, ECOL MODEL, V227, P93, DOI 10.1016/j.ecolmodel.2011.11.026; Allwood AJ, 1999, RAFFLES B ZOOL, P1; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Anonymous, 2010, Bulletin OEPP, V40, P390, DOI 10.1111/j.1365-2338.2010.02421.x; [Anonymous], 2005, Bulletin OEPP/EPPO Bulletin, V35, P371; [Anonymous], 2016, NUCL ACIDS RES, V44, pD7; [Anonymous], 2013, EC J WATCH, V10, pA1; Biber-Freudenberger L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153237; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Breiner FT, 2015, METHODS ECOL EVOL, V6, P1210, DOI 10.1111/2041-210X.12403; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; CABI, 2018, INV SPEC COMP DAT 17; CAREY J R, 1989, California Agriculture, V43, P38; Carrasco Torrecilla LR, 2009, MODELLING PEST RISK, DOI [10.1186/1471-2458-9-48, DOI 10.1186/1471-2458-9-48]; Collins WJ, 2011, GEOSCI MODEL DEV, V4, P1051, DOI 10.5194/gmd-4-1051-2011; Coro G, 2018, ECOL MODEL, V371, P37, DOI 10.1016/j.ecolmodel.2018.01.007; De Meyer M, 2007, INVASIVE FRUIT FLY P; Delrio G., 2012, Acta Horticulturae, P557; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; dos Santos LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174318; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Duyck PF, 2004, B ENTOMOL RES, V94, P89, DOI 10.1079/BER2003285; El-Samea S. A. A., 2006, Egyptian Journal of Agricultural Research, V84, P61; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Fujino J, 2006, ENERG J, P343, DOI 10.5547/issn0195-6574-ej-volsi2006-nosi3-17; GBIF.org, 2018, OCC BACTR ZON; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hijioka Y., 2008, J GLOBAL ENV ENG, V13, P97; Hijmans R, 2006, WORLDCLIM GLOBAL CLI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kapoor V. C., 1993, INDIAN FRUIT FLIES I; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Marchioro CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166142; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Morales NS, 2017, PEERJ, V5, DOI 10.7717/peerj.3093; Nathan R, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P187; Ni WL, 2012, B ENTOMOL RES, V102, P173, DOI 10.1017/S0007485311000538; O'Donnell M.S., 2012, US GEOLOGICAL SURVEY, V691, P10, DOI [DOI 10.3133/DS691, 10.1016/j.mimet.2011.04.001]; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips S.J., 2018, MAXENT SOFTWARE MODE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ., 2017, MAXENT SOFTWARE MODE; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pitt JP, 2008, THESIS; Qureshi ZA, 1975, P S STER PRINC INS C, P201; R Development Core Team, 2009, R LANG ENV STAT COMP; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Rauf I., 2013, African Journal of Agricultural Research, V8, P1300; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y; Richard K, 2018, ISPRS INT J GEO-INF, V7, DOI 10.3390/ijgi7110429; Robinet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043366; RUDD WG, 1985, J ECON ENTOMOL, V78, P295, DOI 10.1093/jee/78.2.295; Sarwar M., 2014, J AGR ALLIED SCI, V3, P36; Senger S.E., 2007, THESIS; Shigesada N., 1997, BIOL INVASIONS THEOR; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; Spaugy L., 1988, Citrograph, V73, P168; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Stonehouse JM, 1998, CROP PROT, V17, P159, DOI 10.1016/S0261-2194(97)00091-4; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Usery E.L., 2004, J GEOGR SYST, V6, P289, DOI [10.1007/s10109-004-0138-z, DOI 10.1007/S10109-004-0138-Z]; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Venette RC, 2015, CABI INVASIVE SER, V7, P1, DOI 10.1079/9781780643946.0001; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wei T, 2017, R PACKAGE CORRPLOT V; White I.M., 1992, P1; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yonow T, 2017, J PEST SCI, V90, P459, DOI 10.1007/s10340-016-0801-4; You L, 2018, 2017 SPATIAL PRODUCT, V2017	78	11	11	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243047	10.1371/journal.pone.0243047	http://dx.doi.org/10.1371/journal.pone.0243047			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362266	gold, Green Published			2022-12-27	WOS:000603071600033
J	Muller, A; Corbeil, P				Muller, Antoine; Corbeil, Philippe			Back loading estimation during team handling: Is the use of only motion data sufficient?	PLOS ONE			English	Article							GROUND REACTION FORCES; HUMAN JOINT MOTION; INVERSE DYNAMICS; ISB RECOMMENDATION; SPINAL LOADS; KINECT DATA; VALIDATION; PARAMEDICS; MOMENT; DEFINITIONS	Analyzing back loading during team manual handling tasks requires the measurement of external contacts and is thus limited to standardized tasks. This paper evaluates the possibility of estimating L5/S1 joint moments based solely on motion data. Ten subjects constituted five two-person teams and handling tasks were analyzed with four different box configurations. Three prediction methods for estimating L5/S1 joint moments were evaluated by comparing them to a gold standard using force platforms: one used only motion data, another used motion data and the traction/compression force applied to the box and one used motion data and the ground reaction forces of one team member. The three prediction methods were based on a contact model with an optimization-based method. Using only motion data did not allow an accurate estimate due to the traction/compression force applied by each team member, which affected L5/S1 joint moments. Back loading can be estimated using motion data and the measurement of the traction/compression force with relatively small errors, comparable to the uncertainty levels reported in other studies. The traction/compression force can be obtained directly with a force measurement unit built into the object to be moved or indirectly by using force platforms on which one of the two handlers stands during the handling task. The use of the proposed prediction methods allows team manual handling tasks to be analyzed in various realistic contexts, with team members who have different anthropometric measurements and with different box characteristics.	[Muller, Antoine] Inst Rech Robert Sauve Sante & Secur Travail IRSS, Montreal, PQ, Canada; [Muller, Antoine] Univ Claude Bernard Lyon 1, Univ Gustave Eiffel, Univ Lyon, LBMC,UMR T 9406, Lyon, France; [Corbeil, Philippe] Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada; [Corbeil, Philippe] Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel; Laval University; Laval University	Muller, A (corresponding author), Inst Rech Robert Sauve Sante & Secur Travail IRSS, Montreal, PQ, Canada.; Muller, A (corresponding author), Univ Claude Bernard Lyon 1, Univ Gustave Eiffel, Univ Lyon, LBMC,UMR T 9406, Lyon, France.; Corbeil, P (corresponding author), Univ Laval, Fac Med, Dept Kinesiol, Quebec City, PQ, Canada.; Corbeil, P (corresponding author), Ctr Integre Univ Sante & Serv Sociaux Capitale Na, Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.	antoine.muller@univ-lyon1.fr; philippe.corbeil@kin.ulaval.ca		Muller, Antoine/0000-0003-2606-1429	IRSST; Natural Sciences and Engineering Research Council of Canada (NSERC)	IRSST; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was partly supported by a scholarship program from the IRSST to AM and supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton D, 2013, J ORTHOP SPORT PHYS, V43, P232, DOI 10.2519/jospt.2013.4249; Barrett RS, 2005, HUM FACTORS ERGONOM, V15, P293, DOI 10.1002/hfm.20027; Chaffin D., 2006, OCCUPATIONAL BIOMECH, V2nd; Daynard D, 2001, APPL ERGON, V32, P199, DOI 10.1016/S0003-6870(00)00070-3; Dennis GJ, 2002, ERGONOMICS, V45, P671, DOI 10.1080/00140130210148537; Dumas R, 2007, J BIOMECH, V40, P543, DOI 10.1016/j.jbiomech.2006.02.013; Elford W, 2000, APPL ERGON, V31, P185, DOI 10.1016/S0003-6870(99)00026-5; Faber GS, 2018, J BIOMECH, V70, P235, DOI 10.1016/j.jbiomech.2017.10.006; Faber GS, 2013, J BIOMECH, V46, P2736, DOI 10.1016/j.jbiomech.2013.07.030; Featherstone r, 2014, RIGID BODY DYNAMICS; Fluit R, 2014, J BIOMECH, V47, P2321, DOI 10.1016/j.jbiomech.2014.04.030; Fregly BJ, 2007, IEEE T BIO-MED ENG, V54, P1687, DOI 10.1109/TBME.2007.891934; Futamure S, 2017, J BIOMECH, V64, P85, DOI 10.1016/j.jbiomech.2017.09.005; Gallagher S, 2009, INT J IND ERGONOM, V39, P828, DOI 10.1016/j.ergon.2009.01.005; Hignett S, 2003, OCCUP ENVIRON MED, V60, DOI 10.1136/oem.60.9.e6; HOF AL, 1992, J BIOMECH, V25, P1209, DOI 10.1016/0021-9290(92)90076-D; Kingma I, 1996, HUM MOVEMENT SCI, V15, P833, DOI 10.1016/S0167-9457(96)00034-6; Lariviere C, 1999, HUM MOVEMENT SCI, V18, P573, DOI 10.1016/S0167-9457(99)00003-2; Larsen FG, 2020, ANN BIOMED ENG, V48, P805, DOI 10.1007/s10439-019-02409-8; Lavender SA, 2000, APPL ERGON, V31, P45, DOI 10.1016/S0003-6870(99)00027-7; Lavender SA, 2014, APPL ERGON, V45, P389, DOI 10.1016/j.apergo.2013.05.005; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Marras W.S., 1992, INT J IND ERGON, V9, P75, DOI [10.1016/0169-8141(92)90078-E, DOI 10.1016/0169-8141(92)90078-E]; Mehrizi R, 2019, J BIOMECH, V84, P87, DOI 10.1016/j.jbiomech.2018.12.022; Muller A, 2020, APPL ERGON, V82, DOI 10.1016/j.apergo.2019.102935; Muller A., 2019, J OPEN SOURCE SOFTWA, V4, P927, DOI [DOI 10.21105/JOSS.00927, 10.21105/joss.00927]; Muller A, 2020, IEEE T BIO-MED ENG, V67, P344, DOI 10.1109/TBME.2019.2913308; Muller A, 2017, MULTIBODY SYST DYN, V40, P177, DOI 10.1007/s11044-017-9566-7; Paskiewicz JK, 2007, INT J IND ERGONOM, V37, P93, DOI 10.1016/j.ergon.2006.10.015; Plamondon A, 1996, CLIN BIOMECH, V11, P101, DOI 10.1016/0268-0033(95)00043-7; Plantard P, 2017, INT J IND ERGONOM, V61, P71, DOI 10.1016/j.ergon.2017.05.010; Plantard P, 2017, APPL ERGON, V65, P562, DOI 10.1016/j.apergo.2016.10.015; Prairie J, 2017, APPL ERGON, V65, P112, DOI 10.1016/j.apergo.2017.06.005; Prairie J, 2014, APPL ERGON, V45, P895, DOI 10.1016/j.apergo.2013.11.006; Puchaud P, 2020, COMPUT METHOD BIOMEC, V23, P114, DOI 10.1080/10255842.2019.1705798; Rao G, 2006, J BIOMECH, V39, P1531, DOI 10.1016/j.jbiomech.2005.04.014; Ren L, 2008, J BIOMECH, V41, P2750, DOI 10.1016/j.jbiomech.2008.06.001; Robert-Lachaine X, 2020, ERGONOMICS, V63, P283, DOI 10.1080/00140139.2019.1612941; Robert-Lachaine X, 2017, MED BIOL ENG COMPUT, V55, P609, DOI 10.1007/s11517-016-1537-2; Sharp MA, 1997, HUM FACTORS, V39, P481, DOI 10.1518/001872097778827106; Skals S, 2017, MULTIBODY SYST DYN, V39, P175, DOI 10.1007/s11044-016-9537-4; Visser S, 2015, APPL ERGON, V50, P56, DOI 10.1016/j.apergo.2015.02.007; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244405	10.1371/journal.pone.0244405	http://dx.doi.org/10.1371/journal.pone.0244405			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351839	gold, Green Published			2022-12-27	WOS:000603071400019
J	Loveday, M; Hlangu, S; Furin, J				Loveday, Marian; Hlangu, Sindisiwe; Furin, Jennifer			"Take the treatment and be brave": Care experiences of pregnant women with rifampicin-resistant tuberculosis	PLOS ONE			English	Article							INTERVIEWS; CANCER; BURDEN	Background There are few data on the on the care experiences of pregnant women with rifampicin-resistant TB. Objective To describe the treatment journeys of pregnant women with RR-TB-including how their care experiences shape their identities-and identify areas in which tailored interventions are needed. Methods In this qualitative study in-depth interviews were conducted among a convenience sample from a population of pregnant women receiving treatment for RR-TB. This paper follows COREQ guidelines. A thematic network analysis using an inductive approach was performed to analyze the interview transcripts and notes. The analysis was iterative and a coding system developed which focused on the care experiences of the women and how these experiences affected their perceptions of themselves, their children, and the health care system in which treatment was received. Results Seventeen women were interviewed. The women described multiple challenges in their treatment journeys which required them to demonstrate sustained resilience (i.e. to "be brave"). Care experiences required them to negotiate seemingly contradictory identities as both new mothers-"givers of life"-and RR-TB patients facing a complicated and potentially deadly disease. In terms of their "pregnancy identity" and "RR-TB patient identity" that emerged as part of their care experiences, four key themes were identified that appeared to have elements that were contradictory to one another (contradictory areas). These included: 1) the experience of physical symptoms or changes; 2) the experience of the "mothering" and "patient" roles; 3) the experience of the care they received for their pregnancy and their RR-TB; and 4) the experience of community engagement. There were also three areas that overlapped with both roles and during which identity was negotiated/reinforced and they included: 1) faith; 2) socioeconomic issues; and 3) long-term concerns over the child's health. At times, the health care system exacerbated these challenges as the women were not given the support they needed by health care providers who were ill-informed or angry and treated the women in a discriminatory fashion. Left to negotiate this confusing time period, the women turned to faith, their own mothers, and the fathers of their unborn children. Conclusion The care experiences of the women who participated in this study highlight several gaps in the current health care system that must be better addressed in both TB and perinatal services in order to improve the therapeutic journeys for pregnant women with RR-TB and their children. Suggestions for optimizing care include the provision of integrated services, including specialized counseling as well as training for health care providers; engagement of peer support networks; provision of socioeconomic support; long-term medical care/follow-up for children born to women who were treated for RR-TB; and inclusion of faith-based services in the provision of care.	[Loveday, Marian; Hlangu, Sindisiwe] South African Med Res Council, HIV Prevent Res Unit, Kwa Zulu, South Africa; [Loveday, Marian] Univ KwaZulu Natal, Doris Duke Med Res Inst, CAPRISA MRC HIV TB Pathogenesis & Treatment Res U, Durban, South Africa; [Furin, Jennifer] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA	South African Medical Research Council; University of Kwazulu Natal; Harvard University; Harvard Medical School	Loveday, M (corresponding author), South African Med Res Council, HIV Prevent Res Unit, Kwa Zulu, South Africa.; Loveday, M (corresponding author), Univ KwaZulu Natal, Doris Duke Med Res Inst, CAPRISA MRC HIV TB Pathogenesis & Treatment Res U, Durban, South Africa.	marian.loveday@mrc.ac.za	Loveday, Marian/M-8016-2013	Loveday, Marian/0000-0001-9205-9314	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the South African Medical Research Council. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; Alvesson M, 2008, ORGANIZATION, V15, P5, DOI 10.1177/1350508407084426; Anderson GD, 1997, SEMIN PERINATOL, V21, P328, DOI 10.1016/S0146-0005(97)80076-6; Attride-Stirling J., 2001, QUAL RES, V1, P385, DOI [DOI 10.1177/146879410100100307, https://doi.org/10.1177/146879410100100307]; Barbour V, 2007, PLOS MED, V4, P1283, DOI 10.1371/journal.pmed.0040258; Bergeron Kimberly G, 2004, Expert Rev Anti Infect Ther, V2, P589, DOI 10.1586/14787210.2.4.589; Bucyibaruta BJ, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3625-5; COHEN RC, 1946, BRIT J TUBERC DIS CH, V40, P10, DOI 10.1016/S0366-0869(46)80029-7; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Drobac PC, 2005, CLIN INFECT DIS, V40, P1689, DOI 10.1086/430066; Dudnyk A, 2016, EUR RESPIR J, V48, DOI 10.1183/13993003.congress-2016.PA1912; Fernandez D, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/5896901; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gupta A, 2016, CLIN INFECT DIS, V62, P761, DOI 10.1093/cid/civ991; Hepner A, 2019, WORLD J ONCOL, V10, P28, DOI 10.14740/wjon1177; Human Sciences Research Council (HSRC), 2018, 5 S AFR NAT HIV PREV; Khan M, 2007, INT J TUBERC LUNG D, V11, P706; Long C., 2009, CONTRADICTING MATERN; Loveday M, 2021, CLIN INFECT DIS, V72, P1158, DOI 10.1093/cid/ciaa189; Loveday M, 2019, EMERG INFECT DIS, V25, P609, DOI 10.3201/eid2503.181571; Massyn N, 2020, DISTRICT HLTH BAROME; McLeish J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011499; Odayar J, 2018, INT J TUBERC LUNG D, V22, P760, DOI 10.5588/ijtld.17.0448; Odjidja EN, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3990-8; Palacios E, 2009, CLIN INFECT DIS, V48, P1413, DOI 10.1086/598191; Rees S, 2016, ASIA-PAC J ONCOL NUR, V3, P252, DOI 10.4103/2347-5625.189814; Salazar-Austin N, 2018, CLIN INFECT DIS, V66, P921, DOI 10.1093/cid/cix851; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Schnippel K, 2016, SAMJ S AFR MED J, V106, P30, DOI [10.7196/SAMJ.2016.v106i4.10205, 10.7196/samj.2016v106i4.10205]; Shin S, 2003, CLIN INFECT DIS, V36, P996, DOI 10.1086/374225; Shringarpure KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150849; Sobhy S, 2017, BJOG-INT J OBSTET GY, V124, P727, DOI 10.1111/1471-0528.14408; Sulis G, 2018, J OBSTET GYNAECOL CA, V40, P1003, DOI 10.1016/j.jogc.2018.04.041; Tabarsi P, 2011, INT J TUBERC LUNG D, V15, P547, DOI 10.5588/ijtld.10.0140; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Weld ED, 2018, CLIN PHARMACOL THER, V104, P1098, DOI 10.1002/cpt.1221; WHO, 2019, GLOB TUB REP, P1; World Health Organization, 2018, RAP COMM KEY CHANG T; Zumla A, 2014, LANCET GLOB HEALTH, V2, pE675, DOI 10.1016/S2214-109X(14)70338-9	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0242604	10.1371/journal.pone.0242604	http://dx.doi.org/10.1371/journal.pone.0242604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347448	Green Published, gold			2022-12-27	WOS:000603071100016
J	Vallabhajosyula, S; Kumar, V; Sundaragiri, PR; Cheungpasitporn, W; Bell, MR; Singh, M; Jaffe, AS; Barsness, GW				Vallabhajosyula, Saraschandra; Kumar, Vinayak; Sundaragiri, Pranathi R.; Cheungpasitporn, Wisit; Bell, Malcolm R.; Singh, Mandeep; Jaffe, Allan S.; Barsness, Gregory W.			Influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction in the United States	PLOS ONE			English	Article							HEALTH-INSURANCE STATUS; CARDIOGENIC SHOCK; MORTALITY; TRENDS	Background There are limited contemporary data on the influence of primary payer status on the management and outcomes of ST-segment elevation myocardial infarction (STEMI). Objective To assess the influence of insurance status on STEMI outcomes. Methods Adult (>18 years) STEMI admissions were identified using the National Inpatient Sample database (2000-2017). Expected primary payer was classified into Medicare, Medicaid, private, uninsured and others. Outcomes of interest included in-hospital mortality, use of coronary angiography and percutaneous coronary intervention (PCI), hospitalization costs, hospital length of stay and discharge disposition. Results Of the 4,310,703 STEMI admissions, Medicare, Medicaid, private, uninsured and other insurances were noted in 49.0%, 6.3%, 34.4%, 7.2% and 3.1%, respectively. Compared to the others, the Medicare cohort was older (75 vs. 53-57 years), more often female (46% vs. 20-36%), of white race, and with higher comorbidity (all p<0.001). The Medicare and Medicaid population had higher rates of cardiogenic shock and cardiac arrest. The Medicare cohort had higher in-hospital mortality (14.2%) compared to the other groups (4.1-6.7%), p<0.001. In a multivariable analysis (Medicare referent), in-hospital mortality was higher in uninsured (adjusted odds ratio (aOR) 1.14 [95% confidence interval {CI} 1.11-1.16]), and lower in Medicaid (aOR 0.96 [95% CI 0.94-0.99]; p = 0.002), privately insured (aOR 0.73 [95% CI 0.72-0.75]) and other insurance (aOR 0.91 [95% CI 0.88-0.94]); all p<0.001. Coronary angiography (60% vs. 77-82%) and PCI (45% vs. 63-70%) were used less frequently in the Medicare population compared to others. The Medicare and Medicaid populations had longer lengths of hospital stay, and the Medicare population had the lowest hospitalization costs and fewer discharges to home. Conclusions Compared to other types of primary payers, STEMI admissions with Medicare insurance had lower use of coronary angiography and PCI, and higher in-hospital mortality.	[Vallabhajosyula, Saraschandra; Bell, Malcolm R.; Singh, Mandeep; Jaffe, Allan S.; Barsness, Gregory W.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55902 USA; [Vallabhajosyula, Saraschandra] Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN 55902 USA; [Vallabhajosyula, Saraschandra] Mayo Clin, Ctr Clin & Translat Sci, Grad Sch Biomed Sci, Rochester, MN 55902 USA; [Vallabhajosyula, Saraschandra] Emory Univ, Sch Med, Dept Med, Sect Intervent Cardiol,Div Cardiovasc Med, Atlanta, GA 30322 USA; [Kumar, Vinayak] Mayo Clin, Dept Med, Rochester, MN USA; [Sundaragiri, Pranathi R.] Mayo Clin, Div Hosp Internal Med, Dept Med, Rochester, MN USA; [Cheungpasitporn, Wisit] Univ Mississippi, Sch Med, Dept Med, Div Nephrol, Jackson, MS 39216 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Emory University; Mayo Clinic; Mayo Clinic; University of Mississippi	Vallabhajosyula, S (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55902 USA.; Vallabhajosyula, S (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN 55902 USA.; Vallabhajosyula, S (corresponding author), Mayo Clin, Ctr Clin & Translat Sci, Grad Sch Biomed Sci, Rochester, MN 55902 USA.; Vallabhajosyula, S (corresponding author), Emory Univ, Sch Med, Dept Med, Sect Intervent Cardiol,Div Cardiovasc Med, Atlanta, GA 30322 USA.	Vallabhajosyula.Saraschandra@mayo.edu	Vallabhajosyula, Saraschandra/I-9707-2019	Vallabhajosyula, Saraschandra/0000-0002-1631-8238	Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]	Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Saraschandra Vallabhajosyula is supported by the Clinical and Translational Science Award (CTSA) Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, INTRO HCUP NATIONWID; [Anonymous], 2020, CIRCULATION, V141, pe59; [Anonymous], 2019, NIPPON GANKA GAKKAI, V123, P489; Berchick ER., 2019, HLTH INSURANCE COVER; Boyd K, 1996, ARCH INTERN MED, V156, P1821, DOI 10.1001/archinte.156.16.1821; Damluji AA, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013686; Egbe AC, INT J CARDIOLOGY, DOI 10.1016/j.ijcard.2019.09.001; Ellis L, 2018, JAMA ONCOL, V4, P317, DOI 10.1001/jamaoncol.2017.3846; Grosmaitre P, 2013, ARCH CARDIOVASC DIS, V106, P586, DOI 10.1016/j.acvd.2013.04.010; Khera R, 2017, JAMA-J AM MED ASSOC, V318, P2011, DOI 10.1001/jama.2017.17653; Khera R, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003846; Mahajan S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.17885; Mahmoud AN, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008235; Niedzwiecki MJ, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008152; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Panaich SS, 2016, AM J CARDIOL, V118, P950, DOI 10.1016/j.amjcard.2016.06.057; Pancholy S, 2017, AM J CARDIOL, V120, P1049, DOI 10.1016/j.amjcard.2017.06.041; Patel N, 2019, CIRC-CARDIOVASC QUAL, V12, DOI 10.1161/CIRCOUTCOMES.118.004971; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Saczynski Jane S, 2012, Clin Epidemiol, V4, P267, DOI 10.2147/CLEP.S32034; Vallabhajosyula S, AM J CARDIOLOGY, DOI 10.1016/j.amjcard.2020.03.015; Vallabhajosyula S, 2019, ASAIO J, DOI 10.1097/mat.0000000000001039; Vallabhajosyula S, 2019, EUROINTERVENTION, DOI 10.4244/eij-d-19-00226; Vallabhajosyula S, 2020, MAYO CLIN PROC, V95, P1916, DOI 10.1016/j.mayocp.2020.01.043; Vallabhajosyula S, 2020, INT J CARDIOL, V310, P9, DOI 10.1016/j.ijcard.2020.02.033; Vallabhajosyula S, 2020, ESC HEART FAIL, V7, P1234, DOI 10.1002/ehf2.12652; Vallabhajosyula S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030839; Vallabhajosyula S, 2020, AM HEART J, V223, P59, DOI 10.1016/j.ahj.2020.01.016; Vallabhajosyula S, 2020, MAYO CLIN PROC, V95, P611, DOI 10.1016/j.mayocp.2019.12.007; Vallabhajosyula S, 2020, CIRC-HEART FAIL, V13, DOI 10.1161/CIRCHEARTFAILURE.119.006661; Vallabhajosyula S, 2020, ASAIO J, V66, P980, DOI 10.1097/MAT.0000000000001125; Vallabhajosyula S, 2019, CIRC-HEART FAIL, V12, DOI 10.1161/CIRCHEARTFAILURE.119.005929; Vallabhajosyula S, 2020, RESUSCITATION, V148, P242, DOI 10.1016/j.resuscitation.2019.11.007; Vallabhajosyula S, 2020, CATHETER CARDIO INTE, V96, pE59, DOI 10.1002/ccd.28543; Vallabhajosyula S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222894; Vallabhajosyula S, 2019, IJC HEART VASC, V24, DOI 10.1016/j.ijcha.2019.100414; Vallabhajosyula S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0571-2; Vallabhajosyula S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.011954; Vallabhajosyula S, 2019, ESC HEART FAIL, V6, P874, DOI 10.1002/ehf2.12482; Vallabhajosyula S, 2019, AM J CARDIOL, V124, P491, DOI 10.1016/j.amjcard.2019.05.038; Vallabhajosyula S, 2019, JACC-HEART FAIL, V7, P469, DOI 10.1016/j.jchf.2018.12.007; Vallabhajosyula S, 2019, J AM COLL CARDIOL, V73, P1781, DOI 10.1016/j.jacc.2019.01.053; Vallabhajosyula S, 2019, INT J CARDIOL, V285, P6, DOI 10.1016/j.ijcard.2019.03.008; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010193; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009160; Vallabhajosyula S, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006930; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009608; Woolhandler S, 2017, ANN INTERN MED, V167, P424, DOI 10.7326/M17-1403	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0243810	10.1371/journal.pone.0243810	http://dx.doi.org/10.1371/journal.pone.0243810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PI8CZ	33338071	Green Published, gold			2022-12-27	WOS:000601313500017
J	Martin, MJ; Zain, NMM; Hearson, G; Rivett, DW; Koller, G; Wooldridge, DJ; Rose, G; Gharbia, SE; Forbes, B; Bruce, KD; Harrison, TW				Martin, Matthew J.; Zain, Nur Masirah M.; Hearson, Glenn; Rivett, Damian W.; Koller, Garrit; Wooldridge, David J.; Rose, Graham; Gharbia, Saheer E.; Forbes, Ben; Bruce, Kenneth D.; Harrison, Tim W.			The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids	PLOS ONE			English	Article							RISK; PNEUMONIA; SPUTUM; QUESTIONNAIRE; IMPACT	Background Inhaled corticosteroids (ICS) are the mainstay of asthma treatment, but evidence suggests a link between ICS usage and increased rates of respiratory infections. We assessed the composition of the asthmatic airways microbiome in asthma patients taking low and high dose ICS and the stability of the microbiome over a 2 week period. Methods We prospectively recruited 55 individuals with asthma. Of these, 22 were on low-dose ICS and 33 on high-dose ICS (16 on budesonide, 17 on fluticasone propionate). Sputum from each subject underwent DNA extraction, amplification and 16S rRNA gene sequencing of the bacterial component of the microbiome. 19 subjects returned for further sputum induction after 24 h and 2 weeks. Results A total of 5,615,037 sequencing reads revealed 167 bacterial taxa in the asthmatic airway samples, with the most abundant being Streptococcus spp. No significant differences in sputum bacterial load or overall community composition were seen between the low- and high-dose ICS groups. However, Streptococcus spp. showed significantly higher relative abundance in subjects taking low-dose ICS (p = 0.002). Haemophilus parainfluenzae was significantly more abundant in subjects on high-dose fluticasone propionate than those on high-dose budesonide (p = 0.047). There were no statistically significant changes in microbiota composition over a 2-week period. Discussion Whilst no significant differences were observed between the low- and high-dose ICS groups, increased abundance of the potential pathogen H. parainfluenzae was observed in patients taking high-dose fluticasone propionate compared to those taking high-dose budesonide. The microbiota were stable over fourteen days, providing novel evidence of the established community of bacteria in the asthmatic airways.	[Martin, Matthew J.; Hearson, Glenn; Harrison, Tim W.] Univ Nottingham, Nottingham City Hosp, Nottingham Resp Res Unit, Asthma Ctr, Nottingham, England; [Zain, Nur Masirah M.; Rivett, Damian W.; Koller, Garrit; Forbes, Ben; Bruce, Kenneth D.] Kings Coll London, Inst Pharmaceut Sci, Sch Canc & Pharmaceut Sci, Fac Life Sci & Med, London, England; [Wooldridge, David J.; Rose, Graham; Gharbia, Saheer E.] Publ Hlth England, Natl Infect Serv, London, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of London; King's College London; Public Health England	Bruce, KD (corresponding author), Kings Coll London, Inst Pharmaceut Sci, Sch Canc & Pharmaceut Sci, Fac Life Sci & Med, London, England.	Kenneth.bruce@kcl.ac.uk	Rivett, Damian/H-6491-2019	Rivett, Damian/0000-0002-1852-6137; Martin, Matthew/0000-0002-6942-5651; Hearson, Glenn/0000-0002-5815-3996	AstraZeneca	AstraZeneca(AstraZeneca)	This investigator-initiated study was funded by an unrestricted research grant from AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bansal Vikas, 2015, Acta Med Acad, V44, P135, DOI 10.5644/ama2006-124.141; Birring SS, 2003, THORAX, V58, P339, DOI 10.1136/thorax.58.4.339; British Thoracic Society, 2019, BRIT GUID MAN ASTHM; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Cox MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170622; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Durack J, 2017, J ALLERGY CLIN IMMUN, V140, P63, DOI 10.1016/j.jaci.2016.08.055; Global Asthma Network, GLOB ASTHM REP 2018; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; HPA, 2011, DEV IN HOUS HLTH PRO; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Janson C, 2017, INT J CHRONIC OBSTR, V12, P3055, DOI 10.2147/COPD.S143656; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kew KM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010115.pub2; Kochling T, 2017, INT MICROBIOL, V20, P11, DOI 10.2436/20.1501.01.281; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Marsh RL, 2018, PNEUMONIA, V10, DOI 10.1186/s41479-018-0051-8; McKeever T, 2013, CHEST, V144, P1788, DOI 10.1378/chest.13-0871; Mukherjee M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0657-8; Murphy EC, 2013, FEMS MICROBIOL REV, V37, P520, DOI 10.1111/1574-6976.12005; Paggiaro PL, 2002, EUR RESPIR J, V20, p3S, DOI 10.1183/09031936.02.00000302; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; Qian CJ, 2017, BRIT J CLIN PHARMACO, V83, P2077, DOI 10.1111/bcp.13295; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Rogers GB, 2013, J CLIN MICROBIOL, V51, P4029, DOI 10.1128/JCM.02164-13; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Simpson JL, 2016, EUR RESPIR J, V47, P792, DOI 10.1183/13993003.00405-2015; Slater M, 2014, THORAX, V69, P673, DOI 10.1136/thoraxjnl-2013-204517; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Taylor SL, 2019, AM J RESP CRIT CARE, V200, P309, DOI 10.1164/rccm.201809-1739OC; Taylor SL, 2018, J ALLERGY CLIN IMMUN, V141, P94, DOI 10.1016/j.jaci.2017.03.044; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Wood LG, 2010, FREE RADICAL RES, V44, P146, DOI 10.3109/10715760903362576; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zhang QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152724	38	7	7	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244681	10.1371/journal.pone.0244681	http://dx.doi.org/10.1371/journal.pone.0244681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378384	gold, Green Accepted, Green Published			2022-12-27	WOS:000605651300036
J	Ehlen, F; Al-Fatly, B; Kuhn, AA; Klostermann, F				Ehlen, Felicitas; Al-Fatly, Bassam; Kuehn, Andrea A.; Klostermann, Fabian			Impact of deep brain stimulation of the subthalamic nucleus on natural language in patients with Parkinson's disease	PLOS ONE			English	Article							VERBAL FLUENCY; SENTENCE COMPREHENSION; ELECTRICAL-STIMULATION; SYNTAX COMPREHENSION; NONDEMENTED PATIENTS; COGNITIVE DEFICITS; CONNECTIVITY; ACTIVATION; VOLUME; INTEGRATION	Background In addition to the typical motor symptoms, a majority of patients suffering from Parkinson's disease experience language impairments. Deep Brain Stimulation of the subthalamic nucleus robustly reduces motor dysfunction, but its impact on language skills remains ambiguous. Method To elucidate the impact of subthalamic deep brain stimulation on natural language production, we systematically analyzed language samples from fourteen individuals (three female / eleven male, average age 66.43 +/- 7.53 years) with Parkinson's disease in the active (ON) versus inactive (OFF) stimulation condition. Significant ON-OFF differences were considered as stimulation effects. To localize their neuroanatomical origin within the subthalamic nucleus, they were correlated with the volume of tissue activated by therapeutic stimulation. Results Word and clause production speed increased significantly under active stimulation. These enhancements correlated with the volume of tissue activated within the associative part of the subthalamic nucleus, but not with that within the dorsolateral motor part, which again correlated with motor improvement. Language error rates were lower in the ON vs. OFF condition, but did not correlate with electrode localization. No significant changes in further semantic or syntactic language features were detected in the current study. Conclusion The findings point towards a facilitation of executive language functions occurring rather independently from motor improvement. Given the presumed origin of this stimulation effect within the associative part of the subthalamic nucleus, this could be due to co-stimulation of the prefrontal-subthalamic circuit.	[Ehlen, Felicitas; Al-Fatly, Bassam; Kuehn, Andrea A.; Klostermann, Fabian] Humboldt Univ, Dept Neurol, Berlin, Germany; [Ehlen, Felicitas; Al-Fatly, Bassam; Kuehn, Andrea A.; Klostermann, Fabian] Charite, Berlin Inst Hlth, Berlin, Germany; [Ehlen, Felicitas] Jud Krankenhaus Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany; [Kuehn, Andrea A.; Klostermann, Fabian] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany; [Kuehn, Andrea A.] Humboldt Univ, Neurocure Cluster Excellence, Berlin, Germany; [Kuehn, Andrea A.] Humboldt Univ, Bernstein Ctr Computat Neurosci, Berlin, Germany; [Kuehn, Andrea A.] Deutsch Zentrum Neurodegenerat Erkrankungen, Berlin, Germany	Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Humboldt University of Berlin; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Ehlen, F (corresponding author), Humboldt Univ, Dept Neurol, Berlin, Germany.; Ehlen, F (corresponding author), Charite, Berlin Inst Hlth, Berlin, Germany.; Ehlen, F (corresponding author), Jud Krankenhaus Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany.	felicitas.ehlen@charite.de	Al-Fatly, Bassam/AAH-7004-2019	Al-Fatly, Bassam/0000-0003-0067-6177; Kuhn, Andrea A./0000-0002-4134-9060	German Research Foundation [Kl-1276/5]; Charite' -Universita<spacing diaeresis>tsmedizin Berlin; German Academic Exchange Service -DAAD	German Research Foundation(German Research Foundation (DFG)); Charite' -Universita<spacing diaeresis>tsmedizin Berlin; German Academic Exchange Service -DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This study was supported by the German Research Foundation (Kl-1276/5 in Clinical Research Group 247) and the Open Access Publication Fund of Charite ' -Universita<spacing diaeresis>tsmedizin Berlin. Author BA has received a Doctoral Research Grant from the German Academic Exchange Service -DAAD. AAK has received honoraria for advisory activities from Medtronic, Boston Scientific, Abbott, Ipsen and Teva. FK has received honoraria for advisory activities from CSL Behring and Theranexus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulSabur NY, 2014, CORTEX, V57, P107, DOI 10.1016/j.cortex.2014.01.017; Accolla EA, 2016, BRAIN, V139, P2503, DOI 10.1093/brain/aww182; Ahn Ji Sook, 2014, J Med Speech Lang Pathol, V21, P179; Al-Fatly B, 2019, BRAIN, V142, P3086, DOI 10.1093/brain/awz236; ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Amunts K, 2015, BRAIN MAPPING ENCY R, V2, P177; Angwin AJ, 2006, J NEUROLINGUIST, V19, P239, DOI 10.1016/j.jneuroling.2005.11.004; Astrom M, 2015, IEEE T BIO-MED ENG, V62, P664, DOI 10.1109/TBME.2014.2363494; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Avecillas-Chasin JM, 2019, NEUROSURGERY, V85, pE294, DOI 10.1093/neuros/nyy633; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Barbas H, 2013, BRAIN LANG, V126, P49, DOI 10.1016/j.bandl.2012.10.001; Batens K, 2015, BRAIN LANG, V147, P76, DOI 10.1016/j.bandl.2015.06.002; Batens K, 2014, J NEUROLINGUIST, V32, P31, DOI 10.1016/j.jneuroling.2014.07.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertella L, 2002, BRAIN COGNITION, V48, P277, DOI 10.1006/brcg.2001.1361; BUTTERWORTH B, 1979, BRAIN LANG, V8, P133, DOI 10.1016/0093-934X(79)90046-4; Caligiore D, 2016, NPJ PARKINSONS DIS, V2, DOI 10.1038/npjparkd.2016.25; Castner JE, 2008, J NEUROL NEUROSUR PS, V79, P700, DOI 10.1136/jnnp.2007.118729; Castner JE, 2007, NEUROPSYCHOLOGIA, V45, P3167, DOI 10.1016/j.neuropsychologia.2007.06.019; Chung GH, 2005, AM J NEURORADIOL, V26, P1819; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cohen J., 1988, STAT POWER ANAL BEHA, P273; Coulthard EJ, 2012, BRAIN, V135, P3721, DOI 10.1093/brain/aws273; CROSSON B, 1985, BRAIN LANG, V25, P257, DOI 10.1016/0093-934X(85)90085-9; Dembek TA, 2017, NEUROIMAGE-CLIN, V13, P164, DOI 10.1016/j.nicl.2016.11.019; Duarscheid C., 2012, SYNTAX GRUNDLAGEN TH; Edlow BL, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0254-8; Ehlen F, 2016, NEUROPSYCHOLOGIA, V89, P74, DOI 10.1016/j.neuropsychologia.2016.05.028; Ehlen F, 2014, BRAIN LANG, V134, P23, DOI 10.1016/j.bandl.2014.04.002; Ehlen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079247; Emmi A, 2020, FRONT NEUROANAT, V14, DOI 10.3389/fnana.2020.00013; Ewert S, 2018, NEUROIMAGE, V170, P271, DOI 10.1016/j.neuroimage.2017.05.015; Fenoy AJ, 2017, J NEUROSURG, V126, P2017, DOI 10.3171/2016.5.JNS16243; Fine EM, 2011, J CLIN EXP NEUROPSYC, V33, P226, DOI 10.1080/13803395.2010.507185; Fox SH, 2018, MOVEMENT DISORD, V33, P1248, DOI 10.1002/mds.27372; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Garrett MF, 1978, PERCEPTION, V8, P611; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Grande M, 2006, SPRACHE-STIMME-GEHOR, V30, P179, DOI 10.1055/s-2006-951756; Greenhouse I, 2013, NEUROPSYCHOLOGIA, V51, P1302, DOI 10.1016/j.neuropsychologia.2013.03.008; Grossman M, 2003, NEUROLOGY, V60, P775, DOI 10.1212/01.WNL.0000044398.73241.13; GROSSMAN M, 1991, NEUROLOGY, V41, P1620; Gungor A, 2019, J NEUROSURG, V130, P716, DOI 10.3171/2017.10.JNS171513; Hall D, 2011, INT J NEUROSCI, V121, P254, DOI 10.3109/00207454.2010.550389; Hancu I, 2019, J MAGN RESON IMAGING, V49, P1736, DOI 10.1002/jmri.26321; Haynes WIA, 2013, J NEUROSCI, V33, P4804, DOI 10.1523/JNEUROSCI.4674-12.2013; Hemm S, 2005, J NEUROSURG, V103, P949, DOI 10.3171/jns.2005.103.6.0949; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Hershey T, 2004, NEUROLOGY, V62, P1110, DOI 10.1212/01.WNL.0000118202.19098.10; Hershey T, 2010, BRAIN, V133, P3625, DOI 10.1093/brain/awq256; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; Hochstadt J, 2006, BRAIN LANG, V97, P243, DOI 10.1016/j.bandl.2005.10.011; Holtgraves T., 2013, ADV PARKINSONS DIS, DOI [10.4236/apd.2013.21006, DOI 10.4236/APD.2013.21006]; Holtgraves T, 2010, BRAIN COGNITION, V72, P189, DOI 10.1016/j.bandc.2009.08.004; Homer MA, 2012, NEUROMODULATION, V15, P238, DOI 10.1111/j.1525-1403.2012.00441.x; Horn A, 2019, NEUROIMAGE, V184, P293, DOI 10.1016/j.neuroimage.2018.08.068; Horn A, 2017, ANN NEUROL, V82, P67, DOI 10.1002/ana.24974; Houvenaghel JF, 2016, NEUROPSYCHOLOGIA, V91, P519, DOI 10.1016/j.neuropsychologia.2016.09.015; Hussmann K, 2012, CLIN LINGUIST PHONET, V26, P661, DOI 10.3109/02699206.2012.683672; ILLES J, 1988, BRAIN LANG, V33, P146, DOI 10.1016/0093-934X(88)90059-4; Irmen F, 2019, MOVEMENT DISORD, V34, P366, DOI 10.1002/mds.27576; Irmen F, 2017, SOC COGN AFFECT NEUR, V12, P1594, DOI 10.1093/scan/nsx090; Jahanshahi M, 2000, BRAIN, V123, P1142, DOI 10.1093/brain/123.6.1142; Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008; Kelley R, 2018, BRAIN, V141, P205, DOI 10.1093/brain/awx300; Klaus J, 2018, NEUROSCIENCE, V377, P197, DOI 10.1016/j.neuroscience.2018.03.002; Kuncel AM, 2008, CLIN NEUROPHYSIOL, V119, P2148, DOI 10.1016/j.clinph.2008.02.025; Labache L, 2019, BRAIN STRUCT FUNCT, V224, P859, DOI 10.1007/s00429-018-1810-2; Levesque JC, 2005, MOVEMENT DISORD, V20, P574, DOI 10.1002/mds.20374; LIEBERMAN P, 1992, BRAIN LANG, V43, P169, DOI 10.1016/0093-934X(92)90127-Z; LIEBERMAN P, 1990, J NERV MENT DIS, V178, P360, DOI 10.1097/00005053-199006000-00003; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Madler B, 2012, AM J NEURORADIOL, V33, P1072, DOI 10.3174/ajnr.A2906; Maks C B, 2009, J Neurol Neurosurg Psychiatry, V80, P659, DOI 10.1136/jnnp.2007.126219; Mallet L, 2007, P NATL ACAD SCI USA, V104, P10661, DOI 10.1073/pnas.0610849104; Manes JL, 2014, HUM BRAIN MAPP, V35, P3499, DOI 10.1002/hbm.22417; McIntyre CC, 2010, NEUROBIOL DIS, V38, P329, DOI 10.1016/j.nbd.2009.09.022; Mikos A, 2011, Neuroimage, V54 Suppl 1, pS238, DOI 10.1016/j.neuroimage.2010.03.068; Mosley PE, 2020, BRAIN, V143, P2235, DOI 10.1093/brain/awaa148; Murray LL, 2000, J SPEECH LANG HEAR R, V43, P1350, DOI 10.1044/jslhr.4306.1350; Nadeau SE, 1997, BRAIN LANG, V58, P355, DOI 10.1006/brln.1997.1707; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Neumann WJ, 2019, NEUROTHERAPEUTICS, V16, P105, DOI 10.1007/s13311-018-00705-0; Neumann WJ, 2018, BRAIN, V141, P2655, DOI 10.1093/brain/awy206; Obeso I, 2012, BEHAV NEUROL, V25, P111, DOI 10.1155/2012/673610; Pennebaker J. W., 2007, LIWC2007 MANUAL, P1; Peran P, 2003, MOVEMENT DISORD, V18, P150, DOI 10.1002/mds.10306; Piatt AL, 1999, J CLIN EXP NEUROPSYC, V21, P435, DOI 10.1076/jcen.21.4.435.885; Pillon B, 2000, NEUROLOGY, V55, P411, DOI 10.1212/WNL.55.3.411; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Rektor I, 2015, CLIN NEUROPHYSIOL, V126, P653, DOI 10.1016/j.clinph.2014.10.156; Scangos KW, 2018, BRAIN STIMUL, V11, P456, DOI 10.1016/j.brs.2017.11.014; Signorini M, 2006, MOVEMENT DISORD, V21, P467, DOI 10.1002/mds.20718; Troche MS, 2012, APPL PSYCHOLINGUIST, V33, P225, DOI 10.1017/S0142716411000336; Van Lier S, 2016, ACTA NEUROL BELG, V116, P163, DOI 10.1007/s13760-015-0546-5; Vassal F, 2020, BRIT J NEUROSURG, V34, P187, DOI 10.1080/02688697.2019.1701630; Volkmann J, 2006, MOVEMENT DISORD, V21, pS284, DOI 10.1002/mds.20961; Vorwerk J, 2014, NEUROIMAGE, V100, P590, DOI 10.1016/j.neuroimage.2014.06.040; Walenski M, 2019, HUM BRAIN MAPP, V40, P2275, DOI 10.1002/hbm.24523; Wallesch C-W., 1988, APHASIA, P256; Walsh B, 2011, J SPEECH LANG HEAR R, V54, P787, DOI 10.1044/1092-4388(2010/09-0085); Weintraub DB, 2013, REV NEUROSCIENCE, V24, P125, DOI 10.1515/revneuro-2012-0075; WESTON AD, 1989, J SPEECH HEAR RES, V32, P755, DOI 10.1044/jshr.3204.755; Witt K, 2004, ARCH NEUROL-CHICAGO, V61, P697, DOI 10.1001/archneur.61.5.697; Wojtecki L, 2006, ARCH NEUROL-CHICAGO, V63, P1273, DOI 10.1001/archneur.63.9.1273; Wojtecki L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024589; York MK, 2009, J NEUROL SCI, V287, P159, DOI 10.1016/j.jns.2009.08.003; Zanini S, 2003, NEUROREPORT, V14, P511, DOI 10.1097/01.wnr.0000058775.36017.86; Zanini S, 2009, PARKINSONISM RELAT D, V15, P606, DOI 10.1016/j.parkreldis.2008.12.003	111	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244148	10.1371/journal.pone.0244148	http://dx.doi.org/10.1371/journal.pone.0244148			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BU	33373418	Green Published, gold			2022-12-27	WOS:000603612300055
J	Evtushenko, EG; Bagrov, DV; Lazarev, VN; Livshits, MA; Khomyakova, E				Evtushenko, Evgeniy G.; Bagrov, Dmitry V.; Lazarev, Vassili N.; Livshits, Mikhail A.; Khomyakova, Elena			Adsorption of extracellular vesicles onto the tube walls during storage in solution	PLOS ONE			English	Article							HUMAN URINARY EXOSOMES; PLASMA EXOSOME; QUANTIFICATION; STABILITY; PROTOCOL; ULTRACENTRIFUGATION; BIOMARKERS; CELLS	Short term storage of extracellular vesicle (EV) solutions at +4 degrees C is a common practice, but the stability of EVs during this procedure has not been fully understood yet. Using nanoparticle tracking analysis, we have shown that EVs isolated from the conditioned medium of HT-29 cells exhibit a pronounced concentration decrease when stored in PBS in ordinary polypropylene tubes within the range of (0.5-2.1) x 10(10) particles/ml. EV losses reach 51 +/- 3% for 0.5 ml of EVs in Eppendorf 2 ml tube at 48 hours of storage at +4 degrees C. Around 2/3 of the observed losses have been attributed to the adsorption of vesicles onto tube walls. This result shows that the lower part (up to at least 2 x 10(10) particles/ml) of the practically relevant concentration range for purified EVs is prone to adsorption losses at +4 degrees C. Total particle losses could be reduced to 18-21% at 48 hours by using either Eppendorf Protein LoBind tubes or ordinary tubes with the surface blocked with bovine serum albumin or EVs. Reduction of losses to 15% has been shown for isolated EVs dissolved in the supernatant after 100 000 g centrifugation as a model of conditioned medium. Also, a previously unknown feature of diffusion-controlled adsorption was revealed for EVs. In addition to the decrease in particle count, this process causes the predominant losses of smaller particles.	[Evtushenko, Evgeniy G.] Lomonosov Moscow State Univ, Dept Chem Enzymol, Fac Chem, Moscow, Russia; [Bagrov, Dmitry V.] Lomonosov Moscow State Univ, Dept Bioengn, Fac Biol, Moscow, Russia; [Lazarev, Vassili N.; Khomyakova, Elena] Fed Med Biol Agcy, Fed Res & Clin Ctr Phys Chem Med, Moscow, Russia; [Livshits, Mikhail A.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia; [Livshits, Mikhail A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia	Lomonosov Moscow State University; Lomonosov Moscow State University; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Evtushenko, EG (corresponding author), Lomonosov Moscow State Univ, Dept Chem Enzymol, Fac Chem, Moscow, Russia.	evtushenko@enzyme.chem.msu.ru	Lazarev, Vassili/A-8313-2014; Evtushenko, Evgeniy G/O-1565-2014	Evtushenko, Evgeniy G/0000-0003-1264-4770; Lazarev, Vassili/0000-0003-0042-966X	Moscow State University [AAAA-A16-116052010081-5]	Moscow State University	This work was carried out within the project "Molecular design, structure-function analysis and regulation of enzyme systems, cellular structures, bionanomaterials: fundamental and applications in technology, medicine, environmental protection" of Moscow State University (AAAA-A16-116052010081-5). Transmission electron microscopy measurements were performed at the User Facilities Centre "Electron microscopy in life sciences" at Lomonosov Moscow State University. Scanning electron microscopy and atomic force microscopy measurements (S2 Appendix) were carried out using the equipment purchased on account of the Lomonosov MSU Development Program.	Akers JC, 2016, CANCER BIOMARK, V17, P125, DOI 10.3233/CBM-160609; [Anonymous], 2018, E2834122018 ASTM INT, DOI [10.1520/E2834-12R18, DOI 10.1520/E2834-12R18]; Baddela VS, 2016, APPL BIOCHEM BIOTECH, V178, P544, DOI 10.1007/s12010-015-1893-7; Baek R, 2016, J IMMUNOL METHODS, V438, P11, DOI 10.1016/j.jim.2016.08.007; Baranyai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145686; Barok M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4418-2; Bosch S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36162; Burns DA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086855, 10.1371/journal.pone.0090913]; Cheng YR, 2019, PROTEIN CELL, V10, P295, DOI 10.1007/s13238-018-0529-4; Cheruvanky A, 2007, AM J PHYSIOL-RENAL, V292, pF1657, DOI 10.1152/ajprenal.00434.2006; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Coumans FAW, 2017, CIRC RES, V120, P1632, DOI 10.1161/CIRCRESAHA.117.309417; Enderle D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136133; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Gaspar LS, 2020, MOL THER-METH CLIN D, V18, P723, DOI 10.1016/j.omtm.2020.07.012; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Greening DW, 2015, METHODS MOL BIOL, V1295, P179, DOI 10.1007/978-1-4939-2550-6_15; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hosoda S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010230; Jin Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2783-2; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Kenigsberg S, 2017, METHODS MOL BIOL, V1660, P321, DOI 10.1007/978-1-4939-7253-1_26; Koberle V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075184; Kumeda N, 2017, BIOL PHARM BULL, V40, P1183, DOI 10.1248/bpb.b16-00891; Kuravi SJ, 2019, INFLAMMATION, V42, P290, DOI 10.1007/s10753-018-0893-5; Kusuma GD, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01199; Lee M, 2016, BIOTECHNOL BIOPROC E, V21, P299, DOI 10.1007/s12257-015-0781-x; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Li M, 2015, METHODS, V87, P26, DOI 10.1016/j.ymeth.2015.03.009; Liu ZG, 2018, CELL STRESS CHAPERON, V23, P943, DOI 10.1007/s12192-018-0902-5; Livshits MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep21447; Livshts MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17319; Lorincz AM, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25465; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lv LL, 2013, INT J BIOL SCI, V9, P1021, DOI 10.7150/ijbs.6100; Maas SLN, 2015, J CONTROL RELEASE, V200, P87, DOI 10.1016/j.jconrel.2014.12.041; Malik ZA, 2013, AM J PHYSIOL-HEART C, V304, pH954, DOI 10.1152/ajpheart.00835.2012; Maroto R, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1359478; Matsumura S, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1579541; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Monguio-Tortajada Marta, 2019, Curr Protoc Stem Cell Biol, V49, pe82, DOI 10.1002/cpsc.82; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Oosthuyzen W, 2013, J PHYSIOL-LONDON, V591, P5833, DOI 10.1113/jphysiol.2013.264069; Park SJ, 2018, IN VITRO CELL DEV-AN, V54, P423, DOI 10.1007/s11626-018-0261-7; Pietrowska M, 2017, METHODS MOL BIOL, V1654, P291, DOI 10.1007/978-1-4939-7231-9_22; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Richter M, 2019, JOVE-J VIS EXP, DOI 10.3791/59584; Richter RP, 2006, LANGMUIR, V22, P3497, DOI 10.1021/la052687c; Silachev DN, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030258; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Stranska R, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-017-1374-6; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1535750; Urabe F, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay3051; van der Vlist EJ, 2012, NAT PROTOC, V7, P1311, DOI 10.1038/nprot.2012.065; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yamashita T, 2016, EUR J PHARM BIOPHARM, V98, P1, DOI 10.1016/j.ejpb.2015.10.017; Zaborowski MP, 2015, BIOSCIENCE, V65, P783, DOI 10.1093/biosci/biv084; Zarovni N, 2015, METHODS, V87, P46, DOI 10.1016/j.ymeth.2015.05.028	60	16	17	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243738	10.1371/journal.pone.0243738	http://dx.doi.org/10.1371/journal.pone.0243738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370319	Green Published, gold			2022-12-27	WOS:000603611900076
J	Gevaert, T; Van Eycke, YR; Vanden Broeck, T; Van Poppel, H; Salmon, I; Rorive, S; Muilwijk, T; Claessens, F; De Ridder, D; Joniau, S; Decaestecker, C				Gevaert, Thomas; Van Eycke, Yves-Remi; Vanden Broeck, Thomas; Van Poppel, Hein; Salmon, Isabelle; Rorive, Sandrine; Muilwijk, Tim; Claessens, Frank; De Ridder, Dirk; Joniau, Steven; Decaestecker, Christine			The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients	PLOS ONE			English	Article							MICROVESSEL DENSITY; ANDROGEN RECEPTOR; BIOCHEMICAL RECURRENCE; RADICAL PROSTATECTOMY; PATHOLOGICAL STAGE; FREE SURVIVAL; PROGRESSION; QUANTIFICATION; EXPRESSION; TISSUE	The tumour micro-environment (TME) plays a crucial role in the onset and progression of prostate cancer (PCa). Here we studied the potential of a selected panel of TME-markers to predict clinical recurrence (CLR) in PCa. Patient cohorts were matched for the presence or absence of CLR 5 years post-prostatectomy. Tissue micro-arrays (TMA) were composed with both prostate non-tumour (PNT) and PCa tissue and subsequently processed for immunohistochemistry (IHC). The IHC panel included markers for cancer activated fibroblasts (CAFs), blood vessels and steroid hormone receptors ((SHR): androgen receptor (AR), progesterone receptor (PR) and estrogen receptor (ER)). Stained slides were digitalised, selectively annotated and analysed for percentage of marker expression with standardized and validated image analysis algorithms. A univariable analysis identified several TME markers with significant impact on CR: expression of CD31 (vascular marker) in PNT stroma, expression of alpha smooth muscle actin (alpha SMA) in PCa stroma, and PR expression ratio between PCa stroma and PNT stroma. A multivariable model, which included CD31 expression (vascular marker) in PNT stroma and PR expression ratio between PCa stroma and PNT stroma, could significantly stratify patients for CLR, with the identification of a low risk and high-risk subgroup. If validated and confirmed in an independent prospective series, this subgroup might have clinical potential for PCa patient stratification.	[Gevaert, Thomas; Vanden Broeck, Thomas; Van Poppel, Hein; Muilwijk, Tim; De Ridder, Dirk; Joniau, Steven] UZ Leuven, Dept Urol, Leuven, Belgium; [Gevaert, Thomas; Van Poppel, Hein; Muilwijk, Tim; De Ridder, Dirk; Joniau, Steven] Katholieke Univ Leuven, Organ Syst, Leuven, Belgium; [Gevaert, Thomas] AZ Klina, Dept Pathol, Brasschaat, Belgium; [Gevaert, Thomas; Vanden Broeck, Thomas; Van Poppel, Hein; Claessens, Frank; De Ridder, Dirk; Joniau, Steven] PEARL ProstatE CAncer Res Leuven, Leuven, Belgium; [Van Eycke, Yves-Remi; Decaestecker, Christine] ULB, Ecole Polytech Bruxelles, Brussels Sch Engn, Labs Image Synth & Anal LISA, Brussels, Belgium; [Van Eycke, Yves-Remi; Salmon, Isabelle; Decaestecker, Christine] ULB, DIAPath, Ctr Microscopy & Mol Imaging CMMI, Gosselies, Belgium; [Vanden Broeck, Thomas; Claessens, Frank] Katholieke Univ Leuven, Dept Mol & Cellular Med, Leuven, Belgium; [Salmon, Isabelle; Rorive, Sandrine] Univ Libre Bruxelles ULB, Erasme Univ Hosp, Dept Pathol, Brussels, Belgium; [Salmon, Isabelle; Rorive, Sandrine] Ctr Univ Inter Reg Expertise Anat Pathol Hosp Cur, Jumet, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; Universite Libre de Bruxelles; Universite Libre de Bruxelles; KU Leuven; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles	Gevaert, T (corresponding author), UZ Leuven, Dept Urol, Leuven, Belgium.; Gevaert, T (corresponding author), Katholieke Univ Leuven, Organ Syst, Leuven, Belgium.; Gevaert, T (corresponding author), AZ Klina, Dept Pathol, Brasschaat, Belgium.; Gevaert, T (corresponding author), PEARL ProstatE CAncer Res Leuven, Leuven, Belgium.	Gevaert.thomas1979@gmail.com	joniau, steven/K-7655-2013; Claessens, Frank/M-8565-2016	joniau, steven/0000-0003-3195-9890; Van Eycke, Yves-Remi/0000-0002-7131-1784; Claessens, Frank/0000-0002-8676-7709	Josef De Wever Fonds (Leuven, Belgium); Foundation Yvonne Boel (Brussels, Belgium); European Regional Development Fund; Walloon Region (Belgium); KU Leuven Research Council [GOA/15/017]; Fonds National de la Recherche Scientifique (Brussels, Belgium)	Josef De Wever Fonds (Leuven, Belgium); Foundation Yvonne Boel (Brussels, Belgium); European Regional Development Fund(European Commission); Walloon Region (Belgium); KU Leuven Research Council(KU Leuven); Fonds National de la Recherche Scientifique (Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the Josef De Wever Fonds (Leuven, Belgium) and the Foundation Yvonne Boel (Brussels, Belgium). The CMMI is supported by the European Regional Development Fund and the Walloon Region (Belgium). FC and SJ received grant GOA/15/017 from the KU Leuven Research Council. CD is a senior research associate supported by the Fonds National de la Recherche Scientifique (Brussels, Belgium).	[Anonymous], 2015, CANC DISCOV, V5, pOF2; Ayala GE, 2011, AM J PATHOL, V178, P79, DOI 10.1016/j.ajpath.2010.09.042; Ballman KV, 2015, J CLIN ONCOL, V33, P3968, DOI 10.1200/JCO.2015.63.3651; Barron DA, 2012, ENDOCR-RELAT CANCER, V19, pR187, DOI 10.1530/ERC-12-0085; Cao K, 2018, DIAGNOSTICS, V8, DOI 10.3390/diagnostics8030049; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Daniels G, 2014, AM J TRANSL RES, V6, P140; de la Taille A, 2000, AM J CLIN PATHOL, V113, P555, DOI 10.1309/02W2-KE50-PKEF-G2G4; Decaestecker C, 2009, PROTEOMICS, V9, P4478, DOI 10.1002/pmic.200800936; Di Vizio D, 2009, CELL CYCLE, V8, P2420, DOI 10.4161/cc.8.15.9116; El-Gohary YM, 2007, AM J CLIN PATHOL, V127, P572, DOI 10.1309/X6NXYE57DLUE2NQ8; Erbersdobler A, 2010, WORLD J UROL, V28, P687, DOI 10.1007/s00345-009-0471-4; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Gevaert T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32711-9; Grindstad T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29520-5; Grindstad T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116691; Hammarsten P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164016; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henshall SM, 2001, CANCER RES, V61, P423; Hinshaw DC, 2019, CANCER RES, V79, P4557, DOI 10.1158/0008-5472.CAN-18-3962; Jia ZY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00539; Kaplan Keith, 2015, MLO Med Lab Obs, V47, P20; Klein EA, 2014, EUR UROL, V66, P550, DOI 10.1016/j.eururo.2014.05.004; Kwa MQ, 2019, CLIN EXP METASTAS, V36, P71, DOI 10.1007/s10585-019-09959-0; Lai KP, 2012, EMBO MOL MED, V4, P791, DOI 10.1002/emmm.201101140; Lalonde E, 2014, LANCET ONCOL, V15, P1521, DOI 10.1016/S1470-2045(14)71021-6; Leach DA, 2017, CANCERS, V9, DOI 10.3390/cancers9010010; Leach DA, 2015, ONCOTARGET, V6, P16135, DOI 10.18632/oncotarget.3873; Liu XD, 2015, CANCER IMMUNOL RES, V3, P1017, DOI 10.1158/2326-6066.CIR-14-0244; Marien KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161496; Marshall HT, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00315; Miyata Y, 2015, INT J UROL, V22, P806, DOI 10.1111/iju.12840; Miyata Y, 2015, PROSTATE, V75, P84, DOI 10.1002/pros.22894; Mo F, 2018, EUR UROL, V73, P524, DOI 10.1016/j.eururo.2017.02.038; Moles Lopez X, 2014, MICROSCOPY ADV SCI R, P776; Nordby Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43378; Ohlson N, 2007, PROSTATE, V67, P32, DOI 10.1002/pros.20480; Rubin MA, 1999, UROLOGY, V53, P542, DOI 10.1016/S0090-4295(98)00561-5; Shiao SL, 2016, CANCER LETT, V380, P340, DOI 10.1016/j.canlet.2015.12.022; Silberman MA, 1997, CANCER, V79, P772, DOI 10.1002/(SICI)1097-0142(19970215)79:4<772::AID-CNCR14>3.0.CO;2-X; Sirinukunwattana K, 2017, MED IMAGE ANAL, V35, P489, DOI 10.1016/j.media.2016.08.008; Tomas D, 2010, SCAND J UROL NEPHROL, V44, P284, DOI 10.3109/00365599.2010.485578; Van Eycke YR, 2018, MED IMAGE ANAL, V49, P35, DOI 10.1016/j.media.2018.07.004; Van Eycke YR, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42964; Wikstrom P, 2009, PROSTATE, V69, P799, DOI 10.1002/pros.20927; Yanagisawa N, 2007, HUM PATHOL, V38, P1611, DOI 10.1016/j.humpath.2007.04.008; Yu SQ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0674-9; Yu Y, 2015, PROSTATE, V75, P1043, DOI 10.1002/pros.22988; 2014, REG ANESTH PAIN MED, V9; 2018, CURR OPIN TOXICOL, V10	50	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244663	10.1371/journal.pone.0244663	http://dx.doi.org/10.1371/journal.pone.0244663			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370412	Green Published, gold			2022-12-27	WOS:000603611900125
J	Lee, J; Oh, S; Bhattacharya, S; Zhang, Y; Florens, L; Washburn, MP; Workman, JL				Lee, Jaehyoun; Oh, Seunghee; Bhattacharya, Saikat; Zhang, Ying; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.			The plasticity of the pyruvate dehydrogenase complex confers a labile structure that is associated with its catalytic activity	PLOS ONE			English	Article							MULTIENZYME COMPLEX; ESCHERICHIA-COLI; NUCLEAR-LOCALIZATION; ENZYMES; INHIBITORS; ACTIVATOR; DOMAINS; SUBUNIT; BINDING; DESIGN	The pyruvate dehydrogenase complex (PDC) is a multienzyme complex that plays a key role in energy metabolism by converting pyruvate to acetyl-CoA. An increase of nuclear PDC has been shown to be correlated with an increase of histone acetylation that requires acetyl-CoA. PDC has been reported to form a similar to 10 MDa macromolecular machine that is proficient in performing sequential catalytic reactions via its three components. In this study, we show that the PDC displays size versatility in an ionic strength-dependent manner using size exclusion chromatography of yeast cell extracts. Biochemical analysis in combination with mass spectrometry indicates that yeast PDC (yPDC) is a salt-labile complex that dissociates into sub-megadalton individual components even under physiological ionic strength. Interestingly, we find that each oligomeric component of yPDC displays a larger size than previously believed. In addition, we show that the mammalian PDC also displays this uncommon characteristic of salt-lability, although it has a somewhat different profile compared to yeast. We show that the activity of yPDC is reduced in higher ionic strength. Our results indicate that the structure of PDC may not always maintain its similar to 10 MDa organization, but is rather variable. We propose that the flexible nature of PDC may allow modulation of its activity.	[Lee, Jaehyoun; Oh, Seunghee; Bhattacharya, Saikat; Zhang, Ying; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Workman, JL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	jlw@stowers.org	Bhattacharya, Saikat/AAK-7785-2021	Bhattacharya, Saikat/0000-0001-6028-4840; Washburn, Michael/0000-0001-7568-2585; Seiler, Jae Hyoun/0000-0002-6351-3546	Stowers Institute for Medical Research; National Institutes of General Medical Sciences [R35GM118068]	Stowers Institute for Medical Research; National Institutes of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Stowers Institute for Medical Research (https://www.stowers.org) and National Institutes of General Medical Sciences (https://www.nigms.nih.gov) grant R35GM118068 (J.L.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATES DL, 1977, NATURE, V268, P313, DOI 10.1038/268313a0; BATES DL, 1975, FEBS LETT, V60, P427, DOI 10.1016/0014-5793(75)80764-2; Brautigam CA, 2009, J BIOL CHEM, V284, P13086, DOI 10.1074/jbc.M806563200; BRUNETTE MG, 1972, PEDIATRICS, V50, P702; Chueh FY, 2011, CELL SIGNAL, V23, P1170, DOI 10.1016/j.cellsig.2011.03.004; DANSON MJ, 1979, J MOL BIOL, V129, P603, DOI 10.1016/0022-2836(79)90471-6; DASILVA LA, 1993, BIOCHIM BIOPHYS ACTA, V1169, P126, DOI 10.1016/0005-2760(93)90197-H; de Boer VCJ, 2014, CELL, V158, P9, DOI 10.1016/j.cell.2014.06.018; Drakulic S, 2018, CELL MOL LIFE SCI, V75, P3009, DOI 10.1007/s00018-018-2775-2; Florens Laurence, 2006, V328, P159; Frank RAW, 2005, STRUCTURE, V13, P1119, DOI 10.1016/j.str.2005.04.021; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; GILBERT GA, 1980, J MOL BIOL, V144, P405, DOI 10.1016/0022-2836(80)90099-6; Gregg Christopher, 2009, J Vis Exp, DOI 10.3791/1417; Gu YQ, 2003, P NATL ACAD SCI USA, V100, P7015, DOI 10.1073/pnas.0732060100; HACKERT ML, 1983, P NATL ACAD SCI-BIOL, V80, P2226, DOI 10.1073/pnas.80.8.2226; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; HINMAN LM, 1981, J BIOL CHEM, V256, P6583; Jung HI, 2002, PROTEIN SCI, V11, P1091, DOI 10.1110/ps.4970102; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kingsbury JM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005714; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Kok De, 1985, FEBS LETT, V152, P35, DOI [10.1111/j.1432-1033.1985.tb09160.x, DOI 10.1111/J.1432-1033.1985.TB09160.X]; Ling MF, 1998, HUM MOL GENET, V7, P501, DOI 10.1093/hmg/7.3.501; Matsuda S, 2016, NUCLEIC ACIDS RES, V44, P636, DOI 10.1093/nar/gkv967; Milne JLS, 2006, J BIOL CHEM, V281, P4364, DOI 10.1074/jbc.M504363200; Nagaraj R, 2017, CELL, V168, P210, DOI 10.1016/j.cell.2016.12.026; Ng F, 2014, MOL MEMBR BIOL, V31, P207, DOI 10.3109/09687688.2014.987183; Oliver RM, 1982, ELECT MIRCOSCOPY PRO; Patel KP, 2012, MOL GENET METAB, V105, P34, DOI 10.1016/j.ymgme.2011.09.032; Patel MS, 2003, BIOCHEM MOL BIOL EDU, V31, P5, DOI 10.1002/bmb.2003.494031010156; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; PAWELCZYK T, 1995, INT J BIOCHEM CELL B, V27, P513, DOI 10.1016/1357-2725(95)00006-B; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Prochasson P, 2003, MOL CELL, V12, P983, DOI 10.1016/S1097-2765(03)00366-6; REED LJ, 1974, ACCOUNTS CHEM RES, V7, P40, DOI 10.1021/ar50074a002; Saunier E, 2016, INT J CANCER, V138, P809, DOI 10.1002/ijc.29564; SCHMITT B, 1980, BIOCHEM BIOPH RES CO, V93, P709, DOI 10.1016/0006-291X(80)91135-3; SCHWARTZ ER, 1969, J BIOL CHEM, V244, P6074; Smolle M, 2006, J BIOL CHEM, V281, P19772, DOI 10.1074/jbc.M601140200; STEPP LR, 1981, BIOCHEMISTRY-US, V20, P4555, DOI 10.1021/bi00519a007; STOOPS JK, 1992, J BIOL CHEM, V267, P24769; Stoops JK, 1997, J BIOL CHEM, V272, P5757, DOI 10.1074/jbc.272.9.5757; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; SUMEGI B, 1987, EUR J BIOCHEM, V169, P223, DOI 10.1111/j.1432-1033.1987.tb13601.x; Sutendra G, 2014, CELL, V158, P84, DOI 10.1016/j.cell.2014.04.046; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tso SC, 2014, J BIOL CHEM, V289, P4432, DOI 10.1074/jbc.M113.533885; Vijayakrishnan S, 2010, J MOL BIOL, V399, P71, DOI 10.1016/j.jmb.2010.03.043; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Zhang Y, 2011, ANAL CHEM, V83, P9344, DOI 10.1021/ac201867h; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhou Y, 2018, BIOORGAN MED CHEM, V26, P84, DOI 10.1016/j.bmc.2017.11.021	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243489	10.1371/journal.pone.0243489	http://dx.doi.org/10.1371/journal.pone.0243489			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370314	Green Published, gold, Green Submitted			2022-12-27	WOS:000603611900043
J	Skaaby, S; Flachs, EM; Lange, P; Schlunssen, V; Marott, JL; Brauer, C; Nordestgaard, BG; Sadhra, S; Kurmi, O; Bonde, JPE				Skaaby, Stinna; Flachs, Esben Meulengracht; Lange, Peter; Schlunssen, Vivi; Marott, Jacob Louis; Brauer, Charlotte; Nordestgaard, Borge G.; Sadhra, Steven; Kurmi, Om; Bonde, Jens Peter Ellekilde			Occupational exposures and exacerbations of asthma and COPD-A general population study	PLOS ONE			English	Article							LUNG-FUNCTION; AIR-POLLUTION; RISK; PREDICTORS; EMPLOYMENT; DISEASE; BURDEN; TRENDS; COHORT	Purpose Recent studies suggest that occupational inhalant exposures trigger exacerbations of asthma and chronic obstructive pulmonary disease, but findings are conflicting. Methods We included 7,768 individuals with self-reported asthma (n = 3,215) and/or spirometric airflow limitation (forced expiratory volume in 1 second (FEV1)/ forced expiratory volume (FVC) <0.70) (n = 5,275) who participated in The Copenhagen City Heart Study or The Copenhagen General Population Study from 2001-2016. Occupational exposure was assigned by linking job codes with job exposure matrices, and exacerbations were defined by register data on oral corticosteroid treatment, emergency care unit assessment or hospital admission. Associations between occupational inhalant exposure each year of follow-up and exacerbation were assessed by Cox regression with time varying exposure and age as the underlying time scale. Results Participants were followed for a median of 4.6 years (interquartile range, IQR 5.4), during which 870 exacerbations occurred. Exacerbations were not associated with any of the selected exposures (high molecular weight sensitizers, low molecular weight sensitizers, irritants or low and high levels of mineral dust, biological dust, gases & fumes or the composite variable vapours, gases, dusts or fumes). Hazards ratios ranged from 0.8 (95% confidence interval: 0.7;1.0) to 1.2 (95% confidence interval: 0.9;1.7). Conclusion Exacerbations of obstructive airway disease were not associated with occupational inhalant exposures assigned by a job exposure matrix. Further studies with alternative exposure assessment are warranted.	[Skaaby, Stinna; Flachs, Esben Meulengracht; Brauer, Charlotte; Bonde, Jens Peter Ellekilde] Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark; [Lange, Peter; Bonde, Jens Peter Ellekilde] Univ Copenhagen, Inst Publ Hlth, Sect Epidemiol, Copenhagen, Denmark; [Lange, Peter] Copenhagen Univ Hosp, Herlev Gentofte Hosp, Dept Med, Herlev, Denmark; [Lange, Peter; Marott, Jacob Louis; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Lange, Peter; Marott, Jacob Louis; Nordestgaard, Borge G.] Copenhagen Univ Hosp, Copenhagen Gen Populat Study, Herlev Gentofte Hosp, Herlev, Denmark; [Schlunssen, Vivi] Univ Aarhus, Danish Ramazzini Ctr, Dept Publ Hlth Environm Work & Hlth, Aarhus, Denmark; [Schlunssen, Vivi] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark; [Sadhra, Steven] Univ Birmingham, Inst Occupat & Environm Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Kurmi, Om] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England; [Kurmi, Om] McMaster Univ, Div Respirol, Dept Med, Hamilton, ON, Canada	Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Aarhus University; National Research Centre for the Working Environment; University of Copenhagen; University of Birmingham; Coventry University; McMaster University	Skaaby, S (corresponding author), Copenhagen Univ Hosp, Bispebjerg Frederiksberg Hosp, Dept Occupat & Environm Med, Copenhagen, Denmark.	stinna.skaaby@regionh.dk		Skaaby, Stinna/0000-0002-0928-8405; Nordestgaard, Borge/0000-0002-1954-7220; Kurmi, Om Prakash/0000-0002-9518-4716; Brauer, Charlotte/0000-0002-2109-3264; Schlunssen, Vivi/0000-0003-4915-1734	Danish Working Environment Research Fund [40-2016-09 20165103813]	Danish Working Environment Research Fund	JPB, grant number 40-2016-09 20165103813, The Danish Working Environment Research Fund https://amff.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeloye D, 2015, J GLOB HEALTH, V5, P186, DOI 10.7189/jogh.05.020415; Andersson E, 2006, EUR RESPIR J, V27, P720, DOI 10.1183/09031936.06.00034305; Antoniu SA, 2009, EXPERT OPIN PHARMACO, V10, P719, DOI [10.1517/14656560902740804 , 10.1517/14656560902740804]; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Bai TR, 2007, EUR RESPIR J, V30, P452, DOI 10.1183/09031936.00165106; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Bleecker ER, 2008, PULM PHARMACOL THER, V21, P682, DOI 10.1016/j.pupt.2008.04.003; Bloom CI, 2018, THORAX, V73, P313, DOI 10.1136/thoraxjnl-2017-210650; Castillo JR, 2017, J ALLER CL IMM-PRACT, V5, P918, DOI 10.1016/j.jaip.2017.05.001; Colak Y, 2019, RESP MED, V155, P141, DOI 10.1016/j.rmed.2019.07.021; Creely KS, 2007, ANN OCCUP HYG, V51, P665, DOI 10.1093/annhyg/mem050; de Marco R, 2011, AM J RESP CRIT CARE, V183, P891, DOI 10.1164/rccm.201007-1125OC; Dunn RM, 2018, ALLERGY, V73, P284, DOI 10.1111/all.13258; Flachs EM, 2019, INT J EPIDEMIOL, P1, DOI [10.1093/ije/dyy184, DOI 10.1093/IJE/DYY184]; Fuhlbrigge A, 2012, J ALLERGY CLIN IMMUN, V129, pS34, DOI 10.1016/j.jaci.2011.12.983; Galan I, 2003, EUR RESPIR J, V22, P802, DOI 10.1183/09031936.03.00013003; Hansen CL, 2012, SCAND J PUBLIC HEALT, V40, P377, DOI 10.1177/1403494812449079; Henneberger PK, 2010, EUR RESPIR J, V36, P743, DOI 10.1183/09031936.00135109; Ingebrigtsen TS, 2015, RESP MED, V109, P1562, DOI 10.1016/j.rmed.2015.10.015; James KA, 2018, ANN AM THORAC SOC, V15, P947, DOI 10.1513/AnnalsATS.201804-273OC; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kim JL, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0306-1; Ko FW, 2016, RESPIROLOGY, V21, P1152, DOI 10.1111/resp.12780; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Lange P, 2016, LANCET RESP MED, V4, P454, DOI 10.1016/S2213-2600(16)00098-9; Le Moual N, 2018, OCCUP ENVIRON MED, V75, P507, DOI 10.1136/oemed-2017-104866; Li JH, 2016, INT J CHRONIC OBSTR, V11, P3079, DOI 10.2147/COPD.S122282; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Lytras T, 2018, THORAX, V73, P1008, DOI 10.1136/thoraxjnl-2017-211158; Miller MK, 2007, RESP MED, V101, P481, DOI 10.1016/j.rmed.2006.07.005; Paulin LM, 2015, AM J RESP CRIT CARE, V191, P557, DOI 10.1164/rccm.201408-1407OC; Pelkonen MK, 2018, RESP MED, V142, P29, DOI 10.1016/j.rmed.2018.07.012; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Rai KK, 2017, INT J CHRONIC OBSTR, V12, P233, DOI 10.2147/COPD.S119467; Sadhra SS, 2016, OCCUP MED-OXFORD, V66, P358, DOI 10.1093/occmed/kqw027; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Schatz M, 2007, J ASTHMA, V44, P341, DOI 10.1080/02770900701344421; Schatz M, 2013, J ALLER CL IMM-PRACT, V1, P618, DOI 10.1016/j.jaip.2013.07.009; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; Sivapalan P, 2019, BMJ OPEN RESPIR RES, V6, DOI 10.1136/bmjresp-2019-000407; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Statistics Denmark, STATBANK DENM; Suruki RY, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0409-3; Taponen S, 2019, RESP MED, V147, P76, DOI 10.1016/j.rmed.2019.01.004; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Toren K, 2004, EUR RESPIR J, V24, P942, DOI 10.1183/09031936.04.00044804; Truelsen T, 2001, INT J EPIDEMIOL, V30, P145, DOI 10.1093/ije/30.1.145; Tzivian L, 2011, J ASTHMA, V48, P470, DOI 10.3109/02770903.2011.570407; Vested A, 2019, OCCUP ENVIRON MED, V76, P105, DOI 10.1136/oemed-2018-105323; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Zuo BQ, 2019, CHEMOSPHERE, V237, DOI 10.1016/j.chemosphere.2019.124497	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243826	10.1371/journal.pone.0243826	http://dx.doi.org/10.1371/journal.pone.0243826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370308	gold, Green Published			2022-12-27	WOS:000603611900037
J	Roslan, MF; Al-Shetwi, AQ; Hannan, MA; Ker, PJ; Zuhdi, AWM				Roslan, M. F.; Al-Shetwi, Ali Q.; Hannan, M. A.; Ker, P. J.; Zuhdi, A. W. M.			Particle swarm optimization algorithm-based PI inverter controller for a grid-connected PV system	PLOS ONE			English	Article							PERFORMANCE	The lack of control in voltage overshoot, transient response, and steady state error are major issues that are frequently encountered in a grid-connected photovoltaic (PV) system, resulting in poor power quality performance and damages to the overall power system. This paper presents the performance of a control strategy for an inverter in a three-phase grid-connected PV system. The system consists of a PV panel, a boost converter, a DC link, an inverter, and a resistor-inductor (RL) filter and is connected to the utility grid through a voltage source inverter. The main objective of the proposed strategy is to improve the power quality performance of the three-phase grid-connected inverter system by optimising the proportional-integral (PI) controller. Such a strategy aims to reduce the DC link input voltage fluctuation, decrease the harmonics, and stabilise the output current, voltage, frequency, and power flow. The particle swarm optimisation (PSO) technique was implemented to tune the PI controller parameters by minimising the error of the voltage regulator and current controller schemes in the inverter system. The system model and control strategies were implemented using MATLAB/Simulink environment (Version 2020A) Simscape-Power system toolbox. Results show that the proposed strategy outperformed other reported research works with total harmonic distortion (THD) at a grid voltage and current of 0.29% and 2.72%, respectively, and a transient response time of 0.1853s. Compared to conventional systems, the PI controller with PSO-based optimization provides less voltage overshoot by 11.1% while reducing the time to reach equilibrium state by 32.6%. The consideration of additional input parameters and the optimization of input parameters were identified to be the two main factors that contribute to the significant improvements in power quality control. Therefore, the proposed strategy effectively enhances the power quality of the utility grid, and such an enhancement contributes to the efficient and smooth integration of the PV system.	[Roslan, M. F.; Hannan, M. A.] Univ Tenaga Nas, Dept Elect Power Engn, Kajang, Selangor, Malaysia; [Al-Shetwi, Ali Q.; Ker, P. J.; Zuhdi, A. W. M.] Univ Tenaga Nas, Inst Sustainable Energy, Kajang, Selangor, Malaysia; [Al-Shetwi, Ali Q.] Fahad bin Sultan Univ, Dept Elect Engn, Tabuk, Saudi Arabia	Universiti Tenaga Nasional; Universiti Tenaga Nasional; Fahad Bin Sultan University	Roslan, MF (corresponding author), Univ Tenaga Nas, Dept Elect Power Engn, Kajang, Selangor, Malaysia.	Mfirdaus@uniten.edu.my	Roslan, Mohd Firdaus Bin/GXZ-5377-2022; Al-Shetwi, Ali Q./G-8887-2019; Mahmood Zuhdi, Ahmad Wafi/GLR-4283-2022; Hannan, M/O-8579-2019	Al-Shetwi, Ali Q./0000-0002-6581-9629; Mahmood Zuhdi, Ahmad Wafi/0000-0003-1884-0449; Hannan, M/0000-0001-8367-4112; Roslan, Mohd Firdaus/0000-0003-0984-4210	Ministry of Higher Education, Malaysia under Universiti Tenaga Nasional using grant [20190101LRGS]	Ministry of Higher Education, Malaysia under Universiti Tenaga Nasional using grant	This work was funded by the Ministry of Higher Education, Malaysia under Universiti Tenaga Nasional using grant no. 20190101LRGS.	Abd Ali J, 2016, MEASUREMENT, V78, P49, DOI 10.1016/j.measurement.2015.09.038; Abdolrasol MGM, 2016, J TEKNOL, V78, P77; Ahmed S., 2011, RENEW ENERG, V5, P116; Al-Masri HMK, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10103650; Al-Shetwi AQ, 2020, J CLEAN PROD, V253, DOI 10.1016/j.jclepro.2019.119831; Al-Shetwi AQ, 2018, SOL ENERGY, V159, P665, DOI 10.1016/j.solener.2017.11.027; Anjum W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228636; Annamraju A, 2019, PROT CONTR MOD POW, V4, DOI 10.1186/s41601-019-0144-2; [Anonymous], 2000, IEEE RECOMMENDED PRA, V2000; [Anonymous], 2006, PLOS CLIN TRIALS, V1, pe33, DOI 10.1371/journal.pctr.0010033; [Anonymous], 2010, CITROGRAPH, V1, P12, DOI DOI 10.1007/s13244-009-0008-9; Arafat MN, 2014, IEEE ENER CONV, P3964, DOI 10.1109/ECCE.2014.6953940; Ashabani SM, 2014, IEEE T POWER SYST, V29, P2257, DOI 10.1109/TPWRS.2014.2306016; Atiq J., 2017, INT J SIMUL SYST SCI, V17, DOI DOI 10.5013/IJSSST.A.17.41.45; Bandara K, 2012, RENEW ENERG, V37, P82, DOI 10.1016/j.renene.2011.05.036; Bao CL, 2014, IEEE T POWER ELECTR, V29, P1239, DOI 10.1109/TPEL.2013.2262378; Basilio JC, 2002, IEEE T EDUC, V45, P364, DOI 10.1109/TE.2002.804399; Besheer AH, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P693, DOI 10.1109/ICIT.2012.6210019; Chuang LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021036; Dai YX, 2016, IEEE ACCESS, V4, P7621, DOI 10.1109/ACCESS.2016.2619691; del Valle Y, 2008, IEEE T EVOLUT COMPUT, V12, P171, DOI 10.1109/TEVC.2007.896686; Dolara A, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8040558; Fahad S, 2018, INTL CONF POWER SYST, P2233, DOI 10.1109/POWERCON.2018.8602128; Farrokhabadi M, 2018, IEEE T POWER SYST, V33, P2301, DOI 10.1109/TPWRS.2017.2740163; Ghazvinian H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217634; Handoko Susatyo, 2015, Journal of Theoretical and Applied Information Technology, V73, P411; Hannan MA, 2018, RENEW SUST ENERG REV, V81, P1611, DOI 10.1016/j.rser.2017.05.240; Hannan MA, 2015, IEEE T IND APPL, V51, P4775, DOI 10.1109/TIA.2015.2455025; Hassan MA, 2011, IEEE T POWER ELECTR, V26, P755, DOI 10.1109/TPEL.2010.2100101; Hongbin Wu, 2009, 2009 International Conference on Power Electronics and Drive Systems (PEDS 2009), P1295, DOI 10.1109/PEDS.2009.5385758; Jin TT, 2010, CHIN CONT DECIS CONF, P3180, DOI 10.1109/CCDC.2010.5498629; Jumani TA, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8010111; Kakkar S, 2020, MEAS CONTROL-UK, V53, P551, DOI 10.1177/0020294019879171; Kapinus O. S. M, 2016, CRIMINOLOGY, V2; Mosaad MI, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101469; Mosalam HA, 2018, AIN SHAMS ENG J, V9, P2931, DOI 10.1016/j.asej.2018.10.001; Nammalvar P, 2018, ADV ELECTR COMPUT EN, V18, P105, DOI 10.4316/AECE.2018.01013; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Oshaba AS, 2017, NEURAL COMPUT APPL, V28, P651, DOI 10.1007/s00521-015-2091-9; Ping Y., 2014, IEEE PES ASIA PACIFI, P5; Rajesh P., 2017, INT J ENG TECHNOL, V9, P529, DOI [10.21817/ijet/2017/v9i3/170903S080, DOI 10.21817/IJET/2017/V9I3/170903S080]; Rizqiawan A, 2019, ENERGIES, V12, DOI 10.3390/en12030476; Selamat N. A., 2019, INT J RECENT TECHNOL, V8, P225, DOI [10.35940/ijrte.c1042.1083s219, DOI 10.35940/IJRTE.C1042.1083S219]; song LiJung Huang L., 2020, ENERGIES, P2020; Nguyen TH, 2017, ENERGIES, V10, DOI 10.3390/en10070907; Vinay Kumar M., 2019, J ADV RES DYN CONTRO, V11, P2979, DOI [10.35940/ijrte.D8937.118419, DOI 10.35940/IJRTE.D8937.118419]; Wang L, 2018, COMPUT ELECTRON AGR, V151, P349, DOI 10.1016/j.compag.2018.06.024; Yang ST, 2010, APPL POWER ELECT CO, P1002, DOI 10.1109/APEC.2010.5433380	48	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243581	10.1371/journal.pone.0243581	http://dx.doi.org/10.1371/journal.pone.0243581			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362200	Green Published, gold			2022-12-27	WOS:000603071600011
J	Dawit, M; Turbale, M; Moges, A; Amare, M				Dawit, Mulugeta; Turbale, Mahilet; Moges, Amsalu; Amare, Meareg			Poly(alizarin red S) modified glassy carbon electrode for square wave adsorptive stripping voltammetric determination of metronidazole in tablet formulation	PLOS ONE			English	Article							ELECTROCHEMICAL DETERMINATION; ANTIBIOTICS; ACID	Potentiodynamically fabricated poly(alizarin red s) modified GCE was characterized using CV and EIS techniques. In contrast to the cyclic voltammetric response of the unmodified GCE for metronidazole, an irreversible reduction peak with three-folds of current enhancement and reduced overpotential at the poly(alizarin red s) modified GCE showed the catalytic effect of the modifier towards reduction of metronidazole. While observed peak potential shift with increasing pH (4.0-10.0) indicated the involvement of protons during the reduction of metronidazole, peak potential shift with scan rate (20-300 mV s(-1)) confirmed the irreversibility of the reduction reaction of metronidazole at the modified GCE. A better correlation for the dependence of peak current on scan rate (r(2) = 0.9883) than on square root of scan rate (r(2) = 0.9740) supplemented by slope value of 0.38 for plot of log(current) versus log(scan rate) indicated the reduction reaction of metronidazole at the surface of the modified electrode was predominantly adsorption controlled. Under the optimized method and solution parameters, reductive current response of tablet sample showed linear dependence on spiked standard concentration in a wide range (0-125 mu M) with excellent determination coefficient r(2), LoD and LoQ of 0.9991, 0.38, and 1.25 mu M, respectively. Spike recovery of 97.9% and interference recovery of 96.2-97.5% in the presence of 21.28 and 31.92 mu M of uric acid and ascorbic acid validated the applicability of the present method for determination of metronidazole in tablet formulation. The metronidazole content of the tested tablet formulation using standard addition method was found to be 97.6% of what is claimed by the tablet manufacturer making the developed method an excellent potential candidate for its applicability to determine metronidazole in real samples with complex matrix.	[Dawit, Mulugeta] Debre Tabor Univ, Debra Tabor, Ethiopia; [Turbale, Mahilet] Samara Univ, Semera, Ethiopia; [Moges, Amsalu] Debre Markos Univ, Debre Markos, Ethiopia; [Amare, Meareg] Bahir Dar Univ, Bahir Dar, Ethiopia	Samara University; Bahir Dar University	Amare, M (corresponding author), Bahir Dar Univ, Bahir Dar, Ethiopia.	amaremeareg@yahoo.com	Amare, Meareg/ABD-5050-2020	Amare, Meareg/0000-0001-8817-9508				Amare M, 2020, J MATER RES TECHNOL, V9, P11484, DOI 10.1016/j.jmrt.2020.08.002; Amare M, 2019, INT J ANAL CHEM, V2019, DOI 10.1155/2019/6428072; Amare M, 2011, ANAL BIOANAL ELECTRO, V3, P365; Baikeli Y, 2020, J ELECTROCHEM SOC, V167, DOI 10.1149/1945-7111/ab9d94; Brett C. M. A., 1993, ELECTROCHEMISTRY PRI, DOI [10.1002/bbpc.19940981033., DOI 10.1002/BBPC.19940981033]; BURKE LD, 1984, J ELECTROANAL CHEM, V163, P117, DOI 10.1016/S0022-0728(84)80045-5; Cudmore SL, 2004, CLIN MICROBIOL REV, V17, P783, DOI 10.1128/CMR.17.4.783-793.2004; El-Ghobashy MR, 2010, J ADV RES, V1, P323, DOI 10.1016/j.jare.2010.06.001; Ezzeldin E, 2012, TROP J PHARM RES, V11, P799, DOI 10.4314/tjpr.v11i5.14; Filik H, 2017, FOOD ANAL METHOD, V10, P31, DOI 10.1007/s12161-016-0545-z; FREUND MS, 1992, J PHYS CHEM-US, V96, P9400, DOI 10.1021/j100202a062; Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400; HASEBE K, 1975, ANAL CHEM, V47, P2412, DOI 10.1021/ac60364a002; Hatefi-Mehrjardi A, 2014, ELECTROANAL, V26, P2491, DOI 10.1002/elan.201400302; Hern-ndez-JimOnez A, 2015, ELECTROANAL, V28, P704; HSUEH CC, 1993, ANAL CHEM, V65, P1570, DOI 10.1021/ac00059a015; Khanfar MF, 2019, INT J ELECTROCHEM SC, V14, P3265, DOI 10.20964/2019.04.43; Khashaba PY, 2017, ELECTROANAL, V29, P1643, DOI 10.1002/elan.201700078; Lin YY, 2012, TALANTA, V88, P646, DOI 10.1016/j.talanta.2011.11.053; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; MANOHARA YN, 2010, PHARM CHEM, V2, P148; Mathew JL, 2004, POSTGRAD MED J, V80, P196, DOI 10.1136/pgmj.2003.011973; Mohamed FA, 2019, COLLOID SURFACE A, V567, P76, DOI 10.1016/j.colsurfa.2019.01.033; Mumin Y, 2016, ANAL LETT, V49, P2716, DOI 10.1080/00032719.2016.1154569; Nikodimos Y, 2016, J ANAL METHODS CHEM, V2016, DOI 10.1155/2016/3612943; Ozkan SA, 1998, J PHARMACEUT BIOMED, V17, P299, DOI 10.1016/S0731-7085(97)00202-1; PENDLAND SL, 1994, ANTIMICROB AGENTS CH, V38, P2106, DOI 10.1128/AAC.38.9.2106; Roy PR, 2003, BIOELECTROCHEMISTRY, V59, P11, DOI 10.1016/S1567-5394(02)00156-1; Saffaj T, 2006, DYES PIGMENTS, V70, P259, DOI 10.1016/j.dyepig.2005.01.009; Siddiqui MR, 2017, ARAB J CHEM, V10, pS1409, DOI 10.1016/j.arabjc.2013.04.016; Wang W, 2006, BIOMEMS TECHNOLOGIES, P463; Wang Y, 2008, SENSORS-BASEL, V8, P2043, DOI 10.3390/s8042043; Wild GE, 2004, INFLAMM BOWEL DIS, V10, P321, DOI 10.1097/00054725-200405000-00022; Zhu MF, 2018, INT J ELECTROCHEM SC, V13, P4100, DOI 10.20964/2018.05.73	34	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244115	10.1371/journal.pone.0244115	http://dx.doi.org/10.1371/journal.pone.0244115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351825	gold, Green Published			2022-12-27	WOS:000603071400002
J	Perlasca, P; Frasca, M; Ba, CT; Gliozzo, J; Notaro, M; Pennacchioni, M; Valentini, G; Mesiti, M				Perlasca, Paolo; Frasca, Marco; Ba, Cheick Tidiane; Gliozzo, Jessica; Notaro, Marco; Pennacchioni, Mario; Valentini, Giorgio; Mesiti, Marco			Multi-resolution visualization and analysis of biomolecular networks through hierarchical community detection and web-based graphical tools	PLOS ONE			English	Article							NF-KAPPA-B; GENE ONTOLOGY; SPIKE PROTEIN; SARS-COV-2; CANCER; PREDICTION; PATHWAY; INFLAMMATION; INTEGRATION; MODULARITY	The visual exploration and analysis of biomolecular networks is of paramount importance for identifying hidden and complex interaction patterns among proteins. Although many tools have been proposed for this task, they are mainly focused on the query and visualization of a single protein with its neighborhood. The global exploration of the entire network and the interpretation of its underlying structure still remains difficult, mainly due to the excessively large size of the biomolecular networks. In this paper we propose a novel multi-resolution representation and exploration approach that exploits hierarchical community detection algorithms for the identification of communities occurring in biomolecular networks. The proposed graphical rendering combines two types of nodes (protein and communities) and three types of edges (protein-protein, community-community, protein-community), and displays communities at different resolutions, allowing the user to interactively zoom in and out from different levels of the hierarchy. Links among communities are shown in terms of relationships and functional correlations among the biomolecules they contain. This form of navigation can be also combined by the user with a vertex centric visualization for identifying the communities holding a target biomolecule. Since communities gather limited-size groups of correlated proteins, the visualization and exploration of complex and large networks becomes feasible on off-the-shelf computer machines. The proposed graphical exploration strategies have been implemented and integrated in UNIPred-Web, a web application that we recently introduced for combining the UNIPred algorithm, able to address both integration and protein function prediction in an imbalance-aware fashion, with an easy to use vertex-centric exploration of the integrated network. The tool has been deeply amended from different standpoints, including the prediction core algorithm. Several tests on networks of different size and connectivity have been conducted to show off the vast potential of our methodology; moreover, enrichment analyses have been performed to assess the biological meaningfulness of detected communities. Finally, a CoV-human network has been embedded in the system, and a corresponding case study presented, including the visualization and the prediction of human host proteins that potentially interact with SARS-CoV2 proteins.	[Perlasca, Paolo; Frasca, Marco; Ba, Cheick Tidiane; Notaro, Marco; Pennacchioni, Mario; Valentini, Giorgio; Mesiti, Marco] Univ Milan, Dept Comp Sci, AnacletoLab, Milan, Italy; [Gliozzo, Jessica] IRCCS San Raffaele Hosp, Neuroradiol Unit, Milan, Italy; [Valentini, Giorgio] CINI Natl Lab Artificial Intelligence & Intellige, Rome, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Mesiti, M (corresponding author), Univ Milan, Dept Comp Sci, AnacletoLab, Milan, Italy.	mesiti@di.unimi.it		PERLASCA, PAOLO/0000-0001-6674-2822; Gliozzo, Jessica/0000-0001-7629-8112; Valentini, Giorgio/0000-0002-5694-3919; Ba, Cheick Tidiane/0000-0002-4035-7464; Mesiti, Marco/0000-0001-5701-0080	University of Milano [PSR2019_DIP_010_GVALE]	University of Milano	This study was partially funded by University of Milano through the internal project "Machine Learning and Big Data Analysis for Bioinformatics" - PSR2019_DIP_010_GVALE.	Ahmed SS, 2020, BIORXIV, DOI [10.1101/2020.04.20.050138, DOI 10.1101/2020.04.20.050138]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashourvan A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215520; Athanasiadis EI, 2015, IEEE ACM T COMPUT BI, V12, P1213, DOI 10.1109/TCBB.2015.2424411; Auber D, 2005, NINTH INTERNATIONAL CONFERENCE ON INFORMATION VISUALISATION, PROCEEDINGS, P703, DOI 10.1109/IV.2005.65; Bertoni A, 2011, LECT NOTES ARTIF INT, V6911, P219, DOI 10.1007/978-3-642-23780-5_24; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Calderone A, 2013, NAT METHODS, V10, P690, DOI 10.1038/nmeth.2561; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2007, LECT NOTES COMPUT SC, V4503, P1; DeDiego ML, 2014, J VIROL, V88, P913, DOI 10.1128/JVI.02576-13; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Eke I, 2015, SEMIN CANCER BIOL, V31, P65, DOI 10.1016/j.semcancer.2014.07.009; Elmqvist N, 2010, IEEE T VIS COMPUT GR, V16, P439, DOI 10.1109/TVCG.2009.84; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Franz M, 2018, NUCLEIC ACIDS RES, V46, pW60, DOI 10.1093/nar/gky311; Frasca M, 2017, NEUROCOMPUTING, V237, P397, DOI 10.1016/j.neucom.2015.11.096; Frasca M, 2015, J COMPUT BIOL, V22, P1057, DOI 10.1089/cmb.2014.0110; Frasca M, 2013, NEURAL NETWORKS, V43, P84, DOI 10.1016/j.neunet.2013.01.021; Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gliozzo J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60235-8; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Grust T, 2002, P109; Herman I, 2000, IEEE T VIS COMPUT GR, V6, P24, DOI 10.1109/2945.841119; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046072; Huntley RP, 2015, NUCLEIC ACIDS RES, V43, pD1057, DOI 10.1093/nar/gku1113; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Jankun J., 2020, TRANSLATION U TOLEDO, V7, P1, DOI 10.46570/utjms.vol7-2020-361; Jiang YX, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1037-6; Kalathur RKR, 2014, NUCLEIC ACIDS RES, V42, pD408, DOI 10.1093/nar/gkt1100; Kernighan B.W., 1970, BELL SYST TECH J, V49, P291, DOI DOI 10.1002/J.1538-7305.1970.TB01770.X; Kimelman D, 1994, INT S GRAPH DRAW, P218; Kohler S, 2019, NUCLEIC ACIDS RES, V47, pD1018, DOI 10.1093/nar/gky1105; Koul Hari K, 2013, Genes Cancer, V4, P342, DOI 10.1177/1947601913507951; Krogan NJ, 2015, MOL CELL, V58, P690, DOI 10.1016/j.molcel.2015.05.008; List M, 2016, NUCLEIC ACIDS RES, V44, pW98, DOI 10.1093/nar/gkw373; Martinez-Limon A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21061913; Mege RM, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028738; Mei Z, 2020, SIGNIFICANT EXPRESSI, DOI [10.1101/2020.04.18.047951, DOI 10.1101/2020.04.18.047951]; Mesiti M, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-5; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Munzner T, 2009, IEEE T VIS COMPUT GR, V15, P921, DOI 10.1109/TVCG.2009.111; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Nicot Christophe, 2015, J Cancer Sci, V2, DOI 10.13188/2377-9292.1000009; Noack A, 2009, LECT NOTES COMPUT SC, V5526, P257; Noubissi FK, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071442; O'Connell MP, 2009, PIGM CELL MELANOMA R, V22, P724, DOI 10.1111/j.1755-148X.2009.00627.x; Ortega OO, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2019.100748; Oughtred R, 2019, NUCLEIC ACIDS RES, V47, pD529, DOI 10.1093/nar/gky1079; Paduano Francesco, 2015, BMC Proc, V9, pS4, DOI 10.1186/1753-6561-9-S6-S4; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pavlopoulos GA, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-12; Peiris M, 2008, PATHOGENESIS AVIAN F, P56; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Perlasca P, 2016, P INT C INF INT WEB, P489; Perlasca P, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2959-2; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qin L, 2016, MOL CLIN ONCOL, V5, P382, DOI 10.3892/mco.2016.989; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rahiminejad S, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2746-0; Renoust B, 2015, COMPUT GRAPH FORUM, V34, P321, DOI 10.1111/cgf.12644; Salazar GA, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-129; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Sedlmair M, 2012, IEEE T VIS COMPUT GR, V18, P2431, DOI 10.1109/TVCG.2012.213; Siu KL, 2019, FASEB J, V33, P8865, DOI 10.1096/fj.201802418R; Skrlj B, 2019, J INTELL INF SYST, V53, P265, DOI 10.1007/s10844-019-00545-0; Strochlic L, 2008, DEVELOPMENT, V135, P333, DOI 10.1242/dev.009563; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Traag VA, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032801; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1; Wong AK, 2015, NUCLEIC ACIDS RES, V43, pW128, DOI 10.1093/nar/gkv486; Wu D, 2020, INT J ACCOUNT INF MA, V28, P184, DOI [10.1108/IJAIM-12-2018-0148, 10.1016/j.ijid.2020.03.004]; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Zhou NH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1835-8	84	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0244241	10.1371/journal.pone.0244241	http://dx.doi.org/10.1371/journal.pone.0244241			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351828	Green Published, gold			2022-12-27	WOS:000603071400024
J	Mostafa, A; Sabry, W; Mostafa, NS				Mostafa, Aya; Sabry, Walaa; Mostafa, Nayera S.			COVID-19-related stigmatization among a sample of Egyptian healthcare workers	PLOS ONE			English	Article							HIV STIGMA; SARS; DISCRIMINATION; IMPACT	Objectives To explore coronavirus disease 2019 (COVID-19)-related stigma and its associated factors among Egyptian physicians. Methods A cross-sectional study using an anonymous online questionnaire was conducted from 7 to 21 June 2020. The survey was distributed via social media and email to physicians working in Egypt through convenience sampling. Results 509 physicians participated in the study (mean age: 41.510.2). 138 (27.1%) participants were directly involved in the care of COVID-19 patients. 159 (31.2%) participants reported severe level of COVID-19-related stigma. Participants' mean overall COVID-19-related stigma score was 40.6 +/- 8.0. The mean subscale scores were: personalized stigma 26.0 +/- 5.7, disclosure concerns 9.3 +/- 2.2, negative self-image 6.9 +/- 1.6, and concern with public attitudes 24.4 +/- 4.9. In the multivariable regression analyses, the overall COVID-19-related stigma score was higher in participants with lower qualifications (beta = -0.19, 95% CI: 2.32, -0.64, p = 0.001), and in those working in a quarantine hospital (beta = 0.08, 95% CI: 0.01, 7.14, p = 0.050). Conclusions A considerable proportion of Egyptian physicians in this exploratory study experienced COVID-19-related stigmatization. These preliminary findings highlight the need for specific research and targeted interventions particularly addressing COVID-19-related stigmatization among healthcare workers.	[Mostafa, Aya; Mostafa, Nayera S.] Ain Shams Univ, Fac Med, Dept Commun Environm & Occupat Med, Cairo, Egypt; [Sabry, Walaa] Ain Shams Univ, Fac Med, Inst Psychiat, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University	Mostafa, NS (corresponding author), Ain Shams Univ, Fac Med, Dept Commun Environm & Occupat Med, Cairo, Egypt.	nayera_samy@med.asu.edu.eg	Sabry, Walaa/AFC-4348-2022; Sabry, Walaa/AAV-8887-2021; Mostafa, Aya/X-6686-2019	Sabry, Walaa/0000-0002-7361-5941; Sabry, Walaa/0000-0002-7361-5941; Mostafa, Aya/0000-0002-2803-2608; mostafa, nayera/0000-0002-4065-3685				Almutairi AF, 2018, J INFECT PUBLIC HEAL, V11, P187, DOI 10.1016/j.jiph.2017.06.011; [Anonymous], 2020, AL MONITOR; [Anonymous], 2020, JAKARTA POST; [Anonymous], 2020, TIMES INDIA; [Anonymous], 2020, NY TIMES; [Anonymous], 2020, GUARDIAN 1026; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Brooks S.K., 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8,10227, 10.1016/S0140-6736]; Charles B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-463; Di Fabio A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01938; Earnshaw VA, 2013, AM PSYCHOL, V68, P225, DOI 10.1037/a0032705; Fischer LS, 2019, DISASTER MED PUBLIC, V13, P989, DOI 10.1017/dmp.2018.157; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Holzemer WL, 2009, SAHARA J-J SOC ASP H, V6, P76, DOI 10.1080/17290376.2009.9724933; Johns Hopkins University, 2022, COVID 19 DASHB CTR S; Li ZJ, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0685-6; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Pulerwitz J, 2015, AIDS BEHAV, V19, P246, DOI 10.1007/s10461-014-0935-4; Quinn DM, 2009, J PERS SOC PSYCHOL, V97, P634, DOI 10.1037/a0015815; Ransing R, 2020, BRAIN BEHAV IMMUN, V89, P555, DOI 10.1016/j.bbi.2020.07.033; Rao D, 2012, AIDS PATIENT CARE ST, V26, P614, DOI 10.1089/apc.2012.0106; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Singh R, 2020, ASIAN J PSYCHIAT, V53, P102222, DOI [10.1016/j.ajp.2020.102222, DOI 10.1016/J.AJP.2020.10222232570096]; Siu JYM, 2008, QUAL HEALTH RES, V18, P729, DOI 10.1177/1049732308318372; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; STANGL AL, 2013, J INT AIDS SOC S2, V0016, DOI DOI 10.7448/IAS.16.3.1873424242268; Stangl AL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1271-3; Verma S, 2004, ANN ACAD MED SINGAP, V33, P743; World Health Organization, 2020, DIR GEN OP REM MED B; World Health Organization (WHO), 2020, HLTH TOP COR; Youm7, 2020, MEMB EG PHYS SYND DE; Zelaya CE, 2012, AIDS CARE, V24, P846, DOI 10.1080/09540121.2011.647674	36	47	47	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244172	10.1371/journal.pone.0244172	http://dx.doi.org/10.1371/journal.pone.0244172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338064	Green Published, gold			2022-12-27	WOS:000601313500012
J	Requena-Mullor, JM; Garcia-Garrido, JM; Garcia, PA; Rodriguez, E				Requena-Mullor, Juan M.; Garcia-Garrido, Jose Manuel; Garcia, Pedro Antonio; Rodriguez, Estefania			Climatic drivers of Verticillium dahliae occurrence in Mediterranean olive-growing areas of southern Spain	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; HOST-RANGE; WILT; MANAGEMENT; EPIDEMIOLOGY; IRRIGATION; PREVALENCE; INDICATORS; DIVERSITY; ORCHARDS	Verticillium wilt, caused by the soil-borne fungus Verticillium dahliae, is one of the most harmful diseases in Mediterranean olive-growing areas. Although, the effects of both soil temperature and moisture on V. dahliae are well known, there is scant knowledge about what climatic drivers affect the occurrence of the pathogen on a large scale. Here, we investigate what climatic drivers determine V. dahliae occurrence in olive-growing areas in southern Spain. In order to bridge this gap in knowledge, a large-scale field survey was carried out to collect data on the occurrence of V. dahliae in 779 olive groves in Granada province. Forty models based on competing combinations of climatic variables were fitted and evaluated using information-theoretic methods. A model that included a multiplicative combination of seasonal and extreme climatic variables was found to be the most viable one. Isothermality and the seasonal distribution of precipitation were the most important variables influencing the occurrence of the pathogen. The isothermal effect was in turn modulated by the seasonality of rainfall, and this became less negative as seasonality increases. Thus, V. dahliae occurs more frequently in olive-growing areas where the day-night temperature oscillation is lower than the summer-winter one. We also found that irrigation reduced the influence of isothermality on occurrence. Our results demonstrate that long-term compound climatic factors rather than "primary" variables, such as annual trends, can better explain the spatial patterns of V. dahliae occurrence in Mediterranean, southern Spain. One important implication of our study is that appropriate irrigation management, when temperature oscillation approaches optimal conditions for V. dahliae to thrive, may reduce the appearance of symptoms in olive trees.	[Requena-Mullor, Juan M.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Requena-Mullor, Juan M.] Univ Almeria, Andalusian Ctr Assessment & Monitoring Global Cha, Almeria, Spain; [Garcia-Garrido, Jose Manuel] CSIC, EEZ, Dept Soil Microbiol & Symbiot Syst, Granada, Spain; [Garcia, Pedro Antonio] Univ Granada, Dept Stat, OR, Granada, Spain; [Rodriguez, Estefania] Inst Agr & Fisheries Res & Training IFAPA, Sustainable Crop Protect, Almeria, Spain	Idaho; Boise State University; Universidad de Almeria; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); University of Granada	Rodriguez, E (corresponding author), Inst Agr & Fisheries Res & Training IFAPA, Sustainable Crop Protect, Almeria, Spain.	mestefania.rodriguez@juntadeandalucia.es	Rodríguez, Estefanía/C-3183-2016; Garcia Garrido, Jose/K-6386-2014	Rodríguez, Estefanía/0000-0003-0083-2950; Requena-Mullor, Juan Miguel/0000-0002-5120-7947; Garcia Garrido, Jose/0000-0001-9420-8926	Caja Rural Foundation of Granada	Caja Rural Foundation of Granada	E. Rodriguez; Caja Rural Foundation of Granada; https://www.fundacioncrg.com/; NO.	Al-Ahmad M. A., 1993, Bulletin OEPP (Organisation Europeenne et Mediterraneenne pour la Protection des Plantes), V23, P521, DOI 10.1111/j.1365-2338.1993.tb01364.x; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2012, US GEOL SURV DATA SE, DOI DOI 10.1016/J.MIMET.2011.04.001; [Anonymous], 2018, FARSOTTAFRETTIR, V11, P1, DOI DOI 10.1186/s13071-017-2573-y; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; [Anonymous], **DATA OBJECT**; BejaranoAlcazar J, 1996, PLANT DIS, V80, P1233, DOI 10.1094/PD-80-1233; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Bivand RS, 2018, TEST-SPAIN, V27, P716, DOI 10.1007/s11749-018-0599-x; Blanco-Lopez M. A., 1984, Phytopathologia Mediterranea, V23, P1; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Bracken LJ, 2008, HYDROL PROCESS, V22, P683, DOI 10.1002/hyp.6641; Bubici G, 2009, J PLANT PATHOL S, V91, pS4; Bubici G, 2012, PLANT SOIL, V352, P363, DOI 10.1007/s11104-011-1002-9; Burnham K.P, 2002, PRACTICAL INFORM THE; Calderon R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110664; CARDER JH, 1994, MODERN ASSAYS FOR PLANT PATHOGENIC FUNGI: IDENTIFICATION, DETECTION AND QUANTIFICATION, P91; Daayf F, 2015, CAN J PLANT PATHOL, V37, P8, DOI 10.1080/07060661.2014.989908; Desprez-Loustau ML, 2007, CAN J PLANT PATHOL, V29, P101, DOI 10.1080/07060660709507447; DEVAY JE, 1974, PHYTOPATHOLOGY, V64, P22, DOI 10.1094/Phyto-64-22; Doohan FM, 2003, EUR J PLANT PATHOL, V109, P755, DOI 10.1023/A:1026090626994; Gallien L, 2012, GLOBAL ECOL BIOGEOGR, V21, P1126, DOI 10.1111/j.1466-8238.2012.00768.x; Garcia-Cabello S, 2012, EUR J PLANT PATHOL, V133, P877, DOI 10.1007/s10658-012-0011-8; Greaves RK, 2006, BIOL CONSERV, V130, P239, DOI 10.1016/j.biocon.2005.12.017; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hao TX, 2020, FUNGAL BIOL REV, V34, P74, DOI 10.1016/j.fbr.2020.01.002; Hardi JW, 2007, GEN LINEAR MODELS EX; Hernandez MES, 1998, EUR J PLANT PATHOL, V104, P347, DOI 10.1023/A:1008624929989; Hiemstra J., 1998, COMPENDIUM VERTICILL; International Olive Oil Council, 2001, Oliva, P30; Ireland KB, 2019, INT J PEST MANAGE, V65, P207, DOI 10.1080/09670874.2018.1543910; Lopez-Escudero FJ, 2011, PLANT SOIL, V344, P1, DOI 10.1007/s11104-010-0629-2; Jimenez-Diaz RM, 2012, PLANT DIS, V96, P304, DOI 10.1094/PDIS-06-11-0496; Jimenez-Diaz RM, 2011, PHYTOPATHOLOGY, V101, P304, DOI 10.1094/PHYTO-07-10-0176; Katan J, 2017, J PLANT PATHOL, V99, P305; Keykhasaber M, 2018, EUR J PLANT PATHOL, V150, P21, DOI 10.1007/s10658-017-1273-y; Kish L, 1995, SCI 1995; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Kocmankova Eva, 2009, Plant Protection Science, V45, pS48; Launay M, 2014, AGR ECOSYST ENVIRON, V197, P147, DOI 10.1016/j.agee.2014.07.020; Lazaro R, 2001, J ARID ENVIRON, V48, P373, DOI 10.1006/jare.2000.0755; Levin AG, 2003, PLANT PATHOL, V52, P212, DOI 10.1046/j.1365-3059.2003.00809.x; Lionello P, 2006, DEV EARTH ENV SCI, V4, P1; Lopez-Escudero FJ, 2007, PLANT DIS, V91, P1372, DOI 10.1094/PDIS-91-11-1372; Lopez-Escudero FJ, 2005, J PHYTOPATHOL, V153, P238, DOI 10.1111/j.1439-0434.2005.00961.x; Martinez JDS, 2011, ESTUD GEOGR, V72, P203, DOI 10.3989/estgeogr.201109; McCain A.H, 1981, PLANTS RESISTANT SUS; Mercado-Blanco J, 2012, PLANT SOIL, V355, P17, DOI 10.1007/s11104-011-1091-5; Molina-Sanchis I, 2016, J HYDROL HYDROMECH, V64, P226, DOI 10.1515/johh-2016-0024; Montes F., 1997, Boletin de Sanidad Vegetal, Plagas, V23, P439; Navas-Cortes JA, 2008, PHYTOPATHOLOGY, V98, P167, DOI 10.1094/PHYTO-98-2-0167; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Perez-Rodriguez M, 2016, PLANT DIS, V100, P1880, DOI 10.1094/PDIS-09-15-1018-RE; Perez-Rodriguez M, 2015, PLANT DIS, V99, P488, DOI 10.1094/PDIS-06-14-0599-RE; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rodriguez E, 2008, EUR J PLANT PATHOL, V122, P287, DOI 10.1007/s10658-008-9287-0; Rodriguez E, 2011, J PLANT PATHOL, V93, P111; Rodriguez E, 2009, CROP PROT, V28, P46, DOI 10.1016/j.cropro.2008.08.009; Rodriguez Jurado D., 1993, Bulletin OEPP (Organisation Europeenne et Mediterraneenne pour la Protection des Plantes), V23, P513, DOI 10.1111/j.1365-2338.1993.tb01362.x; Rodriguez-Jurado D., 2007, Boletin de Sanidad Vegetal, Plagas, V33, P547; SCHNATHORST WC, 1966, PHYTOPATHOLOGY, V56, P1155; Schnathorst WC, 1981, FUNGAL WILT DIS PLAN, P81, DOI DOI 10.1016/B978-0-12-464450-2.50009-7; Serrhini M.N., 1995, OLIVAE, V58, P58; Steduto P., 2012, FAO IRRIGATION DRAIN; Sumner G, 2001, INT J CLIMATOL, V21, P219, DOI 10.1002/joc.600; THANASSOULOPOULOS CC, 1979, PLANT DIS REP, V63, P936; Tosi L., 1998, Oliva, P50; Tsror L, 2011, ISR J PLANT SCI, V59, P59, DOI 10.1560/IJPS.59.1.59; Turkington TK, 2004, CANADIAN PLANT DIS S, V84, P68; VIGOUROUX A, 1975, Annales de Phytopathologie, V7, P37; WILHELM S, 1965, PHYTOPATHOLOGY, V55, P310	73	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0232648	10.1371/journal.pone.0232648	http://dx.doi.org/10.1371/journal.pone.0232648			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378350	Green Published, Green Submitted, gold			2022-12-27	WOS:000605651300081
J	Riggs, MJ; Lin, N; Wang, C; Piecoro, DW; Miller, RW; Hampton, OA; Rao, M; Ueland, FR; Kolesar, JM				Riggs, McKayla J.; Lin, Nan; Wang, Chi; Piecoro, Dava W.; Miller, Rachel W.; Hampton, Oliver A.; Rao, Mahadev; Ueland, Frederick R.; Kolesar, Jill M.			DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; FATE DETERMINATION FACTOR; CYCLIN D1; MICROSATELLITE INSTABILITY; ANTITUMOR-ACTIVITY; PEMBROLIZUMAB; SAFETY	Objective DACH1 is a transcriptional repressor and tumor suppressor gene frequently mutated in melanoma, bladder, and prostate cancer. Loss of DACH1 expression is associated with poor prognostic features and reduced overall survival in uterine cancer. In this study, we utilized the Oncology Research Information Exchange Network (ORIEN) Avatar database to determine the frequency of DACH1 mutations in patients with endometrial cancer in our Kentucky population. Methods We obtained clinical and genomic data for 65 patients with endometrial cancer from the Markey Cancer Center (MCC). We examined the clinical attributes of the cancers by DACH1 status by comparing whole-exome sequencing (WES), RNA Sequencing (RNASeq), microsatellite instability (MSI), and tumor mutational burden (TMB). Results Kentucky women with endometrial cancer had an increased frequency of DACH1 mutations (12/65 patients, 18.5%) compared to The Cancer Genome Atlas (TCGA) endometrial cancer population (25/586 patients, 3.8%) with p-value = 1.04E-05. DACH1 mutations were associated with increased tumor mutation count in both TCGA (median 65 vs. 8972, p-value = 7.35E-09) and our Kentucky population (490 vs. 2160, p-value = 6.0E-04). DACH1 mutated patients have a higher tumor mutation burden compared to DACH1 wild-type (24 vs. 6.02, p-value = 4.29E-05). DACH1 mutations showed significant gene co-occurrence patterns with POLE, MLH1, and PMS2. DACH1 mutations were not associated with an increase in microsatellite instability at MCC (MSI-H) (p-value = 0.1342). Conclusions DACH1 mutations are prevalent in Kentucky patients with endometrial cancer. These mutations are associated with high tumor mutational burden and co-occur with genome destabilizing gene mutations. These findings suggest DACH1 may be a candidate biomarker for future trials with immunotherapy, particularly in endometrial cancers.	[Riggs, McKayla J.; Miller, Rachel W.; Ueland, Frederick R.; Kolesar, Jill M.] Univ Kentucky, Dept Obstet & Gynecol, Div Gynecol Oncol, Lexington, KY 40506 USA; [Lin, Nan; Kolesar, Jill M.] Univ Kentucky, Coll Pharm, Lexington, KY 40506 USA; [Wang, Chi] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY USA; [Wang, Chi; Miller, Rachel W.; Ueland, Frederick R.; Kolesar, Jill M.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Piecoro, Dava W.] Univ Kentucky, Dept Pathol & Lab Med, Div Pathol, Lexington, KY USA; [Hampton, Oliver A.] M2Gen, Dept Bioinformat & Biostat, Tampa, FL USA; [Rao, Mahadev] Manipal Acad Higher Educ, Dept Pharm Practice, Manipal Coll Pharmaceut Sci, Manipal, Karnataka, India	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; Manipal Academy of Higher Education (MAHE)	Kolesar, JM (corresponding author), Univ Kentucky, Dept Obstet & Gynecol, Div Gynecol Oncol, Lexington, KY 40506 USA.; Kolesar, JM (corresponding author), Univ Kentucky, Coll Pharm, Lexington, KY 40506 USA.; Kolesar, JM (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA.	jill.kolesar@uky.edu	Riggs, McKayla/GYV-4252-2022		NCI Cancer Center Support Grant [P30 CA177558]	NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this project was received by the NCI Cancer Center Support Grant (P30 CA177558). Dr. Piecoro's spouse's employment by Exelixis, Inc, is noted but completely unrelated to this project. His funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript in any way. Dr. Hampton is employed by M2Gen and serves as the chief officer of bioinformatics over the ORIEN pipeline. M2Gen did not play a role in the study design, data collection and analysis, or decision to publish. He and his department assisted in separating our patients into DACH1 mutated vs wild-type cohorts through the ORIEN software and provided the information regarding the ORIEN genomic processing pipeline for this paper. Dr. Hampton was not involved in the subsequent bioinformatics analysis. He did provide final proofreading of the manuscript prior to submission. The specific roles of these authors are articulated in the `author contributions' section.	American Cancer Society, 2019, CANC FACTS FIG 2015; Caligiuri MA, 2016, ONCOL ISSUES, V31, P62, DOI DOI 10.1080/10463356.2016.11884100; Cui QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013180; Dalton WS, 2018, CLIN PHARMACOL THER, V104, P23, DOI 10.1002/cpt.1051; Dillon JL, 2017, HUM PATHOL, V70, P121, DOI 10.1016/j.humpath.2017.10.022; Fenstermacher DA, 2011, CANCER J, V17, P528, DOI 10.1097/PPO.0b013e318238216e; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hufnagel RB, 2013, MOL CELL NEUROSCI, V54, P108, DOI 10.1016/j.mcn.2013.02.004; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kautto EA, 2017, ONCOTARGET, V8, P7452, DOI 10.18632/oncotarget.13918; Khabaz MN, 2017, ANN DIAGN PATHOL, V30, P47, DOI 10.1016/j.anndiagpath.2017.04.006; MARDON G, 1994, DEVELOPMENT, V120, P3473; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Melendez B, 2018, TRANSL LUNG CANCER R, V7, P661, DOI 10.21037/tlcr.2018.08.02; Nan FF, 2009, CANCER BIOL THER, V8, P1534, DOI 10.4161/cbt.8.16.8963; Niu BF, 2014, BIOINFORMATICS, V30, P1015, DOI 10.1093/bioinformatics/btt755; Ott PA, 2018, OBSTET GYNECOL SURV, V73, P26, DOI 10.1097/01.ogx.0000527579.58363.20; Ott PA, 2017, J CLIN ONCOL, V35, P2535, DOI 10.1200/JCO.2017.72.5952; Pacary E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2614; Popov VM, 2009, CANCER RES, V69, P5752, DOI 10.1158/0008-5472.CAN-08-3992; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SEER, SEER CANC STAT FACTS; Shankar A, 2016, AM J GASTROENTEROL, V111, pS130, DOI 10.14309/00000434-201610001-00277; Swistowska M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5084689; U.S. Cancer Statistics Working Group, 1999, US CANC STAT DAT VIS; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Zhao F, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.3	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244558	10.1371/journal.pone.0244558	http://dx.doi.org/10.1371/journal.pone.0244558			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378353	gold, Green Published			2022-12-27	WOS:000605651300008
J	Shirama, A; Takeda, T; Ohta, H; Iwanami, A; Toda, S; Kato, N				Shirama, Aya; Takeda, Toshinobu; Ohta, Haruhisa; Iwanami, Akira; Toda, Shigenobu; Kato, Nobumasa			Atypical alert state control in adult patients with ADHD: A pupillometry study	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CONTINUOUS PERFORMANCE-TEST; LOCUS-COERULEUS; YOUNG-CHILDREN; PUPIL DIAMETER; ADAPTIVE GAIN; ATTENTION; TASK; RESPONSES; SYMPTOMS	Although behavioral studies have repeatedly demonstrated that individuals with attention-deficit/hyperactivity disorder (ADHD) have deficits in alertness, little is known about its underlying neural basis. It is hypothesized that pupil diameter reflects the firing of norepinephrine (NE) neurons in the locus coeruleus (LC), and that the LC-NE neuromodulatory system for regulating alertness may be dysfunctional in ADHD. To clinically and non-invasively examine this hypothesis, we monitored the kinetics of pupil diameter in response to stimuli and compared them between adults with ADHD (n = 17) and typically developing (TD) adults (n = 23) during an auditory continuous performance task. Individuals in the ADHD group exhibited a significantly larger tonic pupil diameter, and a suppressed stimulus-evoked phasic pupil dilation, compared to those in the TD group. These findings provide support for the idea that the aberrant regulatory control of pupil diameter in adults with ADHD may be consistent with a compromised state of alertness resulting from a hyperactivated LC-NE system.	[Shirama, Aya; Takeda, Toshinobu; Ohta, Haruhisa; Kato, Nobumasa] Showa Univ, Med Inst Dev Disabil Res, Tokyo, Japan; [Shirama, Aya] NTT Corp, NTT Commun Sci Labs, Yokohama, Kanagawa, Japan; [Takeda, Toshinobu] Ryukoku Univ, Fac Letters, Kyoto, Japan; [Iwanami, Akira] Showa Univ, Sch Med, Dept Psychiat, Tokyo, Japan; [Toda, Shigenobu] Showa Univ, East Hosp, Dept Psychiat, Tokyo, Japan; [Toda, Shigenobu] Kanazawa Univ, Dept Psychiat & Behav Sci, Kanazawa, Ishikawa, Japan; [Shirama, Aya] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Prevent Intervent Psychiat Disorders, Tokyo, Japan	Showa University; Nippon Telegraph & Telephone Corporation; Ryukoku University; Showa University; Showa University; Kanazawa University; National Center for Neurology & Psychiatry - Japan	Shirama, A (corresponding author), Showa Univ, Med Inst Dev Disabil Res, Tokyo, Japan.; Shirama, A (corresponding author), NTT Corp, NTT Commun Sci Labs, Yokohama, Kanagawa, Japan.; Toda, S (corresponding author), Showa Univ, East Hosp, Dept Psychiat, Tokyo, Japan.; Toda, S (corresponding author), Kanazawa Univ, Dept Psychiat & Behav Sci, Kanazawa, Ishikawa, Japan.; Shirama, A (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Prevent Intervent Psychiat Disorders, Tokyo, Japan.	shiramaaya@gmail.com; Todashige@outlook.jp		Shirama, Aya/0000-0003-4174-5175	JSPS KAKENHI [JP19K24495]; Joint Usage/Research Program of the Medical Institute of Developmental Disabilities Research, Showa University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Joint Usage/Research Program of the Medical Institute of Developmental Disabilities Research, Showa University	This work was supported by grants from JSPS KAKENHI [Grant Number JP19K24495] to AS and the Joint Usage/Research Program of the Medical Institute of Developmental Disabilities Research, Showa University to TT and ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1995, J AM ACAD CHILD PSY, V34, P336, DOI 10.1097/00004583-199503000-00020; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anderson CJ, 2009, DEV PSYCHOBIOL, V51, P207, DOI 10.1002/dev.20352; Antshel KM, 2010, PSYCHOL MED, V40, P1909, DOI 10.1017/S0033291709992273; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Bast N, 2018, EUR J NEUROSCI, V47, P115, DOI 10.1111/ejn.13795; BEATTY J, 1982, PSYCHOPHYSIOLOGY, V19, P167, DOI 10.1111/j.1469-8986.1982.tb02540.x; Biederman J, 2000, AM J PSYCHIAT, V157, P816, DOI 10.1176/appi.ajp.157.5.816; Blaser E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04301; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; de Boor C., 2001, APPL MATH SCI, V27; Fredriksen M, 2014, ADHD-ATTEND DEFICIT, V6, P87, DOI 10.1007/s12402-014-0126-1; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Gilzenrat MS, 2003, SOC NEUROSCIENCE ABS; Gjervan B, 2012, J ATTEN DISORD, V16, P544, DOI 10.1177/1087054711413074; Gonon F, 2009, TRENDS NEUROSCI, V32, P2, DOI 10.1016/j.tins.2008.09.010; Gould TD, 2001, BIOL PSYCHIAT, V50, P633, DOI 10.1016/S0006-3223(01)01095-2; Granovetter MC, 2020, J NEUROSCI, V40, P3815, DOI 10.1523/JNEUROSCI.2680-19.2020; HART EL, 1995, J ABNORM CHILD PSYCH, V23, P729, DOI 10.1007/BF01447474; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Huang-Pollock CL, 2012, J ABNORM PSYCHOL, V121, P360, DOI 10.1037/a0027205; Janisse M.P., 1977, PUPILLOMETRY PSYCHOL; Janssen TWP, 2016, CLIN NEUROPHYSIOL, V127, P1351, DOI 10.1016/j.clinph.2015.10.051; Jepma M, 2011, J COGNITIVE NEUROSCI, V23, P1587, DOI 10.1162/jocn.2010.21548; Joshi G, 2017, J ATTEN DISORD, V21, P846, DOI 10.1177/1087054714543368; Joshi S, 2020, TRENDS COGN SCI, V24, P466, DOI 10.1016/j.tics.2020.03.005; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Karatekin C, 2009, INT J PSYCHOPHYSIOL, V73, P294, DOI 10.1016/j.ijpsycho.2009.05.001; Kleberg JL, 2017, AUTISM RES, V10, P539, DOI 10.1002/aur.1675; Lackschewitz H, 2008, PSYCHONEUROENDOCRINO, V33, P612, DOI 10.1016/j.psyneuen.2008.01.016; Larsen RS, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00021; McGee RA, 2000, J ABNORM CHILD PSYCH, V28, P415, DOI 10.1023/A:1005127504982; Mies GW, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02769; Moresi S, 2008, INT J PSYCHOPHYSIOL, V67, P124, DOI 10.1016/j.ijpsycho.2007.10.011; Mullane JC, 2011, J ATTEN DISORD, V15, P310, DOI 10.1177/1087054710366384; Murphy PR, 2011, PSYCHOPHYSIOLOGY, V48, P1531, DOI 10.1111/j.1469-8986.2011.01226.x; Pajkossy P, 2017, PSYCHOPHYSIOLOGY, V54, P1839, DOI 10.1111/psyp.12964; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Raz S, 2015, PSYCHONEUROENDOCRINO, V60, P7, DOI 10.1016/j.psyneuen.2015.05.008; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Salazar F, 2015, J AUTISM DEV DISORD, V45, P2283, DOI 10.1007/s10803-015-2361-5; Stevens MC, 2007, AM J PSYCHIAT, V164, P1737, DOI 10.1176/appi.ajp.2007.06050876; Sturm W, 2001, NEUROIMAGE, V14, pS76, DOI 10.1006/nimg.2001.0839; Takeda T, 2017, RES DEV DISABIL, V63, P59, DOI 10.1016/j.ridd.2017.02.011; Takeda T, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0525-7; Tinius TP, 2003, ARCH CLIN NEUROPSYCH, V18, P439, DOI 10.1016/S0887-6177(02)00144-0; Wainstein G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08246-w; Wong CG, 2012, BIOL PSYCHIAT, V71, P458, DOI 10.1016/j.biopsych.2011.11.011	48	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244662	10.1371/journal.pone.0244662	http://dx.doi.org/10.1371/journal.pone.0244662			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PP1TQ	33378354	gold, Green Published			2022-12-27	WOS:000605651300077
J	Cho, P; Cheung, SW; Boost, MV				Cho, Pauline; Cheung, Sin Wan; Boost, Maureen V.			Categorisation of myopia progression by change in refractive error and axial elongation and their impact on benefit of myopia control using orthokeratology	PLOS ONE			English	Article							ATROPINE; CHILDREN; LENGTH; TRIAL; ONSET; GUIDELINES; IMI	Aims To compare the value of pre-treatment axial elongation (AE) and changes in refractive sphere (M change) for predicting the success in orthokeratology (ortho-k), in order to better identify suitable candidates for myopia control. Methods This study further analysed the data of 66 subjects receiving 7-month ortho-k treatment, following a 7-month observation period, during which single-vision spectacles were worn. Rate of myopia progression was determined by AE and M change and subjects categorised as slow, moderate, or rapid progressors based on these changes. Outcomes of myopia control, based on the AE reduction after ortho-k, were classified as 'ineffectual', 'clinically insignificant', or 'beneficial'. Results Of the 20 subjects, initially categorised as slow by AE and, of whom 95% were similarly categorised by M change, none benefitted from ortho-k. In contrast, of the 22 subjects with moderate AE, 77% and 23% displaying slow and moderate M change, respectively, the majority (73%) benefitted from ortho-k lens wear. The 24 subjects with rapid AE were poorly identified by M change, with only 21% correctly categorised. The vast majority of rapid progressors showed significant benefit after ortho-k. Conclusion Progression of AE is a good indicator of subsequent success of ortho-k treatment. Delaying commencement of therapy is prudent for children with slow progression as results indicate that they would be unlikely to benefit from this intervention. As change in refractive error frequently underestimates rapid progression of AE, its value for identifying appropriate candidates for myopia control is poor.	[Cho, Pauline; Cheung, Sin Wan; Boost, Maureen V.] Hong Kong Polytech Univ, Sch Optometry, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Cheung, SW (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Hong Kong, Peoples R China.	peggy.cheung@polyu.edu.hk			PolyU and Menicon Co. Ltd, Japan [ZG50, ZG7X]	PolyU and Menicon Co. Ltd, Japan	This study was supported by Collaborative Research Agreements between PolyU and Menicon Co. Ltd, Japan (Pauline Cho; ZG50, ZG7X) (http://www.menicon.com).The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Charm J, 2013, OPTOMETRY VISION SCI, V90, P530, DOI 10.1097/OPX.0b013e318293657d; Chen CN, 2013, INVEST OPHTH VIS SCI, V54, P6510, DOI 10.1167/iovs.13-12527; Cheng D, 2010, ARCH OPHTHALMOL-CHIC, V128, P12, DOI 10.1001/archophthalmol.2009.332; Cheung SW, 2019, CONTACT LENS ANTERIO, V42, P392, DOI 10.1016/j.clae.2018.10.006; Chia A, 2016, OPHTHALMOLOGY, V123, P391, DOI 10.1016/j.ophtha.2015.07.004; Cho P, 2019, CLIN EXP OPTOM, V102, P364, DOI 10.1111/cxo.12839; Cho P, 2012, INVEST OPHTH VIS SCI, V53, P7077, DOI 10.1167/iovs.12-10565; Dong LM, 2013, INVEST OPHTH VIS SCI, V54, P7871, DOI 10.1167/iovs.13-12403; Driffield T, 2007, MED DECIS MAKING, V27, P178, DOI 10.1177/0272989X06297390; Fang PC, 2010, J OCUL PHARMACOL TH, V26, P341, DOI 10.1089/jop.2009.0135; Flitcroft DI, 2019, INVEST OPHTH VIS SCI, V60, pM20, DOI 10.1167/iovs.18-25957; Gifford KL, 2019, INVEST OPHTH VIS SCI, V60, pM184, DOI 10.1167/iovs.18-25977; Hiraoka T, 2012, INVEST OPHTH VIS SCI, V53, P3913, DOI 10.1167/iovs.11-8453; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Hsu CC, 2017, BRIT J OPHTHALMOL, V101, P1611, DOI 10.1136/bjophthalmol-2016-309299; Jiang ZP, 2013, EYE CONTACT LENS, V39, P277, DOI 10.1097/ICL.0b013e318296790b; Kesarwani SS, 2019, INDIAN J OPHTHALMOL, V67, P461, DOI 10.4103/ijo.IJO_1457_18; Lam CSY, 2020, BRIT J OPHTHALMOL, V104, P363, DOI 10.1136/bjophthalmol-2018-313739; Lam CSY, 2014, BRIT J OPHTHALMOL, V98, P40, DOI 10.1136/bjophthalmol-2013-303914; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2018, PROG RETIN EYE RES, V62, P134, DOI 10.1016/j.preteyeres.2017.09.004; Mutti DO, 2007, INVEST OPHTH VIS SCI, V48, P2510, DOI 10.1167/iovs.06-0562; Paune J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/507572; Rabbetts RB, 2007, BENNETT RABBETTS CLI, P425; Ruiz-Pomeda A, 2018, GRAEF ARCH CLIN EXP, V256, P1011, DOI 10.1007/s00417-018-3906-z; Sankaridurg P, 2019, OPHTHAL PHYSL OPT, V39, P294, DOI 10.1111/opo.12621; Santodomingo-Rubido J, 2012, INVEST OPHTH VIS SCI, V53, P5060, DOI 10.1167/iovs.11-8005; Swarbrick HA, 2015, OPHTHALMOLOGY, V122, P620, DOI 10.1016/j.ophtha.2014.09.028; Wolffsohn JS, 2020, CONTACT LENS ANTERIO, V43, P9, DOI 10.1016/j.clae.2019.11.002; Wu PC, 2019, EYE, V33, P3, DOI 10.1038/s41433-018-0139-7; Wu PC, 2016, ASIA-PAC J OPHTHALMO, V5, P386, DOI 10.1097/APO.0000000000000236; Yam JC, 2019, OPHTHALMOLOGY, V126, P113, DOI 10.1016/j.ophtha.2018.05.029; Zadnik K, 2015, JAMA OPHTHALMOL, V133, P683, DOI 10.1001/jamaophthalmol.2015.0471; Zhao JL, 2004, OPTOMETRY VISION SCI, V81, P49, DOI 10.1097/00006324-200401000-00010	34	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0243416	10.1371/journal.pone.0243416	http://dx.doi.org/10.1371/journal.pone.0243416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373370	gold, Green Published			2022-12-27	WOS:000603612300059
J	Hummel, T; Meves, SH; Breuer-Kaiser, A; Dusterwald, JO; Muhlberger, D; Mumme, A; Neubauer, H				Hummel, Thomas; Meves, Saskia Hannah; Breuer-Kaiser, Andreas; Duesterwald, Jan-Ole; Muehlberger, Dominic; Mumme, Achim; Neubauer, Horst			Perioperative changes of response to antiplatelet medication in vascular surgery patients	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PLATELET-AGGREGATION; ASPIRIN RESISTANCE; ADENOSINE-DIPHOSPHATE; CLOPIDOGREL TREATMENT; BLOOD-PLATELETS; AGGREGOMETRY; REACTIVITY; INHIBITION; PREVALENCE	Introduction Reduced antiplatelet activity of aspirin (ALR) or clopidogrel (CLR) is associated with an increased risk of thromboembolic events. The reported prevalence data for low-responders vary widely and there have been few investigations in vascular surgery patients even though they are at high risk for thromb-embolic complications. The aim of this prospective observational monocentric study was to elucidate possible changes in ALR or CLR after common vascular procedures. Methods Activity of aspirin and clopidogrel was measured by impedance aggregometry using a multiple electrode aggregometer (Multiplate (R)). Possible risk factors for ALR or CLR were identified by demographical, clinical data and laboratory parameters. In addition, a follow-up aggregometry was performed after completion of the vascular procedure to identify changes in antiplatelet response. Results A total of 176 patients taking antiplatelet medications aspirin and/or clopidogrel with peripheral artery disease (PAD) and/or carotid stenosis (CS) were included in the study. The prevalence of ALR was 13.1% and the prevalence of CLR was 32% in the aggregometry before vascular treatment. Potential risk factors identified in the aspirin group were concomitant insulin medication (p = 0.0006) and elevated C-reactive protein (CRP) (p = 0.0021). The overall ALR increased significantly postoperatively to 27.5% (p = 0.0006); however, there was no significant change in CLR that was detected. In a subgroup analysis elevation of the platelet count was associated with a post-procedure increase of ALR incidence. Conclusion The incidence of ALR in vascular surgery patients increases after vascular procedures. An elevated platelet count was detected as a risk factor. Further studies are necessary to analyse this potential influence on patency rates of vascular reconstructions.	[Hummel, Thomas; Duesterwald, Jan-Ole; Muehlberger, Dominic; Mumme, Achim] Ruhr Univ Bochum, Dept Vasc Surg, St Josef Hosp, Katholisches Klinikum Bochum, Bochum, Germany; [Meves, Saskia Hannah] Ruhr Univ Bochum, Dept Neurol, St Josef Hosp, Katholisches Klinikum Bochum, Bochum, Germany; [Breuer-Kaiser, Andreas] Ruhr Univ Bochum, Dept Anaesthesiol, St Josef Hosp, Katholisches Klinikum Bochum, Bochum, Germany; [Neubauer, Horst] Ruhr Univ Bochum, Dept Cardiol, St Josef Hosp, Katholisches Klinikum Bochum, Bochum, Germany; [Meves, Saskia Hannah] St Marien Hosp, Dept Neurol, Mulheim, Germany; [Duesterwald, Jan-Ole] Bethanien Hosp, Dept Vasc Surg, Moers, Germany; [Neubauer, Horst] St Elizabeth Hosp, Dept Cardiol, Herten, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; St. Marien Hospital	Hummel, T (corresponding author), Ruhr Univ Bochum, Dept Vasc Surg, St Josef Hosp, Katholisches Klinikum Bochum, Bochum, Germany.	thomas.hummel@rub.de	Mühlberger, Dominic/AAQ-9390-2021	Mühlberger, Dominic/0000-0001-9636-5108; Hummel, Thomas/0000-0001-6931-5930				Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Al-Azzam SI, 2012, ACTA CARDIOL, V67, P445, DOI 10.1080/AC.67.4.2170686; [Anonymous], 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19370; Bedenis R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000535.pub3; Ben-Dor I, 2009, AM J CARDIOL, V104, P227, DOI 10.1016/j.amjcard.2009.03.022; Bernlochner I, 2016, VASA, V45, P157, DOI 10.1024/0301-1526/a000510; Busch L, 2021, PLATELETS, V32, P391, DOI 10.1080/09537104.2020.1742314; Franks ZG, 2010, ANN NY ACAD SCI, V1207, P11, DOI 10.1111/j.1749-6632.2010.05733.x; Frelinger AL, 2006, CIRCULATION, V113, P2888, DOI 10.1161/CIRCULATIONAHA.105.596627; Guthikonda S, 2008, J AM COLL CARDIOL, V52, P743, DOI 10.1016/j.jacc.2008.05.031; Hagedorn F, 2013, EUR J ANAEST, V30, P66; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; HARDEMAN MR, 1989, THROMB RES, V54, P719, DOI 10.1016/0049-3848(89)90136-9; Hovens MMC, 2007, AM HEART J, V153, P175, DOI 10.1016/j.ahj.2006.10.040; Hummel T, 2016, CHIRURG, V87, P446, DOI 10.1007/s00104-016-0168-3; Karolczak K, 2013, PHARMACOL RES, V74, P7, DOI 10.1016/j.phrs.2013.04.010; Krasopoulos G, 2008, BMJ-BRIT MED J, V336, P195, DOI 10.1136/bmj.39430.529549.BE; Kreutz RP, 2007, BLOOD COAGUL FIBRIN, V18, P713, DOI 10.1097/MBC.0b013e328201c77e; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Lordkipanidze M, 2007, EUR HEART J, V28, P1702, DOI 10.1093/eurheartj/ehm226; Markuszewski L, 2006, BASIC CLIN PHARMACOL, V98, P503, DOI 10.1111/j.1742-7843.2006.pto_343.x; Marquis-Gravel G, 2020, JAMA CARDIOL, V5, P598, DOI 10.1001/jamacardio.2020.0116; McCabe DJH, 2004, BRIT J HAEMATOL, V125, P777, DOI 10.1111/j.1365-2141.2004.04983.x; MOAKE JL, 1988, BLOOD, V71, P1366; Modica A, 2007, J THROMB HAEMOST, V5, P507, DOI 10.1111/j.1538-7836.2007.02378.x; Muller-Schunk S, 2008, AM J NEURORADIOL, V29, P786, DOI 10.3174/ajnr.A0917; Neubauer H, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-3; Payne DA, 2004, THROMB HAEMOSTASIS, V92, P89, DOI 10.1160/th03-12-0758; Pedersen OH, 2018, CYTOM PART B-CLIN CY, V94, P918, DOI 10.1002/cyto.b.21642; Perneby C, 2006, THROMB HAEMOSTASIS, V95, P652, DOI 10.1160/TH05-10-0653; Price MJ, 2009, AM J CARDIOL, V103, P1339, DOI 10.1016/j.amjcard.2009.01.341; Rahe-Meyer N, 2008, ANESTH ANALG, V107, P1791, DOI 10.1213/ane.0b013e3181865733; Rajagopalan S, 2007, J THROMB HAEMOST, V5, P2028, DOI 10.1111/j.1538-7836.2007.02694.x; Schwartz KA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-46; Sibbing D, 2011, THROMB HAEMOSTASIS, V106, P191, DOI 10.1160/TH11-01-0040; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Snoep JD, 2007, ARCH INTERN MED, V167, P1593, DOI 10.1001/archinte.167.15.1593; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Spiliopoulos S, 2013, J AM COLL CARDIOL, V61, P2428, DOI 10.1016/j.jacc.2013.03.036; SWEENEY JD, 1989, AM J CLIN PATHOL, V92, P676, DOI 10.1093/ajcp/92.5.676; Toth O, 2006, THROMB HAEMOSTASIS, V96, P781, DOI 10.1160/TH06-05-0242; Velik-Salchner C, 2008, ANESTH ANALG, V107, P1798, DOI 10.1213/ane.0b013e31818524c1; WATTS SE, 1986, THROMB RES, V44, P365, DOI 10.1016/0049-3848(86)90011-3; Wurtz M, 2012, THROMB RES, V129, P56, DOI 10.1016/j.thromres.2011.08.019; Zimmermann N, 2008, THROMB HAEMOSTASIS, V100, P379, DOI 10.1160/TH08-01-0056	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244330	10.1371/journal.pone.0244330	http://dx.doi.org/10.1371/journal.pone.0244330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373378	Green Published, gold			2022-12-27	WOS:000603612300043
J	Pawlos, A; Broncel, M; Wlazlowska, E; Jablonowska, E; Gorzelak-Pabis, P				Pawlos, Agnieszka; Broncel, Marlena; Wlazlowska, Ewelina; Jablonowska, Elzbieta; Gorzelak-Pabis, Paulina			Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations	PLOS ONE			English	Article							DISEASE; INDIVIDUALS	Background HIV patients are at increased cardiovascular risk while available European cardiovascular recommendations are ambiguous. Methods Retrospective analysis of 389 HIV-patients was conducted. Cardiovascular risk was determined by D:A:D, Framingham and SCORE scales. Patients were divided into risk groups as recommended by EACS 2019, PTN AIDS 2019 and ESC/EAS 2019 Guidelines and hypolipemic treatment was evaluated. Results In total, 389 HIV-positive patients took part in the study, most of whom were men (n = 312, 80.4%), mean age 41.69 +/- 10years. Mean lipid levels among all HIV patients: Tch:177.2 +/- 36mg/dl, HDL:48.9 +/- 18mg/dl, LDL:103.8 +/- 31mg/dl, TG:143.3 +/- 81mg/dl, AIP:0.45 +/- 0.3, non-HDL:129.2 +/- 36 mg/dl. Most of the participants (n = 360, 92.5%) were assigned to the high cardiovascular risk group according to ESC/EAS and PTN AIDS guidelines. The achievement of therapeutic LDLs according to ESC/EAS was 10.3% for those at very high cardiovascular risk (8.7% on lipid lowering treatment vs. 16.7% without hypolipemic drugs) and 12.0% (5.8% treated vs. 13.6% untreated) at high cardiovascular risk; according to PTN AIDS,17.2% achievement was noted by the very high-risk group (13% treated vs. 33.3% untreated), and 45.9% for the high-risk group (37.7% treated vs. 48.0% untreated); according to EACS Guidelines, 2.5% achievement in secondary prevention (3.8% treatedvs. 0% untreated) and 24.7% in primary prevention (22.2% treated vs. 26.1% untreated). Mean doses of statins were 8.75mg +/- 6mg (Rosuvastatin) and 22.35 +/- 19mg (Atorvastatin). Conclusions The achievement of therapeutic LDLs by all recommendations is unsatisfactory, and generally worse in patients on lipid lowering therapy. Hypolipemic treatment of our HIV patients is based on low doses of statins, even in secondary prevention.	[Pawlos, Agnieszka; Broncel, Marlena; Gorzelak-Pabis, Paulina] Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lodz, Poland; [Wlazlowska, Ewelina; Jablonowska, Elzbieta] Med Univ Lodz, Dept Infect Dis & Hepatol, Lodz, Poland	Medical University Lodz; Medical University Lodz	Gorzelak-Pabis, P (corresponding author), Med Univ Lodz, Dept Internal Dis & Clin Pharmacol, Lodz, Poland.	pau.gorzelak@gmail.com		Jablonowska, Elzbieta/0000-0002-7282-1225; Gorzelak-Pabis, Paulina/0000-0001-7547-8218; Pawlos, Agnieszka/0000-0003-1058-0590; Broncel, Marlena/0000-0003-3659-8115				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Bandosz P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8136; Bednasz C, 2016, CURR VASC PHARMACOL, V14, P280, DOI 10.2174/1570161114666160106151652; Boccara F, 2020, J AM COLL CARDIOL, V75, P2570, DOI 10.1016/j.jacc.2020.03.025; Boccara F, 2017, AM HEART J, V183, P91, DOI 10.1016/j.ahj.2016.10.013; Burkholder GA, 2018, J CLIN LIPIDOL, V12, P988, DOI 10.1016/j.jacl.2018.03.082; Croxford S, 2017, LANCET PUBLIC HEALTH, V2, pE35, DOI 10.1016/S2468-2667(16)30020-2; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Dobiasova M, 2006, Vnitr Lek, V52, P64; European AIDS Clinical Society, EACS GUID; Feinstein MJ, 2019, CIRCULATION, V140, pE98, DOI 10.1161/CIR.0000000000000695; Friis-Moller N, 2016, EUR J PREV CARDIOL, V23, P214, DOI 10.1177/2047487315579291; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Gazzola L, 2021, HIV MED, V22, P140, DOI 10.1111/hiv.12984; Grinspoon SK, 2019, AM HEART J, V212, P23, DOI 10.1016/j.ahj.2018.12.016; Hsue PY, 2012, J INFECT DIS, V205, pS375, DOI 10.1093/infdis/jis200; Kwiatkowska W, 2011, POSTEP HIG MED DOSW, V65, P770, DOI 10.5604/17322693.967075; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Mastrorosa I, 2018, P 25 C RETR OPP INF; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Niroumand Shabnam, 2015, Med J Islam Repub Iran, V29, P240; Noumegni SR, 2017, JRSM CARDIOVASC DIS, V6, DOI 10.1177/2048004017740478; Pinkas J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234820; Polish AIDS Society, REK PTN AIDS; Russell EAB, 2020, HIV MED, V21, P418, DOI 10.1111/hiv.12843; Shah ASV, 2018, CIRCULATION, V138, P1100, DOI 10.1161/CIRCULATIONAHA.117.033369; Sliz D, 2013, KARDIOL POL, V71, P253, DOI 10.5603/KP.2013.0037; So-Armah K, 2018, CURR HIV-AIDS REP, V15, P233, DOI 10.1007/s11904-018-0400-5; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Taramasso L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223181; Triant VA, 2018, CIRCULATION, V137, P2203, DOI [10.1161/CIRCULATIONAHA.117.028975, 10.1161/circulationaha.117.028975]; van Zoest RA, 2017, EUR J PREV CARDIOL, V24, P1297, DOI 10.1177/2047487317714350; Wing E.J., 2017, T AM CLIN CLIMATOL A, V128, P131, DOI DOI 10.1016/J.IJID.2016.10.004; World Health Organization, NUMB PEOPL ALL AG LI; Zdrojewski T, 2015, KARDIOL POL, V73, P958, DOI 10.5603/KP.2015.0182	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244675	10.1371/journal.pone.0244675	http://dx.doi.org/10.1371/journal.pone.0244675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373417	gold, Green Published			2022-12-27	WOS:000603612300001
J	Zaballa, O; Perez, A; Inhiesto, EG; Ayesta, TA; Lozano, JA				Zaballa, Onintze; Perez, Aritz; Gomez Inhiesto, Elisa; Acaiturri Ayesta, Teresa; Lozano, Jose A.			Identifying common treatments from Electronic Health Records with missing information. An application to breast cancer	PLOS ONE			English	Article							CLINICAL PATHWAY PATTERNS; EDIT DISTANCE	The aim of this paper is to analyze the sequence of actions in the health system associated with a particular disease. In order to do that, using Electronic Health Records, we define a general methodology that allows us to: (i) identify the actions in the health system associated with a disease; (ii) identify those patients with a complete treatment for the disease; (iii) and discover common treatment pathways followed by the patients with a specific diagnosis. The methodology takes into account the characteristics of the EHRs, such as record heterogeneity and missing information. As an example, we use the proposed methodology to analyze breast cancer disease. For this diagnosis, 5 groups of treatments, which fit in with medical practice guidelines and expert knowledge, were obtained.	[Zaballa, Onintze; Perez, Aritz; Lozano, Jose A.] BCAM Basque Ctr Appl Math, Bilbao, Spain; [Gomez Inhiesto, Elisa; Acaiturri Ayesta, Teresa] Hosp Univ Cruces, Baracaldo, Spain; [Lozano, Jose A.] Univ Basque Country UPV EHU, Intelligent Syst Grp, Dept Comp Sci & Artificial Intelligence, San Sebastian, Spain	Basque Center for Applied Mathematics (BCAM); Hospital Universitario Cruces; University of Basque Country	Zaballa, O (corresponding author), BCAM Basque Ctr Appl Math, Bilbao, Spain.	ozaballa@bcamath.org	Pérez, Aritz/P-2247-2017; Zaballa, Onintze/AAE-5311-2021; Lozano, Jose A./F-5120-2010	Pérez, Aritz/0000-0002-8128-1099; Zaballa, Onintze/0000-0002-5826-7715; Acaiturri-Ayesta, Maria Teresa/0000-0002-9707-2136; Lozano, Jose A./0000-0002-4683-8111	Basque Government through the BERC 2018-2021 program; ELKARTEK program [IT1244-19]; Spanish Ministry of Science, Innovation and Universities: BCAM Severo Ochoa accreditation [SEV-2017-0718, SVP-2014-068574]; AEI/FEDER, UE [PID2019-104966GB-I00, TIN2016-78365-R, TIN2017-82626-R]; Basque Government EJ-GV 2019; grant "Artificial Intelligence in BCAM" [EXP. 2019/00432]	Basque Government through the BERC 2018-2021 program(Basque Government); ELKARTEK program; Spanish Ministry of Science, Innovation and Universities: BCAM Severo Ochoa accreditation; AEI/FEDER, UE; Basque Government EJ-GV 2019; grant "Artificial Intelligence in BCAM"	This research has been partially supported by the Basque Government through the BERC 2018-2021 program, ELKARTEK program, IT1244-19 and the grant "Artificial Intelligence in BCAM number EXP. 2019/00432", and by the Spanish Ministry of Science, Innovation and Universities: BCAM Severo Ochoa accreditation SEV-2017-0718 and SVP-2014-068574, PID2019-104966GB-I00, TIN2016-78365-R, and through the project TIN2017-82626-R funded by (AEI/FEDER, UE). OZ also holds a grant of the Basque Government EJ-GV 2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DEF EL MED REC NCI D; Cardoso F, 2019, ANN ONCOL, V30, P1194, DOI 10.1093/annonc/mdz173; Cardoso F, 2018, ANN ONCOL, V29, P1634, DOI 10.1093/annonc/mdy192; Chen L., 2004, P 30 INT C VER LARG, V30, P792, DOI DOI 10.1016/B978-012088469-8/50070-X; Deja R, 2017, INFORM SCIENCES, V384, P157, DOI 10.1016/j.ins.2016.07.066; Dong G., 2007, SEQUENCE DATA MINING, V33; Fernandez-Llatas C, 2010, IEEE ENG MED BIO, P6178, DOI 10.1109/IEMBS.2010.5627760; Hu J., 2016, HEALTHCARE INFORM MA, VHI, P529, DOI [10.1007/978-3-319-20765-0_31, DOI 10.1007/978-3-319-20765-0_31]; Huang ZX, 2014, J BIOMED INFORM, V47, P39, DOI 10.1016/j.jbi.2013.09.003; Huang ZX, 2012, ARTIF INTELL MED, V56, P35, DOI 10.1016/j.artmed.2012.06.002; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jin X., 2017, ENCYCL MACH LEARN DA, P697, DOI [10.1007/978-1-4899-7687-1_432, DOI 10.1007/978-1-4899-7687-1, DOI 10.1007/978-1-4899-7687-1_432]; Kaufman L., 2009, FINDING GROUPS DATA; Kovalchuk SV, 2018, J BIOMED INFORM, V82, P128, DOI 10.1016/j.jbi.2018.05.004; Lakshmanan G.T., 2013, LNCS, V8094, P323, DOI [10.1007/978-3-642-40176-3_27, DOI 10.1007/978-3-642-40176-3_27]; Li YJ, 2007, IEEE T PATTERN ANAL, V29, P1091, DOI 10.1109/TPAMI.2007.1070; Marteau PF, 2009, IEEE T PATTERN ANAL, V31, P306, DOI 10.1109/TPAMI.2008.76; MARZAL A, 1993, IEEE T PATTERN ANAL, V15, P926, DOI 10.1109/34.232078; Organization WH, 2004, ICD 10 INT STAT CLAS, V2nd; Rojas E, 2016, J BIOMED INFORM, V61, P224, DOI 10.1016/j.jbi.2016.04.007; Schubert E, 2019, LECT NOTES COMPUT SC, V11807, P171, DOI 10.1007/978-3-030-32047-8_16; van der Aalst W, 2004, IEEE T KNOWL DATA EN, V16, P1128, DOI 10.1109/TKDE.2004.47; Wang X, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P85, DOI 10.1145/2623330.2623754; Zhang YY, 2015, J BIOMED INFORM, V58, P186, DOI 10.1016/j.jbi.2015.09.009	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244004	10.1371/journal.pone.0244004	http://dx.doi.org/10.1371/journal.pone.0244004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373363	Green Published, Green Submitted, gold			2022-12-27	WOS:000603612300013
J	Dylewski, JF; Tonsawan, P; Garcia, G; Lewis, L; Blaine, J				Dylewski, James F.; Tonsawan, Pantipa; Garcia, Gabriela; Lewis, Linda; Blaine, Judith			Podocyte-specific knockout of the neonatal Fc receptor (FcRn) results in differential protection depending on the model of glomerulonephritis	PLOS ONE			English	Article							CLASS-II EXPRESSION; ANTI-GBM NEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; CELLULAR CRESCENTS; IMMUNE-COMPLEXES; IGG HOMEOSTASIS; ALBUMIN; PATHWAY; MOUSE; ACTIVATION	Podocytes have been proposed to be antigen presenting cells (APCs). In traditional APCs, the neonatal Fc receptor (FcRn) is required for antigen presentation and global knockout of FcRn protects against glomerulonephritis. Since podocytes express FcRn, we sought to determine whether the absence of podocyte FcRn ameliorates immune-mediated disease. We examined MHCII and costimulatory markers expression in cultured wild type (WT) and FcRn knockout (KO) podocytes. Interferon gamma (IFN gamma) induced MHCII expression in both WT and KO podocytes but did not change CD80 expression. Neither WT nor KO expressed CD86 or inducible costimulatory ligand (ICOSL) at baseline or with IFN gamma. Using an antigen presentation assay, WT podocytes but not KO treated with immune complexes induced a modest increase in IL-2. Induction of the anti-glomerular basement membrane (anti-GBM) model resulted in a significant decrease in glomerular crescents in podocyte-specific FcRn knockout mouse (podFcRn KO) versus controls but the overall percentage of crescents was low. To examine the effects of the podocyte-specific FcRn knockout in a model with a longer autologous phase, we used the nephrotoxic serum nephritis (NTS) model. We found that the podFcRn KO mice had significantly reduced crescent formation and glomerulosclerosis compared to control mice. This study demonstrates that lack of podocyte FcRn is protective in immune mediated kidney disease that is dependent on an autologous phase. This study also highlights the difference between the anti-GBM model and NTS model of disease.	[Dylewski, James F.; Garcia, Gabriela; Lewis, Linda; Blaine, Judith] Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Dylewski, James F.] Denver Hlth Med Ctr, Dept Nephrol, Denver, CO 80204 USA; [Tonsawan, Pantipa] Khon Kaen Univ, Div Nephrol, Khon Kaen, Thailand	University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; Khon Kaen University	Dylewski, JF (corresponding author), Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.; Dylewski, JF (corresponding author), Denver Hlth Med Ctr, Dept Nephrol, Denver, CO 80204 USA.	James.Dylewski@cuanschutz.edu		Dylewski, James/0000-0002-8158-8605	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [1R01DK104264-01A1, 5R01DK082509-05, 5T32DK007135-42]; Norman Coplon Satellite Healthcare grant; Denver Health Medical Center	National Institute of Diabetes and Digestive and Kidney Disease (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Norman Coplon Satellite Healthcare grant; Denver Health Medical Center	This work was supported by the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [grants 1R01DK104264-01A1, 5R01DK082509-05, and 5T32DK007135-42] a Norman Coplon Satellite Healthcare grant, and a Denver Health Medical Center Pilot Grant.	Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; [Anonymous], 2015, AM J KIDNEY DIS, V66, pS79; [Anonymous], 2012, REGEN MED S3, V7, pS14; ASSMANN KJM, 1985, VIRCHOWS ARCH A, V406, P285, DOI 10.1007/BF00704298; Baker K, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00664, 10.3389/fimmu.2014.00408]; Baker K, 2011, P NATL ACAD SCI USA, V108, P9927, DOI 10.1073/pnas.1019037108; BAUDEAU C, 1994, EXP NEPHROL, V2, P306; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Chalmers SA, 2015, J AUTOIMMUN, V57, P42, DOI 10.1016/j.jaut.2014.11.007; COLLINS T, 1984, P NATL ACAD SCI-BIOL, V81, P4917, DOI 10.1073/pnas.81.15.4917; Corradetti C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163611; Dai Y, 2017, KIDNEY INT, V92, P1444, DOI 10.1016/j.kint.2017.04.026; Dalloneau E, 2016, ONCOTARGET, V7, P54415, DOI 10.18632/oncotarget.10074; Dickson LE, 2014, J AM SOC NEPHROL, V25, P443, DOI 10.1681/ASN.2013090950; Dobrinskikh E, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12510; Dylewski J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209732; Eller K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067693; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; Frigo G, 2016, IMMUNOBIOLOGY, V221, P1329, DOI 10.1016/j.imbio.2016.08.002; Gaut JP, 2014, HUM PATHOL, V45, P628, DOI 10.1016/j.humpath.2013.10.030; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Goldwich A, 2013, J AM SOC NEPHROL, V24, P906, DOI 10.1681/ASN.2012020133; Goto K, 2016, INT IMMUNOL, V28, P197, DOI 10.1093/intimm/dxv067; Haymann JP, 2000, J AM SOC NEPHROL, V11, P632, DOI 10.1681/ASN.V114632; Hoppe John M, 2014, Methods Mol Biol, V1169, P159, DOI 10.1007/978-1-4939-0882-0_15; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kuo TT, 2010, J CLIN IMMUNOL, V30, P777, DOI 10.1007/s10875-010-9468-4; Li S, 2000, CLIN EXP IMMUNOL, V122, P453, DOI 10.1046/j.1365-2249.2000.01387.x; Li S, 1998, J EXP MED, V188, P597, DOI 10.1084/jem.188.3.597; Moeller MJ, 2004, J AM SOC NEPHROL, V15, P61, DOI 10.1097/01.ASN.0000102468.37809.C6; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056316; MULLER GA, 1988, NEPHRON, V49, P132, DOI 10.1159/000185039; Olaru F, 2014, J AM SOC NEPHROL, V25, P918, DOI 10.1681/ASN.2013050498; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rizzo P, 2017, AM J PATHOL, V187, P2441, DOI 10.1016/j.ajpath.2017.07.004; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Salant DJ, 2016, J AM SOC NEPHROL, V27, P963, DOI 10.1681/ASN.2015080947; Sarav M, 2009, J AM SOC NEPHROL, V20, P1941, DOI 10.1681/ASN.2008090976; SCHRIJVER G, 1990, KIDNEY INT, V38, P86, DOI 10.1038/ki.1990.171; Scott NA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02800; Sistani L, 2013, KIDNEY INT, V83, P63, DOI 10.1038/ki.2012.321; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; Thurman JM, 2012, AM J PHYSIOL-RENAL, V302, pF1529, DOI 10.1152/ajprenal.00422.2011; Tian ZH, 2014, J RECEPT SIG TRANSD, V34, P137, DOI 10.3109/10799893.2013.865745; Tipping PG, 1998, AM J PATHOL, V152, P1541; Toda N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42114; Tonsawan P, 2019, AM J PHYSIOL-CELL PH, V317, pC1048, DOI 10.1152/ajpcell.00235.2019; Trostel J, 2018, AM J PHYSIOL-RENAL, V315, pF759, DOI 10.1152/ajprenal.00458.2017; Truong LD, 2015, FASEB J, V29, P3558, DOI 10.1096/fj.14-262493; Weflen AW, 2013, MOL BIOL CELL, V24, P2398, DOI 10.1091/mbc.E13-04-0174; Xia YM, 2012, CLIN IMMUNOL, V145, P108, DOI 10.1016/j.clim.2012.08.008; Zhang Q, 2014, AM J PHYSIOL-RENAL, V306, pF822, DOI 10.1152/ajprenal.00294.2013	57	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0230401	10.1371/journal.pone.0230401	http://dx.doi.org/10.1371/journal.pone.0230401			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370294	Green Published, gold, Green Submitted			2022-12-27	WOS:000603611900032
J	Hanafin, J; Clancy, L				Hanafin, Joan; Clancy, Luke			A qualitative study of e-cigarette use among young people in Ireland: Incentives, disincentives, and putative cessation	PLOS ONE			English	Article							ELECTRONIC CIGARETTES; SMOKING; TOBACCO; ADDICTION; MARIJUANA; ATTITUDES; BENEFITS; SCIENCE; SMOKERS; ADULTS	Background Smoking prevalence in Ireland is falling in all age groups, but e-cigarette use is rising among young people. This qualitative study explores young people's accounts of e-cigarette use in Ireland. Methods Semi-structured individual (22) and focus group (8) interviews were conducted with 62 young people aged 18-22 years, recruited from a higher-education institution and youth organisations working with early school-leavers across Dublin. All were smokers or ex-smokers; 41 had tried e-cigarettes, 11 continued as dual users. We identified themes using thematic data analysis. Results Three broad themes were identified: incentivising features, disincentivising features, and ambivalent and unsuccessful cessation, named putative smoking cessation. Incentivising features included price, pleasing taste/ flavours, and the possibility of indoor use. Disincentivising features related to adverse health effects (pain, discomfort, sore throat, coughing, headache) and unpleasant physical effects (bad taste, problems resulting from device faults). Other disincentives were over-consumption arising from inability to control intake, "greater addictiveness", product taste, and device faults. Putative cessation refers to the conflict between participants' expected use of e-cigarettes as a smoking cessation/reduction aid and their observed reality of e-cigarettes' failure in this regard, with reported outcomes including: failure to quit or reduce; continued or resumed cigarette and/or roll-your-own smoking; dual use of e-cigarettes and other tobacco products; and inability to quit e-cigarettes. Conclusions Participants were sceptical about e-cigarettes' "purported relative healthiness", concerned about addictiveness and potential long-term health consequences, and critically aware of advertising and industry strategies. E-cigarettes were viewed as being less denormalised, in part because they could be used in indoor spaces where smoking is banned in Ireland. Although price, taste, and perceived renormalisation were important motivators for young people's use of e-cigarettes, they wanted to quit smoking. The regulation of e-cigarettes through age restriction of access, licensing of outlets, pricing, point of sale and advertising restrictions as well as through the banning of indoor use should be considered by legislators and tobacco control policymakers.	[Hanafin, Joan; Clancy, Luke] TU Dublin, FOCAS Inst, TobaccoFree Res Inst Ireland TFRI, Dublin, Ireland		Clancy, L (corresponding author), TU Dublin, FOCAS Inst, TobaccoFree Res Inst Ireland TFRI, Dublin, Ireland.	lclancy@tri.ie	Hanafin, Joan/AAD-5841-2022; Clancy, Luke/C-1632-2015	Hanafin, Joan/0000-0002-8016-2266; Clancy, Luke/0000-0003-2407-2263	Royal City of Dublin Hospital Trust (RCDHT) Ireland [184]	Royal City of Dublin Hospital Trust (RCDHT) Ireland	This research was funded by the Royal City of Dublin Hospital Trust (RCDHT) Ireland. Grant number:184. The funding body played no part in the design of the study or collection, analysis, or interpretation of data or in writing the manuscript or in the decision to submit for publication.	Aladeokin A, 2019, TOB PREV CESS, V5, DOI 10.18332/tpc/108553; Amos A, 2006, HEALTH EDUC RES, V21, P181, DOI 10.1093/her/cyh054; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; [Anonymous], 2016, SPIEGEL, V4, P116; Atkins Liz, 2012, QUAL RES EDUC, V1st; Babineau K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126419; Barrington-Trimis JL, 2014, JAMA-J AM MED ASSOC, V312, P2493, DOI 10.1001/jama.2014.14830; Bell K, 2010, SOC SCI MED, V70, P795, DOI 10.1016/j.socscimed.2009.09.060; Bozier J, 2020, CHEST, V157, P1362, DOI 10.1016/j.chest.2019.12.042; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Chao DD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221557; Chapman S, 2008, TOB CONTROL, V17, P25, DOI 10.1136/tc.2007.021386; Clancy L, ESPAD IRELAND 2015 E; Cohen L., 2007, RES METHODS ED, DOI 10.4324/9780203029053-29; Crabtree B. F., 1992, ANN N AM PRIM CAR RE; Department of Health Ireland., HLTH IR; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Felberbaum M, 2013, OLD TOBACCO PLAYBOOK, DOI [10.1007/s10549-013-2772-y, DOI 10.1007/S10549-013-2772-Y]; Fife W, 2020, COUNTING QUALITATIVE, P47; Friel S, 1999, NATL HLTH LIFESTYLES; Gendall P, 2021, TOB CONTROL, V30, P108, DOI 10.1136/tobaccocontrol-2019-055469; Gillett J, 2016, ISS EDUC RES, V26, P592; Grana R, 2014, CIRCULATION, V129, P1972, DOI 10.1161/CIRCULATIONAHA.114.007667; Grana RA, 2014, AM J PREV MED, V46, P395, DOI 10.1016/j.amepre.2013.12.010; Hanafin J, 2015, PROG RESPIR RES, V42, P1, DOI 10.1159/000369289; Hatch J. A., 2002, DOING QUALITATIVE RE; Healthy Ireland, 2019, HLTH IR SUMM REP 201; Hoek J, 2019, TOB CONTROL, V28, pE162, DOI 10.1136/tobaccocontrol-2019-054967; Hoek J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014990; Jia D, 2011, MOL BIOL CELL, V22; Kandel ER, 2014, NEW ENGL J MED, V371, P932, DOI 10.1056/NEJMsa1405092; Keamy-Minor E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026306; Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x; Lee S, 2014, J ADOLESCENT HEALTH, V54, P684, DOI 10.1016/j.jadohealth.2013.11.003; Li SS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-032630; Lincoln Y. S., 2005, SAGE HDB QUALITATIVE, DOI DOI 10.4135/9781849208550.N1; Ling PM, 2002, AM J PUBLIC HEALTH, V92, P908, DOI 10.2105/AJPH.92.6.908; Lippi G, 2014, SEMIN THROMB HEMOST, V40, P60, DOI 10.1055/s-0033-1363468; Lucherini M, 2018, SOCIOL HEALTH ILL, V40, P1037, DOI 10.1111/1467-9566.12741; Majeed BA, 2016, HEALTH BEHAV POLICY, V3, P590, DOI 10.14485/HBPR.3.6.8; Maxwell JA, 2010, QUAL INQ, V16, P475, DOI 10.1177/1077800410364740; McDonald EA, 2015, TOB CONTROL, V24, P588, DOI 10.1136/tobaccocontrol-2014-051743; Morse JM, 2009, QUAL HEALTH RES, V19, P1523, DOI 10.1177/1049732309349360; O'brien D., 2020, ELECT CIGARETTE USE; O'Donoghue T., 2018, PLANNING YOUR QUALIT; Patton MQ, 1999, HEALTH SERV RES, V34, P1189; Popova L, 2017, ADDICTION, V112, P1821, DOI 10.1111/add.13854; Robertson L, 2019, TOB CONTROL, V28, P13, DOI 10.1136/tobaccocontrol-2017-054070; Roditis ML, 2015, J ADOLESCENT HEALTH, V57, P179, DOI 10.1016/j.jadohealth.2015.04.002; Rooke C, 2016, TOB CONTROL, V25, pE60, DOI 10.1136/tobaccocontrol-2014-052151; Rossman GB., 2011, LEARNING FIELD INTRO; Schilling L, 2019, MIDWIFERY, V79, DOI 10.1016/j.midw.2019.102533; Schneider S, 2016, NICOTINE TOB RES, V18, P647, DOI 10.1093/ntr/ntv193; Schwandt T. A., 1994, HDB QUALITATIVE RES, P118; Soneji S, 2017, JAMA PEDIATR, V171, P788, DOI 10.1001/jamapediatrics.2017.1488; Staff J, 2020, J ADOLESCENT HEALTH, V66, P39, DOI 10.1016/j.jadohealth.2019.08.030; Sunday S, 2020, ESPAD 2019 EUROPEAN; Tamimi N, 2018, PRIM HEALTH CARE RES, V19, P189, DOI 10.1017/S1463423617000445; The ESPAD Group, ESPAD REP 2019 RES E; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vanyukov MM, 2012, DRUG ALCOHOL DEPEN, V123, pS3, DOI 10.1016/j.drugalcdep.2011.12.018	62	4	4	646	650	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244203	10.1371/journal.pone.0244203	http://dx.doi.org/10.1371/journal.pone.0244203			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370351	gold, Green Published			2022-12-27	WOS:000603611900082
J	McKenna, J; Bellofiore, N; Catt, S; Pangestu, M; Temple-Smith, P				McKenna, Jarrod; Bellofiore, Nadia; Catt, Sally; Pangestu, Mulyoto; Temple-Smith, Peter			A human-based assisted reproduction protocol for the menstruating spiny mouse, Acomys cahirinus	PLOS ONE			English	Article							MID-PREGNANCY PROTECTS; INDUCED OVULATION RATE; EMBRYO-TRANSFER; ESTROUS-CYCLE; BIRTH; SUPEROVULATION; SUPPRESSION; IMPLANT; GONADOTROPIN; GERBILLINAE	The Egyptian or Common spiny mouse (A. cahirinus) is the first rodent species to show human-like menstruation and spontaneous decidualisation. We consider from these, and its other, human-like characteristics that this species will be a more useful and appropriate small animal model for human reproductive studies. Based on this, there is a need to develop specific laboratory-based assisted reproduction protocols including superovulation, in-vitro fertilisation, embryo cryopreservation and transfer to expand and make this model more relevant. Because standard rodent superovulation has not been successful in the spiny mouse, we have selected to test a human protocol. Female spiny mice will receive a subcutaneous GnRH agonist implant and be allowed to recover. Menstrual cycle lengths will then be allowed to stabilize prior to ovarian stimulation. After recovery, females will be injected IP once a day for 4 days with a FSH analogue, to induce follicular growth, and on day 5 will be injected IP with a hCG analogue to trigger ovulation. Females will either be culled 36hrs after trigger to collect oocytes or immediately paired with a stud male and two cell embryos collected 48hrs later. Mature oocytes will be inseminated using fresh spiny mouse spermatozoa and all in-vitro grown and in-vivo collected two cell embryos will be cryopreserved using methods developed in a close spiny mouse relative, the Mongolian gerbil. For embryo transfer, vitrified embryos will be rapidly warmed and non-surgically transferred to surrogate mice. Surrogates will be monitored until pregnancy is apparent (roughly 30 days) and then left undisturbed until birth, 38-40 days after transfer. By successfully developing robust assisted reproduction protocols in A. cahirinus we will be able to use this rodent as a more effective model for human reproduction.	[McKenna, Jarrod; Bellofiore, Nadia; Catt, Sally; Pangestu, Mulyoto; Temple-Smith, Peter] Monash Univ, Sch Clin Sci, Dept Obstet & Gynaecol, Educ Program Reprod & Dev, Clayton, Vic, Australia; [Bellofiore, Nadia] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia	Monash University; Hudson Institute of Medical Research	McKenna, J (corresponding author), Monash Univ, Sch Clin Sci, Dept Obstet & Gynaecol, Educ Program Reprod & Dev, Clayton, Vic, Australia.	jarrod.mckenna@monash.edu		Pangestu, Mulyoto/0000-0001-5623-3995; McKenna, Jarrod/0000-0001-9025-6429	Australian government by Monash University	Australian government by Monash University	JM was financially supported by the Australian government Research Training Program scholarship supported by Monash University.	Agulnik SI, 1996, MOL BIOL EVOL, V13, P3, DOI 10.1093/oxfordjournals.molbev.a025567; BEATTY RA, 1951, NATURE, V168, P995, DOI 10.1038/168995a0; Bellofiore N, 2020, REPROD FERT DEVELOP, V32, P363, DOI 10.1071/RD18506; Bellofiore N, 2019, HUM REPROD, V34, P308, DOI 10.1093/humrep/dey360; Bellofiore N, 2018, J MOL ENDOCRINOL, V61, pR25, DOI 10.1530/JME-17-0278; Bin Ali R, 2014, TRANSGENIC RES, V23, P691, DOI 10.1007/s11248-014-9802-3; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; Cannata DJ, 2010, PEDIATR RES, V68, P393, DOI 10.1203/PDR.0b013e3181f1c048; Catt J, 2016, EMBRYOLOGY TRAINING; CHEVRET P, 1993, P NATL ACAD SCI USA, V90, P3433, DOI 10.1073/pnas.90.8.3433; Cooke S, 2009, TXB ASSISTED REPROD; Cora MC, 2015, TOXICOL PATHOL, V43, P776, DOI 10.1177/0192623315570339; Cseh S, 2002, ANIM REPROD SCI, V70, P287, DOI 10.1016/S0378-4320(02)00007-6; Cui LF, 2014, J AM ASSOC LAB ANIM, V53, P228; Dickinson H, 2006, NEW MODEL PERINATAL; Dickinson H, 2007, ANZCART NEWS, V20, P4; Dubois JYF, 1999, MOL PHYLOGENET EVOL, V13, P181, DOI 10.1006/mpev.1999.0674; Emera D, 2012, BIOESSAYS, V34, P26, DOI 10.1002/bies.201100099; FRASER LR, 1984, J REPROD FERTIL, V72, P373, DOI 10.1530/jrf.0.0720373; Green MA, 2009, BIOTECHNIQUES, V47, P919, DOI 10.2144/000113257; Hasegawa A, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134023; Hasegawa A, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.098491; Hatasaka HH, 1997, J ASSIST REPROD GEN, V14, P102, DOI 10.1007/BF02765779; Haterius HO, 1933, AM J PHYSIOL, V103, P97, DOI 10.1152/ajplegacy.1932.103.1.97; Haughton CL, 2016, J AM ASSOC LAB ANIM, V55, P9; Ireland Z, 2011, NEUROSCIENCE, V194, P372, DOI 10.1016/j.neuroscience.2011.05.012; Kim JS, 2017, IEEE INT C INT ROBOT, P201; LABRIE F, 1980, J ANDROL, V1, P209; Malhi PS, 2008, ANIM REPROD SCI, V109, P100, DOI 10.1016/j.anireprosci.2007.12.002; Matsota P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/475362; McCue PM, 2002, THERIOGENOLOGY, V58, P865, DOI 10.1016/S0093-691X(02)00923-8; McKenna J, 2020, REPROD FERT DEVELOP, V32, P1293, DOI 10.1071/RD20115; MEINERT C, 1993, EQUINE VET J, V25, P65, DOI 10.1111/j.2042-3306.1993.tb02904.x; Merriman JA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095711; Mochida K, 2005, MOL REPROD DEV, V70, P464, DOI 10.1002/mrd.20226; Mochida K, 2020, J REPROD DEVELOP, V66, P299, DOI 10.1262/jrd.2020-033; Momozawa K, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0249-2; Morello GM, 2020, BIORXIV; Munson L, 2001, J REP FER S, P269; Nyachieo A, 2011, FERTIL STERIL, V95, P1354, DOI 10.1016/j.fertnstert.2010.05.046; O'Connell BA, 2013, PLACENTA, V34, P119, DOI 10.1016/j.placenta.2012.11.009; Pasco R, 2012, REPROD FERT DEVELOP, V24, P1117, DOI 10.1071/RD12044; Qu PX, 2019, REPROD FERT DEVELOP, V31, P324, DOI 10.1071/RD18203; RASWEILER JJ, 1992, J REPROD FERTIL, V95, P231; Risi E, 2014, REPROD DOMEST ANIM, V49, P81, DOI 10.1111/rda.12300; Sbracia M, 2005, FERTIL STERIL, V84, P644, DOI 10.1016/j.fertnstert.2005.02.046; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Society for Maternal-Fetal Medicine (SMFM) Publications Committee, 2017, AM J OBSTET GYNECOL, V216, pB8; SPEAROW JL, 1988, J REPROD FERTIL, V82, P799, DOI 10.1530/jrf.0.0820799; Spearow JL, 1999, BIOL REPROD, V61, P851, DOI 10.1095/biolreprod61.4.851; Stanhiser J, 2017, FERTIL STERIL, V108, pE330, DOI 10.1016/j.fertnstert.2017.07.972; Steele KH, 2013, J AM ASSOC LAB ANIM, V52, P17; Suzuki O, 1996, REPROD FERT DEVELOP, V8, P975, DOI 10.1071/RD9960975; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Trigg TE, 2001, J REP FER S, P255; Vander Horst C. J., 1946, TRANS ROY SOC S AFRICA, V31, P181	57	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244411	10.1371/journal.pone.0244411	http://dx.doi.org/10.1371/journal.pone.0244411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370773	Green Published, gold			2022-12-27	WOS:000603611900094
J	Ono, A; Ishikane, M; Kusama, Y; Tanaka, C; Ono, S; Tsuzuki, S; Muraki, Y; Yamasaki, D; Tanabe, M; Ohmagari, N				Ono, Akane; Ishikane, Masahiro; Kusama, Yoshiki; Tanaka, Chika; Ono, Sachiko; Tsuzuki, Shinya; Muraki, Yuichi; Yamasaki, Daisuke; Tanabe, Masaki; Ohmagari, Norio			The first national survey of antimicrobial use among dentists in Japan from 2015 to 2017 based on the national database of health insurance claims and specific health checkups of Japan	PLOS ONE			English	Article							DENTAL PRACTITIONERS; UNITED-STATES	Purpose To counter the global health threat of antimicrobial resistance, effective antimicrobial stewardship programs are needed to improve antimicrobial use (AMU) among dentists in addition to physicians. This study aimed to investigate the nationwide epidemiology of AMU among Japanese dentists to facilitate the development of dentist-centered programs. Methods We conducted a retrospective population-based study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan to analyze the AMU among Japanese dentists between 2015 and 2017. AMU was quantified as the defined daily doses per 1,000 inhabitants per day (DID). The trends in dentist-prescribed AMU were examined according to antimicrobial category and administration route. We also compared outpatient oral AMU between dentists and physicians as well as between on-site and off-site dispensing. Results The DID values of dentist-prescribed AMU were 1.23 in 2015, 1.22 in 2016, and 1.21 in 2017. During this study period, outpatient oral antimicrobials comprised the majority (approximately 99%) of dentist-prescribed AMU, and cephalosporins were the most frequently prescribed antimicrobials (>60% of all antimicrobials). The DID values of outpatient oral AMU were 1.21 for dentists and 12.11 for physicians. The DID value for on-site dispensing was 0.89 in 2017, in which cephalosporins were the predominantly used antimicrobials (DID: 0.60). Conclusions Interventions that target dentists in Japan should focus on on-site dispensing of oral antimicrobials (especially cephalosporins) for outpatients. Further studies are needed to ascertain the underlying factors of oral cephalosporin prescriptions to guide the development of effective antimicrobial stewardship programs.	[Ono, Akane; Ishikane, Masahiro; Kusama, Yoshiki; Tanaka, Chika; Tsuzuki, Shinya; Ohmagari, Norio] Natl Ctr Global Hlth & Med, AMR Clin Reference Ctr, Tokyo, Japan; [Ishikane, Masahiro; Tanaka, Chika; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Tokyo, Japan; [Ono, Sachiko] Univ Tokyo, Dept Eat Loss Med, Tokyo, Japan; [Muraki, Yuichi] Kyoto Pharmaceut Univ, Dept Clin Pharmacoepidemiol, Kyoto, Japan; [Yamasaki, Daisuke; Tanabe, Masaki] Mie Univ Hosp, Dept Infect Control & Prevent, Tsu, Mie, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; University of Tokyo; Kyoto Pharmaceutical University; Mie University	Kusama, Y (corresponding author), Natl Ctr Global Hlth & Med, AMR Clin Reference Ctr, Tokyo, Japan.	stone.bagle@gmail.com	Ohmagari, Norio/GLN-5290-2022; MURAKI, Yuichi/AAI-1961-2021; Tsuzuki, Shinya/S-7286-2019; Tsuzuki, Shinya/S-7286-2019	Ohmagari, Norio/0000-0002-4622-8970; MURAKI, Yuichi/0000-0001-6951-5676; Tsuzuki, Shinya/0000-0002-8504-1244; Ono, Sachiko/0000-0003-4378-2578; Kusama, Yoshiki/0000-0002-7072-2338; Tsuzuki, Shinya/0000-0001-5732-846X; Ishikane, Masahirio/0000-0002-4719-651X	Ministry of Health, Labour and Welfare of Japan [20HA2003]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by a research grant from the Ministry of Health, Labour and Welfare of Japan (Grant Number: 20HA2003).	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; AMR Clinical Reference Center, 2018, ANT US SURV BAS NDB; [Anonymous], 2020, J THORAC ONCOL, V13, pS322, DOI 10.1016/j.jtho.2018.08.241; Durkin MJ, 2017, J AM DENT ASSOC, V148, P878, DOI 10.1016/j.adaj.2017.07.019; Gross AE, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz067; Halling F, 2017, J CRANIO MAXILL SURG, V45, P1854, DOI 10.1016/j.jcms.2017.08.010; Hicks LA, 2013, NEW ENGL J MED, V369, P1175, DOI 10.1056/NEJMc1306863; Hicks LA, 2013, NEW ENGL J MED, V368, P1461, DOI 10.1056/NEJMc1212055; Japanese Assoc Infect Dis Japanese, 2018, J INFECT CHEMOTHER, V24, P320, DOI 10.1016/j.jiac.2017.09.014; Kano Y, 2019, INFECT CONT HOSP EP, V40, P1081, DOI 10.1017/ice.2019.186; Koizumi R, KANSENSHOGAKU ZASSHI; Kusama Y, 2020, J INFECT CHEMOTHER, V26, P211, DOI 10.1016/j.jiac.2019.08.013; Kusama Y, 2019, JPN J INFECT DIS, V72, P326, DOI 10.7883/yoken.JJID.2018.417; Marra F, 2016, J AM DENT ASSOC, V147, P320, DOI 10.1016/j.adaj.2015.12.014; Ministry of Health Labour and Welfare, 2016, SURV PHYS DENT PHARM; Ministry of Health Labour and Welfare of Japan, 2020, SIT PREV CLAIM SUBM; Ministry of Health Labour and Welfare of Japan, 2018, SURV STAT DYN SURV M; Muraki Y, 2016, J GLOB ANTIMICROB RE, V7, P19, DOI 10.1016/j.jgar.2016.07.002; Nakatani S, 2019, CIRC J, V83, P1767, DOI 10.1253/circj.CJ-19-0549; Public Health England, 2016, DENT ANT STEW TOOLK; Roy KM, 2000, BRIT DENT J, V188, P674; Salako NO, 2004, J DENT, V32, P503, DOI 10.1016/j.jdent.2004.04.001; Statistics Bureau of Japan, RES POP EST; Suda KJ, 2018, CLIN INFECT DIS, V66, P185, DOI 10.1093/cid/cix773; Suda KJ, 2016, J AM PHARM ASSOC, V56, P621, DOI 10.1016/j.japh.2016.08.015; Teoh L, 2018, AUST DENT J, V63, P329, DOI 10.1111/adj.12622; The Government of Japan, 2016, VETFUTURES ACTION PL; [The Japanese Association for Infectious Diseases Japanese Society of Chemotherapy. The Japanese association for infectious diseases], 2014, JAID JSC GUID CLIN M; Thornhill MH, 2019, BRIT DENT J, V227, P1044, DOI 10.1038/s41415-019-1002-3; Tsutsui A, 2018, J INFECT CHEMOTHER, V24, P414, DOI 10.1016/j.jiac.2018.01.003; Yoshida K, 2018, JAPANESE J ENV INFEC, V33, P207; Ziegler J, 2014, IEEE INTEL TRANSP SY, V6, P8, DOI 10.1109/MITS.2014.2306552	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244521	10.1371/journal.pone.0244521	http://dx.doi.org/10.1371/journal.pone.0244521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370390	Green Published, gold			2022-12-27	WOS:000603611900014
J	Mellgren, A; Eriksson, LE; Reinius, M; Marrone, G; Svedhem, V				Mellgren, Asa; Eriksson, Lars E.; Reinius, Maria; Marrone, Gaetano; Svedhem, Veronica			Longitudinal trends and determinants of patient-reported side effects on ART-a Swedish national registry study	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; QUALITY-OF-LIFE; ANTIRETROVIRAL THERAPY; MEDICATION; INFECTION; ADHERENCE; COMMUNICATION; NONADHERENCE; OUTCOMES; EVENTS	Introduction The use of patient-reported outcomes (PROs) to systematically quantify adverse events (AE) will assist in the improvement of medical care and the QoL of patients living with HIV (PLWH). The aim of this study was to investigate the associations between self-reported side effects and other PROs, demographics and laboratory data, and further evaluate the Health Questionnaire (HQ) as a tool for following trends in patient-reported side effects over time in relation to trends in prescribed third agent in ART. Materials and methods The Swedish National Registry InfCareHiv includes an annual self-reported nine-item HQwhich is used in patient-centered HIV care in all Swedish HIV units. In this study, the experience of side effects was addressed. We analyzed 9,476 HQs completed by 4,186 PLWH together with details about their prescribed ART and relevant biomarkers collected during 2011-2017. Data were analyzed using descriptive statistics, Pearson's correlation coefficient and mixed logistic regression. Results The cross-sectional analysis of the HQs showed that the frequency of reported side effects decreased from 32% (2011) to 15% (2017). During the same period, there was a shift in ART prescription from efavirenz (EFV) to dolutegravir (DTG) (positive correlation coefficient r = 0.94, p = 0.0016). Further, PLWH who reported being satisfied with their physical health (OR: 0.47, p = <0.001) or psychological health (OR: 0.70, p = 0.001) were less likely to report side effects than those less satisfied. Conclusions Self-reported side effects were found to have a close relationship with the patient's ratings of their overall health situation and demonstrated a strong correlation with the sharp decline in use of EFV and rise in use of DTG, with reported side effects being halved. This study supports the feasibility of using the HQ as a tool for longitudinal follow up of trends in PROs.	[Mellgren, Asa] Sahlgrens Univ Hosp, Dept Infect Dis, Gothenburg, Sweden; [Mellgren, Asa] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, Gothenburg, Sweden; [Eriksson, Lars E.; Reinius, Maria] Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Eriksson, Lars E.] City Univ London, Sch Hlth Sci, London, England; [Eriksson, Lars E.; Svedhem, Veronica] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Marrone, Gaetano; Svedhem, Veronica] Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden; [Marrone, Gaetano] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Karolinska Institutet; City University London; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Svedhem, V (corresponding author), Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.; Svedhem, V (corresponding author), Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden.	veronica.svedhem-johansson@sll.se	Reinius, Maria/AAA-2277-2022	Reinius, Maria/0000-0003-0864-8701; Mellgren, Asa/0000-0002-1202-3504; svedhemJohansson, veronica/0000-0003-0845-1685	Gilead Sciences Nordic Fellowship Programme; Department of Communicable Disease Control Health Protection Public Health Agency of Sweden	Gilead Sciences Nordic Fellowship Programme; Department of Communicable Disease Control Health Protection Public Health Agency of Sweden	VS has received funding from the Gilead Sciences Nordic Fellowship Programme and the Department of Communicable Disease Control Health Protection Public Health Agency of Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hamid A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005992; Al-Dakkak I, 2013, AIDS CARE, V25, P400, DOI 10.1080/09540121.2012.712667; Avery AJ, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15200; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Basch E, 2009, JNCI-J NATL CANCER I, V101, P1624, DOI 10.1093/jnci/djp386; Colagiuri B, 2012, J PSYCHOPHARMACOL, V26, P1540, DOI 10.1177/0269881112458730; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Dobrozsi S, 2015, HEMATOL-AM SOC HEMAT, P501, DOI 10.1182/asheducation-2015.1.501; Eriksen J, 2017, INFECT DIS-NOR, V49, P1, DOI 10.1080/23744235.2016.1247495; Foster JM, 2008, J ASTHMA, V45, P664, DOI 10.1080/02770900802127022; Fugl-Meyer AR, 2002, J REHABIL MED, V34, P239, DOI 10.1080/165019702760279242; Hauser W, 2012, DTSCH ARZTEBL INT, V109, P459, DOI 10.3238/arztebl.2012.0459; Haggblom A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171227; Johnson MO, 2011, ANN BEHAV MED, V41, P83, DOI 10.1007/s12160-010-9230-4; Jolivot PA, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0643-5; Josephson F, 2009, SCAND J INFECT DIS, V41, P788, DOI 10.3109/00365540903214322; Kall M, 2020, LANCET HIV, V7, pE59, DOI 10.1016/S2352-3018(19)30345-5; Kanters S, 2017, LANCET HIV, V4, pE31, DOI 10.1016/S2352-3018(16)30206-5; Kryst J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124279; Li HC, 2017, AIDS BEHAV, V21, P341, DOI 10.1007/s10461-016-1545-0; Lipscomb J, 2007, CA-CANCER J CLIN, V57, P278, DOI 10.3322/CA.57.5.278; Mahr A, 2017, PHARMACOEPIDEM DR S, V26, P731, DOI 10.1002/pds.4169; Maiese EM, 2016, CURR MED RES OPIN, V32, P2039, DOI 10.1080/03007995.2016.1227776; Marrone G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156916; Naver L, 2014, SCAND J INFECT DIS, V46, P401, DOI 10.3109/00365548.2014.898333; Protopopescu C, 2009, J ANTIMICROB CHEMOTH, V64, P599, DOI 10.1093/jac/dkp232; Thorne S, 2008, INTERPRETIVE DESCRIP, V1; Velikova G, 2004, J CLIN ONCOL, V22, P714, DOI 10.1200/JCO.2004.06.078; Weigmann K, 2016, EMBO REP, V17, P949, DOI 10.15252/embr.201642616; Zanini M, 2014, J INT AIDS SOC, V17, P74, DOI 10.7448/IAS.17.4.19600	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242710	10.1371/journal.pone.0242710	http://dx.doi.org/10.1371/journal.pone.0242710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362248	Green Published, gold			2022-12-27	WOS:000603071600044
J	Rocktaschel, T; Renner-Martin, K; Cuny, C; Brehm, W; Truyen, U; Speck, S				Rocktaschel, Tina; Renner-Martin, Katharina; Cuny, Christiane; Brehm, Walter; Truyen, Uwe; Speck, Stephanie			Surgical hand preparation in an equine hospital: Comparison of general practice with a standardised protocol and characterisation of the methicillin-resistant Staphylococcus aureus recovered	PLOS ONE			English	Article							RISK-FACTORS; GLOVE PERFORATION; ORTHOPEDIC-SURGERY; COMPANION ANIMALS; INFECTIONS; PREVALENCE; EFFICACY; ANTISEPTICS; FREQUENCY; HYGIENE	Presurgical hand asepsis is part of the daily routine in veterinary medicine. Nevertheless, basic knowledge seems to be low, even among specialised veterinary surgeons. The major objectives of our study were to assess current habits for presurgical hand preparation (phase 1) among personnel in a veterinary hospital and their effectiveness in reducing bacteria from hands in comparison to a standardised protocol (phase 2). Assessment of individual habits focused on time for hand washing and disinfection, the amount of disinfectant used, and the usage of brushes. The standardised protocol defined hand washing for 1 min with liquid neutral soap without brushing and disinfection for 3 min. All participants (2 surgeons, 8 clinic members, 32 students) used Sterillium(R). Total bacterial counts were determined before and after hand washing, after disinfection, and after surgery. Hands were immersed in 100 ml sterile sampling fluid for 1 min and samples were inoculated onto Columbia sheep blood agar using the spread-plate method. Bacterial colonies were manually counted. Glove perforation test was carried out at the end of the surgical procedure. Differences in the reduction of relative bacterial numbers between current habits and the standardised protocol were investigated using Mann-Whitney-Test. The relative increase in bacterial numbers as a function of operation time (<= 60 min, >60 min) and glove perforation as well as the interaction of both was investigated by using ANOVA. Forty-six and 41 preparations were carried out during phase 1 and phase 2, respectively. Individual habits differed distinctly with regard to time (up to 8 min) and amount of disinfectant (up to 48 ml) used both between participants and between various applications of a respective participant. Comparison of current habits and the standardised protocol revealed that the duration of hand washing had no significant effect on reducing bacteria. Contrary, the reduction in bacterial numbers after disinfection by the standardised protocol was significantly higher (p<0.001) compared to routine every-day practice. With regard to disinfection efficacy, the standardised protocol completely eliminated individual effects. The mean reduction in phase 1 was 90.72% (LR = 3.23; right hand) and 89.97% (LR = 3.28; left hand) compared to 98.85% (LR = 3.29; right hand) and 98.92% (LR = 3.47; left hand) in phase 2. Eight participants (19%) carried MRSA (spa type t011, CC398) which is well established as a nosocomial pathogen in veterinary clinics. The isolates could further be assigned to a subpopulation which is particularly associated with equine clinics (mainly t011, ST398, gentamicin-resistant). Glove perforation occurred in 54% (surgeons) and 17% (assistants) of gloves, respectively, with a higher number in long-term invasive procedures. Overall, bacterial numbers on hands mainly increased over time, especially when glove perforation occurred. This was most distinct for glove perforations on the left hand and with longer operating times. Our results demonstrate that standardised protocols highly improve the efficacy of hand asepsis measures. Hence, guiding standardised protocols should be prerequisite to ensure state-of-the-art techniques which is essential for a successful infection control intervention.	[Rocktaschel, Tina; Truyen, Uwe; Speck, Stephanie] Univ Leipzig, Fac Vet Med, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany; [Renner-Martin, Katharina] Univ Nat Resources & Life Sci, Inst Math, Dept Integrat Biol & Biodivers Res, Vienna, Austria; [Cuny, Christiane] Natl Reference Ctr Staphylococci & Enterococci, Robert Koch Inst, Wernigerode, Germany; [Brehm, Walter] Univ Leipzig, Dept Horses, Fac Vet Med, Leipzig, Germany	Leipzig University; University of Natural Resources & Life Sciences, Vienna; Robert Koch Institute; Leipzig University	Speck, S (corresponding author), Univ Leipzig, Fac Vet Med, Inst Anim Hyg & Vet Publ Hlth, Leipzig, Germany.	stephanie@speck-kaysser.de			Leipzig University	Leipzig University	Leipzig University provided support in the form of an Open Access Publishing Fund. No additional external funding was received for this study.	Abdelbary MMH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088083; Ahern BJ, 2010, VET SURG, V39, P588, DOI 10.1111/j.1532-950X.2010.00705.x; Anderson MEC, 2008, VET MICROBIOL, V129, P410, DOI 10.1016/j.vetmic.2007.11.031; Anderson MEC, 2015, VET CLIN N AM-SMALL, V45, P343, DOI 10.1016/j.cvsm.2014.11.003; [Anonymous], 14675 EN; [Anonymous], 2009, WHO GUID HAND HYG HL; Assadian O, 2014, SURG INFECT, V15, P43, DOI 10.1089/sur.2012.230; Association for Applied Hygiene (VAH) Disinfectants Commission, 2015, REQ METH VAH CERT CH; Barbadoro P, 2014, J HOSP INFECT, V86, P64, DOI 10.1016/j.jhin.2013.09.013; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Biermann NM, 2018, VET SURG, V47, P212, DOI 10.1111/vsu.12757; Bocher S, 2009, J CLIN MICROBIOL, V47, P946, DOI 10.1128/JCM.01024-08; Bortolami A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05559-8; Character BJ, 2003, J AM ANIM HOSP ASSOC, V39, P311, DOI 10.5326/0390311; Chou PY, 2016, VET SURG, V45, P515, DOI 10.1111/vsu.12473; Chow A, 2012, AM J INFECT CONTROL, V40, P800, DOI 10.1016/j.ajic.2011.10.005; Clark C, 2008, CAN VET J, V49, P153; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cuny C, 2016, ONE HEALTH, V2, P11, DOI 10.1016/j.onehlt.2015.11.004; da Silveira EA, 2016, CAN VET J, V57, P164; Elce YA, 2016, VET SURG, V45, P1066, DOI 10.1111/vsu.12562; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hayes GM, 2014, VET SURG, V43, P400, DOI 10.1111/j.1532-950X.2014.12159.x; Iqbal HJ, 2017, INJURY, V48, P1382, DOI 10.1016/j.injury.2017.04.012; Kampf G, 2005, BMC INFECT DIS, P5, DOI [10.1186/1471-2334-5-5, DOI 10.1186/1471-2334-5-5]; Kampf G, 2006, APPL ENVIRON MICROB, V72, P3856, DOI 10.1128/AEM.02746-05; Kock R, 2017, ALLGEMEINARZT, V39, P48; Koeck R, 2020, MED KLIN-INTENSIVMED, V115, P189, DOI 10.1007/s00063-018-0487-x; KuKanich KS, 2012, JAVMA-J AM VET MED A, V240, P437, DOI 10.2460/javma.240.4.437; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.2307/1170654; Loeb MB, 1997, AM J INFECT CONTROL, V25, P11, DOI 10.1016/S0196-6553(97)90047-X; Lopez-Gigosos RM, 2017, EUR J CLIN MICROBIOL, V36, P1197, DOI 10.1007/s10096-017-2908-9; MACDONALD DG, 1994, EQUINE VET J, V26, P323, DOI 10.1111/j.2042-3306.1994.tb04394.x; Meakin LB, 2016, VET SURG, V45, P709, DOI 10.1111/vsu.12519; Noparat W, 2005, J MED ASS THAI, V88, P177; Panchaud Y, 2010, SCHWEIZ ARCH TIERH, V152, P176, DOI 10.1024/0036-7281/a000040; Perron P, 2016, PLOS ONE, V8, P1; Pietsch H, 2001, J HOSP INFECT, V48, pS33, DOI 10.1016/S0195-6701(01)90010-6; Ruscher C, 2009, VET MICROBIOL, V136, P197, DOI 10.1016/j.vetmic.2008.10.023; Sakr A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02419; Sroka S, 2010, J HOSP INFECT, V74, P204, DOI 10.1016/j.jhin.2009.08.023; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; Traub-Dargatz JL, 2006, CAN VET J, V47, P671; Turk R, 2015, VET SURG, V44, P2, DOI 10.1111/j.1532-950X.2014.12267.x; Uckay I, 2010, EXPERT REV ANTI-INFE, V8, P657, DOI [10.1586/eri.10.41, 10.1586/ERI.10.41]; Verwilghen D, 2015, EQUINE VET J, V47, P753, DOI 10.1111/evj.12480; Verwilghen D, 2011, VET SURG, V40, P515, DOI 10.1111/j.1532-950X.2011.00846.x; Verwilghen DR, 2011, VET J, V190, P372, DOI 10.1016/j.tvjl.2010.12.020; Vincze S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085656; Weese JS, 2006, J VET INTERN MED, V20, P182, DOI 10.1892/0891-6640(2006)20[182:MSAIHA]2.0.CO;2; Wieler LH, 2011, INT J MED MICROBIOL, V301, P635, DOI 10.1016/j.ijmm.2011.09.009; Yinusa W, 2004, INT ORTHOP, V28, P36, DOI 10.1007/s00264-003-0510-5	55	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0242961	10.1371/journal.pone.0242961	http://dx.doi.org/10.1371/journal.pone.0242961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351819	Green Published, gold			2022-12-27	WOS:000603071400045
J	Wittek, A; Bourantas, G; Zwick, BF; Joldes, G; Esteban, L; Miller, K				Wittek, Adam; Bourantas, George; Zwick, Benjamin F.; Joldes, Grand; Esteban, Lionel; Miller, Karol			Mathematical modeling and computer simulation of needle insertion into soft tissue	PLOS ONE			English	Article							MOVING LEAST-SQUARES; FINITE-ELEMENT; COMPUTATIONAL BIOMECHANICS; REAL-TIME; BIOLOGICAL TISSUES; BRAIN; DEFORMATION; TOMOGRAPHY; FRAMEWORK; ALGORITHM	In this study we present a kinematic approach for modeling needle insertion into soft tissues. The kinematic approach allows the presentation of the problem as Dirichlet-type (i.e. driven by enforced motion of boundaries) and therefore weakly sensitive to unknown properties of the tissues and needle-tissue interaction. The parameters used in the kinematic approach are straightforward to determine from images. Our method uses Meshless Total Lagrangian Explicit Dynamics (MTLED) method to compute soft tissue deformations. The proposed scheme was validated against experiments of needle insertion into silicone gel samples. We also present a simulation of needle insertion into the brain demonstrating the method's insensitivity to assumed mechanical properties of tissue.	[Wittek, Adam; Bourantas, George; Zwick, Benjamin F.; Joldes, Grand; Miller, Karol] Univ Western Australia, Intelligent Syst Med Lab, Perth, WA, Australia; [Esteban, Lionel] CSIRO, Med XCT Facil, Kensington, WA, Australia	University of Western Australia; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Wittek, A (corresponding author), Univ Western Australia, Intelligent Syst Med Lab, Perth, WA, Australia.			Wittek, Adam/0000-0001-9780-8361; Zwick, Benjamin/0000-0003-0184-1082; Miller, Karol/0000-0002-6577-2082	Australian Government through the Australian Research Council's Discovery Projects funding scheme [DP160100714]; Australian Research Council [DP160100714]	Australian Government through the Australian Research Council's Discovery Projects funding scheme; Australian Research Council(Australian Research Council)	This research was supported by the Australian Government through the Australian Research Council's Discovery Projects funding scheme (project DP160100714) for Adam Wittek and Karol Miller. In particular, salaries of George Bourantas, Grand Joldes, and Benjamin F. Zwick were paid from the Australian Research Council's funding (Discovery project DP160100714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolhassani N, 2007, MED ENG PHYS, V29, P413, DOI 10.1016/j.medengphy.2006.07.003; Adagolodjo Y, 2019, IEEE T ROBOT, V35, P697, DOI 10.1109/TRO.2019.2897858; Alterovitz R, 2008, INT J ROBOT RES, V27, P1361, DOI 10.1177/0278364908097661; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2018, MED BALTIMORE, V97, pe9654; [Anonymous], 2018, FORENSIC SCI INT-GEN, V34, pe18; [Anonymous], 2017, MEDICINE, V96, pe6504; Aucoin N, 2009, 3D SLICER DOCUMENTAT; Banerji JS, 2016, J UROLOGY, V195, P66, DOI 10.1016/j.juro.2015.07.099; Bathe KJ., 1996, FINITE ELEMENT PROCE; Bilston LE, 2019, BIOL MED PHYS BIOMED, P71, DOI 10.1007/978-3-030-04996-6_4; Bonet J, 2001, COMMUN NUMER METH EN, V17, P551, DOI 10.1002/cnm.429; Brands D W, 2000, Stapp Car Crash J, V44, P249; Carey GF, 1997, COMPUTATIONAL GRID G; Chowdhury HA, 2017, J SCI COMPUT, V71, P1197, DOI 10.1007/s10915-016-0337-z; Cotin S, 1999, IEEE T VIS COMPUT GR, V5, P62, DOI 10.1109/2945.764872; Courtecuisse H, 2019, BIOL MED PHYS BIOMED, P321, DOI 10.1007/978-3-030-04996-6_13; Cowan NJ, 2011, SURGICAL ROBOTICS: SYSTEMS APPLICATIONS AND VISIONS, P557, DOI 10.1007/978-1-4419-1126-1_23; Crisfield MA, 1996, INT J SOLIDS STRUCT, V33, P2969, DOI 10.1016/0020-7683(95)00252-9; De Lorenzo D, 2013, IEEE T BIO-MED ENG, V60, P379, DOI 10.1109/TBME.2012.2227316; De Momi E, 2016, INT J COMPUT ASS RAD, V11, P473, DOI 10.1007/s11548-015-1259-1; DiMaio SP, 2005, IEEE T BIO-MED ENG, V52, P1167, DOI 10.1109/TBME.2005.847548; DiMaio SP, 2002, 10 S HAPT INT VIRT E, P1; Dutta-Roy T, 2006, CISM COURSES LECT, V487, P297; Elgezua I, 2013, PROC CIRP, V5, P94, DOI 10.1016/j.procir.2013.01.019; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Frisken S, 2019, BIOL MED PHYS BIOMED, P303, DOI 10.1007/978-3-030-04996-6_12; Garlapati RR, 2014, J NEUROSURG, V120, P1477, DOI 10.3171/2013.12.JNS131165; Gonzalez-Martinez J, 2014, J NEUROSURG, V120, P639, DOI 10.3171/2013.11.JNS13635; Horton A, 2010, INT J NUMER METH BIO, V26, P977, DOI 10.1002/cnm.1374; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; Hughes T.J.R., 2012, FINITE ELEMENT METHO; Bui HP, 2019, COMPUT METHOD APPL M, V345, P183, DOI 10.1016/j.cma.2018.10.023; Ivarsson J, 2002, J BIOMECH ENG-T ASME, V124, P422, DOI 10.1115/1.1485752; Jahya A, 2013, INT J MED ROBOT COMP, V9, pE52, DOI 10.1002/rcs.1493; Jin X, 2014, COMPUT METHOD BIOMEC, V17, P800, DOI 10.1080/10255842.2012.716829; Joldes G, 2019, MED IMAGE ANAL, V56, P152, DOI 10.1016/j.media.2019.06.004; Joldes GR, 2016, J MECH BEHAV BIOMED, V58, P139, DOI 10.1016/j.jmbbm.2015.07.029; Joldes GR, 2015, APPL MATH COMPUT, V266, P893, DOI 10.1016/j.amc.2015.05.150; Joldes GR, 2012, INT J NUMER METH ENG, V91, P450, DOI 10.1002/nme.4290; Joldes GR, 2009, COMMUN NUMER METH EN, V25, P827, DOI 10.1002/cnm.1185; Julia, 2020, JUL PROGR LANG; Kataoka H, 2002, LECT NOTES COMPUT SC, V2488, P216; Khau A, 2018, BIOMECHANICAL SIMULA, DOI [10.1177/2374373518803630, DOI 10.1177/2374373518803630]; Kitware, 2020, KITW; LANCASTER P, 1981, MATH COMPUT, V37, P141, DOI 10.1090/S0025-5718-1981-0616367-1; Leibinger A, 2016, ANN BIOMED ENG, V44, P2442, DOI 10.1007/s10439-015-1523-0; Li M., 2016, COMPUTATIONAL BIOMEC, P85, DOI [10., 10.1007/978-3-319-28329-6_8, DOI 10.1007/978-3-319-28329-6_8]; Ma JJ, 2010, COMPUTATIONAL BIOMECHANICS FOR MEDICINE, P29, DOI 10.1007/978-1-4419-5874-7_4; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; MEHTA M, 1985, ANAESTHESIA, V40, P1009, DOI 10.1111/j.1365-2044.1985.tb10558.x; Miller K, 2005, J BIOMECH, V38, P153, DOI 10.1016/j.jbiomech.2004.03.004; Miller K, 2000, J BIOMECH, V33, P367, DOI 10.1016/S0021-9290(99)00196-7; Miller K, 2005, COMPUTER METHODS BIO, P1; Miller K, 2019, BIOL MED PHYS BIOMED, P135, DOI 10.1007/978-3-030-04996-6_6; Miller K, 2019, INT J NUMER METH BIO, V35, DOI 10.1002/cnm.3250; Miller K, 2013, J MECH BEHAV BIOMED, V27, P154, DOI 10.1016/j.jmbbm.2013.01.013; Miner RC, 2017, J MED IMAGING RADIAT, V48, P328, DOI 10.1016/j.jmir.2017.06.005; Misra S, 2010, INT J ROBOT RES, V29, P1640, DOI 10.1177/0278364910369714; Morriss L, 2008, J BIOMECH, V41, P235, DOI 10.1016/j.jbiomech.2007.06.025; Mostayed A, 2013, ANN BIOMED ENG, V41, P2409, DOI 10.1007/s10439-013-0838-y; Oldfield M, 2013, COMPUT METHOD BIOMEC, V16, P530, DOI 10.1080/10255842.2011.628448; Park H, 2018, ANN BIOMED ENG, V46, P2012, DOI 10.1007/s10439-018-2100-0; Power SP, 2016, WORLD J RADIOL, V8, P902, DOI 10.4329/wjr.v8.i12.902; Sastry R, 2017, J NEUROIMAGING, V27, P5, DOI 10.1111/jon.12382; Seiler K, 2011, ALGORITHMIC FDN ROBO, P37; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stukelj R, 2017, EUR J PHARM SCI, V98, P17, DOI 10.1016/j.ejps.2016.10.007; Sylvester J, 2013, BRACHYTHERAPY, V12, P375, DOI 10.1016/j.brachy.2012.07.002; Urrea FA, 2016, J MECH BEHAV BIOMED, V56, P98, DOI 10.1016/j.jmbbm.2015.11.024; Phan VA, 2019, ENDOSCOPY, V51, P463, DOI 10.1055/a-0800-0033; VTK, 2020, VTK EX; Warfield S. K., 2002, Computing and Visualization in Science, V5, P3, DOI 10.1007/s00791-002-0083-7; Washio T, 2004, LECT NOTES COMPUT SC, V3217, P113; Washio T, 2020, MED IMAGE COMPUTING, P113; Wittek A, 2008, COMPUT METHOD BIOMEC, V11, P135, DOI [10.1080/10255840701688095, 10.1080/10255840802296665]; Wittek A., 2019, HDB MEDICAL IMAGE CO, P953, DOI [10.1016/B978-0-12-816176-0.00044-2, DOI 10.1016/B978-0-12-816176-0.00044-2, 10.1016/b978-0-12-816176-0.00044-2]; Wittek A, 2016, ANN BIOMED ENG, V44, P3, DOI 10.1007/s10439-015-1469-2; Wittek A, 2010, PROG BIOPHYS MOL BIO, V103, P292, DOI 10.1016/j.pbiomolbio.2010.09.001; Wittek A, 2009, BIOMECH MODEL MECHAN, V8, P77, DOI 10.1007/s10237-008-0118-1; Yang KH, 2018, BASIC FINITE ELEMENT METHOD AS APPLIED TO INJURY BIOMECHANICS, P1; Yao CJ, 2016, INT J NEUROSCI, V126, P53, DOI 10.3109/00207454.2014.992429; Zhang GY, 2014, ENG ANAL BOUND ELEM, V42, P60, DOI 10.1016/j.enganabound.2013.08.014; Zhang JY, 2007, J BIOMECH, V40, P2341, DOI 10.1016/j.jbiomech.2006.10.021; Zhang JY, 2013, INT J NUMER METH BIO, V29, P293, DOI 10.1002/cnm.2507; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	86	5	5	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0242704	10.1371/journal.pone.0242704	http://dx.doi.org/10.1371/journal.pone.0242704			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351854	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071400040
J	Yang, ZH; Shen, NN; Li, CX				Yang, Zhiheng; Shen, Nengneng; Li, Chenxi			Key factors of the willingness of rural populations settling in cities (RPSC) from a Lacanian psychoanalysis theory perspective	PLOS ONE			English	Article							SETTLEMENT INTENTION; URBAN SETTLEMENT; SOCIAL TIES; MIGRANTS; CHINA; MIGRATION; MODEL	The migration of populations from rural to urban areas is a typical phenomenon of urbanization in developing countries. Based on Lacanian psychoanalysis theory, this study analyzes the decision-making mechanism of the willingness of rural populations settling in cities (RPSC), and analyzes the key factors that affect the willingness of RPSC by using the binary Logit regression method based on survey data in Changyi, China. The results show that the willingness of RPSC is a realistic choice under the joint action of the 'mirrored' incarnation and the 'non-mirrored' order. Among the factors, 'age', 'ethnic groups', 'educational attainment', and 'social intercourse', representing the 'mirrored' incarnation, and 'communities' safety gap', 'healthcare services policy', 'public housing policy' and 'employment insurance gap', representing the 'non-mirrored' order, are significant in affecting the willingness of RPSC. These findings validate the adaptability of psychoanalysis to analyze the willingness of RPSC, and increases the understanding of individual willingness and behavioral choice in the context of a specific social background, which can provide decision-making reference for urban and rural planning and public policy makers.	[Yang, Zhiheng; Shen, Nengneng] Shandong Univ Finance & Econ, Inst Reg Econ, Jinan, Shandong, Peoples R China; [Shen, Nengneng] Shandong Univ Finance & Econ, Sch Econ, Jinan, Shandong, Peoples R China; [Li, Chenxi] Xian Univ Architecture & Technol, Sch Publ Adm, Xian, Shaanxi, Peoples R China	Shandong University of Finance & Economics; Shandong University of Finance & Economics; Xi'an University of Architecture & Technology	Li, CX (corresponding author), Xian Univ Architecture & Technol, Sch Publ Adm, Xian, Shaanxi, Peoples R China.	lichenxi@xauat.edu.cn	Li, Chenxi/W-2311-2019	Li, Chenxi/0000-0002-5019-9949; yang, zhiheng/0000-0001-9127-2690	National Natural Science Foundation of China [41501606, 71704094]; Natural Science Foundation of Shandong Province [ZR201911100159]; Social science planning and research project of Shandong Province [19CJJJ13]; Shaanxi Provincial Soft Science Program Fund [2020KRM197]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Social science planning and research project of Shandong Province; Shaanxi Provincial Soft Science Program Fund	This research was financed by National Natural Science Foundation of China (Grant nos. 41501606 & 71704094); Natural Science Foundation of Shandong Province (Grant nos. ZR201911100159); Social science planning and research project of Shandong Province (Grant nos. 19CJJJ13), and Shaanxi Provincial Soft Science Program Fund (Grant nos. 2020KRM197). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, LANCET GASTROENTEROL, V1, P85, DOI [10.1016/S2468-1253(16)30087-5, 10.1136/gutjnl-2016-311964]; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; Auvachez E, 2009, GLOBAL GOV, V15, P43, DOI 10.1163/19426720-01501004; Cao GZ, 2015, URBAN STUD, V52, P639, DOI 10.1177/0042098014529346; Chen SW, 2016, HABITAT INT, V58, P42, DOI 10.1016/j.habitatint.2016.09.004; Cockx L, 2018, WORLD DEV, V110, P140, DOI 10.1016/j.worlddev.2018.04.018; Constant A, 2003, J POPUL ECON, V16, P631, DOI 10.1007/s00148-003-0168-8; Fan CC, 2011, CHINA REV, V11, P11; Fink B., 1997, LACANIAN SUBJECT LAN; He BJ, 2019, LAND USE POLICY, V86, P147, DOI 10.1016/j.landusepol.2019.05.003; He BJ, 2018, HABITAT INT, V82, P83, DOI 10.1016/j.habitatint.2018.10.001; Hodgson G. M., 2012, WORLD EC ASS, V1, P1; Huang X, 2018, CITIES, V83, P203, DOI 10.1016/j.cities.2018.06.023; Johnston A, 2013, CONT PHILOS REV, V46, P251, DOI 10.1007/s11007-013-9263-z; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Khraif R M, 1992, GeoJournal, V26, P363, DOI 10.1007/BF02629816; Knight J, 2010, WORLD DEV, V38, P113, DOI 10.1016/j.worlddev.2009.03.002; Korinek K, 2005, AM SOCIOL REV, V70, P779, DOI 10.1177/000312240507000503; Lahariya Chandrakant, 2008, Indian Pediatr, V45, P481; LEE ES, 1966, DEMOGRAPHY, V3, P47, DOI 10.2307/2060063; Li C., 2020, CHINA SOFT SCI, V7, P52; Li CX, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203952; Li CX, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7547-4; Li H., 2019, POPUL J, V41, P80, DOI [10.16405/j.cnki.1004-129X.2019.01.007, DOI 10.16405/J.CNKI.1004-129X.2019.01.007]; Liu JH, 2020, ENERGIES, V13, DOI 10.3390/en13153786; Liu Y, 2012, HABITAT INT, V36, P192, DOI 10.1016/j.habitatint.2011.08.008; Liu Y, 2018, APPL GEOGR, V96, P130, DOI 10.1016/j.apgeog.2018.05.014; [陆大道 Lu Dadao], 2015, [地理学报, Acta Geographica Sinica], V70, P179; [吕小康 Lu Xiaokang], 2018, [心理科学进展, Advances in Psychological Science], V26, P2249; Mao D., 2009, SOTSIOL ISSLED+, V24, P28, DOI DOI 10.19934/J.CNKI.SHXYJ.2009.04.002; Massey DS, 2006, SOC SCI QUART, V87, P954, DOI 10.1111/j.1540-6237.2006.00410.x; Mohabir N, 2017, HABITAT INT, V60, P101, DOI 10.1016/j.habitatint.2016.12.008; National Bureau of Statistics of China, 2019, CHIN STAT YB 2019; Nicols J., 2008, SPACE CULT, V11, P459; Parson E. R., 1994, PSYCHOANAL PSYCHOL, P142; SIMON HA, 1986, J BUS, V59, pS209, DOI 10.1086/296363; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Tao L, 2014, HABITAT INT, V42, P193, DOI 10.1016/j.habitatint.2013.12.006; Todaro M. P., 1977, SO EC J, V45, P95, DOI [10.2307/1057657, DOI 10.2307/1057657]; TODARO MP, 1969, AM ECON REV, V59, P138; Wang XR, 2015, HABITAT INT, V47, P279, DOI 10.1016/j.habitatint.2015.02.001; Yang J, 2020, J CLEAN PROD, V275, DOI 10.1016/j.jclepro.2020.123767; Yang PD, 2018, J ETHN MIGR STUD, V44, P1015, DOI 10.1080/1369183X.2017.1384157; Zhang GC, 2020, SUSTAIN CITIES SOC, V61, DOI 10.1016/j.scs.2020.102314; Zhang Y., 2011, CHIN J POPUL SCI, P14; Zhao DX, 2021, CATENA, V196, DOI 10.1016/j.catena.2020.104938	46	1	1	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0243775	10.1371/journal.pone.0243775	http://dx.doi.org/10.1371/journal.pone.0243775			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CG	33351811	Green Published, gold			2022-12-27	WOS:000603071400047
J	Laso-Jadart, R; Ambroise, C; Peterlongo, P; Madoui, MA				Laso-Jadart, Romuald; Ambroise, Christophe; Peterlongo, Pierre; Madoui, Mohammed-Amin			metaVaR: Introducing metavariant species models for reference-free metagenomic-based population genomics	PLOS ONE			English	Article								The availability of large metagenomic data offers great opportunities for the population genomic analysis of uncultured organisms, which represent a large part of the unexplored biosphere and play a key ecological role. However, the majority of these organisms lack a reference genome or transcriptome, which constitutes a technical obstacle for classical population genomic analyses. We introduce the metavariant species (MVS) model, in which a species is represented only by intra-species nucleotide polymorphism. We designed a method combining reference-free variant calling, multiple density-based clustering and maximum-weighted independent set algorithms to cluster intra-species variants into MVSs directly from multisample metagenomic raw reads without a reference genome or read assembly. The frequencies of the MVS variants are then used to compute population genomic statistics such as F-ST, in order to estimate genomic differentiation between populations and to identify loci under natural selection. The MVS construction was tested on simulated and real metagenomic data. MVSs showed the required quality for robust population genomics and allowed an accurate estimation of genomic differentiation (Delta F-ST < 0.0001 and <0.03 on simulated and real data respectively). Loci predicted under natural selection on real data were all detected by MVSs. MVSs represent a new paradigm that may simplify and enhance holistic approaches for population genomics and the evolution of microorganisms.	[Laso-Jadart, Romuald; Madoui, Mohammed-Amin] Univ Paris Saclay, Univ Evry, Genom Metab UMR 8030, Inst Francois Jacob,CEA,CNRS, Evry, France; [Ambroise, Christophe] Univ Paris Saclay, Univ Evry, IBGBI LaMME, Evry, France; [Peterlongo, Pierre] Univ Rennes, INRIA, CNRS, IRISA, Rennes, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Inria; Universite de Rennes	Madoui, MA (corresponding author), Univ Paris Saclay, Univ Evry, Genom Metab UMR 8030, Inst Francois Jacob,CEA,CNRS, Evry, France.	amadoui@genoscope.cns.fr	Madoui, Mohammed-Amin/GYD-9411-2022; peterlongo, pierre/J-6742-2019; Madoui, Mohammed-Amin/AAF-3374-2021	peterlongo, pierre/0000-0003-0776-6407; Madoui, Mohammed-Amin/0000-0003-4809-2971				Arif M, 2019, MOL ECOL RESOUR, V19, P526, DOI 10.1111/1755-0998.12985; Campello Ricardo J. G. B., 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference (PAKDD 2013). Proceedings, P160, DOI 10.1007/978-3-642-37456-2_14; Carradec Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02342-1; Chariton AA, 2019, MOL ECOL, V28, P4549, DOI 10.1111/mec.15235; Costea PI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182392; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Delmont TO, 2019, ELIFE, V8, DOI 10.7554/eLife.46497; Ehrlich SD, 2011, METAGENOMICS OF THE HUMAN BODY, P307, DOI 10.1007/978-1-4419-7089-3_15; Ellegaard KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08303-0; Fang H, 2016, NAT PROTOC, V11, P2529, DOI 10.1038/nprot.2016.150; Garud NR, 2020, TRENDS GENET, V36, P53, DOI 10.1016/j.tig.2019.10.010; Huson DH, 2018, BIOL DIRECT, V13, DOI 10.1186/s13062-018-0208-7; Ibarbalz FM, 2019, CELL, V179, P1084, DOI 10.1016/j.cell.2019.10.008; Laso-Jadart R, 2020, ECOL EVOL, V10, P8894, DOI 10.1002/ece3.6588; LEWONTIN RC, 1973, GENETICS, V74, P175; Li Y, 2020, KMER2SNP REFERENCE F, DOI [10.1101/2020.05.17.100305, DOI 10.1101/2020.05.17.100305]; Madoui MA, 2017, MOL ECOL, V26, P4467, DOI 10.1111/mec.14214; MANTEL N, 1967, CANCER RES, V27, P209; Parks DH, 2017, NAT MICROBIOL, V2, P1533, DOI 10.1038/s41564-017-0012-7; Prezza N, 2019, ALGORITHM MOL BIOL, V14, DOI 10.1186/s13015-019-0137-8; Rau A, 2018, BRIEF BIOINFORM, V19, P425, DOI 10.1093/bib/bbw128; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Sakai S, 2003, DISCRETE APPL MATH, V126, P313, DOI 10.1016/S0166-218X(02)00205-6; Salazar G, 2019, CELL, V179, P1068, DOI 10.1016/j.cell.2019.10.014; Sangwan N, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0154-5; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sedlar K, 2017, COMPUT STRUCT BIOTEC, V15, P48, DOI 10.1016/j.csbj.2016.11.005; Somerville V, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1500-0; Standage DS, 2019, ISCIENCE, V18, P28, DOI 10.1016/j.isci.2019.07.032; Stewart RD, 2019, NAT BIOTECHNOL, V37, P953, DOI 10.1038/s41587-019-0202-3; Uricaru R, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1187; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; Willing EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042649	34	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2020	15	12							e0244637	10.1371/journal.pone.0244637	http://dx.doi.org/10.1371/journal.pone.0244637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PP1TQ	33378381	Green Submitted, Green Published, gold			2022-12-27	WOS:000605651300011
J	Wang, D; Wang, LP; Xue, CY; Han, YB; Li, HJ; Geng, JQ; Jie, J				Wang, Dan; Wang, Liping; Xue, Chenyu; Han, Yuebei; Li, Hejing; Geng, Jianqiang; Jie, Jiang			Detection of meat from horse, donkey and their hybrids (mule/hinny) by duplex real-time fluorescent PCR	PLOS ONE			English	Article							DNA; IDENTIFICATION; QUANTIFICATION; BEEF; PORK; NUCLEAR; PRODUCTS; CHICKEN	Meat adulteration is currently a common practice worldwide. In China, adulteration of donkey meat products with the similar species (horse and mule/hinny) meat and mislabeling are becoming widespread concerns. In this study, a sensitive and species-specific duplex real-time PCR assay based on the simultaneous amplification of fragments of the creatine kinase muscle gene family, was developed and optimized for the identification of horse, donkey and mule /hinny species in raw and heat-processed meat products. Duplex real-time PCR results showed different fluorescence amplification curves for horse and donkey. Both kinds of fluorescence amplification curves appeared simultaneously for mule/hinny. The limit of detection (LOD) of the method was up to 0.01 ng /mu L. The method and strategy developed in this study could be applied to detect the presence of adulterants from horse and mule /hinny meat in raw donkey meat and meat products.	[Wang, Dan; Wang, Liping; Xue, Chenyu; Han, Yuebei; Li, Hejing; Geng, Jianqiang; Jie, Jiang] Beijing Municipal Ctr Food Safety Monitoring & Ri, Biol Lab, Beijing, Peoples R China		Jie, J (corresponding author), Beijing Municipal Ctr Food Safety Monitoring & Ri, Biol Lab, Beijing, Peoples R China.	cfqs20200519@126.com	jie, jie/HGT-7778-2022		Ministry of Science and Technology of the People's Republic of China [2019YFC1605001]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This study was funded by Ministry of Science and Technology of the People's Republic of China in the form of a grant awarded to GJ (2019YFC1605001). The funder covered the cost of testing and test materials, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, FORENSIC SCI INT, V139, P141, DOI 10.1016/j.forsciint.2003.10.008; Anna W, 2018, MED WETER, V74, P6061, DOI [10.21521/mw.6061, DOI 10.21521/MW.6061]; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Chen AL, 2015, INT J FOOD SCI TECH, V50, P834, DOI 10.1111/ijfs.12720; Dalsecco LS, 2018, J FOOD SCI, V83, P258, DOI 10.1111/1750-3841.14001; EBBEHOJ KF, 1991, MEAT SCI, V30, P221, DOI 10.1016/0309-1740(91)90068-2; Henriques D, 2019, APIDOLOGIE, V50, P538, DOI 10.1007/s13592-019-00666-z; Hossain MAM, 2019, J AGR FOOD CHEM, V67, P8268, DOI 10.1021/acs.jafc.9b02518; Ilahi A, 2017, CURR MICROBIOL, V74, P671, DOI 10.1007/s00284-017-1237-7; Iwobi A, 2015, FOOD CHEM, V169, P305, DOI 10.1016/j.foodchem.2014.07.139; Kang H, 2018, ASIAN WOMEN, V34, P1, DOI 10.14431/aw.2018.06.34.2.1; Koppel R, 2008, EUR FOOD RES TECHNOL, V227, P1199, DOI 10.1007/s00217-008-0837-7; Koppel R, 2009, EUR FOOD RES TECHNOL, V230, P125, DOI 10.1007/s00217-009-1154-5; LANSMAN RA, 1983, P NATL ACAD SCI-BIOL, V80, P1969, DOI 10.1073/pnas.80.7.1969; Lavergne A, 2003, J MED PRIMATOL, V32, P330, DOI 10.1046/j.1600-0684.2003.00038.x; Li Q, 2012, ACTA OTO-LARYNGOL, V132, P814, DOI 10.3109/00016489.2012.664781; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Matsumoto C, 2019, J FOOD SCI TECH MYS, V56, P4705, DOI 10.1007/s13197-019-03914-3; Matsunaga T, 1999, MEAT SCI, V51, P143, DOI 10.1016/S0309-1740(98)00112-0; Meira L, 2017, LWT-FOOD SCI TECHNOL, V75, P408, DOI 10.1016/j.lwt.2016.08.061; Moustafa GG, 2017, J EQUINE VET SCI, V54, P37, DOI 10.1016/j.jevs.2017.02.014; Ng J, 2014, J FOOD SCI TECH MYS, V51, P4060, DOI 10.1007/s13197-012-0893-7; Perestam AT, 2017, FOOD CONTROL, V71, P346, DOI 10.1016/j.foodcont.2016.07.017; Quinto CA, 2016, FOOD CONTROL, V59, P386, DOI 10.1016/j.foodcont.2015.05.043; Rehbein H, 2013, EUR FOOD RES TECHNOL, V236, P979, DOI 10.1007/s00217-013-1961-6; Ren JN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173567; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Wu QQ, 2018, APPL BIOCHEM BIOTECH, V185, P1, DOI 10.1007/s12010-017-2621-2; [吴亚君 Wu Yajun], 2014, [食品科学, Food Science], V35, P85; Xu XF, 1996, J MOL EVOL, V43, P438, DOI 10.1007/BF02337515; You J, 2014, FOOD SCI BIOTECHNOL, V23, P133, DOI 10.1007/s10068-014-0018-3; Yuan Y, 2014, HUBEI AGR SCI, V53, P5518, DOI [10.7506/spkx1002-6630-201408016, DOI 10.7506/SPKX1002-6630-201408016]; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	33	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0237077	10.1371/journal.pone.0237077	http://dx.doi.org/10.1371/journal.pone.0237077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373374	gold, Green Published			2022-12-27	WOS:000603612300028
J	Zhang, JY; Nie, DB; Williamson, K; McDowell, A; Hogan, MV; Wang, JHC				Zhang, Jianying; Nie, Daibang; Williamson, Kelly; McDowell, Arthur; Hogan, MaCalus V.; Wang, James H-C.			Moderate and intensive mechanical loading differentially modulate the phenotype of tendon stem/progenitor cells in vivo	PLOS ONE			English	Article							PROMOTED OSTEOGENIC DIFFERENTIATION; STEM-CELLS; MATRIX; TENDINOPATHY; EXPRESSION	To examine the differential mechanobiological responses of specific resident tendon cells, we developed an in vivo model of whole-body irradiation followed by injection of either tendon stem/progenitor cells (TSCs) expressing green fluorescent protein (GFP-TSCs) or mature tenocytes expressing GFP (GFP-TNCs) into the patellar tendons of wild type C57 mice. Injected mice were subjected to short term (3 weeks) treadmill running, specifically moderate treadmill running (MTR) and intensive treadmill running (ITR). In MTR mice, both GFP-TSC and GFP-TNC injected tendons maintained normal cell morphology with elevated expression of tendon related markers collagen I and tenomodulin. In ITR mice injected with GFP-TNCs, cells also maintained an elongated shape similar to the shape found in normal/untreated control mice, as well as elevated expression of tendon related markers. However, ITR mice injected with GFP-TSCs showed abnormal changes, such as cell morphology transitioning to a round shape, elevated chondrogenic differentiation, and increased gene expression of non-tenocyte related genes LPL, Runx-2, and SOX-9. Increased gene expression data was supported by immunostaining showing elevated expression of SOX-9, Runx-2, and PPAR gamma. This study provides evidence that while MTR maintains tendon homeostasis by promoting the differentiation of TSCs into TNCs, ITR causes the onset of tendinopathy development by inducing non-tenocyte differentiation of TSCs, which may eventually lead to the formation of non-tendinous tissues in tendon tissue after long term mechanical overloading conditions on the tendon.	[Zhang, Jianying; Nie, Daibang; Williamson, Kelly; McDowell, Arthur; Hogan, MaCalus V.; Wang, James H-C.] Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15260 USA; [Nie, Daibang] Chongqing Med Univ, Dept Immunol, Coll Basic Med, Chongqing, Peoples R China; [McDowell, Arthur] Howard Univ, Coll Med, Washington, DC 20059 USA; [Wang, James H-C.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Wang, James H-C.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chongqing Medical University; Howard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, JHC (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15260 USA.; Wang, JHC (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Wang, JHC (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.	wanghc@pitt.edu	Hogan, MaCalus V/N-5484-2017; Hogan, Macalus/AFS-7589-2022	Hogan, MaCalus V/0000-0002-6598-1095; Williamson, Kelly/0000-0002-7529-0220	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH [AR065949, AR070340]	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All the external funding sources of support received during this study was from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH under awards AR065949 and AR070340 (JHW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cui YZ, 2002, BONE MARROW TRANSPL, V30, P843, DOI 10.1038/sj.bmt.1703766; Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f; Fu SC, 2002, ACTA ORTHOP SCAND, V73, P658, DOI 10.3109/17453670209178031; Fu XR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080784; Hopkins C, 2016, ASIA-PAC J SPORT MED, V4, P9, DOI 10.1016/j.asmart.2016.01.002; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Karousou E, 2008, CLIN ORTHOP RELAT R, V466, P1577, DOI 10.1007/s11999-008-0255-y; Kim SJ, 2018, J CELL PHYSIOL, V233, P6196, DOI 10.1002/jcp.26475; Koch A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161079; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Liang X, 2016, STEM CELL TRANSL MED, V5, P960, DOI 10.5966/sctm.2015-0274; Lui PPY, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0097-y; Lui PPY, 2011, STEM CELL REV REP, V7, P883, DOI 10.1007/s12015-011-9276-0; Lui PPY, 2009, J HISTOCHEM CYTOCHEM, V57, P91, DOI 10.1369/jhc.2008.952143; Maffulli N, 2006, CLIN J SPORT MED, V16, P329, DOI 10.1097/00042752-200607000-00008; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Riley GP, 1996, ANN RHEUM DIS, V55, P109, DOI 10.1136/ard.55.2.109; Ruge T, 2004, AM J PHYSIOL-RENAL, V287, pF1131, DOI 10.1152/ajprenal.00089.2004; Rui YF, 2011, J ORTHOP RES, V29, P390, DOI 10.1002/jor.21218; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shi Y, 2012, J CELL BIOCHEM, V113, P3133, DOI 10.1002/jcb.24190; Teplyuk NM, 2009, MOL ENDOCRINOL, V23, P849, DOI 10.1210/me.2008-0270; Wang JHC, 2012, J HAND THER, V25, P133, DOI 10.1016/j.jht.2011.07.004; Xiong Y, 2015, TISSUE ENG PT A, V21, P1886, DOI [10.1089/ten.tea.2014.0539, 10.1089/ten.TEA.2014.0539]; Yelin E, 2016, SEMIN ARTHRITIS RHEU, V46, P259, DOI 10.1016/j.semarthrit.2016.07.013; Yokota A, 2005, J SHOULDER ELB SURG, V14, p72S, DOI 10.1016/j.jse.2004.09.021; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071740; Zhang JY, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-68; Zhang JY, 2010, J ORTHOP RES, V28, P1178, DOI 10.1002/jor.21123; Zhang JY, 2010, J ORTHOP RES, V28, P639, DOI 10.1002/jor.21046; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhao GY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222369	35	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0242640	10.1371/journal.pone.0242640	http://dx.doi.org/10.1371/journal.pone.0242640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373386	Green Submitted, Green Published, gold			2022-12-27	WOS:000603612300063
J	Deng, YL; Han, SY; Li, JY; Rong, JJ; Fan, WY; Sun, TC				Deng, Yilin; Han, Sang-Yun; Li, Jianyi; Rong, Jinjin; Fan, Wenyu; Sun, Tiancong			The design of tourism product CAD three-dimensional modeling system using VR technology	PLOS ONE			English	Article							VIRTUAL-REALITY; EXPERIENCE	In view of the high homogeneity of tourism products all over the country, an attempt is made to design virtual visit tourism products with cultural experience background, which can reflect the characteristics of culture + tourism in different scenic spots, so that tourists can deeply experience the local culture. Combined with computer aided design (CAD), the virtual three-dimensional (3D) modeling system of scenic spots is designed, and VR real scene visit interactive tourism products suitable for different scenic spots are designed. 360 degrees VR panoramic display technology is used for 360 degrees VR panoramic video shooting and visiting system display production of Elephant Trunk Hill park scenery. A total of 157 images are collected and 720 cloud panoramic interactive H5 tool is selected to produce a display system suitable for 360 degrees VR panoramic display of scenic spots. Meanwhile, based on single view RGB-D image, the latest convolutional neural network (CNN) algorithm and point cloud processing algorithm are used to design the indoor 3D scene reconstruction algorithm based on semantic understanding. Experiments show that the pixel accuracy and mean intersection over union of the indoor scene layout segmentation network segmentation results are 89.5% and 60.9%, respectively, that is, it has high accuracy. The VR real scene visit interactive tourism product can make tourists have a more immersive sense of interaction and experience before, during and after the tour.	[Deng, Yilin] Guilin Univ Technol, Coll Arts, Guilin, Guangxi, Peoples R China; [Deng, Yilin; Han, Sang-Yun; Li, Jianyi; Rong, Jinjin; Fan, Wenyu; Sun, Tiancong] Hanseo Univ, Coll Design & Media Entertainment, Seosan, Chungcheongnam, South Korea; [Deng, Yilin] Guangxi Zhuang Autonomous Reg Virtual Simulat Exp, Guilin, Guangxi, Peoples R China	Guilin University of Technology; Hanseo University	Deng, YL (corresponding author), Guilin Univ Technol, Coll Arts, Guilin, Guangxi, Peoples R China.; Deng, YL (corresponding author), Hanseo Univ, Coll Design & Media Entertainment, Seosan, Chungcheongnam, South Korea.; Deng, YL (corresponding author), Guangxi Zhuang Autonomous Reg Virtual Simulat Exp, Guilin, Guangxi, Peoples R China.	6615042@glut.edu.cn			National Social Science Fund of China [18BMZ138]	National Social Science Fund of China	This study is supported by The National Social Science Fund of China: Research on the Path of Creative Transformation of Yao Nationality's Costume Culture in Tourism Cultural Products (No 18BMZ138). And the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, ISMP MED SAFETY ALER, V22, P1, DOI DOI 10.1016/j.ebiom.2017.07.026; Chen ZZ, 2018, SIGNAL PROCESS, V146, P66, DOI 10.1016/j.sigpro.2018.01.004; Cheng Q, 2019, J MOUNTAIN ENCE, V16, P266; Chirisa I., 2020, J SOCIAL SCI, V64, P1, DOI [10.31901/24566756.2020/64.1-3.2266, DOI 10.31901/24566756.2020/64.1-3.2266]; David D, 2019, PROCEDIA COMPUT SCI, V157, P646, DOI 10.1016/j.procs.2019.08.223; Dawson B., 2019, COLLECTIONS, V15, P62, DOI [10.1177/1550190619832381, DOI 10.1177/1550190619832381]; Dey U, 2020, COMPUT APPL ENG EDUC, V28, P1028, DOI 10.1002/cae.22282; Elbamby MS, 2018, IEEE NETWORK, V32, P78, DOI 10.1109/MNET.2018.1700268; Kataev N, 2019, J SUPERCOMPUT, V75, P7833, DOI 10.1007/s11227-018-2551-y; Krichenbauer M, 2018, IEEE T VIS COMPUT GR, V24, P1038, DOI 10.1109/TVCG.2017.2658570; Liu Q X, 2018, MULTIMED TOOLS APPL, V79, P3107; Meissner M, 2019, J BUS RES, V100, P445, DOI 10.1016/j.jbusres.2017.09.028; Pelau C, 2018, STUD U VASILE GOL EC, V28, P17, DOI 10.2478/sues-2018-0002; Rothbaum B O, 2019, ANN NY ACAD SCI, V208, P126, DOI [10.1016/j.cct.2019.105857, DOI 10.1016/J.CCT.2019.105857]; Shin D, 2018, COMPUT HUM BEHAV, V78, P64, DOI 10.1016/j.chb.2017.09.012; Tussyadiah IP, 2018, TOURISM MANAGE, V66, P140, DOI 10.1016/j.tourman.2017.12.003; Wall G., 2019, J ECOTOURISM, V18, P190, DOI [10.1080/14724049.2018.1465256, DOI 10.1080/14724049.2018.1465256]; Walters G, 2019, TOUR RECREAT RES, V44, P103, DOI 10.1080/02508281.2018.1558510; Wei W, 2019, J HOSP TOUR TECHNOL, V10, P539, DOI 10.1108/JHTT-04-2018-0030; Wenya M A, 2019, LANDSCAPE RES, V11, P141	20	4	4	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244205	10.1371/journal.pone.0244205	http://dx.doi.org/10.1371/journal.pone.0244205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370346	Green Published, gold			2022-12-27	WOS:000603611900084
J	Fallara, G; Lissbrant, IF; Styrke, J; Montorsi, F; Garmo, H; Stattin, P				Fallara, Giuseppe; Lissbrant, Ingela Franck; Styrke, Johan; Montorsi, Francesco; Garmo, Hans; Stattin, Par			Observational study on time on treatment with abiraterone and enzalutamide	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; MEDICATION ADHERENCE; SURVIVAL ANALYSIS; DOUBLE-BLIND; ACETATE; MEN; CHEMOTHERAPY; REGISTER; PREDNISONE; EXPERIENCE	Introduction The aim of this study was to assess time on treatment with abiraterone and enzalutamide, two androgen receptor targeted (ART) drugs, the impact on time on treatment of time interval without drug supply between prescription fillings, and adherence to treatment. Material and methods By use of data from The National Prostate Cancer Register, The Prescribed Drug Registry and the Patient Registry, time on treatment with the abiraterone and enzalutamide was analyzed in all men with castration resistant prostate cancer (CRPC) in Sweden 2015-2019. Three time intervals between consecutive fillings, i.e. time without drug supply, were assessed. Adherence to the treatment was evaluated by use of the Medication Possession Ratio. Kaplan Meier analysis and multivariable Cox regression model were used to assess factors affecting time on treatment. Results Between January 2015 and October 2019, 1803 men filled a prescription for abiraterone and 4 534 men filled a prescription for enzalutamide. With a time interval of 30 days or less between two fillings, median time on treatment was 4.9 months (IQR 2.6-11.7) for abiraterone and 8.0 months (IQR 3.6-16.4) for enzalutamide. In sensitivity analyses, allowing for no more than 14 days without drug supply between fillings, median time on treatment was 3.9 months (IQR 2.1-9.0) for abiraterone and 5.9 months (IQR 2.8-12.1) for enzalutamide. Allowing for any time period without drug between fillings, median time on treatment was 5.7 months (IQR 2.7-14.0) for abiraterone and 9.8 months (IQR 4.4-21.0) for enzalutamide. Adherence to treatment was above 90% for both drugs. Conclusion Time on treatment with abiraterone and enzalutamide was shorter in clinical practice than in randomized controlled trials and varied almost two-fold with time interval without drug. Adherence to treatment was high. The main limitation of our study was the lack of data on use of chemotherapy.	[Fallara, Giuseppe; Montorsi, Francesco] IRCCS Osped San Raffaele, Unit Urol URI, Div Expt Oncol, Milan, Italy; [Fallara, Giuseppe; Montorsi, Francesco] Univ Vita Salute San Raffaele, Milan, Italy; [Fallara, Giuseppe; Garmo, Hans; Stattin, Par] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Lissbrant, Ingela Franck] Univ Goteborg, Sahlgrenska Acad, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden; [Styrke, Johan] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Garmo, Hans] Uppsala Univ Hosp, Reg Canc Ctr, Uppsala, Sweden	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Uppsala University; University of Gothenburg; Umea University; Uppsala University; Uppsala University Hospital	Fallara, G (corresponding author), IRCCS Osped San Raffaele, Unit Urol URI, Div Expt Oncol, Milan, Italy.; Fallara, G (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Fallara, G; Stattin, P (corresponding author), Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.	fallara.giuseppe@hsr.it; par.stattin@surgsci.uu.se	Styrke, Johan/AAE-1193-2021	Fallara, Giuseppe/0000-0001-7872-2650	Swedish Cancer Society [2019-0030]; Swedish Research Council [2017-00847]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project received research support from the Swedish Cancer Society (2019-0030) and the Swedish Research Council (2017-00847).	Al-Ali BM, 2017, WIEN KLIN WOCHENSCHR, V129, P380, DOI 10.1007/s00508-016-1067-9; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; [Anonymous], 2020, CASTRATION RESISTANT; [Anonymous], 2020, NATL CARE PROGRAM PR; [Anonymous], 2019, ACTA ORTHOP TRAUM S1, V53, P1; Azad AA, 2015, EUR UROL, V67, P441, DOI 10.1016/j.eururo.2014.01.030; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Beardo P, 2019, ARCH GERONTOL GERIAT, V82, P179, DOI 10.1016/j.archger.2019.02.008; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Behl AS, 2017, AM HEALTH DRUG BENEF, V10, P296; Biro K, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2017.10.015; Boegemann M, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5280-6; Cazzaniga W, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00051; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; De Nunzio Cosimo, 2020, Prostate Cancer Prostatic Dis, V23, P199, DOI 10.1038/s41391-019-0182-x; Fall K, 2008, SCAND J UROL NEPHROL, V42, P352, DOI 10.1080/00365590802078583; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Flaig T.W., 2015, CANC MED, V5, P182; George DJ, 2020, CLIN GENITOURIN CANC, V18, P284, DOI [10.1016/j.clgc.2019.12.019, 10.1016/j.clgc.2020.12.019]; Harshman LC, 2017, PROSTATE, V77, P1303, DOI 10.1002/pros.23390; Houede N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1257-2; Hussain M, 2018, NEW ENGL J MED, V378, P2465, DOI 10.1056/NEJMoa1800536; Lafeuille MH, 2014, J MANAG CARE SPEC PH, V20, P477, DOI 10.18553/jmcp.2014.20.5.477; Leibowitz-Amit R, 2014, EUR J CANCER, V50, P2399, DOI 10.1016/j.ejca.2014.06.004; Lissbrant IF, 2018, SCAND J UROL, V52, P143, DOI 10.1080/21681805.2018.1426039; Lissbrant IF, 2013, ACTA ONCOL, V52, P1593, DOI 10.3109/0284186X.2013.770164; Lu C, 2020, ANN ONCOL, V31, P1178, DOI 10.1016/j.annonc.2020.04.473; Mckay RR, 2016, PROSTATE CANCER P D, V19, P398, DOI 10.1038/pcan.2016.31; Mottet N., 2020, EUR ASS UROL; Pak K, 2017, JAMA ONCOL, V3, P1692, DOI 10.1001/jamaoncol.2017.2797; Pilon D, 2017, J MANAG CARE SPEC PH, V23, P225, DOI 10.18553/jmcp.2016.16233; Ramalingam S, 2017, UROL ONCOL-SEMIN ORI, V35, P418, DOI 10.1016/j.urolonc.2016.12.016; Regionala Cancercentrum, 2020, PROST NAT VARDPR; Ryan CJ, 2015, LANCET ONCOL, V16, P152, DOI 10.1016/S1470-2045(14)71205-7; Salem S, 2017, CLIN ONCOL-UK, V29, P601, DOI 10.1016/j.clon.2017.03.010; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schultz NM, 2018, ADV THER, V35, P1639, DOI 10.1007/s12325-018-0774-1; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Svensson J, 2016, SCAND J UROL, V50, P286, DOI 10.3109/21681805.2016.1172254; Trinquart L, 2016, J CLIN ONCOL, V34, P1813, DOI 10.1200/JCO.2015.64.2488; Van Hemelrijck M, 2016, BJU INT, V117, P507, DOI 10.1111/bju.13059; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068; Verzoni E, 2016, ONCOTARGET, V7, P40085, DOI 10.18632/oncotarget.9485; Weberpals J, 2017, EUR J EPIDEMIOL, V32, P1019, DOI 10.1007/s10654-017-0304-5; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Zhao LH, 2016, BIOMETRICS, V72, P215, DOI 10.1111/biom.12384	46	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244462	10.1371/journal.pone.0244462	http://dx.doi.org/10.1371/journal.pone.0244462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370378	Green Published, gold			2022-12-27	WOS:000603611900060
J	Scott, RA; Fowler, EW; Jia, XQ; Kiick, KL; Akins, RE				Scott, Rebecca A.; Fowler, Eric W.; Jia, Xinqiao; Kiick, Kristi L.; Akins, Robert E.			Regulation of neovasculogenesis in co-cultures of aortic adventitial fibroblasts and microvascular endothelial cells by cell-cell interactions and TGF-beta/ALK5 signaling	PLOS ONE			English	Article							VASA-VASORUM; SMOOTH-MUSCLE; TGF-BETA; CAPILLARY-LIKE; INTIMAL HYPERPLASIA; CORONARY-ARTERIES; DIFFERENTIATION; GROWTH; HYDROGELS; LAMININ	Adventitial fibroblasts (AFs) are critical mediators of vascular remodeling. However, the contributions of AFs towards development of vasculature and the specific mechanisms by which these cells regulate physiological expansion of the vasa vasorum, the specialized microvasculature that supplies nutrients to the vascular wall, are not well understood. To determine the regulatory role of AFs in microvascular endothelial cell (MVEC) neovasculogenesis and to investigate the regulatory pathways utilized for communication between the two cell types, AFs and MVECs were cultured together in poly(ethylene glycol)-based hydrogels. Following preliminary evaluation of a set of cell adhesion peptides (AG10, AG73, A2G78, YIGSR, RGD), 7.5wt% hydrogels containing 3 mM RGD were selected as these substrates did not initiate primitive tubule structures in 3D MVEC monocultures, thus providing a passive platform to study AF-MVEC interaction. The addition of AFs to hydrogels promoted MVEC viability; however, increasing AF density within hydrogels stimulated MVEC proliferation, increased microvessel density and size, and enhanced deposition of basement membrane proteins, collagen IV and laminin. Importantly, AF-MVEC communication through the transforming growth factor beta (TGF-beta)/activin receptor-like kinase 5 (ALK5) signaling pathway was observed to mediate microvessel formation, as inhibition of ALK5 significantly decreased MVEC proliferation, microvessel formation, mural cell recruitment, and basement membrane production. These data indicate that AFs regulate MVEC neovasculogenesis and suggest that therapeutics targeting the TGF-beta/ALK5 pathway may be useful for regulation of vasculogenic and anti-vasculogenic responses.	[Scott, Rebecca A.; Fowler, Eric W.; Jia, Xinqiao; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE USA; [Scott, Rebecca A.; Akins, Robert E.] Nemours Alfred I duPont Hosp Children, Wilmington, DE USA; [Scott, Rebecca A.; Fowler, Eric W.; Jia, Xinqiao; Kiick, Kristi L.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA	University of Delaware; Nemours Alfred I. duPont Hospital for Children; University of Delaware	Akins, RE (corresponding author), Nemours Alfred I duPont Hosp Children, Wilmington, DE USA.	robert.akins@nemours.org	Akins, Robert/AEU-9620-2022	Akins, Robert/0000-0001-9706-0752; Scott, Rebecca/0000-0002-2409-0712; Fowler, Eric/0000-0002-2640-8915	Nemours Foundation; NIH National Heart Lung and Blood Institute [R01 HL108110, F32 HL127983]; National Institute of General Medical Sciences [P20 GM103446, P30 GM110758, U54 GM104941, S10 OD016361]	Nemours Foundation; NIH National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sources of direct funds supporting the study included a. The Nemours Foundation b. The NIH National Heart Lung and Blood Institute grants Cell Instructive Materials for Engineering Vascular Grafts (R01 HL108110) Instructive Materials for Directing Neovascularization and Inflammation (F32 HL127983) Instrumentation and other material support were provided by a. The National Institute of General Medical Sciences grants The Delaware INBRE (P20 GM103446) The NIH COBRE for the Molecular Design of Advanced Biomaterials (P30 GM110758) The Delaware CTR ACCEL Program (U54 GM104941) Equipment Grant for a Zeiss LSM710 Inverted Microscope (S10 OD016361) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In the conduct of this study, the following authors received salary support: a. Rebecca A. Scott received salary support from F32 HL127983 and R01 HL108110 b. Robert E. Akins received salary support from the Nemours Foundation and R01 HL108110 Eric W. Fowler, Xinqiao Jia, and Kristi L. Kiick received no specific funding for this work.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ali S, 2013, BIORESEARCH OPEN ACC, V2, P241, DOI 10.1089/biores.2013.0021; Annarnalai RT, 2016, ACS BIOMATER SCI ENG, V2, P1914, DOI 10.1021/acsbiomaterials.6b00274; BARGER AC, 1984, NEW ENGL J MED, V310, P175, DOI 10.1056/NEJM198401193100307; BARKER SGE, 1993, ARTERIOSCLER THROMB, V13, P70, DOI 10.1161/01.ATV.13.1.70; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bressanutti S, 2020, J CLIN MED, V9; Brown A, 2020, BIOMATERIALS, V243, DOI 10.1016/j.biomaterials.2020.119921; Burke DL, 2009, AM J PHYSIOL-LUNG C, V297, pL238, DOI 10.1152/ajplung.90591.2008; Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662; Chwalek K, 2014, SCI REP-UK, V4, DOI 10.1038/srep04414; CLARKE JA, 1966, ACTA ANAT, V63, P55; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Davie NJ, 2006, AM J PATHOL, V168, P1793, DOI 10.2353/ajpath.2006.050754; Davie NJ, 2004, AM J PHYSIOL-LUNG C, V286, pL668, DOI 10.1152/ajplung.00108.2003; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; FILLINGER MF, 1993, J VASC SURG, V17, P1058, DOI 10.1016/0741-5214(93)90676-D; Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012; Friedl R, 2004, ANN THORAC SURG, V78, P1312, DOI 10.1016/j.athoracsur.2004.02.066; Genova T, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01291; Gossl M, 2004, ANAT EMBRYOL, V208, P351, DOI 10.1007/s00429-004-0400-7; Goumans MJ, 2009, CELL RES, V19, P116, DOI 10.1038/cr.2008.326; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; Ha JM, 2019, FEBS OPEN BIO, V9, P801, DOI 10.1002/2211-5463.12621; HEISTAD DD, 1981, AM J PHYSIOL, V240, pH781, DOI 10.1152/ajpheart.1981.240.5.H781; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoshino A, 2008, BIOCHEM BIOPH RES CO, V368, P305, DOI 10.1016/j.bbrc.2008.01.090; Hytonen JP, 2018, J MOL CELL CARDIOL, V121, P145, DOI 10.1016/j.yjmcc.2018.07.007; Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h; Kubis N, 2003, INTERV NEURORADIOL, V9, P227, DOI 10.1177/159101990300900301; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Li XD, 2020, CARDIOVASC RES, V116, P708, DOI 10.1093/cvr/cvz159; Mahadevaiah S, 2015, BIOMATERIALS, V62, P24, DOI 10.1016/j.biomaterials.2015.05.021; Malinda KM, 1999, FASEB J, V13, P53, DOI 10.1096/fasebj.13.1.53; Mayo JN, 2015, MICROCIRCULATION, V22, P711, DOI 10.1111/micc.12227; Michelis KC, 2018, STEM CELL REP, V11, P242, DOI 10.1016/j.stemcr.2018.06.001; Monteiro N, 2018, ACS BIOMATER SCI ENG, V4, P2563, DOI 10.1021/acsbiomaterials.8b00502; Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Peters EB, 2016, CELL MOL BIOENG, V9, P38, DOI 10.1007/s12195-015-0423-6; Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012; Poliseno L, 2012, SCI SIGNAL, V5, pre5; Ritman EL, 2007, CARDIOVASC RES, V75, P649, DOI 10.1016/j.cardiores.2007.06.020; Robinson KG, 2012, J BIOMED MATER RES A, V100A, P1356, DOI 10.1002/jbm.a.34075; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; SCHLINGEMANN RO, 1991, AM J PATHOL, V138, P1335; Schweller RM, 2015, ACS BIOMATER SCI ENG, V1, P335, DOI 10.1021/acsbiomaterials.5b00064; Scott R, 2010, J BIOMED MATER RES A, V93A, P817, DOI 10.1002/jbm.a.32775; Scott RA, 2017, BIOMATERIALS, V137, P1, DOI 10.1016/j.biomaterials.2017.05.010; Sedding DG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00706; Shi Y, 1996, CIRCULATION, V93, P340, DOI 10.1161/01.CIR.93.2.340; Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Stenmark KR, 2013, ANNU REV PHYSIOL, V75, P23, DOI 10.1146/annurev-physiol-030212-183802; Suzuki N, 2010, MATRIX BIOL, V29, P143, DOI 10.1016/j.matbio.2009.09.006; Tinajero MG, 2020, AM J PATHOL, V190, P520, DOI 10.1016/j.ajpath.2019.10.021; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Turturro MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058897; Velazquez OC, 2002, FASEB J, V16, P1316, DOI 10.1096/fj.01-1011fje; Verstraeten A, 2016, HUM MUTAT, V37, P524, DOI 10.1002/humu.22977; Wu XP, 2018, EXP CELL RES, V362, P17, DOI 10.1016/j.yexcr.2017.10.004; Zonneville J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4587-z	69	2	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244243	10.1371/journal.pone.0244243	http://dx.doi.org/10.1371/journal.pone.0244243			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370415	gold, Green Published			2022-12-27	WOS:000603611900031
J	Uchida, Y; Tsugawa, T; Tanaka-Mizuno, S; Noma, K; Aoki, K; Fukunaga, K; Nakagawa, H; Kinose, D; Yamaguchi, M; Osawa, M; Nagao, T; Ogawa, E; Nakano, Y				Uchida, Yasuki; Tsugawa, Takuya; Tanaka-Mizuno, Sachiko; Noma, Kazuo; Aoki, Ken; Fukunaga, Kentaro; Nakagawa, Hiroaki; Kinose, Daisuke; Yamaguchi, Masafumi; Osawa, Makoto; Nagao, Taishi; Ogawa, Emiko; Nakano, Yasutaka			Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective study	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; PHASE-III TRIAL; LUNG-CANCER; CHEMOTHERAPY; EMPHYSEMA; RISK; COPD; 1ST; CT	The constraint values of dose-volume histogram (DVH) parameters for radiation pneumonitis (RP) prediction have not been uniform in previous studies. We compared the differences between conventional DVH parameters and DVH parameters with high attenuation volume (HAV) in CT imaging in both esophageal cancer and lung cancer patients to determine the most suitable DVH parameters in predicting RP onset. Seventy-seven and 72 patients who underwent radiation therapy for lung cancer and esophageal cancer, respectively, were retrospectively assessed. RP was valued according to the Common Terminology Criteria for Adverse Events. We quantified HAV with quantitative computed tomography analysis. We compared conventional DVH parameters and DVH parameters with HAV in both groups of patients. Then, the thresholds of DVH parameters that predicted symptomatic RP and the differences in threshold of DVH parameters between lung cancer and esophageal cancer patient groups were compared. The predictive performance of DVH parameters for symptomatic RP was compared using the area under the receiver operating characteristic curve. Mean lung dose, HAV30% (the proportion of the lung with HAV receiving >= 30 Gy), and HAV20% were the top three parameters in lung cancer, while HAV10%, HAV5%, and V10 (the percentage of lung volume receiving 10 Gy or more) were the top three in esophageal cancer. By comparing the differences in the threshold for parameters predicting RP between the two cancers, we saw that HAV30% retained the same value in both cancers. DVH parameters with HAV showed narrow differences in the threshold between the two cancer patient groups compared to conventional DVH parameters. DVH parameters with HAV may have higher commonality than conventional DVH parameters in both patient groups tested.	[Uchida, Yasuki; Fukunaga, Kentaro; Nakagawa, Hiroaki; Kinose, Daisuke; Yamaguchi, Masafumi; Osawa, Makoto; Nagao, Taishi; Ogawa, Emiko; Nakano, Yasutaka] Shiga Univ Med Sci, Div Resp Med, Dept Internal Med, Otsu, Shiga, Japan; [Tsugawa, Takuya; Aoki, Ken] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga, Japan; [Tanaka-Mizuno, Sachiko] Shiga Univ Med Sci, Dept Med Stat, Otsu, Shiga, Japan; [Tanaka-Mizuno, Sachiko] Shiga Univ, Ctr Data Sci Educ & Res, Hikone, Shiga, Japan; [Noma, Kazuo] Shiga Univ Med Sci Hosp, Dept Radiol, Otsu, Shiga, Japan; [Osawa, Makoto] Shiga Univ Med Sci Hosp, Div Infect Control & Prevent, Otsu, Shiga, Japan; [Ogawa, Emiko] Shiga Univ Med Sci, Hlth Adm Ctr, Otsu, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science	Nakano, Y (corresponding author), Shiga Univ Med Sci, Div Resp Med, Dept Internal Med, Otsu, Shiga, Japan.	nakano@belle.shiga-med.ac.jp	TANAKA, Sachiko/HCH-0787-2022	Fukunaga, Kentaro/0000-0002-6261-0344	Daiichi-Sankyo Company, Limited [A19-1287]; Ono Pharmaceutical Company, Limited [ONOS20180618011]; Pfizer Inc [54334665]; Bayer Yakuhin, Limited [BASJ20180409030]; Boehringer Ingelheim GmbH [RS2019A00769379]; Astelas Pharma [RS2019A001313]	Daiichi-Sankyo Company, Limited(Daiichi Sankyo Company Limited); Ono Pharmaceutical Company, Limited; Pfizer Inc(Pfizer); Bayer Yakuhin, Limited; Boehringer Ingelheim GmbH(Boehringer Ingelheim); Astelas Pharma	This work was supported by Daiichi-Sankyo Company, Limited [grant number A19-1287], (YU), https://www.daiichisankyo.co.jp/corporate/ds-shougakukifu/, Ono Pharmaceutical Company, Limited [grant number ONOS20180618011], (NY), https://kifu-shinsei.jp/kifu-entry/cmn/doc/index_N1gsZhJaOt.html, Pfizer Inc [grant number 54334665], (NY), https://pfizerac-web.pfizer.co.jp/detail.html, Bayer Yakuhin, Limited [BASJ20180409030], https://byl.bayer.co.jp/researchers/, Boehringer Ingelheim GmbH [grant number RS2019A00769379], (NY), https://www.boehringer-ingelheim.jp/Research_support_ 2019, and Astelas Pharma [grant number RS2019A001313], (NY), https://www.astellas.com/jp/ja/responsibility/astellas-foundations, and had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; BFAR R02, 2011, KALAP, V12, P9; De Ruysscher D, 2010, J CLIN ONCOL, V28, P5301, DOI 10.1200/JCO.2010.30.3271; Graham MV, 1999, INT J RADIAT ONCOL, V45, P323, DOI 10.1016/S0360-3016(99)00183-2; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Inoue T, 2015, J RADIAT RES, V56, P727, DOI 10.1093/jrr/rrv019; Kimura T, 2012, BRIT J RADIOL, V85, P135, DOI 10.1259/bjr/32629867; Liang J, 2017, ANN ONCOL, V28, P777, DOI 10.1093/annonc/mdx009; Mets OM, 2012, AM J ROENTGENOL, V199, P336, DOI 10.2214/AJR.11.7808; National Cancer Institute, 2009, COMM TERM CRIT ADV E; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; NEWMAN KB, 1994, CHEST, V106, P105, DOI 10.1378/chest.106.1.105; Ramella S, 2010, INT J RADIAT ONCOL, V76, P110, DOI 10.1016/j.ijrobp.2009.01.036; Rancati T, 2003, RADIOTHER ONCOL, V67, P275, DOI 10.1016/S0167-8140(03)00119-1; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Saito T, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170921; Sanuki N, 2012, J RADIAT RES, V53, P110, DOI 10.1269/jrr.110142; Schneider BJ, 2018, J ONCOL PRACT, V14, P180, DOI 10.1200/JOP.2017.028894; Schroeder JD, 2013, AM J ROENTGENOL, V201, pW460, DOI 10.2214/AJR.12.10102; Senan S, 2016, J CLIN ONCOL, V34, P953, DOI 10.1200/JCO.2015.64.8824; Stahel R, 2011, ANN ONCOL, V22, P1973, DOI 10.1093/annonc/mdr313; Sun JM, 2013, ANN ONCOL, V24, P2088, DOI 10.1093/annonc/mdt140; Takeda A, 2012, CHEST, V141, P858, DOI 10.1378/chest.11-1193; Tsujino K, 2003, INT J RADIAT ONCOL, V55, P110, DOI 10.1016/S0360-3016(02)03807-5; Uchida Y, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0891-z; Wang JB, 2013, INT J RADIAT ONCOL, V85, P798, DOI 10.1016/j.ijrobp.2012.06.040; Yamamoto T, 2018, CLIN LUNG CANCER, V19, pE85, DOI 10.1016/j.cllc.2017.05.022	27	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244143	10.1371/journal.pone.0244143	http://dx.doi.org/10.1371/journal.pone.0244143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370345	Green Published, gold			2022-12-27	WOS:000603611900124
J	Bui, LV; Nguyen, HT; Levine, H; Nguyen, HN; Nguyen, TA; Nguyen, TP; Nguyen, TT; Do, TTT; Pham, NT; Bui, MH				Bui, Long V.; Nguyen, Ha T.; Levine, Hagai; Nguyen, Ha N.; Nguyen, Thu-Anh; Nguyen, Thuy P.; Nguyen, Truong T.; Do, Toan T. T.; Pham, Ngoc T.; Bui, My Hanh			Estimation of the incubation period of COVID-19 in Vietnam	PLOS ONE			English	Article								Objective To estimate the incubation period of Vietnamese confirmed COVID-19 cases. Methods Only confirmed COVID-19 cases who are Vietnamese and locally infected with available data on date of symptom onset and clearly defined window of possible SARS-CoV-2 exposure were included. We used three parametric forms with Hamiltonian Monte Carlo method for Bayesian Inference to estimate incubation period for Vietnamese COVID-19 cases. Leave-one-out Information Criterion was used to assess the performance of three models. Results A total of 19 cases identified from 23 Jan 2020 to 13 April 2020 was included in our analysis. Average incubation periods estimated using different distribution model ranged from 6.0 days to 6.4 days with the Weibull distribution demonstrated the best fit to the data. The estimated mean of incubation period using Weibull distribution model was 6.4 days (95% credible interval (CrI): 4.89-8.5), standard deviation (SD) was 3.05 (95%CrI 3.05-5.30), median was 5.6, ranges from 1.35 to 13.04 days (2.5th to 97.5th percentiles). Extreme estimation of incubation periods is within 14 days from possible infection. Conclusion This analysis provides evidence for an average incubation period for COVID-19 of approximately 6.4 days. Our findings support existing guidelines for 14 days of quarantine of persons potentially exposed to SARS-CoV-2. Although for extreme cases, the quarantine period should be extended up to three weeks.	[Bui, Long V.] Ctr Res Consulting & Support Community Heath, Hanoi, Vietnam; [Nguyen, Ha T.] 108 Mil Cent Hosp, Hanoi, Vietnam; [Levine, Hagai] Hadassah Hebrew Univ, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel; [Nguyen, Ha N.] Peoples Police Acad, Hanoi, Vietnam; [Nguyen, Thu-Anh] Woolcock Inst Med Res, Hanoi, Vietnam; [Nguyen, Thu-Anh] Univ Sydney, Fac Med & Hlth, Camperdown, NSW, Australia; [Nguyen, Thuy P.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Nguyen, Truong T.] Minist Sci & Technol, Hanoi, Vietnam; [Do, Toan T. T.; Bui, My Hanh] Hanoi Med Univ, Hanoi, Vietnam; [Pham, Ngoc T.] 198 Hosp, Hanoi, Vietnam; [Bui, My Hanh] Hanoi Med Univ Hosp, Hanoi, Vietnam	Hebrew University of Jerusalem; Hadassah University Medical Center; University of Sydney; University of Tasmania; Menzies Institute for Medical Research; Hanoi Medical University; Hanoi Medical University	Bui, LV (corresponding author), Ctr Res Consulting & Support Community Heath, Hanoi, Vietnam.	buimyhanh@hmu.edu.vn	Bui, Hanh My/AAV-6376-2021; Bui, Long/R-9830-2019; Anh, Nguyễn/HGU-8434-2022	Bui, Hanh My/0000-0002-4137-2906; Bui, Long/0000-0001-9997-593X; Thu Ha, Nguyen/0000-0002-0647-8801; Nguyen, Thu Anh/0000-0002-2089-2902; Nguyen, Thuy Phuong/0000-0002-0558-8662				Assiri A, 2013, HOSP OUTBREAK MIDDLE, DOI [10.1056/NEJMoa1306742, 10.1056/NEJMoa1306742?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dwww.ncbi.nlm.nih.gov, DOI 10.1056/NEJM0A1306742]; Backer JA, 2020, CHINA EURO SURVEILL, V25, P5, DOI DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hoang VM, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1776526; Jiang X, 2020, J MED VIROL, V92, P476, DOI 10.1002/jmv.25708; Kong T, 2020, AGING MED MILTON; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee HS, 2020, J INFECT CHEMOTHER, V26, P1011, DOI 10.1016/j.jiac.2020.06.018; Leung C, INFECT CONTROL HOSP, P1; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; Nguyen THD, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101651; Nishiura H, 2007, EMERG THEMES EPIDEMI, V4, DOI 10.1186/1742-7622-4-2; Pham QT, CLIN INFECT DIS, DOI 10.1093/cid/ciaa1130/5879764; Qin J, 2020, SCI ADV, V6, DOI [10.1126/sciadv.abc1202, 10.1101/2020.03.06.20032417]; R Development Core Team, 2009, R LANG ENV STAT COMP; Stan Development Team, RSTAN R INT STAN; Thanh HN, 2020, LANCET INFECT DIS, V0; Tindale LC, 2020, ELIFE, V9, DOI 10.7554/eLife.57149; TOP AGRAR, 2010, STARKEKARTOFFELN KAM, V10, P50; Vehtari A, 2017, STAT COMPUT, V27, P1433, DOI 10.1007/s11222-016-9709-3; World Health Organization, 2020, 73 WHO	23	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243889	10.1371/journal.pone.0243889	http://dx.doi.org/10.1371/journal.pone.0243889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362233	Green Published, gold, Green Accepted			2022-12-27	WOS:000603071600038
J	Umar, S; Fusheini, A; Ayanore, MA				Umar, Suraiya; Fusheini, Adam; Ayanore, Martin Amogre			The shared experiences of insured members and the uninsured in health care access and utilization under Ghana's national health insurance scheme: Evidence from the Hohoe Municipality	PLOS ONE			English	Article							ENROLLMENT	Background The National Health Insurance Scheme (NHIS) was introduced in Ghana in 2003 to remove financial barriers and to promote equitable access to health care services. Post implementation has been characterized by increases in access and utilization of services among the insured. The uninsured have been less likely to utilize services due to unaffordability of health care costs. In this study, we explored the experiences of the insured members of the NHIS, the uninsured and health professionals in accessing and utilizing health care services under the NHIS in the Hohoe Municipality of Ghana. Methods Qualitative in-depth interviews were held with twenty-five NHIS insured, twenty-five uninsured, and five health care professionals, who were randomly sampled from the Hohoe Municipality to collect data for this study. Data was analyzed using thematic analysis. Results Participants identified both enablers or motivating factors and barriers to health care services of the insured and uninsured. The major factors motivating members to access and use health care services were illness severity and symptom persistence. On the other hand, barriers identified included perceived poor service quality and lack of health insurance among the insured and uninsured respectively. Other barriers participants identified included financial constraints, poor attitudes of service providers, and prolonged waiting time. However, the level of care received were reportedly about the same among the insured and uninsured with access to quality health care much dependent on ability to pay, which favors the rich and thereby creating inequity in accessing the needed quality care services. Conclusion The implication of the financial barriers to health care access identified is that the poor and uninsured still suffer from health care access challenges, which questions the efficiency and core goal of the NHIS in removing financial barrier to health care access. This has the potential of undermining Ghana's ability to meet the Sustainable Development Goal 3.8 of universal health coverage by the year 2030.	[Umar, Suraiya] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Populat & Behav Sci, Ho, Ghana; [Fusheini, Adam] Univ Otago, Otago Med Sch, Dept Prevent & Social Med, Dunedin, New Zealand; [Fusheini, Adam] Ctr Hlth Literacy & Rural Hlth Promot, Accra, Ghana; [Ayanore, Martin Amogre] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Ho, Ghana	University of Otago	Fusheini, A (corresponding author), Univ Otago, Otago Med Sch, Dept Prevent & Social Med, Dunedin, New Zealand.; Fusheini, A (corresponding author), Ctr Hlth Literacy & Rural Hlth Promot, Accra, Ghana.	adam.fusheini@otago.ac.nz	; Fusheini, Adam/H-2400-2016	Ayanore, Martin/0000-0002-4095-3047; Fusheini, Adam/0000-0001-7896-3841				Abuosi AA, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0365-1; Acheampong IO, 2016, THESIS; Akum A. F, 2014, J SCI RES STUDIES, V1, P29; Alhassan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165151; Amo-Adjei J, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1602-4; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Andersen RM, 2008, MED CARE, V46, P647, DOI [10.1097/MLR.0b013e31817a835d, 10.1097/MLR.0b013e31817f4d48]; Anderson J G, 1972, Health Serv Res, V7, P23; [Anonymous], 2014, PEERJ, V2, pe447; [Anonymous], 2014, R J, V6, P82; [Anonymous], 2016, THE TOTAL AUDIENCE R; Atinga RA, 2015, TROP MED INT HEALTH, V20, P312, DOI 10.1111/tmi.12433; Blanchet N J, 2012, Ghana Med J, V46, P76; Boamah EO, 2015, ENROLMENT URBAN POOR; Boateng D, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-50; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, https://doi.org/10.1191/1478088706qp063oa, 10.1191/1478088706qp063oa]; Browne JL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008175; Creswell J. W., 2007, QUALITATIVE INQUIRY; Creswell J. W., 2018, RES DESIGN QUALITATI; Creswell JW, 2007, COUNS PSYCHOL, V35, P236, DOI 10.1177/0011000006287390; Dalinjong PA, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-13; Dixon J, 2014, TROP MED INT HEALTH, V19, P98, DOI 10.1111/tmi.12223; Fenny AP, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1429-z; Fenny AP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1696-3; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Fusheini A, 2016, INT J HEALTH POLICY, V5, P543, DOI 10.15171/ijhpm.2016.47; Ganle JK, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0089-z; Ghana Statistical Service, 2019, SOC DEM POP PROJ; Ghana Statistical Service, 2014, DISTR CENS REP; Ghana Statistical Services, 2018, GHAN LIV STAND SURV; Gobah FF., 2011, GLOBAL J HLTH SCI, V3, P90, DOI [10.5539/gjhs.v3n2p90, DOI 10.5539/GJHS.V3N2P90]; Hohoe Municipal Health Directorate, 2018, HOH MUN HLTH DIR ANN; Kotoh AM, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0320-1; Krumkamp R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080598; Kumi-Kyereme A, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0192-x; Kumi-Kyereme A, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-221; Kusi A, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-014-0130-2; Kuuire VZ, 2016, J PUBLIC HEALTH-UK, V38, pE545, DOI 10.1093/pubmed/fdv176; NCHS, 2020, NAT HLTH NUTR EX SUR; Noi E, 2012, THESIS; Owusu-Sekyere, 2014, AM J PUBLIC HLTH RES, V2, P27, DOI [10.12691/ajphr-2-1-6, DOI 10.12691/AJPHR-2-1-6, DOI 10.12691/ajphr-2-1-6]; Philips R, 2017, COST IS SIGNIFICANT; Singleton JL, 2006, NEGOTIATING CHANGE A; Yirbour E, 2011, THESIS	44	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244155	10.1371/journal.pone.0244155	http://dx.doi.org/10.1371/journal.pone.0244155			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362232	gold, Green Published			2022-12-27	WOS:000603071600014
J	Wong, DWS; Li, Y				Wong, David W. S.; Li, Yun			Spreading of COVID-19: Density matters	PLOS ONE			English	Article							POPULATION-DENSITY; PATTERNS; SCALE	Physical distancing has been argued as one of the effective means to combat the spread of COVID-19 before a vaccine or therapeutic drug becomes available. How far people can be spatially separated is partly behavioral but partly constrained by population density. Most models developed to predict the spread of COVID-19 in the U.S. do not include population density explicitly. This study shows that population density is an effective predictor of cumulative infection cases in the U.S. at the county level. Daily cumulative cases by counties are converted into 7-day moving averages. Treating the weekly averages as the dependent variable and the county population density levels as the explanatory variable, both in logarithmic scale, this study assesses how population density has shaped the distributions of infection cases across the U.S. from early March to late May, 2020. Additional variables reflecting the percentages of African Americans, Hispanic-Latina, and older adults in logarithmic scale are also included. Spatial regression models with a spatial error specification are also used to account for the spatial spillover effect. Population density alone accounts for 57% of the variation (R-squared) in the aspatial models and up to 76% in the spatial models. Adding the three population subgroup percentage variables raised the R-squared of the aspatial models to 72% and the spatial model to 84%. The influences of the three population subgroups were substantial, but changed over time, while the contributions of population density have been quite stable after the first several weeks, ascertaining the importance of population density in shaping the spread of infection in individual counties, and in their neighboring counties. Thus, population density and sizes of vulnerable population subgroups should be explicitly included in transmission models that predict the impacts of COVID-19, particularly at the sub-county level.	[Wong, David W. S.; Li, Yun] George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA; [Li, Yun] George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA	George Mason University; George Mason University	Li, Y (corresponding author), George Mason Univ, Dept Geog & GeoInformat Sci, Fairfax, VA 22030 USA.; Li, Y (corresponding author), George Mason Univ, NSF Spatiotemporal Innovat Ctr, Fairfax, VA 22030 USA.	yli38@gmu.edu			NSF [2027521, 1841520, 1835507]	NSF(National Science Foundation (NSF))	The research presented in this paper was funded by NSF 2027521, 1841520, and 1835507.	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Bahl P, 2022, J INFECT DIS, V225, P1561, DOI 10.1093/infdis/jiaa189; CLARK C, 1951, J ROY STAT SOC A STA, V114, P490, DOI 10.2307/2981088; Das Gupta D, CANADIAN J PUBLIC HL; FAO, 2020, COR DIS 2019 COVID 1; Fonseca JW, 2000, PROF GEOGR, V52, P504, DOI 10.1111/0033-0124.00242; Gale R, WASHINGTON POST; GRIFFITH DA, 1981, PROF GEOGR, V33, P189, DOI 10.1111/j.0033-0124.1981.00189.x; Griffith DA, 2007, J GEOGR SYST, V9, P53, DOI 10.1007/s10109-006-0032-y; Griffith DA, 2016, ECONOMETRICS, V4, DOI 10.3390/econometrics4020029; He Y, 2020, MOVING AVERAGE BASED; Holt J. B., 2004, CARTOGR GEOGR INF SC, V31, P103, DOI [10.1559/1523040041649407, DOI 10.1559/1523040041649407]; Hu H, 2013, MATH BIOSCI, V244, P125, DOI 10.1016/j.mbs.2013.04.013; LAM NSN, 1992, PROF GEOGR, V44, P88, DOI 10.1111/j.0033-0124.1992.00088.x; Larson J, 1993, AM DEMOGR, V15, P38; MacIntyre CR, 2020, LANCET, V0; McMillen DP, 1997, J REGIONAL SCI, V37, P591, DOI 10.1111/0022-4146.00071; Mittal R, 2020, J FLUID MECH, V894, DOI 10.1017/jfm.2020.330; NEWLING BE, 1969, GEOGR REV, V59, P242, DOI 10.2307/213456; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Somsen GA, 2020, LANCET RESP MED, V8, P658, DOI 10.1016/S2213-2600(20)30245-9; Spielman SE, 2014, APPL GEOGR, V46, P147, DOI 10.1016/j.apgeog.2013.11.002; Tarwater Patrick M., 2001, Complexity, V6, P29, DOI 10.1002/cplx.10003	23	77	77	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0242398	10.1371/journal.pone.0242398	http://dx.doi.org/10.1371/journal.pone.0242398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CI	33362283	gold, Green Published			2022-12-27	WOS:000603071600052
J	Martingano, D; Nguyen, A; Nkeih, C; Singh, S; Mitrofanova, A				Martingano, Daniel; Nguyen, Ashley; Nkeih, Claudia; Singh, Shailini; Mitrofanova, Antonina			Clarithromycin use for adjunct surgical prophylaxis before non-elective cesarean deliveries to adapt to azithromycin shortages in COVID-19 pandemic	PLOS ONE			English	Article							MULTICENTER	Objective This study aimed to evaluate safety and effectiveness of clarithromycin as adjunctive antibiotic prophylaxis for patients undergoing non-elective cesarean delivery in comparison with no macrolides, to adapt to azithromycin shortages in COVID-19 pandemic. Study design We conducted a multi-center, prospective observational cohort study from March 23, 2020 through June 1, 2020. We followed all women receiving either clarithromycin or no macrolide antibiotic for adjunct surgical prophylaxis for non-elective cesarean deliveries. The primary outcome was development of postpartum endometritis. Secondary outcomes included meconium-stained amniotic fluid at time of cesarean delivery, neonatal sepsis, neonatal intensive care unit admission, and neonatal acute respiratory distress syndrome. All patients in this study were tested for SARS-CoV-2 infection and resulted negative. Results This study included 240 patients, with 133 patients receiving clarithromycin and 107 patients receiving no adjunct macrolide prophylaxis. Patients receiving clarithromycin were noted to have significantly lower rates of postpartum endometritis as compared to those who did not receive adjunct prophylaxis (4.5% versus 11.2%, p = 0.025). In crude (unadjusted) analysis, a significantly lower risk of developing endometritis was noted in the clarithromycin group as compared to the control group (66% decreased risk, 95% CI 0.12 to 0.95, p = 0.040). When adjusted for perceived confounders, a significant difference was again noted (67% decreased risk, 95% CI 0.11 to 0.97, p = 0.034). Stratified analysis of significantly different demographic factors including Black race, BMI, and age was performed. A significantly decreased risk of development of endometritis when taking clarithromycin versus no adjunct macrolide was noted for Black race women in crude and adjusted models (crude: 87% decreased risk, 95% CI 0.08 to 0.83, p = 0.032; adjusted: 91% decreased risk, 95% CI 0.06 to 0.79, p = 0.026). This was also noted for women aged 18-29 years in crude and adjusted models (crude: model, 79% decreased risk, 95% CI 0.06 to 0.80, p = 0.014; adjusted model: 75% decreased risk, 95% CI 0.06 to 0.94, p = 0.028). All other stratified analyses did not yield significant differences in endometritis risk. Conclusion Our study suggests that administration of clarithromycin for adjunctive surgical prophylaxis for non-elective cesarean deliveries may be a safe option that may provide suitable endometritis prophylaxis in cases where azithromycin is unavailable, as was the case during the start of COVID-19 pandemic, most especially for Black race women and women ages 18-29 years.	[Martingano, Daniel; Nguyen, Ashley; Nkeih, Claudia; Singh, Shailini] St Johns Episcopal Hosp, Dept Obstet & Gynecol, Far Rockaway, NY 11691 USA; [Martingano, Daniel; Mitrofanova, Antonina] Rutgers State Univ, Sch Hlth Profess, Dept Biomed & Hlth Informat, Newark, NJ 07102 USA; [Martingano, Daniel; Nkeih, Claudia] Trinitas Reg Med Ctr, Dept Obstet & Gynecol, Elizabeth, NJ 07202 USA; [Singh, Shailini] Newark Beth Israel Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Newark, NJ USA; [Singh, Shailini] Rutgers Robert Wood Johnson Med Sch, Dept Obstet & Gynecol, New Brunswick, NJ USA; [Mitrofanova, Antonina] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Newark Beth Israel Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Martingano, D (corresponding author), St Johns Episcopal Hosp, Dept Obstet & Gynecol, Far Rockaway, NY 11691 USA.; Martingano, D; Mitrofanova, A (corresponding author), Rutgers State Univ, Sch Hlth Profess, Dept Biomed & Hlth Informat, Newark, NJ 07102 USA.; Martingano, D (corresponding author), Trinitas Reg Med Ctr, Dept Obstet & Gynecol, Elizabeth, NJ 07202 USA.; Mitrofanova, A (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA.	dmartingano@ehs.org; amitrofa@shp.rutgers.edu		Martingano, Daniel/0000-0001-8767-2528	Rutgers School of Health Professions	Rutgers School of Health Professions	Antonina Mitrofanova has been supported by start-up funds from Rutgers School of Health Professions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; American College of Obstetricians and Gynecologists, 2003, Obstet Gynecol, V102, P875; Badreldin HA, 2021, RES SOC ADMIN PHARM, V17, P1946, DOI 10.1016/j.sapharm.2020.05.017; Bar-Oz B, 2008, EUR J OBSTET GYN R B, V141, P31, DOI 10.1016/j.ejogrb.2008.07.008; Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100111; Breslin N, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100118; Catillon M, 2020, NEWS COVERAGE DRUG S; Cavalcanti AB, 2020, HYDROXYCHLOROQUINE A; Drinkard CR, 2000, PHARMACOEPIDEM DR S, V9, P549, DOI 10.1002/pds.538; Einarson A, 1998, AM J PERINAT, V15, P523, DOI 10.1055/s-2007-994053; Franchi M, 2019, EUR J OBSTET GYN R B, V236, P26, DOI 10.1016/j.ejogrb.2019.02.023; Furtado RHM, 2020, LANCET, V396, P959, DOI 10.1016/S0140-6736(20)31862-6; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Gloviczki P, 2011, J VASC SURG, V53, p2S, DOI 10.1016/j.jvs.2011.01.079; Hager RME, 2004, AM J OBSTET GYNECOL, V190, P428, DOI 10.1016/j.ajog.2003.08.037; HOLSHUE ML, 2020, NEW ENGL J MED, V382, P929, DOI [10.1056/NEJMoa2001191, DOI 10.1056/NEJMOA2001191, DOI 10.1056/NEJM0A2001191]; Lane JC, 2020, SAFETY HYDROXYCHLORO; Macones GA, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.04.012; Main EK, 2019, OBSTET GYNECOL, V133, P613, DOI 10.1097/AOG.0000000000003109; Million M, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101738; Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006; R Core Team, 2015, R LANGUAGE ENV STAT; RAPP RP, 1994, ANN PHARMACOTHER, V28, P1255, DOI 10.1177/106002809402801109; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; STURGILL MG, 1992, ANN PHARMACOTHER, V26, P1099, DOI 10.1177/106002809202600912; Tita ATN, 2016, NEW ENGL J MED, V375, P1231, DOI 10.1056/NEJMoa1602044; UPTON GJG, 1992, J ROY STAT SOC A STA, V155, P395, DOI 10.2307/2982890; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; WHO Director-General's opening remarks, 2020, WHO DIR GEN OP REM M, DOI DOI 10.1093/ANNONC/MDY517; Yates F., 1934, JR STATIST SOC     S, V1, P217, DOI DOI 10.2307/2983604; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244266	10.1371/journal.pone.0244266	http://dx.doi.org/10.1371/journal.pone.0244266			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347510	Green Published, gold			2022-12-27	WOS:000603071100058
J	Santos, JE; Magarinos, CR; Gago, LG; Jarrin, DA; Pertega, S; Rodriguez-Carmona, A; Falcon, TG; Fontan, MP				Santos, Joana Eugenio; Rodriguez Magarinos, Catuxa; Garcia Gago, Leticia; Astudillo Jarrin, Daniela; Pertega, Sonia; Rodriguez-Carmona, Ana; Garcia Falcon, Teresa; Perez Fontan, Miguel			Long-term trends in the incidence of peritoneal dialysis-related peritonitis disclose an increasing relevance of streptococcal infections: A longitudinal study	PLOS ONE			English	Article							TECHNIQUE FAILURE; OUTCOMES; MICROBIOLOGY; PREDICTORS; RECOMMENDATIONS; MUPIROCIN; PATIENT	Background The selective impact of strategies for prevention of PD-related peritonitis (PDrP) may have modified, in the long term, the causal spectrum, clinical presentation and outcomes of these infections. Objectives To compare trends in the incidence of PDrP by different microorganisms during a 30-year period, with a particular focus on streptococcal infections. To analyze the clinical presentation and outcomes of these infections. Secondarily, to investigate how the isolation of different species of streptococci can influence the clinical course of PDrP by this genus of bacteria. Method Following a retrospective, observational design we investigated 1061 PDrP (1990-2019). We used joinpoint regression analysis to explore trends in the incidence of PDrP by different microorganisms, and compared the risk profile (Cox), clinical presentation and outcomes (logistic regression) of these infections. Main results Our data showed a progressive decline in the incidence of PDrP by staphylococci and Gram negative bacteria, while the absolute rates of streptococcal (average annual percent change +1.6%, 95% CI -0.1/+3.2) and polymicrobial (+1.8%, +0.1/+3.5) infections tended to increase, during the same period. Remarkably, streptococci were isolated in 58.6% of polymicrobial infections, and patients who suffered a streptococcal PDrP had a 35.8% chance of presenting at least one other infection by the same genus. The risk profile for streptococcal infections was comparable to that observed for PDrP overall. Streptococcal PDrP were associated with a severe initial inflammatory response, but their clinical course was generally nonaggressive thereafter. We did not observe a differential effect of different groups of streptococci on the clinical presentation or outcome of PDrP. Conclusions Time trends in the incidence of PDrP by different microorganisms have granted streptococci an increasing relevance as causative agents of these infections, during the last three decades. This behaviour suggests that current measures of prevention of PDrP may not be sufficiently effective, in the case of this genus of microorganisms.	[Santos, Joana Eugenio] Ctr Hosp Espirito Santo, Evora, Portugal; [Rodriguez Magarinos, Catuxa; Garcia Gago, Leticia; Astudillo Jarrin, Daniela; Rodriguez-Carmona, Ana; Garcia Falcon, Teresa; Perez Fontan, Miguel] Univ Hosp A Coruna, Div Nephrol, La Coruna, Spain; [Pertega, Sonia] Univ Hosp A Coruna, Div Epidmiol, La Coruna, Spain; [Perez Fontan, Miguel] Univ A Coruna, Fac Hlth Sci, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna	Fontan, MP (corresponding author), Univ Hosp A Coruna, Div Nephrol, La Coruna, Spain.; Fontan, MP (corresponding author), Univ A Coruna, Fac Hlth Sci, La Coruna, Spain.	miguel.perez.fontan@sergas.es	Pértega-Díaz, Sonia/E-4353-2013; Perez-Fontán, Miguel/ABG-4064-2020	Pértega-Díaz, Sonia/0000-0003-3891-3203; Perez-Fontán, Miguel/0000-0001-7027-2296				Abranches J, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.GPP3-0042-2018; Barraclough K, 2010, AM J KIDNEY DIS, V55, P121, DOI 10.1053/j.ajkd.2009.08.020; Boudville N, 2019, NEPHROL DIAL TRANSPL, V34, P2118, DOI 10.1093/ndt/gfy204; Burke M, 2011, AM J KIDNEY DIS, V58, P429, DOI 10.1053/j.ajkd.2011.03.022; Chao CT, 2015, PERITON DIALYSIS INT, V35, P333, DOI 10.3747/pdi.2013.00108; Chidambaram M, 2011, PERITON DIALYSIS INT, V31, P565, DOI 10.3747/pdi.2010.00096; Chow KM, 2006, CLIN J AM SOC NEPHRO, V1, P768, DOI 10.2215/CJN.01010306; Basalo FJDY, 2012, CONSTR BUILD MATER, V32, P55, DOI 10.1016/j.conbuildmat.2010.12.063; Fontan MP, 2005, PERITON DIALYSIS INT, V25, P274; Ghali JR, 2011, PERITON DIALYSIS INT, V31, P651, DOI 10.3747/pdi.2010.00131; Govindarajulu S, 2010, PERITON DIALYSIS INT, V30, P311, DOI 10.3747/pdi.2008.00258; Haenni M, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.ARBA-0008-2017; Htay H, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007554.pub3; Htay H, 2018, AM J KIDNEY DIS, V71, P814, DOI 10.1053/j.ajkd.2017.10.017; Kim GC, 2000, AM J KIDNEY DIS, V36, P1000, DOI 10.1053/ajkd.2000.19102; Kim HJ, 2001, STAT MED, V20, P655, DOI 10.1002/sim.811; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kolesnyk I, 2010, PERITON DIALYSIS INT, V30, P170, DOI 10.3747/pdi.2008.00277; Kumar VA, 2014, PERITON DIALYSIS INT, V34, P171, DOI 10.3747/pdi.2012.00165; Li PKT, 2016, PERITON DIALYSIS INT, V36, P481, DOI 10.3747/pdi.2016.00078; Liu Y, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1078-z; McDonald SR, 2004, PERITON DIALYSIS INT, V24, P340; Mujais S, 2006, KIDNEY INT, V70, pS55, DOI 10.1038/sj.ki.5001916; Nataatmadja M, 2016, PERITON DIALYSIS INT, V36, P472, DOI 10.3747/pdi.2016.00114; O'Shea S, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-19; PEREZFONTAN M, 1993, AM J KIDNEY DIS, V22, P708, DOI 10.1016/S0272-6386(12)80434-3; Perl J, 2020, AM J KIDNEY DIS, V76, P42, DOI 10.1053/j.ajkd.2019.09.016; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Pulliam J, 2014, AM J KIDNEY DIS, V64, P761, DOI 10.1053/j.ajkd.2014.04.025; Ribera-Sanchez R, 2018, PERITON DIALYSIS INT, V38, P139, DOI 10.3747/pdi.2017.00184; Rocha A, 2012, BLOOD PURIFICAT, V33, P284, DOI 10.1159/000337377; Ruoff KL, 2015, MANDELL DOUGLAS BENN, P2283; Santos C, 2016, PERITON DIALYSIS INT, V36, P43, DOI 10.3747/pdi.2014.00131; Shukla A, 2006, NEPHROL DIAL TRANSPL, V21, P3545, DOI 10.1093/ndt/gfl407; Szeto CC, 2017, PERITON DIALYSIS INT, V37, P141, DOI 10.3747/pdi.2016.00120; van Esch S, 2014, PERITON DIALYSIS INT, V34, P162, DOI 10.3747/pdi.2013.00275; Wang Q, 2003, AM J KIDNEY DIS, V41, P664, DOI 10.1053/ajkd.2003.50128; Xu R, 2013, PERITON DIALYSIS INT, V33, P436, DOI 10.3747/pdi.2012.00163; Ye HJ, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0588-4; Zelenitsky SA, 2017, PERITON DIALYSIS INT, V37, P170, DOI 10.3747/pdi.2016.00136; Zhang L, 2015, PERITON DIALYSIS INT, V35, P712, DOI 10.3747/pdi.2014.00206	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244283	10.1371/journal.pone.0244283	http://dx.doi.org/10.1371/journal.pone.0244283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347487	gold, Green Published			2022-12-27	WOS:000603071100023
J	Olapeju, B; Adams, C; Hunter, G; Wilson, S; Simpson, J; Mitchum, L; Davis, T; Orkis, J; Cox, H; Trotman, N; Imhoff, H; Storey, D				Olapeju, Bolanle; Adams, Camille; Hunter, Gabrielle; Wilson, Sean; Simpson, Joann; Mitchum, Lyndsey; Davis, TrishAnn; Orkis, Jennifer; Cox, Horace; Trotman, Neil; Imhoff, Helen; Storey, Douglas			Malaria prevention and care seeking among gold miners in Guyana	PLOS ONE			English	Article							AMAZON REGION; COMMUNICATION; TRANSMISSION; BEHAVIOR; CONTEXT; GHANA	Despite being a priority population in malaria elimination, there is scant literature on malaria-related behavior among gold miners. This study explores the prevalence and factors influencing malaria prevention, care seeking and treatment behaviors in Guyana gold mining camps. A cross sectional survey was conducted among adult gold miners living in mining camps in the hinterland Regions 1 (Barima-Waini), 7 (Cuyuni-Mazaruni), and 8 (Potaro-Siparuni). Multivariable logistic regressions explored factors associated with miners' self-report of mosquito net use, prompt care-seeking; self-medication; and testing for malaria. A third of miners used a mosquito net the night preceding the survey and net use was higher among those who believed that net use was the norm in their camp (aOR: 3.11; 95% CI:1.65, 5.88). Less than half (45%) of miners had a fever in the past 12 months, among whom 36% sought care promptly, 48% tested positive for malaria while 54% self-medicated before seeking care. Prompt care-seeking was higher among miners with high malaria knowledge (aOR: 1.44; 95% CI: 1.01, 2.05). Similarly, testing rates increased with secondary education (aOR: 1.71; 95% CI: (1.16, 2.51), high malaria knowledge (aOR: 1.45; 95% CI: 1.02, 2.05), positive beliefs regarding malaria transmission, threat, self-diagnosis, testing and treatment, and, trust in government services (aOR: 1.59; 95% CI (1.12, 2.27) and experience of a prior malaria episode (aOR: 2.62; 95% CI: 1.71, 4.00). Self-medication was lower among male miners (aOR: 0. 52; 95% CI: 0.32, 0.86). Malaria prevention and care seeking behaviors among miners are somewhat low and influenced by mosquito net usage, perceived norms, malaria knowledge and prior episode of confirmed malaria. Study findings have implications for malaria interventions in the hinterland regions of Guyana such as the mass and continuous distribution of insecticide treated nets as well as community case management initiatives using trained malaria testing and treatment volunteers to curb malaria transmission among remote gold mining populations. These include efforts to identify and address gaps in distributing mosquito nets to miners and address miners' barriers to prompt care seeking, malaria testing and treatment adherence. Targeted social and behavior change messaging is needed on net acquisition, use and care, prompt care-seeking, malaria testing and treatment adherence. Additional efforts to ensure the overall sustainability of the community case management initiative include increased publicity of the community case management initiative among miners, use of incentives to promote retention rates among the community case management volunteer testers and public private partnerships between the Guyana Ministry of Health and relevant mining organizations.	[Olapeju, Bolanle; Hunter, Gabrielle; Mitchum, Lyndsey; Davis, TrishAnn; Orkis, Jennifer; Storey, Douglas] Johns Hopkins Ctr Commun Programs, Baltimore, MD 21202 USA; [Adams, Camille; Wilson, Sean; Simpson, Joann] Breakthrough ACT Guyana, Georgetown, Demerara Mahaic, Guyana; [Cox, Horace; Trotman, Neil; Imhoff, Helen] Minist Hlth, Natl Malaria Program, Georgetown, Demerara Mahaic, Guyana	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Olapeju, B (corresponding author), Johns Hopkins Ctr Commun Programs, Baltimore, MD 21202 USA.	bolanle.olapeju@jhu.edu		Olapeju, Bolanle/0000-0002-2958-2708; Cox, Horace/0000-0002-9127-4212; Orkis, Jennifer/0000-0001-6088-3579	United States Agency for International Development under the Breakthrough ACTION Cooperative Agreement [AID-OAA-A-17-00017]	United States Agency for International Development under the Breakthrough ACTION Cooperative Agreement	This work is made possible by the support of the American people through the United States Agency for International Development under the Breakthrough ACTION Cooperative Agreement #AID-OAA-A-17-00017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Filho PG, 2019, FRONT IMMUNOL, P10, DOI [10.3389/fimmu.2019.00010, DOI 10.3389/FIMMU.2019.00010]; Awantang G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2249-x; Babalola S, 2015, DEMOGR RES, V33, P211, DOI 10.4054/DemRes.2015.33.8; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Canavati SE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1117-9; Couto AA, 2001, Cad Saude Publica, V17, P897, DOI 10.1590/S0102-311X2001000400023; de Santi VP, 2016, EMERG INFECT DIS, V22, P903, DOI 10.3201/eid2205.151957; de Santi VP, 2016, EMERG INFECT DIS, V22, P344, DOI 10.3201/eid2202.151292; Diaz G, 2019, AM J TROP MED HYG, V100, P66, DOI 10.4269/ajtmh.18-0515; Douine M, 2020, CURRENT TROPICAL MED, V2020, P1; Douine M, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2721-2; Douine M, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4557-4; Evans L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-203; Figueroa ME, 2017, J HEALTH COMMUN, V22, P5, DOI 10.1080/10810730.2016.1231725; Flores W, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-379; Guyana BoS, 2012, PRELIMINARY REPORT; Jacobson JO, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1679-1; Kilian A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1463-7; Kurup R, 2014, NATURE SCI, V12, P87; Kurup Rajini, 2017, International Journal of Mosquito Research, V4, P48; LaCroix JM, 2014, JAIDS-J ACQ IMM DEF, V66, pS329, DOI 10.1097/QAI.0000000000000230; Li ZJ, 2015, EMERG INFECT DIS, V21, P864, DOI [10.3201/eid2105.141712, 10.3201/2105.141712]; Long RN, 2015, INT J ENV RES PUB HE, V12, P12679, DOI 10.3390/ijerph121012679; Macintyre K, 2012, HEALTH POLICY PLANN, V27, P316, DOI 10.1093/heapol/czr042; Olapeju B, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3020-7; Olapeju B, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2575-z; Palmer CJ, 2002, EMERG INFECT DIS, V8, P330, DOI 10.3201/eid0803.010261; Pimenta PFP, 2015, MEM I OSWALDO CRUZ, V110, P23, DOI 10.1590/0074-02760140266; Recht J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1925-6; Reymondin L, 2014, POTENTIAL IMPACT ROA; Sanchez Juan F, 2017, Am J Trop Med Hyg, V96, P304, DOI 10.4269/ajtmh.16-0030; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-210; Sood S, 2006, J HEALTH COMMUN, V11, P143, DOI 10.1080/10810730600974837; Storey JD, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5372-2; Valle D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-443; Vector Control Services MoPH, 2019, NAT MAL PROGR STRAT; Yan SD, 2020, MALARIA J, V19, P1, DOI [10.1186/s12936-019-3075-5, DOI 10.1186/S12936-019-3075-5]	38	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244454	10.1371/journal.pone.0244454	http://dx.doi.org/10.1371/journal.pone.0244454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373407	Green Published, gold			2022-12-27	WOS:000603612300050
J	Wibbens, PD; Koo, WWY; McGahan, AM				Wibbens, Phebo D.; Koo, Wesley Wu-Yi; McGahan, Anita M.			Which COVID policies are most effective? A Bayesian analysis of COVID-19 by jurisdiction	PLOS ONE			English	Article							EPIDEMIC; SPREAD	This paper reports the results of a Bayesian analysis on large-scale empirical data to assess the effectiveness of eleven types of COVID-control policies that have been implemented at various levels of intensity in 40 countries and U.S. states since the onset of the pandemic. The analysis estimates the marginal impact of each type and level of policy as implemented in concert with other policies. The purpose is to provide policymakers and the general public with an estimate of the relative effectiveness of various COVID-control strategies. We find that a set of widely implemented core policies reduces the spread of virus but not by enough to contain the pandemic except in a few highly compliant jurisdictions. The core policies include the cancellation of public events, restriction of gatherings to fewer than 100 people, recommendation to stay at home, recommended restrictions on internal movement, implementation of a partial international travel ban, and coordination of information campaigns. For the median jurisdiction, these policies reduce growth rate in new infections from an estimated 270% per week to approximately 49% per week, but this impact is insufficient to prevent eventual transmission throughout the population because containment occurs only when a jurisdiction reduces growth in COVID infection to below zero. Most jurisdictions must also implement additional policies, each of which has the potential to reduce weekly COVID growth rate by 10 percentage points or more. The slate of these additional high-impact policies includes targeted or full workplace closings for all but essential workers, stay-at-home requirements, and targeted school closures.	[Wibbens, Phebo D.] INSEAD, Fontainebleau, France; [Koo, Wesley Wu-Yi] INSEAD, Singapore, Singapore; [McGahan, Anita M.] Univ Toronto, Toronto, ON, Canada	INSEAD Business School; INSEAD Business School; University of Toronto	McGahan, AM (corresponding author), Univ Toronto, Toronto, ON, Canada.	anita.mcgahan@rotman.utoronto.ca	Wibbens, Phebo D/I-8315-2017	Wibbens, Phebo D/0000-0002-1517-3858; McGahan, Anita M./0000-0002-5584-8207; Koo, Wesley/0000-0003-4246-9977				Abdollahi E, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01705-8; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; Asadi S, 2020, AEROSOL SCI TECH, V54, P635, DOI 10.1080/02786826.2020.1749229; Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348; Badr HS, 2020, LANCET INFECT DIS, V20, P1247, DOI 10.1016/S1473-3099(20)30553-3; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bastos SB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76257-1; Betsch C, 2020, P NATL ACAD SCI USA, V117, P21851, DOI 10.1073/pnas.2011674117; Bonardi JP., 2020, COVID EC, V23, P325; Cai JH, 2020, CLIN INFECT DIS, V71, P1547, DOI 10.1093/cid/ciaa198; Calafiore GC, 2020, MODIFIED SIR MODEL C, DOI [10.1016/j.arcontrol.2020.10.005, DOI 10.1016/J.ARCONTROL.2020.10.005]; Cascella M, 2020, STATPEARLS; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Cohen J, 2020, SCIENCE, V367, P727, DOI 10.1126/science.367.6479.727; Coleman KK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35896-1; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Dukic V, 2012, J AM STAT ASSOC, V107, P1410, DOI 10.1080/01621459.2012.713876; Ellison G., 2020, 27373 NBER, DOI [10.3386/w27373, DOI 10.3386/W27373]; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Gelman A, 2013, BAYESIAN DATA ANAL, V3rd; Gostic K, 2020, ELIFE, V9, DOI 10.7554/eLife.55570; Hale T., 2021, VARIATION GOVT RESPO; Hsiang S, 2020, NATURE, V585, pE7, DOI [10.1038/s41586-020-2404-8, 10.1038/s41586-020-2691-0]; Hu ZL, 2020, SCI CHINA LIFE SCI, V63, P706, DOI 10.1007/s11427-020-1661-4; Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x; Li W, 2020, CLIN INFECT DIS, V71, P1943, DOI 10.1093/cid/ciaa450; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Peng L, 2020, ENVIRON SCI POLLUT R, V27, P13524, DOI 10.1007/s11356-020-07903-4; Posfay-Barbe KM, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1576; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Ray D., 2020, DATA SCI REV, V2020, P1, DOI [DOI 10.1162/99608F92.60E08ED5, 10.1162/99608f92.60e08ed5, DOI 10.1101/2020.04.15.20067256]; Rossman H, 2020, NAT MED, V26, P634, DOI 10.1038/s41591-020-0857-9; Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Wilson N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3206; Wilson N, 2020, EMERG INFECT DIS, V26, P1339, DOI 10.3201/eid2606.200320; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1038/s41591-020-0822-7, 10.1080/10408398.2020.1828813]; Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2020	15	12							e0244177	10.1371/journal.pone.0244177	http://dx.doi.org/10.1371/journal.pone.0244177			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BU	33373384	gold, Green Published, Green Submitted			2022-12-27	WOS:000603612300046
J	Akande, O; Chen, Q; Toldo, S; Lesnefsky, EJ; Quader, M				Akande, Oluwatoyin; Chen, Qun; Toldo, Stefano; Lesnefsky, Edward J.; Quader, Mohammed			Ischemia and reperfusion injury to mitochondria and cardiac function in donation after circulatory death hearts- an experimental study	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; DECREASES MYOCARDIAL INJURY; ELECTRON-TRANSPORT; PROTECTS MITOCHONDRIA; TRANSPLANTATION; DYSFUNCTION; INHIBITION; BLOCKADE	The ultimate treatment for patients with end-stage heart failure is heart transplantation. The number of donor hearts which are primarily procured from donation after brain death (DBD) donors is limited, but donation after circulatory death (DCD) donor hearts can increase the heart donor pool. However, ischemia and reperfusion injuries associated with the DCD process causes myocardial damage, limiting the use of DCD hearts in transplantation. Addressing this problem is critical in the exploration of DCD hearts as suitable donor hearts for transplantation. In this study, rat hearts were procured following the control beating-heart donor (CBD) or DCD donation process. Changes in mitochondria and cardiac function from DCD hearts subjected to 25 or 35 minutes of ischemia followed by 60 minutes of reperfusion were compared to CBD hearts. Following ischemia, rates of oxidative phosphorylation and calcium retention capacity were progressively impaired in DCD hearts compared to CBD hearts. Reperfusion caused additional mitochondrial dysfunction in DCD hearts. Developed pressure, inotropy and lusitropy, were significantly reduced in DCD hearts compared to CBD hearts. We, therefore, suggest that interventional strategies targeted before the onset of ischemia and at reperfusion could protect mitochondria, thus potentially making DCD hearts suitable for heart transplantation.	[Akande, Oluwatoyin; Quader, Mohammed] Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23284 USA; [Chen, Qun; Toldo, Stefano; Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Med, Div Cardiol, Richmond, VA USA; [Lesnefsky, Edward J.] Hunter Holmes McGuire Vet Adm Med Ctr, Med Serv, Richmond, VA USA; [Quader, Mohammed] Hunter Holmes McGuire Vet Adm Med Ctr, Dept Surg, Richmond, VA 23249 USA	Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Hunter Holmes McGuire Veterinary Affairs Medical Center	Quader, M (corresponding author), Virginia Commonwealth Univ, Dept Surg, Richmond, VA 23284 USA.; Quader, M (corresponding author), Hunter Holmes McGuire Vet Adm Med Ctr, Dept Surg, Richmond, VA 23249 USA.	mohammed.quader@vcuhealth.org	Chen, Qun/HGD-0868-2022		Merit Review Grant [1I01 BX003859, 2IO1 BX001355]; Pauley Heart Center	Merit Review Grant; Pauley Heart Center	This work was supported by Merit Review Grant awarded to Dr. Mohammed Quader (1I01 BX003859), Dr. Edward Lesnefsky (2IO1 BX001355), and funds from the Pauley Heart Center to Drs. Mohammed Quader, Qun Chen and Stefano Toldo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AA, 2011, AM J TRANSPLANT, V11, P1621, DOI 10.1111/j.1600-6143.2011.03622.x; Aravinda P, 2018, ANN CARDIOTHORAC SUR, V7, P75, DOI [10.21037/acs.2018.01.08, DOI 10.21037/ACS.2018.01.08]; Blackstock MJ, 2014, EUR J EMERG MED, V21, P324, DOI 10.1097/MEJ.0000000000000082; Camara AKS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00013; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Chen Q, 2019, AM J PHYSIOL-CELL PH, V317, pC910, DOI 10.1152/ajpcell.00190.2019; Chen Q, 2018, AM J PHYSIOL-HEART C, V314, pH787, DOI 10.1152/ajpheart.00531.2017; Chen Qun, 2012, J Aging Res, V2012, P753949, DOI 10.1155/2012/753949; Chew HC, 2019, J AM COLL CARDIOL, V73, P1447, DOI 10.1016/j.jacc.2018.12.067; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Gao L, 2019, TRANSPLANTATION, V103, P1140, DOI 10.1097/TP.0000000000002629; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hausenloy DJ, 2003, J MOL CELL CARDIOL, V35, P339, DOI 10.1016/S0022-2828(03)00043-9; Iyer A, 2014, AM J TRANSPLANT, V14, P1744, DOI 10.1111/ajt.12782; January C. T., 2019, CIRCULATION, V140, pe125, DOI 10.1161/cir.0000000000000665; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lesnefsky EJ, 1977, AM J PHYSIOL-HEART C, V273, pH1544; Mancini D, 2010, CIRCULATION, V122, P173, DOI 10.1161/CIRCULATIONAHA.109.858076; Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012; McKeown DW, 2012, BRIT J ANAESTH, V108, pI96, DOI 10.1093/bja/aer351; Mohsin AA, 2019, J PHARMACOL EXP THER, V369, P282, DOI 10.1124/jpet.118.254300; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; PALMER JW, 1977, J BIOL CHEM, V252, P8731; PALMER JW, 1986, AM J PHYSIOL, V250, pH741, DOI 10.1152/ajpheart.1986.250.5.H741; Lopez SP, 2009, J HEART LUNG TRANSPL, V28, P815, DOI 10.1016/j.healun.2009.04.021; Quader M, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00681; Riva A, 2005, AM J PHYSIOL-HEART C, V289, pH868, DOI 10.1152/ajpheart.00866.2004; Sade Robert M, 2011, J S C Med Assoc, V107, P146; Schlegel A, 2013, J HEPATOL, V58, P278, DOI 10.1016/j.jhep.2012.10.004; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Stewart S, 2009, TRANSL RES, V153, P224, DOI 10.1016/j.trsl.2009.02.003; Tanaka-Esposito C, 2012, TRANSL RES, V160, P207, DOI 10.1016/j.trsl.2012.01.024; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Wang XC, 2018, AM J TRANSPLANT, V18, P843, DOI 10.1111/ajt.14523; Xie JR, 2007, ACTA ANAESTH SCAND, V51, P909, DOI 10.1111/j.1399-6576.2007.01342.x; Xu AJ, 2014, AM J PHYSIOL-CELL PH, V306, pC1142, DOI 10.1152/ajpcell.00241.2013	40	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0243504	10.1371/journal.pone.0243504	http://dx.doi.org/10.1371/journal.pone.0243504			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370296	Green Published, gold			2022-12-27	WOS:000603611900070
J	Li, ZT; Ahmed, I; Xu, ZQ; Sun, S; Li, T; Gu, DH; Liu, Y; Zhang, X; Yan, SX; Hu, WY; Jiang, ZQ; Duan, XH; Li, QH; Liu, LX; Rong, H; Wang, K; Abdulwahid, AM; Dou, TF; Wang, SR; Su, ZC; Ge, CR; te Pas, MFW; Jia, JJ; Huang, Y				Li, Zhengtian; Ahmed, Irfan; Xu, Zhiqiang; Sun, Shuai; Li, Tao; Gu, Dahai; Liu, Yong; Zhang, Xia; Yan, Shixiong; Hu, Wenyuan; Jiang, Ziqing; Duan, Xiaohua; Li, Qihua; Liu, Lixian; Rong, Hua; Wang, Kun; Abdulwahid, Alsoufi Mohammed; Dou, Tengfei; Wang, Shanrong; Su, Zhengchang; Ge, Changrong; te Pas, Marinus F. W.; Jia, Junjing; Huang, Ying			Profiles of expression pattern and tissue distribution of host defense peptides genes in different chicken (Gallus gallus) breeds related to body weight	PLOS ONE			English	Article							AVIAN BETA-DEFENSIN; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; CATHELICIDINS; MODULATION; INFECTION; TRACT	Host defense peptides (HDPs) are an important first line of defense with antimicrobial and immunomodulatory properties. Selection for increased body weight is hypothesized to be related to reduced immune response. We studied the relationships among body weight, age, and the HDP expression patterns in intestine and immune organs. We used chickens with marked differences of body sizes. The non-selected Daweishan mini chickens showed the highest indexes of immune organs and the lowest concentrations of the plasma immune parameters C3, C4, IgA, and IgY, while the commercial Avian broiler showed the opposite results. The Daweishan mini chickens showed the highest mRNA expressions of HDP genes in small intestine followed by the semi-selected Wuding chickens. Compared with local breeds, broiler chickens showed higher mRNA expression of HDP genes in spleen, thymus, and bursa. Body weight and HDP expression levels were negatively correlated in the intestine and positively in the immune organs. Our results indicated that the HDP immune regulatory roles in small intestine acted as first line of defense in innate immunity in local breeds, and as an adaptive immunity in broiler chickens. Selection was associated with different expression expressions of HDP genes in breed-, age-, and organ-specific manners.	[Li, Zhengtian; Ahmed, Irfan; Xu, Zhiqiang; Sun, Shuai; Li, Tao; Gu, Dahai; Liu, Yong; Zhang, Xia; Yan, Shixiong; Hu, Wenyuan; Jiang, Ziqing; Duan, Xiaohua; Li, Qihua; Liu, Lixian; Rong, Hua; Wang, Kun; Abdulwahid, Alsoufi Mohammed; Dou, Tengfei; Wang, Shanrong; Ge, Changrong; Jia, Junjing; Huang, Ying] Yunnan Agr Univ, Yunnan Prov Key Lab Anim Nutr & Feed, Kunming, Yunnan, Peoples R China; [Xu, Zhiqiang; Gu, Dahai] Yunnan Agr Univ, Dept Food Sci, Kunming, Yunnan, Peoples R China; [Su, Zhengchang] Univ N Carolina, Dept Bioinformat & Genom, Coll Comp & Informat, Charlotte, NC USA; [te Pas, Marinus F. W.] Wageningen UR, Wageningen Livestock Res, Wageningen, Netherlands; [te Pas, Marinus F. W.] Yunnan Agr Univ, Kunming, Yunnan, Peoples R China	Yunnan Agricultural University; Yunnan Agricultural University; University of North Carolina; University of North Carolina Charlotte; Wageningen University & Research; Yunnan Agricultural University	Jia, JJ; Huang, Y (corresponding author), Yunnan Agr Univ, Yunnan Prov Key Lab Anim Nutr & Feed, Kunming, Yunnan, Peoples R China.; te Pas, MFW (corresponding author), Wageningen UR, Wageningen Livestock Res, Wageningen, Netherlands.; te Pas, MFW (corresponding author), Yunnan Agr Univ, Kunming, Yunnan, Peoples R China.	marinus.tepas@wur.nl; junjingj@sina.com; yinghuang@ynau.edu.cn	Ahmed, Irfan/HHD-1948-2022; AHMED, IRFAN/AFW-6944-2022		National Natural Science Foundation of China [U1702232, 31560618]; National Natural Science Foundation of Yunnan Province [2017IC048, 2019HC011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Yunnan Province	CG: National Natural Science Foundation of China (U1702232, 31560618) JJ: National Natural Science Foundation of Yunnan Province (2017IC048 and 2019HC011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta M, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-15; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2012, INSIGHT WORLD J INFR, V3, P18; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Carlander D, 1999, UPSALA J MED SCI, V104, P179, DOI 10.3109/03009739909178961; Cheng YY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0465-3; Chinese chicken Feeding Standard, 2004, FEED STAND CHICK; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Cunliffe RN, 2004, J LEUKOCYTE BIOL, V75, P49, DOI 10.1189/jlb.0503249; Cuperus T, 2013, DEV COMP IMMUNOL, V41, P352, DOI 10.1016/j.dci.2013.04.019; Dou TF, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3845-9; EVANS EW, 1994, J LEUKOCYTE BIOL, V56, P661, DOI 10.1002/jlb.56.5.661; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gong DQ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-12; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Hellgren Olof, 2010, Immunome Res, V6, P3, DOI 10.1186/1745-7580-6-3; Higgs R, 2005, IMMUNOGENETICS, V57, P90, DOI 10.1007/s00251-005-0777-3; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Huff WE, 2002, POULTRY SCI, V81, P437, DOI 10.1093/ps/81.4.437; Kin NW, 2011, EUR J IMMUNOL, V41, P3006, DOI 10.1002/eji.201141606; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Kosciuczuk EM, 2012, MOL BIOL REP, V39, P10957, DOI 10.1007/s11033-012-1997-x; Lee MO, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0866-6; Leshchinsky TV, 2001, DEV COMP IMMUNOL, V25, P629, DOI 10.1016/S0145-305X(01)00023-4; Lu FZ, 2008, POULTRY SCI, V87, P2087, DOI 10.3382/ps.2007-00493; Lu L, 2015, GENET MOL RES, V14, P3330, DOI 10.4238/2015.April.13.12; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Lynn DJ, 2004, IMMUNOGENETICS, V56, P170, DOI 10.1007/s00251-004-0675-0; Ma DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047743; Matusiak L, 2014, ACTA DERM-VENEREOL, V94, P699, DOI 10.2340/00015555-1841; Milona P, 2007, BIOCHEM BIOPH RES CO, V356, P169, DOI 10.1016/j.bbrc.2007.02.098; National Research Council, 1994, NUTR REQ POULTR; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Swaggerty CL, 2009, FOODBORNE PATHOG DIS, V6, P777, DOI 10.1089/fpd.2009.0307; van Dijk A, 2011, VET MICROBIOL, V153, P27, DOI 10.1016/j.vetmic.2011.03.028; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; van Dijk A, 2007, ANTIMICROB AGENTS CH, V51, P912, DOI 10.1128/AAC.00568-06; Wang RQ, 2010, APPL MICROBIOL BIOT, V87, P1395, DOI 10.1007/s00253-010-2591-6; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Xu Y, 2015, APPL MICROBIOL BIOT, V99, P9011, DOI 10.1007/s00253-015-6786-8; Yacoub HA, 2016, DEV COMP IMMUNOL, V65, P8, DOI 10.1016/j.dci.2016.06.012; Yacoub HA, 2016, BIOCHEM CELL BIOL, V94, P176, DOI 10.1139/bcb-2015-0121; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhao CQ, 2001, INFECT IMMUN, V69, P2684, DOI 10.1128/IAI.69.4.2684-2691.2001	50	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0238675	10.1371/journal.pone.0238675	http://dx.doi.org/10.1371/journal.pone.0238675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370283	gold, Green Submitted, Green Published			2022-12-27	WOS:000603611900077
J	Moodley, J; Williams, P; Gohla, G; Major, P; Bonert, M				Moodley, Jinesa; Williams, Phillip; Gohla, Gabriela; Major, Pierre; Bonert, Michael			Variation in breast cancer grading in 1,636 resections assessed using control charts and in silico kappa	PLOS ONE			English	Article							NOTTINGHAM MODIFICATION; REPRODUCIBILITY; BLOOM; SYSTEM	Objective Assess interpretative variation in Nottingham grading using control charts (CCs) and in silico kappa (ISK). Methods In house invasive breast cancer cases (2011-2019) at two institutions with a synoptic report were extracted. Pathologist interpretative rates (PIRs) were calculated and normed for Nottingham grade (G) and its components (tubular score (TS), nuclear score (NS), mitotic score (MS)) for pathologists interpreting >35 cases. ISKs were calculated using the ordered mutually exclusive category assumption (OMECA) and maximal categorical overlap assumption (MCOA). Results The study period included 1,994 resections. Ten pathologists each assessed 38-441 cases and together saw 1,636; these were further analyzed. The PIR medians (normed ranges) were: G1:24%(18-27%), G2:53%(43-56%) and G3:26%(19-33%). The MCOA ISK and the number of statistical outliers (p< 0.05/p< 0.001) to the group median interpretive rate (GMIR) for the ten pathologists was G1: 0.82(2/0 of 10), G2: 0.76(1/1), G3: 0.71(3/1), TS1: 0.79(1/0), TS2: 0.63(5/1), TS3: 0.66(5/1), NS1: 0.37(5/4), NS2: 0.60(4/3), NS3: 0.59(4/4), MS1: 0.78(3/1), MS2: 0.78(3/1), MS3: 0.77(2/0). The OMECA ISK was 0.62, 0.49, 0.69 and 0.71 for TS, NS, MS and G. Conclusions The nuclear score has the most outliers. NS1 appears to be inconsistently used. ISK mirrors trends in conventional kappa studies. CCs and ISK allow insight into interpretive variation and may be essential for the next generation in quality.	[Moodley, Jinesa; Gohla, Gabriela; Bonert, Michael] McMaster Univ, Pathol & Mol Med, Hamilton, ON, Canada; [Williams, Phillip] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Major, Pierre] McMaster Univ, Med Oncol, Hamilton, ON, Canada	McMaster University; University of Toronto; McMaster University	Bonert, M (corresponding author), McMaster Univ, Pathol & Mol Med, Hamilton, ON, Canada.	bonertm@mcmaster.ca						Aleskandarany MA, 2010, BREAST CANCER RES, V12, pS8, DOI 10.1186/bcr2520; Allison KH, 2012, BREAST CANCER RES TR, V131, P413, DOI 10.1007/s10549-011-1416-3; Atanda AT, 2017, ANN TROP PATHOL, V8, P104; Boiesen P, 2000, ACTA ONCOL, V39, P41; Bonert Michael, 2017, J Pathol Inform, V8, P43, DOI 10.4103/jpi.jpi_50_17; Donegan WL, 1997, CA-CANCER J CLIN, V47, P28, DOI 10.3322/canjclin.47.1.28; Eaton AA, 2017, BREAST CANCER RES TR, V161, P435, DOI 10.1007/s10549-016-4069-4; FRIERSON HF, 1995, AM J CLIN PATHOL, V103, P195; Khoury T, 2016, APPL IMMUNOHISTO M M, V24, P703, DOI 10.1097/PAI.0000000000000248; Luttman R J, 1998, Top Health Inf Manage, V19, P22; Luttman R J, 1998, Top Health Inf Manage, V19, P12; Meyer JS, 2005, MODERN PATHOL, V18, P1067, DOI 10.1038/modpathol.3800388; Orlando L, 2016, BREAST, V30, P151, DOI 10.1016/j.breast.2016.09.015; PAGE DL, 1995, AM J CLIN PATHOL, V103, P123; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Rampaul RS, 2001, EUR J SURG ONCOL, V27, P229, DOI 10.1053/ejso.2001.1114; Schuh F, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0320-2; Shewhart WA, 2015, EC CONTROL QUALITY M; Sim J, 2005, PHYS THER, V85, P257; Thor J, 2007, QUAL SAF HEALTH CARE, V16, P387, DOI 10.1136/qshc.2006.022194; van Dooijeweert C, 2020, INT J CANCER, V146, P769, DOI 10.1002/ijc.32330; Zhang R, 2010, CHINESE MED J-PEKING, V123, P1976, DOI 10.3760/cma.j.issn.0366-6999.2010.15.005	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0242656	10.1371/journal.pone.0242656	http://dx.doi.org/10.1371/journal.pone.0242656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370310	Green Published, gold			2022-12-27	WOS:000603611900073
J	Neubert, A; Fernandes, OB; Lucevic, A; Pavlova, M; Gulacsi, L; Baji, P; Klazinga, N; Kringos, D				Neubert, Anne; Brito Fernandes, Oscar; Lucevic, Armin; Pavlova, Milena; Gulacsi, Laszlo; Baji, Petra; Klazinga, Niek; Kringos, Dionne			Understanding the use of patient-reported data by health care insurers: A scoping review	PLOS ONE			English	Review							QUALITY-OF-CARE; OUTCOME MEASURES; INTERVENTIONS; IMPROVEMENT; INSURANCE	Background Patient-reported data are widely used for many purposes by different actors within a health system. However, little is known about the use of such data by health insurers. Our study aims to map the evidence on the use of patient-reported data by health insurers; to explore how collected patient-reported data are utilized; and to elucidate the motives of why patient-reported data are collected by health insurers. Methods The study design is that of a scoping review. In total, 11 databases were searched on. Relevant grey literature was identified through online searches, reference mining and recommendations from experts. Forty-two documents were included. We synthesized the evidence on the uses of patient-reported data by insurers following a structure-process-outcome approach; we also mapped the use and function of those data by a health insurer. Results Health insurers use patient-reported data for assurance and improvement of quality of care and value-based health care. The patient-reported data most often collected are those of outcomes, experiences and satisfaction measures; structure indicators are used to a lesser extent and often combined with process indicators. These data are mainly used for the purposes of procurement and purchasing of services, quality assurance, improvement and reporting, and strengthening the involvement of insured people. Conclusions The breadth to which insurers use patient-reported data in their business models varies greatly. Some hindering factors to the uptake of such data are the varying and overlapping terminology in use in the field and the limited involvement of insured people in a health insurer's business. Health insurers are advised to be more explicit in regard to the role they want to play within the health system and society at large, and accommodate implications for the use of patient-reported data accordingly.	[Neubert, Anne] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Orthopaed & Traumatol, Dusseldorf, Germany; [Neubert, Anne] Heinrich Heine Univ Dusseldorf, Inst Hlth Serv Res & Hlth Econ, Ctr Hlth & Soc, Dusseldorf, Germany; [Brito Fernandes, Oscar; Lucevic, Armin; Gulacsi, Laszlo; Baji, Petra] Corvinus Univ Budapest, Dept Hlth Econ, Budapest, Hungary; [Brito Fernandes, Oscar; Lucevic, Armin; Klazinga, Niek; Kringos, Dionne] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Pavlova, Milena] Maastricht Univ, Med Ctr, Fac Hlth Med & Life Sci, Dept Hlth Serv Res,CAPHRI, Maastricht, Netherlands	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Corvinus University Budapest; University of Amsterdam; Vrije Universiteit Amsterdam; Maastricht University	Fernandes, OB (corresponding author), Corvinus Univ Budapest, Dept Hlth Econ, Budapest, Hungary.; Fernandes, OB (corresponding author), Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Amsterdam UMC, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	obritofernandes@uni-corvinus.hu	Brito Fernandes, Óscar/J-8756-2016; Kringos, Dionne/ABE-2290-2020; Pavlova, Milena/B-4778-2011	Brito Fernandes, Óscar/0000-0002-3212-373X; Kringos, Dionne/0000-0003-2711-4713; Pavlova, Milena/0000-0002-6082-8446; Neubert, Anne/0000-0002-6323-3747; Baji, Petra/0000-0003-2899-8557; Gulacsi, Laszlo/0000-0002-9285-8746	European Union [765141]	European Union(European Commission)	The participation of AL, DK, LG, NK, OBF and PB occurred within a Marie Sklodowska-Curie Innovative Training Network (HealthPros Healthcare Performance Intelligence Professionals) that has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement Nr. 765141 (https://healthpros-h2020.eu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian A-M, 2010, AOK ARZT NAVIGATOR E; Akachi Y, 2017, B WORLD HEALTH ORGAN, V95, P465, DOI 10.2471/BLT.16.180190; [Anonymous], 2010, ARZT BEWERTUNG INTER; [Anonymous], 2004, PRIVATE HLTH INSURAN; [Anonymous], 2010, J ADV NURS, V66, P246, DOI [10.1111/j.1365-2648.2009.05250.x, DOI 10.1111/J.1365-2648.2009.05250.X]; AOK  BARMER  KKH, 2018, METH VERS PAT EXP QU; Arksey, 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]; Barnieh L, 2014, VALUE HEALTH, V17, P98, DOI 10.1016/j.jval.2013.10.008; Bastemeijer CM, 2019, PATIENT-RELAT OUTCOM, V10, P157, DOI 10.2147/PROM.S201737; Bitzer E, 2010, BARMER GEK REPORT KR; Black N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f167; Booth A., 2017, PATIENT INVOLVEMENT, P187; Cacace M., 2012, PUBLIC REPORTING QUA; Cashin C, 2014, PAYING PERFORMANCE H; Cole A, 2019, MAKING OUTCOME BASED; Cunningham PJ, 2017, AM J MANAG CARE, V23, pE215; Damberg CL, 2014, MEASURING SUCCESS HL; Damman OC, 2009, MED CARE, V47, P496, DOI 10.1097/MLR.0b013e31818afa05; Delnoij DMJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-88; Dohmen PJG, 2019, HEALTH POLICY, V123, P300, DOI 10.1016/j.healthpol.2018.09.007; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; DONABEDIAN A, 1990, ARCH PATHOL LAB MED, V114, P1115; Dreyer NA, 2016, CURR MED RES OPIN, V32, P1697, DOI 10.1080/03007995.2016.1203768; Elbel B, 2009, MILBANK Q, V87, P633, DOI 10.1111/j.1468-0009.2009.00574.x; Fernandes OB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235165; Fernandes OB, 2019, EUR J HEALTH ECON, V20, pS79, DOI 10.1007/s10198-019-01064-z; Figueras J., 2005, PURCHASING IMPROVE H; Fleishman JA, 2006, MED CARE, V44, P54; Franklin Patricia, 2017, EGEMS (Wash DC), V5, P17, DOI 10.5334/egems.227; Fujisawa R, 2017, MEASURING PATIENT EX; Galli G, 2017, DIGITAL CULTURAL TRA; Gentry S, 2017, CUREUS, V9, DOI 10.7759/cureus.1079; Gleeson H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011907; Green AW, 2007, AM J MANAG CARE, V13, P482; Greenhalgh J, 2018, J HEALTH SERV RES PO, V23, P57, DOI 10.1177/1355819617740925; Gurria A, 2017, PUTTING PEOPLE CTR H; Health Metrics Network, 2012, FRAM STAND COUNTR HL, V2nd; Hendrikx J, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000202; Hofmann A, 2013, J RISK UNCERTAINTY, V46, P81, DOI 10.1007/s11166-012-9160-6; Hornbrook MC, 1996, HEALTH SERV RES, V31, P283; Hostetter M, 2012, QUAL MATTER; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; International Alliance of Patients' Organizations, 2006, DECL PAT CTR HEALTHC; International Consortium for Health Outcomes Measurement, 2020, STAND SETS; IQhealthcare, 2019, WAT ZIJN PROS PROMS; IQTIG, 2017, QUAL NACH 110A SGB E; Klakow-Franck R, 2014, Z EVIDENZ FORTBILD Q, V108, P456, DOI 10.1016/j.zefq.2014.10.008; Klose K, 2016, HEALTH ECON REV, V6, DOI 10.1186/s13561-016-0094-6; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Liste W, 2020, ONL ARZTS NEUER QUAL; McNamara P, 2006, QUAL SAF HEALTH CARE, V15, P171, DOI 10.1136/qshc.2005.014373; Ministrie van Volksgezondheid Welzijn en Sport, 2018, OUTC BAS HEALTHC 201; Moes FB, 2019, J EVAL CLIN PRACT, V25, P390, DOI 10.1111/jep.12900; Morgan S., 2016, SUMMARIES NATL DRUG; National Quality Forum, 2013, PAT REP OUTC PROS PE; Nickel S, 2010, HEALTH POLICY, V98, P156, DOI 10.1016/j.healthpol.2010.06.012; Organisation for Economic Co-operation and Development, 2020, MEAS WHAT MATT PAT R; Organisation for Economic Co-operation and Development, 2020, PAT REP IND SURV PAR; Ose D, 2008, PRAVENT GESUNDHEIT, V3, P152, DOI 10.1007/s11553-008-0131-3; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Peters M.D.J., 2017, J BRIGGS I REV MANUA, DOI DOI 10.46658/JBIMES-20-01; PricewaterhouseCoopers, 2016, INS 2020 CREAT WINN; Roos AF, 2012, EUR J HEALTH ECON, V13, P51, DOI 10.1007/s10198-010-0279-6; Rupprecht CJ, 2013, FORSCHUNGSJOURNAL SO, V26, P149; Ryan AM, 2014, EFFICIENCY VALUE HEA; Safran DG, 2019, GETTING NEXT GENERAT; Scholz S, 2018, KU GESUNDHEITSMANAGE, V7, P40; Silvello A., 2018, CONNECTED INSURANCE; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Slawomirski L., 2018, WORLD MED J, V64, P8; Slawomirski L, 2018, WORLD HOSP HLTH SERV, V54; Smith PC, 2013, HEALTH ECON, V22, P119, DOI 10.1002/hec.2793; Squitieri L, 2017, VALUE HEALTH, V20, P834, DOI 10.1016/j.jval.2017.02.003; Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850; Triemstra M., 2018, USE PATIENT REPORTED; Tseng EK, 2016, CURR HEMATOL MALIG R, V11, P303, DOI 10.1007/s11899-016-0333-2; Valiance-Owen A, 2011, J ROY SOC MED, V104, P429, DOI 10.1258/jrsm.2011.11k034; Validity LL, 2015, J FAM MED PRIM CARE, V4, P324; van den Berg B, 2008, SOC SCI MED, V66, P2448, DOI 10.1016/j.socscimed.2008.02.021; van Veghel D, 2018, INT J HEALTHCARE MAN, V11, P371, DOI 10.1080/20479700.2018.1458177; Verkerk E, 2018, PROM CYCLE 8 STEPS S; Wendel S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-310; Wiering B, 2017, HEALTH EXPECT, V20, P1330, DOI 10.1111/hex.12573; Wiering B, 2017, HEALTH EXPECT, V20, P11, DOI 10.1111/hex.12442; World Health Organization, 2006, QUAL CAR PROC MAK ST	85	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244546	10.1371/journal.pone.0244546	http://dx.doi.org/10.1371/journal.pone.0244546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370405	gold, Green Published			2022-12-27	WOS:000603611900116
J	Pound, HL; Wilhelm, SW				Pound, Helena L.; Wilhelm, Steven W.			Tracing the active genetic diversity of Microcystis and Microcystis phage through a temporal survey of Taihu	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; LAKE TAIHU; TOXIC MICROCYSTIS; CYANOPHAGE; AERUGINOSA; GENOTYPES; WATER; POPULATIONS; NUTRIENTS; DYNAMICS	Harmful algal blooms are commonly thought to be dominated by a single genus, but they are not homogenous communities. Current approaches, both molecular and culture-based, often overlook fine-scale variations in community composition that can influence bloom dynamics. We combined homology-based searches (BLASTX) and phylogenetics to distinguish and quantify Microcystis host and phage members across a summer season during a 2014 Microcystis- dominated bloom that occurred in Lake Tai (Taihu), China. We found 47 different genotypes of the Microcystis-specific DNA-dependent RNA polymerase (rpoB), which included several morphospecies. Microcystis flos-aquae and Microcystis wesenbergii accounted for similar to 86% of total Microcystis transcripts, while the more commonly studied Microcystis aeruginosa only accounted for similar to 7%. Microcystis genotypes were classified into three temporal groups according to their expression patterns across the course of the bloom: early, constant and late. All Microcystis morphospecies were present in each group, indicating that expression patterns were likely dictated by competition driven by environmental factors, not phylogeny. We identified three primary Microcystis-infecting phages based on the viral terminase, including a novel Siphoviridae phage that may be capable of lysogeny. Within our dataset, Myoviridae phages consistent with those infecting Microcystis in a lytic manner were positively correlated to the early host genotypes, while the Siphoviridae phages were positively correlated to the late host genotypes, when the Myoviridae phages express putative genetic markers for lysogeny. The expression of genes in the microcystin-encoding mcy cassette was estimated using mcyA, which revealed 24 Microcystis-specific genotypes that were negatively correlated to the early host genotypes. Of all environmental factors measured, pH best described the temporal shift in the Microcystis community genotypic composition, promoting hypotheses regarding carbon concentration mechanisms and oxidative stress. Our work expounds on the complexity of HAB events, using a well-studied dataset to highlight the need for increased resolution of community dynamics.	[Pound, Helena L.; Wilhelm, Steven W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Wilhelm, SW (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	wilhelm@utk.edu	; Wilhelm, Steven/B-8963-2008	Pound, Helena/0000-0002-6505-9789; Wilhelm, Steven/0000-0001-6283-8077	National Science Foundation [IOS- 1451528]; NIEHS through the Great Lakes Center for Fresh Waters and Human Health at Bowling Green State University [1P01ES028939-01]; NSF through the Great Lakes Center for Fresh Waters and Human Health at Bowling Green State University [OCE-1840715]; Simons Foundation [735077]; Kenneth & Blaire Mossman Endowment	National Science Foundation(National Science Foundation (NSF)); NIEHS through the Great Lakes Center for Fresh Waters and Human Health at Bowling Green State University; NSF through the Great Lakes Center for Fresh Waters and Human Health at Bowling Green State University; Simons Foundation; Kenneth & Blaire Mossman Endowment	This work was supported by funds from the National Science Foundation (IOS- 1451528 to SWW), and funding from the NIEHS (1P01ES028939-01) and NSF (OCE-1840715) to SWW through the Great Lakes Center for Fresh Waters and Human Health at Bowling Green State University. We also acknowledge support from the Simons Foundation (735077) and the Kenneth & Blaire Mossman Endowment to The University of Tennessee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cai YF, 2012, J ENVIRON SCI, V24, P1832, DOI 10.1016/S1001-0742(11)61007-3; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Carrillo E, 2003, PHYCOLOGIA, V42, P269, DOI 10.2216/i0031-8884-42-3-269.1; China Fisheries, 2018, CHINA FISH, V9, P2; Gann E.R., 2019, PYTHON SCRIPT EXTRAC; Glibert PM, 2005, OCEANOGRAPHY; Hallegraeff G. M., 2003, MAN HARMFUL MAR MICR, V33, P1; Harke MJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2275-9; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; HUGHES EO, 1958, CAN J MICROBIOL, V4, P225, DOI 10.1139/m58-024; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kim SG, 2010, FEMS MICROBIOL ECOL, V74, P93, DOI 10.1111/j.1574-6941.2010.00947.x; Kimura S, 2013, APPL ENVIRON MICROB, V79, P2789, DOI 10.1128/AEM.03751-12; Krausfeldt L, RNA EXTRACTION STERI; Krausfeldt LE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01064; Krausfeldt LE, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix024; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P6723, DOI 10.1128/AEM.69.11.6723-6730.2003; Latta LC, 2011, EVOL ECOL, V25, P1107, DOI 10.1007/s10682-010-9457-3; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li M, 2013, FRESEN ENVIRON BULL, V22, P3474; Luria SE, 1943, GENETICS, V28, P491; Martin RM, 2019, CYLINDROSPERMOPSIS R; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Morimoto D, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01170-19; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; MURRAY AG, 1992, MAR ECOL PROG SER, V89, P103, DOI 10.3354/meps089103; Otten TG, 2011, MICROB ECOL, V62, P907, DOI 10.1007/s00248-011-9884-x; Ou Tong, 2013, Virologica Sinica, V28, P266, DOI 10.1007/s12250-013-3340-7; Ouellette AJA, 2006, MICROB ECOL, V51, P154, DOI 10.1007/s00248-004-0146-z; Parajuli A, 2016, ANGEW CHEM INT EDIT, V55, P3596, DOI 10.1002/anie.201509920; Peng GT, 2018, ENVIRON SCI TECHNOL, V52, P4127, DOI 10.1021/acs.est.7b06532; Penn K, 2014, ISME J, V8, P1866, DOI 10.1038/ismej.2014.27; Pound H, METATRANSCRIPTOMIC S; Pound HL, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00338; Rinta-Kanto JM, 2006, APPL ENVIRON MICROB, V72, P5083, DOI 10.1128/AEM.00312-06; Rinta-Kanto JM, 2009, HARMFUL ALGAE, V8, P665, DOI 10.1016/j.hal.2008.12.004; Steffen MM, 2014, ISME J, V8, P2080, DOI 10.1038/ismej.2014.78; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Stough JMA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184146; Tang XM, 2018, ENVIRON SCI TECHNOL, V52, P11049, DOI 10.1021/acs.est.8b01066; Tillett D, 2001, APPL ENVIRON MICROB, V67, P2810, DOI 10.1128/AEM.67.6.2810-2818.2001; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; VANVALEN L, 1977, AM NAT, V111, P809, DOI 10.1086/283213; Visser PM, 2016, HARMFUL ALGAE, V54, P145, DOI 10.1016/j.hal.2015.12.006; Wang JF, 2019, ALGAL RES, V44, DOI 10.1016/j.algal.2019.101699; Wilhelm SW, 2020, MBIO, V11, DOI 10.1128/mBio.00529-20; Wilhelm SW, 2011, HARMFUL ALGAE, V10, P207, DOI 10.1016/j.hal.2010.10.001; Wright S, 1931, GENETICS, V16, P0097; Yang F, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00484; Yoshida T, 2006, APPL ENVIRON MICROB, V72, P1239, DOI 10.1128/AEM.72.2.1239-1247.2006; Yoshida T, 2008, J BACTERIOL, V190, P1762, DOI 10.1128/JB.01534-07; Yu L, 2014, TOXINS, V6, P3238, DOI 10.3390/toxins6123238; Zingone A, 2000, OCEAN COAST MANAGE, V43, P725, DOI 10.1016/S0964-5691(00)00056-9	58	7	7	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244482	10.1371/journal.pone.0244482	http://dx.doi.org/10.1371/journal.pone.0244482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM2BQ	33370358	Green Published, gold			2022-12-27	WOS:000603611900026
J	Wang, YL; Kala, MP; Jafar, TH				Wang, Yeli; Kala, Monica Palanichamy; Jafar, Tazeen H.			Factors associated with psychological distress during the coronavirus disease 2019 (COVID-19) pandemic on the predominantly general population: A systematic review and meta-analysis	PLOS ONE			English	Review							MENTAL-HEALTH PROBLEMS; DEPRESSION; ANXIETY; PREVALENCE; ADOLESCENTS; OUTBREAK; CHINA; INTERVENTIONS; QUARANTINE; EPIDEMIC	Background The Coronavirus Disease 2019 (COVID-19) outbreak has escalated the burden of psychological distress. We aimed to evaluate factors associated with psychological distress among the predominantly general population during the COVID-19 pandemic. Methods We searched PubMed, EMBASE, Scopus, Cochrane Library, PsycINFO, and World Health Organization COVID-19 databases (Dec 2019-15 July 2020). We included cross-sectional studies that reported factors associated with psychological distress during the COVID-19 pandemic. Primary outcomes were self-reported symptoms of anxiety and depression. Random-effects models were used to pool odds ratios (OR) and 95% confidence intervals (CI). The protocol was registered in PROSPERO (#CRD42020186735). Findings We included 68 studies comprising 288,830 participants from 19 countries. The prevalence of anxiety and depression was 33% (95% CI: 28%-39%) and 30% (26%-36%). Women versus men (OR: 1.48 [95% CI: 1.29-1.71; I-2 = 90.8%]), younger versus older (< versus >= 35 years) adults (1.20 [1.13-1.26]; I-2 = 91.7%), living in rural versus urban areas (1.13 [1.00-1.29]; I-2 = 82.9%), lower versus higher socioeconomic status (e.g. lower versus higher income: 1.45 [1.24-1.69; I-2 = 82.3%]) were associated with higher anxiety odds. These factors (except for residential area) were also associated with higher depression odds. Furthermore, higher COVID-19 infection risk (suspected/confirmed cases, living in hard-hit areas, having pre-existing physical or mental conditions) and longer media exposure were associated with higher odds of anxiety and depression. Interpretation One in three adults in the predominantly general population have COVID-19 related psychological distress. Concerted efforts are urgently needed for interventions in high-risk populations to reduce urban-rural, socioeconomic and gender disparities in COVID-19 related psychological distress.	[Wang, Yeli; Jafar, Tazeen H.] Duke NUS Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore; [Kala, Monica Palanichamy] Duke NUS Med Sch, Singapore, Singapore; [Jafar, Tazeen H.] Singapore Gen Hosp, Dept Renal Med, Singapore, Singapore; [Jafar, Tazeen H.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Singapore General Hospital; Duke University	Jafar, TH (corresponding author), Duke NUS Med Sch, Program Hlth Serv & Syst Res, Singapore, Singapore.; Jafar, TH (corresponding author), Singapore Gen Hosp, Dept Renal Med, Singapore, Singapore.; Jafar, TH (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA.	tazeen.jafar@duke-nus.edu.sg		Palanichamy Kala, Monica/0000-0003-3447-7360	National Medical Research Council, Singapore	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	THJ receives funding from the National Medical Research Council, Singapore. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert PR, 2015, J PSYCHIATR NEUROSCI, V40, P219, DOI 10.1503/jpn.150205; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Astell-Burt T, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8209; Bareeqa SB, 2021, INT J PSYCHIAT MED, V56, P210, DOI 10.1177/0091217420978005; Ben-Ezra M, 2020, J AFFECT DISORDERS, V275, P66, DOI 10.1016/j.jad.2020.06.026; Brooks Samantha K, 2020, Lancet, V395, P912, DOI 10.1016/S0140-6736(20)30460-8; Bruine de Bruin W, 2020, J GERONTOL B-PSYCHOL, DOI [10.1093/geronb/gbaa074, DOI 10.1093/GEROXB/GBAA074]; Caldwell DM, 2019, LANCET PSYCHIAT, V6, P1011, DOI 10.1016/S2215-0366(19)30403-1; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Pedrozo-Pupo JC, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00090520, 10.1590/0102-311X00090520]; Centers for Disease Control and Prevention, 2020, CORONAVIRUS DIS 2019; Chandra PS, 2018, CURR OPIN PSYCHIATR, V31, P276, DOI 10.1097/YCO.0000000000000408; Chang Jinghui, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P171, DOI 10.12122/j.issn.1673-4254.2020.02.06; Chen FP, 2020, BRAIN BEHAV IMMUN, V88, P36, DOI 10.1016/j.bbi.2020.05.061; Chen Su-hong, 2020, Fudan Xuebao (Yixueban), V47, P385, DOI 10.3969/j.issn.1672-8467-2020.03.012; Cheng C., 2014, STUDIES PSYCHOL BEHA, V12, P735, DOI 10.1136/gpsych-2020-100213; Cooke JE, 2020, PSYCHIAT RES, V292, DOI 10.1016/j.psychres.2020.113347; Costantini A, 2020, RIV PSICHIATR, V55, P145, DOI 10.1708/3382.33570; Deng JW, 2021, ANN NY ACAD SCI, V1486, P90, DOI 10.1111/nyas.14506; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Dominguez-Salas S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030190; Duan L, 2020, J AFFECT DISORDERS, V275, P112, DOI 10.1016/j.jad.2020.06.029; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Feigin V.L., 2019, LANCET NEUROL, V18, P459, DOI [DOI 10.1136/BMJ.L94, DOI 10.1136/bmj.l94]; Fekih-Romdhane F, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113131; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Forte G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061802; Fu WN, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00913-3; Galea S, 2005, J EPIDEMIOL COMMUN H, V59, P822, DOI 10.1136/jech.2005.033084; GAO JL, 2020, PLOS ONE, V15, DOI [DOI 10.1371/JOURNAL.PONE.0231924, 10.1371/journal.pone.0231924]; Gomez-Salgado J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113947; Gruebner O, 2017, DTSCH ARZTEBL INT, V114, P121, DOI 10.3238/arztebl.2017.0121; Gualano MR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134779; Guo J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113857; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hao XT, 2020, EPILEPSIA, V61, P1166, DOI 10.1111/epi.16544; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hou TY, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102305; Huang J, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa273; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Iasevoli F, 2021, PSYCHOL MED, V51, P1054, DOI 10.1017/S0033291720001841; Karatzias T, 2020, J TRAUMA STRESS, V33, P365, DOI 10.1002/jts.22565; Kavcic T, 2021, PSYCHIAT QUART, V92, P207, DOI 10.1007/s11126-020-09789-4; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Ko CH, 2006, PSYCHIAT CLIN NEUROS, V60, P397, DOI 10.1111/j.1440-1819.2006.01522.x; Kokou-Kpolou CK, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113128; Krishnamoorthy Y, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113382; Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405; Lee Y, 2020, PSYCHIAT CLIN NEUROS, V74, P552, DOI 10.1111/pcn.13101; Li JF, 2020, WORLD PSYCHIATRY, V19, P249, DOI 10.1002/wps.20758; Li LZ, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113267; Li Xin, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P203, DOI 10.3785/j.issn.1008-9292.2020.03.02; Li Y, 2020, J CLIN SLEEP MED, V16, P1417, DOI 10.5664/jcsm.8524; Lin YL, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00236; Liu CH, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113172; Liu D, 2020, PSYCHIAT RES, V292, DOI 10.1016/j.psychres.2020.113297; Liu X, 2020, BJOG-INT J OBSTET GY, V127, P1229, DOI 10.1111/1471-0528.16381; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; Ma YF, 2020, J AFFECT DISORDERS, V275, P145, DOI 10.1016/j.jad.2020.06.033; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; McKenzie K, 2013, J AFFECT DISORDERS, V150, P1019, DOI 10.1016/j.jad.2013.05.032; Mechili EA, 2021, J PSYCHIATR MENT HLT, V28, P317, DOI 10.1111/jpm.12672; Moccia L, 2020, BRAIN BEHAV IMMUN, V87, P75, DOI 10.1016/j.bbi.2020.04.048; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; Moola S., 2017, JBI MANUAL EVIDENCE; Moreno-Peral P, 2017, JAMA PSYCHIAT, V74, P1021, DOI 10.1001/jamapsychiatry.2017.2509; Mosli M, 2020, SAUDI J GASTROENTERO, V26, P263, DOI 10.4103/sjg.SJG_220_20; Naser AY, 2020, BRAIN BEHAV, V10, DOI 10.1002/brb3.1730; National Institute for Health and Care Excellence (NICE), 2009, DEPR AD REC MAN; Nguyen HC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040965; Ozdin S, 2020, INT J SOC PSYCHIATR, V66, P504, DOI 10.1177/0020764020927051; Palgi Y, 2020, J AFFECT DISORDERS, V275, P109, DOI 10.1016/j.jad.2020.06.036; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Pan R, 2020, PSYCHIAT INVEST, V17, P475, DOI 10.30773/pi.2020.0127; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Patel V, 2017, LANCET, V389, P176, DOI 10.1016/S0140-6736(16)31589-6; Peng M, 2020, J AFFECT DISORDERS, V275, P119, DOI 10.1016/j.jad.2020.06.035; Preis H, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100155; PROSPERO, 2020, SYST REV MET RISK FA; Qi H, 2020, PSYCHIAT CLIN NEUROS, V74, P555, DOI 10.1111/pcn.13102; Qi Rongfeng, 2020, medRxiv, DOI 10.1101/2020.05.08.20031666; Ren X, 2020, PSYCHIAT QUART, V91, P1033, DOI 10.1007/s11126-020-09796-5; Romans S, 2011, SOC PSYCH PSYCH EPID, V46, P567, DOI 10.1007/s00127-010-0222-2; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00620-0; Seyahi E, 2020, RHEUMATOL INT, V40, P1229, DOI 10.1007/s00296-020-04626-0; Sher L, 2020, QJM-INT J MED, V113, P707, DOI 10.1093/qjmed/hcaa202; Shi L, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.14053; Smith L, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113138; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Swendeman D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207055; Tang F, 2021, PSYCHOL HEALTH, V36, P164, DOI 10.1080/08870446.2020.1782410; Teesson M, 2020, LANCET DIGIT HEALTH, V2, pE74, DOI 10.1016/S2589-7500(19)30213-4; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Ueda M, 2020, PSYCHIAT CLIN NEUROS, V74, P505, DOI 10.1111/pcn.13105; United Nations, POL BRIEF COVID 19 U; Venkatesh A, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1379; Verma S, 2020, INT J SOC PSYCHIATR, V66, P756, DOI 10.1177/0020764020934508; Wang Yi, 2020, Fudan Xuebao (Yixueban), V47, P173, DOI 10.3969/j.issn.1672-8467.2020.02.005; Wang Y, 2020, SLEEP MED, V75, P282, DOI 10.1016/j.sleep.2020.06.011; Wang YR, 2022, P I MECH ENG C-J MEC, V236, P1931, DOI 10.1177/0954406220913306; Wang ZH, 2020, J AFFECT DISORDERS, V275, P188, DOI 10.1016/j.jad.2020.06.034; WHO, 2020, COR DIS COVID 19 OUT; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; Wong LP, 2020, TRANSBOUND EMERG DIS, V67, P2892, DOI 10.1111/tbed.13662; World Health Organization, 2017, DEPRESSION OTHER COM; World Health Organization, COUNTR VIETN; World Health Organization, COUNTR CHIN; Wu YT, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.05.009; Xie XY, 2020, JAMA PEDIATR, V174, P898, DOI 10.1001/jamapediatrics.2020.1619; Yang Y, 2020, SLEEP MED, V73, P47, DOI 10.1016/j.sleep.2020.06.034; Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639; Zhou Q, 2020, CLIN TRANSL MED, V10, DOI 10.1002/ctm2.103; Zhou SJ, 2020, SLEEP MED, V74, P39, DOI 10.1016/j.sleep.2020.06.001; Zhou SJ, 2020, EUR CHILD ADOLES PSY, V29, P749, DOI 10.1007/s00787-020-01541-4; Zhu Z, 2020, J PSYCHIATR RES, V129, P1, DOI 10.1016/j.jpsychires.2020.05.026	120	130	131	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2020	15	12							e0244630	10.1371/journal.pone.0244630	http://dx.doi.org/10.1371/journal.pone.0244630			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM2BQ	33370404	gold, Green Published			2022-12-27	WOS:000603611900009
J	Baines, M; Weir, CR				Baines, Mick; Weir, Caroline R.			Predicting suitable coastal habitat for sei whales, southern right whales and dolphins around the Falkland Islands	PLOS ONE			English	Article							SPECIES DISTRIBUTION; SPATIOTEMPORAL PATTERNS; BALAENOPTERA-BOREALIS; MUNIDA-GREGARIA; MODELS; SELECTION; WINTER; AREAS	Species distribution models (SDMs) are valuable tools for describing the occurrence of species and predicting suitable habitats. This study used generalized additive models (GAMs) and MaxEnt models to predict the relative densities of four cetacean species (sei whale Balaeanoptera borealis, southern right whale Eubalaena australis, Peale's dolphin Lagenorhynchus australis, and Commerson's dolphin Cephalorhynchus commersonii) in neritic waters (<= 100 m depth) around the Falkland Islands, using boat survey data collected over three seasons (2017-2019). The model predictor variables (PVs) included remotely sensed environmental variables (sea surface temperature, SST, and chlorophyll-a concentration) and static geographical variables (e.g. water depth, distance to shore, slope). The GAM results explained 35 to 41% of the total deviance for sei whale, combined sei whales and unidentified large baleen whales, and Commerson's dolphins, but only 17% of the deviance for Peale's dolphins. The MaxEnt models for all species had low to moderate discriminatory power. The relative density of sei whales increased with SST in both models, and their predicted distribution was widespread across the inner shelf which is consistent with the use of Falklands' waters as a coastal summer feeding ground. Peale's dolphins and Commerson's dolphins were largely sympatric across the study area. However, the relative densities of Commerson's dolphins were generally predicted to be higher in nearshore, semi-enclosed, waters compared with Peale's dolphins, suggesting some habitat partitioning. The models for southern right whales performed poorly and the results were not considered meaningful, perhaps due to this species exhibiting fewer strong habitat preferences around the Falklands. The modelling results are applicable to marine spatial planning to identify where the occurrence of cetacean species and anthropogenic activities may most overlap. Additionally, the results can inform the process of delineating a potential Key Biodiversity Area for sei whales in the Falkland Islands.	[Baines, Mick] Wildscope, Cadiz, Spain; [Weir, Caroline R.] Falklands Conservat, Stanley, Falkland Island		Weir, CR (corresponding author), Falklands Conservat, Stanley, Falkland Island.	whales@conservation.org.fk		Weir, Caroline/0000-0002-2052-5037; Baines, Mick/0000-0002-6728-2941	European Union BEST 2.0 Programme (2017); Royal Society for the Protection of Birds (2018); Darwin Plus (2019/2020) [DPLUS082]; Wildscope	European Union BEST 2.0 Programme (2017); Royal Society for the Protection of Birds (2018); Darwin Plus (2019/2020); Wildscope	Funding for this study was provided by the European Union BEST 2.0 Programme (2017), The Royal Society for the Protection of Birds (2018), and Darwin Plus (2019/2020; DPLUS082). The funders provided support in the form of salaries for authors [CW, MB]. Some salary for MB was also provided in kind by Wildscope. Funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Aarts G, 2012, METHODS ECOL EVOL, V3, P177, DOI 10.1111/j.2041-210X.2011.00141.x; Abrahms B, 2019, DIVERS DISTRIB, V25, P1182, DOI 10.1111/ddi.12940; Agardy T, 2019, AQUAT CONSERV, V29, P71, DOI 10.1002/aqc.3072; Akaike H, 1973, P 2 INT S INF THEOR, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2017, J CETACEAN RES MAN S, V18, P410; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Austin RA, 2019, J SEA RES, V153, DOI 10.1016/j.seares.2019.101767; Baines Mick E., 2014, Journal of Cetacean Research and Management, V14, P57; Becker EA, 2010, MAR ECOL PROG SER, V413, P163, DOI 10.3354/meps08696; Becker EA, 2019, DIVERS DISTRIB, V25, P626, DOI 10.1111/ddi.12867; Beekmans Bas W. P. M., 2010, Journal of Cetacean Research and Management, V11, P115; Bombosch A, 2014, DEEP-SEA RES PT I, V91, P101, DOI 10.1016/j.dsr.2014.05.017; Byeon DH, 2018, J ASIA-PAC BIODIVERS, V11, P325, DOI 10.1016/j.japb.2018.06.002; Castro LR, 2019, PROG OCEANOGR, V174, P173, DOI 10.1016/j.pocean.2018.09.018; Corrigan CM, 2014, AQUAT CONSERV, V24, P166, DOI 10.1002/aqc.2513; Dellabianca NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163441; Diez MJ, 2018, POLAR BIOL, V41, P2591, DOI 10.1007/s00300-018-2394-2; El-Gabbas A, 2018, ECOGRAPHY, V41, P1161, DOI 10.1111/ecog.03149; Espinosa-Miranda C, 2020, AQUAT MAMM, V46, P337, DOI 10.1578/AM.46.4.2020.337; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Gomez C, 2017, ENDANGER SPECIES RES, V32, P437, DOI 10.3354/esr00823; Carman VG, 2019, PROG OCEANOGR, V176, DOI 10.1016/j.pocean.2019.102123; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heinrich S, 2019, AQUAT CONSERV, V29, P212, DOI 10.1002/aqc.3153; Heinrich S, 2010, DUSKY DOLPHIN: MASTER ACROBAT OFF DIFFERENT SHORES, P313, DOI 10.1016/B978-0-12-373723-6.00015-1; Ishii M, 2017, MAMM STUDY, V42, P191; IUCN, 2016, GUID US GLOB STAND I, VFirst; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Manzoor SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25437-1; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Murase H, 2002, POLAR BIOL, V25, P135, DOI 10.1007/s003000100321; Murase H, 2014, DEEP-SEA RES PT II, V107, P22, DOI 10.1016/j.dsr2.2014.05.002; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Rayment W, 2015, J BIOGEOGR, V42, P463, DOI 10.1111/jbi.12443; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Rhoden CM, 2017, PEERJ, V5, DOI 10.7717/peerj.3632; Sasaki H, 2013, FISH OCEANOGR, V22, P496, DOI 10.1111/fog.12037; Schleimer A, 2019, MAR ECOL PROG SER, V623, P221, DOI 10.3354/meps13020; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Skov H, 2008, DEEP-SEA RES PT II, V55, P254, DOI 10.1016/j.dsr2.2007.09.020; Tobena M, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00202; Torres LG, 2008, ECOL APPL, V18, P1702, DOI 10.1890/07-1455.1; Viddi Francisco A., 2005, Aquatic Mammals, V31, P176, DOI 10.1578/AM.31.2.2005.176; Vikingsson G., 2020, NAMMCO SCI PUBL, V11, P1, DOI [10.7557/3.5211, DOI 10.7557/3.5211]; Weir, 2018, PRELIMINARY ASSESSME; Weir CR, 2020, J MAR BIOL ASSOC UK, V100, P153, DOI 10.1017/S0025315419001024; Weir CR, 2019, WORLD MAR MAMM C BAR; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd, DOI 10.1201/9781315370279; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986	54	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0244068	10.1371/journal.pone.0244068	http://dx.doi.org/10.1371/journal.pone.0244068			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362235	gold, Green Published			2022-12-27	WOS:000603071600068
J	Jiang, JP; Yuan, X; Huang, GH; Shi, W; Yang, XM; Jiang, QY; Jia, YH; Yang, XR; Jiang, HS				Jiang, Jianping; Yuan, Xiang; Huang, Guanghua; Shi, Wen; Yang, Xueming; Jiang, Qinyang; Jia, Yinhai; Yang, Xiurong; Jiang, Hesheng			Hepatopancreatic metabolomics shedding light on the mechanism underlying unsynchronized growth in giant freshwater prawn, Macrobrachium rosenbergii	PLOS ONE			English	Article							METABOLISM; BODY	The giant freshwater prawn, Macrobrachium rosenbergii (M. rosenbergii) as an important freshwater aquaculture species with high commercial value, exhibited unsynchronized growth. However, the potentially metabolic mechanism remains unclear. In this study, we used liquid chromatography tandem mass spectrometry (LC-MS/MS) to investigate the hepatopancreatic metabolic profiles of twenty giant freshwater prawns between the fast-growing group and slow-growing group. In the metabolomics assay, we isolated 8,293 peaks in positive and negative iron mode. Subsequently, 44 significantly differential metabolites were identified. Functional pathway analysis revealed that these metabolites were significantly enriched in three key metabolic pathways. Further integrated analysis indicated that glycerophospholipid metabolism and aminoacyl-tRNA biosynthesis have significant impact on growth performance in M.rosenbergii. Our findings presented here demonstrated the critical metabolites and metabolic pathways involved in growth performance, moreover provided strong evidence for elucidating the potentially metabolic mechanism of the unsynchronized growth in M. rosenbergii.	[Jiang, Jianping] Guangxi Engn Technol Res Ctr Chinese Med Mat Stoc, Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China; [Jiang, Jianping; Yuan, Xiang; Shi, Wen; Jiang, Qinyang; Yang, Xiurong; Jiang, Hesheng] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Guangxi, Peoples R China; [Yuan, Xiang; Shi, Wen] Guangxi Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Guangxi, Peoples R China; [Huang, Guanghua; Yang, Xueming] Guangxi Acad Fisheries Sci, Nanning, Peoples R China; [Jia, Yinhai] Anim Husb Res Inst Guangxi Zhuang Autonomous Reg, Nanning, Guangxi, Peoples R China	Guangxi University; Guangxi University; Guangxi Vocational University of Agriculture	Jiang, JP (corresponding author), Guangxi Engn Technol Res Ctr Chinese Med Mat Stoc, Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China.; Jiang, JP (corresponding author), Guangxi Univ, Coll Anim Sci & Technol, Nanning, Guangxi, Peoples R China.	jiangjianping818@126.com			Natural Science Foundation of Guangxi [2018GXNSFBA281209]; Science and Technology Major Project of Guangxi [Guike AA17204080-6]; Postdoctoral Science Foundation of Guangxi [T3340097968]	Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province); Science and Technology Major Project of Guangxi; Postdoctoral Science Foundation of Guangxi	This work was financially supported by the Natural Science Foundation of Guangxi, grant number 2018GXNSFBA281209; Science and Technology Major Project of Guangxi, grant number Guike AA17204080-6; and Postdoctoral Science Foundation of Guangxi, grant number T3340097968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REV ESTUDIOS INT MED, V9, P70; Biancucci M, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0637-8; Bose U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177064; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Deng M, 2020, PLANT J, V103, P1710, DOI 10.1111/tpj.14856; Hung D, 2013, AQUACULTURE, V404, P122, DOI 10.1016/j.aquaculture.2013.04.027; Dong XX, 2020, ECOTOX ENVIRON SAFE, V189, DOI 10.1016/j.ecoenv.2019.110046; Gomez E, 2020, J AGR FOOD CHEM, V68, P8732, DOI 10.1021/acs.jafc.0c02129; Guo YS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23983-2; Hao RJ, 2019, SCI TOTAL ENVIRON, V666, P46, DOI 10.1016/j.scitotenv.2019.02.221; Hao RJ, 2018, AQUACULTURE, V491, P258, DOI 10.1016/j.aquaculture.2018.03.050; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jiang Q, 2020, COMP BIOCHEM PHYS D, V35, DOI 10.1016/j.cbd.2020.100683; Jin SB, 2020, COMP BIOCHEM PHYS D, V34, DOI 10.1016/j.cbd.2020.100662; Jung H, 2014, CANDIDATE GENE ASS S; Kloska A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124338; Li TY, 2017, AQUAT TOXICOL, V183, P28, DOI 10.1016/j.aquatox.2016.12.010; Longobardi V, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10061065; Loor JJ, 2013, ANNU REV ANIM BIOSCI, V1, P365, DOI 10.1146/annurev-animal-031412-103728; Ma LL, 2020, PEERJ, V8, DOI 10.7717/peerj.9516; Mahmood T, 2016, B ENVIRON CONTAM TOX, V96, P361, DOI 10.1007/s00128-015-1713-3; Mattioli R, 2009, PLANT SIGNAL BEHAV, V4, P1016, DOI 10.4161/psb.4.11.9797; Senn T, 2012, PROG CARDIOVASC DIS, V55, P70, DOI 10.1016/j.pcad.2012.06.004; Sonkar K, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.4112; Srinivasan V, 2017, BIOL TRACE ELEM RES, V177, P196, DOI 10.1007/s12011-016-0855-4; Stratakis N, 2020, HEPATOLOGY, V72, P1758, DOI 10.1002/hep.31483; Suekawa M, 2019, PLANT PHYSIOL BIOCH, V142, P1, DOI 10.1016/j.plaphy.2019.06.032; Sun P, 2020, BRIT J NUTR, V123, P149, DOI 10.1017/S0007114519002563; Tao TQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00651; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang P, 2018, ECOTOX ENVIRON SAFE, V163, P266, DOI 10.1016/j.ecoenv.2018.07.080; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Wen X, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5915-7; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Xie GX, 2014, J PROTEOME RES, V13, P4062, DOI 10.1021/pr500434s; Yebra L, 2004, J PLANKTON RES, V26, P351, DOI 10.1093/plankt/fbh028; Yu YY, 2020, MAR DRUGS, V18, DOI 10.3390/md18040218; Zehra S, 2013, FISH PHYSIOL BIOCHEM, V39, P503, DOI 10.1007/s10695-012-9715-0; Zhao B, 2012, AQUACULT NUTR, V18, P220, DOI 10.1111/j.1365-2095.2011.00898.x; Zhao HH, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy111; Zong L, 2018, ECOTOX ENVIRON SAFE, V147, P26, DOI 10.1016/j.ecoenv.2017.08.028	42	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243778	10.1371/journal.pone.0243778	http://dx.doi.org/10.1371/journal.pone.0243778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362263	Green Published, gold			2022-12-27	WOS:000603071600061
J	Steele, JL; Stevens, RC; Cabrera, OA; Bassill, GJ; Cramer, SM; Guzman, F; Shuber, AP				Steele, Jennifer L.; Stevens, Richard C.; Cabrera, Oscar A.; Bassill, Gary J.; Cramer, Sabrina M.; Guzman, Felipe; Shuber, Anthony P.			Novel CRISPR-based sequence specific enrichment methods for target loci and single base mutations	PLOS ONE			English	Article							NUCLEIC-ACID DETECTION; LIQUID BIOPSIES; PCR; DIAGNOSTICS; CANCER; AMPLIFICATION; ENDONUCLEASE; REVEAL	The programmable sequence specificity of CRISPR has found uses in gene editing and diagnostics. This manuscript describes an additional application of CRISPR through a family of novel DNA enrichment technologies. CAMP (CRISPR Associated Multiplexed PCR) and cCAMP (chimeric CRISPR Associated Multiplexed PCR) utilize the sequence specificity of the Cas9/sgRNA complex to target loci for the ligation of a universal adapter that is used for subsequent amplification. cTRACE (chimeric Targeting Rare Alleles with CRISPR-based Enrichment) also applies this method to use Cas9/sgRNA to target loci for the addition of universal adapters, however it has an additional selection for specific mutations through the use of an allele-specific primer. These three methods can produce multiplex PCR that significantly reduces the optimization required for every target. The methods are also not specific to any downstream analytical platform. We additionally will present a mutation specific enrichment technology that is non-amplification based and leaves the DNA in its native state: TRACE (Targeting Rare Alleles with CRISPR-based Enrichment). TRACE utilizes the Cas9/sgRNA complex to sterically protect the ends of targeted sequences from exonuclease activity which digests both the normal variant as well as any off-target sequences.	[Steele, Jennifer L.; Stevens, Richard C.; Cabrera, Oscar A.; Bassill, Gary J.; Cramer, Sabrina M.; Guzman, Felipe; Shuber, Anthony P.] Genet Res LLC, Waltham, MA 02451 USA		Shuber, AP (corresponding author), Genet Res LLC, Waltham, MA 02451 USA.	APS@gen-res.com		Cramer, Sabrina M./0000-0002-0585-8730				Ballester LY, 2016, EXPERT REV MOL DIAGN, V16, P357, DOI 10.1586/14737159.2016.1133298; Bardelli A, 2017, CANCER CELL, V31, P172, DOI 10.1016/j.ccell.2017.01.002; Beltz K., 2018, ADV BIOSCI BIOTECHNO, V9, P497, DOI [10.4236/abb.2018.99034, DOI 10.4236/ABB.2018.99034]; Bodi K, 2013, J Biomol Tech, V24, P73, DOI 10.7171/jbt.13-2402-002; BOTTEMA CDK, 1993, MUTAT RES, V288, P93, DOI 10.1016/0027-5107(93)90211-W; Bronkhorst Abel Jacobus, 2019, Biomol Detect Quantif, V17, P100087, DOI 10.1016/j.bdq.2019.100087; Broude NE, 2001, P NATL ACAD SCI USA, V98, P206, DOI 10.1073/pnas.98.1.206; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cooper DE, 2005, RATIO, V18, P125, DOI 10.1111/j.1467-9329.2005.00278.x; Dag ZO, 2015, J TURK-GER GYNECOL A, V16, P111, DOI 10.5152/jtgga.2015.15232; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Elnifro EM, 2000, CLIN MICROBIOL REV, V13, P559, DOI 10.1128/CMR.13.4.559-570.2000; Finotti A, 2018, INT J ONCOL, V53, P1395, DOI 10.3892/ijo.2018.4516; Gabriel E, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00297; Garcia-Garcia G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20948; Giesselmann P, 2019, NAT BIOTECHNOL, V37, P1478, DOI 10.1038/s41587-019-0293-x; Gilpatrick T, 2020, NAT BIOTECHNOL, V38, P433, DOI 10.1038/s41587-020-0407-5; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Gray PN, 2015, CANCERS, V7, P1313, DOI 10.3390/cancers7030837; Gu W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0904-5; Hafford-Tear NJ, 2019, GENET MED, V21, P2092, DOI 10.1038/s41436-019-0453-x; Hardigan AA, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz425; Huggett JF, 2015, CLIN CHEM, V61, P79, DOI 10.1373/clinchem.2014.221366; Hyman DM, 2017, CELL, V168, P584, DOI 10.1016/j.cell.2016.12.015; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kozarewa Iwanka, 2015, Curr Protoc Mol Biol, V112, DOI 10.1002/0471142727.mb0721s112; Lemos BR, 2018, P NATL ACAD SCI USA, V115, pE2040, DOI 10.1073/pnas.1716855115; Li H., 2013, ARXIV13033997V1QBIOG; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Little S, 1995, CURR PROTOC HUM GENE, V7, P981; Loree JM, 2017, J GASTROINTEST ONCOL, V8, P199, DOI 10.21037/jgo.2017.01.01; Lu WX, 2019, MOL CELL PROBE, V46, DOI 10.1016/j.mcp.2019.101424; Ma HH, 2016, J CELL BIOL, V214, P529, DOI 10.1083/jcb.201604115; Mader S, 2017, ONCOL RES TREAT, V40, P404, DOI 10.1159/000478018; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Offin M, 2017, J ONCOL, V2017, DOI 10.1155/2017/4517834; Quan J, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz418; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Samorodnitsky E, 2015, HUM MUTAT, V36, P903, DOI 10.1002/humu.22825; Serrati S, 2016, ONCOTARGETS THER, V9, P7355, DOI 10.2147/OTT.S99807; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shou J, 2018, MOL CELL, V71, P498, DOI 10.1016/j.molcel.2018.06.021; Shuber AP, 1995, GENOME RES, V5, P488, DOI 10.1101/gr.5.5.488; Siravegna G, 2017, NAT REV CLIN ONCOL, V14, P531, DOI 10.1038/nrclinonc.2017.14; Slesarev A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39667-4; Stangl C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16641-7; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Stetson D, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00191; Stevens RC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215441; The UniProt C, 2018, NUCLEIC ACIDS RES, V47, pD506; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Volik S, 2016, MOL CANCER RES, V14, P898, DOI 10.1158/1541-7786.MCR-16-0044; Watson CM, 2020, LAB INVEST, V100, P135, DOI 10.1038/s41374-019-0283-0; Wu LR, 2017, NAT BIOMED ENG, V1, P714, DOI 10.1038/s41551-017-0126-5; Yang N, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4199-7; Zakrzewski F, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5584-6; Zuo ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37584	64	0	0	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2020	15	12							e0243781	10.1371/journal.pone.0243781	http://dx.doi.org/10.1371/journal.pone.0243781			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CI	33362267	Green Published, gold			2022-12-27	WOS:000603071600012
J	Chang, LC; Lee, YC; Hsu, C; Chen, PC				Chang, Li-Chuan; Lee, Yue-Chune; Hsu, Chieh; Chen, Pei-Ching			Prevalence of heated tobacco product use among adolescents in Taiwan	PLOS ONE			English	Article								Objective To determine the penetration of heated tobacco products (HTPs) into the youth market in Taiwan, with a particular focus on the correlation between IQOS use and the usage of other tobacco products. Methods Data from the 2018 Global Youth Tobacco Survey were used to assess previous experience with and current use (within 30 days prior to survey completion) of IQOS products by Taiwanese students aged 12-18 years. Independent variables included the usage patterns of conventional cigarettes and e-cigarettes. The control variables included background information (gender, grade, monthly income/allowance, household educational level, smoking status at home and among close friends), access to free cigarettes, as well as exposure to cigarette advertisements and anti-tobacco courses. Logistic regression was used to identify tobacco usage patterns correlated with IQOS use. Results In 2018, 2.33% of Taiwan's adolescents were currently using IQOS and 4.17% had tried IQOS. The use of conventional cigarettes and e-cigarettes (individually and together) were associated with an elevated risk of the ever use and current use of IQOS. Conclusion Despite the fact that HTP products are not sold legally in Taiwan, the use of IQOS products by young people is far from negligible. We recommend amending the "Tobacco Hazards Prevention Act" to include regulations pertaining to the sale and marketing of HTPs.	[Chang, Li-Chuan; Lee, Yue-Chune; Hsu, Chieh] Natl Yang Ming Univ, Sch Med, Inst Hlth & Welf Policy, Taipei, Taiwan; [Lee, Yue-Chune] Natl Yang Ming Univ, Master Program Trans Disciplinary Long Term Care, Taipei, Taiwan; [Chen, Pei-Ching] Univ Taipei, Coll City Management, Dept Hlth & Welf, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; University of Taipei	Chen, PC (corresponding author), Univ Taipei, Coll City Management, Dept Hlth & Welf, Taipei, Taiwan.	peiching@ntu.edu.tw	C, C/AFK-6813-2022	Chen, Pei-Ching/0000-0003-2135-9373	Health and Welfare Surcharge of Tobacco Products; Health Promotion Administration, Ministry of Health and Welfare, Taiwan [G1071219, G1071219-109]; Health Promotion Administration, Ministry of Health and Welfare	Health and Welfare Surcharge of Tobacco Products; Health Promotion Administration, Ministry of Health and Welfare, Taiwan; Health Promotion Administration, Ministry of Health and Welfare	This study was funded by the Health and Welfare Surcharge of Tobacco Products, the Health Promotion Administration, Ministry of Health and Welfare, Taiwan (No. G1071219, No. G1071219-109). The Health Promotion Administration, Ministry of Health and Welfare conducted the Taiwan Global Youth Tobacco Survey, and provided the data for use in this study.	Chen PL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-144; Czoli CD, 2020, TOB CONTROL, V29, P89, DOI 10.1136/tobaccocontrol-2018-054654; Dai HY, 2020, DRUG ALCOHOL DEPEN, V214, DOI 10.1016/j.drugalcdep.2020.108150; Hair EC, 2018, TOB CONTROL, V27, pS70, DOI 10.1136/tobaccocontrol-2018-054322; Health Promotion Administration, 2015, TAIW GLOB YOUTH TOB; Kim J, 2018, TOB CONTROL, V27, pS74, DOI 10.1136/tobaccocontrol-2018-054390; Liu XQ, 2019, TOB CONTROL, V28, P113, DOI 10.1136/tobaccocontrol-2017-054054; McKelvey K, 2018, TOB CONTROL, V27, pS41, DOI 10.1136/tobaccocontrol-2018-054596; Nyman AL, 2018, TOB CONTROL, V27, pS55, DOI 10.1136/tobaccocontrol-2018-054323; Sutanto E, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234630; Tabuchi T, 2016, ADDICTION, V111, P706, DOI 10.1111/add.13231; Warren Charles W., 2008, Morbidity and Mortality Weekly Report, V57, P1; World Health Organization, 2018, HEAT TOB PROD HTPS M	13	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244218	10.1371/journal.pone.0244218	http://dx.doi.org/10.1371/journal.pone.0244218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347476	Green Published, gold			2022-12-27	WOS:000603071100030
J	Ciria-Suarez, L; Jimenez-Fonseca, P; Palacin-Lois, M; Antonanzas-Basa, M; Fernandez-Montes, A; Manzano-Fernandez, A; Castelo, B; Asensio-Martinez, E; Hernando-Polo, S; Calderon, C				Ciria-Suarez, Laura; Jimenez-Fonseca, Paula; Palacin-Lois, Maria; Antonanzas-Basa, Monica; Fernandez-Montes, Ana; Manzano-Fernandez, Aranzazu; Castelo, Beatriz; Asensio-Martinez, Elena; Hernando-Polo, Susana; Calderon, Caterina			Ascertaining breast cancer patient experiences through a journey map: A qualitative study protocol	PLOS ONE			English	Article							OF-LIFE; DEPRESSION; PREVALENCE; MORTALITY; SURVIVORS	Background The current cancer care system must be improved if we are to have in-depth knowledge about breast cancer patients' experiences throughout all the stages of their disease. Aim This study seeks to describe breast cancer patients' experience over the course of the various stages of illness by means of a journey model. Methods This is a qualitative descriptive study. Individual, semi-structured interviews will be administered to women with breast cancer and breast cancer survivors. Patients will be recruited from nine large hospitals in Spain and intentional sampling will be used. Data will be collected by means of a semi-structured interview that was elaborated with the help of medical oncologists, nurses, and psycho-oncologists. Data will be processed adopting a thematic analysis approach. Discussion The outcomes of this study will afford new insights into breast cancer patients' experiences, providing guidance to improve the care given to these individuals. This protocol aims to describe the journey of patients with breast cancer through the healthcare system to establish baseline data that will serve as the basis for the development and implementation of a patient-centered, evidence-based clinical pathway.	[Ciria-Suarez, Laura; Calderon, Caterina] Univ Barcelona, Fac Psychol, Clin Psychol & Psychobiol Dept, Barcelona, Spain; [Jimenez-Fonseca, Paula] Hosp Univ Cent Asturias, Dept Med Oncol, Oviedo, Spain; [Palacin-Lois, Maria] Univ Barcelona, Fac Psychol, Social Psychol & Quantitat Psychol Dept, Barcelona, Spain; [Antonanzas-Basa, Monica; Manzano-Fernandez, Aranzazu] Hosp Univ Clin San Carlos, Dept Med Oncol, Madrid, Spain; [Fernandez-Montes, Ana] Complejo Hosp Univ Orense, Dept Med Oncol, Orense, Spain; [Castelo, Beatriz] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain; [Asensio-Martinez, Elena] Hosp Gen Univ Elche, Dept Med Oncol, Elche, Spain; [Hernando-Polo, Susana] Hosp Univ Fdn Alcorcon, Dept Med Oncol, Madrid, Spain	University of Barcelona; Central University Hospital Asturias; University of Barcelona; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Hospital Universitario La Paz; Alcorcon Foundation University Hospital	Ciria-Suarez, L (corresponding author), Univ Barcelona, Fac Psychol, Clin Psychol & Psychobiol Dept, Barcelona, Spain.	laura.ciria.suarez@gmail.com		Calderon, Caterina/0000-0002-6956-9321; Ciria Suarez, Laura/0000-0002-1388-6686; Antonanzas Basa, Monica/0000-0002-7434-9059; Ana, Fernandez Montes/0000-0003-4630-5830	Spanish Society of Medical Oncology (SEOM)	Spanish Society of Medical Oncology (SEOM)	This work was funded by the Spanish Society of Medical Oncology (SEOM) in 2018. The sponsor of this research has not participated in the design of research, in writing the report, or in the decision to submit the article for publication.	Adam A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231691; [Anonymous], 2010, ORBITAL DEBRIS Q NEW, V14, P17; Antonacci G, 2018, HEALTH SERV MANAG RE, V31, P74, DOI 10.1177/0951484818770411; Avancini A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227846; Blows E, 2012, J ADV NURS, V68, P2155, DOI 10.1111/j.1365-2648.2012.05995.x; Bonsuid AB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208773; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cameron LD, 2007, PSYCHO-ONCOLOGY, V16, P171, DOI 10.1002/pon.1050; Cherif E, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05569-9; Cleries R, 2018, CLIN TRANSL ONCOL, V20, P313, DOI 10.1007/s12094-017-1718-y; Dooley LN, 2017, STRESS HEALTH, V33, P549, DOI 10.1002/smi.2739; FAWZY FI, 1995, ARCH GEN PSYCHIAT, V52, P100; Fradelos Evangelos C, 2017, Asian Pac J Cancer Prev, V18, P2545; Galiano-Castillo N, 2014, EUR J ONCOL NURS, V18, P206, DOI 10.1016/j.ejon.2013.10.008; Gebremariam A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220769; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Habersack M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081770; Hall LK, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3652; Harding C, 2015, JAMA INTERN MED, V175, P1483, DOI 10.1001/jamainternmed.2015.3043; Howard Tharon, 2014, COMMUNICATION DESIGN, V2, P10, DOI [10.1145/2644448.2644451, DOI 10.1145/2644448.2644451]; Kollberg B, 2006, INT J PRODUCT PERFOR, V56, P7, DOI 10.1108/17410400710717064; Krouse HJ, 1982, NURS RES; McCarthy S, 2020, JMIR HUM FACTORS, DOI [10.2196/17416, DOI 10.2196/1741632940610]; Mirosevic S, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13060; Purkayastha D, 2017, INDIAN J PALLIAT CAR, V23, P268, DOI 10.4103/IJPC.IJPC_6_17; Rapport F, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3881-z; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Shin WK, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0706-9; Sociedad Espanola de Oncologia Medica, 2020, CIFR CANC ESP; Spiegel D, 1999, PSYCHO-ONCOLOGY, DOI [10.1002/(sici)1099-1611(199911/12)8:6&LT;482::aid-pon402&GT;3.0.co;2-w, DOI 10.1002/(SICI)1099-1611(199911/12)8:6<LESSTHAN>482::AID-P0N402<GREATERTHAN>3.0.CO;2-W]; Trebble TM, 2010, BMJ; Zainal NZ, 2013, ASIAN PAC J CANCER P, V14, P2649, DOI 10.7314/APJCP.2013.14.4.2649	33	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0244355	10.1371/journal.pone.0244355	http://dx.doi.org/10.1371/journal.pone.0244355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PL4CD	33347475	Green Published, gold			2022-12-27	WOS:000603071100013
J	Murakami, H; Tamura, N; Enomoto, Y; Shimasaki, K; Kurosawa, K; Hanada, K				Murakami, Hiroaki; Tamura, Norito; Enomoto, Yumi; Shimasaki, Kentaro; Kurosawa, Kenji; Hanada, Kentaro			Intellectual disability-associated gain-of-function mutations in CERT1 that encodes the ceramide transport protein CERT	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TRAFFICKING; SPHINGOMYELIN; SERINE; GALACTOCEREBROSIDE; INHIBITOR; EFFICIENT; VARIANTS; SYSTEM	Intellectual disability (ID) is a developmental disorder that includes both intellectual and adaptive functioning deficits in conceptual, social, and practical domains. Although evidence-based interventions for patients have long been desired, their progress has been hindered due to various determinants. One of these determinants is the complexity of the origins of ID. The ceramide transport protein (CERT) encoded by CERT1 mediates inter-organelle trafficking of ceramide for the synthesis of intracellular sphingomyelin. Utilizing whole exome sequencing analysis, we identified a novel CERT variant, which substitutes a serine at position 135 (S135) for a proline in a patient with severe ID. Biochemical analysis showed that S135 is essential for hyperphosphorylation of a serine-repeat motif of CERT, which is required for down-regulation of CERT activity. Amino acid replacements of S135 abnormally activated CERT and induced an intracellular punctate distribution pattern of this protein. These results identified specific ID-associated CERT1 mutations that induced gain-of-function effects on CERT activity. These findings provide a possible molecular basis for not only new diagnostics but also a conceivable pharmaceutical intervention for ID disorders caused by gain-of-function mutations in CERT1.	[Murakami, Hiroaki; Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; [Tamura, Norito; Shimasaki, Kentaro; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Enomoto, Yumi] Kanagawa Childrens Med Ctr, Clin Res Inst, Yokohama, Kanagawa, Japan	National Institute of Infectious Diseases (NIID)	Kurosawa, K (corresponding author), Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan.; Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan.	kkurosawa@kcmc.jp; hanak@nih.go.jp		Murakami, Hiroaki/0000-0002-6646-6263; Hanada, Kentaro/0000-0003-1383-2781; Tamura, Norito/0000-0001-5945-3117	Japan Society for the Promotion of Science [19J01972, 16H06279]; Ministry of Education, Culture, Sports, Science and Technology [JP17H06417]; Japan Agency for Medical Research and Development [JP20gm0910005j0006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	N.T.: Grant No. 19J01972, Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html).K.K.: Grant No. 16H06279, Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html).K.H.: Grant No. JP17H06417, Ministry of Education, Culture, Sports, Science and Technology (https://www.mext.go.jp/en/index.htm).K.H.: Grant No. JP20gm0910005j0006, Japan Agency for Medical Research and Development (https://www.amed.go.jp/en/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Bowling KM, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0433-1; Cardiovascular Disease and Risk Management, 2019, DIABETES CARE, V2, pS103, DOI 10.2337/dc19-S010; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; De Koning TJ, 2003, BIOCHEM J, V371, P653, DOI 10.1042/BJ20021785; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Enomoto Y, 2018, CONGENIT ANOM, V58, P145, DOI 10.1111/cga.12258; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; FUKUSHIMA Y, 1992, JPN J HUM GENET, V37, P149, DOI 10.1007/BF01899737; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2018, J LIPID RES, V59, P2034, DOI 10.1194/jlr.R085324ERR; Hanada K, 2014, BBA-MOL CELL BIOL L, V1841, P704, DOI 10.1016/j.bbalip.2013.06.006; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koslowski N, 2016, BRIT J PSYCHIAT, V209, P469, DOI 10.1192/bjp.bp.114.162313; Kosmicki JA, 2017, NAT GENET, V49, P504, DOI 10.1038/ng.3789; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kumagai K, 2014, J BIOL CHEM, V289, P10748, DOI 10.1074/jbc.M113.528380; Lelieveld SH, 2017, AM J HUM GENET, V101, P478, DOI 10.1016/j.ajhg.2017.08.004; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Quinodoz M, 2017, AM J HUM GENET, V101, P623, DOI 10.1016/j.ajhg.2017.09.001; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roschke AV, 2002, NEOPLASIA, V4, P19, DOI 10.1038/sj.neo.7900197; Schalock RL, 2011, INT PERSPECTIVES INT; Takata A, 2018, CELL REP, V22, P734, DOI 10.1016/j.celrep.2017.12.074; Ueno M, 2013, ORG LETT, V15, P2869, DOI 10.1021/ol401101u; Wang TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13316; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088124; Yasuda S, 2001, J BIOL CHEM, V276, P43994, DOI 10.1074/jbc.M104884200	35	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243980	10.1371/journal.pone.0243980	http://dx.doi.org/10.1371/journal.pone.0243980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347465	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071100011
J	Sharipov, RN; Kondrakhin, YV; Ryabova, AS; Yevshin, IS; Kolpakov, FA				Sharipov, Ruslan N.; Kondrakhin, Yury V.; Ryabova, Anna S.; Yevshin, Ivan S.; Kolpakov, Fedor A.			Assessment of transcriptional importance of cell line-specific features based on GTRD and FANTOM5 data	PLOS ONE			English	Article							CHIP-SEQ; INTEGRATIVE ANALYSIS; BINDING-SITES; COMPUTATION; ENHANCERS; ATLAS	Creating a complete picture of the regulation of transcription seems to be an urgent task of modern biology. Regulation of transcription is a complex process carried out by transcription factors (TFs) and auxiliary proteins. Over the past decade, ChIP-Seq has become the most common experimental technology studying genome-wide interactions between TFs and DNA. We assessed the transcriptional significance of cell line-specific features using regression analysis of ChIP-Seq datasets from the GTRD database and transcriptional start site (TSS) activities from the FANTOM5 expression atlas. For this purpose, we initially generated a large number of features that were defined as the presence or absence of TFs in different promoter regions around TSSs. Using feature selection and regression analysis, we identified sets of the most important TFs that affect expression activity of TSSs in human cell lines such as HepG2, K562 and HEK293. We demonstrated that some TFs can be classified as repressors and activators depending on their location relative to TSS.	[Sharipov, Ruslan N.; Kondrakhin, Yury V.; Ryabova, Anna S.; Yevshin, Ivan S.; Kolpakov, Fedor A.] Fed Res Ctr Informat & Computat Technol, Lab Bioinformat, Novosibirsk, Russia; [Sharipov, Ruslan N.] Novosibirsk State Univ, Specialized Educ Sci Ctr, Novosibirsk, Russia; [Sharipov, Ruslan N.; Kondrakhin, Yury V.; Ryabova, Anna S.; Yevshin, Ivan S.; Kolpakov, Fedor A.] BIOSOFT RU Ltd, Novosibirsk, Russia	Russian Academy of Sciences; Federal Research Center for Information & Computational Technologies; Novosibirsk State University	Sharipov, RN (corresponding author), Fed Res Ctr Informat & Computat Technol, Lab Bioinformat, Novosibirsk, Russia.; Sharipov, RN (corresponding author), Novosibirsk State Univ, Specialized Educ Sci Ctr, Novosibirsk, Russia.; Sharipov, RN (corresponding author), BIOSOFT RU Ltd, Novosibirsk, Russia.	shrus79@gmail.com		Sharipov, Ruslan/0000-0003-2182-5493	Russian Science Foundation [19-14-00295]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Science Foundation in the form of a grant awarded to RNS, YVK, ASR, ISY and FAK (19-14-00295). BIOSOFT.RU, Ltd. supported the integration of the developed methods into the BioUML platform in the form of salaries for RNS, YVK, ASR ISY and FAK. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abugessaisa I, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.107; Abugessaisa I, 2017, METHODS MOL BIOL, V1611, P199, DOI 10.1007/978-1-4939-7015-5_15; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Angelini C, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00051; Cheneby J, 2018, NUCLEIC ACIDS RES, V46, pD267, DOI 10.1093/nar/gkx1092; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Dailey L, 2015, GENOMICS, V106, P151, DOI 10.1016/j.ygeno.2015.06.004; Deviatiiarov R, 2020, PREPRINT; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gao TS, 2016, BIOINFORMATICS, V32, P3543, DOI 10.1093/bioinformatics/btw495; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; He BS, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00394; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kolmykov SK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221760; Li YE, 2020, ATLAS GENE REGULATOR, DOI DOI 10.1101/2020.05.10.087585V2; Memon A, 2018, CANCERS, V10, DOI 10.3390/cancers10060161; Moore JE, 2020, NATURE, V583, P699, DOI 10.1038/s41586-020-2493-4; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Narlikar L, 2012, METHODS MOL BIOL, V802, P305, DOI 10.1007/978-1-61779-400-1_20; Niu M, 2018, NUCLEIC ACIDS RES, V46, P5395, DOI 10.1093/nar/gky338; Oki S, 2018, EMBO REP, V19, DOI 10.15252/embr.201846255; Pang BX, 2020, NAT GENET, V52, P254, DOI 10.1038/s41588-020-0578-5; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Wang J, 2019, NUCLEIC ACIDS RES, V47, pD106, DOI 10.1093/nar/gky864; Yevshin I, 2019, NUCLEIC ACIDS RES, V47, pD100, DOI 10.1093/nar/gky1128; Yevshin I, 2017, NUCLEIC ACIDS RES, V45, pD61, DOI 10.1093/nar/gkw951; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zhang XO, 2019, GENOME RES, V29, P1402, DOI 10.1101/gr.249789.119; Zhang XK, 2011, BIOMETRICS, V67, P151, DOI 10.1111/j.1541-0420.2010.01441.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8122; 2006, REG GEN GEN REG, P31	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2020	15	12							e0243332	10.1371/journal.pone.0243332	http://dx.doi.org/10.1371/journal.pone.0243332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CD	33347457	Green Published, gold			2022-12-27	WOS:000603071100061
J	Medina-Perucha, L; Garcia-Sangenis, A; Moragas, A; Galvez-Hernandez, P; Cots, JM; Lanau-Roig, A; Borras, A; Amo, I; Monfa, R; Llor, C; Berenguera, A				Medina-Perucha, Laura; Garcia-Sangenis, Ana; Moragas, Ana; Galvez-Hernandez, Pablo; Maria Cots, Josep; Lanau-Roig, Anna; Borras, Alicia; Amo, Isabel; Monfa, Ramon; Llor, Carl; Berenguera, Anna			Autonomy, power dynamics and antibiotic use in primary healthcare: A qualitative study	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; SHARED DECISION-MAKING; ACUTE COUGH; PATIENT; GPS; COMMUNICATION; CONSULTATIONS; PERSPECTIVES; RESISTANCE; WORLDWIDE	Antibiotic resistance is a global health concern. Although numerous strategies have tried to reduce inadequate antibiotic prescribing, antibiotics are still prescribed in 60% of acute lower respiratory tract infections (ALRTIs) cases in Catalonia (Spain). This study aims to explore service users' experiences of ALRTIs, the quality and access to healthcare services, and health education. Selective purposive sampling was carried out, based on a prior definition of participant characteristics. These were sex, age, ethnicity, date of the last ALRTI, number of ALRTIs in the last year, and treatments received. Participants with a previous diagnosis of ALRTIs were recruited from three primary health care centres in Barcelona and one in Tarragona. Twenty-nine interviews were conducted between April and June 2019. A content thematic analysis was performed. Three themes were identified: 1) risk perceptions and help-seeking; 2) treatment preferences and antibiotic use; and 3) relationship dynamics and communication with healthcare professionals. Accounts of service users' sense of autonomy towards their health and power dynamics within the healthcare system were apparent. Supporting service users to become reliable, subjective and agentic experts of their health and bodies could help them to voice their healthcare agendas. Power structures embedded within healthcare, political and economic institutions should be challenged so that healthcare services can be co-developed (with service users) and based on service users' autonomy and horizontal relationships. Special consideration should be paid to the intersection of social vulnerabilities. A concordance approach to prescribing could be key to improve the responsible use of antibiotics and to contribute to the prevention of AMR in primary healthcare. The marketisation of health, and the increased demands of private healthcare in Spain due to the financial pressures on public healthcare as a consequence of the financial crisis of 2008 and the COVID-19 pandemic, are a risk for promoting adequate antibiotic prescribing and use. Trial registration The ISAAC-CAT study has been registered in the NCT registry, ID: NCT03931577.	[Medina-Perucha, Laura; Garcia-Sangenis, Ana; Monfa, Ramon; Llor, Carl; Berenguera, Anna] Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain; [Garcia-Sangenis, Ana; Monfa, Ramon; Berenguera, Anna] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Moragas, Ana] Univ Rovira & Virgili, Jaume I Hlth Ctr, Inst Catala Salut, Tarragona, Spain; [Galvez-Hernandez, Pablo; Borras, Alicia; Amo, Isabel] Univ Int Catalunya, Patients Univ Inst, Barcelona, Spain; [Galvez-Hernandez, Pablo] Univ Toronto, IHPME BFON Collaborat PhD Specializat Program Hlt, Toronto, ON, Canada; [Maria Cots, Josep; Lanau-Roig, Anna] Assoc Infermeria Familiar & Comunitaria Catalunya, Inst Catala Salut, La Marina Hlth Ctr, Barcelona, Spain; [Borras, Alicia] Univ Autonoma Barcelona, Escoles Univ Gimbernat, Escola Univ Infermeria, Sant Cugat Del Valles, Spain; [Llor, Carl] Inst Catala Salut, Via Roma Hlth Ctr, Barcelona, Spain; [Berenguera, Anna] Univ Girona, Dept Infermeria, Girona, Spain	Autonomous University of Barcelona; Universitat Rovira i Virgili; Universitat Internacional de Catalunya (UIC); University of Toronto; Autonomous University of Barcelona; Universitat de Girona	Medina-Perucha, L (corresponding author), Fundacio Inst Univ Recerca Atencio Primaria Salut, Barcelona, Spain.	lmedina@idiapjgol.info		Galvez Hernandez, Pablo/0000-0002-6268-559X; Garcia-Sangenis, Ana/0000-0002-6689-6466; Medina-Perucha, Laura/0000-0002-2981-2614; Berenguera, Anna/0000-0002-0889-2002; Monfa, Ramon/0000-0002-1324-3971; Amo, Isabel/0000-0003-0980-2774	Fundacio La Marato de TV3 [201820]	Fundacio La Marato de TV3	This study has been funded by the Fundacio La Marato de TV3 (Ref Number 201820), https://www.ccma.cat/tv3/marato/fundacio/.Funding was granted to CL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Rahman N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1530-2; Adisso EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208449; Altiner A, 2004, FAM PRACT, V21, P500, DOI 10.1093/fampra/cmh505; Altiner A, 2007, J ANTIMICROB CHEMOTH, V60, P638, DOI 10.1093/jac/dkm254; [Anonymous], 2012, J ENDOCRIMOL META, V17, pS1; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Arnold SR, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003539.pub2; Bakhit M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026735; Barker AK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4261-4; Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; Berenguera A, 2017, LISTEN OBSERVE UNDER; Bergen C, 2013, J HEALTH SOC BEHAV, V54, P220, DOI 10.1177/0022146513487379; Brookes-Howell L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000796; Broom J, 2017, J HOSP INFECT, V96, P316, DOI 10.1016/j.jhin.2017.05.001; CALLON M, 1986, SOCIOL RE MONOGR, P196, DOI 10.1111/j.1467-954X.1984.tb00113.x; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Chan YY, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881800331X, 10.1017/s095026881800331x]; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Coxeter Peter, 2015, Cochrane Database Syst Rev, pCD010907, DOI 10.1002/14651858.CD010907.pub2; Dallas A, 2020, FAM PRACT, V37, P406, DOI 10.1093/fampra/cmz079; Davis JE, 2016, FIX HEAL PATIENT CAR; ECDC, 2018, SUMM LAT DAT ANT CON; European Comission, 2013, OPT STRENGHT RESP RE; European Comission, 2016, SPEC EUR 445 ANT RES; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Fletcher-Lartey S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012244; Foucault M., 1973, BIRTH CLIN; Foucault Michel., 1991, DISCIPLINE PUNISH BI, DOI DOI 10.2307/2065008; Founou RC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189621; Gonzalez-Gonzalez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141820; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Guerrier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062537; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Haque OS, 2012, PERSPECT PSYCHOL SCI, V7, P176, DOI 10.1177/1745691611429706; Hardy V, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-012503; Hoffmann TC, 2014, MED J AUSTRALIA, V201, P35, DOI 10.5694/mja14.00002; Hoye S, 2010, BRIT J GEN PRACT, V60, P907, DOI 10.3399/bjgp10X544087; Hruza HR, 2020, INFECT CONT HOSP EP, V41, P672, DOI 10.1017/ice.2020.42; Jacques-Avino C, 2019, PARTICIPACION PUBLIC; Joseph-Williams N, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3178; Kaae Susanne, 2017, J Pharm Policy Pract, V10, P13, DOI 10.1186/s40545-017-0102-1; Kimura Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223835; Koenig CJ, 2011, SOC SCI MED, V72, P1105, DOI 10.1016/j.socscimed.2011.02.010; Kohut MR, 2020, FAM PRACT, V37, P276, DOI 10.1093/fampra/cmz066; Legare F, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-144; Legare F, 2012, CAN MED ASSOC J, V184, pE726, DOI 10.1503/cmaj.120568; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lindenmeyer A, 2016, BRIT J GEN PRACT, V66, pE802, DOI 10.3399/bjgp16X686809; Llor C, 2014, ATEN PRIM, V46, P492, DOI 10.1016/j.aprim.2014.02.006; Lopez-Valcarcel BG, 2017, APPL HEALTH ECON HEA, V15, P13, DOI 10.1007/s40258-016-0263-0; Lum EPM, 2018, INFECT DIS HEALTH, V23, P74, DOI 10.1016/j.idh.2017.12.002; Lupton D., 2012, MED CULTURE ILLNESS, DOI DOI 10.4135/9781446254530; McCullough AR, 2016, J ANTIMICROB CHEMOTH, V71, P27, DOI 10.1093/jac/dkv310; McCullough AR, 2015, J ANTIMICROB CHEMOTH, V70, P2465, DOI 10.1093/jac/dkv164; McDermott L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016903; McNulty CAM, 2013, BRIT J GEN PRACT, V63, pE429, DOI 10.3399/bjgp13X669149; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Mortazhejri S, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-01196-9; Nair M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219002; Nettleton S., 2013, SOCIOLOGY HLTH ILLNE; Nimmon L, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0634-0; O'Doherty J, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-0917-8; ONeill J., 2014, REV ANTIMICROB RESIS; Patel A, 2020, J GEN INTERN MED, V35, P1182, DOI 10.1007/s11606-019-05433-5; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Pollock K., 2005, CONCORDANCE MED CONS; Pound P, 2005, SOC SCI MED, V61, P133, DOI 10.1016/j.socscimed.2004.11.063; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a949; Ryves R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011882; Saliba-Gustafsson EA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225506; Sargent L, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0589-1; Saukko PM, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0587-2; Servia-Dopazo M, 2018, J ANTIMICROB CHEMOTH, V73, P3244, DOI 10.1093/jac/dky319; Skold MB, 2017, EUR J GEN PRACT, V23, P120, DOI 10.1080/13814788.2017.1305105; Smith SM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub4; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; Stevenson FA, 2004, HEALTH EXPECT, V7, P235, DOI 10.1111/j.1369-7625.2004.00281.x; Stewart M., 2014, PATIENT CTR MED TRAN; Strandberg EL, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0494-z; Strumann C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233345; Tillekeratne LG, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0619-z; Tonkin-Crine Sarah Kg, 2017, Cochrane Database Syst Rev, V9, pCD012252, DOI 10.1002/14651858.CD012252.pub2; United Nations, 2015, TRANSF OUR WORLD 203, DOI DOI 10.1163/157180910X12665776638740; Valls-Llobet C, 2009, MUJERES SALUD PODER; van der Velden AW, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659268; van der Zande MM, 2019, BMC FAM PRACT, V20, DOI 10.1186/s12875-019-1065-x; van Esch TEM, 2018, J ANTIMICROB CHEMOTH, V73, P3199, DOI 10.1093/jac/dky321; WHO, 2015, GLOB ACT PLAN ANT RE; Yantzi R, 2019, GLOB PUBLIC HEALTH, V14, P750, DOI 10.1080/17441692.2018.1542017; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302; Yardley L, 2017, J POSIT PSYCHOL, V12, P295, DOI 10.1080/17439760.2016.1262624; Yates TD, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0788-4; Yin J, 2019, T ROY SOC TROP MED H, V113, P714, DOI 10.1093/trstmh/trz058; Zanichelli V, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.04.030	96	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2020	15	12							e0244432	10.1371/journal.pone.0244432	http://dx.doi.org/10.1371/journal.pone.0244432			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PI8CZ	33338078	Green Published, gold			2022-12-27	WOS:000601313500032
J	Monteiro, AC; Suri, R; Emeruwa, IO; Stretch, RJ; Cortes-Lopez, RY; Sherman, A; Lindsay, CC; Fulcher, JA; Goodman-Meza, D; Sapru, A; Buhr, RG; Chang, SY; Wang, TS; Qadir, N				Monteiro, Ana C.; Suri, Rajat; Emeruwa, Iheanacho O.; Stretch, Robert J.; Cortes-Lopez, Roxana Y.; Sherman, Alexander; Lindsay, Catherine C.; Fulcher, Jennifer A.; Goodman-Meza, David; Sapru, Anil; Buhr, Russell G.; Chang, Steven Y.; Wang, Tisha; Qadir, Nida			Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study	PLOS ONE			English	Article							SEVERE ARDS; CARE; PATTERNS	Purpose To describe the trajectory of respiratory failure in COVID-19 and explore factors associated with risk of invasive mechanical ventilation (IMV). Materials and methods A retrospective, observational cohort study of 112 inpatient adults diagnosed with COVID-19 between March 12 and April 16, 2020. Data were manually extracted from electronic medical records. Multivariable and Univariable regression were used to evaluate association between baseline characteristics, initial serum markers and the outcome of IMV. Results Our cohort had median age of 61 (IQR 45-74) and was 66% male. In-hospital mortality was 6% (7/112). ICU mortality was 12.8% (6/47), and 18% (5/28) for those requiring IMV. Obesity (OR 5.82, CI 1.74-19.48), former (OR 8.06, CI 1.51-43.06) and current smoking status (OR 10.33, CI 1.43-74.67) were associated with IMV after adjusting for age, sex, and high prevalence comorbidities by multivariable analysis. Initial absolute lymphocyte count (OR 0.33, CI 0.11-0.96), procalcitonin (OR 1.27, CI 1.02-1.57), IL-6 (OR 1.17, CI 1.03-1.33), ferritin (OR 1.05, CI 1.005-1.11), LDH (OR 1.57, 95% CI 1.13-2.17) and CRP (OR 1.13, CI 1.06-1.21), were associated with IMV by univariate analysis. Conclusions Obesity, smoking history, and elevated inflammatory markers were associated with increased need for IMV in patients with COVID-19.	[Monteiro, Ana C.; Suri, Rajat; Emeruwa, Iheanacho O.; Stretch, Robert J.; Cortes-Lopez, Roxana Y.; Sherman, Alexander; Buhr, Russell G.; Chang, Steven Y.; Wang, Tisha; Qadir, Nida] UCLA, Med Ctr, Dept Med, Div Pulm & Crit Care, Los Angeles, CA 90024 USA; [Lindsay, Catherine C.] UCLA, Med Ctr, Dept Med, Los Angeles, CA 90024 USA; [Fulcher, Jennifer A.; Goodman-Meza, David] UCLA, Med Ctr, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA; [Sapru, Anil] UCLA, Med Ctr, Dept Pediat, Div Crit Care, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Monteiro, AC (corresponding author), UCLA, Med Ctr, Dept Med, Div Pulm & Crit Care, Los Angeles, CA 90024 USA.	acostamonteiro@mednet.ucla.edu	Fulcher, Jennifer A./AAG-1495-2020	Fulcher, Jennifer A./0000-0001-9895-8636; Buhr, Russell/0000-0001-6159-7435; Sherman, Alexander/0000-0002-5622-2804; Costa Monteiro, Ana Carolina/0000-0002-1501-4435; Goodman, David/0000-0001-9382-3564; sapru, anil/0000-0003-1528-8249; Emeruwa, Iheanacho/0000-0002-1424-6437; Stretch, Robert/0000-0002-0514-5925	National Institutes of Health (NIH) [T32 5T32HL072752-1]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ACM is funded by the National Institutes of Health (NIH) training grant T32 5T32HL072752-1 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboodi MS., 2019, A15 CRITICAL CARE BR, pcited, DOI DOI 10.1164/AJRCCM-C0NFERENCE.2019.199.1_MEETINGABSTRACTS.A1013; Alqahtani JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233147; [Anonymous], 2012, JAMA-J AM MED ASSOC, DOI 10.1001/jama.2012.5669; [Anonymous], 2020, CHEMCATCHEM, V12, pXXX; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Brake SJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030841; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carsana L, 2020, LANCET INFECT DIS, V20, P1135, DOI 10.1016/S1473-3099(20)30434-5; Chen T, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m1091, 10.1136/bmj.m1295]; de Lusignan S, 2020, LANCET INFECT DIS, V20, P1034, DOI 10.1016/S1473-3099(20)30371-6; Dietz W, 2020, OBESITY, V28, P1005, DOI 10.1002/oby.22818; Diretrizes [Internet], DIR; Duggal A, 2020, CHEST, V157, P1497, DOI 10.1016/j.chest.2020.01.041; Fan E, 2017, AM J RESP CRIT CARE, V195, P1253, DOI 10.1164/rccm.201703-0548ST; Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; GREENE R, 1981, AM REV RESPIR DIS, V124, P593; GREENE R, 1987, AM J ROENTGENOL, V148, P501, DOI 10.2214/ajr.148.3.501; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Leung JM, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00688-2020; Lippi G, 2020, EUR J INTERN MED, V75, P107, DOI 10.1016/j.ejim.2020.03.014; Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775; Luks AM, 2020, ANN AM THORAC SOC, V17, P918, DOI [10.1513/AnnalsATS.202004-327CME, 10.1513/AnnalsATS.202004-327FR]; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Nahum J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10478; Neil-Sztramko S, 2020, J MED INTERNET RES, V22, DOI 10.2196/15125; Ryan DH, 2020, OBESITY, V28, P847, DOI 10.1002/oby.22808; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Vardavas CI, 2020, TOB INDUC DIS, V18, DOI 10.18332/tid/119324; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE	35	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2020	15	12							e0238552	10.1371/journal.pone.0238552	http://dx.doi.org/10.1371/journal.pone.0238552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PL4CG	33351817	Green Published, gold, Green Submitted			2022-12-27	WOS:000603071400016
